Identification	NN	O
of	IN	O
APC2	NNP	O
,	,	O
a	DT	O
homologue	NN	O
of	IN	O
the	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	VB	I_Disease
tumour	NN	E_Disease
suppressor	NN	O
.	.	O

The	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	I_Disease
(	(	I_Disease
APC	NNP	I_Disease
)	)	I_Disease
tumour	VBP	E_Disease
-	:	O
suppressor	NN	O
protein	NN	O
controls	VBZ	O
the	DT	O
Wnt	NNP	O
signalling	VBG	O
pathway	RB	O
by	IN	O
forming	VBG	O
a	DT	O
complex	JJ	O
with	IN	O
glycogen	NN	O
synthase	NN	O
kinase	NN	O
3beta	CD	O
(	(	O
GSK	NNP	O
-	:	O
3beta	CD	O
)	)	O
,	,	O
axin	JJ	O
/	NNP	O
conductin	NN	O
and	CC	O
betacatenin	NN	O
.	.	O

Complex	JJ	O
formation	NN	O
induces	VBZ	O
the	DT	O
rapid	JJ	O
degradation	NN	O
of	IN	O
betacatenin	NN	O
.	.	O

In	IN	O
colon	NN	B_Disease
carcinoma	NN	E_Disease
cells	NNS	O
,	,	O
loss	NN	O
of	IN	O
APC	NNP	O
leads	VBZ	O
to	TO	O
the	DT	O
accumulation	NN	O
of	IN	O
betacatenin	NN	O
in	IN	O
the	DT	O
nucleus	NN	O
,	,	O
where	WRB	O
it	PRP	O
binds	VBZ	O
to	TO	O
and	CC	O
activates	VBZ	O
the	DT	O
Tcf	NNP	O
-	:	O
4	CD	O
transcription	NN	O
factor	NN	O
(	(	O
reviewed	VBN	O
in	IN	O
[	JJ	O
1	CD	O
]	JJ	O
[	$	O
2	CD	O
]	NN	O
)	)	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
identification	NN	O
and	CC	O
genomic	JJ	O
structure	NN	O
of	IN	O
APC	NNP	O
homologues	NNS	O
.	.	O

Mammalian	JJ	O
APC2	NNP	O
,	,	O
which	WDT	O
closely	RB	O
resembles	VBZ	O
APC	NNP	O
in	IN	O
overall	JJ	O
domain	NN	O
structure	NN	O
,	,	O
was	VBD	O
functionally	RB	O
analyzed	VBN	O
and	CC	O
shown	VBN	O
to	TO	O
contain	VB	O
two	CD	O
SAMP	NNP	O
domains	NNS	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
are	VBP	O
required	VBN	O
for	IN	O
binding	VBG	O
to	TO	O
conductin	VB	O
.	.	O

Like	IN	O
APC	NNP	O
,	,	O
APC2	NNP	O
regulates	VBZ	O
the	DT	O
formation	NN	O
of	IN	O
active	JJ	O
betacatenin	NN	O
-	:	O
Tcf	NN	O
complexes	NNS	O
,	,	O
as	IN	O
demonstrated	VBN	O
using	VBG	O
transient	JJ	O
transcriptional	JJ	O
activation	NN	O
assays	NNS	O
in	IN	O
APC	NNP	O
-	:	O
/	SYM	O
-	:	O
colon	NN	B_Disease
carcinoma	NN	E_Disease
cells	NNS	O
.	.	O

Human	NNP	O
APC2	NNP	O
maps	NNS	O
to	TO	O
chromosome	VB	O
19p13	CD	O
.	.	O

3	CD	O
.	.	O

APC	NNP	O
and	CC	O
APC2	NNP	O
may	MD	O
therefore	RB	O
have	VB	O
comparable	JJ	O
functions	NNS	O
in	IN	O
development	NN	O
and	CC	O
cancer	NN	S_Disease
.	.	O

A	DT	O
common	JJ	O
MSH2	NNP	O
mutation	NN	O
in	IN	O
English	NNP	O
and	CC	O
North	JJ	O
American	JJ	O
HNPCC	NNP	S_Disease
families	NNS	O
:	:	O
origin	NN	O
,	,	O
phenotypic	NN	O
expression	NN	O
,	,	O
and	CC	O
sex	NN	O
specific	JJ	O
differences	NNS	O
in	IN	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

The	DT	O
frequency	NN	O
,	,	O
origin	NN	O
,	,	O
and	CC	O
phenotypic	JJ	O
expression	NN	O
of	IN	O
a	DT	O
germline	NN	O
MSH2	NNP	O
gene	NN	O
mutation	NN	O
previously	RB	O
identified	VBN	O
in	IN	O
seven	CD	O
kindreds	NNS	O
with	IN	O
hereditary	JJ	B_Disease
non	SYM	I_Disease
-	:	I_Disease
polyposis	NN	I_Disease
cancer	NN	I_Disease
syndrome	NN	E_Disease
(	(	O
HNPCC	NNP	S_Disease
)	)	O
was	VBD	O
investigated	VBN	O
.	.	O

The	DT	O
mutation	NN	O
(	(	O
A	DT	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
at	IN	O
nt943	JJ	O
+	NNP	O
3	CD	O
)	)	O
disrupts	VBZ	O
the	DT	O
3	CD	O
splice	NN	O
site	NN	O
of	IN	O
exon	$	O
5	CD	O
leading	VBG	O
to	TO	O
the	DT	O
deletion	NN	O
of	IN	O
this	DT	O
exon	NN	O
from	IN	O
MSH2	NNP	O
mRNA	NN	O
and	CC	O
represents	VBZ	O
the	DT	O
only	JJ	O
frequent	JJ	O
MSH2	NNP	O
mutation	NN	O
so	RB	O
far	RB	O
reported	VBN	O
.	.	O

Although	IN	O
this	DT	O
mutation	NN	O
was	VBD	O
initially	RB	O
detected	VBN	O
in	IN	O
four	CD	O
of	IN	O
33	CD	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
families	NNS	O
analysed	VBN	O
from	IN	O
eastern	JJ	O
England	NNP	O
,	,	O
more	RBR	O
extensive	JJ	O
analysis	NN	O
has	VBZ	O
reduced	VBN	O
the	DT	O
frequency	NN	O
to	TO	O
four	CD	O
of	IN	O
52	CD	O
(	(	O
8	CD	O
%	NN	O
)	)	O
English	NNP	O
HNPCC	NNP	S_Disease
kindreds	NNS	O
analysed	VBD	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
the	DT	O
MSH2	NNP	O
mutation	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
10	CD	O
of	IN	O
20	CD	O
(	(	O
50	CD	O
%	NN	O
)	)	O
separately	RB	O
identified	VBN	O
colorectal	JJ	S_Disease
families	NNS	O
from	IN	O
Newfoundland	NNP	O
.	.	O

To	TO	O
investigate	VB	O
the	DT	O
origin	NN	O
of	IN	O
this	DT	O
mutation	NN	O
in	IN	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
families	NNS	O
from	IN	O
England	NNP	O
(	(	O
n	JJ	O
=	NNP	O
4	CD	O
)	)	O
,	,	O
Newfoundland	NNP	O
(	(	O
n	JJ	O
=	NNP	O
10	CD	O
)	)	O
,	,	O
and	CC	O
the	DT	O
United	NNP	O
States	NNPS	O
(	(	O
n	JJ	O
=	NNP	O
3	CD	O
)	)	O
,	,	O
haplotype	JJ	O
analysis	NN	O
using	VBG	O
microsatellite	JJ	O
markers	NNS	O
linked	VBN	O
to	TO	O
MSH2	NNP	O
was	VBD	O
performed	VBN	O
.	.	O

Within	IN	O
the	DT	O
English	NNP	O
and	CC	O
US	NNP	O
families	NNS	O
there	EX	O
was	VBD	O
little	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
recent	JJ	O
common	JJ	O
origin	NN	O
of	IN	O
the	DT	O
MSH2	NNP	O
splice	NN	O
site	NN	O
mutation	NN	O
in	IN	O
most	JJS	O
families	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
a	DT	O
common	JJ	O
haplotype	NN	O
was	VBD	O
identified	VBN	O
at	IN	O
the	DT	O
two	CD	O
flanking	NN	O
markers	NNS	O
(	(	O
CA5	NNP	O
and	CC	O
D2S288	NNP	O
)	)	O
in	IN	O
eight	CD	O
of	IN	O
the	DT	O
Newfoundland	NNP	O
families	NNS	O
.	.	O

These	DT	O
findings	NNS	O
suggested	VBD	O
a	DT	O
founder	NN	O
effect	NN	O
within	IN	O
Newfoundland	NNP	O
similar	JJ	O
to	TO	O
that	DT	O
reported	VBN	O
by	IN	O
others	NNS	O
for	IN	O
two	CD	O
MLH1	NNP	O
mutations	NNS	O
in	IN	O
Finnish	JJ	O
HNPCC	NNP	S_Disease
families	NNS	O
.	.	O

We	PRP	O
calculated	VBD	O
age	NN	O
related	JJ	O
risks	NNS	O
of	IN	O
all	DT	O
,	,	O
colorectal	NN	B_Disease
,	,	I_Disease
endometrial	JJ	I_Disease
,	,	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
in	IN	O
nt943	JJ	O
+	$	O
3	CD	O
A	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
MSH2	NNP	O
mutation	NN	O
carriers	NNS	O
(	(	O
n	JJ	O
=	NNP	O
76	CD	O
)	)	O
for	IN	O
all	DT	O
patients	NNS	O
and	CC	O
for	IN	O
men	NNS	O
and	CC	O
women	NNS	O
separately	RB	O
.	.	O

For	IN	O
both	DT	O
sexes	NNS	O
combined	VBN	O
,	,	O
the	DT	O
penetrances	NNS	O
at	IN	O
age	NN	O
60	CD	O
years	NNS	O
for	IN	O
all	DT	O
cancers	NNS	S_Disease
and	CC	O
for	IN	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
were	VBD	O
0	CD	O
.	.	O

86	CD	O
and	CC	O
0	CD	O
.	.	O

57	CD	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
risk	NN	O
of	IN	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
was	VBD	O
significantly	RB	O
higher	JJR	O
(	(	O
p	JJ	O
<	NN	O
0	CD	O
.	.	O

01	CD	O
)	)	O
in	IN	O
males	NNS	O
than	IN	O
females	NNS	O
(	(	O
0	CD	O
.	.	O

63	CD	O
v	JJ	O
0	CD	O
.	.	O

30	CD	O
and	CC	O
0	CD	O
.	.	O

84	CD	O
v	JJ	O
0	CD	O
.	.	O

44	CD	O
at	IN	O
ages	NNS	O
50	CD	O
and	CC	O
60	CD	O
years	NNS	O
,	,	O
respectively	RB	O
)	)	O
.	.	O

For	IN	O
females	NNS	O
there	EX	O
was	VBD	O
a	DT	O
high	JJ	O
risk	NN	O
of	IN	O
endometrial	JJ	B_Disease
cancer	NN	E_Disease
(	(	O
0	CD	O
.	.	O

5	CD	O
at	IN	O
age	NN	O
60	CD	O
years	NNS	O
)	)	O
and	CC	O
premenopausal	JJ	B_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
(	(	O
0	CD	O
.	.	O

2	CD	O
at	IN	O
50	CD	O
years	NNS	O
)	)	O
.	.	O

These	DT	O
intersex	NN	O
differences	NNS	O
in	IN	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
risks	NNS	O
have	VBP	O
implications	NNS	O
for	IN	O
screening	VBG	O
programmes	NNS	O
and	CC	O
for	IN	O
attempts	NNS	O
to	TO	O
identify	VB	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
susceptibility	NN	O
modifiers	NNS	O
.	.	O

Age	NNP	O
of	IN	O
onset	NN	O
in	IN	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
:	:	O
sex	NN	O
specific	JJ	O
influence	NN	O
of	IN	O
apolipoprotein	NN	O
E	NNP	O
genotype	NN	O
and	CC	O
normal	JJ	O
CAG	NNP	O
repeat	NN	O
length	NN	O
.	.	O

Age	NNP	O
of	IN	O
onset	NN	O
(	(	O
AO	NNP	O
)	)	O
of	IN	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
correlated	VBN	O
with	IN	O
the	DT	O
length	NN	O
of	IN	O
an	DT	O
expanded	VBN	O
CAG	NNP	O
repeat	NN	O
in	IN	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
.	.	O

Apolipoprotein	NNP	O
E	NNP	O
(	(	O
APOE	NNP	O
)	)	O
genotype	NN	O
,	,	O
in	IN	O
turn	NN	O
,	,	O
is	VBZ	O
known	VBN	O
to	TO	O
influence	VB	O
AO	NNP	O
in	IN	O
Alzheimer	NNP	B_Disease
disease	NN	E_Disease
,	,	O
rendering	VBG	O
the	DT	O
APOE	NNP	O
gene	NN	O
a	DT	O
likely	JJ	O
candidate	NN	O
to	TO	O
affect	VB	O
AO	NNP	O
in	IN	O
other	JJ	O
neurological	JJ	B_Disease
diseases	NNS	E_Disease
too	RB	O
.	.	O

We	PRP	O
therefore	VBP	O
determined	JJ	O
APOE	NNP	O
genotype	NN	O
and	CC	O
normal	JJ	O
CAG	NNP	O
repeat	NN	O
length	NN	O
in	IN	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
for	IN	O
138	CD	O
HD	NNP	S_Disease
patients	NNS	O
who	WP	O
were	VBD	O
previously	RB	O
analysed	VBN	O
with	IN	O
respect	NN	O
to	TO	O
CAG	NNP	O
repeat	NN	O
length	NN	O
.	.	O

Genotyping	VBG	O
for	IN	O
APOE	NNP	O
was	VBD	O
performed	VBN	O
blind	IN	O
to	TO	O
clinical	JJ	O
information	NN	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
highlighting	VBG	O
the	DT	O
effect	NN	O
of	IN	O
the	DT	O
normal	JJ	O
repeat	NN	O
length	NN	O
upon	IN	O
AO	NNP	O
in	IN	O
maternally	RB	O
inherited	VBN	O
HD	NNP	S_Disease
and	CC	O
in	IN	O
male	JJ	O
patients	NNS	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
the	DT	O
APOE	NNP	O
epsilon2epsilon3	NN	O
genotype	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
significantly	RB	O
earlier	JJR	O
AO	NNP	O
in	IN	O
males	NNS	O
than	IN	O
in	IN	O
females	NNS	O
.	.	O

Such	JJ	O
a	DT	O
sex	NN	O
difference	NN	O
in	IN	O
AO	NNP	O
was	VBD	O
not	RB	O
apparent	JJ	O
for	IN	O
any	DT	O
of	IN	O
the	DT	O
other	JJ	O
APOE	NNP	O
genotypes	NNS	O
.	.	O

Our	PRP$	O
findings	NNS	O
suggest	VBP	O
that	IN	O
subtle	JJ	O
differences	NNS	O
in	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
neurodegeneration	NN	S_Disease
in	IN	O
HD	NNP	S_Disease
may	MD	O
allow	VB	O
interacting	VBG	O
genes	NNS	O
to	TO	O
exert	VB	O
gender	NN	O
specific	JJ	O
effects	NNS	O
upon	IN	O
AO	NNP	O
.	.	O

Familial	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
seventh	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
associated	VBN	O
with	IN	O
recurrent	JJ	O
bacteremic	JJ	B_Disease
infections	NNS	I_Disease
due	JJ	I_Disease
to	TO	I_Disease
Neisseria	NNP	E_Disease
.	.	O

The	DT	O
serum	NN	O
of	IN	O
a	DT	O
29	CD	O
-	:	O
year	NN	O
old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
recent	JJ	O
episode	NN	O
of	IN	O
disseminated	JJ	B_Disease
gonococcal	JJ	I_Disease
infection	NN	E_Disease
and	CC	O
a	DT	O
history	NN	O
of	IN	O
meningococcal	JJ	B_Disease
meningitis	NN	E_Disease
and	CC	O
arthritis	NN	S_Disease
as	IN	O
a	DT	O
child	NN	O
was	VBD	O
found	VBN	O
to	TO	O
lack	VB	O
serum	JJ	O
hemolytic	JJ	O
complement	NN	O
activity	NN	O
.	.	O

The	DT	O
seventh	JJ	O
component	NN	O
of	IN	O
complement	NN	O
(	(	O
C7	NNP	O
)	)	O
was	VBD	O
not	RB	O
detected	VBN	O
by	IN	O
functional	JJ	O
or	CC	O
immunochemical	JJ	O
assays	NNS	O
,	,	O
whereas	IN	O
other	JJ	O
components	NNS	O
were	VBD	O
normal	JJ	O
by	IN	O
hemolytic	JJ	O
and	CC	O
immunochemical	JJ	O
assessment	NN	O
.	.	O

Her	PRP$	O
fresh	JJ	O
serum	NN	O
lacked	VBD	O
complement	JJ	O
-	:	O
mediated	VBN	O
bactericidal	JJ	O
activity	NN	O
against	IN	O
Neisseria	NNP	O
gonorrhoeae	NN	O
,	,	O
but	CC	O
the	DT	O
addition	NN	O
of	IN	O
fresh	JJ	O
normal	JJ	O
serum	NN	O
or	CC	O
purified	VBN	O
C7	NNP	O
restored	VBD	O
bactericidal	JJ	O
activity	NN	O
as	RB	O
well	RB	O
as	IN	O
hemolytic	JJ	O
activity	NN	O
.	.	O

The	DT	O
absence	NN	B_Disease
of	IN	I_Disease
functional	JJ	I_Disease
C7	NNP	E_Disease
activity	NN	O
could	MD	O
not	RB	O
be	VB	O
accounted	VBN	O
for	IN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
an	DT	O
inhibitor	NN	O
.	.	O

Opsonization	NN	O
and	CC	O
generation	NN	O
of	IN	O
chemotactic	JJ	O
activity	NN	O
functioned	VBD	O
normally	RB	O
.	.	O

Complete	JJ	B_Disease
absence	NN	I_Disease
of	IN	I_Disease
C7	NNP	E_Disease
was	VBD	O
also	RB	O
found	VBN	O
in	IN	O
one	CD	O
sibling	NN	O
who	WP	O
had	VBD	O
the	DT	O
clinical	JJ	O
syndrome	NN	O
of	IN	O
meningococcal	JJ	B_Disease
meningitis	NN	E_Disease
and	CC	O
arthritis	NN	S_Disease
as	IN	O
a	DT	O
child	NN	O
and	CC	O
in	IN	O
this	DT	O
siblings	NNS	O
clinically	RB	O
well	RB	O
eight	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
son	NN	O
.	.	O

HLA	NNP	O
histocompatibility	NN	O
typing	NN	O
of	IN	O
the	DT	O
family	NN	O
members	NNS	O
did	VBD	O
not	RB	O
demonstrate	VB	O
evidence	NN	O
for	IN	O
genetic	JJ	O
linkage	NN	O
of	IN	O
C7	NNP	B_Disease
deficiency	NN	E_Disease
with	IN	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
loci	NN	O
.	.	O

This	DT	O
report	NN	O
represents	VBZ	O
the	DT	O
first	JJ	O
cases	NNS	O
of	IN	O
C7	NNP	B_Disease
deficiency	NN	E_Disease
associated	VBN	O
with	IN	O
infectious	JJ	O
complications	NNS	O
and	CC	O
suggests	VBZ	O
that	DT	O
bactericidal	JJ	O
activity	NN	O
may	MD	O
be	VB	O
important	JJ	O
in	IN	O
host	NN	O
defense	NN	O
against	IN	O
bacteremic	JJ	B_Disease
neisseria	JJ	I_Disease
infections	NNS	E_Disease
.	.	O

Increased	VBN	O
incidence	NN	O
of	IN	O
cancer	NN	S_Disease
in	IN	O
patients	NNS	O
with	IN	O
cartilage	NN	B_Disease
-	:	I_Disease
hair	NN	I_Disease
hypoplasia	NN	E_Disease
.	.	O

OBJECTIVE	NNP	O
Previous	NNP	O
reports	NNS	O
have	VBP	O
suggested	VBN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
cancer	NN	S_Disease
among	IN	O
patients	NNS	O
with	IN	O
cartilage	NN	B_Disease
-	:	I_Disease
hair	NN	I_Disease
hypoplasia	NN	E_Disease
(	(	O
CHH	NNP	S_Disease
)	)	O
.	.	O

This	DT	O
study	NN	O
was	VBD	O
carried	VBN	O
out	IN	O
to	TO	O
further	JJ	O
evaluate	VB	O
this	DT	O
risk	NN	O
among	IN	O
patients	NNS	O
with	IN	O
CHH	NNP	S_Disease
and	CC	O
their	PRP$	O
first	JJ	O
-	:	O
degree	NN	O
relatives	NNS	O
.	.	O

STUDY	NNP	O
DESIGN	NNP	O
One	CD	O
hundred	VBD	O
twenty	SYM	O
-	:	O
two	CD	O
patients	NNS	O
with	IN	O
CHH	NNP	S_Disease
were	VBD	O
identified	VBN	O
through	IN	O
2	CD	O
countrywide	JJ	O
epidemiologic	JJ	O
surveys	NNS	O
in	IN	O
1974	CD	O
and	CC	O
in	IN	O
1986	CD	O
.	.	O

Their	PRP$	O
parents	NNS	O
and	CC	O
nonaffected	JJ	O
siblings	NNS	O
were	VBD	O
identified	VBN	O
through	IN	O
the	DT	O
Population	NNP	O
Register	NNP	O
Center	NNP	O
.	.	O

This	DT	O
cohort	NN	O
underwent	NN	O
follow	SYM	O
-	:	O
up	RB	O
for	IN	O
cancer	NN	S_Disease
incidence	NN	O
through	IN	O
the	DT	O
Finnish	JJ	O
Cancer	NNP	O
Registry	NNP	O
to	TO	O
the	DT	O
end	NN	O
of	IN	O
1995	CD	O
.	.	O

RESULTS	VB	O
A	NNP	O
statistically	RB	O
significant	JJ	O
excess	JJ	O
risk	NN	O
of	IN	O
cancer	NN	S_Disease
was	VBD	O
seen	VBN	O
among	IN	O
the	DT	O
patients	NNS	O
with	IN	O
CHH	NNP	S_Disease
(	(	O
standardized	VBN	O
incidence	NN	O
ratio	NN	O
6	CD	O
.	.	O

9	CD	O
,	,	O
95	CD	O
%	NN	O
confidence	NN	O
interval	JJ	O
2	CD	O
.	.	O

3	CD	O
to	TO	O
16	CD	O
)	)	O
,	,	O
which	WDT	O
was	VBD	O
mainly	RB	O
attributable	JJ	O
to	TO	O
non	VB	B_Disease
-	:	I_Disease
Hodgkins	VBZ	I_Disease
lymphoma	NN	E_Disease
(	(	O
standardized	JJ	O
incidence	NN	O
ratio	NN	O
90	CD	O
,	,	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
18	CD	O
to	TO	O
264	CD	O
)	)	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
a	DT	O
significant	JJ	O
excess	JJ	O
risk	NN	O
of	IN	O
basal	NN	B_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
was	VBD	O
seen	VBN	O
(	(	O
standardized	JJ	O
incidence	NN	O
ratio	NN	O
35	CD	O
,	,	O
95	CD	O
%	NN	O
confidence	NN	O
interval	JJ	O
7	CD	O
.	.	O

2	CD	O
to	TO	O
102	CD	O
)	)	O
.	.	O

The	DT	O
cancer	NN	S_Disease
incidence	NN	O
among	IN	O
the	DT	O
siblings	NNS	O
or	CC	O
the	DT	O
parents	NNS	O
did	VBD	O
not	RB	O
differ	VB	O
from	IN	O
the	DT	O
average	JJ	O
cancer	NN	S_Disease
incidence	NN	O
in	IN	O
the	DT	O
Finnish	JJ	O
population	NN	O
.	.	O

CONCLUSIONS	NNP	O
This	DT	O
study	NN	O
confirms	VBZ	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
cancer	NN	S_Disease
,	,	O
especially	RB	O
non	JJ	B_Disease
-	:	I_Disease
Hodgkins	VBZ	I_Disease
lymphoma	NN	E_Disease
,	,	O
probably	RB	O
attributable	JJ	O
to	TO	O
defective	JJ	O
immunity	NN	O
,	,	O
among	IN	O
patients	NNS	O
with	IN	O
CHH	NNP	S_Disease
.	.	O

Genotype	NNP	O
and	CC	O
phenotype	NN	O
in	IN	O
patients	NNS	O
with	IN	O
dihydropyrimidine	JJ	B_Disease
dehydrogenase	NN	I_Disease
deficiency	NN	E_Disease
.	.	O

Dihydropyrimidine	NNP	B_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
DPD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disease	NN	E_Disease
characterised	VBN	O
by	IN	O
thymine	JJ	O
-	:	O
uraciluria	NN	O
in	IN	O
homozygous	JJ	O
deficient	NN	O
patients	NNS	O
and	CC	O
has	VBZ	O
been	VBN	O
associated	VBN	O
with	IN	O
a	DT	O
variable	JJ	O
clinical	JJ	O
phenotype	NN	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
understand	VB	O
the	DT	O
genetic	JJ	O
and	CC	O
phenotypic	JJ	O
basis	NN	O
for	IN	O
DPD	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
we	PRP	O
have	VBP	O
reviewed	VBN	O
17	CD	O
families	NNS	O
presenting	VBG	O
22	CD	O
patients	NNS	O
with	IN	O
complete	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
DPD	NNP	E_Disease
.	.	O

In	IN	O
this	DT	O
group	NN	O
of	IN	O
patients	NNS	O
,	,	O
7	CD	O
different	JJ	O
mutations	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
,	,	O
including	VBG	O
2	CD	O
deletions	NNS	O
[	VBP	O
295	CD	O
-	:	O
298delTCAT	CD	O
,	,	O
1897delC	CD	O
]	NN	O
,	,	O
1	CD	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
[	NNP	O
IVS14	NNP	O
+	VBD	O
1G	CD	O
>	IN	O
A	NNP	O
)	)	O
]	NN	O
and	CC	O
4	CD	O
missense	NN	O
mutations	NNS	O
(	(	O
85T	CD	O
>	NNP	O
C	NNP	O
,	,	O
703C	CD	O
>	NN	O
T	NNP	O
,	,	O
2658G	CD	O
>	NN	O
A	NNP	O
,	,	O
2983G	CD	O
>	NNP	O
T	NNP	O
)	)	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
prevalence	NN	O
of	IN	O
the	DT	O
various	JJ	O
mutations	NNS	O
among	IN	O
DPD	NNP	S_Disease
patients	NNS	O
has	VBZ	O
shown	VBN	O
that	IN	O
the	DT	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
point	NN	O
mutation	NN	O
in	IN	O
the	DT	O
invariant	JJ	O
splice	NN	O
donor	NN	O
site	NN	O
is	VBZ	O
by	IN	O
far	RB	O
the	DT	O
most	RBS	O
common	JJ	O
(	(	O
52	CD	O
%	NN	O
)	)	O
,	,	O
whereas	VBP	O
the	DT	O
other	JJ	O
six	CD	O
mutations	NNS	O
are	VBP	O
less	RBR	O
frequently	RB	O
observed	VBN	O
.	.	O

A	DT	O
large	JJ	O
phenotypic	NN	O
variability	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
,	,	O
with	IN	O
convulsive	JJ	B_Disease
disorders	NNS	E_Disease
,	,	O
motor	NN	B_Disease
retardation	NN	E_Disease
and	CC	O
mental	JJ	B_Disease
retardation	NN	E_Disease
being	VBG	O
the	DT	O
most	RBS	O
abundant	JJ	O
manifestations	NNS	O
.	.	O

A	DT	O
clear	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
genotype	NN	O
and	CC	O
phenotype	NN	O
has	VBZ	O
not	RB	O
been	VBN	O
established	VBN	O
.	.	O

An	DT	O
altered	JJ	O
beta	NN	O
-	:	O
alanine	NN	O
,	,	O
uracil	NN	O
and	CC	O
thymine	JJ	O
homeostasis	NN	O
might	MD	O
underlie	VB	O
the	DT	O
various	JJ	O
clinical	JJ	B_Disease
abnormalities	NNS	E_Disease
encountered	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
DPD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Fibroblast	NNP	O
growth	NN	O
factor	NN	O
homologous	JJ	O
factor	NN	O
2	CD	O
(	(	O
FHF2	NNP	O
)	)	O
:	:	O
gene	NN	O
structure	NN	O
,	,	O
expression	NN	O
and	CC	O
mapping	NN	O
to	TO	O
the	DT	O
Borjeson	NNP	B_Disease
-	:	I_Disease
Forssman	NNP	I_Disease
-	:	I_Disease
Lehmann	NNP	I_Disease
syndrome	JJ	E_Disease
region	NN	O
in	IN	O
Xq26	NNP	O
delineated	VBN	O
by	IN	O
a	DT	O
duplication	NN	O
breakpoint	NN	O
in	IN	O
a	DT	O
BFLS	NNP	S_Disease
-	:	O
like	IN	O
patient	NN	O
.	.	O

Borjeson	NNP	B_Disease
-	:	I_Disease
Forssman	NNP	I_Disease
-	:	I_Disease
Lehmann	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
BFLS	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
syndromal	JJ	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
mental	JJ	I_Disease
retardation	NN	E_Disease
,	,	O
which	WDT	O
maps	VBZ	O
by	IN	O
linkage	NN	O
to	TO	O
the	DT	O
q26	JJ	O
region	NN	O
of	IN	O
the	DT	O
human	JJ	O
X	NNP	O
chromosome	NN	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
male	JJ	O
patient	NN	O
with	IN	O
BFLS	NNP	S_Disease
-	:	O
like	IN	O
features	NNS	O
and	CC	O
a	DT	O
duplication	NN	O
,	,	O
46	CD	O
,	,	O
Y	NNP	O
,	,	O
dup	NN	O
(	(	O
X	NNP	O
)	)	O
(	(	O
q26q28	NN	O
)	)	O
,	,	O
inherited	VBN	O
from	IN	O
his	PRP$	O
phenotypically	RB	O
normal	JJ	O
mother	NN	O
.	.	O

Fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridisation	NN	O
using	VBG	O
yeast	JJ	O
artificial	JJ	O
chromosome	NN	O
clones	NNS	O
from	IN	O
Xq26	NNP	O
localised	VBD	O
the	DT	O
duplication	NN	O
breakpoint	NN	O
to	TO	O
an	DT	O
approximately	RB	O
400	CD	O
-	:	O
kb	NN	O
interval	NN	O
in	IN	O
the	DT	O
Xq26	NN	O
.	.	O

3	CD	O
region	NN	O
between	IN	O
DXS155	NNP	O
and	CC	O
DXS294	NNP	O
/	NNP	O
DXS730	NNP	O
.	.	O

Database	NNP	O
searches	NNS	O
and	CC	O
analysis	NN	O
of	IN	O
available	JJ	O
genomic	JJ	O
DNA	NNP	O
sequence	NN	O
from	IN	O
the	DT	O
region	NN	O
revealed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
fibroblast	JJ	O
growth	NN	O
factor	NN	O
homologous	JJ	O
factor	NN	O
gene	NN	O
,	,	O
FHF2	NNP	O
,	,	O
within	IN	O
the	DT	O
duplication	NN	O
breakpoint	NN	O
interval	NN	O
.	.	O

The	DT	O
gene	NN	O
structure	NN	O
of	IN	O
FHF2	NNP	O
was	VBD	O
determined	VBN	O
and	CC	O
two	CD	O
new	JJ	O
exons	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
including	VBG	O
a	DT	O
new	JJ	O
5	CD	O
end	NN	O
exon	NN	O
,	,	O
1B	CD	O
.	.	O

FHF2	NNP	O
is	VBZ	O
a	DT	O
large	JJ	O
gene	NN	O
extending	VBG	O
over	IN	O
approximately	RB	O
200	CD	O
kb	NNS	O
in	IN	O
Xq26	NNP	O
.	.	O

3	CD	O
and	CC	O
is	VBZ	O
composed	VBN	O
of	IN	O
at	IN	O
least	JJS	O
seven	CD	O
exons	NNS	O
.	.	O

It	PRP	O
shows	VBZ	O
tissue	NN	O
-	:	O
specific	JJ	O
alternative	JJ	O
splicing	NN	O
and	CC	O
alternative	JJ	O
transcription	NN	O
starts	NNS	O
.	.	O

Northern	NNP	O
blot	NN	O
hybridisation	NN	O
showed	VBD	O
highest	JJS	O
expression	NN	O
in	IN	O
brain	NN	O
and	CC	O
skeletal	JJ	O
muscle	NN	O
.	.	O

The	DT	O
FHF2	NNP	O
gene	NN	O
localisation	NN	O
and	CC	O
tissue	NN	O
-	:	O
specific	JJ	O
expression	NN	O
pattern	NN	O
suggest	VBP	O
it	PRP	O
to	TO	O
be	VB	O
a	DT	O
candidate	JJ	O
gene	NN	O
for	IN	O
familial	JJ	O
cases	NNS	O
of	IN	O
the	DT	O
BFLS	NNP	B_Disease
syndrome	NN	E_Disease
and	CC	O
other	JJ	O
syndromal	JJ	O
and	CC	O
non	JJ	O
-	:	O
specific	JJ	O
forms	NNS	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
mental	JJ	I_Disease
retardation	NN	E_Disease
mapping	NN	O
to	TO	O
the	DT	O
region	NN	O
.	.	O

Germline	NNP	O
E	NNP	O
-	:	O
cadherin	NN	O
gene	NN	O
(	(	O
CDH1	NNP	O
)	)	O
mutations	NNS	O
predispose	VBP	O
to	TO	O
familial	JJ	B_Disease
gastric	JJ	I_Disease
cancer	NN	E_Disease
and	CC	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Inherited	VBN	O
mutations	NNS	O
in	IN	O
the	DT	O
E	NNP	O
-	:	O
cadherin	NN	O
gene	NN	O
(	(	O
CDH1	NNP	O
)	)	O
were	VBD	O
described	VBN	O
recently	RB	O
in	IN	O
three	CD	O
Maori	NNP	O
kindreds	NNS	O
with	IN	O
familial	JJ	B_Disease
gastric	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

Familial	JJ	B_Disease
gastric	JJ	I_Disease
cancer	NN	E_Disease
is	VBZ	O
genetically	RB	O
heterogeneous	JJ	O
and	CC	O
it	PRP	O
is	VBZ	O
not	RB	O
clear	JJ	O
what	WP	O
proportion	NN	O
of	IN	O
gastric	JJ	B_Disease
cancer	NN	E_Disease
susceptibility	NN	O
in	IN	O
non	JJ	O
-	:	O
Maori	JJ	O
populations	NNS	O
is	VBZ	O
due	JJ	O
to	TO	O
germline	VB	O
CDH1	NNP	O
mutations	NNS	O
.	.	O

Therefore	RB	O
,	,	O
we	PRP	O
screened	VBD	O
eight	CD	O
familial	JJ	B_Disease
gastric	NN	I_Disease
cancer	NN	E_Disease
kindreds	NNS	O
of	IN	O
British	JJ	O
and	CC	O
Irish	JJ	O
origin	NN	O
for	IN	O
germline	NN	O
CDH1	NNP	O
mutations	NNS	O
,	,	O
by	IN	O
SSCP	NNP	O
analysis	NN	O
of	IN	O
all	DT	O
16	CD	O
exons	NNS	O
and	CC	O
flanking	VBG	O
sequences	NNS	O
.	.	O

Each	DT	O
family	NN	O
contained	VBN	O
(	(	O
i	JJ	O
)	)	O
two	CD	O
cases	NNS	O
of	IN	O
gastric	JJ	B_Disease
cancer	NN	E_Disease
in	IN	O
first	JJ	O
degree	NN	O
relatives	NNS	O
with	IN	O
one	CD	O
affected	VBD	O
before	IN	O
age	NN	O
50	CD	O
years	NNS	O
;	:	O
or	CC	O
(	(	O
ii	NN	O
)	)	O
three	CD	O
or	CC	O
more	JJR	O
cases	NNS	O
of	IN	O
gastric	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Novel	NNP	O
germline	NN	O
CDH1	NNP	O
mutations	NNS	O
(	(	O
a	DT	O
nonsense	NN	O
and	CC	O
a	DT	O
splice	JJ	O
site	NN	O
)	)	O
were	VBD	O
detected	VBN	O
in	IN	O
two	CD	O
families	NNS	O
(	(	O
25	CD	O
%	NN	O
)	)	O
.	.	O

Both	DT	O
mutations	NNS	O
were	VBD	O
predicted	VBN	O
to	TO	O
truncate	VB	O
the	DT	O
E	NNP	O
-	:	O
cadherin	NN	O
protein	NN	O
in	IN	O
the	DT	O
signal	JJ	O
peptide	NN	O
domain	NN	O
.	.	O

In	IN	O
one	CD	O
family	NN	O
there	EX	O
was	VBD	O
evidence	NN	O
of	IN	O
non	JJ	O
-	:	O
penetrance	NN	O
and	CC	O
susceptibility	NN	O
to	TO	O
both	DT	O
gastric	JJ	B_Disease
and	CC	I_Disease
colorectal	JJ	I_Disease
cancer	NN	E_Disease
;	:	O
thus	RB	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
six	CD	O
cases	NNS	O
of	IN	O
gastric	JJ	B_Disease
cancer	NN	E_Disease
,	,	O
a	DT	O
CDH1	NNP	O
mutation	NN	O
carrier	NN	O
developed	VBD	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
at	IN	O
age	NN	O
30	CD	O
years	NNS	O
.	.	O

We	PRP	O
have	VBP	O
confirmed	VBN	O
that	IN	O
germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
CDH1	NNP	O
gene	NN	O
cause	NN	O
familial	JJ	B_Disease
gastric	JJ	I_Disease
cancer	NN	E_Disease
in	IN	O
non	JJ	O
-	:	O
Maori	JJ	O
populations	NNS	O
.	.	O

However	RB	O
,	,	O
only	RB	O
a	DT	O
minority	NN	O
of	IN	O
familial	JJ	O
gastric	JJ	B_Disease
cancers	NNS	E_Disease
can	MD	O
be	VB	O
accounted	VBN	O
for	IN	O
by	IN	O
CDH1	NNP	O
mutations	NNS	O
.	.	O

Loss	NNP	O
of	IN	O
E	NNP	O
-	:	O
cadherin	NN	O
function	NN	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
sporadic	JJ	O
colorectal	NN	B_Disease
and	CC	I_Disease
other	JJ	I_Disease
cancers	NNS	E_Disease
,	,	O
and	CC	O
our	PRP$	O
findings	NNS	O
provide	VBP	O
evidence	NN	O
that	IN	O
germline	NN	O
CDH1	NNP	O
mutations	NNS	O
predispose	VBP	O
to	TO	O
early	JJ	O
onset	NN	O
colorectal	NN	B_Disease
cancer	NN	E_Disease
.	.	O

Thus	RB	O
,	,	O
CDH1	NNP	O
should	MD	O
be	VB	O
investigated	VBN	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
inherited	JJ	O
susceptibility	NN	O
to	TO	O
both	DT	O
gastric	JJ	B_Disease
and	CC	I_Disease
colorectal	JJ	I_Disease
cancers	NNS	E_Disease
.	.	O

A	DT	O
zinc	NN	O
finger	NN	O
truncation	NN	O
of	IN	O
murine	NN	O
WT1	NNP	O
results	NNS	O
in	IN	O
the	DT	O
characteristic	JJ	O
urogenital	JJ	B_Disease
abnormalities	NNS	E_Disease
of	IN	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

The	DT	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
-	:	O
suppressor	NN	O
gene	NN	O
,	,	O
WT1	NNP	O
,	,	O
plays	VBZ	O
a	DT	O
key	JJ	O
role	NN	O
in	IN	O
urogenital	JJ	O
development	NN	O
,	,	O
and	CC	O
WT1	NNP	B_Disease
dysfunction	NN	E_Disease
is	VBZ	O
implicated	VBN	O
in	IN	O
both	DT	O
neoplastic	JJ	S_Disease
(	(	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
,	,	O
mesothelioma	NN	S_Disease
,	,	O
leukemias	NN	S_Disease
,	,	O
and	CC	O
breast	NN	B_Disease
cancer	NN	E_Disease
)	)	O
and	CC	O
nonneoplastic	JJ	S_Disease
(	(	O
glomerulosclerosis	NN	S_Disease
)	)	O
disease	NN	O
.	.	O

The	DT	O
analysis	NN	O
of	IN	O
diseases	NNS	O
linked	VBN	O
specifically	RB	O
with	IN	O
WT1	NNP	O
mutations	NNS	O
,	,	O
such	JJ	O
as	IN	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
DDS	NNP	S_Disease
)	)	O
,	,	O
can	MD	O
provide	VB	O
valuable	JJ	O
insight	NN	O
concerning	VBG	O
the	DT	O
role	NN	O
of	IN	O
WT1	NNP	O
in	IN	O
development	NN	O
and	CC	O
disease	NN	O
.	.	O

DDS	NNP	S_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
childhood	NN	O
disease	NN	O
characterized	VBN	O
by	IN	O
a	DT	O
nephropathy	JJ	S_Disease
involving	VBG	O
mesangial	JJ	B_Disease
sclerosis	NN	E_Disease
,	,	O
XY	NNP	O
pseudohermaphroditism	NN	S_Disease
,	,	O
and	CC	O
/	NNP	O
or	CC	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
(	(	O
WT	NNP	S_Disease
)	)	O
.	.	O

DDS	NN	S_Disease
patients	NNS	O
are	VBP	O
constitutionally	RB	O
heterozygous	JJ	O
for	IN	O
exonic	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
WT1	NNP	O
,	,	O
which	WDT	O
include	VBP	O
mutations	NNS	O
predicted	VBD	O
to	TO	O
truncate	VB	O
the	DT	O
protein	NN	O
within	IN	O
the	DT	O
C	NNP	O
-	:	O
terminal	JJ	O
zinc	NN	O
finger	NN	O
(	(	O
ZF	NNP	O
)	)	O
region	NN	O
.	.	O

We	PRP	O
report	VBP	O
that	DT	O
heterozygosity	NN	O
for	IN	O
a	DT	O
targeted	JJ	O
murine	NN	O
Wt1	NNP	O
allele	NN	O
,	,	O
Wt1	NNP	O
(	(	O
tmT396	NN	O
)	)	O
,	,	O
which	WDT	O
truncates	VBZ	O
ZF3	NNP	O
at	IN	O
codon	NN	O
396	CD	O
,	,	O
induces	NNS	O
mesangial	JJ	B_Disease
sclerosis	NN	E_Disease
characteristic	NN	O
of	IN	O
DDS	NNP	S_Disease
in	IN	O
adult	NN	O
heterozygous	JJ	O
and	CC	O
chimeric	JJ	O
mice	NN	O
.	.	O

Male	JJ	B_Disease
genital	NN	I_Disease
defects	NNS	E_Disease
also	RB	O
were	VBD	O
evident	JJ	O
and	CC	O
there	EX	O
was	VBD	O
a	DT	O
single	JJ	O
case	NN	O
of	IN	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
in	IN	O
which	WDT	O
the	DT	O
transcript	NN	O
of	IN	O
the	DT	O
nontargeted	JJ	O
allele	NN	O
showed	VBD	O
an	DT	O
exon	JJ	O
9	CD	O
skipping	VBG	O
event	NN	O
,	,	O
implying	VBG	O
a	DT	O
causal	NN	O
link	NN	O
between	IN	O
Wt1	NNP	B_Disease
dysfunction	NN	E_Disease
and	CC	O
Wilms	NNP	B_Disease
tumorigenesis	NN	E_Disease
in	IN	O
mice	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
mutant	JJ	O
WT1	NNP	O
(	(	O
tmT396	NN	O
)	)	O
protein	NN	O
accounted	VBD	O
for	IN	O
only	RB	O
5	CD	O
%	NN	O
of	IN	O
WT1	NNP	O
in	IN	O
both	DT	O
heterozygous	JJ	O
embryonic	JJ	O
stem	NN	O
cells	NNS	O
and	CC	O
the	DT	O
WT	NNP	S_Disease
.	.	O

This	DT	O
has	VBZ	O
implications	NNS	O
regarding	VBG	O
the	DT	O
mechanism	NN	O
by	IN	O
which	WDT	O
the	DT	O
mutant	NN	O
allele	VBZ	O
exerts	VBZ	O
its	PRP$	O
effect	NN	O
.	.	O

Mechanism	NN	O
of	IN	O
increased	VBN	O
iron	NN	O
absorption	NN	O
in	IN	O
murine	JJ	O
model	NN	O
of	IN	O
hereditary	JJ	B_Disease
hemochromatosis	NN	E_Disease
:	:	O
increased	VBN	O
duodenal	JJ	O
expression	NN	O
of	IN	O
the	DT	O
iron	NN	O
transporter	NN	O
DMT1	NNP	O
.	.	O

Hereditary	JJ	B_Disease
hemochromatosis	NN	E_Disease
(	(	O
HH	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
common	JJ	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
tissue	NN	O
iron	NN	O
deposition	NN	O
secondary	JJ	O
to	TO	O
excessive	JJ	O
dietary	JJ	O
iron	NN	O
absorption	NN	O
.	.	O

We	PRP	O
recently	RB	O
reported	VBD	O
that	IN	O
HFE	NNP	O
,	,	O
the	DT	O
protein	NN	O
defective	JJ	O
in	IN	O
HH	NNP	S_Disease
,	,	O
was	VBD	O
physically	RB	O
associated	VBN	O
with	IN	O
the	DT	O
transferrin	NN	O
receptor	NN	O
(	(	O
TfR	NNP	O
)	)	O
in	IN	O
duodenal	JJ	O
crypt	NN	O
cells	NNS	O
and	CC	O
proposed	VBD	O
that	IN	O
mutations	NNS	O
in	IN	O
HFE	NNP	O
attenuate	VBP	O
the	DT	O
uptake	NN	O
of	IN	O
transferrin	JJ	O
-	:	O
bound	NN	O
iron	NN	O
from	IN	O
plasma	NN	O
by	IN	O
duodenal	JJ	O
crypt	NN	O
cells	NNS	O
,	,	O
leading	VBG	O
to	TO	O
up	RP	O
-	:	O
regulation	NN	O
of	IN	O
transporters	NNS	O
for	IN	O
dietary	JJ	O
iron	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
tested	VBD	O
the	DT	O
hypothesis	NN	O
that	WDT	O
HFE	NNP	O
-	:	O
/	SYM	O
-	:	O
mice	NN	O
have	VBP	O
increased	VBN	O
duodenal	JJ	O
expression	NN	O
of	IN	O
the	DT	O
divalent	NN	O
metal	NN	O
transporter	NN	O
(	(	O
DMT1	NNP	O
)	)	O
.	.	O

By	IN	O
4	CD	O
weeks	NNS	O
of	IN	O
age	NN	O
,	,	O
the	DT	O
HFE	NNP	O
-	:	O
/	SYM	O
-	:	O
mice	NN	O
demonstrated	VBD	O
iron	NN	O
loading	NN	O
when	WRB	O
compared	VBN	O
with	IN	O
HFE	NNP	O
+	NNP	O
/	NNP	O
+	NNP	O
littermates	VBZ	O
,	,	O
with	IN	O
elevated	JJ	O
transferrin	NN	O
saturations	NNS	O
(	(	O
68	CD	O
.	.	O

4	CD	O
%	NN	O
vs	NN	O
.	.	O

49	CD	O
.	.	O

8	CD	O
%	NN	O
)	)	O
and	CC	O
elevated	VBN	O
liver	NN	O
iron	NN	O
concentrations	NNS	O
(	(	O
985	CD	O
micrograms	NNS	O
vs	NN	O
.	.	O

381	CD	O
micrograms	NNS	O
)	)	O
.	.	O

By	IN	O
using	VBG	O
Northern	NNP	O
blot	NN	O
analyses	NNS	O
,	,	O
we	PRP	O
quantitated	VBD	O
duodenal	JJ	O
expression	NN	O
of	IN	O
both	DT	O
classes	NNS	O
of	IN	O
DMT1	NNP	O
transcripts	VBP	O
one	CD	O
containing	VBG	O
an	DT	O
iron	NN	O
responsive	JJ	O
element	NN	O
(	(	O
IRE	NNP	O
)	)	O
,	,	O
called	VBN	O
DMT1	NNP	O
(	(	O
IRE	NNP	O
)	)	O
,	,	O
and	CC	O
one	CD	O
containing	VBG	O
no	DT	O
IRE	NNP	O
,	,	O
called	VBD	O
DMT1	NNP	O
(	(	O
non	SYM	O
-	:	O
IRE	NN	O
)	)	O
.	.	O

The	DT	O
positive	JJ	O
control	NN	O
for	IN	O
DMT1	NNP	O
up	RP	O
-	:	O
regulation	NN	O
was	VBD	O
a	DT	O
murine	JJ	O
model	NN	O
of	IN	O
dietary	JJ	B_Disease
iron	NN	I_Disease
deficiency	NN	E_Disease
that	WDT	O
demonstrated	VBD	O
greatly	RB	O
increased	JJ	O
levels	NNS	O
of	IN	O
duodenal	JJ	O
DMT1	NNP	O
(	(	O
IRE	NNP	O
)	)	O
mRNA	NN	O
.	.	O

HFE	NNP	O
-	:	O
/	SYM	O
-	:	O
mice	NN	O
also	RB	O
demonstrated	VBD	O
an	DT	O
increase	NN	O
in	IN	O
duodenal	JJ	O
DMT1	NNP	O
(	(	O
IRE	NNP	O
)	)	O
mRNA	NN	O
(	(	O
average	JJ	O
7	CD	O
.	.	O

7	CD	O
-	:	O
fold	NN	O
)	)	O
,	,	O
despite	IN	O
their	PRP$	O
elevated	JJ	O
transferrin	NN	O
saturation	NN	O
and	CC	O
hepatic	JJ	O
iron	NN	O
content	NN	O
.	.	O

Duodenal	JJ	O
expression	NN	O
of	IN	O
DMT1	NNP	O
(	(	O
non	SYM	O
-	:	O
IRE	NN	O
)	)	O
was	VBD	O
not	RB	O
increased	VBN	O
,	,	O
nor	CC	O
was	VBD	O
hepatic	JJ	O
expression	NN	O
of	IN	O
DMT1	NNP	O
increased	VBD	O
.	.	O

These	DT	O
data	NNS	O
support	NN	O
the	DT	O
model	NN	O
for	IN	O
HH	NNP	O
in	IN	O
which	WDT	O
HFE	NNP	O
mutations	NNS	O
lead	VBP	O
to	TO	O
inappropriately	RB	O
low	JJ	O
crypt	NN	O
cell	NN	O
iron	NN	O
,	,	O
with	IN	O
resultant	JJ	O
stabilization	NN	O
of	IN	O
DMT1	NNP	O
(	(	O
IRE	NNP	O
)	)	O
mRNA	NN	O
,	,	O
up	RB	O
-	:	O
regulation	NN	O
of	IN	O
DMT1	NNP	O
,	,	O
and	CC	O
increased	VBD	O
absorption	NN	O
of	IN	O
dietary	JJ	O
iron	NN	O
.	.	O

Neurophysiologic	NNP	O
follow	SYM	O
-	:	O
up	IN	O
of	IN	O
long	JJ	O
-	:	O
term	NN	O
dietary	JJ	O
treatment	NN	O
in	IN	O
adult	NN	O
-	:	O
onset	NN	O
adrenoleukodystrophy	NN	S_Disease
.	.	O

OBJECTIVE	NN	O
To	TO	O
monitor	VB	O
the	DT	O
effects	NNS	O
of	IN	O
dietary	JJ	O
treatment	NN	O
in	IN	O
adult	NN	O
-	:	O
onset	NN	O
adrenoleukodystrophy	NN	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
by	IN	O
means	NNS	O
of	IN	O
somatosensory	NN	O
evoked	VBN	O
potentials	NNS	O
(	(	O
SEPs	NNP	O
)	)	O
and	CC	O
motor	NN	O
evoked	JJ	O
potentials	NNS	O
(	(	O
MEPs	NNP	O
)	)	O
.	.	O

BACKGROUND	NNP	O
SEPs	NNP	O
and	CC	O
MEPs	NNP	O
have	VBP	O
proved	VBN	O
useful	JJ	O
in	IN	O
revealing	VBG	O
signs	NNS	O
of	IN	O
progressively	RB	O
severe	JJ	O
,	,	O
central	JJ	O
dying	VBG	B_Disease
-	:	I_Disease
back	RB	I_Disease
axonopathy	NN	E_Disease
in	IN	O
early	JJ	O
stages	NNS	O
of	IN	O
adult	NN	O
-	:	O
onset	NN	O
ALD	NNP	S_Disease
.	.	O

METHODS	NNP	O
Eight	NNP	O
patients	NNS	O
with	IN	O
adult	JJ	O
-	:	O
onset	NN	O
ALD	NNP	S_Disease
underwent	JJ	O
clinical	JJ	O
examination	NN	O
,	,	O
brain	NN	O
and	CC	O
spine	NN	O
MRI	NNP	O
,	,	O
and	CC	O
SEP	NNP	O
and	CC	O
MEP	NNP	O
studies	NNS	O
before	IN	O
and	CC	O
after	IN	O
3	CD	O
years	NNS	O
of	IN	O
Lorenzos	NNP	O
oil	NN	O
dietary	JJ	O
therapy	NN	O
.	.	O

RESULTS	NNP	O
Before	NNP	O
treatment	NN	O
,	,	O
brain	NN	O
MRI	NNP	O
was	VBD	O
normal	JJ	O
in	IN	O
five	CD	O
patients	NNS	O
.	.	O

Three	CD	O
of	IN	O
these	DT	O
patients	NNS	O
had	VBD	O
pure	JJ	O
spinal	JJ	B_Disease
SEP	NNP	I_Disease
abnormalities	NNS	E_Disease
and	CC	O
in	IN	O
the	DT	O
remaining	VBG	O
two	CD	O
patients	NNS	O
SEPs	VBP	O
showed	JJ	O
signs	NNS	O
of	IN	O
involvement	NN	O
of	IN	O
both	CC	O
the	DT	O
spinal	NN	O
and	CC	O
cerebral	JJ	O
somatosensory	NN	O
tracts	NNS	O
.	.	O

After	IN	O
treatment	NN	O
,	,	O
the	DT	O
three	CD	O
patients	NNS	O
with	IN	O
pure	JJ	O
spinal	JJ	B_Disease
abnormalities	NNS	E_Disease
showed	VBD	O
clinical	JJ	O
and	CC	O
neurophysiologic	JJ	O
worsening	NN	O
,	,	O
whereas	IN	O
the	DT	O
two	CD	O
patients	NNS	O
with	IN	O
a	DT	O
more	RBR	O
advanced	JJ	O
stage	NN	O
of	IN	O
disease	NN	O
(	(	O
exhibited	VBN	O
by	IN	O
SEPs	NNP	O
)	)	O
showed	VBD	O
substantially	RB	O
unchanged	JJ	O
clinical	JJ	O
and	CC	O
neurophysiologic	JJ	O
features	NNS	O
.	.	O

The	DT	O
patients	NNS	O
with	IN	O
abnormal	JJ	O
brain	NN	O
MRI	NNP	O
at	IN	O
the	DT	O
onset	NN	O
of	IN	O
treatment	NN	O
showed	VBD	O
clinical	JJ	O
and	CC	O
neurophysiologic	JJ	O
worsening	NN	O
.	.	O

CONCLUSIONS	NNP	O
Lorenzos	NNP	O
oil	NN	O
therapy	NN	O
had	VBD	O
no	DT	O
effect	NN	O
on	IN	O
patients	NNS	O
with	IN	O
evidence	NN	O
of	IN	O
inflammatory	JJ	B_Disease
brain	NN	I_Disease
lesions	NNS	E_Disease
.	.	O

Moreover	RB	O
,	,	O
in	IN	O
patients	NNS	O
without	IN	O
clear	JJ	O
signs	NNS	O
of	IN	O
inflammatory	JJ	O
damage	NN	O
,	,	O
this	DT	O
treatment	NN	O
does	VBZ	O
not	RB	O
modify	VB	O
significantly	RB	O
the	DT	O
natural	JJ	O
course	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

However	RB	O
,	,	O
because	IN	O
effective	JJ	O
treatments	NNS	O
should	MD	O
begin	VB	O
before	IN	O
the	DT	O
onset	NN	O
of	IN	O
severe	JJ	O
neurologic	NN	O
symptoms	NNS	O
,	,	O
SEPs	NNP	O
and	CC	O
MEPs	NNP	O
should	MD	O
be	VB	O
considered	VBN	O
to	TO	O
evaluate	VB	O
the	DT	O
effectiveness	NN	O
of	IN	O
other	JJ	O
experimental	JJ	O
treatments	NNS	O
in	IN	O
the	DT	O
patient	NN	O
with	IN	O
a	DT	O
negative	JJ	O
brain	NN	O
MRI	NNP	O
.	.	O

GCH1	NNP	O
mutation	NN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
adult	JJ	O
-	:	O
onset	NN	O
oromandibular	JJ	B_Disease
dystonia	NN	E_Disease
.	.	O

The	DT	O
authors	NNS	O
report	VBP	O
a	DT	O
mutation	NN	O
in	IN	O
exon	JJ	O
5	CD	O
of	IN	O
GCH1	NNP	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
adult	JJ	O
-	:	O
onset	NN	O
oromandibular	JJ	B_Disease
dystonia	NN	E_Disease
and	CC	O
no	DT	O
obvious	JJ	O
family	NN	O
history	NN	O
of	IN	O
dystonia	NN	S_Disease
.	.	O

The	DT	O
patient	NN	O
responded	VBD	O
positively	RB	O
to	TO	O
treatment	NN	O
with	IN	O
L	NNP	O
-	:	O
dopa	NN	O
.	.	O

These	DT	O
findings	NNS	O
demonstrate	VBP	O
that	IN	O
GCH1	NNP	O
mutations	NNS	O
must	MD	O
be	VB	O
considered	VBN	O
even	RB	O
in	IN	O
patients	NNS	O
with	IN	O
dystonic	JJ	S_Disease
symptoms	NNS	O
not	RB	O
typical	JJ	O
of	IN	O
dopa	JJ	B_Disease
-	:	I_Disease
responsive	JJ	I_Disease
dystonia	NN	E_Disease
.	.	O

Germline	NNP	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
in	IN	O
Korean	NNP	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
patients	NNS	O
.	.	O

We	PRP	O
extensively	RB	O
analyzed	VBD	O
genomic	JJ	O
DNA	NNP	O
and	CC	O
messenger	JJR	O
RNA	NNP	O
(	(	O
mRNA	NN	O
)	)	O
from	IN	O
62	CD	O
unrelated	JJ	O
Korean	JJ	O
patients	NNS	O
with	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
for	IN	O
identification	NN	O
of	IN	O
germline	NN	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
gene	NN	O
mutations	NNS	O
.	.	O

We	PRP	O
adopted	VBD	O
both	DT	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
SSCP	NNP	O
)	)	O
analysis	NN	O
and	CC	O
a	DT	O
method	NN	O
of	IN	O
analysis	NN	O
involving	VBG	O
the	DT	O
reverse	NN	O
transcription	NN	O
-	:	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
RT	NNP	O
-	:	O
PCR	NN	O
)	)	O
followed	VBN	O
by	IN	O
a	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
(	(	O
PTT	NNP	O
)	)	O
.	.	O

DNA	NN	O
sequencing	VBG	O
confirmed	VBD	O
all	DT	O
alterations	NNS	O
represented	VBN	O
by	IN	O
aberrant	JJ	O
bands	NNS	O
.	.	O

Germline	JJ	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
38	CD	O
patients	NNS	O
(	(	O
61	CD	O
%	NN	O
)	)	O
.	.	O

Nineteen	NN	O
of	IN	O
the	DT	O
detected	JJ	O
mutations	NNS	O
were	VBD	O
presumed	VBN	O
to	TO	O
be	VB	O
novel	JJ	O
,	,	O
thus	RB	O
emphasizing	VBG	O
the	DT	O
heterogeneity	NN	O
of	IN	O
the	DT	O
mutational	JJ	O
spectrum	NN	O
in	IN	O
Korean	JJ	O
FAP	NNP	S_Disease
patients	NNS	O
.	.	O

In	IN	O
the	DT	O
initial	JJ	O
48	CD	O
patients	NNS	O
,	,	O
SSCP	NNP	O
analysis	NN	O
was	VBD	O
followed	VBN	O
by	IN	O
PTT	NNP	O
for	IN	O
those	DT	O
patients	NNS	O
for	IN	O
whom	WP	O
no	DT	O
detectable	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
by	IN	O
SSCP	NNP	O
.	.	O

Using	VBG	O
this	DT	O
combined	JJ	O
approach	NN	O
,	,	O
we	PRP	O
identified	VBD	O
germline	JJ	O
APC	NNP	S_Disease
gene	NN	O
mutations	NNS	O
in	IN	O
29	CD	O
of	IN	O
the	DT	O
48	CD	O
FAP	NNP	S_Disease
patients	NNS	O
(	(	O
60	CD	O
%	NN	O
)	)	O
,	,	O
including	VBG	O
6	CD	O
patients	NNS	O
in	IN	O
whom	WP	O
SSCP	NNP	O
analysis	NN	O
failed	VBD	O
to	TO	O
distinguish	VB	O
the	DT	O
mutant	JJ	O
allele	NN	O
.	.	O

In	IN	O
the	DT	O
14	CD	O
later	JJ	O
patients	NNS	O
,	,	O
we	PRP	O
identified	VBD	O
truncating	VBG	O
mutations	NNS	O
in	IN	O
9	CD	O
patients	NNS	O
(	(	O
64	CD	O
%	NN	O
)	)	O
using	VBG	O
PTT	NNP	O
only	RB	O
.	.	O

Our	PRP$	O
results	NNS	O
confirm	VBP	O
that	IN	O
the	DT	O
mutation	NN	O
detection	NN	O
rate	NN	O
with	IN	O
PTT	NNP	O
was	VBD	O
superior	JJ	O
to	TO	O
that	DT	O
with	IN	O
SSCP	NNP	O
,	,	O
and	CC	O
suggest	VBP	O
that	IN	O
PTT	NNP	O
would	MD	O
be	VB	O
a	DT	O
more	RBR	O
practical	JJ	O
screening	NN	O
method	NN	O
to	TO	O
detect	VB	O
germline	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
in	IN	O
FAP	NNP	S_Disease
patients	NNS	O
.	.	O

Molecular	JJ	O
epidemiology	NN	O
of	IN	O
C9	NNP	B_Disease
deficiency	NN	E_Disease
heterozygotes	VBZ	O
with	IN	O
an	DT	O
Arg95Stop	NNP	O
mutation	NN	O
of	IN	O
the	DT	O
C9	NNP	O
gene	NN	O
in	IN	O
Japan	NNP	O
.	.	O

Deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
ninth	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
human	JJ	I_Disease
complement	NN	E_Disease
(	(	O
C9	NNP	O
)	)	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
complement	NN	B_Disease
deficiency	NN	E_Disease
in	IN	O
Japan	NNP	O
,	,	O
with	IN	O
an	DT	O
incidence	NN	O
of	IN	O
approximately	RB	O
one	CD	O
homozygote	NN	O
in	IN	O
1000	CD	O
,	,	O
but	CC	O
is	VBZ	O
very	RB	O
rare	JJ	O
in	IN	O
other	JJ	O
countries	NNS	O
.	.	O

Genetic	JJ	O
analyses	NNS	O
of	IN	O
Japanese	JJ	O
C9	NNP	B_Disease
deficiency	NN	E_Disease
have	VBP	O
shown	VBN	O
that	IN	O
a	DT	O
C	NNP	O
-	:	O
to	TO	O
-	:	O
T	NNP	O
transition	NN	O
leading	VBG	O
to	TO	O
TGA	NNP	O
stop	VB	O
codon	NN	O
for	IN	O
Arg95	NNP	O
in	IN	O
exon	JJ	O
4	CD	O
of	IN	O
the	DT	O
C9	NNP	O
gene	NN	O
(	(	O
Arg95Stop	NNP	O
)	)	O
is	VBZ	O
common	JJ	O
in	IN	O
Japanese	JJ	O
C9	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

To	TO	O
determine	VB	O
the	DT	O
prevalence	NN	O
of	IN	O
heterozygous	JJ	O
carriers	NNS	O
of	IN	O
the	DT	O
Arg95Stop	NNP	O
mutation	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
population	NN	O
,	,	O
we	PRP	O
collected	VBD	O
DNA	NNP	O
samples	NNS	O
from	IN	O
300	CD	O
individuals	NNS	O
in	IN	O
two	CD	O
of	IN	O
the	DT	O
four	CD	O
main	JJ	O
islands	NNS	O
of	IN	O
Japan	NNP	O
.	.	O

Heterozygote	NNP	O
detection	NN	O
was	VBD	O
performed	VBN	O
with	IN	O
an	DT	O
allele	JJ	O
-	:	O
specific	JJ	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
system	NN	O
designed	VBN	O
to	TO	O
detect	VB	O
exclusively	RB	O
only	RB	O
one	CD	O
of	IN	O
the	DT	O
normal	JJ	O
and	CC	O
mutant	JJ	O
alleles	NNS	O
,	,	O
followed	VBN	O
by	IN	O
confirmation	NN	O
with	IN	O
PCR	NNP	O
/	NNP	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
SSCP	NNP	O
)	)	O
analysis	NN	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

Twenty	CD	O
individuals	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
Arg95Stop	NNP	O
mutation	NN	O
.	.	O

None	NN	O
was	VBD	O
homozygous	JJ	O
.	.	O

The	DT	O
prevalence	NN	O
of	IN	O
carriers	NNS	O
of	IN	O
the	DT	O
Arg95Stop	NNP	O
mutation	NN	O
was	VBD	O
6	CD	O
.	.	O

7	CD	O
%	NN	O
(	(	O
20	CD	O
/	RB	O
300	CD	O
)	)	O
.	.	O

An	DT	O
estimated	JJ	O
frequency	NN	O
(	(	O
0	CD	O
.	.	O

12	CD	O
%	NN	O
)	)	O
of	IN	O
complete	JJ	O
C9	NNP	B_Disease
deficiency	NN	E_Disease
due	JJ	O
to	TO	O
homozygous	JJ	O
Arg95Stop	NNP	O
mutation	NN	O
was	VBD	O
consistent	JJ	O
with	IN	O
frequencies	NNS	O
determined	VBN	O
by	IN	O
serological	JJ	O
studies	NNS	O

The	DT	O
hereditary	JJ	B_Disease
hemochromatosis	NN	E_Disease
protein	NN	O
,	,	O
HFE	NNP	O
,	,	O
specifically	RB	O
regulates	VBZ	O
transferrin	JJ	O
-	:	O
mediated	VBN	O
iron	NN	O
uptake	NN	O
in	IN	O
HeLa	NNP	O
cells	NNS	O
.	.	O

HFE	NNP	O
is	VBZ	O
the	DT	O
protein	JJ	O
product	NN	O
of	IN	O
the	DT	O
gene	NN	O
mutated	VBN	O
in	IN	O
the	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disease	NN	E_Disease
hereditary	JJ	B_Disease
hemochromatosis	NN	E_Disease
(	(	O
Feder	NNP	O
,	,	O
J	NNP	O
.	.	O

N	NNP	O
.	.	O
,	,	O
Gnirke	NNP	O
,	,	O
A	NNP	O
.	.	O
,	,	O
Thomas	NNP	O
,	,	O
W	NNP	O
.	.	O
,	,	O
Tsuchihashi	NNP	O
,	,	O
Z	NNP	O
.	.	O
,	,	O
Ruddy	NNP	O
,	,	O
D	NNP	O
.	.	O

A	DT	O
.	.	O
,	,	O
Basava	NNP	O
,	,	O
A	NNP	O
.	.	O
,	,	O
Dormishian	JJ	O
,	,	O
F	NNP	O
.	.	O
,	,	O
Domingo	NNP	O
,	,	O
R	NNP	O
.	.	O

J	NNP	O
.	.	O
,	,	O
Ellis	NNP	O
,	,	O
M	NNP	O
.	.	O

C	NNP	O
.	.	O
,	,	O
Fullan	NNP	O
,	,	O
A	NNP	O
.	.	O
,	,	O
Hinton	NNP	O
,	,	O
L	NNP	O
.	.	O

M	NNP	O
.	.	O
,	,	O
Jones	NNP	O
,	,	O
N	NNP	O
.	.	O

L	NNP	O
.	.	O
,	,	O
Kimmel	NNP	O
,	,	O
B	NNP	O
.	.	O

E	NN	O
.	.	O
,	,	O
Kronmal	NNP	O
,	,	O
G	NNP	O
.	.	O

S	NNP	O
.	.	O
,	,	O
Lauer	NNP	O
,	,	O
P	NNP	O
.	.	O
,	,	O
Lee	NNP	O
,	,	O
V	NNP	O
.	.	O

K	NNP	O
.	.	O
,	,	O
Loeb	NNP	O
,	,	O
D	NNP	O
.	.	O

B	NNP	O
.	.	O
,	,	O
Mapa	NNP	O
,	,	O
F	NNP	O
.	.	O

A	DT	O
.	.	O
,	,	O
McClelland	NNP	O
,	,	O
E	NNP	O
.	.	O
,	,	O
Meyer	NNP	O
,	,	O
N	NNP	O
.	.	O

C	NNP	O
.	.	O
,	,	O
Mintier	NNP	O
,	,	O
G	NNP	O
.	.	O

A	DT	O
.	.	O
,	,	O
Moeller	NNP	O
,	,	O
N	NNP	O
.	.	O
,	,	O
Moore	NNP	O
,	,	O
T	NNP	O
.	.	O
,	,	O
Morikang	NNP	O
,	,	O
E	NNP	O
.	.	O
,	,	O
Prasss	NNP	O
,	,	O
C	NNP	O
.	.	O

E	NN	O
.	.	O
,	,	O
Quintana	NNP	O
,	,	O
L	NNP	O
.	.	O
,	,	O
Starnes	NNPS	O
,	,	O
S	NNP	O
.	.	O

M	NNP	O
.	.	O
,	,	O
Schatzman	NNP	O
,	,	O
R	NNP	O
.	.	O

C	NNP	O
.	.	O
,	,	O
Brunke	NNP	O
,	,	O
K	NNP	O
.	.	O

J	NNP	O
.	.	O
,	,	O
Drayna	NNP	O
,	,	O
D	NNP	O
.	.	O

T	NNP	O
.	.	O
,	,	O
Risch	NNP	O
,	,	O
N	NNP	O
.	.	O

J	NNP	O
.	.	O
,	,	O
Bacon	NNP	O
,	,	O
B	NNP	O
.	.	O

R	NNP	O
.	.	O
,	,	O
and	CC	O
Wolff	NNP	O
,	,	O
R	NNP	O
.	.	O

R	NN	O
.	.	O

(	(	O
1996	CD	O
)	)	O
Nat	NNP	O
.	.	O

Genet	NNP	O
.	.	O

13	CD	O
,	,	O
399	CD	O
-	:	O
408	CD	O
)	)	O
.	.	O

At	IN	O
the	DT	O
cell	NN	O
surface	NN	O
,	,	O
HFE	NNP	O
complexes	NNS	O
with	IN	O
transferrin	JJ	O
receptor	NN	O
(	(	O
TfR	NNP	O
)	)	O
,	,	O
increasing	VBG	O
the	DT	O
dissociation	NN	O
constant	NN	O
of	IN	O
transferrin	NN	O
(	(	O
Tf	NNP	O
)	)	O
for	IN	O
its	PRP$	O
receptor	NN	O
10	CD	O
-	:	O
fold	NN	O
(	(	O
Gross	NNP	O
,	,	O
C	NNP	O
.	.	O

N	NNP	O
.	.	O
,	,	O
Irrinki	NNP	O
,	,	O
A	NNP	O
.	.	O
,	,	O
Feder	NNP	O
,	,	O
J	NNP	O
.	.	O

N	NNP	O
.	.	O
,	,	O
and	CC	O
Enns	NNP	O
,	,	O
C	NNP	O
.	.	O

A	DT	O
.	.	O

(	(	O
1998	CD	O
)	)	O
J	NNP	O
.	.	O

Biol	NNP	O
.	.	O

Chem	NNP	O
.	.	O

273	CD	O
,	,	O
22068	CD	O
-	:	O
22074	CD	O
;	:	O
Feder	NNP	O
,	,	O
J	NNP	O
.	.	O

N	NNP	O
.	.	O
,	,	O
Penny	NNP	O
,	,	O
D	NNP	O
.	.	O

M	NNP	O
.	.	O
,	,	O
Irrinki	NNP	O
,	,	O
A	NNP	O
.	.	O
,	,	O
Lee	NNP	O
,	,	O
V	NNP	O
.	.	O

K	NNP	O
.	.	O
,	,	O
Lebron	NNP	O
,	,	O
J	NNP	O
.	.	O

A	DT	O
.	.	O
,	,	O
Watson	NNP	O
,	,	O
N	NNP	O
.	.	O
,	,	O
Tsuchihashi	NNP	O
,	,	O
Z	NNP	O
.	.	O
,	,	O
Sigal	NNP	O
,	,	O
E	NNP	O
.	.	O
,	,	O
Bjorkman	NNP	O
,	,	O
P	NNP	O
.	.	O

J	NNP	O
.	.	O
,	,	O
and	CC	O
Schatzman	NNP	O
,	,	O
R	NNP	O
.	.	O

C	NNP	O
.	.	O

(	(	O
1998	CD	O
)	)	O
Proc	NNP	O
.	.	O

Natl	NNP	O
.	.	O

Acad	NNP	O
.	.	O

Sci	NNP	O
.	.	O

U	NNP	O
S	NNP	O
A	NNP	O
95	CD	O
,	,	O
1472	CD	O
-	:	O
1477	CD	O
)	)	O
.	.	O

HFE	NNP	O
does	VBZ	O
not	RB	O
remain	VB	O
at	IN	O
the	DT	O
cell	NN	O
surface	NN	O
,	,	O
but	CC	O
traffics	NNS	O
with	IN	O
TfR	NNP	O
to	TO	O
Tf	NNP	O
-	:	O
positive	JJ	O
internal	JJ	O
compartments	NNS	O
(	(	O
Gross	NNP	O
et	VBZ	O
al	NN	O
.	.	O
,	,	O
1998	CD	O
)	)	O
.	.	O

Using	VBG	O
a	DT	O
HeLa	NNP	O
cell	NN	O
line	NN	O
in	IN	O
which	WDT	O
the	DT	O
expression	NN	O
of	IN	O
HFE	NNP	O
is	VBZ	O
controlled	VBN	O
by	IN	O
tetracycline	NN	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
the	DT	O
expression	NN	O
of	IN	O
HFE	NNP	O
reduces	VBZ	O
55Fe	CD	O
uptake	NN	O
from	IN	O
Tf	NNP	O
by	IN	O
33	CD	O
%	NN	O
but	CC	O
does	VBZ	O
not	RB	O
affect	VB	O
the	DT	O
endocytic	JJ	O
or	CC	O
exocytic	JJ	O
rates	NNS	O
of	IN	O
TfR	NNP	O
cycling	NN	O
.	.	O

Therefore	RB	O
,	,	O
HFE	NNP	O
appears	VBZ	O
to	TO	O
reduce	VB	O
cellular	JJ	O
acquisition	NN	O
of	IN	O
iron	NN	O
from	IN	O
Tf	NNP	O
within	IN	O
endocytic	JJ	O
compartments	NNS	O
.	.	O

HFE	NNP	O
specifically	RB	O
reduces	VBZ	O
iron	NN	O
uptake	NN	O
from	IN	O
Tf	NNP	O
,	,	O
as	IN	O
non	JJ	O
-	:	O
Tf	NNP	O
-	:	O
mediated	VBD	O
iron	JJ	O
uptake	NN	O
from	IN	O
Fe	NNP	O
-	:	O
nitrilotriacetic	JJ	O
acid	NN	O
is	VBZ	O
not	RB	O
altered	VBN	O
.	.	O

These	DT	O
results	NNS	O
explain	VBP	O
the	DT	O
decreased	JJ	O
ferritin	NN	O
levels	NNS	O
seen	VBN	O
in	IN	O
our	PRP$	O
HeLa	NNP	O
cell	NN	O
system	NN	O
and	CC	O
demonstrate	VB	O
the	DT	O
specific	JJ	O
control	NN	O
of	IN	O
HFE	NNP	O
over	IN	O
the	DT	O
Tf	NNP	O
-	:	O
mediated	VBD	O
pathway	NN	O
of	IN	O
iron	NN	O
uptake	NN	O
.	.	O

These	DT	O
results	NNS	O
also	RB	O
have	VBP	O
implications	NNS	O
for	IN	O
the	DT	O
understanding	NN	O
of	IN	O
cellular	JJ	O
iron	NN	O
homeostasis	NN	O
in	IN	O
organs	NNS	O
such	JJ	O
as	IN	O
the	DT	O
liver	NN	O
,	,	O
pancreas	NNS	O
,	,	O
heart	NN	O
,	,	O
and	CC	O
spleen	NN	O
that	WDT	O
are	VBP	O
iron	RB	O
loaded	VBN	O
in	IN	O
hereditary	JJ	B_Disease
hemochromatotic	JJ	E_Disease
individuals	NNS	O
lacking	VBG	O
functional	JJ	O
HFE	NNP	O
.	.	O

Mutation	NN	O
and	CC	O
haplotype	JJ	O
studies	NNS	O
of	IN	O
familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
reveal	VBP	O
new	JJ	O
ancestral	JJ	O
relationships	NNS	O
and	CC	O
evidence	NN	O
for	IN	O
a	DT	O
high	JJ	O
carrier	NN	O
frequency	NN	O
with	IN	O
reduced	JJ	O
penetrance	NN	O
in	IN	O
the	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
population	NN	O
.	.	O

Familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
(	(	O
FMF	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
recessive	JJ	B_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
episodes	NNS	O
of	IN	O
fever	NN	O
with	IN	O
serositis	NN	S_Disease
or	CC	O
synovitis	NN	S_Disease
.	.	O

The	DT	O
FMF	NNP	S_Disease
gene	NN	O
(	(	O
MEFV	NNP	O
)	)	O
was	VBD	O
cloned	VBN	O
recently	RB	O
,	,	O
and	CC	O
four	CD	O
missense	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

Here	RB	O
we	PRP	O
present	VBP	O
data	NNS	O
from	IN	O
non	JJ	O
-	:	O
Ashkenazi	JJ	O
Jewish	JJ	O
and	CC	O
Arab	JJ	O
patients	NNS	O
in	IN	O
whom	WP	O
we	PRP	O
had	VBD	O
not	RB	O
originally	RB	O
found	VBN	O
mutations	NNS	O
and	CC	O
from	IN	O
a	DT	O
new	JJ	O
,	,	O
more	RBR	O
ethnically	RB	O
diverse	JJ	O
panel	NN	O
.	.	O

Among	IN	O
90	CD	O
symptomatic	JJ	O
mutation	NN	O
-	:	O
positive	JJ	O
individuals	NNS	O
,	,	O
11	CD	O
mutations	NNS	O
accounted	VBD	O
for	IN	O
79	CD	O
%	NN	O
of	IN	O
carrier	NN	O
chromosomes	NNS	O
.	.	O

Of	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
that	WDT	O
are	VBP	O
novel	JJ	O
,	,	O
one	CD	O
alters	VBZ	O
the	DT	O
same	JJ	O
residue	NN	O
(	(	O
680	CD	O
)	)	O
as	IN	O
a	DT	O
previously	RB	O
known	VBN	O
mutation	NN	O
,	,	O
and	CC	O
the	DT	O
other	JJ	O
(	(	O
P369S	NNP	O
)	)	O
is	VBZ	O
located	VBN	O
in	IN	O
exon	JJ	O
3	CD	O
.	.	O

Consistent	JJ	O
with	IN	O
another	DT	O
recent	JJ	O
report	NN	O
,	,	O
the	DT	O
E148Q	NNP	O
mutation	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
patients	NNS	O
of	IN	O
several	JJ	O
ethnicities	NNS	O
and	CC	O
on	IN	O
multiple	JJ	O
microsatellite	JJ	O
haplotypes	NNS	O
,	,	O
but	CC	O
haplotype	JJ	O
data	NNS	O
indicate	VBP	O
an	DT	O
ancestral	JJ	O
relationships	NNS	O
between	IN	O
non	NN	O
-	:	O
Jewish	JJ	O
Italian	JJ	O
and	CC	O
Ashkenazi	JJ	O
Jewish	JJ	O
patients	NNS	O
with	IN	O
FMF	NNP	S_Disease
and	CC	O
other	JJ	O
affected	JJ	O
populations	NNS	O
.	.	O

Among	IN	O
approximately	RB	O
200	CD	O
anonymous	JJ	O
Ashkenazi	NNP	O
Jewish	NNP	O
DNA	NNP	O
samples	NNS	O
,	,	O
the	DT	O
MEFV	NNP	O
carrier	NN	O
frequency	NN	O
was	VBD	O
21	CD	O
%	NN	O
,	,	O
with	IN	O
E148Q	NNP	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
.	.	O

Several	JJ	O
lines	NNS	O
of	IN	O
evidence	NN	O
indicate	NN	O
reduced	VBN	O
penetrance	NN	O
among	IN	O
Ashkenazi	NNP	O
Jews	NNP	O
,	,	O
especially	RB	O
for	IN	O
E148Q	NNP	O
,	,	O
P369S	NNP	O
,	,	O
and	CC	O
K695R	NNP	O
.	.	O

Nevertheless	RB	O
,	,	O
E148Q	NNP	O
helps	VBZ	O
account	VB	O
for	IN	O
recessive	JJ	O
inheritance	NN	O
in	IN	O
an	DT	O
Ashkenazi	NNP	O
family	NN	O
previously	RB	O
reported	VBD	O
as	IN	O
an	DT	O
unusual	JJ	O
case	NN	O
of	IN	O
dominantly	RB	O
inherited	VBN	O
FMF	NNP	S_Disease
.	.	O

The	DT	O
presence	NN	O
of	IN	O
three	CD	O
frequent	JJ	O
MEFV	NNP	O
mutations	NNS	O
in	IN	O
multiple	JJ	O
Mediterranean	NNP	O
populations	NNS	O
strongly	RB	O
suggests	VBZ	O
a	DT	O
heterozygote	NN	O
advantage	NN	O
in	IN	O
this	DT	O
geographic	JJ	O
region	NN	O
.	.	O

Autoimmune	NNP	B_Disease
lymphoproliferative	JJ	I_Disease
syndrome	NN	E_Disease
with	IN	O
defective	JJ	O
Fas	NNS	O
:	:	O
genotype	NN	O
influences	NNS	O
penetrance	NN	O
.	.	O

Autoimmune	NNP	B_Disease
lymphoproliferative	JJ	I_Disease
syndrome	NN	E_Disease
(	(	O
ALPS	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
disorder	NN	B_Disease
of	IN	I_Disease
lymphocyte	JJ	I_Disease
homeostasis	NN	I_Disease
and	CC	I_Disease
immunological	JJ	I_Disease
tolerance	NN	E_Disease
.	.	O

Most	JJS	O
patients	NNS	O
have	VBP	O
a	DT	O
heterozygous	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
APT1	NNP	O
gene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
Fas	NNP	O
(	(	O
CD95	NNP	O
,	,	O
APO	NNP	O
-	:	O
1	CD	O
)	)	O
,	,	O
mediator	NN	O
of	IN	O
an	DT	O
apoptotic	JJ	O
pathway	NN	O
crucial	JJ	O
to	TO	O
lymphocyte	VB	O
homeostasis	NN	O
.	.	O

Of	IN	O
17	CD	O
unique	JJ	O
APT1	NNP	O
mutations	NNS	O
in	IN	O
unrelated	JJ	O
ALPS	NNP	S_Disease
probands	NNS	O
,	,	O
12	CD	O
(	(	O
71	CD	O
%	NN	O
)	)	O
occurred	VBD	O
in	IN	O
exons	NNS	O
7	CD	O
-	:	O
9	CD	O
,	,	O
which	WDT	O
encode	VBP	O
the	DT	O
intracellular	JJ	O
portion	NN	O
of	IN	O
Fas	NNP	O
.	.	O

In	IN	O
vitro	NN	O
,	,	O
activated	VBN	O
lymphocytes	NNS	O
from	IN	O
all	DT	O
17	CD	O
patients	NNS	O
showed	VBD	O
apoptotic	JJ	O
defects	NNS	O
when	WRB	O
exposed	VBN	O
to	TO	O
an	DT	O
anti	JJ	O
-	:	O
Fas	NNP	O
agonist	VBP	O
monoclonal	JJ	O
antibody	NN	O
.	.	O

Similar	JJ	O
defects	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
a	DT	O
Fas	NNP	O
-	:	O
negative	JJ	O
cell	NN	O
line	NN	O
transfected	VBN	O
with	IN	O
cDNAs	JJ	O
bearing	VBG	O
each	DT	O
of	IN	O
the	DT	O
mutations	NNS	O
.	.	O

In	IN	O
cotransfection	NN	O
experiments	NNS	O
,	,	O
Fas	NNP	O
constructs	VBZ	O
with	IN	O
either	DT	O
intra	JJ	O
-	:	O
or	CC	O
extracellular	JJ	O
mutations	NNS	O
caused	VBD	O
dominant	JJ	O
inhibition	NN	O
of	IN	O
apoptosis	NN	O
mediated	VBN	O
by	IN	O
wild	JJ	O
-	:	O
type	NN	O
Fas	NNP	O
.	.	O

Two	CD	O
missense	NN	O
Fas	NNP	O
variants	NNS	O
,	,	O
not	RB	O
restricted	VBN	O
to	TO	O
patients	NNS	O
with	IN	O
ALPS	NNP	S_Disease
,	,	O
were	VBD	O
identified	VBN	O
.	.	O

Variant	VB	O
A	NNP	O
(	(	O
-	:	O
1	CD	O
)	)	O
T	NN	O
at	IN	O
the	DT	O
Fas	NNP	O
signal	JJ	O
-	:	O
sequence	NN	O
cleavage	NN	O
site	NN	O
,	,	O
which	WDT	O
mediates	VBZ	O
apoptosis	NN	O
less	JJR	O
well	RB	O
than	IN	O
wild	JJ	O
-	:	O
type	NN	O
Fas	NNP	O
and	CC	O
is	VBZ	O
partially	RB	O
inhibitory	JJ	O
,	,	O
was	VBD	O
present	JJ	O
in	IN	O
13	CD	O
%	NN	O
of	IN	O
African	JJ	O
American	JJ	O
alleles	NNS	O
.	.	O

Among	IN	O
the	DT	O
ALPS	NNP	S_Disease
-	:	O
associated	VBN	O
Fas	NNP	O
mutants	NNS	O
,	,	O
dominant	JJ	O
inhibition	NN	O
of	IN	O
apoptosis	NN	O
was	VBD	O
much	RB	O
more	JJR	O
pronounced	JJ	O
in	IN	O
mutants	NNS	O
affecting	VBG	O
the	DT	O
intracellular	NN	O
,	,	O
versus	NN	O
extracellular	NN	O
,	,	O
portion	NN	O
of	IN	O
the	DT	O
Fas	NNP	O
receptor	NN	O
.	.	O

Mutations	NNS	O
causing	VBG	O
disruption	NN	O
of	IN	O
the	DT	O
intracellular	JJ	O
Fas	NNP	O
death	NN	O
domain	NN	O
also	RB	O
showed	VBD	O
a	DT	O
higher	JJR	O
penetrance	NN	O
of	IN	O
ALPS	NNP	S_Disease
phenotype	NN	O
features	NNS	O
in	IN	O
mutation	NN	O
-	:	O
bearing	NN	O
relatives	NNS	O
.	.	O

Significant	NNP	O
ALPS	NNP	S_Disease
-	:	O
related	JJ	O
morbidity	NN	O
occurred	VBD	O
in	IN	O
44	CD	O
%	NN	O
of	IN	O
relatives	NNS	O
with	IN	O
intracellular	JJ	O
mutations	NNS	O
,	,	O
versus	VBP	O
0	CD	O
%	NN	O
of	IN	O
relatives	NNS	O
with	IN	O
extracellular	JJ	O
mutations	NNS	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
location	NN	O
of	IN	O
mutations	NNS	O
within	IN	O
APT1	NNP	O
strongly	RB	O
influences	VBZ	O
the	DT	O
development	NN	O
and	CC	O
the	DT	O
severity	NN	O
of	IN	O
ALPS	NNP	S_Disease
.	.	O

Multicentric	NNP	O
origin	NN	O
of	IN	O
hemochromatosis	NN	S_Disease
gene	NN	O
(	(	O
HFE	NNP	O
)	)	O
mutations	NNS	O
.	.	O

Genetic	JJ	B_Disease
hemochromatosis	NN	E_Disease
(	(	O
GH	NNP	S_Disease
)	)	O
is	VBZ	O
believed	VBN	O
to	TO	O
be	VB	O
a	DT	O
disease	NN	O
restricted	VBN	O
to	TO	O
those	DT	O
of	IN	O
European	JJ	O
ancestry	NN	O
.	.	O

In	IN	O
northwestern	JJ	O
Europe	NNP	O
,	,	O
>	VBD	O
80	CD	O
%	NN	O
of	IN	O
GH	NNP	S_Disease
patients	NNS	O
are	VBP	O
homozygous	JJ	O
for	IN	O
one	CD	O
mutation	NN	O
,	,	O
the	DT	O
substitution	NN	O
of	IN	O
tyrosine	NN	O
for	IN	O
cysteine	NN	O
at	IN	O
position	NN	O
282	CD	O
(	(	O
C282Y	NNP	O
)	)	O
in	IN	O
the	DT	O
unprocessed	JJ	O
protein	NN	O
.	.	O

In	IN	O
a	DT	O
proportion	NN	O
of	IN	O
GH	NNP	S_Disease
patients	NNS	O
,	,	O
two	CD	O
mutations	NNS	O
are	VBP	O
present	JJ	O
,	,	O
C282Y	NNP	O
and	CC	O
H63D	NNP	O
.	.	O

The	DT	O
clinical	JJ	O
significance	NN	O
of	IN	O
this	DT	O
second	JJ	O
mutation	NN	O
is	VBZ	O
such	JJ	O
that	IN	O
it	PRP	O
appears	VBZ	O
to	TO	O
predispose	VB	O
1	CD	O
%	NN	O
-	:	O
2	CD	O
%	NN	O
of	IN	O
compound	NN	O
heterozygotes	NNS	O
to	TO	O
expression	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
distribution	NN	O
of	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
differ	VBP	O
,	,	O
C282Y	NNP	O
being	VBG	O
limited	VBN	O
to	TO	O
those	DT	O
of	IN	O
northwestern	JJ	O
European	JJ	O
ancestry	NN	O
and	CC	O
H63D	NNP	O
being	VBG	O
found	VBN	O
at	IN	O
allele	JJ	O
frequencies	NNS	O
>	VBP	O
5	CD	O
%	NN	O
,	,	O
in	IN	O
Europe	NNP	O
,	,	O
in	IN	O
countries	NNS	O
bordering	VBG	O
the	DT	O
Mediterranean	NNP	O
,	,	O
in	IN	O
the	DT	O
Middle	NNP	O
East	NNP	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
Indian	JJ	O
subcontinent	NN	O
.	.	O

The	DT	O
C282Y	NNP	O
mutation	NN	O
occurs	VBZ	O
on	IN	O
a	DT	O
haplotype	NN	O
that	WDT	O
extends	VBZ	O
<	JJ	O
/	NNP	O
=	NNP	O
6	CD	O
Mb	NNP	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
mutation	NN	O
has	VBZ	O
arisen	VBN	O
during	IN	O
the	DT	O
past	JJ	O
2	CD	O
,	,	O
000	CD	O
years	NNS	O
.	.	O

The	DT	O
H63D	NNP	O
mutation	NN	O
is	VBZ	O
older	JJR	O
and	CC	O
does	VBZ	O
not	RB	O
occur	VB	O
on	IN	O
such	PDT	O
a	DT	O
large	JJ	O
extended	JJ	O
haplotype	NN	O
,	,	O
the	DT	O
haplotype	NN	O
in	IN	O
this	DT	O
case	NN	O
extending	VBG	O
<	NNP	O
/	NNP	O
=	VBD	O
700	CD	O
kb	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
the	DT	O
finding	NN	O
of	IN	O
the	DT	O
H63D	NNP	O
and	CC	O
C282Y	NNP	O
mutations	NNS	O
on	IN	O
new	JJ	O
haplotypes	NNS	O
.	.	O

In	IN	O
Sri	NNP	O
Lanka	NNP	O
we	PRP	O
have	VBP	O
found	VBN	O
H63D	NNP	O
on	IN	O
three	CD	O
new	JJ	O
haplotypes	NNS	O
and	CC	O
have	VBP	O
found	VBN	O
C282Y	NNP	O
on	IN	O
one	CD	O
new	JJ	O
haplotype	NN	O
,	,	O
demonstrating	VBG	O
that	IN	O
these	DT	O
mutations	NNS	O
have	VBP	O
arisen	VBN	O
independently	RB	O
on	IN	O
this	DT	O
island	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
HFE	NNP	O
gene	NN	O
has	VBZ	O
been	VBN	O
the	DT	O
subject	NN	O
of	IN	O
selection	NN	O
pressure	NN	O
.	.	O

These	DT	O
selection	NN	O
pressures	NNS	O
could	MD	O
be	VB	O
due	JJ	O
to	TO	O
infectious	JJ	B_Disease
diseases	NNS	E_Disease
,	,	O
environmental	JJ	O
conditions	NNS	O
,	,	O
or	CC	O
other	JJ	O
genetic	JJ	B_Disease
disorders	NNS	E_Disease
such	JJ	O
as	IN	O
anemia	NN	S_Disease
.	.	O

A	DT	O
retrospective	JJ	O
anonymous	JJ	O
pilot	NN	O
study	NN	O
in	IN	O
screening	VBG	O
newborns	NNS	O
for	IN	O
HFE	NNP	O
mutations	NNS	O
in	IN	O
Scandinavian	JJ	O
populations	NNS	O
.	.	O

We	PRP	O
have	VBP	O
retrospectively	RB	O
analyzed	VBN	O
837	CD	O
random	JJ	O
anonymized	VBN	O
dried	JJ	O
blood	NN	O
spot	NN	O
(	(	O
DBS	NNP	O
)	)	O
samples	VBZ	O
from	IN	O
neonatal	JJ	O
screening	VBG	O
programs	NNS	O
in	IN	O
Scandinavia	NNP	O
for	IN	O
mutations	NNS	O
in	IN	O
HFE	NNP	O
,	,	O
the	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
hemochromatosis	NN	S_Disease
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
C282Y	NNP	O
allele	JJ	O
frequencies	NNS	O
of	IN	O
2	CD	O
.	.	O

3	CD	O
%	NN	O
(	(	O
+	JJ	O
2	CD	O
.	.	O

0	CD	O
%	NN	O
)	)	O
(	(	O
-	:	O
1	CD	O
.	.	O

3	CD	O
%	NN	O
)	)	O
in	IN	O
Greenland	NNP	O
,	,	O
4	CD	O
.	.	O

5	CD	O
%	NN	O
+	NNP	O
/	NNP	O
-	:	O
1	CD	O
.	.	O

9	CD	O
%	NN	O
in	IN	O
Iceland	NNP	O
,	,	O
5	CD	O
.	.	O

1	CD	O
%	NN	O
+	NNP	O
/	NNP	O
-	:	O
2	CD	O
.	.	O

3	CD	O
%	NN	O
in	IN	O
the	DT	O
Faeroe	NNP	O
Islands	NNP	O
,	,	O
and	CC	O
8	CD	O
.	.	O

2	CD	O
%	NN	O
+	NNP	O
/	NNP	O
-	:	O
2	CD	O
.	.	O

7	CD	O
%	NN	O
in	IN	O
Denmark	NNP	O
.	.	O

The	DT	O
high	JJ	O
prevalence	NN	O
of	IN	O
HFE	NNP	O
mutations	NNS	O
in	IN	O
Denmark	NNP	O
suggests	VBZ	O
that	IN	O
population	NN	O
screening	VBG	O
for	IN	O
the	DT	O
C282Y	NNP	O
mutation	NN	O
could	MD	O
be	VB	O
highly	RB	O
advantageous	JJ	O
in	IN	O
terms	NNS	O
of	IN	O
preventive	JJ	O
health	NN	O
care	NN	O
.	.	O

Long	NNP	O
-	:	O
term	NN	O
follow	SYM	O
-	:	O
up	IN	O
evaluation	NN	O
of	IN	O
C282Y	NNP	O
homozygotes	NNS	O
and	CC	O
H63D	NNP	O
/	NNP	O
C282Y	NNP	O
compound	NN	O
heterozygotes	NNS	O
will	MD	O
give	VB	O
an	DT	O
indication	NN	O
of	IN	O
the	DT	O
penetrance	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
.	.	O

Identification	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
the	DT	O
alkaptonuria	NN	S_Disease
mouse	NN	O
model	NN	O
.	.	O

Alkaptonuria	NNP	S_Disease
(	(	O
aku	NN	S_Disease
)	)	O
,	,	O
an	DT	O
inborn	JJ	B_Disease
error	NN	I_Disease
of	IN	I_Disease
metabolism	NN	E_Disease
caused	VBN	O
by	IN	O
the	DT	O
loss	NN	O
of	IN	O
homogentisate	NN	O
1	CD	O
,	,	O
2	CD	O
-	:	O
dioxygenase	NN	O
(	(	O
HGD	NNP	O
)	)	O
,	,	O
has	VBZ	O
been	VBN	O
described	VBN	O
in	IN	O
a	DT	O
mouse	NN	O
model	NN	O
created	VBN	O
by	IN	O
ethylnitrosourea	JJ	O
mutagenesis	NN	O
but	CC	O
the	DT	O
mutation	NN	O
in	IN	O
these	DT	O
mice	NN	O
has	VBZ	O
not	RB	O
previously	RB	O
been	VBN	O
identified	VBN	O
.	.	O

We	PRP	O
used	VBD	O
RT	NNP	O
-	:	O
PCR	NN	O
to	TO	O
amplify	VB	O
the	DT	O
Hgd	NNP	O
cDNA	NN	O
from	IN	O
Hgd	NNP	O
(	(	O
aku	NN	O
)	)	O
/	NN	O
Hgd	NNP	O
(	(	O
aku	NN	O
)	)	O
mice	NN	O
.	.	O

Two	CD	O
products	NNS	O
shorter	JJR	O
than	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
product	NN	O
were	VBD	O
amplified	VBN	O
.	.	O

Restriction	NN	O
mapping	NN	O
and	CC	O
DNA	NNP	O
sequencing	VBG	O
were	VBD	O
then	RB	O
used	VBN	O
to	TO	O
identify	VB	O
the	DT	O
Hgd	NNP	O
(	(	O
aku	NN	O
)	)	O
mouse	NN	O
mutation	NN	O
,	,	O
found	VBN	O
to	TO	O
be	VB	O
a	DT	O
single	JJ	O
base	NN	O
change	NN	O
in	IN	O
a	DT	O
splice	NN	O
donor	NN	O
consensus	NN	O
sequence	NN	O
,	,	O
causing	VBG	O
exon	NN	O
skipping	NN	O
and	CC	O
frame	NN	O
-	:	O
shifted	VBN	O
products	NNS	O
.	.	O

This	DT	O
base	NN	O
change	NN	O
allowed	VBD	O
us	PRP	O
to	TO	O
create	VB	O
a	DT	O
non	JJ	O
-	:	O
radioactive	JJ	O
genotyping	NN	O
assay	NN	O
for	IN	O
this	DT	O
allele	NN	O
.	.	O

Non	NNP	B_Disease
-	:	I_Disease
syndromic	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
associated	VBN	O
with	IN	O
enlarged	JJ	B_Disease
vestibular	JJ	I_Disease
aqueduct	NN	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
PDS	NNP	S_Disease
mutations	NNS	O
.	.	O

Enlarged	NNP	B_Disease
vestibular	JJ	I_Disease
aqueduct	NN	E_Disease
(	(	O
EVA	NNP	S_Disease
)	)	O
,	,	O
known	VBN	O
as	IN	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
inner	JJ	B_Disease
ear	JJ	I_Disease
abnormality	NN	E_Disease
,	,	O
has	VBZ	O
recently	RB	O
been	VBN	O
of	IN	O
particular	JJ	O
genetic	JJ	O
interest	NN	O
because	IN	O
this	DT	O
anomaly	NN	O
is	VBZ	O
inherited	VBN	O
in	IN	O
a	DT	O
recessive	JJ	O
manner	NN	O
.	.	O

The	DT	O
locus	NN	O
for	IN	O
non	JJ	B_Disease
-	:	I_Disease
syndromic	JJ	I_Disease
sensorineural	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
with	IN	O
EVA	NNP	S_Disease
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
the	DT	O
same	JJ	O
chromosomal	JJ	O
region	NN	O
,	,	O
7q31	CD	O
,	,	O
as	IN	O
the	DT	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
locus	NN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
seven	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
PDS	NNP	S_Disease
gene	NN	O
(	(	O
PDS	NNP	O
)	)	O
,	,	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
,	,	O
have	VBP	O
been	VBN	O
found	VBN	O
in	IN	O
families	NNS	O
of	IN	O
non	JJ	B_Disease
-	:	I_Disease
syndromic	JJ	I_Disease
sensorineural	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
with	IN	O
EVA	NNP	S_Disease
.	.	O

One	CD	O
family	NN	O
is	VBZ	O
homozygous	JJ	O
,	,	O
three	CD	O
families	NNS	O
are	VBP	O
compound	JJ	O
heterozygotes	NNS	O
,	,	O
and	CC	O
two	CD	O
families	NNS	O
are	VBP	O
heterozygous	JJ	O
but	CC	O
with	IN	O
no	DT	O
other	JJ	O
mutation	NN	O
detected	VBN	O
.	.	O

The	DT	O
present	JJ	O
results	NNS	O
provide	VBP	O
evidence	NN	O
that	IN	O
mutations	NNS	O
in	IN	O
PDS	NNP	O
cause	NN	O
both	DT	O
syndromic	JJ	B_Disease
and	CC	I_Disease
non	JJ	I_Disease
-	:	I_Disease
syndromic	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
.	.	O
.	.	O

Mutational	JJ	O
analysis	NN	O
and	CC	O
genotype	NN	O
-	:	O
phenotype	JJ	O
correlation	NN	O
of	IN	O
29	CD	O
unrelated	JJ	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
adrenoleukodystrophy	NN	E_Disease
.	.	O

BACKGROUND	NNP	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	NN	E_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
inherited	JJ	B_Disease
disease	NN	E_Disease
characterized	VBN	O
by	IN	O
progressive	JJ	O
neurologic	JJ	B_Disease
dysfunction	NN	E_Disease
,	,	O
occasionally	RB	O
associated	VBN	O
with	IN	O
adrenal	JJ	B_Disease
insufficiency	NN	E_Disease
.	.	O

The	DT	O
classic	JJ	O
form	NN	O
of	IN	O
ALD	NNP	S_Disease
usually	RB	O
has	VBZ	O
onset	VBN	O
in	IN	O
childhood	NN	O
(	(	O
childhood	JJ	B_Disease
cerebral	JJ	I_Disease
ALD	NNP	E_Disease
)	)	O
,	,	O
with	IN	O
rapid	JJ	O
neurologic	JJ	B_Disease
deterioration	NN	E_Disease
leading	VBG	O
to	TO	O
a	DT	O
vegetative	JJ	O
state	NN	O
.	.	O

Adult	NNP	O
-	:	O
onset	JJ	O
cerebral	JJ	B_Disease
ALD	NNP	E_Disease
also	RB	O
presents	VBZ	O
with	IN	O
rapidly	RB	O
progressive	JJ	O
neurologic	JJ	B_Disease
dysfunction	NN	E_Disease
.	.	O

Milder	NNP	O
phenotypes	NNS	O
such	JJ	O
as	IN	O
adrenomyeloneuropathy	JJ	S_Disease
and	CC	O
Addison	NNP	B_Disease
disease	NN	E_Disease
only	RB	O
also	RB	O
have	VBP	O
been	VBN	O
recognized	VBN	O
.	.	O

Despite	IN	O
discovery	NN	O
of	IN	O
the	DT	O
causative	JJ	O
gene	NN	O
,	,	O
a	DT	O
molecular	JJ	O
basis	NN	O
for	IN	O
the	DT	O
diverse	JJ	O
clinical	JJ	O
presentations	NNS	O
remains	VBZ	O
to	TO	O
be	VB	O
elucidated	VBN	O
.	.	O

OBJECTIVES	NNP	O
To	TO	O
conduct	VB	O
mutational	JJ	O
analyses	NNS	O
in	IN	O
29	CD	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
ALD	NNP	S_Disease
from	IN	O
29	CD	O
unrelated	JJ	O
families	NNS	O
,	,	O
to	TO	O
obtain	VB	O
knowledge	NN	O
of	IN	O
the	DT	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
this	DT	O
gene	NN	O
,	,	O
and	CC	O
to	TO	O
study	VB	O
genotype	JJ	O
-	:	O
phenotype	NN	O
correlations	NNS	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
.	.	O

METHODS	NNP	O
The	DT	O
29	CD	O
patients	NNS	O
comprised	VBD	O
13	CD	O
patients	NNS	O
with	IN	O
childhood	JJ	B_Disease
cerebral	JJ	I_Disease
ALD	NNP	E_Disease
,	,	O
11	CD	O
patients	NNS	O
with	IN	O
adult	JJ	O
-	:	O
onset	JJ	O
cerebral	JJ	B_Disease
ALD	NNP	E_Disease
,	,	O
and	CC	O
5	CD	O
patients	NNS	O
with	IN	O
adrenomyeloneuropathy	JJ	S_Disease
.	.	O

We	PRP	O
conducted	VBD	O
detailed	JJ	O
mutational	JJ	O
analyses	NNS	O
of	IN	O
29	CD	O
unrelated	JJ	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
ALD	NNP	S_Disease
by	IN	O
genomic	JJ	O
Southern	NNP	O
blot	NN	O
analysis	NN	O
and	CC	O
direct	JJ	O
nucleotide	JJ	O
sequence	NN	O
analysis	NN	O
of	IN	O
reverse	NN	O
transcriptase	NN	O
-	:	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
products	NNS	O
derived	VBN	O
from	IN	O
total	JJ	O
RNA	NNP	O
that	WDT	O
was	VBD	O
extracted	VBN	O
from	IN	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
,	,	O
lymphoblastoid	JJ	O
cells	NNS	O
,	,	O
or	CC	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
.	.	O

RESULTS	NNP	O
Three	CD	O
patients	NNS	O
with	IN	O
adult	JJ	O
-	:	O
onset	JJ	O
cerebral	JJ	B_Disease
ALD	NNP	E_Disease
were	VBD	O
identified	VBN	O
as	IN	O
having	VBG	O
large	JJ	O
genomic	JJ	O
rearrangements	NNS	O
.	.	O

The	DT	O
remaining	VBG	O
26	CD	O
patients	NNS	O
were	VBD	O
identified	VBN	O
as	IN	O
having	VBG	O
21	CD	O
independent	JJ	O
mutations	NNS	O
,	,	O
including	VBG	O
12	CD	O
novel	JJ	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
small	JJ	O
nucleotide	JJ	O
alterations	NNS	O
in	IN	O
the	DT	O
ALD	NNP	S_Disease
gene	NN	O
.	.	O

Eighteen	NNP	O
(	(	O
69	CD	O
%	NN	O
)	)	O
of	IN	O
26	CD	O
mutations	NNS	O
were	VBD	O
missense	JJ	O
mutations	NNS	O
.	.	O

Most	JJS	O
missense	JJ	O
mutations	NNS	O
involved	VBN	O
amino	JJ	O
acids	NNS	O
conserved	VBN	O
in	IN	O
homologous	JJ	O
gene	NN	O
products	NNS	O
,	,	O
including	VBG	O
PMP70	NNP	O
,	,	O
mALDRP	NN	O
,	,	O
and	CC	O
Pxa1p	NNP	O
.	.	O

The	DT	O
AG	NNP	O
dinucleotide	NN	O
deletion	NN	O
at	IN	O
position	NN	O
1081	CD	O
-	:	O
1082	CD	O
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
reported	VBN	O
previously	RB	O
to	TO	O
be	VB	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
in	IN	O
white	JJ	O
patients	NNS	O
(	(	O
12	CD	O
%	NN	O
-	:	O
17	CD	O
%	NN	O
)	)	O
,	,	O
was	VBD	O
also	RB	O
identified	VBN	O
as	IN	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
(	(	O
12	CD	O
%	NN	O
)	)	O
.	.	O

All	DT	O
phenotypes	NNS	O
were	VBD	O
associated	VBN	O
with	IN	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
protein	NN	O
truncation	NN	O
or	CC	O
subtle	JJ	O
amino	NN	O
acid	NN	O
changes	NNS	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
differences	NNS	O
in	IN	O
phenotypic	JJ	O
expressions	NNS	O
between	IN	O
missense	JJ	O
mutations	NNS	O
involving	VBG	O
conserved	VBD	O
amino	JJ	O
acids	NNS	O
and	CC	O
those	DT	O
involving	VBG	O
nonconserved	JJ	O
amino	JJ	O
acids	NNS	O
.	.	O

CONCLUSIONS	NNP	O
There	EX	O
are	VBP	O
no	DT	O
obvious	JJ	O
correlations	NNS	O
between	IN	O
the	DT	O
phenotypes	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
ALD	NNP	S_Disease
and	CC	O
their	PRP$	O
genotypes	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
other	JJ	O
genetic	JJ	O
or	CC	O
environmental	JJ	O
factors	NNS	O
modify	VBP	O
the	DT	O
phenotypic	NN	O
expressions	NNS	O
of	IN	O
ALD	NNP	S_Disease
.	.	O
.	.	O

A	DT	O
common	JJ	O
human	JJ	O
skin	FW	B_Disease
tumour	NN	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
activating	VBG	O
mutations	NNS	O
in	IN	O
beta	NN	O
-	:	O
catenin	NN	O
.	.	O

WNT	NNP	O
signalling	VBG	O
orchestrates	VBZ	O
a	DT	O
number	NN	O
of	IN	O
developmental	JJ	O
programs	NNS	O
.	.	O

In	IN	O
response	NN	O
to	TO	O
this	DT	O
stimulus	NN	O
,	,	O
cytoplasmic	JJ	O
beta	NN	O
-	:	O
catenin	NN	O
(	(	O
encoded	VBN	O
by	IN	O
CTNNB1	NNP	O
)	)	O
is	VBZ	O
stabilized	VBN	O
,	,	O
enabling	VBG	O
downstream	JJ	O
transcriptional	JJ	O
activation	NN	O
by	IN	O
members	NNS	O
of	IN	O
the	DT	O
LEF	NNP	O
/	NNP	O
TCF	NNP	O
family	NN	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
target	NN	O
genes	NNS	O
for	IN	O
beta	NN	O
-	:	O
catenin	NN	O
/	NN	O
TCF	NNP	O
encodes	VBZ	O
c	SYM	O
-	:	O
MYC	NNP	O
,	,	O
explaining	VBG	O
why	WRB	O
constitutive	JJ	O
activation	NN	O
of	IN	O
the	DT	O
WNT	NNP	O
pathway	NN	O
can	MD	O
lead	VB	O
to	TO	O
cancer	NN	S_Disease
,	,	O
particularly	RB	O
in	IN	O
the	DT	O
colon	NN	O
.	.	O

Most	JJS	O
colon	NN	B_Disease
cancers	NNS	E_Disease
arise	VBP	O
from	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
protein	NN	O
required	VBN	O
for	IN	O
ubiquitin	JJ	O
-	:	O
mediated	VBN	O
degradation	NN	O
of	IN	O
beta	NN	O
-	:	O
catenin	NN	O
,	,	O
but	CC	O
a	DT	O
small	JJ	O
percentage	NN	O
of	IN	O
colon	NN	B_Disease
and	CC	I_Disease
some	DT	I_Disease
other	JJ	I_Disease
cancers	NNS	E_Disease
harbour	VBP	O
beta	SYM	O
-	:	O
catenin	NN	O
-	:	O
stabilizing	NN	O
mutations	NNS	O
.	.	O

Recently	RB	O
,	,	O
we	PRP	O
discovered	VBD	O
that	IN	O
transgenic	JJ	O
mice	NN	O
expressing	VBG	O
an	DT	O
activated	VBN	O
beta	NN	O
-	:	O
catenin	NN	O
are	VBP	O
predisposed	VBN	O
to	TO	O
developing	VBG	O
skin	JJ	B_Disease
tumours	NNS	E_Disease
resembling	VBG	O
pilomatricomas	NN	S_Disease
.	.	O

Given	VBN	O
that	IN	O
the	DT	O
skin	NN	O
of	IN	O
these	DT	O
adult	NN	O
mice	NN	O
also	RB	O
exhibits	VBZ	O
signs	NNS	O
of	IN	O
de	FW	O
novo	FW	O
hair	NN	O
-	:	O
follicle	NN	O
morphogenesis	NN	O
,	,	O
we	PRP	O
wondered	VBD	O
whether	IN	O
human	JJ	O
pilomatricomas	NN	S_Disease
might	MD	O
originate	VB	O
from	IN	O
hair	NN	O
matrix	NN	O
cells	NNS	O
and	CC	O
whether	IN	O
they	PRP	O
might	MD	O
possess	VB	O
beta	SYM	O
-	:	O
catenin	NN	O
-	:	O
stabilizing	NN	O
mutations	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
explore	VBP	O
the	DT	O
cell	NN	O
origin	NN	O
and	CC	O
aetiology	NN	O
of	IN	O
this	DT	O
common	JJ	O
human	JJ	O
skin	FW	B_Disease
tumour	NN	E_Disease
.	.	O

We	PRP	O
found	VBD	O
nuclear	JJ	O
LEF	NNP	O
-	:	O
1	CD	O
in	IN	O
the	DT	O
dividing	VBG	O
tumour	NN	S_Disease
cells	NNS	O
,	,	O
providing	VBG	O
biochemical	JJ	O
evidence	NN	O
that	IN	O
pilomatricomas	NN	S_Disease
are	VBP	O
derived	VBN	O
from	IN	O
hair	NN	O
matrix	NN	O
cells	NNS	O
.	.	O

At	IN	O
least	JJS	O
75	CD	O
%	NN	O
of	IN	O
these	DT	O
tumours	NNS	S_Disease
possess	VBP	O
mutations	NNS	O
affecting	VBG	O
the	DT	O
amino	NN	O
-	:	O
terminal	NN	O
segment	NN	O
,	,	O
normally	RB	O
involved	VBN	O
in	IN	O
phosphorylation	NN	O
-	:	O
dependent	NN	O
,	,	O
ubiquitin	JJ	O
-	:	O
mediated	VBN	O
degradation	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

This	DT	O
percentage	NN	O
of	IN	O
CTNNB1	NNP	O
mutations	NNS	O
is	VBZ	O
greater	JJR	O
than	IN	O
in	IN	O
all	DT	O
other	JJ	O
human	JJ	O
tumours	NNS	S_Disease
examined	VBD	O
thus	RB	O
far	RB	O
,	,	O
and	CC	O
directly	RB	O
implicates	VBZ	O
beta	SYM	O
-	:	O
catenin	NN	O
/	NN	O
LEF	NNP	O
misregulation	NN	O
as	IN	O
the	DT	O
major	JJ	O
cause	NN	O
of	IN	O
hair	NN	O
matrix	NN	O
cell	NN	O
tumorigenesis	NN	O
in	IN	O
humans	NNS	O
.	.	O
.	.	O

The	DT	O
Pendred	NNP	B_Disease
syndrome	JJ	E_Disease
gene	NN	O
encodes	VBZ	O
a	DT	O
chloride	JJ	O
-	:	O
iodide	NN	O
transport	NN	O
protein	NN	O
.	.	O

Pendred	NNP	B_Disease
syndrome	NN	E_Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
syndromic	JJ	B_Disease
deafness	NN	E_Disease
and	CC	O
characterized	VBN	O
by	IN	O
congenital	JJ	O
sensorineural	JJ	B_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
and	CC	O
goitre	NN	S_Disease
.	.	O

This	DT	O
disorder	NN	O
was	VBD	O
mapped	VBN	O
to	TO	O
chromosome	VB	O
7	CD	O
and	CC	O
the	DT	O
gene	NN	O
causing	VBG	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
PDS	NNP	S_Disease
)	)	O
was	VBD	O
subsequently	RB	O
identified	VBN	O
by	IN	O
positional	JJ	O
cloning	NN	O
.	.	O

PDS	NNP	O
encodes	VBZ	O
a	DT	O
putative	JJ	O
transmembrane	NN	O
protein	NN	O
designated	VBD	O
pendrin	NN	O
.	.	O

Pendrin	NNP	O
is	VBZ	O
closely	RB	O
related	VBN	O
to	TO	O
a	DT	O
family	NN	O
of	IN	O
sulfate	NN	O
transport	NN	O
proteins	VBZ	O
that	WDT	O
includes	VBZ	O
the	DT	O
rat	NN	O
sulfate	NN	O
-	:	O
anion	NN	O
transporter	NN	O
(	(	O
encoded	VBN	O
by	IN	O
Sat	NNP	O
-	:	O
1	CD	O
;	:	O
29	CD	O
%	NN	O
amino	NN	O
acid	JJ	O
sequence	NN	O
identity	NN	O
)	)	O
,	,	O
the	DT	O
human	JJ	O
diastrophic	JJ	B_Disease
dysplasia	NN	E_Disease
sulfate	NN	O
transporter	NN	O
(	(	O
encoded	VBN	O
by	IN	O
DTD	NNP	O
;	:	O
32	CD	O
%	NN	O
)	)	O
and	CC	O
the	DT	O
human	JJ	O
sulfate	NN	O
transporter	NN	O
downregulated	VBN	O
in	IN	O
adenoma	NN	S_Disease
(	(	O
encoded	VBN	O
by	IN	O
DRA	NNP	O
;	:	O
45	CD	O
%	NN	O
)	)	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
this	DT	O
homology	NN	O
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
slightly	RB	O
modified	VBN	O
sulfate	NN	O
-	:	O
transporter	NN	O
signature	NN	O
sequence	NN	O
comprising	VBG	O
its	PRP$	O
putative	JJ	O
second	JJ	O
transmembrane	NN	O
domain	NN	O
,	,	O
pendrin	NN	O
has	VBZ	O
been	VBN	O
proposed	VBN	O
to	TO	O
function	VB	O
as	IN	O
a	DT	O
sulfate	NN	O
transporter	NN	O
.	.	O

We	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
detect	VB	O
evidence	NN	O
of	IN	O
sulfate	JJ	O
transport	NN	O
following	VBG	O
the	DT	O
expression	NN	O
of	IN	O
pendrin	NN	O
in	IN	O
Xenopus	NNP	O
laevis	NN	O
oocytes	NNS	O
by	IN	O
microinjection	NN	O
of	IN	O
PDS	NNP	O
cRNA	NN	O
or	CC	O
in	IN	O
Sf9	NNP	O
cells	NNS	O
following	VBG	O
infection	NN	O
with	IN	O
PDS	NNP	O
-	:	O
recombinant	NN	O
baculovirus	NN	O
.	.	O

The	DT	O
rates	NNS	O
of	IN	O
transport	NN	O
for	IN	O
iodide	NN	O
and	CC	O
chloride	NN	O
were	VBD	O
significantly	RB	O
increased	VBN	O
following	VBG	O
the	DT	O
expression	NN	O
of	IN	O
pendrin	NN	O
in	IN	O
both	DT	O
cell	NN	O
systems	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
pendrin	JJ	O
functions	NNS	O
as	IN	O
a	DT	O
transporter	NN	O
of	IN	O
chloride	NN	O
and	CC	O
iodide	NN	O
,	,	O
but	CC	O
not	RB	O
sulfate	VB	O
,	,	O
and	CC	O
may	MD	O
provide	VB	O
insight	NN	O
into	IN	O
thyroid	JJ	O
physiology	NN	O
and	CC	O
the	DT	O
pathophysiology	NN	O
of	IN	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O
.	.	O

HFE	NNP	O
mutations	NNS	O
analysis	NN	O
in	IN	O
711	CD	O
hemochromatosis	NN	S_Disease
probands	NNS	O
:	:	O
evidence	NN	O
for	IN	O
S65C	NNP	O
implication	NN	O
in	IN	O
mild	JJ	O
form	NN	O
of	IN	O
hemochromatosis	NN	S_Disease
.	.	O

Hereditary	JJ	B_Disease
hemochromatosis	NN	E_Disease
(	(	O
HH	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
common	JJ	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
genetic	JJ	I_Disease
disorder	NN	E_Disease
of	IN	O
iron	NN	O
metabolism	NN	O
.	.	O

The	DT	O
HFE	NNP	O
candidate	NN	O
gene	NN	O
encoding	VBG	O
an	DT	O
HLA	NNP	O
class	NN	O
I	PRP	O
-	:	O
like	IN	O
protein	NNS	O
involved	VBN	O
in	IN	O
HH	NNP	S_Disease
was	VBD	O
identified	VBN	O
in	IN	O
1996	CD	O
.	.	O

Two	CD	O
missense	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
described	VBN	O
C282Y	NNP	O
,	,	O
accounting	VBG	O
for	IN	O
80	CD	O
%	NN	O
to	TO	O
90	CD	O
%	NN	O
of	IN	O
HH	NNP	S_Disease
chromosomes	NNS	O
,	,	O
and	CC	O
H63D	NNP	O
,	,	O
which	WDT	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
milder	NN	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
representing	VBG	O
40	CD	O
%	NN	O
to	TO	O
70	CD	O
%	NN	O
of	IN	O
non	JJ	O
-	:	O
C282Y	NNP	O
HH	NNP	S_Disease
chromosomes	NNS	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
on	IN	O
the	DT	O
analysis	NN	O
of	IN	O
C282Y	NNP	O
,	,	O
H63D	NNP	O
,	,	O
and	CC	O
the	DT	O
193A	CD	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
substitution	NN	O
leading	VBG	O
to	TO	O
the	DT	O
S65C	NNP	O
missense	NN	O
substitution	NN	O
in	IN	O
a	DT	O
large	JJ	O
series	NN	O
of	IN	O
probands	NNS	O
and	CC	O
controls	NNS	O
.	.	O

The	DT	O
results	NNS	O
confirm	VBP	O
that	IN	O
the	DT	O
C282Y	NNP	O
substitution	NN	O
was	VBD	O
the	DT	O
main	JJ	O
mutation	NN	O
involved	VBN	O
in	IN	O
hemochromatosis	NN	S_Disease
,	,	O
accounting	VBG	O
for	IN	O
85	CD	O
%	NN	O
of	IN	O
carrier	NN	O
chromosomes	NNS	O
,	,	O
whereas	IN	O
the	DT	O
H63D	NNP	O
substitution	NN	O
represented	VBD	O
39	CD	O
%	NN	O
of	IN	O
the	DT	O
HH	NNP	S_Disease
chromosomes	NNS	O
that	WDT	O
did	VBD	O
not	RB	O
carry	VB	O
the	DT	O
C282Y	NNP	O
mutation	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
our	PRP$	O
screening	NN	O
showed	VBD	O
that	IN	O
the	DT	O
S65C	NNP	O
substitution	NN	O
was	VBD	O
significantly	RB	O
enriched	VBN	O
in	IN	O
probands	NNS	O
with	IN	O
at	IN	O
least	JJS	O
one	CD	O
chromosome	NN	O
without	IN	O
an	DT	O
assigned	JJ	O
mutation	NN	O
.	.	O

This	DT	O
substitution	NN	O
accounted	VBD	O
for	IN	O
7	CD	O
.	.	O

8	CD	O
%	NN	O
of	IN	O
HH	NNP	S_Disease
chromosomes	NNS	O
that	WDT	O
were	VBD	O
neither	DT	O
C282Y	NNP	O
nor	CC	O
H63D	NNP	O
.	.	O

This	DT	O
enrichment	NN	O
of	IN	O
S65C	NNP	O
among	IN	O
HH	NNP	S_Disease
chromosomes	NNS	O
suggests	VBZ	O
that	IN	O
the	DT	O
S65C	NNP	O
substitution	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
the	DT	O
mild	JJ	O
form	NN	O
of	IN	O
hemochromatosis	NN	S_Disease
.	.	O

Germline	NNP	O
BRCA1	NNP	O
alterations	NNS	O
in	IN	O
a	DT	O
population	NN	O
-	:	O
based	VBN	O
series	NN	O
of	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
cases	NNS	O
.	.	O

The	DT	O
objective	NN	O
of	IN	O
this	DT	O
study	NN	O
was	VBD	O
to	TO	O
provide	VB	O
more	JJR	O
accurate	JJ	O
frequency	NN	O
estimates	NNS	O
of	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
susceptibility	NN	O
gene	NN	O
1	CD	O
(	(	O
BRCA1	NNP	O
)	)	O
germline	NN	O
alterations	NNS	O
in	IN	O
the	DT	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
population	NN	O
.	.	O

To	TO	O
achieve	VB	O
this	DT	O
,	,	O
we	PRP	O
determined	VBD	O
the	DT	O
prevalence	NN	O
of	IN	O
BRCA1	NNP	O
alterations	NNS	O
in	IN	O
a	DT	O
population	NN	O
-	:	O
based	VBN	O
series	NN	O
of	IN	O
consecutive	JJ	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
cases	NNS	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
population	NN	O
-	:	O
based	VBN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
study	NN	O
reporting	VBG	O
BRCA1	NNP	O
alterations	NNS	O
derived	VBD	O
from	IN	O
a	DT	O
comprehensive	JJ	O
screen	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
.	.	O

One	CD	O
hundred	CD	O
and	CC	O
seven	CD	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
cases	NNS	O
were	VBD	O
analyzed	VBN	O
for	IN	O
BRCA1	NNP	O
alterations	NNS	O
using	VBG	O
the	DT	O
RNase	NNP	O
mismatch	NN	O
cleavage	NN	O
assay	VBP	O
followed	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
.	.	O

Two	CD	O
truncating	VBG	O
mutations	NNS	O
,	,	O
962del4	CD	O
and	CC	O
3600del11	CD	O
,	,	O
were	VBD	O
identified	VBN	O
.	.	O

Both	DT	O
patients	NNS	O
had	VBD	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
breast	NN	B_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

Several	JJ	O
novel	NN	O
as	RB	O
well	RB	O
as	IN	O
previously	RB	O
reported	VBN	O
uncharacterized	JJ	O
variants	NNS	O
were	VBD	O
also	RB	O
identified	VBN	O
,	,	O
some	DT	O
of	IN	O
which	WDT	O
were	VBD	O
associated	VBN	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
cancer	NN	S_Disease
.	.	O

The	DT	O
frequency	NN	O
distribution	NN	O
of	IN	O
common	JJ	O
polymorphisms	NN	O
was	VBD	O
determined	VBN	O
in	IN	O
the	DT	O
91	CD	O
Caucasian	JJ	O
cancer	NN	S_Disease
cases	NNS	O
in	IN	O
this	DT	O
series	NN	O
and	CC	O
24	CD	O
sister	NN	O
controls	NNS	O
using	VBG	O
allele	JJ	O
-	:	O
specific	JJ	O
amplification	NN	O
.	.	O

The	DT	O
rare	JJ	O
form	NN	O
of	IN	O
the	DT	O
Q356R	NNP	O
polymorphism	NN	O
was	VBD	O
significantly	RB	O
(	(	O
P	NNP	O
=	VBZ	O
0	CD	O
.	.	O

03	CD	O
)	)	O
associated	VBN	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
polymorphism	NN	O
may	MD	O
influence	VB	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
risk	NN	O
.	.	O

In	IN	O
summary	JJ	O
,	,	O
our	PRP$	O
data	NNS	O
suggest	VBP	O
a	DT	O
role	NN	O
for	IN	O
some	DT	O
uncharacterized	JJ	O
variants	NNS	O
and	CC	O
rare	JJ	O
forms	NNS	O
of	IN	O
polymorphisms	NNS	O
in	IN	O
determining	VBG	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
risk	NN	O
,	,	O
and	CC	O
highlight	VBD	O
the	DT	O
necessity	NN	O
to	TO	O
screen	VB	O
for	IN	O
missense	JJ	O
alterations	NNS	O
as	RB	O
well	RB	O
as	IN	O
truncating	VBG	O
mutations	NNS	O
in	IN	O
this	DT	O
population	NN	O
.	.	O

Adrenoleukodystrophy	NNP	O
-	:	O
related	JJ	O
protein	NN	O
can	MD	O
compensate	VB	O
functionally	RB	O
for	IN	O
adrenoleukodystrophy	NN	B_Disease
protein	NN	I_Disease
deficiency	NN	E_Disease
(	(	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NN	E_Disease
)	)	O
:	:	O
implications	NNS	O
for	IN	O
therapy	NN	O
.	.	O

Inherited	VBN	B_Disease
defects	NNS	E_Disease
in	IN	O
the	DT	O
peroxisomal	JJ	O
ATP	NNP	O
-	:	O
binding	NN	O
cassette	NN	O
(	(	O
ABC	NNP	O
)	)	O
transporter	NN	O
adrenoleukodystrophy	NN	S_Disease
protein	NN	O
(	(	O
ALDP	NNP	O
)	)	O
lead	NN	O
to	TO	O
the	DT	O
lethal	JJ	O
peroxisomal	JJ	B_Disease
disorder	NN	E_Disease
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	NN	E_Disease
(	(	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
)	)	O
,	,	O
for	IN	O
which	WDT	O
no	DT	O
efficient	NN	O
treatment	NN	O
has	VBZ	O
been	VBN	O
established	VBN	O
so	RB	O
far	RB	O
.	.	O

Three	CD	O
other	JJ	O
peroxisomal	JJ	O
ABC	NNP	O
transporters	NNS	O
currently	RB	O
are	VBP	O
known	VBN	O
adrenoleukodystrophy	IN	O
-	:	O
related	JJ	O
protein	NN	O
(	(	O
ALDRP	NNP	O
)	)	O
,	,	O
70	CD	O
kDa	NN	O
peroxisomal	JJ	O
membrane	NN	O
protein	NN	O
(	(	O
PMP70	NNP	O
)	)	O
and	CC	O
PMP70	NNP	O
-	:	O
related	JJ	O
protein	NN	O
.	.	O

By	IN	O
using	VBG	O
transient	NN	O
and	CC	O
stable	JJ	O
overexpression	NN	O
of	IN	O
human	JJ	O
cDNAs	NN	O
encoding	VBG	O
ALDP	NNP	O
and	CC	O
its	PRP$	O
closest	JJS	O
relative	JJ	O
ALDRP	NNP	O
,	,	O
we	PRP	O
could	MD	O
restore	VB	O
the	DT	O
impaired	JJ	O
peroxisomal	NN	O
beta	SYM	O
-	:	O
oxidation	NN	O
in	IN	O
fibroblasts	NNS	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
ALD	JJ	E_Disease
patients	NNS	O
.	.	O

The	DT	O
pathognomonic	JJ	O
accumulation	NN	O
of	IN	O
very	RB	O
long	RB	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
could	MD	O
also	RB	O
be	VB	O
prevented	VBN	O
by	IN	O
overexpression	NN	O
of	IN	O
ALDRP	NNP	O
in	IN	O
immortalized	JJ	O
X	NNP	O
-	:	O
ALD	NNP	O
cells	NNS	O
.	.	O

Immunofluorescence	NN	O
analysis	NN	O
demonstrated	VBD	O
that	IN	O
the	DT	O
functional	JJ	O
replacement	NN	O
of	IN	O
ALDP	NNP	O
by	IN	O
ALDRP	NNP	O
was	VBD	O
not	RB	O
due	JJ	O
to	TO	O
stabilization	NN	O
of	IN	O
the	DT	O
mutated	VBN	O
ALDP	NNP	O
itself	PRP	O
.	.	O

Moreover	RB	O
,	,	O
we	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
restore	VB	O
the	DT	O
peroxisomal	JJ	O
beta	NN	O
-	:	O
oxidation	NN	O
defect	NN	O
in	IN	O
the	DT	O
liver	NN	O
of	IN	O
ALDP	NNP	O
-	:	O
deficient	NN	O
mice	NN	O
by	IN	O
stimulation	NN	O
of	IN	O
ALDRP	NNP	O
and	CC	O
PMP70	NNP	O
gene	NN	O
expression	NN	O
through	IN	O
a	DT	O
dietary	JJ	O
treatment	NN	O
with	IN	O
the	DT	O
peroxisome	NN	O
proliferator	NN	O
fenofibrate	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
correction	NN	O
of	IN	O
the	DT	O
biochemical	JJ	O
defect	NN	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
could	MD	O
be	VB	O
possible	JJ	O
by	IN	O
drug	NN	O
-	:	O
induced	JJ	O
overexpression	NN	O
or	CC	O
ectopic	JJ	O
expression	NN	O
of	IN	O
ALDRP	NNP	O
.	.	O
.	.	O

Centrosome	NNP	O
amplification	NN	O
and	CC	O
a	DT	O
defective	JJ	O
G2	NNP	O
-	:	O
M	NNP	O
cell	NN	O
cycle	NN	O
checkpoint	NN	O
induce	VB	O
genetic	JJ	O
instability	NN	O
in	IN	O
BRCA1	NNP	O
exon	VBP	O
11	CD	O
isoform	NN	O
-	:	O
deficient	NN	O
cells	NNS	O
.	.	O

Germline	NNP	O
mutations	NNS	O
of	IN	O
the	DT	O
Brca1	NNP	O
tumor	NN	S_Disease
suppressor	NN	O
gene	NN	O
predispose	JJ	O
women	NNS	O
to	TO	O
breast	VB	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
.	.	O

To	TO	O
study	VB	O
mechanisms	NNS	O
underlying	VBG	O
BRCA1	NNP	O
-	:	O
related	JJ	O
tumorigenesis	NN	O
,	,	O
we	PRP	O
derived	VBD	O
mouse	RB	O
embryonic	JJ	O
fibroblast	NN	O
cells	NNS	O
carrying	VBG	O
a	DT	O
targeted	JJ	O
deletion	NN	O
of	IN	O
exon	JJ	O
11	CD	O
of	IN	O
the	DT	O
Brca1	NNP	O
gene	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
the	DT	O
mutant	JJ	O
cells	NNS	O
maintain	VBP	O
an	DT	O
intact	JJ	O
G1	NNP	O
-	:	O
S	NNP	O
cell	NN	O
cycle	NN	O
checkpoint	NN	O
and	CC	O
proliferate	VB	O
poorly	RB	O
.	.	O

However	RB	O
,	,	O
a	DT	O
defective	JJ	O
G2	NNP	O
-	:	O
M	NNP	O
checkpoint	NN	O
in	IN	O
these	DT	O
cells	NNS	O
is	VBZ	O
accompanied	VBN	O
by	IN	O
extensive	JJ	O
chromosomal	JJ	B_Disease
abnormalities	NNS	E_Disease
.	.	O

Mutant	JJ	O
fibroblasts	NNS	O
contain	VBP	O
multiple	JJ	O
,	,	O
functional	JJ	O
centrosomes	NNS	O
,	,	O
which	WDT	O
lead	VBP	O
to	TO	O
unequal	JJ	O
chromosome	NN	O
segregation	NN	O
,	,	O
abnormal	JJ	O
nuclear	JJ	O
division	NN	O
,	,	O
and	CC	O
aneuploidy	NN	S_Disease
.	.	O

These	DT	O
data	NNS	O
uncover	RB	O
an	DT	O
essential	JJ	O
role	NN	O
of	IN	O
BRCA1	NNP	O
in	IN	O
maintaining	VBG	O
genetic	JJ	O
stability	NN	O
through	IN	O
the	DT	O
regulation	NN	O
of	IN	O
centrosome	JJ	O
duplication	NN	O
and	CC	O
the	DT	O
G2	NNP	O
-	:	O
M	NNP	O
checkpoint	NN	O
and	CC	O
provide	VB	O
a	DT	O
molecular	JJ	O
basis	NN	O
for	IN	O
the	DT	O
role	NN	O
of	IN	O
BRCA1	NNP	O
in	IN	O
tumorigenesis	NN	O
.	.	O
.	.	O

Defective	JJ	O
CD95	NNP	O
/	NNP	O
APO	NNP	O
-	:	O
1	CD	O
/	JJ	O
Fas	NNP	O
signal	NN	O
complex	NN	O
formation	NN	O
in	IN	O
the	DT	O
human	JJ	O
autoimmune	NN	B_Disease
lymphoproliferative	JJ	I_Disease
syndrome	NN	I_Disease
,	,	I_Disease
type	NN	I_Disease
Ia	NNP	E_Disease
.	.	O

Heterozygous	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
CD95	NNP	O
(	(	O
APO	NNP	O
-	:	O
1	CD	O
/	NNP	O
Fas	NNP	O
)	)	O
receptor	NN	O
occur	VBP	O
in	IN	O
most	JJS	O
individuals	NNS	O
with	IN	O
autoimmune	JJ	B_Disease
lymphoproliferative	JJ	I_Disease
syndrome	NN	E_Disease
(	(	O
ALPS	NNP	S_Disease
)	)	O
and	CC	O
dominantly	RB	O
interfere	RB	O
with	IN	O
apoptosis	NN	O
by	IN	O
an	DT	O
unknown	JJ	O
mechanism	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	DT	O
local	JJ	O
or	CC	O
global	JJ	O
alterations	NNS	O
in	IN	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
cytoplasmic	JJ	O
death	NN	O
domain	NN	O
from	IN	O
nine	CD	O
independent	JJ	O
ALPS	NNP	S_Disease
CD95	NNP	O
death	NN	O
-	:	O
domain	NN	O
mutations	NNS	O
result	VBP	O
in	IN	O
a	DT	O
failure	NN	O
to	TO	O
bind	VB	O
the	DT	O
FADD	NNP	O
/	NNP	O
MORT1	NNP	O
signaling	VBG	O
protein	NN	O
.	.	O

Despite	IN	O
heterozygosity	NN	O
for	IN	O
the	DT	O
abnormal	JJ	O
allele	NN	O
,	,	O
lymphocytes	VBZ	O
from	IN	O
ALPS	NNP	S_Disease
patients	NNS	O
showed	VBD	O
markedly	RB	O
decreased	VBN	O
FADD	NNP	O
association	NN	O
and	CC	O
a	DT	O
loss	NN	O
of	IN	O
caspase	NN	O
recruitment	NN	O
and	CC	O
activation	NN	O
after	IN	O
CD95	NNP	O
crosslinking	NN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
intracytoplasmic	JJ	O
CD95	NNP	O
mutations	NNS	O
in	IN	O
ALPS	NNP	S_Disease
impair	NN	O
apoptosis	NN	O
chiefly	NN	O
by	IN	O
disrupting	VBG	O
death	NN	O
-	:	O
domain	NN	O
interactions	NNS	O
with	IN	O
the	DT	O
signaling	VBG	O
protein	NN	O
FADD	NNP	O
/	NNP	O
MORT1	NNP	O
.	.	O
.	.	O

Analysis	NN	O
of	IN	O
alkaptonuria	NN	S_Disease
(	(	O
AKU	NNP	S_Disease
)	)	O
mutations	NNS	O
and	CC	O
polymorphisms	NN	O
reveals	NNS	O
that	IN	O
the	DT	O
CCC	NNP	O
sequence	NN	O
motif	NN	O
is	VBZ	O
a	DT	O
mutational	JJ	O
hot	JJ	O
spot	NN	O
in	IN	O
the	DT	O
homogentisate	NN	O
1	CD	O
,	,	O
2	CD	O
dioxygenase	NN	O
gene	NN	O
(	(	O
HGO	NNP	O
)	)	O
.	.	O

We	PRP	O
recently	RB	O
showed	VBD	O
that	IN	O
alkaptonuria	NN	S_Disease
(	(	O
AKU	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
homogentisate	NN	O
1	CD	O
,	,	O
2	CD	O
dioxygenase	NN	O
gene	NN	O
(	(	O
HGO	NNP	O
)	)	O
.	.	O

Herein	NNP	O
we	PRP	O
describe	VBP	O
haplotype	JJ	O
and	CC	O
mutational	JJ	O
analyses	NNS	O
of	IN	O
HGO	NNP	O
in	IN	O
seven	CD	O
new	JJ	O
AKU	NNP	S_Disease
pedigrees	NNS	O
.	.	O

These	DT	O
analyses	NNS	O
identified	VBD	O
two	CD	O
novel	JJ	O
single	JJ	O
-	:	O
nucleotide	JJ	O
polymorphisms	NN	O
(	(	O
INV4	NNP	O
+	VBZ	O
31A	CD	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
and	CC	O
INV11	NNP	O
+	NNP	O
18A	CD	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
)	)	O
and	CC	O
six	CD	O
novel	JJ	O
AKU	NNP	S_Disease
mutations	NNS	O
(	(	O
INV1	NNP	O
-	:	O
1G	CD	O
-	:	O
-	:	O
>	NN	O
A	NNP	O
,	,	O
W60G	NNP	O
,	,	O
Y62C	NNP	O
,	,	O
A122D	NNP	O
,	,	O
P230T	NNP	O
,	,	O
and	CC	O
D291E	NNP	O
)	)	O
,	,	O
which	WDT	O
further	RB	O
illustrates	VBZ	O
the	DT	O
remarkable	JJ	O
allelic	JJ	O
heterogeneity	NN	O
found	VBN	O
in	IN	O
AKU	NNP	S_Disease
.	.	O

Reexamination	NN	O
of	IN	O
all	DT	O
29	CD	O
mutations	NNS	O
and	CC	O
polymorphisms	NNS	O
thus	RB	O
far	RB	O
described	VBN	O
in	IN	O
HGO	NNP	O
shows	NNS	O
that	IN	O
these	DT	O
nucleotide	IN	O
changes	NNS	O
are	VBP	O
not	RB	O
randomly	RB	O
distributed	VBN	O
;	:	O
the	DT	O
CCC	NNP	O
sequence	NN	O
motif	NN	O
and	CC	O
its	PRP$	O
inverted	JJ	O
complement	NN	O
,	,	O
GGG	NNP	O
,	,	O
are	VBP	O
preferentially	RB	O
mutated	VBN	O
.	.	O

These	DT	O
analyses	NNS	O
also	RB	O
demonstrated	VBD	O
that	IN	O
the	DT	O
nucleotide	JJ	O
substitutions	NNS	O
in	IN	O
HGO	NNP	O
do	VBP	O
not	RB	O
involve	VB	O
CpG	NNP	O
dinucleotides	NNS	O
,	,	O
which	WDT	O
illustrates	VBZ	O
important	JJ	O
differences	NNS	O
between	IN	O
HGO	NNP	O
and	CC	O
other	JJ	O
genes	NNS	O
for	IN	O
the	DT	O
occurrence	NN	O
of	IN	O
mutation	NN	O
at	IN	O
specific	JJ	O
short	JJ	O
-	:	O
sequence	NN	O
motifs	NNS	O
.	.	O

Because	IN	O
the	DT	O
CCC	NNP	O
sequence	NN	O
motifs	NNS	O
comprise	VBP	O
a	DT	O
significant	JJ	O
proportion	NN	O
(	(	O
34	CD	O
.	.	O

5	CD	O
%	NN	O
)	)	O
of	IN	O
all	DT	O
mutated	VBN	O
bases	NNS	O
that	WDT	O
have	VBP	O
been	VBN	O
observed	VBN	O
in	IN	O
HGO	NNP	O
,	,	O
we	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
CCC	NNP	O
triplet	NN	O
is	VBZ	O
a	DT	O
mutational	JJ	O
hot	JJ	O
spot	NN	O
in	IN	O
HGO	NNP	O
.	.	O

Fabry	JJ	B_Disease
disease	NN	E_Disease
:	:	O
identification	NN	O
of	IN	O
novel	JJ	O
alpha	SYM	O
-	:	O
galactosidase	NN	O
A	DT	O
mutations	NNS	O
and	CC	O
molecular	JJ	O
carrier	NN	O
detection	NN	O
by	IN	O
use	NN	O
of	IN	O
fluorescent	JJ	O
chemical	JJ	O
cleavage	NN	O
of	IN	O
mismatches	NNS	O
.	.	O

Fabry	NNP	B_Disease
disease	NN	E_Disease
(	(	O
FD	NNP	S_Disease
)	)	O
(	(	O
angiokeratoma	JJ	B_Disease
corporis	NN	I_Disease
diffusum	NN	E_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
inborn	JJ	I_Disease
error	NN	I_Disease
of	IN	I_Disease
glycosphingolipid	JJ	I_Disease
metabolism	NN	E_Disease
caused	VBN	O
by	IN	O
defects	NNS	O
in	IN	O
the	DT	O
lysosomal	JJ	O
alpha	NN	O
-	:	O
galactosidase	NN	O
A	DT	O
gene	NN	O
(	(	O
GLA	NNP	O
)	)	O
.	.	O

The	DT	O
enzymatic	JJ	O
defect	NN	O
leads	VBZ	O
to	TO	O
the	DT	O
systemic	JJ	O
accumulation	NN	O
of	IN	O
neutral	JJ	O
glycosphingolipids	NNS	O
with	IN	O
terminal	JJ	O
alpha	NN	O
-	:	O
galactosyl	NN	O
moieties	NNS	O
.	.	O

Clinically	RB	O
,	,	O
affected	VBD	O
hemizygous	JJ	O
males	NNS	O
have	VBP	O
angiokeratoma	VBN	S_Disease
,	,	O
severe	JJ	B_Disease
acroparesthesia	NN	E_Disease
,	,	O
renal	JJ	B_Disease
failure	NN	E_Disease
,	,	O
and	CC	O
vasculopathy	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
heart	NN	I_Disease
and	CC	I_Disease
brain	NN	E_Disease
.	.	O

While	IN	O
demonstration	NN	O
of	IN	O
alpha	JJ	B_Disease
-	:	I_Disease
galactosidase	NN	I_Disease
deficiency	NN	E_Disease
in	IN	O
leukocytes	NNS	O
is	VBZ	O
diagnostic	JJ	O
in	IN	O
affected	JJ	O
males	NNS	O
,	,	O
enzymatic	JJ	O
detection	NN	O
of	IN	O
female	JJ	O
carriers	NNS	O
is	VBZ	O
often	RB	O
inconclusive	JJ	O
,	,	O
due	JJ	O
to	TO	O
random	VB	O
X	NNP	O
-	:	O
chromosomal	JJ	O
inactivation	NN	O
,	,	O
underlining	VBG	O
the	DT	O
need	NN	O
of	IN	O
molecular	JJ	O
investigations	NNS	O
for	IN	O
accurate	JJ	O
genetic	JJ	O
counseling	NN	O
.	.	O

By	IN	O
use	NN	O
of	IN	O
chemical	JJ	O
cleavage	NN	O
of	IN	O
mismatches	NNS	O
adapted	VBN	O
to	TO	O
fluorescence	VB	O
-	:	O
based	VBN	O
detection	NN	O
systems	NNS	O
,	,	O
we	PRP	O
have	VBP	O
characterized	VBN	O
the	DT	O
mutations	NNS	O
underlying	VBG	O
alpha	JJ	B_Disease
-	:	I_Disease
Gal	VB	I_Disease
A	DT	I_Disease
deficiency	NN	E_Disease
in	IN	O
16	CD	O
individuals	NNS	O
from	IN	O
six	CD	O
unrelated	JJ	O
families	NNS	O
with	IN	O
FD	NNP	S_Disease
.	.	O

The	DT	O
mutational	JJ	O
spectrum	NN	O
included	VBD	O
five	CD	O
missense	NN	O
mutations	NNS	O
(	(	O
C202W	NNP	O
,	,	O
C223G	NNP	O
,	,	O
N224D	NNP	O
,	,	O
R301Q	NNP	O
,	,	O
and	CC	O
Q327K	NNP	O
)	)	O
and	CC	O
one	CD	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
[	NNP	O
IVS3	NNP	O
G	NNP	O
(	(	O
-	:	O
1	CD	O
)	)	O
-	:	O
-	:	O
>	NN	O
C	NNP	O
]	NNP	O
.	.	O

Studies	NNS	O
at	IN	O
the	DT	O
mRNA	NN	O
level	NN	O
showed	VBD	O
that	IN	O
the	DT	O
latter	NN	O
led	VBD	O
to	TO	O
altered	VB	O
pre	JJ	O
-	:	O
mRNA	NN	O
splicing	VBG	O
with	IN	O
consequent	JJ	O
alteration	NN	O
of	IN	O
the	DT	O
mRNA	JJ	O
translational	JJ	O
reading	NN	O
frame	NN	O
and	CC	O
generation	NN	O
of	IN	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
of	IN	O
translation	NN	O
.	.	O

By	IN	O
use	NN	O
of	IN	O
this	DT	O
strategy	NN	O
,	,	O
carrier	NN	O
status	NN	O
was	VBD	O
accurately	RB	O
assessed	VBN	O
in	IN	O
all	DT	O
seven	CD	O
at	IN	O
-	:	O
risk	NN	O
females	NNS	O
tested	VBN	O
,	,	O
whereas	JJ	O
enzymatic	JJ	O
dosages	NNS	O
failed	VBD	O
to	TO	O
diagnose	VB	O
or	CC	O
exclude	VB	O
heterozygosity	NN	O
.	.	O
.	.	O

Prenatal	JJ	O
diagnosis	NN	O
by	IN	O
FISH	NNP	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
caused	VBN	O
by	IN	O
duplication	NN	O
of	IN	O
PLP	NNP	O
gene	NN	O
.	.	O

A	DT	O
diagnosis	NN	O
of	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
(	(	O
MIM	NNP	O
312080	CD	O
)	)	O
was	VBD	O
made	VBN	O
in	IN	O
a	DT	O
young	JJ	O
boy	NN	O
.	.	O

No	DT	O
mutation	NN	O
in	IN	O
the	DT	O
coding	JJ	O
region	NN	O
of	IN	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
(	(	O
PLP	NNP	O
)	)	O
gene	NN	O
had	VBD	O
been	VBN	O
found	VBN	O
.	.	O

The	DT	O
boys	JJ	O
maternal	JJ	O
aunt	NN	O
came	VBD	O
for	IN	O
prenatal	JJ	O
diagnosis	NN	O
when	WRB	O
16	CD	O
+	JJ	O
weeks	NNS	O
pregnant	JJ	O
and	CC	O
carrying	VBG	O
a	DT	O
male	NN	O
fetus	NN	O
.	.	O

Samples	NNS	O
were	VBD	O
tested	VBN	O
for	IN	O
duplication	NN	O
of	IN	O
the	DT	O
PLP	NNP	O
gene	NN	O
,	,	O
by	IN	O
interphase	JJ	O
FISH	NNP	O
,	,	O
in	IN	O
lymphocyte	JJ	O
preparations	NNS	O
from	IN	O
the	DT	O
proband	NN	O
,	,	O
his	PRP$	O
aunt	NN	O
and	CC	O
an	DT	O
amniotic	JJ	O
fluid	NN	O
cell	NN	O
preparation	NN	O
from	IN	O
the	DT	O
fetus	NN	O
.	.	O

The	DT	O
proband	NN	O
was	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
the	DT	O
duplication	NN	O
,	,	O
thus	RB	O
confirming	VBG	O
the	DT	O
diagnosis	NN	O
of	IN	O
Pelizaeus	NNP	B_Disease
Merzbacher	NNP	I_Disease
disease	NN	E_Disease
,	,	O
but	CC	O
neither	CC	O
the	DT	O
aunt	NN	O
nor	CC	O
the	DT	O
fetus	NN	O
carried	VBD	O
a	DT	O
duplication	NN	O
.	.	O
.	.	O

Dominant	JJ	O
negative	JJ	O
effect	NN	O
of	IN	O
the	DT	O
APC1309	NNP	O
mutation	NN	O
:	:	O
a	DT	O
possible	JJ	O
explanation	NN	O
for	IN	O
genotype	JJ	O
-	:	O
phenotype	NN	O
correlations	NNS	O
in	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
.	.	O

Inactivation	NN	O
of	IN	O
the	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
gene	NN	O
product	NN	O
initiates	VBZ	O
colorectal	JJ	O
tumorigenesis	NN	O
.	.	O

Patients	NNS	O
with	IN	O
familial	JJ	B_Disease
APC	NNP	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
carry	VBP	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
and	CC	O
develop	VB	O
multiple	JJ	O
colorectal	JJ	B_Disease
adenomas	NN	E_Disease
and	CC	O
subsequent	JJ	O
carcinomas	NN	S_Disease
early	RB	O
in	IN	O
life	NN	O
.	.	O

The	DT	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
correlates	VBZ	O
with	IN	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
inherited	JJ	O
APC	NNP	S_Disease
mutation	NN	O
(	(	O
genotype	JJ	O
-	:	O
phenotype	NN	O
correlation	NN	O
)	)	O
.	.	O

Together	RB	O
with	IN	O
the	DT	O
fact	NN	O
that	IN	O
both	DT	O
germ	FW	O
-	:	O
line	NN	O
and	CC	O
sporadic	JJ	O
APC	NNP	S_Disease
mutations	NNS	O
cluster	NN	O
in	IN	O
the	DT	O
central	JJ	O
region	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
,	,	O
this	DT	O
points	NNS	O
to	TO	O
a	DT	O
dominant	JJ	O
negative	JJ	O
effect	NN	O
of	IN	O
certain	JJ	O
APC	NNP	S_Disease
mutants	NNS	O
.	.	O

Loss	NNP	O
of	IN	O
APC	NNP	S_Disease
function	NN	O
was	VBD	O
recently	RB	O
shown	VBN	O
to	TO	O
result	VB	O
in	IN	O
enhanced	JJ	O
beta	NN	O
-	:	O
catenin	NN	O
-	:	O
/	NN	O
Tcf	NNP	O
-	:	O
mediated	VBN	O
transcription	NN	O
in	IN	O
colon	NN	O
epithelial	JJ	O
cells	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
provide	VBP	O
experimental	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
dominant	JJ	O
negative	JJ	O
effect	NN	O
of	IN	O
APC	NNP	S_Disease
gene	NN	O
products	NNS	O
associated	VBN	O
with	IN	O
severe	JJ	O
polyposis	NN	S_Disease
.	.	O

Wild	NNP	O
-	:	O
type	NN	O
APC	NNP	S_Disease
activity	NN	O
in	IN	O
beta	NN	O
-	:	O
catenin	NN	O
-	:	O
/	NN	O
Tcf	NNP	O
-	:	O
mediated	VBD	O
transcription	NN	O
was	VBD	O
strongly	RB	O
inhibited	VBN	O
by	IN	O
a	DT	O
mutant	JJ	O
APC	NNP	S_Disease
that	WDT	O
is	VBZ	O
truncated	VBN	O
at	IN	O
codon	NN	O
1309	CD	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
mutant	JJ	O
APC	NNP	S_Disease
gene	NN	O
products	NNS	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
attenuated	JJ	B_Disease
polyposis	NN	E_Disease
(	(	O
codon	JJ	O
386	CD	O
or	CC	O
1465	CD	O
)	)	O
interfered	VBD	O
only	RB	O
weakly	JJ	O
with	IN	O
wild	JJ	O
-	:	O
type	NN	O
APC	NNP	S_Disease
activity	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
a	DT	O
molecular	JJ	O
explanation	NN	O
for	IN	O
the	DT	O
genotype	NN	O
-	:	O
phenotype	NN	O
correlation	NN	O
in	IN	O
FAP	NNP	S_Disease
patients	NNS	O
and	CC	O
support	VB	O
the	DT	O
idea	NN	O
that	IN	O
colorectal	JJ	B_Disease
tumor	NN	E_Disease
growth	NN	O
might	MD	O
be	VB	O
,	,	O
in	IN	O
part	NN	O
,	,	O
driven	VBN	O
by	IN	O
selection	NN	O
for	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
mutation	NN	O
cluster	NN	O
region	NN	O
.	.	O
.	.	O

BRCA1	NNP	O
interacts	VBZ	O
with	IN	O
components	NNS	O
of	IN	O
the	DT	O
histone	NN	O
deacetylase	NN	O
complex	NN	O
.	.	O

Germ	NNP	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NNP	O
tumor	NN	O
-	:	O
suppressor	NN	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
susceptibility	NN	O
to	TO	O
breast	VB	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

BRCA1	NNP	O
contains	VBZ	O
a	DT	O
carboxyl	NN	O
-	:	O
terminal	NN	O
domain	NN	O
(	(	O
BRCT	NNP	O
)	)	O
that	WDT	O
is	VBZ	O
shared	VBN	O
with	IN	O
several	JJ	O
other	JJ	O
proteins	NNS	O
involved	VBN	O
in	IN	O
maintaining	VBG	O
genome	JJ	O
integrity	NN	O
.	.	O

In	IN	O
an	DT	O
effort	NN	O
to	TO	O
understand	VB	O
the	DT	O
function	NN	O
of	IN	O
BRCA1	NNP	O
,	,	O
we	PRP	O
sought	VBD	O
to	TO	O
isolate	VB	O
proteins	NNS	O
that	WDT	O
interact	VBP	O
with	IN	O
the	DT	O
BRCT	NNP	O
domain	NN	O
.	.	O

Purified	NNP	O
BRCT	NNP	O
polypeptide	NN	O
was	VBD	O
used	VBN	O
as	IN	O
a	DT	O
probe	NN	O
to	TO	O
screen	VB	O
a	DT	O
human	JJ	O
placenta	NN	O
cDNA	NN	O
expression	NN	O
library	NN	O
by	IN	O
Far	NNP	O
Western	JJ	O
analysis	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
BRCA1	NNP	O
interacts	NNS	O
in	IN	O
vivo	NN	O
and	CC	O
in	IN	O
vitro	NN	O
with	IN	O
the	DT	O
Rb	NNP	O
-	:	O
binding	NN	O
proteins	NNS	O
,	,	O
RbAp46	NNP	O
and	CC	O
RbAp48	NNP	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
with	IN	O
Rb	NNP	O
.	.	O

Moreover	RB	O
,	,	O
the	DT	O
BRCT	NNP	O
domain	NN	O
associates	NNS	O
with	IN	O
the	DT	O
histone	NN	O
deacetylases	VBZ	O
HDAC1	NNP	O
and	CC	O
HDAC2	NNP	O
.	.	O

These	DT	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
BRCA1	NNP	O
interacts	VBZ	O
with	IN	O
components	NNS	O
of	IN	O
the	DT	O
histone	NN	O
deacetylase	NN	O
complex	NN	O
,	,	O
and	CC	O
therefore	RB	O
may	MD	O
explain	VB	O
the	DT	O
involvement	NN	O
of	IN	O
BRCA1	NNP	O
in	IN	O
multiple	JJ	O
processes	NNS	O
such	JJ	O
as	IN	O
transcription	NN	O
,	,	O
DNA	NNP	O
repair	NN	O
,	,	O
and	CC	O
recombination	NN	O
.	.	O
.	.	O

Combined	VBN	B_Disease
genetic	JJ	I_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
C6	NNP	I_Disease
and	CC	I_Disease
C7	NNP	E_Disease
in	IN	O
man	NN	O
.	.	O

By	IN	O
routine	JJ	O
screening	NN	O
of	IN	O
sera	NN	O
,	,	O
a	DT	O
subject	NN	O
was	VBD	O
discovered	VBN	O
who	WP	O
showed	VBD	O
a	DT	O
sub	NN	B_Disease
-	:	I_Disease
total	JJ	I_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
C6	NNP	I_Disease
and	CC	I_Disease
C7	NNP	E_Disease
.	.	O

No	DT	O
clinical	JJ	O
disease	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
this	DT	O
deficiency	NN	O
which	WDT	O
was	VBD	O
transmitted	VBN	O
through	IN	O
the	DT	O
subjects	NNS	O
family	NN	O
as	IN	O
a	DT	O
single	JJ	O
genetic	JJ	O
characteristic	NN	O
,	,	O
the	DT	O
C6	NNP	B_Disease
deficiency	NN	E_Disease
being	VBG	O
associated	VBN	O
with	IN	O
a	DT	O
silent	JJ	O
allele	NN	O
at	IN	O
the	DT	O
structural	JJ	O
locus	NN	O
.	.	O

The	DT	O
propositus	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
low	JJ	O
quantities	NNS	O
of	IN	O
an	DT	O
abnormal	JJ	O
C6	NNP	O
which	WDT	O
was	VBD	O
both	DT	O
antigenically	RB	O
deficient	NN	O
and	CC	O
smaller	JJR	O
in	IN	O
size	NN	O
than	IN	O
normal	JJ	O
C6	NNP	O
(	(	O
110	CD	O
,	,	O
000	CD	O
daltons	NNS	O
compared	VBN	O
with	IN	O
140	CD	O
,	,	O
000	CD	O
daltons	NNS	O
)	)	O
and	CC	O
small	JJ	O
quantities	NNS	O
of	IN	O
apparently	RB	O
normal	JJ	O
C7	NNP	O
.	.	O

It	PRP	O
is	VBZ	O
concluded	VBN	O
that	IN	O
the	DT	O
most	RBS	O
likely	JJ	O
explanation	NN	O
for	IN	O
this	DT	O
defect	NN	O
is	VBZ	O
that	IN	O
the	DT	O
subject	NN	O
has	VBZ	O
a	DT	O
structural	JJ	O
mutation	NN	O
in	IN	O
his	PRP$	O
C6	NNP	O
gene	NN	O
which	WDT	O
produces	VBZ	O
hyopsynthesis	NN	O
not	RB	O
only	RB	O
of	IN	O
C6	NNP	O
but	CC	O
also	RB	O
of	IN	O
the	DT	O
closely	RB	O
linked	VBN	O
gene	NN	O
for	IN	O
C7	NNP	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
the	DT	O
possibility	NN	O
that	IN	O
C6	NNP	O
and	CC	O
C7	NNP	O
may	MD	O
function	VB	O
as	IN	O
a	DT	O
single	JJ	O
genetic	JJ	O
unit	NN	O
and	CC	O
that	IN	O
the	DT	O
primary	JJ	O
transcript	NN	O
copied	VBN	O
from	IN	O
the	DT	O
genome	NN	O
includes	VBZ	O
information	NN	O
for	IN	O
both	DT	O
proteins	NNS	O
.	.	O
.	.	O

Changes	NNS	O
at	IN	O
P183	NNP	O
of	IN	O
emerin	RB	O
weaken	VB	O
its	PRP$	O
protein	NN	O
-	:	O
protein	NN	O
interactions	NNS	O
resulting	VBG	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
Emery	NNP	I_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

Emery	NNP	B_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
EDMD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
recessive	JJ	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
characterized	VBN	O
by	IN	O
early	JJ	O
contractures	NNS	B_Disease
of	IN	I_Disease
the	DT	I_Disease
elbows	NNS	I_Disease
,	,	I_Disease
Achilles	NNP	I_Disease
tendons	NNS	I_Disease
and	CC	I_Disease
spine	NN	E_Disease
,	,	O
slowly	RB	O
progressive	JJ	O
muscle	NN	B_Disease
wasting	NN	E_Disease
and	CC	O
weakness	NN	S_Disease
,	,	O
and	CC	O
cardiomyopathy	NN	S_Disease
associated	VBN	O
with	IN	O
cardiac	JJ	B_Disease
conduction	NN	I_Disease
defects	NNS	E_Disease
.	.	O

The	DT	O
emerin	NN	O
gene	NN	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
Xq28	VB	O
and	CC	O
encodes	VB	O
a	DT	O
34	CD	O
-	:	O
kDa	NN	O
serine	NN	O
-	:	O
rich	JJ	O
protein	NN	O
,	,	O
emerin	NN	O
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
localized	VBN	O
to	TO	O
the	DT	O
nuclear	JJ	O
envelope	NN	O
in	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
tissues	NNS	O
,	,	O
including	VBG	O
skeletal	JJ	O
and	CC	O
cardiac	JJ	O
muscle	NN	O
.	.	O

Mutations	NNS	O
spanning	VBG	O
the	DT	O
emerin	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
EDMD	NNP	S_Disease
.	.	O

We	PRP	O
present	VBP	O
here	RB	O
the	DT	O
effect	NN	O
,	,	O
on	IN	O
emerin	JJ	O
protein	NN	O
expression	NN	O
,	,	O
of	IN	O
two	CD	O
missense	JJ	O
mutations	NNS	O
identified	VBN	O
in	IN	O
unrelated	JJ	O
EDMD	NNP	S_Disease
patients	NNS	O
.	.	O

These	DT	O
alterations	NNS	O
predict	VBP	O
the	DT	O
replacement	NN	O
of	IN	O
a	DT	O
proline	NN	O
residue	NN	O
at	IN	O
position	NN	O
183	CD	O
with	IN	O
either	DT	O
a	DT	O
histidine	NN	O
or	CC	O
a	DT	O
threonine	NN	O
.	.	O

Biochemical	JJ	O
analysis	NN	O
has	VBZ	O
demonstrated	VBN	O
that	IN	O
the	DT	O
mobility	NN	O
and	CC	O
expression	NN	O
levels	NNS	O
of	IN	O
the	DT	O
mutant	JJ	O
forms	NNS	O
of	IN	O
emerin	NN	O
are	VBP	O
indistinguishable	JJ	O
from	IN	O
that	DT	O
of	IN	O
wild	JJ	O
-	:	O
type	NN	O
emerin	NN	O
,	,	O
but	CC	O
that	IN	O
they	PRP	O
have	VBP	O
weakened	VBN	O
interactions	NNS	O
with	IN	O
nuclear	JJ	O
lamina	JJ	O
components	NNS	O
.	.	O

In	IN	O
comparison	NN	O
with	IN	O
the	DT	O
usual	JJ	O
EDMD	NNP	S_Disease
phenotype	NN	O
,	,	O
patients	NNS	O
with	IN	O
P183	NNP	O
missense	NN	O
mutations	NNS	O
have	VBP	O
a	DT	O
later	JJ	O
age	NN	O
at	IN	O
onset	NN	O
of	IN	O
first	JJ	O
symptoms	NNS	O
,	,	O
elbow	NN	B_Disease
contractures	NNS	E_Disease
,	,	O
ankle	NN	B_Disease
contractures	NNS	E_Disease
,	,	O
upper	JJ	B_Disease
limb	NN	I_Disease
weakness	NN	E_Disease
and	CC	O
lower	JJR	B_Disease
limb	NN	I_Disease
weakness	NN	E_Disease
,	,	O
but	CC	O
there	EX	O
is	VBZ	O
no	DT	O
difference	NN	O
for	IN	O
the	DT	O
age	NN	O
at	IN	O
onset	NN	O
of	IN	O
cardiac	JJ	B_Disease
involvement	NN	E_Disease
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
of	IN	O
protein	JJ	O
studies	NNS	O
on	IN	O
patients	NNS	O
with	IN	O
missense	JJ	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
the	DT	O
clinical	JJ	O
features	NNS	O
of	IN	O
EDMD	NNP	S_Disease
.	.	O

These	DT	O
studies	NNS	O
demonstrate	VBP	O
the	DT	O
importance	NN	O
of	IN	O
proline	NN	O
183	CD	O
for	IN	O
the	DT	O
proper	JJ	O
structure	NN	O
/	NNP	O
function	NN	O
of	IN	O
emerin	NN	O
.	.	O
.	.	O

Microdeletions	NNS	O
at	IN	O
chromosome	NN	O
bands	NNS	O
1q32	CD	O
-	:	O
q41	NN	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
Van	NNP	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Van	NNP	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
VWS	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
disorder	NN	E_Disease
comprising	VBG	O
cleft	NN	B_Disease
lip	NN	E_Disease
and	CC	O
/	NN	O
or	CC	O
cleft	NN	B_Disease
palate	NN	E_Disease
and	CC	O
lip	NN	B_Disease
pits	NNS	E_Disease
.	.	O

We	PRP	O
reported	VBD	O
previously	RB	O
a	DT	O
family	NN	O
whose	WP$	O
underlying	JJ	O
mutation	NN	O
is	VBZ	O
a	DT	O
500	CD	O
-	:	O
800	CD	O
kb	JJ	O
deletion	NN	O
localized	VBN	O
to	TO	O
chromosome	VB	O
bands	NNS	O
1q32	CD	O
-	:	O
q41	NN	O
[	JJ	O
Sander	NNP	O
et	NN	O
al	NN	O
.	.	O
,	,	O
1994	CD	O
Hum	NNP	O
Mol	NNP	O
Genet	NNP	O
3	CD	O
576	CD	O
-	:	O
578	CD	O
]	NN	O
.	.	O

Along	IN	O
with	IN	O
cleft	NN	B_Disease
lip	NN	I_Disease
/	NNP	I_Disease
palate	NN	E_Disease
and	CC	O
lip	NN	B_Disease
pits	NNS	E_Disease
,	,	O
affected	VBD	O
relatives	NNS	O
exhibit	VBP	O
developmental	JJ	B_Disease
delays	NNS	E_Disease
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
function	NN	O
of	IN	O
a	DT	O
gene	NN	O
nearby	JJ	O
may	MD	O
also	RB	O
be	VB	O
disrupted	VBN	O
.	.	O

To	TO	O
further	RBR	O
localize	VB	O
the	DT	O
VWS	NNP	S_Disease
gene	NN	O
we	PRP	O
searched	VBD	O
for	IN	O
other	JJ	O
deletions	NNS	O
that	WDT	O
cause	VBP	O
VWS	NNP	S_Disease
.	.	O

An	DT	O
allele	JJ	O
loss	NN	O
assay	NN	O
was	VBD	O
performed	VBN	O
using	VBG	O
a	DT	O
novel	JJ	O
highly	RB	O
polymorphic	JJ	O
marker	NN	O
,	,	O
D1S3753	NNP	O
.	.	O

From	IN	O
a	DT	O
panel	NN	O
of	IN	O
37	CD	O
unrelated	JJ	O
individuals	NNS	O
,	,	O
we	PRP	O
detected	VBD	O
an	DT	O
allele	JJ	O
loss	NN	O
in	IN	O
one	CD	O
family	NN	O
,	,	O
indicating	VBG	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
deletion	NN	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
,	,	O
the	DT	O
phenotype	NN	O
in	IN	O
three	CD	O
generations	NNS	O
of	IN	O
affected	JJ	O
individuals	NNS	O
was	VBD	O
confined	VBN	O
to	TO	O
the	DT	O
cardinal	JJ	O
signs	NNS	O
of	IN	O
VWS	NNP	S_Disease
.	.	O

Surprisingly	RB	O
,	,	O
mapping	NN	O
of	IN	O
the	DT	O
new	JJ	O
deletion	NN	O
showed	VBD	O
that	IN	O
it	PRP	O
extended	VBD	O
0	CD	O
.	.	O

2	CD	O
-	:	O
1	CD	O
Mb	NNP	O
beyond	IN	O
the	DT	O
proximal	JJ	O
breakpoint	NN	O
for	IN	O
the	DT	O
deletion	NN	O
described	VBD	O
previously	RB	O
.	.	O

No	DT	O
deletions	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
seven	CD	O
cases	NNS	O
of	IN	O
popliteal	JJ	B_Disease
pterygia	JJ	I_Disease
syndrome	NN	E_Disease
,	,	O
76	CD	O
cases	NNS	O
of	IN	O
mixed	JJ	O
syndromic	JJ	B_Disease
forms	NNS	I_Disease
of	IN	I_Disease
cleft	NN	I_Disease
lip	NN	I_Disease
and	CC	I_Disease
palate	NN	E_Disease
,	,	O
and	CC	O
178	CD	O
cases	NNS	O
of	IN	O
nonsyndromic	JJ	B_Disease
cleft	NN	I_Disease
lip	NN	I_Disease
and	CC	I_Disease
palate	NN	E_Disease
.	.	O

Splicing	VBG	O
defects	NNS	O
in	IN	O
the	DT	O
ataxia	NN	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
gene	NN	O
,	,	O
ATM	NNP	O
:	:	O
underlying	JJ	O
mutations	NNS	O
and	CC	O
consequences	NNS	O
.	.	O

Mutations	NNS	O
resulting	VBG	O
in	IN	O
defective	JJ	O
splicing	VBG	O
constitute	NN	O
a	DT	O
significant	JJ	O
proportion	NN	O
(	(	O
30	CD	O
/	RB	O
62	CD	O
[	JJ	O
48	CD	O
%	NN	O
]	NN	O
)	)	O
of	IN	O
a	DT	O
new	JJ	O
series	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
in	IN	O
patients	NNS	O
with	IN	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
(	(	O
AT	NNP	S_Disease
)	)	O
that	WDT	O
were	VBD	O
detected	VBN	O
by	IN	O
the	DT	O
protein	NN	O
-	:	O
truncation	NN	O
assay	VBP	O
followed	VBN	O
by	IN	O
sequence	NN	O
analysis	NN	O
of	IN	O
genomic	JJ	O
DNA	NNP	O
.	.	O

Fewer	JJR	O
than	IN	O
half	NN	O
of	IN	O
the	DT	O
splicing	JJ	O
mutations	NNS	O
involved	VBD	O
the	DT	O
canonical	JJ	O
AG	NNP	O
splice	NN	O
-	:	O
acceptor	NN	O
site	NN	O
or	CC	O
GT	NNP	O
splice	SYM	O
-	:	O
donor	NN	O
site	NN	O
.	.	O

A	DT	O
higher	JJR	O
percentage	NN	O
of	IN	O
mutations	NNS	O
occurred	VBD	O
at	IN	O
less	RBR	O
stringently	RB	O
conserved	VBN	O
sites	NNS	O
,	,	O
including	VBG	O
silent	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
last	JJ	O
nucleotide	NN	O
of	IN	O
exons	NNS	O
,	,	O
mutations	NNS	O
in	IN	O
nucleotides	NNS	O
other	JJ	O
than	IN	O
the	DT	O
conserved	JJ	O
AG	NNP	O
and	CC	O
GT	NNP	O
in	IN	O
the	DT	O
consensus	NN	O
splice	NN	O
sites	NNS	O
,	,	O
and	CC	O
creation	NN	O
of	IN	O
splice	NN	O
-	:	O
acceptor	NN	O
or	CC	O
splice	NN	O
-	:	O
donor	NN	O
sites	VBZ	O
in	IN	O
either	CC	O
introns	NNS	O
or	CC	O
exons	NNS	O
.	.	O

These	DT	O
splicing	VBG	O
mutations	NNS	O
led	VBD	O
to	TO	O
a	DT	O
variety	NN	O
of	IN	O
consequences	NNS	O
,	,	O
including	VBG	O
exon	JJ	O
skipping	NN	O
and	CC	O
,	,	O
to	TO	O
a	DT	O
lesser	JJR	O
degree	NN	O
,	,	O
intron	NN	O
retention	NN	O
,	,	O
activation	NN	O
of	IN	O
cryptic	JJ	O
splice	NN	O
sites	NNS	O
,	,	O
or	CC	O
creation	NN	O
of	IN	O
new	JJ	O
splice	NN	O
sites	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
5	CD	O
of	IN	O
12	CD	O
nonsense	JJ	O
mutations	NNS	O
and	CC	O
1	CD	O
missense	NN	O
mutation	NN	O
were	VBD	O
associated	VBN	O
with	IN	O
deletion	NN	O
in	IN	O
the	DT	O
cDNA	NN	O
of	IN	O
the	DT	O
exons	NNS	O
in	IN	O
which	WDT	O
the	DT	O
mutations	NNS	O
occurred	VBD	O
.	.	O

No	DT	O
ATM	NNP	O
protein	NN	O
was	VBD	O
detected	VBN	O
by	IN	O
western	JJ	O
blotting	NN	O
in	IN	O
any	DT	O
AT	NNP	S_Disease
cell	NN	O
line	NN	O
in	IN	O
which	WDT	O
splicing	VBG	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

Several	JJ	O
cases	NNS	O
of	IN	O
exon	NN	O
skipping	NN	O
in	IN	O
both	DT	O
normal	JJ	O
controls	NNS	O
and	CC	O
patients	NNS	O
for	IN	O
whom	WP	O
no	DT	O
underlying	VBG	O
defect	NN	O
could	MD	O
be	VB	O
found	VBN	O
in	IN	O
genomic	JJ	O
DNA	NN	O
were	VBD	O
also	RB	O
observed	VBN	O
,	,	O
suggesting	VBG	O
caution	NN	O
in	IN	O
the	DT	O
interpretation	NN	O
of	IN	O
exon	JJ	O
deletions	NNS	O
observed	VBN	O
in	IN	O
ATM	NNP	O
cDNA	NN	O
when	WRB	O
there	EX	O
is	VBZ	O
no	DT	O
accompanying	VBG	O
identification	NN	O
of	IN	O
genomic	JJ	O
mutations	NNS	O
.	.	O
.	.	O

Alpha	NNP	O
-	:	O
cardiac	NN	O
actin	NN	O
is	VBZ	O
a	DT	O
novel	JJ	O
disease	NN	O
gene	NN	O
in	IN	O
familial	JJ	B_Disease
hypertrophic	JJ	I_Disease
cardiomyopathy	NN	E_Disease
.	.	O

We	PRP	O
identified	VBD	O
the	DT	O
alpha	JJ	O
-	:	O
cardiac	NN	O
actin	NN	O
gene	NN	O
(	(	O
ACTC	NNP	O
)	)	O
as	IN	O
a	DT	O
novel	JJ	O
disease	NN	O
gene	NN	O
in	IN	O
a	DT	O
pedigree	JJ	O
suffering	NN	O
from	IN	O
familial	JJ	B_Disease
hypertrophic	JJ	I_Disease
cardiomyopathy	NN	E_Disease
(	(	O
FHC	NNP	S_Disease
)	)	O
.	.	O

Linkage	NN	O
analyses	NNS	O
excluded	VBD	O
all	PDT	O
the	DT	O
previously	RB	O
reported	VBN	O
FHC	NNP	S_Disease
loci	NN	O
as	IN	O
possible	JJ	O
disease	NN	O
loci	NN	O
in	IN	O
the	DT	O
family	NN	O
studied	VBD	O
,	,	O
with	IN	O
lod	JJ	O
scores	NNS	O
varying	VBG	O
between	IN	O
-	:	O
2	CD	O
.	.	O

5	CD	O
and	CC	O
-	:	O
6	CD	O
.	.	O

0	CD	O
0	CD	O
.	.	O

Further	JJ	O
linkage	NN	O
analyses	NNS	O
of	IN	O
plausible	JJ	O
candidate	NN	O
genes	NNS	O
highly	RB	O
expressed	VBN	O
in	IN	O
the	DT	O
adult	NN	O
human	JJ	O
heart	NN	O
identified	VBD	O
ACTC	NNP	O
as	IN	O
the	DT	O
most	RBS	O
likely	JJ	O
disease	NN	O
gene	NN	O
,	,	O
showing	VBG	O
a	DT	O
maximal	JJ	O
lod	NN	O
score	NN	O
of	IN	O
3	CD	O
.	.	O

6	CD	O
6	CD	O
.	.	O

Mutation	NNP	O
analysis	NN	O
of	IN	O
ACTC	NNP	O
revealed	VBD	O
an	DT	O
Ala295Ser	NNP	O
mutation	NN	O
in	IN	O
exon	$	O
5	CD	O
close	NN	O
to	TO	O
2	CD	O
missense	NN	O
mutations	NNS	O
recently	RB	O
described	VBD	O
to	TO	O
cause	VB	O
the	DT	O
inherited	JJ	O
form	NN	O
of	IN	O
idiopathic	JJ	B_Disease
dilated	VBN	I_Disease
cardiomyopathy	NN	E_Disease
(	(	O
IDC	NNP	S_Disease
)	)	O
.	.	O

Overgrowth	NN	B_Disease
of	IN	I_Disease
oral	JJ	I_Disease
mucosa	NN	I_Disease
and	CC	I_Disease
facial	JJ	I_Disease
skin	NN	E_Disease
,	,	O
a	DT	O
novel	JJ	O
feature	NN	O
of	IN	O
aspartylglucosaminuria	NN	S_Disease
.	.	O

Aspartylglucosaminuria	NNP	S_Disease
(	(	O
AGU	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
lysosomal	JJ	B_Disease
storage	NN	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
deficiency	NN	B_Disease
of	IN	I_Disease
aspartylglucosaminidase	NN	E_Disease
(	(	O
AGA	NNP	O
)	)	O
.	.	O

The	DT	O
main	JJ	O
symptom	NN	O
is	VBZ	O
progressive	JJ	O
mental	JJ	B_Disease
retardation	NN	E_Disease
.	.	O

A	DT	O
spectrum	NN	O
of	IN	O
different	JJ	O
mutations	NNS	O
has	VBZ	O
been	VBN	O
reported	VBN	O
in	IN	O
this	DT	O
disease	NN	O
,	,	O
one	CD	O
missense	NN	O
mutation	NN	O
(	(	O
Cys163Ser	NNP	O
)	)	O
being	VBG	O
responsible	JJ	O
for	IN	O
the	DT	O
majority	NN	O
of	IN	O
Finnish	JJ	O
cases	NNS	O
.	.	O

We	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
examine	VB	O
66	CD	O
Finnish	JJ	O
AGU	NNP	S_Disease
patients	NNS	O
for	IN	O
changes	NNS	O
in	IN	O
the	DT	O
oral	JJ	O
mucosa	NN	O
and	CC	O
44	CD	O
of	IN	O
these	DT	O
for	IN	O
changes	NNS	O
in	IN	O
facial	JJ	O
skin	NN	O
.	.	O

Biopsy	NNP	O
specimens	NNS	O
of	IN	O
16	CD	O
oral	JJ	O
lesions	NNS	O
,	,	O
12	CD	O
of	IN	O
them	PRP	O
associated	VBN	O
with	IN	O
the	DT	O
teeth	NNS	O
,	,	O
plus	CC	O
two	CD	O
facial	JJ	B_Disease
lesions	NNS	E_Disease
were	VBD	O
studied	VBN	O
histologically	RB	O
.	.	O

Immunohistochemical	JJ	O
staining	NN	O
for	IN	O
AGA	NNP	O
was	VBD	O
performed	VBN	O
on	IN	O
15	CD	O
oral	JJ	O
specimens	NNS	O
.	.	O

Skin	NNP	O
was	VBD	O
seborrhoeic	VBN	O
in	IN	O
adolescent	NN	O
and	CC	O
adult	NN	O
patients	NNS	O
,	,	O
with	IN	O
erythema	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
facial	JJ	I_Disease
skin	NN	E_Disease
already	RB	O
common	JJ	O
in	IN	O
childhood	NN	O
.	.	O

Of	IN	O
44	CD	O
patients	NNS	O
,	,	O
nine	CD	O
(	(	O
20	CD	O
%	NN	O
)	)	O
had	VBD	O
facial	JJ	B_Disease
angiofibromas	NN	E_Disease
,	,	O
tumours	VBZ	S_Disease
primarily	RB	O
occurring	VBG	O
in	IN	O
association	NN	O
with	IN	O
tuberous	JJ	B_Disease
sclerosis	NN	E_Disease
.	.	O

Oedemic	NNP	B_Disease
buccal	JJ	I_Disease
mucosa	NN	E_Disease
(	(	O
leucoedema	NN	S_Disease
)	)	O
and	CC	O
gingival	JJ	B_Disease
overgrowths	NNS	E_Disease
were	VBD	O
more	RBR	O
frequent	JJ	O
in	IN	O
AGU	NNP	S_Disease
patients	NNS	O
than	IN	O
in	IN	O
controls	NNS	O
(	(	O
p	VB	O
<	RB	O
0	CD	O
.	.	O

001	CD	O
)	)	O
.	.	O

Of	IN	O
16	CD	O
oral	JJ	B_Disease
mucosal	NN	I_Disease
lesions	NNS	E_Disease
studied	VBN	O
histologically	RB	O
,	,	O
15	CD	O
represented	VBN	O
fibroepithelial	JJ	B_Disease
or	CC	I_Disease
epithelial	JJ	I_Disease
hyperplasias	NN	E_Disease
and	CC	O
were	VBD	O
reactive	JJ	O
in	IN	O
nature	NN	O
.	.	O

Cytoplasmic	NNP	O
vacuolisation	NN	O
was	VBD	O
evident	JJ	O
in	IN	O
four	CD	O
.	.	O

Immunohistochemically	RB	O
,	,	O
expression	NN	O
of	IN	O
AGA	NNP	O
in	IN	O
AGU	NNP	S_Disease
patients	NNS	O
mucosal	JJ	B_Disease
lesions	NNS	E_Disease
did	VBD	O
not	RB	O
differ	VB	O
from	IN	O
that	DT	O
seen	VBN	O
in	IN	O
corresponding	VBG	O
lesions	NNS	O
of	IN	O
normal	JJ	O
subjects	NNS	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
mucosal	NN	B_Disease
overgrowth	NN	E_Disease
in	IN	O
AGU	NNP	S_Disease
patients	NNS	O
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
be	VB	O
directly	RB	O
associated	VBN	O
with	IN	O
lysosomal	JJ	O
storage	NN	O
or	CC	O
with	IN	O
alterations	NNS	O
in	IN	O
the	DT	O
level	NN	O
of	IN	O
AGA	NNP	O
expression	NN	O
.	.	O

Characterization	NN	O
of	IN	O
a	DT	O
germline	JJ	O
mosaicism	NN	O
in	IN	O
families	NNS	O
with	IN	O
Lowe	NNP	B_Disease
syndrome	NN	E_Disease
,	,	O
and	CC	O
identification	NN	O
of	IN	O
seven	CD	O
novel	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
OCRL1	NNP	O
gene	NN	O
.	.	O

The	DT	O
oculocerebrorenal	JJ	B_Disease
syndrome	NN	I_Disease
of	IN	I_Disease
Lowe	NNP	E_Disease
(	(	O
OCRL	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
major	JJ	O
abnormalities	NNS	B_Disease
of	IN	I_Disease
eyes	NNS	I_Disease
,	,	I_Disease
nervous	JJ	I_Disease
system	NN	I_Disease
,	,	I_Disease
and	CC	I_Disease
kidneys	NNS	E_Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
OCRL1	NNP	O
gene	NN	O
have	VBP	O
been	VBN	O
associated	VBN	O
with	IN	O
the	DT	O
disease	NN	O
.	.	O

OCRL1	NNP	O
encodes	VBZ	O
a	DT	O
phosphatidylinositol	NN	O
4	CD	O
,	,	O
5	CD	O
-	:	O
biphosphate	NN	O
(	(	O
PtdIns	NNP	O
[	NNP	O
4	CD	O
,	,	O
5	CD	O
]	NNP	O
P2	NNP	O
)	)	O
5	CD	O
-	:	O
phosphatase	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
the	DT	O
OCRL1	NNP	O
gene	NN	O
in	IN	O
eight	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
OCRL	NNP	S_Disease
and	CC	O
have	VBP	O
found	VBN	O
seven	CD	O
new	JJ	O
mutations	NNS	O
and	CC	O
one	CD	O
recurrent	NN	O
in	IN	O
-	:	O
frame	NN	O
deletion	NN	O
.	.	O

Among	IN	O
the	DT	O
new	JJ	O
mutations	NNS	O
,	,	O
two	CD	O
nonsense	JJ	O
mutations	NNS	O
(	(	O
R317X	NNP	O
and	CC	O
E558X	NNP	O
)	)	O
and	CC	O
three	CD	O
other	JJ	O
frameshift	NN	O
mutations	NNS	O
caused	VBD	O
premature	JJ	O
termination	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

A	DT	O
missense	NN	O
mutation	NN	O
,	,	O
R483G	NNP	O
,	,	O
was	VBD	O
located	VBN	O
in	IN	O
the	DT	O
highly	RB	O
conserved	JJ	O
PtdIns	NNP	O
(	(	O
4	CD	O
,	,	O
5	CD	O
)	)	O
P2	VBD	O
5	CD	O
-	:	O
phosphatase	NN	O
domain	NN	O
.	.	O

Finally	RB	O
,	,	O
one	CD	O
frameshift	NN	O
mutation	NN	O
,	,	O
2799delC	CD	O
,	,	O
modifies	VBZ	O
the	DT	O
C	NNP	O
-	:	O
terminal	JJ	O
part	NN	O
of	IN	O
OCRL1	NNP	O
,	,	O
with	IN	O
an	DT	O
extension	NN	O
of	IN	O
six	CD	O
amino	JJ	O
acids	NNS	O
.	.	O

Altogether	RB	O
,	,	O
70	CD	O
%	NN	O
of	IN	O
missense	NN	O
mutations	NNS	O
are	VBP	O
located	VBN	O
in	IN	O
exon	JJ	O
15	CD	O
,	,	O
and	CC	O
52	CD	O
%	NN	O
of	IN	O
all	DT	O
mutations	NNS	O
cluster	VBP	O
in	IN	O
exons	NNS	O
11	CD	O
-	:	O
15	CD	O
.	.	O

We	PRP	O
also	RB	O
identified	VBD	O
two	CD	O
new	JJ	O
microsatellite	JJ	O
markers	NNS	O
for	IN	O
the	DT	O
OCRL1	NNP	O
locus	NN	O
,	,	O
and	CC	O
we	PRP	O
detected	VBD	O
a	DT	O
germline	JJ	O
mosaicism	NN	O
in	IN	O
one	CD	O
family	NN	O
.	.	O

This	DT	O
observation	NN	O
has	VBZ	O
direct	JJ	O
implications	NNS	O
for	IN	O
genetic	JJ	O
counseling	NN	O
of	IN	O
Lowe	NNP	B_Disease
syndrome	JJ	E_Disease
families	NNS	O
.	.	O
.	.	O

MEFV	NNP	O
-	:	O
Gene	NNP	O
analysis	NN	O
in	IN	O
armenian	JJ	O
patients	NNS	O
with	IN	O
Familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
:	:	O
diagnostic	JJ	O
value	NN	O
and	CC	O
unfavorable	JJ	O
renal	JJ	O
prognosis	NN	O
of	IN	O
the	DT	O
M694V	NNP	O
homozygous	JJ	O
genotype	NN	O
-	:	O
genetic	JJ	O
and	CC	O
therapeutic	JJ	O
implications	NNS	O
.	.	O

Familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
(	(	O
FMF	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
recessively	RB	B_Disease
inherited	JJ	I_Disease
disorder	NN	E_Disease
that	WDT	O
is	VBZ	O
common	JJ	O
in	IN	O
patients	NNS	O
of	IN	O
Armenian	JJ	O
ancestry	NN	O
.	.	O

To	TO	O
date	NN	O
,	,	O
its	PRP$	O
diagnosis	NN	O
,	,	O
which	WDT	O
can	MD	O
be	VB	O
made	VBN	O
only	RB	O
retrospectively	RB	O
,	,	O
is	VBZ	O
one	CD	O
of	IN	O
exclusion	NN	O
,	,	O
based	VBN	O
entirely	RB	O
on	IN	O
nonspecific	JJ	O
clinical	JJ	O
signs	NNS	O
that	WDT	O
result	VBP	O
from	IN	O
serosal	NN	B_Disease
inflammation	NN	E_Disease
and	CC	O
that	DT	O
may	MD	O
lead	VB	O
to	TO	O
unnecessary	JJ	O
surgery	NN	O
.	.	O

Renal	JJ	B_Disease
amyloidosis	NN	E_Disease
,	,	O
prevented	VBN	O
by	IN	O
colchicine	NN	O
,	,	O
is	VBZ	O
the	DT	O
most	RBS	O
severe	JJ	O
complication	NN	O
of	IN	O
FMF	NNP	S_Disease
,	,	O
a	DT	O
disorder	NN	O
associated	VBN	O
with	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
MEFV	NNP	O
gene	NN	O
.	.	O

To	TO	O
evaluate	VB	O
the	DT	O
diagnostic	JJ	O
and	CC	O
prognostic	JJ	O
value	NN	O
of	IN	O
MEFV	NNP	O
-	:	O
gene	NN	O
analysis	NN	O
,	,	O
we	PRP	O
investigated	VBD	O
90	CD	O
Armenian	JJ	O
FMF	NNP	S_Disease
patients	NNS	O
from	IN	O
77	CD	O
unrelated	JJ	O
families	NNS	O
that	WDT	O
were	VBD	O
not	RB	O
selected	VBN	O
through	IN	O
genetic	JJ	O
-	:	O
linkage	NN	O
analysis	NN	O
.	.	O

Eight	CD	O
mutations	NNS	O
,	,	O
one	CD	O
of	IN	O
which	WDT	O
(	(	O
R408Q	NNP	O
)	)	O
is	VBZ	O
new	JJ	O
,	,	O
were	VBD	O
found	VBN	O
to	TO	O
account	VB	O
for	IN	O
93	CD	O
%	NN	O
of	IN	O
the	DT	O
163	CD	O
independent	JJ	O
FMF	NNP	S_Disease
alleles	NNS	O
,	,	O
with	IN	O
both	DT	O
FMF	NNP	S_Disease
alleles	NNS	O
identified	VBN	O
in	IN	O
89	CD	O
%	NN	O
of	IN	O
the	DT	O
patients	NNS	O
.	.	O

In	IN	O
several	JJ	O
instances	NNS	O
,	,	O
family	NN	O
studies	NNS	O
provided	VBD	O
molecular	JJ	O
evidence	NN	O
for	IN	O
pseudodominant	JJ	O
transmission	NN	O
and	CC	O
incomplete	JJ	O
penetrance	NN	O
of	IN	O
the	DT	O
disease	NN	O
phenotype	NN	O
.	.	O

The	DT	O
M694V	NNP	O
homozygous	JJ	O
genotype	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
a	DT	O
higher	JJR	O
prevalence	NN	O
of	IN	O
renal	JJ	B_Disease
amyloidosis	NN	E_Disease
and	CC	O
arthritis	NN	S_Disease
,	,	O
compared	VBN	O
with	IN	O
other	JJ	O
genotypes	NNS	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

0002	CD	O
and	CC	O
P	NNP	O
=	NNP	O
.	.	O

006	CD	O
,	,	O
respectively	RB	O
)	)	O
.	.	O

The	DT	O
demonstration	NN	O
of	IN	O
both	CC	O
the	DT	O
diagnostic	JJ	O
and	CC	O
prognostic	JJ	O
value	NN	O
of	IN	O
MEFV	NNP	O
analysis	NN	O
and	CC	O
particular	JJ	O
modes	NNS	O
of	IN	O
inheritance	NN	O
should	MD	O
lead	VB	O
to	TO	O
new	JJ	O
ways	NNS	O
for	IN	O
management	NN	O
of	IN	O
FMF	NNP	O
-	:	O
including	VBG	O
genetic	JJ	O
counseling	NN	O
and	CC	O
therapeutic	JJ	O
decisions	NNS	O
in	IN	O
affected	JJ	O
families	NNS	O
.	.	O

Noninvasive	JJ	O
test	NN	O
for	IN	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
using	VBG	O
hair	NN	O
root	NN	O
analysis	NN	O
.	.	O

Identification	NN	O
of	IN	O
the	DT	O
FMR1	NNP	O
gene	NN	O
and	CC	O
the	DT	O
repeat	NN	O
-	:	O
amplification	NN	O
mechanism	NN	O
causing	VBG	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
led	VBD	O
to	TO	O
development	NN	O
of	IN	O
reliable	JJ	O
DNA	NNP	O
-	:	O
based	VBN	O
diagnostic	JJ	O
methods	NNS	O
,	,	O
including	VBG	O
Southern	JJ	O
blot	NN	O
hybridization	NN	O
and	CC	O
PCR	NNP	O
.	.	O

Both	DT	O
methods	NNS	O
are	VBP	O
performed	VBN	O
on	IN	O
DNA	NNP	O
isolated	VBD	O
from	IN	O
peripheral	JJ	O
blood	NN	O
cells	NNS	O
and	CC	O
measure	NN	O
the	DT	O
repeat	NN	O
size	NN	O
in	IN	O
FMR1	NNP	O
.	.	O

Using	VBG	O
an	DT	O
immunocytochemical	JJ	O
technique	NN	O
on	IN	O
blood	NN	O
smears	NNS	O
,	,	O
we	PRP	O
recently	RB	O
developed	VBD	O
a	DT	O
novel	JJ	O
test	NN	O
for	IN	O
identification	NN	O
of	IN	O
patients	NNS	O
with	IN	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

This	DT	O
method	NN	O
,	,	O
also	RB	O
called	VBD	O
"	NNP	O
antibody	NN	O
test	NN	O
,	,	O
"	JJ	O
uses	VBZ	O
monoclonal	JJ	O
antibodies	NNS	O
against	IN	O
the	DT	O
FMR1	NNP	O
gene	NN	O
product	NN	O
(	(	O
FMRP	NNP	O
)	)	O
and	CC	O
is	VBZ	O
based	VBN	O
on	IN	O
absence	NN	O
of	IN	O
FMRP	NNP	O
in	IN	O
patients	NNS	O
cells	NNS	O
.	.	O

Here	RB	O
we	PRP	O
describe	VBP	O
a	DT	O
new	JJ	O
diagnostic	JJ	O
test	NN	O
to	TO	O
identify	VB	O
male	NN	O
patients	NNS	O
with	IN	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
lack	NN	O
of	IN	O
FMRP	NNP	O
in	IN	O
their	PRP$	O
hair	NN	O
roots	NNS	O
.	.	O

Expression	NN	O
of	IN	O
FMRP	NNP	O
in	IN	O
hair	NN	O
roots	NNS	O
was	VBD	O
studied	VBN	O
by	IN	O
use	NN	O
of	IN	O
an	DT	O
FMRP	NNP	O
-	:	O
specific	JJ	O
antibody	NN	O
test	NN	O
,	,	O
and	CC	O
the	DT	O
percentage	NN	O
of	IN	O
FMRP	NNP	O
-	:	O
expressing	VBG	O
hair	NN	O
roots	NNS	O
in	IN	O
controls	NNS	O
and	CC	O
in	IN	O
male	NN	O
fragile	JJ	B_Disease
X	NN	E_Disease
patients	NNS	O
was	VBD	O
determined	VBN	O
.	.	O

Control	NN	O
individuals	NNS	O
showed	VBD	O
clear	JJ	O
expression	NN	O
of	IN	O
FMRP	NNP	O
in	IN	O
nearly	RB	O
every	DT	O
hair	NN	O
root	NN	O
,	,	O
whereas	WP	O
male	NN	O
fragile	JJ	B_Disease
X	NN	E_Disease
patients	NNS	O
lacked	JJ	O
expression	NN	O
of	IN	O
FMRP	NNP	O
in	IN	O
almost	RB	O
all	DT	O
their	PRP$	O
hair	NN	O
roots	NNS	O
.	.	O

Mentally	RB	B_Disease
retarded	JJ	E_Disease
female	NN	O
patients	NNS	O
with	IN	O
a	DT	O
full	JJ	O
mutation	NN	O
showed	VBD	O
FMRP	NNP	O
expression	NN	O
in	IN	O
only	RB	O
some	DT	O
of	IN	O
their	PRP$	O
hair	NN	O
roots	NNS	O
(	(	O
<	VB	O
55	CD	O
%	NN	O
)	)	O
,	,	O
and	CC	O
no	DT	O
overlap	NN	O
with	IN	O
normal	JJ	O
female	NN	O
controls	NNS	O
was	VBD	O
observed	VBN	O
.	.	O

The	DT	O
advantages	NNS	O
of	IN	O
this	DT	O
test	NN	O
are	VBP	O
(	(	O
1	CD	O
)	)	O
plucking	NN	O
of	IN	O
hair	NN	O
follicles	NNS	O
does	VBZ	O
no	DT	O
appreciable	JJ	O
harm	NN	O
to	TO	O
the	DT	O
mentally	RB	B_Disease
retarded	JJ	E_Disease
patient	NN	O
,	,	O
(	(	O
2	CD	O
)	)	O
hairs	NNS	O
can	MD	O
be	VB	O
sent	VBN	O
in	IN	O
a	DT	O
simple	JJ	O
envelope	NN	O
to	TO	O
a	DT	O
diagnostic	JJ	O
center	NN	O
,	,	O
and	CC	O
(	(	O
3	CD	O
)	)	O
the	DT	O
result	NN	O
of	IN	O
the	DT	O
test	NN	O
is	VBZ	O
available	JJ	O
within	IN	O
5	CD	O
h	NN	O
of	IN	O
plucking	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
this	DT	O
test	NN	O
enabled	VBD	O
us	PRP	O
to	TO	O
identify	VB	O
two	CD	O
fragile	JJ	B_Disease
X	NN	E_Disease
patients	NNS	O
who	WP	O
did	VBD	O
not	RB	O
show	VB	O
the	DT	O
full	JJ	O
mutation	NN	O
by	IN	O
analysis	NN	O
of	IN	O
DNA	NNP	O
isolated	VBD	O
from	IN	O
blood	NN	O
cells	NNS	O
.	.	O
.	.	O

In	IN	O
Swedish	JJ	O
families	NNS	O
with	IN	O
hereditary	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
,	,	O
linkage	NN	O
to	TO	O
the	DT	O
HPC1	NNP	O
locus	NN	O
on	IN	O
chromosome	NN	O
1q24	CD	O
-	:	O
25	CD	O
is	VBZ	O
restricted	VBN	O
to	TO	O
families	NNS	O
with	IN	O
early	JJ	O
-	:	O
onset	NN	O
prostate	NN	B_Disease
cancer	NN	E_Disease
.	.	O

Prostate	NNP	B_Disease
cancer	NN	E_Disease
clusters	NNS	O
in	IN	O
some	DT	O
families	NNS	O
,	,	O
and	CC	O
an	DT	O
estimated	VBN	O
5	CD	O
%	NN	O
-	:	O
10	CD	O
%	NN	O
of	IN	O
all	DT	O
cases	NNS	O
are	VBP	O
estimated	VBN	O
to	TO	O
result	VB	O
from	IN	O
inheritance	NN	O
of	IN	O
prostate	NN	O
cancer	NN	O
-	:	O
susceptibility	NN	O
genes	NNS	O
.	.	O

We	PRP	O
previously	RB	O
reported	VBD	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
the	DT	O
1q24	CD	O
-	:	O
25	CD	O
region	NN	O
(	(	O
HPC1	NNP	O
)	)	O
in	IN	O
91	CD	O
North	JJ	O
American	JJ	O
and	CC	O
Swedish	JJ	O
families	NNS	O
each	DT	O
with	IN	O
multiple	JJ	O
cases	NNS	O
of	IN	O
prostate	NN	B_Disease
cancer	NN	E_Disease
(	(	O
Smith	NNP	O
et	RB	O
al	RB	O
.	.	O

1996	CD	O
)	)	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
report	NN	O
we	PRP	O
analyze	VBP	O
40	CD	O
(	(	O
12	CD	O
original	JJ	O
and	CC	O
28	CD	O
newly	RB	O
identified	VBN	O
)	)	O
Swedish	JJ	O
families	NNS	O
with	IN	O
hereditary	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
(	(	O
HPC	NNP	S_Disease
)	)	O
that	IN	O
,	,	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
40	CD	O
markers	NNS	O
spanning	VBG	O
a	DT	O
25	CD	O
-	:	O
cM	NN	O
interval	NN	O
within	IN	O
1q24	CD	O
-	:	O
25	CD	O
,	,	O
have	VBP	O
evidence	NN	O
of	IN	O
linkage	NN	O
.	.	O

In	IN	O
the	DT	O
complete	JJ	O
set	NN	O
of	IN	O
families	NNS	O
,	,	O
a	DT	O
maximum	JJ	O
two	CD	O
-	:	O
point	NN	O
LOD	NNP	O
score	NN	O
of	IN	O
1	CD	O
.	.	O

10	CD	O
was	VBD	O
observed	VBN	O
at	IN	O
D1S413	NNP	O
(	(	O
at	IN	O
a	DT	O
recombination	NN	O
fraction	NN	O
[	NNP	O
theta	NN	O
]	NN	O
of	IN	O
.	.	O

1	CD	O
)	)	O
,	,	O
with	IN	O
a	DT	O
maximum	JJ	O
NPL	NNP	O
(	(	O
nonparametric	JJ	O
linkage	NN	O
)	)	O
Z	NNP	O
score	NN	O
of	IN	O
1	CD	O
.	.	O

64	CD	O
at	IN	O
D1S202	NNP	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

05	CD	O
)	)	O
.	.	O

The	DT	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
this	DT	O
region	NN	O
originated	VBD	O
almost	RB	O
exclusively	RB	O
from	IN	O
the	DT	O
subset	NN	O
of	IN	O
12	CD	O
early	JJ	O
-	:	O
onset	NN	O
(	(	O
age	NN	O
<	VBZ	O
65	CD	O
years	NNS	O
)	)	O
families	NNS	O
,	,	O
which	WDT	O
yielded	VBD	O
a	DT	O
maximum	JJ	O
LOD	NNP	O
score	NN	O
of	IN	O
2	CD	O
.	.	O

38	CD	O
at	IN	O
D1S413	NNP	O
(	(	O
straight	JJ	O
theta	NN	O
=	NNP	O
0	CD	O
)	)	O
and	CC	O
an	DT	O
NPL	NNP	O
Z	NNP	O
score	NN	O
of	IN	O
1	CD	O
.	.	O

95	CD	O
at	IN	O
D1S422	NNP	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

03	CD	O
)	)	O
.	.	O

Estimates	NNS	O
from	IN	O
heterogeneity	NN	O
tests	NNS	O
suggest	VBP	O
that	IN	O
,	,	O
within	IN	O
Sweden	NNP	O
,	,	O
as	RB	O
many	JJ	O
as	IN	O
50	CD	O
%	NN	O
of	IN	O
early	JJ	O
-	:	O
onset	NN	O
families	NNS	O
had	VBD	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
the	DT	O
HPC1	NNP	O
region	NN	O
.	.	O

These	DT	O
results	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
the	DT	O
hypothesis	NN	O
of	IN	O
linkage	NN	O
to	TO	O
HPC1	NNP	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
families	NNS	O
with	IN	O
prostate	NN	B_Disease
cancer	NN	E_Disease
,	,	O
particularly	RB	O
those	DT	O
with	IN	O
an	DT	O
early	JJ	O
age	NN	O
at	IN	O
diagnosis	NN	O
.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
feline	NN	O
beta	NN	B_Disease
-	:	I_Disease
glucuronidase	NN	I_Disease
deficiency	NN	E_Disease
:	:	O
an	DT	O
animal	JJ	O
model	NN	O
of	IN	O
mucopolysaccharidosis	NN	B_Disease
VII	NNP	E_Disease
.	.	O

A	DT	O
family	NN	O
of	IN	O
domestic	JJ	O
cats	NNS	O
was	VBD	O
found	VBN	O
that	IN	O
exhibited	JJ	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
abnormalities	NNS	O
consistent	VBP	O
with	IN	O
mucopolysaccharidosis	NN	B_Disease
VII	NNP	E_Disease
,	,	O
an	DT	O
autosomal	JJ	B_Disease
recessive	NN	I_Disease
lysosomal	JJ	I_Disease
storage	NN	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
beta	NN	B_Disease
-	:	I_Disease
glucuronidase	NN	I_Disease
deficiency	NN	E_Disease
.	.	O

beta	SYM	O
-	:	O
Glucuronidase	NN	O
activity	NN	O
was	VBD	O
undetectable	JJ	O
in	IN	O
affected	JJ	O
cat	NN	O
fibroblasts	NNS	O
and	CC	O
restored	VBN	O
by	IN	O
retroviral	JJ	O
gene	NN	O
transfer	NN	O
of	IN	O
rat	NN	O
beta	SYM	O
-	:	O
glucuronidase	NN	O
cDNA	NN	O
.	.	O

beta	SYM	O
-	:	O
Glucuronidase	NNP	O
mRNA	NN	O
was	VBD	O
normal	JJ	O
in	IN	O
affected	JJ	O
cat	NN	O
testis	NN	O
by	IN	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
.	.	O

Normal	JJ	O
feline	NN	O
beta	SYM	O
-	:	O
glucuronidase	NN	O
cDNA	NN	O
was	VBD	O
cloned	VBN	O
and	CC	O
characterized	VBN	O
,	,	O
and	CC	O
amplified	VBD	O
from	IN	O
affected	JJ	O
cat	NN	O
fibroblasts	NNS	O
by	IN	O
reverse	JJ	O
transcription	NN	O
coupled	VBD	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
.	.	O

There	EX	O
was	VBD	O
a	DT	O
G	NNP	O
-	:	O
to	TO	O
-	:	O
A	DT	O
transition	NN	O
in	IN	O
the	DT	O
affected	JJ	O
cat	NN	O
cDNA	NN	O
that	WDT	O
predicted	VBD	O
an	DT	O
E351K	NNP	O
substitution	NN	O
,	,	O
destroyed	VBD	O
a	DT	O
BssSI	NNP	O
site	NN	O
,	,	O
and	CC	O
eliminated	VBD	O
GUSB	NNP	O
enzymatic	JJ	O
activity	NN	O
in	IN	O
expression	NN	O
studies	NNS	O
.	.	O

Multiple	JJ	O
species	NNS	O
comparison	NN	O
and	CC	O
the	DT	O
crystal	JJ	O
structure	NN	O
of	IN	O
human	JJ	O
beta	NN	O
-	:	O
glucuronidase	NN	O
indicated	VBD	O
that	IN	O
E351	NNP	O
is	VBZ	O
a	DT	O
highly	RB	O
conserved	VBN	O
residue	NN	O
most	RBS	O
likely	JJ	O
essential	JJ	O
in	IN	O
maintenance	NN	O
of	IN	O
the	DT	O
enzymes	NNS	O
conformation	NN	O
.	.	O

BssSI	NNP	O
digestion	NN	O
of	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
products	NNS	O
amplified	VBN	O
from	IN	O
genomic	JJ	O
DNA	NNP	O
indicated	VBD	O
that	IN	O
affected	JJ	O
cats	NNS	O
were	VBD	O
homozygous	JJ	O
and	CC	O
cats	NNS	O
with	IN	O
half	JJ	O
-	:	O
normal	JJ	O
beta	SYM	O
-	:	O
glucuronidase	NN	O
activity	NN	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
missense	NN	O
mutation	NN	O
.	.	O

Carriers	NNS	O
identified	VBN	O
in	IN	O
this	DT	O
manner	NN	O
produced	VBD	O
affected	JJ	O
kittens	NNS	O
in	IN	O
prospective	JJ	O
breedings	NNS	O
,	,	O
and	CC	O
a	DT	O
feline	JJ	O
MPS	NNP	B_Disease
VII	NNP	E_Disease
breeding	VBG	O
colony	NN	O
has	VBZ	O
been	VBN	O
established	VBN	O
.	.	O
.	.	O

A	DT	O
common	JJ	O
molecular	JJ	O
basis	NN	O
for	IN	O
rearrangement	NN	B_Disease
disorders	NNS	E_Disease
on	IN	O
chromosome	NN	O
22q11	CD	O
.	.	O

The	DT	O
chromosome	NN	O
22q11	CD	O
region	NN	O
is	VBZ	O
susceptible	JJ	O
to	TO	O
rearrangements	NNS	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
congenital	JJ	B_Disease
anomaly	NN	I_Disease
disorders	NNS	E_Disease
and	CC	O
malignant	JJ	B_Disease
tumors	NNS	E_Disease
.	.	O

Three	CD	O
congenital	JJ	B_Disease
anomaly	NN	I_Disease
disorders	NNS	E_Disease
,	,	O
cat	SYM	B_Disease
-	:	I_Disease
eye	NN	I_Disease
syndrome	NN	E_Disease
,	,	O
der	NN	B_Disease
(	(	I_Disease
)	)	I_Disease
syndrome	NN	E_Disease
and	CC	O
velo	NN	B_Disease
-	:	I_Disease
cardio	NN	I_Disease
-	:	I_Disease
facial	JJ	I_Disease
syndrome	NN	E_Disease
/	NNP	O
DiGeorge	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
VCFS	NNP	S_Disease
/	NNP	O
DGS	NNP	S_Disease
)	)	O
are	VBP	O
associated	VBN	O
with	IN	O
tetrasomy	NN	O
,	,	O
trisomy	NN	O
or	CC	O
monosomy	NN	O
,	,	O
respectively	RB	O
,	,	O
for	IN	O
part	NN	O
of	IN	O
chromosome	NN	O
22q11	CD	O
.	.	O

VCFS	NNP	S_Disease
/	NNP	O
DGS	NNP	S_Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
syndrome	NN	O
associated	VBN	O
with	IN	O
22q11	CD	O
rearrangements	NNS	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
determine	VB	O
whether	IN	O
there	EX	O
are	VBP	O
particular	JJ	O
regions	NNS	O
on	IN	O
22q11	CD	O
that	WDT	O
are	VBP	O
prone	JJ	O
to	TO	O
rearrangements	NNS	O
,	,	O
the	DT	O
deletion	NN	O
end	NN	O
-	:	O
points	NNS	O
in	IN	O
a	DT	O
large	JJ	O
number	NN	O
of	IN	O
VCFS	NNP	S_Disease
/	NNP	O
DGS	NNP	S_Disease
patients	NNS	O
were	VBD	O
defined	VBN	O
by	IN	O
haplotype	JJ	O
analysis	NN	O
.	.	O

Most	JJS	O
VCFS	NNP	S_Disease
/	NNP	O
DGS	NNP	S_Disease
patients	NNS	O
have	VBP	O
a	DT	O
similar	JJ	O
3	CD	O
Mb	NNP	O
deletion	NN	O
,	,	O
some	DT	O
have	VBP	O
a	DT	O
nested	JJ	O
distal	JJ	O
deletion	NN	O
breakpoint	NN	O
resulting	VBG	O
in	IN	O
a	DT	O
1	CD	O
.	.	O

5	CD	O
Mb	NNP	O
deletion	NN	O
and	CC	O
a	DT	O
few	JJ	O
rare	JJ	O
patients	NNS	O
have	VBP	O
unique	JJ	O
deletions	NNS	O
or	CC	O
translocations	NNS	O
.	.	O

The	DT	O
high	JJ	O
prevalence	NN	O
of	IN	O
the	DT	O
disorder	NN	O
in	IN	O
the	DT	O
population	NN	O
and	CC	O
the	DT	O
fact	NN	O
that	IN	O
most	JJS	O
cases	NNS	O
occur	VBP	O
sporadically	RB	O
suggest	VBP	O
that	IN	O
sequences	NNS	O
at	IN	O
or	CC	O
near	IN	O
the	DT	O
breakpoints	NNS	O
confer	VBP	O
susceptibility	NN	O
to	TO	O
chromosome	VB	O
rearrangements	NNS	O
.	.	O

To	TO	O
investigate	VB	O
this	DT	O
hypothesis	NN	O
,	,	O
we	PRP	O
developed	VBD	O
hamster	JJR	O
-	:	O
human	JJ	O
somatic	JJ	O
hybrid	NN	O
cell	NN	O
lines	NNS	O
from	IN	O
VCFS	NNP	S_Disease
/	NNP	O
DGS	NNP	S_Disease
patients	NNS	O
with	IN	O
all	DT	O
three	CD	O
classes	NNS	O
of	IN	O
deletions	NNS	O
and	CC	O
we	PRP	O
now	RB	O
show	VBP	O
that	IN	O
the	DT	O
breakpoints	NNS	O
occur	VBP	O
within	IN	O
similar	JJ	O
low	JJ	O
copy	NN	O
repeats	NNS	O
,	,	O
termed	VBD	O
LCR22s	NNP	O
.	.	O

To	TO	O
support	VB	O
this	DT	O
idea	NN	O
further	RB	O
,	,	O
we	PRP	O
identified	VBD	O
a	DT	O
family	NN	O
that	WDT	O
carries	VBZ	O
an	DT	O
interstitial	JJ	O
duplication	NN	O
of	IN	O
the	DT	O
same	JJ	O
3	CD	O
Mb	NNP	O
region	NN	O
that	WDT	O
is	VBZ	O
deleted	VBN	O
in	IN	O
VCFS	NNP	S_Disease
/	NNP	O
DGS	NNP	S_Disease
patients	NNS	O
.	.	O

We	PRP	O
present	JJ	O
models	NNS	O
to	TO	O
explain	VB	O
how	WRB	O
the	DT	O
LCR22s	NNP	O
can	MD	O
mediate	VB	O
different	JJ	O
homologous	JJ	O
recombination	NN	O
events	NNS	O
,	,	O
thereby	RB	O
generating	VBG	O
a	DT	O
number	NN	O
of	IN	O
rearrangements	NNS	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
congenital	JJ	B_Disease
anomaly	NN	I_Disease
disorders	NNS	E_Disease
.	.	O

We	PRP	O
identified	VBD	O
five	CD	O
additional	JJ	O
copies	NNS	O
of	IN	O
the	DT	O
LCR22	NNP	O
on	IN	O
22q11	CD	O
that	WDT	O
may	MD	O
mediate	VB	O
other	JJ	O
rearrangements	NNS	O
leading	VBG	O
to	TO	O
disease	VB	O
.	.	O

Functional	JJ	O
consequences	NNS	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
early	JJ	O
growth	NN	O
response	NN	O
2	CD	O
gene	NN	O
(	(	O
EGR2	NNP	O
)	)	O
correlate	NN	O
with	IN	O
severity	NN	O
of	IN	O
human	JJ	O
myelinopathies	NNS	S_Disease
.	.	O

The	DT	O
early	JJ	O
growth	NN	O
response	NN	O
2	CD	O
gene	NN	O
(	(	O
EGR2	NNP	O
)	)	O
is	VBZ	O
a	DT	O
Cys2His2zinc	NNP	O
finger	NN	O
transcription	NN	O
factor	NN	O
which	WDT	O
is	VBZ	O
thought	VBN	O
to	TO	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
peripheral	JJ	O
nervous	JJ	O
system	NN	O
myelination	NN	O
.	.	O

This	DT	O
idea	NN	O
is	VBZ	O
based	VBN	O
partly	RB	O
on	IN	O
the	DT	O
phenotype	NN	O
of	IN	O
homozygous	JJ	O
Krox20	NNP	O
(	(	O
Egr2	NNP	O
)	)	O
knockout	NN	O
mice	NN	O
,	,	O
which	WDT	O
display	VBP	O
hypomyelination	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
PNS	NNP	E_Disease
and	CC	O
a	DT	O
block	NN	O
of	IN	O
Schwann	NNP	O
cells	NNS	O
at	IN	O
an	DT	O
early	JJ	O
stage	NN	O
of	IN	O
differentiation	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
EGR2	NNP	O
gene	NN	O
have	VBP	O
recently	RB	O
been	VBN	O
associated	VBN	O
with	IN	O
the	DT	O
inherited	JJ	B_Disease
peripheral	JJ	I_Disease
neuropathies	NNS	E_Disease
Charcot	NNP	B_Disease
-	:	I_Disease
Marie	NNP	I_Disease
-	:	I_Disease
Tooth	NNP	I_Disease
type	VBZ	I_Disease
1	CD	E_Disease
,	,	O
Dejerine	NNP	B_Disease
-	:	I_Disease
Sottas	NNP	I_Disease
syndrome	NN	E_Disease
and	CC	O
congenital	JJ	B_Disease
hypomyelinating	NN	I_Disease
neuropathy	NN	E_Disease
.	.	O

Three	CD	O
of	IN	O
the	DT	O
four	CD	O
EGR2	NNP	O
mutations	NNS	O
are	VBP	O
dominant	JJ	O
and	CC	O
occur	VB	O
within	IN	O
the	DT	O
zinc	NN	O
finger	NN	O
DNA	NNP	O
-	:	O
binding	NN	O
domain	NN	O
.	.	O

The	DT	O
fourth	JJ	O
mutation	NN	O
is	VBZ	O
recessive	JJ	O
and	CC	O
affects	VBZ	O
the	DT	O
inhibitory	NN	O
domain	NN	O
(	(	O
R1	NNP	O
)	)	O
that	WDT	O
binds	VBZ	O
the	DT	O
NAB	NNP	O
transcriptional	JJ	O
co	NN	O
-	:	O
repressors	NNS	O
.	.	O

A	DT	O
combination	NN	O
of	IN	O
DNA	NNP	O
-	:	O
binding	NN	O
assays	NNS	O
and	CC	O
transcriptional	JJ	O
analysis	NN	O
was	VBD	O
used	VBN	O
to	TO	O
determine	VB	O
the	DT	O
functional	JJ	O
consequences	NNS	O
of	IN	O
these	DT	O
mutations	NNS	O
.	.	O

The	DT	O
zinc	NN	O
finger	NN	O
mutations	NNS	O
affect	VBP	O
DNA	NNP	O
binding	NN	O
and	CC	O
the	DT	O
amount	NN	O
of	IN	O
residual	JJ	O
binding	VBG	O
directly	RB	O
correlates	VBZ	O
with	IN	O
disease	NN	O
severity	NN	O
.	.	O

The	DT	O
R1	NNP	O
domain	NN	O
mutation	NN	O
prevents	VBZ	O
interaction	NN	O
of	IN	O
EGR2	NNP	O
with	IN	O
the	DT	O
NAB	NNP	O
co	SYM	O
-	:	O
repressors	NNS	O
and	CC	O
thereby	NN	O
increases	NNS	O
transcriptional	JJ	O
activity	NN	O
.	.	O

These	DT	O
data	NNS	O
provide	VBP	O
insight	NN	O
into	IN	O
the	DT	O
possible	JJ	O
disease	NN	O
mechanisms	NNS	O
underlying	VBG	O
EGR2	NNP	O
mutations	NNS	O
and	CC	O
the	DT	O
reason	NN	O
for	IN	O
varying	VBG	O
severity	NN	O
and	CC	O
differences	NNS	O
in	IN	O
inheritance	NN	O
patterns	NNS	O
.	.	O
.	.	O

Autosomal	NNP	B_Disease
recessive	JJ	I_Disease
familial	JJ	I_Disease
neurohypophyseal	NN	I_Disease
diabetes	VBZ	I_Disease
insipidus	NN	E_Disease
with	IN	O
continued	JJ	O
secretion	NN	O
of	IN	O
mutant	JJ	O
weakly	JJ	O
active	JJ	O
vasopressin	NN	O
.	.	O

Familial	JJ	B_Disease
neurohypophyseal	NN	I_Disease
diabetes	NNS	I_Disease
insipidus	VBP	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
post	NN	O
-	:	O
natal	JJ	O
development	NN	O
of	IN	O
arginine	NN	B_Disease
vasopressin	NN	I_Disease
(	(	I_Disease
AVP	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
due	JJ	O
to	TO	O
mutations	NNS	O
in	IN	O
the	DT	O
AVP	NNP	O
gene	NN	O
.	.	O

All	DT	O
published	VBN	O
mutations	NNS	O
affect	VBP	O
the	DT	O
signal	JJ	O
peptide	NN	O
or	CC	O
the	DT	O
neurophysin	JJ	O
-	:	O
II	NNP	O
carrier	NN	O
protein	NN	O
and	CC	O
are	VBP	O
presumed	VBN	O
to	TO	O
interfere	VB	O
with	IN	O
processing	NN	O
of	IN	O
the	DT	O
preprohormone	NN	O
,	,	O
leading	VBG	O
to	TO	O
neuronal	JJ	B_Disease
damage	NN	E_Disease
.	.	O

We	PRP	O
studied	VBD	O
an	DT	O
unusual	JJ	O
Palestinian	JJ	O
family	NN	O
consisting	VBG	O
of	IN	O
asymptomatic	JJ	O
first	JJ	O
cousin	NN	O
parents	NNS	O
and	CC	O
three	CD	O
children	NNS	O
affected	VBD	O
with	IN	O
neurohypophyseal	JJ	B_Disease
diabetes	NNS	I_Disease
insipidus	VBP	E_Disease
,	,	O
suggesting	VBG	O
autosomal	JJ	O
recessive	JJ	O
inheritance	NN	O
.	.	O

All	DT	O
three	CD	O
affected	VBD	O
children	NNS	O
were	VBD	O
homozygous	JJ	O
and	CC	O
the	DT	O
parents	NNS	O
heterozygous	JJ	O
for	IN	O
a	DT	O
single	JJ	O
novel	NN	O
mutation	NN	O
(	(	O
C301	NNP	O
-	:	O
>	NN	O
T	NNP	O
)	)	O
in	IN	O
exon	$	O
1	CD	O
,	,	O
replacing	VBG	O
Pro7	NNP	O
of	IN	O
mature	NN	O
AVP	NNP	O
with	IN	O
Leu	NNP	O
(	(	O
Leu	NNP	O
-	:	O
AVP	NN	O
)	)	O
.	.	O

Leu	NNP	O
-	:	O
AVP	NNP	O
was	VBD	O
a	DT	O
weak	JJ	O
agonist	NN	O
with	IN	O
approximately	RB	O
30	CD	O
-	:	O
fold	NN	O
reduced	VBD	O
binding	VBG	O
to	TO	O
the	DT	O
human	JJ	O
V2	NNP	O
receptor	NN	O
.	.	O

Measured	VBN	O
by	IN	O
radioimmunoassay	NN	O
with	IN	O
a	DT	O
synthetic	JJ	O
Leu	NNP	O
-	:	O
AVP	NNP	O
standard	NN	O
,	,	O
serum	NN	O
Leu	NNP	O
-	:	O
AVP	NN	O
levels	NNS	O
were	VBD	O
elevated	VBN	O
in	IN	O
all	DT	O
three	CD	O
children	NNS	O
and	CC	O
further	RBR	O
increased	VBD	O
during	IN	O
water	NN	O
deprivation	NN	O
to	TO	O
as	RB	O
high	JJ	O
as	IN	O
30	CD	O
times	NNS	O
normal	JJ	O
.	.	O

The	DT	O
youngest	JJS	O
child	NN	O
(	(	O
2	CD	O
years	NNS	O
old	JJ	O
)	)	O
was	VBD	O
only	RB	O
mildly	RB	O
affected	VBN	O
but	CC	O
had	VBD	O
Leu	NNP	O
-	:	O
AVP	NN	O
levels	NNS	O
similar	JJ	O
to	TO	O
her	PRP$	O
severely	RB	O
affected	JJ	O
8	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
brother	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
unknown	JJ	O
mechanisms	NNS	O
may	MD	O
partially	RB	O
compensate	VB	O
for	IN	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
active	JJ	I_Disease
AVP	NNP	E_Disease
in	IN	O
very	RB	O
young	JJ	O
children	NNS	O
.	.	O
.	.	O

X	JJ	O
inactivation	NN	O
and	CC	O
somatic	JJ	O
cell	NN	O
selection	NN	O
rescue	NN	O
female	JJ	O
mice	NN	O
carrying	VBG	O
a	DT	O
Piga	NNP	O
-	:	O
null	JJ	O
mutation	NN	O
.	.	O

A	DT	O
somatic	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
X	NNP	O
linked	VBD	O
PIGA	NNP	O
gene	NN	O
is	VBZ	O
responsible	JJ	O
for	IN	O
the	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
glycosyl	NN	I_Disease
phosphatidylinositol	NN	I_Disease
(	(	I_Disease
GPI	NNP	I_Disease
)	)	I_Disease
-	:	I_Disease
anchored	JJ	I_Disease
proteins	NNS	E_Disease
on	IN	O
blood	NN	O
cells	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
paroxysmal	JJ	B_Disease
nocturnal	JJ	I_Disease
hemoglobinuria	NN	E_Disease
.	.	O

No	DT	O
inherited	JJ	O
form	NN	O
of	IN	O
GPI	NNP	B_Disease
-	:	I_Disease
anchor	NN	I_Disease
deficiency	NN	E_Disease
has	VBZ	O
been	VBN	O
described	VBN	O
.	.	O

Because	IN	O
conventional	JJ	O
Piga	NNP	O
gene	NN	O
knockout	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
high	JJ	O
embryonic	JJ	B_Disease
lethality	NN	E_Disease
in	IN	O
chimeric	JJ	O
mice	NN	O
,	,	O
we	PRP	O
used	VBD	O
the	DT	O
Cre	NNP	O
/	NNP	O
loxP	NN	O
system	NN	O
.	.	O

We	PRP	O
generated	VBD	O
mice	NN	O
in	IN	O
which	WDT	O
two	CD	O
loxP	NN	O
sites	NNS	O
flank	VBP	O
part	NN	O
of	IN	O
Piga	NNP	O
exon	$	O
2	CD	O
.	.	O

After	IN	O
crossbreeding	VBG	O
with	IN	O
female	JJ	O
mice	NN	O
of	IN	O
the	DT	O
EIIa	NNP	O
-	:	O
cre	NN	O
strain	NN	O
,	,	O
the	DT	O
floxed	JJ	O
allele	NN	O
undergoes	NNS	O
Cre	NNP	O
-	:	O
mediated	VBD	O
recombination	NN	O
with	IN	O
high	JJ	O
efficiency	NN	O
during	IN	O
early	JJ	O
embryonic	JJ	O
development	NN	O
.	.	O

Because	IN	O
of	IN	O
X	NNP	O
chromosome	NN	O
inactivation	NN	O
,	,	O
female	JJ	O
offspring	NN	O
are	VBP	O
mosaic	VBN	O
for	IN	O
cells	NNS	O
that	WDT	O
express	VBP	O
or	CC	O
lack	VBP	O
GPI	NNP	O
-	:	O
linked	VBD	O
proteins	NNS	O
.	.	O

Analysis	NN	O
of	IN	O
mosaic	NN	O
mice	NN	O
showed	VBD	O
that	IN	O
in	IN	O
heart	NN	O
,	,	O
lung	NN	O
,	,	O
kidney	NN	O
,	,	O
brain	NN	O
,	,	O
and	CC	O
liver	RB	O
,	,	O
mainly	RB	O
wild	JJ	O
-	:	O
type	NN	O
Piga	NNP	O
is	VBZ	O
active	JJ	O
,	,	O
suggesting	VBG	O
that	IN	O
these	DT	O
tissues	NNS	O
require	VBP	O
GPI	NNP	O
-	:	O
linked	VBD	O
proteins	NNS	O
.	.	O

The	DT	O
salient	JJ	O
exceptions	NNS	O
were	VBD	O
spleen	JJ	O
,	,	O
thymus	NN	O
,	,	O
and	CC	O
red	JJ	O
blood	NN	O
cells	NNS	O
,	,	O
which	WDT	O
had	VBD	O
almost	RB	O
equal	JJ	O
numbers	NNS	O
of	IN	O
cells	NNS	O
expressing	VBG	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
or	CC	O
the	DT	O
recombined	JJ	O
allele	NN	O
,	,	O
implying	VBG	O
that	IN	O
GPI	NNP	O
-	:	O
linked	VBN	O
proteins	NNS	O
are	VBP	O
not	RB	O
essential	JJ	O
for	IN	O
the	DT	O
derivation	NN	O
of	IN	O
these	DT	O
tissues	NNS	O
.	.	O

PIGA	NNP	O
(	(	O
-	:	O
)	)	O
cells	NNS	O
had	VBD	O
no	DT	O
growth	NN	O
advantage	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
other	JJ	O
factors	NNS	O
are	VBP	O
needed	VBN	O
for	IN	O
their	PRP$	O
clonal	JJ	O
dominance	NN	O
in	IN	O
patients	NNS	O
with	IN	O
paroxysmal	JJ	B_Disease
nocturnal	JJ	I_Disease
hemoglobinuria	NN	E_Disease
.	.	O
.	.	O

The	DT	O
C282Y	NNP	O
mutation	NN	O
causing	VBG	O
hereditary	JJ	B_Disease
hemochromatosis	NN	E_Disease
does	VBZ	O
not	RB	O
produce	VB	O
a	DT	O
null	JJ	O
allele	NN	O
.	.	O

Targeted	VBN	O
mutagenesis	NN	O
was	VBD	O
used	VBN	O
to	TO	O
produce	VB	O
two	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
murine	NN	O
hemochromatosis	NN	S_Disease
gene	NN	O
(	(	O
Hfe	NNP	O
)	)	O
locus	NN	O
.	.	O

The	DT	O
first	JJ	O
mutation	NN	O
deletes	VBZ	O
a	DT	O
large	JJ	O
portion	NN	O
of	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
,	,	O
generating	VBG	O
a	DT	O
null	JJ	O
allele	NN	O
.	.	O

The	DT	O
second	JJ	O
mutation	NN	O
introduces	VBZ	O
a	DT	O
missense	JJ	O
mutation	NN	O
(	(	O
C282Y	NNP	O
)	)	O
into	IN	O
the	DT	O
Hfe	NNP	O
locus	NN	O
,	,	O
but	CC	O
otherwise	RB	O
leaves	VBZ	O
the	DT	O
gene	NN	O
intact	JJ	O
.	.	O

This	DT	O
mutation	NN	O
is	VBZ	O
identical	JJ	O
to	TO	O
the	DT	O
disease	NN	O
-	:	O
causing	VBG	O
mutation	NN	O
in	IN	O
patients	NNS	O
with	IN	O
hereditary	JJ	B_Disease
hemochromatosis	NN	E_Disease
.	.	O

Mice	NNP	O
carrying	VBG	O
each	DT	O
of	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
were	VBD	O
bred	VBN	O
and	CC	O
analyzed	VBN	O
.	.	O

Homozygosity	NN	O
for	IN	O
either	DT	O
mutation	NN	O
results	NNS	O
in	IN	O
postnatal	JJ	O
iron	NN	O
loading	NN	O
.	.	O

The	DT	O
effects	NNS	O
of	IN	O
the	DT	O
null	JJ	O
mutation	NN	O
are	VBP	O
more	RBR	O
severe	JJ	O
than	IN	O
the	DT	O
effects	NNS	O
of	IN	O
the	DT	O
C282Y	NNP	O
mutation	NN	O
.	.	O

Mice	NNP	O
heterozygous	JJ	O
for	IN	O
either	DT	O
mutation	NN	O
accumulate	RB	O
more	RBR	O
iron	JJ	O
than	IN	O
normal	JJ	O
controls	NNS	O
.	.	O

Interestingly	RB	O
,	,	O
although	IN	O
liver	NN	O
iron	NN	O
stores	NNS	O
are	VBP	O
greatly	RB	O
increased	VBN	O
,	,	O
splenic	JJ	O
iron	NN	O
is	VBZ	O
decreased	VBN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
C282Y	NNP	O
mutation	NN	O
does	VBZ	O
not	RB	O
result	VB	O
in	IN	O
a	DT	O
null	JJ	O
allele	NN	O
.	.	O
.	.	O

Genotype	NNP	O
-	:	O
phenotype	NN	O
analysis	NN	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
Emery	NNP	I_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
and	CC	O
identification	NN	O
of	IN	O
a	DT	O
missense	JJ	O
mutation	NN	O
associated	VBN	O
with	IN	O
a	DT	O
milder	NN	O
phenotype	NN	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
emerin	JJ	O
gene	NN	O
in	IN	O
22	CD	O
families	NNS	O
with	IN	O
Emery	NNP	B_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
EMD	NNP	S_Disease
)	)	O
revealed	VBD	O
mutations	NNS	O
in	IN	O
21	CD	O
(	(	O
95	CD	O
%	NN	O
)	)	O
,	,	O
confirming	VBG	O
that	IN	O
emerin	JJ	O
mutations	NNS	O
can	MD	O
be	VB	O
identified	VBN	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
families	NNS	O
with	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
EMD	NNP	E_Disease
.	.	O

Most	JJS	O
emerin	JJ	O
mutations	NNS	O
result	VBP	O
in	IN	O
absence	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
three	CD	O
mutations	NNS	O
(	(	O
a	DT	O
missense	NN	O
mutation	NN	O
Pro183Thr	NNP	O
and	CC	O
two	CD	O
in	IN	O
-	:	O
frame	NN	O
deletions	NNS	O
removing	VBG	O
residues	NNS	O
95	CD	O
-	:	O
99	CD	O
and	CC	O
236	CD	O
-	:	O
241	CD	O
,	,	O
respectively	RB	O
)	)	O
were	VBD	O
unusual	JJ	O
in	IN	O
being	VBG	O
associated	VBN	O
with	IN	O
expression	NN	O
of	IN	O
mutant	JJ	O
protein	NN	O
.	.	O

The	DT	O
phenotype	NN	O
in	IN	O
these	DT	O
families	NNS	O
was	VBD	O
compared	VBN	O
in	IN	O
detail	NN	O
with	IN	O
the	DT	O
clinical	JJ	O
features	NNS	O
in	IN	O
cases	NNS	O
with	IN	O
typical	JJ	O
null	JJ	O
mutations	NNS	O
.	.	O

For	IN	O
the	DT	O
in	IN	O
-	:	O
frame	NN	O
deletions	NNS	O
there	EX	O
were	VBD	O
no	DT	O
significant	JJ	O
differences	NNS	O
.	.	O

In	IN	O
the	DT	O
family	NN	O
with	IN	O
the	DT	O
missense	NN	O
mutation	NN	O
the	DT	O
phenotype	NN	O
was	VBD	O
milder	NN	O
.	.	O

Age	NNP	O
at	IN	O
onset	NN	O
was	VBD	O
later	RB	O
for	IN	O
first	JJ	O
symptoms	NNS	O
and	CC	O
for	IN	O
development	NN	O
of	IN	O
ankle	NN	B_Disease
contractures	NNS	E_Disease
and	CC	O
muscle	NN	B_Disease
weakness	NN	E_Disease
.	.	O

These	DT	O
findings	NNS	O
have	VBP	O
diagnostic	JJ	O
implications	NNS	O
as	RB	O
well	RB	O
as	IN	O
pointing	VBG	O
to	TO	O
functionally	RB	O
important	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
emerin	NN	O
protein	NN	O
.	.	O
.	.	O

Severe	NNP	O
clinical	JJ	O
expression	NN	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
Emery	NNP	I_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

X	LS	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
Emery	NNP	I_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
EDMD	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
relatively	RB	O
rare	JJ	O
benign	NN	B_Disease
neuromuscular	JJ	I_Disease
disorder	NN	E_Disease
which	WDT	O
can	MD	O
vary	VB	O
remarkably	RB	O
in	IN	O
onset	NN	O
,	,	O
course	NN	O
and	CC	O
severity	NN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
a	DT	O
TCTAC	NNP	O
deletion	NN	O
spanning	VBG	O
the	DT	O
nucleotides	NNS	O
631	CD	O
-	:	O
635	CD	O
of	IN	O
the	DT	O
emerin	JJ	O
gene	NN	O
caused	VBD	O
an	DT	O
unusually	RB	O
severe	JJ	O
disease	NN	O
phenotype	NN	O
including	VBG	O
loss	NN	B_Disease
of	IN	I_Disease
ambulation	NN	E_Disease
and	CC	O
severe	JJ	O
muscle	NN	B_Disease
wasting	VBG	E_Disease
in	IN	O
two	CD	O
affected	JJ	O
brothers	NNS	O
.	.	O

The	DT	O
same	JJ	O
mutation	NN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
previously	RB	O
in	IN	O
an	DT	O
unrelated	JJ	O
family	NN	O
showing	VBG	O
a	DT	O
significantly	RB	O
milder	JJR	O
phenotype	NN	O
.	.	O

The	DT	O
interfamilial	JJ	O
heterogeneity	NN	O
in	IN	O
distribution	NN	O
and	CC	O
in	IN	O
severity	NN	O
of	IN	O
the	DT	O
features	NNS	O
in	IN	O
the	DT	O
two	CD	O
families	NNS	O
point	VBP	O
to	TO	O
environmental	JJ	O
or	CC	O
genetic	JJ	O
modification	NN	O
as	IN	O
the	DT	O
cause	NN	O
of	IN	O
clinical	JJ	O
variability	NN	O
in	IN	O
Emery	NNP	B_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O
.	.	O

Common	JJ	O
mutations	NNS	O
in	IN	O
BRCA1	NNP	O
and	CC	O
BRCA2	NNP	O
do	VBP	O
not	RB	O
contribute	VB	O
to	TO	O
early	JJ	O
prostate	NN	B_Disease
cancer	NN	E_Disease
in	IN	O
Jewish	JJ	O
men	NNS	O
.	.	O

BACKGROUND	NNP	O
Families	NNP	O
with	IN	O
a	DT	O
high	JJ	O
incidence	NN	O
of	IN	O
hereditary	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
,	,	O
and	CC	O
subsequently	RB	O
shown	VBN	O
to	TO	O
have	VB	O
terminating	VBG	O
mutations	NNS	O
in	IN	O
BRCA1	NNP	O
or	CC	O
BRCA2	NNP	O
,	,	O
appear	VBP	O
to	TO	O
have	VB	O
a	DT	O
higher	JJR	O
incidence	NN	O
of	IN	O
prostate	JJ	B_Disease
cancer	NN	E_Disease
among	IN	O
male	JJ	O
relatives	NNS	O
.	.	O

We	PRP	O
aimed	VBD	O
to	TO	O
determine	VB	O
whether	IN	O
the	DT	O
common	JJ	O
germline	NN	O
mutations	NNS	O
of	IN	O
BRCA1	NNP	O
or	CC	O
BRCA2	NNP	O
in	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
men	NNS	O
predisposed	VBD	O
them	PRP	O
to	TO	O
prostate	VB	B_Disease
cancer	NN	E_Disease
.	.	O

METHODS	NNP	O
We	PRP	O
examined	VBD	O
genomic	JJ	O
DNA	NN	O
from	IN	O
83	CD	O
(	(	O
for	IN	O
BRCA1	NNP	O
185delAG	CD	O
)	)	O
or	CC	O
82	CD	O
(	(	O
for	IN	O
BRCA2	NNP	O
6174delT	CD	O
)	)	O
Ashkenazi	NNP	O
Jewish	JJ	O
prostate	NN	B_Disease
cancer	NN	E_Disease
patients	NNS	O
,	,	O
most	JJS	O
of	IN	O
whom	WP	O
were	VBD	O
treated	VBN	O
at	IN	O
a	DT	O
relatively	RB	O
young	JJ	O
age	NN	O
,	,	O
for	IN	O
the	DT	O
most	RBS	O
common	JJ	O
germline	NN	O
mutation	NN	O
in	IN	O
each	DT	O
gene	NN	O
seen	VBN	O
in	IN	O
the	DT	O
Ashkenazi	NNP	O
population	NN	O
.	.	O

RESULTS	NNP	O
Our	PRP$	O
study	NN	O
should	MD	O
have	VB	O
been	VBN	O
able	JJ	O
to	TO	O
detect	VB	O
a	DT	O
4	CD	O
-	:	O
5	CD	O
-	:	O
fold	JJ	O
increase	NN	O
in	IN	O
the	DT	O
risk	NN	O
of	IN	O
prostate	NN	B_Disease
cancer	NN	E_Disease
due	JJ	O
to	TO	O
mutation	NN	O
of	IN	O
BRCA1	NNP	O
or	CC	O
BRCA2	NNP	O
.	.	O

However	RB	O
,	,	O
only	RB	O
one	CD	O
(	(	O
1	CD	O
.	.	O

15	CD	O
%	NN	O
;	:	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
,	,	O
0	CD	O
-	:	O
3	CD	O
.	.	O

6	CD	O
%	NN	O
)	)	O
of	IN	O
the	DT	O
patients	NNS	O
was	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
BRCA1	NNP	O
mutant	NN	O
allele	NN	O
,	,	O
and	CC	O
only	RB	O
two	CD	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
BRCA2	NNP	O
mutation	NN	O
(	(	O
2	CD	O
.	.	O

4	CD	O
%	NN	O
;	:	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
,	,	O
0	CD	O
-	:	O
6	CD	O
.	.	O

2	CD	O
%	NN	O
)	)	O
.	.	O

CONCLUSIONS	NNP	O
The	DT	O
incidence	NN	O
of	IN	O
each	DT	O
of	IN	O
the	DT	O
germline	NN	O
mutations	NNS	O
in	IN	O
these	DT	O
prostate	JJ	B_Disease
cancer	NN	E_Disease
patients	NNS	O
closely	RB	O
matched	VBD	O
their	PRP$	O
incidence	NN	O
(	(	O
about	IN	O
1	CD	O
%	NN	O
)	)	O
in	IN	O
the	DT	O
general	JJ	O
Ashkenazi	NNP	O
Jewish	NNP	O
population	NN	O
.	.	O

This	DT	O
suggests	VBZ	O
that	IN	O
unlike	IN	O
cases	NNS	O
of	IN	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
,	,	O
mutations	NNS	O
in	IN	O
BRCA1	NNP	O
or	CC	O
BRCA2	NNP	O
do	VBP	O
not	RB	O
significantly	RB	O
predispose	VB	O
men	NNS	O
to	TO	O
prostate	VB	B_Disease
cancer	NN	E_Disease

Beta	NNP	O
-	:	O
catenin	NN	O
accumulation	NN	O
and	CC	O
mutation	NN	O
of	IN	O
the	DT	O
CTNNB1	NNP	O
gene	NN	O
in	IN	O
hepatoblastoma	NN	S_Disease
.	.	O

Hepatoblastoma	NNP	S_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
malignant	JJ	B_Disease
tumor	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
liver	NN	E_Disease
that	WDT	O
occurs	VBZ	O
in	IN	O
children	NNS	O
at	IN	O
an	DT	O
average	JJ	O
age	NN	O
of	IN	O
2	CD	O
to	TO	O
3	CD	O
years	NNS	O
.	.	O

Epidemiologic	NNP	O
studies	NNS	O
have	VBP	O
shown	VBN	O
an	DT	O
increased	JJ	O
frequency	NN	O
of	IN	O
this	DT	O
tumor	NN	S_Disease
type	NN	O
in	IN	O
families	NNS	O
affected	VBN	O
by	IN	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
.	.	O

In	IN	O
addition	NN	O
to	TO	O
the	DT	O
epidemiologic	NN	O
data	NNS	O
,	,	O
molecular	JJ	O
genetic	JJ	O
studies	NNS	O
suggest	VBP	O
that	IN	O
inactivation	NN	O
of	IN	O
the	DT	O
APC	NNP	B_Disease
tumor	NN	E_Disease
suppressor	NN	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
hepatoblastoma	JJ	S_Disease
tumorigenesis	NN	O
.	.	O

A	DT	O
major	JJ	O
function	NN	O
of	IN	O
APC	NNP	O
is	VBZ	O
the	DT	O
downregulation	NN	O
of	IN	O
beta	NN	O
-	:	O
catenin	NN	O
,	,	O
a	DT	O
transcription	NN	O
-	:	O
activating	VBG	O
protein	NN	O
with	IN	O
oncogenic	JJ	O
potential	NN	O
.	.	O

In	IN	O
an	DT	O
ongoing	JJ	O
immunohistochemical	JJ	O
study	NN	O
of	IN	O
beta	NN	O
-	:	O
catenin	NN	O
expression	NN	O
in	IN	O
sporadic	JJ	O
cases	NNS	O
of	IN	O
tumor	NN	S_Disease
types	NNS	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
,	,	O
we	PRP	O
observed	VBD	O
increased	VBN	O
beta	NN	O
-	:	O
catenin	NN	O
levels	NNS	O
in	IN	O
the	DT	O
cytoplasm	NN	O
and	CC	O
in	IN	O
the	DT	O
nuclei	NN	O
of	IN	O
three	CD	O
investigated	JJ	O
hepatoblastomas	NN	S_Disease
.	.	O

Sequencing	VBG	O
of	IN	O
exon	JJ	O
3	CD	O
of	IN	O
the	DT	O
beta	NN	O
-	:	O
catenin	NN	O
gene	NN	O
(	(	O
CTNNB1	NNP	O
)	)	O
revealed	VBD	O
an	DT	O
activating	VBG	O
mutation	NN	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
tumor	NN	S_Disease
samples	NNS	O
.	.	O

Our	PRP$	O
data	NNS	O
indicate	NN	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
that	WDT	O
beta	VBZ	O
-	:	O
catenin	NN	O
accumulation	NN	O
may	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
hepatoblastoma	NN	S_Disease
and	CC	O
that	IN	O
activating	VBG	O
mutations	NNS	O
of	IN	O
the	DT	O
beta	NN	O
-	:	O
catenin	NN	O
gene	NN	O
may	MD	O
substitute	VB	O
biallelic	JJ	O
APC	NNP	O
inactivation	NN	O
in	IN	O
this	DT	O
tumor	NN	S_Disease
type	NN	O
.	.	O

Genes	NNS	O
Chromosomes	NNP	O
Cancer	NNP	O
25	CD	O
399	CD	O
-	:	O
402	CD	O
,	,	O
1999	CD	O
.	.	O
.	.	O

Decrease	NNP	O
in	IN	O
GTP	NNP	O
cyclohydrolase	NN	O
I	PRP	O
gene	NN	O
expression	NN	O
caused	VBN	O
by	IN	O
inactivation	NN	O
of	IN	O
one	CD	O
allele	NN	O
in	IN	O
hereditary	JJ	B_Disease
progressive	JJ	I_Disease
dystonia	NN	E_Disease
with	IN	O
marked	JJ	O
diurnal	JJ	O
fluctuation	NN	O
.	.	O

Hereditary	NNP	B_Disease
progressive	JJ	I_Disease
dystonia	NN	E_Disease
with	IN	O
marked	JJ	O
diurnal	JJ	O
fluctuation	NN	O
(	(	O
HPD	NNP	S_Disease
;	:	O
dopa	SYM	B_Disease
-	:	I_Disease
responsive	JJ	I_Disease
dystonia	NN	E_Disease
,	,	O
DRD	NNP	S_Disease
)	)	O
have	VBP	O
been	VBN	O
recently	RB	O
found	VBN	O
to	TO	O
be	VB	O
caused	VBN	O
by	IN	O
a	DT	O
genetic	JJ	B_Disease
defect	NN	E_Disease
in	IN	O
the	DT	O
GTP	NNP	O
cyclohydrolase	NN	O
I	PRP	O
(	(	O
GCH1	NNP	O
)	)	O
gene	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
quantified	VBD	O
the	DT	O
mRNA	JJ	O
level	NN	O
of	IN	O
GCH1	NNP	O
in	IN	O
phytohemagglutinin	NN	O
(	(	O
PHA	NNP	O
)	)	O
-	:	O
stimulated	VBN	O
mononuclear	JJ	O
blood	NN	O
cells	NNS	O
from	IN	O
one	CD	O
Japanese	JJ	O
family	NN	O
that	WDT	O
do	VBP	O
not	RB	O
have	VB	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
coding	JJ	O
region	NN	O
or	CC	O
splice	NN	O
junctions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

The	DT	O
results	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
amounts	NNS	O
of	IN	O
the	DT	O
GCH1	NNP	O
mRNA	NN	O
were	VBD	O
decreased	VBN	O
to	TO	O
about	IN	O
40	CD	O
%	NN	O
of	IN	O
the	DT	O
normal	JJ	O
level	NN	O
in	IN	O
both	DT	O
patients	NNS	O
and	CC	O
carriers	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
found	VBD	O
that	IN	O
the	DT	O
GCH1	NNP	O
mRNA	NN	O
was	VBD	O
transcribed	VBN	O
from	IN	O
only	RB	O
one	CD	O
allele	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
other	JJ	O
allele	NN	O
was	VBD	O
in	IN	O
an	DT	O
inactive	JJ	O
state	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
some	DT	O
novel	JJ	O
mutations	NNS	O
should	MD	O
exist	VB	O
on	IN	O
one	CD	O
of	IN	O
the	DT	O
alleles	NNS	O
in	IN	O
some	DT	O
unknown	JJ	O
region	NN	O
of	IN	O
the	DT	O
GCH1	NNP	O
gene	NN	O
,	,	O
and	CC	O
may	MD	O
decrease	VB	O
the	DT	O
GCH1	NNP	O
mRNA	NN	O
causing	VBG	O
the	DT	O
HPD	NNP	S_Disease
/	NNP	O
DRD	NNP	S_Disease
symptoms	NNS	O
.	.	O
.	.	O

Sulfate	NNP	O
transport	NN	O
is	VBZ	O
not	RB	O
impaired	VBN	O
in	IN	O
pendred	JJ	B_Disease
syndrome	NN	E_Disease
thyrocytes	NNS	O
.	.	O

Pendred	NNP	B_Disease
syndrome	NN	E_Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
syndromic	JJ	B_Disease
deafness	NN	E_Disease
,	,	O
characterized	VBN	O
by	IN	O
dyshormonogenic	JJ	B_Disease
goiter	NN	E_Disease
associated	VBN	O
with	IN	O
sensory	JJ	B_Disease
-	:	I_Disease
neural	JJ	I_Disease
deafness	NN	E_Disease
.	.	O

The	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
disease	NN	O
(	(	O
PDS	NNP	S_Disease
)	)	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
,	,	O
but	CC	O
its	PRP$	O
function	NN	O
is	VBZ	O
as	IN	O
yet	RB	O
unknown	JJ	O
and	CC	O
the	DT	O
connection	NN	O
between	IN	O
thyroid	JJ	B_Disease
goiter	NN	E_Disease
and	CC	O
sensory	JJ	B_Disease
-	:	I_Disease
neural	JJ	I_Disease
deafness	NN	E_Disease
remains	VBZ	O
an	DT	O
enigma	NN	O
.	.	O

PDS	NNP	O
codes	NNS	O
for	IN	O
a	DT	O
novel	JJ	O
protein	NN	O
,	,	O
pendrin	NN	O
,	,	O
which	WDT	O
is	VBZ	O
closely	RB	O
related	VBN	O
to	TO	O
a	DT	O
number	NN	O
of	IN	O
sufate	JJ	O
transporters	NNS	O
.	.	O

Mechanisms	NNS	O
by	IN	O
which	WDT	O
abnormal	JJ	O
sulfate	NN	O
transport	NN	O
could	MD	O
deleteriously	RB	O
affect	VB	O
iodide	JJ	O
organification	NN	O
have	VBP	O
been	VBN	O
proposed	VBN	O
.	.	O

We	PRP	O
tested	VBD	O
sulfate	JJ	O
transport	NN	O
in	IN	O
thyrocytes	NNS	O
obtained	VBN	O
from	IN	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
patients	NNS	O
and	CC	O
found	VBD	O
that	IN	O
it	PRP	O
was	VBD	O
not	RB	O
defective	JJ	O
.	.	O

This	DT	O
suggests	VBZ	O
that	IN	O
pendrin	NN	O
in	IN	O
fact	NN	O
may	MD	O
not	RB	O
be	VB	O
a	DT	O
sulfate	NN	O
transporter	NN	O
,	,	O
and	CC	O
emphasizes	VBZ	O
the	DT	O
importance	NN	O
of	IN	O
functional	JJ	O
studies	NNS	O
on	IN	O
this	DT	O
novel	JJ	O
protein	NN	O
.	.	O
.	.	O

Small	JJ	O
deletions	NNS	O
in	IN	O
the	DT	O
type	NN	O
II	NNP	O
collagen	NN	O
triple	NN	O
helix	NN	O
produce	VBP	O
kniest	JJS	B_Disease
dysplasia	NN	E_Disease
.	.	O

Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
is	VBZ	O
a	DT	O
moderately	RB	O
severe	JJ	O
type	NN	B_Disease
II	NNP	I_Disease
collagenopathy	NN	E_Disease
,	,	O
characterized	VBN	O
by	IN	O
short	JJ	O
trunk	NN	O
and	CC	O
limbs	NNS	O
,	,	O
kyphoscoliosis	NN	S_Disease
,	,	O
midface	NN	B_Disease
hypoplasia	NN	E_Disease
,	,	O
severe	JJ	O
myopia	NN	S_Disease
,	,	O
and	CC	O
hearing	JJ	B_Disease
loss	NN	E_Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
that	WDT	O
encodes	VBZ	O
type	JJ	O
II	NNP	O
collagen	NN	O
(	(	O
COL2A1	NNP	O
)	)	O
,	,	O
the	DT	O
predominant	JJ	O
protein	NN	O
of	IN	O
cartilage	NN	O
,	,	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
a	DT	O
number	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
.	.	O

All	DT	O
but	CC	O
two	CD	O
of	IN	O
these	DT	O
previously	RB	O
described	VBN	O
mutations	NNS	O
cause	VBP	O
in	IN	O
-	:	O
frame	NN	O
deletions	NNS	O
in	IN	O
type	NN	O
II	NNP	O
collagen	NN	O
,	,	O
either	CC	O
by	IN	O
small	JJ	O
deletions	NNS	O
in	IN	O
the	DT	O
gene	NN	O
or	CC	O
splice	NN	O
site	NN	O
alterations	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
all	DT	O
but	CC	O
one	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
is	VBZ	O
located	VBN	O
between	IN	O
exons	NNS	O
12	CD	O
and	CC	O
24	CD	O
in	IN	O
the	DT	O
COL2A1	NNP	O
gene	NN	O
.	.	O

We	PRP	O
used	VBD	O
heteroduplex	JJ	O
analysis	NN	O
to	TO	O
identify	VB	O
sequence	NN	O
anomalies	NNS	O
in	IN	O
five	CD	O
individuals	NNS	O
with	IN	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
.	.	O

Sequencing	VBG	O
of	IN	O
the	DT	O
index	NN	O
patients	NNS	O
genomic	JJ	O
DNA	NNP	O
identified	VBD	O
four	CD	O
new	JJ	O
dominant	JJ	O
mutations	NNS	O
in	IN	O
COL2A1	NNP	O
that	WDT	O
result	NN	O
in	IN	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
a	DT	O
21	CD	O
-	:	O
bp	NN	O
deletion	NN	O
in	IN	O
exon	JJ	O
16	CD	O
,	,	O
an	DT	O
18	CD	O
-	:	O
bp	NN	O
deletion	NN	O
in	IN	O
exon	JJ	O
19	CD	O
,	,	O
and	CC	O
4	CD	O
-	:	O
bp	NN	O
deletions	NNS	O
in	IN	O
the	DT	O
splice	NN	O
donor	NN	O
sites	NNS	O
of	IN	O
introns	NNS	O
14	CD	O
and	CC	O
20	CD	O
.	.	O

A	DT	O
previously	RB	O
described	VBN	O
28	CD	O
-	:	O
bp	NN	O
deletion	NN	O
at	IN	O
the	DT	O
COL2A1	NNP	O
exon	VBD	O
12	CD	O
-	:	O
intron	NN	O
12	CD	O
junction	NN	O
,	,	O
deleting	VBG	O
the	DT	O
splice	NN	O
donor	NN	O
site	NN	O
,	,	O
was	VBD	O
identified	VBN	O
in	IN	O
the	DT	O
fifth	JJ	O
case	NN	O
.	.	O

The	DT	O
latter	JJ	O
three	CD	O
mutations	NNS	O
are	VBP	O
predicted	VBN	O
to	TO	O
result	VB	O
in	IN	O
exon	NN	O
skipping	NN	O
in	IN	O
the	DT	O
mRNA	NN	O
encoded	VBD	O
from	IN	O
the	DT	O
mutant	JJ	O
allele	NN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
results	NNS	O
from	IN	O
shorter	JJR	O
type	NN	O
II	NNP	O
collagen	NN	O
monomers	NNS	O
,	,	O
and	CC	O
support	VB	O
the	DT	O
hypothesis	NN	O
that	IN	O
alteration	NN	O
of	IN	O
a	DT	O
specific	JJ	O
COL2A1	NNP	O
domain	NN	O
,	,	O
which	WDT	O
may	MD	O
span	VB	O
from	IN	O
exons	NNS	O
12	CD	O
to	TO	O
24	CD	O
,	,	O
leads	VBZ	O
to	TO	O
the	DT	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
phenotype	NN	O
.	.	O
.	.	O

Classical	JJ	B_Disease
galactosemia	NN	E_Disease
and	CC	O
mutations	NNS	O
at	IN	O
the	DT	O
galactose	JJ	O
-	:	O
1	CD	O
-	:	O
phosphate	NN	O
uridyl	JJ	O
transferase	NN	O
(	(	O
GALT	NNP	O
)	)	O
gene	NN	O
.	.	O

Classical	JJ	B_Disease
galactosemia	NN	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	O
in	IN	O
activity	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
galactose	VBD	O
-	:	O
1	CD	O
-	:	O
phosphate	NN	O
uridyl	JJ	O
transferase	NN	O
(	(	O
GALT	NNP	O
)	)	O
,	,	O
which	WDT	O
,	,	O
in	IN	O
turn	NN	O
,	,	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
at	IN	O
the	DT	O
GALT	NNP	O
gene	NN	O
.	.	O

The	DT	O
disorder	NN	O
exhibits	VBZ	O
considerable	JJ	O
allelic	JJ	O
heterogeneity	NN	O
and	CC	O
,	,	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
1998	CD	O
,	,	O
more	JJR	O
than	IN	O
150	CD	O
different	JJ	O
base	NN	O
changes	NNS	O
were	VBD	O
recorded	VBN	O
in	IN	O
24	CD	O
different	JJ	O
populations	NNS	O
and	CC	O
ethnic	JJ	O
groups	NNS	O
in	IN	O
15	CD	O
countries	NNS	O
worldwide	RB	O
.	.	O

The	DT	O
mutations	NNS	O
most	RBS	O
frequently	RB	O
cited	VBN	O
are	VBP	O
Q188R	NNP	O
,	,	O
K285N	NNP	O
,	,	O
S135L	NNP	O
,	,	O
and	CC	O
N314D	NNP	O
.	.	O

Q188R	NNP	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
in	IN	O
European	JJ	O
populations	NNS	O
or	CC	O
in	IN	O
those	DT	O
predominantly	RB	O
of	IN	O
European	JJ	O
descent	NN	O
.	.	O

Overall	JJ	O
,	,	O
it	PRP	O
accounts	VBZ	O
for	IN	O
60	CD	O
-	:	O
70	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
chromosomes	NNS	O
,	,	O
but	CC	O
there	EX	O
are	VBP	O
significant	JJ	O
differences	NNS	O
in	IN	O
its	PRP$	O
relative	JJ	O
frequency	NN	O
in	IN	O
individual	JJ	O
populations	NNS	O
.	.	O

Individuals	NNS	O
homoallelic	VBP	O
for	IN	O
Q188R	NNP	O
tend	VBP	O
to	TO	O
have	VB	O
a	DT	O
severe	JJ	O
phenotype	NN	O
and	CC	O
this	DT	O
is	VBZ	O
in	IN	O
keeping	VBG	O
with	IN	O
the	DT	O
virtually	RB	O
complete	JJ	O
loss	NN	O
of	IN	O
enzyme	JJ	O
activity	NN	O
observed	VBN	O
in	IN	O
in	IN	O
vitro	JJ	O
expression	NN	O
systems	NNS	O
.	.	O

Globally	RB	O
,	,	O
K285N	NNP	O
is	VBZ	O
rarer	JJ	O
,	,	O
but	CC	O
in	IN	O
many	JJ	O
European	JJ	O
populations	NNS	O
it	PRP	O
can	MD	O
be	VB	O
found	VBN	O
on	IN	O
25	CD	O
-	:	O
40	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
chromosomes	NNS	O
.	.	O

It	PRP	O
is	VBZ	O
invariably	RB	O
associated	VBN	O
with	IN	O
a	DT	O
severe	JJ	O
phenotype	NN	O
.	.	O

S135L	NNP	O
is	VBZ	O
found	VBN	O
almost	RB	O
exclusively	RB	O
in	IN	O
African	JJ	O
Americans	NNPS	O
.	.	O

In	IN	O
vitro	JJ	O
expression	NN	O
results	NNS	O
are	VBP	O
discrepant	JJ	O
,	,	O
but	CC	O
some	DT	O
individuals	NNS	O
carrying	VBG	O
S135L	NNP	O
appear	VBP	O
to	TO	O
exhibit	VB	O
GALT	NNP	O
activity	NN	O
in	IN	O
some	DT	O
tissues	NNS	O
.	.	O

Duarte	NNP	O
1	CD	O
(	(	O
or	CC	O
Los	NNP	O
Angeles	NNP	O
)	)	O
and	CC	O
Duarte	$	O
2	CD	O
(	(	O
or	CC	O
Duarte	NNP	O
)	)	O
variants	NNS	O
carry	VBP	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
substitution	NN	O
,	,	O
N314D	NNP	O
,	,	O
even	RB	O
though	IN	O
D1	NNP	O
is	VBZ	O
associated	VBN	O
with	IN	O
increased	JJ	O
erythrocyte	NN	O
GALT	NNP	O
activity	NN	O
and	CC	O
D2	NNP	O
with	IN	O
reduced	JJ	O
activity	NN	O
.	.	O

N314D	NNP	O
is	VBZ	O
in	IN	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
other	JJ	O
base	NN	O
changes	NNS	O
that	WDT	O
differ	VBP	O
on	IN	O
the	DT	O
D1	NNP	O
and	CC	O
D2	NNP	O
alleles	NNS	O
.	.	O

N314D	NN	O
does	VBZ	O
not	RB	O
impair	VB	O
GALT	NNP	O
activity	NN	O
in	IN	O
in	IN	O
vitro	JJ	O
expression	NN	O
systems	NNS	O
.	.	O

However	RB	O
,	,	O
there	EX	O
are	VBP	O
differences	NNS	O
in	IN	O
the	DT	O
abundance	NN	O
of	IN	O
GALT	NNP	O
protein	NN	O
in	IN	O
lymphoblastoid	JJ	O
cells	NNS	O
lines	NNS	O
from	IN	O
D2	NNP	O
and	CC	O
D1	NNP	O
individuals	NNS	O
.	.	O

It	PRP	O
is	VBZ	O
unclear	JJ	O
whether	IN	O
the	DT	O
specific	JJ	O
molecular	JJ	O
changes	NNS	O
that	WDT	O
distinguish	VBP	O
the	DT	O
D1	NNP	O
and	CC	O
D2	NNP	O
alleles	VBZ	O
account	NN	O
for	IN	O
the	DT	O
different	JJ	O
activities	NNS	O
.	.	O

The	DT	O
considerable	JJ	O
genetic	JJ	O
heterogeneity	NN	O
documented	VBN	O
to	TO	O
date	NN	O
undoubtedly	RB	O
contributes	VBZ	O
to	TO	O
the	DT	O
phenotypic	NN	O
heterogeneity	NN	O
that	WDT	O
is	VBZ	O
observed	VBN	O
in	IN	O
galactosemia	NN	S_Disease
.	.	O

The	DT	O
additional	JJ	O
effects	NNS	O
of	IN	O
nonallelic	JJ	O
variation	NN	O
and	CC	O
other	JJ	O
constitutional	JJ	O
factors	NNS	O
on	IN	O
phenotypic	NN	O
variability	NN	O
remain	VBP	O
to	TO	O
be	VB	O
elucidated	VBN	O
.	.	O
.	.	O

Mutations	NNS	O
of	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
in	IN	O
sporadic	JJ	B_Disease
renal	JJ	I_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
:	:	O
definition	NN	O
of	IN	O
a	DT	O
risk	NN	O
factor	NN	O
for	IN	O
VHL	NNP	S_Disease
patients	NNS	O
to	TO	O
develop	VB	O
an	DT	O
RCC	NNP	S_Disease
.	.	O

To	TO	O
investigate	VB	O
the	DT	O
nature	NN	O
of	IN	O
somatic	JJ	O
von	NN	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	E_Disease
(	(	O
VHL	NNP	S_Disease
)	)	O
mutations	NNS	O
,	,	O
we	PRP	O
analyzed	VBD	O
173	CD	O
primary	JJ	O
sporadic	JJ	O
human	JJ	O
renal	NN	B_Disease
cell	NN	I_Disease
carcinomas	NN	E_Disease
for	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
VHL	NNP	B_Disease
tumor	NN	E_Disease
suppressor	NN	O
gene	NN	O
,	,	O
using	VBG	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
and	CC	O
single	JJ	O
-	:	O
strand	NN	O
conformational	JJ	O
polymorphism	NN	O
analysis	NN	O
(	(	O
SSCP	NNP	O
)	)	O
of	IN	O
DNA	NN	O
.	.	O

We	PRP	O
detected	VBD	O
abnormal	JJ	O
SSCP	NNP	O
pattern	NN	O
in	IN	O
73	CD	O
samples	NNS	O
.	.	O

After	IN	O
sequencing	VBG	O
,	,	O
we	PRP	O
identified	VBD	O
microdeletions	NNS	O
in	IN	O
58	CD	O
%	NN	O
of	IN	O
cases	NNS	O
,	,	O
microinsertions	NNS	O
in	IN	O
17	CD	O
%	NN	O
,	,	O
nonsense	JJ	O
mutations	NNS	O
in	IN	O
8	CD	O
%	NN	O
,	,	O
and	CC	O
missense	JJ	O
mutations	NNS	O
in	IN	O
17	CD	O
%	NN	O
.	.	O

Among	IN	O
these	DT	O
mutations	NNS	O
,	,	O
50	CD	O
%	NN	O
correspond	NN	O
to	TO	O
new	JJ	O
mutations	NNS	O
.	.	O

VHL	NNP	S_Disease
mutations	NNS	O
were	VBD	O
found	VBN	O
only	RB	O
in	IN	O
the	DT	O
nonpapillary	JJ	B_Disease
renal	NN	I_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
(	(	O
RCC	NNP	S_Disease
)	)	O
subtype	NN	O
,	,	O
as	IN	O
previously	RB	O
reported	VBN	O
.	.	O

To	TO	O
compare	VB	O
somatic	JJ	O
and	CC	O
germline	JJ	O
mutations	NNS	O
,	,	O
we	PRP	O
used	VBD	O
the	DT	O
VHL	NNP	S_Disease
database	NN	O
,	,	O
which	WDT	O
includes	VBZ	O
507	CD	O
mutations	NNS	O
.	.	O

The	DT	O
study	NN	O
of	IN	O
mutational	JJ	O
events	NNS	O
revealed	VBD	O
a	DT	O
significant	JJ	O
difference	NN	O
between	IN	O
somatic	JJ	O
and	CC	O
germline	JJ	O
mutations	NNS	O
with	IN	O
mutations	NNS	O
leading	VBG	O
to	TO	O
truncated	JJ	O
proteins	NNS	O
observed	VBN	O
in	IN	O
78	CD	O
%	NN	O
of	IN	O
somatic	JJ	O
mutations	NNS	O
vs	VBP	O
only	RB	O
37	CD	O
%	NN	O
in	IN	O
germline	JJ	O
mutations	NNS	O
(	(	O
P	NNP	O
<	VBZ	O
0	CD	O
.	.	O

001	CD	O
)	)	O
.	.	O

We	PRP	O
postulated	VBD	O
that	IN	O
a	DT	O
specific	JJ	O
pattern	NN	O
of	IN	O
VHL	NNP	S_Disease
mutations	NNS	O
is	VBZ	O
associated	VBN	O
with	IN	O
sporadic	JJ	B_Disease
RCC	NNP	E_Disease
.	.	O

This	DT	O
pattern	NN	O
corresponds	VBZ	O
to	TO	O
mutations	NNS	O
leading	VBG	O
mainly	RB	O
to	TO	O
truncated	JJ	O
proteins	NNS	O
with	IN	O
few	JJ	O
specific	JJ	O
missense	NN	O
mutations	NNS	O
.	.	O

We	PRP	O
then	RB	O
analyzed	VBD	O
the	DT	O
occurrence	NN	O
of	IN	O
RCC	NNP	S_Disease
in	IN	O
VHL	NNP	S_Disease
families	NNS	O
,	,	O
based	VBN	O
on	IN	O
the	DT	O
nature	NN	O
of	IN	O
mutations	NNS	O
.	.	O

We	PRP	O
observed	VBD	O
RCC	NNP	S_Disease
in	IN	O
at	IN	O
least	JJS	O
one	CD	O
member	NN	O
of	IN	O
the	DT	O
VHL	NNP	S_Disease
families	NNS	O
in	IN	O
77	CD	O
%	NN	O
of	IN	O
cases	NNS	O
with	IN	O
mutations	NNS	O
leading	VBG	O
to	TO	O
truncated	JJ	O
proteins	NNS	O
versus	VBP	O
55	CD	O
%	NN	O
in	IN	O
cases	NNS	O
with	IN	O
missense	JJ	O
mutations	NNS	O
(	(	O
P	NNP	O
<	VBZ	O
0	CD	O
.	.	O

05	CD	O
)	)	O
.	.	O

Thus	RB	O
,	,	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
truncated	JJ	O
proteins	NNS	O
may	MD	O
lead	VB	O
to	TO	O
a	DT	O
higher	JJR	O
risk	NN	O
of	IN	O
RCC	NNP	S_Disease
in	IN	O
VHL	NNP	S_Disease
patients	NNS	O

Defective	JJ	O
CTLA	NNP	O
-	:	O
4	CD	O
cycling	VBG	O
pathway	NN	O
in	IN	O
Chediak	NNP	B_Disease
-	:	I_Disease
Higashi	NNP	I_Disease
syndrome	NN	E_Disease
:	:	O
a	DT	O
possible	JJ	O
mechanism	NN	O
for	IN	O
deregulation	NN	O
of	IN	O
T	NNP	O
lymphocyte	JJ	O
activation	NN	O
.	.	O

Cytotoxic	NNP	O
T	NNP	O
lymphocyte	SYM	O
-	:	O
associated	VBN	O
antigen	NN	O
4	CD	O
(	(	O
CTLA	NNP	O
-	:	O
4	CD	O
,	,	O
also	RB	O
known	VBN	O
as	IN	O
CD152	NNP	O
)	)	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
play	VB	O
a	DT	O
major	JJ	O
role	NN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
T	NNP	O
cell	NN	O
activation	NN	O
.	.	O

Its	PRP$	O
membrane	NN	O
expression	NN	O
is	VBZ	O
highly	RB	O
regulated	VBN	O
by	IN	O
endocytosis	NN	O
and	CC	O
trafficking	VBG	O
through	IN	O
the	DT	O
secretory	JJ	O
lysosome	JJ	O
pathway	NN	O
.	.	O

Chediak	NNP	B_Disease
-	:	I_Disease
Higashi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
CHS	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
inherited	JJ	B_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
lysosomal	JJ	O
trafficking	NN	O
regulator	NN	O
gene	NN	O
,	,	O
LYST	NNP	O
.	.	O

It	PRP	O
results	NNS	O
in	IN	O
defective	JJ	O
membrane	NN	O
targeting	NN	O
of	IN	O
the	DT	O
proteins	NNS	O
present	JJ	O
in	IN	O
secretory	JJ	O
lysosomes	NNS	O
,	,	O
and	CC	O
it	PRP	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
variety	NN	O
of	IN	O
features	NNS	O
,	,	O
including	VBG	O
a	DT	O
lymphoproliferative	JJ	B_Disease
syndrome	NN	E_Disease
with	IN	O
hemophagocytosis	NN	S_Disease
.	.	O

The	DT	O
murine	JJ	O
equivalent	NN	O
of	IN	O
CHS	NNP	S_Disease
,	,	O
beige	JJ	O
mice	NN	O
,	,	O
present	JJ	O
similar	JJ	O
characteristics	NNS	O
but	CC	O
do	VBP	O
not	RB	O
develop	VB	O
the	DT	O
lymphoproliferative	JJ	B_Disease
syndrome	NN	E_Disease
.	.	O

We	PRP	O
show	VBP	O
herein	JJ	O
that	IN	O
CTLA	NNP	O
-	:	O
4	CD	O
is	VBZ	O
present	JJ	O
in	IN	O
enlarged	JJ	O
,	,	O
abnormal	JJ	O
vesicles	NNS	O
in	IN	O
CHS	NNP	S_Disease
T	NNP	O
cells	NNS	O
and	CC	O
is	VBZ	O
not	RB	O
properly	RB	O
expressed	VBN	O
at	IN	O
the	DT	O
cell	NN	O
surface	NN	O
after	IN	O
T	NNP	O
cell	NN	O
activation	NN	O
,	,	O
whereas	IN	O
its	PRP$	O
surface	NN	O
expression	NN	O
is	VBZ	O
not	RB	O
impaired	JJ	O
.	.	O

It	PRP	O
is	VBZ	O
therefore	RB	O
proposed	VBN	O
that	IN	O
the	DT	O
defective	JJ	O
surface	NN	O
expression	NN	O
of	IN	O
CTLA	NNP	O
-	:	O
4	CD	O
by	IN	O
CHS	NNP	S_Disease
T	NNP	O
cells	NNS	O
is	VBZ	O
involved	VBN	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
lymphoproliferative	JJ	B_Disease
disease	NN	E_Disease
.	.	O

This	DT	O
observation	NN	O
may	MD	O
provide	VB	O
insight	NN	O
into	IN	O
the	DT	O
role	NN	O
of	IN	O
CTLA	NNP	O
-	:	O
4	CD	O
in	IN	O
humans	NNS	O
.	.	O
.	.	O

Proteolipoprotein	NNP	O
gene	NN	O
analysis	NN	O
in	IN	O
82	CD	O
patients	NNS	O
with	IN	O
sporadic	JJ	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
Disease	NN	E_Disease
:	:	O
duplications	NNS	O
,	,	O
the	DT	O
major	JJ	O
cause	NN	O
of	IN	O
the	DT	O
disease	NN	O
,	,	O
originate	VB	O
more	RBR	O
frequently	RB	O
in	IN	O
male	JJ	O
germ	NN	O
cells	NNS	O
,	,	O
but	CC	O
point	NN	O
mutations	NNS	O
do	VBP	O
not	RB	O
.	.	O

The	DT	O
Clinical	JJ	O
European	JJ	O
Network	NNP	O
on	IN	O
Brain	NNP	B_Disease
Dysmyelinating	NNP	I_Disease
Disease	NNP	E_Disease
.	.	O

Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
Disease	NNP	E_Disease
(	(	O
PMD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
developmental	JJ	I_Disease
defect	NN	I_Disease
of	IN	I_Disease
myelination	NN	E_Disease
affecting	VBG	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
and	CC	O
segregating	VBG	O
with	IN	O
the	DT	O
proteolipoprotein	NN	O
(	(	O
PLP	NNP	O
)	)	O
locus	NN	O
.	.	O

Investigating	VBG	O
82	CD	O
strictly	RB	O
selected	VBN	O
sporadic	JJ	O
cases	NNS	O
of	IN	O
PMD	NNP	S_Disease
,	,	O
we	PRP	O
found	VBD	O
PLP	NNP	O
mutations	NNS	O
in	IN	O
77	CD	O
%	NN	O
;	:	O
complete	JJ	O
PLP	NNP	O
-	:	O
gene	NN	O
duplications	NNS	O
were	VBD	O
the	DT	O
most	RBS	O
frequent	JJ	O
abnormality	NN	O
(	(	O
62	CD	O
%	NN	O
)	)	O
,	,	O
whereas	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
coding	VBG	O
or	CC	O
splice	JJ	O
-	:	O
site	NN	O
regions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
were	VBD	O
involved	VBN	O
less	RBR	O
frequently	RB	O
(	(	O
38	CD	O
%	NN	O
)	)	O
.	.	O

We	PRP	O
analyzed	VBD	O
the	DT	O
maternal	JJ	O
status	NN	O
of	IN	O
56	CD	O
cases	NNS	O
to	TO	O
determine	VB	O
the	DT	O
origin	NN	O
of	IN	O
both	DT	O
types	NNS	O
of	IN	O
PLP	NNP	O
mutation	NN	O
,	,	O
since	IN	O
this	DT	O
is	VBZ	O
relevant	JJ	O
to	TO	O
genetic	JJ	O
counseling	NN	O
.	.	O

In	IN	O
the	DT	O
22	CD	O
point	NN	O
mutations	NNS	O
,	,	O
68	CD	O
%	NN	O
of	IN	O
mothers	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
mutation	NN	O
,	,	O
a	DT	O
value	NN	O
identical	JJ	O
to	TO	O
the	DT	O
two	CD	O
-	:	O
thirds	NNS	O
of	IN	O
carrier	NN	O
mothers	NNS	O
that	WDT	O
would	MD	O
be	VB	O
expected	VBN	O
if	IN	O
there	EX	O
were	VBD	O
an	DT	O
equal	JJ	O
mutation	NN	O
rate	NN	O
in	IN	O
male	NN	O
and	CC	O
female	JJ	O
germ	NN	O
cells	NNS	O
.	.	O

In	IN	O
sharp	JJ	O
contrast	NN	O
,	,	O
among	IN	O
the	DT	O
34	CD	O
duplicated	JJ	O
cases	NNS	O
,	,	O
91	CD	O
%	NN	O
of	IN	O
mothers	NNS	O
were	VBD	O
carriers	NNS	O
,	,	O
a	DT	O
value	NN	O
significantly	RB	O
(	(	O
chi2	JJ	O
=	NN	O
9	CD	O
.	.	O

20	CD	O
,	,	O
P	NNP	O
<	NNP	O
.	.	O

01	CD	O
)	)	O
in	IN	O
favor	NN	O
of	IN	O
a	DT	O
male	NN	O
bias	NN	O
,	,	O
with	IN	O
an	DT	O
estimation	NN	O
of	IN	O
the	DT	O
male	NN	O
/	NNP	O
female	JJ	O
mutation	NN	O
frequency	NN	O
(	(	O
k	NN	O
)	)	O
of	IN	O
9	CD	O
.	.	O

3	CD	O
3	CD	O
.	.	O

Moreover	RB	O
,	,	O
we	PRP	O
observed	VBD	O
the	DT	O
occurrence	NN	O
of	IN	O
de	FW	O
novo	FW	O
mutations	NNS	O
between	IN	O
parental	JJ	O
and	CC	O
grandparental	JJ	O
generations	NNS	O
in	IN	O
17	CD	O
three	CD	O
-	:	O
generation	NN	O
families	NNS	O
,	,	O
which	WDT	O
allowed	VBD	O
a	DT	O
direct	JJ	O
estimation	NN	O
of	IN	O
the	DT	O
k	NN	O
value	NN	O
(	(	O
k	VB	O
=	NNP	O
11	CD	O
)	)	O
.	.	O

Again	NNP	O
,	,	O
a	DT	O
significant	JJ	O
male	JJ	O
mutation	NN	O
imbalance	NN	O
was	VBD	O
observed	VBN	O
only	RB	O
for	IN	O
the	DT	O
duplications	NNS	O
.	.	O

Chromosome	NNP	O
breakage	NN	O
in	IN	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
and	CC	I_Disease
Angelman	NNP	I_Disease
syndromes	VBZ	E_Disease
involves	VBZ	O
recombination	NN	O
between	IN	O
large	JJ	O
,	,	O
transcribed	JJ	O
repeats	NNS	O
at	IN	O
proximal	JJ	O
and	CC	O
distal	JJ	O
breakpoints	NNS	O
.	.	O

Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
and	CC	O
Angelman	NNP	B_Disease
syndrome	VBP	E_Disease
(	(	O
AS	IN	S_Disease
)	)	O
are	VBP	O
distinct	JJ	O
neurobehavioral	JJ	B_Disease
disorders	NNS	E_Disease
that	IN	O
most	JJS	O
often	RB	O
arise	VBP	O
from	IN	O
a	DT	O
4	CD	O
-	:	O
Mb	NNP	O
deletion	NN	O
of	IN	O
chromosome	NN	O
15q11	CD	O
-	:	O
q13	NN	O
during	IN	O
paternal	JJ	O
or	CC	O
maternal	JJ	O
gametogenesis	NN	O
,	,	O
respectively	RB	O
.	.	O

At	IN	O
a	DT	O
de	FW	O
novo	FW	O
frequency	NN	O
of	IN	O
approximately	RB	O
.	.	O

67	CD	O
-	:	O
1	CD	O
/	NN	O
10	CD	O
,	,	O
000	CD	O
births	NNS	O
,	,	O
these	DT	O
deletions	NNS	O
represent	VBP	O
a	DT	O
common	JJ	O
structural	JJ	O
chromosome	NN	O
change	NN	O
in	IN	O
the	DT	O
human	JJ	O
genome	NN	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
mechanism	NN	O
underlying	VBG	O
these	DT	O
events	NNS	O
,	,	O
we	PRP	O
characterized	VBD	O
the	DT	O
regions	NNS	O
that	WDT	O
contain	VBP	O
two	CD	O
proximal	JJ	O
breakpoint	NN	O
clusters	NNS	O
and	CC	O
a	DT	O
distal	JJ	O
cluster	NN	O
.	.	O

Novel	NNP	O
DNA	NNP	O
sequences	VBZ	O
potentially	RB	O
associated	VBN	O
with	IN	O
the	DT	O
breakpoints	NNS	O
were	VBD	O
positionally	RB	O
cloned	VBN	O
from	IN	O
YACs	NNP	O
within	IN	O
or	CC	O
near	IN	O
these	DT	O
regions	NNS	O
.	.	O

Analyses	NNS	O
of	IN	O
rodent	JJ	O
-	:	O
human	JJ	O
somatic	JJ	O
-	:	O
cell	NN	O
hybrids	NNS	O
,	,	O
YAC	NNP	O
contigs	NN	O
,	,	O
and	CC	O
FISH	NNP	O
of	IN	O
normal	JJ	O
or	CC	O
rearranged	VBN	O
chromosomes	NNS	O
15	CD	O
identified	VBN	O
duplicated	VBN	O
sequences	NNS	O
(	(	O
the	DT	O
END	NNP	O
repeats	NN	O
)	)	O
at	IN	O
or	CC	O
near	IN	O
the	DT	O
breakpoints	NNS	O
.	.	O

The	DT	O
END	NNP	O
-	:	O
repeat	NN	O
units	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
large	JJ	O
genomic	JJ	O
duplications	NNS	O
of	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
(	(	O
HERC2	NNP	O
)	)	O
,	,	O
many	JJ	O
copies	NNS	O
of	IN	O
which	WDT	O
are	VBP	O
transcriptionally	RB	O
active	JJ	O
in	IN	O
germline	NN	O
tissues	NNS	O
.	.	O

One	CD	O
of	IN	O
five	CD	O
PWS	NNP	S_Disease
/	NN	O
AS	IN	S_Disease
patients	NNS	O
analyzed	VBN	O
to	TO	O
date	NN	O
has	VBZ	O
an	DT	O
identifiable	JJ	O
,	,	O
rearranged	VBD	O
HERC2	NNP	O
transcript	NN	O
derived	VBN	O
from	IN	O
the	DT	O
deletion	NN	O
event	NN	O
.	.	O

We	PRP	O
postulate	VBP	O
that	IN	O
the	DT	O
END	NNP	O
repeats	VBZ	O
flanking	VBG	O
15q11	CD	O
-	:	O
q13	NN	O
mediate	VBP	O
homologous	JJ	O
recombination	NN	O
resulting	VBG	O
in	IN	O
deletion	NN	O
.	.	O

Furthermore	RB	O
,	,	O
we	PRP	O
propose	VBP	O
that	IN	O
active	JJ	O
transcription	NN	O
of	IN	O
these	DT	O
repeats	NNS	O
in	IN	O
male	NN	O
and	CC	O
female	JJ	O
germ	NN	O
cells	NNS	O
may	MD	O
facilitate	VB	O
the	DT	O
homologous	JJ	O
recombination	NN	O
process	NN	O
.	.	O

Linkage	NN	O
analysis	NN	O
in	IN	O
a	DT	O
large	JJ	O
Brazilian	JJ	O
family	NN	O
with	IN	O
van	JJ	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
suggests	VBZ	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
susceptibility	NN	O
locus	NN	O
for	IN	O
cleft	NN	B_Disease
palate	NN	E_Disease
at	IN	O
17p11	CD	O
.	.	O
2	CD	O
-	:	O
11	CD	O
.	.	O
1	CD	O
.	.	O

van	NN	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
VWS	NNP	S_Disease
)	)	O
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
1q32	CD	O
-	:	O
41	CD	O
,	,	O
is	VBZ	O
characterized	VBN	O
by	IN	O
pits	NNS	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
sinuses	NNS	I_Disease
of	IN	I_Disease
the	DT	I_Disease
lower	JJR	I_Disease
lip	NN	E_Disease
,	,	O
cleft	VBD	B_Disease
lip	JJ	I_Disease
/	JJ	I_Disease
palate	NN	E_Disease
(	(	O
CL	NNP	B_Disease
/	NNP	I_Disease
P	NNP	E_Disease
)	)	O
,	,	O
cleft	JJ	B_Disease
palate	NN	E_Disease
(	(	O
CP	NNP	S_Disease
)	)	O
,	,	O
bifid	JJ	B_Disease
uvula	NN	E_Disease
,	,	O
and	CC	O
hypodontia	NN	S_Disease
(	(	O
H	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
expression	NN	O
of	IN	O
VWS	NNP	S_Disease
,	,	O
which	WDT	O
has	VBZ	O
incomplete	JJ	O
penetrance	NN	O
,	,	O
is	VBZ	O
highly	RB	O
variable	JJ	O
.	.	O

Both	DT	O
the	DT	O
occurrence	NN	O
of	IN	O
CL	NNP	B_Disease
/	NNP	I_Disease
P	NNP	E_Disease
and	CC	O
CP	NNP	S_Disease
within	IN	O
the	DT	O
same	JJ	O
genealogy	NN	O
and	CC	O
a	DT	O
recurrence	NN	O
risk	NN	O
<	VBP	O
40	CD	O
%	NN	O
for	IN	O
CP	NNP	S_Disease
among	IN	O
descendants	NNS	O
with	IN	O
VWS	NNP	S_Disease
have	VBP	O
suggested	VBN	O
that	IN	O
the	DT	O
development	NN	O
of	IN	O
clefts	NNS	S_Disease
in	IN	O
this	DT	O
syndrome	NN	O
is	VBZ	O
influenced	VBN	O
by	IN	O
modifying	VBG	O
genes	NNS	O
at	IN	O
other	JJ	O
loci	NN	O
.	.	O

To	TO	O
test	VB	O
this	DT	O
hypothesis	NN	O
,	,	O
we	PRP	O
have	VBP	O
conducted	VBN	O
linkage	NN	O
analysis	NN	O
in	IN	O
a	DT	O
large	JJ	O
Brazilian	JJ	O
kindred	VBN	O
with	IN	O
VWS	NNP	S_Disease
,	,	O
considering	VBG	O
as	IN	O
affected	VBN	O
the	DT	O
individuals	NNS	O
with	IN	O
CP	NNP	S_Disease
,	,	O
regardless	RB	O
of	IN	O
whether	IN	O
it	PRP	O
is	VBZ	O
associated	VBN	O
with	IN	O
other	JJ	O
clinical	JJ	O
signs	NNS	O
of	IN	O
VWS	NNP	S_Disease
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
gene	NN	O
at	IN	O
17p11	CD	O
.	.	O

2	CD	O
-	:	O
11	CD	O
2	CD	O
-	:	O
11	CD	O
.	.	O

1	CD	O
,	,	O
together	RB	O
with	IN	O
the	DT	O
VWS	NNP	S_Disease
gene	NN	O
at	IN	O
1p32	CD	O
-	:	O
41	CD	O
,	,	O
enhances	VBZ	O
the	DT	O
probability	NN	O
of	IN	O
CP	NNP	S_Disease
in	IN	O
an	DT	O
individual	JJ	O
carrying	VBG	O
the	DT	O
two	CD	O
at	IN	O
-	:	O
risk	NN	O
genes	NNS	O
.	.	O

If	IN	O
this	DT	O
hypothesis	NN	O
is	VBZ	O
confirmed	VBN	O
in	IN	O
other	JJ	O
VWS	NNP	S_Disease
pedigrees	NNS	O
,	,	O
it	PRP	O
will	MD	O
represent	VB	O
one	CD	O
of	IN	O
the	DT	O
first	JJ	O
examples	NNS	O
of	IN	O
a	DT	O
gene	NN	O
,	,	O
mapped	VBD	O
through	IN	O
linkage	NN	O
analysis	NN	O
,	,	O
which	WDT	O
modifies	VBZ	O
the	DT	O
expression	NN	O
of	IN	O
a	DT	O
major	JJ	O
gene	NN	O
.	.	O

New	NNP	O
mutations	NNS	O
,	,	O
polymorphisms	NNS	O
,	,	O
and	CC	O
rare	JJ	O
variants	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
detected	VBN	O
by	IN	O
a	DT	O
novel	JJ	O
SSCP	NNP	O
strategy	NN	O
.	.	O

The	DT	O
gene	NN	O
for	IN	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
,	,	O
ATM	NNP	O
,	,	O
spans	VBZ	O
about	IN	O
150	CD	O
kb	NNS	O
of	IN	O
genomic	JJ	O
DNA	NNP	O
.	.	O

ATM	NNP	O
mutations	NNS	O
are	VBP	O
found	VBN	O
along	IN	O
the	DT	O
entire	JJ	O
gene	NN	O
,	,	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
a	DT	O
mutational	JJ	O
hot	JJ	O
spot	NN	O
.	.	O

Using	VBG	O
DNA	NNP	O
as	IN	O
the	DT	O
starting	VBG	O
material	NN	O
,	,	O
we	PRP	O
screened	VBD	O
the	DT	O
ATM	NNP	O
gene	NN	O
in	IN	O
92	CD	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
patients	NNS	O
,	,	O
using	VBG	O
an	DT	O
optimized	VBN	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
SSCP	NNP	O
)	)	O
technique	NN	O
that	WDT	O
detected	VBD	O
all	DT	O
previously	RB	O
known	VBN	O
mutations	NNS	O
in	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
segments	NNS	O
being	VBG	O
analyzed	VBN	O
.	.	O

To	TO	O
expedite	VB	O
screening	NN	O
,	,	O
we	PRP	O
sequentially	RB	O
loaded	VBD	O
the	DT	O
SSCP	NNP	O
gels	NNS	O
with	IN	O
three	CD	O
different	JJ	O
sets	NNS	O
of	IN	O
PCR	NNP	O
products	NNS	O
that	WDT	O
were	VBD	O
pretested	VBN	O
to	TO	O
avoid	VB	O
overlapping	VBG	O
patterns	NNS	O
.	.	O

Many	JJ	O
of	IN	O
the	DT	O
DNA	NN	O
changes	VBZ	O
we	PRP	O
detected	VBD	O
were	VBD	O
intragenic	JJ	O
polymorphisms	NNS	O
.	.	O

Of	IN	O
an	DT	O
expected	JJ	O
177	CD	O
unknown	JJ	O
mutations	NNS	O
,	,	O
we	PRP	O
detected	VBD	O
approximately	RB	O
70	CD	O
%	NN	O
,	,	O
mostly	RB	O
protein	VBZ	O
truncating	VBG	O
mutations	NNS	O
(	(	O
that	WDT	O
would	MD	O
have	VB	O
been	VBN	O
detectable	JJ	O
by	IN	O
protein	JJ	O
truncation	NN	O
testing	VBG	O
if	IN	O
RNA	NNP	O
starting	VBG	O
material	NN	O
had	VBD	O
been	VBN	O
available	JJ	O
)	)	O
.	.	O

Mutations	NNS	O
have	VBP	O
now	RB	O
been	VBN	O
defined	VBN	O
for	IN	O
every	DT	O
exon	NN	O
of	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
.	.	O

Herein	NNP	O
,	,	O
we	PRP	O
present	VBP	O
35	CD	O
new	JJ	O
mutations	NNS	O
and	CC	O
34	CD	O
new	JJ	O
intragenic	JJ	O
polymorphisms	NNS	O
or	CC	O
rare	JJ	O
variants	NNS	O
within	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
most	RBS	O
comprehensive	JJ	O
compilation	NN	O
of	IN	O
ATM	NNP	O
polymorphisms	NNS	O
assembled	VBD	O
to	TO	O
date	NN	O
.	.	O

Defining	VBG	O
polymorphic	JJ	O
sites	NNS	O
as	RB	O
well	RB	O
as	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
will	MD	O
be	VB	O
of	IN	O
great	JJ	O
importance	NN	O
in	IN	O
designing	VBG	O
automated	VBN	O
methods	NNS	O
for	IN	O
detecting	VBG	O
mutations	NNS	O
.	.	O
.	.	O

A	DT	O
novel	JJ	O
frameshift	NN	O
mutation	NN	O
in	IN	O
the	DT	O
McLeod	NNP	B_Disease
syndrome	JJ	E_Disease
gene	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
family	NN	O
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
novel	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
XK	NNP	O
gene	NN	O
(	(	O
XK	NNP	O
)	)	O
in	IN	O
a	DT	O
Japanese	JJ	O
patient	NN	O
with	IN	O
McLeod	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O

A	DT	O
50	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
man	NN	O
showed	VBD	O
progressive	JJ	O
muscular	JJ	B_Disease
atrophy	NN	E_Disease
,	,	O
choreic	JJ	B_Disease
movement	NN	E_Disease
,	,	O
elevated	VBD	O
level	NN	O
of	IN	O
serum	JJ	O
creatinine	NN	O
kinase	NN	O
,	,	O
and	CC	O
acanthocytosis	NN	S_Disease
.	.	O

The	DT	O
expression	NN	O
level	NN	O
of	IN	O
all	PDT	O
the	DT	O
Kell	NNP	O
antigens	NNS	O
in	IN	O
erythrocyte	NN	O
was	VBD	O
decreased	VBN	O
and	CC	O
molecular	JJ	O
analysis	NN	O
revealed	VBD	O
a	DT	O
single	JJ	O
-	:	O
base	NN	O
(	(	O
T	NNP	O
)	)	O
deletion	NN	O
at	IN	O
the	DT	O
nucleotide	JJ	O
position	NN	O
1095	CD	O
in	IN	O
XK	NNP	O
.	.	O

This	DT	O
deletion	NN	O
caused	VBD	O
a	DT	O
frameshift	NN	O
in	IN	O
translation	NN	O
,	,	O
leading	VBG	O
to	TO	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
at	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
position	NN	O
408	CD	O
.	.	O

We	PRP	O
conclude	VBP	O
this	DT	O
single	JJ	O
-	:	O
base	NN	O
deletion	NN	O
causes	VBZ	O
defective	JJ	O
Kx	NNP	O
protein	NN	O
,	,	O
which	WDT	O
is	VBZ	O
responsible	JJ	O
for	IN	O
the	DT	O
McLeod	NNP	S_Disease
phenotype	NN	O
in	IN	O
this	DT	O
patient	NN	O
.	.	O
.	.	O

Association	NNP	O
of	IN	O
BRCA1	NNP	O
with	IN	O
the	DT	O
hRad50	NN	O
-	:	O
hMre11	NN	O
-	:	O
p95	NN	O
complex	NN	O
and	CC	O
the	DT	O
DNA	NNP	O
damage	NN	O
response	NN	O
.	.	O

BRCA1	NNP	O
encodes	VBZ	O
a	DT	O
tumor	NN	S_Disease
suppressor	NN	O
that	WDT	O
is	VBZ	O
mutated	VBN	O
in	IN	O
familial	JJ	B_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
.	.	O

Here	RB	O
,	,	O
it	PRP	O
is	VBZ	O
shown	VBN	O
that	IN	O
BRCA1	NNP	O
interacts	NNS	O
in	IN	O
vitro	NN	O
and	CC	O
in	IN	O
vivo	NN	O
with	IN	O
hRad50	NN	O
,	,	O
which	WDT	O
forms	VBZ	O
a	DT	O
complex	JJ	O
with	IN	O
hMre11	NN	O
and	CC	O
p95	NN	O
/	NNP	O
nibrin	NN	O
.	.	O

Upon	IN	O
irradiation	NN	O
,	,	O
BRCA1	NNP	O
was	VBD	O
detected	VBN	O
in	IN	O
discrete	JJ	O
foci	NN	O
in	IN	O
the	DT	O
nucleus	NN	O
,	,	O
which	WDT	O
colocalize	VBP	O
with	IN	O
hRad50	NN	O
.	.	O

Formation	NN	O
of	IN	O
irradiation	NN	O
-	:	O
induced	JJ	O
foci	NN	O
positive	JJ	O
for	IN	O
BRCA1	NNP	O
,	,	O
hRad50	NN	O
,	,	O
hMre11	NN	O
,	,	O
or	CC	O
p95	NN	O
was	VBD	O
dramatically	RB	O
reduced	VBN	O
in	IN	O
HCC	NNP	O
/	NN	O
1937	CD	O
breast	NN	B_Disease
cancer	NN	E_Disease
cells	NNS	O
carrying	VBG	O
a	DT	O
homozygous	JJ	O
mutation	NN	O
in	IN	O
BRCA1	NNP	O
but	CC	O
was	VBD	O
restored	VBN	O
by	IN	O
transfection	NN	O
of	IN	O
wild	JJ	O
-	:	O
type	NN	O
BRCA1	NNP	O
.	.	O

Ectopic	NNP	O
expression	NN	O
of	IN	O
wild	JJ	O
-	:	O
type	NN	O
,	,	O
but	CC	O
not	RB	O
mutated	VBN	O
,	,	O
BRCA1	NNP	O
in	IN	O
these	DT	O
cells	NNS	O
rendered	VBD	O
them	PRP	O
less	RBR	O
sensitive	JJ	O
to	TO	O
the	DT	O
DNA	NNP	O
damage	NN	O
agent	NN	O
,	,	O
methyl	JJ	O
methanesulfonate	NN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
BRCA1	NNP	O
is	VBZ	O
important	JJ	O
for	IN	O
the	DT	O
cellular	JJ	O
responses	NNS	O
to	TO	O
DNA	NNP	O
damage	NN	O
that	WDT	O
are	VBP	O
mediated	VBN	O
by	IN	O
the	DT	O
hRad50	NN	O
-	:	O
hMre11	NN	O
-	:	O
p95	NN	O
complex	NN	O
.	.	O
.	.	O

Relationship	NNP	O
among	IN	O
genotype	NN	O
,	,	O
biochemical	JJ	O
phenotype	NN	O
,	,	O
and	CC	O
cognitive	JJ	O
performance	NN	O
in	IN	O
females	NNS	O
with	IN	O
phenylalanine	JJ	B_Disease
hydroxylase	NN	I_Disease
deficiency	NN	E_Disease
:	:	O
report	NN	O
from	IN	O
the	DT	O
Maternal	NNP	B_Disease
Phenylketonuria	NNP	E_Disease
Collaborative	NNP	O
Study	NNP	O
.	.	O

OBJECTIVE	NN	O
To	TO	O
examine	VB	O
the	DT	O
relationship	NN	O
of	IN	O
phenylalanine	NN	O
hydroxylase	NN	O
(	(	O
PAH	NNP	O
)	)	O
genotypes	VBZ	O
to	TO	O
biochemical	JJ	O
phenotype	NN	O
and	CC	O
cognitive	JJ	O
development	NN	O
in	IN	O
maternal	JJ	B_Disease
phenylketonuria	NN	E_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
.	.	O

METHODOLOGY	NNP	O
PAH	NNP	O
gene	NN	O
mutations	NNS	O
were	VBD	O
examined	VBN	O
in	IN	O
222	CD	O
hyperphenylalaninemic	JJ	S_Disease
females	NNS	O
enrolled	VBN	O
in	IN	O
the	DT	O
Maternal	NNP	B_Disease
PKU	NNP	E_Disease
Collaborative	NNP	O
Study	NNP	O
(	(	O
MPKUCS	NNP	O
)	)	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
84	CD	O
different	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
,	,	O
and	CC	O
complete	JJ	O
genotype	NN	O
was	VBD	O
obtained	VBN	O
in	IN	O
199	CD	O
individuals	NNS	O
.	.	O

Based	VBN	O
on	IN	O
previous	JJ	O
knowledge	NN	O
about	IN	O
mutation	NN	O
-	:	O
phenotype	NN	O
associations	NNS	O
,	,	O
78	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
could	MD	O
be	VB	O
assigned	VBN	O
to	TO	O
one	CD	O
of	IN	O
four	CD	O
classes	NNS	O
of	IN	O
severity	NN	O
(	(	O
severe	JJ	O
PKU	NNP	S_Disease
,	,	O
moderate	JJ	O
PKU	NNP	S_Disease
,	,	O
mild	JJ	O
PKU	NNP	S_Disease
,	,	O
and	CC	O
mild	JJ	B_Disease
hyperphenylalaninemia	NN	E_Disease
[	NNP	O
MHP	NNP	S_Disease
]	NNP	O
)	)	O
.	.	O

Then	RB	O
,	,	O
189	CD	O
MPKUCS	NNP	O
subjects	NNS	O
were	VBD	O
grouped	VBN	O
according	VBG	O
to	TO	O
the	DT	O
various	JJ	O
combinations	NNS	O
of	IN	O
mutation	NN	O
classifications	NNS	O
.	.	O

The	DT	O
sample	NN	O
sizes	NNS	O
were	VBD	O
large	JJ	O
enough	RB	O
for	IN	O
statistical	JJ	O
testing	NN	O
in	IN	O
four	CD	O
groups	NNS	O
with	IN	O
at	IN	O
least	JJS	O
one	CD	O
mutation	NN	O
that	WDT	O
completely	RB	O
abolishes	VBZ	O
enzyme	JJ	O
activity	NN	O
.	.	O

These	DT	O
patients	NNS	O
are	VBP	O
considered	VBN	O
functionally	RB	O
hemizygous	JJ	O
.	.	O

RESULTS	VB	O
The	DT	O
biochemical	JJ	O
phenotype	NN	O
predicted	VBD	O
from	IN	O
the	DT	O
genotype	NN	O
in	IN	O
functionally	RB	O
hemizygous	JJ	O
patients	NNS	O
was	VBD	O
related	VBN	O
significantly	RB	O
to	TO	O
the	DT	O
assigned	JJ	O
phenylalanine	NN	O
level	NN	O
.	.	O

Cognitive	JJ	O
performance	NN	O
(	(	O
IQ	NNP	O
)	)	O
was	VBD	O
also	RB	O
significantly	RB	O
related	VBN	O
to	TO	O
genotype	NN	O
.	.	O

The	DT	O
IQ	NNP	O
of	IN	O
PAH	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
mothers	NNS	O
with	IN	O
a	DT	O
severe	JJ	O
PKU	NNP	S_Disease
mutation	NN	O
in	IN	O
combination	NN	O
with	IN	O
a	DT	O
MHP	NNP	S_Disease
mutation	NN	O
or	CC	O
a	DT	O
mild	JJ	O
PKU	NNP	S_Disease
mutation	NN	O
was	VBD	O
99	CD	O
and	CC	O
96	CD	O
,	,	O
respectively	RB	O
,	,	O
whereas	IN	O
the	DT	O
IQ	NNP	O
of	IN	O
PKU	NNP	S_Disease
mothers	NNS	O
with	IN	O
two	CD	O
severe	JJ	O
PKU	NNP	S_Disease
mutations	NNS	O
or	CC	O
with	IN	O
one	CD	O
severe	NN	O
and	CC	O
one	CD	O
moderate	NN	O
PKU	NNP	S_Disease
mutation	NN	O
was	VBD	O
83	CD	O
and	CC	O
84	CD	O
,	,	O
respectively	RB	O
.	.	O

Of	IN	O
the	DT	O
patients	NNS	O
with	IN	O
PKU	NNP	S_Disease
,	,	O
92	CD	O
%	NN	O
had	VBD	O
been	VBN	O
treated	VBN	O
during	IN	O
childhood	NN	O
.	.	O

Those	DT	O
who	WP	O
were	VBD	O
untreated	JJ	O
or	CC	O
treated	VBN	O
late	JJ	O
had	VBD	O
lower	JJR	O
than	IN	O
average	JJ	O
IQ	JJ	O
scores	NNS	O
for	IN	O
their	PRP$	O
group	NN	O
of	IN	O
mutation	NN	O
combinations	NNS	O
.	.	O

Females	NNS	O
with	IN	O
moderate	JJ	O
or	CC	O
mild	JJ	O
PKU	NNS	S_Disease
who	WP	O
were	VBD	O
treated	VBN	O
early	RB	O
and	CC	O
treated	VBN	O
for	IN	O
>	JJ	O
6	CD	O
years	NNS	O
showed	VBD	O
IQ	NNP	O
scores	NNS	O
10	CD	O
points	NNS	O
above	JJ	O
average	NN	O
for	IN	O
their	PRP$	O
group	NN	O
.	.	O

CONCLUSIONS	NNP	O
The	DT	O
reproductive	JJ	O
outcome	NN	O
in	IN	O
maternal	JJ	B_Disease
phenylketonuria	NN	E_Disease
is	VBZ	O
dependent	JJ	O
on	IN	O
prenatal	JJ	O
metabolic	JJ	O
control	NN	O
and	CC	O
postnatal	JJ	O
environmental	JJ	O
circumstances	NNS	O
.	.	O

Both	DT	O
factors	NNS	O
depend	VBP	O
on	IN	O
the	DT	O
intellectual	JJ	O
resources	NNS	O
of	IN	O
the	DT	O
mother	NN	O
with	IN	O
PKU	NNP	S_Disease
.	.	O

The	DT	O
significant	JJ	O
relationship	NN	O
among	IN	O
genotype	NN	O
,	,	O
biochemical	JJ	O
phenotype	NN	O
,	,	O
and	CC	O
cognitive	JJ	O
performance	NN	O
observed	VBN	O
in	IN	O
the	DT	O
present	JJ	O
study	NN	O
is	VBZ	O
of	IN	O
importance	NN	O
for	IN	O
the	DT	O
development	NN	O
of	IN	O
an	DT	O
optimal	JJ	O
strategy	NN	O
for	IN	O
future	JJ	O
treatment	NN	O
of	IN	O
females	NNS	O
with	IN	O
PKU	NNP	S_Disease
who	WP	O
plan	VBP	O
pregnancy	NN	O
.	.	O
.	.	O

Spinal	JJ	B_Disease
xanthomatosis	NN	E_Disease
:	:	O
a	DT	O
variant	NN	O
of	IN	O
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
.	.	O

We	PRP	O
describe	VBP	O
seven	CD	O
Dutch	JJ	O
patients	NNS	O
from	IN	O
six	CD	O
families	NNS	O
with	IN	O
a	DT	O
slowly	RB	O
progressive	JJ	O
,	,	O
mainly	RB	O
spinal	JJ	B_Disease
cord	NN	I_Disease
syndrome	NN	E_Disease
that	WDT	O
remained	VBD	O
for	IN	O
many	JJ	O
years	NNS	O
the	DT	O
sole	JJ	O
expression	NN	O
of	IN	O
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
(	(	O
CTX	NNP	S_Disease
)	)	O
.	.	O

MRI	NNP	O
demonstrated	VBD	O
white	JJ	B_Disease
matter	NN	I_Disease
abnormalities	NNS	E_Disease
in	IN	O
the	DT	O
lateral	JJ	O
and	CC	O
dorsal	JJ	O
columns	NN	O
of	IN	O
the	DT	O
spinal	JJ	O
cord	NN	O
.	.	O

Post	NNP	O
-	:	O
mortem	NN	O
examination	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
patients	NNS	O
showed	VBD	O
extensive	JJ	O
myelin	NN	O
loss	NN	O
in	IN	O
these	DT	O
columns	NNS	O
.	.	O

An	DT	O
array	NN	O
of	IN	O
genotypes	NNS	O
was	VBD	O
found	VBN	O
in	IN	O
these	DT	O
patients	NNS	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
spinal	JJ	B_Disease
xanthomatosis	NN	E_Disease
is	VBZ	O
a	DT	O
clinical	JJ	O
and	CC	O
radiological	JJ	O
separate	JJ	O
entity	NN	O
of	IN	O
CTX	NNP	S_Disease
that	WDT	O
should	MD	O
be	VB	O
included	VBN	O
in	IN	O
the	DT	O
differential	JJ	O
diagnosis	NN	O
of	IN	O
chronic	JJ	B_Disease
myelopathy	NN	E_Disease
.	.	O
.	.	O

A	DT	O
transgene	JJ	O
insertion	NN	O
creating	VBG	O
a	DT	O
heritable	JJ	O
chromosome	NN	O
deletion	NN	O
mouse	IN	O
model	NN	O
of	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
and	CC	I_Disease
angelman	JJ	I_Disease
syndromes	NNS	E_Disease
.	.	O

Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
and	CC	O
Angelman	NNP	B_Disease
syndrome	VBP	E_Disease
(	(	O
AS	IN	S_Disease
)	)	O
result	NN	O
from	IN	O
the	DT	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
imprinted	JJ	O
genes	NNS	O
in	IN	O
human	JJ	O
chromosome	NN	O
15q11	CD	O
-	:	O
q13	NN	O
.	.	O

The	DT	O
central	JJ	O
part	NN	O
of	IN	O
mouse	NN	O
chromosome	NN	O
7	CD	O
is	VBZ	O
homologous	JJ	O
to	TO	O
human	JJ	O
15q11	CD	O
-	:	O
q13	NN	O
,	,	O
with	IN	O
conservation	NN	O
of	IN	O
both	DT	O
gene	NN	O
order	NN	O
and	CC	O
imprinted	JJ	O
features	NNS	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
characterization	NN	O
of	IN	O
a	DT	O
transgene	JJ	O
insertion	NN	O
(	(	O
Epstein	NNP	O
-	:	O
Barr	NNP	O
virus	NN	O
Latent	NNP	O
Membrane	NNP	O
Protein	NNP	O
2A	CD	O
,	,	O
LMP2A	NNP	O
)	)	O
into	IN	O
mouse	NN	O
chromosome	NN	O
7C	CD	O
,	,	O
which	WDT	O
has	VBZ	O
resulted	VBN	O
in	IN	O
mouse	NN	O
models	NNS	O
for	IN	O
PWS	NNP	S_Disease
and	CC	O
AS	NNP	S_Disease
dependent	NN	O
on	IN	O
the	DT	O
sex	NN	O
of	IN	O
the	DT	O
transmitting	JJ	O
parent	NN	O
.	.	O

Epigenotype	NNP	O
(	(	O
allelic	JJ	O
expression	NN	O
and	CC	O
DNA	NNP	O
methylation	NN	O
)	)	O
and	CC	O
fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
analyses	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
transgene	NN	O
-	:	O
induced	JJ	O
mutation	NN	O
has	VBZ	O
generated	VBN	O
a	DT	O
complete	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
PWS	NNP	S_Disease
/	NNP	O
AS	NNP	S_Disease
-	:	O
homologous	JJ	O
region	NN	O
but	CC	O
has	VBZ	O
not	RB	O
deleted	VBN	O
flanking	VBG	O
loci	NN	O
.	.	O

Because	IN	O
the	DT	O
intact	JJ	O
chromosome	NN	O
7	CD	O
,	,	O
opposite	PDT	O
the	DT	O
deleted	JJ	O
homolog	NN	O
,	,	O
maintains	VBZ	O
the	DT	O
correct	JJ	O
imprint	NN	O
in	IN	O
somatic	JJ	O
cells	NNS	O
of	IN	O
PWS	NNP	S_Disease
and	CC	O
AS	NNP	S_Disease
mice	NN	O
and	CC	O
establishes	VBZ	O
the	DT	O
correct	JJ	O
imprint	NN	O
in	IN	O
male	NN	O
and	CC	O
female	JJ	O
germ	NN	O
cells	NNS	O
of	IN	O
AS	NNP	S_Disease
mice	NN	O
,	,	O
homologous	JJ	O
association	NN	O
and	CC	O
replication	NN	O
asynchrony	NN	O
are	VBP	O
not	RB	O
part	NN	O
of	IN	O
the	DT	O
imprinting	NN	O
mechanism	NN	O
.	.	O

This	DT	O
heritable	JJ	O
-	:	O
deletion	NN	O
mouse	NN	O
model	NN	O
will	MD	O
be	VB	O
particularly	RB	O
useful	JJ	O
for	IN	O
the	DT	O
identification	NN	O
of	IN	O
the	DT	O
etiological	JJ	O
genes	NNS	O
and	CC	O
mechanisms	NNS	O
,	,	O
phenotypic	JJ	O
basis	NN	O
,	,	O
and	CC	O
investigation	NN	O
of	IN	O
therapeutic	JJ	O
approaches	NNS	O
for	IN	O
PWS	NNP	S_Disease
.	.	O
.	.	O

Linkage	JJ	O
analysis	NN	O
of	IN	O
5	CD	O
novel	JJ	O
van	NN	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
kindreds	NNS	O
to	TO	O
1q32	CD	O
-	:	O
q41	NN	O
markers	NNS	O
further	RBR	O
supports	NNS	O
locus	VBP	O
homogeneity	NN	O
of	IN	O
the	DT	O
disease	NN	O
trait	NN	O
.	.	O

van	NN	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
vWS	NN	S_Disease
,	,	O
MIM	NNP	O
119300	CD	O
)	)	O
is	VBZ	O
a	DT	O
rare	JJ	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
clefting	VBG	I_Disease
condition	NN	E_Disease
with	IN	O
cardinal	JJ	O
features	NNS	O
of	IN	O
mucous	JJ	B_Disease
cysts	NNS	E_Disease
(	(	O
lower	JJR	B_Disease
-	:	I_Disease
lip	NN	I_Disease
pits	NNS	E_Disease
)	)	O
and	CC	O
clefts	NNS	B_Disease
to	TO	I_Disease
the	DT	I_Disease
lip	NN	I_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
palate	NN	E_Disease
.	.	O

The	DT	O
vWS	NN	S_Disease
gene	NN	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
to	TO	O
a	DT	O
locus	NN	O
in	IN	O
1q32	CD	O
-	:	O
q41	NN	O
by	IN	O
linkage	NN	O
analysis	NN	O
and	CC	O
physical	JJ	O
mapping	NN	O
.	.	O

We	PRP	O
have	VBP	O
investigated	VBN	O
5	CD	O
novel	JJ	O
vWS	NN	S_Disease
families	NNS	O
through	IN	O
probands	NNS	O
attended	VBN	O
for	IN	O
cleft	NN	B_Disease
lip	NN	I_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
palate	VB	E_Disease
repair	NN	O
at	IN	O
the	DT	O
Department	NNP	O
of	IN	O
Maxillofacial	NNP	O
Surgery	NNP	O
of	IN	O
Hopital	NNP	O
Trousseau	NNP	O
,	,	O
Paris	NNP	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
tentatively	RB	O
refine	VB	O
the	DT	O
genetic	JJ	O
map	NN	O
of	IN	O
the	DT	O
vWS	JJ	S_Disease
region	NN	O
in	IN	O
1q32	CD	O
-	:	O
q41	NN	O
and	CC	O
possibly	RB	O
identify	VB	O
unlinked	JJ	O
pedigrees	NNS	O
.	.	O

Linkage	NN	O
analysis	NN	O
was	VBD	O
carried	VBN	O
out	IN	O
to	TO	O
6	CD	O
microsatellite	NN	O
markers	NNS	O
(	(	O
D1S249	NNP	O
,	,	O
D1S425	NNP	O
,	,	O
D1S491	NNP	O
,	,	O
D1S205	NNP	O
,	,	O
D1S414	NNP	O
,	,	O
D1S425	NNP	O
)	)	O
,	,	O
yielding	VBG	O
a	DT	O
maximum	JJ	O
cumulative	JJ	O
LOD	NNP	O
score	NN	O
of	IN	O
Z	NNP	O
=	NNP	O
3	CD	O
.	.	O

27	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

00	CD	O
for	IN	O
D1S245	NNP	O
.	.	O

The	DT	O
innermost	NN	O
four	CD	O
markers	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
tightly	RB	O
linked	VBN	O
to	TO	O
one	CD	O
another	DT	O
,	,	O
with	IN	O
no	DT	O
evidence	NN	O
for	IN	O
recombination	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
support	JJ	O
linkage	NN	O
of	IN	O
vWS	NN	S_Disease
within	IN	O
a	DT	O
region	NN	O
of	IN	O
tightly	RB	O
linked	VBN	O
markers	NNS	O
and	CC	O
do	VBP	O
not	RB	O
favour	VB	O
locus	JJ	O
heterogeneity	NN	O
of	IN	O
the	DT	O
disease	NN	O
trait	NN	O
.	.	O

Null	NNP	O
mutation	NN	O
of	IN	O
the	DT	O
murine	NN	O
ATP7B	NNP	O
(	(	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
)	)	O
gene	NN	O
results	NNS	O
in	IN	O
intracellular	JJ	B_Disease
copper	NN	I_Disease
accumulation	NN	E_Disease
and	CC	O
late	JJ	B_Disease
-	:	I_Disease
onset	VBN	I_Disease
hepatic	JJ	I_Disease
nodular	JJ	I_Disease
transformation	NN	E_Disease
.	.	O

The	DT	O
Atp7b	NNP	O
protein	NN	O
is	VBZ	O
a	DT	O
copper	NN	O
-	:	O
transporting	VBG	O
ATPase	NNP	O
expressed	VBD	O
predominantly	RB	O
in	IN	O
the	DT	O
liver	NN	O
and	CC	O
to	TO	O
a	DT	O
lesser	JJR	O
extent	NN	O
in	IN	O
most	JJS	O
other	JJ	O
tissues	NNS	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
ATP7B	NNP	O
gene	NN	O
lead	NN	O
to	TO	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
,	,	O
a	DT	O
copper	NN	B_Disease
toxicity	NN	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
dramatic	JJ	O
build	NN	O
-	:	O
up	IN	O
of	IN	O
intracellular	JJ	O
hepatic	JJ	O
copper	NN	O
with	IN	O
subsequent	JJ	O
hepatic	NN	B_Disease
and	CC	I_Disease
neuro	JJ	I_Disease
-	:	I_Disease
logical	JJ	I_Disease
abnormalities	NNS	E_Disease
.	.	O

Using	VBG	O
homologous	JJ	O
recombination	NN	O
to	TO	O
disrupt	VB	O
the	DT	O
normal	JJ	O
translation	NN	O
of	IN	O
ATP7B	NNP	O
,	,	O
we	PRP	O
have	VBP	O
generated	VBN	O
a	DT	O
strain	NN	O
of	IN	O
mice	NN	O
that	WDT	O
are	VBP	O
homozygous	JJ	O
mutants	NNS	O
(	(	O
null	NN	O
)	)	O
for	IN	O
the	DT	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
.	.	O

The	DT	O
ATP7B	NNP	O
null	JJ	O
mice	NN	O
display	VBD	O
a	DT	O
gradual	JJ	O
accumulation	NN	O
of	IN	O
hepatic	JJ	O
copper	NN	O
that	WDT	O
increases	VBZ	O
to	TO	O
a	DT	O
level	NN	O
60	CD	O
-	:	O
fold	NN	O
greater	JJR	O
than	IN	O
normal	JJ	O
by	IN	O
5	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

An	DT	O
increase	NN	O
in	IN	O
copper	NN	O
concentration	NN	O
was	VBD	O
also	RB	O
observed	VBN	O
in	IN	O
the	DT	O
kidney	NN	O
,	,	O
brain	NN	O
,	,	O
placenta	NN	O
and	CC	O
lactating	VBG	O
mammary	JJ	O
glands	NNS	O
of	IN	O
homo	NN	O
-	:	O
zygous	JJ	O
mutants	NNS	O
,	,	O
although	IN	O
milk	NN	O
from	IN	O
the	DT	O
mutant	JJ	O
glands	NNS	O
was	VBD	O
copper	JJ	B_Disease
deficient	NN	E_Disease
.	.	O

Morphological	JJ	B_Disease
abnormalities	NNS	E_Disease
resembling	VBG	O
cirrhosis	NN	S_Disease
developed	VBD	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
the	DT	O
livers	NNS	O
from	IN	O
homozygous	JJ	O
mutants	NNS	O
older	JJR	O
than	IN	O
7	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

Progeny	NNP	O
of	IN	O
the	DT	O
homozygous	JJ	O
mutant	NN	O
females	NNS	O
demonstrated	VBD	O
neurological	JJ	B_Disease
abnormalities	NNS	E_Disease
and	CC	O
growth	NN	B_Disease
retardation	NN	E_Disease
characteristic	NN	O
of	IN	O
copper	NN	B_Disease
deficiency	NN	E_Disease
.	.	O

Copper	NN	O
concentration	NN	O
in	IN	O
the	DT	O
livers	NNS	O
of	IN	O
the	DT	O
newborn	JJ	O
homozygous	JJ	O
null	NN	O
mutants	NNS	O
was	VBD	O
decreased	VBN	O
dramatically	RB	O
.	.	O

In	IN	O
summary	JJ	O
,	,	O
inactivation	NN	O
of	IN	O
the	DT	O
murine	NN	O
ATP7B	NNP	O
gene	NN	O
produces	VBZ	O
a	DT	O
form	NN	O
of	IN	O
cirrhotic	JJ	B_Disease
liver	NN	I_Disease
disease	NN	E_Disease
that	WDT	O
resembles	VBZ	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
in	IN	O
humans	NNS	O
and	CC	O
the	DT	O
toxic	JJ	O
milk	NN	O
phenotype	NN	O
in	IN	O
the	DT	O
mouse	NN	O
.	.	O
.	.	O

French	JJ	O
Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
patients	NNS	O
do	VBP	O
not	RB	O
exhibit	VB	O
gametic	JJ	O
segregation	NN	O
distortion	NN	O
:	:	O
a	DT	O
sperm	JJ	O
typing	NN	O
analysis	NN	O
.	.	O

Segregation	NN	O
distortion	NN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
to	TO	O
occur	VB	O
in	IN	O
a	DT	O
number	NN	O
of	IN	O
the	DT	O
trinucleotide	JJ	B_Disease
repeat	NN	I_Disease
disorders	NNS	E_Disease
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
a	DT	O
sperm	NN	O
typing	VBG	O
study	NN	O
performed	VBD	O
in	IN	O
patients	NNS	O
of	IN	O
Japanese	JJ	O
descent	NN	O
with	IN	O
Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
(	(	O
MJD	NNP	S_Disease
)	)	O
,	,	O
it	PRP	O
was	VBD	O
reported	VBN	O
that	IN	O
disease	NN	O
alleles	NNS	O
are	VBP	O
preferentially	RB	O
transmitted	VBN	O
during	IN	O
meiosis	NN	O
.	.	O

We	PRP	O
performed	VBD	O
a	DT	O
sperm	NN	O
typing	VBG	O
study	NN	O
of	IN	O
five	CD	O
MJD	NNP	S_Disease
patients	NNS	O
of	IN	O
French	JJ	O
descent	NN	O
and	CC	O
analysis	NN	O
of	IN	O
the	DT	O
pooled	VBN	O
data	NN	O
shows	VBZ	O
a	DT	O
ratio	NN	O
of	IN	O
mutant	JJ	O
to	TO	O
normal	JJ	O
alleles	NNS	O
of	IN	O
379	CD	O
436	CD	O
(	(	O
46	CD	O
.	.	O

5	CD	O
53	CD	O
.	.	O

5	CD	O
%	NN	O
)	)	O
,	,	O
which	WDT	O
does	VBZ	O
not	RB	O
support	VB	O
meiotic	JJ	O
segregation	NN	O
distortion	NN	O
.	.	O

To	TO	O
confirm	VB	O
these	DT	O
results	NNS	O
,	,	O
sperm	JJ	O
typing	VBG	O
analysis	NN	O
was	VBD	O
also	RB	O
performed	VBN	O
using	VBG	O
a	DT	O
polymorphic	JJ	O
marker	NN	O
,	,	O
D14S1050	NNP	O
,	,	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
MJD1	NNP	O
gene	NN	O
.	.	O

Among	IN	O
910	CD	O
sperm	NNS	O
analyzed	VBN	O
,	,	O
the	DT	O
allele	NN	O
linked	VBD	O
to	TO	O
the	DT	O
disease	NN	O
chromosome	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
50	CD	O
.	.	O

3	CD	O
%	NN	O
of	IN	O
the	DT	O
samples	NNS	O
and	CC	O
the	DT	O
allele	NN	O
linked	VBD	O
to	TO	O
the	DT	O
normal	JJ	O
chromosome	NN	O
was	VBD	O
found	VBN	O
in	IN	O
49	CD	O
.	.	O

6	CD	O
%	NN	O
of	IN	O
the	DT	O
sperm	NN	O
.	.	O

The	DT	O
difference	NN	O
in	IN	O
frequency	NN	O
of	IN	O
these	DT	O
two	CD	O
alleles	NNS	O
is	VBZ	O
not	RB	O
significant	JJ	O
(	(	O
P	NNP	O
=	VBZ	O
0	CD	O
.	.	O

8423	CD	O
)	)	O
.	.	O

Likelihood	NNP	O
-	:	O
based	VBN	O
analysis	NN	O
of	IN	O
segregation	NN	O
distortion	NN	O
in	IN	O
the	DT	O
single	JJ	O
sperm	NN	O
data	NNS	O
using	VBG	O
the	DT	O
SPERMSEG	NNP	O
program	NN	O
also	RB	O
showed	VBD	O
no	DT	O
support	NN	O
for	IN	O
segregation	NN	O
distortion	NN	O
at	IN	O
the	DT	O
gamete	JJ	O
level	NN	O
in	IN	O
this	DT	O
patient	JJ	O
population	NN	O
.	.	O

The	DT	O
previous	JJ	O
report	NN	O
on	IN	O
the	DT	O
Japanese	JJ	O
patients	NNS	O
also	RB	O
suggested	VBD	O
that	IN	O
disease	NN	O
allele	JJ	O
stability	NN	O
may	MD	O
be	VB	O
influenced	VBN	O
by	IN	O
a	DT	O
trans	JJ	O
effect	NN	O
of	IN	O
an	DT	O
intragenic	JJ	O
polymorphism	NN	O
(	(	O
987	CD	O
G	NNP	O
/	NNP	O
C	NNP	O
)	)	O
in	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
allele	NN	O
.	.	O

All	DT	O
of	IN	O
the	DT	O
French	JJ	O
patients	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
this	DT	O
polymorphism	NN	O
.	.	O

However	RB	O
,	,	O
analysis	NN	O
of	IN	O
the	DT	O
variance	NN	O
in	IN	O
repeat	NN	O
number	NN	O
in	IN	O
sperm	NN	O
from	IN	O
the	DT	O
French	JJ	O
MJD	NNP	S_Disease
patients	NNS	O
overlapped	VBD	O
significantly	RB	O
with	IN	O
the	DT	O
variance	NN	O
in	IN	O
repeat	NN	O
number	NN	O
observed	VBN	O
in	IN	O
the	DT	O
C	NNP	O
/	NNP	O
C	NNP	O
homozygous	JJ	O
Japanese	JJ	O
patients	NNS	O
.	.	O

Missense	NNP	O
mutation	NN	O
in	IN	O
the	DT	O
alternative	JJ	O
splice	JJ	O
region	NN	O
of	IN	O
the	DT	O
PAX6	NNP	O
gene	NN	O
in	IN	O
eye	NN	B_Disease
anomalies	NNS	E_Disease
.	.	O

The	DT	O
PAX6	NNP	O
gene	NN	O
is	VBZ	O
involved	VBN	O
in	IN	O
ocular	JJ	O
morphogenesis	NN	O
,	,	O
and	CC	O
PAX6	NNP	O
mutations	NNS	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
various	JJ	O
types	NNS	O
of	IN	O
ocular	JJ	B_Disease
anomalies	NNS	E_Disease
,	,	O
including	VBG	O
aniridia	NN	S_Disease
,	,	O
Peters	NNP	B_Disease
anomaly	VBP	E_Disease
,	,	O
corneal	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
congenital	JJ	B_Disease
cataract	NN	E_Disease
,	,	O
and	CC	O
foveal	JJ	B_Disease
hypoplasia	NN	E_Disease
.	.	O

The	DT	O
gene	NN	O
encodes	VBZ	O
a	DT	O
transcriptional	JJ	O
regulator	NN	O
that	WDT	O
recognizes	VBZ	O
target	NN	O
genes	NNS	O
through	IN	O
its	PRP$	O
paired	VBN	O
-	:	O
type	NN	O
DNA	NNP	O
-	:	O
binding	NN	O
domain	NN	O
.	.	O

The	DT	O
paired	JJ	O
domain	NN	O
is	VBZ	O
composed	VBN	O
of	IN	O
two	CD	O
distinct	JJ	O
DNA	NNP	O
-	:	O
binding	NN	O
subdomains	NNS	O
,	,	O
the	DT	O
N	NNP	O
-	:	O
terminal	NN	O
subdomain	NN	O
(	(	O
NTS	NNP	O
)	)	O
and	CC	O
the	DT	O
C	NNP	O
-	:	O
terminal	NN	O
subdomain	NN	O
(	(	O
CTS	NNP	O
)	)	O
,	,	O
which	WDT	O
bind	VBP	O
respective	JJ	O
consensus	NN	O
DNA	NNP	O
sequences	NNS	O
.	.	O

The	DT	O
human	JJ	O
PAX6	NNP	O
gene	NN	O
produces	VBZ	O
two	CD	O
alternative	JJ	O
splice	NN	O
isoforms	NNS	O
that	WDT	O
have	VBP	O
the	DT	O
distinct	JJ	O
structure	NN	O
of	IN	O
the	DT	O
paired	JJ	O
domain	NN	O
.	.	O

The	DT	O
insertion	NN	O
,	,	O
into	IN	O
the	DT	O
NTS	NNP	O
,	,	O
of	IN	O
14	CD	O
additional	JJ	O
amino	NN	O
acids	NNS	O
encoded	VBN	O
by	IN	O
exon	JJ	O
5a	CD	O
abolishes	VBZ	O
the	DT	O
DNA	NNP	O
-	:	O
binding	NN	O
activity	NN	O
of	IN	O
the	DT	O
NTS	NNP	O
and	CC	O
unmasks	VBZ	O
the	DT	O
DNA	NNP	O
-	:	O
binding	VBG	O
ability	NN	O
of	IN	O
the	DT	O
CTS	NNP	O
.	.	O

Thus	RB	O
,	,	O
exon	VBZ	O
5a	CD	O
appears	VBZ	O
to	TO	O
function	VB	O
as	IN	O
a	DT	O
molecular	JJ	O
switch	NN	O
that	IN	O
specifies	VBZ	O
target	NN	O
genes	NNS	O
.	.	O

We	PRP	O
ascertained	VBD	O
a	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
in	IN	O
four	CD	O
pedigrees	NNS	O
with	IN	O
Peters	NNP	B_Disease
anomaly	VBP	E_Disease
,	,	O
congenital	JJ	B_Disease
cataract	NN	E_Disease
,	,	O
Axenfeldt	NNP	B_Disease
anomaly	NN	E_Disease
,	,	O
and	CC	O
/	NNP	O
or	CC	O
foveal	JJ	B_Disease
hypoplasia	NN	E_Disease
,	,	O
which	WDT	O
,	,	O
to	TO	O
our	PRP$	O
knowledge	NN	O
,	,	O
is	VBZ	O
the	DT	O
first	JJ	O
mutation	NN	O
identified	VBN	O
in	IN	O
the	DT	O
splice	NN	O
-	:	O
variant	JJ	O
region	NN	O
.	.	O

A	DT	O
T	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
transition	NN	O
at	IN	O
the	DT	O
20th	JJ	O
nucleotide	JJ	O
position	NN	O
of	IN	O
exon	JJ	O
5a	CD	O
results	NNS	O
in	IN	O
a	DT	O
Val	NNP	O
-	:	O
-	:	O
>	NN	O
Asp	NNP	O
(	(	O
GTC	NNP	O
-	:	O
-	:	O
>	NN	O
GAC	NNP	O
)	)	O
substitution	NN	O
at	IN	O
the	DT	O
7th	CD	O
codon	NN	O
of	IN	O
the	DT	O
alternative	JJ	O
splice	NN	O
region	NN	O
.	.	O

Functional	JJ	O
analyses	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
V54D	NNP	O
mutation	NN	O
slightly	RB	O
increased	VBD	O
NTS	NNP	O
binding	NN	O
and	CC	O
decreased	JJ	O
CTS	NNP	O
transactivation	NN	O
activity	NN	O
to	TO	O
almost	RB	O
half	NN	O
.	.	O
.	.	O

Penetrances	NNS	O
of	IN	O
BRCA1	NNP	O
1675delA	CD	O
and	CC	O
1135insA	CD	O
with	IN	O
respect	NN	O
to	TO	O
breast	VB	B_Disease
cancer	NN	E_Disease
and	CC	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

For	IN	O
genetic	JJ	O
counseling	NN	O
and	CC	O
predictive	JJ	O
testing	NN	O
in	IN	O
families	NNS	O
with	IN	O
inherited	JJ	B_Disease
breast	NN	I_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
,	,	O
penetrances	NNS	O
and	CC	O
expressions	NNS	O
of	IN	O
the	DT	O
underlying	JJ	O
mutations	NNS	O
should	MD	O
be	VB	O
known	VBN	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
reported	VBN	O
two	CD	O
BRCA1	NNP	O
founder	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
Norwegian	JJ	O
population	NN	O
.	.	O

Index	NN	O
cases	NNS	O
for	IN	O
the	DT	O
present	JJ	O
study	NN	O
were	VBD	O
found	VBN	O
two	CD	O
different	JJ	O
ways	NNS	O
through	IN	O
a	DT	O
series	NN	O
of	IN	O
consecutive	JJ	O
ovarian	JJ	B_Disease
cancers	NNS	E_Disease
(	(	O
n	JJ	O
=	NNP	O
16	CD	O
)	)	O
and	CC	O
through	IN	O
our	PRP$	O
family	NN	O
cancer	NN	S_Disease
clinic	NN	O
(	(	O
n	JJ	O
=	NNP	O
14	CD	O
)	)	O
.	.	O

Altogether	RB	O
,	,	O
20	CD	O
of	IN	O
the	DT	O
patients	NNS	O
had	VBD	O
BRCA1	NNP	O
1675delA	CD	O
,	,	O
and	CC	O
10	CD	O
had	VBD	O
1135insA	CD	O
.	.	O

Their	PRP$	O
relatives	NNS	O
were	VBD	O
described	VBN	O
with	IN	O
respect	NN	O
to	TO	O
absence	VB	O
/	JJ	O
presence	NN	O
of	IN	O
breast	NN	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

Of	IN	O
133	CD	O
living	VBG	O
female	JJ	O
relatives	NNS	O
,	,	O
83	CD	O
(	(	O
62	CD	O
%	NN	O
)	)	O
were	VBD	O
tested	VBN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
mutation	NN	O
.	.	O

No	DT	O
difference	NN	O
,	,	O
in	IN	O
penetrance	NN	O
and	CC	O
expression	NN	O
,	,	O
between	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
were	VBD	O
found	VBN	O
,	,	O
whereas	JJ	O
differences	NNS	O
according	VBG	O
to	TO	O
method	NN	O
of	IN	O
ascertainment	NN	O
were	VBD	O
seen	VBN	O
.	.	O

The	DT	O
overall	JJ	O
findings	NNS	O
were	VBD	O
that	IN	O
disease	NN	O
started	VBD	O
to	TO	O
occur	VB	O
at	IN	O
age	NN	O
30	CD	O
years	NNS	O
and	CC	O
that	IN	O
by	IN	O
age	NN	O
50	CD	O
years	NNS	O
48	CD	O
%	NN	O
of	IN	O
the	DT	O
mutation	NN	O
-	:	O
carrying	VBG	O
women	NNS	O
had	VBD	O
experienced	VBN	O
breast	NN	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

More	RBR	O
ovarian	JJ	B_Disease
cancers	NNS	E_Disease
than	IN	O
breast	NN	B_Disease
cancers	NNS	E_Disease
were	VBD	O
recorded	VBN	O
.	.	O

Both	DT	O
penetrance	NN	O
and	CC	O
expression	NN	O
(	(	O
breast	JJ	B_Disease
cancer	NN	E_Disease
vs	NN	O
.	.	O

ovarian	JJ	B_Disease
cancer	NN	E_Disease
)	)	O
were	VBD	O
different	JJ	O
from	IN	O
those	DT	O
in	IN	O
reports	NNS	O
of	IN	O
the	DT	O
Ashkenazi	NNP	O
founder	NN	O
mutations	NNS	O
.	.	O

Whether	IN	O
the	DT	O
reported	JJ	O
differences	NNS	O
reflect	VBP	O
true	JJ	O
differences	NNS	O
and	CC	O
/	NN	O
or	CC	O
methodological	JJ	O
problems	NNS	O
is	VBZ	O
discussed	VBN	O
.	.	O

An	DT	O
observed	JJ	O
excess	NN	O
of	IN	O
mutation	NN	O
carriers	NNS	O
could	MD	O
not	RB	O
be	VB	O
accounted	VBN	O
for	IN	O
by	IN	O
methodological	JJ	O
problems	NNS	O
;	:	O
possible	JJ	O
explanations	NNS	O
were	VBD	O
a	DT	O
"	JJ	O
true	JJ	O
"	NN	O
low	JJ	O
penetrance	NN	O
or	CC	O
preferential	JJ	O
segregation	NN	O
.	.	O
.	.	O

The	DT	O
dermatofibrosarcoma	NN	B_Disease
protuberans	VBZ	E_Disease
-	:	O
associated	VBN	O
collagen	NN	O
type	NN	O
Ialpha1	NNP	O
/	NNP	O
platelet	NN	O
-	:	O
derived	JJ	O
growth	NN	O
factor	NN	O
(	(	O
PDGF	NNP	O
)	)	O
B	NNP	O
-	:	O
chain	NN	O
fusion	NN	O
gene	NN	O
generates	VBZ	O
a	DT	O
transforming	NN	O
protein	NN	O
that	WDT	O
is	VBZ	O
processed	VBN	O
to	TO	O
functional	VB	O
PDGF	NNP	O
-	:	O
BB	NNP	O
.	.	O

Dermatofibrosarcoma	NNP	B_Disease
protuberans	NNS	E_Disease
(	(	O
DFSP	NNP	S_Disease
)	)	O
displays	VBZ	O
chromosomal	JJ	O
rearrangements	NNS	O
involving	VBG	O
chromosome	NN	O
17	CD	O
and	CC	O
22	CD	O
,	,	O
which	WDT	O
fuse	VBP	O
the	DT	O
collagen	NN	O
type	NN	O
Ialpha1	NNP	O
(	(	O
COLIA1	NNP	O
)	)	O
gene	NN	O
to	TO	O
the	DT	O
platelet	NN	O
-	:	O
derived	JJ	O
growth	NN	O
factor	NN	O
(	(	O
PDGF	NNP	O
)	)	O
B	NNP	O
-	:	O
chain	NN	O
(	(	O
PDGFB	NNP	O
)	)	O
gene	NN	O
.	.	O

To	TO	O
characterize	VB	O
the	DT	O
functional	JJ	O
and	CC	O
structural	JJ	O
properties	NNS	O
of	IN	O
the	DT	O
COLIA1	NNP	O
/	NNP	O
PDGFB	NNP	O
fusion	NN	O
protein	NN	O
,	,	O
we	PRP	O
generated	VBD	O
a	DT	O
stable	JJ	O
NIH3T3	NNP	O
cell	NN	O
line	NN	O
that	WDT	O
contained	VBD	O
a	DT	O
tumor	NN	O
-	:	O
derived	VBN	O
chimeric	JJ	O
gene	NN	O
resulting	VBG	O
from	IN	O
a	DT	O
COIA1	NNP	O
intron	NN	O
7	CD	O
-	:	O
PDGFB	NNP	O
intron	VBZ	O
1	CD	O
fusion	NN	O
.	.	O

Expression	NN	O
of	IN	O
the	DT	O
fusion	NN	O
protein	NN	O
led	VBD	O
to	TO	O
morphological	JJ	O
transformation	NN	O
and	CC	O
increased	JJ	O
growth	NN	O
rate	NN	O
of	IN	O
these	DT	O
cells	NNS	O
.	.	O

The	DT	O
PDGF	NNP	O
receptor	NN	O
kinase	NN	O
inhibitor	NN	O
CGP57148B	NNP	O
reversed	VBD	O
the	DT	O
transformed	JJ	O
phenotype	NN	O
and	CC	O
reduced	VBD	O
the	DT	O
growth	NN	O
rate	NN	O
of	IN	O
COLIA1	NNP	O
/	NNP	O
PDGFB	NNP	O
-	:	O
expressing	VBG	O
cells	NNS	O
but	CC	O
had	VBD	O
no	DT	O
effects	NNS	O
on	IN	O
control	NN	O
cells	NNS	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
dimeric	JJ	O
COLIA1	NNP	O
/	NNP	O
PDGFB	NNP	O
precursors	NNS	O
was	VBD	O
demonstrated	VBN	O
through	IN	O
PDGFB	NNP	O
immunoprecipitations	NNS	O
of	IN	O
metabolically	RB	O
labeled	VBN	O
cells	NNS	O
and	CC	O
also	RB	O
by	IN	O
PDGFB	NNP	O
immunoprecipitations	NNS	O
followed	VBN	O
by	IN	O
immunoblotting	VBG	O
with	IN	O
COLIA1	NNP	O
antibodies	NNS	O
.	.	O

Pulse	NNP	O
-	:	O
chase	NN	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
COLIA1	NNP	O
/	NNP	O
PDGFB	NNP	O
precursor	NN	O
was	VBD	O
processed	VBN	O
to	TO	O
an	DT	O
end	NN	O
product	NN	O
that	WDT	O
was	VBD	O
indistinguishable	JJ	O
from	IN	O
wild	JJ	O
-	:	O
type	NN	O
PDGF	NNP	O
-	:	O
BB	NNP	O
.	.	O

Finally	RB	O
,	,	O
COLIA1	NNP	O
/	NNP	O
PDGFB	NNP	O
-	:	O
expressing	VBG	O
cells	NNS	O
generated	VBD	O
tumors	NNS	S_Disease
after	IN	O
s	NN	O
.	.	O

c	JJ	O
c	NN	O
.	.	O

injection	NN	O
into	IN	O
nude	JJ	O
mice	NN	O
,	,	O
and	CC	O
tumor	NN	S_Disease
growth	NN	O
was	VBD	O
reduced	VBN	O
by	IN	O
treatment	NN	O
with	IN	O
CGP57148B	NNP	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
COLIA1	NNP	O
/	NNP	O
PDGFB	NNP	O
fusion	NN	O
associated	VBN	O
with	IN	O
DFSP	NNP	S_Disease
contributes	NNS	O
to	TO	O
tumor	VB	S_Disease
development	NN	O
through	IN	O
ectopic	JJ	O
production	NN	O
of	IN	O
PDGF	NNP	O
-	:	O
BB	NNP	O
and	CC	O
the	DT	O
formation	NN	O
of	IN	O
an	DT	O
autocrine	JJ	O
loop	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
,	,	O
thus	RB	O
,	,	O
suggest	VBP	O
that	IN	O
PDGF	NNP	O
receptors	NNS	O
could	MD	O
be	VB	O
a	DT	O
target	NN	O
for	IN	O
pharmacological	JJ	O
treatment	NN	O
of	IN	O
DFSP	NNP	S_Disease
and	CC	O
giant	JJ	B_Disease
cell	NN	I_Disease
fibroblastoma	NN	E_Disease
,	,	O
e	NN	O
.	.	O

g	NN	O
.	.	O
,	,	O
through	IN	O
the	DT	O
use	NN	O
of	IN	O
PDGF	NNP	O
receptor	NN	O
kinase	NN	O
inhibitors	NNS	O
such	JJ	O
as	IN	O
CGP57148B	NNP	O
.	.	O

Identification	NN	O
of	IN	O
a	DT	O
common	JJ	O
PEX1	NNP	O
mutation	NN	O
in	IN	O
Zellweger	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O

The	DT	O
Zellweger	NNP	B_Disease
spectrum	NN	I_Disease
of	IN	I_Disease
disease	NN	E_Disease
,	,	O
encompassing	VBG	O
Zellweger	NNP	B_Disease
syndrome	NN	E_Disease
and	CC	O
the	DT	O
progressively	RB	O
milder	JJ	O
phenotypes	NNS	O
of	IN	O
neonatal	JJ	B_Disease
adrenoleukodystrophy	NN	E_Disease
and	CC	O
infantile	JJ	B_Disease
Refsum	NNP	I_Disease
disease	NN	E_Disease
,	,	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
failure	NN	O
to	TO	O
form	VB	O
functional	JJ	O
peroxisomes	NNS	O
.	.	O

Cell	NNP	O
fusion	NN	O
complementation	NN	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
these	DT	O
diseases	NNS	O
are	VBP	O
genetically	RB	O
heterogeneous	JJ	O
,	,	O
with	IN	O
two	CD	O
-	:	O
thirds	NNS	O
of	IN	O
all	DT	O
patients	NNS	O
lying	VBG	O
within	IN	O
a	DT	O
single	JJ	O
complementation	NN	O
group	NN	O
,	,	O
CG1	NNP	O
.	.	O

Molecular	JJ	O
genetic	JJ	O
and	CC	O
cell	NN	O
biology	NN	O
studies	NNS	O
have	VBP	O
shown	VBN	O
that	IN	O
PEX1	NNP	O
is	VBZ	O
deficient	JJ	O
in	IN	O
many	JJ	O
CG1	NNP	O
patients	NNS	O
.	.	O

However	RB	O
,	,	O
previous	JJ	O
studies	NNS	O
have	VBP	O
focused	VBN	O
on	IN	O
mildly	RB	O
affected	JJ	O
patients	NNS	O
and	CC	O
there	EX	O
is	VBZ	O
still	RB	O
no	DT	O
report	NN	O
of	IN	O
two	CD	O
mutant	JJ	O
PEX1	NNP	O
alleles	NNS	O
in	IN	O
any	DT	O
Zellweger	NNP	B_Disease
syndrome	JJ	E_Disease
patient	NN	O
.	.	O

Furthermore	RB	O
,	,	O
mutations	NNS	O
in	IN	O
the	DT	O
PMP70	NNP	O
gene	NN	O
have	VBP	O
also	RB	O
been	VBN	O
identified	VBN	O
in	IN	O
two	CD	O
Zellweger	NNP	B_Disease
syndrome	JJ	E_Disease
patients	NNS	O
from	IN	O
CG1	NNP	O
,	,	O
raising	VBG	O
the	DT	O
possibility	NN	O
that	WDT	O
CG1	NNP	O
patients	NNS	O
may	MD	O
represent	VB	O
a	DT	O
mixture	NN	O
of	IN	O
PEX1	NNP	O
-	:	O
deficient	NN	O
and	CC	O
PMP70	NNP	O
-	:	O
deficient	NN	O
individuals	NNS	O
.	.	O

To	TO	O
address	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
disease	NN	O
in	IN	O
Zellweger	NNP	B_Disease
syndrome	JJ	E_Disease
patients	NNS	O
from	IN	O
CG1	NNP	O
,	,	O
we	PRP	O
examined	VBD	O
all	DT	O
24	CD	O
PEX1	NNP	O
exons	NNS	O
in	IN	O
four	CD	O
patients	NNS	O
,	,	O
including	VBG	O
both	DT	O
patients	NNS	O
that	WDT	O
have	VBP	O
mutations	NNS	O
in	IN	O
PMP70	NNP	O
.	.	O

PEX1	NNP	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
all	DT	O
four	CD	O
patients	NNS	O
,	,	O
including	VBG	O
a	DT	O
1	CD	O
-	:	O
bp	NN	O
insertion	NN	O
(	(	O
c	NN	O
.	.	O

2097insT	CD	O
)	)	O
in	IN	O
exon	$	O
13	CD	O
that	WDT	O
was	VBD	O
present	JJ	O
in	IN	O
three	CD	O
of	IN	O
the	DT	O
four	CD	O
patients	NNS	O
.	.	O

Subsequent	JJ	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
one	CD	O
-	:	O
half	NN	O
of	IN	O
all	DT	O
CG1	NNP	O
patients	NNS	O
and	CC	O
correlates	NNS	O
with	IN	O
the	DT	O
Zellweger	NNP	B_Disease
syndrome	NN	E_Disease
phenotype	NN	O
.	.	O

As	IN	O
this	DT	O
mutation	NN	O
leads	VBZ	O
to	TO	O
a	DT	O
loss	NN	O
of	IN	O
protein	JJ	O
function	NN	O
its	PRP$	O
frequency	NN	O
makes	VBZ	O
it	PRP	O
the	DT	O
most	RBS	O
common	JJ	O
cause	NN	O
of	IN	O
Zellweger	NNP	B_Disease
syndrome	NN	E_Disease
,	,	O
helping	VBG	O
to	TO	O
explain	VB	O
the	DT	O
high	JJ	O
percentage	NN	O
of	IN	O
patients	NNS	O
that	WDT	O
belong	VBP	O
to	TO	O
CG1	NNP	O
.	.	O

Novel	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	VBP	E_Disease
protein	JJ	O
gene	NN	O
and	CC	O
their	PRP$	O
effects	NNS	O
on	IN	O
transcriptional	JJ	O
,	,	O
translational	JJ	O
,	,	O
and	CC	O
clinical	JJ	O
phenotypes	NNS	O
.	.	O

Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
recessive	JJ	I_Disease
immunodeficiency	NN	E_Disease
characterized	VBN	O
by	IN	O
thrombocytopenia	NN	S_Disease
,	,	O
eczema	NN	S_Disease
,	,	O
and	CC	O
recurrent	JJ	O
infections	NNS	O
,	,	O
and	CC	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
WAS	NNP	S_Disease
protein	NN	O
(	(	O
WASP	NNP	O
)	)	O
gene	NN	O
.	.	O

WASP	NNP	O
contains	VBZ	O
several	JJ	O
functional	JJ	O
domains	NNS	O
through	IN	O
which	WDT	O
it	PRP	O
interacts	VBZ	O
with	IN	O
proteins	NNS	O
involved	VBN	O
in	IN	O
intracellular	JJ	O
signaling	NN	O
and	CC	O
regulation	NN	O
of	IN	O
the	DT	O
actin	JJ	O
cytoskeleton	NN	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
17	CD	O
WASP	NNP	O
gene	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
12	CD	O
of	IN	O
which	WDT	O
are	VBP	O
novel	JJ	O
.	.	O

DNA	NN	O
of	IN	O
affected	JJ	O
males	NNS	O
and	CC	O
obligate	JJ	O
carriers	NNS	O
was	VBD	O
PCR	NNP	O
amplified	VBD	O
and	CC	O
analyzed	VBN	O
by	IN	O
SSCA	NNP	O
,	,	O
heteroduplex	JJ	O
analysis	NN	O
,	,	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

The	DT	O
effects	NNS	O
of	IN	O
the	DT	O
mutations	NNS	O
at	IN	O
the	DT	O
mRNA	NN	O
and	CC	O
protein	JJ	O
level	NN	O
were	VBD	O
ascertained	VBN	O
by	IN	O
RT	NNP	O
-	:	O
PCR	NN	O
and	CC	O
Western	JJ	O
blot	NN	O
analyses	NNS	O
.	.	O

All	DT	O
missense	JJ	O
mutations	NNS	O
were	VBD	O
located	VBN	O
in	IN	O
exons	NNS	O
1	CD	O
-	:	O
4	CD	O
.	.	O

Most	JJS	O
of	IN	O
the	DT	O
nonsense	NN	O
,	,	O
frameshift	NN	O
and	CC	O
splice	NN	O
site	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
exons	NNS	O
6	CD	O
-	:	O
11	CD	O
.	.	O

Mutations	NNS	O
that	WDT	O
alter	VBP	O
splice	NN	O
sites	NNS	O
led	VBD	O
to	TO	O
the	DT	O
synthesis	NN	O
of	IN	O
several	JJ	O
types	NNS	O
of	IN	O
mRNAs	NN	O
,	,	O
a	DT	O
fraction	NN	O
of	IN	O
which	WDT	O
represented	VBD	O
the	DT	O
normally	RB	O
spliced	JJ	O
product	NN	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
normally	RB	O
spliced	VBN	O
transcripts	NNS	O
was	VBD	O
correlated	VBN	O
with	IN	O
a	DT	O
milder	NN	O
phenotype	NN	O
.	.	O

When	WRB	O
one	CD	O
such	JJ	O
case	NN	O
was	VBD	O
studied	VBN	O
by	IN	O
Western	JJ	O
blotting	NN	O
,	,	O
reduced	VBD	O
amounts	NNS	O
of	IN	O
normal	JJ	O
-	:	O
size	NN	O
WASP	NNP	O
were	VBD	O
present	JJ	O
.	.	O

In	IN	O
other	JJ	O
cases	NNS	O
as	IN	O
well	RB	O
,	,	O
a	DT	O
correlation	NN	O
was	VBD	O
found	VBN	O
between	IN	O
the	DT	O
amount	NN	O
of	IN	O
normal	JJ	O
or	CC	O
mutant	JJ	O
WASP	NNP	O
present	NN	O
and	CC	O
the	DT	O
phenotypes	NNS	O
of	IN	O
the	DT	O
affected	JJ	O
individuals	NNS	O
.	.	O

No	DT	O
protein	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
two	CD	O
individuals	NNS	O
with	IN	O
severe	NN	O
WAS	NNP	S_Disease
.	.	O

Reduced	VBN	O
levels	NNS	O
of	IN	O
a	DT	O
normal	JJ	O
-	:	O
size	NN	O
WASP	NNP	O
with	IN	O
a	DT	O
missense	JJ	O
mutation	NN	O
were	VBD	O
seen	VBN	O
in	IN	O
two	CD	O
individuals	NNS	O
with	IN	O
XLT	NNP	S_Disease
.	.	O

It	PRP	O
is	VBZ	O
concluded	VBN	O
that	IN	O
mutation	NN	O
analysis	NN	O
at	IN	O
the	DT	O
DNA	NNP	O
level	NN	O
is	VBZ	O
not	RB	O
sufficient	JJ	O
for	IN	O
predicting	VBG	O
clinical	JJ	O
course	NN	O
.	.	O

Studies	NNS	O
at	IN	O
the	DT	O
transcript	NN	O
and	CC	O
protein	NN	O
level	NN	O
are	VBP	O
needed	VBN	O
for	IN	O
a	DT	O
better	JJR	O
assessment	NN	O
.	.	O
.	.	O

Aminoglycoside	IN	O
antibiotics	NNS	O
restore	VBP	O
dystrophin	JJ	O
function	NN	O
to	TO	O
skeletal	JJ	O
muscles	NNS	O
of	IN	O
mdx	NN	O
mice	NN	O
.	.	O

Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
dystrophin	JJ	O
gene	NN	O
,	,	O
leading	VBG	O
to	TO	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
dystrophin	JJ	O
protein	NN	O
in	IN	O
striated	JJ	O
muscle	NN	O
.	.	O

A	DT	O
significant	JJ	O
number	NN	O
of	IN	O
these	DT	O
mutations	NNS	O
are	VBP	O
premature	JJ	O
stop	JJ	O
codons	NNS	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
observation	NN	O
that	IN	O
aminoglycoside	JJ	O
treatment	NN	O
can	MD	O
suppress	VB	O
stop	JJ	O
codons	NNS	O
in	IN	O
cultured	JJ	O
cells	NNS	O
,	,	O
we	PRP	O
tested	VBD	O
the	DT	O
effect	NN	O
of	IN	O
gentamicin	NN	O
on	IN	O
cultured	JJ	O
muscle	NN	O
cells	NNS	O
from	IN	O
the	DT	O
mdx	NN	O
mouse	SYM	O
-	:	O
an	DT	O
animal	JJ	O
model	NN	O
for	IN	O
DMD	NNP	S_Disease
that	WDT	O
possesses	VBZ	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
in	IN	O
the	DT	O
dystrophin	JJ	O
gene	NN	O
.	.	O

Exposure	NN	O
of	IN	O
mdx	NN	O
myotubes	NNS	O
to	TO	O
gentamicin	VB	O
led	VBN	O
to	TO	O
the	DT	O
expression	NN	O
and	CC	O
localization	NN	O
of	IN	O
dystrophin	NN	O
to	TO	O
the	DT	O
cell	NN	O
membrane	NN	O
.	.	O

We	PRP	O
then	RB	O
evaluated	VBD	O
the	DT	O
effects	NNS	O
of	IN	O
differing	VBG	O
dosages	NNS	O
of	IN	O
gentamicin	NN	O
on	IN	O
expression	NN	O
and	CC	O
functional	JJ	O
protection	NN	O
of	IN	O
the	DT	O
muscles	NNS	O
of	IN	O
mdx	NN	O
mice	NN	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
treatment	NN	O
regimen	NN	O
that	WDT	O
resulted	VBD	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
dystrophin	NN	O
in	IN	O
the	DT	O
cell	NN	O
membrane	NN	O
in	IN	O
all	DT	O
striated	JJ	O
muscles	NNS	O
examined	VBN	O
and	CC	O
that	IN	O
provided	VBD	O
functional	JJ	O
protection	NN	O
against	IN	O
muscular	JJ	B_Disease
injury	NN	E_Disease
.	.	O

To	TO	O
our	PRP$	O
knowledge	NN	O
,	,	O
our	PRP$	O
results	NNS	O
are	VBP	O
the	DT	O
first	JJ	O
to	TO	O
demonstrate	VB	O
that	DT	O
aminoglycosides	NNS	O
can	MD	O
suppress	VB	O
stop	VB	O
codons	NNS	O
not	RB	O
only	RB	O
in	IN	O
vitro	NN	O
but	CC	O
also	RB	O
in	IN	O
vivo	NN	O
.	.	O

Furthermore	RB	O
,	,	O
these	DT	O
results	NNS	O
raise	VBP	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
novel	JJ	O
treatment	NN	O
regimen	NNS	O
for	IN	O
muscular	JJ	B_Disease
dystrophy	NN	E_Disease
and	CC	O
other	JJ	O
diseases	NNS	O
caused	VBN	O
by	IN	O
premature	JJ	O
stop	JJ	O
codon	NN	O
mutations	NNS	O
.	.	O

This	DT	O
treatment	NN	O
could	MD	O
prove	VB	O
effective	JJ	O
in	IN	O
up	RB	O
to	TO	O
15	CD	O
%	NN	O
of	IN	O
patients	NNS	O
with	IN	O
DMD	NNP	S_Disease
.	.	O
.	.	O

Loss	NNP	O
of	IN	O
the	DT	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
gene	NN	O
product	NN	O
causes	VBZ	O
oxidative	JJ	O
damage	NN	O
in	IN	O
target	NN	O
organs	NNS	O
.	.	O

Ataxia	NNP	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
(	(	O
A	DT	B_Disease
-	:	I_Disease
T	NN	E_Disease
)	)	O
is	VBZ	O
characterized	VBN	O
by	IN	O
a	DT	O
markedly	RB	O
increased	JJ	O
sensitivity	NN	O
to	TO	O
ionizing	VBG	O
radiation	NN	O
,	,	O
increased	VBD	O
incidence	NN	O
of	IN	O
cancer	NN	S_Disease
,	,	O
and	CC	O
neurodegeneration	NN	S_Disease
,	,	O
especially	RB	O
of	IN	O
the	DT	O
cerebellar	JJ	O
Purkinje	NNP	O
cells	NNS	O
.	.	O

Ionizing	VBG	O
radiation	NN	O
oxidizes	VBZ	O
macromolecules	NNS	O
and	CC	O
causes	VBZ	O
tissue	NN	O
damage	NN	O
through	IN	O
the	DT	O
generation	NN	O
of	IN	O
reactive	JJ	O
oxygen	NN	O
species	NNS	O
(	(	O
ROS	NNP	O
)	)	O
.	.	O

We	PRP	O
therefore	VBP	O
hypothesized	VBD	O
that	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
is	VBZ	O
due	JJ	O
to	TO	O
oxidative	JJ	O
damage	NN	O
resulting	VBG	O
from	IN	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
the	DT	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
gene	NN	O
product	NN	O
.	.	O

To	TO	O
assess	VB	O
this	DT	O
hypothesis	NN	O
,	,	O
we	PRP	O
employed	VBD	O
an	DT	O
animal	JJ	O
model	NN	O
of	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
,	,	O
the	DT	O
mouse	NN	O
with	IN	O
a	DT	O
disrupted	VBN	O
Atm	NNP	O
gene	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
organs	NNS	O
which	WDT	O
develop	VBP	O
pathologic	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
Atm	NNP	O
-	:	O
deficient	NN	O
mice	NN	O
are	VBP	O
targets	NNS	O
of	IN	O
oxidative	JJ	O
damage	NN	O
,	,	O
and	CC	O
that	IN	O
cerebellar	JJ	O
Purkinje	NNP	O
cells	NNS	O
are	VBP	O
particularly	RB	O
affected	VBN	O
.	.	O

These	DT	O
observations	NNS	O
provide	VBP	O
a	DT	O
mechanistic	JJ	O
basis	NN	O
for	IN	O
the	DT	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
phenotype	NN	O
and	CC	O
lay	VBD	O
a	DT	O
rational	JJ	O
foundation	NN	O
for	IN	O
therapeutic	JJ	O
intervention	NN	O
.	.	O
.	.	O

Recessively	RB	O
inherited	JJ	O
multiple	JJ	B_Disease
epiphyseal	NN	I_Disease
dysplasia	NN	E_Disease
with	IN	O
normal	JJ	O
stature	NN	O
,	,	O
club	JJ	B_Disease
foot	NN	E_Disease
,	,	O
and	CC	O
double	RB	B_Disease
layered	JJ	I_Disease
patella	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
DTDST	NNP	O
mutation	NN	O
.	.	O

We	PRP	O
have	VBP	O
observed	VBN	O
over	IN	O
25	CD	O
different	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
diastrophic	JJ	B_Disease
dysplasia	NN	E_Disease
sulphate	NN	O
transporter	NN	O
gene	NN	O
(	(	O
DTDST	NNP	O
)	)	O
in	IN	O
association	NN	O
with	IN	O
the	DT	O
recessive	JJ	B_Disease
disorders	NNS	E_Disease
achondrogenesis	VBP	B_Disease
1B	CD	E_Disease
,	,	O
atelosteogenesis	NN	B_Disease
2	CD	E_Disease
,	,	O
and	CC	O
diastrophic	JJ	B_Disease
dysplasia	NN	E_Disease
.	.	O

The	DT	O
c862t	NN	O
(	(	O
R279W	NNP	O
)	)	O
transition	NN	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
in	IN	O
non	JJ	O
-	:	O
Finnish	JJ	O
patients	NNS	O
,	,	O
but	CC	O
in	IN	O
these	DT	O
disorders	NNS	O
it	PRP	O
is	VBZ	O
usually	RB	O
combined	VBN	O
with	IN	O
other	JJ	O
DTDST	NNP	O
mutations	NNS	O
.	.	O

We	PRP	O
had	VBD	O
not	RB	O
seen	VBN	O
a	DT	O
case	NN	O
of	IN	O
homozygosity	NN	O
for	IN	O
c862t	NN	O
(	(	O
R279W	NNP	O
)	)	O
until	IN	O
we	PRP	O
analysed	VBD	O
DNA	NNP	O
from	IN	O
a	DT	O
36	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
tall	JJ	O
-	:	O
normal	JJ	O
stature	NN	O
(	(	O
180	CD	O
cm	NN	O
)	)	O
who	WP	O
asked	VBD	O
for	IN	O
genetic	JJ	O
counselling	NN	O
for	IN	O
suspected	JJ	O
multiple	JJ	B_Disease
epiphyseal	NN	I_Disease
dysplasia	NN	E_Disease
.	.	O

He	PRP	O
was	VBD	O
treated	VBN	O
for	IN	O
club	JJ	B_Disease
foot	NN	E_Disease
and	CC	O
hip	NN	B_Disease
dysplasia	NN	E_Disease
at	IN	O
birth	NN	O
.	.	O

Skeletal	JJ	O
changes	NNS	O
consistent	JJ	O
with	IN	O
multiple	JJ	B_Disease
epiphyseal	NN	I_Disease
dysplasia	NN	E_Disease
,	,	O
with	IN	O
the	DT	O
peculiar	JJ	O
finding	NN	O
of	IN	O
a	DT	O
double	JJ	B_Disease
layered	JJ	I_Disease
patella	NN	E_Disease
,	,	O
were	VBD	O
recognised	VBN	O
during	IN	O
childhood	NN	O
.	.	O

Cleft	NNP	B_Disease
palate	NN	E_Disease
,	,	O
swelling	VBG	B_Disease
of	IN	I_Disease
the	DT	I_Disease
ear	JJ	I_Disease
pinna	NN	E_Disease
,	,	O
and	CC	O
hitch	NN	B_Disease
hiker	NN	I_Disease
thumb	NN	E_Disease
were	VBD	O
absent	JJ	O
.	.	O

He	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
homozygous	JJ	O
,	,	O
and	CC	O
both	DT	O
healthy	JJ	O
parents	NNS	O
heterozygous	JJ	O
,	,	O
for	IN	O
the	DT	O
R279W	NNP	O
mutation	NN	O
in	IN	O
DTDST	NNP	O
,	,	O
and	CC	O
his	PRP$	O
fibroblasts	NNS	O
showed	VBD	O
a	DT	O
sulphate	JJ	O
incorporation	NN	O
defect	JJ	O
typical	JJ	O
of	IN	O
DTDST	NNP	B_Disease
disorders	NNS	E_Disease
.	.	O

Counselling	NN	O
was	VBD	O
given	VBN	O
for	IN	O
a	DT	O
recessive	JJ	B_Disease
disorder	NN	E_Disease
,	,	O
thereby	RB	O
considerably	RB	O
reducing	VBG	O
the	DT	O
probability	NN	O
of	IN	O
affected	JJ	O
offspring	NN	O
.	.	O

Multiple	JJ	B_Disease
epiphyseal	NN	I_Disease
dysplasia	NN	E_Disease
is	VBZ	O
more	RBR	O
frequently	RB	O
caused	VBN	O
by	IN	O
dominant	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
COMP	NNP	O
(	(	O
EDM1	NNP	S_Disease
,	,	O
McKusick	NNP	O
132400	CD	O
)	)	O
and	CC	O
COL9A2	NNP	O
genes	NNS	O
(	(	O
EDM2	NNP	S_Disease
,	,	O
McKusick	NNP	O
600204	CD	O
)	)	O
.	.	O

A	DT	O
few	JJ	O
other	JJ	O
patients	NNS	O
and	CC	O
families	NNS	O
with	IN	O
features	NNS	O
similar	JJ	O
to	TO	O
our	PRP$	O
proband	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
previously	RB	O
and	CC	O
considered	VBN	O
to	TO	O
have	VB	O
autosomal	JJ	O
recessive	NN	O
MED	NNP	S_Disease
(	(	O
EDM4	NNP	S_Disease
,	,	O
McKusick	NNP	O
226900	CD	O
)	)	O
.	.	O

This	DT	O
observation	NN	O
confirms	VBZ	O
the	DT	O
existence	NN	O
of	IN	O
this	DT	O
entity	NN	O
and	CC	O
assigns	VBZ	O
it	PRP	O
to	TO	O
the	DT	O
phenotypic	NN	O
spectrum	NN	O
associated	VBN	O
with	IN	O
mutations	NNS	O
at	IN	O
the	DT	O
DTDST	NNP	O
locus	NN	O
.	.	O
.	.	O

Homozygosity	NNP	O
for	IN	O
a	DT	O
novel	JJ	O
DTDST	NNP	O
mutation	NN	O
in	IN	O
a	DT	O
child	NN	O
with	IN	O
a	DT	O
'	POS	O
broad	JJ	O
bone	NN	O
-	:	O
platyspondylic	NN	O
'	''	O
variant	NN	O
of	IN	O
diastrophic	JJ	B_Disease
dysplasia	NN	E_Disease
.	.	O

Atypical	JJ	O
or	CC	O
variant	JJ	O
forms	NNS	O
of	IN	O
well	RB	O
-	:	O
known	VBN	O
chondrodysplasias	NN	S_Disease
may	MD	O
pose	VB	O
diagnostic	JJ	O
problems	NNS	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
girl	NN	O
with	IN	O
clinical	JJ	O
features	NNS	O
suggesting	VBG	O
diastrophic	JJ	B_Disease
dysplasia	NNS	E_Disease
but	CC	O
with	IN	O
unusual	JJ	O
radiographic	JJ	O
features	NNS	O
including	VBG	O
severe	JJ	O
platyspondyly	NN	S_Disease
,	,	O
wide	JJ	O
metaphyses	NNS	O
,	,	O
and	CC	O
fibular	JJ	O
overgrowth	NN	O
,	,	O
which	WDT	O
are	VBP	O
partially	RB	O
reminiscent	JJ	O
of	IN	O
metatropic	NN	B_Disease
dysplasia	NN	E_Disease
.	.	O

The	DT	O
diagnosis	NN	O
was	VBD	O
clarified	VBN	O
by	IN	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
DTDST	NNP	O
gene	NN	O
,	,	O
which	WDT	O
revealed	VBD	O
homozygosity	NN	O
for	IN	O
a	DT	O
previously	RB	O
undescribed	JJ	O
mutation	NN	O
leading	VBG	O
to	TO	O
a	DT	O
Q454P	NNP	O
substitution	NN	O
in	IN	O
the	DT	O
10th	JJ	O
transmembrane	NN	O
domain	NN	O
of	IN	O
the	DT	O
DTDST	NNP	O
sulfate	NN	O
transporter	NN	O
.	.	O

Molecular	JJ	O
analysis	NN	O
may	MD	O
be	VB	O
of	IN	O
particular	JJ	O
value	NN	O
in	IN	O
such	JJ	O
atypical	JJ	O
cases	NNS	O
.	.	O
.	.	O

The	DT	O
type	NN	O
of	IN	O
somatic	JJ	O
mutation	NN	O
at	IN	O
APC	NNP	O
in	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
is	VBZ	O
determined	VBN	O
by	IN	O
the	DT	O
site	NN	O
of	IN	O
the	DT	O
germline	JJ	O
mutation	NN	O
:	:	O
a	DT	O
new	JJ	O
facet	NN	O
to	TO	O
Knudson	NNP	O
'	POS	O
s	NN	O
'	''	O
two	CD	O
-	:	O
hit	NN	O
'	''	O
hypothesis	NN	O
.	.	O

APC	NNP	O
is	VBZ	O
often	RB	O
cited	VBN	O
as	IN	O
a	DT	O
prime	JJ	O
example	NN	O
of	IN	O
a	DT	O
tumor	NN	S_Disease
suppressor	NN	O
gene	NN	O
.	.	O

Truncating	VBG	O
germline	NN	O
and	CC	O
somatic	JJ	O
mutations	NNS	O
(	(	O
or	CC	O
,	,	O
infrequently	RB	O
,	,	O
allelic	JJ	O
loss	NN	O
)	)	O
occur	VBP	O
in	IN	O
tumors	NNS	S_Disease
in	IN	O
FAP	NNP	S_Disease
(	(	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
)	)	O
.	.	O

Most	JJS	O
sporadic	JJ	B_Disease
colorectal	NN	I_Disease
cancers	NNS	E_Disease
also	RB	O
have	VBP	O
two	CD	O
APC	NNP	S_Disease
mutations	NNS	O
.	.	O

Clues	NNS	O
from	IN	O
attenuated	VBN	B_Disease
polyposis	NN	E_Disease
,	,	O
missense	JJ	O
germline	NN	O
variants	NNS	O
with	IN	O
mild	JJ	O
disease	NN	O
and	CC	O
the	DT	O
somatic	JJ	O
mutation	NN	O
cluster	NN	O
region	NN	O
(	(	O
codons	NNS	O
1	CD	O
,	,	O
250	CD	O
-	:	O
1	CD	O
,	,	O
450	CD	O
)	)	O
indicate	NN	O
,	,	O
however	RB	O
,	,	O
that	IN	O
APC	NNP	S_Disease
mutations	NNS	O
might	MD	O
not	RB	O
result	VB	O
in	IN	O
simple	JJ	O
loss	NN	O
of	IN	O
protein	JJ	O
function	NN	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
FAP	NNP	S_Disease
patients	NNS	O
with	IN	O
germline	JJ	O
APC	NNP	S_Disease
mutations	NNS	O
within	IN	O
a	DT	O
small	JJ	O
region	NN	O
(	(	O
codons	NNS	O
1	CD	O
,	,	O
194	CD	O
-	:	O
1	CD	O
,	,	O
392	CD	O
at	IN	O
most	JJS	O
)	)	O
mainly	RB	O
show	VBP	O
allelic	JJ	O
loss	NN	O
in	IN	O
their	PRP$	O
colorectal	JJ	B_Disease
adenomas	NN	E_Disease
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
other	JJ	O
FAP	NNP	S_Disease
patients	NNS	O
,	,	O
whose	WP$	O
second	JJ	O
hits	NNS	O
tend	VBP	O
to	TO	O
occur	VB	O
by	IN	O
truncating	VBG	O
mutations	NNS	O
in	IN	O
the	DT	O
mutation	NN	O
cluster	NN	O
region	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
different	JJ	O
APC	NNP	S_Disease
mutations	NNS	O
provide	VBP	O
cells	NNS	O
with	IN	O
different	JJ	O
selective	JJ	O
advantages	NNS	O
,	,	O
with	IN	O
mutations	NNS	O
close	RB	O
to	TO	O
codon	VB	O
1	CD	O
,	,	O
300	CD	O
providing	VBG	O
the	DT	O
greatest	JJS	O
advantage	NN	O
.	.	O

Allelic	JJ	O
loss	NN	O
is	VBZ	O
selected	VBN	O
strongly	RB	O
in	IN	O
cells	NNS	O
with	IN	O
one	CD	O
mutation	NN	O
near	IN	O
codon	NN	O
1	CD	O
,	,	O
300	CD	O
.	.	O

A	DT	O
different	JJ	O
germline	NN	O
-	:	O
somatic	JJ	O
APC	NNP	S_Disease
mutation	NN	O
association	NN	O
exists	VBZ	O
in	IN	O
FAP	NNP	B_Disease
desmoids	NNS	E_Disease
.	.	O

APC	NNP	O
is	VBZ	O
not	RB	O
,	,	O
therefore	RB	O
,	,	O
a	DT	O
classical	JJ	O
tumor	NN	S_Disease
suppressor	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
also	RB	O
indicate	VBP	O
a	DT	O
new	JJ	O
mechanism	NN	O
for	IN	O
disease	NN	O
severity	NN	O
if	IN	O
a	DT	O
broader	JJR	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
is	VBZ	O
selected	VBN	O
in	IN	O
tumors	NNS	S_Disease
,	,	O
the	DT	O
somatic	JJ	O
mutation	NN	O
rate	NN	O
is	VBZ	O
effectively	RB	O
higher	JJR	O
and	CC	O
more	RBR	O
tumors	NNS	S_Disease
grow	VBP	O
.	.	O
.	.	O

Mxi1	NNP	O
mutations	NNS	O
in	IN	O
human	JJ	O
neurofibrosarcomas	NN	S_Disease
.	.	O

Mxi1	NNP	O
is	VBZ	O
thought	VBN	O
to	TO	O
negatively	RB	O
regulate	VB	O
Myc	NNP	O
function	NN	O
and	CC	O
may	MD	O
therefore	RB	O
be	VB	O
a	DT	O
potential	JJ	O
tumor	NN	S_Disease
suppressor	NN	O
gene	NN	O
.	.	O

Little	JJ	O
effort	NN	O
has	VBZ	O
yet	RB	O
been	VBN	O
made	VBN	O
to	TO	O
find	VB	O
alterations	NNS	O
involving	VBG	O
this	DT	O
gene	NN	O
in	IN	O
human	JJ	O
solid	JJ	B_Disease
tumors	NNS	E_Disease
.	.	O

We	PRP	O
screened	VBD	O
31	CD	O
human	JJ	O
gastric	NN	B_Disease
cancers	NNS	E_Disease
,	,	O
7	CD	O
esophageal	NN	B_Disease
cancers	NNS	E_Disease
,	,	O
85	CD	O
bone	NN	B_Disease
and	CC	I_Disease
soft	JJ	I_Disease
tissue	NN	I_Disease
tumors	NNS	E_Disease
of	IN	O
various	JJ	O
types	NNS	O
,	,	O
including	VBG	O
4	CD	O
neurofibrosarcomas	NN	S_Disease
.	.	O

We	PRP	O
also	RB	O
examined	VBD	O
29	CD	O
human	JJ	O
tumor	NN	S_Disease
cell	NN	O
lines	NNS	O
consisting	VBG	O
of	IN	O
12	CD	O
esophageal	NN	B_Disease
cancers	NNS	E_Disease
,	,	O
7	CD	O
glioma	NN	S_Disease
/	NNP	O
glioblastomas	NN	S_Disease
and	CC	O
10	CD	O
others	NNS	O
for	IN	O
Mxi1	NNP	O
mutations	NNS	O
in	IN	O
exons	NNS	O
1	CD	O
,	,	O
2	CD	O
,	,	O
4	CD	O
(	(	O
HLH	NNP	O
domain	NN	O
)	)	O
,	,	O
5	CD	O
and	CC	O
6	CD	O
.	.	O

Polymerase	NNP	O
chain	NN	O
reaction	NN	O
-	:	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
PCR	NNP	O
-	:	O
SSCP	NN	O
)	)	O
and	CC	O
subsequent	JJ	O
sequencing	NN	O
revealed	VBD	O
three	CD	O
distinct	JJ	O
polymorphisms	NNS	O
in	IN	O
the	DT	O
intron	NN	O
-	:	O
exon	NN	O
boundary	JJ	O
upstream	NN	O
from	IN	O
exon	JJ	O
6	CD	O
.	.	O

We	PRP	O
discovered	VBD	O
a	DT	O
missense	JJ	O
mutation	NN	O
,	,	O
GCA	NNP	O
to	TO	O
GTA	NNP	O
(	(	O
Ala	NNP	O
54	CD	O
Val	NNP	O
)	)	O
,	,	O
in	IN	O
exon	JJ	O
2	CD	O
in	IN	O
a	DT	O
neurofibrosarcoma	JJ	S_Disease
patient	NN	O
(	(	O
case	NN	O
1	CD	O
)	)	O
,	,	O
two	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
AAA	NNP	O
to	TO	O
CAA	NNP	O
(	(	O
Lys	NNP	O
118	CD	O
Gln	NNP	O
)	)	O
and	CC	O
GAA	NNP	O
to	TO	O
GGA	NNP	O
(	(	O
Glu	NNP	O
154	CD	O
Gly	NNP	O
)	)	O
in	IN	O
exon	$	O
5	CD	O
of	IN	O
another	DT	O
neurofibrosarcoma	JJ	S_Disease
patient	NN	O
(	(	O
case	NN	O
2	CD	O
)	)	O
,	,	O
and	CC	O
3	CD	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
,	,	O
GTG	NNP	O
to	TO	O
GCG	NNP	O
(	(	O
Val	NNP	O
179	CD	O
Ala	NNP	O
)	)	O
,	,	O
GTT	NNP	O
to	TO	O
GCT	NNP	O
(	(	O
Val	NNP	O
181	CD	O
Ala	NNP	O
)	)	O
and	CC	O
TTC	NNP	O
to	TO	O
CTC	NNP	O
(	(	O
Phe	NNP	O
186	CD	O
Leu	NNP	O
)	)	O
,	,	O
in	IN	O
a	DT	O
third	JJ	O
neurofibrosarcoma	JJ	S_Disease
patient	NN	O
(	(	O
case	NN	O
3	CD	O
)	)	O
.	.	O

In	IN	O
case	NN	O
3	CD	O
,	,	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
was	VBD	O
also	RB	O
demonstrated	VBN	O
by	IN	O
informative	JJ	O
(	(	O
TTC	NNP	O
)	)	O
3	CD	O
/	NN	O
(	(	O
TTC	NNP	O
)	)	O
2	CD	O
polymorphism	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
demonstrate	NN	O
that	IN	O
mutations	NNS	O
occur	VBP	O
in	IN	O
the	DT	O
Mxi1	NNP	O
gene	NN	O
in	IN	O
neurofibrosarcoma	NN	S_Disease
.	.	O

Missense	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
functional	JJ	O
domain	NN	O
of	IN	O
Mxi1	NNP	O
in	IN	O
these	DT	O
cases	NNS	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
neurofibrosarcoma	NN	S_Disease
.	.	O
.	.	O

A	DT	O
population	NN	O
-	:	O
based	VBN	O
study	NN	O
of	IN	O
the	DT	O
clinical	JJ	O
expression	NN	O
of	IN	O
the	DT	O
hemochromatosis	NN	S_Disease
gene	NN	O
.	.	O

BACKGROUND	NNP	O
AND	NNP	O
METHODS	NNP	O
Hereditary	NNP	B_Disease
hemochromatosis	NN	E_Disease
is	VBZ	O
associated	VBN	O
with	IN	O
homozygosity	NN	O
for	IN	O
the	DT	O
C282Y	NNP	O
mutation	NN	O
in	IN	O
the	DT	O
hemochromatosis	NN	S_Disease
(	(	O
HFE	NNP	O
)	)	O
gene	NN	O
on	IN	O
chromosome	NN	O
6	CD	O
,	,	O
elevated	VBD	O
serum	JJ	O
transferrin	NN	O
saturation	NN	O
,	,	O
and	CC	O
excess	JJ	B_Disease
iron	NN	I_Disease
deposits	NNS	E_Disease
throughout	IN	O
the	DT	O
body	NN	O
.	.	O

To	TO	O
assess	VB	O
the	DT	O
prevalence	NN	O
and	CC	O
clinical	JJ	O
expression	NN	O
of	IN	O
the	DT	O
HFE	NNP	O
gene	NN	O
,	,	O
we	PRP	O
conducted	VBD	O
a	DT	O
population	NN	O
-	:	O
based	VBN	O
study	NN	O
in	IN	O
Busselton	NNP	O
,	,	O
Australia	NNP	O
.	.	O

In	IN	O
1994	CD	O
,	,	O
we	PRP	O
obtained	VBD	O
blood	NN	O
samples	NNS	O
for	IN	O
the	DT	O
determination	NN	O
of	IN	O
serum	NN	O
transferrin	NN	O
saturation	NN	O
and	CC	O
ferritin	NN	O
levels	NNS	O
and	CC	O
the	DT	O
presence	NN	O
or	CC	O
absence	NN	O
of	IN	O
the	DT	O
C282Y	NNP	O
mutation	NN	O
and	CC	O
the	DT	O
H63D	NNP	O
mutation	NN	O
(	(	O
which	WDT	O
may	MD	O
contribute	VB	O
to	TO	O
increased	VBN	O
hepatic	JJ	O
iron	NN	O
levels	NNS	O
)	)	O
in	IN	O
3011	CD	O
unrelated	JJ	O
white	JJ	O
adults	NNS	O
.	.	O

We	PRP	O
evaluated	VBD	O
all	DT	O
subjects	NNS	O
who	WP	O
had	VBD	O
persistently	RB	O
elevated	VBN	O
transferrin	SYM	O
-	:	O
saturation	NN	O
values	NNS	O
(	(	O
45	CD	O
percent	NN	O
or	CC	O
higher	JJR	O
)	)	O
or	CC	O
were	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
C282Y	NNP	O
mutation	NN	O
.	.	O

We	PRP	O
recommended	VBD	O
liver	RB	O
biopsy	NN	O
for	IN	O
subjects	NNS	O
with	IN	O
serum	JJ	O
ferritin	NN	O
levels	NNS	O
of	IN	O
300	CD	O
ng	NNS	O
per	IN	O
milliliter	NN	O
or	CC	O
higher	JJR	O
.	.	O

The	DT	O
subjects	NNS	O
were	VBD	O
followed	VBN	O
for	IN	O
up	IN	O
to	TO	O
four	CD	O
years	NNS	O
.	.	O

RESULTS	NNP	O
Sixteen	NNP	O
of	IN	O
the	DT	O
subjects	NNS	O
(	(	O
0	CD	O
.	.	O

5	CD	O
percent	NN	O
)	)	O
were	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
C282Y	NNP	O
mutation	NN	O
,	,	O
and	CC	O
424	CD	O
(	(	O
14	CD	O
.	.	O

1	CD	O
percent	NN	O
)	)	O
were	VBD	O
heterozygous	JJ	O
.	.	O

The	DT	O
serum	NN	O
transferrin	NN	O
saturation	NN	O
was	VBD	O
45	CD	O
percent	NN	O
or	CC	O
higher	JJR	O
in	IN	O
15	CD	O
of	IN	O
the	DT	O
16	CD	O
who	WP	O
were	VBD	O
homozygous	JJ	O
;	:	O
in	IN	O
1	CD	O
subject	JJ	O
it	PRP	O
was	VBD	O
43	CD	O
percent	NN	O
.	.	O

Four	CD	O
of	IN	O
the	DT	O
homozygous	JJ	O
subjects	NNS	O
had	VBD	O
previously	RB	O
been	VBN	O
given	VBN	O
a	DT	O
diagnosis	NN	O
of	IN	O
hemochromatosis	NN	S_Disease
,	,	O
and	CC	O
12	CD	O
had	VBD	O
not	RB	O
.	.	O

Seven	CD	O
of	IN	O
these	DT	O
12	CD	O
patients	NNS	O
had	VBD	O
elevated	VBN	O
serum	JJ	O
ferritin	NN	O
levels	NNS	O
in	IN	O
1994	CD	O
;	:	O
6	CD	O
of	IN	O
the	DT	O
7	CD	O
had	VBD	O
further	JJ	O
increases	NNS	O
in	IN	O
1998	CD	O
,	,	O
and	CC	O
1	CD	O
had	VBD	O
a	DT	O
decrease	NN	O
,	,	O
although	IN	O
the	DT	O
value	NN	O
remained	VBD	O
elevated	JJ	O
.	.	O

The	DT	O
serum	NN	O
ferritin	NN	O
levels	NNS	O
in	IN	O
the	DT	O
four	CD	O
other	JJ	O
homozygous	JJ	O
patients	NNS	O
remained	VBN	O
in	IN	O
the	DT	O
normal	JJ	O
range	NN	O
.	.	O

Eleven	NNP	O
of	IN	O
the	DT	O
16	CD	O
homozygous	JJ	O
subjects	NNS	O
underwent	JJ	O
liver	RB	O
biopsy	VBP	O
;	:	O
3	CD	O
had	VBD	O
hepatic	JJ	B_Disease
fibrosis	NN	E_Disease
,	,	O
and	CC	O
1	CD	O
,	,	O
who	WP	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
excessive	JJ	B_Disease
alcohol	NN	I_Disease
consumption	NN	E_Disease
,	,	O
had	VBD	O
cirrhosis	NN	S_Disease
and	CC	O
mild	VB	O
microvesicular	JJ	B_Disease
steatosis	NN	E_Disease
.	.	O

Eight	CD	O
of	IN	O
the	DT	O
16	CD	O
homozygous	JJ	O
subjects	NNS	O
had	VBD	O
clinical	JJ	O
findings	NNS	O
that	WDT	O
were	VBD	O
consistent	JJ	O
with	IN	O
the	DT	O
presence	NN	O
of	IN	O
hereditary	JJ	B_Disease
hemochromatosis	NN	E_Disease
,	,	O
such	JJ	O
as	IN	O
hepatomegaly	NN	S_Disease
,	,	O
skin	JJ	B_Disease
pigmentation	NN	E_Disease
,	,	O
and	CC	O
arthritis	NN	S_Disease
.	.	O

CONCLUSIONS	NNP	O
In	IN	O
a	DT	O
population	NN	O
of	IN	O
white	JJ	O
adults	NNS	O
of	IN	O
northern	JJ	O
European	JJ	O
ancestry	NN	O
,	,	O
0	CD	O
.	.	O

5	CD	O
percent	NN	O
were	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
C282Y	NNP	O
mutation	NN	O
in	IN	O
the	DT	O
HFE	NNP	O
gene	NN	O
.	.	O

However	RB	O
,	,	O
only	RB	O
half	NN	O
of	IN	O
those	DT	O
who	WP	O
were	VBD	O
homozygous	JJ	O
had	VBD	O
clinical	JJ	O
features	NNS	O
of	IN	O
hemochromatosis	NN	S_Disease
,	,	O
and	CC	O
one	CD	O
quarter	NN	O
had	VBD	O
serum	VBN	O
ferritin	NN	O
levels	NNS	O
that	WDT	O
remained	VBD	O
normal	JJ	O
over	IN	O
a	DT	O
four	CD	O
-	:	O
year	NN	O
period	NN	O
.	.	O

Large	JJ	O
heterozygous	JJ	O
deletion	NN	O
masquerading	VBG	O
as	IN	O
homozygous	JJ	O
missense	NN	O
mutation	NN	O
:	:	O
a	DT	O
pitfall	NN	O
in	IN	O
diagnostic	JJ	O
mutation	NN	O
analysis	NN	O
.	.	O

The	DT	O
clinical	JJ	O
use	NN	O
of	IN	O
molecular	JJ	O
analyses	NNS	O
in	IN	O
recessive	JJ	B_Disease
disorders	NNS	E_Disease
relies	NNS	O
on	IN	O
the	DT	O
exact	JJ	O
characterization	NN	O
of	IN	O
both	DT	O
mutant	JJ	O
alleles	NNS	O
in	IN	O
the	DT	O
affected	JJ	O
patient	NN	O
.	.	O

This	DT	O
can	MD	O
be	VB	O
problematic	JJ	O
when	WRB	O
only	RB	O
part	NN	O
of	IN	O
the	DT	O
gene	NN	O
is	VBZ	O
examined	VBN	O
or	CC	O
when	WRB	O
relevant	JJ	O
DNA	NN	O
alterations	NNS	O
are	VBP	O
not	RB	O
recognized	VBN	O
by	IN	O
standard	JJ	O
methods	NNS	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
child	NN	O
in	IN	O
whom	WP	O
phenylketonuria	NN	S_Disease
was	VBD	O
apparently	RB	O
caused	VBN	O
by	IN	O
homozygosity	NN	O
for	IN	O
the	DT	O
mutation	NN	O
E390G	NNP	O
in	IN	O
exon	JJ	O
11	CD	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	(	O
PAH	NNP	O
)	)	O
gene	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
clinical	JJ	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
was	VBD	O
not	RB	O
quite	RB	O
as	RB	O
mild	JJ	O
as	IN	O
expected	VBN	O
,	,	O
the	DT	O
mutation	NN	O
was	VBD	O
not	RB	O
identified	VBN	O
in	IN	O
the	DT	O
father	NN	O
despite	IN	O
confirmed	JJ	O
paternity	NN	O
,	,	O
and	CC	O
the	DT	O
paternal	JJ	O
allele	NN	O
showed	VBD	O
a	DT	O
highly	RB	O
unusual	JJ	O
pattern	NN	O
of	IN	O
polymorphic	JJ	O
markers	NNS	O
in	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
.	.	O

Presence	NN	O
of	IN	O
a	DT	O
large	JJ	O
deletion	NN	O
involving	VBG	O
exons	NNS	O
9	CD	O
,	,	O
10	CD	O
and	CC	O
11	CD	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
was	VBD	O
confirmed	VBN	O
by	IN	O
long	JJ	O
-	:	O
range	NN	O
PCR	NNP	O
.	.	O

Diagnostic	JJ	O
DNA	NNP	O
analyses	NNS	O
should	MD	O
include	VB	O
a	DT	O
comprehensive	JJ	O
examination	NN	O
of	IN	O
the	DT	O
whole	JJ	O
relevant	JJ	O
gene	NN	O
in	IN	O
the	DT	O
patient	NN	O
and	CC	O
confirmation	NN	O
of	IN	O
carrier	NN	O
status	NN	O
in	IN	O
both	DT	O
parents	NNS	O
.	.	O
.	.	O

Early	JJ	O
onset	NN	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
Emery	NNP	I_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
in	IN	O
a	DT	O
boy	NN	O
with	IN	O
emerin	JJ	O
gene	NN	O
deletion	NN	O
.	.	O

A	DT	O
boy	NN	O
developed	VBD	O
contractures	NNS	B_Disease
of	IN	I_Disease
the	DT	I_Disease
Achilles	NNP	I_Disease
tendons	NNS	E_Disease
at	IN	O
3	CD	O
years	NNS	O
and	CC	O
of	IN	O
the	DT	O
postcervical	JJ	O
muscles	NNS	O
at	IN	O
7	CD	O
years	NNS	O
,	,	O
although	IN	O
neither	DT	O
contractures	NNS	B_Disease
of	IN	I_Disease
the	DT	I_Disease
elbows	NNS	E_Disease
nor	CC	O
cardiac	JJ	B_Disease
abnormality	NN	E_Disease
were	VBD	O
recognized	VBN	O
by	IN	O
the	DT	O
age	NN	O
of	IN	O
9	CD	O
years	NNS	O
.	.	O

Muscle	NNP	O
computed	VBD	O
tomography	NN	O
scanning	VBG	O
revealed	VBD	O
changes	NNS	O
characteristic	JJ	O
of	IN	O
muscle	NN	O
involvement	NN	O
.	.	O

Emerin	NNP	O
was	VBD	O
not	RB	O
detected	VBN	O
in	IN	O
the	DT	O
biopsied	JJ	O
muscle	NN	O
,	,	O
and	CC	O
RT	NNP	O
-	:	O
PCR	NN	O
and	CC	O
PCR	NNP	O
-	:	O
based	VBN	O
genomic	JJ	O
DNA	NNP	O
analyses	NNS	O
of	IN	O
the	DT	O
emerin	JJ	O
gene	NN	O
demonstrated	VBD	O
no	DT	O
amplification	NN	O
product	NN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

These	DT	O
results	NNS	O
confirmed	VBD	O
the	DT	O
diagnosis	NN	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
Emery	NNP	I_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
EDMD	NNP	S_Disease
)	)	O
,	,	O
and	CC	O
reinforce	VB	O
the	DT	O
necessity	NN	O
of	IN	O
molecular	JJ	O
genetic	JJ	O
diagnosis	NN	O
of	IN	O
the	DT	O
membrane	NN	O
protein	NN	O
emerin	NN	O
in	IN	O
younger	JJR	O
patients	NNS	O
with	IN	O
possible	JJ	O
EDMD	NNP	S_Disease
before	IN	O
appearance	NN	O
of	IN	O
the	DT	O
typical	JJ	O
symptoms	NNS	O
,	,	O
to	TO	O
avoid	VB	O
sudden	JJ	B_Disease
cardiac	JJ	I_Disease
death	NN	E_Disease
.	.	O
.	.	O

Duchenne	NNP	B_Disease
/	NNP	I_Disease
Becker	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
:	:	O
correlation	NN	O
of	IN	O
phenotype	NN	O
by	IN	O
electroretinography	NN	O
with	IN	O
sites	NNS	O
of	IN	O
dystrophin	JJ	O
mutations	NNS	O
.	.	O

The	DT	O
dark	JJ	O
-	:	O
adapted	VBN	O
electroretinogram	NN	O
(	(	O
ERG	NNP	O
)	)	O
of	IN	O
patients	NNS	O
with	IN	O
Duchenne	NNP	B_Disease
and	CC	I_Disease
Becker	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
/	NNP	O
BMD	NNP	S_Disease
)	)	O
shows	VBZ	O
a	DT	O
marked	JJ	O
reduction	NN	O
in	IN	O
b	NN	O
-	:	O
wave	NN	O
amplitude	NN	O
.	.	O

Genotype	NNP	O
-	:	O
phenotype	NN	O
studies	NNS	O
of	IN	O
mouse	NN	O
models	NNS	O
for	IN	O
DMD	NNP	S_Disease
show	VBP	O
position	NN	O
-	:	O
specific	JJ	O
effects	NNS	O
of	IN	O
the	DT	O
mutations	NNS	O
upon	IN	O
the	DT	O
phenotype	NN	O
mice	NN	O
with	IN	O
5	CD	O
defects	NNS	O
of	IN	O
dystrophin	NNS	O
have	VBP	O
normal	JJ	O
ERGs	NNP	O
,	,	O
those	DT	O
with	IN	O
defects	NNS	O
in	IN	O
the	DT	O
central	JJ	O
region	NN	O
have	VBP	O
a	DT	O
normal	JJ	O
b	SYM	O
-	:	O
wave	NN	O
amplitude	NN	O
associated	VBN	O
with	IN	O
prolonged	JJ	O
implicit	NN	O
times	NNS	O
for	IN	O
both	DT	O
the	DT	O
b	SYM	O
-	:	O
wave	NN	O
and	CC	O
oscillatory	NN	O
potentials	NNS	O
,	,	O
and	CC	O
mice	NN	O
with	IN	O
3	CD	O
defects	NNS	O
have	VBP	O
a	DT	O
phenotype	NN	O
similar	JJ	O
to	TO	O
that	DT	O
seen	VBN	O
in	IN	O
DMD	NNP	S_Disease
/	NNP	O
BMD	NNP	S_Disease
patients	NNS	O
.	.	O

The	DT	O
mouse	NN	O
studies	NNS	O
suggest	VBP	O
a	DT	O
key	JJ	O
role	NN	O
for	IN	O
the	DT	O
carboxyl	JJ	O
terminal	NN	O
dystrophin	NN	O
isoform	NN	O
,	,	O
Dp260	NNP	O
,	,	O
in	IN	O
retinal	JJ	O
electrophysiology	NN	O
.	.	O

We	PRP	O
have	VBP	O
undertaken	VBN	O
a	DT	O
systematic	JJ	O
evaluation	NN	O
of	IN	O
DMD	NNP	S_Disease
/	NNP	O
BMD	NNP	S_Disease
patients	NNS	O
through	IN	O
clinical	JJ	O
examination	NN	O
and	CC	O
review	NN	O
of	IN	O
the	DT	O
literature	NN	O
in	IN	O
order	NN	O
to	TO	O
determine	VB	O
whether	IN	O
the	DT	O
position	NN	O
-	:	O
specific	JJ	O
effects	NNS	O
of	IN	O
mutations	NNS	O
noted	VBN	O
in	IN	O
the	DT	O
mouse	NN	O
are	VBP	O
present	JJ	O
in	IN	O
man	NN	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
,	,	O
in	IN	O
man	NN	O
,	,	O
a	DT	O
wider	JJR	O
variation	NN	O
of	IN	O
DMD	NNP	B_Disease
defects	NNS	E_Disease
correlate	VBP	O
with	IN	O
reductions	NNS	O
in	IN	O
the	DT	O
b	NN	O
-	:	O
wave	NN	O
amplitude	NN	O
.	.	O

Individuals	NNS	O
with	IN	O
normal	JJ	O
ERGs	NNP	O
have	VBP	O
mutations	NNS	O
predominantly	RB	O
located	VBD	O
5	CD	O
of	IN	O
the	DT	O
transcript	NN	O
initiation	NN	O
site	NN	O
of	IN	O
Dp260	NNP	O
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
most	RBS	O
important	JJ	O
determinant	NN	O
in	IN	O
the	DT	O
ERG	NNP	O
b	SYM	O
-	:	O
wave	NN	O
phenotype	NN	O
is	VBZ	O
the	DT	O
mutation	NN	O
position	NN	O
,	,	O
rather	RB	O
than	IN	O
muscle	VB	B_Disease
disease	JJ	E_Disease
severity	NN	O
.	.	O

Forty	NNP	O
-	:	O
six	CD	O
per	IN	O
cent	NN	O
of	IN	O
patients	NNS	O
with	IN	O
mutations	NNS	O
5	CD	O
of	IN	O
the	DT	O
Dp260	NNP	O
transcript	JJ	O
start	NN	O
site	NN	O
have	VBP	O
abnormal	JJ	O
ERGs	NNP	O
,	,	O
as	IN	O
opposed	VBN	O
to	TO	O
94	CD	O
%	NN	O
with	IN	O
more	JJR	O
distal	JJ	O
mutations	NNS	O
.	.	O

The	DT	O
human	JJ	O
genotype	NN	O
-	:	O
phenotype	NN	O
correlations	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
a	DT	O
role	NN	O
for	IN	O
Dp260	NNP	O
in	IN	O
normal	JJ	O
retinal	JJ	O
electrophysiology	NN	O
and	CC	O
may	MD	O
also	RB	O
reflect	VB	O
the	DT	O
expression	NN	O
of	IN	O
other	JJ	O
C	NNP	O
-	:	O
terminal	NN	O
dystrophin	NN	O
isoforms	NNS	O
and	CC	O
their	PRP$	O
contributions	NNS	O
to	TO	O
retinal	JJ	O
signal	JJ	O
transmission	NN	O
.	.	O
.	.	O

Cis	NNP	O
and	CC	O
trans	VBZ	O
effects	NNS	O
of	IN	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
mutation	NN	O
in	IN	O
a	DT	O
cell	NN	O
culture	NN	O
model	NN	O
.	.	O

The	DT	O
mutation	NN	O
causing	VBG	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
has	VBZ	O
been	VBN	O
identified	VBN	O
as	IN	O
a	DT	O
CTG	NNP	O
expansion	NN	O
in	IN	O
the	DT	O
3	CD	O
-	:	O
untranslated	JJ	O
region	NN	O
(	(	O
3	CD	O
-	:	O
UTR	NN	O
)	)	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
protein	NN	O
kinase	NN	O
gene	NN	O
(	(	O
DMPK	NNP	O
)	)	O
,	,	O
but	CC	O
the	DT	O
mechanism	NN	O
(	(	O
s	JJ	O
)	)	O
of	IN	O
pathogenesis	NN	O
remain	VBP	O
unknown	JJ	O
.	.	O

Studies	NNS	O
using	VBG	O
DM	NNP	S_Disease
patient	NN	O
materials	NNS	O
have	VBP	O
often	RB	O
produced	VBN	O
confusing	JJ	O
results	NNS	O
.	.	O

Therefore	RB	O
,	,	O
to	TO	O
study	VB	O
the	DT	O
effects	NNS	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
mutation	NN	O
in	IN	O
a	DT	O
controlled	JJ	O
environment	NN	O
,	,	O
we	PRP	O
have	VBP	O
established	VBN	O
a	DT	O
cell	NN	O
culture	NN	O
model	NN	O
system	NN	O
using	VBG	O
C2C12	NNP	O
mouse	NN	O
myoblasts	NNS	O
.	.	O

By	IN	O
expressing	VBG	O
chimeric	JJ	O
reporter	NN	O
constructs	NNS	O
containing	VBG	O
a	DT	O
reporter	NN	O
gene	NN	O
fused	VBD	O
to	TO	O
a	DT	O
human	JJ	O
DMPK	NNP	O
3	CD	O
-	:	O
UTR	NN	O
,	,	O
we	PRP	O
identified	VBD	O
both	DT	O
cis	NNS	O
and	CC	O
trans	NNS	O
effects	NNS	O
that	WDT	O
are	VBP	O
mediated	VBN	O
by	IN	O
the	DT	O
DM	NNP	S_Disease
mutation	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
show	VBP	O
that	IN	O
a	DT	O
mutant	JJ	O
DMPK	NNP	O
3	CD	O
-	:	O
UTR	NN	O
,	,	O
with	IN	O
as	RB	O
few	JJ	O
as	IN	O
57	CD	O
CTGs	NNP	O
,	,	O
had	VBD	O
a	DT	O
negative	JJ	O
cis	NN	O
effect	NN	O
on	IN	O
protein	NN	O
expression	NN	O
and	CC	O
resulted	VBD	O
in	IN	O
the	DT	O
aggregation	NN	O
of	IN	O
reporter	NN	O
transcripts	NNS	O
into	IN	O
discrete	JJ	O
nuclear	JJ	O
foci	NN	O
.	.	O

We	PRP	O
determined	VBN	O
by	IN	O
deletion	NN	O
analysis	NN	O
that	IN	O
an	DT	O
expanded	VBN	O
(	(	O
CTG	NNP	O
)	)	O
(	(	O
n	JJ	O
)	)	O
tract	NN	O
alone	RB	O
was	VBD	O
sufficient	JJ	O
to	TO	O
mediate	VB	O
these	DT	O
cis	JJ	O
effects	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
the	DT	O
normal	JJ	O
DMPK	NNP	O
3	CD	O
-	:	O
UTR	NN	O
mRNA	NN	O
,	,	O
a	DT	O
mutant	JJ	O
DMPK	NNP	O
3	CD	O
-	:	O
UTR	NN	O
mRNA	NN	O
with	IN	O
(	(	O
CUG	NNP	O
)	)	O
(	(	O
200	CD	O
)	)	O
selectively	RB	O
inhibited	VBN	O
myogenic	JJ	O
differentiation	NN	O
of	IN	O
C2C12	NNP	O
myoblasts	NNS	O
.	.	O

Genetic	JJ	O
analysis	NN	O
and	CC	O
the	DT	O
Cre	NNP	O
-	:	O
loxP	NN	O
system	NN	O
were	VBD	O
used	VBN	O
to	TO	O
clearly	RB	O
demonstrate	VB	O
that	IN	O
the	DT	O
myoblast	NN	O
fusion	NN	O
defect	NN	O
could	MD	O
be	VB	O
rescued	VBN	O
by	IN	O
eliminating	VBG	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
DMPK	NNP	O
3	CD	O
-	:	O
UTR	NN	O
transcript	NN	O
.	.	O

Characterization	NN	O
of	IN	O
spontaneous	JJ	O
deletion	NN	O
events	NNS	O
mapped	VBD	O
the	DT	O
inhibitory	JJ	O
effect	NN	O
to	TO	O
the	DT	O
(	(	O
CTG	NNP	O
)	)	O
(	(	O
n	JJ	O
)	)	O
expansion	NN	O
and	CC	O
/	NN	O
or	CC	O
the	DT	O
3	CD	O
end	NN	O
of	IN	O
the	DT	O
DMPK	NNP	O
3	CD	O
-	:	O
UTR	NN	O
.	.	O

These	DT	O
results	NNS	O
provide	VBP	O
evidence	NN	O
that	IN	O
the	DT	O
DM	NNP	S_Disease
mutation	NN	O
acts	NNS	O
in	IN	O
cis	NN	O
to	TO	O
reduce	VB	O
protein	NN	O
production	NN	O
(	(	O
consistent	JJ	O
with	IN	O
DMPK	NNP	B_Disease
haploinsufficiency	NN	E_Disease
)	)	O
and	CC	O
in	IN	O
trans	NNS	O
as	IN	O
a	DT	O
riboregulator	NN	O
to	TO	O
inhibit	VB	O
myogenesis	NN	O
.	.	O
.	.	O

Coats	NNP	B_Disease
'	POS	I_Disease
disease	NN	E_Disease
of	IN	O
the	DT	O
retina	NN	O
(	(	O
unilateral	JJ	B_Disease
retinal	JJ	I_Disease
telangiectasis	NN	E_Disease
)	)	O
caused	VBN	O
by	IN	O
somatic	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
NDP	NNP	O
gene	NN	O
:	:	O
a	DT	O
role	NN	O
for	IN	O
norrin	NN	O
in	IN	O
retinal	JJ	O
angiogenesis	NN	O
.	.	O

Coats	NNS	B_Disease
disease	NN	E_Disease
is	VBZ	O
characterized	VBN	O
by	IN	O
abnormal	JJ	B_Disease
retinal	JJ	I_Disease
vascular	NN	I_Disease
development	NN	E_Disease
(	(	O
so	IN	O
-	:	O
called	VBN	O
retinal	JJ	B_Disease
telangiectasis	NN	E_Disease
)	)	O
which	WDT	O
results	NNS	O
in	IN	O
massive	JJ	O
intraretinal	NN	B_Disease
and	CC	I_Disease
subretinal	JJ	I_Disease
lipid	JJ	I_Disease
accumulation	NN	E_Disease
(	(	O
exudative	JJ	B_Disease
retinal	JJ	I_Disease
detachment	NN	E_Disease
)	)	O
.	.	O

The	DT	O
classical	JJ	O
form	NN	O
of	IN	O
Coats	NNP	B_Disease
disease	NN	E_Disease
is	VBZ	O
almost	RB	O
invariably	RB	O
isolated	JJ	O
,	,	O
unilateral	JJ	O
and	CC	O
seen	VBN	O
in	IN	O
males	NNS	O
.	.	O

A	DT	O
female	NN	O
with	IN	O
a	DT	O
unilateral	JJ	O
variant	NN	O
of	IN	O
Coats	NNP	B_Disease
disease	NN	E_Disease
gave	VBD	O
birth	NN	O
to	TO	O
a	DT	O
son	NN	O
affected	VBN	O
by	IN	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
.	.	O

Both	DT	O
carried	VBD	O
a	DT	O
missense	NN	O
mutation	NN	O
within	IN	O
the	DT	O
NDP	NNP	O
gene	NN	O
on	IN	O
chromosome	NN	O
Xp11	NN	O
.	.	O

2	CD	O
2	CD	O
.	.	O

Subsequently	RB	O
analysis	NN	O
of	IN	O
the	DT	O
retinas	NN	O
of	IN	O
nine	CD	O
enucleated	JJ	O
eyes	NNS	O
from	IN	O
males	NNS	O
with	IN	O
Coats	NNP	B_Disease
disease	NN	E_Disease
demonstrated	VBD	O
in	IN	O
one	CD	O
a	DT	O
somatic	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
NDP	NNP	O
gene	NN	O
which	WDT	O
was	VBD	O
not	RB	O
present	JJ	O
within	IN	O
non	JJ	O
-	:	O
retinal	JJ	O
tissue	NN	O
.	.	O

We	PRP	O
suggest	VBP	O
that	IN	O
Coats	NNP	B_Disease
telangiectasis	NN	E_Disease
is	VBZ	O
secondary	JJ	O
to	TO	O
somatic	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
NDP	NNP	O
gene	NN	O
which	WDT	O
results	NNS	O
in	IN	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
norrin	NN	E_Disease
(	(	O
the	DT	O
protein	NN	O
product	NN	O
of	IN	O
the	DT	O
NDP	NNP	O
gene	NN	O
)	)	O
within	IN	O
the	DT	O
developing	VBG	O
retina	NN	O
.	.	O

This	DT	O
supports	VBZ	O
recent	JJ	O
observations	NNS	O
that	IN	O
the	DT	O
protein	NN	O
is	VBZ	O
critical	JJ	O
for	IN	O
normal	JJ	O
retinal	JJ	O
vasculogenesis	NN	O
.	.	O

Hereditary	NNP	O
TP53	NNP	O
codon	VBD	O
292	CD	O
and	CC	O
somatic	JJ	O
P16INK4A	NNP	O
codon	NN	O
94	CD	O
mutations	NNS	O
in	IN	O
a	DT	O
Li	NNP	B_Disease
-	:	I_Disease
Fraumeni	NNP	I_Disease
syndrome	VBD	E_Disease
family	NN	O
.	.	O

Li	NNP	B_Disease
-	:	I_Disease
Fraumeni	NNP	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
disorder	NN	E_Disease
that	WDT	O
is	VBZ	O
characterized	VBN	O
by	IN	O
various	JJ	O
types	NNS	O
of	IN	O
cancer	NN	S_Disease
in	IN	O
childhood	NN	O
and	CC	O
adult	NN	O
cases	NNS	O
.	.	O

Although	IN	O
hereditary	JJ	O
TP53	NNP	O
mutation	NN	O
is	VBZ	O
very	RB	O
rare	JJ	O
in	IN	O
different	JJ	O
human	JJ	O
cancers	NNS	S_Disease
,	,	O
it	PRP	O
has	VBZ	O
been	VBN	O
frequently	RB	O
reported	VBN	O
in	IN	O
Li	NNP	B_Disease
-	:	I_Disease
Fraumeni	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
hereditary	JJ	O
mutations	NNS	O
of	IN	O
TP57KIP2	NNP	O
,	,	O
P15INK4B	NNP	O
,	,	O
and	CC	O
P16INK4A	NNP	O
,	,	O
which	WDT	O
affect	VBP	O
the	DT	O
cell	NN	O
cycle	NN	O
similar	JJ	O
to	TO	O
TP53	NNP	O
,	,	O
were	VBD	O
observed	VBN	O
in	IN	O
some	DT	O
types	NNS	O
of	IN	O
cancer	NN	S_Disease
.	.	O

In	IN	O
a	DT	O
Turkish	JJ	O
family	NN	O
with	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
Li	NNP	B_Disease
-	:	I_Disease
Fraumeni	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
we	PRP	O
analyzed	VBD	O
the	DT	O
mutation	NN	O
pattern	NN	O
of	IN	O
TP53	NNP	O
,	,	O
P57KIP2	NNP	O
,	,	O
P15INK4B	NNP	O
,	,	O
and	CC	O
P16INK4A	NNP	O
in	IN	O
the	DT	O
peripheral	JJ	O
blood	NN	O
,	,	O
and	CC	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
(	(	O
homo	JJ	O
/	NNP	O
hemizygous	JJ	O
deletion	NN	O
)	)	O
pattern	NN	O
of	IN	O
TP53	NNP	O
and	CC	O
P15INK4B	NNP	O
/	NNP	O
P16INK4A	NNP	O
in	IN	O
two	CD	O
tumor	NN	S_Disease
tissues	NNS	O
.	.	O

The	DT	O
propositus	NN	O
had	VBD	O
a	DT	O
seminoma	NN	S_Disease
,	,	O
his	PRP$	O
daughter	NN	O
a	DT	O
medulloblastoma	NN	S_Disease
,	,	O
and	CC	O
one	CD	O
of	IN	O
his	PRP$	O
healthy	JJ	O
cousins	NNS	O
,	,	O
a	DT	O
TP53	NNP	O
codon	NN	O
292	CD	O
missense	NN	O
point	NN	O
mutation	NN	O
(	(	O
AAA	NNP	O
-	:	O
-	:	O
>	NN	O
ATA	NNP	O
;	:	O
Lys	NNP	O
-	:	O
-	:	O
>	NN	O
Ile	NNP	O
)	)	O
in	IN	O
the	DT	O
peripheral	JJ	O
blood	NN	O
cells	NNS	O
.	.	O

Tumor	NNP	O
tissue	NN	O
obtained	VBN	O
from	IN	O
the	DT	O
propositus	NN	O
with	IN	O
the	DT	O
seminoma	NN	S_Disease
revealed	VBD	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
in	IN	O
the	DT	O
TP53	NNP	O
gene	NN	O
.	.	O

In	IN	O
the	DT	O
analyses	NNS	O
of	IN	O
tumor	NN	S_Disease
tissues	NNS	O
from	IN	O
the	DT	O
propositus	NN	O
and	CC	O
his	PRP$	O
daughter	NN	O
,	,	O
a	DT	O
P16INK4A	NNP	O
codon	NN	O
94	CD	O
missense	NN	O
point	NN	O
mutation	NN	O
(	(	O
GCG	NNP	O
-	:	O
-	:	O
>	NN	O
GAG	NNP	O
;	:	O
Ala	NNP	O
-	:	O
-	:	O
>	NN	O
Glu	NNP	O
)	)	O
was	VBD	O
observed	VBN	O
with	IN	O
the	DT	O
hereditary	JJ	O
TP53	NNP	O
mutation	NN	O
.	.	O

P16INK4A	NNP	O
codon	VBD	O
94	CD	O
mutation	NN	O
observed	VBN	O
in	IN	O
our	PRP$	O
family	NN	O
is	VBZ	O
a	DT	O
novel	JJ	O
mutation	NN	O
in	IN	O
Li	NNP	B_Disease
-	:	I_Disease
Fraumeni	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

No	DT	O
other	JJ	O
gene	NN	O
alteration	NN	O
in	IN	O
TP53	NNP	O
,	,	O
P57KIP2	NNP	O
,	,	O
P15INK4B	NNP	O
,	,	O
and	CC	O
P16INK4A	NNP	O
was	VBD	O
observed	VBN	O
.	.	O

Existence	NN	O
of	IN	O
the	DT	O
P16INK4A	NNP	O
mutation	NN	O
and	CC	O
the	DT	O
hereditary	JJ	O
TP53	NNP	O
mutation	NN	O
with	IN	O
or	CC	O
without	IN	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
in	IN	O
the	DT	O
TP53	NNP	O
gene	NN	O
(	(	O
seminoma	JJ	S_Disease
/	NNP	O
medulloblastoma	NN	S_Disease
)	)	O
may	MD	O
be	VB	O
evidence	NN	O
for	IN	O
a	DT	O
common	JJ	O
mechanism	NN	O
involved	VBN	O
in	IN	O
tumorogenesis	NN	S_Disease
.	.	O

The	DT	O
gene	NN	O
alterations	NNS	O
in	IN	O
TP53	NNP	O
and	CC	O
P16INK4A	NNP	O
genes	NNS	O
may	MD	O
be	VB	O
used	VBN	O
as	IN	O
tumor	NN	S_Disease
markers	NNS	O
in	IN	O
our	PRP$	O
family	NN	O
.	.	O
.	.	O

A	DT	O
novel	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
sodium	NN	O
/	NNP	O
iodide	RB	O
symporter	RB	O
gene	NN	O
in	IN	O
the	DT	O
largest	JJS	O
family	NN	O
with	IN	O
iodide	JJ	B_Disease
transport	NN	I_Disease
defect	NN	E_Disease
.	.	O

We	PRP	O
previously	RB	O
reported	VBD	O
nine	CD	O
children	NNS	O
with	IN	O
an	DT	O
autosomally	RB	O
recessive	JJ	O
form	NN	O
of	IN	O
congenital	JJ	B_Disease
hypothyroidism	NN	E_Disease
due	JJ	O
to	TO	O
an	DT	O
iodide	JJ	B_Disease
transport	NN	I_Disease
defect	NN	E_Disease
in	IN	O
a	DT	O
large	JJ	O
Hutterite	NNP	O
family	NN	O
with	IN	O
extensive	JJ	O
consanguinity	NN	O
living	NN	O
in	IN	O
central	JJ	O
Canada	NNP	O
.	.	O

Since	IN	O
the	DT	O
original	JJ	O
report	NN	O
,	,	O
we	PRP	O
have	VBP	O
diagnosed	VBN	O
congenital	JJ	B_Disease
hypothyroidism	NN	E_Disease
by	IN	O
newborn	JJ	O
TSH	NNP	O
screening	NN	O
in	IN	O
9	CD	O
additional	JJ	O
children	NNS	O
from	IN	O
the	DT	O
family	NN	O
.	.	O

We	PRP	O
performed	VBD	O
direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
PCR	NNP	O
products	NNS	O
of	IN	O
each	DT	O
NIS	NNP	O
(	(	O
sodium	NN	O
/	NNP	O
iodide	RB	O
symporter	RB	O
)	)	O
gene	NN	O
exon	NN	O
with	IN	O
flanking	JJ	O
introns	NNS	O
amplified	VBN	O
from	IN	O
genomic	JJ	O
DNA	NN	O
extracted	VBN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
cells	NNS	O
of	IN	O
the	DT	O
patients	NNS	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
novel	JJ	O
NIS	NNP	O
gene	NN	O
mutation	NN	O
,	,	O
G395R	NNP	O
(	(	O
Gly395	NNP	O
-	:	O
-	:	O
>	NN	O
Arg	NNP	O
;	:	O
GGA	NNP	O
-	:	O
-	:	O
>	NN	O
AGA	NNP	O
)	)	O
,	,	O
in	IN	O
10	CD	O
patients	NNS	O
examined	VBN	O
in	IN	O
the	DT	O
present	JJ	O
study	NN	O
.	.	O

All	DT	O
of	IN	O
the	DT	O
parents	NNS	O
tested	VBN	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
mutation	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
patients	NNS	O
were	VBD	O
homozygous	JJ	O
.	.	O

The	DT	O
mutation	NN	O
was	VBD	O
located	VBN	O
in	IN	O
the	DT	O
10th	JJ	O
transmembrane	NN	O
helix	NN	O
.	.	O

Expression	NN	O
experiments	NNS	O
by	IN	O
transfection	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
NIS	NNP	O
complimentary	JJ	O
DNA	NNP	O
into	IN	O
COS	NNP	O
-	:	O
7	CD	O
cells	NNS	O
showed	VBD	O
no	DT	O
perchlorate	NN	O
-	:	O
sensitive	JJ	O
iodide	JJ	O
uptake	NN	O
,	,	O
confirming	VBG	O
that	IN	O
the	DT	O
mutation	NN	O
is	VBZ	O
the	DT	O
direct	JJ	O
cause	NN	O
of	IN	O
the	DT	O
iodide	JJ	B_Disease
transport	NN	I_Disease
defect	NN	E_Disease
in	IN	O
these	DT	O
patients	NNS	O
.	.	O

A	DT	O
patient	NN	O
who	WP	O
showed	VBD	O
an	DT	O
intermediate	JJ	O
saliva	NN	O
/	NNP	O
serum	NN	O
technetium	NN	O
ratio	NN	O
(	(	O
14	CD	O
.	.	O

0	CD	O
;	:	O
normal	JJ	O
,	,	O
>	JJ	O
or	CC	O
=	JJ	O
20	CD	O
)	)	O
and	CC	O
was	VBD	O
considered	VBN	O
to	TO	O
have	VB	O
a	DT	O
partial	JJ	O
or	CC	O
less	RBR	O
severe	JJ	O
defect	NN	O
in	IN	O
the	DT	O
previous	JJ	O
report	NN	O
(	(	O
IX	NNP	O
-	:	O
24	CD	O
)	)	O
did	VBD	O
not	RB	O
have	VB	O
a	DT	O
NIS	NNP	O
gene	NN	O
mutation	NN	O
.	.	O

It	PRP	O
is	VBZ	O
now	RB	O
possible	JJ	O
to	TO	O
use	VB	O
gene	NN	O
diagnostics	NNS	O
of	IN	O
this	DT	O
unique	JJ	O
NIS	NNP	O
mutation	NN	O
to	TO	O
identify	VB	O
patients	NNS	O
with	IN	O
congenital	JJ	B_Disease
hypothyroidism	NN	E_Disease
due	JJ	O
to	TO	O
an	DT	O
iodide	JJ	B_Disease
transport	NN	I_Disease
defect	NN	E_Disease
in	IN	O
this	DT	O
family	NN	O
and	CC	O
to	TO	O
determine	VB	O
the	DT	O
carrier	NN	O
state	NN	O
of	IN	O
potential	JJ	O
parents	NNS	O
for	IN	O
genetic	JJ	O
counseling	NN	O
and	CC	O
arranging	VBG	O
rapid	JJ	O
and	CC	O
early	JJ	O
diagnosis	NN	O
of	IN	O
their	PRP$	O
infants	NNS	O
.	.	O

Molecular	JJ	O
analysis	NN	O
in	IN	O
familial	JJ	B_Disease
neurohypophyseal	NN	I_Disease
diabetes	VBZ	I_Disease
insipidus	NN	E_Disease
:	:	O
early	JJ	O
diagnosis	NN	O
of	IN	O
an	DT	O
asymptomatic	JJ	O
carrier	NN	O
.	.	O

Familial	JJ	B_Disease
neurohypophyseal	NN	I_Disease
diabetes	NNS	I_Disease
insipidus	VBP	E_Disease
(	(	O
FNDI	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
inherited	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
hormone	NN	I_Disease
arginine	NN	I_Disease
vasopressin	NN	E_Disease
(	(	O
AVP	NNP	O
)	)	O
and	CC	O
is	VBZ	O
transmitted	VBN	O
as	IN	O
an	DT	O
autosomal	JJ	O
dominant	JJ	O
trait	NN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
we	PRP	O
have	VBP	O
analyzed	VBN	O
the	DT	O
AVP	NNP	O
-	:	O
neurophysin	NN	O
II	NNP	O
(	(	O
AVP	NNP	O
-	:	O
NPII	NN	O
)	)	O
gene	NN	O
in	IN	O
a	DT	O
Spanish	JJ	O
kindred	VBN	O
.	.	O

Studies	NNS	O
were	VBD	O
performed	VBN	O
on	IN	O
seven	CD	O
members	NNS	O
(	(	O
four	CD	O
clinically	RB	O
affected	VBN	O
)	)	O
of	IN	O
the	DT	O
family	NN	O
.	.	O

Patients	NNS	O
were	VBD	O
diagnosed	VBN	O
at	IN	O
the	DT	O
Hospital	NNP	O
Universitario	NNP	O
Gregorio	NNP	O
Maranon	NNP	O
(	(	O
Madrid	NNP	O
,	,	O
Spain	NNP	O
)	)	O
.	.	O

The	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
the	DT	O
AVP	NNP	O
-	:	O
NPII	NNP	O
gene	NN	O
of	IN	O
all	DT	O
family	NN	O
members	NNS	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
and	CC	O
sequenced	VBD	O
.	.	O

All	DT	O
affected	JJ	O
individuals	NNS	O
presented	VBD	O
a	DT	O
missense	JJ	O
mutation	NN	O
(	(	O
G1757	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
)	)	O
that	WDT	O
replaces	VBZ	O
glycine	NN	O
at	IN	O
position	NN	O
23	CD	O
with	IN	O
arginine	NN	O
within	IN	O
the	DT	O
NPII	NNP	O
domain	NN	O
.	.	O

The	DT	O
substitution	NN	O
was	VBD	O
confirmed	VBN	O
by	IN	O
restriction	NN	O
endonuclease	NN	O
analysis	NN	O
and	CC	O
was	VBD	O
present	JJ	O
in	IN	O
heterozygosis	NN	O
.	.	O

Additionally	RB	O
,	,	O
one	CD	O
of	IN	O
the	DT	O
asymptomatic	JJ	O
relatives	NNS	O
(	(	O
a	DT	O
girl	NN	O
8	CD	O
months	NNS	O
old	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
study	NN	O
)	)	O
was	VBD	O
identified	VBN	O
as	IN	O
carrier	NN	O
of	IN	O
the	DT	O
same	JJ	O
mutation	NN	O
and	CC	O
developed	VBD	O
the	DT	O
disease	NN	O
3	CD	O
months	NNS	O
later	RB	O
.	.	O

The	DT	O
alteration	NN	O
found	VBD	O
in	IN	O
the	DT	O
second	JJ	O
exon	NN	O
of	IN	O
the	DT	O
gene	NN	O
in	IN	O
this	DT	O
family	NN	O
seems	VBZ	O
to	TO	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
disease	NN	O
,	,	O
as	IN	O
all	DT	O
individuals	NNS	O
harboring	VBG	O
the	DT	O
mutation	NN	O
had	VBD	O
been	VBN	O
previously	RB	O
diagnosed	VBN	O
or	CC	O
have	VBP	O
eventually	RB	O
developed	VBN	O
FNDI	NNP	S_Disease
.	.	O

Identification	NN	O
of	IN	O
the	DT	O
molecular	JJ	O
defect	NN	O
underlying	VBG	O
FNDI	NNP	S_Disease
in	IN	O
affected	JJ	O
families	NNS	O
is	VBZ	O
a	DT	O
powerful	JJ	O
tool	NN	O
for	IN	O
early	JJ	O
asymptomatic	JJ	O
diagnosis	NN	O
in	IN	O
infants	NNS	O
.	.	O
.	.	O

Deficit	NNP	O
of	IN	O
in	IN	O
vivo	JJ	O
mitochondrial	JJ	O
ATP	NNP	O
production	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
.	.	O

Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
(	(	O
FRDA	NNP	S_Disease
)	)	O
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
of	IN	O
the	DT	O
inherited	JJ	B_Disease
ataxias	NN	E_Disease
,	,	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
degenerative	JJ	I_Disease
disorder	NN	E_Disease
,	,	O
characterized	VBN	O
clinically	RB	O
by	IN	O
onset	NN	O
before	IN	O
the	DT	O
age	NN	O
of	IN	O
25	CD	O
of	IN	O
progressive	JJ	B_Disease
gait	NN	I_Disease
and	CC	I_Disease
limb	NN	I_Disease
ataxia	NN	E_Disease
,	,	O
absence	NN	B_Disease
of	IN	I_Disease
deep	JJ	I_Disease
tendon	NN	I_Disease
reflexes	NNS	E_Disease
,	,	O
extensor	NN	B_Disease
plantar	NN	I_Disease
responses	NNS	E_Disease
,	,	O
and	CC	O
loss	NN	B_Disease
of	IN	I_Disease
position	NN	I_Disease
and	CC	I_Disease
vibration	NN	I_Disease
sense	NN	E_Disease
in	IN	O
the	DT	O
lower	JJR	O
limbs	NN	O
.	.	O

FRDA	NNP	S_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
GAA	NNP	O
triplet	NN	O
expansion	NN	O
in	IN	O
the	DT	O
first	JJ	O
intron	NN	O
of	IN	O
the	DT	O
FRDA	NNP	S_Disease
gene	NN	O
on	IN	O
chromosome	NN	O
9q13	CD	O
in	IN	O
97	CD	O
%	NN	O
of	IN	O
patients	NNS	O
.	.	O

The	DT	O
FRDA	NNP	S_Disease
gene	NN	O
encodes	VBZ	O
a	DT	O
widely	RB	O
expressed	VBN	O
210	CD	O
-	:	O
aa	NN	O
protein	NN	O
,	,	O
frataxin	NN	O
,	,	O
which	WDT	O
is	VBZ	O
located	VBN	O
in	IN	O
mitochondria	NN	O
and	CC	O
is	VBZ	O
severely	RB	O
reduced	VBN	O
in	IN	O
FRDA	NNP	S_Disease
patients	NNS	O
.	.	O

Frataxin	NNP	O
function	NN	O
is	VBZ	O
still	RB	O
unknown	JJ	O
but	CC	O
the	DT	O
knockout	NN	O
of	IN	O
the	DT	O
yeast	NN	O
frataxin	NN	O
homologue	NN	O
gene	NN	O
(	(	O
YFH1	NNP	O
)	)	O
showed	VBD	O
a	DT	O
severe	JJ	O
defect	NN	O
of	IN	O
mitochondrial	JJ	O
respiration	NN	O
and	CC	O
loss	NN	O
of	IN	O
mtDNA	NN	O
associated	VBN	O
with	IN	O
elevated	JJ	O
intramitochondrial	JJ	O
iron	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
in	IN	O
vivo	JJ	O
evidence	NN	O
of	IN	O
impaired	JJ	O
mitochondrial	JJ	O
respiration	NN	O
in	IN	O
skeletal	JJ	O
muscle	NN	O
of	IN	O
FRDA	NNP	S_Disease
patients	NNS	O
.	.	O

Using	VBG	O
phosphorus	JJ	O
magnetic	JJ	O
resonance	NN	O
spectroscopy	NN	O
we	PRP	O
demonstrated	VBD	O
a	DT	O
maximum	JJ	O
rate	NN	O
of	IN	O
muscle	NN	O
mitochondrial	JJ	O
ATP	NNP	O
production	NN	O
(	(	O
V	NNP	O
(	(	O
max	NN	O
)	)	O
)	)	O
below	IN	O
the	DT	O
normal	JJ	O
range	NN	O
in	IN	O
all	DT	O
12	CD	O
FRDA	NNP	S_Disease
patients	NNS	O
and	CC	O
a	DT	O
strong	JJ	O
negative	JJ	O
correlation	NN	O
between	IN	O
mitochondrial	JJ	O
V	NNP	O
(	(	O
max	NN	O
)	)	O
and	CC	O
the	DT	O
number	NN	O
of	IN	O
GAA	NNP	O
repeats	NNS	O
in	IN	O
the	DT	O
smaller	JJR	O
allele	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
show	VBP	O
that	IN	O
FRDA	NNP	S_Disease
is	VBZ	O
a	DT	O
nuclear	JJ	O
-	:	O
encoded	VBN	O
mitochondrial	JJ	B_Disease
disorder	NN	E_Disease
affecting	VBG	O
oxidative	JJ	O
phosphorylation	NN	O
and	CC	O
give	VB	O
a	DT	O
rationale	NN	O
for	IN	O
treatments	NNS	O
aimed	VBN	O
to	TO	O
improve	VB	O
mitochondrial	JJ	O
function	NN	O
in	IN	O
this	DT	O
condition	NN	O
.	.	O
.	.	O

Identification	NN	O
of	IN	O
a	DT	O
novel	JJ	O
R21X	NNP	O
mutation	NN	O
in	IN	O
the	DT	O
liver	NN	O
-	:	O
type	NN	O
arginase	NN	O
gene	NN	O
(	(	O
ARG1	NNP	O
)	)	O
in	IN	O
four	CD	O
Portuguese	JJ	O
patients	NNS	O
with	IN	O
argininemia	NN	S_Disease
.	.	O

Argininemia	NNP	S_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
autossomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
deficiency	NN	B_Disease
in	IN	I_Disease
the	DT	I_Disease
cytosolic	NN	I_Disease
liver	SYM	I_Disease
-	:	I_Disease
type	NN	I_Disease
arginase	NN	I_Disease
enzyme	NN	E_Disease
(	(	O
L	NNP	O
-	:	O
arginine	NN	O
urea	JJ	O
-	:	O
hydrolase	NN	O
;	:	O
E	NNP	O
.	.	O

C	NNP	O
.	.	O

3	CD	O
.	.	O

5	CD	O
.	.	O

3	CD	O
.	.	O

1	CD	O
)	)	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
investigate	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
for	IN	O
argininemia	NN	S_Disease
in	IN	O
four	CD	O
unrelated	JJ	O
Portuguese	JJ	O
patients	NNS	O
(	(	O
two	CD	O
from	IN	O
northern	JJ	O
Portugal	NNP	O
and	CC	O
two	CD	O
from	IN	O
Madeira	NNP	O
Island	NNP	O
)	)	O
we	PRP	O
performed	VBD	O
a	DT	O
DNA	NN	O
sequence	NN	O
analysis	NN	O
of	IN	O
all	PDT	O
the	DT	O
exons	NNS	O
and	CC	O
exon	VB	O
/	NNP	O
intron	NN	O
boundaries	NNS	O
of	IN	O
the	DT	O
liver	NN	O
-	:	O
type	NN	O
arginase	NN	O
gene	NN	O
(	(	O
ARG1	NNP	O
)	)	O
.	.	O

All	DT	O
patients	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
homozygous	JJ	O
for	IN	O
a	DT	O
newly	RB	O
identified	VBN	O
C	NNP	O
-	:	O
>	NN	O
T	NNP	O
transition	NN	O
in	IN	O
codon	NN	O
21	CD	O
(	(	O
exon	VB	O
2	CD	O
)	)	O
substituting	VBG	O
arginine	NN	O
for	IN	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
(	(	O
R21X	NNP	O
CGA	NNP	O
to	TO	O
TGA	NNP	O
)	)	O
and	CC	O
generating	VBG	O
a	DT	O
NlaIII	NNP	O
restriction	NN	O
site	NN	O
.	.	O

Restriction	NNP	O
digestion	NN	O
following	VBG	O
PCR	NNP	O
amplification	NN	O
of	IN	O
ARG1	NNP	O
exon	FW	O
2	CD	O
confirmed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
mutation	NN	O
.	.	O

Mutation	NN	O
of	IN	O
the	DT	O
sterol	NN	O
27	CD	O
-	:	O
hydroxylase	NN	O
gene	NN	O
(	(	O
CYP27	NNP	O
)	)	O
results	NNS	O
in	IN	O
truncation	NN	O
of	IN	O
mRNA	NN	O
expressed	VBN	O
in	IN	O
leucocytes	NNS	O
in	IN	O
a	DT	O
Japanese	JJ	O
family	NN	O
with	IN	O
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
.	.	O

OBJECTIVES	IN	O
A	NNP	O
Japanese	JJ	O
family	NN	O
with	IN	O
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
(	(	O
CTX	NNP	S_Disease
)	)	O
was	VBD	O
investigated	VBN	O
for	IN	O
a	DT	O
sequence	NN	O
alteration	NN	O
in	IN	O
the	DT	O
sterol	NN	O
27	CD	O
-	:	O
hydroxylase	NN	O
gene	NN	O
(	(	O
CYP27	NNP	O
)	)	O
.	.	O

The	DT	O
expression	NN	O
of	IN	O
CYP27	NNP	O
has	VBZ	O
been	VBN	O
mostly	RB	O
explored	VBN	O
using	VBG	O
cultured	JJ	O
fibroblasts	NNS	O
,	,	O
prompting	VBG	O
the	DT	O
examination	NN	O
of	IN	O
the	DT	O
transcripts	NNS	O
from	IN	O
blood	NN	O
leucocytes	NNS	O
as	IN	O
a	DT	O
simple	JJ	O
and	CC	O
rapid	JJ	O
technique	NN	O
.	.	O

METHODS	NNP	O
An	DT	O
alteration	NN	O
in	IN	O
CYP27	NNP	O
of	IN	O
the	DT	O
proband	NN	O
was	VBD	O
searched	VBN	O
for	IN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
-	:	O
single	JJ	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
PCR	NNP	O
-	:	O
SSCP	NN	O
)	)	O
analysis	NN	O
and	CC	O
subsequent	JJ	O
sequencing	NN	O
.	.	O

Samples	NNS	O
of	IN	O
RNA	NNP	O
were	VBD	O
subjected	VBN	O
to	TO	O
reverse	VB	O
transcription	NN	O
PCR	NNP	O
(	(	O
RT	NNP	O
-	:	O
PCR	NN	O
)	)	O
and	CC	O
the	DT	O
product	NN	O
of	IN	O
the	DT	O
proband	NN	O
was	VBD	O
amplified	VBN	O
with	IN	O
nested	JJ	O
primers	NNS	O
and	CC	O
sequenced	VBD	O
.	.	O

RESULTS	VB	O
A	DT	O
homozygous	JJ	O
G	NNP	O
to	TO	O
A	DT	O
transition	NN	O
at	IN	O
the	DT	O
5	CD	O
end	NN	O
of	IN	O
intron	NN	O
7	CD	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

In	IN	O
RT	NNP	O
-	:	O
PCR	NN	O
analysis	NN	O
,	,	O
only	RB	O
a	DT	O
truncated	JJ	O
transcript	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
patient	NN	O
,	,	O
whereas	IN	O
both	DT	O
normal	JJ	O
and	CC	O
truncated	JJ	O
transcripts	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
siblings	NNS	O
.	.	O

The	DT	O
sequencing	NN	O
of	IN	O
the	DT	O
patients	NNS	O
cDNA	VBP	O
fragment	JJ	O
disclosed	VBD	O
a	DT	O
direct	JJ	O
conjuction	NN	O
of	IN	O
exon	$	O
6	CD	O
and	CC	O
exon	$	O
8	CD	O
.	.	O

CONCLUSION	NNP	O
The	DT	O
mutation	NN	O
at	IN	O
splice	NN	O
donor	NN	O
site	NN	O
and	CC	O
the	DT	O
truncation	NN	O
of	IN	O
mRNA	NN	O
were	VBD	O
identical	JJ	O
with	IN	O
those	DT	O
of	IN	O
a	DT	O
recently	RB	O
reported	VBN	O
Italian	JJ	O
patient	NN	O
,	,	O
although	IN	O
different	JJ	O
in	IN	O
symptomatology	NN	O
.	.	O

The	DT	O
application	NN	O
of	IN	O
blood	NN	O
leucocytes	NNS	O
can	MD	O
be	VB	O
a	DT	O
simple	JJ	O
technique	NN	O
on	IN	O
analysing	VBG	O
a	DT	O
constructive	JJ	O
abnormality	NN	B_Disease
of	IN	I_Disease
CYP27	NNP	E_Disease
mRNA	NN	O
.	.	O
.	.	O

Clinical	JJ	O
and	CC	O
molecular	JJ	O
genetic	JJ	O
analysis	NN	O
of	IN	O
19	CD	O
Wolfram	NNP	B_Disease
syndrome	NN	E_Disease
kindreds	NNS	O
demonstrating	VBG	O
a	DT	O
wide	JJ	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
WFS1	NNP	O
.	.	O

Wolfram	NNP	B_Disease
syndrome	NN	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
neurodegenerative	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
juvenile	NN	B_Disease
-	:	I_Disease
onset	NN	I_Disease
diabetes	VBZ	I_Disease
mellitus	NNS	E_Disease
and	CC	O
progressive	JJ	O
optic	JJ	B_Disease
atrophy	NN	E_Disease
.	.	O

mtDNA	NN	O
deletions	NNS	O
have	VBP	O
been	VBN	O
described	VBN	O
,	,	O
and	CC	O
a	DT	O
gene	NN	O
(	(	O
WFS1	NNP	O
)	)	O
recently	RB	O
has	VBZ	O
been	VBN	O
identified	VBN	O
,	,	O
on	IN	O
chromosome	NN	O
4p16	CD	O
,	,	O
encoding	VBG	O
a	DT	O
predicted	JJ	O
890	CD	O
amino	NN	O
acid	NN	O
transmembrane	NN	O
protein	NN	O
.	.	O

Direct	JJ	O
DNA	NNP	O
sequencing	NN	O
was	VBD	O
done	VBN	O
to	TO	O
screen	VB	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
the	DT	O
WFS1	NNP	O
gene	NN	O
in	IN	O
30	CD	O
patients	NNS	O
from	IN	O
19	CD	O
British	JJ	O
kindreds	NNS	O
with	IN	O
Wolfram	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O

DNA	NN	O
was	VBD	O
also	RB	O
screened	VBN	O
for	IN	O
structural	JJ	O
rearrangements	NNS	O
(	(	O
deletions	NNS	O
and	CC	O
duplications	NNS	O
)	)	O
and	CC	O
point	NN	O
mutations	NNS	O
in	IN	O
mtDNA	NN	O
.	.	O

No	DT	O
pathogenic	JJ	O
mtDNA	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
our	PRP$	O
cohort	NN	O
.	.	O

We	PRP	O
identified	VBD	O
24	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
WFS1	NNP	O
gene	NN	O
8	CD	O
nonsense	JJ	O
mutations	NNS	O
,	,	O
8	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
3	CD	O
in	IN	O
-	:	O
frame	NN	O
deletions	NNS	O
,	,	O
1	CD	O
in	IN	O
-	:	O
frame	NN	O
insertion	NN	O
,	,	O
and	CC	O
4	CD	O
frameshift	NN	O
mutations	NNS	O
.	.	O

Of	IN	O
these	DT	O
,	,	O
23	CD	O
were	VBD	O
novel	JJ	O
mutations	NNS	O
,	,	O
and	CC	O
most	JJS	O
occurred	VBN	O
in	IN	O
exon	NN	O
8	CD	O
.	.	O

The	DT	O
majority	NN	O
of	IN	O
patients	NNS	O
were	VBD	O
compound	JJ	O
heterozygotes	NNS	O
for	IN	O
two	CD	O
mutations	NNS	O
,	,	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
common	JJ	O
founder	NN	O
mutation	NN	O
.	.	O

The	DT	O
data	NNS	O
were	VBD	O
also	RB	O
analyzed	VBN	O
for	IN	O
genotype	NN	O
-	:	O
phenotype	JJ	O
relationships	NNS	O
.	.	O

Although	IN	O
some	DT	O
interesting	JJ	O
cases	NNS	O
were	VBD	O
noted	VBN	O
,	,	O
consideration	NN	O
of	IN	O
the	DT	O
small	JJ	O
sample	NN	O
size	NN	O
and	CC	O
frequency	NN	O
of	IN	O
each	DT	O
mutation	NN	O
indicated	VBD	O
no	DT	O
clear	JJ	O
-	:	O
cut	NN	O
correlations	NNS	O
between	IN	O
any	DT	O
of	IN	O
the	DT	O
observed	JJ	O
mutations	NNS	O
and	CC	O
disease	NN	O
severity	NN	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
obvious	JJ	O
mutation	NN	O
hot	JJ	O
spots	NNS	O
or	CC	O
clusters	NNS	O
.	.	O

Hence	NNP	O
,	,	O
molecular	JJ	O
screening	NN	O
for	IN	O
Wolfram	NNP	B_Disease
syndrome	NN	E_Disease
in	IN	O
affected	JJ	O
families	NNS	O
and	CC	O
for	IN	O
Wolfram	NNP	B_Disease
syndrome	JJ	E_Disease
-	:	O
carrier	NN	O
status	NN	O
in	IN	O
subjects	NNS	O
with	IN	O
psychiatric	JJ	B_Disease
disorders	NNS	E_Disease
or	CC	O
diabetes	VBZ	B_Disease
mellitus	NNS	E_Disease
will	MD	O
require	VB	O
complete	JJ	O
analysis	NN	O
of	IN	O
exon	$	O
8	CD	O
and	CC	O
upstream	JJ	O
exons	NNS	O
.	.	O
.	.	O

Late	JJ	O
-	:	O
onset	VBN	O
familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
(	(	O
FMF	NNP	S_Disease
)	)	O
:	:	O
a	DT	O
subset	NN	O
with	IN	O
distinct	JJ	O
clinical	JJ	O
,	,	O
demographic	JJ	O
,	,	O
and	CC	O
molecular	JJ	O
genetic	JJ	O
characteristics	NNS	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
prevalence	NN	O
and	CC	O
characterize	VB	O
demographic	JJ	O
,	,	O
clinical	JJ	O
,	,	O
and	CC	O
genetic	JJ	O
features	NNS	O
of	IN	O
familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
(	(	O
FMF	NNP	S_Disease
)	)	O
of	IN	O
late	JJ	O
onset	NN	O
,	,	O
all	DT	O
patients	NNS	O
experiencing	VBG	O
their	PRP$	O
first	JJ	O
FMF	NNP	S_Disease
attack	NN	O
at	IN	O
age	NN	O
40	CD	O
years	NNS	O
or	CC	O
more	JJR	O
were	VBD	O
identified	VBN	O
using	VBG	O
the	DT	O
computerized	JJ	O
registry	NN	O
of	IN	O
our	PRP$	O
FMF	NNP	S_Disease
clinic	NN	O
,	,	O
and	CC	O
then	RB	O
thoroughly	RB	O
interviewed	VBN	O
and	CC	O
examined	VBN	O
.	.	O

The	DT	O
control	NN	O
group	NN	O
consisted	VBD	O
of	IN	O
40	CD	O
consecutive	JJ	O
FMF	NNP	S_Disease
patients	NNS	O
,	,	O
who	WP	O
arrived	VBD	O
at	IN	O
the	DT	O
FMF	NNP	S_Disease
clinic	NN	O
for	IN	O
their	PRP$	O
regular	JJ	O
follow	NN	O
-	:	O
up	IN	O
visit	NN	O
and	CC	O
were	VBD	O
40	CD	O
years	NNS	O
of	IN	O
age	NN	O
or	CC	O
older	JJR	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
the	DT	O
examination	NN	O
.	.	O

The	DT	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
in	IN	O
patients	NNS	O
and	CC	O
controls	NNS	O
was	VBD	O
determined	VBN	O
using	VBG	O
a	DT	O
modified	VBN	O
score	NN	O
,	,	O
developed	VBD	O
previously	RB	O
.	.	O

Mutational	JJ	O
analysis	NN	O
in	IN	O
the	DT	O
FMF	NNP	S_Disease
gene	NN	O
was	VBD	O
performed	VBN	O
using	VBG	O
a	DT	O
commercial	JJ	O
kit	NN	O
.	.	O

Only	RB	O
20	CD	O
of	IN	O
4000	CD	O
(	(	O
0	CD	O
.	.	O

5	CD	O
%	NN	O
)	)	O
patients	NNS	O
had	VBD	O
late	JJ	O
-	:	O
onset	NN	O
FMF	NNP	S_Disease
.	.	O

These	DT	O
patients	NNS	O
were	VBD	O
mostly	RB	O
men	NNS	O
,	,	O
of	IN	O
non	JJ	O
-	:	O
North	JJ	O
African	JJ	O
origin	NN	O
,	,	O
P	NNP	O
<	VBZ	O
0	CD	O
.	.	O

05	CD	O
compared	VBN	O
to	TO	O
controls	NNS	O
.	.	O

All	DT	O
had	VBD	O
abdominal	JJ	O
attacks	NNS	O
and	CC	O
in	IN	O
most	JJS	O
these	DT	O
were	VBD	O
the	DT	O
only	JJ	O
manifestation	NN	O
of	IN	O
their	PRP$	O
disease	NN	O
,	,	O
P	NNP	O
<	VBZ	O
0	CD	O
.	.	O

001	CD	O
001	CD	O
.	.	O

None	NN	O
had	VBD	O
chronic	JJ	O
or	CC	O
prolonged	JJ	O
manifestations	NNS	O
of	IN	O
FMF	NNP	S_Disease
,	,	O
for	IN	O
example	NN	O
,	,	O
amyloidosis	NN	S_Disease
,	,	O
chronic	JJ	B_Disease
arthritis	NN	E_Disease
,	,	O
or	CC	O
protracted	VBN	O
myalgia	NN	S_Disease
,	,	O
P	NNP	O
<	VBZ	O
0	CD	O
.	.	O

001	CD	O
.	.	O

The	DT	O
response	NN	O
to	TO	O
treatment	NN	O
was	VBD	O
good	JJ	O
despite	IN	O
using	VBG	O
low	JJ	O
colchicine	NN	O
dose	NN	O
,	,	O
P	NNP	O
<	VBZ	O
0	CD	O
.	.	O

05	CD	O
.	.	O

The	DT	O
overall	JJ	O
severity	NN	O
score	NN	O
indicated	VBD	O
a	DT	O
mild	JJ	O
disease	NN	O
,	,	O
P	NNP	O
<	VBZ	O
0	CD	O
.	.	O

001	CD	O
.	.	O

Mutational	JJ	O
analysis	NN	O
revealed	VBD	O
absence	NN	O
of	IN	O
M694V	NNP	O
homozygosity	NN	O
,	,	O
P	NNP	O
<	VBZ	O
0	CD	O
.	.	O

01	CD	O
,	,	O
compared	VBN	O
to	TO	O
our	PRP$	O
regular	JJ	O
FMF	NNP	S_Disease
population	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
onset	NN	O
of	IN	O
FMF	NNP	S_Disease
in	IN	O
a	DT	O
late	JJ	O
age	NN	O
defines	VBZ	O
a	DT	O
milder	NN	O
form	NN	O
of	IN	O
disease	NN	O
with	IN	O
typical	JJ	O
clinical	JJ	O
,	,	O
demographic	JJ	O
,	,	O
and	CC	O
molecular	JJ	O
genetic	JJ	O
characteristics	NNS	O

A	DT	O
highly	RB	O
accurate	JJ	O
,	,	O
low	JJ	O
cost	NN	O
test	NN	O
for	IN	O
BRCA1	NNP	O
mutations	NNS	O
.	.	O

The	DT	O
hereditary	JJ	B_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
BRCA1	NNP	O
mutations	NNS	O
.	.	O

However	RB	O
,	,	O
the	DT	O
widespread	JJ	O
use	NN	O
of	IN	O
BRCA1	NNP	O
testing	NN	O
has	VBZ	O
been	VBN	O
limited	VBN	O
to	TO	O
date	NN	O
by	IN	O
three	CD	O
principal	JJ	O
concerns	NNS	O
the	DT	O
fear	NN	O
of	IN	O
loss	NN	O
of	IN	O
health	NN	O
and	CC	O
life	NN	O
insurance	NN	O
,	,	O
the	DT	O
uncertain	JJ	O
clinical	JJ	O
value	NN	O
of	IN	O
a	DT	O
positive	JJ	O
test	NN	O
result	NN	O
,	,	O
and	CC	O
the	DT	O
current	JJ	O
lack	NN	O
of	IN	O
an	DT	O
inexpensive	JJ	O
and	CC	O
sensitive	JJ	O
screening	NN	O
test	NN	O
for	IN	O
BRCA1	NNP	O
mutations	NNS	O
.	.	O

We	PRP	O
have	VBP	O
developed	VBN	O
an	DT	O
inexpensive	JJ	O
system	NN	O
for	IN	O
gene	NN	O
mutational	JJ	O
scanning	NN	O
,	,	O
based	VBN	O
on	IN	O
a	DT	O
combination	NN	O
of	IN	O
extensive	JJ	O
multiplex	NN	O
PCR	NNP	O
amplification	NN	O
and	CC	O
two	CD	O
dimensional	JJ	O
electrophoresis	NN	O
.	.	O

The	DT	O
efficiency	NN	O
of	IN	O
this	DT	O
system	NN	O
,	,	O
as	IN	O
a	DT	O
screening	JJ	O
test	NN	O
for	IN	O
BRCA1	NNP	O
mutations	NNS	O
,	,	O
was	VBD	O
evaluated	VBN	O
in	IN	O
a	DT	O
panel	NN	O
of	IN	O
60	CD	O
samples	NNS	O
from	IN	O
high	JJ	O
risk	NN	O
women	NNS	O
,	,	O
14	CD	O
of	IN	O
which	WDT	O
contained	VBD	O
a	DT	O
previously	RB	O
identified	VBN	O
mutation	NN	O
in	IN	O
BRCA1	NNP	O
.	.	O

All	DT	O
14	CD	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
additional	JJ	O
five	CD	O
that	WDT	O
had	VBD	O
previously	RB	O
escaped	VBN	O
detection	NN	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
the	DT	O
19	CD	O
mutations	NNS	O
,	,	O
a	DT	O
total	NN	O
of	IN	O
15	CD	O
different	JJ	O
polymorphic	JJ	O
variants	NNS	O
were	VBD	O
scored	VBN	O
,	,	O
most	JJS	O
of	IN	O
which	WDT	O
were	VBD	O
recurring	VBG	O
.	.	O

All	DT	O
were	VBD	O
confirmed	VBN	O
by	IN	O
nucleotide	JJ	O
sequencing	NN	O
.	.	O

The	DT	O
cost	NN	O
of	IN	O
screening	VBG	O
per	IN	O
sample	NN	O
was	VBD	O
calculated	VBN	O
to	TO	O
be	VB	O
approximately	RB	O
US	NNP	O
$	$	O
70	CD	O
for	IN	O
the	DT	O
manual	JJ	O
technique	NN	O
used	VBN	O
in	IN	O
this	DT	O
study	NN	O
,	,	O
and	CC	O
may	MD	O
be	VB	O
reduced	VBN	O
to	TO	O
approximately	RB	O
US	VB	O
$	$	O
10	CD	O
with	IN	O
the	DT	O
introduction	NN	O
of	IN	O
commercially	RB	O
available	JJ	O
PCR	NNP	O
robotics	NNS	O
and	CC	O
fluorescent	JJ	O
imaging	NN	O
.	.	O

Implementation	NN	O
of	IN	O
this	DT	O
method	NN	O
of	IN	O
mutation	NN	O
screening	NN	O
in	IN	O
the	DT	O
research	NN	O
and	CC	O
clinical	JJ	O
setting	NN	O
should	MD	O
permit	VB	O
rapid	JJ	O
accrual	NNS	O
of	IN	O
quantitative	JJ	O
data	NNS	O
on	IN	O
genotype	NN	O
-	:	O
phenotype	NN	O
associations	NNS	O
for	IN	O
the	DT	O
evaluation	NN	O
of	IN	O
diagnostic	JJ	O
testing	NN	O
.	.	O
.	.	O

Maternal	NNP	B_Disease
uniparental	JJ	I_Disease
disomy	NN	I_Disease
for	IN	I_Disease
chromosome	NN	I_Disease
14	CD	E_Disease
in	IN	O
a	DT	O
boy	NN	O
with	IN	O
a	DT	O
normal	JJ	O
karyotype	NN	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
boy	NN	O
with	IN	O
a	DT	O
maternal	JJ	B_Disease
uniparental	JJ	I_Disease
disomy	NN	I_Disease
for	IN	I_Disease
chromosome	NN	I_Disease
14	CD	E_Disease
(	(	O
UPD	NNP	S_Disease
(	(	O
14	CD	O
)	)	O
)	)	O
.	.	O

At	IN	O
7	CD	O
years	NNS	O
of	IN	O
age	NN	O
he	PRP	O
was	VBD	O
referred	VBN	O
to	TO	O
us	PRP	O
by	IN	O
the	DT	O
paediatrician	JJ	O
because	IN	O
of	IN	O
symptoms	NNS	O
of	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
.	.	O

He	PRP	O
showed	VBD	O
short	JJ	B_Disease
stature	NN	E_Disease
,	,	O
obesity	NN	S_Disease
,	,	O
mild	JJ	O
developmental	JJ	B_Disease
delay	NN	E_Disease
,	,	O
cryptorchidism	NN	S_Disease
,	,	O
and	CC	O
some	DT	O
mild	JJ	O
dysmorphic	JJ	B_Disease
features	NNS	E_Disease
.	.	O

The	DT	O
history	NN	O
further	RB	O
indicated	VBD	O
intrauterine	JJ	B_Disease
growth	NN	I_Disease
retardation	NN	E_Disease
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
pregnancy	NN	O
.	.	O

His	PRP$	O
mother	NN	O
was	VBD	O
44	CD	O
years	NNS	O
of	IN	O
age	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	O
birth	NN	O
.	.	O

After	IN	O
birth	NN	O
he	PRP	O
showed	VBD	O
hypotonia	NN	S_Disease
with	IN	O
poor	JJ	O
sucking	NN	O
,	,	O
for	IN	O
which	WDT	O
gavage	NN	O
feeding	NN	O
was	VBD	O
needed	VBN	O
.	.	O

Motor	NNP	O
development	NN	O
was	VBD	O
delayed	VBN	O
.	.	O

After	IN	O
1	CD	O
year	NN	O
he	PRP	O
became	VBD	O
obese	JJ	S_Disease
despite	IN	O
a	DT	O
normal	JJ	O
appetite	NN	O
.	.	O

Recurrent	NNP	O
middle	JJ	B_Disease
ear	JJ	I_Disease
infections	NNS	E_Disease
,	,	O
a	DT	O
high	JJ	O
pain	NN	O
threshold	NN	O
,	,	O
and	CC	O
a	DT	O
great	JJ	O
skill	NN	O
with	IN	O
jigsaw	NN	O
puzzles	NNS	O
were	VBD	O
reported	VBN	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
behavioural	JJ	O
problems	NNS	O
or	CC	O
sleep	JJ	O
disturbance	NN	O
.	.	O

Chromosomal	JJ	O
analysis	NN	O
was	VBD	O
normal	JJ	O
(	(	O
46	CD	O
,	,	O
XY	NNP	O
)	)	O
.	.	O

DNA	NN	O
analysis	NN	O
for	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
showed	VBD	O
no	DT	O
abnormalities	NNS	O
.	.	O

Two	CD	O
years	NNS	O
later	RB	O
he	PRP	O
was	VBD	O
re	JJ	O
-	:	O
examined	VBN	O
because	IN	O
we	PRP	O
thought	VBD	O
his	PRP$	O
features	NNS	O
fitted	VBD	O
the	DT	O
PWS	NNP	S_Disease
-	:	O
like	IN	O
phenotype	NN	O
associated	VBN	O
with	IN	O
maternal	JJ	O
UPD	NNP	S_Disease
(	(	O
14	CD	O
)	)	O
.	.	O

At	IN	O
that	DT	O
time	NN	O
precocious	JJ	O
puberty	NN	O
was	VBD	O
evident	JJ	O
.	.	O

DNA	NN	O
analysis	NN	O
showed	VBD	O
maternal	JJ	B_Disease
heterodisomy	NN	E_Disease
for	IN	O
chromosome	NN	O
14	CD	O
.	.	O

In	IN	O
all	PDT	O
the	DT	O
previously	RB	O
described	VBN	O
11	CD	O
cases	NNS	O
with	IN	O
maternal	JJ	O
UPD	NNP	S_Disease
(	(	O
14	CD	O
)	)	O
,	,	O
a	DT	O
Robertsonian	JJ	O
translocation	NN	O
involving	VBG	O
chromosome	NN	O
14	CD	O
was	VBD	O
detected	VBN	O
cytogenetically	RB	O
before	IN	O
DNA	NNP	O
analysis	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
of	IN	O
diagnosis	NN	O
of	IN	O
maternal	JJ	O
UPD	NNP	S_Disease
(	(	O
14	CD	O
)	)	O
based	VBN	O
on	IN	O
clinical	JJ	O
features	NNS	O
.	.	O

This	DT	O
finding	NN	O
underlines	VBZ	O
the	DT	O
importance	NN	O
of	IN	O
DNA	NNP	O
analysis	NN	O
for	IN	O
maternal	JJ	O
UPD	NNP	O
(	(	O
14	CD	O
)	)	O
in	IN	O
patients	NNS	O
with	IN	O
a	DT	O
similar	JJ	O
PWS	NNP	S_Disease
-	:	O
like	IN	O
phenotype	NN	O
even	RB	O
without	IN	O
previous	JJ	O
identification	NN	O
of	IN	O
a	DT	O
Robertsonian	JJ	O
translocation	NN	O
involving	VBG	O
chromosome	NN	O
14	CD	O
.	.	O
.	.	O

Clinical	JJ	O
and	CC	O
genetic	JJ	O
study	NN	O
of	IN	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
in	IN	O
an	DT	O
Australian	JJ	O
population	NN	O
.	.	O

Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
FRDA	NNP	S_Disease
gene	NN	O
that	WDT	O
encodes	VBZ	O
a	DT	O
210	CD	O
-	:	O
amino	NN	O
acid	NN	O
protein	NN	O
called	VBD	O
frataxin	NN	O
.	.	O

An	DT	O
expansion	NN	O
of	IN	O
a	DT	O
GAA	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
intron	NN	O
1	CD	O
of	IN	O
the	DT	O
gene	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
more	JJR	O
than	IN	O
95	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
.	.	O

Of	IN	O
the	DT	O
83	CD	O
people	NNS	O
we	PRP	O
studied	VBD	O
who	WP	O
have	VBP	O
mutations	NNS	O
in	IN	O
FRDA	NNP	O
,	,	O
78	CD	O
are	VBP	O
homozygous	JJ	O
for	IN	O
an	DT	O
expanded	VBN	O
GAA	NNP	O
repeat	NN	O
;	:	O
the	DT	O
other	JJ	O
five	CD	O
patients	NNS	O
have	VBP	O
an	DT	O
expansion	NN	O
in	IN	O
one	CD	O
allele	NN	O
and	CC	O
a	DT	O
point	NN	O
mutation	NN	O
in	IN	O
the	DT	O
other	JJ	O
.	.	O

Here	RB	O
we	PRP	O
present	VBP	O
a	DT	O
detailed	JJ	O
clinical	JJ	O
and	CC	O
genetic	JJ	O
study	NN	O
of	IN	O
a	DT	O
subset	NN	O
of	IN	O
51	CD	O
patients	NNS	O
homozygous	JJ	O
for	IN	O
an	DT	O
expansion	NN	O
of	IN	O
the	DT	O
GAA	NNP	O
repeat	NN	O
.	.	O

We	PRP	O
found	VBD	O
a	DT	O
correlation	NN	O
between	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
smaller	JJR	O
of	IN	O
the	DT	O
two	CD	O
expanded	VBD	O
alleles	NNS	O
and	CC	O
age	NN	O
at	IN	O
onset	NN	O
,	,	O
age	NN	O
into	IN	O
wheelchair	NN	O
,	,	O
scoliosis	NN	S_Disease
,	,	O
impaired	JJ	O
vibration	NN	O
sense	NN	O
,	,	O
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
foot	NN	B_Disease
deformity	NN	E_Disease
.	.	O

There	EX	O
was	VBD	O
no	DT	O
significant	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
smaller	JJR	O
allele	NN	O
and	CC	O
cardiomyopathy	NN	S_Disease
,	,	O
diabetes	VBZ	B_Disease
mellitus	NNS	E_Disease
,	,	O
loss	NN	B_Disease
of	IN	I_Disease
proprioception	NN	E_Disease
,	,	O
or	CC	O
bladder	NN	B_Disease
symptoms	NNS	E_Disease
.	.	O

The	DT	O
larger	JJR	O
allele	JJ	O
size	NN	O
correlated	VBN	O
with	IN	O
bladder	NN	B_Disease
symptoms	NNS	E_Disease
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
foot	NN	B_Disease
deformity	NN	E_Disease
.	.	O

The	DT	O
duration	NN	O
of	IN	O
disease	NN	O
is	VBZ	O
correlated	VBN	O
with	IN	O
wheelchair	NN	O
use	NN	O
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
diabetes	NNS	S_Disease
,	,	O
scoliosis	NN	S_Disease
,	,	O
bladder	NN	B_Disease
symptoms	NNS	E_Disease
and	CC	O
impaired	JJ	B_Disease
proprioception	NN	E_Disease
,	,	O
and	CC	O
vibration	NN	O
sense	NN	O
but	CC	O
no	DT	O
other	JJ	O
complications	NNS	O
studied	VBN	O
.	.	O
.	.	O

Novel	JJ	O
mutations	NNS	O
in	IN	O
XLRS1	NNP	O
causing	VBG	O
retinoschisis	NN	S_Disease
,	,	O
including	VBG	O
first	JJ	O
evidence	NN	O
of	IN	O
putative	JJ	O
leader	NN	O
sequence	NN	O
change	NN	O
.	.	O

Juvenile	JJ	B_Disease
retinoschisis	NN	E_Disease
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
recessive	JJ	I_Disease
disease	NN	E_Disease
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
XLRS1	NNP	O
gene	NN	O
.	.	O

We	PRP	O
screened	VBD	O
31	CD	O
new	JJ	O
unrelated	JJ	O
patients	NNS	O
and	CC	O
families	NNS	O
for	IN	O
XLRS1	NNP	O
mutations	NNS	O
in	IN	O
addition	NN	O
to	TO	O
previously	RB	O
reported	VBN	O
mutations	NNS	O
for	IN	O
60	CD	O
of	IN	O
our	PRP$	O
families	NNS	O
(	(	O
Retinoschisis	NNP	S_Disease
Consortium	NNP	O
,	,	O
Hum	NNP	O
Mol	NNP	O
Genet	NNP	O
1998	CD	O
;	:	O
7	CD	O
1185	CD	O
-	:	O
1192	CD	O
)	)	O
.	.	O

Twenty	NNP	O
-	:	O
three	CD	O
different	JJ	O
mutations	NNS	O
including	VBG	O
12	CD	O
novel	JJ	O
ones	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
28	CD	O
patients	NNS	O
.	.	O

Mutations	NNS	O
identified	VBN	O
in	IN	O
this	DT	O
study	NN	O
include	VBP	O
19	CD	O
missense	JJ	O
mutations	NNS	O
,	,	O
two	CD	O
nonsense	JJ	O
mutations	NNS	O
,	,	O
one	CD	O
intragenic	JJ	O
deletion	NN	O
,	,	O
four	CD	O
microdeletions	NNS	O
,	,	O
one	CD	O
insertion	NN	O
,	,	O
and	CC	O
one	CD	O
intronic	JJ	O
sequence	NN	O
substitution	NN	O
that	WDT	O
is	VBZ	O
likely	JJ	O
to	TO	O
result	VB	O
in	IN	O
a	DT	O
splice	NN	O
site	NN	O
defect	NN	O
.	.	O

Two	CD	O
novel	JJ	O
mutations	NNS	O
,	,	O
c	NN	O
.	.	O

38T	LS	O
-	:	O
-	:	O
>	NN	O
C	NNP	O
(	(	O
L13P	NNP	O
)	)	O
and	CC	O
c	$	O
.	.	O

667T	CD	O
-	:	O
-	:	O
>	NN	O
C	NNP	O
(	(	O
C223R	NNP	O
)	)	O
,	,	O
respectively	RB	O
,	,	O
present	VBD	O
the	DT	O
first	JJ	O
genetic	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
functional	JJ	O
significance	NN	O
of	IN	O
the	DT	O
putative	JJ	O
leader	NN	O
peptide	NN	O
sequence	NN	O
and	CC	O
for	IN	O
the	DT	O
functional	JJ	O
significance	NN	O
at	IN	O
the	DT	O
carboxyl	JJ	O
terminal	NN	O
of	IN	O
the	DT	O
XLRS1	NNP	O
protein	NN	O
beyond	IN	O
the	DT	O
discoidin	NN	O
domain	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
25	CD	O
of	IN	O
the	DT	O
families	NNS	O
were	VBD	O
localized	VBN	O
to	TO	O
exons	NNS	O
4	CD	O
-	:	O
6	CD	O
,	,	O
emphasizing	VBG	O
the	DT	O
critical	JJ	O
functional	JJ	O
significance	NN	O
of	IN	O
the	DT	O
discoidin	NN	O
domain	NN	O
of	IN	O
the	DT	O
XLRS1	NNP	O
protein	NN	O

Growth	NNP	O
hormone	NN	O
treatment	NN	O
increases	NNS	O
CO	NNP	O
(	(	O
2	CD	O
)	)	O
response	NN	O
,	,	O
ventilation	NN	O
and	CC	O
central	JJ	O
inspiratory	NN	O
drive	NN	O
in	IN	O
children	NNS	O
with	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

We	PRP	O
studied	VBD	O
whether	IN	O
the	DT	O
beneficial	JJ	O
effects	NNS	O
of	IN	O
growth	NN	O
hormone	NN	O
(	(	O
GH	NNP	O
)	)	O
treatment	NN	O
on	IN	O
growth	NN	O
and	CC	O
body	NN	O
composition	NN	O
in	IN	O
PWS	NNP	S_Disease
are	VBP	O
accompanied	VBN	O
by	IN	O
an	DT	O
improvement	NN	O
in	IN	O
respiratory	NN	O
function	NN	O
.	.	O

We	PRP	O
measured	VBD	O
resting	VBG	O
ventilation	NN	O
,	,	O
airway	JJ	O
occlusion	NN	O
pressure	NN	O
(	(	O
P	NNP	O
(	(	O
0	CD	O
.	.	O

1	CD	O
)	)	O
)	)	O
and	CC	O
ventilatory	JJ	O
response	NN	O
to	TO	O
CO	NNP	O
(	(	O
2	CD	O
)	)	O
in	IN	O
nine	CD	O
children	NNS	O
,	,	O
aged	VBD	O
7	CD	O
-	:	O
14	CD	O
years	NNS	O
,	,	O
before	IN	O
and	CC	O
6	CD	O
-	:	O
9	CD	O
months	NNS	O
after	IN	O
the	DT	O
start	NN	O
of	IN	O
GH	NNP	O
treatment	NN	O
.	.	O

During	IN	O
GH	NNP	O
treatment	NN	O
,	,	O
resting	VBG	O
ventilation	NN	O
increased	VBN	O
by	IN	O
26	CD	O
%	NN	O
,	,	O
P	NNP	O
(	(	O
0	CD	O
.	.	O

1	CD	O
)	)	O
by	IN	O
72	CD	O
%	NN	O
and	CC	O
the	DT	O
response	NN	O
to	TO	O
CO	NNP	O
(	(	O
2	CD	O
)	)	O
by	IN	O
65	CD	O
%	NN	O
(	(	O
P	NNP	O
<	VBZ	O
0	CD	O
.	.	O

002	CD	O
,	,	O
<	VBD	O
0	CD	O
.	.	O

04	CD	O
and	CC	O
<	$	O
0	CD	O
.	.	O

02	CD	O
,	,	O
respectively	RB	O
)	)	O
.	.	O

This	DT	O
observed	JJ	O
increase	NN	O
in	IN	O
ventilatory	JJ	O
output	NN	O
was	VBD	O
not	RB	O
correlated	VBN	O
to	TO	O
changes	NNS	O
in	IN	O
body	NN	O
mass	NN	O
index	NN	O
.	.	O

CONCLUSION	NNP	O
Treatment	NNP	O
of	IN	O
children	NNS	O
with	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
seems	VBZ	O
to	TO	O
have	VB	O
a	DT	O
stimulatory	JJ	O
effect	NN	O
on	IN	O
central	JJ	O
respiratory	NN	O
structures	NNS	O
.	.	O

The	DT	O
observed	JJ	O
increase	NN	O
in	IN	O
ventilation	NN	O
and	CC	O
inspiratory	JJ	O
drive	NN	O
may	MD	O
contribute	VB	O
to	TO	O
the	DT	O
improved	JJ	O
activity	NN	O
level	NN	O
reported	VBN	O
by	IN	O
parents	NNS	O
of	IN	O
PWS	NNP	S_Disease
children	NNS	O
during	IN	O
growth	NN	O
hormone	CD	O
therapy	NN	O

G130V	NNP	O
,	,	O
a	DT	O
common	JJ	O
FRDA	NNP	S_Disease
point	NN	O
mutation	NN	O
,	,	O
appears	VBZ	O
to	TO	O
have	VB	O
arisen	VBN	O
from	IN	O
a	DT	O
common	JJ	O
founder	NN	O
.	.	O

Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
(	(	O
FRDA	NNP	S_Disease
)	)	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
inherited	JJ	B_Disease
ataxia	NN	E_Disease
.	.	O

About	RB	O
98	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
have	VBP	O
an	DT	O
expansion	NN	O
of	IN	O
a	DT	O
GAA	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
intron	NN	O
1	CD	O
of	IN	O
the	DT	O
affected	JJ	O
gene	NN	O
,	,	O
FRDA	NNP	O
.	.	O

The	DT	O
other	JJ	O
2	CD	O
%	NN	O
are	VBP	O
point	JJ	O
mutations	NNS	O
.	.	O

Of	IN	O
the	DT	O
17	CD	O
point	NN	O
mutations	NNS	O
so	RB	O
far	RB	O
described	VBN	O
,	,	O
three	CD	O
appear	VBP	O
to	TO	O
be	VB	O
more	JJR	O
common	JJ	O
.	.	O

One	CD	O
of	IN	O
these	DT	O
is	VBZ	O
the	DT	O
G130V	NNP	O
mutation	NN	O
in	IN	O
exon	JJ	O
4	CD	O
of	IN	O
FRDA	NNP	O
.	.	O

G130V	NNP	O
,	,	O
when	WRB	O
present	NN	O
with	IN	O
an	DT	O
expanded	VBN	O
GAA	NNP	O
repeat	NN	O
on	IN	O
the	DT	O
other	JJ	O
allele	NN	O
,	,	O
is	VBZ	O
associated	VBN	O
with	IN	O
an	DT	O
atypical	JJ	O
FRDA	NNP	S_Disease
phenotype	NN	O
.	.	O

Haplotype	NNP	O
analysis	NN	O
was	VBD	O
undertaken	VBN	O
on	IN	O
the	DT	O
four	CD	O
families	NNS	O
who	WP	O
have	VBP	O
been	VBN	O
described	VBN	O
with	IN	O
this	DT	O
mutation	NN	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
a	DT	O
common	JJ	O
founder	NN	O
for	IN	O
this	DT	O
mutation	NN	O
.	.	O

Although	IN	O
marked	JJ	O
differences	NNS	O
in	IN	O
extragenic	JJ	O
marker	NN	O
haplotypes	NNS	O
were	VBD	O
seen	VBN	O
in	IN	O
one	CD	O
family	NN	O
,	,	O
similar	JJ	O
intragenic	JJ	O
haplotyping	NN	O
suggests	VBZ	O
the	DT	O
same	JJ	O
mutation	NN	O
founder	NN	O
for	IN	O
this	DT	O
family	NN	O
with	IN	O
the	DT	O
differences	NNS	O
explicable	JJ	O
by	IN	O
two	CD	O
recombination	NN	O
events	NNS	O
.	.	O
.	.	O

Synergistic	JJ	O
effect	NN	O
of	IN	O
histone	NN	O
hyperacetylation	NN	O
and	CC	O
DNA	NNP	O
demethylation	NN	O
in	IN	O
the	DT	O
reactivation	NN	O
of	IN	O
the	DT	O
FMR1	NNP	O
gene	NN	O
.	.	O

Most	JJS	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
patients	NNS	O
have	VBP	O
expansion	NN	O
of	IN	O
a	DT	O
(	(	O
CGG	NNP	O
)	)	O
(	(	O
n	JJ	O
)	)	O
sequence	NN	O
with	IN	O
>	JJ	O
200	CD	O
repeats	NNS	O
(	(	O
full	JJ	O
mutation	NN	O
)	)	O
in	IN	O
the	DT	O
FMR1	NNP	O
gene	NN	O
responsible	JJ	O
for	IN	O
this	DT	O
condition	NN	O
.	.	O

Hypermethylation	NN	O
of	IN	O
the	DT	O
expanded	VBN	O
repeat	NN	O
and	CC	O
of	IN	O
the	DT	O
FMR1	NNP	O
promoter	NN	O
is	VBZ	O
almost	RB	O
always	RB	O
present	JJ	O
and	CC	O
apparently	RB	O
suppresses	VBZ	O
transcription	NN	O
,	,	O
resulting	VBG	O
in	IN	O
absence	NN	O
of	IN	O
the	DT	O
FMR1	NNP	O
protein	NN	O
.	.	O

We	PRP	O
recently	RB	O
showed	VBD	O
that	IN	O
transcriptional	JJ	O
reactivation	NN	O
of	IN	O
FMR1	NNP	O
full	JJ	O
mutations	NNS	O
can	MD	O
be	VB	O
achieved	VBN	O
by	IN	O
inducing	VBG	O
DNA	NNP	O
demethylation	NN	O
with	IN	O
5	CD	O
-	:	O
azadeoxycytidine	NN	O
(	(	O
5	CD	O
-	:	O
azadC	NN	O
)	)	O
.	.	O

The	DT	O
level	NN	O
of	IN	O
histone	NN	O
acetylation	NN	O
is	VBZ	O
another	DT	O
important	JJ	O
factor	NN	O
in	IN	O
regulating	VBG	O
gene	NN	O
expression	NN	O
;	:	O
therefore	RB	O
,	,	O
we	PRP	O
treated	VBD	O
lymphoblastoid	JJ	O
cell	NN	O
lines	NNS	O
of	IN	O
non	JJ	O
-	:	O
mosaic	NN	O
full	JJ	O
mutation	NN	O
patients	NNS	O
with	IN	O
three	CD	O
drugs	NNS	O
capable	JJ	O
of	IN	O
inducing	VBG	O
histone	NN	O
hyperacetylation	NN	O
.	.	O

We	PRP	O
observed	VBD	O
a	DT	O
consistent	NN	O
,	,	O
although	IN	O
modest	JJ	O
,	,	O
reactivation	NN	O
of	IN	O
the	DT	O
FMR1	NNP	O
gene	NN	O
with	IN	O
4	CD	O
-	:	O
phenylbutyrate	NN	O
,	,	O
sodium	NN	O
butyrate	NN	O
and	CC	O
trichostatin	VB	O
A	NNP	O
,	,	O
as	IN	O
shown	VBN	O
by	IN	O
RT	NNP	O
-	:	O
PCR	NN	O
.	.	O

However	RB	O
,	,	O
we	PRP	O
report	VBP	O
that	IN	O
combining	VBG	O
these	DT	O
drugs	NNS	O
with	IN	O
5	CD	O
-	:	O
azadC	NN	O
results	NNS	O
in	IN	O
a	DT	O
2	CD	O
-	:	O
to	TO	O
5	CD	O
-	:	O
fold	JJ	O
increase	NN	O
in	IN	O
FMR1	NNP	O
mRNA	NN	O
levels	NNS	O
obtained	VBN	O
with	IN	O
5	CD	O
-	:	O
azadC	NN	O
alone	RB	O
,	,	O
thus	RB	O
showing	VBG	O
a	DT	O
marked	JJ	O
synergistic	JJ	O
effect	NN	O
of	IN	O
histone	NN	O
hyperacetylation	NN	O
and	CC	O
DNA	NNP	O
demethylation	NN	O
in	IN	O
the	DT	O
reactivation	NN	O
of	IN	O
FMR1	NNP	O
full	JJ	O
mutations	NNS	O
.	.	O
.	.	O

Constitutional	NNP	O
von	NN	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	E_Disease
(	(	O
VHL	NNP	S_Disease
)	)	O
gene	NN	O
deletions	NNS	O
detected	VBN	O
in	IN	O
VHL	NNP	S_Disease
families	NNS	O
by	IN	O
fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
.	.	O

von	NN	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	I_Disease
(	(	I_Disease
VHL	NNP	I_Disease
)	)	I_Disease
disease	NN	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
dominantly	RB	I_Disease
inherited	VBN	I_Disease
cancer	NN	I_Disease
syndrome	NN	E_Disease
predisposing	VBG	O
to	TO	O
a	DT	O
variety	NN	O
of	IN	O
tumor	NN	S_Disease
types	NNS	O
that	WDT	O
include	VBP	O
retinal	JJ	O
hemangioblastomas	NN	S_Disease
,	,	O
hemangioblastomas	NN	S_Disease
of	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
renal	JJ	B_Disease
cell	NN	I_Disease
carcinomas	NN	E_Disease
,	,	O
pancreatic	JJ	B_Disease
cysts	NNS	I_Disease
and	CC	I_Disease
tumors	NNS	E_Disease
,	,	O
pheochromocytomas	NN	S_Disease
,	,	O
endolymphatic	JJ	B_Disease
sac	NN	I_Disease
tumors	NNS	E_Disease
,	,	O
and	CC	O
epididymal	JJ	B_Disease
cystadenomas	NN	E_Disease
[	NNP	O
W	NNP	O
.	.	O

M	NNP	O
.	.	O

Linehan	NNP	O
et	CC	O
al	NN	O
.	.	O
,	,	O
J	NNP	O
.	.	O

Am	NNP	O
.	.	O

Med	NNP	O
.	.	O

Assoc	NNP	O
.	.	O
,	,	O
273	CD	O
564	CD	O
-	:	O
570	CD	O
,	,	O
1995	CD	O
;	:	O
E	NNP	O
.	.	O

A	DT	O
.	.	O

Maher	NNP	O
and	CC	O
W	NNP	O
.	.	O

G	NNP	O
.	.	O

Kaelin	NNP	O
,	,	O
Jr	NNP	O
.	.	O
,	,	O
Medicine	NNP	O
(	(	O
Baltimore	NNP	O
)	)	O
,	,	O
76	CD	O
381	CD	O
-	:	O
391	CD	O
,	,	O
1997	CD	O
;	:	O
W	NNP	O
.	.	O

M	NNP	O
.	.	O

Linehan	NNP	O
and	CC	O
R	NNP	O
.	.	O

D	NNP	O
.	.	O

Klausner	NNP	O
,	,	O
In	IN	O
B	NNP	O
.	.	O

Vogelstein	NNP	O
and	CC	O
K	NNP	O
.	.	O

Kinzler	NNP	O
(	(	O
eds	NNS	O
.	.	O
)	)	O
,	,	O
The	DT	O
Genetic	JJ	O
Basis	NNP	O
of	IN	O
Human	NNP	O
Cancer	NNP	O
,	,	O
pp	NN	O
.	.	O

455	CD	O
-	:	O
473	CD	O
,	,	O
McGraw	NNP	O
-	:	O
Hill	NNP	O
,	,	O
1998	CD	O
]	NN	O
.	.	O

The	DT	O
VHL	NNP	S_Disease
gene	NN	O
was	VBD	O
localized	VBN	O
to	TO	O
chromosome	VB	O
3p25	CD	O
-	:	O
26	CD	O
and	CC	O
cloned	VBD	O
[	NNP	O
F	NNP	O
.	.	O

Latif	NNP	O
et	CC	O
al	NN	O
.	.	O
,	,	O
Science	NNP	O
(	(	O
Washington	NNP	O
DC	NNP	O
)	)	O
,	,	O
260	CD	O
1317	CD	O
-	:	O
1320	CD	O
,	,	O
1993	CD	O
]	NN	O
.	.	O

Germline	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
VHL	NNP	S_Disease
kindreds	NNS	O
.	.	O

The	DT	O
reported	JJ	O
frequency	NN	O
of	IN	O
detection	NN	O
of	IN	O
VHL	NNP	S_Disease
germline	NN	O
mutations	NNS	O
has	VBZ	O
varied	VBN	O
from	IN	O
39	CD	O
to	TO	O
80	CD	O
%	NN	O
(	(	O
J	NNP	O
.	.	O

M	NNP	O
.	.	O

Whaley	NNP	O
et	CC	O
al	NN	O
.	.	O
,	,	O
Am	NNP	O
.	.	O

J	NNP	O
.	.	O

Hum	NNP	O
.	.	O

Genet	NNP	O
.	.	O
,	,	O
55	CD	O
1092	CD	O
-	:	O
1102	CD	O
,	,	O
1994	CD	O
;	:	O
Clinical	NNP	O
Research	NNP	O
Group	NNP	O
for	IN	O
Japan	NNP	O
,	,	O
Hum	NNP	O
.	.	O

Mol	NNP	O
.	.	O

Genet	NNP	O
.	.	O
,	,	O
4	CD	O
2233	CD	O
-	:	O
2237	CD	O
,	,	O
1995	CD	O
;	:	O
F	NNP	O
.	.	O

Chen	NNP	O
et	CC	O
al	NN	O
.	.	O
,	,	O
Hum	NNP	O
.	.	O

Mutat	NNP	O
.	.	O
,	,	O
5	CD	O
66	CD	O
-	:	O
75	CD	O
,	,	O
1995	CD	O
;	:	O
E	NNP	O
.	.	O

R	NN	O
.	.	O

Maher	NNP	O
et	CC	O
al	NN	O
.	.	O
,	,	O
J	NNP	O
.	.	O

Med	NNP	O
.	.	O

Genet	NNP	O
.	.	O
,	,	O
33	CD	O
328	CD	O
-	:	O
332	CD	O
,	,	O
1996	CD	O
;	:	O
B	NNP	O
.	.	O

Zbar	NNP	O
,	,	O
Cancer	NNP	O
Surv	NNP	O
.	.	O
,	,	O
25	CD	O
219	CD	O
-	:	O
232	CD	O
,	,	O
1995	CD	O
)	)	O
.	.	O

Recently	RB	O
a	DT	O
quantitative	JJ	O
Southern	NNP	O
blotting	NN	O
procedure	NN	O
was	VBD	O
found	VBN	O
to	TO	O
improve	VB	O
this	DT	O
frequency	NN	O
(	(	O
C	NNP	O
.	.	O

Stolle	NNP	O
et	CC	O
al	NN	O
.	.	O
,	,	O
Hum	NNP	O
.	.	O

Mutat	NNP	O
.	.	O
,	,	O
12	CD	O
417	CD	O
-	:	O
423	CD	O
,	,	O
1998	CD	O
)	)	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
use	NN	O
of	IN	O
fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
(	(	O
FISH	NNP	O
)	)	O
as	IN	O
a	DT	O
method	NN	O
to	TO	O
detect	VB	O
and	CC	O
characterize	VB	O
VHL	NNP	S_Disease
germline	JJ	O
deletions	NNS	O
.	.	O

We	PRP	O
reexamined	VBD	O
a	DT	O
group	NN	O
of	IN	O
VHL	NNP	S_Disease
patients	NNS	O
shown	VBN	O
previously	RB	O
by	IN	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
and	CC	O
sequencing	VBG	O
analysis	NN	O
not	RB	O
to	TO	O
harbor	VB	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
VHL	NNP	S_Disease
locus	NN	O
.	.	O

We	PRP	O
found	VBD	O
constitutional	JJ	O
deletions	NNS	O
in	IN	O
29	CD	O
of	IN	O
30	CD	O
VHL	NNP	S_Disease
patients	NNS	O
in	IN	O
this	DT	O
group	NN	O
using	VBG	O
cosmid	NN	O
and	CC	O
P1	NNP	O
probes	VBP	O
that	IN	O
cover	VBP	O
the	DT	O
VHL	NNP	S_Disease
locus	NN	O
.	.	O

We	PRP	O
then	RB	O
tested	VBD	O
six	CD	O
phenotypically	RB	O
normal	JJ	O
offspring	VBG	O
from	IN	O
four	CD	O
of	IN	O
these	DT	O
VHL	NNP	S_Disease
families	NNS	O
two	CD	O
were	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
the	DT	O
deletion	NN	O
and	CC	O
the	DT	O
other	JJ	O
four	CD	O
were	VBD	O
deletion	NN	O
-	:	O
free	JJ	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
germline	JJ	O
mosaicism	NN	O
of	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
one	CD	O
family	NN	O
.	.	O

In	IN	O
sum	NN	O
,	,	O
FISH	NNP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
a	DT	O
simple	JJ	O
and	CC	O
reliable	JJ	O
method	NN	O
to	TO	O
detect	VB	O
VHL	NNP	S_Disease
germline	NN	O
deletions	NNS	O
and	CC	O
practically	RB	O
useful	JJ	O
in	IN	O
cases	NNS	O
where	WRB	O
other	JJ	O
methods	NNS	O
of	IN	O
screening	VBG	O
have	VB	O
failed	VBN	O
to	TO	O
detect	VB	O
a	DT	O
VHL	NNP	B_Disease
gene	NN	I_Disease
abnormality	NN	E_Disease

Spectrum	NNP	O
of	IN	O
hSNF5	NN	O
/	NNP	O
INI1	NNP	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
human	JJ	O
cancer	NN	S_Disease
and	CC	O
genotype	JJ	O
-	:	O
phenotype	NN	O
correlations	NNS	O
.	.	O

The	DT	O
hSNF5	NN	O
/	NNP	O
INI1	NNP	O
gene	NN	O
which	WDT	O
encodes	VBZ	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
SWI	NNP	O
/	NNP	O
SNF	NNP	O
chromatin	NN	O
ATP	NNP	O
-	:	O
dependent	JJ	O
remodeling	VBG	O
complex	JJ	O
,	,	O
is	VBZ	O
a	DT	O
new	JJ	O
tumor	NN	S_Disease
suppressor	NN	O
gene	NN	O
localized	VBN	O
on	IN	O
chromosome	NN	O
22q11	CD	O
.	.	O

2	CD	O
and	CC	O
recently	RB	O
shown	VBN	O
to	TO	O
be	VB	O
mutated	VBN	O
in	IN	O
malignant	JJ	B_Disease
rhabdoid	NN	I_Disease
tumors	NNS	E_Disease
.	.	O

We	PRP	O
have	VBP	O
searched	VBN	O
for	IN	O
hSNF5	NN	O
/	NNP	O
INI1	NNP	O
mutations	NNS	O
in	IN	O
229	CD	O
tumors	NNS	S_Disease
of	IN	O
various	JJ	O
origins	NNS	O
using	VBG	O
a	DT	O
screening	NN	O
method	NN	O
based	VBN	O
on	IN	O
denaturing	VBG	O
high	JJ	O
-	:	O
performance	NN	O
liquid	NN	O
chromatography	NN	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
31	CD	O
homozygous	JJ	O
deletions	NNS	O
and	CC	O
36	CD	O
point	NN	O
alterations	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

Point	NN	O
mutations	NNS	O
were	VBD	O
scattered	VBN	O
along	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
and	CC	O
included	VBD	O
15	CD	O
nonsense	NN	O
,	,	O
15	CD	O
frameshift	NN	O
,	,	O
three	CD	O
splice	NN	O
site	NN	O
,	,	O
two	CD	O
missense	NN	O
and	CC	O
one	CD	O
editing	NN	O
mutations	NNS	O
.	.	O

Mutations	NNS	O
were	VBD	O
retrieved	VBN	O
in	IN	O
most	JJS	O
rhabdoid	JJ	B_Disease
tumors	NNS	E_Disease
,	,	O
whatever	WDT	O
their	PRP$	O
sites	NNS	O
of	IN	O
occurrence	NN	O
,	,	O
indicating	VBG	O
the	DT	O
common	JJ	O
pathogenetic	JJ	O
origin	NN	O
of	IN	O
these	DT	O
tumors	NNS	S_Disease
.	.	O

Recurrent	NNP	O
hSNF5	NN	O
/	NNP	O
INI1	NNP	O
alterations	NNS	O
were	VBD	O
also	RB	O
observed	VBN	O
in	IN	O
choroid	JJ	B_Disease
plexus	NN	I_Disease
carcinomas	NN	E_Disease
and	CC	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
central	JJ	O
primitive	JJ	O
neuroectodermal	JJ	B_Disease
tumors	NNS	E_Disease
(	(	O
cPNETs	NN	O
)	)	O
and	CC	O
medulloblastomas	$	S_Disease
.	.	O

In	IN	O
contrast	NN	O
,	,	O
hSNF5	VBP	O
/	JJ	O
INI1	NNP	O
point	NN	O
mutations	NNS	O
were	VBD	O
not	RB	O
detected	VBN	O
in	IN	O
breast	NN	B_Disease
cancers	NNS	E_Disease
,	,	O
Wilms	NNP	B_Disease
tumors	NNS	E_Disease
,	,	O
gliomas	NN	S_Disease
,	,	O
ependymomas	NN	S_Disease
,	,	O
sarcomas	NN	S_Disease
and	CC	O
other	JJ	O
tumor	NN	S_Disease
types	NNS	O
,	,	O
even	RB	O
though	IN	O
most	JJS	O
analyzed	JJ	O
cases	NNS	O
harbored	VBD	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
at	IN	O
22q11	CD	O
.	.	O

2	CD	O
loci	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
rhabdoid	NN	B_Disease
tumors	NNS	E_Disease
,	,	O
choroid	JJ	B_Disease
plexus	NN	I_Disease
carcinomas	NN	E_Disease
and	CC	O
a	DT	O
subset	NN	O
of	IN	O
medulloblastomas	NN	S_Disease
and	CC	O
cPNETs	NN	O
share	NN	O
common	JJ	O
pathways	NNS	O
of	IN	O
oncogenesis	NN	O
related	VBN	O
to	TO	O
hSNF5	VB	O
/	NNP	O
INI1	NNP	O
alteration	NN	O
and	CC	O
that	IN	O
hSNF5	JJ	O
/	NNP	O
INI1	NNP	O
mutations	NNS	O
define	VBP	O
a	DT	O
genetically	RB	O
homogeneous	JJ	O
family	NN	O
of	IN	O
highly	RB	O
aggressive	JJ	O
cancers	NNS	S_Disease
mainly	RB	O
occurring	VBG	O
in	IN	O
young	JJ	O
children	NNS	O
and	CC	O
frequently	RB	O
,	,	O
but	CC	O
not	RB	O
always	RB	O
,	,	O
exhibiting	VBG	O
a	DT	O
rhabdoid	NN	S_Disease
phenotype	NN	O

Ataxin	NNP	O
-	:	O
3	CD	O
with	IN	O
an	DT	O
altered	JJ	O
conformation	NN	O
that	WDT	O
exposes	VBZ	O
the	DT	O
polyglutamine	NN	O
domain	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
the	DT	O
nuclear	JJ	O
matrix	NN	O
.	.	O

Spinocerebellar	JJ	B_Disease
ataxia	NN	I_Disease
type	NN	I_Disease
-	:	I_Disease
3	CD	E_Disease
or	CC	O
Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
(	(	O
SCA3	NNP	S_Disease
/	NNP	O
MJD	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
CAG	NNP	B_Disease
/	NNP	I_Disease
polyglutamine	NN	I_Disease
repeat	NN	I_Disease
disease	NN	E_Disease
family	NN	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
of	IN	O
disorders	NNS	O
,	,	O
a	DT	O
normally	RB	O
polymorphic	JJ	O
CAG	NNP	O
repeat	NN	O
becomes	NNS	O
expanded	VBD	O
,	,	O
resulting	VBG	O
in	IN	O
expression	NN	O
of	IN	O
an	DT	O
expanded	JJ	O
polyglutamine	NN	O
domain	NN	O
in	IN	O
the	DT	O
disease	NN	O
gene	NN	O
product	NN	O
.	.	O

Experimental	JJ	O
models	NNS	O
of	IN	O
polyglutamine	JJ	B_Disease
disease	NN	E_Disease
implicate	VB	O
the	DT	O
nucleus	NN	O
in	IN	O
pathogenesis	NN	O
;	:	O
however	RB	O
,	,	O
the	DT	O
link	NN	O
between	IN	O
intranuclear	JJ	O
expression	NN	O
of	IN	O
expanded	JJ	O
polyglutamine	NN	O
and	CC	O
neuronal	JJ	B_Disease
dysfunction	NN	E_Disease
remains	VBZ	O
unclear	JJ	O
.	.	O

Here	RB	O
we	PRP	O
demonstrate	VBP	O
that	IN	O
ataxin	NN	O
-	:	O
3	CD	O
,	,	O
the	DT	O
disease	NN	O
protein	NN	O
in	IN	O
SCA3	NNP	S_Disease
/	NNP	O
MJD	NNP	S_Disease
,	,	O
adopts	VBZ	O
a	DT	O
unique	JJ	O
conformation	NN	O
when	WRB	O
expressed	VBN	O
within	IN	O
the	DT	O
nucleus	NN	O
of	IN	O
transfected	JJ	O
cells	NNS	O
.	.	O

The	DT	O
monoclonal	JJ	O
antibody	NN	O
1C2	CD	O
is	VBZ	O
known	VBN	O
preferentially	RB	O
to	TO	O
bind	VB	O
expanded	JJ	O
polyglutamine	NN	O
,	,	O
but	CC	O
we	PRP	O
find	VBP	O
that	IN	O
it	PRP	O
also	RB	O
binds	VBZ	O
a	DT	O
fragment	NN	O
of	IN	O
ataxin	NN	O
-	:	O
3	CD	O
containing	VBG	O
a	DT	O
normal	JJ	O
glutamine	NN	O
repeat	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
expression	NN	O
of	IN	O
ataxin	NN	O
-	:	O
3	CD	O
within	IN	O
the	DT	O
nucleus	JJ	O
exposes	VBZ	O
the	DT	O
glutamine	NN	O
domain	NN	O
of	IN	O
the	DT	O
full	JJ	O
-	:	O
length	NN	O
non	SYM	O
-	:	O
pathological	JJ	O
protein	NN	O
,	,	O
allowing	VBG	O
it	PRP	O
to	TO	O
bind	VB	O
the	DT	O
monoclonal	JJ	O
antibody	NN	O
1C2	CD	O
.	.	O

Fractionation	NN	O
and	CC	O
immunochemical	JJ	O
experiments	NNS	O
indicate	VBP	O
that	IN	O
this	DT	O
novel	JJ	O
conformation	NN	O
of	IN	O
intranuclear	JJ	O
ataxin	NN	O
-	:	O
3	CD	O
is	VBZ	O
not	RB	O
due	JJ	O
to	TO	O
proteolysis	VB	O
,	,	O
suggesting	VBG	O
instead	RB	O
that	IN	O
association	NN	O
with	IN	O
nuclear	JJ	O
protein	NN	O
(	(	O
s	PRP	O
)	)	O
alters	VBZ	O
the	DT	O
structure	NN	O
of	IN	O
full	JJ	O
-	:	O
length	NN	O
ataxin	NN	O
-	:	O
3	CD	O
which	WDT	O
exposes	VBZ	O
the	DT	O
polyglutamine	NN	O
domain	NN	O
.	.	O

This	DT	O
conformationally	RB	O
altered	VBN	O
ataxin	NN	O
-	:	O
3	CD	O
is	VBZ	O
bound	VBN	O
to	TO	O
the	DT	O
nuclear	JJ	O
matrix	NN	O
.	.	O

The	DT	O
pathological	JJ	O
form	NN	O
of	IN	O
ataxin	NN	O
-	:	O
3	CD	O
with	IN	O
an	DT	O
expanded	VBN	O
polyglutamine	NN	O
domain	NN	O
also	RB	O
associates	VBZ	O
with	IN	O
the	DT	O
nuclear	JJ	O
matrix	NN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
an	DT	O
early	JJ	O
event	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
SCA3	NNP	S_Disease
/	NNP	O
MJD	NNP	S_Disease
may	MD	O
be	VB	O
an	DT	O
altered	JJ	O
conformation	NN	O
of	IN	O
ataxin	NN	O
-	:	O
3	CD	O
within	IN	O
the	DT	O
nucleus	NN	O
that	WDT	O
exposes	VBZ	O
the	DT	O
polyglutamine	NN	O
domain	NN	O
.	.	O
.	.	O

The	DT	O
human	JJ	O
MAGEL2	NNP	O
gene	NN	O
and	CC	O
its	PRP$	O
mouse	NN	O
homologue	NN	O
are	VBP	O
paternally	RB	O
expressed	VBN	O
and	CC	O
mapped	VBN	O
to	TO	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	JJ	E_Disease
region	NN	O
.	.	O

Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
complex	JJ	O
neurogenetic	JJ	B_Disease
disorder	NN	E_Disease
.	.	O

The	DT	O
phenotype	NN	O
is	VBZ	O
likely	JJ	O
to	TO	O
be	VB	O
a	DT	O
contiguous	JJ	B_Disease
gene	NN	I_Disease
syndrome	NN	E_Disease
involving	VBG	O
genes	NNS	O
which	WDT	O
are	VBP	O
paternally	RB	O
expressed	VBN	O
only	RB	O
,	,	O
located	VBN	O
in	IN	O
the	DT	O
human	JJ	O
15q11	CD	O
-	:	O
q13	JJ	O
region	NN	O
.	.	O

Four	CD	O
mouse	NN	O
models	NNS	O
of	IN	O
PWS	NNP	S_Disease
have	VBP	O
been	VBN	O
reported	VBN	O
but	CC	O
these	DT	O
do	VBP	O
not	RB	O
definitively	RB	O
allow	VB	O
the	DT	O
delineation	NN	O
of	IN	O
the	DT	O
critical	JJ	O
region	NN	O
and	CC	O
the	DT	O
associated	VBN	O
genes	NNS	O
involved	VBN	O
in	IN	O
the	DT	O
aetiology	NN	O
of	IN	O
PWS	NNP	S_Disease
.	.	O

Moreover	RB	O
,	,	O
targeted	VBD	O
mutagenesis	NN	O
of	IN	O
mouse	NN	O
homologues	NNS	O
of	IN	O
the	DT	O
human	JJ	O
candidate	NN	O
PWS	NNP	S_Disease
genes	NNS	O
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
result	VB	O
in	IN	O
any	DT	O
of	IN	O
the	DT	O
features	NNS	O
of	IN	O
PWS	NNP	S_Disease
.	.	O

Therefore	RB	O
,	,	O
the	DT	O
isolation	NN	O
of	IN	O
new	JJ	O
genes	NNS	O
in	IN	O
this	DT	O
region	NN	O
remains	VBZ	O
crucial	JJ	O
for	IN	O
a	DT	O
better	JJR	O
understanding	NN	O
of	IN	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
PWS	NNP	S_Disease
.	.	O

In	IN	O
this	DT	O
manuscript	NN	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
characterization	NN	O
of	IN	O
MAGEL2	NNP	O
and	CC	O
its	PRP$	O
mouse	NN	O
homologue	NN	O
Magel2	NNP	O
.	.	O

These	DT	O
are	VBP	O
located	VBN	O
in	IN	O
the	DT	O
human	JJ	O
15q11	CD	O
-	:	O
q13	NN	O
and	CC	O
mouse	NN	O
7C	CD	O
regions	NNS	O
,	,	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
NDN	NNP	O
/	NNP	O
Ndn	NNP	O
.	.	O

By	IN	O
northern	JJ	O
blot	NN	O
analysis	NN	O
we	PRP	O
did	VBD	O
not	RB	O
detect	VB	O
any	DT	O
expression	NN	O
of	IN	O
MAGEL2	NNP	O
/	NNP	O
Magel2	NNP	O
but	CC	O
by	IN	O
RT	NNP	O
-	:	O
PCR	NN	O
analysis	NN	O
,	,	O
specific	JJ	O
expression	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
fetal	JJ	O
and	CC	O
adult	NN	O
brain	NN	O
and	CC	O
in	IN	O
placenta	NN	O
.	.	O

Both	DT	O
genes	NNS	O
are	VBP	O
intronless	JJ	O
with	IN	O
tandem	JJ	O
direct	JJ	O
repeat	NN	O
sequences	NNS	O
contained	VBD	O
within	IN	O
a	DT	O
CpG	NNP	O
island	NN	O
in	IN	O
the	DT	O
5	CD	O
-	:	O
untranscribed	JJ	O
region	NN	O
.	.	O

The	DT	O
transcripts	NNS	O
encode	VBP	O
putative	JJ	O
proteins	NNS	O
that	WDT	O
are	VBP	O
homologous	JJ	O
to	TO	O
the	DT	O
MAGE	NNP	O
proteins	NNS	O
and	CC	O
NDN	NNP	O
.	.	O

Moreover	RB	O
,	,	O
MAGEL2	NNP	O
/	NNP	O
Magel2	NNP	O
are	VBP	O
expressed	VBN	O
only	RB	O
from	IN	O
the	DT	O
paternal	JJ	O
allele	NN	O
in	IN	O
brain	NN	O
,	,	O
suggesting	VBG	O
a	DT	O
potential	JJ	O
role	NN	O
in	IN	O
the	DT	O
aetiology	NN	O
of	IN	O
PWS	NNP	S_Disease
and	CC	O
its	PRP$	O
mouse	NN	O
model	NN	O
,	,	O
respectively	RB	O
.	.	O
.	.	O

cDNA	NN	O
microarrays	NNS	O
detect	VBP	O
activation	NN	O
of	IN	O
a	DT	O
myogenic	JJ	O
transcription	NN	O
program	NN	O
by	IN	O
the	DT	O
PAX3	NNP	O
-	:	O
FKHR	NNP	O
fusion	NN	O
oncogene	NN	O
.	.	O

Alveolar	JJ	B_Disease
rhabdomyosarcoma	NN	E_Disease
is	VBZ	O
an	DT	O
aggressive	JJ	O
pediatric	JJ	B_Disease
cancer	NN	I_Disease
of	IN	I_Disease
striated	JJ	I_Disease
muscle	NN	E_Disease
characterized	VBN	O
in	IN	O
60	CD	O
%	NN	O
of	IN	O
cases	NNS	O
by	IN	O
a	DT	O
t	NN	O
(	(	O
2	CD	O
;	:	O
13	CD	O
)	)	O
(	(	O
q35	NN	O
;	:	O
q14	NN	O
)	)	O
.	.	O

This	DT	O
results	NNS	O
in	IN	O
the	DT	O
fusion	NN	O
of	IN	O
PAX3	NNP	O
,	,	O
a	DT	O
developmental	JJ	O
transcription	NN	O
factor	NN	O
required	VBN	O
for	IN	O
limb	JJ	O
myogenesis	NN	O
,	,	O
with	IN	O
FKHR	NNP	O
,	,	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
forkhead	JJ	O
family	NN	O
of	IN	O
transcription	NN	O
factors	NNS	O
.	.	O

The	DT	O
resultant	NN	O
PAX3	NNP	O
-	:	O
FKHR	NNP	O
gene	NN	O
possesses	NNS	O
transforming	VBG	O
properties	NNS	O
;	:	O
however	RB	O
,	,	O
the	DT	O
effects	NNS	O
of	IN	O
this	DT	O
chimeric	JJ	O
oncogene	NN	O
on	IN	O
gene	NN	O
expression	NN	O
are	VBP	O
largely	RB	O
unknown	JJ	O
.	.	O

To	TO	O
investigate	VB	O
the	DT	O
actions	NNS	O
of	IN	O
these	DT	O
transcription	NN	O
factors	NNS	O
,	,	O
both	DT	O
Pax3	NNP	O
and	CC	O
PAX3	NNP	O
-	:	O
FKHR	NN	O
were	VBD	O
introduced	VBN	O
into	IN	O
NIH	NNP	O
3T3	CD	O
cells	NNS	O
,	,	O
and	CC	O
the	DT	O
resultant	JJ	O
gene	NN	O
expression	NN	O
changes	NNS	O
were	VBD	O
analyzed	VBN	O
with	IN	O
a	DT	O
murine	NN	O
cDNA	NN	O
microarray	NN	O
containing	VBG	O
2	CD	O
,	,	O
225	CD	O
elements	NNS	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
PAX3	NNP	O
-	:	O
FKHR	NN	O
but	CC	O
not	RB	O
PAX3	NNP	O
activated	VBD	O
a	DT	O
myogenic	JJ	O
transcription	NN	O
program	NN	O
including	VBG	O
the	DT	O
induction	NN	O
of	IN	O
transcription	NN	O
factors	NNS	O
MyoD	NNP	O
,	,	O
Myogenin	NNP	O
,	,	O
Six1	NNP	O
,	,	O
and	CC	O
Slug	NNP	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
battery	NN	O
of	IN	O
genes	NNS	O
involved	VBN	O
in	IN	O
several	JJ	O
aspects	NNS	O
of	IN	O
muscle	NN	O
function	NN	O
.	.	O

Notable	JJ	O
among	IN	O
this	DT	O
group	NN	O
were	VBD	O
the	DT	O
growth	NN	O
factor	NN	O
gene	NN	O
Igf2	NNP	O
and	CC	O
its	PRP$	O
binding	NN	O
protein	NN	O
Igfbp5	NNP	O
.	.	O

Relevance	NN	O
of	IN	O
this	DT	O
model	NN	O
was	VBD	O
suggested	VBN	O
by	IN	O
verification	NN	O
that	IN	O
three	CD	O
of	IN	O
these	DT	O
genes	NNS	O
(	(	O
IGFBP5	NNP	O
,	,	O
HSIX1	NNP	O
,	,	O
and	CC	O
Slug	NNP	O
)	)	O
were	VBD	O
also	RB	O
expressed	VBN	O
in	IN	O
alveolar	JJ	B_Disease
rhabdomyosarcoma	NN	E_Disease
cell	NN	O
lines	NNS	O
.	.	O

This	DT	O
study	NN	O
utilizes	VBZ	O
cDNA	NN	O
microarrays	NNS	O
to	TO	O
elucidate	VB	O
the	DT	O
pattern	NN	O
of	IN	O
gene	NN	O
expression	NN	O
induced	VBN	O
by	IN	O
an	DT	O
oncogenic	JJ	O
transcription	NN	O
factor	NN	O
and	CC	O
demonstrates	VBZ	O
the	DT	O
profound	NN	O
myogenic	JJ	O
properties	NNS	O
of	IN	O
PAX3	NNP	O
-	:	O
FKHR	NN	O
in	IN	O
NIH	NNP	O
3T3	CD	O
cells	NNS	O
.	.	O
.	.	O

Experimental	JJ	O
hemochromatosis	NN	S_Disease
due	JJ	O
to	TO	O
MHC	NNP	O
class	NN	O
I	PRP	O
HFE	VBP	B_Disease
deficiency	NN	E_Disease
:	:	O
immune	JJ	O
status	NN	O
and	CC	O
iron	NN	O
metabolism	NN	O
.	.	O

The	DT	O
puzzling	VBG	O
linkage	NN	O
between	IN	O
genetic	JJ	O
hemochromatosis	NN	S_Disease
and	CC	O
histocompatibility	NN	O
loci	NN	O
became	VBD	O
even	RB	O
more	RBR	O
so	RB	O
when	WRB	O
the	DT	O
gene	NN	O
involved	VBN	O
,	,	O
HFE	NNP	O
,	,	O
was	VBD	O
identified	VBN	O
.	.	O

Indeed	RB	O
,	,	O
within	IN	O
the	DT	O
well	NN	O
defined	VBN	O
,	,	O
mainly	RB	O
peptide	IN	O
-	:	O
binding	NN	O
,	,	O
MHC	NNP	O
class	NN	O
I	PRP	O
family	NN	O
of	IN	O
molecules	NNS	O
,	,	O
HFE	NNP	O
seems	VBZ	O
to	TO	O
perform	VB	O
an	DT	O
unusual	JJ	O
yet	RB	O
essential	JJ	O
function	NN	O
.	.	O

As	IN	O
yet	RB	O
,	,	O
our	PRP$	O
understanding	NN	O
of	IN	O
HFE	NNP	O
function	NN	O
in	IN	O
iron	NN	O
homeostasis	NN	O
is	VBZ	O
only	RB	O
partial	JJ	O
;	:	O
an	DT	O
even	RB	O
more	RBR	O
open	JJ	O
question	NN	O
is	VBZ	O
its	PRP$	O
possible	JJ	O
role	NN	O
in	IN	O
the	DT	O
immune	NN	O
system	NN	O
.	.	O

To	TO	O
advance	VB	O
on	IN	O
both	DT	O
of	IN	O
these	DT	O
avenues	NNS	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
deletion	NN	O
of	IN	O
HFE	NNP	O
alpha1	NN	O
and	CC	O
alpha2	JJ	O
putative	JJ	O
ligand	NN	O
binding	VBG	O
domains	NNS	O
in	IN	O
vivo	NN	O
.	.	O

HFE	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
animals	NNS	O
were	VBD	O
analyzed	VBN	O
for	IN	O
a	DT	O
comprehensive	JJ	O
set	NN	O
of	IN	O
metabolic	JJ	O
and	CC	O
immune	JJ	O
parameters	NNS	O
.	.	O

Faithfully	RB	O
mimicking	VBG	O
human	JJ	O
hemochromatosis	NN	S_Disease
,	,	O
mice	RB	O
homozygous	JJ	O
for	IN	O
this	DT	O
deletion	NN	O
develop	VB	O
iron	NN	O
overload	NN	O
,	,	O
characterized	VBN	O
by	IN	O
a	DT	O
higher	JJR	O
plasma	NN	O
iron	NN	O
content	NN	O
and	CC	O
a	DT	O
raised	VBN	O
transferrin	NN	O
saturation	NN	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
elevated	JJ	O
hepatic	JJ	O
iron	NN	O
load	NN	O
.	.	O

The	DT	O
primary	JJ	O
defect	NN	O
could	MD	O
,	,	O
indeed	RB	O
,	,	O
be	VB	O
traced	VBN	O
to	TO	O
an	DT	O
augmented	VBN	O
duodenal	JJ	O
iron	NN	O
absorption	NN	O
.	.	O

In	IN	O
parallel	NN	O
,	,	O
measurement	NN	O
of	IN	O
the	DT	O
gut	NN	O
mucosal	NN	O
iron	NN	O
content	NN	O
as	RB	O
well	RB	O
as	IN	O
iron	NN	O
regulatory	JJ	O
proteins	NNS	O
allows	VBZ	O
a	DT	O
more	RBR	O
informed	JJ	O
evaluation	NN	O
of	IN	O
various	JJ	O
hypotheses	NNS	O
regarding	VBG	O
the	DT	O
precise	JJ	O
role	NN	O
of	IN	O
HFE	NNP	O
in	IN	O
iron	NN	O
homeostasis	NN	O
.	.	O

Finally	RB	O
,	,	O
an	DT	O
extensive	JJ	O
phenotyping	NN	O
of	IN	O
primary	JJ	O
and	CC	O
secondary	JJ	O
lymphoid	NNS	O
organs	NNS	O
including	VBG	O
the	DT	O
gut	NN	O
provides	VBZ	O
no	DT	O
compelling	JJ	O
evidence	NN	O
for	IN	O
an	DT	O
obvious	JJ	O
immune	NN	O
-	:	O
linked	VBN	O
function	NN	O
for	IN	O
HFE	NNP	O
.	.	O
.	.	O

Somatic	JJ	O
rearrangement	NN	O
of	IN	O
chromosome	NN	O
14	CD	O
in	IN	O
human	JJ	O
lymphocytes	NNS	O
.	.	O

Ataxia	NNP	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
genetic	JJ	B_Disease
disorder	NN	E_Disease
associated	VBN	O
with	IN	O
immune	JJ	B_Disease
deficiency	NN	E_Disease
,	,	O
chromosome	NN	B_Disease
instability	NN	E_Disease
,	,	O
and	CC	O
a	DT	O
predisposition	NN	O
to	TO	O
lymphoid	VB	B_Disease
malignancy	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
detected	VBN	O
chromosomally	RB	O
anomalous	JJ	O
clones	NNS	O
of	IN	O
lymphocytes	NNS	O
in	IN	O
eight	CD	O
patients	NNS	O
with	IN	O
this	DT	O
disorder	NN	O
.	.	O

Chromosome	NNP	O
banding	NN	O
disclosed	VBD	O
that	IN	O
the	DT	O
clones	NNS	O
are	VBP	O
consistently	RB	O
marked	VBN	O
by	IN	O
structural	JJ	O
rearrangement	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
(	(	O
q	NN	O
)	)	O
of	IN	O
chromosome	NN	O
14	CD	O
.	.	O

A	DT	O
translocation	NN	O
involving	VBG	O
14q	CD	O
was	VBD	O
found	VBN	O
in	IN	O
clones	NNS	O
obtained	VBN	O
from	IN	O
seven	CD	O
of	IN	O
the	DT	O
eight	CD	O
patients	NNS	O
whereas	IN	O
a	DT	O
ring	NN	O
14	CD	O
chromosome	NN	O
was	VBD	O
found	VBN	O
in	IN	O
a	DT	O
clone	NN	O
obtained	VBN	O
from	IN	O
the	DT	O
other	JJ	O
.	.	O

These	DT	O
findings	NNS	O
as	RB	O
well	RB	O
as	IN	O
data	NNS	O
obtained	VBN	O
by	IN	O
others	NNS	O
for	IN	O
patients	NNS	O
with	IN	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
suggest	VBP	O
that	IN	O
structural	JJ	O
rearrangement	NN	O
of	IN	O
14q	CD	O
is	VBZ	O
the	DT	O
initial	JJ	O
chromosomal	JJ	O
change	NN	O
in	IN	O
lymphocyte	JJ	O
clones	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
this	DT	O
disorder	NN	O
.	.	O

Chromosomes	NNS	O
of	IN	O
lymphocytes	NNS	O
from	IN	O
one	CD	O
of	IN	O
the	DT	O
patients	NNS	O
were	VBD	O
studied	VBN	O
before	IN	O
and	CC	O
after	IN	O
the	DT	O
onset	NN	O
of	IN	O
chronic	JJ	B_Disease
lymphocytic	JJ	I_Disease
leukemia	NN	E_Disease
.	.	O

Before	IN	O
leukemia	NN	S_Disease
was	VBD	O
diagnosed	VBN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
lymphocyte	JJ	O
clone	NN	O
with	IN	O
a	DT	O
14q	CD	O
translocation	NN	O
.	.	O

This	DT	O
clone	NN	O
appears	VBZ	O
to	TO	O
have	VB	O
given	VBN	O
rise	NN	O
to	TO	O
the	DT	O
leukemic	JJ	S_Disease
cells	NNS	O
.	.	O

We	PRP	O
hypothesize	VBP	O
that	IN	O
structural	JJ	O
rearrangement	NN	O
of	IN	O
14q	CD	O
is	VBZ	O
directly	RB	O
related	VBN	O
to	TO	O
abnormal	JJ	O
growth	NN	O
of	IN	O
lymphocytes	NNS	O
and	CC	O
that	IN	O
it	PRP	O
may	MD	O
be	VB	O
a	DT	O
step	NN	O
toward	IN	O
the	DT	O
development	NN	O
of	IN	O
lymphoid	JJ	B_Disease
malignancies	NNS	E_Disease
.	.	O

Increasing	VBG	O
evidence	NN	O
,	,	O
provided	VBN	O
by	IN	O
others	NNS	O
,	,	O
for	IN	O
the	DT	O
nonrandom	JJ	O
involvement	NN	O
of	IN	O
14q	CD	O
in	IN	O
African	JJ	O
-	:	O
type	NN	O
Burkitts	NNP	B_Disease
lymphoma	NN	E_Disease
and	CC	O
other	JJ	O
lymphoid	JJ	B_Disease
neoplasms	NNS	E_Disease
further	RB	O
strengthens	VBZ	O
this	DT	O
hypothesis	NN	O
.	.	O
.	.	O

Exon	NNP	O
9	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
WT1	NNP	O
gene	NN	O
,	,	O
without	IN	O
influencing	VBG	O
KTS	NNP	O
splice	NN	O
isoforms	NNS	O
,	,	O
are	VBP	O
also	RB	O
responsible	JJ	O
for	IN	O
Frasier	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O

We	PRP	O
report	VBP	O
new	JJ	O
mutations	NNS	O
in	IN	O
exon	JJ	O
9	CD	O
of	IN	O
the	DT	O
WT1	NNP	O
gene	NN	O
that	WDT	O
did	VBD	O
not	RB	O
alter	VB	O
the	DT	O
ratio	NN	O
of	IN	O
+	NNP	O
/	NNP	O
-	:	O
KTS	NNP	O
splice	NN	O
isoforms	NNS	O
in	IN	O
two	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
Frasier	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
FS	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
mutation	NN	O
of	IN	O
intron	NN	O
9	CD	O
inducing	VBG	O
defective	JJ	O
alternative	JJ	O
splicing	NN	O
was	VBD	O
reported	VBN	O
to	TO	O
be	VB	O
responsible	JJ	O
for	IN	O
this	DT	O
syndrome	NN	O
.	.	O

The	DT	O
mutations	NNS	O
found	VBN	O
in	IN	O
our	PRP$	O
cases	NNS	O
occurred	VBD	O
in	IN	O
the	DT	O
same	JJ	O
exon	NN	O
of	IN	O
the	DT	O
WT1	NNP	O
gene	NN	O
as	IN	O
detected	VBN	O
in	IN	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
DDS	NNP	S_Disease
)	)	O
and	CC	O
could	MD	O
not	RB	O
be	VB	O
explained	VBN	O
by	IN	O
the	DT	O
previously	RB	O
proposed	VBN	O
mechanism	NN	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
two	CD	O
syndromes	NNS	O
originate	VBP	O
from	IN	O
the	DT	O
same	JJ	O
WT1	NNP	B_Disease
gene	NN	I_Disease
abnormality	NN	E_Disease
.	.	O

From	IN	O
a	DT	O
molecular	JJ	O
biological	JJ	O
point	NN	O
of	IN	O
view	NN	O
,	,	O
we	PRP	O
concluded	VBD	O
that	IN	O
the	DT	O
two	CD	O
diseases	NNS	O
were	VBD	O
not	RB	O
separable	JJ	O
,	,	O
and	CC	O
that	IN	O
FS	NNP	S_Disease
should	MD	O
be	VB	O
included	VBN	O
as	IN	O
an	DT	O
atypical	JJ	O
form	NN	O
of	IN	O
DDS	NNP	S_Disease
.	.	O
.	.	O

Splice	NNP	O
-	:	O
site	NN	O
mutation	NN	O
in	IN	O
the	DT	O
PDS	NNP	S_Disease
gene	NN	O
may	MD	O
result	VB	O
in	IN	O
intrafamilial	JJ	O
variability	NN	O
for	IN	O
deafness	NN	S_Disease
in	IN	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O

Pendred	NNP	B_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
recessive	JJ	B_Disease
inherited	JJ	I_Disease
disorder	NN	E_Disease
that	IN	O
consists	VBZ	O
of	IN	O
developmental	JJ	B_Disease
abnormalities	NNS	I_Disease
of	IN	I_Disease
the	DT	I_Disease
cochlea	NN	E_Disease
,	,	O
sensorineural	JJ	B_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
,	,	O
and	CC	O
diffuse	VB	B_Disease
thyroid	JJ	I_Disease
enlargement	NN	E_Disease
(	(	O
goiter	NN	S_Disease
)	)	O
.	.	O

This	DT	O
disorder	NN	O
may	MD	O
account	VB	O
for	IN	O
up	RB	O
to	TO	O
10	CD	O
%	NN	O
of	IN	O
cases	NNS	O
of	IN	O
hereditary	JJ	B_Disease
deafness	NN	E_Disease
.	.	O

The	DT	O
disease	NN	O
gene	NN	O
(	(	O
PDS	NNP	S_Disease
)	)	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
chromosome	VB	O
7q22	CD	O
-	:	O
q31	NN	O
,	,	O
and	CC	O
encodes	VBZ	O
a	DT	O
chloride	JJ	O
-	:	O
iodide	NN	O
transport	NN	O
protein	NN	O
.	.	O

We	PRP	O
performed	VBD	O
mutation	NN	O
analysis	NN	O
of	IN	O
individual	JJ	O
exons	NNS	O
of	IN	O
the	DT	O
PDS	NNP	S_Disease
gene	NN	O
in	IN	O
one	CD	O
Spanish	JJ	O
family	NN	O
that	WDT	O
shows	VBZ	O
intrafamilial	JJ	O
variability	NN	O
of	IN	O
the	DT	O
deafness	NN	S_Disease
phenotype	NN	O
(	(	O
two	CD	O
patients	NNS	O
with	IN	O
profound	NN	O
and	CC	O
one	CD	O
with	IN	O
moderate	JJ	O
-	:	O
severe	JJ	O
deafness	NN	S_Disease
)	)	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
new	JJ	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
affecting	VBG	O
intron	JJ	O
4	CD	O
of	IN	O
the	DT	O
PDS	NNP	S_Disease
gene	NN	O
,	,	O
at	IN	O
nucleotide	JJ	O
position	NN	O
639	CD	O
+	JJ	O
7	CD	O
.	.	O

RNA	JJ	O
analysis	NN	O
from	IN	O
lymphocytes	NNS	O
of	IN	O
the	DT	O
affected	JJ	O
patients	NNS	O
showed	VBD	O
that	IN	O
mutation	NN	O
639	CD	O
+	NN	O
7A	CD	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
generates	VBZ	O
a	DT	O
new	JJ	O
donor	NN	O
splice	NN	O
site	NN	O
,	,	O
leading	VBG	O
to	TO	O
an	DT	O
mRNA	NN	O
with	IN	O
an	DT	O
insertion	NN	O
of	IN	O
six	CD	O
nucleotides	NNS	O
from	IN	O
intron	NN	O
4	CD	O
of	IN	O
PDS	NNP	O
.	.	O

Since	IN	O
the	DT	O
newly	RB	O
created	VBN	O
donor	NN	O
splice	NN	O
site	NN	O
is	VBZ	O
likely	JJ	O
to	TO	O
compete	VB	O
with	IN	O
the	DT	O
normal	JJ	O
one	CD	O
,	,	O
variations	NNS	O
of	IN	O
the	DT	O
levels	NNS	O
of	IN	O
normal	JJ	O
and	CC	O
aberrant	JJ	O
transcripts	NNS	O
of	IN	O
the	DT	O
PDS	NNP	S_Disease
gene	NN	O
in	IN	O
the	DT	O
cochlea	NN	O
may	MD	O
explain	VB	O
the	DT	O
variability	NN	O
in	IN	O
the	DT	O
deafness	NN	S_Disease
presentation	NN	O
.	.	O
.	.	O

The	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
Sjogren	NNP	B_Disease
-	:	I_Disease
Larsson	NNP	I_Disease
syndrome	NN	E_Disease
:	:	O
mutation	NN	O
analysis	NN	O
of	IN	O
the	DT	O
fatty	JJ	O
aldehyde	JJ	O
dehydrogenase	NN	O
gene	NN	O
.	.	O

Sjogren	NNP	B_Disease
-	:	I_Disease
Larsson	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
SLS	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
ichthyosis	NN	S_Disease
,	,	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
spasticity	NN	S_Disease
,	,	O
and	CC	O
deficient	JJ	B_Disease
activity	NN	I_Disease
of	IN	I_Disease
fatty	JJ	I_Disease
aldehyde	JJ	I_Disease
dehydrogenase	NN	E_Disease
(	(	O
FALDH	NNP	O
)	)	O
.	.	O

To	TO	O
define	VB	O
the	DT	O
molecular	JJ	O
defects	NNS	O
causing	VBG	O
SLS	NNP	S_Disease
,	,	O
we	PRP	O
performed	VBD	O
mutation	NN	O
analysis	NN	O
of	IN	O
the	DT	O
FALDH	NNP	O
gene	NN	O
in	IN	O
probands	NNS	O
from	IN	O
63	CD	O
kindreds	NNS	O
with	IN	O
SLS	NNP	S_Disease
.	.	O

Among	IN	O
these	DT	O
patients	NNS	O
,	,	O
49	CD	O
different	JJ	O
mutations	NNS	O
-	:	O
including	VBG	O
10	CD	O
deletions	NNS	O
,	,	O
2	CD	O
insertions	NNS	O
,	,	O
22	CD	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
,	,	O
3	CD	O
nonsense	NN	O
mutations	NNS	O
,	,	O
9	CD	O
splice	NN	O
-	:	O
site	NN	O
defects	NNS	O
,	,	O
and	CC	O
3	CD	O
complex	JJ	O
mutations	NNS	O
-	:	O
were	VBD	O
found	VBN	O
.	.	O

All	DT	O
of	IN	O
the	DT	O
patients	NNS	O
with	IN	O
SLS	NNP	S_Disease
were	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
mutations	NNS	O
.	.	O

Nineteen	NN	O
of	IN	O
the	DT	O
missense	NN	O
mutations	NNS	O
resulted	VBD	O
in	IN	O
a	DT	O
severe	JJ	O
reduction	NN	O
of	IN	O
FALDH	NNP	O
enzyme	FW	O
catalytic	JJ	O
activity	NN	O
when	WRB	O
expressed	VBN	O
in	IN	O
mammalian	JJ	O
cells	NNS	O
,	,	O
but	CC	O
one	CD	O
mutation	NN	O
(	(	O
798G	CD	O
-	:	O
-	:	O
>	NN	O
C	NNP	O
[	NNP	O
K266N	NNP	O
]	NNP	O
)	)	O
seemed	VBD	O
to	TO	O
have	VB	O
a	DT	O
greater	JJR	O
effect	NN	O
on	IN	O
mRNA	NN	O
stability	NN	O
.	.	O

The	DT	O
splice	NN	O
-	:	O
site	NN	O
mutations	NNS	O
led	VBD	O
to	TO	O
exon	VB	O
skipping	VBG	O
or	CC	O
utilization	NN	O
of	IN	O
cryptic	JJ	O
acceptor	NN	O
-	:	O
splice	NN	O
sites	NNS	O
.	.	O

Thirty	NNP	O
-	:	O
seven	CD	O
mutations	NNS	O
were	VBD	O
private	JJ	O
,	,	O
and	CC	O
12	CD	O
mutations	NNS	O
were	VBD	O
seen	VBN	O
in	IN	O
two	CD	O
or	CC	O
more	JJR	O
probands	NNS	O
of	IN	O
European	JJ	O
or	CC	O
Middle	JJ	O
Eastern	JJ	O
descent	NN	O
.	.	O

Four	CD	O
single	JJ	O
-	:	O
nucleotide	JJ	O
polymorphisms	NN	O
(	(	O
SNPs	NNP	O
)	)	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
FALDH	NNP	O
gene	NN	O
.	.	O

At	IN	O
least	JJS	O
four	CD	O
of	IN	O
the	DT	O
common	JJ	O
mutations	NNS	O
(	(	O
551C	CD	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
,	,	O
682C	CD	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
,	,	O
733G	CD	O
-	:	O
-	:	O
>	NN	O
A	NNP	O
,	,	O
and	CC	O
798	CD	O
+	NNS	O
1delG	CD	O
)	)	O
were	VBD	O
associated	VBN	O
with	IN	O
multiple	JJ	O
SNP	NNP	O
haplotypes	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
these	DT	O
mutations	NNS	O
originated	VBD	O
independently	RB	O
on	IN	O
more	JJR	O
than	IN	O
one	CD	O
occasion	NN	O
or	CC	O
were	VBD	O
ancient	JJ	O
SLS	NNP	S_Disease
genes	NNS	O
that	WDT	O
had	VBD	O
undergone	JJ	O
intragenic	JJ	O
recombination	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
SLS	NNP	S_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
strikingly	RB	O
heterogeneous	JJ	O
group	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
FALDH	NNP	O
gene	NN	O
and	CC	O
provide	VB	O
a	DT	O
framework	NN	O
for	IN	O
understanding	VBG	O
the	DT	O
genetic	JJ	O
basis	NN	O
of	IN	O
SLS	NNP	S_Disease
and	CC	O
the	DT	O
development	NN	O
of	IN	O
DNA	NNP	O
-	:	O
based	VBN	O
diagnostic	JJ	O
tests	NNS	O
.	.	O
.	.	O

Loss	NNP	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
cathepsin	NN	O
C	NNP	O
gene	NN	O
result	NN	O
in	IN	O
periodontal	JJ	B_Disease
disease	NN	E_Disease
and	CC	O
palmoplantar	NN	B_Disease
keratosis	NN	E_Disease
.	.	O

Papillon	NNP	B_Disease
-	:	I_Disease
Lefevre	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
or	CC	O
keratosis	VB	B_Disease
palmoplantaris	NN	E_Disease
with	IN	O
periodontopathia	NN	S_Disease
(	(	O
PLS	NNP	S_Disease
,	,	O
MIM	NNP	O
245000	CD	O
)	)	O
,	,	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
that	WDT	O
is	VBZ	O
mainly	RB	O
ascertained	VBN	O
by	IN	O
dentists	NNS	O
because	IN	O
of	IN	O
the	DT	O
severe	JJ	O
periodontitis	NN	S_Disease
that	WDT	O
afflicts	VBZ	O
patients	NNS	O
.	.	O

Both	DT	O
the	DT	O
deciduous	JJ	O
and	CC	O
permanent	JJ	O
dentitions	NNS	O
are	VBP	O
affected	VBN	O
,	,	O
resulting	VBG	O
in	IN	O
premature	NN	O
tooth	JJ	B_Disease
loss	NN	E_Disease
.	.	O

Palmoplantar	NNP	B_Disease
keratosis	NN	E_Disease
,	,	O
varying	VBG	O
from	IN	O
mild	JJ	O
psoriasiform	NN	O
scaly	NN	O
skin	NN	O
to	TO	O
overt	VB	O
hyperkeratosis	NN	S_Disease
,	,	O
typically	RB	O
develops	VBZ	O
within	IN	O
the	DT	O
first	JJ	O
three	CD	O
years	NNS	O
of	IN	O
life	NN	O
.	.	O

Keratosis	NNP	S_Disease
also	RB	O
affects	VBZ	O
other	JJ	O
sites	NNS	O
such	JJ	O
as	IN	O
elbows	NNS	O
and	CC	O
knees	NNS	O
.	.	O

Most	JJS	O
PLS	JJ	S_Disease
patients	NNS	O
display	VBP	O
both	DT	O
periodontitis	NN	S_Disease
and	CC	O
hyperkeratosis	NN	S_Disease
.	.	O

Some	DT	O
patients	NNS	O
have	VBP	O
only	RB	O
palmoplantar	JJ	B_Disease
keratosis	NN	E_Disease
or	CC	O
periodontitis	NN	S_Disease
,	,	O
and	CC	O
in	IN	O
rare	JJ	O
individuals	NNS	O
the	DT	O
periodontitis	NN	S_Disease
is	VBZ	O
mild	JJ	O
and	CC	O
of	IN	O
late	JJ	O
onset	NN	O
.	.	O

The	DT	O
PLS	NNP	O
locus	NN	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
chromosome	VB	O
11q14	CD	O
-	:	O
q21	NN	O
(	(	O
refs	JJ	O
7	CD	O
,	,	O
8	CD	O
,	,	O
9	CD	O
)	)	O
.	.	O

Using	VBG	O
homozygosity	NN	O
mapping	NN	O
in	IN	O
eight	CD	O
small	JJ	O
consanguineous	JJ	O
families	NNS	O
,	,	O
we	PRP	O
have	VBP	O
narrowed	VBN	O
the	DT	O
candidate	NN	O
region	NN	O
to	TO	O
a	DT	O
1	CD	O
.	.	O

2	CD	O
-	:	O
cM	NN	O
interval	NN	O
between	IN	O
D11S4082	NNP	O
and	CC	O
D11S931	NNP	O
.	.	O

The	DT	O
gene	NN	O
(	(	O
CTSC	NNP	O
)	)	O
encoding	VBG	O
the	DT	O
lysosomal	JJ	O
protease	NN	O
cathepsin	NN	O
C	NNP	O
(	(	O
or	CC	O
dipeptidyl	VB	O
aminopeptidase	NN	O
I	PRP	O
)	)	O
lies	VBZ	O
within	IN	O
this	DT	O
interval	NN	O
.	.	O

We	PRP	O
defined	VBD	O
the	DT	O
genomic	JJ	O
structure	NN	O
of	IN	O
CTSC	NNP	O
and	CC	O
found	VBD	O
mutations	NNS	O
in	IN	O
all	DT	O
eight	CD	O
families	NNS	O
.	.	O

In	IN	O
two	CD	O
of	IN	O
these	DT	O
families	NNS	O
we	PRP	O
used	VBD	O
a	DT	O
functional	JJ	O
assay	NN	O
to	TO	O
demonstrate	VB	O
an	DT	O
almost	RB	O
total	JJ	O
loss	NN	O
of	IN	O
cathepsin	JJ	O
C	NNP	O
activity	NN	O
in	IN	O
PLS	NNP	S_Disease
patients	NNS	O
and	CC	O
reduced	JJ	O
activity	NN	O
in	IN	O
obligate	NN	O
carriers	NNS	O
.	.	O

Confirmation	NN	O
of	IN	O
linkage	NN	O
of	IN	O
Van	NNP	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
to	TO	O
chromosome	VB	O
1q32	CD	O
:	:	O
evidence	NN	O
of	IN	O
association	NN	O
with	IN	O
STR	NNP	O
alleles	NNS	O
suggests	VBZ	O
possible	JJ	O
unique	JJ	O
origin	NN	O
of	IN	O
the	DT	O
disease	NN	O
mutation	NN	O
.	.	O

Van	NNP	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
VWS	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
craniofacial	JJ	I_Disease
disorder	NN	E_Disease
with	IN	O
high	JJ	O
penetrance	NN	O
and	CC	O
variable	JJ	O
expression	NN	O
.	.	O

Its	PRP$	O
clinical	JJ	O
features	NNS	O
are	VBP	O
variably	RB	O
expressed	VBN	O
,	,	O
but	CC	O
include	VBP	O
cleft	JJ	B_Disease
lip	NN	E_Disease
and	CC	O
/	NN	O
or	CC	O
cleft	NN	B_Disease
palate	NN	E_Disease
,	,	O
lip	NN	B_Disease
pits	NNS	E_Disease
and	CC	O
hypodontia	NN	S_Disease
.	.	O

All	DT	O
VWS	NNP	S_Disease
families	NNS	O
studied	VBD	O
to	TO	O
date	NN	O
map	VB	O
the	DT	O
disease	NN	O
gene	NN	O
to	TO	O
a	DT	O
<	JJ	O
2	CD	O
cM	JJ	O
region	NN	O
of	IN	O
chromosome	NN	O
1q32	CD	O
,	,	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
locus	JJ	O
heterogeneity	NN	O
.	.	O

The	DT	O
aim	NN	O
of	IN	O
this	DT	O
study	NN	O
is	VBZ	O
to	TO	O
refine	VB	O
the	DT	O
localization	NN	O
of	IN	O
the	DT	O
VWS	NNP	S_Disease
gene	NN	O
and	CC	O
to	TO	O
further	RB	O
assess	VB	O
possible	JJ	O
heterogeneity	NN	O
.	.	O

We	PRP	O
analyzed	VBD	O
four	CD	O
multiplex	NN	O
VWS	NNP	S_Disease
families	NNS	O
.	.	O

All	DT	O
available	JJ	O
members	NNS	O
were	VBD	O
clinically	RB	O
assessed	VBN	O
and	CC	O
genotyped	VBN	O
for	IN	O
19	CD	O
short	JJ	O
tandem	NN	O
repeat	NN	O
markers	NNS	O
on	IN	O
chromosome	NN	O
1	CD	O
in	IN	O
the	DT	O
VWS	NNP	S_Disease
candidate	NN	O
gene	NN	O
region	NN	O
.	.	O

We	PRP	O
performed	VBD	O
two	CD	O
-	:	O
point	NN	O
and	CC	O
multipoint	NN	O
limit	NN	O
of	IN	O
detection	NN	O
(	(	O
LOD	NNP	O
)	)	O
score	NN	O
analyses	NNS	O
using	VBG	O
a	DT	O
high	JJ	O
penetrance	NN	O
autosomal	JJ	O
dominant	JJ	O
model	NN	O
.	.	O

All	DT	O
families	NNS	O
showed	VBD	O
positive	JJ	O
LOD	NNP	O
scores	NNS	O
without	IN	O
any	DT	O
recombination	NN	O
in	IN	O
the	DT	O
candidate	NN	O
region	NN	O
.	.	O

The	DT	O
largest	JJS	O
two	CD	O
-	:	O
point	NN	O
LOD	NNP	O
score	NN	O
was	VBD	O
5	CD	O
.	.	O

87	CD	O
87	CD	O
.	.	O

Our	PRP$	O
assay	NN	O
method	NN	O
for	IN	O
short	JJ	O
tandem	NN	O
repeat	NN	O
(	(	O
STR	NNP	O
)	)	O
markers	NNS	O
provided	VBD	O
highly	RB	O
accurate	JJ	O
size	NN	O
estimation	NN	O
of	IN	O
marker	NN	O
allele	FW	O
fragment	NN	O
sizes	NNS	O
,	,	O
and	CC	O
therefore	RB	O
enabled	VBD	O
us	PRP	O
to	TO	O
determine	VB	O
the	DT	O
specific	JJ	O
alleles	NNS	O
segregating	VBG	O
with	IN	O
the	DT	O
VWS	NNP	S_Disease
gene	NN	O
in	IN	O
each	DT	O
of	IN	O
our	PRP$	O
four	CD	O
families	NNS	O
.	.	O

We	PRP	O
observed	VBD	O
a	DT	O
striking	JJ	O
pattern	NN	O
of	IN	O
STR	NNP	O
allele	FW	O
sharing	VBG	O
at	IN	O
several	JJ	O
closely	RB	O
linked	VBN	O
loci	NN	O
among	IN	O
our	PRP$	O
four	CD	O
Caucasian	JJ	O
VWS	NNP	S_Disease
families	NNS	O
recruited	VBD	O
at	IN	O
three	CD	O
different	JJ	O
locations	NNS	O
in	IN	O
the	DT	O
US	NNP	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
unique	JJ	O
origin	NN	O
for	IN	O
a	DT	O
mutation	NN	O
responsible	JJ	O
for	IN	O
many	JJ	O
or	CC	O
most	JJS	O
cases	NNS	O
of	IN	O
VWS	NNP	S_Disease
.	.	O

A	DT	O
point	NN	O
mutation	NN	O
Thr	NNP	O
(	(	O
799	CD	O
)	)	O
Met	NNP	O
on	IN	O
the	DT	O
alpha	NN	O
(	(	O
2	CD	O
)	)	O
integrin	NN	O
leads	VBZ	O
to	TO	O
the	DT	O
formation	NN	O
of	IN	O
new	JJ	O
human	JJ	O
platelet	NN	O
alloantigen	NN	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
and	CC	O
affects	VBZ	O
collagen	NN	O
-	:	O
induced	JJ	O
aggregation	NN	O
.	.	O

A	DT	O
new	JJ	O
platelet	NN	O
-	:	O
specific	JJ	O
alloantigen	NN	O
,	,	O
termed	VBN	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
,	,	O
was	VBD	O
identified	VBN	O
in	IN	O
a	DT	O
severe	JJ	O
case	NN	O
of	IN	O
neonatal	JJ	B_Disease
alloimmune	NN	I_Disease
thrombocytopenia	NN	E_Disease
.	.	O

The	DT	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
alloantigen	NN	O
is	VBZ	O
of	IN	O
low	JJ	O
frequency	NN	O
(	(	O
1	CD	O
/	RB	O
400	CD	O
)	)	O
in	IN	O
the	DT	O
German	JJ	O
population	NN	O
.	.	O

Immunochemical	JJ	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
epitopes	VBZ	O
reside	NN	O
on	IN	O
platelet	NN	O
glycoprotein	NN	O
(	(	O
GP	NNP	O
)	)	O
Ia	NNP	O
.	.	O

Nucleotide	NNP	O
sequence	NN	O
analysis	NN	O
of	IN	O
GPIa	NNP	O
cDNA	NN	O
derived	VBD	O
from	IN	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
-	:	O
positive	JJ	O
platelets	NNS	O
showed	VBD	O
C	NNP	O
(	(	O
2531	CD	O
)	)	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
(	(	O
2531	CD	O
)	)	O
point	NN	O
mutation	NN	O
,	,	O
resulting	VBG	O
in	IN	O
Thr	NNP	O
(	(	O
799	CD	O
)	)	O
Met	NNP	O
dimorphism	NN	O
.	.	O

Analysis	NN	O
of	IN	O
genomic	JJ	O
DNA	NN	O
from	IN	O
22	CD	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
-	:	O
negative	JJ	O
normal	JJ	O
individuals	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
Thr	NNP	O
(	(	O
799	CD	O
)	)	O
is	VBZ	O
encoded	VBN	O
by	IN	O
ACG	NNP	O
(	(	O
2532	CD	O
)	)	O
(	(	O
90	CD	O
.	.	O

9	CD	O
%	NN	O
)	)	O
or	CC	O
ACA	NNP	O
(	(	O
2532	CD	O
)	)	O
(	(	O
9	CD	O
.	.	O

1	CD	O
%	NN	O
)	)	O
.	.	O

To	TO	O
establish	VB	O
a	DT	O
DNA	NN	O
typing	NN	O
technique	NN	O
,	,	O
we	PRP	O
elucidated	VBD	O
the	DT	O
organization	NN	O
of	IN	O
the	DT	O
GPIa	NNP	O
gene	NN	O
adjacent	NN	O
to	TO	O
the	DT	O
polymorphic	JJ	O
bases	NNS	O
.	.	O

The	DT	O
introns	NNS	O
(	(	O
421	CD	O
bp	NN	O
and	CC	O
1	CD	O
.	.	O

2	CD	O
kb	NN	O
)	)	O
encompass	VBZ	O
a	DT	O
142	CD	O
-	:	O
bp	NN	O
exon	NN	O
with	IN	O
the	DT	O
2	CD	O
polymorphic	JJ	O
bases	NNS	O
2531	CD	O
and	CC	O
2532	CD	O
.	.	O

Polymerase	NNP	O
chain	NN	O
reaction	NN	O
-	:	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
analysis	NN	O
on	IN	O
DNA	NNP	O
derived	VBD	O
from	IN	O
100	CD	O
donors	NNS	O
using	VBG	O
the	DT	O
restriction	NN	O
enzyme	VBZ	O
Mae	NNP	O
III	NNP	O
showed	VBD	O
that	IN	O
the	DT	O
Met	NNP	O
(	(	O
799	CD	O
)	)	O
form	NN	O
of	IN	O
GPIa	NNP	O
is	VBZ	O
restricted	VBN	O
to	TO	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
(	(	O
+	$	O
)	)	O
phenotype	NN	O
.	.	O

Analysis	NN	O
of	IN	O
stable	JJ	O
Chinese	JJ	O
hamster	NN	O
ovary	JJ	O
transfectants	NNS	O
expressing	VBG	O
allele	JJ	O
-	:	O
specific	JJ	O
recombinant	JJ	O
forms	NNS	O
of	IN	O
GPIa	NNP	O
showed	VBD	O
that	IN	O
anti	SYM	O
-	:	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
exclusively	RB	O
reacted	VBN	O
with	IN	O
the	DT	O
Glu	NNP	O
(	(	O
505	CD	O
)	)	O
Met	NNP	O
(	(	O
799	CD	O
)	)	O
,	,	O
but	CC	O
not	RB	O
with	IN	O
the	DT	O
Glu	NNP	O
(	(	O
505	CD	O
)	)	O
Thr	NNP	O
(	(	O
799	CD	O
)	)	O
and	CC	O
the	DT	O
Lys	NNP	O
(	(	O
505	CD	O
)	)	O
Thr	NNP	O
(	(	O
799	CD	O
)	)	O
isoforms	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
anti	SYM	O
-	:	O
Br	NNP	O
(	(	O
a	DT	O
)	)	O
(	(	O
HPA	NNP	O
-	:	O
5b	CD	O
)	)	O
only	RB	O
recognized	VBD	O
the	DT	O
Lys	NNP	O
(	(	O
505	CD	O
)	)	O
Thr	NNP	O
(	(	O
799	CD	O
)	)	O
form	NN	O
,	,	O
whereas	WP	O
anti	SYM	O
-	:	O
Br	NNP	O
(	(	O
b	NN	O
)	)	O
(	(	O
HPA	NNP	O
-	:	O
5a	CD	O
)	)	O
reacted	VBN	O
with	IN	O
both	DT	O
Glu	NNP	O
(	(	O
505	CD	O
)	)	O
Thr	NNP	O
(	(	O
799	CD	O
)	)	O
and	CC	O
Glu	NNP	O
(	(	O
505	CD	O
)	)	O
Met	NNP	O
(	(	O
799	CD	O
)	)	O
isoforms	NNS	O
.	.	O

These	DT	O
results	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
Met	NNP	O
(	(	O
799	CD	O
)	)	O
is	VBZ	O
responsible	JJ	O
for	IN	O
formation	NN	O
of	IN	O
the	DT	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
alloantigenic	JJ	O
determinants	NNS	O
,	,	O
whereas	NNS	O
amino	VBP	O
acid	JJ	O
505	CD	O
(	(	O
Lys	NNP	O
or	CC	O
Glu	NNP	O
)	)	O
specifically	RB	O
controls	VBZ	O
the	DT	O
expression	NN	O
of	IN	O
Br	NNP	O
(	(	O
a	DT	O
)	)	O
and	CC	O
Br	NNP	O
(	(	O
b	NN	O
)	)	O
epitopes	VBZ	O
,	,	O
respectively	RB	O
.	.	O

Platelet	NNP	O
aggregation	NN	O
responses	NNS	O
of	IN	O
Sit	NNP	O
(	(	O
a	DT	O
)	)	O
(	(	O
+	$	O
)	)	O
individuals	NNS	O
were	VBD	O
diminished	VBN	O
in	IN	O
response	NN	O
to	TO	O
collagen	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
Thr	NNP	O
(	(	O
799	CD	O
)	)	O
Met	NNP	O
mutation	NN	O
affects	VBZ	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
GPIa	NNP	O
/	NNP	O
IIa	NNP	O
complex	NN	O

Mutations	NNS	O
of	IN	O
the	DT	O
cathepsin	NN	O
C	NNP	O
gene	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
Papillon	NNP	B_Disease
-	:	I_Disease
Lefevre	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Papillon	NNP	B_Disease
-	:	I_Disease
Lefevre	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PLS	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
characterised	VBN	O
by	IN	O
palmoplantar	NN	B_Disease
hyperkeratosis	NN	E_Disease
and	CC	O
severe	JJ	O
early	JJ	O
onset	NN	O
periodontitis	NN	S_Disease
that	WDT	O
results	NNS	O
in	IN	O
the	DT	O
premature	JJ	O
loss	NN	O
of	IN	O
the	DT	O
primary	JJ	O
and	CC	O
secondary	JJ	O
dentitions	NNS	O
.	.	O

A	DT	O
major	JJ	O
gene	NN	O
locus	NN	O
for	IN	O
PLS	NNP	S_Disease
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
a	DT	O
2	CD	O
.	.	O

8	CD	O
cM	NN	O
interval	NN	O
on	IN	O
chromosome	NN	O
11q14	CD	O
.	.	O

Correlation	NN	O
of	IN	O
physical	JJ	O
and	CC	O
genetic	JJ	O
maps	NNS	O
of	IN	O
this	DT	O
interval	JJ	O
indicate	VBP	O
it	PRP	O
includes	VBZ	O
at	IN	O
least	JJS	O
40	CD	O
ESTs	NNP	O
and	CC	O
six	CD	O
known	VBN	O
genes	NNS	O
including	VBG	O
the	DT	O
lysosomal	JJ	O
protease	NN	O
cathepsin	NN	O
C	NNP	O
gene	NN	O
(	(	O
CTSC	NNP	O
)	)	O
.	.	O

The	DT	O
CTSC	NNP	O
message	NN	O
is	VBZ	O
expressed	VBN	O
at	IN	O
high	JJ	O
levels	NNS	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
immune	JJ	O
cells	NNS	O
including	VBG	O
polymorphonuclear	JJ	O
leucocytes	NNS	O
,	,	O
macrophages	NNS	O
,	,	O
and	CC	O
their	PRP$	O
precursors	NNS	O
.	.	O

By	IN	O
RT	NNP	O
-	:	O
PCR	NN	O
,	,	O
we	PRP	O
found	VBD	O
CTSC	NNP	O
is	VBZ	O
also	RB	O
expressed	VBN	O
in	IN	O
epithelial	JJ	O
regions	NNS	O
commonly	RB	O
affected	VBN	O
by	IN	O
PLS	NNP	S_Disease
,	,	O
including	VBG	O
the	DT	O
palms	NN	O
,	,	O
soles	NNS	O
,	,	O
knees	NNS	O
,	,	O
and	CC	O
oral	JJ	O
keratinised	VBN	O
gingiva	NN	O
.	.	O

The	DT	O
4	CD	O
.	.	O

7	CD	O
kb	NN	O
CTSC	NNP	O
gene	NN	O
consists	VBZ	O
of	IN	O
two	CD	O
exons	NNS	O
.	.	O

Sequence	NNP	O
analysis	NN	O
of	IN	O
CTSC	NNP	O
from	IN	O
subjects	NNS	O
affected	VBN	O
with	IN	O
PLS	NNP	S_Disease
from	IN	O
five	CD	O
consanguineous	JJ	O
Turkish	JJ	O
families	NNS	O
identified	VBN	O
four	CD	O
different	JJ	O
mutations	NNS	O
.	.	O

An	DT	O
exon	JJ	O
1	CD	O
nonsense	JJ	O
mutation	NN	O
(	(	O
856C	CD	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
)	)	O
introduces	VBZ	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
at	IN	O
amino	NN	O
acid	NN	O
286	CD	O
.	.	O

Three	CD	O
exon	$	O
2	CD	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
including	VBG	O
a	DT	O
single	JJ	O
nucleotide	JJ	O
deletion	NN	O
(	(	O
2692delA	CD	O
)	)	O
of	IN	O
codon	NN	O
349	CD	O
introducing	VBG	O
a	DT	O
frameshift	NN	O
and	CC	O
premature	NN	O
termination	NN	O
codon	NN	O
,	,	O
a	DT	O
2	CD	O
bp	NN	O
deletion	NN	O
(	(	O
2673	CD	O
-	:	O
2674delCT	CD	O
)	)	O
that	WDT	O
results	NNS	O
in	IN	O
introduction	NN	O
of	IN	O
a	DT	O
stop	JJ	O
codon	NN	O
at	IN	O
amino	NN	O
acid	NN	O
343	CD	O
,	,	O
and	CC	O
a	DT	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
substitution	NN	O
in	IN	O
codon	NN	O
429	CD	O
(	(	O
2931G	CD	O
-	:	O
-	:	O
>	VB	O
A	DT	O
)	)	O
introducing	VBG	O
a	DT	O
premature	NN	O
termination	NN	O
codon	NN	O
.	.	O

All	DT	O
PLS	NNP	S_Disease
patients	NNS	O
were	VBD	O
homozygous	JJ	O
for	IN	O
cathepsin	NN	O
C	NNP	O
mutations	NNS	O
inherited	VBN	O
from	IN	O
a	DT	O
common	JJ	O
ancestor	NN	O
.	.	O

Parents	NNS	O
and	CC	O
sibs	VBP	O
heterozygous	JJ	O
for	IN	O
cathepsin	NN	O
C	NNP	O
mutations	NNS	O
do	VBP	O
not	RB	O
show	VB	O
either	RB	O
the	DT	O
palmoplantar	NN	B_Disease
hyperkeratosis	NN	E_Disease
or	CC	O
severe	JJ	O
early	JJ	O
onset	NN	O
periodontitis	NN	S_Disease
characteristic	NN	O
of	IN	O
PLS	NNP	S_Disease
.	.	O

A	DT	O
more	RBR	O
complete	JJ	O
understanding	NN	O
of	IN	O
the	DT	O
functional	JJ	O
physiology	NN	O
of	IN	O
cathepsin	NN	O
C	NNP	O
carries	VBZ	O
significant	JJ	O
implications	NNS	O
for	IN	O
understanding	VBG	O
normal	JJ	O
and	CC	O
abnormal	JJ	O
skin	NN	O
development	NN	O
and	CC	O
periodontal	JJ	B_Disease
disease	NN	E_Disease
susceptibility	NN	O

Mutational	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
HGO	NNP	O
gene	NN	O
in	IN	O
Finnish	JJ	O
alkaptonuria	NN	S_Disease
patients	NNS	O
.	.	O

Alkaptonuria	NNP	S_Disease
(	(	O
AKU	NNP	S_Disease
)	)	O
,	,	O
the	DT	O
prototypic	NN	O
inborn	JJ	B_Disease
error	NN	I_Disease
of	IN	I_Disease
metabolism	NN	E_Disease
,	,	O
has	VBZ	O
recently	RB	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
caused	VBN	O
by	IN	O
loss	NN	O
of	IN	O
function	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
homogentisate	NN	O
-	:	O
1	CD	O
,	,	O
2	CD	O
-	:	O
dioxygenase	NN	O
gene	NN	O
(	(	O
HGO	NNP	O
)	)	O
.	.	O

So	RB	O
far	RB	O
17	CD	O
mutations	NNS	O
have	VBP	O
been	VBN	O
characterised	VBN	O
in	IN	O
AKU	NNP	S_Disease
patients	NNS	O
of	IN	O
different	JJ	O
ethnic	JJ	O
origin	NN	O
.	.	O

We	PRP	O
describe	VBP	O
three	CD	O
novel	JJ	O
mutations	NNS	O
(	(	O
R58fs	NNP	O
,	,	O
R330S	NNP	O
,	,	O
and	CC	O
H371R	NNP	O
)	)	O
and	CC	O
one	CD	O
common	JJ	O
AKU	NNP	S_Disease
mutation	NN	O
(	(	O
M368V	NNP	O
)	)	O
,	,	O
detected	VBN	O
by	IN	O
mutational	JJ	O
and	CC	O
polymorphism	NN	O
analysis	NN	O
of	IN	O
the	DT	O
HGO	NNP	O
gene	NN	O
in	IN	O
five	CD	O
Finnish	JJ	O
AKU	NNP	S_Disease
pedigrees	NNS	O
.	.	O

The	DT	O
three	CD	O
novel	NN	O
AKU	NNP	S_Disease
mutations	NNS	O
are	VBP	O
most	RBS	O
likely	JJ	O
specific	NN	O
for	IN	O
the	DT	O
Finnish	JJ	O
population	NN	O
and	CC	O
have	VBP	O
originated	VBN	O
recently	RB	O
.	.	O
.	.	O

The	DT	O
identical	JJ	O
5	CD	O
'	POS	O
splice	NN	O
-	:	O
site	NN	O
acceptor	NN	O
mutation	NN	O
in	IN	O
five	CD	O
attenuated	JJ	B_Disease
APC	NNP	E_Disease
families	NNS	O
from	IN	O
Newfoundland	NNP	O
demonstrates	VBZ	O
a	DT	O
founder	NN	O
effect	NN	O
.	.	O

Inherited	VBN	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
predispose	JJ	O
carriers	NNS	O
to	TO	O
multiple	VB	O
adenomatous	JJ	B_Disease
polyps	NNS	I_Disease
of	IN	I_Disease
the	DT	I_Disease
colon	NN	I_Disease
and	CC	I_Disease
rectum	NN	E_Disease
and	CC	O
to	TO	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Mutations	NNS	O
located	VBN	O
at	IN	O
the	DT	O
extreme	JJ	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
,	,	O
however	RB	O
,	,	O
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
less	RBR	O
severe	JJ	O
disease	NN	O
known	VBN	O
as	IN	O
attenuated	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
AAPC	NNP	S_Disease
)	)	O
.	.	O

Many	JJ	O
individuals	NNS	O
with	IN	O
AAPC	NNP	S_Disease
develop	VBP	O
relatively	RB	O
few	JJ	O
colorectal	JJ	B_Disease
polyps	NNS	E_Disease
but	CC	O
are	VBP	O
still	RB	O
at	IN	O
high	JJ	O
risk	NN	O
for	IN	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
5	CD	O
APC	NNP	S_Disease
germline	NN	O
mutation	NN	O
in	IN	O
five	CD	O
separately	RB	O
ascertained	VBN	O
AAPC	NNP	S_Disease
families	NNS	O
from	IN	O
Newfoundland	NNP	O
,	,	O
Canada	NNP	O
.	.	O

This	DT	O
disease	NN	O
-	:	O
causing	NN	O
mutation	NN	O
is	VBZ	O
a	DT	O
single	JJ	O
basepair	NN	O
change	NN	O
(	(	O
G	NNP	O
to	TO	O
A	NNP	O
)	)	O
in	IN	O
the	DT	O
splice	NN	O
-	:	O
acceptor	NN	O
region	NN	O
of	IN	O
APC	NNP	S_Disease
intron	NN	O
3	CD	O
that	WDT	O
creates	VBZ	O
a	DT	O
mutant	JJ	O
RNA	NNP	O
without	IN	O
exon	RB	O
4	CD	O
of	IN	O
APC	NNP	O
.	.	O

The	DT	O
observation	NN	O
of	IN	O
the	DT	O
same	JJ	O
APC	NNP	S_Disease
mutation	NN	O
in	IN	O
five	CD	O
families	NNS	O
from	IN	O
the	DT	O
same	JJ	O
geographic	JJ	O
area	NN	O
demonstrates	VBZ	O
a	DT	O
founder	NN	O
effect	NN	O
.	.	O

Furthermore	RB	O
,	,	O
the	DT	O
identification	NN	O
of	IN	O
this	DT	O
germline	JJ	O
mutation	NN	O
strengthens	VBZ	O
the	DT	O
correlation	NN	O
between	IN	O
the	DT	O
5	CD	O
location	NN	O
of	IN	O
an	DT	O
APC	NNP	S_Disease
disease	NN	O
-	:	O
causing	NN	O
mutation	NN	O
and	CC	O
the	DT	O
attenuated	JJ	B_Disease
polyposis	NN	E_Disease
phenotype	NN	O
.	.	O
.	.	O

Alstrom	IN	B_Disease
syndrome	NN	E_Disease
:	:	O
further	JJ	O
evidence	NN	O
for	IN	O
linkage	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
2p13	CD	O
.	.	O

Alstrom	NNP	B_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
retinal	JJ	B_Disease
degeneration	NN	E_Disease
,	,	O
sensorineural	JJ	B_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
,	,	O
early	JJ	O
-	:	O
onset	NN	O
obesity	NN	S_Disease
,	,	O
and	CC	O
non	SYM	B_Disease
-	:	I_Disease
insulin	NN	I_Disease
-	:	I_Disease
dependent	NN	I_Disease
diabetes	VBZ	I_Disease
mellitus	NNS	E_Disease
.	.	O

The	DT	O
gene	NN	O
for	IN	O
Alstrom	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
ALMS1	NNP	O
)	)	O
has	VBZ	O
been	VBN	O
previously	RB	O
localized	VBN	O
to	TO	O
human	JJ	O
chromosome	NN	O
2p13	CD	O
by	IN	O
homozygosity	NN	O
mapping	NN	O
in	IN	O
two	CD	O
distinct	JJ	O
isolated	VBD	O
populations	NNS	O
-	:	O
French	JJ	O
Acadian	NNP	O
and	CC	O
North	JJ	O
African	NNP	O
.	.	O

Pair	NNP	O
-	:	O
wise	NN	O
analyses	NNS	O
resulted	VBD	O
in	IN	O
maximum	JJ	O
lod	NN	O
(	(	O
logarithm	NN	O
of	IN	O
the	DT	O
odds	NNS	O
ratio	NN	O
)	)	O
scores	NNS	O
of	IN	O
3	CD	O
.	.	O

84	CD	O
and	CC	O
2	CD	O
.	.	O

9	CD	O
,	,	O
respectively	RB	O
.	.	O

To	TO	O
confirm	VB	O
these	DT	O
findings	NNS	O
,	,	O
a	DT	O
large	JJ	O
linkage	NN	O
study	NN	O
was	VBD	O
performed	VBN	O
in	IN	O
twelve	JJ	O
additional	JJ	O
families	NNS	O
segregating	VBG	O
for	IN	O
Alstrom	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O

A	DT	O
maximum	JJ	O
two	CD	O
-	:	O
point	NN	O
lod	VBZ	O
score	NN	O
of	IN	O
7	CD	O
.	.	O

13	CD	O
(	(	O
theta	NN	O
=	RB	O
0	CD	O
.	.	O

00	CD	O
)	)	O
for	IN	O
marker	NN	O
D2S2110	NNP	O
and	CC	O
a	DT	O
maximum	JJ	O
cumulative	JJ	O
multipoint	NN	O
lod	VBD	O
score	NN	O
of	IN	O
9	CD	O
.	.	O

16	CD	O
for	IN	O
marker	NN	O
D2S2110	NNP	O
were	VBD	O
observed	VBN	O
,	,	O
further	RBR	O
supporting	VBG	O
linkage	NN	O
to	TO	O
chromosome	VB	O
2p13	CD	O
.	.	O

No	DT	O
evidence	NN	O
of	IN	O
genetic	JJ	O
heterogeneity	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
these	DT	O
families	NNS	O
.	.	O

Meiotic	JJ	O
recombination	NN	O
events	NNS	O
have	VBP	O
localized	VBN	O
the	DT	O
critical	JJ	O
region	NN	O
containing	VBG	O
ALMS1	NNP	O
to	TO	O
a	DT	O
6	CD	O
.	.	O

1	CD	O
-	:	O
cM	NN	O
interval	NN	O
flanked	VBN	O
by	IN	O
markers	NNS	O
D2S327	NNP	O
and	CC	O
D2S286	NNP	O
.	.	O

A	DT	O
fine	JJ	O
resolution	NN	O
radiation	NN	O
hybrid	JJ	O
map	NN	O
of	IN	O
31	CD	O
genes	NNS	O
and	CC	O
markers	NNS	O
has	VBZ	O
been	VBN	O
constructed	VBN	O
.	.	O

Pendred	VBN	B_Disease
syndrome	NN	E_Disease
:	:	O
phenotypic	NN	O
variability	NN	O
in	IN	O
two	CD	O
families	NNS	O
carrying	VBG	O
the	DT	O
same	JJ	O
PDS	NNP	S_Disease
missense	NN	O
mutation	NN	O
.	.	O

Pendred	NNP	B_Disease
syndrome	NN	E_Disease
comprises	NNS	O
congenital	JJ	B_Disease
sensorineural	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
,	,	O
thyroid	JJ	B_Disease
goiter	NN	E_Disease
,	,	O
and	CC	O
positive	JJ	O
perchlorate	NN	O
discharge	NN	O
test	NN	O
.	.	O

Recently	RB	O
,	,	O
this	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
was	VBD	O
shown	VBN	O
to	TO	O
be	VB	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
PDS	NNP	S_Disease
gene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
an	DT	O
anion	NN	O
transporter	NN	O
called	VBN	O
pendrin	NN	O
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
PDS	NNP	S_Disease
gene	NN	O
was	VBD	O
performed	VBN	O
in	IN	O
two	CD	O
consanguineous	JJ	O
large	JJ	O
families	NNS	O
from	IN	O
Southern	NNP	O
Tunisia	NNP	O
comprising	VBG	O
a	DT	O
total	NN	O
of	IN	O
23	CD	O
individuals	NNS	O
affected	VBN	O
with	IN	O
profound	JJ	O
congenital	JJ	B_Disease
deafness	NN	E_Disease
;	:	O
the	DT	O
same	JJ	O
missense	NN	O
mutation	NN	O
,	,	O
L445W	NNP	O
,	,	O
was	VBD	O
identified	VBN	O
in	IN	O
all	DT	O
affected	JJ	O
individuals	NNS	O
.	.	O

A	DT	O
widened	JJ	B_Disease
vestibular	JJ	I_Disease
aqueduct	NN	E_Disease
was	VBD	O
found	VBN	O
in	IN	O
all	DT	O
patients	NNS	O
who	WP	O
underwent	VBP	O
computed	VBN	O
tomography	NN	O
(	(	O
CT	NNP	O
)	)	O
scan	JJ	O
exploration	NN	O
of	IN	O
the	DT	O
inner	JJ	O
ear	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
goiter	NN	S_Disease
was	VBD	O
present	JJ	O
in	IN	O
only	RB	O
11	CD	O
affected	JJ	O
individuals	NNS	O
,	,	O
who	WP	O
interestingly	RB	O
had	VBD	O
a	DT	O
normal	JJ	O
result	NN	O
of	IN	O
the	DT	O
perchlorate	NN	O
discharge	NN	O
test	NN	O
whenever	NN	O
performed	VBD	O
.	.	O

The	DT	O
present	JJ	O
results	NNS	O
question	VBP	O
the	DT	O
sensitivity	NN	O
of	IN	O
the	DT	O
perchlorate	NN	O
test	NN	O
for	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
and	CC	O
support	VB	O
the	DT	O
use	NN	O
of	IN	O
a	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
PDS	NNP	S_Disease
gene	NN	O
in	IN	O
the	DT	O
assessment	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
severe	JJ	O
to	TO	O
profound	VB	O
congenital	JJ	B_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
associated	VBN	O
with	IN	O
inner	JJ	B_Disease
ear	JJ	I_Disease
morphological	JJ	I_Disease
anomaly	NN	E_Disease
even	RB	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
thyroid	JJ	B_Disease
goiter	NN	E_Disease
.	.	O
.	.	O

Knobloch	NNP	B_Disease
syndrome	NN	E_Disease
involving	VBG	O
midline	NN	B_Disease
scalp	NN	I_Disease
defect	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
frontal	JJ	I_Disease
region	NN	E_Disease
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
4	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
boy	NN	O
with	IN	O
Knobloch	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O

He	PRP	O
has	VBZ	O
vitreoretinal	JJ	B_Disease
degeneration	NN	E_Disease
,	,	O
high	JJ	B_Disease
myopia	NN	E_Disease
,	,	O
cataract	NN	S_Disease
,	,	O
telecanthus	RB	S_Disease
,	,	O
hypertelorism	NN	S_Disease
,	,	O
and	CC	O
a	DT	O
high	JJ	B_Disease
-	:	I_Disease
arched	JJ	I_Disease
palate	NN	E_Disease
.	.	O

He	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
defect	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
anterior	JJ	I_Disease
midline	NN	I_Disease
scalp	NN	E_Disease
with	IN	O
involvement	NN	O
of	IN	O
the	DT	O
frontal	JJ	O
bone	NN	O
as	IN	O
documented	VBN	O
by	IN	O
a	DT	O
computed	JJ	O
tomography	NN	O
(	(	O
CT	NNP	O
)	)	O
scan	NN	O
.	.	O

The	DT	O
brain	NN	O
was	VBD	O
normal	JJ	O
on	IN	O
CT	NNP	O
scan	JJ	O
and	CC	O
magnetic	JJ	O
resonance	NN	O
imaging	NN	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
review	NN	O
of	IN	O
the	DT	O
23	CD	O
published	VBN	O
cases	NNS	O
with	IN	O
this	DT	O
syndrome	NN	O
.	.	O

Our	PRP$	O
patient	NN	O
illustrates	VBZ	O
the	DT	O
importance	NN	O
of	IN	O
investigating	VBG	O
for	IN	O
underlying	VBG	O
ocular	JJ	O
and	CC	O
central	JJ	O
nervous	JJ	O
system	NN	O
pathology	NN	O
whenever	WRB	O
midline	NN	B_Disease
scalp	NN	I_Disease
defects	NNS	E_Disease
are	VBP	O
present	JJ	O
.	.	O
.	.	O

The	DT	O
DNA	NNP	O
double	JJ	O
-	:	O
strand	NN	O
break	NN	O
repair	NN	O
gene	NN	O
hMRE11	NN	O
is	VBZ	O
mutated	VBN	O
in	IN	O
individuals	NNS	O
with	IN	O
an	DT	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	I_Disease
-	:	I_Disease
like	IN	I_Disease
disorder	NN	E_Disease
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
hypomorphic	JJ	O
mutations	NNS	O
in	IN	O
hMRE11	NN	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
ATM	NNP	O
,	,	O
are	VBP	O
present	JJ	O
in	IN	O
certain	JJ	O
individuals	NNS	O
with	IN	O
an	DT	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	I_Disease
-	:	I_Disease
like	IN	I_Disease
disorder	NN	E_Disease
(	(	O
ATLD	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
cellular	JJ	O
features	NNS	O
resulting	VBG	O
from	IN	O
these	DT	O
hMRE11	JJ	O
mutations	NNS	O
are	VBP	O
similar	JJ	O
to	TO	O
those	DT	O
seen	VBN	O
in	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
as	RB	O
well	RB	O
as	IN	O
NBS	NNP	S_Disease
and	CC	O
include	VBP	O
hypersensitivity	NN	B_Disease
to	TO	I_Disease
ionizing	VBG	I_Disease
radiation	NN	E_Disease
,	,	O
radioresistant	JJ	O
DNA	NNP	O
synthesis	NN	O
,	,	O
and	CC	O
abrogation	NN	O
of	IN	O
ATM	NNP	O
-	:	O
dependent	JJ	O
events	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
activation	NN	O
of	IN	O
Jun	NNP	O
kinase	NN	O
following	VBG	O
exposure	NN	O
to	TO	O
gamma	VB	O
irradiation	NN	O
.	.	O

Although	IN	O
the	DT	O
mutant	JJ	O
hMre11	NN	O
proteins	NNS	O
retain	VBP	O
some	DT	O
ability	NN	O
to	TO	O
interact	VB	O
with	IN	O
hRad50	NN	O
and	CC	O
Nbs1	NNP	O
,	,	O
formation	NN	O
of	IN	O
ionizing	VBG	O
radiation	NN	O
-	:	O
induced	JJ	O
hMre11	NN	O
and	CC	O
Nbs1	NNP	O
foci	NN	O
was	VBD	O
absent	JJ	O
in	IN	O
hMRE11	NN	O
mutant	NN	O
cells	NNS	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	NN	O
that	IN	O
ATM	NNP	O
and	CC	O
the	DT	O
hMre11	NN	O
/	NNP	O
hRad50	NN	O
/	NNP	O
Nbs1	NNP	O
protein	NN	O
complex	JJ	O
act	NN	O
in	IN	O
the	DT	O
same	JJ	O
DNA	NNP	O
damage	NN	O
response	NN	O
pathway	NN	O
and	CC	O
link	NN	O
hMre11	NN	O
to	TO	O
the	DT	O
complex	JJ	O
pathology	NN	O
of	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
.	.	O
.	.	O

Mutations	NNS	O
in	IN	O
TNFRSF11A	NNP	O
,	,	O
affecting	VBG	O
the	DT	O
signal	JJ	O
peptide	NN	O
of	IN	O
RANK	NNP	O
,	,	O
cause	NN	O
familial	JJ	B_Disease
expansile	JJ	I_Disease
osteolysis	NN	E_Disease
.	.	O

Familial	NNP	B_Disease
expansile	JJ	I_Disease
osteolysis	NN	E_Disease
(	(	O
FEO	NNP	S_Disease
,	,	O
MIM	NNP	O
174810	CD	O
)	)	O
is	VBZ	O
a	DT	O
rare	JJ	O
,	,	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
bone	NN	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
focal	JJ	O
areas	NNS	O
of	IN	O
increased	JJ	B_Disease
bone	NN	I_Disease
remodelling	NN	E_Disease
.	.	O

The	DT	O
osteolytic	JJ	B_Disease
lesions	NNS	E_Disease
,	,	O
which	WDT	O
develop	VBP	O
usually	RB	O
in	IN	O
the	DT	O
long	JJ	O
bones	NNS	O
during	IN	O
early	JJ	O
adulthood	NN	O
,	,	O
show	VBP	O
increased	VBN	O
osteoblast	NN	O
and	CC	O
osteoclast	JJ	O
activity	NN	O
.	.	O

Our	PRP$	O
previous	JJ	O
linkage	NN	O
studies	NNS	O
mapped	VBD	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
FEO	NNP	S_Disease
to	TO	O
an	DT	O
interval	NN	O
of	IN	O
less	JJR	O
than	IN	O
5	CD	O
cM	NN	O
between	IN	O
D18S64	NNP	O
and	CC	O
D18S51	NNP	O
on	IN	O
chromosome	NN	O
18q21	CD	O
.	.	O

2	CD	O
-	:	O
21	CD	O
2	CD	O
-	:	O
21	CD	O
.	.	O

3	CD	O
in	IN	O
a	DT	O
large	JJ	O
Northern	NNP	O
Irish	NNP	O
family	NN	O
.	.	O

The	DT	O
gene	NN	O
encoding	VBG	O
receptor	NN	O
activator	NN	O
of	IN	O
nuclear	JJ	O
factor	NN	O
-	:	O
kappa	NN	O
B	NNP	O
(	(	O
RANK	NNP	O
;	:	O
ref	NN	O
.	.	O

5	CD	O
)	)	O
,	,	O
TNFRSF11A	NNP	O
,	,	O
maps	VBZ	O
to	TO	O
this	DT	O
region	NN	O
.	.	O

RANK	NNP	O
is	VBZ	O
essential	JJ	O
in	IN	O
osteoclast	JJ	O
formation	NN	O
.	.	O

We	PRP	O
identified	VBD	O
two	CD	O
heterozygous	JJ	O
insertion	NN	O
mutations	NNS	O
in	IN	O
exon	JJ	O
1	CD	O
of	IN	O
TNFRSF11A	NNP	O
in	IN	O
affected	JJ	O
members	NNS	O
of	IN	O
four	CD	O
families	NNS	O
with	IN	O
FEO	NNP	S_Disease
or	CC	O
familial	JJ	B_Disease
Paget	NNP	I_Disease
disease	NN	I_Disease
of	IN	I_Disease
bone	NN	E_Disease
(	(	O
PDB	NNP	S_Disease
)	)	O
.	.	O

One	CD	O
was	VBD	O
a	DT	O
duplication	NN	O
of	IN	O
18	CD	O
bases	NNS	O
and	CC	O
the	DT	O
other	JJ	O
a	DT	O
duplication	NN	O
of	IN	O
27	CD	O
bases	NNS	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
affected	VBD	O
the	DT	O
signal	JJ	O
peptide	JJ	O
region	NN	O
of	IN	O
the	DT	O
RANK	NNP	O
molecule	NN	O
.	.	O

Expression	NN	O
of	IN	O
recombinant	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
mutant	JJ	O
RANK	NNP	O
proteins	NNS	O
revealed	VBD	O
perturbations	NNS	O
in	IN	O
expression	NN	O
levels	NNS	O
and	CC	O
lack	NN	O
of	IN	O
normal	JJ	O
cleavage	NN	O
of	IN	O
the	DT	O
signal	JJ	O
peptide	NN	O
.	.	O

Both	DT	O
mutations	NNS	O
caused	VBD	O
an	DT	O
increase	NN	O
in	IN	O
RANK	NNP	O
-	:	O
mediated	VBD	O
nuclear	JJ	O
factor	NN	O
-	:	O
kappaB	NN	O
(	(	O
NF	NNP	O
-	:	O
kappaB	NN	O
)	)	O
signalling	NN	O
in	IN	O
vitro	NN	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
activating	JJ	O
mutation	NN	O
.	.	O

Cardiac	NNP	O
Na	NNP	O
(	(	O
+	NNP	O
)	)	O
channel	NN	O
dysfunction	NN	O
in	IN	O
Brugada	NNP	B_Disease
syndrome	NN	E_Disease
is	VBZ	O
aggravated	VBN	O
by	IN	O
beta	NN	O
(	(	O
1	CD	O
)	)	O
-	:	O
subunit	NN	O
.	.	O

BACKGROUND	NNP	O
Mutations	NNP	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
human	JJ	O
cardiac	NN	O
Na	NNP	O
(	(	O
+	NNP	O
)	)	O
channel	NN	O
alpha	SYM	O
-	:	O
subunit	NN	O
(	(	O
hH1	NN	O
)	)	O
are	VBP	O
responsible	JJ	O
for	IN	O
chromosome	NN	O
3	CD	O
-	:	O
linked	VBN	O
congenital	JJ	B_Disease
long	JJ	I_Disease
-	:	I_Disease
QT	NN	I_Disease
syndrome	NN	E_Disease
(	(	O
LQT3	NNP	S_Disease
)	)	O
and	CC	O
idiopathic	JJ	B_Disease
ventricular	JJ	I_Disease
fibrillation	NN	E_Disease
(	(	O
IVF	NNP	S_Disease
)	)	O
.	.	O

An	DT	O
auxiliary	JJ	O
beta	NN	O
(	(	O
1	CD	O
)	)	O
-	:	O
subunit	NN	O
,	,	O
widely	RB	O
expressed	VBN	O
in	IN	O
excitable	JJ	O
tissues	NNS	O
,	,	O
shifts	VBP	O
the	DT	O
voltage	NN	O
dependence	NN	O
of	IN	O
steady	JJ	O
-	:	O
state	NN	O
inactivation	NN	O
toward	IN	O
more	RBR	O
negative	JJ	O
potentials	NNS	O
and	CC	O
restores	NNS	O
normal	JJ	O
gating	VBG	O
kinetics	NNS	O
of	IN	O
brain	NN	O
and	CC	O
skeletal	JJ	O
muscle	NN	O
Na	NNP	O
(	(	O
+	NNP	O
)	)	O
channels	NNS	O
expressed	VBN	O
in	IN	O
Xenopus	NNP	O
oocytes	NNS	O
but	CC	O
has	VBZ	O
little	RB	O
if	IN	O
any	DT	O
functional	JJ	O
effect	NN	O
on	IN	O
the	DT	O
cardiac	JJ	O
isoform	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
characterize	VBP	O
the	DT	O
altered	JJ	O
effects	NNS	O
of	IN	O
a	DT	O
human	JJ	O
beta	NN	O
(	(	O
1	CD	O
)	)	O
-	:	O
subunit	NN	O
(	(	O
hbeta	NN	O
(	(	O
1	CD	O
)	)	O
)	)	O
on	IN	O
the	DT	O
heterologously	RB	O
expressed	VBN	O
hH1	NN	O
mutation	NN	O
(	(	O
T1620M	NNP	O
)	)	O
previously	RB	O
associated	VBN	O
with	IN	O
IVF	NNP	S_Disease
.	.	O

METHODS	NNP	O
AND	CC	O
RESULTS	NNP	O
When	WRB	O
expressed	VBD	O
alone	RB	O
in	IN	O
Xenopus	NNP	O
oocytes	NNS	O
,	,	O
T1620M	NNP	O
exhibited	VBD	O
no	DT	O
persistent	JJ	O
currents	NNS	O
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
the	DT	O
LQT3	NNP	S_Disease
mutant	NN	O
channels	NNS	O
,	,	O
but	CC	O
the	DT	O
midpoint	NN	O
of	IN	O
steady	JJ	O
-	:	O
state	NN	O
inactivation	NN	O
(	(	O
V	NNP	O
(	(	O
1	CD	O
/	RB	O
2	CD	O
)	)	O
)	)	O
was	VBD	O
significantly	RB	O
shifted	VBN	O
toward	IN	O
more	RBR	O
positive	JJ	O
potentials	NNS	O
than	IN	O
for	IN	O
wild	JJ	O
-	:	O
type	NN	O
hH1	NN	O
.	.	O

Coexpression	NN	O
of	IN	O
hbeta	NN	O
(	(	O
1	CD	O
)	)	O
did	VBD	O
not	RB	O
significantly	RB	O
alter	RBR	O
current	JJ	O
decay	NN	O
or	CC	O
recovery	NN	O
from	IN	O
inactivation	NN	O
of	IN	O
wild	JJ	O
-	:	O
type	NN	O
hH1	NN	O
;	:	O
however	RB	O
,	,	O
it	PRP	O
further	RB	O
shifted	VBD	O
the	DT	O
V	NNP	O
(	(	O
1	CD	O
/	RB	O
2	CD	O
)	)	O
and	CC	O
accelerated	VBD	O
the	DT	O
recovery	NN	O
from	IN	O
inactivation	NN	O
of	IN	O
T1620M	NNP	O
.	.	O

Oocyte	NNP	O
macropatch	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
activation	NN	O
kinetics	NNS	O
of	IN	O
T1620M	NNP	O
were	VBD	O
normal	JJ	O
.	.	O

CONCLUSIONS	NN	O
It	PRP	O
is	VBZ	O
suggested	VBN	O
that	IN	O
coexpression	NN	O
of	IN	O
hbeta	NN	O
(	(	O
1	CD	O
)	)	O
exposes	VBZ	O
a	DT	O
more	RBR	O
severe	JJ	O
functional	JJ	O
defect	NN	O
that	WDT	O
results	NNS	O
in	IN	O
a	DT	O
greater	JJR	O
overlap	NN	O
in	IN	O
the	DT	O
relationship	NN	O
between	IN	O
channel	NN	O
inactivation	NN	O
and	CC	O
activation	NN	O
(	(	O
window	JJ	O
current	JJ	O
)	)	O
in	IN	O
T1620M	NNP	O
,	,	O
which	WDT	O
is	VBZ	O
proposed	VBN	O
to	TO	O
be	VB	O
a	DT	O
potential	JJ	O
pathophysiological	JJ	O
mechanism	NN	O
of	IN	O
IVF	NNP	S_Disease
in	IN	O
vivo	NN	O
.	.	O

One	CD	O
possible	JJ	O
explanation	NN	O
for	IN	O
our	PRP$	O
finding	NN	O
is	VBZ	O
an	DT	O
altered	JJ	O
alpha	NN	O
-	:	O
/	NN	O
beta	NN	O
(	(	O
1	CD	O
)	)	O
-	:	O
subunit	NN	O
association	NN	O
in	IN	O
the	DT	O
mutant	NN	O
.	.	O
.	.	O

Meiotic	JJ	O
segregation	NN	O
analysis	NN	O
of	IN	O
RB1	NNP	O
alleles	NNS	O
in	IN	O
retinoblastoma	NN	S_Disease
pedigrees	NNS	O
by	IN	O
use	NN	O
of	IN	O
single	JJ	O
-	:	O
sperm	NN	O
typing	NN	O
.	.	O

In	IN	O
hereditary	JJ	B_Disease
retinoblastoma	NN	E_Disease
,	,	O
different	JJ	O
epidemiological	JJ	O
studies	NNS	O
have	VBP	O
indicated	VBN	O
a	DT	O
preferential	JJ	O
paternal	JJ	O
transmission	NN	O
of	IN	O
mutant	JJ	O
retinoblastoma	NN	S_Disease
alleles	NNS	O
to	TO	O
offspring	VBG	O
,	,	O
suggesting	VBG	O
the	DT	O
occurrence	NN	O
of	IN	O
a	DT	O
meiotic	JJ	O
drive	NN	O
.	.	O

To	TO	O
investigate	VB	O
this	DT	O
mechanism	NN	O
,	,	O
we	PRP	O
analyzed	VBD	O
sperm	JJ	O
samples	NNS	O
from	IN	O
six	CD	O
individuals	NNS	O
from	IN	O
five	CD	O
unrelated	JJ	O
families	NNS	O
affected	VBN	O
with	IN	O
hereditary	JJ	B_Disease
retinoblastoma	NN	E_Disease
.	.	O

Single	NNP	O
-	:	O
sperm	NN	O
typing	VBG	O
techniques	NNS	O
were	VBD	O
performed	VBN	O
for	IN	O
each	DT	O
sample	NN	O
by	IN	O
study	NN	O
of	IN	O
two	CD	O
informative	JJ	O
short	JJ	O
tandem	NN	O
repeats	NNS	O
located	VBD	O
either	RB	O
in	IN	O
or	CC	O
close	VB	O
to	TO	O
the	DT	O
retinoblastoma	NN	S_Disease
gene	NN	O
(	(	O
RB1	NNP	O
)	)	O
.	.	O

The	DT	O
segregation	NN	O
probability	NN	O
of	IN	O
mutant	JJ	O
RB1	NNP	O
alleles	NNS	O
in	IN	O
sperm	JJ	O
samples	NNS	O
was	VBD	O
assessed	VBN	O
by	IN	O
use	NN	O
of	IN	O
the	DT	O
SPERMSEG	NNP	O
program	NN	O
,	,	O
which	WDT	O
includes	VBZ	O
experimental	JJ	O
parameters	NNS	O
,	,	O
recombination	NN	O
fractions	NNS	O
between	IN	O
the	DT	O
markers	NNS	O
,	,	O
and	CC	O
segregation	NN	O
parameters	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
2	CD	O
,	,	O
952	CD	O
single	JJ	O
sperm	NN	O
from	IN	O
the	DT	O
six	CD	O
donors	NNS	O
were	VBD	O
analyzed	VBN	O
.	.	O

We	PRP	O
detected	VBD	O
a	DT	O
significant	JJ	O
segregation	NN	O
distortion	NN	O
in	IN	O
the	DT	O
data	NN	O
as	IN	O
a	DT	O
whole	NN	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

0099	CD	O
)	)	O
and	CC	O
a	DT	O
significant	JJ	O
heterogeneity	NN	O
in	IN	O
the	DT	O
segregation	NN	O
rate	NN	O
across	IN	O
donors	NNS	O
(	(	O
.	.	O

0092	CD	O
)	)	O
.	.	O

Further	JJ	O
analysis	NN	O
shows	VBZ	O
that	IN	O
this	DT	O
result	NN	O
can	MD	O
be	VB	O
explained	VBN	O
by	IN	O
segregation	NN	O
distortion	NN	O
in	IN	O
favor	NN	O
of	IN	O
the	DT	O
normal	JJ	O
allele	NN	O
in	IN	O
one	CD	O
donor	NN	O
only	RB	O
and	CC	O
that	IN	O
it	PRP	O
does	VBZ	O
not	RB	O
provide	VB	O
evidence	NN	O
of	IN	O
a	DT	O
significant	JJ	O
segregation	NN	O
distortion	NN	O
in	IN	O
the	DT	O
other	JJ	O
donors	NNS	O
.	.	O

The	DT	O
segregation	NN	O
distortion	NN	O
favoring	VBG	O
the	DT	O
mutant	JJ	O
RB1	NNP	O
allele	NN	O
does	VBZ	O
not	RB	O
seem	VB	O
to	TO	O
occur	VB	O
during	IN	O
spermatogenesis	NN	O
,	,	O
and	CC	O
,	,	O
thus	RB	O
,	,	O
meiotic	JJ	O
drive	NN	O
may	MD	O
result	VB	O
either	CC	O
from	IN	O
various	JJ	O
mechanisms	NNS	O
,	,	O
including	VBG	O
a	DT	O
fertilization	NN	O
advantage	NN	O
or	CC	O
a	DT	O
better	JJR	O
mobility	NN	O
in	IN	O
sperm	JJ	O
bearing	VBG	O
a	DT	O
mutant	JJ	O
RB1	NNP	O
gene	NN	O
,	,	O
or	CC	O
from	IN	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
defectively	RB	O
imprinted	JJ	O
gene	NN	O
located	VBN	O
on	IN	O
the	DT	O
human	JJ	O
X	NNP	O
chromosome	NN	O
.	.	O

Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
:	:	O
an	DT	O
overview	NN	O
.	.	O

Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
,	,	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
neurodegenerative	JJ	I_Disease
disease	NN	E_Disease
,	,	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
of	IN	O
the	DT	O
inherited	JJ	B_Disease
ataxias	NN	E_Disease
.	.	O

The	DT	O
recent	JJ	O
discovery	NN	O
of	IN	O
the	DT	O
gene	NN	O
that	WDT	O
is	VBZ	O
mutated	VBN	O
in	IN	O
this	DT	O
condition	NN	O
,	,	O
FRDA	NNP	O
,	,	O
has	VBZ	O
led	VBN	O
to	TO	O
rapid	JJ	O
advances	NNS	O
in	IN	O
the	DT	O
understanding	NN	O
of	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
.	.	O

About	RB	O
98	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
have	VBP	O
an	DT	O
expansion	NN	O
of	IN	O
a	DT	O
GAA	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
intron	NN	O
1	CD	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

This	DT	O
leads	VBZ	O
to	TO	O
reduced	JJ	O
levels	NNS	O
of	IN	O
the	DT	O
protein	NN	O
,	,	O
frataxin	NN	O
.	.	O

There	EX	O
is	VBZ	O
mounting	VBG	O
evidence	NN	O
to	TO	O
suggest	VB	O
that	IN	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
is	VBZ	O
the	DT	O
result	NN	O
of	IN	O
accumulation	NN	O
of	IN	O
iron	NN	O
in	IN	O
mitochondria	NN	O
leading	VBG	O
to	TO	O
excess	JJ	O
production	NN	O
of	IN	O
free	JJ	O
radicals	NNS	O
,	,	O
which	WDT	O
then	RB	O
results	NNS	O
in	IN	O
cellular	JJ	O
damage	NN	O
and	CC	O
death	NN	O
.	.	O

Currently	RB	O
there	EX	O
is	VBZ	O
no	DT	O
known	JJ	O
treatment	NN	O
that	WDT	O
alters	VBZ	O
the	DT	O
natural	JJ	O
course	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
discovery	NN	O
of	IN	O
the	DT	O
FRDA	NNP	S_Disease
gene	NN	O
and	CC	O
its	PRP$	O
possible	JJ	O
function	NN	O
has	VBZ	O
raised	VBN	O
hope	NN	O
that	IN	O
rational	JJ	O
therapeutic	JJ	O
strategies	NNS	O
will	MD	O
be	VB	O
developed	VBN	O
.	.	O
.	.	O

X	LS	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
retinoschisis	NN	E_Disease
with	IN	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
XLRS1	NNP	O
gene	NN	O
.	.	O

BACKGROUND	NNP	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
retinoschisis	NN	E_Disease
(	(	O
XLRS	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
relatively	RB	O
rare	JJ	O
vitreoretinal	JJ	B_Disease
dystrophy	NN	E_Disease
that	WDT	O
causes	VBZ	O
visual	JJ	B_Disease
loss	NN	E_Disease
in	IN	O
young	JJ	O
men	NNS	O
.	.	O

Recently	RB	O
,	,	O
a	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
this	DT	O
disease	NN	O
,	,	O
designated	VBN	O
XLRS1	NN	O
,	,	O
was	VBD	O
identified	VBN	O
,	,	O
and	CC	O
several	JJ	O
deleterious	JJ	O
gene	NN	O
mutations	NNS	O
were	VBD	O
reported	VBN	O
.	.	O

OBJECTIVE	NN	O
To	TO	O
analyze	VB	O
Japanese	JJ	O
patients	NNS	O
clinically	RB	O
diagnosed	VBN	O
as	IN	O
having	VBG	O
XLRS	NNP	S_Disease
formutational	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
XLRS1	NNP	O
gene	NN	O
.	.	O

METHODS	NNP	O
Ten	CD	O
patients	NNS	O
with	IN	O
XLRS	NNP	S_Disease
underwent	JJ	O
full	JJ	O
ophthalmologic	NN	O
examination	NN	O
,	,	O
including	VBG	O
slitlamp	JJ	O
biomicroscopy	NN	O
and	CC	O
dilated	VBD	O
funduscopy	NN	O
.	.	O

Genomic	NNP	O
DNA	NNP	O
was	VBD	O
isolated	VBN	O
from	IN	O
leukocytes	NNS	O
,	,	O
and	CC	O
all	DT	O
exons	NNS	O
of	IN	O
the	DT	O
XLRS1	NNP	O
gene	NN	O
were	VBD	O
amplified	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
and	CC	O
analyzed	VBD	O
using	VBG	O
a	DT	O
direct	JJ	O
sequencing	NN	O
method	NN	O
.	.	O

RESULTS	NNP	O
Point	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
XLRS1	NNP	O
gene	NN	O
were	VBD	O
identified	VBN	O
in	IN	O
all	DT	O
10	CD	O
patients	NNS	O
.	.	O

The	DT	O
mutations	NNS	O
were	VBD	O
identical	JJ	O
in	IN	O
each	DT	O
of	IN	O
2	CD	O
pairs	NNS	O
of	IN	O
brothers	NNS	O
.	.	O

Six	CD	O
of	IN	O
the	DT	O
point	NN	O
mutations	NNS	O
represented	VBD	O
missense	JJ	O
mutations	NNS	O
,	,	O
1	CD	O
was	VBD	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
,	,	O
and	CC	O
1	CD	O
was	VBD	O
a	DT	O
frameshift	JJ	O
mutation	NN	O
.	.	O

Five	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
are	VBP	O
newly	RB	O
reported	VBN	O
herein	NN	O
.	.	O

CONCLUSIONS	NNP	O
The	DT	O
discovery	NN	O
of	IN	O
new	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
this	DT	O
study	NN	O
increases	VBZ	O
the	DT	O
available	JJ	O
information	NN	O
regarding	VBG	O
the	DT	O
spectrum	NN	O
of	IN	O
genetic	JJ	B_Disease
abnormalities	NNS	E_Disease
and	CC	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
XLRS	NNP	S_Disease
.	.	O

However	RB	O
,	,	O
the	DT	O
limited	JJ	O
data	NNS	O
failed	VBD	O
to	TO	O
reveal	VB	O
a	DT	O
correlation	NN	O
between	IN	O
mutation	NN	O
and	CC	O
disease	NN	O
phenotype	NN	O
.	.	O

CLINICAL	JJ	O
RELEVANCE	NNP	O
Identification	NNP	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
XLRS1	NNP	O
gene	NN	O
and	CC	O
expanded	VBN	O
information	NN	O
on	IN	O
clinical	JJ	O
manifestations	NNS	O
will	MD	O
facilitate	VB	O
early	JJ	O
diagnosis	NN	O
,	,	O
appropriate	JJ	O
early	JJ	O
therapy	NN	O
,	,	O
and	CC	O
genetic	JJ	O
counseling	NN	O
regarding	VBG	O
the	DT	O
prognosis	NN	O
of	IN	O
XLRS	NNP	S_Disease
.	.	O
.	.	O

Atm	NNP	O
and	CC	O
Bax	NNP	O
cooperate	NN	O
in	IN	O
ionizing	VBG	O
radiation	NN	O
-	:	O
induced	JJ	O
apoptosis	NN	O
in	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
.	.	O

Ataxia	NNP	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
is	VBZ	O
a	DT	O
hereditary	JJ	B_Disease
multisystemic	JJ	I_Disease
disease	NN	E_Disease
resulting	VBG	O
from	IN	O
mutations	NNS	O
of	IN	O
ataxia	NN	B_Disease
telangiectasia	NN	E_Disease
,	,	O
mutated	VBN	O
(	(	O
ATM	NNP	O
)	)	O
and	CC	O
is	VBZ	O
characterized	VBN	O
by	IN	O
neurodegeneration	NN	S_Disease
,	,	O
cancer	NN	S_Disease
,	,	O
immune	JJ	B_Disease
defects	NNS	E_Disease
,	,	O
and	CC	O
hypersensitivity	NN	B_Disease
to	TO	I_Disease
ionizing	VBG	I_Disease
radiation	NN	E_Disease
.	.	O

The	DT	O
molecular	JJ	O
details	NNS	O
of	IN	O
ATM	NNP	O
function	NN	O
in	IN	O
the	DT	O
nervous	JJ	O
system	NN	O
are	VBP	O
unclear	JJ	O
,	,	O
although	IN	O
the	DT	O
neurological	JJ	B_Disease
lesion	NN	E_Disease
in	IN	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
becomes	VBZ	O
apparent	JJ	O
early	JJ	O
in	IN	O
life	NN	O
,	,	O
suggesting	VBG	O
a	DT	O
developmental	JJ	O
origin	NN	O
.	.	O

The	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
(	(	O
CNS	NNP	O
)	)	O
of	IN	O
Atm	NNP	O
-	:	O
null	NN	O
mice	NN	O
shows	VBZ	O
a	DT	O
pronounced	JJ	O
defect	NN	O
in	IN	O
apoptosis	NN	O
induced	VBN	O
by	IN	O
genotoxic	NN	O
stress	NN	O
,	,	O
suggesting	VBG	O
ATM	NNP	O
functions	NNS	O
to	TO	O
eliminate	VB	O
neurons	NNS	O
with	IN	O
excessive	JJ	O
genomic	JJ	O
damage	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
that	IN	O
the	DT	O
death	NN	O
effector	NN	O
Bax	NNP	O
is	VBZ	O
required	VBN	O
for	IN	O
a	DT	O
large	JJ	O
proportion	NN	O
of	IN	O
Atm	NNP	O
-	:	O
dependent	JJ	O
apoptosis	NN	O
in	IN	O
the	DT	O
developing	NN	O
CNS	NNP	O
after	IN	O
ionizing	VBG	O
radiation	NN	O
(	(	O
IR	NNP	O
)	)	O
.	.	O

Although	IN	O
many	JJ	O
of	IN	O
the	DT	O
same	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
CNS	NNP	O
in	IN	O
both	DT	O
Bax	NNP	O
-	:	O
/	SYM	O
-	:	O
and	CC	O
Atm	NNP	O
-	:	O
/	SYM	O
-	:	O
mice	NN	O
were	VBD	O
radioresistant	JJ	O
,	,	O
mice	RB	O
nullizygous	JJ	O
for	IN	O
both	DT	O
Bax	NNP	O
and	CC	O
Atm	NNP	O
showed	VBD	O
additional	JJ	O
reduction	NN	O
in	IN	O
IR	NNP	O
-	:	O
induced	JJ	O
apoptosis	NN	O
in	IN	O
the	DT	O
CNS	NNP	O
.	.	O

Therefore	RB	O
,	,	O
although	IN	O
the	DT	O
major	JJ	O
IR	NNP	O
-	:	O
induced	VBD	O
apoptotic	JJ	O
pathway	NN	O
in	IN	O
the	DT	O
CNS	NNP	O
requires	VBZ	O
Atm	NNP	O
and	CC	O
Bax	NNP	O
,	,	O
a	DT	O
p53	NN	O
-	:	O
dependent	JJ	O
collateral	JJ	O
pathway	NN	O
exists	VBZ	O
that	WDT	O
has	VBZ	O
both	DT	O
Atm	NNP	O
-	:	O
and	CC	O
Bax	NNP	O
-	:	O
independent	JJ	O
branches	NNS	O
.	.	O

Further	RB	O
,	,	O
Atm	NNP	O
-	:	O
and	CC	O
Bax	NNP	O
-	:	O
dependent	JJ	O
apoptosis	NN	O
in	IN	O
the	DT	O
CNS	NNP	O
also	RB	O
required	VBD	O
caspase	NN	O
-	:	O
3	CD	O
activation	NN	O
.	.	O

These	DT	O
data	NNS	O
implicate	NN	O
Bax	NNP	O
and	CC	O
caspase	VB	O
-	:	O
3	CD	O
as	IN	O
death	NN	O
effectors	NNS	O
in	IN	O
neurodegenerative	JJ	O
pathways	NNS	O
.	.	O
.	.	O

Haim	NNP	B_Disease
-	:	I_Disease
Munk	NNP	I_Disease
syndrome	NN	E_Disease
and	CC	O
Papillon	NNP	B_Disease
-	:	I_Disease
Lefevre	NNP	I_Disease
syndrome	NN	E_Disease
are	VBP	O
allelic	JJ	O
mutations	NNS	O
in	IN	O
cathepsin	NN	O
C	NNP	O
.	.	O

Of	IN	O
the	DT	O
many	JJ	O
palmoplantar	NN	B_Disease
keratoderma	NNS	I_Disease
(	(	I_Disease
PPK	NNP	I_Disease
)	)	I_Disease
conditions	NNS	E_Disease
,	,	O
only	RB	O
Papillon	NNP	B_Disease
-	:	I_Disease
Lefevre	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PLS	NNP	S_Disease
)	)	O
and	CC	O
Haim	NNP	B_Disease
-	:	I_Disease
Munk	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
HMS	NNP	S_Disease
)	)	O
are	VBP	O
associated	VBN	O
with	IN	O
premature	JJ	O
periodontal	JJ	O
destruction	NN	O
.	.	O

Although	IN	O
both	DT	O
PLS	NNP	S_Disease
and	CC	O
HMS	NNP	S_Disease
share	NN	O
the	DT	O
cardinal	JJ	O
features	NNS	O
of	IN	O
PPK	NNP	S_Disease
and	CC	O
severe	JJ	O
periodontitis	NN	S_Disease
,	,	O
a	DT	O
number	NN	O
of	IN	O
additional	JJ	O
findings	NNS	O
are	VBP	O
reported	VBN	O
in	IN	O
HMS	NNP	S_Disease
including	VBG	O
arachnodactyly	NN	S_Disease
,	,	O
acro	SYM	B_Disease
-	:	I_Disease
osteolysis	NN	E_Disease
,	,	O
atrophic	JJ	B_Disease
changes	NNS	I_Disease
of	IN	I_Disease
the	DT	I_Disease
nails	NNS	E_Disease
,	,	O
and	CC	O
a	DT	O
radiographic	JJ	B_Disease
deformity	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
fingers	NNS	E_Disease
.	.	O

While	IN	O
PLS	NNP	S_Disease
cases	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
throughout	IN	O
the	DT	O
world	NN	O
,	,	O
HMS	NNP	S_Disease
has	VBZ	O
only	RB	O
been	VBN	O
described	VBN	O
among	IN	O
descendants	NNS	O
of	IN	O
a	DT	O
religious	JJ	O
isolate	NN	O
originally	RB	O
from	IN	O
Cochin	NNP	O
,	,	O
India	NNP	O
.	.	O

Parental	JJ	O
consanguinity	NN	O
is	VBZ	O
a	DT	O
characteristic	JJ	O
of	IN	O
many	JJ	O
cases	NNS	O
of	IN	O
both	DT	O
conditions	NNS	O
.	.	O

Although	IN	O
autosomal	JJ	O
recessive	JJ	O
transmission	NN	O
of	IN	O
PLS	NNP	S_Disease
is	VBZ	O
evident	JJ	O
,	,	O
a	DT	O
more	RBR	O
"	JJ	O
complex	JJ	O
"	NN	O
autosomal	JJ	O
recessive	JJ	O
pattern	NN	O
of	IN	O
inheritance	NN	O
with	IN	O
phenotypic	JJ	O
influences	NNS	O
from	IN	O
a	DT	O
closely	RB	O
linked	VBN	O
modifying	NN	O
locus	NN	O
has	VBZ	O
been	VBN	O
hypothesised	VBN	O
for	IN	O
HMS	NNP	S_Disease
.	.	O

Recently	RB	O
,	,	O
mutations	NNS	O
of	IN	O
the	DT	O
cathepsin	NN	O
C	NNP	O
gene	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
as	IN	O
the	DT	O
underlying	JJ	O
genetic	JJ	B_Disease
defect	NN	E_Disease
in	IN	O
PLS	NNP	S_Disease
.	.	O

To	TO	O
determine	VB	O
if	IN	O
a	DT	O
cathepsin	NN	O
C	NNP	O
mutation	NN	O
is	VBZ	O
also	RB	O
responsible	JJ	O
for	IN	O
HMS	NNP	S_Disease
,	,	O
we	PRP	O
sequenced	VBD	O
the	DT	O
gene	NN	O
in	IN	O
affected	JJ	O
and	CC	O
unaffected	JJ	O
subjects	NNS	O
from	IN	O
the	DT	O
Cochin	NNP	O
isolate	NN	O
in	IN	O
which	WDT	O
both	CC	O
the	DT	O
PLS	NNP	S_Disease
and	CC	O
HMS	NNP	S_Disease
phenotypes	NNS	O
appear	VBP	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
identification	NN	O
of	IN	O
a	DT	O
mutation	NN	O
of	IN	O
cathepsin	NN	O
C	NNP	O
(	(	O
exon	JJ	O
6	CD	O
,	,	O
2127A	CD	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
)	)	O
that	WDT	O
changes	VBZ	O
a	DT	O
highly	RB	O
conserved	VBN	O
amino	NN	O
acid	NN	O
in	IN	O
the	DT	O
cathepsin	NN	O
C	NNP	O
peptide	NN	O
.	.	O

This	DT	O
mutation	NN	O
segregates	VBZ	O
with	IN	O
HMS	NNP	S_Disease
in	IN	O
four	CD	O
nuclear	JJ	O
families	NNS	O
.	.	O

Additionally	RB	O
,	,	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
shared	JJ	O
common	JJ	O
haplotype	NN	O
for	IN	O
genetic	JJ	O
loci	NN	O
flanking	VBG	O
the	DT	O
cathepsin	NN	O
C	NNP	O
gene	NN	O
suggests	VBZ	O
that	IN	O
affected	JJ	O
subjects	NNS	O
descended	VBN	O
from	IN	O
the	DT	O
Cochin	NNP	O
isolate	NN	O
are	VBP	O
homozygous	JJ	O
for	IN	O
a	DT	O
mutation	NN	O
inherited	VBN	O
"	NNP	O
identical	JJ	O
by	IN	O
descent	JJ	O
"	NN	O
from	IN	O
a	DT	O
common	JJ	O
ancestor	NN	O
.	.	O

This	DT	O
finding	NN	O
supports	VBZ	O
simple	JJ	O
autosomal	JJ	O
recessive	JJ	O
inheritance	NN	O
for	IN	O
HMS	NNP	S_Disease
in	IN	O
these	DT	O
families	NNS	O
.	.	O

We	PRP	O
also	RB	O
report	VBP	O
a	DT	O
mutation	NN	O
of	IN	O
the	DT	O
same	JJ	O
exon	NN	O
6	CD	O
CTSC	NNP	O
codon	NN	O
(	(	O
2126C	CD	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
)	)	O
in	IN	O
a	DT	O
Turkish	JJ	O
family	NN	O
with	IN	O
classical	JJ	O
PLS	NNP	S_Disease
.	.	O

These	DT	O
findings	NNS	O
provide	VBP	O
evidence	NN	O
that	IN	O
PLS	NNP	S_Disease
and	CC	O
HMS	NNP	S_Disease
are	VBP	O
allelic	JJ	O
variants	NNS	O
of	IN	O
cathepsin	NN	O
C	NNP	O
gene	NN	O
mutations	NNS	O
.	.	O
.	.	O

ATM	NNP	O
-	:	O
heterozygous	JJ	O
germline	NN	O
mutations	NNS	O
contribute	VBP	O
to	TO	O
breast	VB	B_Disease
cancer	NN	E_Disease
-	:	O
susceptibility	NN	O
.	.	O

Approximately	RB	O
0	CD	O
.	.	O

5	CD	O
%	NN	O
-	:	O
1	CD	O
%	NN	O
of	IN	O
the	DT	O
general	JJ	O
population	NN	O
has	VBZ	O
been	VBN	O
estimated	VBN	O
to	TO	O
be	VB	O
heterozygous	JJ	O
for	IN	O
a	DT	O
germline	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
the	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
ataxia	SYM	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
(	(	O
A	DT	B_Disease
-	:	I_Disease
T	NN	E_Disease
)	)	O
(	(	O
MIM	NNP	O
208900	CD	O
)	)	O
.	.	O

The	DT	O
finding	NN	O
that	WDT	O
ATM	NNP	O
-	:	O
heterozygotes	NNS	O
have	VBP	O
an	DT	O
increased	VBN	O
relative	NN	O
risk	NN	O
for	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
was	VBD	O
supported	VBN	O
by	IN	O
some	DT	O
studies	NNS	O
but	CC	O
not	RB	O
confirmed	VBN	O
by	IN	O
others	NNS	O
.	.	O

In	IN	O
view	NN	O
of	IN	O
this	DT	O
discrepancy	NN	O
,	,	O
we	PRP	O
examined	VBD	O
the	DT	O
frequency	NN	O
of	IN	O
ATM	NNP	O
germline	NN	O
mutations	NNS	O
in	IN	O
a	DT	O
selected	VBN	O
group	NN	O
of	IN	O
Dutch	JJ	O
patients	NNS	O
with	IN	O
breast	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
analyzed	VBN	O
ATM	NNP	O
germline	JJ	O
mutations	NNS	O
in	IN	O
normal	JJ	O
blood	NN	O
lymphocytes	NNS	O
,	,	O
using	VBG	O
the	DT	O
protein	NN	O
-	:	O
truncation	NN	O
test	NN	O
followed	VBN	O
by	IN	O
genomic	JJ	O
-	:	O
sequence	NN	O
analysis	NN	O
.	.	O

A	DT	O
high	JJ	O
percentage	NN	O
of	IN	O
ATM	NNP	O
germline	NN	O
mutations	NNS	O
was	VBD	O
demonstrated	VBN	O
among	IN	O
patients	NNS	O
with	IN	O
sporadic	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
.	.	O

The	DT	O
82	CD	O
patients	NNS	O
included	VBN	O
in	IN	O
this	DT	O
study	NN	O
had	VBD	O
developed	VBN	O
breast	NN	B_Disease
cancer	NN	E_Disease
at	IN	O
age	NN	O
<	$	O
45	CD	O
and	CC	O
had	VBD	O
survived	VBN	O
>	JJ	O
/	NNP	O
=	NNP	O
5	CD	O
years	NNS	O
(	(	O
mean	JJ	O
15	CD	O
years	NNS	O
)	)	O
,	,	O
and	CC	O
in	IN	O
33	CD	O
(	(	O
40	CD	O
%	NN	O
)	)	O
of	IN	O
the	DT	O
patients	NNS	O
a	DT	O
contralateral	JJ	O
breast	NN	O
tumor	NN	O
had	VBD	O
been	VBN	O
diagnosed	VBN	O
.	.	O

Among	IN	O
these	DT	O
patients	NNS	O
we	PRP	O
identified	VBD	O
seven	CD	O
(	(	O
8	CD	O
.	.	O

5	CD	O
%	NN	O
)	)	O
ATM	NNP	O
germline	NN	O
mutations	NNS	O
,	,	O
of	IN	O
which	WDT	O
five	CD	O
are	VBP	O
distinct	JJ	O
.	.	O

One	CD	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
(	(	O
IVS10	NNP	O
-	:	O
6T	CD	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
)	)	O
was	VBD	O
detected	VBN	O
three	CD	O
times	NNS	O
in	IN	O
our	PRP$	O
series	NN	O
.	.	O

Four	CD	O
heterozygous	JJ	O
carriers	NNS	O
were	VBD	O
patients	NNS	O
with	IN	O
bilateral	JJ	O
breast	NN	O
cancer	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
mutations	NNS	O
identified	VBN	O
in	IN	O
this	DT	O
study	NN	O
are	VBP	O
"	VBZ	O
A	NNP	O
-	:	O
T	NN	O
disease	NN	O
-	:	O
causing	NN	O
"	JJ	O
mutations	NNS	O
that	WDT	O
might	MD	O
be	VB	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
breast	NN	O
cancer	NN	O
in	IN	O
heterozygotes	NNS	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
ATM	NNP	O
heterozygotes	NNS	O
have	VBP	O
an	DT	O
approximately	RB	O
ninefold	JJ	O
-	:	O
increased	VBN	O
risk	NN	O
of	IN	O
developing	VBG	O
a	DT	O
type	NN	O
of	IN	O
breast	NN	O
cancer	NN	O
characterized	VBN	O
by	IN	O
frequent	JJ	O
bilateral	JJ	O
occurrence	NN	O
,	,	O
early	JJ	O
age	NN	O
at	IN	O
onset	NN	O
,	,	O
and	CC	O
long	RB	O
-	:	O
term	NN	O
survival	NN	O
.	.	O

The	DT	O
specific	JJ	O
characteristics	NNS	O
of	IN	O
our	PRP$	O
population	NN	O
of	IN	O
patients	NNS	O
may	MD	O
explain	VB	O
why	WRB	O
such	PDT	O
a	DT	O
high	JJ	O
frequency	NN	O
was	VBD	O
not	RB	O
found	VBN	O
in	IN	O
other	JJ	O
series	NN	O
.	.	O

Human	JJ	O
mutations	NNS	O
in	IN	O
glucose	JJ	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
reflect	VBP	O
evolutionary	JJ	O
history	NN	O
.	.	O

Glucose	NNP	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
is	VBZ	O
a	DT	O
cytosolic	JJ	O
enzyme	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
housekeeping	NN	O
X	SYM	O
-	:	O
linked	VBN	O
gene	NN	O
whose	WP$	O
main	JJ	O
function	NN	O
is	VBZ	O
to	TO	O
produce	VB	O
NADPH	NNP	O
,	,	O
a	DT	O
key	JJ	O
electron	NN	O
donor	NN	O
in	IN	O
the	DT	O
defense	NN	O
against	IN	O
oxidizing	VBG	O
agents	NNS	O
and	CC	O
in	IN	O
reductive	JJ	O
biosynthetic	JJ	O
reactions	NNS	O
.	.	O

Inherited	VBN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
associated	VBN	O
with	IN	O
either	DT	O
episodic	JJ	B_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
(	(	O
triggered	VBN	O
by	IN	O
fava	JJ	O
beans	NNS	O
or	CC	O
other	JJ	O
agents	NNS	O
)	)	O
or	CC	O
life	NN	B_Disease
-	:	I_Disease
long	JJ	I_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
.	.	O

We	PRP	O
show	VBP	O
here	RB	O
that	IN	O
an	DT	O
evolutionary	JJ	O
analysis	NN	O
is	VBZ	O
a	DT	O
key	JJ	O
to	TO	O
understanding	VBG	O
the	DT	O
biology	NN	O
of	IN	O
a	DT	O
housekeeping	JJ	O
gene	NN	O
.	.	O

From	IN	O
the	DT	O
alignment	NN	O
of	IN	O
the	DT	O
amino	NN	O
acid	NN	O
(	(	O
aa	NN	O
)	)	O
sequence	NN	O
of	IN	O
52	CD	O
glucose	JJ	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
species	VBZ	O
from	IN	O
42	CD	O
different	JJ	O
organisms	NNS	O
,	,	O
we	PRP	O
found	VBD	O
a	DT	O
striking	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
aa	NN	O
replacements	NNS	O
that	WDT	O
cause	VBP	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
humans	NNS	O
and	CC	O
the	DT	O
sequence	NN	O
conservation	NN	O
of	IN	O
G6PD	NNP	O
two	CD	O
-	:	O
thirds	NNS	O
of	IN	O
such	JJ	O
replacements	NNS	O
are	VBP	O
in	IN	O
highly	RB	O
and	CC	O
moderately	RB	O
conserved	VBD	O
(	(	O
50	CD	O
-	:	O
99	CD	O
%	NN	O
)	)	O
aa	NN	O
;	:	O
relatively	RB	O
few	JJ	O
are	VBP	O
in	IN	O
fully	RB	O
conserved	VBN	O
aa	NN	O
(	(	O
where	WRB	O
they	PRP	O
might	MD	O
be	VB	O
lethal	JJ	O
)	)	O
or	CC	O
in	IN	O
poorly	RB	O
conserved	VBN	O
aa	NN	O
,	,	O
where	WRB	O
presumably	RB	O
they	PRP	O
simply	RB	O
would	MD	O
not	RB	O
cause	VB	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

This	DT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
notion	NN	O
that	IN	O
all	DT	O
human	JJ	O
mutants	NNS	O
have	VBP	O
residual	JJ	O
enzyme	NN	O
activity	NN	O
and	CC	O
that	IN	O
null	JJ	O
mutations	NNS	O
are	VBP	O
lethal	VBN	O
at	IN	O
some	DT	O
stage	NN	O
of	IN	O
development	NN	O
.	.	O

Comparing	VBG	O
the	DT	O
distribution	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
a	DT	O
human	JJ	O
housekeeping	NN	O
gene	NN	O
with	IN	O
evolutionary	JJ	O
conservation	NN	O
is	VBZ	O
a	DT	O
useful	JJ	O
tool	NN	O
for	IN	O
pinpointing	VBG	O
amino	NN	O
acid	NN	O
residues	NNS	O
important	JJ	O
for	IN	O
the	DT	O
stability	NN	O
or	CC	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
corresponding	JJ	O
protein	NN	O
.	.	O

In	IN	O
view	NN	O
of	IN	O
the	DT	O
current	JJ	O
explosive	JJ	O
increase	NN	O
in	IN	O
full	JJ	O
genome	NN	O
sequencing	VBG	O
projects	NNS	O
,	,	O
this	DT	O
tool	NN	O
will	MD	O
become	VB	O
rapidly	RB	O
available	JJ	O
for	IN	O
numerous	JJ	O
other	JJ	O
genes	NNS	O
.	.	O
.	.	O

Constitutive	JJ	O
and	CC	O
regulated	JJ	O
modes	NNS	O
of	IN	O
splicing	VBG	O
produce	NN	O
six	CD	O
major	JJ	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
protein	NN	O
kinase	NN	O
(	(	O
DMPK	NNP	O
)	)	O
isoforms	VBZ	O
with	IN	O
distinct	JJ	O
properties	NNS	O
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
is	VBZ	O
the	DT	O
most	RBS	O
prevalent	JJ	O
inherited	JJ	B_Disease
neuromuscular	JJ	I_Disease
disease	NN	E_Disease
in	IN	O
adults	NNS	O
.	.	O

The	DT	O
genetic	JJ	B_Disease
defect	NN	E_Disease
is	VBZ	O
a	DT	O
CTG	NNP	O
triplet	NN	O
repeat	NN	O
expansion	NN	O
in	IN	O
the	DT	O
3	CD	O
-	:	O
untranslated	JJ	O
region	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
protein	NN	O
kinase	NN	O
(	(	O
DMPK	NNP	O
)	)	O
gene	NN	O
,	,	O
consisting	VBG	O
of	IN	O
15	CD	O
exons	NNS	O
.	.	O

Using	VBG	O
a	DT	O
transgenic	JJ	O
DMPK	NNP	O
-	:	O
overexpressor	NN	O
mouse	NN	O
model	NN	O
,	,	O
we	PRP	O
demonstrate	VBP	O
here	RB	O
that	IN	O
the	DT	O
endogenous	JJ	O
mouse	NN	O
DMPK	NNP	O
gene	NN	O
and	CC	O
the	DT	O
human	JJ	O
DMPK	NNP	O
transgene	NN	O
produce	VBP	O
six	CD	O
major	JJ	O
alternatively	RB	O
spliced	VBN	O
mRNAs	NN	O
which	WDT	O
have	VBP	O
almost	RB	O
identical	JJ	O
cell	NN	O
type	SYM	O
-	:	O
dependent	JJ	O
distribution	NN	O
frequencies	NNS	O
and	CC	O
expression	NN	O
patterns	NNS	O
.	.	O

Use	NNP	O
of	IN	O
a	DT	O
cryptic	JJ	O
5	CD	O
splice	NN	O
site	NN	O
in	IN	O
exon	JJ	O
8	CD	O
,	,	O
which	WDT	O
results	NNS	O
in	IN	O
absence	NN	O
or	CC	O
presence	NN	O
of	IN	O
15	CD	O
nucleotides	NNS	O
specifying	VBG	O
a	DT	O
VSGGG	NNP	O
peptide	NN	O
motif	NN	O
,	,	O
and	CC	O
/	NNP	O
or	CC	O
use	NN	O
of	IN	O
a	DT	O
cryptic	JJ	O
3	CD	O
splice	NN	O
site	NN	O
in	IN	O
exon	JJ	O
14	CD	O
,	,	O
which	WDT	O
leads	VBZ	O
to	TO	O
a	DT	O
frameshift	NN	O
in	IN	O
the	DT	O
mRNA	NN	O
reading	NN	O
frame	NN	O
,	,	O
occur	VBP	O
as	IN	O
independent	JJ	O
stochastic	JJ	O
events	NNS	O
in	IN	O
all	DT	O
tissues	NNS	O
examined	VBN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
the	DT	O
excision	NN	O
of	IN	O
exons	NNS	O
13	CD	O
/	$	O
14	CD	O
that	WDT	O
causes	VBZ	O
a	DT	O
frameshift	NN	O
and	CC	O
creates	VBZ	O
a	DT	O
C	NNP	O
-	:	O
terminally	RB	O
truncated	VBN	O
protein	NN	O
is	VBZ	O
clearly	RB	O
cell	JJ	O
type	NN	O
dependent	NN	O
and	CC	O
occurs	VBZ	O
predominantly	RB	O
in	IN	O
smooth	JJ	O
muscle	NN	O
.	.	O

We	PRP	O
generated	VBD	O
all	DT	O
six	CD	O
full	JJ	O
-	:	O
length	NN	O
mouse	NN	O
cDNAs	NN	O
that	WDT	O
result	NN	O
from	IN	O
combinations	NNS	O
of	IN	O
these	DT	O
three	CD	O
major	JJ	O
splicing	VBG	O
events	NNS	O
and	CC	O
show	VBP	O
that	IN	O
their	PRP$	O
transfection	NN	O
into	IN	O
cells	NNS	O
in	IN	O
culture	NN	O
leads	VBZ	O
to	TO	O
production	NN	O
of	IN	O
four	CD	O
different	JJ	O
approximately	RB	O
74	CD	O
kDa	NNS	O
full	JJ	O
-	:	O
length	NN	O
(	(	O
heart	NN	O
-	:	O
,	,	O
skeletal	JJ	O
muscle	NN	O
-	:	O
or	CC	O
brain	NN	O
-	:	O
specific	NN	O
)	)	O
and	CC	O
two	CD	O
C	NNP	O
-	:	O
terminally	RB	O
truncated	VBD	O
approximately	RB	O
68	CD	O
kDa	NNS	O
(	(	O
smooth	JJ	O
muscle	NN	O
-	:	O
specific	NN	O
)	)	O
isoforms	NNS	O
.	.	O

Information	NN	O
on	IN	O
DMPK	NNP	O
mRNA	NN	O
and	CC	O
protein	NN	O
isoform	NN	O
expression	NN	O
patterns	NNS	O
will	MD	O
be	VB	O
useful	JJ	O
for	IN	O
recognizing	VBG	O
differential	JJ	O
effects	NNS	O
of	IN	O
(	(	O
CTG	NNP	O
)	)	O
(	(	O
n	JJ	O
)	)	O
expansion	NN	O
in	IN	O
DM	NNP	S_Disease
manifestation	NN	O
.	.	O
.	.	O

Genetic	JJ	O
analysis	NN	O
,	,	O
phenotypic	NN	O
diagnosis	NN	O
,	,	O
and	CC	O
risk	NN	O
of	IN	O
venous	JJ	B_Disease
thrombosis	NN	E_Disease
in	IN	O
families	NNS	O
with	IN	O
inherited	JJ	O
deficiencies	NNS	B_Disease
of	IN	I_Disease
protein	NN	I_Disease
S	NNP	E_Disease
.	.	O

Protein	NNP	B_Disease
S	NNP	I_Disease
deficiency	NN	E_Disease
is	VBZ	O
a	DT	O
recognized	VBN	O
risk	NN	O
factor	NN	O
for	IN	O
venous	JJ	B_Disease
thrombosis	NN	E_Disease
.	.	O

Of	IN	O
all	PDT	O
the	DT	O
inherited	VBN	O
thrombophilic	JJ	B_Disease
conditions	NNS	E_Disease
,	,	O
it	PRP	O
remains	VBZ	O
the	DT	O
most	RBS	O
difficult	JJ	O
to	TO	O
diagnose	VB	O
because	IN	O
of	IN	O
phenotypic	NN	O
variability	NN	O
,	,	O
which	WDT	O
can	MD	O
lead	VB	O
to	TO	O
inconclusive	JJ	O
results	NNS	O
.	.	O

We	PRP	O
have	VBP	O
overcome	VBN	O
this	DT	O
problem	NN	O
by	IN	O
studying	VBG	O
a	DT	O
cohort	NN	O
of	IN	O
patients	NNS	O
from	IN	O
a	DT	O
single	JJ	O
center	NN	O
where	WRB	O
the	DT	O
diagnosis	NN	O
was	VBD	O
confirmed	VBN	O
at	IN	O
the	DT	O
genetic	JJ	O
level	NN	O
.	.	O

Twenty	NNP	O
-	:	O
eight	CD	O
index	NN	O
patients	NNS	O
with	IN	O
protein	JJ	B_Disease
S	NNP	I_Disease
deficiency	NN	E_Disease
and	CC	O
a	DT	O
PROS1	NNP	B_Disease
gene	NN	I_Disease
defect	NN	E_Disease
were	VBD	O
studied	VBN	O
,	,	O
together	RB	O
with	IN	O
109	CD	O
first	JJ	O
-	:	O
degree	NN	O
relatives	NNS	O
.	.	O

To	TO	O
avoid	VB	O
selection	NN	O
bias	NN	O
,	,	O
we	PRP	O
confined	VBD	O
analysis	NN	O
of	IN	O
total	JJ	O
and	CC	O
free	JJ	O
protein	NN	O
S	NNP	O
levels	NNS	O
and	CC	O
thrombotic	JJ	O
risk	NN	O
to	TO	O
the	DT	O
patients	NNS	O
relatives	NNS	O
.	.	O

In	IN	O
this	DT	O
group	NN	O
of	IN	O
relatives	NNS	O
,	,	O
a	DT	O
low	JJ	O
free	JJ	O
protein	NN	O
S	NNP	O
level	NN	O
was	VBD	O
the	DT	O
most	RBS	O
reliable	JJ	O
predictor	NN	O
of	IN	O
a	DT	O
PROS1	NNP	B_Disease
gene	NN	I_Disease
defect	NN	E_Disease
(	(	O
sensitivity	NN	O
97	CD	O
.	.	O

7	CD	O
%	NN	O
,	,	O
specificity	NN	O
100	CD	O
%	NN	O
)	)	O
.	.	O

First	LS	O
-	:	O
degree	NN	O
relatives	VBZ	O
with	IN	O
a	DT	O
PROS1	NNP	B_Disease
gene	NN	I_Disease
defect	NN	E_Disease
had	VBD	O
a	DT	O
5	CD	O
.	.	O

0	CD	O
-	:	O
fold	NN	O
higher	JJR	O
risk	NN	O
of	IN	O
thrombosis	NN	S_Disease
(	(	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
,	,	O
1	CD	O
.	.	O

5	CD	O
-	:	O
16	CD	O
.	.	O

8	CD	O
)	)	O
than	IN	O
those	DT	O
with	IN	O
a	DT	O
normal	JJ	O
PROS1	NNP	O
gene	NN	O
and	CC	O
no	DT	O
other	JJ	O
recognized	VBN	O
thrombophilic	JJ	B_Disease
defect	NN	E_Disease
.	.	O

Although	IN	O
pregnancy	NN	O
/	NNP	O
puerperium	NN	O
and	CC	O
immobility	NN	O
/	VBP	O
trauma	NN	S_Disease
were	VBD	O
important	JJ	O
precipitating	NN	O
factors	NNS	O
for	IN	O
thrombosis	NN	S_Disease
,	,	O
almost	RB	O
half	NN	O
of	IN	O
the	DT	O
events	NNS	O
were	VBD	O
spontaneous	JJ	O
.	.	O

Relatives	NNS	O
with	IN	O
splice	NN	O
-	:	O
site	NN	O
or	CC	O
major	JJ	O
structural	JJ	O
defects	NNS	B_Disease
in	IN	I_Disease
the	DT	I_Disease
PROS1	NNP	I_Disease
gene	NN	E_Disease
were	VBD	O
more	RBR	O
likely	JJ	O
to	TO	O
have	VB	O
had	VBN	O
a	DT	O
thrombotic	JJ	O
event	NN	O
and	CC	O
had	VBD	O
significantly	RB	O
lower	JJR	O
total	NN	O
and	CC	O
free	JJ	O
protein	NN	O
S	NNP	O
levels	NNS	O
than	IN	O
those	DT	O
relatives	NNS	O
having	VBG	O
missense	JJ	O
mutations	NNS	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
persons	NNS	O
with	IN	O
PROS1	NNP	B_Disease
gene	NN	I_Disease
defects	NNS	E_Disease
and	CC	O
protein	NN	B_Disease
S	NNP	I_Disease
deficiency	NN	E_Disease
are	VBP	O
at	IN	O
increased	JJ	O
risk	NN	O
of	IN	O
thrombosis	NN	S_Disease
and	CC	O
that	IN	O
free	JJ	O
protein	NN	O
S	NNP	O
estimation	NN	O
offers	VBZ	O
the	DT	O
most	RBS	O
reliable	JJ	O
way	NN	O
of	IN	O
diagnosing	VBG	O
the	DT	O
deficiency	NN	O
.	.	O

(	(	O
Blood	NNP	O
.	.	O

2000	CD	O
;	:	O
95	CD	O
1935	CD	O
-	:	O
1941	CD	O
)	)	O
.	.	O

Autoimmune	NNP	B_Disease
lymphoproliferative	JJ	I_Disease
syndrome	NN	E_Disease
(	(	O
ALPS	NNP	S_Disease
)	)	O
in	IN	O
a	DT	O
child	NN	O
from	IN	O
consanguineous	JJ	O
parents	NNS	O
:	:	O
a	DT	O
dominant	JJ	O
or	CC	O
recessive	JJ	O
disease	NN	O
?	.	O
Autoimmune	NNP	B_Disease
lymphoproliferative	JJ	I_Disease
syndrome	NN	E_Disease
(	(	O
ALPS	NNP	S_Disease
)	)	O
is	VBZ	O
characterized	VBN	O
by	IN	O
autoimmune	NN	O
features	NNS	O
and	CC	O
lymphoproliferations	NNS	O
and	CC	O
is	VBZ	O
generally	RB	O
caused	VBN	O
by	IN	O
defective	JJ	O
Fas	NNP	O
-	:	O
mediated	VBD	O
apoptosis	NN	O
.	.	O

This	DT	O
report	NN	O
describes	VBZ	O
a	DT	O
child	NN	O
with	IN	O
clinical	JJ	O
features	NNS	O
of	IN	O
ALPS	NNP	S_Disease
without	IN	O
detectable	JJ	O
Fas	NNP	O
expression	NN	O
on	IN	O
freshly	RB	O
isolated	VBN	O
blood	NN	O
leukocytes	NNS	O
.	.	O

Detection	NN	O
of	IN	O
FAS	NNP	O
transcripts	NNS	O
via	IN	O
real	JJ	O
-	:	O
time	NN	O
quantitative	JJ	O
PCR	NNP	O
made	VBD	O
a	DT	O
severe	JJ	O
transcriptional	JJ	O
defect	NN	O
unlikely	JJ	O
.	.	O

Sequencing	VBG	O
of	IN	O
the	DT	O
FAS	NNP	O
gene	NN	O
revealed	VBD	O
a	DT	O
20	CD	O
-	:	O
nucleotide	JJ	O
duplication	NN	O
in	IN	O
the	DT	O
last	JJ	O
exon	NN	O
affecting	VBG	O
the	DT	O
cytoplasmic	JJ	O
signaling	NN	O
domain	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
homozygous	JJ	O
for	IN	O
this	DT	O
mutation	NN	O
,	,	O
whereas	IN	O
the	DT	O
consanguineous	JJ	O
parents	NNS	O
and	CC	O
the	DT	O
siblings	NNS	O
were	VBD	O
heterozygous	JJ	O
.	.	O

The	DT	O
patient	NN	O
reported	VBD	O
here	RB	O
is	VBZ	O
a	DT	O
human	JJ	O
homologue	NN	O
of	IN	O
the	DT	O
Fas	NNP	O
-	:	O
null	NN	O
mouse	NN	O
,	,	O
inasmuch	JJ	O
as	IN	O
she	PRP	O
carries	VBZ	O
an	DT	O
autosomal	JJ	O
homozygous	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
FAS	NNP	O
gene	NN	O
and	CC	O
she	PRP	O
shows	VBZ	O
the	DT	O
severe	JJ	O
and	CC	O
accelerated	JJ	O
ALPS	NNP	S_Disease
phenotype	NN	O
.	.	O

The	DT	O
heterozygous	JJ	O
family	NN	O
members	NNS	O
did	VBD	O
not	RB	O
have	VB	O
the	DT	O
ALPS	NNP	S_Disease
phenotype	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
disease	NN	O
-	:	O
causing	NN	O
FAS	NNP	O
mutation	NN	O
in	IN	O
this	DT	O
family	NN	O
is	VBZ	O
autosomal	JJ	O
recessive	JJ	O
.	.	O
.	.	O

Identification	NN	O
of	IN	O
novel	NN	O
imprinted	VBN	O
transcripts	NNS	O
in	IN	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
and	CC	O
Angelman	NNP	B_Disease
syndrome	VBP	E_Disease
deletion	NN	O
region	NN	O
:	:	O
further	JJ	O
evidence	NN	O
for	IN	O
regional	JJ	O
imprinting	NN	O
control	NN	O
.	.	O

Deletions	NNS	O
and	CC	O
other	JJ	O
abnormalities	NNS	O
of	IN	O
human	JJ	O
chromosome	NN	O
15q11	CD	O
-	:	O
q13	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
two	CD	O
developmental	JJ	O
disorders	NNS	O
,	,	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
and	CC	O
Angelman	NNP	B_Disease
syndrome	VBP	E_Disease
(	(	O
AS	IN	S_Disease
)	)	O
.	.	O

Loss	NNP	O
of	IN	O
expression	NN	O
of	IN	O
imprinted	JJ	O
,	,	O
paternally	RB	O
expressed	VBN	O
genes	NNS	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
in	IN	O
PWS	NNP	S_Disease
.	.	O

However	RB	O
,	,	O
the	DT	O
number	NN	O
of	IN	O
imprinted	JJ	O
genes	NNS	O
that	WDT	O
contribute	VBP	O
to	TO	O
PWS	NNP	S_Disease
,	,	O
and	CC	O
the	DT	O
range	NN	O
over	IN	O
which	WDT	O
the	DT	O
imprinting	VBG	O
signal	JJ	O
acts	NNS	O
to	TO	O
silence	VB	O
one	CD	O
copy	NN	O
of	IN	O
the	DT	O
gene	NN	O
in	IN	O
a	DT	O
parent	NN	O
-	:	O
of	IN	O
-	:	O
origin	NN	O
-	:	O
specific	JJ	O
manner	NN	O
,	,	O
are	VBP	O
unknown	JJ	O
.	.	O

To	TO	O
identify	VB	O
additional	JJ	O
imprinted	VBN	O
genes	NNS	O
that	WDT	O
could	MD	O
contribute	VB	O
to	TO	O
the	DT	O
PWS	NNP	S_Disease
phenotype	NN	O
and	CC	O
to	TO	O
understand	VB	O
the	DT	O
regional	JJ	O
control	NN	O
of	IN	O
imprinting	VBG	O
in	IN	O
15q11	CD	O
-	:	O
q13	NN	O
,	,	O
we	PRP	O
have	VBP	O
constructed	VBN	O
an	DT	O
imprinted	JJ	O
transcript	NN	O
map	NN	O
of	IN	O
the	DT	O
PWS	NNP	O
-	:	O
AS	IN	O
deletion	NN	O
interval	NN	O
.	.	O

The	DT	O
imprinting	NN	O
status	NN	O
of	IN	O
22	CD	O
expressed	JJ	O
sequence	NN	O
tags	NNS	O
derived	VBN	O
from	IN	O
the	DT	O
radiation	NN	O
-	:	O
hybrid	JJ	O
human	JJ	O
transcript	NN	O
maps	NNS	O
or	CC	O
physical	JJ	O
maps	NNS	O
was	VBD	O
determined	VBN	O
in	IN	O
a	DT	O
reverse	NN	O
transcriptase	NN	O
-	:	O
PCR	NNP	O
assay	NN	O
and	CC	O
correlated	VBN	O
with	IN	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
transcripts	NNS	O
on	IN	O
the	DT	O
physical	JJ	O
map	NN	O
.	.	O

Seven	RB	O
new	JJ	O
paternally	RB	O
expressed	VBN	O
transcripts	NNS	O
localize	VB	O
to	TO	O
an	DT	O
approximately	RB	O
1	CD	O
.	.	O

5	CD	O
-	:	O
Mb	NN	O
domain	NN	O
surrounding	VBG	O
the	DT	O
SNRPN	NNP	O
-	:	O
associated	VBD	O
imprinting	JJ	O
center	NN	O
,	,	O
which	WDT	O
already	RB	O
includes	VBZ	O
four	CD	O
imprinted	VBN	O
,	,	O
paternally	RB	O
expressed	VBN	O
genes	NNS	O
.	.	O

All	DT	O
other	JJ	O
tested	VBD	O
new	JJ	O
transcripts	NNS	O
in	IN	O
the	DT	O
deletion	NN	O
region	NN	O
were	VBD	O
expressed	VBN	O
from	IN	O
both	DT	O
alleles	NNS	O
.	.	O

A	DT	O
domain	NN	O
of	IN	O
exclusive	JJ	O
paternal	JJ	O
expression	NN	O
surrounding	VBG	O
the	DT	O
imprinting	NN	O
center	NN	O
suggests	VBZ	O
strong	JJ	O
regional	JJ	O
control	NN	O
of	IN	O
the	DT	O
imprinting	NN	O
process	NN	O
.	.	O

This	DT	O
study	NN	O
provides	VBZ	O
the	DT	O
means	NNS	O
for	IN	O
further	JJ	O
investigation	NN	O
of	IN	O
additional	JJ	O
genes	NNS	O
that	WDT	O
cause	VBP	O
or	CC	O
modify	VBP	O
the	DT	O
phenotypes	NNS	O
associated	VBN	O
with	IN	O
rearrangements	NNS	O
of	IN	O
15q11	CD	O
-	:	O
q13	NN	O
.	.	O

Combined	VBN	O
analysis	NN	O
of	IN	O
hereditary	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
linkage	NN	O
to	TO	O
1q24	CD	O
-	:	O
25	CD	O
:	:	O
results	NNS	O
from	IN	O
772	CD	O
hereditary	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
families	NNS	O
from	IN	O
the	DT	O
International	NNP	O
Consortium	NNP	O
for	IN	O
Prostate	NNP	B_Disease
Cancer	NNP	E_Disease
Genetics	NNP	O
.	.	O

A	DT	O
previous	JJ	O
linkage	NN	O
study	NN	O
provided	VBD	O
evidence	NN	O
for	IN	O
a	DT	O
prostate	NN	B_Disease
cancer	NN	E_Disease
-	:	O
susceptibility	NN	O
locus	NN	O
at	IN	O
1q24	CD	O
-	:	O
25	CD	O
.	.	O

Subsequent	JJ	O
reports	NNS	O
in	IN	O
additional	JJ	O
collections	NNS	O
of	IN	O
families	NNS	O
have	VBP	O
yielded	VBN	O
conflicting	NN	O
results	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
evidence	NN	O
for	IN	O
locus	NN	O
heterogeneity	NN	O
has	VBZ	O
been	VBN	O
provided	VBN	O
by	IN	O
the	DT	O
identification	NN	O
of	IN	O
other	JJ	O
putative	JJ	O
hereditary	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
loci	NN	O
on	IN	O
Xq27	NNP	O
-	:	O
28	CD	O
,	,	O
1q42	CD	O
-	:	O
43	CD	O
,	,	O
and	CC	O
1p36	CD	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
describes	VBZ	O
a	DT	O
combined	JJ	O
analysis	NN	O
for	IN	O
six	CD	O
markers	NNS	O
in	IN	O
the	DT	O
1q24	CD	O
-	:	O
25	CD	O
region	NN	O
in	IN	O
772	CD	O
families	NNS	O
affected	VBN	O
by	IN	O
hereditary	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
and	CC	O
ascertained	VBN	O
by	IN	O
the	DT	O
members	NNS	O
of	IN	O
the	DT	O
International	NNP	O
Consortium	NNP	O
for	IN	O
Prostate	NNP	B_Disease
Cancer	NNP	E_Disease
Genetics	NNP	O
(	(	O
ICPCG	NNP	O
)	)	O
from	IN	O
North	NNP	O
America	NNP	O
,	,	O
Australia	NNP	O
,	,	O
Finland	NNP	O
,	,	O
Norway	NNP	O
,	,	O
Sweden	NNP	O
,	,	O
and	CC	O
the	DT	O
United	NNP	O
Kingdom	NNP	O
.	.	O

Overall	JJ	O
,	,	O
there	EX	O
was	VBD	O
some	DT	O
evidence	NN	O
for	IN	O
linkage	NN	O
,	,	O
with	IN	O
a	DT	O
peak	JJ	O
parametric	JJ	O
multipoint	NN	O
LOD	NNP	O
score	NN	O
assuming	VBG	O
heterogeneity	NN	O
(	(	O
HLOD	NNP	O
)	)	O
of	IN	O
1	CD	O
.	.	O

40	CD	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

01	CD	O
)	)	O
at	IN	O
D1S212	NNP	O
.	.	O

The	DT	O
estimated	JJ	O
proportion	NN	O
of	IN	O
families	NNS	O
(	(	O
alpha	NN	O
)	)	O
linked	VBD	O
to	TO	O
the	DT	O
locus	NN	O
was	VBD	O
.	.	O

06	CD	O
(	(	O
1	CD	O
-	:	O
LOD	JJ	O
support	NN	O
interval	NN	O
.	.	O

01	CD	O
-	:	O
.	.	O

12	CD	O
)	)	O
.	.	O

This	DT	O
evidence	NN	O
was	VBD	O
not	RB	O
observed	VBN	O
by	IN	O
a	DT	O
nonparametric	JJ	O
approach	NN	O
,	,	O
presumably	RB	O
because	IN	O
of	IN	O
the	DT	O
extensive	JJ	O
heterogeneity	NN	O
.	.	O

Further	RB	O
parametric	JJ	O
analysis	NN	O
revealed	VBD	O
a	DT	O
significant	JJ	O
effect	NN	O
of	IN	O
the	DT	O
presence	NN	O
of	IN	O
male	JJ	O
-	:	O
to	TO	O
-	:	O
male	NN	O
disease	NN	O
transmission	NN	O
within	IN	O
the	DT	O
families	NNS	O
.	.	O

In	IN	O
the	DT	O
subset	NN	O
of	IN	O
491	CD	O
such	JJ	O
families	NNS	O
,	,	O
the	DT	O
peak	NN	O
HLOD	NNP	O
was	VBD	O
2	CD	O
.	.	O

In	IN	O
the	DT	O
subset	NN	O
of	IN	O
491	CD	O
such	JJ	O
families	NNS	O
,	,	O
the	DT	O
peak	NN	O
HLOD	NNP	O
was	VBD	O
2	CD	O
.	.	O

56	CD	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

0006	CD	O
)	)	O
and	CC	O
alpha	JJ	O
=	NN	O
.	.	O

11	CD	O
(	(	O
1	CD	O
-	:	O
LOD	JJ	O
support	NN	O
interval	NN	O
.	.	O

04	CD	O
-	:	O
.	.	O

19	CD	O
)	)	O
,	,	O
compared	VBN	O
with	IN	O
HLODs	NNP	O
of	IN	O
0	CD	O
in	IN	O
the	DT	O
remaining	VBG	O
281	CD	O
families	NNS	O
.	.	O

Within	IN	O
the	DT	O
families	NNS	O
with	IN	O
male	JJ	O
-	:	O
to	TO	O
-	:	O
male	NN	O
disease	NN	O
transmission	NN	O
,	,	O
alpha	NN	O
increased	VBD	O
with	IN	O
the	DT	O
early	JJ	O
mean	NN	O
age	NN	O
at	IN	O
diagnosis	NN	O
(	(	O
<	JJ	O
65	CD	O
years	NNS	O
,	,	O
alpha	RB	O
=	NN	O
.	.	O

19	CD	O
,	,	O
with	IN	O
1	CD	O
-	:	O
LOD	JJ	O
support	NN	O
interval	NN	O
.	.	O

06	CD	O
-	:	O
.	.	O

34	CD	O
)	)	O
and	CC	O
the	DT	O
number	NN	O
of	IN	O
affected	JJ	O
family	NN	O
members	NNS	O
(	(	O
five	CD	O
or	CC	O
more	JJR	O
family	NN	O
members	NNS	O
,	,	O
alpha	JJ	O
=	NN	O
.	.	O

15	CD	O
,	,	O
with	IN	O
1	CD	O
-	:	O
LOD	JJ	O
support	NN	O
interval	NN	O
.	.	O

04	CD	O
-	:	O
.	.	O

28	CD	O
)	)	O
.	.	O

The	DT	O
highest	JJS	O
value	NN	O
of	IN	O
alpha	NN	O
was	VBD	O
observed	VBN	O
for	IN	O
the	DT	O
48	CD	O
families	NNS	O
that	WDT	O
met	VBD	O
all	DT	O
three	CD	O
criteria	NNS	O
(	(	O
peak	JJ	O
HLOD	NNP	O
=	NNP	O
2	CD	O
.	.	O

25	CD	O
,	,	O
P	NNP	O
=	NNP	O
.	.	O

001	CD	O
,	,	O
alpha	RB	O
=	NN	O
.	.	O

29	CD	O
,	,	O
with	IN	O
1	CD	O
-	:	O
LOD	JJ	O
support	NN	O
interval	NN	O
.	.	O

08	CD	O
-	:	O
.	.	O

53	CD	O
)	)	O
.	.	O

These	DT	O
results	NNS	O
support	VBD	O
the	DT	O
finding	NN	O
of	IN	O
a	DT	O
prostate	NN	B_Disease
cancer	NN	E_Disease
-	:	O
susceptibility	NN	O
gene	NN	O
linked	VBD	O
to	TO	O
1q24	CD	O
-	:	O
25	CD	O
,	,	O
albeit	NN	O
in	IN	O
a	DT	O
defined	JJ	O
subset	NN	O
of	IN	O
prostate	NN	B_Disease
cancer	NN	E_Disease
families	NNS	O
.	.	O

Although	IN	O
HPC1	NNP	O
accounts	NNS	O
for	IN	O
only	RB	O
a	DT	O
small	JJ	O
proportion	NN	O
of	IN	O
all	DT	O
families	NNS	O
affected	VBN	O
by	IN	O
hereditary	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
,	,	O
it	PRP	O
appears	VBZ	O
to	TO	O
play	VB	O
a	DT	O
more	RBR	O
prominent	JJ	O
role	NN	O
in	IN	O
the	DT	O
subset	NN	O
of	IN	O
families	NNS	O
with	IN	O
several	JJ	O
members	NNS	O
affected	VBD	O
at	IN	O
an	DT	O
early	JJ	O
age	NN	O
and	CC	O
with	IN	O
male	JJ	O
-	:	O
to	TO	O
-	:	O
male	NN	O
disease	NN	O
transmission	NN	O
.	.	O

A	DT	O
recurrent	JJ	O
expansion	NN	O
of	IN	O
a	DT	O
maternal	JJ	O
allele	NN	O
with	IN	O
36	CD	O
CAG	NNP	O
repeats	NNS	O
causes	VBZ	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
in	IN	O
two	CD	O
sisters	NNS	O
.	.	O

Large	JJ	O
intergenerational	JJ	O
repeat	NN	O
expansions	NNS	O
of	IN	O
the	DT	O
CAG	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
have	VBP	O
been	VBN	O
well	RB	O
documented	VBN	O
for	IN	O
the	DT	O
male	JJ	O
germline	NN	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
recurrent	NN	O
large	JJ	O
expansion	NN	O
of	IN	O
a	DT	O
maternal	JJ	O
allele	NN	O
with	IN	O
36	CD	O
CAG	NNP	O
repeats	NNS	O
(	(	O
to	TO	O
66	CD	O
and	CC	O
57	CD	O
repeats	NNS	O
,	,	O
respectively	RB	O
,	,	O
in	IN	O
two	CD	O
daughters	NNS	O
)	)	O
associated	VBN	O
with	IN	O
onset	NN	O
of	IN	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
in	IN	O
the	DT	O
second	JJ	O
and	CC	O
third	JJ	O
decade	NN	O
in	IN	O
a	DT	O
family	NN	O
without	IN	O
history	NN	O
of	IN	O
HD	NNP	S_Disease
.	.	O

Our	PRP$	O
findings	NNS	O
give	VBP	O
evidence	NN	O
of	IN	O
a	DT	O
gonadal	JJ	O
mosaicism	NN	O
in	IN	O
the	DT	O
unaffected	JJ	O
mother	NN	O
.	.	O

We	PRP	O
hypothesize	VBP	O
that	IN	O
large	JJ	O
expansions	NNS	O
also	RB	O
occur	VBP	O
in	IN	O
the	DT	O
female	JJ	O
germline	NN	O
and	CC	O
that	IN	O
a	DT	O
negative	JJ	O
selection	NN	O
of	IN	O
oocytes	NNS	O
with	IN	O
long	JJ	O
repeats	NNS	O
might	MD	O
explain	VB	O
the	DT	O
different	JJ	O
instability	NN	O
behavior	NN	O
of	IN	O
the	DT	O
male	NN	O
and	CC	O
the	DT	O
female	JJ	O
germlines	NNS	O
.	.	O
.	.	O

Abnormal	NNP	O
development	NN	O
of	IN	O
Purkinje	NNP	O
cells	NNS	O
and	CC	O
lymphocytes	NNS	O
in	IN	O
Atm	NNP	O
mutant	JJ	O
mice	NN	O
.	.	O

Motor	NNP	B_Disease
incoordination	NN	E_Disease
,	,	O
immune	JJ	B_Disease
deficiencies	NNS	E_Disease
,	,	O
and	CC	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
cancer	NN	S_Disease
are	VBP	O
the	DT	O
characteristic	JJ	O
features	NNS	O
of	IN	O
the	DT	O
hereditary	JJ	B_Disease
disease	NN	E_Disease
ataxia	SYM	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
(	(	O
A	DT	B_Disease
-	:	I_Disease
T	NN	E_Disease
)	)	O
,	,	O
which	WDT	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
.	.	O

Through	IN	O
gene	NN	O
targeting	NN	O
,	,	O
we	PRP	O
have	VBP	O
generated	VBN	O
a	DT	O
line	NN	O
of	IN	O
Atm	NNP	O
mutant	JJ	O
mice	NN	O
,	,	O
Atm	NNP	O
(	(	O
y	JJ	O
/	NNP	O
y	NN	O
)	)	O
mice	NN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
other	JJ	O
Atm	NNP	O
mutant	NN	O
mice	NN	O
,	,	O
Atm	NNP	O
(	(	O
y	JJ	O
/	NNP	O
y	NN	O
)	)	O
mice	NN	O
show	VBP	O
a	DT	O
lower	JJR	O
incidence	NN	O
of	IN	O
thymic	JJ	B_Disease
lymphoma	NN	E_Disease
and	CC	O
survive	JJ	O
beyond	IN	O
a	DT	O
few	JJ	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

Atm	NNP	O
(	(	O
y	JJ	O
/	NNP	O
y	NN	O
)	)	O
mice	NN	O
exhibit	NN	O
deficits	NNS	O
in	IN	O
motor	NN	O
learning	VBG	O
indicative	JJ	O
of	IN	O
cerebellar	JJ	B_Disease
dysfunction	NN	E_Disease
.	.	O

Even	RB	O
though	IN	O
we	PRP	O
found	VBD	O
no	DT	O
gross	JJ	O
cerebellar	JJ	B_Disease
degeneration	NN	E_Disease
in	IN	O
older	JJR	O
Atm	NNP	O
(	(	O
y	JJ	O
/	NNP	O
y	NN	O
)	)	O
animals	NNS	O
,	,	O
ectopic	NN	O
and	CC	O
abnormally	RB	O
differentiated	VBN	O
Purkinje	NNP	O
cells	NNS	O
were	VBD	O
apparent	JJ	O
in	IN	O
mutant	JJ	O
mice	NN	O
of	IN	O
all	DT	O
ages	NNS	O
.	.	O

These	DT	O
findings	NNS	O
establish	VB	O
that	IN	O
some	DT	O
neuropathological	JJ	B_Disease
abnormalities	NNS	E_Disease
seen	VBN	O
in	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
patients	NNS	O
also	RB	O
are	VBP	O
present	JJ	O
in	IN	O
Atm	NNP	O
mutant	JJ	O
mice	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
report	VBP	O
a	DT	O
previously	RB	O
unrecognized	JJ	O
effect	NN	O
of	IN	O
Atm	NNP	B_Disease
deficiency	NN	E_Disease
on	IN	O
development	NN	O
or	CC	O
maintenance	NN	O
of	IN	O
CD4	NNP	O
(	(	O
+	NNP	O
)	)	O
8	CD	O
(	(	O
+	NN	O
)	)	O
thymocytes	VBZ	O
.	.	O

We	PRP	O
discuss	VBP	O
these	DT	O
findings	NNS	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
the	DT	O
hypothesis	NN	O
that	WDT	O
abnormal	JJ	O
development	NN	O
of	IN	O
Purkinje	NNP	O
cells	NNS	O
and	CC	O
lymphocytes	VBZ	O
contributes	NNS	O
to	TO	O
the	DT	O
pathogenesis	NN	O
of	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
.	.	O
.	.	O

Novel	NNP	O
mutations	NNS	O
of	IN	O
the	DT	O
ATP7B	NNP	O
gene	NN	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
.	.	O

Wilson	NNP	B_Disease
disease	NN	E_Disease
(	(	O
WD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
copper	NN	O
accumulation	NN	O
in	IN	O
the	DT	O
liver	NN	O
,	,	O
brain	NN	O
,	,	O
kidneys	NNS	O
,	,	O
and	CC	O
corneas	NNS	O
,	,	O
and	CC	O
culminating	VBG	O
in	IN	O
copper	NN	O
toxication	NN	O
in	IN	O
these	DT	O
organs	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
analyzed	VBD	O
mutations	NNS	O
of	IN	O
the	DT	O
responsible	JJ	O
gene	NN	O
,	,	O
ATP7B	NNP	O
,	,	O
in	IN	O
four	CD	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
WD	NNP	S_Disease
.	.	O

By	IN	O
direct	JJ	O
sequencing	NN	O
,	,	O
we	PRP	O
identified	VBD	O
five	CD	O
mutations	NNS	O
,	,	O
of	IN	O
which	WDT	O
two	CD	O
were	VBD	O
novel	JJ	O
,	,	O
and	CC	O
16	CD	O
polymorphisms	NNS	O
,	,	O
of	IN	O
which	WDT	O
6	CD	O
were	VBD	O
novel	NN	O
.	.	O

The	DT	O
mutations	NNS	O
2871delC	CD	O
and	CC	O
2513delA	CD	O
shift	NN	O
the	DT	O
reading	NN	O
frame	NN	O
so	IN	O
that	DT	O
truncated	VBD	O
abnormal	JJ	O
protein	NN	O
is	VBZ	O
expected	VBN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
these	DT	O
mutations	NNS	O
found	VBD	O
in	IN	O
patients	NNS	O
with	IN	O
hepatic	JJ	O
-	:	O
type	NN	O
of	IN	O
early	JJ	O
onset	NN	O
,	,	O
the	DT	O
mutations	NNS	O
A874V	NNP	O
,	,	O
R778L	NNP	O
,	,	O
and	CC	O
3892delGTC	CD	O
were	VBD	O
either	RB	O
missense	JJ	O
mutations	NNS	O
or	CC	O
in	IN	O
frame	JJ	O
1	CD	O
-	:	O
amino	NN	O
acid	JJ	O
deletion	NN	O
,	,	O
and	CC	O
occurred	VBD	O
in	IN	O
the	DT	O
patients	NNS	O
with	IN	O
hepato	JJ	O
-	:	O
neurologic	JJ	O
type	NN	O
of	IN	O
late	JJ	O
onset	NN	O
.	.	O

The	DT	O
mutations	NNS	O
2871delC	CD	O
and	CC	O
R778L	NNP	O
have	VBP	O
been	VBN	O
previously	RB	O
reported	VBN	O
in	IN	O
a	DT	O
relatively	RB	O
large	JJ	O
number	NN	O
of	IN	O
Japanese	JJ	O
patients	NNS	O
.	.	O

In	IN	O
particular	JJ	O
,	,	O
R778L	NNP	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
more	RBR	O
prevalent	JJ	O
in	IN	O
Asian	JJ	O
countries	NNS	O
than	IN	O
in	IN	O
other	JJ	O
countries	NNS	O
of	IN	O
the	DT	O
world	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
are	VBP	O
compatible	JJ	O
with	IN	O
the	DT	O
hypothesis	NN	O
that	IN	O
the	DT	O
mutations	NNS	O
tend	VBP	O
to	TO	O
occur	VB	O
in	IN	O
a	DT	O
population	NN	O
-	:	O
specific	JJ	O
manner	NN	O
.	.	O

Therefore	RB	O
,	,	O
the	DT	O
accumulation	NN	O
of	IN	O
the	DT	O
types	NNS	O
of	IN	O
mutations	NNS	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
WD	NNP	S_Disease
will	MD	O
facilitate	VB	O
the	DT	O
fast	NN	O
and	CC	O
effective	JJ	O
genetic	JJ	O
diagnosis	NN	O
of	IN	O
WD	NNP	S_Disease
in	IN	O
Japanese	JJ	O
patients	NNS	O
.	.	O
.	.	O

Autoinhibition	NN	O
and	CC	O
activation	NN	O
mechanisms	NNS	O
of	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	VBD	E_Disease
protein	NN	O
.	.	O

The	DT	O
Rho	NNP	O
-	:	O
family	NN	O
GTPase	NNP	O
,	,	O
Cdc42	NNP	O
,	,	O
can	MD	O
regulate	VB	O
the	DT	O
actin	NN	O
cytoskeleton	NN	O
through	IN	O
activation	NN	O
of	IN	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	VBP	E_Disease
protein	NN	O
(	(	O
WASP	NNP	O
)	)	O
family	NN	O
members	NNS	O
.	.	O

Activation	NNP	O
relieves	VBZ	O
an	DT	O
autoinhibitory	JJ	O
contact	NN	O
between	IN	O
the	DT	O
GTPase	NNP	O
-	:	O
binding	NN	O
domain	NN	O
and	CC	O
the	DT	O
carboxy	JJ	O
-	:	O
terminal	JJ	O
region	NN	O
of	IN	O
WASP	NNP	O
proteins	NNS	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
the	DT	O
autoinhibited	JJ	O
structure	NN	O
of	IN	O
the	DT	O
GTPase	NNP	O
-	:	O
binding	VBG	O
domain	NN	O
of	IN	O
WASP	NNP	O
,	,	O
which	WDT	O
can	MD	O
be	VB	O
induced	VBN	O
by	IN	O
the	DT	O
C	NNP	O
-	:	O
terminal	JJ	O
region	NN	O
or	CC	O
by	IN	O
organic	JJ	O
co	NN	O
-	:	O
solvents	NNS	O
.	.	O

In	IN	O
the	DT	O
autoinhibited	JJ	O
complex	NN	O
,	,	O
intramolecular	JJ	O
interactions	NNS	O
with	IN	O
the	DT	O
GTPase	NNP	O
-	:	O
binding	NN	O
domain	NN	O
occlude	VBP	O
residues	NNS	O
of	IN	O
the	DT	O
C	NNP	O
terminus	NN	O
that	WDT	O
regulate	VBP	O
the	DT	O
Arp2	NNP	O
/	NNP	O
3	CD	O
actin	SYM	O
-	:	O
nucleating	NN	O
complex	NN	O
.	.	O

Binding	NNP	O
of	IN	O
Cdc42	NNP	O
to	TO	O
the	DT	O
GTPase	NNP	O
-	:	O
binding	NN	O
domain	NN	O
causes	VBZ	O
a	DT	O
dramatic	JJ	O
conformational	JJ	O
change	NN	O
,	,	O
resulting	VBG	O
in	IN	O
disruption	NN	O
of	IN	O
the	DT	O
hydrophobic	NN	O
core	NN	O
and	CC	O
release	NN	O
of	IN	O
the	DT	O
C	NNP	O
terminus	NN	O
,	,	O
enabling	VBG	O
its	PRP$	O
interaction	NN	O
with	IN	O
the	DT	O
actin	JJ	O
regulatory	JJ	O
machinery	NN	O
.	.	O

These	DT	O
data	NNS	O
show	VBP	O
that	IN	O
intrinsically	RB	O
unstructured	JJ	O
peptides	NNS	O
such	JJ	O
as	IN	O
the	DT	O
GTPase	NNP	O
-	:	O
binding	VBG	O
domain	NN	O
of	IN	O
WASP	NNP	O
can	MD	O
be	VB	O
induced	VBN	O
into	IN	O
distinct	JJ	O
structural	JJ	O
and	CC	O
functional	JJ	O
states	NNS	O
depending	VBG	O
on	IN	O
context	NN	O
.	.	O
.	.	O

hCds1	SYM	O
-	:	O
mediated	VBN	O
phosphorylation	NN	O
of	IN	O
BRCA1	NNP	O
regulates	VBZ	O
the	DT	O
DNA	NNP	O
damage	NN	O
response	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NNP	O
(	(	O
ref	NN	O
.	.	O

1	CD	O
)	)	O
tumour	NN	S_Disease
suppressor	NN	O
gene	NN	O
are	VBP	O
found	VBN	O
in	IN	O
almost	RB	O
all	DT	O
of	IN	O
the	DT	O
families	NNS	O
with	IN	O
inherited	JJ	B_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
and	CC	O
about	IN	O
half	NN	O
of	IN	O
the	DT	O
families	NNS	O
with	IN	O
only	JJ	O
breast	NN	B_Disease
cancer	NN	E_Disease
.	.	O

Although	IN	O
the	DT	O
biochemical	JJ	O
function	NN	O
of	IN	O
BRCA1	NNP	O
is	VBZ	O
not	RB	O
well	RB	O
understood	RB	O
,	,	O
it	PRP	O
is	VBZ	O
important	JJ	O
for	IN	O
DNA	NNP	O
damage	NN	O
repair	NN	O
and	CC	O
cell	NN	O
-	:	O
cycle	NN	O
checkpoint	NN	O
.	.	O

BRCA1	NNP	O
exists	VBZ	O
in	IN	O
nuclear	JJ	O
foci	NN	O
but	CC	O
is	VBZ	O
hyperphosphorylated	VBN	O
and	CC	O
disperses	NNS	O
after	IN	O
DNA	NNP	O
damage	NN	O
.	.	O

It	PRP	O
is	VBZ	O
not	RB	O
known	VBN	O
whether	IN	O
BRCA1	NNP	O
phosphorylation	NN	O
and	CC	O
dispersion	NN	O
and	CC	O
its	PRP$	O
function	NN	O
in	IN	O
DNA	NNP	O
damage	NN	O
response	NN	O
are	VBP	O
related	VBN	O
.	.	O

In	IN	O
yeast	PDT	O
the	DT	O
DNA	NNP	O
damage	NN	O
response	NN	O
and	CC	O
the	DT	O
replication	NN	O
-	:	O
block	NN	O
checkpoint	NN	O
are	VBP	O
mediated	VBN	O
partly	RB	O
through	IN	O
the	DT	O
Cds1	NNP	O
kinase	NNP	O
family	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
the	DT	O
human	JJ	O
Cds1	NNP	O
kinase	NN	O
(	(	O
hCds1	JJ	O
/	NNP	O
Chk2	NNP	O
)	)	O
regulates	VBZ	O
BRCA1	NNP	O
function	NN	O
after	IN	O
DNA	NNP	O
damage	NN	O
by	IN	O
phosphorylating	VBG	O
serine	JJ	O
988	CD	O
of	IN	O
BRCA1	NNP	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
hCds1	NN	O
and	CC	O
BRCA1	NNP	O
interact	NN	O
and	CC	O
co	NN	O
-	:	O
localize	NN	O
within	IN	O
discrete	JJ	O
nuclear	JJ	O
foci	NN	O
but	CC	O
separate	JJ	O
after	IN	O
gamma	JJ	O
irradiation	NN	O
.	.	O

Phosphorylation	NN	O
of	IN	O
BRCA1	NNP	O
at	IN	O
serine	JJ	O
988	CD	O
is	VBZ	O
required	VBN	O
for	IN	O
the	DT	O
release	NN	O
of	IN	O
BRCA1	NNP	O
from	IN	O
hCds1	NN	O
.	.	O

This	DT	O
phosphorylation	NN	O
is	VBZ	O
also	RB	O
important	JJ	O
for	IN	O
the	DT	O
ability	NN	O
of	IN	O
BRCA1	NNP	O
to	TO	O
restore	VB	O
survival	NN	O
after	IN	O
DNA	NNP	O
damage	NN	O
in	IN	O
the	DT	O
BRCA1	NNP	O
-	:	O
mutated	VBN	O
cell	NN	O
line	NN	O
HCC1937	NNP	O
.	.	O
.	.	O

Characterization	NN	O
of	IN	O
the	DT	O
rat	NN	O
spinocerebellar	JJ	O
ataxia	NN	O
type	NN	O
3	CD	O
gene	NN	O
.	.	O

Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
(	(	O
MJD	NNP	S_Disease
)	)	O
belongs	VBZ	O
to	TO	O
a	DT	O
group	NN	O
of	IN	O
clinically	RB	O
and	CC	O
genetically	RB	O
heterogeneous	JJ	O
neurodegenerative	JJ	B_Disease
disorders	NNS	E_Disease
characterized	VBN	O
by	IN	O
progressive	JJ	B_Disease
cerebellar	JJ	I_Disease
ataxia	NN	E_Disease
.	.	O

The	DT	O
disease	NN	O
-	:	O
causing	NN	O
mutation	NN	O
has	VBZ	O
recently	RB	O
been	VBN	O
identified	VBN	O
as	IN	O
an	DT	O
unstable	JJ	O
and	CC	O
expanded	VBN	O
(	(	O
CAG	NNP	O
)	)	O
n	FW	O
trinucleotide	JJ	O
repeat	NN	O
in	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
of	IN	O
unknown	JJ	O
function	NN	O
.	.	O

In	IN	O
Caucasians	NNP	O
,	,	O
repeat	NN	O
expansions	NNS	O
in	IN	O
the	DT	O
MJD1	NNP	O
gene	NN	O
have	VBP	O
also	RB	O
been	VBN	O
found	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
clinically	RB	O
distinct	JJ	O
autosomal	JJ	O
dominant	JJ	O
spinocerebellar	JJ	B_Disease
ataxia	NN	I_Disease
type	NN	I_Disease
3	CD	E_Disease
(	(	O
SCA3	NNP	S_Disease
)	)	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
gain	VB	O
insight	NN	O
into	IN	O
the	DT	O
biology	NN	O
of	IN	O
the	DT	O
MJD1	NNP	O
/	NNP	O
SCA3	NNP	O
gene	NN	O
we	PRP	O
cloned	VBD	O
the	DT	O
rat	NN	O
homologue	NN	O
and	CC	O
studied	VBD	O
its	PRP$	O
expression	NN	O
.	.	O

The	DT	O
rat	NN	O
and	CC	O
human	JJ	O
ataxin	NN	O
-	:	O
3	CD	O
genes	NNS	O
are	VBP	O
highly	RB	O
homologous	JJ	O
with	IN	O
an	DT	O
overall	JJ	O
sequence	NN	O
identity	NN	O
of	IN	O
approximately	RB	O
88	CD	O
%	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
C	NNP	O
-	:	O
terminal	JJ	O
end	NN	O
of	IN	O
the	DT	O
putative	JJ	O
protein	NN	O
differs	NNS	O
strongly	RB	O
from	IN	O
the	DT	O
published	VBN	O
human	JJ	O
sequence	NN	O
.	.	O

The	DT	O
(	(	O
CAG	NNP	O
)	)	O
n	NN	O
block	NN	O
in	IN	O
the	DT	O
rat	NN	O
cDNA	NN	O
consists	VBZ	O
of	IN	O
just	RB	O
three	CD	O
interrupted	VBD	O
units	NNS	O
suggesting	VBG	O
that	IN	O
a	DT	O
long	JJ	O
polyglutamine	NN	O
stretch	NN	O
is	VBZ	O
not	RB	O
essential	JJ	O
for	IN	O
the	DT	O
normal	JJ	O
function	NN	O
of	IN	O
the	DT	O
ataxin	NN	O
-	:	O
3	CD	O
protein	NN	O
in	IN	O
rodents	NNS	O
.	.	O

The	DT	O
expression	NN	O
pattern	NN	O
of	IN	O
the	DT	O
SCA3	NNP	O
gene	NN	O
in	IN	O
various	JJ	O
rat	NN	O
and	CC	O
human	JJ	O
tissues	NNS	O
was	VBD	O
investigated	VBN	O
by	IN	O
Northern	NNP	O
blot	NN	O
analyses	NNS	O
.	.	O

The	DT	O
mature	NN	O
transcript	NN	O
is	VBZ	O
approximately	RB	O
6	CD	O
kb	NNS	O
in	IN	O
length	NN	O
.	.	O

In	IN	O
rat	NN	O
testis	NN	O
,	,	O
a	DT	O
smaller	JJR	O
transcript	NN	O
of	IN	O
1	CD	O
.	.	O

3	CD	O
kb	NN	O
was	VBD	O
identified	VBN	O
.	.	O

Transcription	NN	O
of	IN	O
rsca3	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
most	JJS	O
rat	NNS	O
tissues	NNS	O
including	VBG	O
brain	NN	O
.	.	O

Analyzing	VBG	O
the	DT	O
expression	NN	O
level	NN	O
of	IN	O
the	DT	O
SCA3	NNP	O
gene	NN	O
in	IN	O
several	JJ	O
human	JJ	O
brain	NN	O
sections	NNS	O
revealed	VBD	O
no	DT	O
significant	JJ	O
higher	JJR	O
mRNA	NN	O
level	NN	O
in	IN	O
regions	NNS	O
predominantly	RB	O
affected	VBN	O
in	IN	O
MJD	NNP	S_Disease
.	.	O

Thus	RB	O
additional	JJ	O
molecules	NNS	O
and	CC	O
/	NN	O
or	CC	O
regulatory	JJ	O
events	NNS	O
are	VBP	O
necessary	JJ	O
to	TO	O
explain	VB	O
the	DT	O
exclusive	JJ	O
degeneration	NN	B_Disease
of	IN	I_Disease
certain	JJ	I_Disease
brain	NN	I_Disease
areas	NNS	E_Disease
.	.	O

Emerin	NNP	B_Disease
,	,	I_Disease
deficiency	NN	E_Disease
of	IN	O
which	WDT	O
causes	VBZ	O
Emery	NNP	B_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
,	,	O
is	VBZ	O
localized	VBN	O
at	IN	O
the	DT	O
inner	JJ	O
nuclear	JJ	O
membrane	NN	O
.	.	O

X	LS	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
recessive	JJ	I_Disease
Emery	NNP	I_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
EDMD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
inherited	JJ	B_Disease
muscle	NN	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
the	DT	O
clinical	JJ	O
triad	NN	O
of	IN	O
progressive	JJ	O
wasting	NN	B_Disease
of	IN	I_Disease
humero	NN	I_Disease
-	:	I_Disease
peroneal	NN	I_Disease
muscles	NNS	E_Disease
,	,	O
early	JJ	O
contractures	NNS	B_Disease
of	IN	I_Disease
the	DT	I_Disease
elbows	NNS	I_Disease
,	,	I_Disease
Achilles	NNP	I_Disease
tendons	NNS	I_Disease
and	CC	I_Disease
postcervical	JJ	I_Disease
muscles	NNS	E_Disease
,	,	O
and	CC	O
cardiac	JJ	B_Disease
conduction	NN	I_Disease
block	NN	E_Disease
with	IN	O
a	DT	O
high	JJ	O
risk	NN	O
of	IN	O
sudden	JJ	B_Disease
death	NN	E_Disease
.	.	O

The	DT	O
gene	NN	O
for	IN	O
EDMD	NNP	S_Disease
on	IN	O
Xq28	NNP	O
encodes	VBZ	O
a	DT	O
novel	JJ	O
protein	NN	O
named	VBN	O
emerin	NN	O
that	WDT	O
localizes	VBZ	O
at	IN	O
the	DT	O
nuclear	JJ	O
membrane	NN	O
of	IN	O
skeletal	JJ	O
,	,	O
cardiac	JJ	O
and	CC	O
smooth	JJ	O
muscles	NNS	O
and	CC	O
some	DT	O
other	JJ	O
non	JJ	O
-	:	O
muscle	NN	O
tissues	NNS	O
.	.	O

To	TO	O
investigate	VB	O
a	DT	O
possible	JJ	O
physiological	JJ	O
role	NN	O
for	IN	O
emerin	NN	O
,	,	O
we	PRP	O
examined	VBD	O
the	DT	O
ultrastructural	JJ	O
localization	NN	O
of	IN	O
the	DT	O
protein	NN	O
in	IN	O
human	JJ	O
skeletal	JJ	O
muscle	NN	O
and	CC	O
HeLa	NNP	O
cells	NNS	O
,	,	O
using	VBG	O
ultrathin	JJ	O
cryosections	NNS	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
the	DT	O
immune	JJ	O
-	:	O
labeled	VBN	O
colloidal	JJ	O
gold	NN	O
particles	NNS	O
were	VBD	O
localized	VBN	O
on	IN	O
the	DT	O
nucleoplasmic	JJ	O
surface	NN	O
of	IN	O
the	DT	O
inner	JJ	O
nuclear	JJ	O
membrane	NN	O
,	,	O
but	CC	O
not	RB	O
on	IN	O
the	DT	O
nuclear	JJ	O
pore	NN	O
.	.	O

Emerin	NNP	O
stayed	VBD	O
on	IN	O
the	DT	O
cytoplasmic	JJ	O
surface	NN	O
of	IN	O
the	DT	O
nuclear	JJ	O
lamina	NN	O
,	,	O
even	RB	O
after	IN	O
detergent	NN	O
treatment	NN	O
that	WDT	O
solubilizes	VBZ	O
membrane	NN	O
lipids	NNS	O
and	CC	O
washes	NNS	O
out	RP	O
membrane	NN	O
proteins	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
emerin	JJ	O
anchors	NNS	O
at	IN	O
the	DT	O
inner	JJ	O
nuclear	JJ	O
membrane	NN	O
through	IN	O
the	DT	O
hydrophobic	JJ	O
stretch	NN	O
,	,	O
and	CC	O
protrudes	NNS	O
from	IN	O
the	DT	O
hydrophilic	JJ	O
region	NN	O
to	TO	O
the	DT	O
nucleoplasm	NN	O
where	WRB	O
it	PRP	O
interacts	VBZ	O
with	IN	O
the	DT	O
nuclear	JJ	O
lamina	NN	O
.	.	O

We	PRP	O
speculate	VBP	O
that	IN	O
emerin	NN	O
contributes	NNS	O
to	TO	O
maintain	VB	O
the	DT	O
nuclear	JJ	O
structure	NN	O
and	CC	O
stability	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
nuclear	JJ	O
functions	NNS	O
,	,	O
particularly	RB	O
in	IN	O
muscle	NN	O
tissues	NNS	O
that	WDT	O
have	VBP	O
severe	JJ	O
stress	NN	O
with	IN	O
rigorous	JJ	O
contraction	NN	O
-	:	O
relaxation	NN	O
movements	NNS	O
and	CC	O
calcium	NN	O
flux	NN	O
.	.	O
.	.	O

Locus	NNP	O
heterogeneity	NN	O
in	IN	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
.	.	O

Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
(	(	O
FRDA	NNP	S_Disease
)	)	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
ataxia	NN	E_Disease
.	.	O

The	DT	O
disease	NN	O
locus	NN	O
was	VBD	O
assigned	VBN	O
to	TO	O
chromosome	VB	O
9	CD	O
and	CC	O
the	DT	O
disease	NN	O
gene	NN	O
,	,	O
STM7	NNP	O
/	NNP	O
X25	NNP	O
,	,	O
has	VBZ	O
been	VBN	O
isolated	VBN	O
.	.	O

To	TO	O
date	NN	O
most	RBS	O
data	NNS	O
suggest	VBP	O
locus	NN	O
homogeneity	NN	O
in	IN	O
FRDA	NNP	S_Disease
.	.	O

We	PRP	O
now	RB	O
provide	VBP	O
strong	JJ	O
evidence	NN	O
of	IN	O
a	DT	O
second	JJ	O
FRDA	NNP	S_Disease
locus	NN	O
.	.	O

Studying	VBG	O
two	CD	O
siblings	NNS	O
with	IN	O
FRDA	NNP	S_Disease
from	IN	O
two	CD	O
families	NNS	O
we	PRP	O
did	VBD	O
not	RB	O
detect	VB	O
a	DT	O
mutation	NN	O
in	IN	O
STM7	NNP	O
/	NNP	O
X25	NNP	O
.	.	O

Haplotype	NNP	O
analysis	NN	O
of	IN	O
the	DT	O
STM7	NNP	O
/	NNP	O
X25	NNP	O
region	NN	O
of	IN	O
chromosome	NN	O
9	CD	O
demonstrated	VBD	O
that	IN	O
the	DT	O
relevant	JJ	O
portion	NN	O
of	IN	O
chromosome	NN	O
9	CD	O
differs	NNS	O
in	IN	O
the	DT	O
patients	NNS	O
.	.	O

Although	IN	O
the	DT	O
patients	NNS	O
studied	VBN	O
had	VBD	O
typical	JJ	O
FRDA	NNP	S_Disease
,	,	O
one	CD	O
sibpair	NN	O
had	VBD	O
the	DT	O
uncommon	JJ	O
symptom	NN	O
of	IN	O
retained	JJ	O
tendon	NN	O
reflexes	NNS	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
investigate	VB	O
whether	IN	O
retained	JJ	O
tendon	NN	O
reflexes	NNS	O
are	VBP	O
characteristic	JJ	O
of	IN	O
FRDA	NNP	S_Disease
caused	VBN	O
by	IN	O
the	DT	O
second	JJ	O
locus	NN	O
,	,	O
FRDA2	NNP	O
,	,	O
we	PRP	O
studied	VBD	O
an	DT	O
unrelated	JJ	O
FRDA	NNP	S_Disease
patient	NN	O
with	IN	O
retained	JJ	O
tendon	NN	O
reflexes	NNS	O
.	.	O

The	DT	O
observation	NN	O
of	IN	O
typical	JJ	O
mutations	NNS	O
in	IN	O
STM7	NNP	O
/	NNP	O
X25	NNP	O
(	(	O
GAA	NNP	O
expansions	NNS	O
)	)	O
in	IN	O
this	DT	O
patient	NN	O
demonstrates	VBZ	O
that	IN	O
the	DT	O
two	CD	O
genetically	RB	O
different	JJ	O
forms	NNS	O
of	IN	O
FRDA	NNP	S_Disease
cannot	NN	O
be	VB	O
distinguished	VBN	O
clinically	RB	O
.	.	O
.	.	O

Glycerol	NNP	O
as	IN	O
a	DT	O
correlate	NN	O
of	IN	O
impaired	JJ	B_Disease
glucose	JJ	I_Disease
tolerance	NN	E_Disease
:	:	O
dissection	NN	O
of	IN	O
a	DT	O
complex	JJ	O
system	NN	O
by	IN	O
use	NN	O
of	IN	O
a	DT	O
simple	JJ	O
genetic	JJ	O
trait	NN	O
.	.	O

Glycerol	NNP	O
kinase	NN	O
(	(	O
GK	NNP	O
)	)	O
represents	VBZ	O
the	DT	O
primary	JJ	O
entry	NN	O
of	IN	O
glycerol	NN	O
into	IN	O
glucose	JJ	O
and	CC	O
triglyceride	JJ	O
metabolism	NN	O
.	.	O

Impaired	NNP	B_Disease
glucose	JJ	I_Disease
tolerance	NN	E_Disease
(	(	O
IGT	NNP	S_Disease
)	)	O
and	CC	O
hypertriglyceridemia	NN	S_Disease
are	VBP	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
diabetes	NNS	B_Disease
mellitus	NNS	E_Disease
and	CC	O
cardiovascular	JJ	B_Disease
disease	NN	E_Disease
.	.	O

The	DT	O
relationship	NN	O
between	IN	O
glycerol	NN	O
and	CC	O
the	DT	O
risk	NN	O
of	IN	O
IGT	NNP	S_Disease
,	,	O
however	RB	O
,	,	O
is	VBZ	O
poorly	RB	O
understood	JJ	O
.	.	O

We	PRP	O
therefore	VBP	O
undertook	IN	O
the	DT	O
study	NN	O
of	IN	O
fasting	VBG	O
plasma	JJ	O
glycerol	NN	O
levels	NNS	O
in	IN	O
a	DT	O
cohort	NN	O
of	IN	O
1	CD	O
,	,	O
056	CD	O
unrelated	JJ	O
men	NNS	O
and	CC	O
women	NNS	O
of	IN	O
French	JJ	O
-	:	O
Canadian	JJ	O
descent	NN	O
.	.	O

Family	RB	O
screening	VBG	O
in	IN	O
the	DT	O
initial	JJ	O
cohort	NN	O
identified	VBD	O
18	CD	O
men	NNS	O
from	IN	O
five	CD	O
families	NNS	O
with	IN	O
severe	JJ	O
hyperglycerolemia	NN	S_Disease
(	(	O
values	NNS	O
above	IN	O
2	CD	O
.	.	O

0	CD	O
mmol	NN	O
/	NNP	O
liter	NN	O
)	)	O
and	CC	O
demonstrated	VBD	O
an	DT	O
X	NNP	O
-	:	O
linked	VBD	O
pattern	NN	O
of	IN	O
inheritance	NN	O
.	.	O

Linkage	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
data	NNS	O
from	IN	O
12	CD	O
microsatellite	JJ	O
markers	NNS	O
surrounding	VBG	O
the	DT	O
Xp21	NN	O
.	.	O

3	CD	O
GK	NNP	O
gene	NN	O
resulted	VBD	O
in	IN	O
a	DT	O
peak	JJ	O
LOD	NNP	O
score	NN	O
of	IN	O
3	CD	O
.	.	O

46	CD	O
,	,	O
centered	VBN	O
around	IN	O
marker	NN	O
DXS8039	NNP	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
since	IN	O
all	DT	O
of	IN	O
the	DT	O
families	NNS	O
originated	VBN	O
in	IN	O
a	DT	O
population	NN	O
with	IN	O
a	DT	O
proven	JJ	O
founder	NN	O
effect	NN	O
-	:	O
the	DT	O
Saguenay	NNP	O
Lac	NNP	O
-	:	O
St	NN	O
.	.	O

-	:	O
Jean	JJ	O
region	NN	O
of	IN	O
Quebec	NNP	O
-	:	O
a	DT	O
common	JJ	O
disease	NN	O
haplotype	NN	O
was	VBD	O
sought	VBN	O
.	.	O

Indeed	RB	O
,	,	O
a	DT	O
six	CD	O
-	:	O
marker	NN	O
haplotype	NN	O
extending	VBG	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
5	CD	O
.	.	O

5	CD	O
cM	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
all	DT	O
families	NNS	O
.	.	O

Resequencing	VBG	O
of	IN	O
the	DT	O
GK	NNP	O
gene	NN	O
in	IN	O
family	NN	O
members	NNS	O
led	VBD	O
to	TO	O
the	DT	O
discovery	NN	O
of	IN	O
a	DT	O
N288D	NNP	O
missense	NN	O
mutation	NN	O
in	IN	O
exon	JJ	O
10	CD	O
,	,	O
which	WDT	O
resulted	VBD	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
asparagine	NN	O
residue	NN	O
by	IN	O
a	DT	O
negatively	RB	O
charged	VBN	O
aspartic	JJ	O
acid	NN	O
.	.	O

Clinical	JJ	O
and	CC	O
molecular	JJ	O
genetics	NNS	O
of	IN	O
primary	JJ	B_Disease
dystonias	NNS	E_Disease
.	.	O

Primary	JJ	B_Disease
dystonias	NNS	E_Disease
are	VBP	O
movement	NN	B_Disease
disorders	NNS	E_Disease
with	IN	O
dystonia	NN	S_Disease
as	IN	O
a	DT	O
major	JJ	O
symptom	NN	O
.	.	O

They	PRP	O
are	VBP	O
frequently	RB	O
inherited	VBN	O
as	IN	O
Mendelian	JJ	O
traits	NNS	O
.	.	O

There	EX	O
are	VBP	O
at	IN	O
least	JJS	O
eight	CD	O
clinically	RB	O
distinct	JJ	O
autosomal	JJ	O
dominant	JJ	O
and	CC	O
two	CD	O
X	NNP	O
-	:	O
linked	VBD	O
recessive	JJ	O
forms	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
pedigree	JJ	O
analyses	NNS	O
suggest	VBP	O
the	DT	O
occurrence	NN	O
of	IN	O
an	DT	O
autosomal	JJ	O
recessive	NN	O
variant	NN	O
.	.	O

The	DT	O
clinical	JJ	O
classification	NN	O
is	VBZ	O
increasingly	RB	O
being	VBG	O
replaced	VBN	O
by	IN	O
a	DT	O
genetic	JJ	O
one	NN	O
.	.	O

To	TO	O
date	NN	O
gene	NN	O
loci	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
at	IN	O
least	JJS	O
six	CD	O
autosomal	JJ	O
dominant	JJ	O
forms	NNS	O
,	,	O
i	NN	O
.	.	O

e	NN	O
.	.	O
,	,	O
in	IN	O
idiopathic	JJ	B_Disease
torsion	NN	I_Disease
dystonia	NN	E_Disease
(	(	O
9q34	CD	O
)	)	O
,	,	O
focal	JJ	B_Disease
dystonia	NN	E_Disease
(	(	O
18p	CD	O
)	)	O
,	,	O
adult	SYM	O
-	:	O
onset	NN	O
idiopathic	JJ	B_Disease
torsion	NN	I_Disease
dystonia	NN	E_Disease
of	IN	O
mixed	JJ	O
type	NN	O
(	(	O
8p21	CD	O
-	:	O
q22	NN	O
)	)	O
,	,	O
dopa	JJ	B_Disease
-	:	I_Disease
responsive	JJ	I_Disease
dystonia	NN	E_Disease
(	(	O
14q22	CD	O
.	.	O

1	CD	O
-	:	O
q22	NN	O
.	.	O

2	CD	O
)	)	O
,	,	O
and	CC	O
paroxysmal	JJ	B_Disease
dystonic	JJ	I_Disease
choreoathetosis	NN	E_Disease
(	(	O
2q25	CD	O
-	:	O
q33	NN	O
;	:	O
1p21	CD	O
-	:	O
p13	NN	O
.	.	O

3	LS	O
)	)	O
.	.	O

Gene	NNP	O
loci	NN	O
in	IN	O
the	DT	O
X	NNP	O
-	:	O
linked	VBD	O
recessive	JJ	O
forms	NNS	O
have	VBP	O
been	VBN	O
assigned	VBN	O
to	TO	O
Xq13	NNP	O
.	.	O

1	CD	O
in	IN	O
the	DT	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
dystonia	JJ	I_Disease
parkinsonism	NN	I_Disease
syndrome	NN	E_Disease
and	CC	O
to	TO	O
Xq22	VB	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
sensorineural	JJ	I_Disease
deafness	NN	E_Disease
,	,	O
dystonia	NN	S_Disease
,	,	O
and	CC	O
mental	JJ	B_Disease
retardation	NN	E_Disease
.	.	O

The	DT	O
disease	NN	O
genes	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
two	CD	O
autosomal	JJ	O
dominant	JJ	O
forms	NNS	O
and	CC	O
in	IN	O
one	CD	O
X	NNP	O
-	:	O
linked	VBD	O
recessive	JJ	O
form	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
a	DT	O
gene	NN	O
coding	VBG	O
for	IN	O
an	DT	O
ATP	NNP	O
-	:	O
binding	NN	O
protein	NN	O
were	VBD	O
detected	VBN	O
in	IN	O
idiopathic	JJ	B_Disease
torsion	NN	I_Disease
dystonia	NN	E_Disease
(	(	O
DYT1	NNP	O
)	)	O
,	,	O
and	CC	O
the	DT	O
GTP	NNP	O
cyclohydrolase	NN	O
1	CD	O
gene	NN	O
is	VBZ	O
mutated	VBN	O
in	IN	O
dopa	JJ	B_Disease
-	:	I_Disease
responsive	JJ	I_Disease
dystonia	NN	E_Disease
(	(	O
DYT5	NNP	O
)	)	O
.	.	O

In	IN	O
sensorineural	JJ	B_Disease
deafness	NN	E_Disease
,	,	O
dystonia	NN	S_Disease
,	,	O
and	CC	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
gene	NN	O
DDP	NNP	O
coding	VBG	O
for	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
unknown	JJ	O
function	NN	O
.	.	O

This	DT	O
article	NN	O
reviews	VBZ	O
the	DT	O
clinical	JJ	O
and	CC	O
molecular	JJ	O
genetics	NNS	O
of	IN	O
primary	JJ	B_Disease
dystonias	NNS	E_Disease
,	,	O
critically	RB	O
discusses	VBZ	O
present	JJ	O
findings	NNS	O
,	,	O
and	CC	O
proposes	VBZ	O
referring	VBG	O
to	TO	O
the	DT	O
known	VBN	O
forms	NNS	O
,	,	O
most	JJS	O
of	IN	O
which	WDT	O
can	MD	O
be	VB	O
distinguished	VBN	O
by	IN	O
genetic	JJ	O
criteria	NNS	O
,	,	O
as	IN	O
dystonias	JJ	B_Disease
1	CD	I_Disease
-	:	I_Disease
12	CD	E_Disease
.	.	O

Determination	NN	O
of	IN	O
30	CD	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
adrenoleukodystrophy	JJ	E_Disease
mutations	NNS	O
,	,	O
including	VBG	O
15	CD	O
not	RB	O
previously	RB	O
described	VBN	O
.	.	O

X	LS	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
Adrenoleukodystrophy	NNP	E_Disease
(	(	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
)	)	O
is	VBZ	O
the	DT	O
most	RBS	O
frequent	JJ	O
peroxisomal	JJ	B_Disease
disease	NN	E_Disease
.	.	O

It	PRP	O
mainly	RB	O
involves	VBZ	O
the	DT	O
nervous	JJ	O
system	NN	O
white	JJ	O
matter	NN	O
,	,	O
adrenal	JJ	O
cortex	NN	O
and	CC	O
testes	NNS	O
.	.	O

Several	JJ	O
distinct	JJ	O
clinical	JJ	O
phenotypes	NNS	O
are	VBP	O
known	VBN	O
.	.	O

The	DT	O
principal	JJ	O
biochemical	JJ	O
abnormality	NN	O
is	VBZ	O
the	DT	O
accumulation	NN	O
of	IN	O
saturated	JJ	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
(	(	O
VLCFAs	NNP	O
>	NNP	O
C22	NNP	O
0	CD	O
,	,	O
mainly	RB	O
C26	NNP	O
0	CD	O
)	)	O
,	,	O
which	WDT	O
is	VBZ	O
due	JJ	O
to	TO	O
impaired	JJ	O
capacity	NN	O
for	IN	O
beta	NN	O
-	:	O
oxidation	NN	O
in	IN	O
peroxisomes	NNS	O
.	.	O

Diagnosis	NN	O
is	VBZ	O
usually	RB	O
based	VBN	O
on	IN	O
the	DT	O
VLCFA	NNP	O
levels	NNS	O
in	IN	O
plasma	NN	O
or	CC	O
cultured	VBN	O
skin	JJ	O
fibroblasts	NNS	O
in	IN	O
both	DT	O
patients	NNS	O
and	CC	O
carriers	NNS	O
.	.	O

In	IN	O
0	CD	O
.	.	O

1	CD	O
%	NN	O
of	IN	O
affected	JJ	O
males	NNS	O
,	,	O
however	RB	O
,	,	O
the	DT	O
plasma	NN	O
C26	NNP	O
0	CD	O
level	NN	O
is	VBZ	O
borderline	JJ	O
normal	JJ	O
,	,	O
and	CC	O
15	CD	O
%	NN	O
of	IN	O
obligate	JJ	O
female	NN	O
carriers	NNS	O
have	VBP	O
normal	JJ	O
results	NNS	O
.	.	O

Effective	JJ	O
mutation	NN	O
detection	NN	O
in	IN	O
these	DT	O
families	NNS	O
is	VBZ	O
therefore	RB	O
fundamental	JJ	O
to	TO	O
unambiguously	RB	O
determine	VB	O
the	DT	O
genetic	JJ	O
status	NN	O
of	IN	O
each	DT	O
individual	NN	O
at	IN	O
risk	NN	O
.	.	O

Of	IN	O
particular	JJ	O
concern	NN	O
are	VBP	O
female	JJ	O
members	NNS	O
of	IN	O
kindreds	NNS	O
segregating	VBG	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
mutations	NNS	O
,	,	O
because	IN	O
normal	JJ	O
VLCFA	NNP	O
levels	NNS	O
do	VBP	O
not	RB	O
guarantee	VB	O
lack	NN	O
of	IN	O
carrier	NN	O
status	NN	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
fast	JJ	O
method	NN	O
for	IN	O
detection	NN	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
ALD	JJ	E_Disease
mutations	NNS	O
.	.	O

The	DT	O
method	NN	O
is	VBZ	O
based	VBN	O
on	IN	O
SSCP	NNP	O
analysis	NN	O
of	IN	O
nested	JJ	O
PCR	NNP	O
fragments	NNS	O
followed	VBN	O
by	IN	O
sequence	NN	O
-	:	O
determination	NN	O
reactions	NNS	O
.	.	O

Using	VBG	O
this	DT	O
methodology	NN	O
we	PRP	O
have	VBP	O
found	VBN	O
X	NNP	B_Disease
-	:	I_Disease
ALD	JJ	E_Disease
mutations	NNS	O
in	IN	O
30	CD	O
kindreds	NNS	O
,	,	O
including	VBG	O
15	CD	O
not	RB	O
previously	RB	O
reported	VBN	O
.	.	O

beta	SYM	O
-	:	O
galactosidase	NN	O
gene	NN	O
mutations	NNS	O
affecting	VBG	O
the	DT	O
lysosomal	JJ	O
enzyme	NN	O
and	CC	O
the	DT	O
elastin	NN	O
-	:	O
binding	NN	O
protein	NN	O
in	IN	O
GM1	NNP	B_Disease
-	:	I_Disease
gangliosidosis	NN	E_Disease
patients	NNS	O
with	IN	O
cardiac	JJ	B_Disease
involvement	NN	E_Disease
.	.	O

GM1	NNP	B_Disease
-	:	I_Disease
gangliosidosis	NN	E_Disease
is	VBZ	O
a	DT	O
lysosomal	JJ	B_Disease
storage	NN	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
deficiency	NN	B_Disease
of	IN	I_Disease
acid	NN	I_Disease
beta	SYM	I_Disease
-	:	I_Disease
galactosidase	NN	E_Disease
(	(	O
GLB1	NNP	O
)	)	O
.	.	O

We	PRP	O
report	VBP	O
five	CD	O
new	JJ	O
beta	NN	O
-	:	O
galactosidase	NN	O
gene	NN	O
mutations	NNS	O
in	IN	O
nine	CD	O
Italian	JJ	O
patients	NNS	O
and	CC	O
one	CD	O
fetus	NN	O
,	,	O
segregating	VBG	O
in	IN	O
seven	CD	O
unrelated	JJ	O
families	NNS	O
.	.	O

Six	CD	O
of	IN	O
the	DT	O
eight	CD	O
patients	NNS	O
with	IN	O
the	DT	O
infantile	NN	O
,	,	O
severe	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
presented	VBD	O
cardiac	JJ	B_Disease
involvement	NN	E_Disease
,	,	O
a	DT	O
feature	NN	O
rarely	RB	O
associated	VBN	O
with	IN	O
GM1	NNP	B_Disease
-	:	I_Disease
gangliosidosis	NN	E_Disease
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
patients	NNS	O
RNA	NNP	O
and	CC	O
DNA	NNP	O
identified	VBD	O
two	CD	O
new	JJ	O
RNA	NNP	O
splicing	NN	O
defects	NNS	O
,	,	O
three	CD	O
new	JJ	O
and	CC	O
three	CD	O
previously	RB	O
described	VBN	O
amino	JJ	O
acid	JJ	O
substitutions	NNS	O
.	.	O

Interestingly	RB	O
,	,	O
all	DT	O
patients	NNS	O
with	IN	O
cardiac	JJ	B_Disease
involvement	NN	E_Disease
were	VBD	O
homozygous	JJ	O
for	IN	O
one	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
R59H	NNP	O
,	,	O
Y591C	NNP	O
,	,	O
Y591N	NNP	O
,	,	O
or	CC	O
IVS14	NNP	O
-	:	O
2A	CD	O
>	JJ	O
G	NNP	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
all	DT	O
other	JJ	O
patients	NNS	O
were	VBD	O
compound	RB	O
heterozygous	JJ	O
for	IN	O
one	CD	O
of	IN	O
the	DT	O
following	JJ	O
mutations	NNS	O
R201H	NNP	O
,	,	O
R482H	NNP	O
,	,	O
G579D	NNP	O
,	,	O
IVS8	NNP	O
+	VBZ	O
2T	CD	O
>	JJ	O
C	NNP	O
.	.	O

Although	IN	O
we	PRP	O
could	MD	O
not	RB	O
directly	RB	O
correlate	VB	O
the	DT	O
presence	NN	O
of	IN	O
cardiac	JJ	B_Disease
abnormalities	NNS	E_Disease
with	IN	O
specific	JJ	O
genetic	JJ	B_Disease
lesions	NNS	E_Disease
,	,	O
the	DT	O
mutations	NNS	O
identified	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
cardiomyopathy	NN	S_Disease
fell	VBD	O
in	IN	O
the	DT	O
GLB1	NNP	O
cDNA	NN	O
region	NN	O
common	JJ	O
to	TO	O
the	DT	O
lysosomal	JJ	O
enzyme	NN	O
and	CC	O
the	DT	O
Hbeta	NNP	O
-	:	O
Gal	NNP	O
-	:	O
related	JJ	O
protein	NN	O
,	,	O
also	RB	O
known	VBN	O
as	IN	O
the	DT	O
elastin	NN	O
binding	VBG	O
protein	NN	O
(	(	O
EBP	NNP	O
)	)	O
.	.	O

Consequently	RB	O
,	,	O
both	DT	O
molecules	NNS	O
are	VBP	O
affected	VBN	O
by	IN	O
the	DT	O
mutations	NNS	O
,	,	O
and	CC	O
they	PRP	O
may	MD	O
contribute	VB	O
differently	RB	O
to	TO	O
the	DT	O
occurrence	NN	O
of	IN	O
specific	JJ	O
clinical	JJ	O
manifestations	NNS	O
.	.	O
.	.	O

In	IN	O
vivo	JJ	O
modulation	NN	O
of	IN	O
Hmgic	NNP	O
reduces	NNS	O
obesity	NN	S_Disease
.	.	O

The	DT	O
HMGI	NNP	O
family	NN	O
of	IN	O
proteins	NNS	O
consists	NNS	O
of	IN	O
three	CD	O
members	NNS	O
,	,	O
HMGIC	NNP	O
,	,	O
HMGI	NNP	O
and	CC	O
HMGI	NNP	O
(	(	O
Y	NNP	O
)	)	O
,	,	O
that	DT	O
function	NN	O
as	IN	O
architectural	JJ	O
factors	NNS	O
and	CC	O
are	VBP	O
essential	JJ	O
components	NNS	O
of	IN	O
the	DT	O
enhancesome	NN	O
.	.	O

HMGIC	NNP	O
is	VBZ	O
predominantly	RB	O
expressed	VBN	O
in	IN	O
proliferating	NN	O
,	,	O
undifferentiated	JJ	O
mesenchymal	JJ	O
cells	NNS	O
and	CC	O
is	VBZ	O
not	RB	O
detected	VBN	O
in	IN	O
adult	NN	O
tissues	NNS	O
.	.	O

It	PRP	O
is	VBZ	O
disrupted	VBN	O
and	CC	O
misexpressed	VBN	O
in	IN	O
a	DT	O
number	NN	O
of	IN	O
mesenchymal	JJ	B_Disease
tumour	NN	E_Disease
cell	NN	O
types	NNS	O
,	,	O
including	VBG	O
fat	JJ	B_Disease
-	:	I_Disease
cell	NN	I_Disease
tumours	NNS	E_Disease
(	(	O
lipomas	NN	S_Disease
)	)	O
.	.	O

In	IN	O
addition	NN	O
Hmgic	NNP	O
-	:	O
/	SYM	O
-	:	O
mice	NN	O
have	VBP	O
a	DT	O
deficiency	NN	O
in	IN	O
fat	JJ	O
tissue	NN	O
.	.	O

To	TO	O
study	VB	O
its	PRP$	O
role	NN	O
in	IN	O
adipogenesis	NN	O
and	CC	O
obesity	NN	S_Disease
,	,	O
we	PRP	O
examined	VBD	O
Hmgic	NNP	O
expression	NN	O
in	IN	O
the	DT	O
adipose	JJ	O
tissue	NN	O
of	IN	O
adult	NN	O
,	,	O
obese	JJ	S_Disease
mice	NN	O
.	.	O

Mice	NNP	O
with	IN	O
a	DT	O
partial	JJ	B_Disease
or	CC	I_Disease
complete	JJ	I_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
Hmgic	NNP	E_Disease
resisted	VBD	O
diet	JJ	O
-	:	O
induced	JJ	O
obesity	NN	S_Disease
.	.	O

Disruption	NN	O
of	IN	O
Hmgic	NNP	O
caused	VBD	O
a	DT	O
reduction	NN	O
in	IN	O
the	DT	O
obesity	NN	S_Disease
induced	VBN	O
by	IN	O
leptin	JJ	B_Disease
deficiency	NN	E_Disease
(	(	O
Lepob	NNP	O
/	NNP	O
Lepob	NNP	O
)	)	O
in	IN	O
a	DT	O
gene	NN	O
-	:	O
dose	JJ	O
-	:	O
dependent	JJ	O
manner	NN	O
.	.	O

Our	PRP$	O
studies	NNS	O
implicate	VBP	O
a	DT	O
role	NN	O
for	IN	O
HMGIC	NNP	O
in	IN	O
fat	JJ	O
-	:	O
cell	NN	O
proliferation	NN	O
,	,	O
indicating	VBG	O
that	IN	O
it	PRP	O
may	MD	O
be	VB	O
an	DT	O
adipose	JJ	O
-	:	O
specific	JJ	O
target	NN	O
for	IN	O
the	DT	O
treatment	NN	O
of	IN	O
obesity	NN	S_Disease
.	.	O
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
genotype	NN	O
-	:	O
phenotype	NN	O
relationship	NN	O
in	IN	O
factor	NN	B_Disease
X	NNP	I_Disease
deficiency	NN	E_Disease
.	.	O

Factor	NNP	B_Disease
X	NNP	I_Disease
deficiency	NN	E_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
haemorrhagic	JJ	B_Disease
condition	NN	E_Disease
,	,	O
normally	RB	O
inherited	VBN	O
as	IN	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
trait	NN	O
,	,	O
in	IN	O
which	WDT	O
a	DT	O
variable	JJ	O
clinical	JJ	O
presentation	NN	O
correlates	VBZ	O
poorly	RB	O
with	IN	O
laboratory	JJ	O
phenotype	NN	O
.	.	O

The	DT	O
factor	NN	O
X	NNP	O
(	(	O
F10	NNP	O
)	)	O
genes	NNS	O
of	IN	O
14	CD	O
unrelated	JJ	O
individuals	NNS	O
with	IN	O
factor	NN	B_Disease
X	NNP	I_Disease
deficiency	NN	E_Disease
(	(	O
12	CD	O
familial	NN	O
and	CC	O
two	CD	O
sporadic	JJ	O
cases	NNS	O
)	)	O
were	VBD	O
sequenced	VBN	O
yielding	VBG	O
a	DT	O
total	NN	O
of	IN	O
13	CD	O
novel	JJ	O
mutations	NNS	O
.	.	O

Family	RB	O
studies	NNS	O
were	VBD	O
performed	VBN	O
in	IN	O
order	NN	O
to	TO	O
distinguish	VB	O
the	DT	O
contributions	NNS	O
of	IN	O
individual	JJ	O
mutant	NN	O
F10	NNP	O
alleles	VBZ	O
to	TO	O
the	DT	O
clinical	JJ	O
and	CC	O
laboratory	JJ	O
phenotypes	NNS	O
.	.	O

Missense	JJ	O
mutations	NNS	O
were	VBD	O
studied	VBN	O
by	IN	O
means	NNS	O
of	IN	O
molecular	JJ	O
modelling	NN	O
,	,	O
whereas	WP	O
single	JJ	O
basepair	NN	O
substitutions	NNS	O
in	IN	O
splice	NN	O
sites	NNS	O
and	CC	O
the	DT	O
5	CD	O
flanking	JJ	O
region	NN	O
were	VBD	O
examined	VBN	O
by	IN	O
in	IN	O
vitro	NN	O
splicing	VBG	O
assay	NN	O
and	CC	O
luciferase	NN	O
reporter	NN	O
gene	NN	O
assay	VBP	O
respectively	RB	O
.	.	O

The	DT	O
deletion	NN	O
allele	NN	O
of	IN	O
a	DT	O
novel	JJ	O
hexanucleotide	NN	O
insertion	NN	O
/	NNP	O
deletion	NN	O
polymorphism	NN	O
in	IN	O
the	DT	O
F10	NNP	O
gene	NN	O
promoter	NN	O
region	NN	O
was	VBD	O
shown	VBN	O
by	IN	O
reporter	NN	O
gene	NN	O
assay	VBP	O
,	,	O
to	TO	O
reduce	VB	O
promoter	NN	O
activity	NN	O
by	IN	O
approximately	RB	O
20	CD	O
%	NN	O
.	.	O

One	CD	O
family	NN	O
manifesting	VBG	O
an	DT	O
autosomal	JJ	O
dominant	JJ	O
pattern	NN	O
of	IN	O
inheritance	NN	O
possessed	VBD	O
three	CD	O
clinically	RB	O
affected	JJ	O
members	NNS	O
who	WP	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
a	DT	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
that	WDT	O
was	VBD	O
predicted	VBN	O
to	TO	O
lead	VB	O
to	TO	O
the	DT	O
production	NN	O
of	IN	O
a	DT	O
truncated	JJ	O
protein	NN	O
product	NN	O
.	.	O

A	DT	O
model	NN	O
which	WDT	O
accounts	VBZ	O
for	IN	O
the	DT	O
dominant	JJ	O
negative	JJ	O
effect	NN	O
of	IN	O
this	DT	O
lesion	NN	O
is	VBZ	O
presented	VBN	O
.	.	O

Variation	NN	O
in	IN	O
the	DT	O
antigen	NN	O
level	NN	O
of	IN	O
heterozygous	JJ	O
relatives	NNS	O
of	IN	O
probands	NNS	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
significantly	RB	O
higher	JJR	O
between	IN	O
families	NNS	O
than	IN	O
within	IN	O
families	NNS	O
,	,	O
consistent	NN	O
with	IN	O
the	DT	O
view	NN	O
that	IN	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
F10	NNP	O
lesion	NN	O
(	(	O
s	PRP	O
)	)	O
segregating	VBG	O
in	IN	O
a	DT	O
given	VBN	O
family	NN	O
is	VBZ	O
a	DT	O
prime	JJ	O
determinant	NN	O
of	IN	O
the	DT	O
laboratory	NN	O
phenotype	NN	O
.	.	O

By	IN	O
contrast	NN	O
,	,	O
no	DT	O
such	JJ	O
relationship	NN	O
could	MD	O
be	VB	O
discerned	VBN	O
between	IN	O
laboratory	NN	O
phenotype	NN	O
and	CC	O
polymorphism	NN	O
genotype	NN	O
.	.	O
.	.	O

Transgenic	NNP	O
mice	NN	O
expressing	VBG	O
a	DT	O
truncated	JJ	O
form	NN	O
of	IN	O
the	DT	O
high	JJ	O
mobility	NN	O
group	NN	O
I	PRP	O
-	:	O
C	NNP	O
protein	NN	O
develop	VB	O
adiposity	NN	O
and	CC	O
an	DT	O
abnormally	RB	O
high	JJ	O
prevalence	NN	O
of	IN	O
lipomas	NN	S_Disease
.	.	O

Chromosomal	JJ	O
translocations	NNS	O
in	IN	O
human	JJ	O
lipomas	NN	S_Disease
frequently	RB	O
create	JJ	O
fusion	NN	O
transcripts	NNS	O
encoding	VBG	O
high	JJ	O
mobility	NN	O
group	NN	O
(	(	O
HMG	NNP	O
)	)	O
I	PRP	O
-	:	O
C	NNP	O
DNA	NNP	O
-	:	O
binding	NN	O
domains	NNS	O
and	CC	O
C	NNP	O
-	:	O
terminal	JJ	O
sequences	NNS	O
from	IN	O
different	JJ	O
presumed	VBN	O
transcription	NN	O
factors	NNS	O
,	,	O
suggesting	VBG	O
a	DT	O
potential	JJ	O
role	NN	O
for	IN	O
HMG	NNP	O
I	PRP	O
-	:	O
C	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
lipomas	NN	S_Disease
.	.	O

To	TO	O
evaluate	VB	O
the	DT	O
role	NN	O
of	IN	O
the	DT	O
HMG	NNP	O
I	PRP	O
-	:	O
C	NNP	O
component	NN	O
,	,	O
the	DT	O
three	CD	O
DNA	NNP	O
-	:	O
binding	NN	O
domains	NNS	O
of	IN	O
HMG	NNP	O
I	PRP	O
-	:	O
C	NNS	O
have	VBP	O
now	RB	O
been	VBN	O
expressed	VBN	O
in	IN	O
transgenic	JJ	O
mice	NN	O
.	.	O

Despite	IN	O
the	DT	O
ubiquitous	JJ	O
expression	NN	O
of	IN	O
the	DT	O
truncated	JJ	O
HMG	NNP	O
I	PRP	O
-	:	O
C	NNP	O
protein	NN	O
,	,	O
the	DT	O
transgenic	JJ	O
mice	NN	O
develop	VB	O
a	DT	O
selective	JJ	O
abundance	NN	O
of	IN	O
fat	JJ	O
tissue	NN	O
early	RB	O
in	IN	O
life	NN	O
,	,	O
show	VBP	O
marked	VBN	O
adipose	JJ	B_Disease
tissue	NN	I_Disease
inflammation	NN	E_Disease
,	,	O
and	CC	O
have	VBP	O
an	DT	O
abnormally	RB	O
high	JJ	O
incidence	NN	O
of	IN	O
lipomas	NN	S_Disease
.	.	O

These	DT	O
findings	NNS	O
demonstrate	VBP	O
that	IN	O
the	DT	O
DNA	NNP	O
-	:	O
binding	NN	O
domains	NNS	O
of	IN	O
HMG	NNP	O
I	PRP	O
-	:	O
C	NN	O
,	,	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
C	NNP	O
-	:	O
terminal	JJ	O
fusion	NN	O
partner	NN	O
,	,	O
are	VBP	O
sufficient	JJ	O
to	TO	O
perturb	VB	O
adipogenesis	NN	O
and	CC	O
predispose	VB	O
to	TO	O
lipomas	VB	S_Disease
.	.	O

We	PRP	O
provide	VBP	O
data	NNS	O
supporting	VBG	O
the	DT	O
central	JJ	O
utility	NN	O
of	IN	O
this	DT	O
animal	JJ	O
model	NN	O
as	IN	O
a	DT	O
tool	NN	O
to	TO	O
understand	VB	O
the	DT	O
molecular	JJ	O
mechanisms	NNS	O
underlying	VBG	O
the	DT	O
development	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
most	RBS	O
common	JJ	O
kind	NN	O
of	IN	O
human	JJ	O
benign	NN	B_Disease
tumors	NNS	E_Disease
.	.	O
.	.	O

ATM	NNP	O
phosphorylates	VBZ	O
p95	JJ	O
/	NNP	O
nbs1	NN	O
in	IN	O
an	DT	O
S	NNP	O
-	:	O
phase	NN	O
checkpoint	NN	O
pathway	NN	O
.	.	O

The	DT	O
rare	JJ	B_Disease
diseases	NNS	E_Disease
ataxia	VBP	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
(	(	O
AT	NNP	S_Disease
)	)	O
,	,	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
,	,	O
and	CC	O
Nijmegen	NNP	B_Disease
breakage	NN	I_Disease
syndrome	NN	E_Disease
(	(	O
NBS	NNP	S_Disease
)	)	O
,	,	O
with	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
p95	NN	O
/	NNP	O
nbs1	NN	O
gene	NN	O
,	,	O
share	NN	O
a	DT	O
variety	NN	O
of	IN	O
phenotypic	JJ	B_Disease
abnormalities	NNS	E_Disease
such	JJ	O
as	IN	O
chromosomal	JJ	B_Disease
instability	NN	E_Disease
,	,	O
radiation	NN	O
sensitivity	NN	O
and	CC	O
defects	NNS	O
in	IN	O
cell	NN	O
-	:	O
cycle	NN	O
checkpoints	NNS	O
in	IN	O
response	NN	O
to	TO	O
ionizing	VBG	O
radiation	NN	O
.	.	O

The	DT	O
ATM	NNP	O
gene	NN	O
encodes	VBZ	O
a	DT	O
protein	NN	O
kinase	NN	O
that	WDT	O
is	VBZ	O
activated	VBN	O
by	IN	O
ionizing	VBG	O
radiation	NN	O
or	CC	O
radiomimetic	JJ	O
drugs	NNS	O
,	,	O
whereas	NNS	O
p95	VBP	O
/	JJ	O
nbs1	NN	O
is	VBZ	O
part	NN	O
of	IN	O
a	DT	O
protein	NN	O
complex	NN	O
that	WDT	O
is	VBZ	O
involved	VBN	O
in	IN	O
responses	NNS	O
to	TO	O
DNA	NNP	O
double	JJ	O
-	:	O
strand	NN	O
breaks	NNS	O
.	.	O

Here	RB	O
,	,	O
because	IN	O
of	IN	O
the	DT	O
similarities	NNS	O
between	IN	O
AT	NNP	S_Disease
and	CC	O
NBS	NNP	S_Disease
,	,	O
we	PRP	O
evaluated	VBD	O
the	DT	O
functional	JJ	O
interactions	NNS	O
between	IN	O
ATM	NNP	O
and	CC	O
p95	VB	O
/	NNP	O
nbs1	NN	O
.	.	O

Activation	NN	O
of	IN	O
the	DT	O
ATM	NNP	O
kinase	NN	O
by	IN	O
ionizing	VBG	O
radiation	NN	O
and	CC	O
induction	NN	O
of	IN	O
ATM	NNP	O
-	:	O
dependent	NN	O
responses	NNS	O
in	IN	O
NBS	NNP	S_Disease
cells	NNS	O
indicated	VBD	O
that	IN	O
p95	NN	O
/	NNP	O
nbs1	NN	O
may	MD	O
not	RB	O
be	VB	O
required	VBN	O
for	IN	O
signalling	VBG	O
to	TO	O
ATM	NNP	O
after	IN	O
ionizing	VBG	O
radiation	NN	O
.	.	O

However	RB	O
,	,	O
p95	JJ	O
/	NNP	O
nbs1	NN	O
was	VBD	O
phosphorylated	VBN	O
on	IN	O
serine	NN	O
343	CD	O
in	IN	O
an	DT	O
ATM	NNP	O
-	:	O
dependent	JJ	O
manner	NN	O
in	IN	O
vitro	NN	O
and	CC	O
in	IN	O
vivo	NN	O
after	IN	O
ionizing	VBG	O
radiation	NN	O
.	.	O

A	DT	O
p95	NN	O
/	NNP	O
nbs1	CC	O
construct	NN	O
mutated	VBN	O
at	IN	O
the	DT	O
ATM	NNP	O
phosphorylation	NN	O
site	NN	O
abrogated	VBD	O
an	DT	O
S	NNP	O
-	:	O
phase	NN	O
checkpoint	NN	O
induced	VBN	O
by	IN	O
ionizing	VBG	O
radiation	NN	O
in	IN	O
normal	JJ	O
cells	NNS	O
and	CC	O
failed	VBD	O
to	TO	O
compensate	VB	O
for	IN	O
this	DT	O
functional	JJ	O
deficiency	NN	O
in	IN	O
NBS	NNP	S_Disease
cells	NNS	O
.	.	O

These	DT	O
observations	NNS	O
link	VBP	O
ATM	NNP	O
and	CC	O
p95	VB	O
/	NNP	O
nbs1	NN	O
in	IN	O
a	DT	O
common	JJ	O
signalling	NN	O
pathway	NN	O
and	CC	O
provide	VB	O
an	DT	O
explanation	NN	O
for	IN	O
phenotypic	NN	O
similarities	NNS	O
in	IN	O
these	DT	O
two	CD	O
diseases	NNS	O
.	.	O
.	.	O

Understanding	VBG	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Fragile	NNP	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
a	DT	O
common	JJ	O
form	NN	O
of	IN	O
inherited	JJ	B_Disease
mental	JJ	I_Disease
retardation	NN	E_Disease
,	,	O
is	VBZ	O
mainly	RB	O
caused	VBN	O
by	IN	O
massive	JJ	O
expansion	NN	O
of	IN	O
CGG	NNP	O
triplet	NN	O
repeats	NNS	O
located	VBN	O
in	IN	O
the	DT	O
5	CD	O
-	:	O
untranslated	JJ	O
region	NN	O
of	IN	O
the	DT	O
fragile	JJ	B_Disease
X	NNP	I_Disease
mental	NN	I_Disease
retardation	NN	E_Disease
-	:	O
1	CD	O
(	(	O
FMR1	NNP	O
)	)	O
gene	NN	O
.	.	O

In	IN	O
patients	NNS	O
with	IN	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
the	DT	O
expanded	VBN	O
CGG	NNP	O
triplet	NN	O
repeats	NNS	O
are	VBP	O
hypermethylated	VBN	O
and	CC	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
FMR1	NNP	O
gene	NN	O
is	VBZ	O
repressed	VBN	O
,	,	O
which	WDT	O
leads	VBZ	O
to	TO	O
the	DT	O
absence	NN	O
of	IN	O
FMR1	NNP	O
protein	NN	O
(	(	O
FMRP	NNP	O
)	)	O
and	CC	O
subsequent	JJ	O
mental	JJ	B_Disease
retardation	NN	E_Disease
.	.	O

FMRP	NNP	O
is	VBZ	O
an	DT	O
RNA	NNP	O
-	:	O
binding	NN	O
protein	NN	O
that	WDT	O
shuttles	VBZ	O
between	IN	O
the	DT	O
nucleus	NN	O
and	CC	O
cytoplasm	NN	O
.	.	O

This	DT	O
protein	NN	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
in	IN	O
protein	JJ	O
translation	NN	O
as	IN	O
it	PRP	O
is	VBZ	O
found	VBN	O
associated	VBN	O
with	IN	O
polyribosomes	NNS	O
and	CC	O
the	DT	O
rough	JJ	O
endoplasmic	JJ	O
reticulum	NN	O
.	.	O

We	PRP	O
discuss	VBP	O
here	RB	O
the	DT	O
recent	JJ	O
progress	NN	O
made	VBD	O
towards	NNS	O
understanding	VBG	O
the	DT	O
molecular	JJ	O
mechanism	NN	O
of	IN	O
CGG	NNP	O
repeat	NN	O
expansion	NN	O
and	CC	O
physiological	JJ	O
function	NN	O
(	(	O
s	JJ	O
)	)	O
of	IN	O
FMRP	NNP	O
.	.	O

These	DT	O
studies	NNS	O
will	MD	O
not	RB	O
only	RB	O
help	VB	O
to	TO	O
illuminate	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
the	DT	O
general	JJ	O
class	NN	O
of	IN	O
human	JJ	O
diseases	NNS	O
with	IN	O
trinucleotide	JJ	O
repeat	NN	O
expansion	NN	O
but	CC	O
also	RB	O
provide	VBP	O
an	DT	O
avenue	NN	O
to	TO	O
understand	VB	O
aspects	NNS	O
of	IN	O
human	JJ	O
cognition	NN	O
and	CC	O
intelligence	NN	O
.	.	O
.	.	O

Haploinsufficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
transcription	NN	I_Disease
factors	NNS	I_Disease
FOXC1	NNP	I_Disease
and	CC	I_Disease
FOXC2	NNP	E_Disease
results	NNS	O
in	IN	O
aberrant	JJ	O
ocular	JJ	O
development	NN	O
.	.	O

Anterior	NNP	B_Disease
segment	NN	I_Disease
developmental	NN	I_Disease
disorders	NNS	E_Disease
,	,	O
including	VBG	O
Axenfeld	NNP	B_Disease
-	:	I_Disease
Rieger	NN	I_Disease
anomaly	NN	E_Disease
(	(	O
ARA	NNP	S_Disease
)	)	O
,	,	O
variably	RB	O
associate	JJ	O
with	IN	O
harmfully	RB	O
elevated	VBN	O
intraocular	JJ	O
pressure	NN	O
(	(	O
IOP	NNP	O
)	)	O
,	,	O
which	WDT	O
causes	VBZ	O
glaucoma	NN	S_Disease
.	.	O

Clinically	RB	O
observed	VBN	O
dysgenesis	NN	O
does	VBZ	O
not	RB	O
correlate	VB	O
with	IN	O
IOP	NNP	O
,	,	O
however	RB	O
,	,	O
and	CC	O
the	DT	O
etiology	NN	O
of	IN	O
glaucoma	NN	S_Disease
development	NN	O
is	VBZ	O
not	RB	O
understood	JJ	O
.	.	O

The	DT	O
forkhead	JJ	O
transcription	NN	O
factor	NN	O
genes	NNS	O
Foxc1	NNP	O
(	(	O
formerly	RB	O
Mf1	NNP	O
)	)	O
and	CC	O
Foxc2	NNP	O
(	(	O
formerly	RB	O
Mfh1	NNP	O
)	)	O
are	VBP	O
expressed	VBN	O
in	IN	O
the	DT	O
mesenchyme	NN	O
from	IN	O
which	WDT	O
the	DT	O
ocular	JJ	O
drainage	NN	O
structures	NNS	O
derive	VBP	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
homolog	NN	O
of	IN	O
Foxc1	NNP	O
,	,	O
FKHL7	NNP	O
,	,	O
cause	NN	O
dominant	JJ	O
anterior	JJ	B_Disease
segment	NN	I_Disease
defects	NNS	E_Disease
and	CC	O
glaucoma	NN	S_Disease
in	IN	O
various	JJ	O
families	NNS	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
Foxc1	NNP	O
(	(	O
+	NNP	O
/	NNP	O
-	:	O
)	)	O
mice	NN	O
have	VBP	O
anterior	VBN	B_Disease
segment	NN	I_Disease
abnormalities	NNS	E_Disease
similar	JJ	O
to	TO	O
those	DT	O
reported	VBN	O
in	IN	O
human	JJ	O
patients	NNS	O
.	.	O

These	DT	O
abnormalities	NNS	O
include	VBP	O
small	JJ	O
or	CC	O
absent	JJ	O
Schlemms	NNP	O
canal	NN	O
,	,	O
aberrantly	RB	O
developed	VBD	O
trabecular	JJ	O
meshwork	NN	O
,	,	O
iris	JJ	B_Disease
hypoplasia	NN	E_Disease
,	,	O
severely	RB	O
eccentric	JJ	O
pupils	NNS	O
and	CC	O
displaced	VBD	O
Schwalbes	NNP	O
line	NN	O
.	.	O

The	DT	O
penetrance	NN	O
of	IN	O
clinically	RB	O
obvious	JJ	O
abnormalities	NNS	O
varies	NNS	O
with	IN	O
genetic	JJ	O
background	NN	O
.	.	O

In	IN	O
some	DT	O
affected	JJ	O
eyes	NNS	O
,	,	O
collagen	NN	O
bundles	NNS	O
were	VBD	O
half	JJ	O
normal	JJ	O
diameter	NN	O
,	,	O
or	CC	O
collagen	NN	O
and	CC	O
elastic	JJ	O
tissue	NN	O
were	VBD	O
very	RB	O
sparse	JJ	O
.	.	O

Thus	RB	O
,	,	O
abnormalities	NNS	O
in	IN	O
extracellular	JJ	O
matrix	NN	O
synthesis	NN	O
or	CC	O
organization	NN	O
may	MD	O
contribute	VB	O
to	TO	O
development	NN	O
of	IN	O
the	DT	O
ocular	JJ	O
phenotypes	NNS	O
.	.	O

Despite	IN	O
the	DT	O
abnormalities	NNS	O
in	IN	O
ocular	JJ	O
drainage	NN	O
structures	NNS	O
in	IN	O
Foxc1	NNP	O
(	(	O
+	NNP	O
/	NNP	O
-	:	O
)	)	O
mice	NN	O
,	,	O
IOP	NNP	O
was	VBD	O
normal	JJ	O
in	IN	O
almost	RB	O
all	DT	O
mice	NNS	O
analyzed	VBN	O
,	,	O
on	IN	O
all	DT	O
genetic	JJ	O
backgrounds	NNS	O
and	CC	O
at	IN	O
all	DT	O
ages	NNS	O
.	.	O

Similar	JJ	O
abnormalities	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
Foxc2	NNP	O
(	(	O
+	NNP	O
/	NNP	O
-	:	O
)	)	O
mice	NN	O
,	,	O
but	CC	O
no	DT	O
disease	NN	O
-	:	O
associated	VBN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
the	DT	O
human	JJ	O
homolog	NN	O
FKHL14	NNP	O
in	IN	O
32	CD	O
ARA	NNP	S_Disease
patients	NNS	O
.	.	O

Foxc1	NNP	O
(	(	O
+	NNP	O
/	NNP	O
-	:	O
)	)	O
and	CC	O
Foxc2	NNP	O
(	(	O
+	NNP	O
/	NNP	O
-	:	O
)	)	O
mice	NN	O
are	VBP	O
useful	JJ	O
models	NNS	O
for	IN	O
studying	VBG	O
anterior	JJ	O
segment	NN	O
development	NN	O
and	CC	O
its	PRP$	O
anomalies	NNS	O
,	,	O
and	CC	O
may	MD	O
allow	VB	O
identification	NN	O
of	IN	O
genes	NNS	O
that	WDT	O
interact	VBP	O
with	IN	O
Foxc1	NNP	O
and	CC	O
Foxc2	NNP	O
(	(	O
or	CC	O
FKHL7	NNP	O
and	CC	O
FKHL14	NNP	O
)	)	O
to	TO	O
produce	VB	O
a	DT	O
phenotype	NN	O
with	IN	O
elevated	JJ	O
IOP	NNP	O
and	CC	O
glaucoma	NN	S_Disease
.	.	O
.	.	O

(	(	O
Over	IN	O
)	)	O
correction	NN	O
of	IN	O
FMR1	NNP	B_Disease
deficiency	NN	E_Disease
with	IN	O
YAC	NNP	O
transgenics	NNS	O
:	:	O
behavioral	JJ	O
and	CC	O
physical	JJ	O
features	NNS	O
.	.	O

Fragile	NNP	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
common	JJ	O
cause	NN	O
of	IN	O
mental	JJ	B_Disease
retardation	NN	E_Disease
involving	VBG	O
loss	NN	O
of	IN	O
expression	NN	O
of	IN	O
the	DT	O
FMR1	NNP	O
gene	NN	O
.	.	O

The	DT	O
role	NN	O
of	IN	O
FMR1	NNP	O
remains	NNS	O
undetermined	JJ	O
but	CC	O
the	DT	O
protein	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
involved	VBN	O
in	IN	O
RNA	NNP	O
metabolism	NN	O
.	.	O

Fmr1	NNP	O
knockout	NN	O
mice	NN	O
exhibit	NN	O
a	DT	O
phenotype	NN	O
with	IN	O
some	DT	O
similarities	NNS	O
to	TO	O
humans	NNS	O
,	,	O
such	JJ	O
as	IN	O
macroorchidism	NN	S_Disease
and	CC	O
behavioral	JJ	O
abnormalities	NNS	O
.	.	O

As	IN	O
a	DT	O
step	NN	O
toward	IN	O
understanding	VBG	O
the	DT	O
function	NN	O
of	IN	O
FMR1	NNP	O
and	CC	O
the	DT	O
determination	NN	O
of	IN	O
the	DT	O
potential	NN	O
for	IN	O
therapeutic	JJ	O
approaches	NNS	O
to	TO	O
fragile	VB	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
yeast	RB	O
artificial	JJ	O
chromosome	NN	O
(	(	O
YAC	NNP	O
)	)	O
transgenic	JJ	O
mice	NN	O
were	VBD	O
generated	VBN	O
in	IN	O
order	NN	O
to	TO	O
determine	VB	O
whether	IN	O
the	DT	O
Fmr1	NNP	O
knockout	NN	O
mouse	NN	O
phenotype	NN	O
could	MD	O
be	VB	O
rescued	VBN	O
.	.	O

Several	JJ	O
transgenic	JJ	O
lines	NNS	O
were	VBD	O
generated	VBN	O
that	IN	O
carried	VBD	O
the	DT	O
entire	JJ	O
FMR1	NNP	O
locus	NN	O
with	IN	O
extensive	JJ	O
amounts	NNS	O
of	IN	O
flanking	VBG	O
sequence	NN	O
.	.	O

We	PRP	O
observed	VBD	O
that	IN	O
the	DT	O
YAC	NNP	O
transgene	NN	O
supported	VBD	O
production	NN	O
of	IN	O
the	DT	O
human	JJ	O
protein	NN	O
(	(	O
FMRP	NNP	O
)	)	O
which	WDT	O
was	VBD	O
present	JJ	O
at	IN	O
levels	NNS	O
10	CD	O
to	TO	O
15	CD	O
times	NNS	O
that	IN	O
of	IN	O
endogenous	JJ	O
protein	NN	O
and	CC	O
was	VBD	O
expressed	VBN	O
in	IN	O
a	DT	O
cell	NN	O
-	:	O
and	CC	O
tissue	VB	O
-	:	O
specific	JJ	O
manner	NN	O
.	.	O

Macro	NNP	O
-	:	O
orchidism	NN	O
was	VBD	O
absent	JJ	O
in	IN	O
knockout	NN	O
mice	NN	O
carrying	VBG	O
the	DT	O
YAC	NNP	O
transgene	NN	O
indicating	VBG	O
functional	JJ	O
rescue	NN	O
by	IN	O
the	DT	O
human	JJ	O
protein	NN	O
.	.	O

Given	VBN	O
the	DT	O
complex	JJ	O
behavioral	JJ	O
phenotype	NN	O
in	IN	O
fragile	JJ	B_Disease
X	NN	E_Disease
patients	NNS	O
and	CC	O
the	DT	O
mild	JJ	O
phenotype	NN	O
previously	RB	O
reported	VBD	O
for	IN	O
the	DT	O
Fmr1	NNP	O
knockout	NN	O
mouse	NN	O
,	,	O
we	PRP	O
performed	VBD	O
a	DT	O
more	RBR	O
thorough	JJ	O
evaluation	NN	O
of	IN	O
the	DT	O
Fmr1	NNP	O
knockout	NN	O
phenotype	NN	O
using	VBG	O
additional	JJ	O
behavioral	JJ	O
assays	NNS	O
that	WDT	O
had	VBD	O
not	RB	O
previously	RB	O
been	VBN	O
reported	VBN	O
for	IN	O
this	DT	O
animal	JJ	O
model	NN	O
.	.	O

The	DT	O
mouse	NN	O
displayed	VBD	O
reduced	VBN	O
anxiety	NN	S_Disease
-	:	O
related	JJ	O
responses	NNS	O
with	IN	O
increased	JJ	O
exploratory	NN	O
behavior	NN	O
.	.	O

FMR1	NNP	O
YAC	NNP	O
transgenic	JJ	O
mice	NN	O
overexpressing	VBG	O
the	DT	O
human	JJ	O
protein	NN	O
did	VBD	O
produce	VB	O
opposing	VBG	O
behavioral	JJ	O
responses	NNS	O
and	CC	O
additional	JJ	O
abnormal	JJ	O
behaviors	NNS	O
were	VBD	O
also	RB	O
observed	VBN	O
.	.	O

These	DT	O
findings	NNS	O
have	VBP	O
significant	JJ	O
implications	NNS	O
for	IN	O
gene	NN	O
therapy	NN	O
for	IN	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
since	IN	O
overexpression	NN	O
of	IN	O
the	DT	O
gene	NN	O
may	MD	O
harbor	VB	O
its	PRP$	O
own	JJ	O
phenotype	NN	O
.	.	O
.	.	O

Transgenic	NNP	O
mice	NN	O
carrying	VBG	O
large	JJ	O
human	JJ	O
genomic	JJ	O
sequences	NNS	O
with	IN	O
expanded	JJ	O
CTG	NNP	O
repeat	NN	O
mimic	RBR	O
closely	RB	O
the	DT	O
DM	NNP	S_Disease
CTG	NNP	O
repeat	NN	O
intergenerational	JJ	O
and	CC	O
somatic	JJ	O
instability	NN	O
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
CTG	NNP	O
repeat	NN	O
expansion	NN	O
in	IN	O
the	DT	O
3UTR	CD	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
protein	NN	O
kinase	NN	O
(	(	O
DMPK	NNP	O
)	)	O
gene	NN	O
.	.	O

A	DT	O
very	RB	O
high	JJ	O
level	NN	O
of	IN	O
instability	NN	O
is	VBZ	O
observed	VBN	O
through	IN	O
successive	JJ	O
generations	NNS	O
and	CC	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
repeat	NN	O
is	VBZ	O
generally	RB	O
correlated	VBN	O
with	IN	O
the	DT	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
and	CC	O
with	IN	O
age	NN	O
at	IN	O
onset	NN	O
.	.	O

Furthermore	RB	O
,	,	O
tissues	NNS	O
from	IN	O
DM	NNP	S_Disease
patients	NNS	O
exhibit	VBP	O
somatic	JJ	O
mosaicism	NN	O
that	WDT	O
increases	VBZ	O
with	IN	O
age	NN	O
.	.	O

We	PRP	O
generated	VBD	O
transgenic	JJ	O
mice	NN	O
carrying	VBG	O
large	JJ	O
human	JJ	O
genomic	JJ	O
sequences	NNS	O
with	IN	O
20	CD	O
,	,	O
55	CD	O
or	CC	O
>	VB	O
300	CD	O
CTG	NNP	O
,	,	O
cloned	VBD	O
from	IN	O
patients	NNS	O
from	IN	O
the	DT	O
same	JJ	O
affected	JJ	O
DM	NNP	S_Disease
family	NN	O
.	.	O

Using	VBG	O
large	JJ	O
human	JJ	O
flanking	NN	O
sequences	NNS	O
and	CC	O
a	DT	O
large	JJ	O
amplification	NN	O
,	,	O
we	PRP	O
demonstrate	VBP	O
that	IN	O
the	DT	O
intergenerational	JJ	O
CTG	NNP	O
repeat	NN	O
instability	NN	O
is	VBZ	O
reproduced	VBN	O
in	IN	O
mice	NN	O
,	,	O
with	IN	O
a	DT	O
strong	JJ	O
bias	NN	O
towards	NNS	O
expansions	NNS	O
and	CC	O
with	IN	O
the	DT	O
same	JJ	O
sex	NN	O
-	:	O
and	CC	O
size	NN	O
-	:	O
dependent	JJ	O
characteristics	NNS	O
as	IN	O
in	IN	O
humans	NNS	O
.	.	O

Moreover	RB	O
,	,	O
a	DT	O
high	JJ	O
level	NN	O
of	IN	O
instability	NN	O
,	,	O
increasing	VBG	O
with	IN	O
age	NN	O
,	,	O
can	MD	O
be	VB	O
observed	VBN	O
in	IN	O
tissues	NNS	O
and	CC	O
in	IN	O
sperm	NN	O
.	.	O

Although	IN	O
we	PRP	O
did	VBD	O
not	RB	O
observe	VB	O
dramatic	JJ	O
expansions	NNS	O
(	(	O
or	CC	O
big	JJ	O
jumps	NNS	O
over	IN	O
several	JJ	O
hundred	CD	O
CTG	NNP	O
repeats	NNS	O
)	)	O
as	IN	O
in	IN	O
congenital	JJ	O
forms	NNS	O
of	IN	O
DM	NNP	S_Disease
,	,	O
our	PRP$	O
model	NN	O
carrying	VBG	O
>	JJ	O
300	CD	O
CTG	NNP	O
is	VBZ	O
the	DT	O
first	JJ	O
to	TO	O
show	VB	O
instability	NN	O
so	RB	O
close	RB	O
to	TO	O
the	DT	O
human	JJ	O
DM	NNP	S_Disease
situation	NN	O
.	.	O

Our	PRP$	O
three	CD	O
models	NNS	O
carrying	VBG	O
different	JJ	O
sizes	NNS	O
of	IN	O
CTG	NNP	O
repeat	NN	O
provide	VBP	O
insight	NN	O
on	IN	O
the	DT	O
different	JJ	O
factors	NNS	O
modulating	VBG	O
the	DT	O
CTG	NNP	O
repeat	NN	O
instability	NN	O
.	.	O
.	.	O

Inactivation	NN	O
of	IN	O
the	DT	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
mouse	NN	O
gene	NN	O
leads	VBZ	O
to	TO	O
early	JJ	O
embryonic	JJ	B_Disease
lethality	NN	E_Disease
without	IN	O
iron	NN	O
accumulation	NN	O
.	.	O

Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
(	(	O
FRDA	NNP	S_Disease
)	)	O
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
ataxia	NN	E_Disease
,	,	O
is	VBZ	O
caused	VBN	O
in	IN	O
almost	RB	O
all	DT	O
cases	NNS	O
by	IN	O
homozygous	JJ	O
intronic	JJ	O
expansions	NNS	O
resulting	VBG	O
in	IN	O
the	DT	O
loss	NN	O
of	IN	O
frataxin	NN	O
,	,	O
a	DT	O
mitochondrial	JJ	O
protein	NN	O
conserved	VBD	O
through	IN	O
evolution	NN	O
,	,	O
and	CC	O
involved	VBN	O
in	IN	O
mitochondrial	JJ	O
iron	NN	O
homeostasis	NN	O
.	.	O

Yeast	NN	O
knockout	NN	O
models	NNS	O
,	,	O
and	CC	O
histological	JJ	O
and	CC	O
biochemical	JJ	O
data	NNS	O
from	IN	O
patient	JJ	O
heart	NN	O
biopsies	NNS	O
or	CC	O
autopsies	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
frataxin	NN	O
defect	NN	O
causes	VBZ	O
a	DT	O
specific	JJ	O
iron	NN	B_Disease
-	:	I_Disease
sulfur	NN	I_Disease
protein	NN	I_Disease
deficiency	NN	E_Disease
and	CC	O
mitochondrial	JJ	O
iron	NN	O
accumulation	NN	O
leading	VBG	O
to	TO	O
the	DT	O
pathological	JJ	O
changes	NNS	O
.	.	O

Affected	JJ	O
human	JJ	O
tissues	NNS	O
are	VBP	O
rarely	RB	O
available	JJ	O
to	TO	O
further	JJ	O
examine	NN	O
this	DT	O
hypothesis	NN	O
.	.	O

To	TO	O
study	VB	O
the	DT	O
mechanism	NN	O
of	IN	O
the	DT	O
disease	NN	O
,	,	O
we	PRP	O
generated	VBD	O
a	DT	O
mouse	NN	O
model	NN	O
by	IN	O
deletion	NN	O
of	IN	O
exon	$	O
4	CD	O
leading	VBG	O
to	TO	O
inactivation	NN	O
of	IN	O
the	DT	O
Frda	NNP	S_Disease
gene	NN	O
product	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
homozygous	JJ	O
deletions	NNS	O
cause	VBP	O
embryonic	JJ	B_Disease
lethality	NN	E_Disease
a	DT	O
few	JJ	O
days	NNS	O
after	IN	O
implantation	NN	O
,	,	O
demonstrating	VBG	O
an	DT	O
important	JJ	O
role	NN	O
for	IN	O
frataxin	NN	O
during	IN	O
early	JJ	O
development	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
milder	NN	O
phenotype	NN	O
in	IN	O
humans	NNS	O
is	VBZ	O
due	JJ	O
to	TO	O
residual	JJ	O
frataxin	NN	O
expression	NN	O
associated	VBN	O
with	IN	O
the	DT	O
expansion	NN	O
mutations	NNS	O
.	.	O

Surprisingly	RB	O
,	,	O
in	IN	O
the	DT	O
frataxin	NN	O
knockout	NN	O
mouse	NN	O
,	,	O
no	DT	O
iron	NN	O
accumulation	NN	O
was	VBD	O
observed	VBN	O
during	IN	O
embryonic	JJ	O
resorption	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
cell	NN	O
death	NN	O
could	MD	O
be	VB	O
due	JJ	O
to	TO	O
a	DT	O
mechanism	NN	O
independent	JJ	O
of	IN	O
iron	NN	O
accumulation	NN	O
.	.	O
.	.	O

Gaucher	PRP$	B_Disease
disease	NN	E_Disease
:	:	O
the	DT	O
origins	NNS	O
of	IN	O
the	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
N370S	NNP	O
and	CC	O
84GG	CD	O
acid	NN	O
beta	NN	O
-	:	O
glucosidase	NN	O
mutations	NNS	O
.	.	O

Type	$	O
1	CD	O
Gaucher	NNP	B_Disease
disease	NN	E_Disease
(	(	O
GD	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
non	JJ	O
-	:	O
neuronopathic	JJ	O
lysosomal	JJ	B_Disease
storage	NN	I_Disease
disorder	NN	E_Disease
,	,	O
results	NNS	O
from	IN	O
the	DT	O
deficient	NN	O
activity	NN	O
of	IN	O
acid	NN	O
beta	SYM	O
-	:	O
glucosidase	NN	O
(	(	O
GBA	NNP	O
)	)	O
.	.	O

Type	$	O
1	CD	O
disease	NN	O
is	VBZ	O
panethnic	JJ	O
but	CC	O
is	VBZ	O
more	RBR	O
prevalent	JJ	O
in	IN	O
individuals	NNS	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
(	(	O
AJ	NNP	O
)	)	O
descent	NN	O
.	.	O

Of	IN	O
the	DT	O
causative	JJ	O
GBA	NNP	O
mutations	NNS	O
,	,	O
N370S	NNP	O
is	VBZ	O
particularly	RB	O
frequent	JJ	O
in	IN	O
the	DT	O
AJ	NNP	O
population	NN	O
,	,	O
(	(	O
q	JJ	O
approximately	RB	O
.	.	O

03	CD	O
)	)	O
,	,	O
whereas	VBD	O
the	DT	O
84GG	CD	O
insertion	NN	O
(	(	O
q	JJ	O
approximately	RB	O
.	.	O

003	CD	O
)	)	O
occurs	VBZ	O
exclusively	RB	O
in	IN	O
the	DT	O
Ashkenazim	NNP	O
.	.	O

To	TO	O
investigate	VB	O
the	DT	O
genetic	JJ	O
history	NN	O
of	IN	O
these	DT	O
mutations	NNS	O
in	IN	O
the	DT	O
AJ	NNP	O
population	NN	O
,	,	O
short	JJ	O
tandem	NN	O
repeat	NN	O
(	(	O
STR	NNP	O
)	)	O
markers	NNS	O
were	VBD	O
used	VBN	O
to	TO	O
map	VB	O
a	DT	O
9	CD	O
.	.	O

3	LS	O
-	:	O
cM	NN	O
region	NN	O
containing	VBG	O
the	DT	O
GBA	NNP	O
locus	NN	O
and	CC	O
to	TO	O
genotype	VB	O
261	CD	O
AJ	NNP	O
N370S	NNP	O
chromosomes	NNS	O
,	,	O
60	CD	O
European	JJ	O
non	NN	O
-	:	O
Jewish	JJ	O
N370S	NNP	O
chromosomes	NNS	O
,	,	O
and	CC	O
62	CD	O
AJ	NNP	O
84GG	CD	O
chromosomes	NNS	O
.	.	O

A	DT	O
highly	RB	O
conserved	VBN	O
haplotype	NN	O
at	IN	O
four	CD	O
markers	NNS	O
flanking	VBG	O
GBA	NNP	O
(	(	O
PKLR	NNP	O
,	,	O
D1S1595	NNP	O
,	,	O
D1S2721	NNP	O
,	,	O
and	CC	O
D1S2777	NNP	O
)	)	O
was	VBD	O
observed	VBN	O
on	IN	O
both	DT	O
the	DT	O
AJ	NNP	O
chromosomes	NNS	O
and	CC	O
the	DT	O
non	NN	O
-	:	O
Jewish	JJ	O
N370S	NNP	O
chromosomes	NNS	O
,	,	O
suggesting	VBG	O
the	DT	O
occurrence	NN	O
of	IN	O
a	DT	O
founder	NN	O
common	JJ	O
to	TO	O
both	DT	O
populations	NNS	O
.	.	O

Of	IN	O
note	NN	O
,	,	O
the	DT	O
presence	NN	O
of	IN	O
different	JJ	O
divergent	NN	O
haplotypes	NNS	O
suggested	VBD	O
the	DT	O
occurrence	NN	O
of	IN	O
de	FW	O
novo	FW	O
,	,	O
recurrent	NN	O
N370S	NNP	O
mutations	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
a	DT	O
different	JJ	O
conserved	VBN	O
haplotype	NN	O
at	IN	O
these	DT	O
markers	NNS	O
was	VBD	O
identified	VBN	O
on	IN	O
the	DT	O
84GG	CD	O
chromosomes	NNS	O
,	,	O
which	WDT	O
was	VBD	O
unique	JJ	O
to	TO	O
the	DT	O
AJ	NNP	O
population	NN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
linkage	NN	O
disequilibrium	NN	O
(	(	O
LD	NNP	O
)	)	O
delta	NN	O
values	NNS	O
,	,	O
the	DT	O
non	NN	O
-	:	O
Jewish	JJ	O
European	JJ	O
N370S	NNP	O
chromosomes	NNS	O
had	VBD	O
greater	JJR	O
haplotype	JJ	O
diversity	NN	O
and	CC	O
less	JJR	O
LD	NNP	O
at	IN	O
the	DT	O
markers	NNS	O
flanking	VBG	O
the	DT	O
conserved	VBN	O
haplotype	NN	O
than	IN	O
did	VBD	O
the	DT	O
AJ	NNP	O
N370S	NNP	O
chromosomes	NNS	O
.	.	O

This	DT	O
finding	NN	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
N370S	NNP	O
mutation	NN	O
in	IN	O
the	DT	O
non	NN	O
-	:	O
Jewish	JJ	O
European	JJ	O
population	NN	O
prior	RB	O
to	TO	O
the	DT	O
founding	NN	O
of	IN	O
the	DT	O
AJ	NNP	O
population	NN	O
.	.	O

Coalescence	NN	O
analyses	NNS	O
for	IN	O
the	DT	O
N370S	NNP	O
and	CC	O
84GG	CD	O
mutations	NNS	O
estimated	VBD	O
similar	JJ	O
coalescence	NN	O
times	NNS	O
,	,	O
of	IN	O
48	CD	O
and	CC	O
55	CD	O
.	.	O
5	CD	O
generations	NNS	O
ago	RB	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
these	DT	O
studies	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
a	DT	O
significant	JJ	O
bottleneck	NN	O
occurring	VBG	O
in	IN	O
the	DT	O
AJ	NNP	O
population	NN	O
during	IN	O
the	DT	O
first	JJ	O
millennium	NN	O
,	,	O
when	WRB	O
the	DT	O
population	NN	O
became	VBD	O
established	VBN	O
in	IN	O
Europe	NNP	O
.	.	O

HLA	NNP	O
B27	NNP	O
and	CC	O
the	DT	O
genetics	NNS	O
of	IN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
.	.	O

One	CD	O
hundred	CD	O
and	CC	O
twenty	VB	O
-	:	O
eight	CD	O
of	IN	O
145	CD	O
patients	NNS	O
with	IN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
(	(	O
AS	IN	S_Disease
)	)	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
HLA	NNP	O
B27	NNP	O
positive	JJ	O
.	.	O

Five	CD	O
patients	NNS	O
had	VBD	O
evidence	NN	O
of	IN	O
a	DT	O
sero	JJ	O
-	:	O
negative	JJ	O
peripheral	JJ	B_Disease
arthritis	NN	E_Disease
resembling	VBG	O
peripheral	JJ	B_Disease
psoriatic	JJ	I_Disease
arthritis	NN	E_Disease
and	CC	O
3	CD	O
of	IN	O
these	DT	O
were	VBD	O
B27	NNP	O
negative	JJ	O
.	.	O

One	CD	O
further	JJ	O
B27	NNP	O
negative	JJ	O
patients	NNS	O
had	VBD	O
a	DT	O
sister	NN	O
with	IN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
and	CC	O
ulcerative	JJ	B_Disease
colitis	NN	E_Disease
and	CC	O
a	DT	O
mother	NN	O
with	IN	O
ulcerative	JJ	B_Disease
colitis	NN	E_Disease
.	.	O

There	EX	O
was	VBD	O
evidence	NN	O
of	IN	O
a	DT	O
somewhat	RB	O
later	JJ	O
age	NN	O
of	IN	O
onset	NN	O
of	IN	O
symptoms	NNS	O
in	IN	O
B27	NNP	O
negative	JJ	O
patients	NNS	O
.	.	O

These	DT	O
findings	NNS	O
are	VBP	O
interpreted	VBN	O
as	IN	O
suggesting	VBG	O
some	DT	O
degree	NN	O
of	IN	O
clinical	JJ	O
and	CC	O
genetic	JJ	O
heterogeneity	NN	O
in	IN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
with	IN	O
genes	NNS	O
for	IN	O
psoriasis	NN	S_Disease
and	CC	O
inflammatory	JJ	B_Disease
bowel	NN	I_Disease
disease	NN	E_Disease
being	VBG	O
important	JJ	O
in	IN	O
some	DT	O
individuals	NNS	O
,	,	O
particularly	RB	O
those	DT	O
who	WP	O
are	VBP	O
B27	NNP	O
negative	JJ	O
.	.	O

Twenty	CD	O
-	:	O
five	CD	O
first	JJ	O
-	:	O
degree	NN	O
relatives	NNS	O
with	IN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
were	VBD	O
all	DT	O
B27	NNP	O
positive	JJ	O
.	.	O

The	DT	O
only	JJ	O
instance	NN	O
of	IN	O
disassociation	NN	O
of	IN	O
B27	NNP	O
and	CC	O
spondylitis	NN	S_Disease
in	IN	O
a	DT	O
family	NN	O
was	VBD	O
where	WRB	O
the	DT	O
proband	NN	O
had	VBD	O
ulcerative	JJ	B_Disease
colitis	NN	E_Disease
as	RB	O
well	RB	O
as	IN	O
spondylitis	NN	S_Disease
.	.	O

Of	IN	O
13	CD	O
B27	NNP	O
positive	JJ	O
fathers	NNS	O
3	CD	O
could	MD	O
be	VB	O
diagnosed	VBN	O
as	IN	O
having	VBG	O
definite	JJ	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
(	(	O
23	CD	O
%	NN	O
)	)	O
.	.	O

These	DT	O
findings	NNS	O
are	VBP	O
thought	VBN	O
to	TO	O
provide	VB	O
evidence	NN	O
against	IN	O
the	DT	O
concept	NN	O
that	IN	O
the	DT	O
gene	NN	O
for	IN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
is	VBZ	O
not	RB	O
B27	NNP	O
but	CC	O
a	DT	O
closely	RB	O
linked	VBN	O
gene	NN	O
and	CC	O
favour	VB	O
the	DT	O
occurrence	NN	O
of	IN	O
an	DT	O
environmental	JJ	O
event	NN	O
affecting	VBG	O
approximately	RB	O
one	CD	O
-	:	O
fifth	NN	O
of	IN	O
B27	NNP	O
positive	JJ	O
males	NNS	O
to	TO	O
result	VB	O
in	IN	O
disease	NN	O
.	.	O
.	.	O

Founder	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
in	IN	O
Polish	JJ	O
families	NNS	O
with	IN	O
breast	NN	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
undertaken	VBN	O
a	DT	O
hospital	NN	O
-	:	O
based	VBN	O
study	NN	O
,	,	O
to	TO	O
identify	VB	O
possible	JJ	O
BRCA1	NNP	O
and	CC	O
BRCA2	NNP	O
founder	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
Polish	JJ	O
population	NN	O
.	.	O

The	DT	O
study	NN	O
group	NN	O
consisted	VBD	O
of	IN	O
66	CD	O
Polish	JJ	O
families	NNS	O
with	IN	O
cancer	NN	S_Disease
who	WP	O
have	VBP	O
at	IN	O
least	JJS	O
three	CD	O
related	JJ	O
females	NNS	O
affected	VBN	O
with	IN	O
breast	NN	B_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
and	CC	O
who	WP	O
had	VBD	O
cancer	NN	S_Disease
diagnosed	VBN	O
,	,	O
in	IN	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
three	CD	O
affected	VBD	O
females	NNS	O
,	,	O
at	IN	O
age	NN	O
<	$	O
50	CD	O
years	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
26	CD	O
families	NNS	O
had	VBD	O
both	DT	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
,	,	O
4	CD	O
families	NNS	O
had	VBD	O
ovarian	JJ	B_Disease
cancers	NNS	E_Disease
only	RB	O
,	,	O
and	CC	O
36	CD	O
families	NNS	O
had	VBD	O
breast	NN	B_Disease
cancers	NNS	E_Disease
only	RB	O
.	.	O

Genomic	NNP	O
DNA	NNP	O
was	VBD	O
prepared	VBN	O
from	IN	O
the	DT	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
of	IN	O
at	IN	O
least	JJS	O
one	CD	O
affected	JJ	O
woman	NN	O
from	IN	O
each	DT	O
family	NN	O
.	.	O

The	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
BRCA1	NNP	O
and	CC	O
BRCA2	NNP	O
was	VBD	O
screened	VBN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
germline	JJ	O
mutations	NNS	O
,	,	O
by	IN	O
use	NN	O
of	IN	O
SSCP	NNP	O
followed	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
of	IN	O
observed	JJ	O
variants	NNS	O
.	.	O

Mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
35	CD	O
(	(	O
53	CD	O
%	NN	O
)	)	O
of	IN	O
the	DT	O
66	CD	O
families	NNS	O
studied	VBN	O
.	.	O

All	DT	O
but	CC	O
one	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
within	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
.	.	O

BRCA1	NNP	B_Disease
abnormalities	NNS	E_Disease
were	VBD	O
identified	VBN	O
in	IN	O
all	DT	O
four	CD	O
families	NNS	O
with	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
only	RB	O
,	,	O
in	IN	O
67	CD	O
%	NN	O
of	IN	O
27	CD	O
families	NNS	O
with	IN	O
both	DT	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
,	,	O
and	CC	O
in	IN	O
34	CD	O
%	NN	O
of	IN	O
35	CD	O
families	NNS	O
with	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
only	RB	O
.	.	O

The	DT	O
single	JJ	O
family	NN	O
with	IN	O
a	DT	O
BRCA2	NNP	O
mutation	NN	O
had	VBD	O
the	DT	O
breast	NN	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	I_Disease
syndrome	NN	E_Disease
.	.	O

Seven	NNP	O
distinct	JJ	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
;	:	O
five	CD	O
of	IN	O
these	DT	O
occurred	VBN	O
in	IN	O
two	CD	O
or	CC	O
more	JJR	O
families	NNS	O
.	.	O

In	IN	O
total	JJ	O
,	,	O
recurrent	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
33	CD	O
(	(	O
94	CD	O
%	NN	O
)	)	O
of	IN	O
the	DT	O
35	CD	O
families	NNS	O
with	IN	O
detected	JJ	O
mutations	NNS	O
.	.	O

Three	CD	O
BRCA1	NNP	B_Disease
abnormalities	NNS	E_Disease
-	:	O
5382insC	CD	O
,	,	O
C61G	NNP	O
,	,	O
and	CC	O
4153delA	CD	O
-	:	O
accounted	VBN	O
for	IN	O
51	CD	O
%	NN	O
,	,	O
20	CD	O
%	NN	O
,	,	O
and	CC	O
11	CD	O
%	NN	O
of	IN	O
the	DT	O
identified	JJ	O
mutations	NNS	O
,	,	O
respectively	RB	O
.	.	O
.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
very	RB	B_Disease
long	RB	I_Disease
chain	NN	I_Disease
acyl	JJ	I_Disease
-	:	I_Disease
CoA	NNP	I_Disease
dehydrogenase	NN	I_Disease
deficiency	NN	E_Disease
in	IN	O
three	CD	O
Israeli	JJ	O
patients	NNS	O
:	:	O
identification	NN	O
of	IN	O
a	DT	O
complex	JJ	O
mutant	NN	O
allele	NN	O
with	IN	O
P65L	NNP	O
and	CC	O
K247Q	NNP	O
mutations	NNS	O
,	,	O
the	DT	O
former	JJ	O
being	VBG	O
an	DT	O
exonic	JJ	O
mutation	NN	O
causing	VBG	O
exon	$	O
3	CD	O
skipping	NN	O
.	.	O

Very	RB	B_Disease
long	RB	I_Disease
chain	NN	I_Disease
acyl	JJ	I_Disease
-	:	I_Disease
CoA	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
VLCAD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
is	VBZ	O
a	DT	O
life	NN	O
-	:	O
threatening	VBG	O
disorder	NN	O
of	IN	O
mitochondrial	JJ	O
fatty	JJ	O
acid	NN	O
beta	SYM	O
-	:	O
oxidation	NN	O
.	.	O

We	PRP	O
identified	VBD	O
four	CD	O
novel	JJ	O
mutations	NNS	O
in	IN	O
three	CD	O
unrelated	JJ	O
patients	NNS	O
.	.	O

All	DT	O
patients	NNS	O
had	VBD	O
the	DT	O
severe	JJ	O
childhood	NN	O
form	NN	O
of	IN	O
VLCAD	NNP	B_Disease
deficiency	NN	E_Disease
with	IN	O
early	JJ	O
onset	NN	O
and	CC	O
high	JJ	O
mortality	NN	O
.	.	O

Immunoblot	NNP	O
analysis	NN	O
revealed	VBD	O
that	IN	O
VLCAD	NNP	O
protein	NN	O
was	VBD	O
undetectable	JJ	O
in	IN	O
patients	NNS	O
2	CD	O
and	CC	O
3	CD	O
,	,	O
whereas	NNS	O
normal	JJ	O
-	:	O
size	NN	O
VLCAD	NNP	O
protein	NN	O
and	CC	O
an	DT	O
aberrant	JJ	O
form	NN	O
of	IN	O
VLCAD	NNP	O
(	(	O
4kDa	CD	O
smaller	JJR	O
)	)	O
were	VBD	O
detected	VBN	O
in	IN	O
patient	JJ	O
1	CD	O
.	.	O

As	IN	O
expected	VBN	O
,	,	O
null	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
patients	NNS	O
2	CD	O
and	CC	O
3	CD	O
patient	NN	O
2	CD	O
is	VBZ	O
homozygous	JJ	O
for	IN	O
a	DT	O
frameshift	NN	O
mutation	NN	O
,	,	O
del	FW	O
4	CD	O
bp	NN	O
at	IN	O
798	CD	O
-	:	O
801	CD	O
,	,	O
and	CC	O
patient	JJ	O
3	CD	O
is	VBZ	O
homozygous	JJ	O
for	IN	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
65C	CD	O
>	NN	O
A	NNP	O
(	(	O
S22X	NNP	O
)	)	O
.	.	O

Patient	JJ	O
1	CD	O
was	VBD	O
homozygous	JJ	O
for	IN	O
a	DT	O
complex	JJ	O
mutant	NN	O
allele	IN	O
containing	VBG	O
two	CD	O
alterations	NNS	O
,	,	O
including	VBG	O
a	DT	O
194C	CD	O
>	NN	O
T	NNP	O
transition	NN	O
(	(	O
P65L	NNP	O
)	)	O
and	CC	O
739A	CD	O
>	NNS	O
C	NNP	O
transversion	NN	O
(	(	O
K247Q	NNP	O
)	)	O
;	:	O
in	IN	O
the	DT	O
case	NN	O
of	IN	O
P65L	NNP	O
,	,	O
the	DT	O
amino	NN	O
acid	JJ	O
change	NN	O
does	VBZ	O
not	RB	O
reduce	VB	O
enzyme	NN	O
activity	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
nucleotide	JJ	O
change	NN	O
resulted	VBD	O
in	IN	O
exon	JJ	O
3	CD	O
skipping	NN	O
,	,	O
whereas	IN	O
the	DT	O
latter	JJ	O
K247Q	NNP	O
mutation	NN	O
had	VBD	O
a	DT	O
drastic	JJ	O
effect	NN	O
on	IN	O
enzyme	NN	O
activity	NN	O
.	.	O

We	PRP	O
verified	VBD	O
these	DT	O
events	NNS	O
by	IN	O
in	IN	O
vivo	NN	O
splicing	NN	O
experiments	NNS	O
and	CC	O
transient	JJ	O
expression	NN	O
analysis	NN	O
of	IN	O
mutant	JJ	O
cDNAs	NN	O
.	.	O

The	DT	O
P65L	NNP	O
mutation	NN	O
locates	VBZ	O
11	CD	O
bases	NNS	O
upstream	RB	O
of	IN	O
a	DT	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
intron	NN	O
3	CD	O
.	.	O

This	DT	O
is	VBZ	O
an	DT	O
example	NN	O
of	IN	O
an	DT	O
exonic	JJ	O
mutation	NN	O
which	WDT	O
affects	VBZ	O
exon	SYM	O
-	:	O
splicing	NN	O
.	.	O
.	.	O

Submicroscopic	NNP	O
deletion	NN	O
in	IN	O
cousins	NNS	O
with	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	VBP	E_Disease
causes	VBZ	O
a	DT	O
grandmatrilineal	JJ	O
inheritance	NN	O
pattern	NN	O
:	:	O
effects	NNS	O
of	IN	O
imprinting	NN	O
.	.	O

The	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
critical	JJ	O
region	NN	O
on	IN	O
15q11	CD	O
-	:	O
q13	NN	O
is	VBZ	O
subject	JJ	O
to	TO	O
imprinting	VBG	O
.	.	O

PWS	NNP	S_Disease
becomes	VBZ	O
apparent	JJ	O
when	WRB	O
genes	NNS	O
on	IN	O
the	DT	O
paternally	RB	O
inherited	JJ	O
chromosome	NN	O
are	VBP	O
not	RB	O
expressed	VBN	O
.	.	O

Familial	JJ	B_Disease
PWS	NNP	E_Disease
is	VBZ	O
rare	JJ	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
family	NN	O
in	IN	O
which	WDT	O
a	DT	O
male	NN	O
and	CC	O
a	DT	O
female	JJ	O
paternal	NN	O
first	RB	O
cousin	VBZ	O
both	DT	O
have	VBP	O
PWS	VBN	S_Disease
with	IN	O
cytogenetically	RB	O
normal	JJ	O
karyotypes	NNS	O
.	.	O

Fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
(	(	O
FISH	NNP	O
)	)	O
analysis	NN	O
shows	VBZ	O
a	DT	O
submicroscopic	JJ	O
deletion	NN	O
of	IN	O
SNRPN	NNP	O
,	,	O
but	CC	O
not	RB	O
the	DT	O
closely	RB	O
associated	VBN	O
loci	NN	O
D15S10	NNP	O
,	,	O
D15S11	NNP	O
,	,	O
D15S63	NNP	O
,	,	O
and	CC	O
GABRB3	NNP	O
.	.	O

The	DT	O
cousins	NNS	O
fathers	NNS	O
and	CC	O
two	CD	O
paternal	JJ	O
aunts	NNS	O
have	VBP	O
the	DT	O
same	JJ	O
deletion	NN	O
and	CC	O
are	VBP	O
clinically	RB	O
normal	JJ	O
.	.	O

The	DT	O
grandmother	NN	O
of	IN	O
the	DT	O
cousins	NNS	O
is	VBZ	O
deceased	VBN	O
and	CC	O
not	RB	O
available	JJ	O
for	IN	O
study	NN	O
,	,	O
and	CC	O
their	PRP$	O
grandfather	NN	O
is	VBZ	O
not	RB	O
deleted	VBN	O
for	IN	O
SNRPN	NNP	O
.	.	O

DNA	NN	O
methylation	NN	O
analysis	NN	O
of	IN	O
D15S63	NNP	O
is	VBZ	O
consistent	JJ	O
with	IN	O
an	DT	O
abnormality	NN	O
of	IN	O
the	DT	O
imprinting	NN	O
center	NN	O
associated	VBN	O
with	IN	O
PWS	NNP	S_Disease
.	.	O

"	JJ	O
Grandmatrilineal	NNP	O
"	NNP	O
inheritance	NN	O
occurs	VBZ	O
when	WRB	O
a	DT	O
woman	NN	O
with	IN	O
deletion	NN	O
of	IN	O
an	DT	O
imprinted	JJ	O
,	,	O
paternally	RB	O
expressed	VBN	O
gene	NN	O
is	VBZ	O
at	IN	O
risk	NN	O
of	IN	O
having	VBG	O
affected	VBN	O
grandchildren	NNS	O
through	IN	O
her	PRP$	O
sons	NNS	O
.	.	O

In	IN	O
this	DT	O
case	NN	O
,	,	O
PWS	NNP	S_Disease
does	VBZ	O
not	RB	O
become	VB	O
evident	JJ	O
as	RB	O
long	RB	O
as	IN	O
the	DT	O
deletion	NN	O
is	VBZ	O
passed	VBN	O
through	IN	O
the	DT	O
matrilineal	JJ	O
line	NN	O
.	.	O

This	DT	O
represents	VBZ	O
a	DT	O
unique	JJ	O
inheritance	NN	O
pattern	NN	O
due	JJ	O
to	TO	O
imprinting	VBG	O
.	.	O
.	.	O

Human	NNP	O
glycine	NN	O
decarboxylase	NN	O
gene	NN	O
(	(	O
GLDC	NNP	O
)	)	O
and	CC	O
its	PRP$	O
highly	RB	O
conserved	VBN	O
processed	VBN	O
pseudogene	NN	O
(	(	O
psiGLDC	NN	O
)	)	O
:	:	O
their	PRP$	O
structure	NN	O
and	CC	O
expression	NN	O
,	,	O
and	CC	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
large	JJ	O
deletion	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
nonketotic	JJ	B_Disease
hyperglycinemia	NN	E_Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
glycine	NN	O
decarboxylase	NN	O
gene	NN	O
(	(	O
GLDC	NNP	O
)	)	O
cause	NN	O
nonketotic	JJ	B_Disease
hyperglycinemia	NN	E_Disease
(	(	O
NKH	NNP	S_Disease
)	)	O
,	,	O
an	DT	O
in	IN	B_Disease
-	:	I_Disease
born	JJ	I_Disease
error	NN	I_Disease
of	IN	I_Disease
metabolism	NN	E_Disease
characterized	VBN	O
by	IN	O
severe	JJ	O
neurological	JJ	B_Disease
disturbance	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
determined	VBN	O
the	DT	O
structure	NN	O
of	IN	O
GLDC	NNP	O
and	CC	O
of	IN	O
its	PRP$	O
pseudogene	NN	O
(	(	O
psiGLDC	NN	O
)	)	O
and	CC	O
studied	VBN	O
their	PRP$	O
expression	NN	O
for	IN	O
a	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
NKH	NNP	S_Disease
.	.	O

The	DT	O
GLDC	NNP	O
gene	NN	O
spans	NNS	O
at	IN	O
least	JJS	O
135	CD	O
kb	NN	O
and	CC	O
consists	VBZ	O
of	IN	O
25	CD	O
exons	NNS	O
.	.	O

All	DT	O
donor	NN	O
and	CC	O
acceptor	NN	O
sites	NNS	O
adhere	RB	O
to	TO	O
the	DT	O
canonical	JJ	O
GT	NNP	O
-	:	O
AG	NNP	O
rule	NN	O
,	,	O
except	IN	O
for	IN	O
the	DT	O
donor	JJ	O
site	NN	O
of	IN	O
intron	NN	O
21	CD	O
,	,	O
where	WRB	O
a	DT	O
variant	JJ	O
form	NN	O
GC	NNP	O
is	VBZ	O
used	VBN	O
instead	RB	O
of	IN	O
GT	NNP	O
.	.	O

The	DT	O
transcription	NN	O
initiation	NN	O
site	NN	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
to	TO	O
a	DT	O
residue	JJ	O
163	CD	O
bp	NN	O
upstream	NN	O
from	IN	O
the	DT	O
translation	NN	O
initiation	NN	O
triplet	NN	O
by	IN	O
primer	JJ	O
extension	NN	O
analysis	NN	O
.	.	O

The	DT	O
psiGLDC	NN	O
gene	NN	O
has	VBZ	O
no	DT	O
intron	NN	O
and	CC	O
shares	NNS	O
97	CD	O
.	.	O

5	CD	O
%	NN	O
homology	NN	O
with	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
functional	JJ	O
GLDC	NNP	O
,	,	O
suggesting	VBG	O
that	IN	O
psiGLDC	NN	O
is	VBZ	O
a	DT	O
processed	JJ	O
pseudogene	NN	O
that	WDT	O
arose	VBP	O
from	IN	O
the	DT	O
GLDC	NNP	O
transcript	NN	O
about	IN	O
4	CD	O
-	:	O
8	CD	O
million	CD	O
years	NNS	O
ago	RB	O
.	.	O

RNA	NNP	O
blotting	VBG	O
analysis	NN	O
has	VBZ	O
revealed	VBN	O
that	IN	O
GLDC	NNP	O
is	VBZ	O
expressed	VBN	O
in	IN	O
human	JJ	O
liver	NN	O
,	,	O
kidney	NN	O
,	,	O
brain	NN	O
,	,	O
and	CC	O
placenta	NN	O
.	.	O

We	PRP	O
have	VBP	O
also	RB	O
examined	VBN	O
a	DT	O
patient	NN	O
with	IN	O
NKH	NNP	S_Disease
with	IN	O
no	DT	O
detectable	JJ	O
GLDC	NNP	O
mRNA	NN	O
in	IN	O
his	PRP$	O
lymphoblasts	NNS	O
.	.	O

Exons	NNS	O
1	CD	O
-	:	O
3	CD	O
of	IN	O
the	DT	O
functional	JJ	O
GLDC	NNP	O
gene	NN	O
from	IN	O
this	DT	O
patient	NN	O
are	VBP	O
not	RB	O
amplified	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
,	,	O
whereas	VBP	O
those	DT	O
from	IN	O
control	NN	O
subjects	NNS	O
are	VBP	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
a	DT	O
large	JJ	O
homozygous	JJ	O
deletion	NN	O
(	(	O
at	IN	O
least	JJS	O
30	CD	O
kb	NN	O
)	)	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

Furthermore	RB	O
,	,	O
we	PRP	O
have	VBP	O
devised	VBN	O
a	DT	O
semi	JJ	O
-	:	O
quantitative	JJ	O
PCR	NNP	O
to	TO	O
estimate	VB	O
the	DT	O
number	NN	O
of	IN	O
GLDC	NNP	O
alleles	NNS	O
by	IN	O
using	VBG	O
psiGLDC	NN	O
as	IN	O
an	DT	O
internal	JJ	O
control	NN	O
and	CC	O
have	VBP	O
confirmed	VBN	O
the	DT	O
homozygosity	NN	O
and	CC	O
heterozygosity	NN	O
of	IN	O
the	DT	O
deletion	NN	O
in	IN	O
the	DT	O
patient	NN	O
and	CC	O
his	PRP$	O
parents	NNS	O
,	,	O
respectively	RB	O
.	.	O

Structural	JJ	O
information	NN	O
of	IN	O
GLDC	NNP	O
and	CC	O
psiGLDC	NN	O
should	MD	O
facilitate	VB	O
the	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
NKH	NNP	S_Disease
.	.	O

De	NNP	O
novo	FW	O
deletions	NNS	O
of	IN	O
SNRPN	NNP	O
exon	VBP	O
1	CD	O
in	IN	O
early	JJ	O
human	NN	O
and	CC	O
mouse	NN	O
embryos	NN	O
result	NN	O
in	IN	O
a	DT	O
paternal	JJ	O
to	TO	O
maternal	JJ	O
imprint	NN	O
switch	NN	O
.	.	O

Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
neurogenetic	JJ	B_Disease
disease	NN	E_Disease
characterized	VBN	O
by	IN	O
infantile	JJ	B_Disease
hypotonia	NN	E_Disease
,	,	O
gonadal	JJ	B_Disease
hypoplasia	NN	E_Disease
,	,	O
obsessive	JJ	O
behaviour	NN	O
and	CC	O
neonatal	JJ	O
feeding	NN	O
difficulties	NNS	O
followed	VBN	O
by	IN	O
hyperphagia	NN	S_Disease
,	,	O
leading	VBG	O
to	TO	O
profound	VB	O
obesity	NN	S_Disease
.	.	O

PWS	NNP	S_Disease
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
lack	NN	O
of	IN	O
paternal	JJ	O
genetic	JJ	O
information	NN	O
at	IN	O
15q11	CD	O
-	:	O
q13	NN	O
(	(	O
ref	NN	O
.	.	O

2	CD	O
)	)	O
.	.	O

Five	CD	O
imprinted	VBN	O
,	,	O
paternally	RB	O
expressed	VBN	O
genes	NNS	O
map	RBR	O
to	TO	O
the	DT	O
PWS	NNP	S_Disease
region	NN	O
,	,	O
MKRN3	NNP	O
(	(	O
ref	NN	O
.	.	O

3	CD	O
)	)	O
,	,	O
NDN	NNP	O
(	(	O
ref	NN	O
.	.	O

4	CD	O
)	)	O
,	,	O
NDNL1	NNP	O
(	(	O
ref	NN	O
.	.	O

5	CD	O
)	)	O
,	,	O
SNRPN	NNP	O
(	(	O
refs	VB	O
6	CD	O
-	:	O
8	CD	O
)	)	O
and	CC	O
IPW	NNP	O
(	(	O
ref	NN	O
.	.	O

9	CD	O
)	)	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
two	CD	O
poorly	RB	O
characterized	VBN	O
framents	NNS	O
designated	VBN	O
PAR	NNP	O
-	:	O
1	CD	O
and	CC	O
PAR	NNP	O
-	:	O
5	CD	O
(	(	O
ref	NN	O
.	.	O

10	CD	O
)	)	O
.	.	O

Imprinting	NN	O
of	IN	O
this	DT	O
region	NN	O
involves	VBZ	O
a	DT	O
bipartite	NN	O
imprinting	VBG	O
centre	NN	O
(	(	O
IC	NNP	O
)	)	O
,	,	O
which	WDT	O
overlaps	VBZ	O
SNRPN	NNP	O
(	(	O
refs	JJ	O
10	CD	O
,	,	O
11	CD	O
)	)	O
.	.	O

Deletion	NN	O
of	IN	O
the	DT	O
SNRPN	NNP	O
promoter	NN	O
/	NNP	O
exon	VBZ	O
1	CD	O
region	NN	O
(	(	O
the	DT	O
PWS	NNP	S_Disease
IC	NNP	O
element	NN	O
)	)	O
appears	VBZ	O
to	TO	O
impair	VB	O
the	DT	O
establishment	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
imprint	NN	O
in	IN	O
the	DT	O
male	JJ	O
germ	JJ	O
line	NN	O
and	CC	O
leads	VBZ	O
to	TO	O
PWS	NNP	S_Disease
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
a	DT	O
PWS	NNP	S_Disease
family	NN	O
in	IN	O
which	WDT	O
the	DT	O
father	NN	O
is	VBZ	O
mosaic	VBN	O
for	IN	O
an	DT	O
IC	NNP	O
deletion	NN	O
on	IN	O
his	PRP$	O
paternal	JJ	O
chromosome	NN	O
.	.	O

The	DT	O
deletion	NN	O
chromosome	NN	O
has	VBZ	O
acquired	VBN	O
a	DT	O
maternal	JJ	O
methylation	NN	O
imprint	NN	O
in	IN	O
his	PRP$	O
somatic	JJ	O
cells	NNS	O
.	.	O

We	PRP	O
have	VBP	O
made	VBN	O
identical	JJ	O
findings	NNS	O
in	IN	O
chimaeric	JJ	O
mice	NN	O
generated	VBN	O
from	IN	O
two	CD	O
independent	JJ	O
embryonic	JJ	O
stem	NN	O
(	(	O
ES	NNP	O
)	)	O
cell	NN	O
lines	NNS	O
harbouring	VBG	O
a	DT	O
similar	JJ	O
deletion	NN	O
.	.	O

Our	PRP$	O
studies	NNS	O
demonstrate	VBP	O
that	IN	O
the	DT	O
PWS	NNP	S_Disease
IC	NNP	O
element	NN	O
is	VBZ	O
not	RB	O
only	RB	O
required	VBN	O
for	IN	O
the	DT	O
establishment	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
imprint	NN	O
,	,	O
but	CC	O
also	RB	O
for	IN	O
its	PRP$	O
postzygotic	JJ	O
maintenance	NN	O
.	.	O
.	.	O

Mice	NNP	O
deficient	NN	B_Disease
in	IN	I_Disease
Six5	NNP	E_Disease
develop	NN	O
cataracts	NNS	S_Disease
:	:	O
implications	NNS	O
for	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
.	.	O

Expansion	NN	O
of	IN	O
a	DT	O
CTG	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
the	DT	O
3	CD	O
UTR	NNP	O
of	IN	O
the	DT	O
gene	NN	O
DMPK	NNP	O
at	IN	O
the	DT	O
DM1	NNP	O
locus	NN	O
on	IN	O
chromosome	NN	O
19	CD	O
causes	VBZ	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
a	DT	O
dominantly	RB	B_Disease
inherited	VBN	I_Disease
disease	NN	E_Disease
characterized	VBN	O
by	IN	O
skeletal	JJ	O
muscle	NN	B_Disease
dystrophy	NN	E_Disease
and	CC	O
myotonia	NN	S_Disease
,	,	O
cataracts	NNS	S_Disease
and	CC	O
cardiac	JJ	B_Disease
conduction	NN	I_Disease
defects	NNS	E_Disease
.	.	O

Targeted	VBN	O
deletion	NN	O
of	IN	O
Dm15	NNP	O
,	,	O
the	DT	O
mouse	NN	O
orthologue	NN	O
of	IN	O
human	JJ	O
DMPK	NNP	O
,	,	O
produced	VBD	O
mice	NN	O
with	IN	O
a	DT	O
mild	JJ	O
myopathy	NN	S_Disease
and	CC	O
cardiac	JJ	B_Disease
conduction	NN	I_Disease
abnormalities	NNS	E_Disease
,	,	O
but	CC	O
without	IN	O
other	JJ	O
features	NNS	O
of	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
such	JJ	O
as	IN	O
myotonia	NN	S_Disease
and	CC	O
cataracts	NNS	S_Disease
.	.	O

We	PRP	O
,	,	O
and	CC	O
others	NNS	O
,	,	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
repeat	NN	O
expansion	NN	O
decreases	VBZ	O
expression	NN	O
of	IN	O
the	DT	O
adjacent	JJ	O
gene	NN	O
SIX5	NNP	O
(	(	O
refs	JJ	O
7	CD	O
,	,	O
8	CD	O
)	)	O
,	,	O
which	WDT	O
encodes	VBZ	O
a	DT	O
homeodomain	NN	O
transcription	NN	O
factor	NN	O
.	.	O

To	TO	O
determine	VB	O
whether	IN	O
SIX5	NNP	B_Disease
deficiency	NN	E_Disease
contributes	VBZ	O
to	TO	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
phenotype	NN	O
,	,	O
we	PRP	O
disrupted	VBD	O
mouse	RB	O
Six5	NNP	O
by	IN	O
replacing	VBG	O
the	DT	O
first	JJ	O
exon	NN	O
with	IN	O
a	DT	O
beta	NN	O
-	:	O
galactosidase	NN	O
reporter	NN	O
.	.	O

Six5	NNP	O
-	:	O
mutant	NN	O
mice	NN	O
showed	VBD	O
reporter	JJ	O
expression	NN	O
in	IN	O
multiple	JJ	O
tissues	NNS	O
,	,	O
including	VBG	O
the	DT	O
developing	NN	O
lens	VBZ	O
.	.	O

Homozygous	JJ	O
mutant	JJ	O
mice	NN	O
had	VBD	O
no	DT	O
apparent	JJ	O
abnormalities	NNS	B_Disease
of	IN	I_Disease
skeletal	JJ	I_Disease
muscle	NN	I_Disease
function	NN	E_Disease
,	,	O
but	CC	O
developed	VBD	O
lenticular	JJ	B_Disease
opacities	NNS	E_Disease
at	IN	O
a	DT	O
higher	JJR	O
rate	NN	O
than	IN	O
controls	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
SIX5	NNP	B_Disease
deficiency	NN	E_Disease
contributes	VBZ	O
to	TO	O
the	DT	O
cataract	NN	S_Disease
phenotype	NN	O
in	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
and	CC	O
that	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
represents	VBZ	O
a	DT	O
multigenic	JJ	B_Disease
disorder	NN	E_Disease
.	.	O
.	.	O

Heterozygous	JJ	O
loss	NN	O
of	IN	O
Six5	NNP	O
in	IN	O
mice	NN	O
is	VBZ	O
sufficient	JJ	O
to	TO	O
cause	VB	O
ocular	JJ	O
cataracts	NNS	S_Disease
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
skeletal	JJ	O
muscle	NN	B_Disease
wasting	NN	E_Disease
,	,	O
myotonia	NN	S_Disease
,	,	O
cardiac	JJ	B_Disease
arrhythmia	NN	E_Disease
,	,	O
hyperinsulinaemia	NN	S_Disease
,	,	O
mental	JJ	B_Disease
retardation	NN	E_Disease
and	CC	O
ocular	JJ	O
cataracts	NNS	S_Disease
.	.	O

The	DT	O
genetic	JJ	B_Disease
defect	NN	E_Disease
in	IN	O
DM	NNP	S_Disease
is	VBZ	O
a	DT	O
CTG	NNP	O
repeat	NN	O
expansion	NN	O
located	VBN	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
DMPK	NNP	O
and	CC	O
5	CD	O
of	IN	O
a	DT	O
homeodomain	NN	O
-	:	O
encoding	VBG	O
gene	NN	O
,	,	O
SIX5	NNP	O
(	(	O
formerly	RB	O
DMAHP	NNP	O
;	:	O
refs	VBZ	O
2	CD	O
-	:	O
5	CD	O
)	)	O
.	.	O

There	EX	O
are	VBP	O
three	CD	O
mechanisms	NNS	O
by	IN	O
which	WDT	O
CTG	NNP	O
expansion	NN	O
can	MD	O
result	VB	O
in	IN	O
DM	NNP	S_Disease
.	.	O

First	RB	O
,	,	O
repeat	JJ	O
expansion	NN	O
may	MD	O
alter	VB	O
the	DT	O
processing	NN	O
or	CC	O
transport	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
DMPK	NNP	O
mRNA	NN	O
and	CC	O
consequently	RB	O
reduce	VB	O
DMPK	NNP	O
levels	NNS	O
.	.	O

Second	JJ	O
,	,	O
CTG	NNP	O
expansion	NN	O
may	MD	O
establish	VB	O
a	DT	O
region	NN	O
of	IN	O
heterochromatin	NN	O
3	CD	O
of	IN	O
the	DT	O
repeat	NN	O
sequence	NN	O
and	CC	O
decrease	NN	O
SIX5	NNP	O
transcription	NN	O
.	.	O

Third	NNP	O
,	,	O
toxic	JJ	O
effects	NNS	O
of	IN	O
the	DT	O
repeat	NN	O
expansion	NN	O
may	MD	O
be	VB	O
intrinsic	JJ	O
to	TO	O
the	DT	O
repeated	JJ	O
elements	NNS	O
at	IN	O
the	DT	O
level	NN	O
of	IN	O
DNA	NNP	O
or	CC	O
RNA	NNP	O
(	(	O
refs	JJ	O
10	CD	O
,	,	O
11	CD	O
)	)	O
.	.	O

Previous	JJ	O
studies	NNS	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
a	DT	O
dose	JJ	O
-	:	O
dependent	JJ	O
loss	NN	O
of	IN	O
Dm15	NNP	O
(	(	O
the	DT	O
mouse	NN	O
DMPK	NNP	O
homologue	NN	O
)	)	O
in	IN	O
mice	NN	O
produces	VBZ	O
a	DT	O
partial	JJ	O
DM	NNP	S_Disease
phenotype	NN	O
characterized	VBN	O
by	IN	O
decreased	JJ	O
development	NN	O
of	IN	O
skeletal	JJ	O
muscle	NN	O
force	NN	O
and	CC	O
cardiac	JJ	B_Disease
conduction	NN	I_Disease
disorders	NNS	E_Disease
.	.	O

To	TO	O
test	VB	O
the	DT	O
role	NN	O
of	IN	O
Six5	NNP	O
loss	NN	O
in	IN	O
DM	NNP	S_Disease
,	,	O
we	PRP	O
have	VBP	O
analysed	VBN	O
a	DT	O
strain	NN	O
of	IN	O
mice	NN	O
in	IN	O
which	WDT	O
Six5	NNP	O
was	VBD	O
deleted	VBN	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
the	DT	O
rate	NN	O
and	CC	O
severity	NN	O
of	IN	O
cataract	JJ	S_Disease
formation	NN	O
is	VBZ	O
inversely	RB	O
related	VBN	O
to	TO	O
Six5	NNP	O
dosage	NN	O
and	CC	O
is	VBZ	O
temporally	RB	O
progressive	JJ	O
.	.	O

Six5	NNP	O
+	NNP	O
/	NNP	O
-	:	O
and	CC	O
Six5	NNP	O
-	:	O
/	SYM	O
-	:	O
mice	NN	O
show	NN	O
increased	VBD	O
steady	JJ	O
-	:	O
state	NN	O
levels	NNS	O
of	IN	O
the	DT	O
Na	NNP	O
+	NNP	O
/	NNP	O
K	NNP	O
+	NNP	O
-	:	O
ATPase	NNP	O
alpha	VBZ	O
-	:	O
1	CD	O
subunit	NN	O
and	CC	O
decreased	VBD	O
Dm15	NNP	O
mRNA	NN	O
levels	NNS	O
.	.	O

Thus	RB	O
,	,	O
altered	VBD	O
ion	NN	O
homeostasis	NN	O
within	IN	O
the	DT	O
lens	NNS	O
may	MD	O
contribute	VB	O
to	TO	O
cataract	VB	S_Disease
formation	NN	O
.	.	O

As	IN	O
ocular	JJ	O
cataracts	NNS	S_Disease
are	VBP	O
a	DT	O
characteristic	JJ	O
feature	NN	O
of	IN	O
DM	NNP	S_Disease
,	,	O
these	DT	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
decreased	VBD	O
SIX5	NNP	O
transcription	NN	O
is	VBZ	O
important	JJ	O
in	IN	O
the	DT	O
aetiology	NN	O
of	IN	O
DM	NNP	S_Disease
.	.	O

Our	PRP$	O
data	NNS	O
support	NN	O
the	DT	O
hypothesis	NN	O
that	IN	O
DM	NNP	S_Disease
is	VBZ	O
a	DT	O
contiguous	JJ	O
gene	NN	O
syndrome	NN	O
associated	VBN	O
with	IN	O
the	DT	O
partial	JJ	O
loss	NN	O
of	IN	O
both	DT	O
DMPK	NNP	O
and	CC	O
SIX5	NNP	O
.	.	O
.	.	O

ATM	NNP	O
-	:	O
dependent	JJ	O
phosphorylation	NN	O
of	IN	O
nibrin	NN	O
in	IN	O
response	NN	O
to	TO	O
radiation	NN	O
exposure	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
ATM	NNP	O
are	VBP	O
responsible	JJ	O
for	IN	O
the	DT	O
genetic	JJ	B_Disease
disorder	NN	E_Disease
ataxia	NN	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
(	(	O
A	DT	B_Disease
-	:	I_Disease
T	NN	E_Disease
)	)	O
,	,	O
which	WDT	O
is	VBZ	O
characterized	VBN	O
by	IN	O
cerebellar	JJ	B_Disease
dysfunction	NN	E_Disease
,	,	O
radiosensitivity	NN	O
,	,	O
chromosomal	JJ	O
instability	NN	O
and	CC	O
cancer	NN	S_Disease
predisposition	NN	O
.	.	O

Both	DT	O
the	DT	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
phenotype	NN	O
and	CC	O
the	DT	O
similarity	NN	O
of	IN	O
the	DT	O
ATM	NNP	O
protein	NN	O
to	TO	O
other	JJ	O
DNA	NNP	O
-	:	O
damage	NN	O
sensors	NNS	O
suggests	VBZ	O
a	DT	O
role	NN	O
for	IN	O
ATM	NNP	O
in	IN	O
biochemical	JJ	O
pathways	NNS	O
involved	VBN	O
in	IN	O
the	DT	O
recognition	NN	O
,	,	O
signalling	VBG	O
and	CC	O
repair	NN	O
of	IN	O
DNA	NNP	O
double	JJ	O
-	:	O
strand	NN	O
breaks	NNS	O
(	(	O
DSBs	NNP	O
)	)	O
.	.	O

There	EX	O
are	VBP	O
strong	JJ	O
parallels	NNS	O
between	IN	O
the	DT	O
pattern	NN	O
of	IN	O
radiosensitivity	NN	O
,	,	O
chromosomal	JJ	O
instability	NN	O
and	CC	O
cancer	NN	S_Disease
predisposition	NN	O
in	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
patients	NNS	O
and	CC	O
that	DT	O
in	IN	O
patients	NNS	O
with	IN	O
Nijmegen	NNP	B_Disease
breakage	NN	I_Disease
syndrome	NN	E_Disease
(	(	O
NBS	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
protein	NN	O
defective	JJ	O
in	IN	O
NBS	NNP	S_Disease
,	,	O
nibrin	NN	O
(	(	O
encoded	VBN	O
by	IN	O
NBS1	NNP	O
)	)	O
,	,	O
forms	VBZ	O
a	DT	O
complex	JJ	O
with	IN	O
MRE11	NNP	O
and	CC	O
RAD50	NNP	O
(	(	O
refs	JJ	O
1	CD	O
,	,	O
2	CD	O
)	)	O
.	.	O

This	DT	O
complex	JJ	O
localizes	VBZ	O
to	TO	O
DSBs	NNP	O
within	IN	O
30	CD	O
minutes	NNS	O
after	IN	O
cellular	JJ	O
exposure	NN	O
to	TO	O
ionizing	VBG	O
radiation	NN	O
(	(	O
IR	NNP	O
)	)	O
and	CC	O
is	VBZ	O
observed	VBN	O
in	IN	O
brightly	RB	O
staining	VBG	O
nuclear	JJ	O
foci	NN	O
after	IN	O
a	DT	O
longer	RBR	O
period	NN	O
of	IN	O
time	NN	O
.	.	O

The	DT	O
overlap	NN	O
between	IN	O
clinical	JJ	O
and	CC	O
cellular	JJ	O
phenotypes	NNS	O
in	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
and	CC	O
NBS	NNP	S_Disease
suggests	VBZ	O
that	IN	O
ATM	NNP	O
and	CC	O
nibrin	NN	O
may	MD	O
function	VB	O
in	IN	O
the	DT	O
same	JJ	O
biochemical	JJ	O
pathway	NN	O
.	.	O

Here	RB	O
we	PRP	O
demonstrate	VBP	O
that	DT	O
nibrin	NN	O
is	VBZ	O
phosphorylated	VBN	O
within	IN	O
one	CD	O
hour	NN	O
of	IN	O
treatment	NN	O
of	IN	O
cells	NNS	O
with	IN	O
IR	NNP	O
.	.	O

This	DT	O
response	NN	O
is	VBZ	O
abrogated	VBN	O
in	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
cells	NNS	O
that	IN	O
either	DT	O
do	VBP	O
not	RB	O
express	VB	O
ATM	NNP	O
protein	NN	O
or	CC	O
express	NN	O
near	IN	O
full	JJ	O
-	:	O
length	NN	O
mutant	JJ	O
protein	NN	O
.	.	O

We	PRP	O
also	RB	O
show	VBP	O
that	IN	O
ATM	NNP	O
physically	RB	O
interacts	VBZ	O
with	IN	O
and	CC	O
phosphorylates	NNS	O
nibrin	VBP	O
on	IN	O
serine	NN	O
343	CD	O
both	DT	O
in	IN	O
vivo	NN	O
and	CC	O
in	IN	O
vitro	NN	O
.	.	O

Phosphorylation	NN	O
of	IN	O
this	DT	O
site	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
functionally	RB	O
important	JJ	O
because	IN	O
mutated	VBN	O
nibrin	NN	O
(	(	O
S343A	NNP	O
)	)	O
does	VBZ	O
not	RB	O
completely	RB	O
complement	JJ	O
radiosensitivity	NN	O
in	IN	O
NBS	NNP	S_Disease
cells	NNS	O
.	.	O

ATM	NNP	O
phosphorylation	NN	O
of	IN	O
nibrin	NN	O
does	VBZ	O
not	RB	O
affect	VB	O
nibrin	SYM	O
-	:	O
MRE11	NNP	O
-	:	O
RAD50	NNP	O
association	NN	O
as	IN	O
revealed	VBN	O
by	IN	O
radiation	NN	O
-	:	O
induced	JJ	O
foci	JJ	O
formation	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
provide	VB	O
a	DT	O
biochemical	JJ	O
explanation	NN	O
for	IN	O
the	DT	O
similarity	NN	O
in	IN	O
phenotype	NN	O
between	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
and	CC	O
NBS	NNP	S_Disease
.	.	O
.	.	O

Clinicopathologic	NNP	O
features	NNS	O
of	IN	O
BRCA	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
and	CC	I_Disease
sporadic	JJ	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

CONTEXT	NNP	O
Most	NNP	O
hereditary	JJ	B_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
are	VBP	O
associated	VBN	O
with	IN	O
germline	JJ	O
mutations	NNS	O
in	IN	O
BRCA1	NNP	O
or	CC	O
BRCA2	NNP	O
.	.	O

Attempts	NNS	O
to	TO	O
define	VB	O
the	DT	O
clinical	JJ	O
significance	NN	O
of	IN	O
BRCA	NNP	O
mutation	NN	O
status	NN	O
in	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
have	VBP	O
produced	VBN	O
conflicting	JJ	O
results	NNS	O
,	,	O
especially	RB	O
regarding	VBG	O
survival	NN	O
.	.	O

OBJECTIVE	NN	O
To	TO	O
determine	VB	O
whether	IN	O
hereditary	JJ	B_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
have	VBP	O
distinct	JJ	O
clinical	JJ	O
and	CC	O
pathological	JJ	O
features	NNS	O
compared	VBN	O
with	IN	O
sporadic	JJ	B_Disease
(	(	I_Disease
nonhereditary	JJ	I_Disease
)	)	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
.	.	O

DESIGN	NNP	O
AND	CC	O
SETTING	NNP	O
Retrospective	NNP	O
cohort	NN	O
study	NN	O
of	IN	O
a	DT	O
consecutive	JJ	O
series	NN	O
of	IN	O
933	CD	O
ovarian	JJ	B_Disease
cancers	NNS	E_Disease
diagnosed	VBD	O
and	CC	O
treated	VBD	O
at	IN	O
our	PRP$	O
institution	NN	O
,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
comprehensive	JJ	O
cancer	NN	S_Disease
center	NN	O
as	IN	O
designated	VBN	O
by	IN	O
the	DT	O
National	NNP	O
Cancer	NNP	S_Disease
Institute	NNP	O
,	,	O
over	IN	O
a	DT	O
12	CD	O
-	:	O
year	NN	O
period	NN	O
(	(	O
December	NNP	O
1986	CD	O
to	TO	O
August	NNP	O
1998	CD	O
)	)	O
.	.	O

PATIENTS	VB	O
The	DT	O
study	NN	O
was	VBD	O
restricted	VBN	O
to	TO	O
patients	NNS	O
of	IN	O
Jewish	JJ	O
origin	NN	O
because	IN	O
of	IN	O
the	DT	O
ease	NN	O
of	IN	O
BRCA1	NNP	O
and	CC	O
BRCA2	NNP	O
genotyping	NN	O
in	IN	O
this	DT	O
ethnic	JJ	O
group	NN	O
.	.	O

From	IN	O
the	DT	O
189	CD	O
patients	NNS	O
who	WP	O
identified	VBD	O
themselves	PRP	O
as	IN	O
Jewish	NNP	O
,	,	O
88	CD	O
hereditary	JJ	O
cases	NNS	O
were	VBD	O
identified	VBN	O
with	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
germline	NN	O
founder	NN	O
mutation	NN	O
in	IN	O
BRCA1	NNP	O
or	CC	O
BRCA2	NNP	O
.	.	O

The	DT	O
remaining	VBG	O
101	CD	O
cases	NNS	O
from	IN	O
the	DT	O
same	JJ	O
series	NN	O
not	RB	O
associated	VBN	O
with	IN	O
a	DT	O
BRCA	NNP	O
mutation	NN	O
and	CC	O
2	CD	O
additional	JJ	O
groups	NNS	O
(	(	O
Gynecologic	NNP	O
Oncology	NNP	O
Group	NNP	O
protocols	VBZ	O
52	CD	O
and	CC	O
111	CD	O
)	)	O
with	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
from	IN	O
clinical	JJ	O
trials	NNS	O
(	(	O
for	IN	O
the	DT	O
survival	JJ	O
analysis	NN	O
)	)	O
were	VBD	O
included	VBN	O
for	IN	O
comparison	NN	O
.	.	O

MAIN	NNP	O
OUTCOME	NNP	O
MEASURES	NNP	O
Age	NNP	O
at	IN	O
diagnosis	NN	O
,	,	O
surgical	JJ	O
stage	NN	O
,	,	O
histologic	NN	O
cell	NN	O
type	NN	O
and	CC	O
grade	NN	O
,	,	O
and	CC	O
surgical	JJ	O
outcome	NN	O
;	:	O
and	CC	O
response	NN	O
to	TO	O
chemotherapy	NN	O
and	CC	O
survival	NN	O
for	IN	O
advanced	JJ	O
-	:	O
stage	NN	O
(	(	O
II	NNP	O
and	CC	O
IV	NNP	O
)	)	O
cases	NNS	O
.	.	O

RESULTS	NNP	O
Hereditary	NNP	B_Disease
cancers	NNS	E_Disease
were	VBD	O
rarely	RB	O
diagnosed	VBN	O
before	RB	O
age	NN	O
40	CD	O
years	NNS	O
and	CC	O
were	VBD	O
common	JJ	O
after	IN	O
age	NN	O
60	CD	O
years	NNS	O
,	,	O
with	IN	O
mean	JJ	O
age	NN	O
at	IN	O
diagnosis	NN	O
being	VBG	O
significantly	RB	O
younger	JJR	O
for	IN	O
BRCA1	NNP	O
-	:	O
vs	NN	O
BRCA2	NNP	O
-	:	O
linked	VBN	O
patients	NNS	O
(	(	O
54	CD	O
vs	RB	O
62	CD	O
years	NNS	O
;	:	O
P	NNP	O
=	NNP	O
.	.	O

04	CD	O
)	)	O
.	.	O

Histology	NNP	O
,	,	O
grade	NN	O
,	,	O
stage	NN	O
,	,	O
and	CC	O
success	NN	O
of	IN	O
cytoreductive	JJ	O
surgery	NN	O
were	VBD	O
similar	JJ	O
for	IN	O
hereditary	JJ	O
and	CC	O
sporadic	JJ	O
cases	NNS	O
.	.	O

The	DT	O
hereditary	JJ	O
group	NN	O
had	VBD	O
a	DT	O
longer	RBR	O
disease	JJ	O
-	:	O
free	JJ	O
interval	NN	O
following	VBG	O
primary	JJ	O
chemotherapy	NN	O
in	IN	O
comparison	NN	O
with	IN	O
the	DT	O
nonhereditary	JJ	O
group	NN	O
,	,	O
with	IN	O
a	DT	O
median	JJ	O
time	NN	O
to	TO	O
recurrence	VB	O
of	IN	O
14	CD	O
months	NNS	O
and	CC	O
7	CD	O
months	NNS	O
,	,	O
respectively	RB	O
(	(	O
P	NNP	O
<	NNP	O
.	.	O

001	CD	O
)	)	O
.	.	O

Those	DT	O
with	IN	O
hereditary	JJ	B_Disease
cancers	NNS	E_Disease
had	VBD	O
improved	VBN	O
survival	JJ	O
compared	VBN	O
with	IN	O
the	DT	O
nonhereditary	JJ	O
group	NN	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

004	CD	O
)	)	O
.	.	O

For	IN	O
stage	NN	B_Disease
III	NNP	I_Disease
cancers	NNS	E_Disease
,	,	O
BRCA	NNP	O
mutation	NN	O
status	NN	O
was	VBD	O
an	DT	O
independent	JJ	O
prognostic	JJ	O
variable	NN	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

03	CD	O
)	)	O
.	.	O

CONCLUSIONS	NNP	O
Although	IN	O
BRCA	NNP	B_Disease
-	:	I_Disease
associated	VBN	I_Disease
hereditary	JJ	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
in	IN	O
this	DT	O
population	NN	O
have	VBP	O
surgical	JJ	O
and	CC	O
pathological	JJ	O
characteristics	NNS	O
similar	JJ	O
to	TO	O
those	DT	O
of	IN	O
sporadic	JJ	B_Disease
cancers	NNS	E_Disease
,	,	O
advanced	VBD	B_Disease
-	:	I_Disease
stage	NN	I_Disease
hereditary	JJ	I_Disease
cancer	NN	E_Disease
patients	NNS	O
survive	VBP	O
longer	JJR	O
than	IN	O
nonhereditary	JJ	B_Disease
cancer	NN	E_Disease
patients	NNS	O
.	.	O

Age	NNP	O
penetrance	NN	O
is	VBZ	O
greater	JJR	O
for	IN	O
BRCA1	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
than	IN	I_Disease
for	IN	I_Disease
BRCA2	NNP	I_Disease
-	:	I_Disease
linked	VBD	I_Disease
cancers	NNS	E_Disease
in	IN	O
this	DT	O
population	NN	O
.	.	O

The	DT	O
gene	NN	O
for	IN	O
familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
,	,	O
MEFV	NNP	O
,	,	O
is	VBZ	O
expressed	VBN	O
in	IN	O
early	JJ	O
leukocyte	NN	O
development	NN	O
and	CC	O
is	VBZ	O
regulated	VBN	O
in	IN	O
response	NN	O
to	TO	O
inflammatory	JJ	O
mediators	NNS	O
.	.	O

Familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
(	(	O
FMF	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
recessive	JJ	B_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
episodes	NNS	O
of	IN	O
fever	NN	S_Disease
and	CC	O
neutrophil	JJ	B_Disease
-	:	I_Disease
mediated	VBN	I_Disease
serosal	JJ	I_Disease
inflammation	NN	E_Disease
.	.	O

We	PRP	O
recently	RB	O
identified	VBD	O
the	DT	O
gene	NN	O
causing	VBG	O
FMF	NNP	S_Disease
,	,	O
designated	VBD	O
MEFV	NNP	O
,	,	O
and	CC	O
found	VBD	O
it	PRP	O
to	TO	O
be	VB	O
expressed	VBN	O
in	IN	O
mature	NN	O
neutrophils	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
it	PRP	O
functions	VBZ	O
as	IN	O
an	DT	O
inflammatory	JJ	O
regulator	NN	O
.	.	O

To	TO	O
facilitate	VB	O
our	PRP$	O
understanding	NN	O
of	IN	O
the	DT	O
normal	JJ	O
function	NN	O
of	IN	O
MEFV	NNP	O
,	,	O
we	PRP	O
extended	VBD	O
our	PRP$	O
previous	JJ	O
studies	NNS	O
.	.	O

MEFV	NNP	O
messenger	NN	O
RNA	NNP	O
was	VBD	O
detected	VBN	O
by	IN	O
reverse	NN	O
transcriptase	NN	O
-	:	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
in	IN	O
bone	NN	O
marrow	NN	O
leukocytes	VBZ	O
,	,	O
with	IN	O
differential	JJ	O
expression	NN	O
observed	VBD	O
among	IN	O
cells	NNS	O
by	IN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
.	.	O

CD34	NNP	O
hematopoietic	JJ	O
stem	NN	O
-	:	O
cell	NN	O
cultures	NNS	O
induced	VBD	O
toward	IN	O
the	DT	O
granulocytic	JJ	O
lineage	NN	O
expressed	VBD	O
MEFV	NNP	O
at	IN	O
the	DT	O
myelocyte	NN	O
stage	NN	O
,	,	O
concurrently	RB	O
with	IN	O
lineage	JJ	O
commitment	NN	O
.	.	O

The	DT	O
prepromyelocytic	JJ	O
cell	NN	O
line	NN	O
HL60	NNP	O
expressed	VBD	O
MEFV	NNP	O
only	RB	O
at	IN	O
granulocytic	JJ	O
and	CC	O
monocytic	JJ	O
differentiation	NN	O
.	.	O

MEFV	NNP	O
was	VBD	O
also	RB	O
expressed	VBN	O
in	IN	O
the	DT	O
monocytic	JJ	O
cell	NN	O
lines	NNS	O
U937	NNP	O
and	CC	O
THP	NNP	O
-	:	O
1	CD	O
.	.	O

Among	IN	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
,	,	O
MEFV	NNP	O
expression	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
neutrophils	NNS	O
,	,	O
eosinophils	NNS	O
,	,	O
and	CC	O
to	TO	O
varying	VBG	O
degrees	NNS	O
,	,	O
monocytes	NNS	O
.	.	O

Consistent	JJ	O
with	IN	O
the	DT	O
tissue	NN	O
specificity	NN	O
of	IN	O
expression	NN	O
,	,	O
complete	JJ	O
sequencing	NN	O
and	CC	O
analysis	NN	O
of	IN	O
upstream	JJ	O
regulatory	JJ	O
regions	NNS	O
of	IN	O
MEFV	NNP	O
revealed	VBD	O
homology	NN	O
to	TO	O
myeloid	VB	O
-	:	O
specific	JJ	O
promoters	NNS	O
and	CC	O
to	TO	O
more	RBR	O
broadly	RB	O
expressed	VBD	O
inflammatory	JJ	O
promoter	NN	O
elements	NNS	O
.	.	O

In	IN	O
vitro	JJ	O
stimulation	NN	O
of	IN	O
monocytes	NNS	O
with	IN	O
the	DT	O
proinflammatory	NN	O
agents	NNS	O
interferon	VBP	O
(	(	O
IFN	NNP	O
)	)	O
gamma	NN	O
,	,	O
tumor	NN	S_Disease
necrosis	NN	O
factor	NN	O
,	,	O
and	CC	O
lipopolysaccharide	RB	O
induced	VBD	O
MEFV	NNP	O
expression	NN	O
,	,	O
whereas	IN	O
the	DT	O
antiinflammatory	NN	O
cytokines	NNS	O
interleukin	FW	O
(	(	O
IL	NNP	O
)	)	O
4	CD	O
,	,	O
IL	NNP	O
-	:	O
10	CD	O
,	,	O
and	CC	O
transforming	VBG	O
growth	NN	O
factor	NN	O
beta	NN	O
inhibited	VBD	O
such	JJ	O
expression	NN	O
.	.	O

Induction	NN	O
by	IN	O
IFN	NNP	O
-	:	O
gamma	NN	O
occurred	VBD	O
rapidly	RB	O
and	CC	O
was	VBD	O
resistant	JJ	O
to	TO	O
cycloheximide	VB	O
.	.	O

IFN	NNP	O
-	:	O
alpha	NN	O
also	RB	O
induced	VBD	O
MEFV	NNP	O
expression	NN	O
.	.	O

In	IN	O
granulocytes	NNS	O
,	,	O
MEFV	NNP	O
was	VBD	O
up	RP	O
-	:	O
regulated	VBN	O
by	IN	O
IFN	NNP	O
-	:	O
gamma	NN	O
and	CC	O
the	DT	O
combination	NN	O
of	IN	O
IFN	NNP	O
-	:	O
alpha	NN	O
and	CC	O
colchicine	NN	O
.	.	O

These	DT	O
results	NNS	O
refine	VBP	O
understanding	NN	O
of	IN	O
MEFV	NNP	O
by	IN	O
placing	VBG	O
the	DT	O
gene	NN	O
in	IN	O
the	DT	O
myelomonocytic	JJ	O
-	:	O
specific	JJ	O
proinflammatory	JJ	O
pathway	NN	O
and	CC	O
identifying	VBG	O
it	PRP	O
as	IN	O
an	DT	O
IFN	NNP	O
-	:	O
gamma	NN	O
immediate	VBP	O
early	JJ	O
gene	NN	O
.	.	O
.	.	O

Biochemical	NNP	O
and	CC	O
structural	JJ	O
analysis	NN	O
of	IN	O
missense	JJ	O
mutations	NNS	O
in	IN	O
N	NNP	O
-	:	O
acetylgalactosamine	NN	O
-	:	O
6	CD	O
-	:	O
sulfate	NN	O
sulfatase	NN	O
causing	VBG	O
mucopolysaccharidosis	NN	B_Disease
IVA	NNP	E_Disease
phenotypes	NNS	O
.	.	O

Mucopolysaccharidosis	NN	B_Disease
IVA	NNP	E_Disease
(	(	O
MPS	NNP	B_Disease
IVA	NNP	E_Disease
;	:	O
OMIM	NNP	O
#	#	O
253000	CD	O
)	)	O
,	,	O
a	DT	O
lysosomal	JJ	B_Disease
storage	NN	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
N	NNP	I_Disease
-	:	I_Disease
acetylgalactosamine	NN	I_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
sulfate	NN	I_Disease
sulfatase	NN	E_Disease
(	(	O
GALNS	NNP	O
)	)	O
,	,	O
has	VBZ	O
variable	JJ	O
clinical	JJ	O
phenotypes	NNS	O
.	.	O

To	TO	O
date	NN	O
we	PRP	O
have	VBP	O
identified	VBN	O
65	CD	O
missense	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
GALNS	NNP	O
gene	NN	O
from	IN	O
MPS	NNP	B_Disease
IVA	NNP	E_Disease
patients	NNS	O
,	,	O
but	CC	O
the	DT	O
correlation	NN	O
between	IN	O
genotype	NN	O
and	CC	O
phenotype	NN	O
has	VBZ	O
remained	VBN	O
unclear	JJ	O
.	.	O

We	PRP	O
studied	VBD	O
17	CD	O
missense	NN	O
mutations	NNS	O
using	VBG	O
biochemical	JJ	O
approaches	NNS	O
and	CC	O
32	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
using	VBG	O
structural	JJ	O
analyses	NNS	O
.	.	O

Fifteen	NNP	O
missense	NN	O
mutations	NNS	O
and	CC	O
two	CD	O
newly	RB	O
engineered	VBN	O
active	JJ	O
site	NN	O
mutations	NNS	O
(	(	O
C79S	NNP	O
,	,	O
C79T	NNP	O
)	)	O
were	VBD	O
characterized	VBN	O
by	IN	O
transient	JJ	O
expression	NN	O
analysis	NN	O
.	.	O

Mutant	JJ	O
proteins	NNS	O
,	,	O
except	IN	O
for	IN	O
C79S	NNP	O
and	CC	O
C79T	NNP	O
,	,	O
were	VBD	O
destabilized	VBN	O
and	CC	O
detected	VBN	O
as	IN	O
insoluble	JJ	O
precursor	NN	O
forms	NNS	O
while	IN	O
the	DT	O
C79S	NNP	O
and	CC	O
C79T	NNP	O
mutants	NNS	O
were	VBD	O
of	IN	O
a	DT	O
soluble	JJ	O
mature	NN	O
size	NN	O
.	.	O

Mutants	NNS	O
found	VBN	O
in	IN	O
the	DT	O
severe	JJ	O
phenotype	NN	O
had	VBD	O
no	DT	O
activity	NN	O
.	.	O

Mutants	NNS	O
found	VBN	O
in	IN	O
the	DT	O
mild	JJ	O
phenotype	NN	O
had	VBD	O
a	DT	O
considerable	JJ	O
residual	JJ	O
activity	NN	O
(	(	O
1	CD	O
.	.	O

3	LS	O
-	:	O
13	CD	O
.	.	O

3	CD	O
%	NN	O
of	IN	O
wild	JJ	O
-	:	O
type	NN	O
GALNS	NNP	O
activity	NN	O
)	)	O
.	.	O

Sulfatases	NNS	O
,	,	O
including	VBG	O
GALNS	NNP	O
,	,	O
are	VBP	O
members	NNS	O
of	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
gene	NN	O
family	NN	O
sharing	VBG	O
an	DT	O
extensive	JJ	O
sequence	NN	O
homology	NN	O
.	.	O

Thus	RB	O
,	,	O
a	DT	O
tertiary	JJ	O
structural	JJ	O
model	NN	O
of	IN	O
human	JJ	O
GALNS	NNP	O
was	VBD	O
constructed	VBN	O
from	IN	O
the	DT	O
X	NNP	O
-	:	O
ray	JJ	O
crystal	JJ	O
structure	NN	O
of	IN	O
N	NNP	O
-	:	O
acetylgalacto	NN	O
-	:	O
samine	NN	O
-	:	O
4	CD	O
-	:	O
sulfatase	NN	O
and	CC	O
arylsulfatase	VB	O
A	NNP	O
,	,	O
using	VBG	O
homology	NN	O
modeling	NN	O
,	,	O
and	CC	O
32	CD	O
missense	NN	O
mutations	NNS	O
were	VBD	O
investigated	VBN	O
.	.	O

Consequently	RB	O
,	,	O
we	PRP	O
propose	VBP	O
that	IN	O
there	EX	O
are	VBP	O
at	IN	O
least	JJS	O
three	CD	O
different	JJ	O
reasons	NNS	O
for	IN	O
the	DT	O
severe	JJ	O
phenotype	NN	O
(	(	O
i	NN	O
)	)	O
destruction	NN	O
of	IN	O
the	DT	O
hydrophobic	JJ	O
core	NN	O
or	CC	O
modification	NN	O
of	IN	O
the	DT	O
packing	NN	O
;	:	O
(	(	O
ii	NN	O
)	)	O
removal	NN	O
of	IN	O
a	DT	O
salt	NN	O
bridge	NN	O
to	TO	O
destabilize	VB	O
the	DT	O
entire	JJ	O
conformation	NN	O
;	:	O
(	(	O
iii	NN	O
)	)	O
modification	NN	O
of	IN	O
the	DT	O
active	JJ	O
site	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
mild	JJ	O
mutations	NNS	O
were	VBD	O
mostly	RB	O
located	VBN	O
on	IN	O
the	DT	O
surface	NN	O
of	IN	O
the	DT	O
GALNS	NNP	O
protein	NN	O
.	.	O

These	DT	O
studies	NNS	O
shed	VBD	O
further	RB	O
light	NN	O
on	IN	O
the	DT	O
genotype	NN	O
-	:	O
phenotype	JJ	O
correlation	NN	O
of	IN	O
MPS	NNP	B_Disease
IVA	NNP	E_Disease
and	CC	O
structure	NN	O
-	:	O
function	NN	O
relationship	NN	O
in	IN	O
the	DT	O
sulfatase	NN	O
family	NN	O
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
locus	NN	O
and	CC	O
clinical	JJ	O
phenotypes	NNS	O
of	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
patients	NNS	O
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
(	(	O
A	DT	B_Disease
-	:	I_Disease
T	NN	E_Disease
)	)	O
locus	NN	O
on	IN	O
chromosome	NN	O
band	NN	O
11q22	CD	O
cause	NN	O
a	DT	O
distinctive	JJ	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
syndrome	NN	E_Disease
in	IN	O
homozygotes	NNS	O
and	CC	O
predispose	VB	O
heterozygotes	NNS	O
to	TO	O
cancer	NN	S_Disease
,	,	O
ischemic	JJ	B_Disease
heart	NN	I_Disease
disease	NN	E_Disease
,	,	O
and	CC	O
early	JJ	O
mortality	NN	O
.	.	O

PCR	NNP	O
amplification	NN	O
from	IN	O
genomic	JJ	O
DNA	NNP	O
and	CC	O
automated	VBD	O
sequencing	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
(	(	O
66	CD	O
exons	NNS	O
)	)	O
and	CC	O
splice	JJ	O
junctions	NNS	O
detected	VBD	O
77	CD	O
mutations	NNS	O
(	(	O
85	CD	O
%	NN	O
)	)	O
in	IN	O
90	CD	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
chromosomes	NNS	O
.	.	O

Heteroduplex	NNP	O
analysis	NN	O
detected	VBD	O
another	DT	O
42	CD	O
mutations	NNS	O
at	IN	O
the	DT	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
locus	NN	O
.	.	O

Out	IN	O
of	IN	O
a	DT	O
total	NN	O
of	IN	O
71	CD	O
unique	JJ	O
mutations	NNS	O
,	,	O
50	CD	O
were	VBD	O
found	VBN	O
only	RB	O
in	IN	O
a	DT	O
single	JJ	O
family	NN	O
,	,	O
and	CC	O
51	CD	O
had	VBD	O
not	RB	O
been	VBN	O
reported	VBN	O
previously	RB	O
.	.	O

Most	JJS	O
(	(	O
58	CD	O
/	RB	O
71	CD	O
,	,	O
82	CD	O
%	NN	O
)	)	O
mutations	NNS	O
were	VBD	O
frameshift	JJ	O
and	CC	O
nonsense	JJ	O
mutations	NNS	O
that	WDT	O
are	VBP	O
predicted	VBN	O
to	TO	O
cause	VB	O
truncation	NN	O
of	IN	O
the	DT	O
A	NNP	B_Disease
-	:	I_Disease
T	NNP	E_Disease
protein	NN	O
;	:	O
the	DT	O
less	JJR	O
common	JJ	O
mutation	NN	O
types	NNS	O
were	VBD	O
missense	NN	O
(	(	O
9	CD	O
/	RB	O
71	CD	O
,	,	O
13	CD	O
%	NN	O
)	)	O
,	,	O
splicing	VBG	O
(	(	O
3	CD	O
/	RB	O
71	CD	O
,	,	O
4	CD	O
%	NN	O
)	)	O
and	CC	O
one	CD	O
in	IN	O
-	:	O
frame	NN	O
deletion	NN	O
,	,	O
2546	CD	O
3	CD	O
(	(	O
1	CD	O
/	RB	O
71	CD	O
,	,	O
1	CD	O
%	NN	O
)	)	O
.	.	O

The	DT	O
mean	JJ	O
survival	NN	O
and	CC	O
height	JJ	O
distribution	NN	O
of	IN	O
134	CD	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
patients	NNS	O
correlated	VBD	O
significantly	RB	O
with	IN	O
the	DT	O
specific	JJ	O
mutations	NNS	O
present	JJ	O
in	IN	O
the	DT	O
patients	NNS	O
.	.	O

Patients	NNS	O
homozygous	JJ	O
for	IN	O
a	DT	O
single	JJ	O
truncating	NN	O
mutation	NN	O
,	,	O
typically	RB	O
near	IN	O
the	DT	O
N	NNP	O
-	:	O
terminal	JJ	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
or	CC	O
heterozygous	JJ	O
for	IN	O
the	DT	O
in	IN	O
-	:	O
frame	NN	O
deletion	NN	O
2546	CD	O
3	CD	O
,	,	O
were	VBD	O
shorter	JJR	O
and	CC	O
had	VBD	O
significantly	RB	O
shorter	JJR	O
survival	NN	O
than	IN	O
those	DT	O
heterozygous	JJ	O
for	IN	O
a	DT	O
splice	NN	O
site	NN	O
or	CC	O
missense	JJ	O
mutation	NN	O
,	,	O
or	CC	O
heterozygous	JJ	O
for	IN	O
two	CD	O
truncating	VBG	O
mutations	NNS	O
.	.	O

Alterations	NNS	O
of	IN	O
the	DT	O
length	NN	O
or	CC	O
amino	NN	O
acid	JJ	O
composition	NN	O
of	IN	O
the	DT	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
gene	NN	O
product	NN	O
affect	VB	O
the	DT	O
A	NNP	B_Disease
-	:	I_Disease
T	NNP	E_Disease
clinical	JJ	O
phenotype	NN	O
in	IN	O
different	JJ	O
ways	NNS	O
.	.	O

Mutation	NN	O
analysis	NN	O
at	IN	O
the	DT	O
A	NNP	B_Disease
-	:	I_Disease
T	NNP	E_Disease
locus	NN	O
may	MD	O
help	VB	O
estimate	VB	O
the	DT	O
prognosis	NN	O
of	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
patients	NNS	O
.	.	O
.	.	O

Isolation	NN	O
,	,	O
genomic	JJ	O
organization	NN	O
,	,	O
and	CC	O
expression	NN	O
analysis	NN	O
of	IN	O
the	DT	O
mouse	NN	O
and	CC	O
rat	VB	O
homologs	NNS	O
of	IN	O
MEFV	NNP	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
familial	JJ	B_Disease
mediterranean	NN	I_Disease
fever	NN	E_Disease
.	.	O

Familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
(	(	O
FMF	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
recessive	JJ	B_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
episodes	NNS	O
of	IN	O
fever	NN	S_Disease
with	IN	O
serositis	NN	S_Disease
or	CC	O
synovitis	NN	S_Disease
.	.	O

Recently	RB	O
the	DT	O
FMF	NNP	S_Disease
gene	NN	O
(	(	O
MEFV	NNP	O
)	)	O
was	VBD	O
cloned	VBN	O
;	:	O
the	DT	O
protein	NN	O
product	NN	O
,	,	O
pyrin	JJ	O
/	NNP	O
marenostrin	NN	O
,	,	O
is	VBZ	O
thought	VBN	O
to	TO	O
regulate	VB	O
inflammation	NN	O
in	IN	O
myeloid	JJ	O
cells	NNS	O
.	.	O

In	IN	O
this	DT	O
manuscript	NN	O
we	PRP	O
report	VBP	O
the	DT	O
mouse	NN	O
and	CC	O
rat	VB	O
homologs	NNS	O
of	IN	O
MEFV	NNP	O
.	.	O

The	DT	O
murine	NN	O
gene	NN	O
contains	NNS	O
ten	JJ	O
exons	NNS	O
with	IN	O
a	DT	O
coding	VBG	O
sequence	NN	O
of	IN	O
2304	CD	O
bp	NN	O
,	,	O
while	IN	O
the	DT	O
rat	NN	O
homolog	NN	O
has	VBZ	O
nine	CD	O
exons	NNS	O
with	IN	O
a	DT	O
coding	VBG	O
sequence	NN	O
of	IN	O
2253	CD	O
bp	NN	O
.	.	O

A	DT	O
considerable	JJ	O
amino	NN	O
acid	NN	O
sequence	NN	O
homology	NN	O
was	VBD	O
observed	VBN	O
between	IN	O
the	DT	O
mouse	NN	O
and	CC	O
human	NN	O
(	(	O
47	CD	O
.	.	O

6	CD	O
%	NN	O
identity	NN	O
and	CC	O
65	CD	O
.	.	O

5	CD	O
%	NN	O
similarity	NN	O
)	)	O
and	CC	O
between	IN	O
the	DT	O
mouse	NN	O
and	CC	O
rat	NN	O
genes	NNS	O
(	(	O
73	CD	O
.	.	O

5	CD	O
%	NN	O
identity	NN	O
and	CC	O
82	CD	O
.	.	O

1	CD	O
%	NN	O
similarity	NN	O
)	)	O
.	.	O

The	DT	O
predicted	JJ	O
rodent	NN	O
proteins	NNS	O
have	VBP	O
several	JJ	O
important	JJ	O
domains	NNS	O
and	CC	O
signals	NNS	O
found	VBN	O
in	IN	O
human	JJ	O
pyrin	NN	O
,	,	O
including	VBG	O
a	DT	O
B	NNP	O
-	:	O
box	NN	O
zinc	NN	O
finger	NN	O
domain	NN	O
,	,	O
Robbins	NNP	O
-	:	O
Dingwall	NN	O
nuclear	JJ	O
localization	NN	O
signal	NN	O
,	,	O
and	CC	O
coiled	VBD	O
-	:	O
coil	NN	O
domain	NN	O
.	.	O

However	RB	O
,	,	O
perhaps	RB	O
because	IN	O
of	IN	O
an	DT	O
ancient	NN	O
frame	NN	O
-	:	O
shift	NN	O
mutation	NN	O
,	,	O
neither	CC	O
the	DT	O
mouse	NN	O
nor	CC	O
the	DT	O
rat	NN	O
protein	NN	O
has	VBZ	O
an	DT	O
intact	JJ	O
C	NNP	O
-	:	O
terminal	JJ	O
B30	NNP	O
.	.	O

2	CD	O
domain	NN	O
,	,	O
in	IN	O
which	WDT	O
most	JJS	O
FMF	NNP	S_Disease
-	:	O
associated	VBN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
found	VBN	O
in	IN	O
human	JJ	O
MEFV	NNP	O
.	.	O

Nevertheless	RB	O
,	,	O
like	IN	O
the	DT	O
human	JJ	O
gene	NN	O
,	,	O
mouse	NN	O
Mefv	NNP	O
is	VBZ	O
expressed	VBN	O
in	IN	O
peripheral	JJ	O
blood	NN	O
granulocytes	NNS	O
but	CC	O
not	RB	O
lymphocytes	NNS	O
.	.	O

Consistent	JJ	O
with	IN	O
its	PRP$	O
expression	NN	O
in	IN	O
granulocytes	NNS	O
,	,	O
Mefv	NNP	O
was	VBD	O
detected	VBN	O
at	IN	O
high	JJ	O
levels	NNS	O
in	IN	O
the	DT	O
primary	JJ	O
follicles	NNS	O
and	CC	O
marginal	JJ	O
zones	NNS	O
of	IN	O
the	DT	O
splenic	JJ	O
white	JJ	O
pulp	NN	O
.	.	O

Mefv	NNP	O
is	VBZ	O
localized	VBN	O
on	IN	O
mouse	NN	O
Chromosome	NNP	O
(	(	O
Chr	NNP	O
)	)	O
16	CD	O
,	,	O
region	NN	O
A3	NNP	O
-	:	O
B1	NNP	O
,	,	O
extending	VBG	O
a	DT	O
region	NN	O
of	IN	O
synteny	NN	O
with	IN	O
human	JJ	O
Chr	NNP	O
16p13	CD	O
.	.	O

3	CD	O
.	.	O

Development	NNP	O
of	IN	O
knockout	NN	O
and	CC	O
knockin	VB	O
mouse	NN	O
models	NNS	O
may	MD	O
provide	VB	O
further	JJR	O
insights	NNS	O
into	IN	O
the	DT	O
functional	JJ	O
evolution	NN	O
of	IN	O
this	DT	O
gene	NN	O
.	.	O

Additional	JJ	O
copies	NNS	O
of	IN	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
gene	NN	O
causing	VBG	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
arise	NN	O
by	IN	O
separate	JJ	O
integration	NN	O
into	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
.	.	O

The	DT	O
proteolipid	JJ	O
protein	NN	O
gene	NN	O
(	(	O
PLP	NNP	O
)	)	O
is	VBZ	O
normally	RB	O
present	JJ	O
at	IN	O
chromosome	NN	O
Xq22	NN	O
.	.	O

Mutations	NNS	O
and	CC	O
duplications	NNS	O
of	IN	O
this	DT	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
(	(	O
PMD	NNP	S_Disease
)	)	O
.	.	O

Here	RB	O
we	PRP	O
describe	VBP	O
two	CD	O
new	JJ	O
families	NNS	O
in	IN	O
which	WDT	O
males	NNS	O
affected	VBD	O
with	IN	O
PMD	NNP	S_Disease
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
copy	NN	O
of	IN	O
PLP	NNP	O
on	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
a	DT	O
normal	JJ	O
copy	NN	O
on	IN	O
Xq22	NN	O
.	.	O

In	IN	O
the	DT	O
first	JJ	O
family	NN	O
,	,	O
the	DT	O
extra	JJ	O
copy	NN	O
was	VBD	O
first	RB	O
detected	VBN	O
by	IN	O
the	DT	O
presence	NN	O
of	IN	O
heterozygosity	NN	O
of	IN	O
the	DT	O
AhaII	NNP	O
dimorphism	NN	O
within	IN	O
the	DT	O
PLP	NNP	O
gene	NN	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
FISH	NNP	O
analysis	NN	O
showed	VBD	O
an	DT	O
additional	JJ	O
copy	NN	O
of	IN	O
PLP	NNP	O
in	IN	O
Xp22	NNP	O
.	.	O

1	CD	O
,	,	O
although	IN	O
no	DT	O
chromosomal	JJ	O
rearrangements	NNS	O
could	MD	O
be	VB	O
detected	VBN	O
by	IN	O
standard	JJ	O
karyotype	NN	O
analysis	NN	O
.	.	O

Another	DT	O
three	CD	O
affected	VBD	O
males	NNS	O
from	IN	O
the	DT	O
family	NN	O
had	VBD	O
similar	JJ	O
findings	NNS	O
.	.	O

In	IN	O
a	DT	O
second	JJ	O
unrelated	JJ	O
family	NN	O
with	IN	O
signs	NNS	O
of	IN	O
PMD	NNP	S_Disease
,	,	O
cytogenetic	JJ	O
analysis	NN	O
showed	VBD	O
a	DT	O
pericentric	JJ	O
inversion	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
.	.	O

In	IN	O
the	DT	O
inv	NN	O
(	(	O
X	NNP	O
)	)	O
carried	VBN	O
by	IN	O
several	JJ	O
affected	JJ	O
family	NN	O
members	NNS	O
,	,	O
FISH	NNP	O
showed	VBD	O
PLP	NNP	O
signals	NNS	O
at	IN	O
Xp11	NNP	O
.	.	O

4	CD	O
and	CC	O
Xq22	NNP	O
.	.	O

A	DT	O
third	JJ	O
family	NN	O
has	VBZ	O
previously	RB	O
been	VBN	O
reported	VBN	O
,	,	O
in	IN	O
which	WDT	O
affected	VBD	O
members	NNS	O
had	VBD	O
an	DT	O
extra	JJ	O
copy	NN	O
of	IN	O
the	DT	O
PLP	NNP	O
gene	NN	O
detected	VBD	O
at	IN	O
Xq26	NNP	O
in	IN	O
a	DT	O
chromosome	NN	O
with	IN	O
an	DT	O
otherwise	NN	O
normal	JJ	O
banding	NN	O
pattern	NN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
three	CD	O
separate	JJ	O
families	NNS	O
in	IN	O
which	WDT	O
PLP	NNP	O
is	VBZ	O
duplicated	VBN	O
at	IN	O
a	DT	O
noncontiguous	JJ	O
site	NN	O
suggests	VBZ	O
that	IN	O
such	JJ	O
duplications	NNS	O
could	MD	O
be	VB	O
a	DT	O
relatively	RB	O
common	JJ	O
but	CC	O
previously	RB	O
undetected	JJ	O
cause	NN	O
of	IN	O
genetic	JJ	B_Disease
disorders	NNS	E_Disease
.	.	O

The	DT	O
exon	NN	O
13	CD	O
duplication	NN	O
in	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
is	VBZ	O
a	DT	O
founder	NN	O
mutation	NN	O
present	NN	O
in	IN	O
geographically	RB	O
diverse	JJ	O
populations	NNS	O
.	.	O

The	DT	O
BRCA1	NNP	O
Exon	NNP	O
13	CD	O
Duplication	NNP	O
Screening	NNP	O
Group	NNP	O
.	.	O

Recently	RB	O
,	,	O
a	DT	O
6	CD	O
-	:	O
kb	NN	O
duplication	NN	O
of	IN	O
exon	$	O
13	CD	O
,	,	O
which	WDT	O
creates	VBZ	O
a	DT	O
frameshift	NN	O
in	IN	O
the	DT	O
coding	VBG	O
sequence	NN	O
of	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
,	,	O
has	VBZ	O
been	VBN	O
described	VBN	O
in	IN	O
three	CD	O
unrelated	JJ	O
U	NNP	O
.	.	O

S	NNP	O
S	NNP	O
.	.	O

families	NNS	O
of	IN	O
European	JJ	O
ancestry	NN	O
and	CC	O
in	IN	O
one	CD	O
Portuguese	JJ	O
family	NN	O
.	.	O

Here	RB	O
,	,	O
our	PRP$	O
goal	NN	O
was	VBD	O
to	TO	O
estimate	VB	O
the	DT	O
frequency	NN	O
and	CC	O
geographic	JJ	O
diversity	NN	O
of	IN	O
carriers	NNS	O
of	IN	O
this	DT	O
duplication	NN	O
.	.	O

To	TO	O
do	VB	O
this	DT	O
,	,	O
a	DT	O
collaborative	JJ	O
screening	NN	O
study	NN	O
was	VBD	O
set	VBN	O
up	RP	O
that	DT	O
involved	VBD	O
39	CD	O
institutions	NNS	O
from	IN	O
19	CD	O
countries	NNS	O
and	CC	O
included	VBD	O
3	CD	O
,	,	O
580	CD	O
unrelated	JJ	O
individuals	NNS	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
the	DT	O
disease	NN	O
and	CC	O
934	CD	O
early	JJ	O
-	:	O
onset	NN	O
breast	NN	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
cases	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
11	CD	O
additional	JJ	O
families	NNS	O
carrying	VBG	O
this	DT	O
mutation	NN	O
were	VBD	O
identified	VBN	O
in	IN	O
Australia	NNP	O
(	(	O
1	CD	O
)	)	O
,	,	O
Belgium	NNP	O
(	(	O
1	CD	O
)	)	O
,	,	O
Canada	NNP	O
(	(	O
1	CD	O
)	)	O
,	,	O
Great	NNP	O
Britain	NNP	O
(	(	O
6	CD	O
)	)	O
,	,	O
and	CC	O
the	DT	O
United	NNP	O
States	NNPS	O
(	(	O
2	CD	O
)	)	O
.	.	O

Haplotyping	VBG	O
showed	VBD	O
that	IN	O
they	PRP	O
are	VBP	O
likely	JJ	O
to	TO	O
derive	VB	O
from	IN	O
a	DT	O
common	JJ	O
ancestor	NN	O
,	,	O
possibly	RB	O
of	IN	O
northern	JJ	O
British	JJ	O
origin	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
it	PRP	O
is	VBZ	O
strongly	RB	O
advisable	JJ	O
,	,	O
for	IN	O
laboratories	NNS	O
carrying	VBG	O
out	RP	O
screening	VBG	O
either	RB	O
in	IN	O
English	NNP	O
-	:	O
speaking	NN	O
countries	NNS	O
or	CC	O
in	IN	O
countries	NNS	O
with	IN	O
historical	JJ	O
links	NNS	O
with	IN	O
Britain	NNP	O
,	,	O
to	TO	O
include	VB	O
within	IN	O
their	PRP$	O
BRCA1	NNP	O
screening	NN	O
protocols	VBZ	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
-	:	O
based	VBN	O
assay	NN	O
described	VBN	O
in	IN	O
this	DT	O
report	NN	O
.	.	O

Genotype	NNP	O
-	:	O
phenotype	NN	O
correlations	NNS	O
in	IN	O
families	NNS	O
with	IN	O
deletions	NNS	O
in	IN	O
the	DT	O
von	NN	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	E_Disease
(	(	O
VHL	NNP	S_Disease
)	)	O
gene	NN	O
.	.	O

Von	NNP	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	I_Disease
(	(	I_Disease
VHL	NNP	I_Disease
)	)	I_Disease
disease	NN	E_Disease
is	VBZ	O
a	DT	O
hereditary	JJ	B_Disease
tumor	NN	I_Disease
syndrome	NN	E_Disease
characterized	VBN	O
by	IN	O
predisposition	NN	O
for	IN	O
bilateral	JJ	B_Disease
and	CC	I_Disease
multi	JJ	I_Disease
-	:	I_Disease
centric	JJ	I_Disease
hemangioblastoma	NN	E_Disease
in	IN	O
the	DT	O
retina	NN	O
and	CC	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
pheochromocytoma	NN	S_Disease
,	,	O
renal	JJ	B_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
,	,	O
and	CC	O
cysts	NNS	B_Disease
in	IN	I_Disease
the	DT	I_Disease
kidney	NN	I_Disease
,	,	I_Disease
pancreas	NNS	I_Disease
,	,	I_Disease
and	CC	I_Disease
epididymis	NN	E_Disease
.	.	O

We	PRP	O
describe	VBP	O
five	CD	O
families	NNS	O
for	IN	O
which	WDT	O
direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
had	VBD	O
failed	VBN	O
to	TO	O
identify	VB	O
the	DT	O
family	NN	O
-	:	O
specific	JJ	O
mutation	NN	O
.	.	O

Further	RB	O
molecular	JJ	O
analysis	NN	O
revealed	VBD	O
deletions	NNS	O
involving	VBG	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
in	IN	O
each	DT	O
of	IN	O
these	DT	O
families	NNS	O
.	.	O

In	IN	O
four	CD	O
families	NNS	O
,	,	O
partial	JJ	O
deletions	NNS	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
exons	NNS	O
were	VBD	O
detected	VBN	O
by	IN	O
Southern	NNP	O
blot	NN	O
analysis	NN	O
.	.	O

In	IN	O
the	DT	O
fifth	JJ	O
family	NN	O
,	,	O
FISH	NNP	O
analysis	NN	O
demonstrated	VBD	O
the	DT	O
deletion	NN	O
of	IN	O
the	DT	O
entire	JJ	O
VHL	NNP	S_Disease
gene	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
show	VBP	O
that	IN	O
(	(	O
quantitative	JJ	O
)	)	O
Southern	NNP	O
blot	NN	O
analysis	NN	O
is	VBZ	O
a	DT	O
sensitive	JJ	O
method	NN	O
for	IN	O
detecting	VBG	O
germline	JJ	O
deletions	NNS	O
of	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
and	CC	O
should	MD	O
be	VB	O
implemented	VBN	O
in	IN	O
routine	JJ	O
DNA	NNP	O
diagnosis	NN	O
for	IN	O
VHL	NNP	B_Disease
disease	NN	E_Disease
.	.	O

Our	PRP$	O
data	NNS	O
support	NN	O
the	DT	O
previously	RB	O
established	VBN	O
observation	NN	O
that	IN	O
families	NNS	O
with	IN	O
a	DT	O
germline	NN	O
deletion	NN	O
have	VBP	O
a	DT	O
low	JJ	O
risk	NN	O
for	IN	O
pheochromocytoma	NN	S_Disease
.	.	O

Further	RB	O
unraveling	NN	O
of	IN	O
genotype	JJ	O
-	:	O
phenotype	NN	O
correlations	NNS	O
in	IN	O
VHL	NNP	B_Disease
disease	NN	E_Disease
has	VBZ	O
revealed	VBN	O
that	IN	O
families	NNS	O
with	IN	O
a	DT	O
full	JJ	O
or	CC	O
partial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
exhibit	NN	O
a	DT	O
phenotype	NN	O
with	IN	O
a	DT	O
preponderance	NN	O
of	IN	O
central	JJ	B_Disease
nervous	JJ	I_Disease
system	NN	I_Disease
hemangioblastoma	NN	E_Disease
.	.	O
.	.	O

Age	NNP	O
of	IN	O
the	DT	O
intronic	JJ	O
GAA	NNP	O
triplet	NN	O
repeat	NN	O
expansion	NN	O
mutation	NN	O
in	IN	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
.	.	O

Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
(	(	O
FRDA	NNP	S_Disease
)	)	O
,	,	O
the	DT	O
most	RBS	O
frequently	RB	O
inherited	VBN	B_Disease
ataxia	NN	E_Disease
,	,	O
is	VBZ	O
due	JJ	O
in	IN	O
the	DT	O
vast	JJ	O
majority	NN	O
of	IN	O
cases	NNS	O
to	TO	O
a	DT	O
large	JJ	O
expansion	NN	O
of	IN	O
an	DT	O
intronic	JJ	O
GAA	NNP	O
repeat	NN	O
.	.	O

Using	VBG	O
linkage	NN	O
disequilibrium	NN	O
analysis	NN	O
based	VBN	O
on	IN	O
haplotype	NN	O
data	NNS	O
of	IN	O
seven	CD	O
polymorphic	JJ	O
markers	NNS	O
close	RB	O
to	TO	O
the	DT	O
frataxin	NN	O
gene	NN	O
,	,	O
the	DT	O
age	NN	O
of	IN	O
FRDA	NNP	S_Disease
founding	VBG	O
mutational	JJ	O
event	NN	O
(	(	O
s	NN	O
)	)	O
is	VBZ	O
estimated	VBN	O
to	TO	O
be	VB	O
at	IN	O
least	JJS	O
682	CD	O
+	JJ	O
/	NNP	O
-	:	O
203	CD	O
generations	NNS	O
(	(	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
564	CD	O
-	:	O
801	CD	O
g	NN	O
)	)	O
,	,	O
a	DT	O
dating	NN	O
which	WDT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
little	JJ	O
or	CC	O
no	DT	O
negative	JJ	O
selection	NN	O
and	CC	O
provides	VBZ	O
further	JJ	O
evidence	NN	O
for	IN	O
an	DT	O
ancient	JJ	O
spread	NN	O
of	IN	O
a	DT	O
pre	JJ	O
-	:	O
mutation	NN	O
(	(	O
at	IN	O
-	:	O
risk	NN	O
alleles	NNS	O
)	)	O
in	IN	O
western	JJ	O
Europe	NNP	O
.	.	O
.	.	O

Functional	JJ	O
link	NN	O
between	IN	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
and	CC	O
Nijmegen	NNP	B_Disease
breakage	NN	I_Disease
syndrome	VBD	E_Disease
gene	NN	O
products	NNS	O
.	.	O

Ataxia	NNP	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
(	(	O
A	DT	B_Disease
-	:	I_Disease
T	NN	E_Disease
)	)	O
and	CC	O
Nijmegen	NNP	B_Disease
breakage	NN	I_Disease
syndrome	NN	E_Disease
(	(	O
NBS	NNP	S_Disease
)	)	O
are	VBP	O
recessive	JJ	B_Disease
genetic	JJ	I_Disease
disorders	NNS	E_Disease
with	IN	O
susceptibility	NN	O
to	TO	O
cancer	NN	S_Disease
and	CC	O
similar	JJ	O
cellular	JJ	O
phenotypes	NNS	O
.	.	O

The	DT	O
protein	JJ	O
product	NN	O
of	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
A	DT	B_Disease
-	:	I_Disease
T	NN	E_Disease
,	,	O
designated	VBN	O
ATM	NNP	O
,	,	O
is	VBZ	O
a	DT	O
member	NN	O
of	IN	O
a	DT	O
family	NN	O
of	IN	O
kinases	NNS	O
characterized	VBN	O
by	IN	O
a	DT	O
carboxy	JJ	O
-	:	O
terminal	JJ	O
phosphatidylinositol	NN	O
3	CD	O
-	:	O
kinase	NN	O
-	:	O
like	IN	O
domain	NN	O
.	.	O

The	DT	O
NBS1	NNP	O
protein	NN	O
is	VBZ	O
specifically	RB	O
mutated	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
Nijmegen	NNP	B_Disease
breakage	NN	I_Disease
syndrome	NN	E_Disease
and	CC	O
forms	VBZ	O
a	DT	O
complex	JJ	O
with	IN	O
the	DT	O
DNA	NNP	O
repair	NN	O
proteins	NNS	O
Rad50	NNP	O
and	CC	O
Mrel1	NNP	O
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	DT	O
phosphorylation	NN	O
of	IN	O
NBS1	NNP	O
,	,	O
induced	VBN	O
by	IN	O
ionizing	VBG	O
radiation	NN	O
,	,	O
requires	VBZ	O
catalytically	RB	O
active	JJ	O
ATM	NNP	O
.	.	O

Complexes	NNP	O
containing	VBG	O
ATM	NNP	O
and	CC	O
NBS1	NNP	O
exist	VBP	O
in	IN	O
vivo	NN	O
in	IN	O
both	DT	O
untreated	JJ	O
cells	NNS	O
and	CC	O
cells	NNS	O
treated	VBN	O
with	IN	O
ionizing	VBG	O
radiation	NN	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
two	CD	O
residues	NNS	O
of	IN	O
NBS1	NNP	O
,	,	O
Ser	NNP	O
278	CD	O
and	CC	O
Ser	NNP	O
343	CD	O
that	WDT	O
are	VBP	O
phosphorylated	VBN	O
in	IN	O
vitro	NN	O
by	IN	O
ATM	NNP	O
and	CC	O
whose	WP$	O
modification	NN	O
in	IN	O
vivo	NN	O
is	VBZ	O
essential	JJ	O
for	IN	O
the	DT	O
cellular	JJ	O
response	NN	O
to	TO	O
DNA	NNP	O
damage	NN	O
.	.	O

This	DT	O
response	NN	O
includes	VBZ	O
S	NNP	O
-	:	O
phase	NN	O
checkpoint	NN	O
activation	NN	O
,	,	O
formation	NN	O
of	IN	O
the	DT	O
NBS1	NNP	O
/	NNP	O
Mrel1	NNP	O
/	NNP	O
Rad50	NNP	O
nuclear	JJ	O
foci	NN	O
and	CC	O
rescue	NN	O
of	IN	O
hypersensitivity	NN	B_Disease
to	TO	I_Disease
ionizing	VBG	I_Disease
radiation	NN	E_Disease
.	.	O

Together	RB	O
,	,	O
these	DT	O
results	NNS	O
demonstrate	VBP	O
a	DT	O
biochemical	JJ	O
link	NN	O
between	IN	O
cell	NN	O
-	:	O
cycle	NN	O
checkpoints	NNS	O
activated	VBN	O
by	IN	O
DNA	NNP	O
damage	NN	O
and	CC	O
DNA	NNP	O
repair	NN	O
in	IN	O
two	CD	O
genetic	JJ	B_Disease
diseases	NNS	E_Disease
with	IN	O
overlapping	VBG	O
phenotypes	NNS	O
.	.	O
.	.	O

Homozygosity	NNP	O
mapping	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
microcephaly	NN	S_Disease
,	,	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
and	CC	O
short	JJ	B_Disease
stature	NN	E_Disease
to	TO	O
a	DT	O
Cohen	NNP	B_Disease
syndrome	JJ	E_Disease
region	NN	O
on	IN	O
8q21	CD	O
.	.	O
3	CD	O
-	:	O
8q22	CD	O
.	.	O
1	CD	O
:	:	O
redefining	VBG	O
a	DT	O
clinical	JJ	O
entity	NN	O
.	.	O

A	DT	O
syndrome	NN	O
of	IN	O
microcephaly	NN	S_Disease
,	,	O
progressive	JJ	O
postnatal	JJ	B_Disease
growth	NN	I_Disease
deficiency	NN	E_Disease
,	,	O
and	CC	O
mental	JJ	B_Disease
retardation	NN	E_Disease
was	VBD	O
observed	VBN	O
in	IN	O
two	CD	O
brothers	NNS	O
and	CC	O
their	PRP$	O
cousin	NN	O
from	IN	O
a	DT	O
multiply	NN	O
consanguineous	JJ	O
kindred	VBN	O
of	IN	O
Lebanese	JJ	O
descent	NN	O
.	.	O

Hypotonia	NNP	S_Disease
,	,	O
chorioretinal	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
and	CC	O
myopia	NN	S_Disease
were	VBD	O
also	RB	O
identified	VBN	O
.	.	O

The	DT	O
severity	NN	O
of	IN	O
the	DT	O
condition	NN	O
varied	VBD	O
among	IN	O
the	DT	O
closely	RB	O
related	JJ	O
patients	NNS	O
.	.	O

Because	IN	O
of	IN	O
absence	NN	O
of	IN	O
a	DT	O
distinctive	JJ	O
facial	JJ	O
appearance	NN	O
,	,	O
the	DT	O
degree	NN	O
of	IN	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
and	CC	O
short	JJ	B_Disease
stature	NN	E_Disease
,	,	O
the	DT	O
initially	RB	O
considered	VBN	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
Cohen	NNP	B_Disease
syndrome	NN	E_Disease
was	VBD	O
withdrawn	VBN	O
and	CC	O
a	DT	O
novel	JJ	O
genetic	JJ	O
entity	NN	O
was	VBD	O
assumed	VBN	O
.	.	O

Homozygosity	NNP	O
mapping	NN	O
in	IN	O
this	DT	O
family	NN	O
assigned	VBD	O
the	DT	O
gene	NN	O
to	TO	O
a	DT	O
26	CD	O
.	.	O

8	CD	O
-	:	O
cM	NN	O
region	NN	O
on	IN	O
the	DT	O
chromosome	NN	O
band	NN	O
8q21	CD	O
.	.	O

3	LS	O
-	:	O
22	CD	O
.	.	O

1	CD	O
,	,	O
between	IN	O
the	DT	O
microsatellites	NNS	O
at	IN	O
D8S270	NNP	O
and	CC	O
D8S514	NNP	O
.	.	O

The	DT	O
maximum	JJ	O
two	CD	O
-	:	O
point	NN	O
LOD	NNP	O
score	NN	O
was	VBD	O
found	VBN	O
for	IN	O
marker	NN	O
at	IN	O
D8S267	NNP	O
(	(	O
Zmax	NNP	O
=	VBZ	O
3	CD	O
.	.	O
.	.	O

237	CD	O
at	IN	O
Omax	NNP	O
=	NNP	O
0	CD	O
.	.	O

00	CD	O
)	)	O
.	.	O

Intriguingly	RB	O
enough	RB	O
,	,	O
the	DT	O
identified	VBN	O
gene	NN	O
region	NN	O
overlaps	VBZ	O
the	DT	O
refined	JJ	O
gene	NN	O
region	NN	O
for	IN	O
Cohen	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
COH1	NNP	O
)	)	O
[	VBP	O
Kolehmainen	NNP	O
et	CC	O
al	NN	O
.	.	O
,	,	O
1997	CD	O
Euro	NNP	O
J	NNP	O
Hum	NNP	O
Genet	NNP	O
5	CD	O
206	CD	O
-	:	O
213	CD	O
]	NN	O
.	.	O

This	DT	O
fact	NN	O
encourages	VBZ	O
the	DT	O
hypothesis	NN	O
that	IN	O
the	DT	O
described	NN	O
kindred	VBD	O
segregates	NNS	O
for	IN	O
a	DT	O
variant	NN	O
of	IN	O
Cohen	NNP	B_Disease
syndrome	NN	E_Disease
and	CC	O
suggests	VBZ	O
a	DT	O
redefinition	NN	O
of	IN	O
its	PRP$	O
phenotype	NN	O

Polymorphisms	NNP	O
of	IN	O
the	DT	O
CYP2D6	NNP	O
gene	NN	O
increase	NN	O
susceptibility	NN	O
to	TO	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
.	.	O

Ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
(	(	O
AS	IN	S_Disease
)	)	O
is	VBZ	O
a	DT	O
common	JJ	O
and	CC	O
highly	RB	O
familial	JJ	O
rheumatic	JJ	B_Disease
disorder	NN	E_Disease
.	.	O

The	DT	O
sibling	VBG	O
recurrence	NN	O
risk	NN	O
ratio	NN	O
for	IN	O
the	DT	O
disease	NN	O
is	VBZ	O
63	CD	O
and	CC	O
heritability	NN	O
assessed	VBN	O
in	IN	O
twins	NNS	O
>	VBP	O
90	CD	O
%	NN	O
.	.	O

Although	IN	O
MHC	NNP	O
genes	NNS	O
,	,	O
including	VBG	O
HLA	NNP	O
-	:	O
B27	NNP	O
,	,	O
contribute	VBZ	O
only	RB	O
20	CD	O
-	:	O
50	CD	O
%	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
risk	NN	O
for	IN	O
the	DT	O
disease	NN	O
,	,	O
no	DT	O
non	JJ	O
-	:	O
MHC	NNP	O
gene	NN	O
has	VBZ	O
yet	RB	O
been	VBN	O
convincingly	RB	O
demonstrated	VBN	O
to	TO	O
influence	VB	O
either	DT	O
susceptibility	NN	O
to	TO	O
the	DT	O
disease	NN	O
or	CC	O
its	PRP$	O
phenotypic	JJ	O
expression	NN	O
.	.	O

Previous	JJ	O
linkage	NN	O
and	CC	O
association	NN	O
studies	NNS	O
have	VBP	O
suggested	VBN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
susceptibility	NN	O
gene	NN	O
for	IN	O
AS	NNP	S_Disease
close	NN	O
to	TO	O
,	,	O
or	CC	O
within	IN	O
,	,	O
the	DT	O
cytochrome	NN	O
P450	NNP	O
2D6	CD	O
gene	NN	O
(	(	O
CYP2D6	NNP	O
,	,	O
debrisoquine	JJ	O
hydroxylase	NN	O
)	)	O
located	VBN	O
at	IN	O
chromosome	NN	O
22q13	CD	O
.	.	O
1	CD	O
.	.	O

We	PRP	O
performed	VBD	O
a	DT	O
linkage	NN	O
study	NN	O
of	IN	O
chromosome	NN	O
22	CD	O
in	IN	O
200	CD	O
families	NNS	O
with	IN	O
AS	NNP	S_Disease
affected	VBD	O
sibling	VBG	O
-	:	O
pairs	NN	O
.	.	O

Association	NNP	O
of	IN	O
alleles	NNS	O
of	IN	O
the	DT	O
CYP2D6	NNP	O
gene	NN	O
was	VBD	O
examined	VBN	O
by	IN	O
both	DT	O
case	NN	O
-	:	O
control	NN	O
and	CC	O
within	IN	O
-	:	O
family	NN	O
means	VBZ	O
.	.	O

For	IN	O
case	NN	O
-	:	O
control	NN	O
studies	NNS	O
,	,	O
617	CD	O
unrelated	JJ	O
individuals	NNS	O
with	IN	O
AS	NNP	S_Disease
(	(	O
361	CD	O
probands	NNS	O
from	IN	O
sibling	VBG	O
-	:	O
pair	NN	O
and	CC	O
parent	NN	O
-	:	O
case	NN	O
trio	NN	O
families	NNS	O
and	CC	O
256	CD	O
unrelated	JJ	O
non	SYM	O
-	:	O
familial	JJ	O
sporadic	JJ	O
cases	NNS	O
)	)	O
and	CC	O
402	CD	O
healthy	JJ	O
ethnically	RB	O
matched	VBN	O
controls	NNS	O
were	VBD	O
employed	VBN	O
.	.	O

For	IN	O
within	IN	O
-	:	O
family	NN	O
association	NN	O
studies	NNS	O
,	,	O
361	CD	O
families	NNS	O
including	VBG	O
161	CD	O
parent	NN	O
-	:	O
case	NN	O
trios	NNS	O
and	CC	O
200	CD	O
affected	VBD	O
sibling	VBG	O
-	:	O
pair	NN	O
families	NNS	O
were	VBD	O
employed	VBN	O
.	.	O

Homozygosity	NN	O
for	IN	O
poor	JJ	O
metabolizer	NN	O
alleles	NNS	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
AS	NNP	S_Disease
.	.	O

Heterozygosity	NN	O
for	IN	O
the	DT	O
most	RBS	O
frequent	JJ	O
poor	JJ	O
metabolizer	NN	O
allele	NN	O
(	(	O
CYP2D6	NNP	O
*	NNP	O
4	CD	O
)	)	O
was	VBD	O
not	RB	O
associated	VBN	O
with	IN	O
increased	JJ	O
susceptibility	NN	O
to	TO	O
AS	NNP	S_Disease
.	.	O

Significant	NNP	O
within	IN	O
-	:	O
family	NN	O
association	NN	O
of	IN	O
CYP2D6	NNP	O
*	NNP	O
4	CD	O
alleles	NNS	O
and	CC	O
AS	NNP	S_Disease
was	VBD	O
demonstrated	VBN	O
.	.	O

Weak	NNP	O
linkage	NN	O
was	VBD	O
also	RB	O
demonstrated	VBN	O
between	IN	O
CYP2D6	NNP	O
and	CC	O
AS	NNP	S_Disease
.	.	O

We	PRP	O
postulate	VBP	O
that	IN	O
altered	VBD	O
metabolism	NN	O
of	IN	O
a	DT	O
natural	JJ	O
toxin	NN	O
or	CC	O
antigen	NN	O
by	IN	O
the	DT	O
CYP2D6	NNP	O
gene	NN	O
may	MD	O
increase	VB	O
susceptibility	NN	O
to	TO	O
AS	NNP	S_Disease
.	.	O

Functional	JJ	O
differences	NNS	O
of	IN	O
the	DT	O
PDS	NNP	S_Disease
gene	NN	O
product	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
phenotypic	NN	O
variation	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
and	CC	O
non	JJ	B_Disease
-	:	I_Disease
syndromic	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
(	(	O
DFNB4	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
PDS	NNP	S_Disease
gene	NN	O
encodes	VBZ	O
a	DT	O
transmembrane	NN	O
protein	NN	O
,	,	O
known	VBN	O
as	IN	O
pendrin	NN	O
,	,	O
which	WDT	O
functions	VBZ	O
as	IN	O
a	DT	O
transporter	NN	O
of	IN	O
iodide	NN	O
and	CC	O
chloride	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
this	DT	O
gene	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
and	CC	O
autosomal	JJ	B_Disease
recessive	NN	I_Disease
non	SYM	I_Disease
-	:	I_Disease
syndromic	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
at	IN	O
the	DT	O
DFNB4	NNP	S_Disease
locus	NN	O
on	IN	O
chromosome	NN	O
7q31	CD	O
.	.	O

A	DT	O
screen	NN	O
of	IN	O
20	CD	O
individuals	NNS	O
from	IN	O
the	DT	O
midwestern	JJ	O
USA	NNP	O
with	IN	O
non	JJ	B_Disease
-	:	I_Disease
syndromic	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
and	CC	O
dilated	VBD	O
vestibular	JJ	O
aqueducts	NNS	O
identified	VBN	O
three	CD	O
people	NNS	O
(	(	O
15	CD	O
%	NN	O
)	)	O
with	IN	O
PDS	NNP	S_Disease
mutations	NNS	O
.	.	O

To	TO	O
determine	VB	O
whether	IN	O
PDS	NNP	S_Disease
mutations	NNS	O
in	IN	O
individuals	NNS	O
with	IN	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
differ	VBP	O
functionally	RB	O
from	IN	O
PDS	NNP	S_Disease
mutations	NNS	O
in	IN	O
individuals	NNS	O
with	IN	O
non	JJ	B_Disease
-	:	I_Disease
syndromic	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
,	,	O
we	PRP	O
compared	VBN	O
three	CD	O
common	JJ	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
allele	NN	O
variants	NNS	O
(	(	O
L236P	NNP	O
,	,	O
T416P	NNP	O
and	CC	O
E384G	NNP	O
)	)	O
,	,	O
with	IN	O
three	CD	O
PDS	NNP	S_Disease
mutations	NNS	O
reported	VBD	O
only	RB	O
in	IN	O
individuals	NNS	O
with	IN	O
non	JJ	B_Disease
-	:	I_Disease
syndromic	JJ	I_Disease
hearing	NN	I_Disease
loss	NN	E_Disease
(	(	O
V480D	NNP	O
,	,	O
V653A	NNP	O
and	CC	O
I490L	NNP	O
/	NNP	O
G497S	NNP	O
)	)	O
.	.	O

The	DT	O
mutations	NNS	O
associated	VBN	O
with	IN	O
Pendred	NNP	B_Disease
syndrome	NN	E_Disease
have	VBP	O
complete	JJ	O
loss	NN	O
of	IN	O
pendrin	JJ	O
-	:	O
induced	JJ	O
chloride	NN	O
and	CC	O
iodide	JJ	O
transport	NN	O
,	,	O
while	IN	O
alleles	NNS	O
unique	JJ	O
to	TO	O
people	NNS	O
with	IN	O
DFNB4	NNP	S_Disease
are	VBP	O
able	JJ	O
to	TO	O
transport	VB	O
both	DT	O
iodide	JJ	O
and	CC	O
chloride	NN	O
,	,	O
albeit	NN	O
at	IN	O
a	DT	O
much	RB	O
lower	JJR	O
level	NN	O
than	IN	O
wild	JJ	O
-	:	O
type	NN	O
pendrin	NN	O
.	.	O

We	PRP	O
hypothesize	VBP	O
that	IN	O
this	DT	O
residual	JJ	O
level	NN	O
of	IN	O
anion	NN	O
transport	NN	O
is	VBZ	O
sufficient	JJ	O
to	TO	O
eliminate	VB	O
or	CC	O
postpone	VB	O
the	DT	O
onset	NN	O
of	IN	O
goiter	NN	S_Disease
in	IN	O
individuals	NNS	O
with	IN	O
DFNB4	NNP	S_Disease
.	.	O

We	PRP	O
propose	VBP	O
a	DT	O
model	NN	O
for	IN	O
pendrin	JJ	O
function	NN	O
in	IN	O
the	DT	O
thyroid	NN	O
in	IN	O
which	WDT	O
pendrin	NN	O
transports	NNS	O
iodide	RB	O
across	IN	O
the	DT	O
apical	JJ	O
membrane	NN	O
of	IN	O
the	DT	O
thyrocyte	NN	O
into	IN	O
the	DT	O
colloid	JJ	O
space	NN	O
.	.	O
.	.	O

The	DT	O
human	JJ	O
factor	NN	O
IX	NNP	O
gene	NN	O
as	IN	O
germline	JJ	O
mutagen	NN	O
test	NN	O
:	:	O
samples	NNS	O
from	IN	O
Mainland	NNP	O
China	NNP	O
have	VBP	O
the	DT	O
putatively	RB	O
endogenous	JJ	O
pattern	NN	O
of	IN	O
mutation	NN	O
.	.	O

Germline	NNP	O
mutations	NNS	O
are	VBP	O
the	DT	O
major	JJ	O
source	NN	O
of	IN	O
genetic	JJ	O
variation	NN	O
that	WDT	O
allows	VBZ	O
a	DT	O
species	NNS	O
to	TO	O
evolve	VB	O
over	IN	O
time	NN	O
but	CC	O
at	IN	O
the	DT	O
cost	NN	O
of	IN	O
Mendelian	JJ	B_Disease
disease	NN	E_Disease
and	CC	O
genetic	JJ	O
predisposition	NN	O
to	TO	O
multifactorial	JJ	B_Disease
diseases	NNS	E_Disease
.	.	O

Previous	JJ	O
analyses	NNS	O
have	VBP	O
revealed	VBN	O
that	IN	O
the	DT	O
pattern	NN	O
of	IN	O
germline	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
factor	NN	O
IX	NNP	O
gene	NN	O
(	(	O
F9	NNP	O
)	)	O
is	VBZ	O
similar	JJ	O
among	IN	O
a	DT	O
variety	NN	O
of	IN	O
ethnically	RB	O
and	CC	O
geographically	RB	O
diverse	JJ	O
populations	NNS	O
and	CC	O
compatible	JJ	O
with	IN	O
the	DT	O
ancient	NN	O
pattern	NN	O
that	WDT	O
has	VBZ	O
shaped	VBN	O
the	DT	O
mammalian	JJ	O
genome	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
compare	VBP	O
the	DT	O
pattern	NN	O
of	IN	O
germline	JJ	O
mutation	NN	O
in	IN	O
a	DT	O
population	NN	O
of	IN	O
hemophilia	NN	B_Disease
B	NNP	E_Disease
patients	NNS	O
from	IN	O
Mainland	NNP	O
China	NNP	O
(	(	O
n	JJ	O
=	NNP	O
66	CD	O
)	)	O
to	TO	O
that	DT	O
in	IN	O
U	NNP	O
.	.	O

S	NNP	O
.	.	O

Caucasians	NNS	O
,	,	O
Blacks	NNP	O
,	,	O
and	CC	O
Mexican	NNP	O
Hispanics	NNP	O
and	CC	O
stratify	VBN	O
by	IN	O
disease	NN	O
severity	NN	O
and	CC	O
ethnicity	NN	O
.	.	O

The	DT	O
similar	JJ	O
pattern	NN	O
of	IN	O
germline	JJ	O
mutation	NN	O
in	IN	O
all	DT	O
ethnic	JJ	O
groups	NNS	O
studied	VBD	O
to	TO	O
date	NN	O
provides	VBZ	O
additional	JJ	O
data	NNS	O
compatible	NN	O
with	IN	O
the	DT	O
inference	NN	O
that	WDT	O
endogenous	JJ	O
processes	NNS	O
predominate	VBP	O
in	IN	O
germline	JJ	O
mutations	NNS	O
.	.	O

Fas	NNP	O
preassociation	NN	O
required	VBN	O
for	IN	O
apoptosis	NN	O
signaling	NN	O
and	CC	O
dominant	JJ	O
inhibition	NN	O
by	IN	O
pathogenic	JJ	O
mutations	NNS	O
.	.	O

Heterozygous	JJ	O
mutations	NNS	O
encoding	VBG	O
abnormal	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
death	NN	O
receptor	NN	O
Fas	NNP	O
dominantly	RB	O
interfere	RB	O
with	IN	O
Fas	NNP	O
-	:	O
induced	VBD	O
lymphocyte	JJ	O
apoptosis	NN	O
in	IN	O
human	JJ	O
autoimmune	JJ	B_Disease
lymphoproliferative	JJ	I_Disease
syndrome	NN	E_Disease
.	.	O

This	DT	O
effect	NN	O
,	,	O
rather	RB	O
than	IN	O
depending	VBG	O
on	IN	O
ligand	NN	O
-	:	O
induced	JJ	O
receptor	NN	O
oligomerization	NN	O
,	,	O
was	VBD	O
found	VBN	O
to	TO	O
stem	VB	O
from	IN	O
ligand	NN	O
-	:	O
independent	JJ	O
interaction	NN	O
of	IN	O
wild	JJ	O
-	:	O
type	NN	O
and	CC	O
mutant	JJ	O
Fas	NNP	O
receptors	NNS	O
through	IN	O
a	DT	O
specific	JJ	O
region	NN	O
in	IN	O
the	DT	O
extracellular	JJ	O
domain	NN	O
.	.	O

Preassociated	VBN	O
Fas	NNP	O
complexes	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
living	VBG	O
cells	NNS	O
by	IN	O
means	NNS	O
of	IN	O
fluorescence	NN	O
resonance	NN	O
energy	NN	O
transfer	NN	O
between	IN	O
variants	NNS	O
of	IN	O
green	JJ	O
fluorescent	NN	O
protein	NN	O
.	.	O

These	DT	O
results	NNS	O
show	VBP	O
that	IN	O
formation	NN	O
of	IN	O
preassociated	JJ	O
receptor	NN	O
complexes	NNS	O
is	VBZ	O
necessary	JJ	O
for	IN	O
Fas	NNP	O
signaling	VBG	O
and	CC	O
dominant	JJ	O
interference	NN	O
in	IN	O
human	JJ	O
disease	NN	O
.	.	O
.	.	O

Determination	NN	O
of	IN	O
carrier	NN	O
status	NN	O
for	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
by	IN	O
flow	JJ	O
cytometric	JJ	O
analysis	NN	O
of	IN	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	VBP	E_Disease
protein	JJ	O
expression	NN	O
in	IN	O
peripheral	JJ	O
blood	NN	O
mononuclear	NN	O
cells	NNS	O
.	.	O

The	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
defects	NNS	O
in	IN	O
the	DT	O
WAS	NNP	S_Disease
protein	NN	O
(	(	O
WASP	NNP	O
)	)	O
gene	NN	O
on	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
.	.	O

Previous	JJ	O
study	NN	O
disclosed	VBD	O
that	IN	O
flow	JJ	O
cytometric	JJ	O
analysis	NN	O
of	IN	O
intracellular	JJ	O
WASP	NNP	O
expression	NN	O
(	(	O
FCM	NNP	O
-	:	O
WASP	NNP	O
analysis	NN	O
)	)	O
in	IN	O
lymphocytes	NN	O
was	VBD	O
useful	JJ	O
for	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
WAS	NNP	S_Disease
patients	NNS	O
.	.	O

Lymphocytes	NNS	O
from	IN	O
all	DT	O
WAS	NNP	S_Disease
patients	NNS	O
showed	VBD	O
WASPdim	NNP	O
instead	RB	O
of	IN	O
WASPbright	NNP	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
FCM	NNP	O
-	:	O
WASP	JJ	O
analysis	NN	O
in	IN	O
monocytes	NNS	O
could	MD	O
be	VB	O
a	DT	O
useful	JJ	O
tool	NN	O
for	IN	O
the	DT	O
WAS	NNP	S_Disease
carrier	NN	O
diagnosis	NN	O
.	.	O

Monocytes	NNS	O
from	IN	O
all	DT	O
nine	CD	O
WAS	NNP	S_Disease
carriers	NNS	O
showed	VBD	O
varied	JJ	O
population	NN	O
of	IN	O
WASPdim	NNP	O
together	RB	O
with	IN	O
WASPbright	NNP	O
.	.	O

None	NN	O
of	IN	O
control	NN	O
individuals	NNS	O
possessed	VBD	O
the	DT	O
WASPdim	NNP	O
population	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
lymphocytes	VBZ	O
from	IN	O
all	PDT	O
the	DT	O
carriers	NNS	O
except	IN	O
two	CD	O
lacked	VBD	O
the	DT	O
WASPdim	NNP	O
population	NN	O
.	.	O

The	DT	O
difference	NN	O
of	IN	O
the	DT	O
WASPdim	NNP	O
population	NN	O
in	IN	O
monocytes	NNS	O
and	CC	O
lymphocytes	VBZ	O
observed	VBN	O
in	IN	O
WAS	NNP	S_Disease
carriers	NNS	O
suggests	VBZ	O
that	IN	O
WASP	NNP	O
plays	VBZ	O
a	DT	O
more	RBR	O
critical	JJ	O
role	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
lymphocytes	NNS	O
than	IN	O
in	IN	O
that	DT	O
of	IN	O
monocytes	NNS	O
.	.	O

The	DT	O
present	JJ	O
studies	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
skewed	JJ	O
X	NNP	O
-	:	O
chromosomal	JJ	O
inactivation	NN	O
pattern	NN	O
observed	VBN	O
in	IN	O
WAS	NNP	S_Disease
carrier	NN	O
peripheral	JJ	O
blood	NN	O
cells	NNS	O
is	VBZ	O
not	RB	O
fixed	VBN	O
at	IN	O
the	DT	O
hemopoietic	JJ	O
stem	NN	O
cell	NN	O
level	NN	O
but	CC	O
progresses	VBZ	O
after	IN	O
the	DT	O
lineage	NN	O
commitment	NN	O
.	.	O
.	.	O

Restoration	NN	O
of	IN	O
photoreceptor	NN	O
ultrastructure	NN	O
and	CC	O
function	NN	O
in	IN	O
retinal	JJ	B_Disease
degeneration	NN	E_Disease
slow	JJ	O
mice	NN	O
by	IN	O
gene	NN	O
therapy	NN	O
.	.	O

The	DT	O
gene	NN	O
Prph2	NNP	O
encodes	VBZ	O
a	DT	O
photoreceptor	NN	O
-	:	O
specific	JJ	O
membrane	NN	O
glycoprotein	NN	O
,	,	O
peripherin	SYM	O
-	:	O
2	CD	O
(	(	O
also	RB	O
known	VBN	O
as	IN	O
peripherin	NN	O
/	NNP	O
rds	NNS	O
)	)	O
,	,	O
which	WDT	O
is	VBZ	O
inserted	VBN	O
into	IN	O
the	DT	O
rims	NNS	O
of	IN	O
photoreceptor	NN	O
outer	NN	O
segment	NN	O
discs	NN	O
in	IN	O
a	DT	O
complex	JJ	O
with	IN	O
rom	NN	O
-	:	O
1	CD	O
(	(	O
ref	NN	O
.	.	O

2	CD	O
)	)	O
.	.	O

The	DT	O
complex	NN	O
is	VBZ	O
necessary	JJ	O
for	IN	O
the	DT	O
stabilization	NN	O
of	IN	O
the	DT	O
discs	NN	O
,	,	O
which	WDT	O
are	VBP	O
renewed	VBN	O
constantly	RB	O
throughout	IN	O
life	NN	O
,	,	O
and	CC	O
which	WDT	O
contain	VBP	O
the	DT	O
visual	JJ	O
pigments	NNS	O
necessary	JJ	O
for	IN	O
photon	NN	O
capture	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
Prph2	NNP	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
result	VB	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
photoreceptor	NN	B_Disease
dystrophies	NNS	E_Disease
,	,	O
including	VBG	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
retinitis	NN	I_Disease
pigmentosa	NN	E_Disease
and	CC	O
macular	JJ	B_Disease
dystrophy	NN	E_Disease
.	.	O

A	DT	O
common	JJ	O
feature	NN	O
of	IN	O
these	DT	O
diseases	NNS	O
is	VBZ	O
the	DT	O
loss	NN	O
of	IN	O
photoreceptor	NN	O
function	NN	O
,	,	O
also	RB	O
seen	VBN	O
in	IN	O
the	DT	O
retinal	JJ	B_Disease
degeneration	NN	E_Disease
slow	NN	O
(	(	O
rds	NNS	O
or	CC	O
Prph2	NNP	O
Rd2	NNP	O
/	NNP	O
Rd2	NNP	O
)	)	O
mouse	NN	O
,	,	O
which	WDT	O
is	VBZ	O
homozygous	JJ	O
for	IN	O
a	DT	O
null	JJ	O
mutation	NN	O
in	IN	O
Prph2	NNP	O
.	.	O

It	PRP	O
is	VBZ	O
characterized	VBN	O
by	IN	O
a	DT	O
complete	JJ	O
failure	NN	O
to	TO	O
develop	VB	O
photoreceptor	NN	O
discs	NN	O
and	CC	O
outer	NN	O
segments	NNS	O
,	,	O
downregulation	NN	O
of	IN	O
rhodopsin	NN	O
and	CC	O
apoptotic	JJ	O
loss	NN	O
of	IN	O
photoreceptor	NN	O
cells	NNS	O
.	.	O

The	DT	O
electroretinograms	NN	O
(	(	O
ERGs	NNP	O
)	)	O
of	IN	O
Prph2Rd2	NNP	O
/	NNP	O
Rd2	NNP	O
mice	NN	O
have	VBP	O
greatly	RB	O
diminished	VBN	O
a	DT	O
-	:	O
wave	NN	O
and	CC	O
b	SYM	O
-	:	O
wave	NN	O
amplitudes	NNS	O
,	,	O
which	WDT	O
decline	VBP	O
to	TO	O
virtually	RB	O
undetectable	JJ	O
concentrations	NNS	O
by	IN	O
two	CD	O
months	NNS	O
.	.	O

Subretinal	JJ	O
injection	NN	O
of	IN	O
recombinant	JJ	O
adeno	JJ	O
-	:	O
associated	VBN	O
virus	NN	O
(	(	O
AAV	NNP	O
)	)	O
encoding	VBG	O
a	DT	O
Prph2	NNP	O
transgene	NN	O
results	NNS	O
in	IN	O
stable	JJ	O
generation	NN	O
of	IN	O
outer	NN	O
segment	NN	O
structures	NNS	O
and	CC	O
formation	NN	O
of	IN	O
new	JJ	O
stacks	NNS	O
of	IN	O
discs	NN	O
containing	VBG	O
both	DT	O
perpherin	JJ	O
-	:	O
2	CD	O
and	CC	O
rhodopsin	NN	O
,	,	O
which	WDT	O
in	IN	O
many	JJ	O
cases	NNS	O
are	VBP	O
morphologically	RB	O
similar	JJ	O
to	TO	O
normal	JJ	O
outer	JJ	O
segments	NNS	O
.	.	O

Moreover	RB	O
,	,	O
the	DT	O
re	NN	O
-	:	O
establishment	NN	O
of	IN	O
the	DT	O
structural	JJ	O
integrity	NN	O
of	IN	O
the	DT	O
photoreceptor	NN	O
layer	NN	O
also	RB	O
results	NNS	O
in	IN	O
electrophysiological	JJ	O
correction	NN	O
.	.	O

These	DT	O
studies	NNS	O
demonstrate	VBP	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
that	IN	O
a	DT	O
complex	JJ	O
ultrastructural	JJ	O
cell	NN	O
defect	NN	O
can	MD	O
be	VB	O
corrected	VBN	O
both	DT	O
morphologically	RB	O
and	CC	O
functionally	RB	O
by	IN	O
in	IN	O
vivo	JJ	O
gene	NN	O
transfer	NN	O
.	.	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
fibrinogen	NN	O
aalpha	JJ	O
gene	NN	O
account	NN	O
for	IN	O
the	DT	O
majority	NN	O
of	IN	O
cases	NNS	O
of	IN	O
congenital	JJ	B_Disease
afibrinogenemia	NN	E_Disease
.	.	O

Congenital	JJ	B_Disease
afibrinogenemia	NN	E_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
,	,	O
autosomal	JJ	B_Disease
,	,	I_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
the	DT	O
complete	JJ	O
absence	NN	O
of	IN	O
detectable	JJ	O
fibrinogen	NN	O
.	.	O

We	PRP	O
previously	RB	O
identified	VBD	O
the	DT	O
first	JJ	O
causative	JJ	O
mutations	NNS	O
in	IN	O
a	DT	O
nonconsanguineous	JJ	O
Swiss	JJ	O
family	NN	O
;	:	O
the	DT	O
4	CD	O
affected	JJ	O
persons	NNS	O
have	VBP	O
homozygous	JJ	O
deletions	NNS	O
of	IN	O
approximately	RB	O
11	CD	O
kb	NNS	O
of	IN	O
the	DT	O
fibrinogen	NN	O
alpha	NN	O
(	(	O
FGA	NNP	O
)	)	O
gene	NN	O
.	.	O

Haplotype	NNP	O
data	NNS	O
implied	VBD	O
that	IN	O
these	DT	O
deletions	NNS	O
occurred	VBD	O
on	IN	O
distinct	JJ	O
ancestral	JJ	O
chromosomes	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
region	NN	O
may	MD	O
be	VB	O
susceptible	JJ	O
to	TO	O
deletion	NN	O
by	IN	O
a	DT	O
common	JJ	O
mechanism	NN	O
.	.	O

We	PRP	O
subsequently	RB	O
showed	VBD	O
that	IN	O
all	PDT	O
the	DT	O
deletions	NNS	O
were	VBD	O
identical	JJ	O
to	TO	O
the	DT	O
base	NN	O
pair	NN	O
and	CC	O
probably	RB	O
resulted	VBD	O
from	IN	O
a	DT	O
nonhomologous	JJ	O
recombination	NN	O
mediated	VBN	O
by	IN	O
7	CD	O
-	:	O
bp	NN	O
direct	JJ	O
repeats	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
have	VBP	O
collected	VBN	O
data	NNS	O
on	IN	O
13	CD	O
additional	JJ	O
unrelated	JJ	O
patients	NNS	O
to	TO	O
identify	VB	O
the	DT	O
causative	JJ	O
mutations	NNS	O
and	CC	O
to	TO	O
determine	VB	O
the	DT	O
prevalence	NN	O
of	IN	O
the	DT	O
11	CD	O
-	:	O
kb	NN	O
deletion	NN	O
.	.	O

A	DT	O
common	JJ	O
recurrent	NN	O
mutation	NN	O
,	,	O
at	IN	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
of	IN	O
FGA	NNP	O
intron	NN	O
4	CD	O
(	(	O
IVS4	NNP	O
+	VBZ	O
1	CD	O
G	NNP	O
>	NNP	O
T	NNP	O
)	)	O
,	,	O
accounted	VBD	O
for	IN	O
14	CD	O
of	IN	O
the	DT	O
26	CD	O
(	(	O
54	CD	O
%	NN	O
)	)	O
alleles	VBZ	O
.	.	O

One	CD	O
patient	NN	O
was	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
previously	RB	O
identified	VBN	O
deletion	NN	O
.	.	O

Three	CD	O
more	JJR	O
frameshift	NN	O
mutations	NNS	O
,	,	O
2	CD	O
nonsense	NN	O
mutations	NNS	O
,	,	O
and	CC	O
a	DT	O
second	JJ	O
splice	NN	O
site	NN	O
mutation	NN	O
were	VBD	O
also	RB	O
identified	VBN	O
.	.	O

Consequently	RB	O
,	,	O
86	CD	O
%	NN	O
of	IN	O
afibrinogenemia	NN	S_Disease
alleles	NNS	O
analyzed	VBN	O
to	TO	O
date	NN	O
have	VB	O
truncating	VBG	O
mutations	NNS	O
of	IN	O
FGA	NNP	O
,	,	O
though	IN	O
mutations	NNS	O
in	IN	O
all	DT	O
3	CD	O
fibrinogen	NN	O
genes	NNS	O
,	,	O
FGG	NNP	O
,	,	O
FGA	NNP	O
,	,	O
and	CC	O
FGB	NNP	O
,	,	O
might	MD	O
be	VB	O
predicted	VBN	O
to	TO	O
cause	VB	O
congenital	JJ	B_Disease
afibrinogenemia	NN	E_Disease
.	.	O
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
:	:	O
the	DT	O
role	NN	O
of	IN	O
the	DT	O
CUG	NNP	O
triplet	NN	O
repeats	NNS	O
in	IN	O
splicing	NN	O
of	IN	O
a	DT	O
novel	JJ	O
DMPK	NNP	O
exon	NN	O
and	CC	O
altered	VBD	O
cytoplasmic	JJ	O
DMPK	NNP	O
mRNA	NN	O
isoform	NN	O
ratios	NNS	O
.	.	O

The	DT	O
mechanism	NN	O
by	IN	O
which	WDT	O
(	(	O
CTG	NNP	O
)	)	O
n	JJ	O
expansion	NN	O
in	IN	O
the	DT	O
3	CD	O
UTR	NNP	O
of	IN	O
the	DT	O
DMPK	NNP	O
gene	NN	O
causes	VBZ	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
is	VBZ	O
unknown	JJ	O
.	.	O

We	PRP	O
identified	VBD	O
four	CD	O
RNA	NNP	O
splicing	VBG	O
factors	NNS	O
-	:	O
-	:	O
hnRNP	NN	O
C	NNP	O
,	,	O
U2AF	NNP	O
(	(	O
U2	NNP	O
auxiliary	JJ	O
factor	NN	O
)	)	O
,	,	O
PTB	NNP	O
(	(	O
polypyrimidine	JJ	O
tract	NN	O
binding	VBG	O
protein	NN	O
)	)	O
,	,	O
and	CC	O
PSF	NNP	O
(	(	O
PTB	NNP	O
associated	VBD	O
splicing	VBG	O
factor	NN	O
)	)	O
-	:	O
-	:	O
that	WDT	O
bind	VBP	O
to	TO	O
two	CD	O
short	JJ	O
regions	NNS	O
3	CD	O
of	IN	O
the	DT	O
(	(	O
CUG	NNP	O
)	)	O
n	NN	O
,	,	O
and	CC	O
found	VBD	O
a	DT	O
novel	JJ	O
3	CD	O
DMPK	NNP	O
exon	NN	O
resulting	VBG	O
in	IN	O
an	DT	O
mRNA	NN	O
lacking	VBG	O
the	DT	O
repeats	NNS	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
the	DT	O
(	(	O
CUG	NNP	O
)	)	O
n	NN	O
is	VBZ	O
an	DT	O
essential	JJ	O
cis	NN	O
acting	VBG	O
element	NN	O
for	IN	O
this	DT	O
splicing	JJ	O
event	NN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
(	(	O
CUG	NNP	O
)	)	O
n	VBP	O
containing	VBG	O
mRNAs	NN	O
,	,	O
the	DT	O
novel	JJ	O
isoform	NN	O
is	VBZ	O
not	RB	O
retained	VBN	O
in	IN	O
the	DT	O
nucleus	NN	O
in	IN	O
DM	NNP	S_Disease
cells	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
imbalances	NNS	O
in	IN	O
relative	JJ	O
levels	NNS	O
of	IN	O
cytoplasmic	JJ	O
DMPK	NNP	O
mRNA	NN	O
isoforms	NNS	O
and	CC	O
a	DT	O
new	JJ	O
dominant	JJ	O
effect	NN	O
of	IN	O
the	DT	O
mutation	NN	O
on	IN	O
DMPK	NNP	O
.	.	O
.	.	O

Expression	NN	O
and	CC	O
imprinting	NN	O
of	IN	O
MAGEL2	NNP	O
suggest	VBP	O
a	DT	O
role	NN	O
in	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
willi	NN	I_Disease
syndrome	NN	E_Disease
and	CC	O
the	DT	O
homologous	JJ	O
murine	NN	O
imprinting	VBG	O
phenotype	NN	O
.	.	O

Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
the	DT	O
loss	NN	O
of	IN	O
expression	NN	O
of	IN	O
imprinted	JJ	O
genes	NNS	O
in	IN	O
chromosome	NN	O
15q11	CD	O
-	:	O
q13	NN	O
.	.	O

Affected	JJ	O
individuals	NNS	O
exhibit	VBP	O
neonatal	JJ	B_Disease
hypotonia	NN	E_Disease
,	,	O
developmental	JJ	B_Disease
delay	NN	E_Disease
and	CC	O
childhood	NN	B_Disease
-	:	I_Disease
onset	NN	I_Disease
obesity	NN	E_Disease
.	.	O

Necdin	NNP	O
,	,	O
a	DT	O
protein	NN	O
implicated	VBN	O
in	IN	O
the	DT	O
terminal	JJ	O
differentiation	NN	O
of	IN	O
neurons	NNS	O
,	,	O
is	VBZ	O
the	DT	O
only	JJ	O
PWS	NNP	S_Disease
candidate	NN	O
gene	NN	O
to	TO	O
reduce	VB	O
viability	NN	O
when	WRB	O
disrupted	VBN	O
in	IN	O
a	DT	O
mouse	NN	O
model	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
have	VBP	O
characterized	VBN	O
MAGEL2	NNP	O
(	(	O
also	RB	O
known	VBN	O
as	IN	O
NDNL1	NNP	O
)	)	O
,	,	O
a	DT	O
gene	NN	O
with	IN	O
51	CD	O
%	NN	O
amino	NN	O
acid	JJ	O
sequence	NN	O
similarity	NN	O
to	TO	O
necdin	VB	O
and	CC	O
located	VBN	O
41	CD	O
kb	JJ	O
distal	NN	O
to	TO	O
NDN	NNP	O
in	IN	O
the	DT	O
PWS	NNP	S_Disease
deletion	NN	O
region	NN	O
.	.	O

MAGEL2	NNP	O
is	VBZ	O
expressed	VBN	O
predominantly	RB	O
in	IN	O
brain	NN	O
,	,	O
the	DT	O
primary	JJ	O
tissue	NN	O
affected	VBD	O
in	IN	O
PWS	NNP	S_Disease
and	CC	O
in	IN	O
several	JJ	O
fetal	JJ	O
tissues	NNS	O
as	IN	O
shown	VBN	O
by	IN	O
northern	JJ	O
blot	NN	O
analysis	NN	O
.	.	O

MAGEL2	NNP	O
is	VBZ	O
imprinted	VBN	O
with	IN	O
monoallelic	JJ	O
expression	NN	O
in	IN	O
control	NN	O
brain	NN	O
,	,	O
and	CC	O
paternal	JJ	O
-	:	O
only	RB	O
expression	NN	O
in	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
as	IN	O
demonstrated	VBN	O
by	IN	O
its	PRP$	O
lack	NN	O
of	IN	O
expression	NN	O
in	IN	O
brain	NN	O
from	IN	O
a	DT	O
PWS	NNP	S_Disease
-	:	O
affected	VBD	O
individual	JJ	O
.	.	O

The	DT	O
orthologous	JJ	O
mouse	NN	O
gene	NN	O
(	(	O
Magel2	NNP	O
)	)	O
is	VBZ	O
located	VBN	O
within	IN	O
150	CD	O
kb	NNS	O
of	IN	O
NDN	NNP	O
,	,	O
is	VBZ	O
imprinted	VBN	O
with	IN	O
paternal	JJ	O
-	:	O
only	JJ	O
expression	NN	O
and	CC	O
is	VBZ	O
expressed	VBN	O
predominantly	RB	O
in	IN	O
late	JJ	O
developmental	JJ	O
stages	NNS	O
and	CC	O
adult	NN	O
brain	NN	O
as	IN	O
shown	VBN	O
by	IN	O
northern	JJ	O
blotting	NN	O
,	,	O
RT	NNP	O
-	:	O
PCR	NN	O
and	CC	O
whole	JJ	O
-	:	O
mount	NN	O
RNA	NNP	O
in	IN	O
situ	JJ	O
hybridization	NN	O
.	.	O

Magel2	NNP	O
distribution	NN	O
partially	RB	O
overlaps	VBZ	O
that	IN	O
of	IN	O
NDN	NNP	O
,	,	O
with	IN	O
strong	JJ	O
expression	NN	O
being	VBG	O
detected	VBN	O
in	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
in	IN	O
mid	JJ	O
-	:	O
gestation	NN	O
mouse	IN	O
embryos	NN	O
by	IN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
.	.	O

We	PRP	O
hypothesize	VBP	O
that	IN	O
,	,	O
although	IN	O
loss	NN	O
of	IN	O
necdin	JJ	O
expression	NN	O
may	MD	O
be	VB	O
important	JJ	O
in	IN	O
the	DT	O
neonatal	JJ	O
presentation	NN	O
of	IN	O
PWS	NNP	S_Disease
,	,	O
loss	NN	O
of	IN	O
MAGEL2	NNP	O
may	MD	O
be	VB	O
critical	JJ	O
to	TO	O
abnormalities	NNS	B_Disease
in	IN	I_Disease
brain	NN	I_Disease
development	NN	E_Disease
and	CC	O
dysmorphic	JJ	B_Disease
features	NNS	E_Disease
in	IN	O
individuals	NNS	O
with	IN	O
PWS	NNP	S_Disease
.	.	O
.	.	O

Retinoschisin	NNP	O
,	,	O
the	DT	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
retinoschisis	NN	E_Disease
protein	NN	O
,	,	O
is	VBZ	O
a	DT	O
secreted	JJ	O
photoreceptor	NN	O
protein	NN	O
,	,	O
and	CC	O
is	VBZ	O
expressed	VBN	O
and	CC	O
released	VBN	O
by	IN	O
Weri	NNP	O
-	:	O
Rb1	NNP	O
cells	NNS	O
.	.	O

X	LS	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
retinoschisis	NN	E_Disease
is	VBZ	O
characterized	VBN	O
by	IN	O
microcystic	JJ	O
-	:	O
like	IN	O
changes	NNS	O
of	IN	O
the	DT	O
macular	JJ	O
region	NN	O
and	CC	O
schisis	NN	O
within	IN	O
the	DT	O
inner	JJ	O
retinal	JJ	O
layers	NNS	O
,	,	O
leading	VBG	O
to	TO	O
visual	JJ	B_Disease
deterioration	NN	E_Disease
in	IN	O
males	NNS	O
.	.	O

Many	JJ	O
missense	NN	O
and	CC	O
protein	NN	O
-	:	O
truncating	VBG	O
mutations	NNS	O
of	IN	O
the	DT	O
causative	JJ	O
gene	NN	O
RS1	NNP	O
have	VBP	O
now	RB	O
been	VBN	O
identified	VBN	O
and	CC	O
are	VBP	O
thought	VBN	O
to	TO	O
be	VB	O
inactivating	VBG	O
.	.	O

RS1	NNP	O
encodes	VBZ	O
a	DT	O
224	CD	O
amino	NN	O
acid	NN	O
protein	NN	O
,	,	O
retinoschisin	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
a	DT	O
discoidin	NN	O
domain	NN	O
but	CC	O
is	VBZ	O
of	IN	O
unknown	JJ	O
function	NN	O
.	.	O

We	PRP	O
have	VBP	O
generated	VBN	O
a	DT	O
polyclonal	JJ	O
antibody	NN	O
against	IN	O
a	DT	O
peptide	NN	O
from	IN	O
a	DT	O
unique	JJ	O
region	NN	O
within	IN	O
retinoschisin	NN	O
,	,	O
which	WDT	O
detects	VBZ	O
a	DT	O
protein	NN	O
of	IN	O
approximately	RB	O
28	CD	O
kDa	NNS	O
in	IN	O
retinal	JJ	O
samples	NNS	O
reduced	VBN	O
with	IN	O
dithiothreitol	NN	O
,	,	O
but	CC	O
multimers	NNS	O
sized	VBD	O
>	RB	O
40	CD	O
kDa	NNS	O
under	IN	O
non	JJ	O
-	:	O
reducing	VBG	O
conditions	NNS	O
.	.	O

A	DT	O
screen	NN	O
of	IN	O
human	JJ	O
tissues	NNS	O
with	IN	O
this	DT	O
antibody	NN	O
reveals	VBZ	O
retinoschisin	NN	O
to	TO	O
be	VB	O
retina	VBN	O
specific	JJ	O
and	CC	O
the	DT	O
antibody	NN	O
detects	VBZ	O
a	DT	O
protein	NN	O
of	IN	O
similar	JJ	O
size	NN	O
in	IN	O
bovine	NN	O
and	CC	O
murine	NN	O
retinae	NN	O
.	.	O

We	PRP	O
investigated	VBD	O
the	DT	O
expression	NN	O
pattern	NN	O
in	IN	O
the	DT	O
retina	NN	O
of	IN	O
both	DT	O
RS1	NNP	O
mRNA	NN	O
(	(	O
using	VBG	O
in	IN	O
situ	JJ	O
hybridization	NN	O
with	IN	O
riboprobes	NNS	O
)	)	O
and	CC	O
retinoschisin	NN	O
(	(	O
using	VBG	O
immunohistochemistry	NN	O
)	)	O
.	.	O

The	DT	O
antisense	NN	O
riboprobe	NN	O
detected	VBD	O
RS1	NNP	O
mRNA	MD	O
only	RB	O
in	IN	O
the	DT	O
photoreceptor	NN	O
layer	NN	O
but	CC	O
the	DT	O
protein	JJ	O
product	NN	O
of	IN	O
the	DT	O
gene	NN	O
was	VBD	O
present	JJ	O
both	DT	O
in	IN	O
the	DT	O
photoreceptors	NNS	O
and	CC	O
within	IN	O
the	DT	O
inner	JJ	O
portions	NNS	O
of	IN	O
the	DT	O
retina	NN	O
.	.	O

Furthermore	RB	O
,	,	O
differentiated	VBD	O
retinoblastoma	NN	S_Disease
cells	NNS	O
(	(	O
Weri	NNP	O
-	:	O
Rb1	NNP	O
cells	NNS	O
)	)	O
were	VBD	O
found	VBN	O
to	TO	O
express	VB	O
RS1	NNP	O
mRNA	NN	O
and	CC	O
to	TO	O
release	VB	O
retinoschisin	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
retinoschisin	NN	O
is	VBZ	O
released	VBN	O
by	IN	O
photo	NN	O
-	:	O
receptors	NNS	O
and	CC	O
has	VBZ	O
functions	NNS	O
within	IN	O
the	DT	O
inner	JJ	O
retinal	JJ	O
layers	NNS	O
.	.	O

Thus	RB	O
,	,	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
retinoschisis	NN	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
abnormalities	NNS	O
in	IN	O
a	DT	O
putative	JJ	O
secreted	JJ	O
photoreceptor	NN	O
protein	NN	O
and	CC	O
is	VBZ	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
a	DT	O
secreted	JJ	O
photo	NN	O
-	:	O
receptor	NN	O
protein	NN	O
associated	VBN	O
with	IN	O
a	DT	O
retinal	JJ	B_Disease
dystrophy	NN	E_Disease
.	.	O
.	.	O

Study	NN	O
of	IN	O
the	DT	O
voltage	NN	O
-	:	O
gated	JJ	O
sodium	NN	O
channel	NN	O
beta	NN	O
1	CD	O
subunit	NN	O
gene	NN	O
(	(	O
SCN1B	NNP	O
)	)	O
in	IN	O
the	DT	O
benign	JJ	B_Disease
familial	JJ	I_Disease
infantile	NN	I_Disease
convulsions	NNS	I_Disease
syndrome	VBP	E_Disease
(	(	O
BFIC	NNP	S_Disease
)	)	O
.	.	O

Benign	NNP	B_Disease
familial	JJ	I_Disease
infantile	NN	I_Disease
convulsions	NNS	E_Disease
(	(	O
BFIC	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
rare	JJ	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
epilepsy	NN	I_Disease
syndrome	NN	E_Disease
.	.	O

This	DT	O
syndrome	NN	O
has	VBZ	O
been	VBN	O
recently	RB	O
described	VBN	O
in	IN	O
Italian	JJ	O
and	CC	O
French	JJ	O
pedigrees	NNS	O
.	.	O

Patients	NNS	O
present	JJ	O
with	IN	O
partial	JJ	O
,	,	O
then	RB	O
generalized	VBD	O
seizures	NNS	O
,	,	O
with	IN	O
onset	VBN	O
at	IN	O
age	NN	O
three	CD	O
months	NNS	O
.	.	O

The	DT	O
seizures	NNS	O
usually	RB	O
spontaneously	RB	O
cease	NN	O
after	IN	O
one	CD	O
year	NN	O
without	IN	O
treatment	NN	O
,	,	O
leaving	VBG	O
no	DT	O
neurological	JJ	B_Disease
abnormalities	NNS	E_Disease
.	.	O

We	PRP	O
have	VBP	O
mapped	VBN	O
BFIC	NNP	S_Disease
to	TO	O
chromosome	VB	O
19q	CD	O
in	IN	O
five	CD	O
Italian	JJ	O
pedigrees	NNS	O
.	.	O

The	DT	O
sodium	NN	O
channel	NN	O
beta1	NN	O
subunit	NN	O
gene	NN	O
(	(	O
SCN1B	NNP	O
)	)	O
maps	VBZ	O
to	TO	O
this	DT	O
candidate	NN	O
region	NN	O
and	CC	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
involved	VBN	O
in	IN	O
one	CD	O
Australian	JJ	O
pedigree	NN	O
with	IN	O
generalized	JJ	B_Disease
epilepsy	NN	I_Disease
and	CC	I_Disease
febrile	NN	I_Disease
seizures	NNS	I_Disease
"	VBP	I_Disease
plus	CC	I_Disease
"	NNP	E_Disease
(	(	O
GEFS	NNP	O
+	NNP	O
)	)	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
,	,	O
a	DT	O
missense	JJ	O
mutation	NN	O
in	IN	O
SCN1B	NNP	O
cosegregates	NNS	O
with	IN	O
the	DT	O
GEFS	NNP	O
+	NNP	O
phenotype	NN	O
.	.	O

BFIC	NNP	S_Disease
and	CC	O
GEFS	NNP	O
+	NNP	O
have	VBP	O
clinical	JJ	O
features	NNS	O
in	IN	O
common	JJ	O
,	,	O
therefore	RB	O
SCN1B	NNP	O
is	VBZ	O
a	DT	O
candidate	JJ	O
gene	NN	O
for	IN	O
BFIC	NNP	S_Disease
.	.	O

We	PRP	O
studied	VBD	O
SCN1B	NNP	O
exons	NNS	O
1	CD	O
,	,	O
2	CD	O
,	,	O
3	CD	O
,	,	O
4	CD	O
,	,	O
and	CC	O
5	CD	O
,	,	O
using	VBG	O
four	CD	O
SSCP	NNP	O
methods	NNS	O
in	IN	O
10	CD	O
Caucasian	JJ	O
BFIC	NNP	S_Disease
probands	NNS	O
of	IN	O
Western	NNP	O
Europe	NNP	O
.	.	O

We	PRP	O
found	VBD	O
no	DT	O
exon	JJ	O
variants	NNS	O
.	.	O

One	CD	O
variant	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
intron	NN	O
5	CD	O
(	(	O
IVS5	NNP	O
-	:	O
10C	CD	O
>	NNP	O
G	NNP	O
)	)	O
,	,	O
which	WDT	O
did	VBD	O
not	RB	O
segregate	VB	O
with	IN	O
BFIC	NNP	S_Disease
and	CC	O
was	VBD	O
observed	VBN	O
in	IN	O
9	CD	O
.	.	O

2	CD	O
%	NN	O
controls	NNS	O
.	.	O

A	DT	O
second	JJ	O
variant	NN	O
in	IN	O
intron	NN	O
5	CD	O
was	VBD	O
identified	VBN	O
(	(	O
IVS5	NNP	O
+	VBZ	O
30G	CD	O
>	IN	O
A	DT	O
)	)	O
.	.	O

It	PRP	O
was	VBD	O
rare	JJ	O
,	,	O
as	IN	O
not	RB	O
observed	VBN	O
in	IN	O
controls	NNS	O
,	,	O
but	CC	O
not	RB	O
segregating	VBG	O
with	IN	O
the	DT	O
BFIC	NNP	S_Disease
phenotype	NN	O
.	.	O

Inactivation	NN	O
of	IN	O
germline	NN	O
mutant	NN	O
APC	NNP	S_Disease
alleles	NNS	O
by	IN	O
attenuated	JJ	O
somatic	JJ	O
mutations	NNS	O
:	:	O
a	DT	O
molecular	JJ	O
genetic	JJ	O
mechanism	NN	O
for	IN	O
attenuated	JJ	B_Disease
familial	JJ	I_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
.	.	O

Germline	NNP	O
mutations	NNS	O
of	IN	O
the	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	I_Disease
(	(	I_Disease
APC	NNP	I_Disease
)	)	I_Disease
tumor	NN	E_Disease
-	:	O
suppressor	NN	O
gene	NN	O
result	NN	O
in	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
.	.	O

Patients	NNS	O
with	IN	O
FAP	NNP	S_Disease
typically	RB	O
develop	VB	O
hundreds	NNS	O
to	TO	O
thousands	NNS	O
of	IN	O
benign	JJ	B_Disease
colorectal	JJ	I_Disease
tumors	NNS	E_Disease
and	CC	O
early	JJ	O
-	:	O
onset	NN	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

A	DT	O
subset	NN	O
of	IN	O
germline	NN	O
APC	NNP	S_Disease
mutations	NNS	O
results	NNS	O
in	IN	O
an	DT	O
attenuated	JJ	B_Disease
FAP	NNP	E_Disease
(	(	O
AFAP	NNP	S_Disease
)	)	O
phenotype	NN	O
,	,	O
in	IN	O
which	WDT	O
patients	NNS	O
develop	VB	O
fewer	JJR	O
tumors	NNS	S_Disease
and	CC	O
develop	VB	O
them	PRP	O
at	IN	O
an	DT	O
older	JJR	O
age	NN	O
.	.	O

Although	IN	O
a	DT	O
genotype	JJ	O
-	:	O
phenotype	NN	O
correlation	NN	O
between	IN	O
the	DT	O
locations	NNS	O
of	IN	O
APC	NNP	S_Disease
germline	NN	O
mutations	NNS	O
and	CC	O
the	DT	O
development	NN	O
of	IN	O
AFAP	NNP	S_Disease
has	VBZ	O
been	VBN	O
well	RB	O
documented	VBN	O
,	,	O
the	DT	O
mechanism	NN	O
for	IN	O
AFAP	NNP	S_Disease
has	VBZ	O
not	RB	O
been	VBN	O
well	RB	O
defined	VBN	O
.	.	O

We	PRP	O
investigated	VBD	O
the	DT	O
mechanism	NN	O
for	IN	O
AFAP	NNP	S_Disease
in	IN	O
patients	NNS	O
carrying	VBG	O
a	DT	O
mutant	JJ	O
APC	NNP	S_Disease
allele	NN	O
(	(	O
APC	NNP	O
(	(	O
AS9	NNP	O
)	)	O
)	)	O
that	WDT	O
has	VBZ	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
alternatively	RB	O
spliced	JJ	O
region	NN	O
of	IN	O
exon	$	O
9	CD	O
.	.	O

APC	NNP	O
(	(	O
AS9	NNP	O
)	)	O
was	VBD	O
found	VBN	O
to	TO	O
down	VB	O
-	:	O
regulate	NN	O
beta	SYM	O
-	:	O
catenin	NN	O
-	:	O
regulated	VBN	O
transcription	NN	O
,	,	O
the	DT	O
major	JJ	O
tumor	NN	S_Disease
-	:	O
suppressor	NN	O
function	NN	O
of	IN	O
APC	NNP	O
,	,	O
as	IN	O
did	VBD	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
APC	NNP	O
.	.	O

Mutation	NN	O
analysis	NN	O
showed	VBD	O
that	IN	O
both	DT	O
APC	NNP	O
(	(	O
AS9	NNP	O
)	)	O
and	CC	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
APC	NNP	S_Disease
alleles	NNS	O
were	VBD	O
somatically	RB	O
mutated	VBN	O
in	IN	O
most	JJS	O
colorectal	JJ	B_Disease
tumors	NNS	E_Disease
from	IN	O
these	DT	O
patients	NNS	O
.	.	O

Functional	JJ	O
analysis	NN	O
showed	VBD	O
that	IN	O
4666insA	CD	O
,	,	O
a	DT	O
common	JJ	O
somatic	JJ	O
mutation	NN	O
in	IN	O
APC	NNP	O
(	(	O
AS9	NNP	O
)	)	O
in	IN	O
these	DT	O
tumors	NNS	S_Disease
,	,	O
did	VBD	O
not	RB	O
inactivate	VB	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
APC	NNP	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
carriers	NNS	O
of	IN	O
APC	NNP	O
(	(	O
AS9	NNP	O
)	)	O
develop	VB	O
fewer	JJR	O
colorectal	NN	B_Disease
tumors	NNS	E_Disease
than	IN	O
do	VBP	O
typical	JJ	O
patients	NNS	O
with	IN	O
FAP	NNP	S_Disease
because	IN	O
somatic	JJ	O
inactivation	NN	O
of	IN	O
both	DT	O
APC	NNP	S_Disease
alleles	NNS	O
is	VBZ	O
necessary	JJ	O
for	IN	O
colorectal	JJ	O
tumorigenesis	NN	O
.	.	O

However	RB	O
,	,	O
these	DT	O
patients	NNS	O
develop	VBP	O
colorectal	JJ	B_Disease
tumors	NNS	E_Disease
more	RBR	O
frequently	RB	O
than	IN	O
does	VBZ	O
the	DT	O
general	JJ	O
population	NN	O
because	IN	O
APC	NNP	O
(	(	O
AS9	NNP	O
)	)	O
is	VBZ	O
inactivated	VBN	O
by	IN	O
mutations	NNS	O
that	WDT	O
do	VBP	O
not	RB	O
inactivate	VB	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
APC	NNP	O
.	.	O
.	.	O

Iron	NNP	O
-	:	O
dependent	NN	O
self	PRP	O
-	:	O
assembly	NN	O
of	IN	O
recombinant	JJ	O
yeast	NN	O
frataxin	NN	O
:	:	O
implications	NNS	O
for	IN	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
.	.	O

Frataxin	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
the	DT	O
primary	JJ	O
cause	NN	O
of	IN	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
(	(	O
FRDA	NNP	S_Disease
)	)	O
,	,	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
cardiodegenerative	NN	I_Disease
and	CC	I_Disease
neurodegenerative	JJ	I_Disease
disease	NN	E_Disease
.	.	O

Frataxin	NNP	O
is	VBZ	O
a	DT	O
nuclear	JJ	O
-	:	O
encoded	VBN	O
mitochondrial	JJ	O
protein	NN	O
that	WDT	O
is	VBZ	O
widely	RB	O
conserved	VBN	O
among	IN	O
eukaryotes	NNS	O
.	.	O

Genetic	JJ	O
inactivation	NN	O
of	IN	O
the	DT	O
yeast	NN	O
frataxin	NN	O
homologue	NN	O
(	(	O
Yfh1p	NNP	O
)	)	O
results	NNS	O
in	IN	O
mitochondrial	JJ	B_Disease
iron	NN	I_Disease
accumulation	NN	E_Disease
and	CC	O
hypersensitivity	NN	B_Disease
to	TO	I_Disease
oxidative	JJ	I_Disease
stress	NN	E_Disease
.	.	O

Increased	VBN	O
iron	NN	O
deposition	NN	O
and	CC	O
evidence	NN	O
of	IN	O
oxidative	JJ	O
damage	NN	O
have	VBP	O
also	RB	O
been	VBN	O
observed	VBN	O
in	IN	O
cardiac	JJ	O
tissue	NN	O
and	CC	O
cultured	JJ	O
fibroblasts	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
FRDA	NNP	S_Disease
.	.	O

These	DT	O
findings	NNS	O
indicate	VBP	O
that	IN	O
frataxin	NN	O
is	VBZ	O
essential	JJ	O
for	IN	O
mitochondrial	JJ	O
iron	NN	O
homeostasis	NN	O
and	CC	O
protection	NN	O
from	IN	O
iron	NN	O
-	:	O
induced	JJ	O
formation	NN	O
of	IN	O
free	JJ	O
radicals	NNS	O
.	.	O

The	DT	O
functional	JJ	O
mechanism	NN	O
of	IN	O
frataxin	NN	O
,	,	O
however	RB	O
,	,	O
is	VBZ	O
still	RB	O
unknown	JJ	O
.	.	O

We	PRP	O
have	VBP	O
expressed	VBN	O
the	DT	O
mature	NN	O
form	NN	O
of	IN	O
Yfh1p	NNP	O
(	(	O
mYfh1p	NN	O
)	)	O
in	IN	O
Escherichia	NNP	O
coli	NN	O
and	CC	O
have	VB	O
analyzed	VBN	O
its	PRP$	O
function	NN	O
in	IN	O
vitro	NN	O
.	.	O

Isolated	VBN	O
mYfh1p	NN	O
is	VBZ	O
a	DT	O
soluble	JJ	O
monomer	NN	O
(	(	O
13	CD	O
,	,	O
783	CD	O
Da	NNP	O
)	)	O
that	WDT	O
contains	VBZ	O
no	DT	O
iron	NN	O
and	CC	O
shows	VBZ	O
no	DT	O
significant	JJ	O
tendency	NN	O
to	TO	O
self	VB	O
-	:	O
associate	NN	O
.	.	O

Aerobic	NNP	O
addition	NN	O
of	IN	O
ferrous	JJ	O
iron	NN	O
to	TO	O
mYfh1p	VB	O
results	NNS	O
in	IN	O
assembly	NN	O
of	IN	O
regular	JJ	O
spherical	JJ	O
multimers	NNS	O
with	IN	O
a	DT	O
molecular	JJ	O
mass	NN	O
of	IN	O
approximately	RB	O
1	CD	O
.	.	O

1	CD	O
MDa	NNP	O
(	(	O
megadaltons	NNS	O
)	)	O
and	CC	O
a	DT	O
diameter	NN	O
of	IN	O
13	CD	O
+	NNS	O
/	SYM	O
-	:	O
2	CD	O
nm	NN	O
.	.	O

Each	DT	O
multimer	NN	O
consists	VBZ	O
of	IN	O
approximately	RB	O
60	CD	O
subunits	NNS	O
and	CC	O
can	MD	O
sequester	VB	O
>	JJ	O
3	CD	O
,	,	O
000	CD	O
atoms	NNS	O
of	IN	O
iron	NN	O
.	.	O

Titration	NN	O
of	IN	O
mYfh1p	NN	O
with	IN	O
increasing	VBG	O
iron	NN	O
concentrations	NNS	O
supports	VBZ	O
a	DT	O
stepwise	NN	O
mechanism	NN	O
of	IN	O
multimer	NN	O
assembly	NN	O
.	.	O

Sequential	JJ	O
addition	NN	O
of	IN	O
an	DT	O
iron	NN	O
chelator	NN	O
and	CC	O
a	DT	O
reducing	VBG	O
agent	NN	O
results	NNS	O
in	IN	O
quantitative	JJ	O
iron	NN	O
release	NN	O
with	IN	O
concomitant	JJ	O
disassembly	NN	O
of	IN	O
the	DT	O
multimer	NN	O
,	,	O
indicating	VBG	O
that	IN	O
mYfh1p	NN	O
sequesters	NNS	O
iron	VBP	O
in	IN	O
an	DT	O
available	JJ	O
form	NN	O
.	.	O

In	IN	O
yeast	NN	O
mitochondria	NN	O
,	,	O
native	JJ	O
mYfh1p	NN	O
exists	VBZ	O
as	IN	O
monomer	NN	O
and	CC	O
a	DT	O
higher	JJR	O
-	:	O
order	NN	O
species	NNS	O
with	IN	O
a	DT	O
molecular	JJ	O
weight	NN	O
>	NN	O
600	CD	O
,	,	O
000	CD	O
.	.	O

After	IN	O
addition	NN	O
of	IN	O
(	(	O
55	CD	O
)	)	O
Fe	NNP	O
to	TO	O
the	DT	O
medium	NN	O
,	,	O
immunoprecipitates	NNS	O
of	IN	O
this	DT	O
species	NNS	O
contain	VBP	O
>	JJ	O
16	CD	O
atoms	NNS	O
of	IN	O
(	(	O
55	CD	O
)	)	O
Fe	NNP	O
per	IN	O
molecule	NN	O
of	IN	O
mYfh1p	NN	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
iron	NN	O
-	:	O
dependent	NN	O
self	PRP	O
-	:	O
assembly	NN	O
of	IN	O
recombinant	JJ	O
mYfh1p	NN	O
reflects	VBZ	O
a	DT	O
physiological	JJ	O
role	NN	O
for	IN	O
frataxin	NN	O
in	IN	O
mitochondrial	JJ	O
iron	NN	O
sequestration	NN	O
and	CC	O
bioavailability	NN	O
.	.	O
.	.	O

A	DT	O
mutation	NN	O
in	IN	O
the	DT	O
pleckstrin	NN	O
homology	NN	O
(	(	O
PH	NNP	O
)	)	O
domain	NN	O
of	IN	O
the	DT	O
FGD1	NNP	O
gene	NN	O
in	IN	O
an	DT	O
Italian	JJ	O
family	NN	O
with	IN	O
faciogenital	JJ	B_Disease
dysplasia	NN	E_Disease
(	(	O
Aarskog	NNP	B_Disease
-	:	I_Disease
Scott	NNP	I_Disease
syndrome	NN	E_Disease
)	)	O
.	.	O

Aarskog	NNP	B_Disease
-	:	I_Disease
Scott	NNP	I_Disease
Syndrome	NNP	E_Disease
(	(	O
AAS	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
disorder	NN	E_Disease
characterised	VBN	O
by	IN	O
short	JJ	B_Disease
stature	NN	E_Disease
and	CC	O
multiple	JJ	O
facial	NN	B_Disease
,	,	I_Disease
limb	NN	I_Disease
and	CC	I_Disease
genital	JJ	I_Disease
abnormalities	NNS	E_Disease
.	.	O

A	DT	O
gene	NN	O
,	,	O
FGD1	NNP	O
,	,	O
altered	VBD	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
AAS	NNP	S_Disease
phenotype	NN	O
,	,	O
has	VBZ	O
been	VBN	O
identified	VBN	O
and	CC	O
found	VBN	O
to	TO	O
encode	VB	O
a	DT	O
protein	NN	O
with	IN	O
homology	NN	O
to	TO	O
Rho	NNP	O
/	NNP	O
Rac	NNP	O
guanine	NNP	O
nucleotide	IN	O
exchange	NN	O
factors	NNS	O
(	(	O
Rho	NNP	O
/	NNP	O
Rac	NNP	O
GEF	NNP	O
)	)	O
.	.	O

However	RB	O
,	,	O
since	IN	O
this	DT	O
original	JJ	O
report	NN	O
on	IN	O
identification	NN	O
of	IN	O
a	DT	O
mutated	VBN	O
FGD1	NNP	O
gene	NN	O
in	IN	O
an	DT	O
AAS	NNP	S_Disease
patient	NN	O
,	,	O
no	DT	O
additional	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
FGD1	NNP	O
gene	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
.	.	O

We	PRP	O
analysed	VBD	O
13	CD	O
independent	JJ	O
patients	NNS	O
with	IN	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
AAS	NNP	S_Disease
.	.	O

One	CD	O
patient	NN	O
presented	VBD	O
a	DT	O
mutation	NN	O
that	WDT	O
results	NNS	O
in	IN	O
a	DT	O
nucleotide	JJ	O
change	NN	O
in	IN	O
exon	JJ	O
10	CD	O
of	IN	O
the	DT	O
FGD1	NNP	O
gene	NN	O
(	(	O
G2559	NNP	O
>	NNP	O
A	NNP	O
)	)	O
substituting	VBG	O
a	DT	O
Gln	NNP	O
for	IN	O
Arg	NNP	O
in	IN	O
position	NN	O
610	CD	O
.	.	O

The	DT	O
mutation	NN	O
was	VBD	O
found	VBN	O
to	TO	O
segregate	VB	O
with	IN	O
the	DT	O
AAS	NNP	S_Disease
phenotype	NN	O
in	IN	O
affected	JJ	O
males	NNS	O
and	CC	O
carrier	NN	O
females	NNS	O
in	IN	O
the	DT	O
family	NN	O
of	IN	O
this	DT	O
patient	NN	O
.	.	O

Interestingly	RB	O
,	,	O
Arg	NNP	O
-	:	O
610	CD	O
is	VBZ	O
located	VBN	O
within	IN	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
pleckstrin	NN	O
homology	NN	O
(	(	O
PH	NNP	O
)	)	O
domains	VBZ	O
of	IN	O
the	DT	O
FGD1	NNP	O
gene	NN	O
and	CC	O
it	PRP	O
corresponds	VBZ	O
to	TO	O
a	DT	O
highly	RB	O
conserved	VBN	O
residue	NN	O
which	WDT	O
has	VBZ	O
been	VBN	O
involved	VBN	O
in	IN	O
InsP	NNP	O
binding	NN	O
in	IN	O
PH	NNP	O
domains	NNS	O
of	IN	O
other	JJ	O
proteins	NNS	O
.	.	O

The	DT	O
same	JJ	O
residue	NN	O
is	VBZ	O
often	RB	O
mutated	VBN	O
in	IN	O
the	DT	O
Brutons	NNP	O
tyrosine	NN	O
kinase	NN	O
(	(	O
Btk	NNP	O
)	)	O
gene	NN	O
in	IN	O
patients	NNS	O
with	IN	O
an	DT	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
agammaglobulinemia	NN	E_Disease
.	.	O

The	DT	O
Arg610Gln	NNP	O
mutation	NN	O
represents	VBZ	O
the	DT	O
first	JJ	O
case	NN	O
of	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
PH	NNP	O
domain	NN	O
of	IN	O
the	DT	O
FGD1	NNP	O
gene	NN	O
and	CC	O
additional	JJ	O
evidence	NN	O
that	IN	O
mutations	NNS	O
in	IN	O
PH	NNP	O
domains	NNS	O
can	MD	O
be	VB	O
associated	VBN	O
to	TO	O
human	JJ	O
diseases	NNS	O
.	.	O
.	.	O

Amino	NNP	O
-	:	O
terminal	JJ	O
fragments	NNS	O
of	IN	O
mutant	JJ	O
huntingtin	NN	O
show	NN	O
selective	JJ	O
accumulation	NN	O
in	IN	O
striatal	JJ	O
neurons	NNS	O
and	CC	O
synaptic	JJ	O
toxicity	NN	O
.	.	O

Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
expansion	NN	O
of	IN	O
a	DT	O
glutamine	JJ	O
repeat	NN	O
in	IN	O
the	DT	O
amino	NN	O
-	:	O
terminal	JJ	O
region	NN	O
of	IN	O
huntingtin	NN	O
.	.	O

Despite	IN	O
its	PRP$	O
widespread	JJ	O
expression	NN	O
,	,	O
mutant	JJ	O
huntingtin	NN	O
induces	NNS	O
selective	JJ	O
neuronal	JJ	O
loss	NN	O
in	IN	O
striatal	JJ	O
neurons	NNS	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	DT	O
,	,	O
in	IN	O
mutant	JJ	O
mice	NN	O
expressing	VBG	O
HD	NNP	S_Disease
repeats	NNS	O
,	,	O
the	DT	O
production	NN	O
and	CC	O
aggregation	NN	O
of	IN	O
N	NNP	O
-	:	O
terminal	NN	O
huntingtin	NN	O
fragments	NNS	O
preferentially	RB	O
occur	VBP	O
in	IN	O
HD	NNP	S_Disease
-	:	O
affected	JJ	O
neurons	NNS	O
and	CC	O
their	PRP$	O
processes	NNS	O
and	CC	O
axonal	JJ	O
terminals	NNS	O
.	.	O

N	NNP	O
-	:	O
terminal	JJ	O
fragments	NNS	O
of	IN	O
mutant	JJ	O
huntingtin	NN	O
form	NN	O
aggregates	NNS	O
and	CC	O
induce	VB	O
neuritic	JJ	B_Disease
degeneration	NN	E_Disease
in	IN	O
cultured	JJ	O
striatal	JJ	O
neurons	NNS	O
.	.	O

N	NNP	O
-	:	O
terminal	NN	O
mutant	NN	O
huntingtin	NN	O
also	RB	O
binds	VBZ	O
to	TO	O
synaptic	JJ	O
vesicles	NNS	O
and	CC	O
inhibits	NNS	O
their	PRP$	O
glutamate	JJ	O
uptake	NN	O
in	IN	O
vitro	NN	O
.	.	O

The	DT	O
specific	JJ	O
processing	NN	O
and	CC	O
accumulation	NN	O
of	IN	O
toxic	JJ	O
fragments	NNS	O
of	IN	O
N	NNP	O
-	:	O
terminal	NN	O
huntingtin	NN	O
in	IN	O
HD	NNP	S_Disease
-	:	O
affected	VBD	O
striatal	JJ	O
neurons	NNS	O
,	,	O
especially	RB	O
in	IN	O
their	PRP$	O
neuronal	JJ	O
processes	NNS	O
and	CC	O
axonal	JJ	O
terminals	NNS	O
,	,	O
may	MD	O
contribute	VB	O
to	TO	O
the	DT	O
selective	JJ	O
neuropathology	NN	O
of	IN	O
HD	NNP	S_Disease
.	.	O
.	.	O

BRCA1	NNP	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
human	JJ	O
SWI	NNP	O
/	NNP	O
SNF	NNP	O
-	:	O
related	VBN	O
complex	JJ	O
:	:	O
linking	VBG	O
chromatin	NN	O
remodeling	VBG	O
to	TO	O
breast	VB	B_Disease
cancer	NN	E_Disease
.	.	O

Germline	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
tumor	NN	S_Disease
suppressor	NN	O
gene	NN	O
,	,	O
BRCA1	NNP	O
,	,	O
predispose	JJ	O
individuals	NNS	O
to	TO	O
breast	VB	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
.	.	O

Using	VBG	O
a	DT	O
combination	NN	O
of	IN	O
affinity	NN	O
-	:	O
and	CC	O
conventional	JJ	O
chromatographic	JJ	O
techniques	NNS	O
,	,	O
we	PRP	O
have	VBP	O
isolated	VBN	O
a	DT	O
predominant	JJ	O
form	NN	O
of	IN	O
a	DT	O
multiprotein	NN	O
BRCA1	NNP	O
-	:	O
containing	VBG	O
complex	JJ	O
from	IN	O
human	JJ	O
cells	NNS	O
displaying	VBG	O
chromatin	NN	O
-	:	O
remodeling	NN	O
activity	NN	O
.	.	O

Mass	NNP	O
spectrometric	JJ	O
sequencing	NN	O
of	IN	O
components	NNS	O
of	IN	O
this	DT	O
complex	JJ	O
indicated	VBD	O
that	IN	O
BRCA1	NNP	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
SWI	NNP	O
/	NNP	O
SNF	NNP	O
-	:	O
related	VBN	O
complex	JJ	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
BRCA1	NNP	O
can	MD	O
directly	RB	O
interact	VB	O
with	IN	O
the	DT	O
BRG1	NNP	O
subunit	NN	O
of	IN	O
the	DT	O
SWI	NNP	O
/	NNP	O
SNF	NNP	O
complex	NN	O
.	.	O

Moreover	RB	O
,	,	O
p53	SYM	O
-	:	O
mediated	JJ	O
stimulation	NN	O
of	IN	O
transcription	NN	O
by	IN	O
BRCA1	NNP	O
was	VBD	O
completely	RB	O
abrogated	VBN	O
by	IN	O
either	CC	O
a	DT	O
dominant	JJ	O
-	:	O
negative	JJ	O
mutant	NN	O
of	IN	O
BRG1	NNP	O
or	CC	O
the	DT	O
cancer	NN	S_Disease
-	:	O
causing	VBG	O
deletion	NN	O
in	IN	O
exon	JJ	O
11	CD	O
of	IN	O
BRCA1	NNP	O
.	.	O

These	DT	O
findings	NNS	O
reveal	VBP	O
a	DT	O
direct	JJ	O
function	NN	O
for	IN	O
BRCA1	NNP	O
in	IN	O
transcriptional	JJ	O
control	NN	O
through	IN	O
modulation	NN	O
of	IN	O
chromatin	NN	O
structure	NN	O
.	.	O
.	.	O

Asef	NNP	O
,	,	O
a	DT	O
link	NN	O
between	IN	O
the	DT	O
tumor	NN	S_Disease
suppressor	NN	O
APC	NNP	O
and	CC	O
G	NNP	O
-	:	O
protein	NN	O
signaling	NN	O
.	.	O

The	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NNS	E_Disease
gene	NN	O
(	(	O
APC	NNP	O
)	)	O
is	VBZ	O
mutated	VBN	O
in	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
and	CC	O
in	IN	O
sporadic	JJ	O
colorectal	JJ	B_Disease
tumors	NNS	E_Disease
.	.	O

Here	RB	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
product	NN	O
is	VBZ	O
shown	VBN	O
to	TO	O
bind	VB	O
through	IN	O
its	PRP$	O
armadillo	JJ	O
repeat	NN	O
domain	NN	O
to	TO	O
a	DT	O
Rac	NNP	O
-	:	O
specific	JJ	O
guanine	NN	O
nucleotide	JJ	O
exchange	NN	O
factor	NN	O
(	(	O
GEF	NNP	O
)	)	O
,	,	O
termed	VBD	O
Asef	NNP	O
.	.	O

Endogenous	JJ	O
APC	NNP	O
colocalized	VBD	O
with	IN	O
Asef	NNP	O
in	IN	O
mouse	NN	O
colon	NN	O
epithelial	JJ	O
cells	NNS	O
and	CC	O
neuronal	JJ	O
cells	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
APC	NNP	O
enhanced	VBD	O
the	DT	O
GEF	NNP	O
activity	NN	O
of	IN	O
Asef	NNP	O
and	CC	O
stimulated	VBD	O
Asef	NNP	O
-	:	O
mediated	VBN	O
cell	NN	O
flattening	NN	O
,	,	O
membrane	NN	O
ruffling	NN	O
,	,	O
and	CC	O
lamellipodia	JJS	O
formation	NN	O
in	IN	O
MDCK	NNP	O
cells	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
APC	NNP	O
-	:	O
Asef	NNP	O
complex	NN	O
may	MD	O
regulate	VB	O
the	DT	O
actin	NN	O
cytoskeletal	JJ	O
network	NN	O
,	,	O
cell	NN	O
morphology	NN	O
and	CC	O
migration	NN	O
,	,	O
and	CC	O
neuronal	JJ	O
function	NN	O
.	.	O
.	.	O

Function	NN	O
of	IN	O
an	DT	O
axonal	JJ	O
chemoattractant	NN	O
modulated	VBN	O
by	IN	O
metalloprotease	NN	O
activity	NN	O
.	.	O

The	DT	O
axonal	JJ	O
chemoattractant	NN	O
netrin	SYM	O
-	:	O
1	CD	O
guides	NNS	O
spinal	JJ	O
commissural	JJ	O
axons	NNS	O
by	IN	O
activating	VBG	O
its	PRP$	O
receptor	NN	O
DCC	NNP	O
(	(	O
Deleted	VBN	O
in	IN	O
Colorectal	NNP	B_Disease
Cancer	NNP	E_Disease
)	)	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
chemical	JJ	O
inhibitors	NNS	O
of	IN	O
metalloproteases	NNS	O
potentiate	VBP	O
netrin	JJ	O
-	:	O
mediated	VBN	O
axon	JJ	O
outgrowth	NN	O
in	IN	O
vitro	NN	O
.	.	O

We	PRP	O
have	VBP	O
also	RB	O
found	VBN	O
that	IN	O
DCC	NNP	O
is	VBZ	O
a	DT	O
substrate	NN	O
for	IN	O
metalloprotease	NN	O
-	:	O
dependent	NN	O
ectodomain	NN	O
shedding	NN	O
,	,	O
and	CC	O
that	IN	O
the	DT	O
inhibitors	NNS	O
block	VBP	O
proteolytic	JJ	O
processing	NN	O
of	IN	O
DCC	NNP	O
and	CC	O
cause	VB	O
an	DT	O
increase	NN	O
in	IN	O
DCC	NNP	O
protein	NN	O
levels	NNS	O
on	IN	O
axons	NNS	O
within	IN	O
spinal	JJ	O
cord	NN	O
explants	NNS	O
.	.	O

Thus	RB	O
,	,	O
potentiation	NN	O
of	IN	O
netrin	JJ	O
activity	NN	O
by	IN	O
inhibitors	NNS	O
may	MD	O
result	VB	O
from	IN	O
stabilization	NN	O
of	IN	O
DCC	NNP	O
on	IN	O
the	DT	O
axons	NNS	O
,	,	O
and	CC	O
proteolytic	JJ	O
activity	NN	O
may	MD	O
regulate	VB	O
axon	NNS	O
migration	NN	O
by	IN	O
controlling	VBG	O
the	DT	O
number	NN	O
of	IN	O
functional	JJ	O
extracellular	JJ	O
axon	NN	O
guidance	NN	O
receptors	NNS	O
.	.	O
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
in	IN	O
transgenic	JJ	O
mice	NN	O
expressing	VBG	O
an	DT	O
expanded	VBN	O
CUG	NNP	O
repeat	NN	O
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
muscular	JJ	B_Disease
dystrophy	NN	E_Disease
in	IN	O
adult	NN	O
humans	NNS	O
,	,	O
results	NNS	O
from	IN	O
expansion	NN	O
of	IN	O
a	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
the	DT	O
DMPK	NNP	O
gene	NN	O
.	.	O

The	DT	O
mutant	JJ	O
DMPK	NNP	O
messenger	NN	O
RNA	NNP	O
(	(	O
mRNA	NN	O
)	)	O
contains	VBZ	O
an	DT	O
expanded	JJ	O
CUG	NNP	O
repeat	NN	O
and	CC	O
is	VBZ	O
retained	VBN	O
in	IN	O
the	DT	O
nucleus	NN	O
.	.	O

We	PRP	O
have	VBP	O
expressed	VBN	O
an	DT	O
untranslated	JJ	O
CUG	NNP	O
repeat	NN	O
in	IN	O
an	DT	O
unrelated	JJ	O
mRNA	NN	O
in	IN	O
transgenic	JJ	O
mice	NN	O
.	.	O

Mice	NNP	O
that	WDT	O
expressed	VBD	O
expanded	VBD	O
CUG	NNP	O
repeats	NNS	O
developed	VBD	O
myotonia	NN	S_Disease
and	CC	O
myopathy	NN	S_Disease
,	,	O
whereas	JJ	O
mice	NN	O
expressing	VBG	O
a	DT	O
nonexpanded	JJ	O
repeat	NN	O
did	VBD	O
not	RB	O
.	.	O

Thus	RB	O
,	,	O
transcripts	NNS	O
with	IN	O
expanded	JJ	O
CUG	NNP	O
repeats	NNS	O
are	VBP	O
sufficient	JJ	O
to	TO	O
generate	VB	O
a	DT	O
DM	NNP	S_Disease
phenotype	NN	O
.	.	O

This	DT	O
result	NN	O
supports	VBZ	O
a	DT	O
role	NN	O
for	IN	O
RNA	NNP	O
gain	NN	O
of	IN	O
function	NN	O
in	IN	O
disease	NN	O
pathogenesis	NN	O
.	.	O
.	.	O

Genomic	JJ	O
rearrangements	NNS	O
of	IN	O
the	DT	O
APC	NNP	B_Disease
tumor	NN	E_Disease
-	:	O
suppressor	NN	O
gene	NN	O
in	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
.	.	O

Germline	NNP	O
mutations	NNS	O
of	IN	O
the	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	I_Disease
(	(	I_Disease
APC	NNP	I_Disease
)	)	I_Disease
tumor	NN	E_Disease
-	:	O
suppressor	NN	O
gene	NN	O
result	NN	O
in	IN	O
the	DT	O
hereditary	JJ	B_Disease
colorectal	NN	I_Disease
cancer	NN	I_Disease
syndrome	VBP	E_Disease
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
.	.	O

Almost	RB	O
all	DT	O
APC	NNP	S_Disease
mutations	NNS	O
that	WDT	O
have	VBP	O
been	VBN	O
identified	VBN	O
are	VBP	O
single	JJ	O
-	:	O
nucleotide	JJ	O
alterations	NNS	O
,	,	O
small	JJ	O
insertions	NNS	O
,	,	O
or	CC	O
small	JJ	O
deletions	NNS	O
that	WDT	O
would	MD	O
truncate	VB	O
the	DT	O
protein	JJ	O
product	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

No	DT	O
well	NN	O
-	:	O
characterized	VBN	O
intragenic	JJ	O
rearrangement	NN	O
of	IN	O
APC	NNP	O
has	VBZ	O
been	VBN	O
described	VBN	O
,	,	O
and	CC	O
the	DT	O
prevalence	NN	O
of	IN	O
this	DT	O
type	NN	O
of	IN	O
mutation	NN	O
in	IN	O
FAP	NNP	S_Disease
patients	NNS	O
is	VBZ	O
not	RB	O
clear	JJ	O
.	.	O

We	PRP	O
screened	VBD	O
49	CD	O
potential	JJ	O
FAP	NNP	S_Disease
families	NNS	O
and	CC	O
identified	VBD	O
26	CD	O
different	JJ	O
germline	NN	O
APC	NNP	S_Disease
mutations	NNS	O
in	IN	O
30	CD	O
families	NNS	O
.	.	O

Four	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
were	VBD	O
genomic	JJ	O
rearrangements	NNS	O
resulting	VBG	O
from	IN	O
homologous	JJ	O
and	CC	O
nonhomologous	JJ	O
recombinations	NNS	O
mediated	VBN	O
by	IN	O
Alu	NNP	O
elements	NNS	O
.	.	O

Two	CD	O
of	IN	O
these	DT	O
four	CD	O
rearrangements	NNS	O
were	VBD	O
complex	JJ	O
,	,	O
involving	VBG	O
deletion	NN	O
and	CC	O
insertion	NN	O
of	IN	O
nucleotides	NNS	O
.	.	O

Of	IN	O
these	DT	O
four	CD	O
rearrangements	NNS	O
,	,	O
one	CD	O
resulted	VBD	O
in	IN	O
the	DT	O
deletion	NN	O
of	IN	O
exons	NNS	O
11	CD	O
and	CC	O
12	CD	O
and	CC	O
two	CD	O
others	NNS	O
resulted	VBD	O
in	IN	O
either	CC	O
complete	JJ	O
or	CC	O
partial	JJ	O
deletion	NN	O
of	IN	O
exon	$	O
14	CD	O
.	.	O

The	DT	O
fourth	JJ	O
rearrangement	NN	O
grossly	RB	O
altered	VBD	O
the	DT	O
sequence	NN	O
within	IN	O
intron	$	O
14	CD	O
.	.	O

Although	IN	O
this	DT	O
rearrangement	NN	O
did	VBD	O
not	RB	O
affect	VB	O
any	DT	O
coding	VBG	O
sequence	NN	O
of	IN	O
APC	NNP	O
at	IN	O
the	DT	O
genomic	JJ	O
DNA	NNP	O
level	NN	O
,	,	O
it	PRP	O
caused	VBD	O
inappropriate	JJ	O
splicing	NN	O
of	IN	O
exon	$	O
14	CD	O
.	.	O

These	DT	O
rearrangements	NNS	O
were	VBD	O
initially	RB	O
revealed	VBN	O
by	IN	O
analyzing	VBG	O
cDNAs	NN	O
and	CC	O
could	MD	O
not	RB	O
have	VB	O
been	VBN	O
identified	VBN	O
by	IN	O
using	VBG	O
mutation	NN	O
detection	NN	O
methods	NNS	O
that	WDT	O
screened	VBD	O
each	DT	O
exon	NN	O
individually	RB	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
a	DT	O
rearrangement	NN	O
that	WDT	O
did	VBD	O
not	RB	O
alter	VB	O
any	DT	O
coding	NN	O
exons	NNS	O
yet	RB	O
affected	VBD	O
the	DT	O
splicing	VBG	O
further	JJ	O
underscores	NNS	O
the	DT	O
importance	NN	O
of	IN	O
using	VBG	O
cDNA	NN	O
for	IN	O
mutation	NN	O
analysis	NN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
four	CD	O
genomic	JJ	O
rearrangements	NNS	O
among	IN	O
30	CD	O
mutations	NNS	O
suggests	VBZ	O
that	IN	O
genomic	JJ	O
rearrangements	NNS	O
are	VBP	O
frequent	JJ	O
germline	NN	O
APC	NNP	S_Disease
mutations	NNS	O
.	.	O
.	.	O

Detection	NN	O
of	IN	O
a	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
and	CC	O
second	JJ	O
recurrent	NN	O
mutation	NN	O
in	IN	O
the	DT	O
CACNA1A	NNP	O
gene	NN	O
in	IN	O
individuals	NNS	O
with	IN	O
EA	NNP	B_Disease
-	:	I_Disease
2	CD	E_Disease
and	CC	O
FHM	NNP	S_Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
brain	NN	O
specific	JJ	O
P	NNP	O
/	NNP	O
Q	NNP	O
type	NN	O
Ca2	NNP	O
+	NNP	O
channel	NN	O
alpha1	NN	O
subunit	NN	O
gene	NN	O
,	,	O
CACNA1A	NNP	O
,	,	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
three	CD	O
clinically	RB	O
distinct	JJ	O
disorders	NNS	O
,	,	O
viz	NN	O
.	.	O

episodic	JJ	B_Disease
ataxia	NN	I_Disease
type	NN	I_Disease
2	CD	E_Disease
(	(	O
EA	NNP	B_Disease
-	:	I_Disease
2	CD	E_Disease
)	)	O
,	,	O
familial	JJ	B_Disease
hemiplegic	NN	I_Disease
migraine	NN	E_Disease
(	(	O
FHM	NNP	S_Disease
)	)	O
and	CC	O
spinocerebellar	JJ	B_Disease
ataxia	NN	I_Disease
6	CD	E_Disease
(	(	O
SCA6	NNP	S_Disease
)	)	O
.	.	O

For	IN	O
individuals	NNS	O
with	IN	O
EA	NNP	B_Disease
-	:	I_Disease
2	CD	E_Disease
,	,	O
the	DT	O
mutations	NNS	O
described	VBD	O
thus	RB	O
far	RB	O
are	VBP	O
presumed	VBN	O
to	TO	O
result	VB	O
in	IN	O
a	DT	O
truncated	JJ	O
protein	NN	O
product	NN	O
.	.	O

Several	JJ	O
different	JJ	O
missense	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
FHM	NNP	S_Disease
.	.	O

At	IN	O
least	JJS	O
two	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
on	IN	O
two	CD	O
different	JJ	O
chromosome	NN	O
19p13	CD	O
haplotypes	NNS	O
and	CC	O
thus	RB	O
represent	VB	O
recurrent	JJ	O
mutations	NNS	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
we	PRP	O
have	VBP	O
screened	VBN	O
several	JJ	O
individuals	NNS	O
for	IN	O
mutations	NNS	O
in	IN	O
all	DT	O
47	CD	O
exons	NNS	O
in	IN	O
the	DT	O
CACNA1A	NNP	O
gene	NN	O
by	IN	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
analysis	NN	O
.	.	O

We	PRP	O
have	VBP	O
characterised	VBN	O
a	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
,	,	O
G5260A	NNP	O
,	,	O
in	IN	O
exon	JJ	O
32	CD	O
in	IN	O
a	DT	O
family	NN	O
segregating	VBG	O
for	IN	O
EA	NNP	B_Disease
-	:	I_Disease
2	CD	E_Disease
.	.	O

The	DT	O
consequence	NN	O
of	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
an	DT	O
amino	JJ	O
acid	NN	O
substitution	NN	O
at	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
position	NN	O
within	IN	O
the	DT	O
CACNA1A	NNP	O
gene	NN	O
.	.	O

This	DT	O
represents	VBZ	O
the	DT	O
first	JJ	O
point	NN	O
mutation	NN	O
not	RB	O
resulting	VBG	O
in	IN	O
a	DT	O
proposed	VBN	O
truncated	VBN	O
protein	NN	O
.	.	O

Furthermore	RB	O
,	,	O
this	DT	O
mutation	NN	O
has	VBZ	O
been	VBN	O
detected	VBN	O
in	IN	O
a	DT	O
family	NN	O
member	NN	O
with	IN	O
mild	JJ	O
clinical	JJ	O
signs	NNS	O
including	VBG	O
only	RB	O
migraine	NN	S_Disease
.	.	O

Additionally	RB	O
,	,	O
a	DT	O
second	JJ	O
previously	RB	O
identified	VBN	O
recurrent	NN	O
muta	NN	O
tion	NN	O
,	,	O
C2272T	NNP	O
,	,	O
in	IN	O
exon	JJ	O
16	CD	O
has	VBZ	O
been	VBN	O
discovered	VBN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
FHM	NNP	S_Disease
.	.	O
.	.	O

Analbuminemia	NNP	S_Disease
in	IN	O
a	DT	O
neonate	NN	O
.	.	O

A	DT	O
small	JJ	O
-	:	O
for	IN	O
-	:	O
gestational	JJ	O
-	:	O
age	NN	O
infant	NN	O
,	,	O
found	VBN	O
to	TO	O
have	VB	O
analbuminemia	VBN	S_Disease
in	IN	O
the	DT	O
neonatal	JJ	O
period	NN	O
,	,	O
is	VBZ	O
reported	VBN	O
and	CC	O
the	DT	O
twelve	NN	O
cases	NNS	O
recorded	VBN	O
in	IN	O
the	DT	O
world	NN	O
literature	NN	O
are	VBP	O
reviewed	VBN	O
.	.	O

Patients	NNS	O
lacking	VBG	O
this	DT	O
serum	NN	O
protein	NN	O
are	VBP	O
essentially	RB	O
asymptomatic	JJ	O
,	,	O
apart	RB	O
from	IN	O
minimal	JJ	O
ankle	NN	B_Disease
edema	NN	E_Disease
and	CC	O
ease	NN	B_Disease
of	IN	I_Disease
fatigue	NN	E_Disease
.	.	O

Apparent	JJ	O
compensatory	NN	O
mechanisms	NNS	O
which	WDT	O
come	VBP	O
into	IN	O
play	NN	O
when	WRB	O
serum	NN	O
albumin	NN	O
is	VBZ	O
low	JJ	O
include	VBP	O
prolonged	VBN	O
half	NN	O
-	:	O
life	NN	O
of	IN	O
albumin	NN	O
and	CC	O
transferrin	NN	O
,	,	O
an	DT	O
increase	NN	O
in	IN	O
serum	JJ	O
globulins	NNS	O
,	,	O
beta	NN	O
lipoprotein	NN	O
,	,	O
and	CC	O
glycoproteins	NNS	O
,	,	O
arterial	JJ	B_Disease
hypotension	NN	E_Disease
with	IN	O
reduced	JJ	O
capillary	JJ	O
hydrostatic	JJ	O
pressure	NN	O
,	,	O
and	CC	O
the	DT	O
ability	NN	O
to	TO	O
respond	VB	O
with	IN	O
rapid	JJ	O
sodium	NN	O
and	CC	O
chloride	JJ	O
diuresis	NN	O
in	IN	O
response	NN	O
to	TO	O
small	JJ	O
volume	NN	O
changes	NNS	O
.	.	O

Examination	NN	O
of	IN	O
plasma	NN	O
amino	NN	O
acids	NNS	O
,	,	O
an	DT	O
investigation	NN	O
not	RB	O
previously	RB	O
reported	VBN	O
,	,	O
revealed	VBD	O
an	DT	O
extremely	RB	O
low	JJ	O
plasma	NN	O
tryptophan	NN	O
level	NN	O
,	,	O
a	DT	O
finding	NN	O
which	WDT	O
may	MD	O
be	VB	O
important	JJ	O
in	IN	O
view	NN	O
of	IN	O
the	DT	O
role	NN	O
of	IN	O
tryptophan	NN	O
in	IN	O
albumin	JJ	O
synthesis	NN	O
.	.	O
.	.	O

Histidinemia	NNP	S_Disease
.	.	O

Classical	JJ	O
and	CC	O
atypical	JJ	O
form	NN	O
in	IN	O
siblings	NNS	O
.	.	O

Two	CD	O
brothers	NNS	O
,	,	O
6	CD	O
and	CC	O
13	CD	O
years	NNS	O
old	JJ	O
,	,	O
had	VBD	O
histidinemia	NN	S_Disease
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
observations	NNS	O
,	,	O
the	DT	O
younger	JJR	O
boy	NN	O
was	VBD	O
considered	VBN	O
to	TO	O
have	VB	O
a	DT	O
classical	JJ	O
type	NN	O
of	IN	O
the	DT	O
disease	NN	O
,	,	O
while	IN	O
the	DT	O
older	JJR	O
boy	NN	O
had	VBD	O
an	DT	O
atypical	JJ	O
form	NN	O
characterized	VBN	O
by	IN	O
partial	JJ	O
impairment	NN	O
of	IN	O
the	DT	O
skin	JJ	O
histidase	NN	O
activity	NN	O
and	CC	O
a	DT	O
moderately	RB	O
prolonged	JJ	O
half	NN	O
-	:	O
life	NN	O
of	IN	O
blood	NN	O
histidine	NN	O
.	.	O

The	DT	O
mother	NN	O
is	VBZ	O
a	DT	O
heterozygous	JJ	O
carrier	NN	O
,	,	O
while	IN	O
the	DT	O
father	NN	O
and	CC	O
sister	NN	O
seem	VBP	O
to	TO	O
be	VB	O
normal	JJ	O
.	.	O
.	.	O

Carrier	NNP	O
detection	NN	O
of	IN	O
pyruvate	JJ	B_Disease
carboxylase	NN	I_Disease
deficiency	NN	E_Disease
in	IN	O
fibroblasts	NNS	O
and	CC	O
lymphocytes	NNS	O
.	.	O

Pyruvate	NNP	O
carboxylase	NN	O
(	(	O
E	NNP	O
.	.	O

C	NNP	O
.	.	O

6	CD	O
.	.	O

4	CD	O
.	.	O

1	CD	O
.	.	O

1	CD	O
)	)	O
activity	NN	O
was	VBD	O
determined	VBN	O
in	IN	O
the	DT	O
circulating	VBG	O
peripheral	JJ	O
lymphocytes	NNS	O
and	CC	O
cultured	VBD	O
skin	JJ	O
fibroblasts	NNS	O
from	IN	O
the	DT	O
family	NN	O
of	IN	O
a	DT	O
patient	NN	O
with	IN	O
hepatic	JJ	O
,	,	O
cerebral	JJ	O
,	,	O
renal	JJ	O
cortical	NN	O
,	,	O
leukocyte	NN	O
,	,	O
and	CC	O
fibroblast	JJ	O
pyruvate	NN	B_Disease
carboxylase	NN	I_Disease
deficiency	NN	E_Disease
(	(	O
PC	NN	B_Disease
Portland	NNP	I_Disease
deficiency	NN	E_Disease
)	)	O
.	.	O

Lymphocyte	JJ	O
activities	NNS	O
were	VBD	O
mother	RB	O
,	,	O
33	CD	O
-	:	O
-	:	O
39	CD	O
%	NN	O
;	:	O
father	CC	O
,	,	O
11	CD	O
-	:	O
-	:	O
29	CD	O
%	NN	O
;	:	O
brother	CC	O
,	,	O
82	CD	O
-	:	O
-	:	O
103	CD	O
%	NN	O
;	:	O
and	CC	O
sister	NN	O
,	,	O
38	CD	O
-	:	O
-	:	O
48	CD	O
%	NN	O
of	IN	O
the	DT	O
lowest	JJS	O
normal	JJ	O
.	.	O

Fibroblasts	NNS	O
from	IN	O
the	DT	O
patients	NNS	O
mother	NN	O
and	CC	O
father	NN	O
had	VBD	O
42	CD	O
and	CC	O
34	CD	O
%	NN	O
,	,	O
respectively	RB	O
,	,	O
of	IN	O
the	DT	O
activity	NN	O
of	IN	O
the	DT	O
lowest	JJS	O
normal	JJ	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	NN	O
that	IN	O
the	DT	O
disease	NN	O
is	VBZ	O
inherited	VBN	O
in	IN	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
manner	NN	O
and	CC	O
that	IN	O
lymphocytes	NNS	O
and	CC	O
fibroblasts	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
detect	VB	O
carriers	NNS	O
.	.	O

Neither	DT	O
pyruvate	NN	O
carboxylase	NN	O
nor	CC	O
mitochondrial	JJ	O
PEPCK	NNP	O
activity	NN	O
in	IN	O
lymphocytes	NNS	O
was	VBD	O
increased	VBN	O
by	IN	O
a	DT	O
21	CD	O
-	:	O
hr	NN	O
fast	NN	O
.	.	O

Glucose	NNP	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
variants	NNS	O
from	IN	O
Italian	JJ	O
subjects	NNS	O
associated	VBN	O
with	IN	O
severe	JJ	B_Disease
neonatal	JJ	I_Disease
jaundice	NN	E_Disease
.	.	O

Screening	VBG	O
for	IN	O
the	DT	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
was	VBD	O
carried	VBN	O
out	RP	O
at	IN	O
the	DT	O
Maternity	NNP	O
Division	NNP	O
of	IN	O
the	DT	O
Galliera	NNP	O
Hospital	NNP	O
in	IN	O
Genoa	NNP	O
,	,	O
Italy	NNP	O
.	.	O

Two	CD	O
groups	NNS	O
of	IN	O
subjects	NNS	O
with	IN	O
hyperbilirubinaemia	NN	S_Disease
of	IN	O
non	JJ	O
-	:	O
immunological	JJ	O
origin	NN	O
were	VBD	O
examined	VBN	O
(	(	O
a	DT	O
)	)	O
302	CD	O
newborn	JJ	O
babies	NNS	O
of	IN	O
Sardinian	JJ	O
extraction	NN	O
(	(	O
on	IN	O
cord	NN	O
blood	NN	O
)	)	O
and	CC	O
(	(	O
b	NN	O
)	)	O
201	CD	O
newborn	JJ	O
babies	NNS	O
of	IN	O
south	JJ	O
Italian	JJ	O
ancestry	NN	O
(	(	O
on	IN	O
peripheral	JJ	O
blood	NN	O
)	)	O
.	.	O

Among	IN	O
503	CD	O
subjects	NNS	O
,	,	O
43	CD	O
showed	VBD	O
an	DT	O
enzyme	JJ	O
deficiency	NN	O
;	:	O
in	IN	O
39	CD	O
the	DT	O
defect	NN	O
was	VBD	O
of	IN	O
the	DT	O
Mediterranean	NNP	O
type	NN	O
.	.	O

In	IN	O
one	CD	O
case	NN	O
,	,	O
previously	RB	O
described	VBN	O
,	,	O
the	DT	O
enzyme	NN	O
was	VBD	O
of	IN	O
the	DT	O
A	NNP	O
-	:	O
type	NN	O
.	.	O

In	IN	O
the	DT	O
remaining	VBG	O
cases	NNS	O
three	CD	O
different	JJ	O
variants	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
work	NN	O
these	DT	O
three	CD	O
cases	NNS	O
,	,	O
each	DT	O
with	IN	O
severe	JJ	B_Disease
neonatal	JJ	I_Disease
jaundice	NN	E_Disease
,	,	O
are	VBP	O
reported	VBN	O
.	.	O

Their	PRP$	O
parents	NNS	O
originated	VBN	O
from	IN	O
Calabria	NNP	O
,	,	O
from	IN	O
Sardinia	NNP	O
and	CC	O
from	IN	O
Sicily	NNP	O
.	.	O

The	DT	O
abnormal	JJ	O
enzymes	NNS	O
are	VBP	O
respectively	RB	O
designated	VBN	O
as	IN	O
GdDcbrousse	NNP	O
-	:	O
like	IN	O
,	,	O
GdGallura	NNP	O
and	CC	O
GdAgrigento	NNP	O
.	.	O
.	.	O

Cytogenetic	JJ	O
investigations	NNS	O
in	IN	O
families	NNS	O
with	IN	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
.	.	O

Chromosomal	JJ	O
studies	NNS	O
were	VBD	O
performed	VBN	O
on	IN	O
peripheral	JJ	O
blood	NN	O
lymphocytes	NNS	O
and	CC	O
cultured	VBD	O
skin	JJ	O
fibroblasts	NNS	O
from	IN	O
five	CD	O
Israeli	NNP	O
-	:	O
Moroccan	JJ	O
families	NNS	O
with	IN	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
.	.	O

A	DT	O
total	NN	O
of	IN	O
24	CD	O
individuals	NNS	O
,	,	O
including	VBG	O
seven	CD	O
propositi	NN	O
,	,	O
was	VBD	O
investigated	VBN	O
.	.	O

Among	IN	O
the	DT	O
probands	NNS	O
,	,	O
significantly	RB	O
elevated	VBN	O
rates	NNS	O
of	IN	O
chromosome	NN	O
damage	NN	O
were	VBD	O
observed	VBN	O
in	IN	O
both	DT	O
blood	NN	O
and	CC	O
skin	NN	O
.	.	O

Skin	NNP	O
fibroblasts	NNS	O
of	IN	O
affected	JJ	O
individuals	NNS	O
showed	VBD	O
several	JJ	O
orders	NNS	O
of	IN	O
magnitude	NN	O
more	RBR	O
chromosome	NN	O
breakage	NN	O
than	IN	O
lymphocytes	NNS	O
.	.	O

Increased	VBN	O
rates	NNS	O
of	IN	O
chromosome	NN	O
damage	NN	O
were	VBD	O
also	RB	O
observed	VBN	O
in	IN	O
the	DT	O
fibroblasts	NNS	O
of	IN	O
some	DT	O
phenotypically	RB	O
normal	JJ	O
family	NN	O
members	NNS	O
(	(	O
obligate	JJ	O
heterozygotes	NNS	O
and	CC	O
sibs	NN	O
)	)	O
when	WRB	O
compared	VBN	O
to	TO	O
normal	JJ	O
controls	NNS	O
.	.	O

An	DT	O
apparent	JJ	O
abnormal	JJ	O
clone	NN	O
of	IN	O
cells	NNS	O
,	,	O
possessing	VBG	O
a	DT	O
large	JJ	O
acrocentric	JJ	O
marker	NN	O
chromosome	NN	O
(	(	O
14q	CD	O
+	NN	O
)	)	O
,	,	O
was	VBD	O
observed	VBN	O
in	IN	O
varying	VBG	O
proportions	NNS	O
among	IN	O
cells	NNS	O
of	IN	O
all	PDT	O
the	DT	O
propositi	NN	O
(	(	O
2	CD	O
-	:	O
5	CD	O
%	NN	O
of	IN	O
lymphocytes	NNS	O
;	:	O
1	CD	O
-	:	O
9	CD	O
%	NN	O
of	IN	O
fibroblasts	NNS	O
)	)	O
.	.	O
.	.	O

Prenatal	JJ	O
diagnosis	NN	O
of	IN	O
Wolman	NNP	B_Disease
disease	NN	E_Disease
.	.	O

Two	CD	O
pregnancies	NNS	O
at	IN	O
risk	NN	O
for	IN	O
Wolman	NNP	B_Disease
disease	NN	E_Disease
were	VBD	O
monitored	VBN	O
by	IN	O
assay	NN	O
and	CC	O
electrophoresis	NN	O
of	IN	O
acid	JJ	O
lipase	NN	O
in	IN	O
cultured	JJ	O
amniotic	JJ	O
-	:	O
fluid	NN	O
cells	NNS	O
.	.	O

Cells	NNS	O
from	IN	O
patient	JJ	O
1	CD	O
had	VBD	O
5	CD	O
%	NN	O
of	IN	O
control	NN	O
levels	NNS	O
of	IN	O
acid	NN	O
lipase	NN	O
,	,	O
using	VBG	O
14C	CD	O
-	:	O
triolein	NN	O
as	IN	O
substrate	NN	O
;	:	O
however	RB	O
,	,	O
when	WRB	O
artificial	JJ	O
substrates	NNS	O
(	(	O
esters	NNS	O
of	IN	O
4	CD	O
-	:	O
methylumbelliferone	NN	O
and	CC	O
p	NN	O
-	:	O
nitrophenol	NN	O
)	)	O
were	VBD	O
used	VBN	O
to	TO	O
measure	VB	O
acid	JJ	O
lipase	NN	O
,	,	O
these	DT	O
cells	NNS	O
had	VBD	O
30	CD	O
%	NN	O
of	IN	O
control	NN	O
levels	NNS	O
.	.	O

Electrophoresis	NN	O
of	IN	O
cell	NN	O
extracts	NNS	O
revealed	VBD	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
A	NNP	O
form	NN	O
of	IN	O
acid	JJ	O
lipase	NN	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
Wolman	NNP	B_Disease
disease	NN	E_Disease
.	.	O

Analysis	NN	O
of	IN	O
fetal	JJ	O
tissues	NNS	O
following	VBG	O
prostaglandin	JJ	O
termination	NN	O
of	IN	O
this	DT	O
pregnancy	NN	O
confirmed	VBD	O
the	DT	O
diagnosis	NN	O
.	.	O

Assay	NNP	O
of	IN	O
fetal	JJ	O
-	:	O
skin	NN	O
fibroblasts	NNS	O
with	IN	O
14C	CD	O
-	:	O
triolein	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
with	IN	O
artificial	JJ	O
substrates	NNS	O
,	,	O
showed	VBD	O
marked	JJ	O
deficiency	NN	O
of	IN	O
acid	JJ	O
lipase	NN	O
activity	NN	O
.	.	O

Electrophoresis	NN	O
of	IN	O
fetal	JJ	O
-	:	O
tissue	NN	O
extracts	NNS	O
also	RB	O
demonstrated	VBD	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
A	NNP	O
form	NN	O
of	IN	O
acid	JJ	O
lipase	NN	O
.	.	O

Amniotic	JJ	O
-	:	O
fluid	NN	O
cells	NNS	O
from	IN	O
patient	NN	O
2	CD	O
showed	VBD	O
normal	JJ	O
levels	NNS	O
of	IN	O
acid	JJ	O
lipase	NN	O
with	IN	O
all	DT	O
substrates	NNS	O
tested	VBN	O
;	:	O
the	DT	O
electrophoretic	JJ	O
pattern	NN	O
of	IN	O
acid	JJ	O
lipase	NN	O
was	VBD	O
normal	JJ	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
prenatal	JJ	O
diagnosis	NN	O
of	IN	O
Wolman	NNP	B_Disease
disease	NN	E_Disease
be	VB	O
made	VBN	O
using	VBG	O
the	DT	O
radioassay	NN	O
of	IN	O
acid	JJ	O
lipase	NN	O
and	CC	O
/	NN	O
or	CC	O
electrophoresis	NN	O
.	.	O
.	.	O

Malignant	JJ	B_Disease
neoplasms	NNS	E_Disease
in	IN	O
the	DT	O
families	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
.	.	O

Ataxia	NNP	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
(	(	O
A	DT	B_Disease
-	:	I_Disease
T	NN	E_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
syndrome	NN	E_Disease
associated	VBN	O
with	IN	O
a	DT	O
greatly	RB	O
increased	JJ	O
incidence	NN	O
of	IN	O
malignant	JJ	B_Disease
neoplasms	NNS	E_Disease
in	IN	O
homozygous	JJ	O
affected	JJ	O
individuals	NNS	O
.	.	O

Heterozygotes	NNS	O
for	IN	O
the	DT	O
gene	NN	O
for	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
are	VBP	O
thought	VBN	O
to	TO	O
comprise	VB	O
about	RB	O
1	CD	O
%	NN	O
of	IN	O
the	DT	O
general	JJ	O
population	NN	O
and	CC	O
,	,	O
therefore	RB	O
,	,	O
it	PRP	O
is	VBZ	O
important	JJ	O
to	TO	O
know	VB	O
whether	IN	O
this	DT	O
gene	NN	O
also	RB	O
predisposes	VBZ	O
the	DT	O
heterozygous	JJ	O
carrier	NN	O
to	TO	O
cancers	NNS	S_Disease
.	.	O

Heterozygous	JJ	O
carriers	NNS	O
of	IN	O
this	DT	O
gene	NN	O
are	VBP	O
common	JJ	O
among	IN	O
the	DT	O
close	JJ	O
relatives	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
,	,	O
although	IN	O
individual	JJ	O
carriers	NNS	O
cannot	VBP	O
be	VB	O
identified	VBN	O
by	IN	O
any	DT	O
clinical	JJ	O
criterion	NN	O
or	CC	O
laboratory	JJ	O
test	NN	O
.	.	O

For	IN	O
this	DT	O
reason	NN	O
,	,	O
we	PRP	O
compared	VBN	O
the	DT	O
incidence	NN	O
of	IN	O
death	NN	O
from	IN	O
malignant	JJ	B_Disease
neoplasms	NNS	E_Disease
in	IN	O
2	CD	O
families	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
to	TO	O
that	DT	O
expected	VBN	O
in	IN	O
a	DT	O
random	JJ	O
sample	NN	O
of	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

There	EX	O
were	VBD	O
59	CD	O
deaths	NNS	O
from	IN	O
malignant	JJ	B_Disease
neoplasms	NNS	E_Disease
in	IN	O
relatives	NNS	O
dying	VBG	O
before	IN	O
age	NN	O
75	CD	O
,	,	O
compared	VBN	O
to	TO	O
42	CD	O
.	.	O

6	CD	O
expected	VBN	O
(	(	O
p	NN	O
less	JJR	O
than	IN	O
0	CD	O
.	.	O

02	CD	O
)	)	O
.	.	O

For	IN	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
heterozygotes	VBZ	O
younger	JJR	O
than	IN	O
age	NN	O
45	CD	O
,	,	O
the	DT	O
risk	NN	O
of	IN	O
dying	VBG	O
from	IN	O
a	DT	O
malignant	JJ	B_Disease
neoplasm	NN	E_Disease
was	VBD	O
estimated	VBN	O
to	TO	O
be	VB	O
greater	JJR	O
than	IN	O
5	CD	O
times	NNS	O
the	DT	O
risk	NN	O
for	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

A	DT	B_Disease
-	:	I_Disease
T	NN	E_Disease
heterozygotes	NNS	O
may	MD	O
comprise	VB	O
more	JJR	O
than	IN	O
5	CD	O
%	NN	O
of	IN	O
all	DT	O
persons	NNS	O
dying	VBG	O
from	IN	O
a	DT	O
cancer	NN	S_Disease
before	IN	O
age	NN	O
45	CD	O
.	.	O

The	DT	O
incidence	NN	O
of	IN	O
ovarian	JJ	B_Disease
,	,	I_Disease
gastric	JJ	I_Disease
,	,	I_Disease
and	CC	I_Disease
biliary	JJ	I_Disease
system	NN	I_Disease
carcinomas	NN	E_Disease
and	CC	O
of	IN	O
leukemia	NN	S_Disease
and	CC	O
lymphoma	NN	S_Disease
was	VBD	O
increased	VBN	O
in	IN	O
these	DT	O
A	NNP	B_Disease
-	:	I_Disease
T	NN	E_Disease
families	NNS	O
.	.	O

Other	JJ	O
neoplasms	NNS	S_Disease
that	WDT	O
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
this	DT	O
gene	NN	O
in	IN	O
heterozygotes	NNS	O
include	VBP	O
pancreatic	JJ	B_Disease
,	,	I_Disease
basal	NN	I_Disease
cell	NN	I_Disease
,	,	I_Disease
colonic	NN	I_Disease
,	,	I_Disease
breast	NN	I_Disease
,	,	I_Disease
and	CC	I_Disease
cervical	JJ	I_Disease
carcinomas	NN	E_Disease
.	.	O

Striking	VBG	O
prevalence	NN	O
of	IN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
in	IN	O
"	NNP	O
healthy	JJ	O
"	NNP	O
w27	NN	O
positive	JJ	O
males	NNS	O
and	CC	O
females	NNS	O
.	.	O

Ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
is	VBZ	O
diagnosed	VBN	O
once	RB	O
or	CC	O
twice	RB	O
in	IN	O
each	DT	O
1000	CD	O
males	NNS	O
and	CC	O
one	CD	O
tenth	NN	O
as	IN	O
frequently	RB	O
in	IN	O
females	NNS	O
,	,	O
but	CC	O
the	DT	O
true	JJ	O
prevalence	NN	O
is	VBZ	O
unknown	JJ	O
.	.	O

Indentification	NN	O
of	IN	O
genetic	JJ	O
marker	NN	O
,	,	O
HL	NNP	O
-	:	O
A	DT	O
W27	NNP	O
,	,	O
for	IN	O
susceptible	JJ	O
persons	NNS	O
has	VBZ	O
provided	VBN	O
a	DT	O
tool	NN	O
facilitating	VBG	O
epidemiologic	JJ	O
studies	NNS	O
and	CC	O
allowing	VBG	O
identification	NN	O
of	IN	O
"	NNP	O
control	NN	O
"	NNP	O
populations	NNS	O
without	IN	O
the	DT	O
marker	NN	O
.	.	O

Evaluation	NN	O
by	IN	O
postal	JJ	O
questionnaires	NNS	O
,	,	O
and	CC	O
pelvic	JJ	O
radiography	NN	O
of	IN	O
78	CD	O
HL	NNP	O
-	:	O
A	DT	O
27W	CD	O
-	:	O
positive	JJ	O
blood	NN	O
donors	NNS	O
selected	VBD	O
from	IN	O
a	DT	O
group	NN	O
of	IN	O
apparently	RB	O
healthy	JJ	O
subjects	NNS	O
revealed	VBD	O
14	CD	O
who	WP	O
satisfied	VBD	O
the	DT	O
criteria	NNS	O
for	IN	O
definite	NN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
.	.	O

The	DT	O
prevalence	NN	O
was	VBD	O
similar	JJ	O
in	IN	O
both	DT	O
sexes	NNS	O
.	.	O

One	CD	O
hundred	CD	O
and	CC	O
twenty	VB	O
-	:	O
six	CD	O
W27	NNP	O
-	:	O
negative	JJ	O
controls	NNS	O
matched	VBN	O
for	IN	O
race	NN	O
,	,	O
sex	NN	O
,	,	O
and	CC	O
age	NN	O
failed	VBD	O
to	TO	O
yield	VB	O
a	DT	O
single	JJ	O
case	NN	O
.	.	O

For	IN	O
a	DT	O
person	NN	O
of	IN	O
either	DT	O
sex	NN	O
with	IN	O
HL	NNP	O
-	:	O
A	DT	O
W27	NNP	O
,	,	O
there	EX	O
appears	VBZ	O
to	TO	O
be	VB	O
about	IN	O
a	DT	O
20	CD	O
per	IN	O
cent	NN	O
chance	NN	O
that	IN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
will	MD	O
develop	VB	O
,	,	O
suggesting	VBG	O
a	DT	O
prevalence	NN	O
of	IN	O
10	CD	O
to	TO	O
15	CD	O
per	IN	O
thousand	NN	O
.	.	O

Hitherto	NNP	O
accepted	VBD	O
figures	NNS	O
may	MD	O
underestimate	VB	O
the	DT	O
frequency	NN	O
by	IN	O
a	DT	O
factor	NN	O
of	IN	O
10	CD	O
to	TO	O
20	CD	O
.	.	O
.	.	O

Analbuminemia	NNP	S_Disease
in	IN	O
an	DT	O
American	JJ	O
Indian	JJ	O
girl	NN	O
.	.	O

Analbuminemia	NNP	S_Disease
was	VBD	O
fortuitously	RB	O
detected	VBN	O
in	IN	O
a	DT	O
nonedematous	JJ	O
12	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
American	JJ	O
Indian	NNP	O
girl	NN	O
with	IN	O
atopic	NN	B_Disease
dermatitis	NN	E_Disease
,	,	O
mild	JJ	O
bronchial	JJ	B_Disease
asthma	NN	E_Disease
,	,	O
a	DT	O
mild	JJ	O
seizure	NN	B_Disease
disorder	NN	E_Disease
,	,	O
and	CC	O
hyperlipoproteinemia	NN	S_Disease
with	IN	O
a	DT	O
corneal	JJ	B_Disease
arcus	NN	E_Disease
.	.	O

Immunologic	NNP	O
methods	NNS	O
revealed	VBD	O
trace	NN	O
amounts	NNS	O
(	(	O
17	CD	O
mg	NN	O
/	VBD	O
100	CD	O
ml	NN	O
)	)	O
of	IN	O
apparently	RB	O
normal	JJ	O
serum	JJ	O
albumin	NN	O
.	.	O

The	DT	O
patients	NNS	O
parents	NNS	O
were	VBD	O
remotely	RB	O
related	VBN	O
.	.	O

The	DT	O
pedigree	NN	O
and	CC	O
clinical	JJ	O
findings	NNS	O
were	VBD	O
compatible	JJ	O
with	IN	O
autosomal	JJ	O
recessive	JJ	O
transmission	NN	O
of	IN	O
analbuminemia	NN	S_Disease
.	.	O

Heterozygotes	NNS	O
had	VBD	O
subnormal	JJ	O
levels	NNS	O
of	IN	O
serum	NN	O
albumin	NN	O
.	.	O

The	DT	O
Gc	NNP	O
-	:	O
locus	NN	O
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
structural	JJ	O
albumin	NN	O
locus	NN	O
.	.	O

Gc	NNP	O
-	:	O
protein	NN	O
levels	NNS	O
were	VBD	O
normal	JJ	O
in	IN	O
the	DT	O
patient	NN	O
and	CC	O
together	RB	O
with	IN	O
normal	JJ	O
chromosomal	JJ	O
banding	NN	O
studies	NNS	O
make	VBP	O
it	PRP	O
unlikely	JJ	O
that	IN	O
a	DT	O
chromosomal	JJ	O
deletion	NN	O
caused	VBD	O
analbuminemia	NN	S_Disease
.	.	O

Gc	NNP	O
-	:	O
types	NNS	O
in	IN	O
the	DT	O
family	NN	O
were	VBD	O
compatible	JJ	O
with	IN	O
,	,	O
but	CC	O
did	VBD	O
not	RB	O
prove	VB	O
,	,	O
linkage	NN	O
of	IN	O
analbuminemia	NN	S_Disease
to	TO	O
the	DT	O
Gc	NNP	O
-	:	O
locus	NN	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
a	DT	O
"	JJ	O
thalassemia	NN	S_Disease
"	SYM	O
-	:	O
like	IN	O
mutation	NN	O
for	IN	O
this	DT	O
disorder	NN	O
.	.	O
.	.	O

Deletion	NN	O
of	IN	O
the	DT	O
KIT	NNP	O
and	CC	O
PDGFRA	NNP	O
genes	NNS	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
piebaldism	NN	S_Disease
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
shown	VBN	O
that	IN	O
human	JJ	O
piebaldism	NN	S_Disease
results	NNS	O
from	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
KIT	NNP	O
gene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
the	DT	O
receptor	NN	O
for	IN	O
the	DT	O
mast	NN	O
/	JJ	O
stem	NN	O
cell	NN	O
growth	NN	O
factor	NN	O
and	CC	O
is	VBZ	O
located	VBN	O
in	IN	O
chromosome	NN	O
segment	NN	O
4q12	CD	O
.	.	O

Using	VBG	O
DNA	NNP	O
of	IN	O
a	DT	O
patient	NN	O
with	IN	O
piebaldism	NN	S_Disease
,	,	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
and	CC	O
multiple	JJ	B_Disease
congenital	JJ	I_Disease
anomalies	NNS	E_Disease
associated	VBN	O
with	IN	O
a	DT	O
46	CD	O
,	,	O
XY	NNP	O
,	,	O
del	NN	O
(	(	O
4	CD	O
)	)	O
(	(	O
q12q21	UH	O
.	.	O

1	CD	O
)	)	O
karyotype	NN	O
,	,	O
we	PRP	O
carried	VBD	O
out	RP	O
quantitative	JJ	O
Southern	NNP	O
blot	NN	O
hybridization	NN	O
analyses	NNS	O
of	IN	O
the	DT	O
KIT	NNP	O
gene	NN	O
and	CC	O
the	DT	O
adjacent	JJ	O
PDGFRA	NNP	O
(	(	O
platelet	VB	O
-	:	O
derived	VBN	O
growth	NN	O
factor	NN	O
receptor	NN	O
alpha	IN	O
subunit	NN	O
)	)	O
genes	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
hemizygous	JJ	O
for	IN	O
both	DT	O
the	DT	O
KIT	NNP	O
and	CC	O
PDGFRA	NNP	O
genes	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
both	DT	O
of	IN	O
these	DT	O
genes	NNS	O
are	VBP	O
included	VBN	O
within	IN	O
the	DT	O
deleted	JJ	O
region	NN	O
.	.	O

Therefore	RB	O
,	,	O
deletion	NN	O
of	IN	O
the	DT	O
KIT	NNP	O
and	CC	O
PDGFRA	NNP	O
genes	NNS	O
may	MD	O
account	VB	O
for	IN	O
the	DT	O
piebald	NN	S_Disease
phenotype	NN	O
in	IN	O
this	DT	O
patient	NN	O
.	.	O

A	DT	O
germ	JJ	O
line	NN	O
mutation	NN	O
within	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
for	IN	O
the	DT	O
putative	JJ	O
5	CD	O
-	:	O
phosphoribosyl	NN	O
-	:	O
1	CD	O
-	:	O
pyrophosphate	NN	O
binding	VBG	O
site	NN	O
of	IN	O
hypoxanthine	JJ	O
-	:	O
guanine	NN	O
phosphoribosyltransferase	NN	O
(	(	O
HPRT	NNP	O
)	)	O
in	IN	O
a	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	JJ	E_Disease
patient	NN	O
:	:	O
missense	NN	O
mutations	NNS	O
within	IN	O
a	DT	O
functionally	RB	O
important	JJ	O
region	NN	O
probably	RB	O
cause	NN	O
disease	NN	O
.	.	O

Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
complete	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
hypoxanthine	JJ	I_Disease
guanine	NN	I_Disease
phosphoribosyltransferase	NN	E_Disease
(	(	O
HPRT	NNP	O
)	)	O
is	VBZ	O
the	DT	O
result	NN	O
of	IN	O
a	DT	O
heterogeneous	JJ	O
group	NN	O
of	IN	O
germ	JJ	O
line	NN	O
mutations	NNS	O
.	.	O

Identification	NN	O
of	IN	O
each	DT	O
mutant	JJ	O
gene	NN	O
provides	VBZ	O
valuable	JJ	O
information	NN	O
as	IN	O
to	TO	O
the	DT	O
type	NN	O
of	IN	O
mutation	NN	O
that	WDT	O
occurs	VBZ	O
spontaneously	RB	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
a	DT	O
newly	RB	O
identified	VBN	O
HPRT	NNP	O
mutation	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
patient	NN	O
with	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

This	DT	O
gene	NN	O
,	,	O
designated	VBN	O
HPRT	NNP	O
Tokyo	NNP	O
,	,	O
had	VBD	O
a	DT	O
single	JJ	O
nucleotide	JJ	O
change	NN	O
from	IN	O
G	NNP	O
to	TO	O
A	NNP	O
,	,	O
as	IN	O
identified	VBN	O
by	IN	O
sequencing	VBG	O
cDNA	NN	O
amplified	VBN	O
by	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
.	.	O

Allele	NNP	O
specific	JJ	O
oligonucleotide	JJ	O
hybridization	NN	O
analysis	NN	O
using	VBG	O
amplified	JJ	O
genomic	JJ	O
DNA	NN	O
showed	VBD	O
that	IN	O
the	DT	O
mutant	JJ	O
gene	NN	O
was	VBD	O
transmitted	VBN	O
from	IN	O
the	DT	O
maternal	JJ	O
germ	NN	O
line	NN	O
.	.	O

This	DT	O
mutation	NN	O
would	MD	O
lead	VB	O
to	TO	O
an	DT	O
amino	NN	O
acid	JJ	O
substitution	NN	O
of	IN	O
Asp	NNP	O
for	IN	O
Gly	NNP	O
at	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
position	NN	O
140	CD	O
located	VBN	O
within	IN	O
the	DT	O
putative	JJ	O
5	CD	O
-	:	O
phosphoribosyl	NN	O
-	:	O
1	CD	O
-	:	O
pyrophosphate	NN	O
(	(	O
PRPP	NNP	O
)	)	O
binding	VBG	O
region	NN	O
.	.	O

Missense	JJ	O
mutations	NNS	O
in	IN	O
human	JJ	O
HPRT	NNP	B_Disease
deficient	NN	E_Disease
patients	NNS	O
thus	RB	O
far	RB	O
reported	JJ	O
tend	VBP	O
to	TO	O
accumulate	VB	O
in	IN	O
this	DT	O
functionally	RB	O
active	JJ	O
region	NN	O
.	.	O

However	RB	O
,	,	O
a	DT	O
comparison	NN	O
of	IN	O
the	DT	O
data	NNS	O
suggested	VBD	O
that	IN	O
both	DT	O
missense	NN	O
and	CC	O
synonymous	JJ	O
mutations	NNS	O
can	MD	O
occur	VB	O
at	IN	O
any	DT	O
coding	VBG	O
sequence	NN	O
of	IN	O
the	DT	O
human	JJ	O
germ	NN	O
line	NN	O
HPRT	NNP	O
gene	NN	O
,	,	O
but	CC	O
that	IN	O
a	DT	O
limited	JJ	O
percentage	NN	O
of	IN	O
all	PDT	O
the	DT	O
missense	JJ	O
mutations	NNS	O
cause	VBP	O
disease	NN	O
.	.	O

The	DT	O
probability	NN	O
that	IN	O
a	DT	O
mutation	NN	O
will	MD	O
cause	VB	O
disease	NN	O
tends	VBZ	O
to	TO	O
be	VB	O
higher	JJR	O
when	WRB	O
the	DT	O
missense	NN	O
mutation	NN	O
is	VBZ	O
within	IN	O
a	DT	O
functionally	RB	O
important	JJ	O
sequence	NN	O
.	.	O
.	.	O

Characterisation	NN	O
of	IN	O
a	DT	O
new	JJ	O
rare	JJ	O
fragile	JJ	O
site	NN	O
easily	RB	O
confused	VBN	O
with	IN	O
the	DT	O
fragile	JJ	B_Disease
X	NN	E_Disease
.	.	O

A	DT	O
new	JJ	O
fragile	JJ	O
site	NN	O
(	(	O
FRAXE	NNP	O
)	)	O
in	IN	O
Xq28	NNP	O
is	VBZ	O
described	VBN	O
.	.	O

It	PRP	O
appears	VBZ	O
to	TO	O
be	VB	O
a	DT	O
typical	JJ	O
folate	NN	O
sensitive	JJ	O
fragile	JJ	O
site	NN	O
.	.	O

The	DT	O
fragile	JJ	O
site	NN	O
is	VBZ	O
not	RB	O
associated	VBN	O
with	IN	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
it	PRP	O
does	VBZ	O
not	RB	O
give	VB	O
abnormal	JJ	O
results	NNS	O
when	WRB	O
subjected	VBN	O
to	TO	O
Southern	NNP	O
analysis	NN	O
with	IN	O
probe	NN	O
pfxa3	NN	O
which	WDT	O
detects	VBZ	O
the	DT	O
unstable	JJ	O
DNA	NNP	O
sequence	NN	O
characteristic	NN	O
of	IN	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

In	IN	O
situ	JJ	O
hybridization	NN	O
mapping	NN	O
locates	VBZ	O
the	DT	O
fragile	JJ	O
site	NN	O
between	IN	O
150	CD	O
kb	NNS	O
and	CC	O
600	CD	O
kb	NNS	O
distal	JJ	O
to	TO	O
FRAXA	NNP	O
.	.	O

The	DT	O
distinction	NN	O
between	IN	O
the	DT	O
two	CD	O
fragile	NN	O
sites	NNS	O
is	VBZ	O
important	JJ	O
clinically	RB	O
since	IN	O
cytogenetic	JJ	O
detection	NN	O
of	IN	O
FRAXE	NNP	O
,	,	O
without	IN	O
molecular	JJ	O
analysis	NN	O
,	,	O
could	MD	O
result	VB	O
in	IN	O
misdiagnosis	NN	O
of	IN	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O
.	.	O

The	DT	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
maps	NNS	O
to	TO	O
a	DT	O
150	CD	O
kb	JJ	O
region	NN	O
on	IN	O
chromosome	NN	O
Xp11	NNP	O
.	.	O
3	CD	O
.	.	O

Norrie	NNP	B_Disease
disease	NN	E_Disease
is	VBZ	O
a	DT	O
human	JJ	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
of	IN	O
unknown	JJ	O
etiology	NN	O
characterized	VBN	O
by	IN	O
congenital	JJ	B_Disease
blindness	NN	E_Disease
,	,	O
sensory	JJ	B_Disease
neural	JJ	I_Disease
deafness	NN	E_Disease
and	CC	O
mental	JJ	B_Disease
retardation	NN	E_Disease
.	.	O

This	DT	O
disease	NN	O
gene	NN	O
was	VBD	O
previously	RB	O
linked	VBN	O
to	TO	O
the	DT	O
DXS7	NNP	O
(	(	O
L1	NNP	O
.	.	O

28	CD	O
)	)	O
locus	NN	O
and	CC	O
the	DT	O
MAO	NNP	O
genes	NNS	O
in	IN	O
band	NN	O
Xp11	NNP	O
.	.	O

3	CD	O
3	CD	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
fine	JJ	O
physical	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
obligate	JJ	O
region	NN	O
containing	VBG	O
the	DT	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
(	(	O
NDP	NNP	O
)	)	O
defined	VBN	O
by	IN	O
a	DT	O
recombination	NN	O
and	CC	O
by	IN	O
the	DT	O
smallest	JJS	O
submicroscopic	NN	O
chromosomal	JJ	O
deletion	NN	O
associated	VBN	O
with	IN	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
identified	VBD	O
to	TO	O
date	NN	O
.	.	O

Analysis	NN	O
,	,	O
using	VBG	O
in	IN	O
addition	NN	O
two	CD	O
overlapping	VBG	O
YAC	NNP	O
clones	NNS	O
from	IN	O
this	DT	O
region	NN	O
,	,	O
allowed	VBN	O
orientation	NN	O
of	IN	O
the	DT	O
MAOA	NNP	O
and	CC	O
MAOB	NNP	O
genes	NNS	O
in	IN	O
a	DT	O
5	CD	O
-	:	O
3	CD	O
-	:	O
3	CD	O
-	:	O
5	CD	O
configuration	NN	O
.	.	O

A	DT	O
recombination	NN	O
event	NN	O
between	IN	O
a	DT	O
(	(	O
GT	NNP	O
)	)	O
n	VBP	O
polymorphism	NN	O
in	IN	O
intron	NN	O
2	CD	O
of	IN	O
the	DT	O
MAOB	NNP	O
gene	NN	O
and	CC	O
the	DT	O
NDP	NNP	O
locus	NN	O
,	,	O
in	IN	O
a	DT	O
family	NN	O
previously	RB	O
reported	VBN	O
to	TO	O
have	VB	O
a	DT	O
recombination	NN	O
between	IN	O
DXS7	NNP	O
and	CC	O
NDP	NNP	O
,	,	O
delineates	VBZ	O
a	DT	O
flanking	NN	O
marker	NN	O
telomeric	NN	O
to	TO	O
this	DT	O
disease	NN	O
gene	NN	O
.	.	O

An	DT	O
anonymous	JJ	O
DNA	NN	O
probe	NN	O
,	,	O
dc12	NN	O
,	,	O
present	NN	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
YACs	NNP	O
and	CC	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
submicroscopic	NN	O
deletion	NN	O
which	WDT	O
includes	VBZ	O
MAOA	NNP	O
and	CC	O
MAOB	NNP	O
but	CC	O
not	RB	O
L1	NNP	O
.	.	O

28	CD	O
,	,	O
serves	VBZ	O
as	IN	O
a	DT	O
flanking	NN	O
marker	NN	O
centromeric	NN	O
to	TO	O
the	DT	O
disease	NN	O
gene	NN	O
.	.	O

An	DT	O
Alu	NNP	O
-	:	O
PCR	NNP	O
fragment	NN	O
from	IN	O
the	DT	O
right	JJ	O
arm	NN	O
of	IN	O
the	DT	O
MAO	NNP	O
YAC	NNP	O
(	(	O
YMAO	NNP	O
.	.	O

AluR	NNP	O
)	)	O
is	VBZ	O
not	RB	O
deleted	VBN	O
in	IN	O
this	DT	O
patient	NN	O
and	CC	O
also	RB	O
delineates	VBZ	O
the	DT	O
centromeric	JJ	O
extent	NN	O
of	IN	O
the	DT	O
obligate	JJ	O
disease	NN	O
region	NN	O
.	.	O

The	DT	O
apparent	JJ	O
order	NN	O
of	IN	O
these	DT	O
loci	NN	O
is	VBZ	O
telomere	RB	O
.	.	O

DXS7	NNP	O
-	:	O
MAOA	NNP	O
-	:	O
MAOB	NNP	O
-	:	O
NDP	NNP	O
-	:	O
dc12	NN	O
-	:	O
YMAO	NN	O
DXS7	NNP	O
-	:	O
MAOA	NNP	O
-	:	O
MAOB	NNP	O
-	:	O
NDP	NNP	O
-	:	O
dc12	NN	O
-	:	O
YMAO	NN	O
.	.	O

AluR	NNP	O
.	.	O

centromere	RB	O
.	.	O

Together	RB	O
these	DT	O
data	NNS	O
define	VBP	O
the	DT	O
obligate	JJ	O
region	NN	O
containing	VBG	O
the	DT	O
NDP	NNP	O
gene	NN	O
to	TO	O
a	DT	O
chromosomal	JJ	O
segment	NN	O
less	JJR	O
than	IN	O
150	CD	O
kb	NN	O
.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
phenylketonuria	NNS	S_Disease
and	CC	O
related	JJ	O
hyperphenylalaninemias	NN	S_Disease
:	:	O
mutations	NNS	O
and	CC	O
polymorphisms	NNS	O
in	IN	O
the	DT	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
producing	VBG	O
phenylketonuria	NNS	S_Disease
or	CC	O
hyperphenylalaninemia	NNS	S_Disease
have	VBP	O
now	RB	O
been	VBN	O
identified	VBN	O
in	IN	O
many	JJ	O
patients	NNS	O
from	IN	O
various	JJ	O
ethnic	JJ	O
groups	NNS	O
.	.	O

These	DT	O
mutations	NNS	O
all	DT	O
exhibit	VBP	O
a	DT	O
high	JJ	O
degree	NN	O
of	IN	O
association	NN	O
with	IN	O
specific	JJ	O
restriction	NN	O
fragment	NN	O
-	:	O
length	NN	O
polymorphism	NN	O
haplotypes	NNS	O
at	IN	O
the	DT	O
PAH	NNP	O
locus	NN	O
.	.	O

About	IN	O
50	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
are	VBP	O
single	JJ	O
-	:	O
base	NN	O
substitutions	NNS	O
,	,	O
including	VBG	O
six	CD	O
nonsense	JJ	O
mutations	NNS	O
and	CC	O
eight	CD	O
splicing	VBG	O
mutations	NNS	O
,	,	O
with	IN	O
the	DT	O
remainder	NN	O
being	VBG	O
missense	JJ	O
mutations	NNS	O
.	.	O

One	CD	O
splicing	VBG	O
mutation	NN	O
results	NNS	O
in	IN	O
a	DT	O
3	CD	O
amino	NN	O
acid	NN	O
in	IN	O
-	:	O
frame	NN	O
insertion	NN	O
.	.	O

Two	CD	O
or	CC	O
3	CD	O
large	JJ	O
deletions	NNS	O
,	,	O
2	CD	O
single	JJ	O
codon	NN	O
deletions	NNS	O
,	,	O
and	CC	O
2	CD	O
single	JJ	O
base	NN	O
deletions	NNS	O
have	VBP	O
been	VBN	O
found	VBN	O
.	.	O

Twelve	NN	O
of	IN	O
the	DT	O
missense	NN	O
mutations	NNS	O
apparently	RB	O
result	VBP	O
from	IN	O
the	DT	O
methylation	NN	O
and	CC	O
subsequent	JJ	O
deamination	NN	O
of	IN	O
highly	RB	O
mutagenic	JJ	O
CpG	NNP	O
dinucleotides	NNS	O
.	.	O

Recurrent	JJ	O
mutation	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
at	IN	O
several	JJ	O
of	IN	O
these	DT	O
sites	NNS	O
,	,	O
producing	VBG	O
associations	NNS	O
with	IN	O
different	JJ	O
haplotypes	NNS	O
in	IN	O
different	JJ	O
populations	NNS	O
.	.	O

About	IN	O
half	NN	O
of	IN	O
all	DT	O
missense	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
examined	VBN	O
by	IN	O
in	IN	O
vitro	JJ	O
expression	NN	O
analysis	NN	O
,	,	O
and	CC	O
a	DT	O
significant	JJ	O
correlation	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
between	IN	O
residual	JJ	O
PAH	NNP	O
activity	NN	O
and	CC	O
disease	NN	O
phenotype	NN	O
.	.	O

Since	IN	O
continuing	VBG	O
advances	NNS	O
in	IN	O
molecular	JJ	O
methodologies	NNS	O
have	VBP	O
dramatically	RB	O
accelerated	VBN	O
the	DT	O
rate	NN	O
in	IN	O
which	WDT	O
new	JJ	O
mutations	NNS	O
are	VBP	O
being	VBG	O
identified	VBN	O
and	CC	O
characterized	VBN	O
,	,	O
this	DT	O
register	NN	O
of	IN	O
mutations	NNS	O
will	MD	O
be	VB	O
updated	VBN	O
periodically	RB	O
.	.	O
.	.	O

A	DT	O
glycine250	NN	O
-	:	O
-	:	O
>	NN	O
aspartate	JJ	O
substitution	NN	O
in	IN	O
the	DT	O
alpha	NN	O
-	:	O
subunit	NN	O
of	IN	O
hexosaminidase	NN	O
A	NNP	O
causes	VBZ	O
juvenile	JJ	O
-	:	O
onset	NN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
in	IN	O
a	DT	O
Lebanese	JJ	O
-	:	O
Canadian	JJ	O
family	NN	O
.	.	O

The	DT	O
mutation	NN	O
causing	VBG	O
juvenile	NN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
TSD	NNP	S_Disease
)	)	O
in	IN	O
two	CD	O
sibs	NN	O
of	IN	O
Lebanese	NNP	O
-	:	O
Maronite	NNP	O
origin	NN	O
is	VBZ	O
described	VBN	O
.	.	O

An	DT	O
mRNA	NN	O
-	:	O
containing	VBG	O
extract	NN	O
of	IN	O
cultured	JJ	O
fibroblasts	NNS	O
obtained	VBD	O
from	IN	O
one	CD	O
of	IN	O
the	DT	O
probands	NNS	O
was	VBD	O
used	VBN	O
as	IN	O
a	DT	O
template	NN	O
to	TO	O
amplify	VB	O
the	DT	O
coding	VBG	O
sequence	NN	O
of	IN	O
the	DT	O
hexosaminidase	NN	O
A	NNP	O
(	(	O
Hex	NNP	O
A	NNP	O
)	)	O
alpha	SYM	O
-	:	O
subunit	NN	O
.	.	O

Sequencing	VBG	O
of	IN	O
amplified	JJ	O
cDNA	NN	O
fragments	NNS	O
revealed	VBD	O
a	DT	O
single	JJ	O
alteration	NN	O
,	,	O
guanine	NN	O
to	TO	O
adenine	VB	O
at	IN	O
nt	JJ	O
749	CD	O
creating	VBG	O
a	DT	O
G250D	NNP	O
mutation	NN	O
.	.	O

The	DT	O
mutation	NN	O
introduces	VBZ	O
a	DT	O
new	JJ	O
recognition	NN	O
site	NN	O
for	IN	O
the	DT	O
restriction	NN	O
enzyme	VBZ	O
Eco	NNP	O
RV	NNP	O
,	,	O
permitting	VBG	O
identification	NN	O
of	IN	O
heterozygotes	NNS	O
for	IN	O
this	DT	O
allele	NN	O
following	VBG	O
PCR	NNP	O
amplification	NN	O
and	CC	O
Eco	NNP	O
RV	NNP	O
digestion	NN	O
of	IN	O
exon	$	O
7	CD	O
sequences	NNS	O
from	IN	O
genomic	JJ	O
DNA	NNP	O
templates	NNS	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
test	VB	O
the	DT	O
effect	NN	O
of	IN	O
this	DT	O
substitution	NN	O
,	,	O
an	DT	O
in	IN	O
vitro	NN	O
mutagenized	VBN	O
cDNA	NN	O
construct	NN	O
was	VBD	O
introduced	VBN	O
into	IN	O
a	DT	O
mammalian	JJ	O
expression	NN	O
vector	NN	O
and	CC	O
transfected	VBD	O
into	IN	O
monkey	JJ	O
Cos	NNP	O
-	:	O
1	CD	O
cells	NNS	O
separately	RB	O
or	CC	O
along	RB	O
with	IN	O
a	DT	O
beta	NN	O
-	:	O
cDNA	NN	O
expression	NN	O
vector	NN	O
.	.	O

When	WRB	O
the	DT	O
mutant	NN	O
alpha	SYM	O
-	:	O
cDNA	NN	O
was	VBD	O
the	DT	O
only	JJ	O
gene	NN	O
introduced	VBD	O
into	IN	O
COS	NNP	O
cells	NNS	O
no	DT	O
enzymatic	JJ	O
activity	NN	O
above	IN	O
endogenous	JJ	O
COS	NNP	O
cell	NN	O
activity	NN	O
was	VBD	O
detected	VBN	O
.	.	O

Cotransfection	NN	O
of	IN	O
normal	JJ	O
alpha	JJ	O
-	:	O
cDNA	NN	O
and	CC	O
beta	NN	O
-	:	O
cDNA	NN	O
followed	VBN	O
by	IN	O
immunoprecipitation	NN	O
of	IN	O
human	JJ	O
Hex	NNP	O
A	NNP	O
resulted	VBD	O
in	IN	O
20	CD	O
-	:	O
fold	JJ	O
increase	NN	O
in	IN	O
the	DT	O
ratio	NN	O
between	IN	O
positive	JJ	O
and	CC	O
negative	JJ	O
(	(	O
mock	JJ	O
transfection	NN	O
)	)	O
control	NN	O
values	NNS	O
.	.	O

This	DT	O
allowed	VBD	O
the	DT	O
detection	NN	O
of	IN	O
some	DT	O
residual	JJ	O
activity	NN	O
(	(	O
12	CD	O
%	NN	O
of	IN	O
the	DT	O
positive	JJ	O
control	NN	O
)	)	O
when	WRB	O
the	DT	O
mutant	NN	O
alpha	SYM	O
-	:	O
cDNA	NN	O
replaced	VBD	O
its	PRP$	O
wild	JJ	O
-	:	O
type	NN	O
counterpart	NN	O
.	.	O

The	DT	O
predicted	JJ	O
protein	NN	O
environment	NN	O
in	IN	O
which	WDT	O
the	DT	O
mutation	NN	O
occurs	VBZ	O
is	VBZ	O
compared	VBN	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
adult	NN	O
-	:	O
onset	NN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
mutation	NN	O
caused	VBN	O
by	IN	O
a	DT	O
Gly269	NNP	O
-	:	O
-	:	O
>	NN	O
Ser	NNP	O
substitution	NN	O
in	IN	O
exon	JJ	O
7	CD	O
.	.	O

(	(	O
ABSTRACT	NNP	O
TRUNCATED	NNP	O
AT	NNP	O
250	CD	O
WORDS	NNP	O
)	)	O
.	.	O

Novel	NNP	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
mutations	NNS	O
from	IN	O
China	NNP	O
.	.	O

We	PRP	O
describe	VBP	O
three	CD	O
HEXA	NNP	O
mutations	NNS	O
associated	VBN	O
with	IN	O
infantile	JJ	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
TSD	NNP	S_Disease
)	)	O
in	IN	O
three	CD	O
unrelated	JJ	O
nonconsanguineous	JJ	O
Chinese	JJ	O
families	NNS	O
.	.	O

Novel	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
two	CD	O
of	IN	O
these	DT	O
families	NNS	O
.	.	O

The	DT	O
third	JJ	O
is	VBZ	O
a	DT	O
previously	RB	O
reported	VBN	O
mutation	NN	O
(	(	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
transition	NN	O
at	IN	O
nt	JJ	O
1444	CD	O
)	)	O
(	(	O
Nakano	NNP	O
et	RB	O
al	RB	O
.	.	O
,	,	O
1988	CD	O
)	)	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
PCR	NNP	O
products	NNS	O
identified	VBD	O
a	DT	O
novel	JJ	O
insertion	NN	O
of	IN	O
an	DT	O
A	NNP	O
after	IN	O
nt	JJ	O
547	CD	O
in	IN	O
family	NN	O
1	CD	O
.	.	O

This	DT	O
change	NN	O
generates	VBZ	O
an	DT	O
early	JJ	O
termination	NN	O
codon	VBZ	O
6	CD	O
bp	NN	O
downstream	NN	O
from	IN	O
the	DT	O
insertion	NN	O
site	NN	O
.	.	O

Allele	NNP	O
-	:	O
specific	JJ	O
oligonucleotide	JJ	O
hybridization	NN	O
confirmed	VBD	O
homozygosity	NN	O
in	IN	O
the	DT	O
proband	NN	O
.	.	O

Single	NNP	O
strand	VBP	O
conformational	JJ	O
polymorphism	NN	O
analysis	NN	O
and	CC	O
direct	JJ	O
sequencing	NN	O
of	IN	O
amplified	JJ	O
exon	NN	O
13	CD	O
revealed	VBD	O
a	DT	O
T	NNP	O
-	:	O
-	:	O
>	NN	O
C	NNP	O
transition	NN	O
at	IN	O
nt	JJ	O
1453	CD	O
with	IN	O
the	DT	O
corresponding	VBG	O
amino	NN	O
acid	JJ	O
substitution	NN	O
W485R	NNP	O
in	IN	O
the	DT	O
second	JJ	O
family	NN	O
.	.	O

This	DT	O
mutation	NN	O
creates	VBZ	O
an	DT	O
Fnu4HI	NNP	O
restriction	NN	O
site	NN	O
.	.	O

The	DT	O
proband	NN	O
is	VBZ	O
homozygous	JJ	O
for	IN	O
this	DT	O
allele	NN	O
.	.	O

When	WRB	O
the	DT	O
site	NN	O
-	:	O
specific	JJ	O
mutagenized	VBN	O
alpha	JJ	O
cDNA	NN	O
carrying	VBG	O
the	DT	O
T	NNP	O
-	:	O
-	:	O
>	NN	O
C	NNP	O
transition	NN	O
at	IN	O
nt	JJ	O
1453	CD	O
was	VBD	O
expressed	VBN	O
in	IN	O
COS	NNP	O
1	CD	O
cells	NNS	O
hexosaminidase	JJ	O
S	NNP	O
activity	NN	O
was	VBD	O
not	RB	O
detectable	JJ	O
above	IN	O
background	NN	O
.	.	O

A	DT	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
transition	NN	O
at	IN	O
nt	JJ	O
1444	CD	O
(	(	O
exon	VB	O
13	CD	O
)	)	O
corresponding	NN	O
to	TO	O
the	DT	O
E482K	NNP	O
substitution	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
third	JJ	O
family	NN	O
.	.	O

This	DT	O
mutation	NN	O
occurs	VBZ	O
at	IN	O
a	DT	O
CpG	NNP	O
dinucleotide	NN	O
.	.	O

It	PRP	O
has	VBZ	O
been	VBN	O
reported	VBN	O
in	IN	O
an	DT	O
Italian	JJ	O
TSD	NNP	S_Disease
proband	NN	O
and	CC	O
causes	VBZ	O
defective	JJ	O
intracellular	JJ	O
transport	NN	O
of	IN	O
the	DT	O
alpha	JJ	O
-	:	O
subunit	NN	O
from	IN	O
the	DT	O
rough	JJ	O
endoplasmic	JJ	O
reticulum	NN	O
to	TO	O
the	DT	O
Golgi	NNP	O
apparatus	NN	O
.	.	O

Two	CD	O
missense	JJ	O
mutations	NNS	O
causing	VBG	O
mild	JJ	O
hyperphenylalaninemia	NN	S_Disease
associated	VBN	O
with	IN	O
DNA	NNP	O
haplotype	NN	O
12	CD	O
.	.	O

The	DT	O
genetic	JJ	B_Disease
defects	NNS	E_Disease
responsible	JJ	O
for	IN	O
most	JJS	O
phenylketonuria	NNS	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
and	CC	O
hyperphenylalaninemia	NN	S_Disease
(	(	O
HPA	NNP	S_Disease
)	)	O
cases	NNS	O
are	VBP	O
located	VBN	O
in	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	(	O
PAH	NNP	O
)	)	O
gene	NN	O
.	.	O

Approximately	RB	O
50	CD	O
-	:	O
60	CD	O
mutations	NNS	O
have	VBP	O
been	VBN	O
reported	VBN	O
in	IN	O
Caucasians	NNPS	O
and	CC	O
are	VBP	O
reflected	VBN	O
in	IN	O
a	DT	O
wide	JJ	O
range	NN	O
of	IN	O
clinical	JJ	O
severities	NNS	O
.	.	O

Most	JJS	O
mutations	NNS	O
are	VBP	O
linked	VBN	O
to	TO	O
specific	JJ	O
haplotypes	NNS	O
,	,	O
as	IN	O
defined	VBN	O
by	IN	O
eight	CD	O
polymorphic	JJ	O
restriction	NN	O
sites	NNS	O
in	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
.	.	O

We	PRP	O
hypothesized	VBD	O
that	IN	O
there	EX	O
is	VBZ	O
at	IN	O
least	JJS	O
one	CD	O
mild	JJ	O
mutation	NN	O
linked	VBD	O
to	TO	O
haplotype	VB	O
12	CD	O
in	IN	O
the	DT	O
Swedish	JJ	O
PKU	NNP	S_Disease
/	NNP	O
HPA	NNP	S_Disease
population	NN	O
,	,	O
since	IN	O
7	CD	O
of	IN	O
8	CD	O
patients	NNS	O
carrying	VBG	O
haplotype	JJ	O
12	CD	O
had	VBD	O
mild	VBN	O
HPA	NNP	S_Disease
.	.	O

Sequence	NN	O
analysis	NN	O
revealed	VBD	O
a	DT	O
C	NNP	O
-	:	O
to	TO	O
-	:	O
G	NNP	O
transversion	NN	O
at	IN	O
the	DT	O
second	JJ	O
base	NN	O
of	IN	O
codon	NN	O
322	CD	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
substitution	NN	O
of	IN	O
glycine	NN	O
for	IN	O
alanine	NN	O
,	,	O
in	IN	O
four	CD	O
mutant	NN	O
haplotype	NN	O
12	CD	O
genes	NNS	O
,	,	O
and	CC	O
a	DT	O
G	NNP	O
-	:	O
to	TO	O
-	:	O
A	DT	O
transition	NN	O
at	IN	O
the	DT	O
second	JJ	O
base	NN	O
of	IN	O
codon	NN	O
408	CD	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
substitution	NN	O
of	IN	O
glutamine	NN	O
for	IN	O
arginine	NN	O
,	,	O
in	IN	O
another	DT	O
three	CD	O
mutant	NN	O
haplotype	VBD	O
12	CD	O
genes	NNS	O
.	.	O

These	DT	O
mutations	NNS	O
segregated	VBD	O
with	IN	O
mutant	JJ	O
haplotype	NN	O
12	CD	O
alleles	NNS	O
in	IN	O
nuclear	JJ	O
families	NNS	O
but	CC	O
were	VBD	O
not	RB	O
present	JJ	O
on	IN	O
normal	JJ	O
or	CC	O
other	JJ	O
mutant	JJ	O
alleles	NNS	O
.	.	O

Both	DT	O
mutations	NNS	O
were	VBD	O
tested	VBN	O
in	IN	O
a	DT	O
eukaryotic	JJ	O
expression	NN	O
system	NN	O
in	IN	O
which	WDT	O
enzyme	JJ	O
activities	NNS	O
of	IN	O
different	JJ	O
mutant	JJ	O
PAH	NNP	O
enzymes	NNS	O
reflect	VBP	O
the	DT	O
relative	JJ	O
severities	NNS	O
of	IN	O
the	DT	O
mutations	NNS	O
,	,	O
although	IN	O
these	DT	O
in	IN	O
vitro	NN	O
activities	NNS	O
cannot	VBP	O
be	VB	O
translated	VBN	O
directly	RB	O
into	IN	O
in	IN	O
vivo	JJ	O
hepatic	JJ	O
activities	NNS	O
.	.	O

The	DT	O
A322G	NNP	O
mutant	NN	O
PAH	NNP	O
had	VBD	O
about	IN	O
75	CD	O
%	NN	O
and	CC	O
the	DT	O
R408Q	NNP	O
mutant	NN	O
PAH	NNP	O
about	IN	O
55	CD	O
%	NN	O
of	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
PAH	NNP	O
enzyme	NN	O
activity	NN	O
.	.	O

These	DT	O
in	IN	O
vitro	NN	O
activities	NNS	O
are	VBP	O
the	DT	O
highest	JJS	O
reported	VBD	O
for	IN	O
mutant	JJ	O
PAH	NNP	O
enzymes	NNS	O
produced	VBD	O
in	IN	O
the	DT	O
same	JJ	O
expression	NN	O
system	NN	O
.	.	O

(	(	O
ABSTRACT	NNP	O
TRUNCATED	NNP	O
AT	NNP	O
250	CD	O
WORDS	NNP	O
)	)	O
.	.	O

In	IN	O
vitro	NN	O
and	CC	O
in	IN	O
vivo	JJ	O
correlations	NNS	O
for	IN	O
I65T	NNP	O
and	CC	O
M1V	NNP	O
mutations	NNS	O
at	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
locus	NN	O
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	(	O
PAH	NNP	O
)	)	O
locus	NN	O
are	VBP	O
the	DT	O
major	JJ	O
cause	NN	O
of	IN	O
hyperphenylalaninemia	NN	S_Disease
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
described	VBN	O
four	CD	O
mutations	NNS	O
(	(	O
M1V	NNP	O
,	,	O
IVS12nt1	NNP	O
,	,	O
R408W	NNP	O
,	,	O
and	CC	O
S349P	NNP	O
)	)	O
at	IN	O
the	DT	O
PAH	NNP	O
locus	NN	O
in	IN	O
French	JJ	O
Canadians	NNPS	O
with	IN	O
ancestry	NN	O
in	IN	O
eastern	JJ	O
Quebec	NNP	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
(	(	O
1	CD	O
)	)	O
identification	NN	O
of	IN	O
another	DT	O
mutation	NN	O
,	,	O
on	IN	O
a	DT	O
haplotype	NN	O
9	CD	O
chromosome	NN	O
,	,	O
which	WDT	O
converts	VBZ	O
codon	NN	O
65	CD	O
from	IN	O
isoleucine	NN	O
(	(	O
ATT	NNP	O
)	)	O
to	TO	O
threonine	VB	O
(	(	O
ACT	NNP	O
)	)	O
,	,	O
(	(	O
2	CD	O
)	)	O
expression	NN	O
analysis	NN	O
of	IN	O
the	DT	O
I65T	NNP	O
mutation	NN	O
in	IN	O
COS	NNP	O
cells	NNS	O
demonstrating	VBG	O
75	CD	O
%	NN	O
loss	NN	O
of	IN	O
both	DT	O
immunoreactive	JJ	O
protein	NN	O
and	CC	O
enzyme	NN	O
activity	NN	O
,	,	O
and	CC	O
(	(	O
3	CD	O
)	)	O
expression	NN	O
analysis	NN	O
of	IN	O
the	DT	O
most	RBS	O
prevalent	JJ	O
PKU	NNP	S_Disease
allele	NN	O
(	(	O
M1V	NNP	O
)	)	O
in	IN	O
eastern	JJ	O
Quebec	NNP	O
,	,	O
showing	VBG	O
nondetectable	JJ	O
levels	NNS	O
of	IN	O
PAH	NNP	O
protein	NN	O
and	CC	O
activity	NN	O
,	,	O
a	DT	O
finding	NN	O
compatible	JJ	O
with	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
translation	NN	O
initiation	NN	O
codon	NN	O
.	.	O

Homozygosity	NN	O
for	IN	O
M1V	NNP	O
and	CC	O
codominant	JJ	O
inheritance	NN	O
of	IN	O
I65T	NNP	O
/	NNP	O
R408W	NNP	O
were	VBD	O
both	DT	O
associated	VBN	O
with	IN	O
classical	JJ	B_Disease
phenylketonuria	NN	E_Disease
.	.	O
.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
hexosaminidase	NN	B_Disease
A	NNP	I_Disease
deficiency	NN	E_Disease
and	CC	O
pseudodeficiency	NN	O
in	IN	O
the	DT	O
Berks	NNP	O
County	NNP	O
Pennsylvania	NNP	O
Dutch	NNP	O
.	.	O

Following	VBG	O
the	DT	O
birth	NN	O
of	IN	O
two	CD	O
infants	NNS	O
with	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
TSD	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
non	JJ	O
-	:	O
Jewish	NN	O
,	,	O
Pennsylvania	NNP	O
Dutch	NNP	O
kindred	VBD	O
was	VBD	O
screened	VBN	O
for	IN	O
TSD	NNP	S_Disease
carriers	NNS	O
using	VBG	O
the	DT	O
biochemical	JJ	O
assay	NN	O
.	.	O

A	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
individuals	NNS	O
who	WP	O
appeared	VBD	O
to	TO	O
be	VB	O
TSD	NNP	S_Disease
heterozygotes	NNS	O
was	VBD	O
detected	VBN	O
(	(	O
Kelly	NNP	O
et	VBZ	O
al	NN	O
.	.	O
,	,	O
1975	CD	O
)	)	O
.	.	O

Clinical	JJ	O
and	CC	O
biochemical	JJ	O
evidence	NN	O
suggested	VBD	O
that	IN	O
the	DT	O
increased	VBN	O
carrier	NN	O
frequency	NN	O
was	VBD	O
due	JJ	O
to	TO	O
at	IN	O
least	JJS	O
two	CD	O
altered	JJ	O
alleles	NNS	O
for	IN	O
the	DT	O
hexosaminidase	NN	O
A	NNP	O
alpha	NN	O
-	:	O
subunit	NN	O
.	.	O

We	PRP	O
now	RB	O
report	VBP	O
two	CD	O
mutant	JJ	O
alleles	NNS	O
in	IN	O
this	DT	O
Pennsylvania	NNP	O
Dutch	NNP	O
kindred	VBD	O
,	,	O
and	CC	O
one	CD	O
polymorphism	NN	O
.	.	O

One	CD	O
allele	NN	O
,	,	O
reported	VBD	O
originally	RB	O
in	IN	O
a	DT	O
French	JJ	O
TSD	NNP	S_Disease
patient	NN	O
(	(	O
Akli	NNP	O
et	RB	O
al	RB	O
.	.	O
,	,	O
1991	CD	O
)	)	O
,	,	O
is	VBZ	O
a	DT	O
GT	NNP	O
-	:	O
-	:	O
>	NN	O
AT	NNP	O
transition	NN	O
at	IN	O
the	DT	O
donor	NN	O
splice	NN	O
-	:	O
site	NN	O
of	IN	O
intron	NN	O
9	CD	O
.	.	O

The	DT	O
second	JJ	O
,	,	O
a	DT	O
C	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
transition	NN	O
at	IN	O
nucleotide	JJ	O
739	CD	O
(	(	O
Arg247Trp	NNP	O
)	)	O
,	,	O
has	VBZ	O
been	VBN	O
shown	VBN	O
by	IN	O
Triggs	NNP	O
-	:	O
Raine	NNP	O
et	CC	O
al	NN	O
.	.	O

(	(	O
1992	CD	O
)	)	O
to	TO	O
be	VB	O
a	DT	O
clinically	RB	O
benign	JJ	O
"	NNP	O
pseudodeficient	NN	O
"	NNP	O
allele	RB	O
associated	VBD	O
with	IN	O
reduced	JJ	O
enzyme	JJ	O
activity	NN	O
against	IN	O
artificial	JJ	O
substrate	NN	O
.	.	O

Finally	RB	O
,	,	O
a	DT	O
polymorphism	NN	O
[	NNP	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	NNP	O
(	(	O
759	CD	O
)	)	O
]	NN	O
,	,	O
which	WDT	O
leaves	VBZ	O
valine	NN	O
at	IN	O
codon	$	O
253	CD	O
unchanged	JJ	O
,	,	O
is	VBZ	O
described	VBN	O
.	.	O

A	DT	O
mutation	NN	O
common	JJ	O
in	IN	O
non	JJ	O
-	:	O
Jewish	JJ	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
:	:	O
frequency	NN	O
and	CC	O
RNA	NNP	O
studies	NNS	O
.	.	O

Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
TSD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
genetic	JJ	I_Disease
disorder	NN	E_Disease
resulting	VBG	O
from	IN	O
mutation	NN	O
of	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
encoding	VBG	O
the	DT	O
alpha	NN	O
-	:	O
subunit	NN	O
of	IN	O
the	DT	O
lysosomal	JJ	O
enzyme	NN	O
,	,	O
beta	SYM	O
-	:	O
N	NNP	O
-	:	O
acetylhexosaminidase	NN	O
A	NNP	O
(	(	O
Hex	NNP	O
A	NNP	O
)	)	O
.	.	O

We	PRP	O
have	VBP	O
discovered	VBN	O
that	IN	O
a	DT	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	E_Disease
mutation	NN	O
,	,	O
IVS	NNP	O
-	:	O
9	CD	O
+	$	O
1	CD	O
G	NNP	O
-	:	O
-	:	O
>	NN	O
A	NNP	O
,	,	O
first	RB	O
detected	VBN	O
by	IN	O
Akli	NNP	O
et	CC	O
al	NN	O
.	.	O

(	(	O
Genomics	NNS	O
11	CD	O
124	CD	O
-	:	O
134	CD	O
,	,	O
1991	CD	O
)	)	O
,	,	O
is	VBZ	O
a	DT	O
common	JJ	O
disease	NN	O
allele	NN	O
in	IN	O
non	JJ	O
-	:	O
Jewish	JJ	O
Caucasians	NNPS	O
(	(	O
10	CD	O
/	RB	O
58	CD	O
alleles	NNS	O
examined	VBN	O
)	)	O
.	.	O

A	DT	O
PCR	NNP	O
-	:	O
based	VBN	O
diagnostic	JJ	O
test	NN	O
,	,	O
which	WDT	O
detects	VBZ	O
an	DT	O
NlaIII	NNP	O
site	NN	O
generated	VBN	O
by	IN	O
the	DT	O
mutation	NN	O
,	,	O
revealed	VBD	O
a	DT	O
frequency	NN	O
among	IN	O
enzyme	JJ	O
-	:	O
defined	JJ	O
carriers	NNS	O
of	IN	O
9	CD	O
/	NNS	O
64	CD	O
(	(	O
14	CD	O
%	NN	O
)	)	O
.	.	O

Most	JJS	O
of	IN	O
those	DT	O
carrying	VBG	O
the	DT	O
allele	JJ	O
trace	VBP	O
their	PRP$	O
origins	NNS	O
to	TO	O
the	DT	O
United	NNP	O
Kingdom	NNP	O
,	,	O
Ireland	NNP	O
,	,	O
or	CC	O
Western	NNP	O
Europe	NNP	O
.	.	O

It	PRP	O
was	VBD	O
not	RB	O
identified	VBN	O
among	IN	O
12	CD	O
Black	NNP	O
American	NNP	O
TSD	NNP	S_Disease
alleles	VBZ	O
or	CC	O
in	IN	O
any	DT	O
of	IN	O
18	CD	O
Ashkenazi	NNP	O
Jewish	NNP	O
,	,	O
enzyme	SYM	O
-	:	O
defined	VBN	O
carriers	NNS	O
who	WP	O
did	VBD	O
not	RB	O
carry	VB	O
any	DT	O
of	IN	O
the	DT	O
mutations	NNS	O
common	JJ	O
to	TO	O
this	DT	O
population	NN	O
.	.	O

No	DT	O
normally	RB	O
spliced	VBN	O
RNA	NNP	O
was	VBD	O
detected	VBN	O
in	IN	O
PCR	NNP	O
products	NNS	O
generated	VBD	O
from	IN	O
reverse	JJ	O
transcription	NN	O
of	IN	O
RNA	NNP	O
carrying	VBG	O
the	DT	O
IVS	NNP	O
-	:	O
9	CD	O
mutation	NN	O
.	.	O

Instead	RB	O
,	,	O
the	DT	O
low	JJ	O
levels	NNS	O
of	IN	O
mRNA	NN	O
from	IN	O
this	DT	O
allele	NN	O
were	VBD	O
comprised	VBN	O
of	IN	O
aberrant	JJ	O
species	NNS	O
resulting	VBG	O
from	IN	O
the	DT	O
use	NN	O
of	IN	O
either	DT	O
of	IN	O
two	CD	O
cryptic	JJ	O
donor	NN	O
sites	NNS	O
,	,	O
one	CD	O
truncating	NN	O
exon	CC	O
9	CD	O
and	CC	O
the	DT	O
other	JJ	O
within	IN	O
IVS	NNP	O
-	:	O
9	CD	O
,	,	O
spliced	VBD	O
to	TO	O
exon	VB	O
10	CD	O
.	.	O

Numerous	JJ	O
additional	JJ	O
splice	NN	O
products	NNS	O
were	VBD	O
detected	VBN	O
,	,	O
most	JJS	O
involving	VBG	O
skipping	NN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
surrounding	JJ	O
exons	NNS	O
.	.	O

Together	RB	O
with	IN	O
a	DT	O
recently	RB	O
identified	VBN	O
allele	NN	O
responsible	JJ	O
for	IN	O
Hex	NNP	O
A	NNP	O
pseudodeficiency	NN	O
(	(	O
Triggs	NNP	O
-	:	O
Raine	NNP	O
et	CC	O
al	NN	O
.	.	O

Am	NNP	O
J	NNP	O
Hum	NNP	O
Genet	NNP	O
,	,	O
1992	CD	O
)	)	O
,	,	O
these	DT	O
two	CD	O
alleles	NNS	O
accounted	VBD	O
for	IN	O
almost	RB	O
50	CD	O
%	NN	O
(	(	O
29	CD	O
/	RB	O
64	CD	O
)	)	O
of	IN	O
TSD	NNP	S_Disease
or	CC	O
carrier	NN	O
alleles	NNS	O
ascertained	VBN	O
by	IN	O
enzyme	JJ	O
screening	VBG	O
tests	NNS	O
in	IN	O
non	JJ	O
-	:	O
Jewish	JJ	O
Caucasians	NNPS	O
.	.	O
.	.	O

Aberrant	JJ	O
splicing	NN	O
of	IN	O
the	DT	O
CHM	NNP	S_Disease
gene	NN	O
is	VBZ	O
a	DT	O
significant	JJ	O
cause	NN	O
of	IN	O
choroideremia	NN	S_Disease
.	.	O

Choroideremia	NNP	S_Disease
(	(	O
CHM	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
progressive	JJ	I_Disease
degeneration	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
choroid	NN	I_Disease
and	CC	I_Disease
retina	NN	E_Disease
.	.	O

12	CD	O
%	NN	O
of	IN	O
unrelated	JJ	O
male	JJ	O
patients	NNS	O
carry	VBP	O
deletions	NNS	O
of	IN	O
the	DT	O
partially	RB	O
cloned	VBN	O
CHM	NNP	S_Disease
gene	NN	O
.	.	O

In	IN	O
Finland	NNP	O
,	,	O
there	EX	O
are	VBP	O
more	JJR	O
than	IN	O
120	CD	O
living	VBG	O
CHM	NNP	S_Disease
patients	NNS	O
belonging	VBG	O
to	TO	O
eight	CD	O
apparently	RB	O
unrelated	JJ	O
pedigrees	NNS	O
.	.	O

Molecular	JJ	O
deletions	NNS	O
involving	VBG	O
the	DT	O
CHM	NNP	S_Disease
gene	NN	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
three	CD	O
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
screened	VBN	O
the	DT	O
remaining	VBG	O
five	CD	O
families	NNS	O
for	IN	O
point	NN	O
mutations	NNS	O
.	.	O

In	IN	O
one	CD	O
large	JJ	O
family	NN	O
a	DT	O
single	JJ	O
nucleotide	NN	O
(	(	O
T	NNP	O
)	)	O
insertion	NN	O
into	IN	O
the	DT	O
donor	JJ	O
splice	NN	O
site	NN	O
of	IN	O
exon	JJ	O
C	NNP	O
leads	VBZ	O
to	TO	O
two	CD	O
aberrantly	RB	O
spliced	VBN	O
mRNAs	JJ	O
both	DT	O
producing	VBG	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
.	.	O

The	DT	O
mutation	NN	O
can	MD	O
be	VB	O
assayed	VBN	O
easily	RB	O
by	IN	O
amplification	NN	O
and	CC	O
digestion	NN	O
with	IN	O
Msel	NNP	O
.	.	O

Our	PRP$	O
findings	NNS	O
provide	VBP	O
additional	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
pathogenetic	JJ	O
role	NN	O
of	IN	O
CHM	NNP	S_Disease
mutations	NNS	O
and	CC	O
provide	VB	O
a	DT	O
diagnostic	JJ	O
tool	NN	O
for	IN	O
one	CD	O
fifth	NN	O
of	IN	O
the	DT	O
worlds	NNS	O
known	VBN	O
CHM	NNP	S_Disease
patients	NNS	O
.	.	O
.	.	O

Germline	NNP	O
intronic	NN	O
and	CC	O
exonic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
Wilms	NNP	B_Disease
'	POS	I_Disease
tumour	NN	E_Disease
gene	NN	O
(	(	O
WT1	NNP	O
)	)	O
affecting	VBG	O
urogenital	JJ	O
development	NN	O
.	.	O

Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
human	JJ	O
developmental	JJ	B_Disease
disorder	NN	E_Disease
affecting	VBG	O
the	DT	O
urogenital	JJ	O
system	NN	O
and	CC	O
leading	VBG	O
to	TO	O
renal	JJ	B_Disease
failure	NN	E_Disease
,	,	O
intersex	NN	B_Disease
disorders	NNS	E_Disease
and	CC	O
Wilms	NNP	B_Disease
tumour	NN	E_Disease
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
four	CD	O
individuals	NNS	O
with	IN	O
this	DT	O
syndrome	NN	O
are	VBP	O
described	VBN	O
carrying	VBG	O
germline	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
Wilms	NNP	B_Disease
tumour	NN	E_Disease
suppressor	NN	O
gene	NN	O
,	,	O
WT1	NNP	O
.	.	O

Three	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
were	VBD	O
in	IN	O
the	DT	O
zinc	NN	O
finger	NN	O
domains	NNS	O
of	IN	O
WT1	NNP	O
.	.	O

The	DT	O
fourth	JJ	O
occurred	VBD	O
within	IN	O
intron	NN	O
9	CD	O
,	,	O
preventing	VBG	O
splicing	VBG	O
at	IN	O
one	CD	O
of	IN	O
the	DT	O
alternatively	RB	O
chosen	VBN	O
splice	NN	O
donor	NN	O
sites	NNS	O
of	IN	O
exon	NN	O
9	CD	O
when	WRB	O
assayed	VBN	O
in	IN	O
vitro	NN	O
.	.	O

These	DT	O
results	NNS	O
provide	VBP	O
genetic	JJ	O
evidence	NN	O
for	IN	O
distinct	JJ	O
functional	JJ	O
roles	NNS	O
of	IN	O
the	DT	O
WT1	NNP	O
isoforms	NNS	O
in	IN	O
urogenital	JJ	O
development	NN	O
.	.	O
.	.	O

Characterization	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
region	NN	O
predicts	VBZ	O
multiple	JJ	O
protein	NN	O
isoform	NN	O
-	:	O
encoding	VBG	O
mRNAs	NN	O
.	.	O

The	DT	O
mutation	NN	O
underlying	VBG	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
has	VBZ	O
been	VBN	O
identified	VBN	O
as	IN	O
an	DT	O
expansion	NN	O
of	IN	O
a	DT	O
polymorphic	JJ	O
CTG	NNP	O
-	:	O
repeat	NN	O
in	IN	O
a	DT	O
gene	NN	O
encoding	VBG	O
protein	JJ	O
kinase	NN	O
activity	NN	O
.	.	O

Brain	NNP	O
and	CC	O
heart	NN	O
transcripts	NNS	O
of	IN	O
the	DT	O
DM	NNP	O
-	:	O
kinase	NN	O
(	(	O
DMR	NNP	O
-	:	O
B15	NNP	O
)	)	O
gene	NN	O
are	VBP	O
subject	JJ	O
to	TO	O
alternative	JJ	O
RNA	NNP	O
splicing	NN	O
in	IN	O
both	DT	O
human	JJ	O
and	CC	O
mouse	NN	O
.	.	O

The	DT	O
unstable	JJ	O
[	NN	O
CTG	NNP	O
]	VBZ	O
5	CD	O
-	:	O
30	CD	O
motif	NN	O
is	VBZ	O
found	VBN	O
uniquely	RB	O
in	IN	O
humans	NNS	O
,	,	O
although	IN	O
the	DT	O
flanking	NN	O
nucleotides	NNS	O
are	VBP	O
also	RB	O
present	JJ	O
in	IN	O
mouse	NN	O
.	.	O

Characterization	NN	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
region	NN	O
of	IN	O
both	DT	O
species	NNS	O
reveals	VBP	O
another	DT	O
active	JJ	O
gene	NN	O
(	(	O
DMR	NNP	O
-	:	O
N9	NN	O
)	)	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
the	DT	O
kinase	NN	O
gene	NN	O
.	.	O

DMR	NNP	O
-	:	O
N9	NNP	O
transcripts	NNS	O
,	,	O
mainly	RB	O
expressed	VBN	O
in	IN	O
brain	NN	O
and	CC	O
testis	NN	O
,	,	O
possess	VB	O
a	DT	O
single	JJ	O
,	,	O
large	JJ	O
open	JJ	O
reading	NN	O
frame	NN	O
,	,	O
but	CC	O
the	DT	O
function	NN	O
of	IN	O
its	PRP$	O
protein	JJ	O
product	NN	O
is	VBZ	O
unknown	JJ	O
.	.	O

Clinical	JJ	O
manifestation	NN	O
of	IN	O
DM	NNP	S_Disease
may	MD	O
be	VB	O
caused	VBN	O
by	IN	O
the	DT	O
expanded	VBN	O
CTG	NNP	O
-	:	O
repeat	NN	O
compromising	VBG	O
the	DT	O
(	(	O
alternative	JJ	O
)	)	O
expression	NN	O
of	IN	O
DM	NNP	O
-	:	O
kinase	NN	O
or	CC	O
DMR	NNP	O
-	:	O
N9	NN	O
proteins	NNS	O
.	.	O
.	.	O

Fragile	NNP	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
without	IN	O
CCG	NNP	O
amplification	NN	O
has	VBZ	O
an	DT	O
FMR1	NNP	O
deletion	NN	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
patient	NN	O
with	IN	O
typical	JJ	O
clinical	JJ	O
features	NNS	O
of	IN	O
the	DT	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
but	CC	O
without	IN	O
cytogenetic	JJ	O
expression	NN	O
of	IN	O
the	DT	O
fragile	JJ	B_Disease
X	NN	E_Disease
or	CC	O
an	DT	O
amplified	JJ	O
CCG	NNP	O
trinucleotide	NN	O
repeat	NN	O
fragment	NN	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
previously	RB	O
uncharacterized	JJ	O
submicroscopic	NN	O
deletion	NN	O
encompassing	VBG	O
the	DT	O
CCG	NNP	O
repeat	NN	O
,	,	O
the	DT	O
entire	JJ	O
FMR1	NNP	O
gene	NN	O
and	CC	O
about	IN	O
2	CD	O
.	.	O

5	CD	O
megabases	NNS	O
of	IN	O
flanking	VBG	O
sequences	NNS	O
.	.	O

This	DT	O
finding	NN	O
confirms	VBZ	O
that	IN	O
the	DT	O
fragile	JJ	B_Disease
X	NNP	E_Disease
phenotype	NN	O
can	MD	O
exist	VB	O
,	,	O
without	IN	O
amplification	NN	O
of	IN	O
the	DT	O
CCG	NNP	O
repeat	NN	O
or	CC	O
cytogenetic	JJ	O
expression	NN	O
of	IN	O
the	DT	O
fragile	JJ	B_Disease
X	NN	E_Disease
,	,	O
and	CC	O
that	IN	O
fragile	JJ	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
genetically	RB	O
homogeneous	JJ	O
disorder	NN	O
involving	VBG	O
FMR1	NNP	O
.	.	O

We	PRP	O
also	RB	O
found	VBD	O
random	RB	O
X	NNP	O
-	:	O
inactivation	NN	O
in	IN	O
the	DT	O
mother	NN	O
of	IN	O
the	DT	O
patient	NN	O
who	WP	O
was	VBD	O
shown	VBN	O
to	TO	O
be	VB	O
a	DT	O
carrier	NN	O
of	IN	O
this	DT	O
deletion	NN	O
.	.	O

Cloning	NN	O
of	IN	O
the	DT	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
region	NN	O
in	IN	O
yeast	JJ	O
artificial	JJ	O
chromosomes	NNS	O
.	.	O

The	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
has	VBZ	O
been	VBN	O
localized	VBN	O
to	TO	O
a	DT	O
2	CD	O
.	.	O

5	CD	O
million	CD	O
base	NN	O
pair	NN	O
(	(	O
Mb	NNP	O
)	)	O
region	NN	O
between	IN	O
the	DT	O
loci	NN	O
D4S10	NNP	O
and	CC	O
D4S168	NNP	O
on	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
4	CD	O
.	.	O

As	IN	O
part	NN	O
of	IN	O
a	DT	O
strategy	NN	O
to	TO	O
clone	VB	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
its	PRP$	O
chromosomal	JJ	O
location	NN	O
,	,	O
we	PRP	O
isolated	VBD	O
genomic	JJ	O
DNA	NN	O
from	IN	O
the	DT	O
HD	NNP	S_Disease
region	NN	O
as	IN	O
a	DT	O
set	NN	O
of	IN	O
overlapping	VBG	O
yeast	JJ	O
artificial	JJ	O
chromosome	NN	O
(	(	O
YAC	NNP	O
)	)	O
clones	NNS	O
.	.	O

Twenty	NNP	O
-	:	O
eight	CD	O
YAC	NNP	O
clones	NNS	O
were	VBD	O
identified	VBN	O
by	IN	O
screening	VBG	O
human	JJ	O
YAC	NNP	O
libraries	NNS	O
with	IN	O
twelve	NN	O
PCR	NNP	O
-	:	O
based	VBN	O
sequence	NN	O
-	:	O
tagged	VBN	O
sites	NNS	O
(	(	O
STSs	NNP	O
)	)	O
from	IN	O
the	DT	O
region	NN	O
.	.	O

We	PRP	O
assembled	VBD	O
the	DT	O
YAC	NNP	O
clones	NNS	O
into	IN	O
overlapping	VBG	O
sets	NNS	O
by	IN	O
hybridizing	VBG	O
them	PRP	O
to	TO	O
a	DT	O
large	JJ	O
number	NN	O
of	IN	O
DNA	NNP	O
probes	NNS	O
from	IN	O
the	DT	O
HD	NNP	S_Disease
region	NN	O
,	,	O
including	VBG	O
the	DT	O
STSs	NNP	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
isolated	VBD	O
the	DT	O
ends	NNS	O
of	IN	O
the	DT	O
human	JJ	O
DNA	NNP	O
inserts	NNS	O
of	IN	O
most	JJS	O
of	IN	O
the	DT	O
YAC	NNP	O
clones	NNS	O
to	TO	O
assist	VB	O
in	IN	O
the	DT	O
construction	NN	O
of	IN	O
the	DT	O
contig	NN	O
.	.	O

Although	IN	O
almost	RB	O
half	NN	O
of	IN	O
the	DT	O
YACs	NNPS	O
appear	VBP	O
to	TO	O
contain	VB	O
chimeric	JJ	O
inserts	NNS	O
and	CC	O
several	JJ	O
contain	NN	O
internal	JJ	O
deletions	NNS	O
or	CC	O
other	JJ	O
rearrangements	NNS	O
,	,	O
we	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
obtain	VB	O
over	IN	O
2	CD	O
.	.	O

2	CD	O
Mb	NNP	O
of	IN	O
the	DT	O
HD	NNP	S_Disease
region	NN	O
in	IN	O
YACs	NNP	O
,	,	O
including	VBG	O
one	CD	O
continuous	JJ	O
segment	NN	O
of	IN	O
2	CD	O
.	.	O

0	CD	O
Mb	NNP	O
covering	VBG	O
the	DT	O
region	NN	O
that	IN	O
most	JJS	O
likely	JJ	O
contains	VBZ	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
.	.	O

Ten	CD	O
of	IN	O
the	DT	O
twenty	NN	O
eight	CD	O
YAC	NNP	O
clones	NNS	O
comprise	VBP	O
a	DT	O
minimal	JJ	O
set	NN	O
spanning	VBG	O
the	DT	O
2	CD	O
.	.	O

2	CD	O
Mb	NNP	O
.	.	O

These	DT	O
clones	NNS	O
provide	VBP	O
reagents	NNS	O
for	IN	O
the	DT	O
complete	JJ	O
characterization	NN	O
of	IN	O
this	DT	O
region	NN	O
of	IN	O
the	DT	O
genome	NN	O
and	CC	O
for	IN	O
the	DT	O
eventual	JJ	O
isolation	NN	O
of	IN	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
.	.	O

Characterization	NN	O
of	IN	O
a	DT	O
YAC	NNP	O
containing	VBG	O
part	NN	O
or	CC	O
all	DT	O
of	IN	O
the	DT	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
locus	NN	O
.	.	O

It	PRP	O
has	VBZ	O
been	VBN	O
shown	VBN	O
from	IN	O
pulsed	VBN	O
-	:	O
field	NN	O
gel	JJ	O
electrophoresis	NN	O
(	(	O
PFGE	NNP	O
)	)	O
that	IN	O
the	DT	O
monoamine	NN	O
oxidase	NN	O
genes	NNS	O
A	NNP	O
and	CC	O
B	NNP	O
(	(	O
MAOA	NNP	O
&	CC	O
MAOB	NNP	O
)	)	O
and	CC	O
DXS7	NNP	O
loci	NN	O
are	VBP	O
physically	RB	O
very	RB	O
close	RB	O
.	.	O

We	PRP	O
have	VBP	O
therefore	RB	O
extended	VBN	O
studies	NNS	O
on	IN	O
their	PRP$	O
relationship	NN	O
through	IN	O
the	DT	O
characterisation	NN	O
of	IN	O
a	DT	O
650	CD	O
kb	NN	O
YAC	NNP	O
isolated	VBD	O
using	VBG	O
L1	NNP	O
.	.	O

28	CD	O
(	(	O
recognising	VBG	O
the	DT	O
DXS7	NNP	O
locus	NN	O
)	)	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O

Restriction	NNP	O
mapping	NN	O
of	IN	O
the	DT	O
YAC	NNP	O
indicates	VBZ	O
that	IN	O
it	PRP	O
contains	VBZ	O
both	DT	O
MAOA	NNP	O
and	CC	O
MAOB	NNP	O
genes	NNS	O
in	IN	O
addition	NN	O
to	TO	O
the	DT	O
DXS7	NNP	O
locus	NN	O
.	.	O

The	DT	O
map	NN	O
derived	VBN	O
from	IN	O
the	DT	O
YL1	NNP	O
.	.	O

28	CD	O
-	:	O
YAC	NN	O
is	VBZ	O
compatible	JJ	O
both	DT	O
with	IN	O
the	DT	O
map	NN	O
from	IN	O
an	DT	O
independently	RB	O
derived	VBN	O
YAC	NNP	O
carrying	VBG	O
MAOA	NNP	O
and	CC	O
B	NNP	O
genes	NNS	O
and	CC	O
with	IN	O
the	DT	O
long	JJ	O
range	NN	O
genomic	JJ	O
map	NN	O
for	IN	O
the	DT	O
region	NN	O
.	.	O

A	DT	O
series	NN	O
of	IN	O
subclones	NNS	O
prepared	VBN	O
from	IN	O
a	DT	O
phage	NN	O
library	NN	O
(	(	O
lambda	JJ	O
DASH	NNP	O
II	NNP	O
)	)	O
of	IN	O
the	DT	O
YAC	NNP	O
have	VBP	O
been	VBN	O
characterised	VBN	O
and	CC	O
have	VBP	O
been	VBN	O
employed	VBN	O
to	TO	O
determine	VB	O
the	DT	O
end	NN	O
point	NN	O
of	IN	O
the	DT	O
deletion	NN	O
of	IN	O
a	DT	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
(	(	O
NDP	NNP	S_Disease
)	)	O
patient	NN	O
who	WP	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
lack	VB	O
both	DT	O
DXS7	NNP	O
and	CC	O
MAO	NNP	O
coding	VBG	O
sequences	NNS	O
.	.	O

The	DT	O
pattern	NN	O
of	IN	O
retention	NN	O
of	IN	O
subclones	NNS	O
in	IN	O
the	DT	O
deletion	NN	O
patient	JJ	O
place	NN	O
the	DT	O
end	NN	O
point	NN	O
of	IN	O
the	DT	O
deletion	NN	O
within	IN	O
30	CD	O
-	:	O
130	CD	O
kb	NN	O
of	IN	O
the	DT	O
proximal	JJ	O
end	NN	O
of	IN	O
the	DT	O
YAC	NNP	O
.	.	O

By	IN	O
combining	VBG	O
the	DT	O
data	NN	O
with	IN	O
established	VBN	O
recombination	NN	O
analysis	NN	O
,	,	O
we	PRP	O
provide	VBP	O
evidence	NN	O
that	IN	O
all	DT	O
or	CC	O
part	NN	O
of	IN	O
the	DT	O
NDP	NNP	O
lies	VBZ	O
in	IN	O
the	DT	O
interval	NN	O
of	IN	O
approximately	RB	O
250kb	CD	O
within	IN	O
the	DT	O
YAC	NNP	O
.	.	O

Both	DT	O
mutations	NNS	O
in	IN	O
G6PD	NNP	O
A	NNP	O
-	:	O
are	VBP	O
necessary	JJ	O
to	TO	O
produce	VB	O
the	DT	O
G6PD	NNP	B_Disease
deficient	NN	E_Disease
phenotype	NN	O
.	.	O

The	DT	O
high	JJ	O
prevalence	NN	O
of	IN	O
glucose	JJ	B_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
in	IN	O
African	JJ	O
populations	NNS	O
is	VBZ	O
due	JJ	O
almost	RB	O
entirely	RB	O
to	TO	O
the	DT	O
enzyme	NN	O
variant	NN	O
A	NNP	O
-	:	O
,	,	O
which	WDT	O
differs	VBZ	O
from	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
G6PD	NNP	O
B	NNP	O
by	IN	O
two	CD	O
amino	NN	O
acid	NN	O
replacements	NNS	O
,	,	O
68	CD	O
Val	NNP	O
-	:	O
-	:	O
>	NN	O
Met	NNP	O
and	CC	O
126	CD	O
Asn	NNP	O
-	:	O
-	:	O
>	NN	O
Asp	NNP	O
.	.	O

The	DT	O
non	JJ	O
-	:	O
deficient	NN	O
polymorphic	JJ	O
variant	NN	O
G6PD	NNP	O
A	NNP	O
contains	VBZ	O
only	RB	O
the	DT	O
mutation	NN	O
126	CD	O
Asn	NNP	O
-	:	O
-	:	O
>	NN	O
Asp	NNP	O
.	.	O

The	DT	O
frequencies	NNS	O
of	IN	O
the	DT	O
G6PD	NNP	O
A	NNP	O
and	CC	O
of	IN	O
the	DT	O
G6PD	NNP	O
A	NNP	O
-	:	O
genes	NNS	O
in	IN	O
parts	NNS	O
of	IN	O
Africa	NNP	O
are	VBP	O
both	DT	O
about	IN	O
0	CD	O
.	.	O

2	CD	O
.	.	O

The	DT	O
68	CD	O
Val	NNP	O
-	:	O
-	:	O
>	NN	O
Met	NNP	O
mutation	NN	O
has	VBZ	O
not	RB	O
been	VBN	O
found	VBN	O
in	IN	O
a	DT	O
B	NNP	O
background	NN	O
.	.	O

This	DT	O
could	MD	O
be	VB	O
because	IN	O
the	DT	O
68	CD	O
Val	NNP	O
-	:	O
-	:	O
>	NN	O
Met	NNP	O
mutation	NN	O
happened	VBD	O
to	TO	O
arise	VB	O
in	IN	O
an	DT	O
A	NNP	O
gene	NN	O
in	IN	O
the	DT	O
first	JJ	O
instance	NN	O
,	,	O
or	CC	O
because	IN	O
the	DT	O
68	CD	O
Val	NNP	O
-	:	O
-	:	O
>	NN	O
Met	NNP	O
mutation	NN	O
alone	RB	O
is	VBZ	O
not	RB	O
sufficient	JJ	O
to	TO	O
cause	VB	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
approached	VBN	O
this	DT	O
question	NN	O
by	IN	O
producing	VBG	O
G6PD	NNP	O
B	NNP	O
,	,	O
A	NNP	O
,	,	O
A	NNP	O
-	:	O
,	,	O
and	CC	O
G6PD	NNP	O
68	CD	O
Val	NNP	O
-	:	O
-	:	O
>	NN	O
Met	NNP	O
in	IN	O
a	DT	O
bacterial	JJ	O
expression	NN	O
system	NN	O
and	CC	O
analysing	VBG	O
their	PRP$	O
biochemical	JJ	O
properties	NNS	O
.	.	O

With	IN	O
each	DT	O
single	JJ	O
mutation	NN	O
we	PRP	O
found	VBD	O
a	DT	O
slight	JJ	O
decrease	NN	O
in	IN	O
both	CC	O
the	DT	O
specific	JJ	O
activity	NN	O
and	CC	O
the	DT	O
yield	NN	O
of	IN	O
enzyme	NN	O
when	WRB	O
compared	VBN	O
to	TO	O
G6PD	NNP	O
B	NNP	O
.	.	O

When	WRB	O
both	DT	O
mutations	NNS	O
were	VBD	O
introduced	VBN	O
together	RB	O
,	,	O
there	EX	O
was	VBD	O
a	DT	O
roughly	RB	O
additive	JJ	O
effect	NN	O
on	IN	O
specific	JJ	O
activity	NN	O
,	,	O
but	CC	O
a	DT	O
much	RB	O
more	RBR	O
drastic	JJ	O
effect	NN	O
on	IN	O
enzyme	JJ	O
yield	NN	O
(	(	O
4	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	)	O
.	.	O

This	DT	O
synergistic	JJ	O
effect	NN	O
was	VBD	O
also	RB	O
demonstrated	VBN	O
on	IN	O
thermal	JJ	O
stability	NN	O
,	,	O
especially	RB	O
at	IN	O
low	JJ	O
NADP	NNP	O
concentrations	NNS	O
.	.	O

Comparable	JJ	O
results	NNS	O
were	VBD	O
produced	VBN	O
when	WRB	O
the	DT	O
replacement	NN	O
119	CD	O
Gln	NNP	O
-	:	O
-	:	O
>	NN	O
Glu	NNP	O
was	VBD	O
studied	VBN	O
instead	RB	O
of	IN	O
126	CD	O
Asn	NNP	O
-	:	O
-	:	O
>	NN	O
Asp	NNP	O
.	.	O

We	PRP	O
infer	VBP	O
that	IN	O
the	DT	O
coexistence	NN	O
of	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
is	VBZ	O
responsible	JJ	O
for	IN	O
enzyme	JJ	B_Disease
deficiency	NN	I_Disease
in	IN	I_Disease
G6PD	NNP	E_Disease
A	NNP	O
-	:	O
because	IN	O
they	PRP	O
act	VBP	O
synergistically	RB	O
in	IN	O
causing	VBG	O
instability	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
.	.	O

Small	JJ	O
nuclear	JJ	O
ribonucleoprotein	NN	O
polypeptide	IN	O
N	NNP	O
(	(	O
SNRPN	NNP	O
)	)	O
,	,	O
an	DT	O
expressed	VBN	O
gene	NN	O
in	IN	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	VB	E_Disease
critical	JJ	O
region	NN	O
.	.	O

Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
is	VBZ	O
associated	VBN	O
with	IN	O
paternally	RB	O
derived	VBN	O
chromosomal	JJ	O
deletions	NNS	O
in	IN	O
region	NN	O
15q11	CD	O
-	:	O
13	CD	O
or	CC	O
with	IN	O
maternal	JJ	B_Disease
disomy	NN	I_Disease
for	IN	I_Disease
chromosome	NN	I_Disease
15	CD	E_Disease
.	.	O

Therefore	RB	O
,	,	O
loss	NN	O
of	IN	O
the	DT	O
expressed	JJ	O
paternal	JJ	O
alleles	NNS	O
of	IN	O
maternally	RB	O
imprinted	VBN	O
genes	NNS	O
must	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
PWS	NNP	S_Disease
phenotype	NN	O
.	.	O

We	PRP	O
have	VBP	O
mapped	VBN	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
small	JJ	O
nuclear	JJ	O
RNA	NNP	O
associated	VBD	O
polypeptide	JJ	O
SmN	NNP	O
(	(	O
SNRPN	NNP	O
)	)	O
to	TO	O
human	JJ	O
chromosome	NN	O
15q12	CD	O
and	CC	O
a	DT	O
processed	JJ	O
pseudogene	NN	O
SNRPNP1	NNP	O
to	TO	O
chromosome	VB	O
region	NN	O
6pter	CD	O
-	:	O
p21	NN	O
.	.	O

Furthermore	RB	O
,	,	O
SNRPN	NNP	O
was	VBD	O
mapped	VBN	O
to	TO	O
the	DT	O
minimal	JJ	O
deletion	NN	O
interval	NN	O
that	WDT	O
is	VBZ	O
critical	JJ	O
for	IN	O
PWS	NNP	S_Disease
.	.	O

The	DT	O
fact	NN	O
that	IN	O
the	DT	O
mouse	NN	O
Snrpn	NNP	O
gene	NN	O
is	VBZ	O
maternally	RB	O
imprinted	VBN	O
in	IN	O
brain	NN	O
suggests	NNS	O
that	IN	O
loss	NN	O
of	IN	O
the	DT	O
paternally	RB	O
derived	VBN	O
SNRPN	NNP	O
allele	NN	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
the	DT	O
PWS	NNP	S_Disease
phenotype	NN	O
.	.	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
two	CD	O
different	JJ	O
infantile	NN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
mutations	NNS	O
in	IN	O
a	DT	O
Cajun	NNP	O
population	NN	O
.	.	O

A	DT	O
study	NN	O
was	VBD	O
undertaken	VBN	O
to	TO	O
characterize	VB	O
the	DT	O
mutation	NN	O
(	(	O
s	PRP	O
)	)	O
responsible	JJ	O
for	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
TSD	NNP	S_Disease
)	)	O
in	IN	O
a	DT	O
Cajun	NNP	O
population	NN	O
in	IN	O
southwest	JJ	O
Louisiana	NNP	O
and	CC	O
to	TO	O
identify	VB	O
the	DT	O
origins	NNS	O
of	IN	O
these	DT	O
mutations	NNS	O
.	.	O

Eleven	NNP	O
of	IN	O
12	CD	O
infantile	JJ	O
TSD	NNP	S_Disease
alleles	NNS	O
examined	VBD	O
in	IN	O
six	CD	O
families	NNS	O
had	VBD	O
the	DT	O
beta	NN	O
-	:	O
hexosaminidase	NN	O
A	NNP	O
(	(	O
Hex	NNP	O
A	NNP	O
)	)	O
alpha	SYM	O
-	:	O
subunit	NN	O
exon	VBZ	O
11	CD	O
insertion	NN	O
mutation	NN	O
that	WDT	O
is	VBZ	O
present	JJ	O
in	IN	O
approximately	RB	O
70	CD	O
%	NN	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
TSD	NNP	S_Disease
heterozygotes	VBZ	O
.	.	O

The	DT	O
mutation	NN	O
in	IN	O
the	DT	O
remaining	VBG	O
allele	NN	O
was	VBD	O
a	DT	O
single	JJ	O
-	:	O
base	NN	O
transition	NN	O
in	IN	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
of	IN	O
the	DT	O
alpha	JJ	O
-	:	O
subunit	NN	O
intron	NN	O
9	CD	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
origins	NNS	O
of	IN	O
these	DT	O
two	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
Cajun	NNP	O
population	NN	O
,	,	O
the	DT	O
TSD	NNP	S_Disease
carrier	NN	O
status	NN	O
was	VBD	O
enzymatically	RB	O
determined	VBN	O
for	IN	O
90	CD	O
members	NNS	O
of	IN	O
four	CD	O
of	IN	O
the	DT	O
six	CD	O
families	NNS	O
,	,	O
and	CC	O
extensive	JJ	O
pedigrees	NNS	O
were	VBD	O
constructed	VBN	O
for	IN	O
all	DT	O
carriers	NNS	O
.	.	O

A	DT	O
single	JJ	O
ancestral	JJ	O
couple	NN	O
from	IN	O
France	NNP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
common	JJ	O
to	TO	O
most	JJS	O
of	IN	O
the	DT	O
carriers	NNS	O
of	IN	O
the	DT	O
exon	NN	O
11	CD	O
insertion	NN	O
.	.	O

Pedigree	NNP	O
data	NNS	O
suggest	VBP	O
that	IN	O
this	DT	O
mutation	NN	O
has	VBZ	O
been	VBN	O
in	IN	O
the	DT	O
Cajun	NNP	O
population	NN	O
since	IN	O
its	PRP$	O
founding	NN	O
over	IN	O
2	CD	O
centuries	NNS	O
ago	RB	O
and	CC	O
that	IN	O
it	PRP	O
may	MD	O
be	VB	O
widely	RB	O
distributed	VBN	O
within	IN	O
the	DT	O
population	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
the	DT	O
intron	NN	O
9	CD	O
mutation	NN	O
apparently	RB	O
was	VBD	O
introduced	VBN	O
within	IN	O
the	DT	O
last	JJ	O
century	NN	O
and	CC	O
probably	RB	O
is	VBZ	O
limited	VBN	O
to	TO	O
a	DT	O
few	JJ	O
Louisiana	NNP	O
families	NNS	O
.	.	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
.	.	O

Recently	RB	O
,	,	O
we	PRP	O
and	CC	O
others	NNS	O
have	VBP	O
isolated	VBN	O
a	DT	O
candidate	JJ	O
gene	NN	O
for	IN	O
X	NNP	B_Disease
linked	VBD	I_Disease
Norrie	NNP	I_Disease
disease	NN	E_Disease
(	(	O
ND	NNP	S_Disease
)	)	O
which	WDT	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
deleted	VBN	O
or	CC	O
disrupted	VBN	O
in	IN	O
several	JJ	O
patients	NNS	O
.	.	O

As	IN	O
a	DT	O
prerequisite	NN	O
for	IN	O
the	DT	O
identification	NN	O
of	IN	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
ND	NNP	S_Disease
gene	NN	O
we	PRP	O
have	VBP	O
established	VBN	O
the	DT	O
exon	NN	O
-	:	O
intron	NN	O
structure	NN	O
of	IN	O
this	DT	O
gene	NN	O
.	.	O

In	IN	O
17	CD	O
unrelated	JJ	O
patients	NNS	O
and	CC	O
15	CD	O
controls	NNS	O
,	,	O
PCR	NNP	O
products	NNS	O
derived	VBN	O
from	IN	O
the	DT	O
promoter	NN	O
region	NN	O
,	,	O
exons	NNS	O
1	CD	O
and	CC	O
2	CD	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
coding	VBG	O
part	NN	O
of	IN	O
exon	$	O
3	CD	O
were	VBD	O
analysed	VBN	O
with	IN	O
the	DT	O
single	JJ	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
SSCP	NNP	O
)	)	O
technique	NN	O
.	.	O

In	IN	O
12	CD	O
patients	NNS	O
altered	VBD	O
PCR	NNP	O
fragments	NNS	O
were	VBD	O
detected	VBN	O
which	WDT	O
were	VBD	O
studied	VBN	O
in	IN	O
detail	NN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
.	.	O

Eleven	RB	O
different	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
,	,	O
and	CC	O
all	DT	O
but	CC	O
one	CD	O
are	VBP	O
likely	JJ	O
to	TO	O
give	VB	O
rise	NN	O
to	TO	O
significant	JJ	O
structural	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
predicted	JJ	O
protein	NN	O
.	.	O

These	DT	O
findings	NNS	O
,	,	O
and	CC	O
the	DT	O
absence	NN	O
of	IN	O
functionally	RB	O
relevant	JJ	O
base	NN	O
changes	NNS	O
in	IN	O
healthy	JJ	O
controls	NNS	O
,	,	O
emphasize	VB	O
the	DT	O
causal	JJ	O
role	NN	O
of	IN	O
this	DT	O
candidate	NN	O
gene	NN	O
in	IN	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
and	CC	O
pave	VB	O
the	DT	O
way	NN	O
for	IN	O
reliable	JJ	O
diagnosis	NN	O
and	CC	O
carrier	NN	O
detection	NN	O
.	.	O
.	.	O

Detection	NN	O
of	IN	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
dystrophin	JJ	O
gene	NN	O
by	IN	O
multiple	JJ	O
SSCP	NNP	O
.	.	O

A	DT	O
combination	NN	O
of	IN	O
multiplex	JJ	O
PCR	NNP	O
with	IN	O
the	DT	O
single	JJ	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
SSCP	NNP	O
)	)	O
technique	NN	O
was	VBD	O
employed	VBN	O
to	TO	O
screen	VB	O
for	IN	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
dystrophin	JJ	O
gene	NN	O
.	.	O

Co	NNP	O
-	:	O
amplification	NN	O
of	IN	O
11	CD	O
exons	NNS	O
from	IN	O
genomic	JJ	O
DNA	NN	O
of	IN	O
Duchenne	NNP	B_Disease
and	CC	I_Disease
Becker	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
/	NNP	O
BMD	NNP	S_Disease
)	)	O
patients	NNS	O
with	IN	O
no	DT	O
deletion	NN	O
or	CC	O
duplication	NN	O
was	VBD	O
performed	VBN	O
and	CC	O
the	DT	O
samples	NNS	O
subjected	VBN	O
to	TO	O
multiple	VB	O
SSCP	NNP	O
analysis	NN	O
.	.	O

We	PRP	O
report	VBP	O
the	DT	O
case	NN	O
of	IN	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
in	IN	O
a	DT	O
Duchenne	NNP	S_Disease
patient	NN	O
identified	VBN	O
by	IN	O
this	DT	O
approach	NN	O
.	.	O

The	DT	O
mutation	NN	O
introduces	VBZ	O
a	DT	O
termination	NN	O
codon	NN	O
within	IN	O
exon	$	O
8	CD	O
of	IN	O
the	DT	O
dystrophin	JJ	O
gene	NN	O
.	.	O

It	PRP	O
is	VBZ	O
predicted	VBN	O
to	TO	O
cause	VB	O
a	DT	O
very	RB	O
premature	JJ	O
translational	JJ	O
termination	NN	O
accounting	NN	O
for	IN	O
the	DT	O
severe	JJ	O
phenotype	NN	O
observed	VBD	O
.	.	O

The	DT	O
patient	NN	O
inherited	VBD	O
this	DT	O
mutation	NN	O
from	IN	O
his	PRP$	O
mother	NN	O
.	.	O

In	IN	O
addition	NN	O
the	DT	O
analysis	NN	O
revealed	VBD	O
5	CD	O
polymorphisms	NNS	O
useful	JJ	O
for	IN	O
internal	JJ	O
control	NN	O
.	.	O
.	.	O

Proliferation	NNP	O
-	:	O
related	JJ	O
expression	NN	O
of	IN	O
p19	NN	O
/	NNP	O
nm23	NN	O
nucleoside	RB	O
diphosphate	JJ	O
kinase	NN	O
.	.	O

High	JJ	O
level	NN	O
expression	NN	O
of	IN	O
the	DT	O
nm23	JJ	O
-	:	O
H1	NNP	O
gene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
for	IN	O
a	DT	O
nucleoside	JJ	O
diphosphate	NN	O
kinase	NN	O
,	,	O
has	VBZ	O
been	VBN	O
found	VBN	O
to	TO	O
correlate	VB	O
with	IN	O
diminished	JJ	O
metastasis	NN	O
in	IN	O
some	DT	O
tumors	NNS	S_Disease
but	CC	O
not	RB	O
in	IN	O
others	NNS	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
identified	VBN	O
the	DT	O
protein	JJ	O
product	NN	O
of	IN	O
the	DT	O
nm23	JJ	O
-	:	O
H1	NNP	O
gene	NN	O
in	IN	O
two	CD	O
-	:	O
dimensional	JJ	O
electrophoretic	JJ	O
gels	NNS	O
and	CC	O
have	VBP	O
designated	VBN	O
it	PRP	O
p19	JJ	O
/	JJ	O
nm23	NN	O
.	.	O

In	IN	O
neuroblastoma	NN	S_Disease
,	,	O
higher	JJR	O
levels	NNS	O
of	IN	O
p19	NN	O
/	NNP	O
nm23	NN	O
,	,	O
which	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
amplification	NN	O
of	IN	O
the	DT	O
N	NNP	O
-	:	O
myc	NN	O
oncogene	NN	O
,	,	O
large	JJ	O
tumor	NN	S_Disease
mass	NN	O
,	,	O
and	CC	O
metastasis	NN	O
,	,	O
were	VBD	O
observed	VBN	O
in	IN	O
advanced	JJ	O
stage	NN	O
tumors	NNS	S_Disease
compared	VBN	O
with	IN	O
limited	JJ	O
stage	NN	O
disease	NN	O
.	.	O

Because	IN	O
of	IN	O
the	DT	O
variable	JJ	O
expression	NN	O
of	IN	O
nm23	JJ	O
-	:	O
H1	NN	O
in	IN	O
different	JJ	O
tumors	NNS	S_Disease
,	,	O
we	PRP	O
have	VBP	O
investigated	VBN	O
the	DT	O
relationship	NN	O
between	IN	O
amounts	NNS	O
of	IN	O
the	DT	O
protein	NN	O
and	CC	O
cell	NN	O
proliferation	NN	O
.	.	O

The	DT	O
levels	NNS	O
of	IN	O
p19	NN	O
/	NNP	O
nm23	NN	O
were	VBD	O
compared	VBN	O
between	IN	O
resting	VBG	O
and	CC	O
mitotically	RB	O
stimulated	VBN	O
normal	JJ	O
human	JJ	O
PBLs	NNP	O
and	CC	O
in	IN	O
leukemia	JJ	S_Disease
cells	NNS	O
.	.	O

The	DT	O
amount	NN	O
of	IN	O
p19	NN	O
/	NNP	O
nm23	NN	O
increased	VBD	O
in	IN	O
normal	JJ	O
lymphocytes	NNS	O
in	IN	O
response	NN	O
to	TO	O
mitotic	JJ	O
stimulation	NN	O
and	CC	O
paralleled	VBD	O
the	DT	O
increase	NN	O
in	IN	O
DNA	NNP	O
synthesis	NN	O
.	.	O

In	IN	O
leukemia	NN	S_Disease
cells	NNS	O
obtained	VBN	O
from	IN	O
patients	NNS	O
with	IN	O
different	JJ	O
subtypes	NNS	O
of	IN	O
acute	JJ	B_Disease
leukemia	NN	E_Disease
,	,	O
p19	NN	O
/	NNP	O
nm23	NN	O
levels	NNS	O
were	VBD	O
also	RB	O
increased	VBN	O
relative	NN	O
to	TO	O
resting	VBG	O
normal	JJ	O
lymphocytes	NNS	O
.	.	O

Treatment	NN	O
of	IN	O
mitotically	RB	O
stimulated	VBN	O
lymphocytes	NNS	O
with	IN	O
cyclosporin	NN	O
,	,	O
which	WDT	O
inhibits	VBZ	O
proliferation	NN	O
,	,	O
blocked	VBD	O
the	DT	O
increase	NN	O
in	IN	O
p19	JJ	O
/	NNP	O
nm23	NN	O
;	:	O
treatment	NN	O
of	IN	O
the	DT	O
leukemia	NN	S_Disease
cell	NN	O
line	NN	O
HL	NNP	O
-	:	O
60	CD	O
with	IN	O
dimethylsulfoxide	NN	O
,	,	O
which	WDT	O
induces	VBZ	O
terminal	JJ	O
differentiation	NN	O
,	,	O
resulted	VBD	O
in	IN	O
diminished	JJ	O
levels	NNS	O
of	IN	O
p19	NN	O
/	NNP	O
nm23	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
therefore	RB	O
provide	VBP	O
evidence	NN	O
that	IN	O
nm23	JJ	O
-	:	O
H1	NNP	O
expression	NN	O
is	VBZ	O
related	VBN	O
to	TO	O
cell	VB	O
proliferative	JJ	O
activity	NN	O
.	.	O
.	.	O

An	DT	O
intrachromosomal	JJ	O
insertion	NN	O
causing	VBG	O
5q22	CD	O
deletion	NN	O
and	CC	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	I_Disease
coli	NNS	E_Disease
in	IN	O
two	CD	O
generations	NNS	O
.	.	O

We	PRP	O
report	VBP	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
FAPC	NNP	S_Disease
)	)	O
with	IN	O
epidermoid	JJ	B_Disease
cysts	NNS	E_Disease
,	,	O
osteomata	NNS	S_Disease
,	,	O
and	CC	O
areas	NNS	O
of	IN	O
congenital	JJ	B_Disease
hypertrophy	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
retinal	JJ	I_Disease
pigment	NN	I_Disease
epithelium	NN	E_Disease
(	(	O
CHRPEs	NNP	S_Disease
)	)	O
in	IN	O
a	DT	O
male	JJ	O
patient	NN	O
and	CC	O
his	PRP$	O
maternal	JJ	O
aunt	NN	O
,	,	O
both	DT	O
of	IN	O
whom	WP	O
suffered	VBD	O
a	DT	O
mild	NN	O
to	TO	O
moderate	VB	O
degree	NN	O
of	IN	O
mental	JJ	B_Disease
handicap	NN	E_Disease
.	.	O

Both	DT	O
had	VBD	O
an	DT	O
interstitial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
(	(	O
del	NN	O
(	(	O
5	CD	O
)	)	O
(	(	O
q22q23	UH	O
.	.	O

2	CD	O
)	)	O
)	)	O
.	.	O

Two	CD	O
other	JJ	O
normal	JJ	O
family	NN	O
members	NNS	O
had	VBD	O
the	DT	O
underlying	VBG	O
direct	JJ	O
insertion	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
(	(	O
dir	NN	O
ins	NNS	O
(	(	O
5	CD	O
)	)	O
(	(	O
q31	UH	O
.	.	O

3q22q23	CD	O
3q22q23	CD	O
.	.	O

2	CD	O
)	)	O
)	)	O
.	.	O

Molecular	JJ	O
genetic	JJ	O
and	CC	O
fluorescent	JJ	O
hybridisation	NN	O
studies	NNS	O
have	VBP	O
shown	VBN	O
that	IN	O
loci	NN	O
D5S37	NNP	O
and	CC	O
D5S98	NNP	O
are	VBP	O
outside	IN	O
the	DT	O
deletion	NN	O
whereas	IN	O
loci	NN	O
detected	VBN	O
by	IN	O
probes	NNS	O
EF5	NNP	O
.	.	O

44	CD	O
and	CC	O
YN5	NNP	O
.	.	O

48	CD	O
are	VBP	O
lost	VBN	O
.	.	O

As	IN	O
expected	VBN	O
,	,	O
the	DT	O
molecular	JJ	O
analyses	NNS	O
indicate	VBP	O
loss	NN	O
of	IN	O
one	CD	O
allele	NN	O
at	IN	O
the	DT	O
MCC	NNP	O
and	CC	O
APC	NNP	S_Disease
loci	NN	O
.	.	O

The	DT	O
APC	NNP	S_Disease
gene	NN	O
is	VBZ	O
located	VBN	O
within	IN	O
band	NN	O
5q22	CD	O
.	.	O

Familial	JJ	O
direct	JJ	O
insertions	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
recurrent	JJ	O
microdeletion	NN	O
syndromes	NNS	O
.	.	O

Chromosome	NNP	O
mapping	NN	O
of	IN	O
the	DT	O
rod	NN	O
photoreceptor	NN	O
cGMP	NN	O
phosphodiesterase	NN	O
beta	SYM	O
-	:	O
subunit	NN	O
gene	NN	O
in	IN	O
mouse	NN	O
and	CC	O
human	NN	O
:	:	O
tight	JJ	O
linkage	NN	O
to	TO	O
the	DT	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
region	NN	O
(	(	O
4p16	CD	O
.	.	O
3	CD	O
)	)	O
.	.	O

The	DT	O
retinal	JJ	B_Disease
degeneration	NN	E_Disease
mouse	NN	O
(	(	O
gene	NN	O
symbol	NN	O
,	,	O
rd	NN	O
)	)	O
is	VBZ	O
an	DT	O
animal	JJ	O
model	NN	O
for	IN	O
certain	JJ	O
forms	NNS	O
of	IN	O
human	JJ	O
hereditary	JJ	B_Disease
retinopathies	NNS	E_Disease
.	.	O

Recent	JJ	O
findings	NNS	O
of	IN	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
rd	NN	O
mouse	NN	O
PDE	NNP	O
beta	SYM	O
-	:	O
subunit	NN	O
gene	NN	O
(	(	O
Pdeb	NNP	O
)	)	O
prompted	VBD	O
us	PRP	O
to	TO	O
investigate	VB	O
the	DT	O
chromosome	NN	O
locations	NNS	O
of	IN	O
the	DT	O
mouse	NN	O
and	CC	O
human	JJ	O
genes	NNS	O
.	.	O

We	PRP	O
have	VBP	O
utilized	VBN	O
backcross	NN	O
analysis	NN	O
in	IN	O
mice	NN	O
to	TO	O
verify	VB	O
and	CC	O
define	VB	O
more	RBR	O
precisely	RB	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
Pdeb	NNP	O
locus	NN	O
6	CD	O
.	.	O

1	CD	O
+	JJ	O
/	NNP	O
-	:	O
2	CD	O
.	.	O

3	CD	O
cM	JJ	O
distal	NN	O
of	IN	O
Mgsa	NNP	O
on	IN	O
mouse	NN	O
chromosome	NN	O
5	CD	O
.	.	O

We	PRP	O
have	VBP	O
determined	VBN	O
that	IN	O
the	DT	O
human	JJ	O
gene	NN	O
(	(	O
PDEB	NNP	O
)	)	O
maps	VBZ	O
to	TO	O
4p16	CD	O
.	.	O

3	CD	O
,	,	O
very	RB	O
close	RB	O
to	TO	O
the	DT	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
region	NN	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
comparative	JJ	O
map	NN	O
for	IN	O
mice	NN	O
and	CC	O
humans	NNS	O
shows	VBZ	O
that	IN	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
will	MD	O
reside	VB	O
on	IN	O
chromosome	NN	O
5	CD	O
.	.	O

Linkage	NN	O
of	IN	O
the	DT	O
mouse	NN	O
Pdeb	NNP	O
locus	NN	O
with	IN	O
other	JJ	O
homologues	NNS	O
in	IN	O
the	DT	O
human	JJ	O
4p16	CD	O
.	.	O

3	CD	O
region	NN	O
is	VBZ	O
maintained	VBN	O
but	CC	O
gene	NN	O
order	NN	O
is	VBZ	O
not	RB	O
,	,	O
suggesting	VBG	O
at	IN	O
least	JJS	O
three	CD	O
possible	JJ	O
sites	NNS	O
for	IN	O
the	DT	O
corresponding	JJ	O
mouse	NN	O
HD	NNP	S_Disease
gene	NN	O
.	.	O

Coincident	NNP	O
Kaposi	NNP	B_Disease
sarcoma	NN	E_Disease
and	CC	O
T	NNP	B_Disease
-	:	I_Disease
cell	NN	I_Disease
lymphoma	NN	E_Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

A	DT	O
24	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
eczema	NN	S_Disease
,	,	O
recurrent	JJ	O
mild	NN	O
infections	NNS	O
,	,	O
and	CC	O
thrombocytopenia	VB	S_Disease
consistent	NN	O
with	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
presented	VBD	O
with	IN	O
a	DT	O
mediastinal	JJ	O
mass	NN	O
,	,	O
generalized	VBN	O
lymphadenopathy	NN	S_Disease
,	,	O
splenomegaly	NN	S_Disease
,	,	O
and	CC	O
severe	JJ	O
thrombocytopenia	NN	S_Disease
.	.	O

Studies	NNS	O
of	IN	O
immune	JJ	O
function	NN	O
including	VBG	O
immunoglobulin	NN	O
levels	NNS	O
and	CC	O
T	NNP	O
-	:	O
cell	NN	O
subsets	NNS	O
were	VBD	O
normal	JJ	O
.	.	O

Furthermore	RB	O
,	,	O
his	PRP$	O
T	NNP	O
lymphocytes	VBZ	O
proliferated	VBN	O
normally	RB	O
in	IN	O
response	NN	O
to	TO	O
phytohemagglutinin	VB	O
,	,	O
concanavalin	VB	O
A	NNP	O
,	,	O
and	CC	O
the	DT	O
combination	NN	O
of	IN	O
neuraminidase	JJ	O
/	NNP	O
galactose	NN	O
oxidase	NN	O
.	.	O

However	RB	O
,	,	O
their	PRP$	O
proliferative	JJ	O
responses	NNS	O
to	TO	O
anti	VB	O
-	:	O
CD43	NNP	O
antibody	NN	O
and	CC	O
periodate	NN	O
were	VBD	O
diminished	VBN	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
WAS	NNP	S_Disease
.	.	O

An	DT	O
initial	JJ	O
inguinal	JJ	O
lymph	NN	O
node	NN	O
biopsy	NN	O
surprisingly	RB	O
revealed	VBD	O
Kaposi	NNP	B_Disease
sarcoma	NN	E_Disease
.	.	O

However	RB	O
,	,	O
following	VBG	O
splenectomy	NN	O
to	TO	O
increase	VB	O
the	DT	O
platelet	NN	O
count	NN	O
,	,	O
biopsy	NN	O
of	IN	O
the	DT	O
mediastinal	JJ	O
mass	NN	O
revealed	VBD	O
T	NNP	B_Disease
-	:	I_Disease
cell	NN	I_Disease
large	JJ	I_Disease
cell	NN	I_Disease
lymphoma	NN	E_Disease
.	.	O

Studies	NNS	O
of	IN	O
biopsied	JJ	O
tissue	NN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
Epstein	NNP	B_Disease
-	:	I_Disease
Barr	NNP	I_Disease
virus	NN	E_Disease
and	CC	O
cytomegalovirus	NN	S_Disease
were	VBD	O
negative	JJ	O
,	,	O
as	IN	O
were	VBD	O
studies	NNS	O
of	IN	O
blood	NN	O
,	,	O
including	VBG	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
,	,	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
human	JJ	B_Disease
immunodeficiency	NN	I_Disease
virus	NN	E_Disease
(	(	O
HIV	NNP	S_Disease
)	)	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
of	IN	O
Kaposi	NNP	B_Disease
sarcoma	NN	E_Disease
arising	VBG	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
congenital	JJ	B_Disease
immunodeficiency	NN	I_Disease
syndrome	NN	E_Disease
.	.	O

Although	IN	O
Kaposi	NNP	B_Disease
sarcoma	NN	E_Disease
can	MD	O
arise	VB	O
in	IN	O
the	DT	O
face	NN	O
of	IN	O
the	DT	O
severe	JJ	O
immunosuppression	NN	O
that	WDT	O
follows	VBZ	O
allograft	NN	O
transplantation	NN	O
and	CC	O
in	IN	O
patients	NNS	O
infected	VBN	O
with	IN	O
HIV	NNP	S_Disease
,	,	O
we	PRP	O
postulate	VBP	O
that	DT	O
longevity	NN	O
in	IN	O
the	DT	O
face	NN	O
of	IN	O
mild	JJ	O
immunosuppression	NN	O
was	VBD	O
the	DT	O
major	JJ	O
factor	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
Kaposi	NNP	B_Disease
sarcoma	NN	E_Disease
in	IN	O
this	DT	O
patient	NN	O
.	.	O
.	.	O

The	DT	O
APC	NNP	S_Disease
gene	NN	O
,	,	O
responsible	JJ	O
for	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
,	,	O
is	VBZ	O
mutated	VBN	O
in	IN	O
human	JJ	O
gastric	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Although	IN	O
gastric	JJ	B_Disease
cancer	NN	E_Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
cancer	NN	S_Disease
in	IN	O
the	DT	O
world	NN	O
,	,	O
genetic	JJ	O
changes	NNS	O
during	IN	O
its	PRP$	O
carcinogenesis	NN	O
are	VBP	O
not	RB	O
well	RB	O
understood	RB	O
.	.	O

Since	IN	O
some	DT	O
gastric	JJ	B_Disease
cancers	NNS	E_Disease
are	VBP	O
considered	VBN	O
to	TO	O
originate	VB	O
from	IN	O
the	DT	O
intestinal	JJ	O
metaplasia	NN	O
,	,	O
it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
the	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
gene	NN	O
,	,	O
the	DT	O
mutation	NN	O
of	IN	O
which	WDT	O
causes	VBZ	O
adenomatous	JJ	B_Disease
polyps	NNS	I_Disease
in	IN	I_Disease
the	DT	I_Disease
colon	NN	E_Disease
,	,	O
is	VBZ	O
associated	VBN	O
with	IN	O
carcinogenesis	NN	O
of	IN	O
gastric	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Based	VBN	O
on	IN	O
this	DT	O
idea	NN	O
,	,	O
DNAs	NNP	O
isolated	VBD	O
from	IN	O
gastric	JJ	B_Disease
cancers	NNS	E_Disease
were	VBD	O
examined	VBN	O
by	IN	O
means	NNS	O
of	IN	O
a	DT	O
RNase	NNP	O
protection	NN	O
analysis	NN	O
coupled	VBN	O
with	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
followed	VBN	O
by	IN	O
sequencing	VBG	O
of	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
products	NNS	O
.	.	O

By	IN	O
screening	VBG	O
nearly	RB	O
one	CD	O
-	:	O
half	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
in	IN	O
44	CD	O
tumors	NNS	S_Disease
,	,	O
somatic	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
three	CD	O
tumors	NNS	S_Disease
a	DT	O
missense	NN	O
mutation	NN	O
,	,	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
,	,	O
and	CC	O
a	DT	O
5	CD	O
-	:	O
base	NN	O
pair	NN	O
deletion	NN	O
resulting	VBG	O
in	IN	O
a	DT	O
frame	NN	O
shift	NN	O
which	WDT	O
causes	VBZ	O
truncation	NN	O
of	IN	O
the	DT	O
gene	NN	O
product	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
mutation	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
also	RB	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
during	IN	O
the	DT	O
carcinogenesis	NN	O
of	IN	O
at	IN	O
least	JJS	O
some	DT	O
gastric	JJ	B_Disease
cancers	NNS	E_Disease
.	.	O
.	.	O

A	DT	O
71	CD	O
-	:	O
kilodalton	NN	O
protein	NN	O
is	VBZ	O
a	DT	O
major	JJ	O
product	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
gene	NN	O
in	IN	O
brain	NN	O
and	CC	O
other	JJ	O
nonmuscle	NN	O
tissues	NNS	O
.	.	O

The	DT	O
known	VBN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
gene	NN	O
products	NNS	O
,	,	O
the	DT	O
muscle	NN	O
-	:	O
and	CC	O
brain	NN	O
-	:	O
type	NN	O
dystrophin	NN	O
isoforms	NNS	O
,	,	O
are	VBP	O
427	CD	O
-	:	O
kDa	NN	O
proteins	NNS	O
translated	VBN	O
from	IN	O
14	CD	O
-	:	O
kilobase	NN	O
(	(	O
kb	NN	O
)	)	O
mRNAs	NN	O
.	.	O

Recently	RB	O
we	PRP	O
described	VBD	O
a	DT	O
6	CD	O
.	.	O

5	CD	O
-	:	O
kb	NN	O
mRNA	NN	O
that	IN	O
also	RB	O
is	VBZ	O
transcribed	VBN	O
from	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
.	.	O

Cloning	VBG	O
and	CC	O
in	IN	O
vitro	JJ	O
transcription	NN	O
and	CC	O
translation	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
show	NN	O
that	IN	O
the	DT	O
6	CD	O
.	.	O

5	CD	O
-	:	O
kb	NN	O
mRNA	NN	O
encodes	VBZ	O
a	DT	O
70	CD	O
.	.	O

8	CD	O
-	:	O
kDa	NN	O
protein	NN	O
that	WDT	O
is	VBZ	O
a	DT	O
major	JJ	O
product	NN	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
.	.	O

It	PRP	O
contains	VBZ	O
the	DT	O
C	NNP	O
-	:	O
terminal	NN	O
and	CC	O
the	DT	O
cysteine	NN	O
-	:	O
rich	JJ	O
domains	NNS	O
of	IN	O
dystrophin	NN	O
,	,	O
seven	CD	O
additional	JJ	O
amino	NN	O
acids	NNS	O
at	IN	O
the	DT	O
N	NNP	O
terminus	NN	O
,	,	O
and	CC	O
some	DT	O
modifications	NNS	O
formed	VBN	O
by	IN	O
alternative	JJ	O
splicing	NN	O
in	IN	O
the	DT	O
C	NNP	O
-	:	O
terminal	NN	O
domain	NN	O
.	.	O

It	PRP	O
lacks	VBZ	O
the	DT	O
entire	JJ	O
large	JJ	O
domain	NN	O
of	IN	O
spectrin	JJ	O
-	:	O
like	IN	O
repeats	NNS	O
and	CC	O
the	DT	O
actin	NN	O
-	:	O
binding	NN	O
N	NNP	O
-	:	O
terminal	JJ	O
domain	NN	O
of	IN	O
dystrophin	NN	O
.	.	O

This	DT	O
protein	NN	O
is	VBZ	O
the	DT	O
major	JJ	O
DMD	NNP	S_Disease
gene	NN	O
product	NN	O
in	IN	O
brain	NN	O
and	CC	O
other	JJ	O
nonmuscle	NN	O
tissues	NNS	O
but	CC	O
is	VBZ	O
undetectable	JJ	O
in	IN	O
skeletal	JJ	O
muscle	NN	O
extracts	NNS	O
.	.	O

Correlation	NN	O
between	IN	O
the	DT	O
location	NN	O
of	IN	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
and	CC	O
the	DT	O
number	NN	O
of	IN	O
colorectal	JJ	B_Disease
polyps	NNS	E_Disease
in	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
patients	NNS	O
.	.	O

Recently	RB	O
we	PRP	O
have	VBP	O
isolated	VBN	O
the	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
gene	NN	O
which	WDT	O
causes	VBZ	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
,	,	O
and	CC	O
its	PRP$	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
a	DT	O
substantial	JJ	O
number	NN	O
of	IN	O
FAP	NNP	S_Disease
patients	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
this	DT	O
information	NN	O
,	,	O
we	PRP	O
compared	VBN	O
the	DT	O
location	NN	O
of	IN	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
in	IN	O
22	CD	O
unrelated	JJ	O
patients	NNS	O
(	(	O
12	CD	O
of	IN	O
whom	WP	O
have	VBP	O
been	VBN	O
reported	VBN	O
previously	RB	O
)	)	O
with	IN	O
the	DT	O
number	NN	O
of	IN	O
colorectal	JJ	B_Disease
polyps	NNS	E_Disease
developed	VBN	O
in	IN	O
FAP	NNP	S_Disease
patients	NNS	O
;	:	O
17	CD	O
were	VBD	O
sparse	JJ	O
types	NNS	O
and	CC	O
five	CD	O
were	VBD	O
profuse	NN	O
types	NNS	O
.	.	O

All	DT	O
but	CC	O
one	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
considered	VBN	O
to	TO	O
cause	VB	O
truncation	NN	O
of	IN	O
the	DT	O
gene	NN	O
product	NN	O
by	IN	O
frame	JJ	O
-	:	O
shift	NN	O
due	JJ	O
to	TO	O
deletion	NN	O
(	(	O
14	CD	O
cases	NNS	O
)	)	O
or	CC	O
nonsense	JJ	O
mutation	NN	O
(	(	O
seven	CD	O
cases	NNS	O
)	)	O
.	.	O

The	DT	O
location	NN	O
of	IN	O
the	DT	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
seems	VBZ	O
to	TO	O
correlate	VB	O
with	IN	O
the	DT	O
two	CD	O
clinical	JJ	O
types	NNS	O
;	:	O
germ	SYM	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
five	CD	O
FAP	NNP	S_Disease
patients	NNS	O
with	IN	O
profuse	JJ	O
polyps	NNS	S_Disease
were	VBD	O
observed	VBN	O
between	IN	O
codon	NN	O
1250	CD	O
and	CC	O
codon	VB	O
1464	CD	O
,	,	O
whereas	JJ	O
mutations	NNS	O
in	IN	O
17	CD	O
FAP	NNP	S_Disease
patients	NNS	O
with	IN	O
fewer	JJR	O
polyps	NNS	S_Disease
were	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
other	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
.	.	O

The	DT	O
result	NN	O
suggests	VBZ	O
that	IN	O
the	DT	O
number	NN	O
of	IN	O
colorectal	JJ	B_Disease
polyps	NNS	E_Disease
in	IN	O
FAP	NNP	S_Disease
patients	NNS	O
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
a	DT	O
difference	NN	O
in	IN	O
the	DT	O
stability	NN	O
or	CC	O
biological	JJ	O
function	NN	O
of	IN	O
the	DT	O
truncated	JJ	O
APC	NNP	S_Disease
protein	NN	O
.	.	O
.	.	O

Identification	NN	O
and	CC	O
rapid	JJ	O
detection	NN	O
of	IN	O
three	CD	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	E_Disease
mutations	NNS	O
in	IN	O
the	DT	O
Moroccan	NNP	O
Jewish	NNP	O
population	NN	O
.	.	O

Infantile	NNP	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
TSD	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
that	WDT	O
result	NN	O
in	IN	O
the	DT	O
complete	JJ	O
absence	NN	O
of	IN	O
beta	NN	O
-	:	O
hexosaminidase	NN	O
A	DT	O
activity	NN	O
.	.	O

It	PRP	O
is	VBZ	O
well	RB	O
known	VBN	O
that	IN	O
an	DT	O
elevated	JJ	O
frequency	NN	O
of	IN	O
TSD	NNP	S_Disease
mutations	NNS	O
exists	VBZ	O
among	IN	O
Ashkenazi	JJ	O
Jews	NNPS	O
.	.	O

More	RBR	O
recently	RB	O
it	PRP	O
has	VBZ	O
become	VBN	O
apparent	JJ	O
that	IN	O
elevated	VBD	O
carrier	NN	O
frequencies	NNS	O
for	IN	O
TSD	NNP	S_Disease
also	RB	O
occur	VBP	O
in	IN	O
several	JJ	O
other	JJ	O
ethnic	JJ	O
groups	NNS	O
,	,	O
including	VBG	O
Moroccan	JJ	O
Jews	NNP	O
,	,	O
a	DT	O
subgroup	NN	O
of	IN	O
Sephardic	NNP	O
Jews	NNP	O
.	.	O

Elsewhere	RB	O
we	PRP	O
reported	VBD	O
an	DT	O
in	IN	O
-	:	O
frame	NN	O
deletion	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
adjacent	JJ	O
phenylalanine	NN	O
codons	NNS	O
at	IN	O
position	NN	O
304	CD	O
or	CC	O
305	CD	O
(	(	O
delta	JJ	O
F304	NNP	O
/	NNP	O
305	CD	O
)	)	O
in	IN	O
one	CD	O
HEXA	NNP	O
allele	NN	O
of	IN	O
a	DT	O
Moroccan	JJ	O
Jewish	NNP	O
TSD	NNP	S_Disease
patient	NN	O
and	CC	O
in	IN	O
three	CD	O
obligate	JJ	O
carriers	NNS	O
from	IN	O
six	CD	O
unrelated	JJ	O
Moroccan	NNP	O
Jewish	NNP	O
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
identified	VBN	O
two	CD	O
additional	JJ	O
mutations	NNS	O
within	IN	O
exon	JJ	O
5	CD	O
of	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
that	WDT	O
account	VBP	O
for	IN	O
the	DT	O
remaining	VBG	O
TSD	NNP	S_Disease
alleles	NNS	O
in	IN	O
the	DT	O
patient	NN	O
and	CC	O
carriers	NNS	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
is	VBZ	O
a	DT	O
novel	JJ	O
C	NNP	O
-	:	O
to	TO	O
-	:	O
G	NNP	O
transversion	NN	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
replacement	NN	O
of	IN	O
Tyr180	NNP	O
by	IN	O
a	DT	O
stop	JJ	O
codon	NN	O
.	.	O

The	DT	O
other	JJ	O
mutation	NN	O
is	VBZ	O
a	DT	O
G	NNP	O
-	:	O
to	TO	O
-	:	O
A	DT	O
transition	NN	O
resulting	VBG	O
in	IN	O
an	DT	O
Arg170	NNP	O
-	:	O
to	TO	O
-	:	O
Gln	NNP	O
substitution	NN	O
.	.	O

This	DT	O
mutation	NN	O
is	VBZ	O
at	IN	O
a	DT	O
CpG	NNP	O
site	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
infant	NN	O
with	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
and	CC	O
was	VBD	O
described	VBN	O
elsewhere	RB	O
.	.	O

Analysis	NN	O
of	IN	O
nine	CD	O
obligate	JJ	O
carriers	NNS	O
from	IN	O
seven	CD	O
unrelated	JJ	O
families	NNS	O
showed	VBD	O
that	IN	O
four	CD	O
harbor	NN	O
the	DT	O
delta	NN	O
F304	NNP	O
/	VBZ	O
305	CD	O
mutation	NN	O
,	,	O
two	CD	O
the	DT	O
Arg170	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
Gln	NNP	O
mutation	NN	O
,	,	O
and	CC	O
one	CD	O
the	DT	O
Tyr180	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
Stop	JJ	O
mutation	NN	O
.	.	O

We	PRP	O
also	RB	O
have	VBP	O
developed	VBN	O
rapid	JJ	O
,	,	O
nonradioactive	JJ	O
assays	NNS	O
for	IN	O
the	DT	O
detection	NN	O
of	IN	O
each	DT	O
mutation	NN	O
,	,	O
which	WDT	O
should	MD	O
be	VB	O
helpful	JJ	O
for	IN	O
carrier	NN	O
screening	NN	O
.	.	O
.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
glucose	JJ	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
by	IN	O
natural	JJ	O
and	CC	O
amplification	NN	O
created	VBD	O
restriction	NN	O
sites	NNS	O
:	:	O
five	CD	O
mutations	NNS	O
account	VBP	O
for	IN	O
most	JJS	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
cases	NNS	O
in	IN	O
Taiwan	NNP	O
.	.	O

We	PRP	O
have	VBP	O
developed	VBN	O
a	DT	O
rapid	JJ	O
and	CC	O
simple	JJ	O
method	NN	O
to	TO	O
diagnose	VB	O
the	DT	O
molecular	JJ	O
defects	NNS	O
of	IN	O
glucose	JJ	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
in	IN	O
Chinese	NNP	O
in	IN	O
Taiwan	NNP	O
.	.	O

This	DT	O
method	NN	O
involves	VBZ	O
the	DT	O
selective	JJ	O
amplification	NN	O
of	IN	O
a	DT	O
DNA	NNP	O
fragment	NN	O
from	IN	O
human	JJ	O
G6PD	NNP	O
gene	NN	O
with	IN	O
specific	JJ	O
oligonucleotide	NN	O
primers	NNS	O
followed	VBN	O
by	IN	O
digestion	NN	O
with	IN	O
restriction	NN	O
enzymes	NNS	O
that	WDT	O
recognize	VBP	O
artificially	RB	O
created	VBN	O
or	CC	O
naturally	RB	O
occurring	VBG	O
restriction	NN	O
sites	NNS	O
.	.	O

Ninety	NNP	O
-	:	O
four	CD	O
Chinese	JJ	O
males	NNS	O
with	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
were	VBD	O
studied	VBN	O
.	.	O

The	DT	O
results	NNS	O
show	VBP	O
that	IN	O
50	CD	O
%	NN	O
(	(	O
47	CD	O
of	IN	O
94	CD	O
)	)	O
were	VBD	O
G	NNP	O
to	TO	O
T	VB	O
mutation	NN	O
at	IN	O
nucleotide	NN	O
(	(	O
nt	NN	O
)	)	O
1376	CD	O
,	,	O
21	CD	O
.	.	O

3	CD	O
%	NN	O
(	(	O
20	CD	O
of	IN	O
94	CD	O
)	)	O
were	VBD	O
G	NNP	O
to	TO	O
A	DT	O
mutation	NN	O
at	IN	O
nt	JJ	O
1388	CD	O
,	,	O
7	CD	O
.	.	O

4	CD	O
%	NN	O
(	(	O
7	CD	O
of	IN	O
94	CD	O
)	)	O
were	VBD	O
A	DT	O
to	TO	O
G	NNP	O
mutation	NN	O
at	IN	O
nt	JJ	O
493	CD	O
,	,	O
7	CD	O
.	.	O

4	CD	O
%	NN	O
(	(	O
7	CD	O
of	IN	O
94	CD	O
)	)	O
were	VBD	O
A	DT	O
to	TO	O
G	NNP	O
mutation	NN	O
at	IN	O
nt	JJ	O
95	CD	O
,	,	O
4	CD	O
.	.	O

2	CD	O
%	NN	O
(	(	O
4	CD	O
of	IN	O
94	CD	O
)	)	O
were	VBD	O
C	NNP	O
to	TO	O
T	VB	O
mutation	NN	O
at	IN	O
nt	JJ	O
1024	CD	O
,	,	O
1	CD	O
.	.	O

1	CD	O
%	NN	O
(	(	O
1	CD	O
of	IN	O
94	CD	O
)	)	O
was	VBD	O
G	NNP	O
to	TO	O
T	VB	O
mutation	NN	O
at	IN	O
nt	JJ	O
392	CD	O
,	,	O
and	CC	O
1	CD	O
.	.	O

1	CD	O
%	NN	O
(	(	O
1	CD	O
of	IN	O
94	CD	O
)	)	O
was	VBD	O
G	NNP	O
to	TO	O
A	DT	O
mutation	NN	O
at	IN	O
nt	JJ	O
487	CD	O
.	.	O

These	DT	O
results	NNS	O
show	VBP	O
that	IN	O
the	DT	O
former	JJ	O
five	CD	O
mutations	NNS	O
account	VBP	O
for	IN	O
more	JJR	O
than	IN	O
90	CD	O
%	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
cases	NNS	O
in	IN	O
Taiwan	NNP	O
.	.	O

Aside	RB	O
from	IN	O
showing	VBG	O
that	IN	O
G	NNP	O
to	TO	O
T	VB	O
change	NN	O
at	IN	O
nt	JJ	O
1376	CD	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
,	,	O
our	PRP$	O
research	NN	O
indicates	VBZ	O
that	IN	O
nt	$	O
493	CD	O
mutation	NN	O
is	VBZ	O
a	DT	O
frequent	JJ	O
mutation	NN	O
among	IN	O
Chinese	JJ	O
in	IN	O
Taiwan	NNP	O
.	.	O

We	PRP	O
compared	VBN	O
G6PD	NNP	O
activity	NN	O
among	IN	O
different	JJ	O
mutations	NNS	O
,	,	O
without	IN	O
discovering	VBG	O
significant	JJ	O
differences	NNS	O
between	IN	O
them	PRP	O
.	.	O

Eight	CD	O
novel	JJ	O
inactivating	VBG	O
germ	JJ	O
line	NN	O
mutations	NNS	O
at	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
identified	VBN	O
by	IN	O
denaturing	VBG	O
gradient	JJ	O
gel	JJ	O
electrophoresis	NN	O
.	.	O

Familial	NNP	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
dominantly	RB	O
inherited	VBN	O
condition	NN	O
predisposing	VBG	O
to	TO	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

The	DT	O
recent	JJ	O
isolation	NN	O
of	IN	O
the	DT	O
responsible	JJ	O
gene	NN	O
(	(	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
or	CC	O
APC	NNP	S_Disease
)	)	O
has	VBZ	O
facilitated	VBN	O
the	DT	O
search	NN	O
for	IN	O
germ	JJ	O
line	NN	O
mutations	NNS	O
in	IN	O
affected	JJ	O
individuals	NNS	O
.	.	O

Previous	JJ	O
authors	NNS	O
have	VBP	O
used	VBN	O
the	DT	O
RNase	NNP	O
protection	NN	O
assay	NN	O
and	CC	O
the	DT	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphisms	VBZ	O
procedure	NN	O
to	TO	O
screen	VB	O
for	IN	O
mutations	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
we	PRP	O
used	VBD	O
denaturing	VBG	O
gradient	JJ	O
gel	NN	O
electrophoresis	NN	O
(	(	O
DGGE	NNP	O
)	)	O
.	.	O

DGGE	NNP	O
analysis	NN	O
of	IN	O
10	CD	O
APC	NNP	S_Disease
exons	NNS	O
(	(	O
4	CD	O
,	,	O
5	CD	O
,	,	O
7	CD	O
,	,	O
8	CD	O
,	,	O
9	CD	O
,	,	O
10	CD	O
,	,	O
12	CD	O
,	,	O
13	CD	O
,	,	O
14	CD	O
,	,	O
and	CC	O
part	NN	O
of	IN	O
15	CD	O
)	)	O
in	IN	O
33	CD	O
unrelated	JJ	O
Dutch	NNP	O
FAP	NNP	S_Disease
patients	NNS	O
has	VBZ	O
led	VBN	O
to	TO	O
the	DT	O
identification	NN	O
of	IN	O
eight	CD	O
novel	JJ	O
germ	FW	O
line	NN	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
stop	JJ	O
codons	NNS	O
or	CC	O
frameshifts	NNS	O
.	.	O

The	DT	O
results	NNS	O
reported	VBD	O
here	RB	O
indicate	JJ	O
that	IN	O
(	(	O
1	CD	O
)	)	O
familial	NN	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
an	DT	O
extremely	RB	O
heterogeneous	JJ	O
spectrum	NN	O
of	IN	O
point	NN	O
mutations	NNS	O
;	:	O
(	(	O
2	CD	O
)	)	O
all	PDT	O
the	DT	O
mutations	NNS	O
found	VBN	O
in	IN	O
this	DT	O
study	NN	O
are	VBP	O
chain	NN	O
terminating	NN	O
;	:	O
and	CC	O
(	(	O
3	CD	O
)	)	O
DGGE	NNP	O
represents	VBZ	O
a	DT	O
rapid	JJ	O
and	CC	O
sensitive	JJ	O
technique	NN	O
for	IN	O
the	DT	O
detection	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
unusually	RB	O
large	JJ	O
APC	NNP	S_Disease
gene	NN	O
.	.	O

An	DT	O
extension	NN	O
of	IN	O
the	DT	O
DGGE	NNP	O
analysis	NN	O
to	TO	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
in	IN	O
a	DT	O
sufficient	JJ	O
number	NN	O
of	IN	O
clinically	RB	O
well	RB	O
-	:	O
characterized	VBN	O
,	,	O
unrelated	JJ	O
patients	NNS	O
will	MD	O
facilitate	VB	O
the	DT	O
establishment	NN	O
of	IN	O
genotype	JJ	O
-	:	O
phenotype	NN	O
correlations	NNS	O
.	.	O

On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
the	DT	O
occurrence	NN	O
of	IN	O
an	DT	O
extremely	RB	O
heterogeneous	JJ	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
spread	VBP	O
throughout	IN	O
the	DT	O
entire	JJ	O
length	NN	O
of	IN	O
the	DT	O
large	JJ	O
APC	NNP	S_Disease
gene	NN	O
among	IN	O
the	DT	O
FAP	NNP	S_Disease
patients	NNS	O
indicates	VBZ	O
that	IN	O
this	DT	O
approach	NN	O
may	MD	O
not	RB	O
be	VB	O
useful	JJ	O
as	IN	O
a	DT	O
rapid	JJ	O
presymptomatic	JJ	O
diagnostic	JJ	O
procedure	NN	O
in	IN	O
a	DT	O
routine	JJ	O
laboratory	NN	O
.	.	O

Nevertheless	RB	O
,	,	O
the	DT	O
above	JJ	O
DGGE	NNP	O
approach	NN	O
has	VBZ	O
incidentally	RB	O
led	VBN	O
to	TO	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
common	JJ	O
polymorphism	NN	O
in	IN	O
exon	JJ	O
13	CD	O
.	.	O

Such	JJ	O
intragenic	JJ	O
polymorphisms	NNS	O
offer	VBP	O
a	DT	O
practical	JJ	O
approach	NN	O
to	TO	O
a	DT	O
more	RBR	O
rapid	JJ	O
procedure	NN	O
for	IN	O
presymptomatic	JJ	O
diagnosis	NN	O
of	IN	O
FAP	NNP	S_Disease
by	IN	O
linkage	NN	O
analysis	NN	O
in	IN	O
informative	JJ	O
families	NNS	O
.	.	O
.	.	O

Yeast	NNP	O
artificial	JJ	O
chromosomes	NNS	O
for	IN	O
the	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
familial	JJ	B_Disease
polyposis	NN	I_Disease
APC	NNP	E_Disease
gene	NN	O
region	NN	O
.	.	O

Two	CD	O
yeast	JJ	O
artificial	JJ	O
chromosomes	NNS	O
(	(	O
YACs	NNP	O
)	)	O
spanning	VBG	O
a	DT	O
total	JJ	O
distance	NN	O
of	IN	O
1	CD	O
.	.	O

1	CD	O
megabase	NN	O
pairs	NNS	O
of	IN	O
DNA	NNP	O
around	IN	O
the	DT	O
MCC	NNP	O
(	(	O
for	IN	O
mutated	VBN	O
in	IN	O
colorectal	JJ	B_Disease
carcinoma	NN	E_Disease
)	)	O
and	CC	O
APC	NNP	S_Disease
(	(	O
for	IN	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
)	)	O
genes	NNS	O
at	IN	O
5q21	CD	O
have	VBP	O
been	VBN	O
isolated	VBN	O
and	CC	O
characterized	VBN	O
.	.	O

Starting	VBG	O
from	IN	O
the	DT	O
MCC	NNP	O
gene	NN	O
,	,	O
a	DT	O
strategy	NN	O
was	VBD	O
undertaken	VBN	O
to	TO	O
identify	VB	O
constitutional	JJ	O
submicroscopic	NN	O
deletions	NNS	O
in	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
patients	NNS	O
that	WDT	O
might	MD	O
considerably	RB	O
narrow	VB	O
down	RP	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
.	.	O

To	TO	O
this	DT	O
end	NN	O
,	,	O
YACs	NNP	O
identified	VBN	O
by	IN	O
the	DT	O
MCC	NNP	O
gene	NN	O
were	VBD	O
screened	VBN	O
across	IN	O
a	DT	O
chromosome	NN	O
5	CD	O
-	:	O
specific	JJ	O
cosmid	JJ	O
library	NN	O
to	TO	O
provide	VB	O
a	DT	O
source	NN	O
of	IN	O
DNA	NNP	O
probes	NNS	O
for	IN	O
genomic	JJ	O
scanning	NN	O
.	.	O

The	DT	O
cosmids	NNS	O
isolated	VBD	O
from	IN	O
these	DT	O
experiments	NNS	O
were	VBD	O
used	VBN	O
to	TO	O
screen	VB	O
a	DT	O
panel	NN	O
of	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
containing	VBG	O
chromosome	NN	O
5	CD	O
segregated	VBN	O
from	IN	O
patients	NNS	O
suspected	VBN	O
to	TO	O
carry	VB	O
putative	JJ	O
interstitial	JJ	O
deletions	NNS	O
.	.	O

This	DT	O
screening	NN	O
approach	NN	O
led	VBD	O
to	TO	O
the	DT	O
confirmation	NN	O
of	IN	O
a	DT	O
small	JJ	O
heterozygous	JJ	O
deletion	NN	O
in	IN	O
a	DT	O
polyposis	NN	S_Disease
patient	NN	O
that	WDT	O
overlaps	VBZ	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
isolated	JJ	O
YACs	NNPS	O
.	.	O

This	DT	O
YAC	NNP	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
contain	VB	O
the	DT	O
entire	JJ	O
APC	NNP	S_Disease
gene	NN	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
a	DT	O
significant	JJ	O
portion	NN	O
of	IN	O
DNA	NNP	O
flanking	VBG	O
the	DT	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
and	CC	O
should	MD	O
therefore	VB	O
prove	VB	O
a	DT	O
valuable	JJ	O
resource	NN	O
for	IN	O
functional	JJ	O
studies	NNS	O
by	IN	O
transfer	NN	O
to	TO	O
colorectal	VB	B_Disease
tumor	NN	E_Disease
-	:	O
derived	VBN	O
cell	NN	O
lines	NNS	O
.	.	O

Inherited	VBN	O
WT1	NNP	O
mutation	NN	O
in	IN	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Patients	NNS	O
with	IN	O
the	DT	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
,	,	O
genital	JJ	B_Disease
anomalies	NNS	E_Disease
,	,	O
and	CC	O
nephropathy	RB	S_Disease
)	)	O
have	VBP	O
been	VBN	O
demonstrated	VBN	O
to	TO	O
carry	VB	O
de	FW	O
novo	FW	O
constitutional	JJ	O
mutations	NNS	O
in	IN	O
WT1	NNP	O
,	,	O
the	DT	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
gene	NN	O
at	IN	O
chromosome	NN	O
11p13	CD	O
.	.	O

We	PRP	O
report	VBP	O
three	CD	O
new	JJ	O
cases	NNS	O
,	,	O
two	CD	O
carrying	VBG	O
a	DT	O
previously	RB	O
described	VBN	O
WT1	NNP	O
exon	VBZ	O
9	CD	O
mutation	NN	O
and	CC	O
one	CD	O
with	IN	O
a	DT	O
novel	JJ	O
WT1	NNP	O
exon	NN	O
8	CD	O
mutation	NN	O
.	.	O

However	RB	O
,	,	O
unlike	IN	O
patients	NNS	O
in	IN	O
previous	JJ	O
reports	NNS	O
,	,	O
one	CD	O
of	IN	O
our	PRP$	O
three	CD	O
patients	NNS	O
inherited	VBD	O
the	DT	O
affected	JJ	O
allele	NN	O
from	IN	O
his	PRP$	O
phenotypically	RB	O
unaffected	JJ	O
father	NN	O
.	.	O

This	DT	O
observation	NN	O
indicates	VBZ	O
that	IN	O
the	DT	O
WT1	NNP	O
exon	VBD	O
9	CD	O
mutation	NN	O
affecting	VBG	O
394Arg	CD	O
demonstrated	VBN	O
in	IN	O
over	IN	O
one	CD	O
-	:	O
half	NN	O
of	IN	O
the	DT	O
patients	NNS	O
with	IN	O
the	DT	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
may	MD	O
exhibit	VB	O
incomplete	JJ	O
penetrance	NN	O
.	.	O

Consequently	RB	O
,	,	O
familial	JJ	O
studies	NNS	O
in	IN	O
patients	NNS	O
affected	VBN	O
by	IN	O
this	DT	O
syndrome	NN	O
are	VBP	O
recommended	VBN	O
.	.	O
.	.	O

Submicroscopic	NNP	O
deletions	NNS	O
at	IN	O
the	DT	O
WAGR	NNP	S_Disease
locus	NN	O
,	,	O
revealed	VBN	O
by	IN	O
nonradioactive	JJ	O
in	IN	O
situ	JJ	O
hybridization	NN	O
.	.	O

Fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
(	(	O
FISH	NNP	O
)	)	O
with	IN	O
biotin	NN	O
-	:	O
labeled	VBN	O
probes	NNS	O
mapping	VBG	O
to	TO	O
11p13	CD	O
has	VBZ	O
been	VBN	O
used	VBN	O
for	IN	O
the	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
deletions	NNS	O
of	IN	O
the	DT	O
WAGR	NNP	S_Disease
(	(	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
,	,	O
aniridia	NN	S_Disease
,	,	O
genitourinary	JJ	B_Disease
abnormalities	NNS	E_Disease
,	,	O
and	CC	O
mental	JJ	B_Disease
retardation	NN	E_Disease
)	)	O
locus	NN	O
.	.	O

We	PRP	O
have	VBP	O
detected	VBN	O
a	DT	O
submicroscopic	NN	O
11p13	CD	O
deletion	NN	O
in	IN	O
a	DT	O
child	NN	O
with	IN	O
inherited	JJ	O
aniridia	NN	S_Disease
who	WP	O
subsequently	RB	O
presented	VBN	O
with	IN	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
in	IN	O
a	DT	O
horseshoe	NN	O
kidney	NN	O
,	,	O
only	RB	O
revealed	VBD	O
at	IN	O
surgery	NN	O
.	.	O

The	DT	O
mother	NN	O
,	,	O
who	WP	O
has	VBZ	O
aniridia	NN	S_Disease
,	,	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
carry	VB	O
a	DT	O
deletion	NN	O
including	VBG	O
both	CC	O
the	DT	O
aniridia	NN	S_Disease
candidate	NN	O
gene	NN	O
(	(	O
AN2	NNP	O
)	)	O
and	CC	O
the	DT	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
predisposition	NN	O
gene	NN	O
(	(	O
WT1	NNP	O
)	)	O
.	.	O

This	DT	O
is	VBZ	O
therefore	RB	O
a	DT	O
rare	JJ	O
case	NN	O
of	IN	O
an	DT	O
inherited	JJ	O
WAGR	NNP	S_Disease
deletion	NN	O
.	.	O

Wilms	NNP	B_Disease
tumor	NN	E_Disease
has	VBZ	O
so	RB	O
far	RB	O
only	RB	O
been	VBN	O
associated	VBN	O
with	IN	O
sporadic	JJ	O
de	FW	O
novo	FW	O
aniridia	NN	S_Disease
cases	NNS	O
.	.	O

We	PRP	O
have	VBP	O
shown	VBN	O
that	IN	O
a	DT	O
cosmid	NN	O
probe	NN	O
for	IN	O
a	DT	O
candidate	NN	O
aniridia	NN	S_Disease
gene	NN	O
,	,	O
homologous	JJ	O
to	TO	O
the	DT	O
mouse	NN	O
Pax	NNP	O
-	:	O
6	CD	O
gene	NN	O
,	,	O
is	VBZ	O
deleted	VBN	O
in	IN	O
cell	NN	O
lines	NNS	O
from	IN	O
aniridia	JJ	S_Disease
patients	NNS	O
with	IN	O
previously	RB	O
characterized	VBN	O
deletions	NNS	O
at	IN	O
11p13	CD	O
,	,	O
while	IN	O
another	DT	O
cosmid	NN	O
marker	NN	O
mapping	VBG	O
between	IN	O
two	CD	O
aniridia	SYM	S_Disease
-	:	O
associated	VBN	O
translocation	NN	O
breakpoints	NNS	O
(	(	O
and	CC	O
hence	RB	O
a	DT	O
second	JJ	O
candidate	NN	O
marker	NN	O
)	)	O
is	VBZ	O
present	JJ	O
on	IN	O
both	DT	O
chromosomes	NNS	O
.	.	O

These	DT	O
results	NNS	O
support	VBD	O
the	DT	O
Pax	NNP	O
-	:	O
6	CD	O
homologue	NN	O
as	IN	O
a	DT	O
strong	JJ	O
candidate	NN	O
for	IN	O
the	DT	O
AN2	NNP	O
gene	NN	O
.	.	O

FISH	NN	O
with	IN	O
cosmid	NN	O
probes	NNS	O
has	VBZ	O
proved	VBN	O
to	TO	O
be	VB	O
a	DT	O
fast	JJ	O
and	CC	O
reliable	JJ	O
technique	NN	O
for	IN	O
the	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
deletions	NNS	O
.	.	O

It	PRP	O
can	MD	O
be	VB	O
used	VBN	O
with	IN	O
limited	JJ	O
amounts	NNS	O
of	IN	O
material	NN	O
and	CC	O
has	VBZ	O
strong	JJ	O
potential	NN	O
for	IN	O
clinical	JJ	O
applications	NNS	O
.	.	O
.	.	O

Linkage	NN	O
of	IN	O
gene	NN	O
for	IN	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
and	CC	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
complex	JJ	O
MHC	NNP	O
in	IN	O
man	NN	O
.	.	O

Family	RB	O
study	NN	O
of	IN	O
a	DT	O
further	JJ	O
case	NN	O
.	.	O

Close	JJ	O
linkage	NN	O
between	IN	O
HL	NNP	O
-	:	O
A	DT	O
and	CC	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
was	VBD	O
first	RB	O
reported	VBN	O
by	IN	O
FU	NNP	O
and	CC	O
co	SYM	O
-	:	O
workers	NNS	O
in	IN	O
1974	CD	O
.	.	O

We	PRP	O
present	VBP	O
here	RB	O
a	DT	O
pedigree	NN	O
of	IN	O
a	DT	O
31	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
C2	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
individual	JJ	O
with	IN	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
Hodgkins	NNP	B_Disease
disease	NN	E_Disease
.	.	O

The	DT	O
following	JJ	O
markers	NNS	O
were	VBD	O
tested	VBN	O
C2	NNP	O
levels	NNS	O
,	,	O
factor	NN	O
B	NNP	O
polymorphism	NN	O
,	,	O
blood	NN	O
groups	NNS	O
,	,	O
and	CC	O
enzyme	RB	O
typing	NN	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
close	VB	O
linkage	NN	O
between	IN	O
HL	NNP	O
-	:	O
A	DT	O
and	CC	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
both	DT	O
parents	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
Bf	NNP	O
(	(	O
HL	NNP	O
-	:	O
A	DT	O
linked	VBN	O
,	,	O
electrophoretic	JJ	O
variation	NN	O
of	IN	O
B	NNP	O
)	)	O
.	.	O

The	DT	O
two	CD	O
HL	NNP	O
-	:	O
A	DT	O
haplotypes	NNS	O
closely	RB	O
linked	VBN	O
to	TO	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
are	VBP	O
different	JJ	O
2	CD	O
,	,	O
W18	NNP	O
and	CC	O
W24	NNP	O
,	,	O
W18	NNP	O
.	.	O

They	PRP	O
share	NN	O
,	,	O
however	RB	O
,	,	O
the	DT	O
SD2	NNP	O
antigen	NN	O
W18	NNP	O
and	CC	O
the	DT	O
LD	NNP	O
type	NN	O
7a	CD	O
.	.	O
.	.	O

Screening	VBG	O
for	IN	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
patients	NNS	O
:	:	O
61	CD	O
new	JJ	O
patients	NNS	O
and	CC	O
a	DT	O
summary	NN	O
of	IN	O
150	CD	O
unrelated	JJ	O
patients	NNS	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
result	NN	O
of	IN	O
a	DT	O
screening	NN	O
for	IN	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
gene	NN	O
in	IN	O
61	CD	O
new	JJ	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
patients	NNS	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
summary	NN	O
of	IN	O
the	DT	O
results	NNS	O
of	IN	O
150	CD	O
patients	NNS	O
.	.	O

Examination	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
,	,	O
based	VBN	O
on	IN	O
a	DT	O
ribonuclease	NN	O
protection	NN	O
assay	VBP	O
coupled	VBN	O
with	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
,	,	O
disclosed	VBD	O
mutations	NNS	O
that	WDT	O
were	VBD	O
considered	VBN	O
to	TO	O
cause	VB	O
significant	JJ	O
defects	NNS	O
in	IN	O
the	DT	O
APC	NNP	S_Disease
product	NN	O
in	IN	O
97	CD	O
of	IN	O
150	CD	O
unrelated	JJ	O
FAP	NNP	S_Disease
patients	NNS	O
.	.	O

Our	PRP$	O
findings	NNS	O
revealed	VBD	O
the	DT	O
following	JJ	O
characteristics	NNS	O
of	IN	O
the	DT	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
of	IN	O
APC	NNP	O
1	CD	O
)	)	O
the	DT	O
great	JJ	O
majority	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
truncate	VB	O
the	DT	O
APC	NNP	S_Disease
product	NN	O
;	:	O
2	CD	O
)	)	O
almost	RB	O
all	DT	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
located	VBN	O
within	IN	O
the	DT	O
first	JJ	O
half	NN	O
of	IN	O
the	DT	O
coding	JJ	O
region	NN	O
;	:	O
3	CD	O
)	)	O
no	DT	O
correlation	NN	O
was	VBD	O
observed	VBN	O
between	IN	O
the	DT	O
locations	NNS	O
of	IN	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
and	CC	O
extracolonic	JJ	O
manifestations	NNS	O
in	IN	O
FAP	NNP	S_Disease
patients	NNS	O
;	:	O
4	CD	O
)	)	O
more	JJR	O
than	IN	O
80	CD	O
%	NN	O
of	IN	O
base	NN	O
substitutions	NNS	O
in	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
were	VBD	O
from	IN	O
cytosine	NN	O
to	TO	O
other	JJ	O
nucleotides	NNS	O
,	,	O
nearly	RB	O
one	CD	O
-	:	O
third	NN	O
of	IN	O
which	WDT	O
occurred	VBD	O
at	IN	O
the	DT	O
GpG	NNP	O
site	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
provide	VB	O
information	NN	O
helpful	NN	O
to	TO	O
an	DT	O
understanding	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
and	CC	O
will	MD	O
also	RB	O
contribute	VB	O
to	TO	O
presymptomatic	JJ	O
diagnosis	NN	O
of	IN	O
members	NNS	O
in	IN	O
FAP	NNP	S_Disease
families	NNS	O
.	.	O
.	.	O

Somatic	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
in	IN	O
colorectal	JJ	B_Disease
tumors	NNS	E_Disease
:	:	O
mutation	NN	O
cluster	NN	O
region	NN	O
in	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
.	.	O

We	PRP	O
examined	VBD	O
somatic	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
gene	NN	O
in	IN	O
63	CD	O
colorectal	JJ	B_Disease
tumors	NNS	E_Disease
(	(	O
16	CD	O
adenomas	NN	S_Disease
and	CC	O
47	CD	O
carcinomas	NN	S_Disease
)	)	O
developed	VBD	O
in	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
and	CC	O
non	$	O
-	:	O
FAP	NN	O
patients	NNS	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
(	(	O
LOH	NNP	O
)	)	O
at	IN	O
the	DT	O
APC	NNP	S_Disease
locus	NN	O
in	IN	O
30	CD	O
tumors	NNS	S_Disease
,	,	O
43	CD	O
other	JJ	O
somatic	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
.	.	O

Twenty	NNP	O
-	:	O
one	CD	O
of	IN	O
them	PRP	O
were	VBD	O
point	JJ	O
mutations	NNS	O
;	:	O
16	CD	O
nonsense	NN	O
and	CC	O
two	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
and	CC	O
three	CD	O
occurred	VBD	O
in	IN	O
introns	NNS	O
at	IN	O
the	DT	O
splicing	VBG	O
site	NN	O
.	.	O

Twenty	CD	O
-	:	O
two	CD	O
tumors	NNS	S_Disease
had	VBD	O
frameshift	JJ	O
mutations	NNS	O
due	JJ	O
to	TO	O
deletion	NN	O
or	CC	O
insertion	NN	O
;	:	O
nineteen	NN	O
of	IN	O
them	PRP	O
were	VBD	O
deletions	NNS	O
of	IN	O
one	CD	O
to	TO	O
31	CD	O
bp	NN	O
and	CC	O
three	CD	O
were	VBD	O
a	DT	O
1	CD	O
-	:	O
bp	NN	O
insertion	NN	O
.	.	O

One	CD	O
tumor	NN	S_Disease
had	VBD	O
a	DT	O
1	CD	O
-	:	O
bp	NN	O
deletion	NN	O
in	IN	O
an	DT	O
intron	NN	O
near	IN	O
the	DT	O
splicing	VBG	O
site	NN	O
.	.	O

Hence	NNP	O
,	,	O
41	CD	O
(	(	O
95	CD	O
%	NN	O
)	)	O
of	IN	O
43	CD	O
mutations	NNS	O
resulted	VBD	O
in	IN	O
truncation	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
protein	NN	O
.	.	O

Over	IN	O
60	CD	O
%	NN	O
of	IN	O
the	DT	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
were	VBD	O
clustered	VBN	O
within	IN	O
a	DT	O
small	JJ	O
region	NN	O
of	IN	O
exon	NN	O
15	CD	O
,	,	O
designated	VBN	O
as	IN	O
MCR	NNP	O
(	(	O
mutation	NN	O
cluster	NN	O
region	NN	O
)	)	O
,	,	O
which	WDT	O
accounted	VBD	O
for	IN	O
less	JJR	O
than	IN	O
10	CD	O
%	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
.	.	O

Combining	VBG	O
these	DT	O
data	NNS	O
and	CC	O
the	DT	O
results	NNS	O
of	IN	O
LOH	NNP	O
,	,	O
more	JJR	O
than	IN	O
80	CD	O
%	NN	O
of	IN	O
tumors	NNS	S_Disease
(	(	O
14	CD	O
adenomas	NN	S_Disease
and	CC	O
39	CD	O
carcinomas	NN	S_Disease
)	)	O
had	VBD	O
at	IN	O
least	JJS	O
one	CD	O
mutation	NN	O
in	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
,	,	O
of	IN	O
which	WDT	O
more	JJR	O
than	IN	O
60	CD	O
%	NN	O
(	(	O
9	CD	O
adenomas	NN	S_Disease
and	CC	O
23	CD	O
carcinomas	NN	S_Disease
)	)	O
had	VBD	O
two	CD	O
mutations	NNS	O
.	.	O

These	DT	O
results	NNS	O
strongly	RB	O
suggest	VBP	O
that	IN	O
somatic	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
development	NN	O
of	IN	O
a	DT	O
great	JJ	O
majority	NN	O
of	IN	O
colorectal	JJ	B_Disease
tumors	NNS	E_Disease
.	.	O
.	.	O

Constitutional	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
WT1	NNP	O
gene	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

The	DT	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
characterised	VBN	O
by	IN	O
a	DT	O
typical	JJ	O
nephropathy	NN	S_Disease
,	,	O
genital	JJ	B_Disease
abnormalities	NNS	E_Disease
and	CC	O
also	RB	O
predisposes	VBZ	O
to	TO	O
the	DT	O
development	NN	O
of	IN	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
.	.	O

These	DT	O
patients	NNS	O
eventually	RB	O
go	VBP	O
into	IN	O
end	NN	O
stage	NN	O
renal	JJ	B_Disease
failure	NN	E_Disease
.	.	O

A	DT	O
candidate	NN	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
gene	NN	O
,	,	O
WT1	NNP	O
,	,	O
from	IN	O
the	DT	O
11p13	CD	O
chromosome	NN	O
region	NN	O
has	VBZ	O
recently	RB	O
been	VBN	O
cloned	VBN	O
.	.	O

We	PRP	O
have	VBP	O
analysed	VBN	O
the	DT	O
DNA	NNP	O
sequence	NN	O
in	IN	O
constitutional	JJ	O
cells	NNS	O
from	IN	O
eight	CD	O
patients	NNS	O
and	CC	O
have	VBP	O
shown	VBN	O
heterozygous	JJ	O
mutations	NNS	O
in	IN	O
six	CD	O
of	IN	O
them	PRP	O
.	.	O

Four	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
in	IN	O
exon	JJ	O
9	CD	O
,	,	O
all	DT	O
resulting	VBG	O
in	IN	O
missense	NN	O
mutations	NNS	O
.	.	O

Three	CD	O
were	VBD	O
at	IN	O
nucleotide	JJ	O
position	NN	O
1180	CD	O
resulting	VBG	O
in	IN	O
an	DT	O
arg	NN	O
>	NN	O
trp	NN	O
amino	NN	O
acid	JJ	O
change	NN	O
.	.	O

The	DT	O
other	JJ	O
was	VBD	O
at	IN	O
position	NN	O
1186	CD	O
converting	VBG	O
an	DT	O
asp	JJ	O
>	NN	O
asn	NN	O
in	IN	O
the	DT	O
predicted	JJ	O
resultant	NN	O
protein	NN	O
.	.	O

One	CD	O
patient	NN	O
had	VBD	O
a	DT	O
missense	JJ	O
mutation	NN	O
in	IN	O
exon	JJ	O
8	CD	O
,	,	O
converting	VBG	O
an	DT	O
arg	NN	O
>	VBD	O
his	PRP$	O
.	.	O

A	DT	O
single	JJ	O
base	NN	O
pair	NN	O
insertion	NN	O
at	IN	O
nucleotide	JJ	O
position	NN	O
821	CD	O
in	IN	O
exon	NN	O
6	CD	O
resulted	VBD	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
in	IN	O
the	DT	O
last	JJ	O
patient	NN	O
.	.	O

We	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
find	VB	O
a	DT	O
mutation	NN	O
in	IN	O
one	CD	O
patient	NN	O
despite	IN	O
complete	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
genomic	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

The	DT	O
last	JJ	O
patient	NN	O
carried	VBD	O
a	DT	O
constitutional	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
11p13	CD	O
region	NN	O
and	CC	O
no	DT	O
additional	JJ	O
mutation	NN	O
was	VBD	O
found	VBN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
obvious	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
type	NN	O
of	IN	O
mutation	NN	O
and	CC	O
phenotypic	NN	O
expression	NN	O
.	.	O

These	DT	O
results	NNS	O
further	RBR	O
demonstrate	NN	O
that	IN	O
the	DT	O
WT1	NNP	O
gene	NN	O
is	VBZ	O
important	JJ	O
in	IN	O
both	DT	O
the	DT	O
development	NN	O
of	IN	O
the	DT	O
kidney	NN	O
and	CC	O
the	DT	O
genito	NN	O
-	:	O
urinary	JJ	O
system	NN	O
.	.	O
.	.	O

Linkage	NNP	O
disequilibrium	NN	O
mapping	NN	O
in	IN	O
isolated	JJ	O
founder	NN	O
populations	NNS	O
:	:	O
diastrophic	JJ	B_Disease
dysplasia	NN	E_Disease
in	IN	O
Finland	NNP	O
.	.	O

Linkage	NNP	O
disequilibrium	NN	O
mapping	NN	O
in	IN	O
isolated	JJ	O
populations	NNS	O
provides	VBZ	O
a	DT	O
powerful	JJ	O
tool	NN	O
for	IN	O
fine	JJ	O
structure	NN	O
localization	NN	O
of	IN	O
disease	NN	O
genes	NNS	O
.	.	O

Here	RB	O
,	,	O
Luria	NNP	O
and	CC	O
Delbrucks	NNP	O
classical	JJ	O
methods	NNS	O
for	IN	O
analysing	VBG	O
bacterial	JJ	O
cultures	NNS	O
are	VBP	O
adapted	VBN	O
to	TO	O
the	DT	O
study	NN	O
of	IN	O
human	JJ	O
isolated	JJ	O
founder	NN	O
populations	NNS	O
in	IN	O
order	NN	O
to	TO	O
estimate	VB	O
(	(	O
i	NN	O
)	)	O
the	DT	O
recombination	NN	O
fraction	NN	O
between	IN	O
a	DT	O
disease	NN	O
locus	NN	O
and	CC	O
a	DT	O
marker	NN	O
;	:	O
(	(	O
ii	NN	O
)	)	O
the	DT	O
expected	JJ	O
degree	NN	O
of	IN	O
allelic	JJ	O
homogeneity	NN	O
in	IN	O
a	DT	O
population	NN	O
;	:	O
and	CC	O
(	(	O
iii	NN	O
)	)	O
the	DT	O
mutation	NN	O
rate	NN	O
of	IN	O
marker	NN	O
loci	NN	O
.	.	O

Using	VBG	O
these	DT	O
methods	NNS	O
,	,	O
we	PRP	O
report	VBP	O
striking	VBG	O
linkage	NN	O
disequilibrium	NN	O
for	IN	O
diastrophic	JJ	B_Disease
dysplasia	NN	E_Disease
(	(	O
DTD	NNP	S_Disease
)	)	O
in	IN	O
Finland	NNP	O
indicating	VBG	O
that	IN	O
the	DT	O
DTD	NNP	S_Disease
gene	NN	O
should	MD	O
lie	VB	O
within	IN	O
0	CD	O
.	.	O

06	CD	O
centimorgans	NNS	O
(	(	O
or	CC	O
about	IN	O
60	CD	O
kilobases	NNS	O
)	)	O
of	IN	O
the	DT	O
CSF1R	NNP	O
gene	NN	O
.	.	O

Predictions	NNS	O
about	IN	O
allelic	JJ	O
homogeneity	NN	O
in	IN	O
Finland	NNP	O
and	CC	O
mutation	NN	O
rates	NNS	O
in	IN	O
simple	JJ	O
sequence	NN	O
repeats	NNS	O
are	VBP	O
confirmed	VBN	O
by	IN	O
independent	JJ	O
observations	NNS	O
.	.	O

The	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	JJ	I_Disease
syndrome	NN	E_Disease
:	:	O
refinement	NN	O
of	IN	O
the	DT	O
localization	NN	O
on	IN	O
Xp	NNP	O
and	CC	O
identification	NN	O
of	IN	O
another	DT	O
closely	RB	O
linked	VBN	O
marker	NN	O
locus	NN	O
,	,	O
OATL1	NNP	O
.	.	O

The	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
has	VBZ	O
previously	RB	O
been	VBN	O
mapped	VBN	O
to	TO	O
the	DT	O
proximal	JJ	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
between	IN	O
the	DT	O
DXS14	NNP	O
and	CC	O
DXS7	NNP	O
loci	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
further	JJ	O
segregation	NN	O
analysis	NN	O
has	VBZ	O
been	VBN	O
performed	VBN	O
using	VBG	O
a	DT	O
newly	RB	O
identified	VBN	O
WAS	NNP	S_Disease
family	NN	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
additional	JJ	O
marker	NN	O
probe	NN	O
,	,	O
HOATL1	NNP	O
.	.	O

The	DT	O
results	NNS	O
indicate	VBP	O
close	JJ	O
linkage	NN	O
between	IN	O
the	DT	O
WAS	NNP	S_Disease
and	CC	O
OATL1	NNP	O
loci	NN	O
(	(	O
Z	NNP	O
=	VBZ	O
6	CD	O
.	.	O

08	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

00	CD	O
)	)	O
and	CC	O
localize	VB	O
the	DT	O
TIMP	NNP	O
,	,	O
OATL1	NNP	O
,	,	O
DXS255	NNP	O
,	,	O
and	CC	O
WAS	NNP	S_Disease
loci	JJ	O
distal	NN	O
to	TO	O
DXS146	NNP	O
and	CC	O
the	DT	O
OATL1	NNP	O
and	CC	O
WAS	NNP	S_Disease
loci	RB	O
proximal	JJ	O
to	TO	O
TIMP	NNP	O
.	.	O

These	DT	O
linkage	NN	O
data	NNS	O
narrow	VBP	O
the	DT	O
boundaries	NNS	O
within	IN	O
which	WDT	O
the	DT	O
WAS	NNP	S_Disease
locus	NN	O
maps	NNS	O
to	TO	O
the	DT	O
chromosomal	JJ	O
region	NN	O
bracketed	VBN	O
by	IN	O
TIMP	NNP	O
and	CC	O
DXS146	NNP	O
and	CC	O
support	VB	O
the	DT	O
loci	NN	O
order	NN	O
Xpter	NNP	O
-	:	O
DXS7	NNP	O
-	:	O
TIMP	NNP	O
-	:	O
(	(	O
OATL1	NNP	O
,	,	O
WAS	NNP	O
,	,	O
DXS255	NNP	O
)	)	O
-	:	O
DXS146	NN	O
.	.	O

Detection	NN	O
of	IN	O
an	DT	O
unstable	JJ	O
fragment	NN	O
of	IN	O
DNA	NNP	O
specific	JJ	O
to	TO	O
individuals	NNS	O
with	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
adult	NN	O
muscular	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
with	IN	O
a	DT	O
prevalence	NN	O
of	IN	O
2	CD	O
-	:	O
14	CD	O
per	IN	O
100	CD	O
,	,	O
000	CD	O
individuals	NNS	O
.	.	O

The	DT	O
disease	NN	O
is	VBZ	O
characterized	VBN	O
by	IN	O
progressive	JJ	O
muscle	NN	B_Disease
weakness	NN	E_Disease
and	CC	O
sustained	JJ	B_Disease
muscle	NN	I_Disease
contraction	NN	E_Disease
,	,	O
often	RB	O
with	IN	O
a	DT	O
wide	JJ	O
range	NN	O
of	IN	O
accompanying	VBG	O
symptoms	NNS	O
.	.	O

The	DT	O
age	NN	O
at	IN	O
onset	NN	O
and	CC	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
show	NN	O
extreme	JJ	O
variation	NN	O
,	,	O
both	DT	O
within	IN	O
and	CC	O
between	IN	O
families	NNS	O
.	.	O

Despite	IN	O
its	PRP$	O
clinical	JJ	O
variability	NN	O
,	,	O
this	DT	O
dominant	JJ	O
condition	NN	O
segregates	NNS	O
as	IN	O
a	DT	O
single	JJ	O
locus	NN	O
at	IN	O
chromosome	NN	O
19q13	CD	O
.	.	O

3	CD	O
in	IN	O
every	DT	O
population	NN	O
studied	VBN	O
.	.	O

It	PRP	O
is	VBZ	O
flanked	VBN	O
by	IN	O
the	DT	O
tightly	RB	O
linked	VBN	O
genetic	JJ	O
markers	NNS	O
ERCC1	NNP	O
proximally	RB	O
and	CC	O
D19S51	NNP	O
distally	RB	O
;	:	O
these	DT	O
define	VBP	O
the	DT	O
DM	NNP	S_Disease
critical	JJ	O
region	NN	O
.	.	O

We	PRP	O
report	VBP	O
the	DT	O
isolation	NN	O
of	IN	O
an	DT	O
expressed	JJ	O
sequence	NN	O
from	IN	O
this	DT	O
region	NN	O
which	WDT	O
detects	VBZ	O
a	DT	O
DNA	NN	O
fragment	NN	O
that	WDT	O
is	VBZ	O
larger	JJR	O
in	IN	O
affected	JJ	O
individuals	NNS	O
than	IN	O
in	IN	O
normal	JJ	O
siblings	NNS	O
or	CC	O
unaffected	JJ	O
controls	NNS	O
.	.	O

The	DT	O
size	NN	O
of	IN	O
this	DT	O
fragment	JJ	O
varies	NNS	O
between	IN	O
affected	JJ	O
siblings	NNS	O
,	,	O
and	CC	O
increases	VBZ	O
in	IN	O
size	NN	O
through	IN	O
generations	NNS	O
in	IN	O
parallel	JJ	O
with	IN	O
increasing	VBG	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

We	PRP	O
postulate	VBP	O
that	IN	O
this	DT	O
unstable	JJ	O
DNA	NN	O
sequence	NN	O
is	VBZ	O
the	DT	O
molecular	JJ	O
feature	NN	O
that	WDT	O
underlies	VBZ	O
DM	NNP	S_Disease
.	.	O

Common	JJ	O
sequence	NN	O
motifs	NNS	O
at	IN	O
the	DT	O
rearrangement	NN	O
sites	NNS	O
of	IN	O
a	DT	O
constitutional	JJ	O
X	NN	O
/	NNP	O
autosome	JJ	O
translocation	NN	O
and	CC	O
associated	VBN	O
deletion	NN	O
.	.	O

Reciprocal	JJ	O
chromosome	NN	O
translocations	NNS	O
are	VBP	O
common	JJ	O
de	IN	O
novo	JJ	O
rearrangements	NNS	O
that	WDT	O
occur	VBP	O
randomly	RB	O
throughout	IN	O
the	DT	O
human	JJ	O
genome	NN	O
.	.	O

To	TO	O
learn	VB	O
about	IN	O
causative	JJ	O
mechanisms	NNS	O
,	,	O
we	PRP	O
have	VBP	O
cloned	VBN	O
and	CC	O
sequenced	VBD	O
the	DT	O
breakpoints	NNS	O
of	IN	O
a	DT	O
cytologically	RB	O
balanced	JJ	O
constitutional	JJ	O
reciprocal	JJ	O
translocation	NN	O
,	,	O
t	NN	O
(	(	O
X	NNP	O
;	:	O
4	CD	O
)	)	O
(	(	O
p21	NN	O
.	.	O

2	CD	O
;	:	O
q31	NN	O
.	.	O

22	CD	O
)	)	O
,	,	O
present	JJ	O
in	IN	O
a	DT	O
girl	NN	O
with	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
.	.	O

Physical	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
derivative	JJ	O
chromosomes	NNS	O
,	,	O
after	IN	O
their	PRP$	O
separation	NN	O
in	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
,	,	O
reveals	NNS	O
that	IN	O
the	DT	O
translocation	NN	O
disrupts	VBZ	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
in	IN	O
Xp21	NNP	O
within	IN	O
the	DT	O
18	CD	O
-	:	O
kb	NN	O
intron	NN	O
16	CD	O
.	.	O

Restriction	NN	O
mapping	NN	O
and	CC	O
sequencing	NN	O
of	IN	O
clones	NNS	O
that	WDT	O
span	VBP	O
both	DT	O
translocation	NN	O
breakpoints	NNS	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
corresponding	VBG	O
normal	JJ	O
regions	NNS	O
indicate	VBP	O
the	DT	O
loss	NN	O
of	IN	O
approximately	RB	O
5	CD	O
kb	NNS	O
in	IN	O
the	DT	O
formation	NN	O
of	IN	O
the	DT	O
derivative	JJ	O
X	NNP	O
chromosome	NN	O
,	,	O
with	IN	O
4	CD	O
-	:	O
6	CD	O
bp	NN	O
deleted	VBN	O
from	IN	O
chromosome	NN	O
4	CD	O
.	.	O

RFLP	NNP	O
and	CC	O
Southern	NNP	O
analyses	VBZ	O
indicate	VBP	O
that	IN	O
the	DT	O
de	FW	O
novo	FW	O
translocation	NN	O
is	VBZ	O
a	DT	O
paternal	JJ	O
origin	NN	O
and	CC	O
that	IN	O
the	DT	O
fathers	NNS	O
X	VBP	O
chromosome	NN	O
contains	VBZ	O
the	DT	O
DNA	NN	O
that	WDT	O
is	VBZ	O
deleted	VBN	O
in	IN	O
the	DT	O
derivative	JJ	O
X	NN	O
.	.	O

Most	JJS	O
likely	JJ	O
,	,	O
deletion	NN	O
and	CC	O
translation	NN	O
arose	VBP	O
simultaneously	RB	O
from	IN	O
a	DT	O
complex	JJ	O
rearrangement	NN	O
event	NN	O
that	WDT	O
involves	VBZ	O
three	CD	O
chromosomal	JJ	O
breakpoints	NNS	O
.	.	O

Short	JJ	O
regions	NNS	O
of	IN	O
sequence	NN	O
homology	NN	O
were	VBD	O
present	JJ	O
at	IN	O
the	DT	O
three	CD	O
sites	NNS	O
.	.	O

A	DT	O
5	CD	O
-	:	O
bp	NN	O
sequence	NN	O
,	,	O
GGAAT	NNP	O
,	,	O
found	VBD	O
exactly	RB	O
at	IN	O
the	DT	O
translocation	NN	O
breakpoints	NNS	O
on	IN	O
both	DT	O
normal	JJ	O
chromosomes	NNS	O
X	NNP	O
and	CC	O
4	CD	O
,	,	O
has	VBZ	O
been	VBN	O
preserved	VBN	O
only	RB	O
on	IN	O
the	DT	O
der	NN	O
(	(	O
4	CD	O
)	)	O
chromosome	NN	O
.	.	O

It	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
the	DT	O
X	NNP	O
-	:	O
derived	VBD	O
sequence	NN	O
GGAATCA	NNP	O
has	VBZ	O
been	VBN	O
lost	VBN	O
in	IN	O
the	DT	O
formation	NN	O
of	IN	O
the	DT	O
der	NN	O
(	(	O
X	NNP	O
)	)	O
chromosome	NN	O
,	,	O
as	IN	O
it	PRP	O
matches	VBZ	O
an	DT	O
inverted	JJ	O
GAATCA	NNP	O
sequence	NN	O
present	NN	O
on	IN	O
the	DT	O
opposite	JJ	O
strand	NN	O
exactly	RB	O
at	IN	O
the	DT	O
other	JJ	O
end	NN	O
of	IN	O
the	DT	O
deleted	JJ	O
5	CD	O
-	:	O
kb	NN	O
fragment	NN	O
.	.	O

A	DT	O
genetic	JJ	O
etiology	NN	O
for	IN	O
DiGeorge	NNP	B_Disease
syndrome	NN	E_Disease
:	:	O
consistent	JJ	O
deletions	NNS	O
and	CC	O
microdeletions	NNS	O
of	IN	O
22q11	CD	O
.	.	O

DiGeorge	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
DGS	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
developmental	JJ	O
field	NN	O
defect	NN	O
of	IN	O
the	DT	O
third	JJ	O
and	CC	O
fourth	JJ	O
pharyngeal	NN	O
pouches	NNS	O
,	,	O
is	VBZ	O
characterized	VBN	O
by	IN	O
aplasia	NN	B_Disease
or	CC	I_Disease
hypoplasia	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
thymus	NN	I_Disease
and	CC	I_Disease
parathyroid	JJ	I_Disease
glands	NNS	E_Disease
and	CC	O
by	IN	O
conotruncal	JJ	B_Disease
cardiac	JJ	I_Disease
malformations	NNS	E_Disease
.	.	O

Cytogenetic	JJ	O
studies	NNS	O
support	VBP	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
DGS	NNP	S_Disease
critical	JJ	O
region	NN	O
in	IN	O
band	NN	O
22q11	CD	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
results	NNS	O
of	IN	O
clinical	JJ	O
,	,	O
cytogenetic	JJ	O
,	,	O
and	CC	O
molecular	JJ	O
studies	NNS	O
of	IN	O
14	CD	O
patients	NNS	O
with	IN	O
DGS	NNP	S_Disease
.	.	O

Chromosome	NNP	O
analysis	NN	O
,	,	O
utilizing	VBG	O
high	JJ	O
-	:	O
resolution	NN	O
banding	VBG	O
techniques	NNS	O
,	,	O
detected	VBN	O
interstitial	JJ	O
deletions	NNS	O
in	IN	O
five	CD	O
probands	NNS	O
and	CC	O
was	VBD	O
inconclusive	JJ	O
for	IN	O
a	DT	O
deletion	NN	O
in	IN	O
three	CD	O
probands	NNS	O
.	.	O

The	DT	O
remaining	VBG	O
six	CD	O
patients	NNS	O
had	VBD	O
normal	JJ	O
karyotypes	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
molecular	JJ	O
analysis	NN	O
detected	VBD	O
DNA	NNP	O
deletions	NNS	O
in	IN	O
all	DT	O
14	CD	O
probands	NNS	O
.	.	O

Two	CD	O
of	IN	O
10	CD	O
loci	NN	O
tested	VBN	O
,	,	O
D22S75	NNP	O
and	CC	O
D22S259	NNP	O
,	,	O
are	VBP	O
deleted	VBN	O
in	IN	O
all	DT	O
14	CD	O
patients	NNS	O
.	.	O

A	DT	O
third	JJ	O
locus	NN	O
,	,	O
D22S66	NNP	O
,	,	O
is	VBZ	O
deleted	VBN	O
in	IN	O
the	DT	O
eight	CD	O
DGS	NNP	S_Disease
probands	NNS	O
tested	VBD	O
.	.	O

Physical	JJ	O
mapping	NN	O
using	VBG	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
places	VBZ	O
D22S66	NNP	O
between	IN	O
D22S75	NNP	O
and	CC	O
D22S259	NNP	O
,	,	O
suggesting	VBG	O
that	IN	O
it	PRP	O
should	MD	O
be	VB	O
deleted	VBN	O
in	IN	O
the	DT	O
remaining	VBG	O
six	CD	O
cases	NNS	O
.	.	O

Parent	NNP	O
-	:	O
of	IN	O
-	:	O
origin	NN	O
studies	NNS	O
were	VBD	O
performed	VBN	O
in	IN	O
five	CD	O
families	NNS	O
.	.	O

Four	CD	O
probands	NNS	O
failed	VBD	O
to	TO	O
inherit	VB	O
a	DT	O
maternal	JJ	O
allele	NN	O
,	,	O
and	CC	O
one	CD	O
failed	VBD	O
to	TO	O
inherit	VB	O
a	DT	O
paternal	JJ	O
allele	NN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
these	DT	O
families	NNS	O
,	,	O
and	CC	O
of	IN	O
six	CD	O
maternally	RB	O
and	CC	O
five	CD	O
paternally	RB	O
derived	VBN	O
unbalanced	JJ	O
-	:	O
translocation	NN	O
DGS	NNP	S_Disease
probands	VBZ	O
in	IN	O
the	DT	O
literature	NN	O
,	,	O
parent	NN	O
of	IN	O
origin	NN	O
or	CC	O
imprinting	NN	O
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
play	VB	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
DGS	NNP	S_Disease
.	.	O

Deletion	NN	O
of	IN	O
the	DT	O
same	JJ	O
three	CD	O
loci	NN	O
in	IN	O
all	DT	O
14	CD	O
DGS	NNP	S_Disease
probands	NNS	O
begins	VBZ	O
to	TO	O
delineate	VB	O
the	DT	O
region	NN	O
of	IN	O
chromosome	NN	O
22	CD	O
critical	JJ	O
for	IN	O
DGS	NNP	S_Disease
and	CC	O
confirms	VBZ	O
the	DT	O
hypothesis	NN	O
that	WDT	O
submicroscopic	VBD	O
deletions	NNS	O
of	IN	O
22q11	CD	O
are	VBP	O
etiologic	VBN	O
in	IN	O
the	DT	O
vast	JJ	O
majority	NN	O
of	IN	O
cases	NNS	O
.	.	O
.	.	O

Loss	NNP	O
of	IN	O
normal	JJ	O
allele	NNS	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
in	IN	O
an	DT	O
adrenocortical	JJ	B_Disease
carcinoma	NN	E_Disease
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
.	.	O

Endocrine	NNP	B_Disease
neoplasms	NNS	E_Disease
have	VBP	O
been	VBN	O
reported	VBN	O
occasionally	RB	O
in	IN	O
patients	NNS	O
with	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
.	.	O

An	DT	O
adrenocorotical	JJ	B_Disease
carcinoma	NN	E_Disease
was	VBD	O
studied	VBN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
FAP	NNP	S_Disease
.	.	O

Loss	NNP	O
of	IN	O
heterozygosity	NN	O
(	(	O
LOH	NNP	O
)	)	O
in	IN	O
the	DT	O
region	NN	O
close	RB	O
to	TO	O
the	DT	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
gene	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
this	DT	O
carcinoma	NN	S_Disease
,	,	O
and	CC	O
evidence	NN	O
was	VBD	O
obtained	VBN	O
that	IN	O
there	EX	O
was	VBD	O
a	DT	O
loss	NN	O
of	IN	O
the	DT	O
normal	JJ	O
allele	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
demonstration	NN	O
of	IN	O
LOH	NNP	O
at	IN	O
the	DT	O
APC	NNP	S_Disease
locus	NN	O
in	IN	O
adrenocortical	JJ	B_Disease
tumors	NNS	E_Disease
.	.	O

The	DT	O
present	JJ	O
results	NNS	O
and	CC	O
our	PRP$	O
previous	JJ	O
data	NNS	O
on	IN	O
LOH	NNP	O
in	IN	O
a	DT	O
recurring	VBG	O
desmoid	JJ	B_Disease
tumor	NN	E_Disease
suggest	VBP	O
that	IN	O
the	DT	O
heterozygous	JJ	O
mutant	NN	O
/	NNP	O
wild	SYM	O
-	:	O
type	JJ	O
condition	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
may	MD	O
give	VB	O
rise	NN	O
to	TO	O
benign	VB	B_Disease
tumors	NNS	E_Disease
,	,	O
and	CC	O
that	IN	O
functional	JJ	O
loss	NN	O
of	IN	O
this	DT	O
gene	NN	O
leads	VBZ	O
to	TO	O
development	NN	O
of	IN	O
tumors	NNS	S_Disease
not	RB	O
only	RB	O
in	IN	O
the	DT	O
colon	NN	O
but	CC	O
also	RB	O
in	IN	O
other	JJ	O
various	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
body	NN	O
in	IN	O
FAP	NNP	S_Disease
patients	NNS	O
.	.	O
.	.	O

Oncogenic	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
exon	JJ	O
20	CD	O
of	IN	O
the	DT	O
RB1	NNP	O
gene	NN	O
in	IN	O
families	NNS	O
showing	VBG	O
incomplete	JJ	O
penetrance	NN	O
and	CC	O
mild	JJ	O
expression	NN	O
of	IN	O
the	DT	O
retinoblastoma	NN	S_Disease
phenotype	NN	O
.	.	O

The	DT	O
retinoblastoma	NN	S_Disease
-	:	O
predisposition	NN	O
gene	NN	O
,	,	O
RB1	NNP	O
,	,	O
segregates	VBZ	O
as	IN	O
an	DT	O
autosomal	JJ	O
dominant	JJ	O
trait	NN	O
with	IN	O
high	JJ	O
(	(	O
90	CD	O
%	NN	O
)	)	O
penetrance	NN	O
.	.	O

Certain	NNP	O
families	NNS	O
,	,	O
however	RB	O
,	,	O
show	VBP	O
an	DT	O
unusual	JJ	O
low	JJ	O
-	:	O
penetrance	NN	O
phenotype	NN	O
with	IN	O
many	JJ	O
individuals	NNS	O
being	VBG	O
unaffected	JJ	O
,	,	O
unilaterally	RB	O
affected	VBN	O
,	,	O
or	CC	O
with	IN	O
evidence	NN	O
of	IN	O
spontaneously	RB	O
regressed	VBN	O
tumors	NNS	S_Disease
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
analysis	NN	O
and	CC	O
PCR	NNP	O
sequencing	VBG	O
to	TO	O
study	VB	O
two	CD	O
such	JJ	O
families	NNS	O
.	.	O

Mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
exon	JJ	O
20	CD	O
of	IN	O
RB1	NNP	O
in	IN	O
both	DT	O
cases	NNS	O
.	.	O

In	IN	O
one	CD	O
family	NN	O
a	DT	O
C	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
T	DT	O
transition	NN	O
in	IN	O
codon	NN	O
661	CD	O
converts	NNS	O
an	DT	O
arginine	NN	O
(	(	O
CGG	NNP	O
)	)	O
to	TO	O
a	DT	O
tryptophan	NN	O
(	(	O
TGG	NNP	O
)	)	O
codon	NN	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
,	,	O
incomplete	JJ	O
penetrance	NN	O
and	CC	O
mild	JJ	O
phenotypic	NN	O
expression	NN	O
were	VBD	O
observed	VBN	O
in	IN	O
virtually	RB	O
all	DT	O
patients	NNS	O
,	,	O
possibly	RB	O
indicating	VBG	O
that	IN	O
single	JJ	O
amino	NN	O
acid	IN	O
changes	NNS	O
may	MD	O
modify	VB	O
protein	NN	O
structure	NN	O
/	JJ	O
function	NN	O
such	JJ	O
that	IN	O
tumorigenesis	NN	O
is	VBZ	O
not	RB	O
inevitable	JJ	O
.	.	O

In	IN	O
the	DT	O
second	JJ	O
family	NN	O
the	DT	O
mutation	NN	O
in	IN	O
codon	NN	O
675	CD	O
is	VBZ	O
a	DT	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
T	NN	O
transversion	NN	O
that	WDT	O
converts	VBZ	O
a	DT	O
glutamine	NN	O
(	(	O
GAA	NNP	O
)	)	O
to	TO	O
a	DT	O
stop	NN	O
(	(	O
TAA	NNP	O
)	)	O
codon	NN	O
.	.	O

However	RB	O
,	,	O
this	DT	O
mutation	NN	O
also	RB	O
occurs	VBZ	O
near	IN	O
a	DT	O
potential	JJ	O
cryptic	JJ	O
splice	NN	O
acceptor	NN	O
site	NN	O
,	,	O
raising	VBG	O
the	DT	O
possibility	NN	O
of	IN	O
alternative	JJ	O
splicing	VBG	O
resulting	VBG	O
in	IN	O
a	DT	O
less	RBR	O
severely	RB	O
disrupted	VBN	O
protein	NN	O
.	.	O
.	.	O

Late	JJ	O
-	:	O
onset	VBN	O
metachromatic	JJ	B_Disease
leukodystrophy	NN	E_Disease
:	:	O
molecular	JJ	O
pathology	NN	O
in	IN	O
two	CD	O
siblings	NNS	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
new	JJ	O
allele	NN	O
at	IN	O
the	DT	O
arylsulfatase	NN	O
A	NNP	O
(	(	O
ARSA	NNP	O
)	)	O
locus	VBD	O
causing	VBG	O
late	JJ	O
-	:	O
onset	VBN	O
metachromatic	JJ	B_Disease
leukodystrophy	NN	E_Disease
(	(	O
MLD	NNP	S_Disease
)	)	O
.	.	O

In	IN	O
that	DT	O
allele	NN	O
arginine84	NN	O
,	,	O
a	DT	O
residue	NN	O
that	WDT	O
is	VBZ	O
highly	RB	O
conserved	VBN	O
in	IN	O
the	DT	O
arylsulfatase	NN	O
gene	NN	O
family	NN	O
,	,	O
is	VBZ	O
replaced	VBN	O
by	IN	O
glutamine	NN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
alleles	NNS	O
that	WDT	O
cause	VBP	O
early	JJ	O
-	:	O
onset	NN	O
MLD	NNP	S_Disease
,	,	O
the	DT	O
arginine84	NN	O
to	TO	O
glutamine	VB	O
substitution	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
some	DT	O
residual	JJ	O
ARSA	NNP	O
activity	NN	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
genotypes	NNS	O
,	,	O
ARSA	NNP	O
activities	NNS	O
,	,	O
and	CC	O
clinical	JJ	O
data	NNS	O
on	IN	O
4	CD	O
individuals	NNS	O
carrying	VBG	O
the	DT	O
allele	NN	O
of	IN	O
81	CD	O
patients	NNS	O
with	IN	O
MLD	NNP	S_Disease
examined	VBD	O
,	,	O
further	JJ	O
validates	VBZ	O
the	DT	O
concept	NN	O
that	WDT	O
different	JJ	O
degrees	NNS	O
of	IN	O
residual	JJ	O
ARSA	NNP	O
activity	NN	O
are	VBP	O
the	DT	O
basis	NN	O
of	IN	O
phenotypical	JJ	O
variation	NN	O
in	IN	O
MLD	NNP	S_Disease
.	.	O
.	.	O

Trisomy	$	B_Disease
15	CD	E_Disease
with	IN	O
loss	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
15	CD	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
due	JJ	O
to	TO	O
maternal	JJ	B_Disease
disomy	NN	E_Disease
.	.	O

Uniparental	JJ	B_Disease
disomy	NN	E_Disease
has	VBZ	O
recently	RB	O
been	VBN	O
recognized	VBN	O
to	TO	O
cause	VB	O
human	JJ	O
disorders	NNS	O
,	,	O
including	VBG	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
particularly	RB	O
instructive	JJ	O
case	NN	O
which	WDT	O
raises	VBZ	O
important	JJ	O
issues	NNS	O
concerning	VBG	O
the	DT	O
mechanisms	NN	O
producing	VBG	O
uniparental	JJ	B_Disease
disomy	NN	E_Disease
and	CC	O
whose	WP$	O
evaluation	NN	O
provides	VBZ	O
evidence	NN	O
that	IN	O
trisomy	NN	O
may	MD	O
precede	VB	O
uniparental	JJ	B_Disease
disomy	NN	E_Disease
in	IN	O
a	DT	O
fetus	NN	O
.	.	O

Chorionic	JJ	O
villus	NN	O
sampling	NN	O
performed	VBD	O
for	IN	O
advanced	JJ	O
maternal	JJ	O
age	NN	O
revealed	VBD	O
trisomy	JJ	B_Disease
15	CD	E_Disease
in	IN	O
all	DT	O
direct	JJ	O
and	CC	O
cultured	JJ	O
cells	NNS	O
,	,	O
though	IN	O
the	DT	O
fetus	NN	O
appeared	VBD	O
normal	JJ	O
.	.	O

Chromosome	NNP	O
analysis	NN	O
of	IN	O
amniocytes	NNS	O
obtained	VBN	O
at	IN	O
15	CD	O
wk	NN	O
was	VBD	O
normal	JJ	O
in	IN	O
over	IN	O
100	CD	O
cells	NNS	O
studied	VBN	O
.	.	O

The	DT	O
child	NN	O
was	VBD	O
hypotonic	JJ	S_Disease
at	IN	O
birth	NN	O
,	,	O
and	CC	O
high	JJ	O
-	:	O
resolution	NN	O
banding	VBG	O
failed	VBD	O
to	TO	O
reveal	VB	O
the	DT	O
deletion	NN	O
of	IN	O
15q11	CD	O
-	:	O
13	CD	O
,	,	O
a	DT	O
deletion	NN	O
which	WDT	O
is	VBZ	O
found	VBN	O
in	IN	O
50	CD	O
%	NN	O
-	:	O
70	CD	O
%	NN	O
of	IN	O
patients	NNS	O
with	IN	O
PWS	NNP	S_Disease
.	.	O

Over	IN	O
time	NN	O
,	,	O
typical	JJ	O
features	NNS	O
of	IN	O
PWS	NNP	S_Disease
developed	VBD	O
.	.	O

Molecular	JJ	O
genetic	JJ	O
analysis	NN	O
using	VBG	O
probes	NNS	O
for	IN	O
chromosome	NN	O
15	CD	O
revealed	VBD	O
maternal	JJ	O
disomy	NN	O
.	.	O

Maternal	JJ	O
nondisjunction	NN	O
with	IN	O
fertilization	NN	O
of	IN	O
a	DT	O
disomic	JJ	O
egg	NN	O
by	IN	O
a	DT	O
normal	JJ	O
sperm	NN	O
,	,	O
followed	VBN	O
by	IN	O
loss	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
15	CD	O
,	,	O
is	VBZ	O
a	DT	O
likely	JJ	O
cause	NN	O
of	IN	O
confined	JJ	O
placental	JJ	O
mosaicism	NN	O
and	CC	O
uniparental	JJ	B_Disease
disomy	NN	E_Disease
in	IN	O
this	DT	O
case	NN	O
of	IN	O
PWS	NNP	S_Disease
,	,	O
and	CC	O
advanced	VBD	O
maternal	JJ	O
age	NN	O
may	MD	O
be	VB	O
a	DT	O
predisposing	JJ	O
factor	NN	O
.	.	O
.	.	O

Genetic	JJ	O
heterogeneity	NN	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
amelogenesis	NN	I_Disease
imperfecta	NN	E_Disease
.	.	O

The	DT	O
AMELX	NNP	O
gene	NN	O
located	VBN	O
at	IN	O
Xp22	NNP	O
.	.	O

1	CD	O
-	:	O
p22	NN	O
.	.	O

3	CD	O
encodes	NNS	O
for	IN	O
the	DT	O
enamel	NN	O
protein	NN	O
amelogenin	NN	O
and	CC	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
as	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
inherited	JJ	B_Disease
dental	JJ	I_Disease
abnormality	NN	E_Disease
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
amelogenesis	NN	I_Disease
imperfecta	NN	E_Disease
(	(	O
XAI	NNP	S_Disease
)	)	O
.	.	O

Three	CD	O
families	NNS	O
with	IN	O
XAI	NNS	S_Disease
have	VBP	O
been	VBN	O
investigated	VBN	O
using	VBG	O
polymorphic	JJ	O
DNA	NNP	O
markers	NNS	O
flanking	VBG	O
the	DT	O
position	NN	O
of	IN	O
AMELX	NNP	O
.	.	O

Using	VBG	O
two	CD	O
-	:	O
point	NN	O
linkage	NN	O
analysis	NN	O
,	,	O
linkage	NN	O
was	VBD	O
established	VBN	O
between	IN	O
XAI	NNP	S_Disease
and	CC	O
several	JJ	O
of	IN	O
these	DT	O
markers	NNS	O
in	IN	O
two	CD	O
families	NNS	O
,	,	O
with	IN	O
a	DT	O
combined	JJ	O
lod	NN	O
score	NN	O
of	IN	O
6	CD	O
.	.	O

05	CD	O
for	IN	O
DXS16	NNP	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

04	CD	O
04	CD	O
.	.	O

This	DT	O
supports	VBZ	O
the	DT	O
involvement	NN	O
of	IN	O
AMELX	NNP	O
,	,	O
located	VBN	O
close	RB	O
to	TO	O
DXS16	NNP	O
,	,	O
in	IN	O
the	DT	O
XAI	NNP	B_Disease
disease	NN	E_Disease
process	NN	O
(	(	O
AIH1	NNP	O
)	)	O
in	IN	O
those	DT	O
families	NNS	O
.	.	O

Using	VBG	O
multipoint	NN	O
linkage	NN	O
analysis	NN	O
,	,	O
the	DT	O
combined	JJ	O
maximum	JJ	O
lod	NN	O
score	NN	O
for	IN	O
these	DT	O
two	CD	O
families	NNS	O
was	VBD	O
7	CD	O
.	.	O

30	CD	O
for	IN	O
a	DT	O
location	NN	O
of	IN	O
AIH1	NNP	O
at	IN	O
2	CD	O
cM	NN	O
distal	NN	O
to	TO	O
DXS16	NNP	O
.	.	O

The	DT	O
support	NN	O
interval	NN	O
around	IN	O
this	DT	O
location	NN	O
extended	VBD	O
about	IN	O
8	CD	O
cM	NNS	O
proximal	JJ	O
to	TO	O
DXS92	NNP	O
,	,	O
and	CC	O
the	DT	O
AIH1	NNP	O
location	NN	O
could	MD	O
not	RB	O
be	VB	O
precisely	RB	O
defined	VBN	O
by	IN	O
multipoint	NN	O
mapping	NN	O
.	.	O

Study	NNP	O
of	IN	O
recombination	NN	O
events	NNS	O
indicated	VBD	O
that	IN	O
AIH1	NNP	O
lies	VBZ	O
in	IN	O
the	DT	O
interval	NN	O
between	IN	O
DXS143	NNP	O
and	CC	O
DXS85	NNP	O
.	.	O

There	EX	O
was	VBD	O
significant	JJ	O
evidence	NN	O
against	IN	O
linkage	NN	O
to	TO	O
this	DT	O
region	NN	O
in	IN	O
the	DT	O
third	JJ	O
family	NN	O
,	,	O
indicating	VBG	O
locus	NN	O
heterogeneity	NN	O
in	IN	O
XAI	NNP	S_Disease
.	.	O

Further	JJ	O
analysis	NN	O
with	IN	O
markers	NNS	O
on	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
showed	VBD	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
DXS144E	NNP	O
and	CC	O
F9	NNP	O
with	IN	O
no	DT	O
recombination	NN	O
with	IN	O
either	DT	O
of	IN	O
these	DT	O
markers	NNS	O
.	.	O

Two	CD	O
-	:	O
point	NN	O
analysis	NN	O
gave	VBD	O
a	DT	O
peak	JJ	O
lod	NN	O
score	NN	O
at	IN	O
DXS144E	NNP	O
with	IN	O
a	DT	O
maximum	JJ	O
lod	JJ	O
score	NN	O
of	IN	O
2	CD	O
.	.	O

83	CD	O
at	IN	O
theta	NN	O
=	NN	O
0	CD	O
,	,	O
with	IN	O
a	DT	O
peak	JJ	O
lod	NN	O
score	NN	O
in	IN	O
multipoint	NN	O
linkage	NN	O
analysis	NN	O
of	IN	O
2	CD	O
.	.	O

84	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

The	DT	O
support	NN	O
interval	NN	O
extended	VBD	O
9	CD	O
cM	NN	O
proximal	NN	O
to	TO	O
DXS144E	NNP	O
and	CC	O
14	CD	O
cM	NN	O
distal	NN	O
to	TO	O
F9	NNP	O
.	.	O

(	(	O
ABSTRACT	NNP	O
TRUNCATED	NNP	O
AT	NNP	O
250	CD	O
WORDS	NNP	O
)	)	O
.	.	O

Multiple	JJ	O
origins	NNS	O
for	IN	O
phenylketonuria	NN	S_Disease
in	IN	O
Europe	NNP	O
.	.	O

Phenylketonuria	NNP	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
disorder	NN	B_Disease
of	IN	I_Disease
amino	NN	I_Disease
acid	JJ	I_Disease
metabolism	NN	E_Disease
prevalent	NN	O
among	IN	O
Caucasians	NNPS	O
and	CC	O
other	JJ	O
ethnic	JJ	O
groups	NNS	O
,	,	O
is	VBZ	O
caused	VBN	O
primarily	RB	O
by	IN	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
hepatic	JJ	I_Disease
enzyme	NN	I_Disease
phenylalanine	NN	I_Disease
hydroxylase	NN	E_Disease
(	(	O
PAH	NNP	O
)	)	O
.	.	O

PKU	NNP	S_Disease
is	VBZ	O
a	DT	O
highly	RB	O
heterogeneous	JJ	O
disorder	NN	O
,	,	O
with	IN	O
more	JJR	O
than	IN	O
60	CD	O
molecular	JJ	O
lesions	NNS	O
identified	VBN	O
in	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
.	.	O

The	DT	O
haplotype	NN	O
associations	NNS	O
,	,	O
relative	JJ	O
frequencies	NNS	O
,	,	O
and	CC	O
distributions	NNS	O
of	IN	O
five	CD	O
prevalent	JJ	O
PAH	NNP	O
mutations	NNS	O
(	(	O
R158Q	NNP	O
,	,	O
R261Q	NNP	O
,	,	O
IVS10nt546	NNP	O
,	,	O
R408W	NNP	O
,	,	O
and	CC	O
IVS12n1	NNP	O
)	)	O
were	VBD	O
established	VBN	O
in	IN	O
a	DT	O
comprehensive	JJ	O
European	JJ	O
sample	NN	O
population	NN	O
and	CC	O
subsequently	RB	O
were	VBD	O
examined	VBN	O
to	TO	O
determine	VB	O
the	DT	O
potential	JJ	O
roles	NNS	O
of	IN	O
several	JJ	O
genetic	JJ	O
mechanisms	NNS	O
in	IN	O
explaining	VBG	O
the	DT	O
present	JJ	O
distribution	NN	O
of	IN	O
the	DT	O
major	JJ	O
PKU	NNP	S_Disease
alleles	NNS	O
.	.	O

Each	DT	O
of	IN	O
these	DT	O
five	CD	O
mutations	NNS	O
was	VBD	O
strongly	RB	O
associated	VBN	O
with	IN	O
only	RB	O
one	CD	O
of	IN	O
the	DT	O
more	JJR	O
than	IN	O
70	CD	O
chromosomal	JJ	O
haplotypes	NNS	O
defined	VBN	O
by	IN	O
eight	CD	O
RFLPs	NNP	O
in	IN	O
or	CC	O
near	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
each	DT	O
of	IN	O
these	DT	O
mutations	NNS	O
arose	VBP	O
through	IN	O
a	DT	O
single	JJ	O
founding	NN	O
event	NN	O
that	WDT	O
occurred	VBD	O
within	IN	O
time	NN	O
periods	NNS	O
ranging	VBG	O
from	IN	O
several	JJ	O
hundred	CD	O
to	TO	O
several	JJ	O
thousand	CD	O
years	NNS	O
ago	RB	O
.	.	O

From	IN	O
the	DT	O
significant	JJ	O
differences	NNS	O
observed	VBN	O
in	IN	O
the	DT	O
relative	JJ	O
frequencies	NNS	O
and	CC	O
distributions	NNS	O
of	IN	O
these	DT	O
five	CD	O
alleles	NNS	O
throughout	IN	O
Europe	NNP	O
,	,	O
four	CD	O
of	IN	O
these	DT	O
putative	JJ	O
founding	NN	O
events	NNS	O
could	MD	O
be	VB	O
localized	VBN	O
to	TO	O
specific	VB	O
ethnic	JJ	O
subgroups	NNS	O
.	.	O

Together	RB	O
,	,	O
these	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
there	EX	O
were	VBD	O
multiple	NNS	O
,	,	O
geographically	RB	O
and	CC	O
ethnically	RB	O
distinct	JJ	O
origins	NNS	O
for	IN	O
PKU	NNP	S_Disease
within	IN	O
the	DT	O
European	JJ	O
population	NN	O
.	.	O
.	.	O

Complement	NNP	B_Disease
factor	NN	I_Disease
2	CD	I_Disease
deficiency	NN	E_Disease
:	:	O
a	DT	O
clinical	JJ	O
and	CC	O
serological	JJ	O
family	NN	O
study	NN	O
.	.	O

Inherited	VBN	B_Disease
complement	NN	I_Disease
deficiencies	NNS	E_Disease
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
variety	NN	O
of	IN	O
connective	JJ	O
tissue	NN	O
diseases	NNS	O
.	.	O

A	DT	O
family	NN	O
with	IN	O
inherited	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
complement	JJ	I_Disease
factor	NN	I_Disease
2	CD	E_Disease
(	(	O
C2	NNP	O
)	)	O
is	VBZ	O
described	VBN	O
in	IN	O
which	WDT	O
two	CD	O
family	NN	O
members	NNS	O
with	IN	O
homozygous	JJ	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
developed	VBD	O
cutaneous	JJ	B_Disease
vasculitis	NN	E_Disease
and	CC	O
sicca	JJ	B_Disease
syndrome	NN	E_Disease
.	.	O

The	DT	O
other	JJ	O
family	NN	O
members	NNS	O
had	VBD	O
heterozygous	JJ	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
and	CC	O
each	DT	O
member	NN	O
had	VBD	O
the	DT	O
HLA	NNP	O
-	:	O
A25	NNP	O
,	,	O
B18	NNP	O
,	,	O
DR2	NNP	O
(	(	O
w15	NN	O
)	)	O
haplotype	NN	O
.	.	O

The	DT	O
mother	NN	O
had	VBD	O
seropositive	JJ	B_Disease
rheumatoid	NN	I_Disease
arthritis	NN	E_Disease
.	.	O

Further	JJ	O
studies	NNS	O
showed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
cryoglobulins	NNS	O
,	,	O
antibodies	NNS	O
against	IN	O
endothelial	JJ	O
cells	NNS	O
,	,	O
and	CC	O
anticardiolipin	JJ	O
antibodies	NNS	O
.	.	O
.	.	O

New	NNP	O
variant	NN	O
in	IN	O
exon	JJ	O
3	CD	O
of	IN	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
(	(	O
PLP	NNP	O
)	)	O
gene	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
.	.	O

A	DT	O
C	NNP	O
-	:	O
-	:	O
greater	JJR	O
than	IN	O
G	NNP	O
transversion	NN	O
has	VBZ	O
been	VBN	O
found	VBN	O
in	IN	O
exon	JJ	O
3	CD	O
of	IN	O
the	DT	O
PLP	NNP	O
gene	NN	O
of	IN	O
affected	JJ	O
males	NNS	O
and	CC	O
their	PRP$	O
mother	NN	O
in	IN	O
a	DT	O
single	JJ	O
sibship	NN	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
merzbacher	NN	I_Disease
disease	NN	E_Disease
(	(	O
PMD	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
transversion	NN	O
should	MD	O
not	RB	O
result	VB	O
in	IN	O
an	DT	O
amino	NN	O
acid	NN	O
change	NN	O
in	IN	O
the	DT	O
protein	NN	O
but	CC	O
it	PRP	O
does	VBZ	O
result	VB	O
in	IN	O
the	DT	O
loss	NN	O
of	IN	O
a	DT	O
HaeIII	NNP	O
restriction	NN	O
endonuclease	NN	O
cleavage	NN	O
site	NN	O
.	.	O

It	PRP	O
is	VBZ	O
concordant	JJ	O
with	IN	O
the	DT	O
disease	NN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

One	CD	O
-	:	O
hundred	VBD	O
-	:	O
ten	NN	O
unrelated	JJ	O
X	NNP	O
chromosomes	NNS	O
are	VBP	O
negative	JJ	O
for	IN	O
this	DT	O
mutation	NN	O
.	.	O

No	DT	O
other	JJ	O
sequence	NN	O
defect	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
PLP	NNP	O
exons	NNS	O
of	IN	O
the	DT	O
affected	JJ	O
males	NNS	O
.	.	O

The	DT	O
cause	NN	O
of	IN	O
disease	NN	O
in	IN	O
this	DT	O
family	NN	O
remains	VBZ	O
unknown	JJ	O
,	,	O
but	CC	O
the	DT	O
association	NN	O
between	IN	O
this	DT	O
rare	JJ	O
mutation	NN	O
and	CC	O
PMD	NNP	S_Disease
is	VBZ	O
intriguing	VBG	O
.	.	O

The	DT	O
mutation	NN	O
can	MD	O
serve	VB	O
as	IN	O
a	DT	O
marker	NN	O
for	IN	O
following	VBG	O
segregation	NN	O
of	IN	O
the	DT	O
PLP	NNP	O
gene	NN	O
.	.	O
.	.	O

Uncoupling	NN	O
of	IN	O
hypomyelination	NN	S_Disease
and	CC	O
glial	JJ	B_Disease
cell	NN	I_Disease
death	NN	E_Disease
by	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
gene	NN	O
.	.	O

Proteolipid	NNP	O
protein	NN	O
(	(	O
PLP	NNP	O
;	:	O
M	NNP	O
(	(	O
r	NN	O
)	)	O
30	CD	O
,	,	O
000	CD	O
)	)	O
is	VBZ	O
a	DT	O
highly	RB	O
conserved	JJ	O
major	JJ	O
polytopic	NN	O
membrane	NN	O
protein	NN	O
in	IN	O
myelin	NN	O
but	CC	O
its	PRP$	O
cellular	JJ	O
function	NN	O
remains	VBZ	O
obscure	JJ	O
.	.	O

Neurological	JJ	O
mutant	JJ	O
mice	NN	O
can	MD	O
often	RB	O
provide	VB	O
model	NN	O
systems	NNS	O
for	IN	O
human	JJ	O
genetic	JJ	B_Disease
disorders	NNS	E_Disease
.	.	O

Mutations	NNS	O
of	IN	O
the	DT	O
X	NNP	O
-	:	O
chromosome	NN	O
-	:	O
linked	VBN	O
PLP	NNP	O
gene	NN	O
are	VBP	O
lethal	JJ	O
,	,	O
identified	VBN	O
first	RB	O
in	IN	O
the	DT	O
jimpy	NN	O
mouse	NN	O
and	CC	O
subsequently	RB	O
in	IN	O
patients	NNS	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
.	.	O

The	DT	O
unexplained	JJ	O
phenotype	NN	O
of	IN	O
these	DT	O
mutations	NNS	O
includes	VBZ	O
degeneration	NN	B_Disease
and	CC	I_Disease
premature	NN	I_Disease
cell	VBP	I_Disease
death	NN	I_Disease
of	IN	I_Disease
oligodendrocytes	NNS	E_Disease
with	IN	O
associated	JJ	O
hypomyelination	NN	S_Disease
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
a	DT	O
new	JJ	O
mouse	NN	O
mutant	JJ	O
rumpshaker	NN	O
is	VBZ	O
defined	VBN	O
by	IN	O
the	DT	O
amino	NN	O
-	:	O
acid	NN	O
substitution	NN	O
Ile	NNP	O
-	:	O
to	TO	O
-	:	O
Thr	NN	O
at	IN	O
residue	JJ	O
186	CD	O
in	IN	O
a	DT	O
membrane	NN	O
-	:	O
embedded	VBD	O
domain	NN	O
of	IN	O
PLP	NNP	O
.	.	O

Surprisingly	RB	O
,	,	O
rumpshaker	NN	O
mice	NN	O
,	,	O
although	IN	O
myelin	SYM	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
,	,	O
have	VBP	O
normal	JJ	O
longevity	NN	O
and	CC	O
a	DT	O
full	JJ	O
complement	NN	O
of	IN	O
morphologically	RB	O
normal	JJ	O
oligodendrocytes	NNS	O
.	.	O

Hypomyelination	NN	S_Disease
can	MD	O
thus	RB	O
be	VB	O
genetically	RB	O
separated	VBN	O
from	IN	O
the	DT	O
PLP	NNP	O
-	:	O
dependent	NN	O
oligodendrocyte	JJ	B_Disease
degeneration	NN	E_Disease
.	.	O

We	PRP	O
suggest	VBP	O
that	IN	O
PLP	NNP	O
has	VBZ	O
a	DT	O
vital	JJ	O
function	NN	O
in	IN	O
glial	JJ	O
cell	NN	O
development	NN	O
,	,	O
distinct	NN	O
from	IN	O
its	PRP$	O
later	JJ	O
role	NN	O
in	IN	O
myelin	NN	O
assembly	NN	O
,	,	O
and	CC	O
that	IN	O
this	DT	O
dichotomy	NN	O
of	IN	O
action	NN	O
may	MD	O
explain	VB	O
the	DT	O
clinical	JJ	O
spectrum	NN	O
of	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
.	.	O
.	.	O

A	DT	O
pseudodeficiency	NN	O
allele	JJ	O
common	JJ	O
in	IN	O
non	JJ	O
-	:	O
Jewish	JJ	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	E_Disease
carriers	NNS	O
:	:	O
implications	NNS	O
for	IN	O
carrier	NN	O
screening	NN	O
.	.	O

Deficiency	NN	B_Disease
of	IN	I_Disease
beta	NN	I_Disease
-	:	I_Disease
hexosaminidase	NN	I_Disease
A	NNP	E_Disease
(	(	O
Hex	NNP	O
A	NNP	O
)	)	O
activity	NN	O
typically	RB	O
results	NNS	O
in	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
.	.	O

However	RB	O
,	,	O
healthy	JJ	O
subjects	NNS	O
found	VBN	O
to	TO	O
be	VB	O
deficient	JJ	B_Disease
in	IN	I_Disease
Hex	NNP	I_Disease
A	NNP	E_Disease
activity	NN	O
(	(	O
i	NN	O
.	.	O

e	NN	O
.	.	O
,	,	O
pseudodeficient	NN	O
)	)	O
by	IN	O
means	NNS	O
of	IN	O
in	IN	O
vitro	JJ	O
biochemical	JJ	O
tests	NNS	O
have	VBP	O
been	VBN	O
described	VBN	O
.	.	O

We	PRP	O
analyzed	VBD	O
the	DT	O
HEXA	NNP	O
gene	NN	O
of	IN	O
one	CD	O
pseudodeficient	NN	O
subject	NN	O
and	CC	O
identified	VBD	O
both	DT	O
a	DT	O
C739	NNP	O
-	:	O
to	TO	O
-	:	O
T	NNP	O
substitution	NN	O
that	IN	O
changes	VBZ	O
Arg247	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
Trp	NN	O
on	IN	O
one	CD	O
allele	NN	O
and	CC	O
a	DT	O
previously	RB	O
identified	VBN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
mutation	NN	O
on	IN	O
the	DT	O
second	JJ	O
allele	NN	O
.	.	O

Six	NNP	O
additional	JJ	O
pseudodeficient	NN	O
subjects	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
the	DT	O
C739	NNP	O
-	:	O
to	TO	O
-	:	O
T	NNP	O
mutation	NN	O
.	.	O

This	DT	O
allele	NN	O
accounted	VBD	O
for	IN	O
32	CD	O
%	NN	O
(	(	O
20	CD	O
/	RB	O
62	CD	O
)	)	O
of	IN	O
non	NN	O
-	:	O
Jewish	JJ	O
enzyme	SYM	O
-	:	O
defined	VBN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
carriers	NNS	O
but	CC	O
for	IN	O
none	NN	O
of	IN	O
36	CD	O
Jewish	JJ	O
enzyme	SYM	O
-	:	O
defined	VBN	O
carriers	NNS	O
who	WP	O
did	VBD	O
not	RB	O
have	VB	O
one	CD	O
of	IN	O
three	CD	O
known	JJ	O
mutations	NNS	O
common	JJ	O
to	TO	O
this	DT	O
group	NN	O
.	.	O

The	DT	O
C739	NNP	O
-	:	O
to	TO	O
-	:	O
T	NNP	O
allele	NN	O
,	,	O
together	RB	O
with	IN	O
a	DT	O
"	JJ	O
true	JJ	O
"	NN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
allele	NN	O
,	,	O
causes	VBZ	O
Hex	NNP	O
A	NNP	O
pseudodeficiency	NN	O
.	.	O

Given	VBN	O
both	DT	O
the	DT	O
large	JJ	O
proportion	NN	O
of	IN	O
non	JJ	O
-	:	O
Jewish	JJ	O
carriers	NNS	O
with	IN	O
this	DT	O
allele	NN	O
and	CC	O
that	DT	O
standard	JJ	O
biochemical	JJ	O
screening	NN	O
cannot	NN	O
differentiate	NN	O
between	IN	O
heterozygotes	NNS	O
for	IN	O
the	DT	O
C739	NNP	O
-	:	O
to	TO	O
-	:	O
T	NNP	O
mutations	NNS	O
and	CC	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
carriers	NNS	O
,	,	O
DNA	NNP	O
testing	VBG	O
for	IN	O
this	DT	O
mutation	NN	O
in	IN	O
at	IN	O
-	:	O
risk	NN	O
couples	NNS	O
is	VBZ	O
essential	JJ	O
.	.	O

Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
:	:	O
detection	NN	O
of	IN	O
mutations	NNS	O
Thr181	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
Pro	NN	O
and	CC	O
Leu223	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
Pro	NN	O
in	IN	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
gene	NN	O
,	,	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
.	.	O

A	DT	O
family	NN	O
with	IN	O
an	DT	O
apparent	JJ	O
history	NN	O
of	IN	O
X	NNP	O
-	:	O
linked	VBN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
presented	VBN	O
for	IN	O
genetic	JJ	O
counseling	NN	O
,	,	O
requesting	VBG	O
carrier	NN	O
detection	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
.	.	O

RFLP	NNP	O
analysis	NN	O
using	VBG	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
(	(	O
PLP	NNP	O
)	)	O
gene	NN	O
probe	NN	O
was	VBD	O
uninformative	JJ	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

A	DT	O
prenatal	JJ	O
diagnosis	NN	O
on	IN	O
a	DT	O
chorionic	JJ	O
villus	NN	O
sample	NN	O
(	(	O
CVS	NNP	O
)	)	O
was	VBD	O
carried	VBN	O
out	RP	O
using	VBG	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
SSCP	NNP	O
)	)	O
analysis	NN	O
of	IN	O
a	DT	O
variant	NN	O
in	IN	O
exon	JJ	O
4	CD	O
of	IN	O
the	DT	O
PLP	NNP	O
gene	NN	O
.	.	O

The	DT	O
fetus	NN	O
was	VBD	O
predicted	VBN	O
to	TO	O
be	VB	O
unaffected	VBN	O
.	.	O

Sequencing	VBG	O
of	IN	O
the	DT	O
exon	NN	O
from	IN	O
the	DT	O
CVS	NNP	O
,	,	O
the	DT	O
predicted	VBN	O
-	:	O
carrier	NN	O
mother	NN	O
,	,	O
and	CC	O
the	DT	O
obligate	JJ	O
-	:	O
carrier	NN	O
grandmother	NN	O
revealed	VBD	O
an	DT	O
A	NNP	O
-	:	O
to	TO	O
-	:	O
C	NNP	O
change	NN	O
at	IN	O
nucleotide	JJ	O
541	CD	O
in	IN	O
the	DT	O
two	CD	O
women	NNS	O
but	CC	O
not	RB	O
in	IN	O
the	DT	O
fetus	NN	O
.	.	O

As	IN	O
this	DT	O
change	NN	O
results	NNS	O
in	IN	O
a	DT	O
Thr	NNP	O
-	:	O
to	TO	O
-	:	O
Pro	VB	O
change	NN	O
at	IN	O
amino	NN	O
acid	VBP	O
181	CD	O
in	IN	O
a	DT	O
region	NN	O
of	IN	O
the	DT	O
gene	NN	O
predicted	VBD	O
to	TO	O
be	VB	O
part	NN	O
of	IN	O
a	DT	O
transmembrane	NN	O
segment	NN	O
,	,	O
it	PRP	O
was	VBD	O
concluded	VBN	O
that	IN	O
this	DT	O
was	VBD	O
the	DT	O
mutation	NN	O
causing	VBG	O
the	DT	O
disease	NN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
in	IN	O
a	DT	O
second	JJ	O
family	NN	O
,	,	O
an	DT	O
exon	JJ	O
5	CD	O
variant	JJ	O
band	NN	O
pattern	NN	O
on	IN	O
SSCP	NNP	O
analysis	NN	O
was	VBD	O
shown	VBN	O
by	IN	O
sequencing	VBG	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
a	DT	O
T	NNP	O
-	:	O
to	TO	O
-	:	O
C	NNP	O
change	NN	O
at	IN	O
nucleotide	JJ	O
668	CD	O
.	.	O

This	DT	O
results	NNS	O
in	IN	O
a	DT	O
Leu	NNP	O
-	:	O
to	TO	O
-	:	O
Pro	NNP	O
change	NN	O
in	IN	O
a	DT	O
carrier	NN	O
mother	NN	O
and	CC	O
in	IN	O
her	PRP$	O
two	CD	O
affected	JJ	O
sons	NNS	O
.	.	O

These	DT	O
results	NNS	O
provide	VBP	O
further	JJ	O
examples	NNS	O
of	IN	O
mutations	NNS	O
in	IN	O
PLP	NNP	O
that	IN	O
cause	NN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
and	CC	O
illustrate	VB	O
the	DT	O
value	NN	O
of	IN	O
SSCP	NNP	O
in	IN	O
genetic	JJ	O
analysis	NN	O
.	.	O
.	.	O

von	NN	B_Disease
Willebrand	NNP	I_Disease
disease	NN	I_Disease
type	NN	I_Disease
B	NNP	E_Disease
:	:	O
a	DT	O
missense	NN	O
mutation	NN	O
selectively	RB	O
abolishes	VBZ	O
ristocetin	JJ	O
-	:	O
induced	JJ	O
von	NN	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
binding	VBG	O
to	TO	O
platelet	VB	O
glycoprotein	JJ	O
Ib	NNP	O
.	.	O

von	NN	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
(	(	O
vWF	NN	O
)	)	O
is	VBZ	O
a	DT	O
multimeric	JJ	O
glycoprotein	NN	O
that	WDT	O
mediates	VBZ	O
the	DT	O
adhesion	NN	O
of	IN	O
platelets	NNS	O
to	TO	O
the	DT	O
subendothelium	NN	O
by	IN	O
binding	VBG	O
to	TO	O
platelet	VB	O
glycoprotein	JJ	O
Ib	NNP	O
.	.	O

For	IN	O
human	JJ	O
vWF	NN	O
,	,	O
this	DT	O
interaction	NN	O
can	MD	O
be	VB	O
induced	VBN	O
in	IN	O
vitro	NN	O
by	IN	O
the	DT	O
antibiotic	JJ	O
ristocetin	NN	O
or	CC	O
the	DT	O
snake	JJ	O
venom	NN	O
protein	NN	O
botrocetin	NN	O
.	.	O

A	DT	O
missense	NN	O
mutation	NN	O
,	,	O
Gly	NNP	O
-	:	O
561	CD	O
-	:	O
-	:	O
>	NN	O
Ser	NNP	O
,	,	O
was	VBD	O
identified	VBN	O
within	IN	O
the	DT	O
proposed	VBN	O
glycoprotein	NN	O
Ib	NNP	O
binding	VBG	O
domain	NN	O
of	IN	O
vWF	NN	O
in	IN	O
the	DT	O
proband	NN	O
with	IN	O
von	JJ	B_Disease
Willebrand	NNP	I_Disease
disease	NN	I_Disease
type	NN	I_Disease
B	NNP	E_Disease
,	,	O
a	DT	O
unique	JJ	O
variant	NN	O
characterized	VBN	O
by	IN	O
no	DT	O
ristocetin	NN	O
-	:	O
induced	JJ	O
,	,	O
but	CC	O
normal	JJ	O
botrocetin	SYM	O
-	:	O
induced	VBN	O
,	,	O
binding	VBG	O
to	TO	O
glycoprotein	VB	O
Ib	NNP	O
.	.	O

The	DT	O
corresponding	JJ	O
mutant	NN	O
recombinant	NN	O
protein	NN	O
,	,	O
rvWF	NN	O
(	(	O
G561S	NNP	O
)	)	O
,	,	O
formed	VBN	O
normal	JJ	O
multimers	NNS	O
and	CC	O
exhibited	VBD	O
the	DT	O
same	JJ	O
functional	JJ	O
defect	NN	O
as	IN	O
the	DT	O
patients	NNS	O
plasma	VBP	O
vWF	NN	O
,	,	O
confirming	VBG	O
that	IN	O
this	DT	O
mutation	NN	O
causes	VBZ	O
von	JJ	B_Disease
Willebrand	NNP	I_Disease
disease	NN	I_Disease
type	NN	I_Disease
B	NNP	E_Disease
.	.	O

These	DT	O
data	NNS	O
show	VBP	O
that	IN	O
botrocetin	NN	O
and	CC	O
ristocetin	NN	O
cofactor	NN	O
activities	NNS	O
of	IN	O
vWF	NN	O
can	MD	O
be	VB	O
dissociated	VBN	O
by	IN	O
a	DT	O
point	NN	O
mutation	NN	O
and	CC	O
confirm	NN	O
that	IN	O
these	DT	O
mediators	NNS	O
promote	VBP	O
vWF	JJ	O
binding	NN	O
to	TO	O
platelets	NNS	O
by	IN	O
different	JJ	O
mechanisms	NNS	O
.	.	O

The	DT	O
normal	JJ	O
botrocetin	NN	O
-	:	O
induced	JJ	O
binding	NN	O
and	CC	O
the	DT	O
defective	JJ	O
ristocetin	NN	O
-	:	O
induced	JJ	O
binding	NN	O
of	IN	O
rvWF	NN	O
(	(	O
G561S	NNP	O
)	)	O
suggest	VBP	O
that	IN	O
the	DT	O
primary	JJ	O
defect	NN	O
in	IN	O
von	JJ	B_Disease
Willebrand	NNP	I_Disease
disease	NN	I_Disease
type	NN	I_Disease
B	NNP	E_Disease
may	MD	O
be	VB	O
a	DT	O
failure	NN	O
of	IN	O
normal	JJ	O
allosteric	JJ	O
regulation	NN	O
of	IN	O
the	DT	O
glycoprotein	NN	O
Ib	NNP	O
binding	VBG	O
function	NN	O
of	IN	O
vWF	NN	O
.	.	O
.	.	O

Typical	JJ	O
and	CC	O
partial	JJ	O
cat	NN	B_Disease
eye	NN	I_Disease
syndrome	NN	E_Disease
:	:	O
identification	NN	O
of	IN	O
the	DT	O
marker	NN	O
chromosome	NN	O
by	IN	O
FISH	NNP	O
.	.	O

Three	CD	O
children	NNS	O
are	VBP	O
reported	VBN	O
with	IN	O
typical	JJ	O
cat	NN	B_Disease
eye	NN	I_Disease
syndrome	NN	E_Disease
(	(	O
CES	NNP	S_Disease
)	)	O
and	CC	O
three	CD	O
more	JJR	O
children	NNS	O
with	IN	O
partial	JJ	O
CES	NNP	S_Disease
because	IN	O
of	IN	O
absence	NN	O
of	IN	O
coloboma	NN	O
,	,	O
in	IN	O
which	WDT	O
the	DT	O
supernumerary	NN	O
marker	NN	O
chromosome	NN	O
was	VBD	O
studied	VBN	O
by	IN	O
FISH	NNP	O
.	.	O

Using	VBG	O
a	DT	O
genomic	JJ	O
library	NN	O
,	,	O
and	CC	O
also	RB	O
a	DT	O
centromeric	JJ	O
and	CC	O
particularly	RB	O
a	DT	O
cosmid	JJ	O
probe	NN	O
of	IN	O
22q11	CD	O
,	,	O
partial	JJ	O
tetrasomy	NN	S_Disease
was	VBD	O
shown	VBN	O
in	IN	O
all	DT	O
cases	NNS	O
.	.	O
.	.	O

[	JJ	O
Genetic	NNP	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
:	:	O
mutant	JJ	O
alleles	NNS	O
of	IN	O
G6PD	NNP	O
in	IN	O
the	DT	O
Shekii	NNP	O
district	NN	O
of	IN	O
Azerbaijan	NNP	O
]	NNP	O
Examination	NNP	O
on	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
349	CD	O
patients	NNS	O
of	IN	O
Shekii	NNP	O
district	NN	O
hospital	NN	O
(	(	O
Azerbaijan	NNP	O
)	)	O
revealed	VBD	O
16	CD	O
hemi	NN	O
-	:	O
,	,	O
4	CD	O
homo	NN	O
-	:	O
and	CC	O
9	CD	O
heterozygotic	JJ	O
carriers	NNS	O
of	IN	O
the	DT	O
defect	NN	O
.	.	O

Gd	NNP	O
-	:	O
frequency	NN	O
,	,	O
calculated	VBN	O
from	IN	O
the	DT	O
data	NNS	O
obtained	VBD	O
(	(	O
7	CD	O
.	.	O

7	CD	O
%	NN	O
)	)	O
,	,	O
may	MD	O
be	VB	O
compared	VBN	O
to	TO	O
neighbouring	VBG	O
regions	NNS	O
frequencies	NNS	O
(	(	O
6	CD	O
-	:	O
30	CD	O
%	NN	O
)	)	O
.	.	O

Carriers	NNS	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
are	VBP	O
residents	NNS	O
of	IN	O
11	CD	O
villages	NNS	O
located	VBN	O
in	IN	O
Alasani	NNP	O
-	:	O
Aphtalan	NNP	O
valley	NNP	O
,	,	O
highly	RB	O
endemic	JJ	O
with	IN	O
malaria	NNS	S_Disease
in	IN	O
the	DT	O
past	NN	O
;	:	O
nearly	RB	O
all	DT	O
marriages	NNS	O
are	VBP	O
endogamic	JJ	O
.	.	O

Physico	NNP	O
-	:	O
chemical	NN	O
and	CC	O
kinetic	JJ	O
study	NN	O
of	IN	O
10	CD	O
mutant	JJ	O
forms	NNS	O
of	IN	O
G6PD	NNP	O
,	,	O
according	VBG	O
to	TO	O
WHO	NNP	O
program	NN	O
,	,	O
led	VBD	O
to	TO	O
identification	NN	O
of	IN	O
5	CD	O
variants	NNS	O
of	IN	O
the	DT	O
II	NNP	O
class	NN	O
(	(	O
Shekii	NNP	O
,	,	O
Bideiz	NNP	O
,	,	O
Shirin	NNP	O
-	:	O
Bulakh	NNP	O
,	,	O
Okhut	NNP	O
I	PRP	O
and	CC	O
Zakataly	NNP	O
)	)	O
and	CC	O
2	CD	O
variants	NNS	O
of	IN	O
the	DT	O
III	NNP	O
class	NN	O
(	(	O
Okhut	NNP	O
II	NNP	O
and	CC	O
Martinique	NNP	O
-	:	O
like	IN	O
)	)	O
.	.	O

Resemblance	NN	O
of	IN	O
the	DT	O
majority	NN	O
of	IN	O
variants	NNS	O
in	IN	O
electrophoretic	JJ	O
mobility	NN	O
and	CC	O
the	DT	O
level	NN	O
of	IN	O
erythrocyte	JJ	O
enzyme	JJ	O
activity	NN	O
permit	NN	O
to	TO	O
suggest	VB	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
common	JJ	O
parental	NN	O
mutant	JJ	O
G6PD	NNP	O
allele	NN	O
distributed	VBN	O
in	IN	O
this	DT	O
area	NN	O
.	.	O

Craniofrontonasal	NNP	B_Disease
dysplasia	NN	E_Disease
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
nine	CD	O
patients	NNS	O
with	IN	O
craniofrontonasal	JJ	B_Disease
dysplasia	NN	E_Disease
(	(	O
CFND	NNP	S_Disease
)	)	O
.	.	O

Seven	RB	O
classical	JJ	O
cases	NNS	O
had	VBD	O
facial	JJ	O
features	NNS	O
suggestive	VBP	O
of	IN	O
frontonasal	NN	B_Disease
dysplasia	NN	E_Disease
and	CC	O
coronal	JJ	B_Disease
craniosynostosis	NN	E_Disease
.	.	O

Extracranial	JJ	B_Disease
abnormalities	NNS	E_Disease
such	JJ	O
as	IN	O
brittle	JJ	B_Disease
nails	NNS	I_Disease
with	IN	I_Disease
prominent	JJ	I_Disease
longitudinal	JJ	I_Disease
grooves	NNS	E_Disease
or	CC	O
syndactyly	NN	B_Disease
of	IN	I_Disease
fingers	NNS	I_Disease
and	CC	I_Disease
toes	NNS	E_Disease
were	VBD	O
observed	VBN	O
in	IN	O
individual	JJ	O
patients	NNS	O
.	.	O

In	IN	O
two	CD	O
families	NNS	O
the	DT	O
father	NN	O
of	IN	O
classical	JJ	O
cases	NNS	O
showed	VBD	O
a	DT	O
milder	NN	O
pattern	NN	O
of	IN	O
abnormalities	NNS	O
,	,	O
consistent	NN	O
with	IN	O
the	DT	O
diagnosis	NN	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
2	CD	O
-	:	O
to	TO	O
13	CD	O
-	:	O
year	NN	O
follow	SYM	O
-	:	O
up	RB	O
on	IN	O
our	PRP$	O
patients	NNS	O
.	.	O

Hypotonia	NNP	S_Disease
and	CC	O
laxity	NN	B_Disease
of	IN	I_Disease
joints	NNS	E_Disease
are	VBP	O
common	JJ	O
and	CC	O
may	MD	O
necessitate	VB	O
supportive	JJ	O
measures	NNS	O
.	.	O

Mild	NNP	O
developmental	JJ	B_Disease
delay	NN	E_Disease
was	VBD	O
noted	VBN	O
in	IN	O
three	CD	O
out	IN	O
of	IN	O
six	CD	O
classical	JJ	O
cases	NNS	O
studied	VBN	O
in	IN	O
detail	NN	O
.	.	O

Unlike	IN	O
almost	RB	O
all	DT	O
other	JJ	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
disorders	NNS	E_Disease
,	,	O
clinical	JJ	O
expression	NN	O
in	IN	O
CFND	NNP	S_Disease
is	VBZ	O
generally	RB	O
much	RB	O
more	RBR	O
severe	JJ	O
in	IN	O
females	NNS	O
than	IN	O
in	IN	O
males	NNS	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
previous	JJ	O
reports	NNS	O
of	IN	O
this	DT	O
condition	NN	O
,	,	O
one	CD	O
of	IN	O
our	PRP$	O
severely	RB	O
affected	JJ	O
cases	NNS	O
is	VBZ	O
a	DT	O
male	NN	O
.	.	O
.	.	O

The	DT	O
intron	NN	O
7	CD	O
donor	NN	O
splice	NN	O
site	NN	O
transition	NN	O
:	:	O
a	DT	O
second	JJ	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
mutation	NN	O
in	IN	O
French	NNP	O
Canada	NNP	O
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
hexosaminidase	NN	O
A	NNP	O
(	(	O
HEXA	NNP	O
)	)	O
gene	NN	O
which	WDT	O
cause	VBP	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
TSD	NNP	S_Disease
)	)	O
have	VBP	O
elevated	VBN	O
frequency	NN	O
in	IN	O
the	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
and	CC	O
French	NNP	O
-	:	O
Canadian	JJ	O
populations	NNS	O
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
novel	JJ	O
TSD	NNP	S_Disease
allele	NN	O
in	IN	O
the	DT	O
French	JJ	O
-	:	O
Canadian	JJ	O
population	NN	O
associated	VBN	O
with	IN	O
the	DT	O
infantile	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
mutation	NN	O
,	,	O
a	DT	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
transition	NN	O
at	IN	O
the	DT	O
+	NN	O
1	CD	O
position	NN	O
of	IN	O
intron	NN	O
7	CD	O
,	,	O
abolishes	VBZ	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
.	.	O

Cultured	NNP	O
human	JJ	O
fibroblasts	NNS	O
from	IN	O
a	DT	O
compound	NN	O
heterozygote	NN	O
for	IN	O
this	DT	O
transition	NN	O
(	(	O
and	CC	O
for	IN	O
a	DT	O
deletion	NN	O
mutation	NN	O
)	)	O
produce	VBP	O
no	DT	O
detectable	JJ	O
HEXA	NNP	O
mRNA	NN	O
.	.	O

The	DT	O
intron	NN	O
7	CD	O
+	NN	O
1	CD	O
mutation	NN	O
occurs	NNS	O
in	IN	O
the	DT	O
base	NN	O
adjacent	NN	O
to	TO	O
the	DT	O
site	NN	O
of	IN	O
the	DT	O
adult	NN	O
-	:	O
onset	NN	O
TSD	NNP	S_Disease
mutation	NN	O
(	(	O
G805A	NNP	O
)	)	O
.	.	O

In	IN	O
both	DT	O
mutations	NNS	O
a	DT	O
restriction	NN	O
site	NN	O
for	IN	O
the	DT	O
endonuclease	NN	O
EcoRII	NNP	O
is	VBZ	O
abolished	VBN	O
.	.	O

Unambiguous	JJ	O
diagnosis	NN	O
,	,	O
therefore	RB	O
,	,	O
requires	VBZ	O
allele	SYM	O
-	:	O
specific	JJ	O
oligonucleotide	JJ	O
hybridization	NN	O
to	TO	O
distinguish	VB	O
between	IN	O
these	DT	O
two	CD	O
mutant	NN	O
alleles	NNS	O
.	.	O

The	DT	O
intron	NN	O
7	CD	O
+	NN	O
1	CD	O
mutation	NN	O
has	VBZ	O
been	VBN	O
detected	VBN	O
in	IN	O
three	CD	O
unrelated	JJ	O
families	NNS	O
.	.	O

Obligate	NNP	O
heterozygotes	NNS	O
for	IN	O
the	DT	O
intron	NN	O
7	CD	O
+	NN	O
1	CD	O
mutation	NN	O
were	VBD	O
born	VBN	O
in	IN	O
the	DT	O
Saguenay	NNP	O
-	:	O
Lac	NNP	O
-	:	O
St	NNP	O
-	:	O
Jean	JJ	O
region	NN	O
of	IN	O
Quebec	NNP	O
.	.	O

The	DT	O
most	RBS	O
recent	JJ	O
ancestors	NNS	O
common	JJ	O
to	TO	O
obligate	VB	O
carriers	NNS	O
of	IN	O
this	DT	O
mutation	NN	O
were	VBD	O
from	IN	O
the	DT	O
Charlevoix	NNP	O
region	NN	O
of	IN	O
the	DT	O
province	NN	O
of	IN	O
Quebec	NNP	O
.	.	O

This	DT	O
mutation	NN	O
thus	RB	O
has	VBZ	O
a	DT	O
different	JJ	O
geographic	JJ	O
centre	NN	O
of	IN	O
diffusion	NN	O
and	CC	O
is	VBZ	O
probably	RB	O
less	RBR	O
common	JJ	O
than	IN	O
the	DT	O
exon	JJ	O
1	CD	O
deletion	NN	O
TSD	NNP	S_Disease
mutation	NN	O
in	IN	O
French	JJ	O
Canadians	NNPS	O
.	.	O

Neither	DT	O
mutation	NN	O
has	VBZ	O
been	VBN	O
detected	VBN	O
in	IN	O
France	NNP	O
,	,	O
the	DT	O
ancestral	JJ	O
homeland	NN	O
of	IN	O
French	NNP	O
Canada	NNP	O
.	.	O
.	.	O

Assignment	NN	O
of	IN	O
the	DT	O
aspartylglucosaminidase	NN	O
gene	NN	O
(	(	O
AGA	NNP	O
)	)	O
to	TO	O
4q33	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
q35	NN	O
based	VBN	O
on	IN	O
decreased	JJ	O
activity	NN	O
in	IN	O
a	DT	O
girl	NN	O
with	IN	O
a	DT	O
46	CD	O
,	,	O
XX	NNP	O
,	,	O
del	NN	O
(	(	O
4	CD	O
)	)	O
(	(	O
q33	NN	O
)	)	O
karyotype	NN	O
.	.	O

Aspartylglucosaminuria	NNP	S_Disease
(	(	O
AGU	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
recessive	JJ	O
autosomally	RB	O
inherited	VBN	O
lysosomal	JJ	B_Disease
storage	NN	I_Disease
disorder	NN	E_Disease
due	JJ	O
to	TO	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
enzyme	JJ	I_Disease
aspartylglucosaminidase	NN	E_Disease
(	(	O
AGA	NNP	O
)	)	O
.	.	O

The	DT	O
structural	JJ	O
gene	NN	O
for	IN	O
this	DT	O
human	JJ	O
enzyme	NN	O
(	(	O
AGA	NNP	O
)	)	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
to	TO	O
the	DT	O
region	NN	O
4q21	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
qter	NN	O
.	.	O

We	PRP	O
determined	VBD	O
the	DT	O
AGA	NNP	O
activity	NN	O
in	IN	O
cultured	JJ	O
fibroblasts	NNS	O
of	IN	O
a	DT	O
girl	NN	O
with	IN	O
a	DT	O
46	CD	O
,	,	O
XX	NNP	O
,	,	O
del	NN	O
(	(	O
4	CD	O
)	)	O
(	(	O
q33	NN	O
)	)	O
karyotype	NN	O
.	.	O

The	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
girl	NN	O
is	VBZ	O
a	DT	O
hemizygote	NN	O
for	IN	O
AGA	NNP	O
,	,	O
permitting	VBG	O
the	DT	O
assignment	NN	O
of	IN	O
human	JJ	O
AGA	NNP	O
to	TO	O
the	DT	O
region	NN	O
4q33	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
qter	NN	O
.	.	O
.	.	O

Resolution	NN	O
of	IN	O
the	DT	O
two	CD	O
loci	NN	O
for	IN	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	S_Disease
,	,	O
AN1	NNP	O
and	CC	O
AN2	NNP	O
,	,	O
to	TO	O
a	DT	O
single	JJ	O
locus	NN	O
on	IN	O
chromosome	NN	O
11p13	CD	O
.	.	O

Two	CD	O
distinct	JJ	O
loci	NNS	O
have	VBP	O
been	VBN	O
proposed	VBN	O
for	IN	O
aniridia	NN	S_Disease
;	:	O
AN1	NNP	O
for	IN	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	S_Disease
on	IN	O
chromosome	NN	O
2p	CD	O
and	CC	O
AN2	NNP	O
for	IN	O
the	DT	O
aniridia	NN	S_Disease
in	IN	O
the	DT	O
WAGR	NNP	B_Disease
contiguous	JJ	I_Disease
gene	NN	I_Disease
syndrome	NN	E_Disease
on	IN	O
chromosome	NN	O
11p13	CD	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
the	DT	O
kindred	JJ	O
segregating	NN	O
for	IN	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	S_Disease
,	,	O
which	WDT	O
suggested	VBD	O
linkage	NN	O
to	TO	O
acid	VB	O
phosphatase	NN	O
-	:	O
1	CD	O
(	(	O
ACP1	NNP	O
)	)	O
and	CC	O
led	VBN	O
to	TO	O
the	DT	O
assignment	NN	O
of	IN	O
the	DT	O
AN1	NNP	O
locus	NN	O
on	IN	O
chromosome	NN	O
2p	CD	O
,	,	O
has	VBZ	O
been	VBN	O
updated	VBN	O
and	CC	O
expanded	VBN	O
.	.	O

Linkage	NN	O
analysis	NN	O
between	IN	O
the	DT	O
aniridia	NN	S_Disease
phenotype	NN	O
and	CC	O
ACP1	NNP	O
does	VBZ	O
not	RB	O
support	VB	O
the	DT	O
original	JJ	O
linkage	NN	O
results	NNS	O
,	,	O
excluding	VBG	O
linkage	NN	O
up	RB	O
to	TO	O
theta	VB	O
=	JJ	O
0	CD	O
.	.	O

17	CD	O
with	IN	O
Z	NNP	O
=	NNP	O
-	:	O
2	CD	O
.	.	O

Tests	NNS	O
for	IN	O
linkage	NN	O
to	TO	O
other	JJ	O
chromosome	NN	O
2p	CD	O
markers	NNS	O
.	.	O

APOB	NNP	O
,	,	O
D2S71	NNP	O
,	,	O
D2S5	NNP	O
,	,	O
and	CC	O
D2S1	NNP	O
,	,	O
also	RB	O
excluded	VBD	O
linkage	NN	O
to	TO	O
aniridia	VB	S_Disease
.	.	O

Markers	NNS	O
that	WDT	O
have	VBP	O
been	VBN	O
isolated	VBN	O
from	IN	O
the	DT	O
chromosome	NN	O
11p13	CD	O
region	NN	O
were	VBD	O
then	RB	O
analyzed	VBN	O
in	IN	O
this	DT	O
aniridia	JJ	S_Disease
family	NN	O
.	.	O

Two	CD	O
RFLPs	NNP	O
at	IN	O
the	DT	O
D11S323	NNP	O
locus	NN	O
give	VBP	O
significant	JJ	O
evidence	NN	O
for	IN	O
linkage	NN	O
.	.	O

The	DT	O
PvuII	NNP	O
polymorphism	NN	O
detected	VBN	O
by	IN	O
probe	NN	O
p5S1	NN	O
.	.	O

6	CD	O
detects	VBZ	O
no	DT	O
recombinants	NNS	O
,	,	O
with	IN	O
a	DT	O
maximum	JJ	O
lod	JJ	O
score	NN	O
of	IN	O
Z	NNP	O
=	NNP	O
6	CD	O
.	.	O

97	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

00	CD	O
00	CD	O
.	.	O

The	DT	O
HaeIII	NNP	O
polymorphism	NN	O
detected	VBN	O
by	IN	O
the	DT	O
probe	NN	O
p5BE1	NN	O
.	.	O

2	CD	O
gives	VBZ	O
a	DT	O
maximum	JJ	O
lod	JJ	O
score	NN	O
of	IN	O
Z	NNP	O
=	NNP	O
2	CD	O
.	.	O

57	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

00	CD	O
00	CD	O
.	.	O

Locus	NNP	O
D11S325	NNP	O
gives	VBZ	O
a	DT	O
lod	JJ	O
score	NN	O
of	IN	O
Z	NNP	O
=	NNP	O
1	CD	O
.	.	O

53	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

00	CD	O
00	CD	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
locus	NN	O
for	IN	O
aniridia	NN	S_Disease
(	(	O
AN1	NNP	O
)	)	O
on	IN	O
chromosome	NN	O
2p	CD	O
has	VBZ	O
been	VBN	O
misassigned	VBN	O
and	CC	O
that	IN	O
this	DT	O
autosomal	JJ	O
dominant	JJ	O
aniridia	JJ	S_Disease
family	NN	O
is	VBZ	O
segregating	VBG	O
for	IN	O
an	DT	O
aniridia	JJ	S_Disease
mutation	NN	O
linked	VBD	O
to	TO	O
markers	NNS	O
in	IN	O
the	DT	O
11p13	CD	O
region	NN	O
.	.	O

Fatal	NNP	O
pyoderma	NN	B_Disease
gangrenosum	NN	E_Disease
in	IN	O
association	NN	O
with	IN	O
C7	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Although	IN	O
pyoderma	JJ	B_Disease
gangrenosum	NN	E_Disease
(	(	O
PG	NNP	S_Disease
)	)	O
is	VBZ	O
often	RB	O
associated	VBN	O
with	IN	O
systemic	JJ	B_Disease
diseases	NNS	E_Disease
,	,	O
it	PRP	O
has	VBZ	O
not	RB	O
been	VBN	O
reported	VBN	O
in	IN	O
association	NN	O
with	IN	O
congenital	JJ	B_Disease
complement	NN	I_Disease
deficiencies	NNS	E_Disease
.	.	O

We	PRP	O
describe	VBP	O
an	DT	O
aggressive	JJ	O
and	CC	O
ultimately	RB	O
fatal	JJ	O
case	NN	O
of	IN	O
PG	NNP	S_Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
congenital	JJ	O
C7	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Deficiencies	NNS	B_Disease
of	IN	I_Disease
C7	NNP	E_Disease
can	MD	O
be	VB	O
associated	VBN	O
with	IN	O
decreased	JJ	O
neutrophil	NN	O
chemotaxis	NN	O
,	,	O
phagocytosis	NN	O
,	,	O
and	CC	O
opsonization	NN	O
,	,	O
similar	JJ	O
to	TO	O
the	DT	O
immunologic	JJ	B_Disease
abnormalities	NNS	E_Disease
described	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
PG	NNP	S_Disease
.	.	O

Our	PRP$	O
patients	NNS	O
decreased	VBN	O
complement	JJ	O
level	NN	O
,	,	O
if	IN	O
not	RB	O
directly	RB	O
related	VBN	O
to	TO	O
the	DT	O
development	NN	O
of	IN	O
PG	NNP	S_Disease
,	,	O
may	MD	O
have	VB	O
contributed	VBN	O
to	TO	O
the	DT	O
aggressive	JJ	O
nature	NN	O
of	IN	O
her	PRP$	O
disease	NN	O
.	.	O
.	.	O

Diverse	NNP	O
point	NN	O
mutations	NNS	O
result	VBP	O
in	IN	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
polymorphism	NN	O
in	IN	O
Taiwan	NNP	O
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
PHOSPHATE	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
;	:	I_Disease
EC	NNP	I_Disease
1	CD	I_Disease
.	.	I_Disease
1	CD	I_Disease
.	.	I_Disease
1	CD	I_Disease
.	.	I_Disease
49	CD	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
human	JJ	O
enzymopathy	NN	S_Disease
,	,	O
affecting	VBG	O
more	JJR	O
than	IN	O
200	CD	O
million	CD	O
people	NNS	O
worldwide	VBP	O
.	.	O

Although	IN	O
greater	JJR	O
than	IN	O
400	CD	O
variants	NNS	O
have	VBP	O
been	VBN	O
described	VBN	O
based	VBN	O
on	IN	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
criteria	NNS	O
,	,	O
little	JJ	O
is	VBZ	O
known	VBN	O
about	IN	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
these	DT	O
G6PD	NNP	B_Disease
deficiencies	NNS	E_Disease
.	.	O

Recently	RB	O
,	,	O
the	DT	O
gene	NN	O
that	WDT	O
encodes	VBZ	O
human	JJ	O
G6PD	NNP	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
,	,	O
which	WDT	O
enables	VBZ	O
us	PRP	O
to	TO	O
examine	VB	O
directly	RB	O
the	DT	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	O
at	IN	O
the	DT	O
DNA	NNP	O
level	NN	O
.	.	O

During	IN	O
the	DT	O
past	JJ	O
10	CD	O
years	NNS	O
,	,	O
we	PRP	O
examined	VBD	O
the	DT	O
G6PD	NNP	O
activity	NN	O
in	IN	O
21	CD	O
,	,	O
271	CD	O
newborn	JJ	O
Chinese	JJ	O
infants	NNS	O
(	(	O
11	CD	O
,	,	O
400	CD	O
males	NNS	O
and	CC	O
9	CD	O
,	,	O
871	CD	O
females	NNS	O
)	)	O
and	CC	O
identified	VBN	O
314	CD	O
(	(	O
2	CD	O
.	.	O

8	CD	O
%	NN	O
)	)	O
males	NNS	O
and	CC	O
246	CD	O
(	(	O
2	CD	O
.	.	O

5	CD	O
%	NN	O
)	)	O
females	VBZ	O
having	VBG	O
low	JJ	O
G6PD	NNP	O
activity	NN	O
.	.	O

The	DT	O
G6PD	NNP	O
gene	NN	O
from	IN	O
10	CD	O
randomly	RB	O
selected	VBN	O
affected	JJ	O
individuals	NNS	O
and	CC	O
their	PRP$	O
relatives	NNS	O
was	VBD	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
amplified	VBD	O
,	,	O
subcloned	VBD	O
,	,	O
and	CC	O
sequenced	VBD	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	DT	O
at	IN	O
least	JJS	O
four	CD	O
types	NNS	O
of	IN	O
mutation	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
the	DT	O
G6PD	NNP	O
polymorphism	NN	O
in	IN	O
Taiwan	NNP	O
.	.	O

The	DT	O
first	JJ	O
type	NN	O
of	IN	O
mutation	NN	O
(	(	O
487	CD	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
A	DT	O
)	)	O
was	VBD	O
found	VBN	O
in	IN	O
an	DT	O
affected	JJ	O
Chinese	JJ	O
with	IN	O
a	DT	O
G	NNP	O
to	TO	O
A	DT	O
change	NN	O
at	IN	O
nucleotide	JJ	O
487	CD	O
,	,	O
which	WDT	O
results	NNS	O
in	IN	O
a	DT	O
(	(	O
163	CD	O
)	)	O
Gly	NNP	O
to	TO	O
Ser	NNP	O
substitution	NN	O
.	.	O

The	DT	O
second	JJ	O
type	NN	O
of	IN	O
mutation	NN	O
(	(	O
493	CD	O
A	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
G	NN	O
)	)	O
is	VBZ	O
a	DT	O
novel	JJ	O
mutation	NN	O
that	WDT	O
has	VBZ	O
not	RB	O
been	VBN	O
reported	VBN	O
in	IN	O
any	DT	O
other	JJ	O
ethnic	JJ	O
group	NN	O
and	CC	O
was	VBD	O
identified	VBN	O
in	IN	O
two	CD	O
affected	JJ	O
Chinese	NNPS	O
.	.	O

This	DT	O
mutation	NN	O
causes	VBZ	O
an	DT	O
A	NN	O
to	TO	O
G	NNP	O
change	NN	O
at	IN	O
nucleotide	JJ	O
position	NN	O
493	CD	O
,	,	O
producing	VBG	O
an	DT	O
(	(	O
165	CD	O
)	)	O
Asn	NNP	O
to	TO	O
Asp	NNP	O
substitution	NN	O
.	.	O

Interestingly	RB	O
,	,	O
the	DT	O
487	CD	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
A	DT	O
and	CC	O
493	CD	O
A	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
G	NNP	O
mutations	NNS	O
create	VBP	O
Alu	NNP	O
I	PRP	O
and	CC	O
Ava	NNP	O
II	NNP	O
recognition	NN	O
sites	NNS	O
,	,	O
respectively	RB	O
,	,	O
which	WDT	O
enabled	VBD	O
us	PRP	O
to	TO	O
rapidly	RB	O
detect	VB	O
these	DT	O
two	CD	O
mutations	NNS	O
by	IN	O
PCR	NNP	O
/	NNP	O
restriction	NN	O
enzyme	NN	O
(	(	O
RE	NNP	O
)	)	O
digestion	NN	O
method	NN	O
.	.	O

The	DT	O
third	JJ	O
mutation	NN	O
(	(	O
1376	CD	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
T	NN	O
)	)	O
was	VBD	O
found	VBN	O
in	IN	O
four	CD	O
affected	JJ	O
Chinese	NNP	O
.	.	O

This	DT	O
mutation	NN	O
causes	VBZ	O
a	DT	O
G	NNP	O
to	TO	O
T	VB	O
change	NN	O
at	IN	O
nucleotide	JJ	O
position	NN	O
1376	CD	O
that	WDT	O
results	NNS	O
in	IN	O
an	DT	O
(	(	O
459	CD	O
)	)	O
Arg	NNP	O
to	TO	O
Leu	NNP	O
substitution	NN	O
.	.	O

The	DT	O
1376	CD	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
T	NN	O
mutation	NN	O
seems	VBZ	O
to	TO	O
be	VB	O
the	DT	O
dominant	JJ	O
allele	NN	O
that	WDT	O
causes	VBZ	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
Taiwan	NNP	O
.	.	O

Finally	RB	O
,	,	O
two	CD	O
affected	VBD	O
Chinese	NNPS	O
were	VBD	O
identified	VBN	O
as	IN	O
having	VBG	O
the	DT	O
fourth	JJ	O
mutation	NN	O
(	(	O
1388	CD	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
A	DT	O
)	)	O
.	.	O

This	DT	O
mutation	NN	O
causes	VBZ	O
a	DT	O
G	NNP	O
to	TO	O
A	DT	O
change	NN	O
at	IN	O
nucleotide	JJ	O
1388	CD	O
that	WDT	O
produces	VBZ	O
an	DT	O
(	(	O
463	CD	O
)	)	O
Arg	NN	O
to	TO	O
His	PRP$	O
substitution	NN	O
.	.	O

Our	PRP$	O
studies	NNS	O
provide	VBP	O
the	DT	O
direct	JJ	O
proof	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
the	DT	O
Chinese	JJ	O
populations	NNS	O
of	IN	O
Taiwan	NNP	O
and	CC	O
the	DT	O
PCR	NNP	O
/	NNP	O
RE	NNP	O
digestion	NN	O
method	NN	O
is	VBZ	O
suitable	JJ	O
for	IN	O
simultaneous	JJ	O
detection	NN	O
of	IN	O
the	DT	O
487	CD	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
A	DT	O
and	CC	O
493	CD	O
A	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
G	NN	O
mutations	NNS	O
.	.	O

An	DT	O
error	NN	O
in	IN	O
dystrophin	JJ	O
mRNA	NN	O
processing	NN	O
in	IN	O
golden	JJ	B_Disease
retriever	NN	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
,	,	O
an	DT	O
animal	JJ	O
homologue	NN	O
of	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

Golden	NNP	B_Disease
retriever	NN	I_Disease
muscular	NN	I_Disease
dystrophy	NN	E_Disease
(	(	O
GRMD	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
spontaneous	JJ	O
,	,	O
X	NNP	O
-	:	O
linked	VBN	O
,	,	O
progressively	RB	O
fatal	JJ	O
disease	NN	O
of	IN	O
dogs	NNS	O
and	CC	O
is	VBZ	O
also	RB	O
a	DT	O
homologue	NN	O
of	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
.	.	O

Two	CD	O
-	:	O
thirds	NNS	O
of	IN	O
DMD	NNP	S_Disease
patients	NNS	O
carry	VBP	O
detectable	JJ	O
deletions	NNS	O
in	IN	O
their	PRP$	O
dystrophin	JJ	O
gene	NN	O
.	.	O

The	DT	O
defect	NN	O
underlying	VBG	O
the	DT	O
remaining	VBG	O
one	CD	O
-	:	O
third	NN	O
of	IN	O
DMD	NNP	S_Disease
patients	NNS	O
is	VBZ	O
undetermined	JJ	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
canine	NN	O
dystrophin	JJ	O
gene	NN	O
in	IN	O
normal	JJ	O
and	CC	O
GRMD	NNP	S_Disease
dogs	NNS	O
has	VBZ	O
failed	VBN	O
to	TO	O
demonstrate	VB	O
any	DT	O
detectable	JJ	O
loss	NN	O
of	IN	O
exons	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
have	VBP	O
demonstrated	VBN	O
a	DT	O
RNA	NNP	O
processing	NN	O
error	NN	O
in	IN	O
GRMD	NNP	S_Disease
that	WDT	O
results	NNS	O
from	IN	O
a	DT	O
single	JJ	O
base	NN	O
change	NN	O
in	IN	O
the	DT	O
3	CD	O
consensus	NN	O
splice	NN	O
site	NN	O
of	IN	O
intron	NN	O
6	CD	O
.	.	O

The	DT	O
seventh	JJ	O
exon	NN	O
is	VBZ	O
then	RB	O
skipped	VBN	O
,	,	O
which	WDT	O
predicts	VBZ	O
a	DT	O
termination	NN	O
of	IN	O
the	DT	O
dystrophin	JJ	O
reading	NN	O
frame	NN	O
within	IN	O
its	PRP$	O
N	NNP	O
-	:	O
terminal	NN	O
domain	NN	O
in	IN	O
exon	JJ	O
8	CD	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
dystrophin	JJ	B_Disease
deficiency	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
.	.	O
.	.	O

Type	NN	B_Disease
I	PRP	I_Disease
human	VBP	I_Disease
complement	JJ	I_Disease
C2	NNP	I_Disease
deficiency	NN	E_Disease
.	.	O

A	DT	O
28	CD	O
-	:	O
base	NN	O
pair	NN	O
gene	NN	O
deletion	NN	O
causes	VBZ	O
skipping	VBG	O
of	IN	O
exon	JJ	O
6	CD	O
during	IN	O
RNA	NNP	O
splicing	NN	O
.	.	O

Two	CD	O
variants	NNS	O
of	IN	O
a	DT	O
genetic	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
complement	NN	I_Disease
protein	NN	I_Disease
C2	NNP	E_Disease
(	(	O
C2D	NNP	O
)	)	O
have	VBP	O
been	VBN	O
previously	RB	O
identified	VBN	O
.	.	O

No	DT	O
C2	NNP	O
protein	NN	O
translation	NN	O
is	VBZ	O
detected	VBN	O
in	IN	O
type	NN	O
I	PRP	O
deficiency	VBP	O
,	,	O
while	IN	O
type	JJ	O
II	NNP	O
deficiency	NN	O
is	VBZ	O
characterized	VBN	O
by	IN	O
a	DT	O
selective	JJ	O
block	NN	O
in	IN	O
C2	NNP	O
secretion	NN	O
.	.	O

Type	NN	B_Disease
I	PRP	I_Disease
C2	NNP	I_Disease
deficiency	NN	E_Disease
was	VBD	O
described	VBN	O
in	IN	O
a	DT	O
family	NN	O
in	IN	O
which	WDT	O
the	DT	O
C2	NNP	O
null	NN	O
allele	NN	O
(	(	O
C2Q0	NNP	O
)	)	O
is	VBZ	O
associated	VBN	O
with	IN	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
haplotype	NN	O
/	NNP	O
complotype	NN	O
HLA	NNP	O
-	:	O
A25	NNP	O
,	,	O
B18	NNP	O
,	,	O
C2Q0	NNP	O
,	,	O
BfS	NNP	O
,	,	O
C4A4	NNP	O
,	,	O
C4B2	NNP	O
,	,	O
Drw2	NNP	O
;	:	O
this	DT	O
extended	VBD	O
haplotype	NN	O
occurs	NNS	O
in	IN	O
over	IN	O
90	CD	O
%	NN	O
of	IN	O
C2	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
individuals	NNS	O
(	(	O
common	JJ	O
complotype	NN	O
/	NNP	O
haplotype	NN	O
)	)	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
type	NN	B_Disease
I	PRP	I_Disease
C2	NNP	I_Disease
deficiency	NN	E_Disease
,	,	O
the	DT	O
C2	NNP	O
gene	NN	O
and	CC	O
cDNA	NN	O
were	VBD	O
characterized	VBN	O
from	IN	O
a	DT	O
homozygous	JJ	O
type	NN	B_Disease
I	PRP	I_Disease
C2	NNP	I_Disease
-	:	I_Disease
deficient	NN	E_Disease
individual	NN	O
with	IN	O
the	DT	O
common	JJ	O
associated	VBN	O
haplotype	JJ	O
/	NN	O
complotype	NN	O
.	.	O

We	PRP	O
found	VBD	O
a	DT	O
28	CD	O
-	:	O
base	NN	O
pair	NN	O
deletion	NN	O
in	IN	O
the	DT	O
type	NN	O
I	PRP	O
C2Q0	NNP	O
gene	NN	O
,	,	O
beginning	VBG	O
9	CD	O
base	JJ	O
pairs	NNS	O
upstream	NN	O
of	IN	O
the	DT	O
3	CD	O
-	:	O
end	NN	O
of	IN	O
exon	JJ	O
6	CD	O
,	,	O
that	WDT	O
generates	VBZ	O
a	DT	O
C2	NNP	O
transcript	NN	O
with	IN	O
a	DT	O
complete	JJ	O
deletion	NN	O
of	IN	O
exon	$	O
6	CD	O
(	(	O
134	CD	O
base	NN	O
pair	NN	O
)	)	O
and	CC	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
.	.	O

In	IN	O
studies	NNS	O
of	IN	O
eight	CD	O
kindred	NNS	O
,	,	O
the	DT	O
28	CD	O
-	:	O
base	NN	O
pair	NN	O
deletion	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
all	DT	O
C2Q0	NNP	O
alleles	NNS	O
associated	VBN	O
with	IN	O
the	DT	O
common	JJ	O
type	NN	O
I	PRP	O
deficient	VBP	O
complotype	JJ	O
/	NNP	O
haplotype	NN	O
;	:	O
this	DT	O
deletion	NN	O
was	VBD	O
not	RB	O
present	JJ	O
in	IN	O
normal	JJ	O
C2	NNP	O
nor	CC	O
in	IN	O
type	JJ	B_Disease
II	NNP	I_Disease
C2	NNP	I_Disease
-	:	I_Disease
deficient	NN	E_Disease
genes	NNS	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	VBP	O
that	IN	O
1	CD	O
)	)	O
type	NN	B_Disease
I	PRP	I_Disease
human	VBP	I_Disease
complement	JJ	I_Disease
C2	NNP	I_Disease
deficiency	NN	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
28	CD	O
-	:	O
base	NN	O
pair	NN	O
genomic	JJ	O
deletion	NN	O
that	WDT	O
causes	VBZ	O
skipping	NN	O
of	IN	O
exon	$	O
6	CD	O
during	IN	O
RNA	NNP	O
splicing	NN	O
,	,	O
resulting	VBG	O
in	IN	O
generation	NN	O
of	IN	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
,	,	O
2	CD	O
)	)	O
the	DT	O
28	CD	O
-	:	O
base	NN	O
pair	NN	O
deletion	NN	O
in	IN	O
the	DT	O
type	NN	O
I	PRP	O
C2Q0	NNP	O
gene	NN	O
is	VBZ	O
strongly	RB	O
associated	VBN	O
with	IN	O
the	DT	O
HLA	NNP	O
haplotype	NN	O
/	NNP	O
complotype	NN	O
A25	NNP	O
,	,	O
B18	NNP	O
,	,	O
C2Q0	NNP	O
,	,	O
BfS	NNP	O
,	,	O
C4A4	NNP	O
,	,	O
C4B2	NNP	O
,	,	O
Drw2	NNP	O
,	,	O
suggesting	VBG	O
that	IN	O
all	DT	O
C2	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
individuals	NNS	O
with	IN	O
this	DT	O
haplotype	NN	O
/	NN	O
complotype	NN	O
will	MD	O
harbor	VB	O
the	DT	O
28	CD	O
-	:	O
base	NN	O
pair	NN	O
C2	NNP	O
gene	NN	O
deletion	NN	O
,	,	O
and	CC	O
3	CD	O
)	)	O
type	NN	B_Disease
II	NNP	I_Disease
C2	NNP	I_Disease
deficiency	NN	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
different	JJ	O
,	,	O
as	IN	O
yet	RB	O
uncharacterized	VBN	O
,	,	O
molecular	JJ	O
genetic	JJ	B_Disease
defect	NN	E_Disease
.	.	O
.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
two	CD	O
galactosemia	NN	S_Disease
mutations	NNS	O
and	CC	O
one	CD	O
polymorphism	NN	O
:	:	O
implications	NNS	O
for	IN	O
structure	NN	O
-	:	O
function	NN	O
analysis	NN	O
of	IN	O
human	JJ	O
galactose	JJ	O
-	:	O
1	CD	O
-	:	O
phosphate	NN	O
uridyltransferase	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
molecular	JJ	O
characterization	NN	O
of	IN	O
two	CD	O
galactosemia	NN	S_Disease
mutations	NNS	O
,	,	O
L74P	NNP	O
and	CC	O
F171S	NNP	O
,	,	O
and	CC	O
one	CD	O
polymorphism	NN	O
,	,	O
S135L	NNP	O
,	,	O
in	IN	O
human	JJ	O
galactose	JJ	O
-	:	O
1	CD	O
-	:	O
phosphate	NN	O
uridyltransferase	NN	O
(	(	O
GALT	NNP	O
)	)	O
.	.	O

Both	DT	O
galactosemia	JJ	S_Disease
mutations	NNS	O
result	VBP	O
in	IN	O
reduced	JJ	O
enzymatic	JJ	O
activity	NN	O
when	WRB	O
reconstructed	VBN	O
in	IN	O
the	DT	O
cDNA	NN	O
and	CC	O
overexpressed	VBN	O
.	.	O

The	DT	O
polymorphism	NN	O
,	,	O
in	IN	O
contrast	NN	O
,	,	O
has	VBZ	O
near	IN	O
normal	JJ	O
activity	NN	O
.	.	O

Both	DT	O
mutations	NNS	O
affect	VBP	O
evolutionarily	RB	O
conserved	VBN	O
residues	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
they	PRP	O
are	VBP	O
functionally	RB	O
important	JJ	O
,	,	O
while	IN	O
the	DT	O
polymorphism	NN	O
occurs	VBZ	O
in	IN	O
a	DT	O
nonconserved	JJ	O
domain	NN	O
which	WDT	O
is	VBZ	O
presumably	RB	O
not	RB	O
critical	JJ	O
for	IN	O
enzymatic	JJ	O
function	NN	O
.	.	O

The	DT	O
F171S	NNP	O
mutation	NN	O
is	VBZ	O
close	RB	O
to	TO	O
the	DT	O
putative	JJ	O
active	JJ	O
-	:	O
site	NN	O
nucleophile	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
further	RBR	O
support	VB	O
the	DT	O
notion	NN	O
of	IN	O
molecular	JJ	O
heterogeneity	NN	O
of	IN	O
galactosemia	NN	S_Disease
and	CC	O
suggest	VBP	O
that	IN	O
galactosemia	NN	S_Disease
mutations	NNS	O
and	CC	O
GALT	NNP	O
polymorphisms	NNS	O
may	MD	O
be	VB	O
useful	JJ	O
tools	NNS	O
in	IN	O
highlighting	VBG	O
different	JJ	O
functional	JJ	O
domains	NNS	O
in	IN	O
human	JJ	O
GALT	NNP	O
.	.	O
.	.	O

Linkage	NN	O
relationship	NN	O
of	IN	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
HLA	NNP	O
and	CC	O
glyoxalase	NN	O
I	PRP	O
loci	VBP	O
.	.	O

Immunogenetic	JJ	O
analysis	NN	O
of	IN	O
a	DT	O
homozygous	JJ	O
C2	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
individual	JJ	O
and	CC	O
family	NN	O
members	NNS	O
demonstrated	VBD	O
linkage	NN	O
of	IN	O
HLA	NNP	O
-	:	O
A25	NNP	O
,	,	O
B18	NNP	O
and	CC	O
C2o	NNP	O
.	.	O

HLA	NNP	O
-	:	O
D	NN	O
typing	NN	O
showed	VBD	O
that	IN	O
5	CD	O
members	NNS	O
typed	VBD	O
with	IN	O
homozygous	JJ	O
Dw2	NNP	O
typing	VBG	O
cells	NNS	O
from	IN	O
an	DT	O
individual	NN	O
with	IN	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
but	CC	O
not	RB	O
with	IN	O
Dw2	NNP	O
typing	VBG	O
cells	NNS	O
from	IN	O
2	CD	O
individuals	NNS	O
with	IN	O
normal	JJ	O
C2	NNP	O
.	.	O

The	DT	O
homozygous	JJ	O
C2	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
propositus	NN	O
and	CC	O
brother	NN	O
were	VBD	O
HLA	NNP	O
-	:	O
A	DT	O
and	CC	O
B	NNP	O
homozygous	JJ	O
but	CC	O
heterozygous	JJ	O
at	IN	O
the	DT	O
HLA	NNP	O
-	:	O
D	NN	O
and	CC	O
glyoxalase	NN	O
I	PRP	O
loci	VBP	O
.	.	O

Therefore	RB	O
,	,	O
in	IN	O
this	DT	O
family	NN	O
,	,	O
the	DT	O
C2o	NNP	O
gene	NN	O
is	VBZ	O
linked	VBN	O
with	IN	O
two	CD	O
distinct	JJ	O
haplotypes	NNS	O
HLA	NNP	O
-	:	O
A25	NNP	O
,	,	O
B18	NNP	O
,	,	O
Dw2	NNP	O
,	,	O
GLO1	NNP	O
and	CC	O
HLA	NNP	O
-	:	O
A25	NNP	O
,	,	O
B18	NNP	O
,	,	O
D	NNP	O
unknown	RB	O
,	,	O
GL02	NNP	O
.	.	O

These	DT	O
results	NNS	O
could	MD	O
be	VB	O
explained	VBN	O
by	IN	O
an	DT	O
ancestral	JJ	O
recombinant	JJ	O
event	NN	O
,	,	O
which	WDT	O
occurred	VBD	O
between	IN	O
the	DT	O
C2o	NNP	O
locus	NN	O
and	CC	O
HLA	NNP	O
-	:	O
D	NNP	O
locus	NN	O
in	IN	O
which	WDT	O
C2o	NNP	O
segregated	VBD	O
with	IN	O
HLA	NNP	O
-	:	O
B	NN	O
.	.	O

This	DT	O
would	MD	O
suggest	VB	O
that	IN	O
the	DT	O
locus	NN	O
for	IN	O
the	DT	O
C2o	NNP	O
gene	NN	O
maps	NNS	O
between	IN	O
HLA	NNP	O
-	:	O
B	NN	O
and	CC	O
HLA	NNP	O
-	:	O
D	NN	O
on	IN	O
the	DT	O
sixth	JJ	O
chromosome	NN	O
.	.	O
.	.	O

Germline	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
Wilms	NNP	B_Disease
'	POS	I_Disease
tumor	NN	E_Disease
suppressor	NN	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
abnormal	JJ	O
urogenital	JJ	O
development	NN	O
in	IN	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
human	JJ	O
condition	NN	O
in	IN	O
which	WDT	O
severe	JJ	O
urogenital	JJ	B_Disease
aberrations	NNS	E_Disease
result	VBP	O
in	IN	O
renal	JJ	B_Disease
failure	NN	E_Disease
,	,	O
pseudohermaphroditism	NN	S_Disease
,	,	O
and	CC	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
(	(	O
nephroblastoma	NN	S_Disease
)	)	O
.	.	O

To	TO	O
investigate	VB	O
its	PRP$	O
possible	JJ	O
role	NN	O
,	,	O
we	PRP	O
have	VBP	O
analyzed	VBN	O
the	DT	O
coding	VBG	O
exons	NNS	O
of	IN	O
the	DT	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
suppressor	NN	O
gene	NN	O
(	(	O
WT1	NNP	O
)	)	O
for	IN	O
germline	NN	O
mutations	NNS	O
.	.	O

In	IN	O
ten	JJ	O
independent	JJ	O
cases	NNS	O
of	IN	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
zinc	NN	O
finger	NN	O
domains	NNS	O
of	IN	O
one	CD	O
WT1	NNP	O
gene	NN	O
copy	NN	O
were	VBD	O
found	VBN	O
.	.	O

Nine	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
are	VBP	O
found	VBN	O
within	IN	O
exon	JJ	O
9	CD	O
(	(	O
zinc	NN	O
finger	NN	O
III	NNP	O
)	)	O
;	:	O
the	DT	O
remaining	VBG	O
mutation	NN	O
is	VBZ	O
in	IN	O
exon	JJ	O
8	CD	O
(	(	O
zinc	NN	O
finger	NN	O
II	NNP	O
)	)	O
.	.	O

These	DT	O
mutations	NNS	O
directly	RB	O
affect	VBP	O
DNA	NNP	O
sequence	NN	O
recognition	NN	O
.	.	O

In	IN	O
two	CD	O
families	NNS	O
analyzed	VBN	O
,	,	O
the	DT	O
mutations	NNS	O
were	VBD	O
shown	VBN	O
to	TO	O
arise	VB	O
de	FW	O
novo	FW	O
.	.	O

Wilms	JJ	B_Disease
tumors	NNS	E_Disease
from	IN	O
three	CD	O
individuals	NNS	O
and	CC	O
one	CD	O
juvenile	NN	O
granulosa	NN	O
cell	NN	O
tumor	NN	S_Disease
demonstrate	NN	O
reduction	NN	O
to	TO	O
homozygosity	NN	O
for	IN	O
the	DT	O
mutated	JJ	O
WT1	NNP	O
allele	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
provide	VBP	O
evidence	NN	O
of	IN	O
a	DT	O
direct	JJ	O
role	NN	O
for	IN	O
WT1	NNP	O
in	IN	O
Denys	NNP	B_Disease
-	:	I_Disease
Drash	NNP	I_Disease
syndrome	NN	E_Disease
and	CC	O
thus	RB	O
urogenital	JJ	O
system	NN	O
development	NN	O
.	.	O
.	.	O

Linkage	NN	O
analysis	NN	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	NN	E_Disease
and	CC	O
application	NN	O
in	IN	O
post	NN	O
-	:	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
.	.	O

We	PRP	O
have	VBP	O
performed	VBN	O
linkage	JJ	O
analysis	NN	O
with	IN	O
the	DT	O
DNA	NN	O
markers	NNS	O
DXS52	NNP	O
and	CC	O
the	DT	O
clotting	NN	O
factor	NN	O
VIII	NNP	O
gene	NN	O
(	(	O
F8C	NNP	O
)	)	O
,	,	O
in	IN	O
several	JJ	O
large	JJ	O
families	NNS	O
with	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	NN	E_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
tight	JJ	O
linkage	NN	O
to	TO	O
DXS52	NNP	O
could	MD	O
be	VB	O
extended	VBN	O
giving	VBG	O
a	DT	O
maximal	JJ	O
LOD	NNP	O
score	NN	O
of	IN	O
22	CD	O
.	.	O

5	CD	O
at	IN	O
1	CD	O
cM	NN	O
.	.	O

F8C	NNP	O
was	VBD	O
also	RB	O
tightly	RB	O
linked	VBN	O
to	TO	O
ALD	NNP	S_Disease
with	IN	O
a	DT	O
maximal	JJ	O
LOD	NNP	O
score	NN	O
of	IN	O
7	CD	O
.	.	O

8	CD	O
without	IN	O
recombination	NN	O
.	.	O

Multipoint	NNP	O
linkage	NN	O
analysis	NN	O
with	IN	O
the	DT	O
markers	NNS	O
DXS304	NNP	O
,	,	O
DXS52	NNP	O
,	,	O
and	CC	O
F8C	NNP	O
indicated	VBD	O
that	IN	O
both	DT	O
the	DT	O
gene	NN	O
for	IN	O
ALD	NNP	S_Disease
and	CC	O
for	IN	O
F8C	NNP	O
are	VBP	O
distal	JJ	O
to	TO	O
DXS52	NNP	O
.	.	O

In	IN	O
four	CD	O
patients	NNS	O
with	IN	O
ALD	NNP	S_Disease
,	,	O
no	DT	O
major	JJ	O
structural	JJ	O
rearrangement	NN	O
in	IN	O
the	DT	O
Xqter	NNP	O
region	NN	O
was	VBD	O
observed	VBN	O
;	:	O
in	IN	O
particular	JJ	O
,	,	O
there	EX	O
were	VBD	O
no	DT	O
abnormalities	NNS	B_Disease
in	IN	I_Disease
the	DT	I_Disease
vision	NN	I_Disease
blindness	NN	I_Disease
genes	NNS	E_Disease
.	.	O

DNA	NN	O
analysis	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
of	IN	O
use	NN	O
in	IN	O
determination	NN	O
of	IN	O
the	DT	O
carrier	NN	O
status	NN	O
of	IN	O
females	NNS	O
at	IN	O
risk	NN	O
,	,	O
for	IN	O
the	DT	O
determination	NN	O
of	IN	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
a	DT	O
particular	JJ	O
family	NN	O
,	,	O
and	CC	O
for	IN	O
prenatal	JJ	O
diagnosis	NN	O
.	.	O

Two	CD	O
distinct	JJ	O
mutations	NNS	O
at	IN	O
a	DT	O
single	JJ	O
BamHI	NNP	O
site	NN	O
in	IN	O
phenylketonuria	NN	S_Disease
.	.	O

Classical	JJ	B_Disease
phenylketonuria	NN	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disease	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
hepatic	JJ	I_Disease
phenylalanine	NN	I_Disease
hydroxylase	NN	E_Disease
(	(	O
PAH	NNP	O
)	)	O
.	.	O

The	DT	O
abolition	NN	O
of	IN	O
an	DT	O
invariant	JJ	O
BamHI	NNP	O
site	NN	O
located	VBN	O
in	IN	O
the	DT	O
coding	VBG	O
sequence	NN	O
of	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
(	(	O
exon	JJ	O
7	CD	O
)	)	O
led	VBN	O
to	TO	O
the	DT	O
recognition	NN	O
of	IN	O
two	CD	O
new	JJ	O
point	NN	O
mutations	NNS	O
at	IN	O
codon	NN	O
272	CD	O
and	CC	O
273	CD	O
(	(	O
272gly	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
stop	NN	O
and	CC	O
273ser	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
phe	NN	O
,	,	O
respectively	RB	O
)	)	O
.	.	O

Both	DT	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
north	JJ	O
eastern	JJ	O
France	NNP	O
or	CC	O
Belgium	NNP	O
and	CC	O
occurred	VBD	O
on	IN	O
the	DT	O
background	NN	O
of	IN	O
RFLP	NNP	O
haplotype	NN	O
7	CD	O
alleles	NNS	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
supports	VBZ	O
the	DT	O
view	NN	O
that	IN	O
the	DT	O
clinical	JJ	O
heterogeneity	NN	O
in	IN	O
PKU	NNP	S_Disease
is	VBZ	O
accounted	VBN	O
for	IN	O
by	IN	O
the	DT	O
large	JJ	O
variety	NN	O
of	IN	O
mutant	JJ	O
genotypes	NNS	O
associated	VBN	O
with	IN	O
PAH	NNP	B_Disease
deficiencies	NNS	E_Disease
.	.	O
.	.	O

A	DT	O
detailed	JJ	O
multipoint	NN	O
map	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
4	CD	O
provides	VBZ	O
evidence	NN	O
for	IN	O
linkage	NN	O
heterogeneity	NN	O
and	CC	O
position	NN	O
-	:	O
specific	JJ	O
recombination	NN	O
rates	NNS	O
.	.	O

Utilizing	VBG	O
the	DT	O
CEPH	NNP	O
reference	NN	O
panel	NN	O
and	CC	O
genotypic	NN	O
data	NNS	O
for	IN	O
53	CD	O
markers	NNS	O
,	,	O
we	PRP	O
have	VBP	O
constructed	VBN	O
a	DT	O
20	CD	O
-	:	O
locus	NN	O
multipoint	NN	O
genetic	JJ	O
map	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
4	CD	O
.	.	O

New	NNP	O
RFLPs	NNP	O
are	VBP	O
reported	VBN	O
for	IN	O
four	CD	O
loci	NN	O
.	.	O

The	DT	O
map	NN	O
integrates	VBZ	O
a	DT	O
high	JJ	O
-	:	O
resolution	NN	O
genetic	JJ	O
map	NN	O
of	IN	O
4p16	CD	O
into	IN	O
a	DT	O
continuous	JJ	O
map	NN	O
extending	VBG	O
to	TO	O
4q31	CD	O
and	CC	O
an	DT	O
unlinked	JJ	O
cluster	NN	O
of	IN	O
three	CD	O
loci	NN	O
at	IN	O
4q35	CD	O
.	.	O

The	DT	O
20	CD	O
linked	VBD	O
markers	NNS	O
form	VBP	O
a	DT	O
continuous	JJ	O
linkage	NN	O
group	NN	O
of	IN	O
152	CD	O
cM	NN	O
in	IN	O
males	NNS	O
and	CC	O
202	CD	O
cM	NN	O
in	IN	O
females	NNS	O
.	.	O

Likely	JJ	O
genetic	JJ	O
locations	NNS	O
are	VBP	O
provided	VBN	O
for	IN	O
25	CD	O
polymorphic	JJ	O
anonymous	JJ	O
sequences	NNS	O
and	CC	O
28	CD	O
gene	NN	O
-	:	O
specific	JJ	O
RFLPs	NNP	O
.	.	O

The	DT	O
map	NN	O
was	VBD	O
constructed	VBN	O
employing	VBG	O
the	DT	O
LINKAGE	NNP	O
and	CC	O
CRIMAP	NNP	O
computational	JJ	O
methodologies	NNS	O
to	TO	O
build	VB	O
the	DT	O
multipoint	NN	O
map	NN	O
via	IN	O
a	DT	O
stepwise	NN	O
algorithm	NN	O
.	.	O

A	DT	O
detailed	JJ	O
10	CD	O
-	:	O
point	NN	O
map	NN	O
of	IN	O
the	DT	O
4p16	CD	O
region	NN	O
constructed	VBN	O
from	IN	O
the	DT	O
CEPH	NNP	O
panel	NN	O
provides	VBZ	O
evidence	NN	O
for	IN	O
heterogeneity	NN	O
in	IN	O
the	DT	O
linkage	NN	O
maps	NNS	O
constructed	VBN	O
from	IN	O
families	NNS	O
segregating	VBG	O
for	IN	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
.	.	O

It	PRP	O
additionally	RB	O
provides	VBZ	O
evidence	NN	O
for	IN	O
position	NN	O
-	:	O
specific	JJ	O
recombination	NN	O
frequencies	NNS	O
in	IN	O
the	DT	O
telomeric	JJ	O
region	NN	O
of	IN	O
4p	CD	O
.	.	O
.	.	O

Carrier	NNP	O
detection	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
of	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
using	VBG	O
a	DT	O
combination	NN	O
of	IN	O
anonymous	JJ	O
DNA	NNP	O
polymorphisms	NN	O
and	CC	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
(	(	O
PLP	NNP	O
)	)	O
gene	NN	O
cDNA	NN	O
.	.	O

We	PRP	O
report	VBP	O
carrier	NN	O
identification	NN	O
and	CC	O
a	DT	O
prenatal	JJ	O
diagnosis	NN	O
using	VBG	O
DNA	NNP	O
polymorphisms	NNS	O
in	IN	O
2	CD	O
families	NNS	O
with	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
Pelizaeus	NNP	I_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
(	(	O
PMD	NNP	S_Disease
)	)	O
.	.	O

In	IN	O
both	DT	O
families	NNS	O
,	,	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
(	(	O
PLP	NNP	O
)	)	O
gene	NN	O
in	IN	O
the	DT	O
single	JJ	O
affected	JJ	O
male	NN	O
could	MD	O
be	VB	O
traced	VBN	O
back	RB	O
to	TO	O
his	PRP$	O
unaffected	JJ	O
maternal	JJ	O
grandfather	NN	O
.	.	O

Therefore	RB	O
,	,	O
each	DT	O
family	NN	O
contains	VBZ	O
a	DT	O
new	JJ	O
mutation	NN	O
.	.	O

In	IN	O
the	DT	O
case	NN	O
of	IN	O
the	DT	O
prenatal	JJ	O
diagnosis	NN	O
,	,	O
the	DT	O
fetus	NN	O
was	VBD	O
shown	VBN	O
by	IN	O
cytogenetic	JJ	O
analysis	NN	O
to	TO	O
be	VB	O
a	DT	O
female	JJ	O
,	,	O
who	WP	O
we	PRP	O
predict	VBP	O
will	MD	O
be	VB	O
a	DT	O
noncarrier	JJR	O
of	IN	O
PMD	NNP	S_Disease
based	VBN	O
on	IN	O
her	PRP$	O
genotype	NN	O
with	IN	O
the	DT	O
PLP	NNP	O
intragenic	JJ	O
polymorphism	NN	O
.	.	O
.	.	O

Identification	NN	O
of	IN	O
deletion	NN	O
mutations	NNS	O
and	CC	O
three	CD	O
new	JJ	O
genes	NNS	O
at	IN	O
the	DT	O
familial	JJ	B_Disease
polyposis	NN	E_Disease
locus	NN	O
.	.	O

Small	NNP	O
(	(	O
100	CD	O
-	:	O
260	CD	O
kb	NN	O
)	)	O
,	,	O
nested	JJ	O
deletions	NNS	O
were	VBD	O
characterized	VBN	O
in	IN	O
DNA	NN	O
from	IN	O
two	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
.	.	O

Three	CD	O
candidate	NN	O
genes	NNS	O
located	VBN	O
within	IN	O
the	DT	O
deleted	JJ	O
region	NN	O
were	VBD	O
ascertained	VBN	O
and	CC	O
a	DT	O
previous	JJ	O
candidate	NN	O
gene	NN	O
,	,	O
MCC	NNP	O
,	,	O
was	VBD	O
shown	VBN	O
to	TO	O
be	VB	O
located	VBN	O
outside	IN	O
the	DT	O
deleted	JJ	O
region	NN	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
new	JJ	O
genes	NNS	O
contained	VBN	O
sequence	RB	O
identical	JJ	O
to	TO	O
SRP19	NNP	O
,	,	O
the	DT	O
gene	NN	O
coding	VBG	O
for	IN	O
the	DT	O
19	CD	O
kd	JJ	O
component	NN	O
of	IN	O
the	DT	O
ribosomal	JJ	O
signal	JJ	O
recognition	NN	O
particle	NN	O
.	.	O

The	DT	O
second	JJ	O
,	,	O
provisionally	RB	O
designated	VBN	O
DP1	NNP	O
(	(	O
deleted	VBN	O
in	IN	O
polyposis	NN	O
1	CD	O
)	)	O
,	,	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
transcribed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
orientation	NN	O
as	IN	O
MCC	NNP	O
.	.	O

Two	CD	O
other	JJ	O
cDNAs	NN	O
,	,	O
DP2	NNP	O
and	CC	O
DP3	NNP	O
,	,	O
were	VBD	O
found	VBN	O
to	TO	O
overlap	VB	O
,	,	O
forming	VBG	O
a	DT	O
single	JJ	O
gene	NN	O
,	,	O
DP2	NNP	O
.	.	O

5	CD	O
,	,	O
that	WDT	O
is	VBZ	O
transcribed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
orientation	NN	O
as	IN	O
SRP19	NNP	O
.	.	O

Exclusion	NN	O
of	IN	O
linkage	NN	O
between	IN	O
familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
and	CC	O
the	DT	O
human	JJ	O
serum	NN	O
amyloid	VBZ	O
A	NNP	O
(	(	O
SAA	NNP	O
)	)	O
gene	NN	O
cluster	NN	O
.	.	O

We	PRP	O
studied	VBD	O
the	DT	O
relationship	NN	O
between	IN	O
the	DT	O
autosomal	JJ	O
recessive	JJ	O
trait	NN	O
familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
(	(	O
FMF	NNP	S_Disease
)	)	O
and	CC	O
the	DT	O
serum	NN	O
amyloid	VBZ	O
A	NNP	O
(	(	O
SAA	NNP	O
)	)	O
genes	NNS	O
by	IN	O
comparing	VBG	O
alleles	NNS	O
of	IN	O
a	DT	O
highly	RB	O
polymorphic	JJ	O
dinucleotide	NN	O
repeat	NN	O
and	CC	O
a	DT	O
conventional	JJ	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
(	(	O
RFLP	NNP	O
)	)	O
in	IN	O
the	DT	O
SAA	NNP	O
gene	NN	O
cluster	NN	O
in	IN	O
Israeli	NNP	O
FMF	NNP	S_Disease
kindreds	NNS	O
.	.	O

By	IN	O
haplotype	JJ	O
analysis	NN	O
,	,	O
our	PRP$	O
data	NNS	O
indicate	VBP	O
a	DT	O
minimum	JJ	O
crossover	NN	O
frequency	NN	O
of	IN	O
22	CD	O
%	NN	O
between	IN	O
the	DT	O
SAA	NNP	O
gene	NN	O
marker	NN	O
and	CC	O
FMF	NNP	S_Disease
.	.	O

By	IN	O
conventional	JJ	O
linkage	NN	O
analysis	NN	O
this	DT	O
eliminates	VBZ	O
a	DT	O
minimum	NN	O
of	IN	O
10	CD	O
.	.	O

4	CD	O
cM	NN	O
including	VBG	O
and	CC	O
surrounding	VBG	O
the	DT	O
SAA	NNP	O
gene	NN	O
cluster	NN	O
as	IN	O
the	DT	O
site	NN	O
of	IN	O
the	DT	O
FMF	NNP	S_Disease
mutation	NN	O
although	IN	O
SAA	NNP	O
proteins	NNS	O
are	VBP	O
prominent	JJ	O
physiologic	JJ	O
markers	NNS	O
of	IN	O
the	DT	O
acute	NN	O
attacks	NNS	O
.	.	O

PRAD1	NNP	O
,	,	O
a	DT	O
candidate	NN	O
BCL1	NNP	O
oncogene	NN	O
:	:	O
mapping	NN	O
and	CC	O
expression	NN	O
in	IN	O
centrocytic	JJ	B_Disease
lymphoma	NN	E_Disease
.	.	O

Rearrangement	NN	O
of	IN	O
the	DT	O
BCL1	NNP	O
(	(	O
B	NNP	O
-	:	O
cell	NN	O
lymphoma	VBZ	O
1	CD	O
)	)	O
region	NN	O
on	IN	O
chromosome	NN	O
11q13	CD	O
appears	VBZ	O
to	TO	O
be	VB	O
highly	RB	O
characteristic	JJ	O
of	IN	O
centrocytic	JJ	B_Disease
lymphoma	NN	E_Disease
and	CC	O
also	RB	O
is	VBZ	O
found	VBN	O
infrequently	RB	O
in	IN	O
other	JJ	O
B	NNP	B_Disease
-	:	I_Disease
cell	NN	I_Disease
neoplasms	NNS	E_Disease
.	.	O

Rearrangement	NNP	O
is	VBZ	O
thought	VBN	O
to	TO	O
deregulate	VB	O
a	DT	O
nearby	JJ	O
protooncogene	NN	O
,	,	O
but	CC	O
transcribed	VBD	O
sequences	NNS	O
in	IN	O
the	DT	O
immediate	JJ	O
vicinity	NN	O
of	IN	O
BCL1	NNP	O
breakpoints	NNS	O
had	VBD	O
not	RB	O
been	VBN	O
identified	VBN	O
.	.	O

PRAD1	NNP	O
,	,	O
previously	RB	O
designated	VBN	O
D11S287E	NNP	O
,	,	O
was	VBD	O
identified	VBN	O
on	IN	O
11q13	CD	O
as	IN	O
a	DT	O
chromosomal	JJ	O
breakpoint	NN	O
region	NN	O
rearranged	VBN	O
with	IN	O
the	DT	O
parathyroid	NN	O
hormone	NN	O
gene	NN	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
parathyroid	JJ	B_Disease
adenomas	NN	E_Disease
;	:	O
this	DT	O
highly	RB	O
conserved	JJ	O
putative	JJ	O
oncogene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
a	DT	O
novel	JJ	O
cyclin	NN	O
,	,	O
has	VBZ	O
been	VBN	O
linked	VBN	O
to	TO	O
BCL1	NNP	O
and	CC	O
implicated	VBN	O
also	RB	O
in	IN	O
subsets	NNS	O
of	IN	O
breast	NN	B_Disease
and	CC	I_Disease
squamous	JJ	I_Disease
cell	NN	I_Disease
neoplasms	NNS	E_Disease
with	IN	O
11q13	CD	O
amplification	NN	O
.	.	O

We	PRP	O
report	VBP	O
pulsed	VBD	O
-	:	O
field	NN	O
gel	JJ	O
electrophoresis	NN	O
data	NNS	O
showing	VBG	O
BCL1	NNP	O
and	CC	O
PRAD1	NNP	O
to	TO	O
be	VB	O
no	RB	O
more	JJR	O
than	IN	O
130	CD	O
kilobases	NNS	O
apart	RB	O
.	.	O

PRAD1	NNP	O
mRNA	NN	O
is	VBZ	O
abundantly	RB	O
expressed	VBN	O
in	IN	O
seven	CD	O
of	IN	O
seven	CD	O
centrocytic	JJ	B_Disease
lymphomas	NN	E_Disease
(	(	O
Kiel	NNP	O
classification	NN	O
)	)	O
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
13	CD	O
closely	RB	O
related	JJ	O
but	CC	O
noncentrocytic	JJ	B_Disease
lymphomas	NN	E_Disease
.	.	O

Three	CD	O
of	IN	O
the	DT	O
seven	CD	O
centrocytic	JJ	B_Disease
lymphomas	NN	E_Disease
had	VBD	O
detectable	JJ	O
BCL1	NNP	O
DNA	NNP	O
rearrangement	NN	O
.	.	O

Also	RB	O
,	,	O
two	CD	O
unusual	JJ	O
cases	NNS	O
of	IN	O
CLL	NNP	O
with	IN	O
BCL1	NNP	O
rearrangement	NN	O
overexpressed	VBD	O
PRAD1	NNP	O
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
five	CD	O
CLL	NNP	O
controls	NNS	O
.	.	O

Thus	RB	O
,	,	O
PRAD1	NNP	O
is	VBZ	O
an	DT	O
excellent	JJ	O
candidate	NN	O
"	NNP	O
BCL1	NNP	O
oncogene	NN	O
.	.	O

"	VB	O
Its	PRP$	O
overexpression	NN	O
may	MD	O
be	VB	O
a	DT	O
key	JJ	O
consequence	NN	O
of	IN	O
rearrangement	NN	O
of	IN	O
the	DT	O
BCL1	NNP	O
vicinity	NN	O
in	IN	O
B	NNP	B_Disease
-	:	I_Disease
cell	NN	I_Disease
neoplasms	NNS	E_Disease
and	CC	O
a	DT	O
unifying	JJ	O
pathogenetic	JJ	O
feature	NN	O
in	IN	O
centrocytic	JJ	B_Disease
lymphoma	NN	E_Disease
.	.	O

Two	CD	O
new	JJ	O
arylsulfatase	NN	O
A	NNP	O
(	(	O
ARSA	NNP	O
)	)	O
mutations	NNS	O
in	IN	O
a	DT	O
juvenile	NN	O
metachromatic	JJ	B_Disease
leukodystrophy	NN	E_Disease
(	(	O
MLD	NNP	S_Disease
)	)	O
patient	NN	O
.	.	O

Fragments	NNS	O
of	IN	O
the	DT	O
arylsulfatase	NN	O
A	NNP	O
(	(	O
ARSA	NNP	O
)	)	O
gene	NN	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
juvenile	JJ	O
-	:	O
onset	VBN	O
metachromatic	JJ	B_Disease
leukodystrophy	NN	E_Disease
(	(	O
MLD	NNP	S_Disease
)	)	O
were	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
and	CC	O
ligated	VBN	O
into	IN	O
MP13	NNP	O
cloning	VBG	O
vectors	NNS	O
.	.	O

Clones	NNS	O
hybridizing	VBG	O
with	IN	O
cDNA	NN	O
for	IN	O
human	JJ	O
ARSA	NNP	O
were	VBD	O
selected	VBN	O
,	,	O
examined	VBN	O
for	IN	O
appropriate	JJ	O
size	NN	O
inserts	NNS	O
,	,	O
and	CC	O
used	VBD	O
to	TO	O
prepare	VB	O
single	JJ	O
-	:	O
stranded	JJ	O
phage	NN	O
DNA	NN	O
.	.	O

Examination	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
and	CC	O
most	JJS	O
of	IN	O
the	DT	O
intronic	JJ	O
sequence	NN	O
revealed	VBD	O
two	CD	O
putative	JJ	O
disease	NN	O
-	:	O
related	JJ	O
mutations	NNS	O
.	.	O

One	CD	O
,	,	O
a	DT	O
point	NN	O
mutation	NN	O
in	IN	O
exon	JJ	O
3	CD	O
,	,	O
resulted	VBD	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
isoleucine	NN	O
by	IN	O
serine	NN	O
.	.	O

Introduction	NN	O
of	IN	O
this	DT	O
alteration	NN	O
into	IN	O
the	DT	O
normal	JJ	O
ARSA	NNP	O
cDNA	NN	O
sequence	NN	O
resulted	VBD	O
in	IN	O
a	DT	O
substantial	JJ	O
decrease	NN	O
in	IN	O
ARSA	NNP	O
activity	NN	O
on	IN	O
transient	JJ	O
expression	NN	O
in	IN	O
cultured	JJ	O
baby	NN	O
hamster	NN	O
kidney	NN	O
cells	NNS	O
.	.	O

About	RB	O
5	CD	O
%	NN	O
of	IN	O
the	DT	O
control	NN	O
expression	NN	O
was	VBD	O
observed	VBN	O
,	,	O
suggesting	VBG	O
a	DT	O
small	JJ	O
residual	JJ	O
activity	NN	O
in	IN	O
the	DT	O
mutated	JJ	O
ARSA	NNP	O
.	.	O

The	DT	O
second	JJ	O
mutation	NN	O
,	,	O
a	DT	O
G	NNP	O
-	:	O
to	TO	O
-	:	O
A	DT	O
transition	NN	O
,	,	O
occurred	VBD	O
in	IN	O
the	DT	O
other	JJ	O
allele	NN	O
and	CC	O
resulted	VBD	O
in	IN	O
an	DT	O
altered	JJ	O
splice	NN	O
-	:	O
recognition	NN	O
sequence	NN	O
between	IN	O
exon	$	O
7	CD	O
and	CC	O
the	DT	O
following	JJ	O
intron	NN	O
.	.	O

The	DT	O
mutation	NN	O
also	RB	O
resulted	VBD	O
in	IN	O
the	DT	O
loss	NN	O
of	IN	O
a	DT	O
restriction	NN	O
site	NN	O
.	.	O

Apparently	RB	O
normal	JJ	O
levels	NNS	O
of	IN	O
mRNA	NN	O
were	VBD	O
generated	VBN	O
from	IN	O
this	DT	O
allele	NN	O
,	,	O
but	CC	O
no	DT	O
ARSA	NNP	O
activity	NN	O
or	CC	O
immuno	NN	O
-	:	O
cross	NN	O
-	:	O
reactive	JJ	O
material	NN	O
could	MD	O
be	VB	O
detected	VBN	O
.	.	O

A	DT	O
collection	NN	O
of	IN	O
DNA	NNP	O
samples	NNS	O
from	IN	O
known	VBN	O
or	CC	O
suspected	VBN	O
MLD	NNP	S_Disease
patients	NNS	O
,	,	O
members	NNS	O
of	IN	O
their	PRP$	O
families	NNS	O
,	,	O
and	CC	O
normal	JJ	O
controls	NNS	O
was	VBD	O
screened	VBN	O
for	IN	O
these	DT	O
mutations	NNS	O
.	.	O

Four	CD	O
additional	JJ	O
individuals	NNS	O
carrying	VBG	O
each	DT	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
found	VBN	O
among	IN	O
the	DT	O
nearly	RB	O
100	CD	O
MLD	JJ	S_Disease
patients	NNS	O
in	IN	O
the	DT	O
sample	NN	O
.	.	O

Gene	NNP	O
segregation	NN	O
in	IN	O
the	DT	O
original	JJ	O
patients	NNS	O
family	NN	O
was	VBD	O
consistent	JJ	O
with	IN	O
available	JJ	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
data	NNS	O
.	.	O

No	DT	O
individuals	NNS	O
homozygous	JJ	O
for	IN	O
either	DT	O
of	IN	O
these	DT	O
two	CD	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

However	RB	O
,	,	O
combinations	NNS	O
with	IN	O
other	JJ	O
MLD	NNP	S_Disease
mutations	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
point	NN	O
mutation	NN	O
in	IN	O
exon	JJ	O
3	CD	O
does	VBZ	O
result	NN	O
in	IN	O
some	DT	O
residual	JJ	O
enzyme	NN	O
activity	NN	O
and	CC	O
is	VBZ	O
associated	VBN	O
with	IN	O
late	JJ	O
-	:	O
onset	NN	O
forms	NNS	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
following	VBG	O
exon	$	O
7	CD	O
produces	NNS	O
late	JJ	O
-	:	O
infantile	NN	O
MLD	NNP	S_Disease
when	WRB	O
combined	VBN	O
with	IN	O
other	JJ	O
enzyme	JJ	O
-	:	O
null	JJ	O
mutations	NNS	O
,	,	O
implying	VBG	O
that	IN	O
it	PRP	O
is	VBZ	O
completely	RB	O
silent	JJ	O
enzymatically	RB	O
.	.	O
.	.	O

Analysis	NN	O
of	IN	O
X	NNP	O
-	:	O
chromosome	NN	O
inactivation	NN	O
and	CC	O
presumptive	JJ	O
expression	NN	O
of	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
gene	NN	O
in	IN	O
hematopoietic	JJ	O
cell	NN	O
lineages	NNS	O
of	IN	O
a	DT	O
thrombocytopenic	JJ	O
carrier	NN	O
female	NN	O
of	IN	O
WAS	NNP	S_Disease
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
thrombocytopenic	JJ	S_Disease
female	NN	O
belonging	NN	O
to	TO	O
a	DT	O
pedigree	NN	O
with	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
.	.	O

Restriction	NNP	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
(	(	O
RFLP	NNP	O
)	)	O
analysis	NN	O
with	IN	O
probe	NN	O
M27	NNP	O
beta	NN	O
,	,	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
WAS	NNP	S_Disease
gene	NN	O
,	,	O
demonstrated	VBD	O
that	IN	O
she	PRP	O
is	VBZ	O
a	DT	O
carrier	NN	O
of	IN	O
WAS	NNP	S_Disease
.	.	O

Both	DT	O
small	JJ	O
-	:	O
sized	VBN	O
and	CC	O
normal	JJ	O
-	:	O
sized	VBN	O
platelets	NNS	O
were	VBD	O
present	JJ	O
,	,	O
suggesting	VBG	O
that	IN	O
,	,	O
unlike	IN	O
the	DT	O
vast	JJ	O
majority	NN	O
of	IN	O
WAS	NNP	S_Disease
carriers	NNS	O
,	,	O
she	PRP	O
does	VBZ	O
not	RB	O
manifest	VB	O
nonrandom	RB	O
X	NNP	O
-	:	O
chromosome	NN	O
inactivation	NN	O
in	IN	O
the	DT	O
thrombopoietic	JJ	O
cell	NN	O
lineage	NN	O
.	.	O

Study	NNP	O
of	IN	O
X	NNP	O
-	:	O
chromosome	NN	O
inactivation	NN	O
by	IN	O
means	NNS	O
of	IN	O
RFLP	NNP	O
and	CC	O
methylation	NN	O
analysis	NN	O
demonstrated	VBD	O
that	IN	O
the	DT	O
pattern	NN	O
of	IN	O
X	NNP	O
-	:	O
chromosome	NN	O
inactivation	NN	O
was	VBD	O
nonrandom	RB	O
in	IN	O
T	NNP	O
lymphocytes	NNS	O
,	,	O
but	CC	O
random	NN	O
in	IN	O
granulocytes	NNS	O
.	.	O

While	IN	O
this	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
complete	JJ	O
report	NN	O
on	IN	O
the	DT	O
occurrence	NN	O
of	IN	O
thrombocytopenia	NN	S_Disease
in	IN	O
a	DT	O
carrier	NN	O
female	NN	O
of	IN	O
WAS	NNP	S_Disease
as	IN	O
the	DT	O
result	NN	O
of	IN	O
atypical	JJ	O
lyonization	NN	O
,	,	O
it	PRP	O
also	RB	O
suggests	VBZ	O
that	IN	O
expression	NN	O
of	IN	O
the	DT	O
WAS	NNP	S_Disease
gene	NN	O
occurs	VBZ	O
at	IN	O
(	(	O
or	CC	O
extends	VBZ	O
up	RP	O
to	TO	O
)	)	O
a	DT	O
later	RBR	O
stage	NN	O
than	IN	O
the	DT	O
multipotent	JJ	O
stem	NN	O
cell	NN	O
along	IN	O
the	DT	O
hematopoietic	JJ	O
differentiation	NN	O
pathway	NN	O
.	.	O
.	.	O

A	DT	O
new	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
(	(	O
PLP	NNP	O
)	)	O
gene	NN	O
in	IN	O
a	DT	O
German	JJ	O
family	NN	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
.	.	O

A	DT	O
C	NNP	O
-	:	O
to	TO	O
-	:	O
T	NNP	O
transition	NN	O
in	IN	O
exon	JJ	O
4	CD	O
of	IN	O
the	DT	O
PLP	NNP	O
gene	NN	O
was	VBD	O
found	VBN	O
in	IN	O
2	CD	O
affected	JJ	O
males	NNS	O
and	CC	O
two	CD	O
obligate	NN	O
carriers	NNS	O
in	IN	O
a	DT	O
German	JJ	O
family	NN	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
.	.	O

The	DT	O
mutation	NN	O
,	,	O
which	WDT	O
causes	VBZ	O
loss	NN	O
of	IN	O
an	DT	O
HphI	NNP	O
site	NN	O
and	CC	O
changes	NNS	O
amino	VBP	O
acid	JJ	O
155	CD	O
from	IN	O
threonine	NN	O
to	TO	O
isoleucine	VB	O
,	,	O
was	VBD	O
absent	NN	O
from	IN	O
108	CD	O
normal	JJ	O
chromosomes	NNS	O
.	.	O

There	EX	O
are	VBP	O
5	CD	O
concordances	NNS	O
and	CC	O
1	CD	O
discrepancy	NN	O
between	IN	O
these	DT	O
results	NNS	O
and	CC	O
those	DT	O
obtained	VBN	O
by	IN	O
magnetic	JJ	O
resonance	NN	O
imaging	NN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O
.	.	O

A	DT	O
3	CD	O
-	:	O
base	NN	O
pair	NN	O
in	IN	O
-	:	O
frame	NN	O
deletion	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
results	NNS	O
in	IN	O
a	DT	O
kinetic	JJ	O
variant	NN	O
of	IN	O
phenylketonuria	NN	S_Disease
.	.	O

Phenylketonuria	NNP	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disease	NN	E_Disease
due	JJ	O
to	TO	O
deficiency	NN	B_Disease
of	IN	I_Disease
a	DT	I_Disease
hepatic	JJ	I_Disease
enzyme	NN	I_Disease
,	,	I_Disease
phenylalanine	JJ	I_Disease
hydroxylase	NN	E_Disease
(	(	O
PAH	NNP	O
)	)	O
.	.	O

The	DT	O
absence	NN	O
of	IN	O
PAH	NNP	O
activity	NN	O
results	NNS	O
in	IN	O
typical	JJ	O
PKU	NNP	S_Disease
while	IN	O
persistence	NN	O
of	IN	O
a	DT	O
residual	JJ	O
enzyme	NN	O
activity	NN	O
gives	VBZ	O
rise	NN	O
to	TO	O
variant	VB	O
forms	NNS	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
a	DT	O
3	CD	O
-	:	O
base	NN	O
pair	NN	O
in	IN	O
-	:	O
frame	NN	O
deletion	NN	O
of	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
(	(	O
delta	JJ	O
194	CD	O
)	)	O
in	IN	O
a	DT	O
mild	JJ	O
variant	NN	O
,	,	O
with	IN	O
markedly	RB	O
reduced	VBN	O
affinity	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
for	IN	O
phenylalanine	NN	O
(	(	O
Km	NNP	O
=	VBZ	O
160	CD	O
nM	NN	O
)	)	O
,	,	O
and	CC	O
we	PRP	O
provide	VBP	O
functional	JJ	O
evidence	NN	O
for	IN	O
responsibility	NN	O
of	IN	O
the	DT	O
deletion	NN	O
in	IN	O
the	DT	O
mutant	JJ	O
phenotype	NN	O
.	.	O

Since	IN	O
the	DT	O
deletion	NN	O
was	VBD	O
located	VBN	O
in	IN	O
the	DT	O
third	JJ	O
exon	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
which	WDT	O
presents	VBZ	O
no	DT	O
homology	NN	O
with	IN	O
other	JJ	O
hydroxylases	NNS	O
,	,	O
we	PRP	O
suggest	VBP	O
that	IN	O
exon	$	O
3	CD	O
is	VBZ	O
involved	VBN	O
in	IN	O
the	DT	O
specificity	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
for	IN	O
phenylalanine	NN	O
.	.	O

Finally	RB	O
,	,	O
since	IN	O
none	NN	O
of	IN	O
the	DT	O
98	CD	O
PKU	NNP	S_Disease
patients	NNS	O
tested	VBN	O
were	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
this	DT	O
particular	JJ	O
deletion	NN	O
,	,	O
our	PRP$	O
study	NN	O
suggests	VBZ	O
that	IN	O
this	DT	O
molecular	JJ	O
event	NN	O
probably	RB	O
occurred	VBD	O
recently	RB	O
on	IN	O
the	DT	O
background	NN	O
of	IN	O
a	DT	O
haplotype	NN	O
2	CD	O
gene	NN	O
in	IN	O
Portugal	NNP	O
.	.	O
.	.	O

Mutation	NN	O
of	IN	O
the	DT	O
KIT	NNP	O
(	(	O
mast	JJ	O
/	NNP	O
stem	NN	O
cell	NN	O
growth	NN	O
factor	NN	O
receptor	NN	O
)	)	O
protooncogene	NN	O
in	IN	O
human	JJ	O
piebaldism	NN	S_Disease
.	.	O

Piebaldism	NN	S_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
genetic	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
cogenital	JJ	O
patches	NNS	O
of	IN	O
skin	NN	O
and	CC	O
hair	NN	O
from	IN	O
which	WDT	O
melanocytes	NNS	O
are	VBP	O
completely	RB	O
absent	JJ	O
.	.	O

A	DT	O
similar	JJ	O
disorder	NN	O
of	IN	O
mouse	NN	O
,	,	O
dominant	JJ	O
white	JJ	O
spotting	NN	O
(	(	O
W	NNP	O
)	)	O
,	,	O
results	NNS	O
from	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
c	JJ	O
-	:	O
Kit	NNP	O
protooncogene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
and	CC	O
receptor	NN	O
for	IN	O
mast	NN	O
/	JJ	O
stem	NN	O
cell	NN	O
growth	NN	O
factor	NN	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
KIT	NNP	O
gene	NN	O
mutation	NN	O
in	IN	O
a	DT	O
proband	NN	O
with	IN	O
classic	JJ	O
autosomal	JJ	O
dominant	JJ	O
piebaldism	NN	S_Disease
.	.	O

This	DT	O
mutation	NN	O
results	NNS	O
in	IN	O
a	DT	O
Gly	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
Arg	DT	O
substitution	NN	O
at	IN	O
codon	NN	O
664	CD	O
,	,	O
within	IN	O
the	DT	O
tyrosine	JJ	O
kinase	NN	O
domain	NN	O
.	.	O

This	DT	O
substitution	NN	O
was	VBD	O
not	RB	O
seen	VBN	O
in	IN	O
any	DT	O
normal	JJ	O
individuals	NNS	O
and	CC	O
was	VBD	O
completely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
piebald	NN	S_Disease
phenotype	NN	O
in	IN	O
the	DT	O
probands	NNS	O
family	NN	O
.	.	O

Piebaldism	NN	S_Disease
in	IN	O
this	DT	O
family	NN	O
thus	RB	O
appears	VBZ	O
to	TO	O
be	VB	O
the	DT	O
human	JJ	O
homologue	NN	O
to	TO	O
dominant	VB	O
white	JJ	O
spotting	NN	O
(	(	O
W	NNP	O
)	)	O
of	IN	O
the	DT	O
mouse	NN	O
.	.	O
.	.	O

Genetic	JJ	O
analysis	NN	O
of	IN	O
a	DT	O
Japanese	JJ	O
family	NN	O
with	IN	O
normotriglyceridemic	JJ	B_Disease
abetalipoproteinemia	NN	E_Disease
indicates	VBZ	O
a	DT	O
lack	NN	O
of	IN	O
linkage	NN	O
to	TO	O
the	DT	O
apolipoprotein	NN	O
B	NNP	O
gene	NN	O
.	.	O

Normotriglyceridemic	NNP	B_Disease
abetalipoproteinemia	NN	E_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
familial	JJ	B_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
an	DT	O
isolated	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
apoB	JJ	I_Disease
-	:	I_Disease
100	CD	E_Disease
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
reported	VBN	O
a	DT	O
patient	NN	O
with	IN	O
this	DT	O
disease	NN	O
,	,	O
who	WP	O
had	VBD	O
normal	JJ	O
apoB	JJ	O
-	:	O
48	CD	O
but	CC	O
no	DT	O
apoB	JJ	O
-	:	O
100	CD	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
genetic	JJ	B_Disease
abnormalities	NNS	E_Disease
in	IN	O
this	DT	O
family	NN	O
,	,	O
we	PRP	O
studied	VBD	O
the	DT	O
linkage	NN	O
of	IN	O
apoB	JJ	O
gene	NN	O
using	VBG	O
three	CD	O
genetic	JJ	O
markers	NNS	O
.	.	O

The	DT	O
proband	NN	O
and	CC	O
her	PRP$	O
affected	JJ	O
brother	NN	O
showed	VBD	O
completely	RB	O
different	JJ	O
apoB	NNS	O
gene	NN	O
alleles	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
apoB	NN	O
gene	NN	O
itself	PRP	O
is	VBZ	O
not	RB	O
related	VBN	O
to	TO	O
this	DT	O
disorder	NN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

By	IN	O
contrast	NN	O
,	,	O
an	DT	O
American	JJ	O
case	NN	O
had	VBD	O
a	DT	O
point	NN	O
substitution	NN	O
in	IN	O
the	DT	O
apoB	JJ	O
gene	NN	O
generating	VBG	O
an	DT	O
in	IN	O
-	:	O
frame	NN	O
stop	JJ	O
codon	NN	O
.	.	O

These	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
this	DT	O
disorder	NN	O
can	MD	O
be	VB	O
caused	VBN	O
by	IN	O
defect	NN	O
(	(	O
s	JJ	O
)	)	O
of	IN	O
either	DT	O
an	DT	O
apoB	JJ	O
gene	NN	O
or	CC	O
other	JJ	O
genes	NNS	O
.	.	O
.	.	O

Localisation	NN	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
to	TO	O
between	IN	O
DXS7	NNP	O
and	CC	O
DXS426	NNP	O
on	IN	O
Xp	NNP	O
.	.	O

A	DT	O
highly	RB	O
informative	JJ	O
microsatellite	NN	O
marker	NN	O
,	,	O
DXS426	NNP	O
,	,	O
which	WDT	O
maps	VBZ	O
proximal	NN	O
to	TO	O
DXS7	NNP	O
in	IN	O
the	DT	O
interval	JJ	O
Xp11	NNP	O
.	.	O

4	CD	O
-	:	O
Xp11	NN	O
4	CD	O
-	:	O
Xp11	NN	O
.	.	O

23	CD	O
,	,	O
has	VBZ	O
been	VBN	O
used	VBN	O
to	TO	O
refine	VB	O
further	RB	O
the	DT	O
localisation	NN	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
(	(	O
NDP	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
results	NNS	O
from	IN	O
a	DT	O
multiply	NN	O
informative	JJ	O
crossover	NN	O
localize	VB	O
the	DT	O
NDP	NNP	S_Disease
gene	NN	O
proximal	NN	O
to	TO	O
DXS7	NNP	O
.	.	O

In	IN	O
conjunction	NN	O
with	IN	O
information	NN	O
from	IN	O
2	CD	O
NDP	NNP	S_Disease
patients	NNS	O
who	WP	O
have	VBP	O
a	DT	O
deletion	NN	O
for	IN	O
DXS7	NNP	O
but	CC	O
not	RB	O
for	IN	O
DSX426	NNP	O
,	,	O
our	PRP$	O
data	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
NDP	NNP	S_Disease
gene	NN	O
lies	VBZ	O
between	IN	O
DXS7	NNP	O
and	CC	O
DXS426	NNP	O
on	IN	O
proximal	JJ	O
Xp	NNP	O
.	.	O

Aberrant	JJ	O
splicing	NN	O
of	IN	O
phenylalanine	JJ	O
hydroxylase	NN	O
mRNA	NN	O
:	:	O
the	DT	O
major	JJ	O
cause	NN	O
for	IN	O
phenylketonuria	NN	S_Disease
in	IN	O
parts	NNS	O
of	IN	O
southern	JJ	O
Europe	NNP	O
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
mutation	NN	O
within	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	(	O
PAH	NNP	O
)	)	O
gene	NN	O
that	WDT	O
causes	VBZ	O
aberrant	JJ	O
splicing	NN	O
of	IN	O
the	DT	O
mRNA	NN	O
and	CC	O
that	DT	O
is	VBZ	O
in	IN	O
tight	JJ	O
association	NN	O
with	IN	O
chromosomal	JJ	O
haplotypes	NNS	O
6	CD	O
,	,	O
10	CD	O
,	,	O
and	CC	O
36	CD	O
.	.	O

Because	IN	O
of	IN	O
the	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
these	DT	O
particular	JJ	O
haplotypes	NNS	O
in	IN	O
Bulgaria	NNP	O
,	,	O
Italy	NNP	O
,	,	O
and	CC	O
Turkey	NNP	O
,	,	O
it	PRP	O
appears	VBZ	O
to	TO	O
be	VB	O
one	CD	O
of	IN	O
the	DT	O
more	RBR	O
frequent	JJ	O
defects	NNS	O
in	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
causing	VBG	O
classical	JJ	O
phenylketonuria	NN	S_Disease
in	IN	O
this	DT	O
part	NN	O
of	IN	O
Europe	NNP	O
.	.	O

The	DT	O
mutation	NN	O
is	VBZ	O
a	DT	O
G	NNP	O
to	TO	O
A	DT	O
transition	NN	O
at	IN	O
position	NN	O
546	CD	O
in	IN	O
intron	NN	O
10	CD	O
of	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
,	,	O
11	CD	O
bp	NN	O
upstream	NN	O
from	IN	O
the	DT	O
intron	NN	O
10	CD	O
/	NNP	O
exon	VBD	O
11	CD	O
boundary	NN	O
.	.	O

It	PRP	O
activates	VBZ	O
a	DT	O
cryptic	JJ	O
splice	NN	O
site	NN	O
and	CC	O
results	NNS	O
in	IN	O
an	DT	O
in	IN	O
-	:	O
frame	NN	O
insertion	NN	O
of	IN	O
9	CD	O
nucleotides	NNS	O
between	IN	O
exon	$	O
10	CD	O
and	CC	O
exon	$	O
11	CD	O
of	IN	O
the	DT	O
processed	JJ	O
mRNA	NN	O
.	.	O

Normal	JJ	O
amounts	NNS	O
of	IN	O
liver	NN	O
PAH	NNP	O
protein	NN	O
are	VBP	O
present	JJ	O
in	IN	O
homozygous	JJ	O
patients	NNS	O
,	,	O
but	CC	O
no	DT	O
catalytic	JJ	O
activity	NN	O
can	MD	O
be	VB	O
detected	VBN	O
.	.	O

This	DT	O
loss	NN	O
of	IN	O
enzyme	JJ	O
activity	NN	O
is	VBZ	O
probably	RB	O
caused	VBN	O
by	IN	O
conformational	JJ	O
changes	NNS	O
resulting	VBG	O
from	IN	O
the	DT	O
insertion	NN	O
of	IN	O
three	CD	O
additional	JJ	O
amino	NN	O
acids	NNS	O
(	(	O
Gly	NNP	O
-	:	O
Leu	NNP	O
-	:	O
Gln	NN	O
)	)	O
between	IN	O
the	DT	O
normal	JJ	O
sequences	NNS	O
encoded	VBN	O
by	IN	O
exon	JJ	O
10	CD	O
and	CC	O
exon	$	O
11	CD	O
.	.	O
.	.	O

Gardner	NNP	B_Disease
syndrome	NN	E_Disease
in	IN	O
a	DT	O
boy	NN	O
with	IN	O
interstitial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
.	.	O

We	PRP	O
described	VBD	O
a	DT	O
15	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
boy	NN	O
with	IN	O
Gardner	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
GS	NNP	S_Disease
)	)	O
,	,	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
and	CC	O
craniofacial	JJ	B_Disease
abnormalities	NNS	E_Disease
.	.	O

High	JJ	O
-	:	O
resolution	NN	O
banding	NN	O
analysis	NN	O
showed	VBD	O
an	DT	O
interstitial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
(	(	O
q22	NN	O
.	.	O

1	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
q31	NN	O
1	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
q31	NN	O
.	.	O

1	CD	O
)	)	O
.	.	O

The	DT	O
breakpoints	NNS	O
in	IN	O
the	DT	O
present	JJ	O
case	NN	O
and	CC	O
in	IN	O
3	CD	O
previously	RB	O
reported	VBD	O
5q	CD	O
-	:	O
patients	NNS	O
with	IN	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
suggest	VBP	O
that	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
GS	NNP	S_Disease
/	NNP	O
or	CC	O
familial	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
FPC	NNP	S_Disease
)	)	O
is	VBZ	O
in	IN	O
the	DT	O
5q22	CD	O
region	NN	O
,	,	O
a	DT	O
result	NN	O
consistent	NN	O
with	IN	O
the	DT	O
findings	NNS	O
of	IN	O
linkage	NN	O
studies	NNS	O

Huntington	NNP	B_Disease
disease	NN	E_Disease
and	CC	O
childhood	NN	O
-	:	O
onset	NN	O
Tourette	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O

A	DT	O
40	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
man	NN	O
with	IN	O
childhood	NN	O
-	:	O
onset	NN	O
Tourette	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
TS	NNP	S_Disease
)	)	O
developed	VBD	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
.	.	O

We	PRP	O
believe	VBP	O
this	DT	O
to	TO	O
be	VB	O
the	DT	O
first	JJ	O
reported	VBD	O
case	NN	O
of	IN	O
childhood	NN	O
-	:	O
onset	NN	O
TS	NNP	S_Disease
with	IN	O
adult	NN	O
onset	VBN	O
HD	NNP	S_Disease
.	.	O

Discovery	NN	O
of	IN	O
other	JJ	O
cases	NNS	O
with	IN	O
both	DT	O
disorders	NNS	O
may	MD	O
provide	VB	O
clues	NNS	O
to	TO	O
the	DT	O
pathophysiology	NN	O
of	IN	O
both	DT	O
conditions	NNS	O
.	.	O
.	.	O

Sequence	NN	O
of	IN	O
DNA	NNP	O
flanking	VBG	O
the	DT	O
exons	NNS	O
of	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
,	,	O
and	CC	O
identification	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
.	.	O

The	DT	O
rapid	JJ	O
identification	NN	O
of	IN	O
mutations	NNS	O
causing	VBG	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
requires	VBZ	O
the	DT	O
capacity	NN	O
to	TO	O
readily	RB	O
screen	VB	O
the	DT	O
regions	NNS	O
of	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
most	RBS	O
likely	JJ	O
to	TO	O
be	VB	O
affected	VBN	O
by	IN	O
mutation	NN	O
.	.	O

We	PRP	O
have	VBP	O
sequenced	VBN	O
the	DT	O
portions	NNS	O
of	IN	O
the	DT	O
introns	NNS	O
flanking	VBG	O
each	DT	O
of	IN	O
the	DT	O
14	CD	O
HEXA	NNP	O
exons	NNS	O
in	IN	O
order	NN	O
to	TO	O
specify	VB	O
oligonucleotide	JJ	O
primers	NNS	O
for	IN	O
the	DT	O
PCR	NNP	O
-	:	O
dependent	JJ	O
amplification	NN	O
of	IN	O
each	DT	O
exon	NN	O
and	CC	O
splice	NN	O
-	:	O
junction	NN	O
sequence	NN	O
.	.	O

The	DT	O
amplified	JJ	O
products	NNS	O
were	VBD	O
analyzed	VBN	O
,	,	O
by	IN	O
electrophoresis	NN	O
in	IN	O
nondenaturing	VBG	O
polyacrylamide	NN	O
gels	NNS	O
,	,	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
either	DT	O
heteroduplexes	NNS	O
,	,	O
derived	VBN	O
from	IN	O
the	DT	O
annealing	NN	O
of	IN	O
normal	JJ	O
and	CC	O
mutant	JJ	O
DNA	NNP	O
strands	NNS	O
,	,	O
or	CC	O
single	JJ	O
-	:	O
strand	NN	O
conformational	JJ	O
polymorphisms	NN	O
(	(	O
SSCP	NNP	O
)	)	O
,	,	O
derived	VBN	O
from	IN	O
the	DT	O
renaturation	NN	O
of	IN	O
single	JJ	O
-	:	O
stranded	VBD	O
DNA	NN	O
.	.	O

Five	CD	O
novel	JJ	O
mutations	NNS	O
from	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
patients	NNS	O
were	VBD	O
detected	VBN	O
a	DT	O
5	CD	O
-	:	O
bp	NN	O
deletion	NN	O
of	IN	O
TCTCC	NNP	O
in	IN	O
IVS	NNP	O
-	:	O
9	CD	O
;	:	O
a	DT	O
2	CD	O
-	:	O
bp	NN	O
deletion	NN	O
of	IN	O
TG	NNP	O
in	IN	O
exon	JJ	O
5	CD	O
;	:	O
G78	NNP	O
to	TO	O
A	NNP	O
,	,	O
giving	VBG	O
a	DT	O
stop	JJ	O
codon	NN	O
in	IN	O
exon	JJ	O
1	CD	O
;	:	O
G533	NNP	O
to	TO	O
T	NNP	O
in	IN	O
exon	JJ	O
5	CD	O
,	,	O
producing	VBG	O
the	DT	O
third	JJ	O
amino	NN	O
acid	JJ	O
substitution	NN	O
detected	VBN	O
at	IN	O
this	DT	O
site	NN	O
;	:	O
and	CC	O
G	NNP	O
to	TO	O
C	NNP	O
at	IN	O
position	NN	O
1	CD	O
of	IN	O
IVS	NNP	O
-	:	O
2	CD	O
,	,	O
expected	VBN	O
to	TO	O
produce	VB	O
abnormal	JJ	O
splicing	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
two	CD	O
mutations	NNS	O
,	,	O
(	(	O
G1496	NNP	O
to	TO	O
A	NNP	O
in	IN	O
exon	JJ	O
13	CD	O
and	CC	O
a	DT	O
4	CD	O
-	:	O
bp	NN	O
insertion	NN	O
in	IN	O
exon	$	O
11	CD	O
)	)	O
that	WDT	O
have	VBP	O
previously	RB	O
been	VBN	O
reported	VBN	O
were	VBD	O
identified	VBN	O
.	.	O
.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
two	CD	O
galactosemia	JJ	S_Disease
mutations	NNS	O
:	:	O
correlation	NN	O
of	IN	O
mutations	NNS	O
with	IN	O
highly	RB	O
conserved	VBN	O
domains	NNS	O
in	IN	O
galactose	JJ	O
-	:	O
1	CD	O
-	:	O
phosphate	NN	O
uridyl	JJ	O
transferase	NN	O
.	.	O

Galactosemia	NNP	S_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	I_Disease
of	IN	I_Disease
human	JJ	I_Disease
galactose	JJ	I_Disease
metabolism	NN	E_Disease
caused	VBN	O
by	IN	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
enzyme	NN	I_Disease
galactose	VBD	I_Disease
-	:	I_Disease
1	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
uridyl	JJ	I_Disease
transferase	NN	E_Disease
(	(	O
GALT	NNP	O
)	)	O
.	.	O

The	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
this	DT	O
disorder	NN	O
is	VBZ	O
at	IN	O
present	JJ	O
not	RB	O
well	RB	O
understood	RB	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
two	CD	O
missense	NN	O
mutations	NNS	O
which	WDT	O
result	VBP	O
in	IN	O
low	JJ	O
or	CC	O
undetectable	JJ	O
enzymatic	JJ	O
activity	NN	O
.	.	O

First	RB	O
,	,	O
we	PRP	O
identified	VBD	O
at	IN	O
nucleotide	RB	O
591	CD	O
a	DT	O
transition	NN	O
which	WDT	O
substitutes	VBZ	O
glutamine	VBP	O
188	CD	O
by	IN	O
arginine	NN	O
.	.	O

The	DT	O
mutated	JJ	O
glutamine	NN	O
is	VBZ	O
not	RB	O
only	RB	O
highly	RB	O
conserved	VBN	O
in	IN	O
evolution	NN	O
(	(	O
conserved	VBN	O
also	RB	O
in	IN	O
Escherichia	NNP	O
coli	NN	O
and	CC	O
Saccharomyces	NNP	O
cerevisiae	NN	O
)	)	O
,	,	O
but	CC	O
is	VBZ	O
also	RB	O
two	CD	O
amino	JJ	O
acid	NN	O
residues	NNS	O
downstream	VBP	O
from	IN	O
the	DT	O
active	JJ	O
site	NN	O
histidine	NN	O
-	:	O
proline	NN	O
-	:	O
histidine	NN	O
triad	NN	O
and	CC	O
results	NNS	O
in	IN	O
about	RB	O
10	CD	O
%	NN	O
of	IN	O
normal	JJ	O
enzymatic	JJ	O
activity	NN	O
.	.	O

The	DT	O
arginine	NN	O
188	CD	O
mutation	NN	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
galactosemia	NN	S_Disease
mutation	NN	O
characterized	VBN	O
to	TO	O
date	NN	O
.	.	O

It	PRP	O
accounts	VBZ	O
for	IN	O
one	CD	O
-	:	O
fourth	JJ	O
of	IN	O
the	DT	O
galactosemia	NN	S_Disease
alleles	VBZ	O
studied	VBN	O
.	.	O

Second	JJ	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
substitution	NN	O
of	IN	O
arginine	JJ	O
333	CD	O
by	IN	O
tryptophan	NN	O
,	,	O
caused	VBN	O
by	IN	O
a	DT	O
transition	NN	O
at	IN	O
nucleotide	JJ	O
1025	CD	O
.	.	O

The	DT	O
area	NN	O
surrounding	VBG	O
this	DT	O
missense	NN	O
mutation	NN	O
is	VBZ	O
the	DT	O
most	RBS	O
highly	RB	O
conserved	JJ	O
domain	NN	O
in	IN	O
the	DT	O
homologous	JJ	O
enzymes	NNS	O
from	IN	O
E	NNP	O
.	.	O

coli	NNS	O
,	,	O
yeast	NN	O
,	,	O
and	CC	O
humans	NNS	O
,	,	O
and	CC	O
this	DT	O
mutation	NN	O
results	NNS	O
in	IN	O
undetectable	JJ	O
enzymatic	JJ	O
activity	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
is	VBZ	O
a	DT	O
severe	JJ	O
mutation	NN	O
.	.	O

This	DT	O
second	JJ	O
mutation	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
rare	JJ	O
,	,	O
since	IN	O
it	PRP	O
was	VBD	O
found	VBN	O
only	RB	O
in	IN	O
the	DT	O
patient	NN	O
we	PRP	O
sequenced	VBD	O
.	.	O

Our	PRP$	O
data	NNS	O
provide	VB	O
further	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
heterogeneity	NN	O
of	IN	O
galactosemia	NN	S_Disease
at	IN	O
the	DT	O
molecular	JJ	O
level	NN	O
,	,	O
heterogeneity	NN	O
which	WDT	O
might	MD	O
be	VB	O
related	VBN	O
to	TO	O
the	DT	O
variable	JJ	O
clinical	JJ	O
outcome	NN	O
observed	VBN	O
in	IN	O
this	DT	O
disorder	NN	O
.	.	O
.	.	O

Hypoxanthine	NNP	B_Disease
-	:	I_Disease
guanine	NN	I_Disease
phosphoribosyltransferase	NN	I_Disease
deficiency	NN	E_Disease
:	:	O
analysis	NN	O
of	IN	O
HPRT	NNP	O
mutations	NNS	O
by	IN	O
direct	JJ	O
sequencing	NN	O
and	CC	O
allele	VB	O
-	:	O
specific	JJ	O
amplification	NN	O
.	.	O

The	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
severe	JJ	O
X	NNP	B_Disease
chromosome	NN	I_Disease
-	:	I_Disease
linked	VBN	I_Disease
human	JJ	I_Disease
disease	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
virtual	JJ	O
absence	NN	B_Disease
of	IN	I_Disease
hypoxanthine	NN	I_Disease
-	:	I_Disease
guanine	NN	I_Disease
phosphoribosyltransferase	NN	I_Disease
(	(	I_Disease
HPRT	NNP	I_Disease
)	)	I_Disease
activity	NN	E_Disease
.	.	O

A	DT	O
partial	JJ	O
deficiency	NN	O
in	IN	O
the	DT	O
activity	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
can	MD	O
result	VB	O
in	IN	O
gouty	NN	B_Disease
arthritis	NN	E_Disease
.	.	O

To	TO	O
determine	VB	O
the	DT	O
genetic	JJ	O
basis	NN	O
for	IN	O
reduction	NN	O
or	CC	O
loss	NN	O
of	IN	O
enzyme	JJ	O
activity	NN	O
,	,	O
we	PRP	O
have	VBP	O
amplified	VBN	O
and	CC	O
sequenced	VBD	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
HPRT	NNP	O
cDNA	NN	O
from	IN	O
four	CD	O
patients	NNS	O
one	CD	O
with	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
HPRTPerth	NNP	O
)	)	O
and	CC	O
three	CD	O
with	IN	O
partial	JJ	B_Disease
deficiencies	NNS	I_Disease
of	IN	I_Disease
HPRT	NNP	I_Disease
activity	NN	E_Disease
,	,	O
which	WDT	O
have	VBP	O
been	VBN	O
designated	VBN	O
HPRTUrangan	NNP	O
,	,	O
HPRTSwan	NNP	O
and	CC	O
HPRTToowong	NNP	O
.	.	O

In	IN	O
all	DT	O
four	CD	O
patients	NNS	O
,	,	O
the	DT	O
only	JJ	O
mutation	NN	O
identified	VBN	O
was	VBD	O
a	DT	O
single	JJ	O
base	NN	O
substitution	NN	O
in	IN	O
exons	NNS	O
2	CD	O
or	CC	O
3	CD	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
,	,	O
which	WDT	O
in	IN	O
each	DT	O
case	NN	O
predicts	VBZ	O
a	DT	O
single	JJ	O
amino	NN	O
acid	JJ	O
substitution	NN	O
in	IN	O
the	DT	O
translated	JJ	O
protein	NN	O
.	.	O

Each	DT	O
base	NN	O
change	NN	O
was	VBD	O
confirmed	VBN	O
by	IN	O
allele	NN	O
-	:	O
specific	JJ	O
amplification	NN	O
of	IN	O
the	DT	O
patients	NNS	O
genomic	JJ	O
DNA	NNP	O
.	.	O

It	PRP	O
is	VBZ	O
interesting	VBG	O
to	TO	O
note	VB	O
that	IN	O
the	DT	O
mutation	NN	O
found	VBD	O
for	IN	O
HPRTPerth	NNP	O
is	VBZ	O
identical	JJ	O
to	TO	O
that	DT	O
reported	VBD	O
for	IN	O
HPRTFlint	NNP	O
.	.	O

It	PRP	O
appears	VBZ	O
that	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
are	VBP	O
de	JJ	O
novo	JJ	O
events	NNS	O
.	.	O
.	.	O

Molecular	JJ	O
and	CC	O
metabolic	JJ	O
basis	NN	O
for	IN	O
the	DT	O
metabolic	JJ	B_Disease
disorder	NN	E_Disease
normotriglyceridemic	JJ	B_Disease
abetalipoproteinemia	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
described	VBN	O
a	DT	O
disorder	NN	O
,	,	O
normotriglyceridemic	JJ	B_Disease
abetalipoproteinemia	NN	E_Disease
,	,	O
that	WDT	O
is	VBZ	O
characterized	VBN	O
by	IN	O
the	DT	O
virtual	JJ	O
absence	NN	O
of	IN	O
plasma	NN	O
low	JJ	O
density	NN	O
lipoproteins	NNS	O
and	CC	O
complete	JJ	O
absence	NN	O
of	IN	O
apoB	JJ	O
-	:	O
100	CD	O
,	,	O
but	CC	O
with	IN	O
apparently	RB	O
normal	JJ	O
secretion	NN	O
of	IN	O
triglyceride	JJ	O
-	:	O
rich	JJ	O
lipoproteins	VBZ	O
containing	VBG	O
apoB	SYM	O
-	:	O
48	CD	O
.	.	O

The	DT	O
patients	NNS	O
plasma	VBP	O
lipoproteins	NNS	O
were	VBD	O
shown	VBN	O
on	IN	O
polyacrylamide	NN	O
gels	NNS	O
and	CC	O
by	IN	O
antibody	NN	O
mapping	NN	O
to	TO	O
have	VB	O
a	DT	O
new	JJ	O
truncated	VBN	O
apoB	NN	O
variant	NN	O
,	,	O
apoB	SYM	O
-	:	O
50	CD	O
,	,	O
circulating	VBG	O
along	RB	O
with	IN	O
her	PRP$	O
apoB	JJ	O
-	:	O
48	CD	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
this	DT	O
individual	NN	O
to	TO	O
be	VB	O
homozygous	JJ	O
for	IN	O
a	DT	O
single	JJ	O
C	NNP	O
-	:	O
to	TO	O
-	:	O
T	NNP	O
nucleotide	JJ	O
substitution	NN	O
at	IN	O
apoB	NN	O
codon	NN	O
2252	CD	O
,	,	O
which	WDT	O
produces	VBZ	O
a	DT	O
premature	NN	O
in	IN	O
-	:	O
frame	NN	O
stop	JJ	O
codon	NN	O
.	.	O

Thus	RB	O
,	,	O
this	DT	O
is	VBZ	O
a	DT	O
rare	JJ	O
example	NN	O
of	IN	O
homozygous	JJ	B_Disease
hypobetalipoproteinemia	NN	E_Disease
.	.	O

Electron	NNP	O
photomicrographs	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
diameters	NNS	O
of	IN	O
particles	NNS	O
in	IN	O
the	DT	O
d	NN	O
less	JJR	O
than	IN	O
1	CD	O
.	.	O

006	CD	O
g	JJ	O
/	NNP	O
ml	NN	O
lipoprotein	NN	O
fraction	NN	O
,	,	O
in	IN	O
both	DT	O
the	DT	O
postprandial	NN	O
and	CC	O
postabsorptive	JJ	O
state	NN	O
,	,	O
are	VBP	O
bimodally	RB	O
distributed	VBN	O
.	.	O

The	DT	O
molar	JJ	O
ratio	NN	O
of	IN	O
apoE	NN	O
to	TO	O
apoB	VB	O
in	IN	O
these	DT	O
particles	NNS	O
is	VBZ	O
3	CD	O
.	.	O

5	CD	O
1	CD	O
,	,	O
similar	JJ	O
to	TO	O
normal	JJ	O
VLDL	NNP	O
.	.	O

The	DT	O
plasma	NN	O
LDL	NNP	O
interval	NN	O
contains	VBZ	O
both	DT	O
spherical	JJ	O
and	CC	O
cuboidal	JJ	O
particles	NNS	O
.	.	O

Autologous	JJ	O
reinfusion	NN	O
of	IN	O
labeled	JJ	O
d	NN	O
less	JJR	O
than	IN	O
1	CD	O
.	.	O

006	CD	O
g	JJ	O
/	NNP	O
ml	NN	O
lipoproteins	VBZ	O
showed	VBN	O
exponential	JJ	O
disappearance	NN	O
from	IN	O
plasma	NN	O
,	,	O
with	IN	O
an	DT	O
apparent	JJ	O
half	NN	O
-	:	O
removal	JJ	O
time	NN	O
of	IN	O
50	CD	O
min	NNS	O
,	,	O
somewhat	RB	O
slower	JJR	O
than	IN	O
for	IN	O
normal	JJ	O
chylomicrons	NNS	O
but	CC	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
for	IN	O
VLDL	NNP	O
.	.	O

The	DT	O
calculated	JJ	O
production	NN	O
rate	NN	O
for	IN	O
apoB	NN	O
was	VBD	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
in	IN	O
this	DT	O
subject	NN	O
.	.	O

A	DT	O
single	JJ	O
origin	NN	O
of	IN	O
phenylketonuria	NN	S_Disease
in	IN	O
Yemenite	NNP	O
Jews	NNPS	O
.	.	O

Phenylketonuria	NNP	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
metabolic	JJ	B_Disease
disease	NN	E_Disease
caused	VBN	O
by	IN	O
recessive	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
hepatic	JJ	O
enzyme	NN	O
phenylalanine	NN	O
hydroxylase	NN	O
(	(	O
PAH	NNP	O
)	)	O
.	.	O

The	DT	O
incidence	NN	O
of	IN	O
PKU	NNP	S_Disease
varies	NNS	O
widely	RB	O
across	IN	O
different	JJ	O
geographic	JJ	O
areas	NNS	O
,	,	O
and	CC	O
is	VBZ	O
highest	JJS	O
(	(	O
about	IN	O
1	CD	O
in	IN	O
5	CD	O
,	,	O
000	CD	O
live	JJ	O
births	NNS	O
)	)	O
in	IN	O
Ireland	NNP	O
and	CC	O
western	JJ	O
Scotland	NNP	O
,	,	O
and	CC	O
among	IN	O
Yemenite	JJ	O
Jews	NNPS	O
.	.	O

A	DT	O
limited	JJ	O
number	NN	O
of	IN	O
point	NN	O
mutations	NNS	O
account	VBP	O
for	IN	O
most	JJS	O
of	IN	O
the	DT	O
PKU	NNP	S_Disease
cases	NNS	O
in	IN	O
the	DT	O
European	JJ	O
population	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
a	DT	O
single	JJ	O
molecular	NN	O
defect	NN	O
-	:	O
-	:	O
a	DT	O
deletion	NN	O
spanning	VBG	O
the	DT	O
third	JJ	O
exon	NN	O
of	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
-	:	O
-	:	O
is	VBZ	O
responsible	JJ	O
for	IN	O
all	PDT	O
the	DT	O
PKU	NNP	S_Disease
cases	NNS	O
among	IN	O
the	DT	O
Yemenite	NNP	O
Jews	NNPS	O
.	.	O

Examination	NN	O
of	IN	O
a	DT	O
random	JJ	O
sample	NN	O
of	IN	O
Yemenite	NNP	O
Jews	NNPS	O
using	VBG	O
a	DT	O
molecular	JJ	O
probe	NN	O
that	WDT	O
detects	VBZ	O
the	DT	O
carriers	NNS	O
of	IN	O
this	DT	O
deletion	NN	O
indicated	VBD	O
a	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
the	DT	O
defective	JJ	O
gene	NN	O
in	IN	O
this	DT	O
community	NN	O
.	.	O

Although	IN	O
the	DT	O
deleted	JJ	O
PAH	NNP	O
gene	NN	O
was	VBD	O
traced	VBN	O
to	TO	O
25	CD	O
different	JJ	O
locations	NNS	O
throughout	IN	O
Yemen	NNP	O
,	,	O
family	NN	O
histories	NNS	O
and	CC	O
official	JJ	O
documents	NNS	O
of	IN	O
the	DT	O
Yemenite	NNP	O
Jewish	NNP	O
community	NN	O
showed	VBD	O
that	IN	O
the	DT	O
common	JJ	O
ancestor	NN	O
of	IN	O
all	PDT	O
the	DT	O
carriers	NNS	O
of	IN	O
this	DT	O
genetic	JJ	B_Disease
defect	NN	E_Disease
lived	VBN	O
in	IN	O
Sana	NNP	O
,	,	O
the	DT	O
capital	NN	O
of	IN	O
Yemen	NNP	O
,	,	O
before	IN	O
the	DT	O
eighteenth	JJ	O
century	NN	O
.	.	O
.	.	O

Linkage	NN	O
of	IN	O
aspartylglucosaminuria	NN	S_Disease
(	(	O
AGU	NNP	S_Disease
)	)	O
to	TO	O
marker	VB	O
loci	NN	O
on	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
4	CD	O
.	.	O

Aspartylglucosaminuria	NNP	S_Disease
(	(	O
AGU	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
deficient	JJ	O
activity	NN	O
of	IN	O
the	DT	O
enzyme	JJ	O
aspartylglucosaminidase	NN	O
(	(	O
AGA	NNP	O
)	)	O
.	.	O

The	DT	O
structural	JJ	O
gene	NN	O
for	IN	O
AGA	NNP	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
to	TO	O
the	DT	O
region	NN	O
4q21	CD	O
-	:	O
qter	NN	O
of	IN	O
chromosome	NN	O
4	CD	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
the	DT	O
map	JJ	O
position	NN	O
of	IN	O
the	DT	O
AGU	NNP	O
locus	NN	O
in	IN	O
relation	NN	O
to	TO	O
other	JJ	O
marker	NN	O
loci	NN	O
on	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
4	CD	O
using	VBG	O
linkage	NN	O
analyses	NNS	O
.	.	O

Restriction	NNP	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
alleles	NNS	O
for	IN	O
the	DT	O
ADH2	NNP	O
,	,	O
ADH3	NNP	O
,	,	O
EGF	NNP	O
,	,	O
FG	NNP	O
alpha	NN	O
and	CC	O
FG	NNP	O
beta	NN	O
loci	NN	O
and	CC	O
blood	NN	O
group	NN	O
antigens	VBZ	O
for	IN	O
the	DT	O
MNS	NNP	O
locus	NN	O
were	VBD	O
determined	VBN	O
in	IN	O
a	DT	O
panel	NN	O
of	IN	O
12	CD	O
Finnish	JJ	O
AGU	NNP	S_Disease
families	NNS	O
.	.	O

The	DT	O
heterozygous	JJ	O
family	NN	O
members	NNS	O
were	VBD	O
identified	VBN	O
by	IN	O
reduced	JJ	O
activity	NN	O
of	IN	O
AGA	NNP	O
in	IN	O
lymphocytes	NNS	O
.	.	O

Linkage	NN	O
studies	NNS	O
were	VBD	O
performed	VBN	O
using	VBG	O
both	DT	O
pairwise	NN	O
and	CC	O
multipoint	NN	O
analyses	NNS	O
.	.	O

Loose	JJ	O
linkage	NN	O
of	IN	O
the	DT	O
AGU	NNP	S_Disease
locus	NN	O
to	TO	O
the	DT	O
FG	NNP	O
and	CC	O
MNS	NNP	O
loci	NN	O
was	VBD	O
observed	VBN	O
(	(	O
z	JJ	O
=	NN	O
1	CD	O
.	.	O

16	CD	O
,	,	O
z	NN	O
=	VBD	O
1	CD	O
.	.	O

39	CD	O
,	,	O
respectively	RB	O
)	)	O
.	.	O

Multipoint	NN	O
analysis	NN	O
to	TO	O
the	DT	O
fixed	VBN	O
map	NN	O
[	NN	O
ADH	NNP	O
-	:	O
(	(	O
0	CD	O
.	.	O

03	CD	O
)	)	O
-	:	O
EGF	SYM	O
-	:	O
(	(	O
0	CD	O
.	.	O

35	CD	O
)	)	O
-	:	O
FG	NNP	O
-	:	O
(	(	O
0	CD	O
.	.	O

11	CD	O
)	)	O
-	:	O
MNS	NNP	O
]	NNP	O
suggests	VBZ	O
that	IN	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
AGU	NNP	O
locus	NN	O
is	VBZ	O
0	CD	O
.	.	O

05	CD	O
-	:	O
0	CD	O
.	.	O

30	CD	O
recombination	NN	O
units	NNS	O
distal	VBP	O
to	TO	O
MNS	NNP	O
(	(	O
z	NNP	O
=	VBZ	O
3	CD	O
.	.	O

03	CD	O
)	)	O
.	.	O

The	DT	O
order	NN	O
cen	SYM	O
-	:	O
ADH	NNP	O
-	:	O
EGF	NNP	O
-	:	O
FG	NNP	O
-	:	O
MNS	NNP	O
-	:	O
AGU	NNP	O
is	VBZ	O
35	CD	O
times	NNS	O
more	RBR	O
likely	JJ	O
than	IN	O
the	DT	O
next	JJ	O
best	JJS	O
order	NN	O
cen	NN	O
-	:	O
ADH	NNP	O
-	:	O
EGF	NNP	O
-	:	O
AGU	NNP	O
-	:	O
FG	NNP	O
-	:	O
MNS	NN	O
.	.	O

Linkage	JJ	O
relationships	NNS	O
of	IN	O
the	DT	O
apolipoprotein	NN	O
C1	NNP	O
gene	NN	O
and	CC	O
a	DT	O
cytochrome	JJ	O
P450	NNP	O
gene	NN	O
(	(	O
CYP2A	NNP	O
)	)	O
to	TO	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
the	DT	O
genetic	JJ	O
linkage	NN	O
of	IN	O
two	CD	O
markers	NNS	O
,	,	O
the	DT	O
apolipoprotein	NN	O
C1	NNP	O
(	(	O
APOC1	NNP	O
)	)	O
gene	NN	O
and	CC	O
a	DT	O
cytochrome	JJ	O
P450	NNP	O
(	(	O
CYP2A	NNP	O
)	)	O
gene	NN	O
,	,	O
in	IN	O
relation	NN	O
to	TO	O
the	DT	O
gene	NN	O
for	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
.	.	O

A	DT	O
peak	JJ	O
lod	NN	O
score	NN	O
of	IN	O
9	CD	O
.	.	O

29	CD	O
at	IN	O
2	CD	O
cM	NN	O
was	VBD	O
observed	VBN	O
for	IN	O
APOC1	NNP	O
-	:	O
DM	NNP	O
,	,	O
with	IN	O
a	DT	O
lod	JJ	O
score	NN	O
of	IN	O
8	CD	O
.	.	O

55	CD	O
at	IN	O
4	CD	O
cM	NN	O
for	IN	O
CYP2A	NNP	O
-	:	O
DM	NN	O
.	.	O

These	DT	O
two	CD	O
markers	NNS	O
also	RB	O
show	VBP	O
close	JJ	O
linkage	NN	O
to	TO	O
each	DT	O
other	JJ	O
(	(	O
theta	JJ	O
max	NN	O
=	VBD	O
0	CD	O
.	.	O

05	CD	O
,	,	O
Zmax	NNP	O
=	VBZ	O
9	CD	O
.	.	O

09	CD	O
)	)	O
.	.	O

From	IN	O
examination	NN	O
of	IN	O
the	DT	O
genotypes	NNS	O
of	IN	O
the	DT	O
recombinant	JJ	O
individuals	NNS	O
,	,	O
CYP2A	NNP	O
appears	VBZ	O
to	TO	O
map	VB	O
proximal	JJ	O
to	TO	O
DM	NNP	O
because	IN	O
in	IN	O
one	CD	O
recombinant	JJ	O
individual	JJ	O
CYP2A	NNP	O
,	,	O
APOC2	NNP	O
and	CC	O
CKMM	NNP	O
had	VBD	O
all	DT	O
recombined	VBN	O
with	IN	O
DM	NNP	O
.	.	O

Evidence	NN	O
from	IN	O
another	DT	O
CYP2A	NNP	O
-	:	O
DM	NNP	O
recombinant	JJ	O
individual	JJ	O
places	NNS	O
CYP2A	NNP	O
proximal	NN	O
to	TO	O
APOC2	NNP	O
and	CC	O
CKMM	NNP	O
.	.	O

Localisation	NN	O
of	IN	O
CYP2A	NNP	O
on	IN	O
a	DT	O
panel	NN	O
of	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
also	RB	O
suggests	VBZ	O
that	IN	O
it	PRP	O
is	VBZ	O
proximal	JJ	O
to	TO	O
DM	NNP	O
and	CC	O
APOC2	NNP	O
/	NNP	O
C1	NNP	O
/	NNP	O
E	NNP	O
gene	NN	O
cluster	NN	O
.	.	O

Genetic	JJ	O
linkage	NN	O
map	NN	O
of	IN	O
six	CD	O
polymorphic	JJ	O
DNA	NN	O
markers	NNS	O
around	IN	O
the	DT	O
gene	NN	O
for	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
on	IN	O
chromosome	NN	O
5	CD	O
.	.	O

A	DT	O
genetic	JJ	O
linkage	NN	O
map	NN	O
of	IN	O
six	CD	O
polymorphic	JJ	O
DNA	NNP	O
markers	NNS	O
close	RB	O
to	TO	O
the	DT	O
gene	NN	O
(	(	O
APC	NNP	O
)	)	O
for	IN	O
familial	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
on	IN	O
chromosome	NN	O
5q	CD	O
is	VBZ	O
reported	VBN	O
.	.	O

One	CD	O
hundred	CD	O
fifty	SYM	O
-	:	O
five	CD	O
typed	VBD	O
members	NNS	O
of	IN	O
nine	CD	O
FAP	NNP	S_Disease
kindred	VBD	O
provided	VBD	O
more	JJR	O
than	IN	O
90	CD	O
meioses	NNS	O
for	IN	O
linkage	NN	O
analysis	NN	O
.	.	O

A	DT	O
number	NN	O
of	IN	O
crucial	JJ	O
recombination	NN	O
events	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
which	WDT	O
are	VBP	O
informative	JJ	O
at	IN	O
three	CD	O
or	CC	O
more	JJR	O
loci	NNS	O
,	,	O
allowing	VBG	O
confident	JJ	O
ordering	NN	O
of	IN	O
parts	NNS	O
of	IN	O
the	DT	O
map	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
genetic	JJ	O
heterogeneity	NN	O
,	,	O
with	IN	O
all	DT	O
families	NNS	O
showing	VBG	O
linkage	NN	O
of	IN	O
at	IN	O
least	JJS	O
one	CD	O
chromosome	NN	O
5	CD	O
marker	NN	O
to	TO	O
the	DT	O
gene	NN	O
.	.	O

Recombination	NNP	O
data	NNS	O
and	CC	O
two	CD	O
-	:	O
point	NN	O
linkage	NN	O
analysis	NN	O
support	NN	O
a	DT	O
locus	NN	O
order	NN	O
of	IN	O
centromere	JJ	O
-	:	O
pi	NN	O
227	CD	O
-	:	O
C11P11	NNP	O
-	:	O
ECB27	NNP	O
-	:	O
L5	NN	O
.	.	O

62	CD	O
-	:	O
APC	NNP	O
-	:	O
EF5	NN	O
62	CD	O
-	:	O
APC	NNP	O
-	:	O
EF5	NN	O
.	.	O

44	CD	O
-	:	O
YN5	NN	O
44	CD	O
-	:	O
YN5	NN	O
.	.	O

48	CD	O
-	:	O
telomer	NN	O
e	NN	O
,	,	O
although	IN	O
EF5	NNP	O
.	.	O

44	CD	O
could	MD	O
lie	VB	O
in	IN	O
the	DT	O
interval	JJ	O
L5	NNP	O
.	.	O

62	CD	O
-	:	O
APC	NN	O
or	CC	O
ECB27	NNP	O
-	:	O
L5	NN	O
.	.	O

62	CD	O
.	.	O

No	DT	O
recombinants	NNS	O
were	VBD	O
identified	VBN	O
between	IN	O
APC	NNP	O
and	CC	O
either	DT	O
EF5	NNP	O
.	.	O

44	CD	O
or	CC	O
YN5	NNP	O
.	.	O

48	CD	O
,	,	O
but	CC	O
published	VBN	O
deletion	NN	O
mapping	NN	O
in	IN	O
colorectal	JJ	B_Disease
carcinomas	NN	E_Disease
and	CC	O
linkage	NN	O
analysis	NN	O
in	IN	O
FAP	NNP	S_Disease
suggest	VBP	O
that	IN	O
YN5	NNP	O
.	.	O

48	CD	O
is	VBZ	O
1	CD	O
-	:	O
3	CD	O
cM	NN	O
from	IN	O
APC	NNP	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
suggests	VBZ	O
that	IN	O
YN5	NNP	O
.	.	O

48	CD	O
and	CC	O
L5	NNP	O
.	.	O

62	CD	O
delineate	NN	O
a	DT	O
small	JJ	O
region	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
within	IN	O
which	WDT	O
the	DT	O
EF5	NNP	O
.	.	O

44	CD	O
locus	NN	O
lies	VBZ	O
very	RB	O
close	RB	O
to	TO	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
.	.	O

These	DT	O
data	NNS	O
not	RB	O
only	RB	O
allow	VB	O
use	NN	O
of	IN	O
flanking	VBG	O
markers	NNS	O
for	IN	O
presymptomatic	JJ	O
diagnosis	NN	O
of	IN	O
FAP	NNP	S_Disease
but	CC	O
also	RB	O
provide	VBP	O
a	DT	O
high	JJ	O
-	:	O
density	NN	O
map	NN	O
of	IN	O
the	DT	O
region	NN	O
for	IN	O
isolation	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
itself	PRP	O
and	CC	O
for	IN	O
further	JJ	O
assessment	NN	O
of	IN	O
the	DT	O
role	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
deletions	NNS	O
in	IN	O
the	DT	O
biology	NN	O
of	IN	O
sporadic	JJ	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Serum	NNP	O
amyloid	VBZ	O
A	NNP	O
and	CC	O
P	NNP	O
protein	VBP	O
genes	NNS	O
in	IN	O
familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
.	.	O

Two	CD	O
recent	JJ	O
studies	NNS	O
have	VBP	O
suggested	VBN	O
the	DT	O
involvement	NN	O
of	IN	O
serum	NN	O
amyloid	NN	O
A	NNP	O
(	(	O
SAA	NNP	O
)	)	O
and	CC	O
P	NNP	O
(	(	O
APCS	NNP	O
)	)	O
genes	NNS	O
in	IN	O
familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
(	(	O
MEF	NNP	S_Disease
)	)	O
.	.	O

To	TO	O
test	VB	O
the	DT	O
role	NN	O
of	IN	O
SAA	NNP	O
and	CC	O
APCS	NNP	O
in	IN	O
MEF	NNP	S_Disease
and	CC	O
MEF	NNP	B_Disease
-	:	I_Disease
amyloidosis	NN	E_Disease
,	,	O
we	PRP	O
studied	VBD	O
17	CD	O
informative	JJ	O
families	NNS	O
(	(	O
15	CD	O
Armenians	NNPS	O
,	,	O
2	CD	O
non	SYM	O
-	:	O
Ashkenazi	NNP	O
Jews	NNPS	O
)	)	O
and	CC	O
8	CD	O
MEF	NNP	S_Disease
patients	NNS	O
with	IN	O
amyloidosis	NN	S_Disease
using	VBG	O
a	DT	O
candidate	NN	O
gene	NN	O
approach	NN	O
.	.	O

No	DT	O
evidence	NN	O
for	IN	O
any	DT	O
MEF	NNP	S_Disease
-	:	O
associated	VBD	O
polymorphism	NN	O
was	VBD	O
found	VBN	O
in	IN	O
any	DT	O
of	IN	O
the	DT	O
41	CD	O
Armenian	JJ	O
and	CC	O
Jewish	JJ	O
MEF	NNP	S_Disease
patients	NNS	O
tested	VBD	O
.	.	O

Our	PRP$	O
family	NN	O
studies	NNS	O
allowed	VBD	O
us	PRP	O
to	TO	O
rule	VB	O
out	RP	O
tight	JJ	O
linkage	NN	O
between	IN	O
SAA	NNP	O
and	CC	O
MEF	NNP	S_Disease
(	(	O
lod	JJ	O
score	NN	O
=	NNP	O
-	:	O
2	CD	O
.	.	O

16	CD	O
,	,	O
theta	NN	O
less	JJR	O
than	IN	O
or	CC	O
equal	JJ	O
to	TO	O
0	CD	O
.	.	O

06	CD	O
)	)	O
.	.	O

For	IN	O
APCS	NNP	O
we	PRP	O
found	VBD	O
that	IN	O
the	DT	O
allele	JJ	O
frequency	NN	O
in	IN	O
the	DT	O
MEF	NNP	B_Disease
-	:	I_Disease
amyloidosis	NN	E_Disease
patients	NNS	O
was	VBD	O
similar	JJ	O
to	TO	O
that	DT	O
in	IN	O
18	CD	O
unrelated	JJ	O
MEF	NNP	S_Disease
patients	NNS	O
without	IN	O
amyloidosis	NN	S_Disease
and	CC	O
their	PRP$	O
33	CD	O
healthy	JJ	O
parents	NNS	O
.	.	O

Some	DT	O
Mexican	NNP	O
glucose	VBD	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
variants	NNS	O
revisited	VBD	O
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
appears	VBZ	O
to	TO	O
be	VB	O
fairly	RB	O
common	JJ	O
in	IN	O
Mexico	NNP	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
examined	VBN	O
the	DT	O
DNA	NN	O
of	IN	O
three	CD	O
previously	RB	O
reported	VBN	O
electrophoretically	RB	O
fast	JJ	O
Mexican	NNP	O
G6PD	NNP	O
variants	NNS	O
,	,	O
-	:	O
G6PD	NNP	O
Distrito	NNP	O
Federal	NNP	O
,	,	O
G6PD	NNP	O
Tepic	NNP	O
,	,	O
and	CC	O
G6PD	NNP	O
Castilla	NNP	O
.	.	O

All	DT	O
three	CD	O
of	IN	O
these	DT	O
variants	NNS	O
,	,	O
believed	VBN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
biochemical	JJ	O
characterization	NN	O
and	CC	O
population	NN	O
origin	NN	O
to	TO	O
be	VB	O
unique	JJ	O
,	,	O
have	VBP	O
the	DT	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
A	DT	O
transition	NN	O
at	IN	O
nucleotide	JJ	O
202	CD	O
and	CC	O
the	DT	O
A	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
G	JJ	O
transition	NN	O
at	IN	O
nucleotide	JJ	O
376	CD	O
,	,	O
mutations	NNS	O
that	IN	O
we	PRP	O
now	RB	O
recognize	VBP	O
to	TO	O
be	VB	O
characteristic	JJ	O
of	IN	O
G6PD	NNP	O
A	NNP	O
-	:	O
.	.	O

Two	CD	O
other	JJ	O
Mexican	JJ	O
males	NNS	O
with	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
the	DT	O
same	JJ	O
mutation	NN	O
.	.	O

All	DT	O
five	CD	O
have	VBP	O
the	DT	O
(	(	O
NlaIII	NNP	O
/	NNP	O
FokI	NNP	O
/	NNP	O
PvuII	NNP	O
/	NNP	O
PstI	NNP	O
)	)	O
haplotype	VBD	O
characteristic	JJ	O
of	IN	O
G6PD	NNP	O
A	NNP	O
-	:	O
in	IN	O
Africa	NNP	O
.	.	O

Since	IN	O
the	DT	O
PvuII	NNP	O
+	NNP	O
genotype	NN	O
seems	VBZ	O
to	TO	O
be	VB	O
rare	JJ	O
in	IN	O
Europe	NNP	O
,	,	O
we	PRP	O
conclude	VBP	O
that	IN	O
all	DT	O
of	IN	O
these	DT	O
G6PD	NNP	O
A	NNP	O
-	:	O
genes	NNS	O
had	VBD	O
their	PRP$	O
ancient	JJ	O
origin	NN	O
in	IN	O
Africa	NNP	O
,	,	O
although	IN	O
in	IN	O
many	JJ	O
of	IN	O
the	DT	O
Mexican	JJ	O
patients	NNS	O
with	IN	O
G6PD	NNP	O
A	NNP	O
-	:	O
202A	CD	O
/	$	O
376G	CD	O
the	DT	O
gene	NN	O
may	MD	O
have	VB	O
been	VBN	O
imported	VBN	O
more	RBR	O
recently	RB	O
from	IN	O
Spain	NNP	O
,	,	O
where	WRB	O
this	DT	O
variant	NN	O
,	,	O
formerly	RB	O
known	VBN	O
as	IN	O
G6PD	NNP	O
Betica	NNP	O
,	,	O
is	VBZ	O
also	RB	O
prevalent	JJ	O
.	.	O
.	.	O

Hereditary	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
C5	NNP	E_Disease
in	IN	O
association	NN	O
with	IN	O
discoid	JJ	B_Disease
lupus	NN	I_Disease
erythematosus	NN	E_Disease
.	.	O

A	DT	O
29	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
woman	NN	O
with	IN	O
discoid	JJ	B_Disease
lupus	NN	I_Disease
erythematosus	NN	E_Disease
had	VBD	O
undetectable	JJ	O
classic	JJ	O
pathway	NN	O
complement	NN	O
activity	NN	O
.	.	O

Hypocomplementemia	NNP	S_Disease
was	VBD	O
due	JJ	O
to	TO	O
selective	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
C5	NNP	E_Disease
.	.	O

One	CD	O
of	IN	O
her	PRP$	O
children	NNS	O
was	VBD	O
also	RB	O
deficient	JJ	O
.	.	O

To	TO	O
our	PRP$	O
knowledge	NN	O
this	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
documented	JJ	O
case	NN	O
of	IN	O
an	DT	O
association	NN	O
between	IN	O
discoid	JJ	B_Disease
lupus	NN	I_Disease
erythematosus	NN	E_Disease
and	CC	O
C5	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O
.	.	O

Founder	NNP	O
effect	NN	O
of	IN	O
a	DT	O
prevalent	JJ	O
phenylketonuria	NN	S_Disease
mutation	NN	O
in	IN	O
the	DT	O
Oriental	JJ	O
population	NN	O
.	.	O

A	DT	O
missense	NN	O
mutation	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
in	IN	O
the	DT	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
[	NNP	O
PAH	NNP	O
;	:	O
phenylalanine	NN	O
4	CD	O
-	:	O
monooxygenase	NN	O
;	:	O
L	NNP	O
-	:	O
phenylalanine	NN	O
,	,	O
tetrahydrobiopterin	JJ	O
oxygen	NN	O
oxidoreductase	NN	O
(	(	O
4	CD	O
-	:	O
hydroxylating	NN	O
)	)	O
,	,	O
EC	NNP	O
1	CD	O
.	.	O

14	CD	O
.	.	O

16	CD	O
.	.	O

1	CD	O
]	JJ	O
gene	NN	O
in	IN	O
a	DT	O
Chinese	JJ	O
patient	NN	O
with	IN	O
classic	JJ	O
phenylketonuria	NN	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
.	.	O

A	DT	O
G	NNP	O
-	:	O
to	TO	O
-	:	O
C	NNP	O
transition	NN	O
at	IN	O
the	DT	O
second	JJ	O
base	NN	O
of	IN	O
codon	NN	O
413	CD	O
in	IN	O
exon	JJ	O
12	CD	O
of	IN	O
the	DT	O
gene	NN	O
results	NNS	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
Pro413	NNP	O
for	IN	O
Arg413	NNP	O
in	IN	O
the	DT	O
mutant	JJ	O
protein	NN	O
.	.	O

This	DT	O
mutation	NN	O
(	(	O
R413P	NNP	O
)	)	O
results	NNS	O
in	IN	O
negligible	JJ	O
enzymatic	JJ	O
activity	NN	O
when	WRB	O
expressed	VBN	O
in	IN	O
heterologous	JJ	O
mammalian	JJ	O
cells	NNS	O
and	CC	O
is	VBZ	O
compatible	JJ	O
with	IN	O
a	DT	O
classic	JJ	O
PKU	NNP	S_Disease
phenotype	NN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

Population	NNP	O
genetic	JJ	O
studies	NNS	O
reveal	VBP	O
that	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
tightly	RB	O
linked	VBN	O
to	TO	O
restriction	VB	O
fragment	JJ	O
length	NN	O
polymorphism	NN	O
haplotype	NN	O
4	CD	O
,	,	O
which	WDT	O
is	VBZ	O
the	DT	O
predominant	JJ	O
haplotype	NN	O
of	IN	O
the	DT	O
PAH	NNP	O
locus	NN	O
in	IN	O
the	DT	O
Oriental	JJ	O
population	NN	O
.	.	O

It	PRP	O
accounts	VBZ	O
for	IN	O
13	CD	O
.	.	O

8	CD	O
%	NN	O
of	IN	O
northern	JJ	O
Chinese	NNP	O
and	CC	O
27	CD	O
%	NN	O
of	IN	O
Japanese	JJ	O
PKU	NNP	S_Disease
alleles	NNS	O
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
rare	JJ	O
in	IN	O
southern	JJ	O
Chinese	NNP	O
(	(	O
2	CD	O
.	.	O

2	CD	O
%	NN	O
)	)	O
and	CC	O
is	VBZ	O
absent	JJ	O
in	IN	O
the	DT	O
Caucasian	JJ	O
population	NN	O
.	.	O

The	DT	O
data	NN	O
demonstrate	NN	O
unambiguously	RB	O
that	IN	O
the	DT	O
mutation	NN	O
occurred	VBD	O
after	IN	O
racial	JJ	O
divergence	NN	O
of	IN	O
Orientals	NNS	O
and	CC	O
Caucasians	NNPS	O
and	CC	O
suggest	VB	O
that	IN	O
the	DT	O
allele	NN	O
has	VBZ	O
spread	VBN	O
throughout	IN	O
the	DT	O
Orient	NNP	O
by	IN	O
a	DT	O
founder	NN	O
effect	NN	O
.	.	O

Previous	JJ	O
protein	NN	O
polymorphism	NN	O
studies	NNS	O
in	IN	O
eastern	JJ	O
Asia	NNP	O
have	VBP	O
led	VBN	O
to	TO	O
the	DT	O
hypothesis	NN	O
that	WDT	O
"	VBZ	O
northern	JJ	O
Mongoloids	NNP	O
"	NNP	O
represented	VBD	O
a	DT	O
founding	JJ	O
population	NN	O
in	IN	O
Asia	NNP	O
.	.	O

Our	PRP$	O
results	NNS	O
are	VBP	O
compatible	JJ	O
with	IN	O
this	DT	O
hypothesis	NN	O
in	IN	O
that	DT	O
the	DT	O
PKU	NNP	S_Disease
mutation	NN	O
might	MD	O
have	VB	O
occurred	VBN	O
in	IN	O
northern	JJ	O
Mongoloids	NNP	O
and	CC	O
subsequently	RB	O
spread	VBN	O
to	TO	O
the	DT	O
Chinese	NNPS	O
and	CC	O
Japanese	JJ	O
populations	NNS	O
.	.	O

Glucose	NNP	B_Disease
/	NNP	I_Disease
galactose	JJ	I_Disease
malabsorption	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
defect	NN	O
in	IN	O
the	DT	O
Na	NNP	O
+	NNP	O
/	NNP	O
glucose	JJ	O
cotransporter	NN	O
.	.	O

Glucose	NNP	B_Disease
/	NNP	I_Disease
galactose	JJ	I_Disease
malabsorption	NN	E_Disease
(	(	O
GGM	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disease	NN	E_Disease
manifesting	VBG	O
within	IN	O
the	DT	O
first	JJ	O
weeks	NNS	O
of	IN	O
life	NN	O
and	CC	O
characterized	VBN	O
by	IN	O
a	DT	O
selective	JJ	O
failure	NN	O
to	TO	O
absorb	VB	O
dietary	JJ	O
glucose	NN	O
and	CC	O
galactose	NN	O
from	IN	O
the	DT	O
intestine	NN	O
.	.	O

The	DT	O
consequent	NN	O
severe	JJ	O
diarrhoea	NN	S_Disease
and	CC	O
dehydration	NN	S_Disease
are	VBP	O
usually	RB	O
fatal	JJ	O
unless	IN	O
these	DT	O
sugars	NNS	O
are	VBP	O
eliminated	VBN	O
from	IN	O
the	DT	O
diet	NN	O
.	.	O

Intestinal	JJ	O
biopsies	NNS	O
of	IN	O
GGM	NNP	S_Disease
patients	NNS	O
have	VBP	O
revealed	VBN	O
a	DT	O
specific	JJ	O
defect	NN	O
in	IN	O
Na	NNP	O
(	(	O
+	NNP	O
)	)	O
-	:	O
dependent	JJ	O
absorption	NN	O
of	IN	O
glucose	NN	O
in	IN	O
the	DT	O
brush	NN	O
border	NN	O
.	.	O

Normal	NNP	O
glucose	JJ	O
absorption	NN	O
is	VBZ	O
mediated	VBN	O
by	IN	O
the	DT	O
Na	NNP	O
+	NNP	O
/	NNP	O
glucose	VBP	O
cotransporter	NN	O
in	IN	O
the	DT	O
brush	NN	O
border	NN	O
membrane	NN	O
of	IN	O
the	DT	O
intestinal	JJ	O
epithelium	NN	O
.	.	O

Cellular	JJ	O
influx	NN	O
is	VBZ	O
driven	VBN	O
by	IN	O
the	DT	O
transmembrane	NN	O
Na	NNP	O
+	NNP	O
electrochemical	JJ	O
potential	JJ	O
gradient	NN	O
;	:	O
thereafter	RB	O
the	DT	O
sugar	NN	O
moves	NNS	O
to	TO	O
the	DT	O
blood	NN	O
across	IN	O
the	DT	O
basolateral	JJ	O
membrane	NN	O
via	IN	O
the	DT	O
facilitated	VBN	O
glucose	NN	O
carrier	NN	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
cloned	VBN	O
and	CC	O
sequenced	VBD	O
a	DT	O
Na	NNP	O
+	NNP	O
/	NNP	O
glucose	VBP	O
cotransporter	NN	O
from	IN	O
normal	JJ	O
human	JJ	O
ileum	NN	O
and	CC	O
shown	VBN	O
that	IN	O
this	DT	O
gene	NN	O
,	,	O
SGLT1	NNP	O
,	,	O
resides	VBZ	O
on	IN	O
the	DT	O
distal	JJ	O
q	NN	O
arm	NN	O
of	IN	O
chromosome	NN	O
22	CD	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
amplified	VBN	O
SGLT1	NNP	O
complementary	JJ	O
DNA	NNP	O
and	CC	O
genomic	JJ	O
DNA	NN	O
from	IN	O
members	NNS	O
of	IN	O
a	DT	O
family	NN	O
affected	VBN	O
with	IN	O
GGM	NNP	S_Disease
by	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
.	.	O

Sequence	NNP	O
analysis	NN	O
of	IN	O
the	DT	O
amplified	JJ	O
products	NNS	O
has	VBZ	O
revealed	VBN	O
a	DT	O
single	JJ	O
missense	NN	O
mutation	NN	O
in	IN	O
SGLT1	NNP	O
which	WDT	O
cosegregates	VBZ	O
with	IN	O
the	DT	O
GGM	NNP	S_Disease
phenotype	NN	O
and	CC	O
results	NNS	O
in	IN	O
a	DT	O
complete	JJ	O
loss	NN	O
of	IN	O
Na	NNP	O
(	(	O
+	NNP	O
)	)	O
-	:	O
dependent	NN	O
glucose	JJ	O
transport	NN	O
in	IN	O
Xenopus	NNP	O
oocytes	NNS	O
injected	VBD	O
with	IN	O
this	DT	O
complementary	JJ	O
RNA	NNP	O
.	.	O
.	.	O

A	DT	O
de	FW	O
novo	FW	O
unbalanced	JJ	O
reciprocal	JJ	O
translocation	NN	O
identified	VBN	O
as	IN	O
paternal	JJ	O
in	IN	O
origin	NN	O
in	IN	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Interstitial	NNP	O
cytogenetic	JJ	O
deletions	NNS	O
involving	VBG	O
the	DT	O
paternally	RB	O
derived	VBN	O
chromosome	NN	O
15q11	CD	O
-	:	O
13	CD	O
have	VBP	O
been	VBN	O
described	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
child	NN	O
with	IN	O
PWS	NNP	S_Disease
and	CC	O
a	DT	O
de	FW	O
novo	FW	O
unbalanced	JJ	O
karyotype	NN	O
-	:	O
45	CD	O
,	,	O
XY	NNP	O
,	,	O
-	:	O
9	CD	O
,	,	O
-	:	O
15	CD	O
,	,	O
+	FW	O
der	NN	O
(	(	O
9	CD	O
)	)	O
t	NN	O
(	(	O
9	CD	O
;	:	O
15	CD	O
)	)	O
(	(	O
q34	NN	O
;	:	O
q13	NN	O
)	)	O
.	.	O

Molecular	JJ	O
studies	NNS	O
with	IN	O
the	DT	O
DNA	NNP	O
probe	NN	O
pML34	NN	O
confirmed	VBD	O
that	IN	O
only	RB	O
a	DT	O
single	JJ	O
Prader	NNP	B_Disease
Willi	NNP	E_Disease
critical	JJ	O
region	NN	O
(	(	O
PWCR	NNP	O
15q11	CD	O
.	.	O

2	CD	O
-	:	O
q12	NN	O
)	)	O
copy	NN	O
was	VBD	O
present	JJ	O
.	.	O

Hybridisation	NN	O
of	IN	O
patient	NN	O
and	CC	O
parental	JJ	O
DNA	NN	O
with	IN	O
the	DT	O
multi	NN	O
-	:	O
allelic	JJ	O
probe	NN	O
CMW1	NNP	O
,	,	O
which	WDT	O
maps	VBZ	O
to	TO	O
pter	VB	O
-	:	O
15q13	CD	O
,	,	O
showed	VBD	O
that	IN	O
the	DT	O
chromosome	NN	O
involved	VBN	O
in	IN	O
the	DT	O
translocation	NN	O
was	VBD	O
paternal	JJ	O
in	IN	O
origin	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
a	DT	O
paternally	RB	O
-	:	O
derived	VBN	O
PWCR	NNP	O
allele	JJ	O
loss	NN	O
caused	VBN	O
by	IN	O
an	DT	O
unbalanced	JJ	O
translocation	NN	O
that	WDT	O
has	VBZ	O
arisen	VBN	O
de	IN	O
novo	FW	O
.	.	O

Localisation	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
locus	NN	O
to	TO	O
19q13	CD	O
.	.	O
2	CD	O
-	:	O
19q13	CD	O
.	.	O
3	CD	O
and	CC	O
its	PRP$	O
relationship	NN	O
to	TO	O
twelve	VB	O
polymorphic	JJ	O
loci	NN	O
on	IN	O
19q	CD	O
.	.	O

The	DT	O
order	NN	O
of	IN	O
fourteen	JJ	O
polymorphic	JJ	O
markers	NNS	O
localised	VBD	O
to	TO	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
19	CD	O
has	VBZ	O
been	VBN	O
established	VBN	O
by	IN	O
multipoint	NN	O
mapping	NN	O
in	IN	O
a	DT	O
set	NN	O
of	IN	O
40	CD	O
CEPH	NNP	O
(	(	O
Centre	NNP	O
dEtude	VBP	O
de	FW	O
Polymorphisme	NNP	O
Humain	NNP	O
,	,	O
Paris	NNP	O
)	)	O
reference	NN	O
families	NNS	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
linkage	NN	O
relationship	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
locus	NN	O
to	TO	O
twelve	VB	O
of	IN	O
these	DT	O
markers	NNS	O
as	IN	O
studied	VBN	O
in	IN	O
45	CD	O
families	NNS	O
with	IN	O
DM	NNP	S_Disease
.	.	O

The	DT	O
resulting	JJ	O
genetic	JJ	O
map	NN	O
is	VBZ	O
supported	VBN	O
by	IN	O
the	DT	O
localisation	NN	O
of	IN	O
the	DT	O
DNA	NN	O
markers	NNS	O
in	IN	O
a	DT	O
panel	NN	O
of	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
.	.	O

Ten	CD	O
of	IN	O
the	DT	O
twelve	NN	O
markers	NNS	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
proximal	JJ	O
to	TO	O
the	DT	O
DM	NNP	S_Disease
gene	NN	O
and	CC	O
two	CD	O
,	,	O
PRKCG	NNP	O
and	CC	O
D19S22	NNP	O
,	,	O
distal	JJ	O
but	CC	O
at	IN	O
distances	NNS	O
of	IN	O
approximately	RB	O
25	CD	O
cM	NNS	O
and	CC	O
15	CD	O
cM	NN	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
closest	JJS	O
proximal	JJ	O
markers	NNS	O
are	VBP	O
APOC2	NNP	O
(	(	O
apolipoprotein	JJ	O
C	NNP	O
-	:	O
II	NNP	O
)	)	O
and	CC	O
CKM	NNP	O
(	(	O
creatine	JJ	O
kinase	NN	O
,	,	O
muscle	NN	O
)	)	O
approximately	RB	O
3	CD	O
cM	NNS	O
and	CC	O
2	CD	O
cM	NN	O
from	IN	O
the	DT	O
DM	NNP	S_Disease
gene	NN	O
respectively	RB	O
,	,	O
in	IN	O
the	DT	O
order	NN	O
APOC2	NNP	O
-	:	O
CKM	NNP	O
-	:	O
DM	NN	O
.	.	O

The	DT	O
distance	NN	O
between	IN	O
APOC2	NNP	O
,	,	O
CKM	NNP	O
and	CC	O
DM	NNP	S_Disease
(	(	O
of	IN	O
the	DT	O
order	NN	O
of	IN	O
2	CD	O
million	CD	O
base	NN	O
pairs	NN	O
)	)	O
and	CC	O
their	PRP$	O
known	VBN	O
orientation	NN	O
should	MD	O
permit	VB	O
directional	JJ	O
chromosome	NN	O
walking	NN	O
and	CC	O
jumping	NN	O
.	.	O

The	DT	O
data	NN	O
presented	VBD	O
here	RB	O
should	MD	O
enable	VB	O
us	PRP	O
to	TO	O
determine	VB	O
whether	IN	O
or	CC	O
not	RB	O
new	JJ	O
markers	NNS	O
are	VBP	O
distal	JJ	O
to	TO	O
APOC2	NNP	O
/	NNP	O
CKM	NNP	O
and	CC	O
thus	RB	O
potentially	RB	O
flank	VBZ	O
the	DT	O
DM	NNP	S_Disease
gene	NN	O
.	.	O
.	.	O

Localization	NN	O
of	IN	O
histidase	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
region	NN	O
12q22	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
q24	NN	O
.	.	O
1	CD	O
and	CC	O
mouse	VB	O
chromosome	JJ	O
region	NN	O
10C2	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
D1	NN	O
.	.	O

The	DT	O
human	JJ	O
gene	NN	O
for	IN	O
histidase	NN	O
(	(	O
histidine	JJ	O
ammonia	NN	O
-	:	O
lyase	NN	O
;	:	O
HAL	NNP	O
)	)	O
,	,	O
the	DT	O
enzyme	JJ	O
deficient	NN	O
in	IN	O
histidinemia	NN	S_Disease
,	,	O
was	VBD	O
assigned	VBN	O
to	TO	O
human	JJ	O
chromosome	NN	O
12	CD	O
by	IN	O
Southern	NNP	O
blot	NN	O
analysis	NN	O
of	IN	O
human	JJ	O
X	NNP	O
mouse	NN	O
somatic	JJ	O
cell	NN	O
hybrid	JJ	O
DNA	NNP	O
.	.	O

The	DT	O
gene	NN	O
was	VBD	O
sublocalized	VBN	O
to	TO	O
region	NN	O
12q22	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
q24	NN	O
.	.	O

1	CD	O
by	IN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
,	,	O
using	VBG	O
a	DT	O
human	JJ	O
histidase	NN	O
cDNA	NN	O
.	.	O

The	DT	O
homologous	JJ	O
locus	NN	O
in	IN	O
the	DT	O
mouse	NN	O
(	(	O
Hal	NNP	O
)	)	O
was	VBD	O
mapped	VBN	O
to	TO	O
region	NN	O
10C2	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
D1	NN	O
by	IN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
,	,	O
using	VBG	O
a	DT	O
cell	NN	O
line	NN	O
from	IN	O
a	DT	O
mouse	NN	O
homozygous	JJ	O
for	IN	O
a	DT	O
1	CD	O
.	.	O

10	CD	O
Robertsonian	JJ	O
translocation	NN	O
.	.	O

These	DT	O
assignments	NNS	O
extend	VBP	O
the	DT	O
conserved	JJ	O
syntenic	JJ	O
region	NN	O
between	IN	O
human	JJ	O
chromosome	NN	O
12	CD	O
and	CC	O
mouse	VB	O
chromosome	NN	O
10	CD	O
that	WDT	O
includes	VBZ	O
the	DT	O
genes	NNS	O
for	IN	O
phenylalanine	NN	O
hydroxylase	NN	O
,	,	O
gamma	NN	O
interferon	NN	O
,	,	O
peptidase	NN	O
,	,	O
and	CC	O
citrate	JJ	O
synthase	NN	O
.	.	O

The	DT	O
localization	NN	O
of	IN	O
histidase	NN	O
to	TO	O
mouse	VB	O
chromosome	NN	O
10	CD	O
suggests	VBZ	O
that	IN	O
the	DT	O
histidase	NN	O
regulatory	JJ	O
locus	NN	O
(	(	O
Hsd	NNP	O
)	)	O
and	CC	O
the	DT	O
histidinemia	NN	O
mutation	NN	O
(	(	O
his	PRP$	O
)	)	O
,	,	O
which	WDT	O
are	VBP	O
both	DT	O
known	VBN	O
to	TO	O
be	VB	O
on	IN	O
chromosome	NN	O
10	CD	O
,	,	O
may	MD	O
be	VB	O
alleles	NNS	O
of	IN	O
the	DT	O
histidase	JJ	O
structural	JJ	O
gene	NN	O
locus	NN	O
.	.	O

Determination	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
responsible	JJ	O
for	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	VBP	E_Disease
in	IN	O
17	CD	O
subjects	NNS	O
.	.	O

Hypoxanthine	NNP	O
-	:	O
-	:	O
guanine	NN	O
phosphoribosyltransferase	NN	O
(	(	O
HPRT	NNP	O
)	)	O
is	VBZ	O
a	DT	O
purine	JJ	O
salvage	NN	O
enzyme	NN	O
that	WDT	O
catalyzes	VBZ	O
the	DT	O
conversion	NN	O
of	IN	O
hypoxanthine	NN	O
to	TO	O
inosine	VB	O
monophosphate	NN	O
and	CC	O
guanine	NN	O
to	TO	O
guanosine	VB	O
monophosphate	NN	O
.	.	O

Previous	JJ	O
studies	NNS	O
of	IN	O
mutant	JJ	O
HPRT	NNP	O
proteins	VBZ	O
analyzed	VBN	O
at	IN	O
the	DT	O
molecular	JJ	O
level	NN	O
have	VBP	O
shown	VBN	O
a	DT	O
significant	JJ	O
heterogeneity	NN	O
.	.	O

This	DT	O
investigation	NN	O
further	RB	O
verifies	VBZ	O
this	DT	O
heterogeneity	NN	O
and	CC	O
identifies	NNS	O
insertions	NNS	O
,	,	O
deletions	NNS	O
,	,	O
and	CC	O
point	NN	O
mutations	NNS	O
.	.	O

The	DT	O
direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
-	:	O
amplified	JJ	O
product	NN	O
of	IN	O
reverse	JJ	O
-	:	O
transcribed	NN	O
HPRT	NNP	O
mRNA	NN	O
enabled	VBD	O
the	DT	O
rapid	JJ	O
identification	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
found	VBD	O
in	IN	O
17	CD	O
previously	RB	O
uncharacterized	VBN	O
cell	NN	O
lines	NNS	O
derived	VBN	O
from	IN	O
patients	NNS	O
with	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O
.	.	O

Linkage	NN	O
of	IN	O
DNA	NN	O
markers	NNS	O
at	IN	O
Xq28	NNP	O
to	TO	O
adrenoleukodystrophy	VB	S_Disease
and	CC	O
adrenomyeloneuropathy	VB	S_Disease
present	NN	O
within	IN	O
the	DT	O
same	JJ	O
family	NN	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
large	JJ	O
kindred	VBD	O
that	IN	O
contained	VBD	O
patients	NNS	O
with	IN	O
either	DT	O
adrenoleukodystrophy	NN	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
or	CC	O
adrenomyeloneuropathy	JJ	S_Disease
(	(	O
AMN	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
pedigree	JJ	O
clearly	RB	O
supported	VBD	O
the	DT	O
X	NNP	O
-	:	O
linked	VBD	O
mode	NN	O
of	IN	O
inheritance	NN	O
of	IN	O
the	DT	O
nonneonatal	JJ	O
form	NN	O
of	IN	O
ALD	NNP	S_Disease
/	NNP	O
AMN	NNP	S_Disease
.	.	O

Analysis	NN	O
with	IN	O
DNA	NNP	O
markers	NNS	O
at	IN	O
Xq28	NNP	O
suggested	VBD	O
segregation	NN	O
of	IN	O
both	DT	O
ALD	NNP	S_Disease
and	CC	O
AMN	NNP	S_Disease
with	IN	O
an	DT	O
identical	JJ	O
haplotype	NN	O
.	.	O

This	DT	O
indicated	VBD	O
that	IN	O
nonneonatal	JJ	O
ALD	NNP	S_Disease
and	CC	O
AMN	NNP	S_Disease
are	VBP	O
caused	VBN	O
by	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
same	JJ	O
gene	NN	O
at	IN	O
Xq28	NNP	O
.	.	O

It	PRP	O
showed	VBD	O
,	,	O
furthermore	RB	O
,	,	O
that	IN	O
phenotypic	NN	O
differences	NNS	O
between	IN	O
ALD	NNP	S_Disease
and	CC	O
AMN	NNP	S_Disease
are	VBP	O
not	RB	O
necessarily	RB	O
the	DT	O
consequence	NN	O
of	IN	O
allelic	JJ	O
heterogeneity	NN	O
due	JJ	O
to	TO	O
different	JJ	O
mutations	NNS	O
within	IN	O
the	DT	O
same	JJ	O
gene	NN	O
.	.	O

The	DT	O
maximal	JJ	O
lod	NN	O
score	NN	O
for	IN	O
linkage	NN	O
of	IN	O
the	DT	O
ALD	NNP	S_Disease
/	NNP	O
AMN	NNP	S_Disease
gene	NN	O
and	CC	O
the	DT	O
multiallelic	JJ	O
anonymous	JJ	O
DNA	NN	O
marker	NN	O
at	IN	O
DXS52	NNP	O
was	VBD	O
3	CD	O
.	.	O

0	CD	O
at	IN	O
a	DT	O
recombination	NN	O
fraction	NN	O
of	IN	O
0	CD	O
.	.	O

00	CD	O
.	.	O

This	DT	O
made	VBD	O
a	DT	O
prenatal	JJ	O
or	CC	O
presymptomatic	JJ	O
diagnosis	NN	O
and	CC	O
heterozygote	NN	O
detection	NN	O
by	IN	O
DNA	NNP	O
analysis	NN	O
with	IN	O
this	DT	O
marker	NN	O
reliable	NN	O
.	.	O

Skewed	NNP	O
X	NNP	O
inactivation	NN	O
in	IN	O
a	DT	O
female	JJ	O
MZ	NNP	O
twin	NN	O
results	NNS	O
in	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

One	CD	O
of	IN	O
female	JJ	O
MZ	NNP	O
twins	NNS	O
presented	VBN	O
with	IN	O
muscular	JJ	B_Disease
dystrophy	NN	E_Disease
.	.	O

Physical	JJ	O
examination	NN	O
,	,	O
creatine	JJ	O
phosphokinase	NN	O
levels	NNS	O
,	,	O
and	CC	O
muscle	NN	O
biopsy	NN	O
were	VBD	O
consistent	JJ	O
with	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
.	.	O

However	RB	O
,	,	O
because	IN	O
of	IN	O
her	PRP$	O
sex	NN	O
she	PRP	O
was	VBD	O
diagnosed	VBN	O
as	IN	O
having	VBG	O
limb	SYM	B_Disease
-	:	I_Disease
girdle	JJ	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

With	IN	O
cDNA	NN	O
probes	NNS	O
to	TO	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
,	,	O
a	DT	O
gene	NN	O
deletion	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
twins	NNS	O
and	CC	O
their	PRP$	O
mother	NN	O
.	.	O

The	DT	O
de	FW	O
novo	FW	O
mutation	NN	O
which	WDT	O
arose	VBP	O
in	IN	O
the	DT	O
mother	NN	O
was	VBD	O
shown	VBN	O
by	IN	O
novel	JJ	O
junction	NN	O
fragments	NNS	O
generated	VBN	O
by	IN	O
HindIII	NNP	O
,	,	O
PstI	NNP	O
,	,	O
or	CC	O
TaqI	NNP	O
when	WRB	O
probed	NN	O
with	IN	O
cDNA8	NN	O
.	.	O

Additional	JJ	O
evidence	NN	O
of	IN	O
a	DT	O
large	JJ	O
gene	NN	O
deletion	NN	O
was	VBD	O
given	VBN	O
by	IN	O
novel	JJ	O
SfiI	NNP	O
junction	NN	O
fragments	NNS	O
detected	VBN	O
by	IN	O
probes	NNS	O
p20	NNS	O
,	,	O
J	NNP	O
-	:	O
Bir	NNP	O
,	,	O
and	CC	O
J	NNP	O
-	:	O
66	CD	O
on	IN	O
pulsed	JJ	O
-	:	O
field	NN	O
gel	JJ	O
electrophoresis	NN	O
(	(	O
PFGE	NNP	O
)	)	O
.	.	O

Immunoblot	NNP	O
analysis	NN	O
of	IN	O
muscle	NN	O
from	IN	O
the	DT	O
affected	JJ	O
twin	NN	O
showed	VBD	O
dystrophin	IN	O
of	IN	O
normal	JJ	O
size	NN	O
but	CC	O
of	IN	O
reduced	JJ	O
amount	NN	O
.	.	O

Immunofluorescent	JJ	O
visualization	NN	O
of	IN	O
dystrophin	NN	O
revealed	VBD	O
foci	NN	O
of	IN	O
dystrophin	JJ	O
-	:	O
positive	JJ	O
fibers	NNS	O
adjacent	JJ	O
to	TO	O
foci	VB	O
of	IN	O
dystrophin	JJ	O
-	:	O
negative	JJ	O
fibers	NNS	O
.	.	O

These	DT	O
data	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
affected	JJ	O
twin	NN	O
is	VBZ	O
a	DT	O
manifesting	VBG	O
carrier	NN	O
of	IN	O
an	DT	O
abnormal	JJ	O
DMD	NNP	S_Disease
gene	NN	O
,	,	O
her	PRP$	O
myopathy	JJ	S_Disease
being	VBG	O
a	DT	O
direct	JJ	O
result	NN	O
of	IN	O
underexpression	NN	O
of	IN	O
dystrophin	NN	O
.	.	O

Cytogenetic	JJ	O
analysis	NN	O
revealed	VBD	O
normal	JJ	O
karyotypes	NNS	O
,	,	O
eliminating	VBG	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
translocation	NN	O
affecting	VBG	O
DMD	NNP	S_Disease
gene	NN	O
function	NN	O
.	.	O

Both	DT	O
linkage	JJ	O
analysis	NN	O
and	CC	O
DNA	NNP	O
fingerprint	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
each	DT	O
twin	NN	O
has	VBZ	O
two	CD	O
different	JJ	O
X	NNP	O
chromosomes	NNS	O
,	,	O
eliminating	VBG	O
the	DT	O
possibility	NN	O
of	IN	O
uniparental	JJ	B_Disease
disomy	NN	E_Disease
as	IN	O
a	DT	O
mechanism	NN	O
for	IN	O
DMD	NNP	S_Disease
expression	NN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
methylation	NN	O
differences	NNS	O
of	IN	O
the	DT	O
paternal	JJ	O
and	CC	O
maternal	JJ	O
X	NNP	O
chromosomes	NNS	O
in	IN	O
these	DT	O
MZ	NNP	O
twins	NNS	O
,	,	O
we	PRP	O
propose	VBP	O
uneven	JJ	O
lyonization	NN	O
(	(	O
X	NNP	O
chromosome	VBP	O
inactivation	NN	O
)	)	O
as	IN	O
the	DT	O
underlying	VBG	O
mechanism	NN	O
for	IN	O
disease	NN	O
expression	NN	O
in	IN	O
the	DT	O
affected	JJ	O
female	NN	O
.	.	O
.	.	O

Adrenoleukodystrophy	NNP	S_Disease
and	CC	O
adrenomyeloneuropathy	RB	S_Disease
associated	VBN	O
with	IN	O
partial	JJ	O
adrenal	JJ	B_Disease
insufficiency	NN	E_Disease
in	IN	O
three	CD	O
generations	NNS	O
of	IN	O
a	DT	O
kindred	VBN	O
.	.	O

Four	CD	O
cases	NNS	O
of	IN	O
adrenoleukodystrophy	NN	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
and	CC	O
one	CD	O
case	NN	O
of	IN	O
adrenomyeloneuropathy	NN	S_Disease
(	(	O
AMN	NNP	S_Disease
)	)	O
have	VBP	O
developed	VBN	O
in	IN	O
a	DT	O
kindred	VBN	O
over	IN	O
three	CD	O
generations	NNS	O
demonstrating	VBG	O
that	IN	O
AMN	NNP	S_Disease
is	VBZ	O
a	DT	O
clinical	JJ	O
variant	NN	O
of	IN	O
ALD	NNP	S_Disease
.	.	O

Pituitary	NNP	O
-	:	O
adrenal	JJ	O
function	NN	O
studies	NNS	O
were	VBD	O
performed	VBN	O
in	IN	O
10	CD	O
family	NN	O
members	NNS	O
,	,	O
including	VBG	O
two	CD	O
affected	JJ	O
males	NNS	O
and	CC	O
four	CD	O
females	NNS	O
identified	VBN	O
as	IN	O
carriers	NNS	O
of	IN	O
ALD	NNP	S_Disease
/	NNP	O
AMN	NNP	S_Disease
.	.	O

No	DT	O
pituitary	JJ	B_Disease
-	:	I_Disease
adrenal	JJ	I_Disease
abnormality	NN	E_Disease
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
carriers	NNS	O
.	.	O

However	RB	O
,	,	O
basal	JJ	O
morning	NN	O
plasma	NN	O
adrenocorticotropic	NN	O
hormone	NN	O
(	(	O
ACTH	NNP	O
)	)	O
levels	NNS	O
were	VBD	O
markedly	RB	O
elevated	VBN	O
in	IN	O
the	DT	O
two	CD	O
males	NNS	O
with	IN	O
ALD	NNP	S_Disease
and	CC	O
AMN	NNP	S_Disease
,	,	O
despite	IN	O
the	DT	O
fact	NN	O
that	IN	O
they	PRP	O
had	VBD	O
no	DT	O
clinical	JJ	O
signs	NNS	O
of	IN	O
adrenal	JJ	B_Disease
insufficiency	NN	E_Disease
and	CC	O
that	IN	O
morning	NN	O
plasma	NN	O
cortisol	NN	O
levels	NNS	O
and	CC	O
their	PRP$	O
response	NN	O
to	TO	O
maximal	VB	O
exogenous	JJ	O
ACTH	NNP	O
stimulation	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
normal	JJ	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
integrated	VBN	O
24	CD	O
-	:	O
hour	NN	O
response	NN	O
to	TO	O
the	DT	O
administration	NN	O
were	VBD	O
also	RB	O
subnormal	JJ	O
in	IN	O
these	DT	O
two	CD	O
cases	NNS	O
.	.	O

Thus	RB	O
,	,	O
people	NNS	O
with	IN	O
ALD	NNP	S_Disease
and	CC	O
AMN	NNP	S_Disease
may	MD	O
have	VB	O
subclinical	JJ	O
partial	JJ	O
adrenocrotical	JJ	B_Disease
insufficiency	NN	E_Disease
.	.	O

No	DT	O
other	JJ	O
endocrinologic	JJ	B_Disease
dysfunction	NN	E_Disease
was	VBD	O
identified	VBN	O
.	.	O
.	.	O

Regional	JJ	O
localisation	NN	O
of	IN	O
the	DT	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
locus	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
9q13	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
q21	NN	O
.	.	O
1	CD	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
assigned	VBN	O
the	DT	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
locus	NN	O
(	(	O
FRDA	NNP	O
)	)	O
to	TO	O
chromosome	VB	O
9	CD	O
;	:	O
the	DT	O
current	JJ	O
maximal	JJ	O
lod	NN	O
score	NN	O
between	IN	O
FRDA	NNP	O
and	CC	O
MCT112	NNP	O
(	(	O
D9S15	NNP	O
)	)	O
is	VBZ	O
greater	JJR	O
than	IN	O
50	CD	O
at	IN	O
a	DT	O
recombination	NN	O
fraction	NN	O
of	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

The	DT	O
physical	JJ	O
assignment	NN	O
of	IN	O
the	DT	O
locus	NN	O
defined	VBN	O
by	IN	O
MCT112	NNP	O
,	,	O
and	CC	O
hence	RB	O
FRDA	NNP	O
,	,	O
has	VBZ	O
not	RB	O
been	VBN	O
determined	VBN	O
,	,	O
although	IN	O
linkage	JJ	O
analysis	NN	O
of	IN	O
MCT112	NNP	O
with	IN	O
other	JJ	O
chromosome	NN	O
9	CD	O
markers	NNS	O
inferred	VBD	O
a	DT	O
location	NN	O
close	RB	O
to	TO	O
the	DT	O
centromere	NN	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
in	IN	O
situ	JJ	O
hybridisation	NN	O
with	IN	O
MCT112	NNP	O
,	,	O
a	DT	O
corresponding	JJ	O
cosmid	NN	O
MJ1	NNP	O
,	,	O
and	CC	O
DR47	NNP	O
(	(	O
D9S5	NNP	O
)	)	O
,	,	O
coupled	VBN	O
with	IN	O
mapping	VBG	O
studies	NNS	O
on	IN	O
hybrid	JJ	O
cell	NN	O
panels	NNS	O
,	,	O
to	TO	O
define	VB	O
more	RBR	O
precisely	RB	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
disease	NN	O
locus	NN	O
.	.	O

The	DT	O
in	IN	O
situ	JJ	O
location	NN	O
of	IN	O
all	DT	O
three	CD	O
probes	NNS	O
is	VBZ	O
9q13	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
q21	NN	O
.	.	O

1	CD	O
,	,	O
distal	NN	O
to	TO	O
the	DT	O
variable	JJ	O
heterochromatin	NN	O
region	NN	O
.	.	O

Physical	JJ	O
assignment	NN	O
of	IN	O
FRDA	NNP	O
will	MD	O
allow	VB	O
us	PRP	O
to	TO	O
identify	VB	O
hybrid	NN	O
cell	NN	O
lines	NNS	O
containing	VBG	O
the	DT	O
mutated	VBN	O
gene	NN	O
.	.	O

Increased	VBN	O
high	JJ	O
-	:	O
density	NN	O
lipoprotein	NN	O
levels	NNS	O
caused	VBN	O
by	IN	O
a	DT	O
common	JJ	O
cholesteryl	NN	O
-	:	O
ester	NN	O
transfer	NN	O
protein	NN	O
gene	NN	O
mutation	NN	O
.	.	O

BACKGROUND	NNP	O
AND	NNP	O
METHODS	NNP	O
.	.	O

The	DT	O
plasma	NN	O
cholesteryl	SYM	O
-	:	O
ester	NN	O
transfer	NN	O
protein	NN	O
(	(	O
CETP	NNP	O
)	)	O
catalyzes	VBZ	O
the	DT	O
transfer	NN	O
of	IN	O
cholesteryl	NN	O
esters	NNS	O
from	IN	O
high	JJ	O
-	:	O
density	NN	O
lipoprotein	NN	O
(	(	O
HDL	NNP	O
)	)	O
to	TO	O
other	JJ	O
lipoproteins	NNS	O
.	.	O

We	PRP	O
recently	RB	O
described	VBD	O
a	DT	O
Japanese	JJ	O
family	NN	O
with	IN	O
increased	JJ	O
HDL	NNP	O
levels	NNS	O
and	CC	O
CETP	NNP	B_Disease
deficiency	NN	E_Disease
due	JJ	O
to	TO	O
a	DT	O
splicing	VBG	O
defect	NN	O
of	IN	O
the	DT	O
CETP	NNP	O
gene	NN	O
.	.	O

To	TO	O
assess	VB	O
the	DT	O
frequency	NN	O
and	CC	O
phenotype	NN	O
of	IN	O
this	DT	O
condition	NN	O
,	,	O
we	PRP	O
screened	VBD	O
11	CD	O
additional	JJ	O
families	NNS	O
with	IN	O
high	JJ	O
HDL	NNP	O
levels	NNS	O
by	IN	O
means	NNS	O
of	IN	O
a	DT	O
radioimmunoassay	NN	O
for	IN	O
CETP	NNP	O
and	CC	O
DNA	NNP	O
analysis	NN	O
.	.	O

RESULTS	NNP	O
.	.	O

We	PRP	O
found	VBD	O
the	DT	O
same	JJ	O
CETP	NNP	O
gene	NN	O
mutation	NN	O
in	IN	O
four	CD	O
families	NNS	O
from	IN	O
three	CD	O
different	JJ	O
regions	NNS	O
of	IN	O
Japan	NNP	O
.	.	O

Analysis	NN	O
of	IN	O
restriction	NN	O
-	:	O
fragment	NN	O
-	:	O
length	NN	O
polymorphisms	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
CETP	NNP	O
allele	NN	O
showed	VBD	O
that	IN	O
all	DT	O
probands	NNS	O
were	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
identical	JJ	O
haplotype	NN	O
.	.	O

Family	RB	O
members	NNS	O
homozygous	JJ	O
for	IN	O
CETP	NNP	B_Disease
deficiency	NN	E_Disease
(	(	O
n	JJ	O
=	NNP	O
10	CD	O
)	)	O
had	VBD	O
moderate	JJ	O
hypercholesterolemia	NN	S_Disease
(	(	O
mean	JJ	O
total	NN	O
cholesterol	NN	O
level	NN	O
[	NNP	O
+	NNP	O
/	NNP	O
-	:	O
SD	NNP	O
]	NNP	O
,	,	O
7	CD	O
.	.	O

01	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

83	CD	O
mmol	NN	O
per	IN	O
liter	NN	O
)	)	O
,	,	O
markedly	RB	O
increased	VBD	O
levels	NNS	O
of	IN	O
HDL	NNP	O
cholesterol	NN	O
(	(	O
4	CD	O
.	.	O

24	CD	O
+	JJ	O
/	NNP	O
-	:	O
1	CD	O
.	.	O

01	CD	O
mmol	NN	O
per	IN	O
liter	NN	O
)	)	O
and	CC	O
apolipoprotein	VBZ	O
A	DT	O
-	:	O
I	PRP	O
,	,	O
and	CC	O
decreased	JJ	O
levels	NNS	O
of	IN	O
low	JJ	O
-	:	O
density	NN	O
lipoprotein	NN	O
cholesterol	NN	O
(	(	O
1	CD	O
.	.	O

99	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

80	CD	O
mmol	NN	O
per	IN	O
liter	NN	O
)	)	O
and	CC	O
apolipoprotein	$	O
B	NNP	O
.	.	O

Members	NNS	O
heterozygous	JJ	O
for	IN	O
the	DT	O
deficiency	NN	O
(	(	O
n	JJ	O
=	NNP	O
20	CD	O
)	)	O
,	,	O
whose	WP$	O
CETP	NNP	O
levels	NNS	O
were	VBD	O
in	IN	O
the	DT	O
lower	JJR	O
part	NN	O
of	IN	O
the	DT	O
normal	JJ	O
range	NN	O
,	,	O
had	VBD	O
moderately	RB	O
increased	JJ	O
levels	NNS	O
of	IN	O
HDL	NNP	O
cholesterol	NN	O
and	CC	O
apolipoprotein	VB	O
A	NNP	O
-	:	O
I	PRP	O
and	CC	O
an	DT	O
increased	VBN	O
ratio	NN	O
of	IN	O
HDL	NNP	O
subclass	NN	O
2	CD	O
to	TO	O
HDL	NNP	O
subclass	NN	O
3	CD	O
,	,	O
as	IN	O
compared	VBN	O
with	IN	O
unaffected	JJ	O
family	NN	O
members	NNS	O
(	(	O
1	CD	O
.	.	O

5	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

8	CD	O
vs	NN	O
.	.	O

0	CD	O
.	.	O

7	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

4	CD	O
)	)	O
.	.	O

CETP	NNP	B_Disease
deficiency	NN	E_Disease
was	VBD	O
not	RB	O
found	VBN	O
in	IN	O
six	CD	O
unrelated	JJ	O
subjects	NNS	O
with	IN	O
elevated	JJ	O
HDL	NNP	O
cholesterol	NN	O
levels	NNS	O
who	WP	O
were	VBD	O
from	IN	O
different	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
United	NNP	O
States	NNPS	O
.	.	O

CONCLUSIONS	NNP	O
.	.	O

CETP	NNP	B_Disease
deficiency	NN	E_Disease
appears	VBZ	O
to	TO	O
be	VB	O
a	DT	O
frequent	JJ	O
cause	NN	O
of	IN	O
increased	VBN	O
HDL	NNP	O
levels	NNS	O
in	IN	O
the	DT	O
population	NN	O
of	IN	O
Japan	NNP	O
,	,	O
possibly	RB	O
because	IN	O
of	IN	O
a	DT	O
founder	NN	O
effect	NN	O
.	.	O

The	DT	O
results	NNS	O
that	IN	O
we	PRP	O
observed	VBD	O
in	IN	O
heterozygotes	NNS	O
suggest	VBP	O
that	IN	O
CETP	NNP	O
normally	RB	O
plays	VBZ	O
a	DT	O
part	NN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
levels	NNS	O
of	IN	O
HDL	NNP	O
subclass	NN	O
2	CD	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
premature	JJ	B_Disease
atherosclerosis	NN	E_Disease
in	IN	O
the	DT	O
families	NNS	O
with	IN	O
CETP	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

In	IN	O
fact	NN	O
,	,	O
the	DT	O
lipoprotein	NN	O
profile	NN	O
of	IN	O
persons	NNS	O
with	IN	O
CETP	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
potentially	RB	O
antiatherogenic	JJ	O
and	CC	O
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
an	DT	O
increased	JJ	O
life	NN	O
span	NN	O
.	.	O

Further	RB	O
mapping	NN	O
of	IN	O
an	DT	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
locus	NN	O
to	TO	O
the	DT	O
chromosome	NN	O
11q23	CD	O
region	NN	O
.	.	O

We	PRP	O
recently	RB	O
mapped	VBD	O
the	DT	O
gene	NN	O
for	IN	O
ataxia	JJ	B_Disease
-	:	I_Disease
telangiectasia	NN	E_Disease
group	NN	O
A	NNP	O
(	(	O
ATA	NNP	O
)	)	O
to	TO	O
chromosome	VB	O
11q22	CD	O
-	:	O
23	CD	O
by	IN	O
linkage	NN	O
analysis	NN	O
,	,	O
using	VBG	O
the	DT	O
genetic	JJ	O
markers	NNS	O
THY1	NNP	O
and	CC	O
pYNB3	NN	O
.	.	O

12	CD	O
(	(	O
D11S144	NNP	O
)	)	O
.	.	O

The	DT	O
most	RBS	O
likely	JJ	O
order	NN	O
was	VBD	O
cent	JJ	O
-	:	O
AT	NNP	O
-	:	O
S144	NNP	O
-	:	O
THY1	NN	O
.	.	O

The	DT	O
present	JJ	O
paper	NN	O
describes	VBZ	O
further	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
AT	NNP	S_Disease
locus	NN	O
by	IN	O
means	NNS	O
of	IN	O
a	DT	O
panel	NN	O
of	IN	O
10	CD	O
markers	NNS	O
that	IN	O
span	VBP	O
approximately	RB	O
60	CD	O
cM	NN	O
in	IN	O
the	DT	O
11q22	CD	O
-	:	O
23	CD	O
region	NN	O
centered	VBN	O
around	IN	O
S144	NNP	O
and	CC	O
THY1	NNP	O
.	.	O

Location	NN	O
scores	NNS	O
indicate	VBP	O
that	IN	O
three	CD	O
contiguous	JJ	O
subsegments	NNS	O
within	IN	O
the	DT	O
[	NNP	O
S144	NNP	O
-	:	O
THY1	NNP	O
]	NNP	O
segment	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
three	CD	O
contiguous	JJ	O
segments	NNS	O
telomeric	JJ	O
to	TO	O
THY1	NNP	O
,	,	O
are	VBP	O
each	DT	O
unlikely	JJ	O
to	TO	O
contain	VB	O
the	DT	O
AT	NNP	S_Disease
locus	NN	O
,	,	O
while	IN	O
the	DT	O
more	JJR	O
centromeric	JJ	O
[	NN	O
STMY	NNP	O
-	:	O
S144	NNP	O
]	NNP	O
segment	NN	O
is	VBZ	O
most	RBS	O
likely	JJ	O
to	TO	O
contain	VB	O
the	DT	O
AT	NNP	S_Disease
locus	NN	O
.	.	O

These	DT	O
data	NNS	O
,	,	O
together	RB	O
with	IN	O
recent	JJ	O
refinements	NNS	O
in	IN	O
the	DT	O
linkage	NN	O
and	CC	O
physical	JJ	O
maps	NNS	O
of	IN	O
11q22	CD	O
-	:	O
23	CD	O
,	,	O
place	NN	O
the	DT	O
AT	NNP	S_Disease
locus	NN	O
at	IN	O
11q23	CD	O
.	.	O

Recurrent	JJ	O
meningitis	NN	S_Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
congenital	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
C9	NNP	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
.	.	O

First	NNP	O
case	NN	O
of	IN	O
C9	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
Europe	NNP	O
.	.	O

We	PRP	O
describe	VBP	O
the	DT	O
first	JJ	O
cases	NNS	O
,	,	O
to	TO	O
our	PRP$	O
knowledge	NN	O
,	,	O
of	IN	O
C9	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
Europe	NNP	O
that	WDT	O
were	VBD	O
detected	VBN	O
in	IN	O
a	DT	O
Swiss	JJ	O
family	NN	O
,	,	O
of	IN	O
which	WDT	O
two	CD	O
members	NNS	O
-	:	O
-	:	O
one	NN	O
with	IN	O
a	DT	O
complete	JJ	O
deficiency	NN	O
and	CC	O
the	DT	O
other	JJ	O
with	IN	O
approximately	RB	O
half	JJ	O
-	:	O
normal	JJ	O
C9	NNP	O
levels	NNS	O
-	:	O
-	:	O
experienced	JJ	O
bacterial	JJ	B_Disease
meningitis	NN	E_Disease
.	.	O

The	DT	O
index	NN	O
patient	NN	O
,	,	O
a	DT	O
56	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
white	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
purulent	NN	B_Disease
meningitis	NN	E_Disease
at	IN	O
the	DT	O
age	NN	O
of	IN	O
23	CD	O
years	NNS	O
,	,	O
presented	VBN	O
with	IN	O
an	DT	O
acute	JJ	B_Disease
meningococcal	JJ	I_Disease
meningitis	NN	E_Disease
.	.	O

No	DT	O
impairment	NN	B_Disease
of	IN	I_Disease
cellular	JJ	I_Disease
immunity	NN	E_Disease
or	CC	O
immunoglobulin	JJ	B_Disease
deficiency	NN	E_Disease
could	MD	O
be	VB	O
found	VBN	O
.	.	O

Complement	NNP	O
assays	VBZ	O
showed	VBD	O
a	DT	O
complete	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
C9	NNP	I_Disease
component	NN	E_Disease
,	,	O
while	IN	O
the	DT	O
other	JJ	O
individual	JJ	O
component	NN	O
levels	NNS	O
were	VBD	O
normal	JJ	O
and	CC	O
the	DT	O
hemolytic	JJ	O
activity	NN	O
(	(	O
measured	VBN	O
using	VBG	O
the	DT	O
CH50	NNP	O
assay	NN	O
)	)	O
was	VBD	O
only	RB	O
slightly	RB	O
reduced	VBN	O
.	.	O

A	DT	O
family	NN	O
study	NN	O
revealed	VBD	O
complete	JJ	B_Disease
C9	NNP	I_Disease
deficiency	NN	E_Disease
in	IN	O
the	DT	O
patients	NNS	O
healthy	JJ	O
brother	NN	O
and	CC	O
half	NN	O
-	:	O
normal	JJ	O
C9	NNP	O
concentrations	NNS	O
in	IN	O
his	PRP$	O
sister	NN	O
,	,	O
his	PRP$	O
son	NN	O
(	(	O
who	WP	O
also	RB	O
had	VBD	O
experienced	VBN	O
an	DT	O
episode	NN	O
of	IN	O
bacterial	JJ	B_Disease
meningitis	NN	E_Disease
)	)	O
,	,	O
and	CC	O
his	PRP$	O
niece	NN	O
,	,	O
consistent	NN	O
with	IN	O
an	DT	O
inherited	JJ	O
C9	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

This	DT	O
first	JJ	O
case	NN	O
of	IN	O
recurrent	NN	B_Disease
meningitis	NN	E_Disease
in	IN	O
a	DT	O
white	JJ	O
patient	NN	O
with	IN	O
complete	JJ	B_Disease
C9	NNP	I_Disease
deficiency	NN	E_Disease
suggests	VBZ	O
that	IN	O
this	DT	O
complement	NN	B_Disease
defect	NN	E_Disease
may	MD	O
also	RB	O
be	VB	O
a	DT	O
risk	NN	O
factor	NN	O
for	IN	O
bacterial	JJ	B_Disease
,	,	I_Disease
especially	RB	I_Disease
neisserial	JJ	I_Disease
,	,	I_Disease
infections	NNS	E_Disease
.	.	O
.	.	O

Detection	NN	O
of	IN	O
98	CD	O
%	NN	O
of	IN	O
DMD	NNP	S_Disease
/	NNP	O
BMD	NNP	S_Disease
gene	NN	O
deletions	NNS	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
.	.	O

We	PRP	O
describe	VBP	O
oligonucleotide	JJ	O
primer	NN	O
sequences	NNS	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
amplify	VB	O
eight	CD	O
exons	NNS	O
plus	CC	O
the	DT	O
muscle	NN	O
promoter	NN	O
of	IN	O
the	DT	O
dystrophin	JJ	O
gene	NN	O
in	IN	O
a	DT	O
single	JJ	O
multiplex	JJ	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
.	.	O

When	WRB	O
used	VBN	O
in	IN	O
conjunction	NN	O
with	IN	O
an	DT	O
existing	VBG	O
primer	NN	O
set	NN	O
,	,	O
these	DT	O
two	CD	O
multiplex	NN	O
reactions	NNS	O
detect	VBP	O
about	IN	O
98	CD	O
%	NN	O
of	IN	O
deletions	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
Duchenne	NNP	B_Disease
or	CC	I_Disease
Becker	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
,	,	O
BMD	NNP	S_Disease
)	)	O
.	.	O

Furthermore	RB	O
,	,	O
these	DT	O
primers	NNS	O
amplify	VBP	O
most	JJS	O
of	IN	O
the	DT	O
exons	NNS	O
in	IN	O
the	DT	O
deletion	NN	O
prone	NN	O
"	NNP	O
hot	JJ	O
spot	NN	O
"	JJ	O
region	NN	O
around	IN	O
exons	NNS	O
44	CD	O
to	TO	O
53	CD	O
,	,	O
allowing	VBG	O
determination	NN	O
of	IN	O
deletion	NN	O
endpoints	NNS	O
and	CC	O
prediction	NN	O
of	IN	O
mutational	JJ	O
effects	NNS	O
on	IN	O
the	DT	O
translational	JJ	O
reading	NN	O
frame	NN	O
.	.	O

Thus	RB	O
,	,	O
use	NN	O
of	IN	O
these	DT	O
PCR	NNP	O
-	:	O
based	VBN	O
assays	NNS	O
will	MD	O
allow	VB	O
deletion	NN	O
detection	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
for	IN	O
most	JJS	O
DMD	NNP	S_Disease
/	NNP	O
BMD	NNP	S_Disease
patients	NNS	O
in	IN	O
a	DT	O
fraction	NN	O
of	IN	O
the	DT	O
time	NN	O
required	VBN	O
for	IN	O
Southern	NNP	O
blot	NN	O
analysis	NN	O
.	.	O
.	.	O

Genetic	JJ	O
heterogeneity	NN	O
at	IN	O
the	DT	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
locus	NN	O
in	IN	O
southern	JJ	O
Italy	NNP	O
:	:	O
a	DT	O
study	NN	O
on	IN	O
a	DT	O
population	NN	O
from	IN	O
the	DT	O
Matera	NNP	O
district	NN	O
.	.	O

Glucose	NNP	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
has	VBZ	O
been	VBN	O
analyzed	VBN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
and	CC	O
by	IN	O
quantitative	JJ	O
assay	NN	O
in	IN	O
an	DT	O
unselected	JJ	O
sample	NN	O
of	IN	O
1524	CD	O
schoolboys	NNS	O
from	IN	O
the	DT	O
province	NN	O
of	IN	O
Matera	NNP	O
(	(	O
Lucania	NNP	O
)	)	O
in	IN	O
southern	JJ	O
Italy	NNP	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
43	CD	O
subjects	NNS	O
with	IN	O
a	DT	O
G6PD	NNP	O
variant	NN	O
.	.	O

Of	IN	O
these	DT	O
,	,	O
31	CD	O
had	VBD	O
severe	VBN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
nine	CD	O
had	VBD	O
mild	VBN	O
to	TO	O
moderate	VB	O
deficiency	NN	O
,	,	O
and	CC	O
three	CD	O
had	VBD	O
a	DT	O
non	JJ	O
-	:	O
deficient	NN	O
electrophoretic	JJ	O
variant	NN	O
.	.	O

The	DT	O
overall	JJ	O
rate	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
was	VBD	O
2	CD	O
.	.	O

6	CD	O
%	NN	O
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
ranging	VBG	O
from	IN	O
7	CD	O
.	.	O

2	CD	O
%	NN	O
on	IN	O
the	DT	O
Ionian	JJ	O
Coast	NNP	O
to	TO	O
zero	VB	O
on	IN	O
the	DT	O
eastern	JJ	O
side	NN	O
of	IN	O
the	DT	O
Lucanian	JJ	O
Apennines	NNP	O
,	,	O
appears	VBZ	O
to	TO	O
be	VB	O
inversely	RB	O
related	VBN	O
to	TO	O
the	DT	O
distance	NN	O
of	IN	O
each	DT	O
town	NN	O
examined	VBD	O
from	IN	O
the	DT	O
Ionian	NNP	O
Coast	NNP	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
geographic	JJ	O
distribution	NN	O
may	MD	O
reflect	VB	O
,	,	O
at	IN	O
least	JJS	O
in	IN	O
part	NN	O
,	,	O
gene	NN	O
flow	NN	O
from	IN	O
Greek	JJ	O
settlers	NNS	O
.	.	O

Biochemical	JJ	O
characterization	NN	O
has	VBZ	O
shown	VBN	O
that	IN	O
most	JJS	O
of	IN	O
the	DT	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
this	DT	O
population	NN	O
is	VBZ	O
accounted	VBN	O
for	IN	O
by	IN	O
G6PD	NNP	O
Mediterranean	NNP	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
have	VBP	O
found	VBN	O
several	JJ	O
examples	NNS	O
of	IN	O
two	CD	O
other	JJ	O
known	VBN	O
polymorphic	JJ	O
variants	NNS	O
(	(	O
G6PD	NNP	O
Cagliari	NNP	O
and	CC	O
G6PD	NNP	O
A	NNP	O
-	:	O
)	)	O
;	:	O
three	CD	O
new	JJ	O
polymorphic	JJ	O
variants	NNS	O
,	,	O
G6PD	NNP	O
Metaponto	NNP	O
(	(	O
class	NN	O
III	NNP	O
)	)	O
,	,	O
G6PD	NNP	O
Montalbano	NNP	O
(	(	O
class	NN	O
III	NNP	O
)	)	O
,	,	O
and	CC	O
G6PD	NNP	O
Pisticci	NNP	O
(	(	O
class	NN	O
IV	NNP	O
)	)	O
;	:	O
and	CC	O
two	CD	O
sporadic	JJ	O
variants	NNS	O
,	,	O
G6PD	NNP	O
Tursi	NNP	O
(	(	O
class	NN	O
III	NNP	O
)	)	O
and	CC	O
G6PD	NNP	O
Ferrandina	NNP	O
(	(	O
class	NN	O
II	NNP	O
)	)	O
.	.	O

These	DT	O
data	NNS	O
provide	VBP	O
further	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
marked	JJ	O
genetic	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
within	IN	O
a	DT	O
relatively	RB	O
narrow	JJ	O
geographic	JJ	O
area	NN	O
and	CC	O
they	PRP	O
prove	VBP	O
the	DT	O
presence	NN	O
in	IN	O
the	DT	O
Italian	JJ	O
peninsula	NN	O
of	IN	O
a	DT	O
gene	NN	O
(	(	O
GdA	NNP	O
-	:	O
)	)	O
regarded	VBD	O
as	IN	O
characteristically	RB	O
African	NNP	O
.	.	O

Deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
murine	NN	I_Disease
fifth	JJ	I_Disease
complement	NN	I_Disease
component	NN	I_Disease
(	(	I_Disease
C5	NNP	I_Disease
)	)	E_Disease
.	.	O

A	DT	O
2	CD	O
-	:	O
base	NN	O
pair	NN	O
gene	NN	O
deletion	NN	O
in	IN	O
a	DT	O
5	CD	O
'	POS	O
-	:	O
exon	NN	O
.	.	O

To	TO	O
ascertain	VB	O
the	DT	O
molecular	JJ	O
mechanism	NN	O
that	WDT	O
causes	VBZ	O
murine	JJ	O
C5	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
genomic	JJ	O
and	CC	O
cDNA	JJ	O
libraries	NNS	O
were	VBD	O
constructed	VBN	O
from	IN	O
mouse	NN	O
liver	NN	O
DNA	NNP	O
and	CC	O
mRNA	NN	O
employing	VBG	O
the	DT	O
congenic	JJ	O
strains	NNS	O
B10	NNP	O
.	.	O

D2	NNP	O
/	NNP	O
nSnJ	NN	O
and	CC	O
B10	NNP	O
.	.	O

D2	NNP	O
/	NNP	O
oSnJ	IN	O
that	DT	O
are	VBP	O
sufficient	JJ	O
and	CC	O
deficient	NN	B_Disease
for	IN	I_Disease
C5	NNP	E_Disease
,	,	O
respectively	RB	O
.	.	O

Genomic	JJ	O
fragments	NNS	O
were	VBD	O
isolated	VBN	O
which	WDT	O
correspond	NN	O
to	TO	O
PvuII	NNP	O
and	CC	O
HindIII	NNP	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
associated	VBN	O
with	IN	O
C5	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Sequence	NN	O
analyses	NNS	O
demonstrated	VBD	O
that	IN	O
each	DT	O
of	IN	O
these	DT	O
polymorphisms	NNS	O
resulted	VBD	O
from	IN	O
single	JJ	O
base	NN	O
pair	NN	O
substitutions	NNS	O
and	CC	O
that	IN	O
neither	DT	O
substitution	NN	O
would	MD	O
probably	RB	O
cause	VB	O
or	CC	O
contribute	VB	O
to	TO	O
the	DT	O
C5	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Sequence	NN	O
analyses	NNS	O
of	IN	O
C5	NNP	O
sufficient	NN	O
and	CC	O
deficient	NN	O
cDNAs	NN	O
revealed	VBD	O
a	DT	O
2	CD	O
base	NN	O
-	:	O
pair	NN	O
deletion	NN	O
in	IN	O
the	DT	O
deficient	NN	O
cDNAs	NN	O
.	.	O

The	DT	O
"	NNP	O
TA	NNP	O
"	NNP	O
deletion	NN	O
was	VBD	O
located	VBN	O
near	IN	O
the	DT	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
cDNA	NN	O
.	.	O

This	DT	O
deletion	NN	O
shifts	VBZ	O
the	DT	O
reading	NN	O
frame	NN	O
of	IN	O
the	DT	O
C5	NNP	O
mRNA	NN	O
so	RB	O
that	IN	O
the	DT	O
termination	NN	O
codon	NN	O
UGA	NNP	O
is	VBZ	O
present	JJ	O
4	CD	O
base	NN	O
pairs	NNS	O
downstream	NN	O
from	IN	O
the	DT	O
deletion	NN	O
.	.	O

Genomic	NNP	O
DNA	NNP	O
was	VBD	O
amplified	VBN	O
and	CC	O
sequenced	VBN	O
corresponding	NN	O
to	TO	O
the	DT	O
area	NN	O
surrounding	VBG	O
the	DT	O
2	CD	O
-	:	O
base	NN	O
pair	NN	O
deletion	NN	O
.	.	O

Six	NNP	O
C5	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
strains	NNS	O
,	,	O
A	NNP	O
/	NNP	O
HeJ	NNP	O
,	,	O
AKR	NNP	O
/	NNP	O
J	NNP	O
,	,	O
DBA	NNP	O
/	NNP	O
2J	CD	O
,	,	O
NZB	NNP	O
/	NNP	O
B1NJ	NNP	O
,	,	O
SWR	NNP	O
/	NNP	O
J	NNP	O
,	,	O
and	CC	O
B10	NNP	O
.	.	O

D2	NNP	O
/	NNP	O
oSnJ	NN	O
,	,	O
and	CC	O
four	CD	O
C5	NNP	O
-	:	O
sufficient	NN	O
strains	NNS	O
,	,	O
Balb	NNP	O
/	NNP	O
CJ	NNP	O
,	,	O
C57Bl	NNP	O
/	NNP	O
6J	CD	O
,	,	O
DBA	NNP	O
/	NNP	O
1J	CD	O
,	,	O
and	CC	O
B10	NNP	O
.	.	O

D2	NNP	O
/	NNP	O
nSnJ	NN	O
,	,	O
were	VBD	O
analyzed	VBN	O
.	.	O

The	DT	O
sequencing	NN	O
data	NNS	O
revealed	VBD	O
that	IN	O
the	DT	O
2	CD	O
base	NN	O
pairs	NNS	O
were	VBD	O
deleted	VBN	O
from	IN	O
the	DT	O
C5	NNP	O
gene	NN	O
of	IN	O
each	DT	O
deficient	NN	O
mouse	NN	O
tested	VBD	O
but	CC	O
not	RB	O
from	IN	O
the	DT	O
C5	NNP	O
gene	NN	O
of	IN	O
any	DT	O
sufficient	JJ	O
mouse	NN	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	VBP	O
that	IN	O
1	CD	O
)	)	O
there	EX	O
is	VBZ	O
an	DT	O
identical	JJ	O
2	CD	O
-	:	O
base	NN	O
pair	NN	O
deletion	NN	O
in	IN	O
an	DT	O
exon	NN	O
of	IN	O
the	DT	O
C5	NNP	O
gene	NN	O
in	IN	O
several	JJ	O
different	JJ	O
C5	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
mouse	NN	O
strains	VBZ	O
;	:	O
2	CD	O
)	)	O
the	DT	O
mRNA	NN	O
transcribed	VBD	O
from	IN	O
the	DT	O
C5D	NNP	O
gene	NN	O
retains	VBZ	O
this	DT	O
deletion	NN	O
;	:	O
and	CC	O
3	CD	O
)	)	O
this	DT	O
mutation	NN	O
should	MD	O
result	VB	O
in	IN	O
C5	NNP	B_Disease
protein	NN	I_Disease
deficiency	NN	E_Disease
.	.	O

Molecular	JJ	O
genetics	NNS	O
of	IN	O
PKU	NNP	S_Disease
in	IN	O
eastern	JJ	O
Europe	NNP	O
:	:	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
associated	VBN	O
with	IN	O
haplotype	JJ	O
4	CD	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
.	.	O

Phenylketonuria	NNP	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
genetic	JJ	B_Disease
disorder	NN	E_Disease
secondary	NN	O
to	TO	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
hepatic	JJ	I_Disease
phenylalanine	NN	I_Disease
hydroxylase	NN	E_Disease
(	(	O
PAH	NNP	O
)	)	O
.	.	O

Several	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
have	VBP	O
recently	RB	O
been	VBN	O
reported	VBN	O
,	,	O
and	CC	O
linkage	NN	O
disequilibrium	NN	O
was	VBD	O
observed	VBN	O
between	IN	O
RFLP	NNP	O
haplotypes	NNS	O
and	CC	O
specific	JJ	O
mutations	NNS	O
.	.	O

A	DT	O
new	JJ	O
molecular	JJ	B_Disease
lesion	NN	E_Disease
has	VBZ	O
been	VBN	O
identified	VBN	O
in	IN	O
exon	JJ	O
7	CD	O
of	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
in	IN	O
a	DT	O
Hungarian	JJ	O
PKU	NNP	S_Disease
patient	NN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
of	IN	O
PCR	NNP	O
-	:	O
amplified	VBD	O
DNA	NNP	O
.	.	O

The	DT	O
C	NNP	O
-	:	O
to	TO	O
-	:	O
T	NNP	O
transition	NN	O
causes	VBZ	O
the	DT	O
substitution	NN	O
of	IN	O
Arg243	NNP	O
to	TO	O
a	DT	O
termination	NN	O
codon	NN	O
,	,	O
and	CC	O
the	DT	O
mutant	JJ	O
allele	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
haplotype	JJ	O
4	CD	O
of	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
.	.	O

The	DT	O
mutation	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
two	CD	O
of	IN	O
nine	CD	O
mutant	JJ	O
haplotype	NN	O
4	CD	O
alleles	NNS	O
among	IN	O
Eastern	JJ	O
Europeans	NNPS	O
and	CC	O
is	VBZ	O
not	RB	O
present	JJ	O
among	IN	O
Western	JJ	O
Europeans	NNPS	O
and	CC	O
Asians	NNPS	O
.	.	O

The	DT	O
rarity	NN	O
of	IN	O
this	DT	O
mutant	JJ	O
allele	NN	O
and	CC	O
its	PRP$	O
restricted	JJ	O
geographic	JJ	O
distribution	NN	O
suggest	VBP	O
that	IN	O
the	DT	O
mutational	JJ	O
event	NN	O
occurred	VBD	O
recently	RB	O
on	IN	O
a	DT	O
normal	JJ	O
haplotype	NN	O
4	CD	O
background	NN	O
in	IN	O
Eastern	NNP	O
Europe	NNP	O
.	.	O
.	.	O

The	DT	O
red	JJ	O
-	:	O
green	JJ	O
visual	JJ	O
pigment	NN	O
gene	NN	O
region	NN	O
in	IN	O
adrenoleukodystrophy	NN	S_Disease
.	.	O

Although	IN	O
recent	JJ	O
data	NNS	O
established	VBD	O
that	IN	O
a	DT	O
specific	JJ	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
fatty	JJ	O
acyl	JJ	O
-	:	O
CoA	JJ	O
synthetase	NN	O
is	VBZ	O
defective	JJ	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	NN	E_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
,	,	O
the	DT	O
ALD	NNP	S_Disease
gene	NN	O
is	VBZ	O
still	RB	O
unidentified	JJ	O
.	.	O

The	DT	O
ALD	NNP	S_Disease
locus	NN	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
Xq28	VB	O
,	,	O
like	IN	O
the	DT	O
red	JJ	O
and	CC	O
green	JJ	O
color	NN	O
pigment	NN	O
genes	NNS	O
.	.	O

Abnormal	NNP	B_Disease
color	NN	I_Disease
vision	NN	E_Disease
has	VBZ	O
been	VBN	O
observed	VBN	O
in	IN	O
12	CD	O
of	IN	O
27	CD	O
patients	NNS	O
with	IN	O
adrenomyeloneuropathy	JJ	S_Disease
(	(	O
AMN	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
milder	NN	O
form	NN	O
of	IN	O
ALD	NNP	S_Disease
.	.	O

Furthermore	RB	O
,	,	O
rearrangements	NNS	O
of	IN	O
the	DT	O
color	NN	O
vision	NN	O
gene	NN	O
cluster	NN	O
were	VBD	O
found	VBN	O
in	IN	O
four	CD	O
of	IN	O
eight	CD	O
ALD	NNP	S_Disease
kindreds	NNS	O
.	.	O

This	DT	O
led	VBD	O
us	PRP	O
to	TO	O
propose	VB	O
that	IN	O
a	DT	O
single	JJ	O
DNA	NNP	O
rearrangement	NN	O
could	MD	O
underlie	VB	O
both	DT	O
ALD	NNP	S_Disease
and	CC	O
abnormal	JJ	B_Disease
color	NN	I_Disease
vision	NN	E_Disease
in	IN	O
these	DT	O
patients	NNS	O
.	.	O

Study	NNP	O
of	IN	O
34	CD	O
French	JJ	O
ALD	NNP	S_Disease
patients	NNS	O
failed	VBD	O
to	TO	O
reveal	VB	O
a	DT	O
higher	JJR	O
than	IN	O
expected	VBN	O
frequency	NN	O
of	IN	O
green	JJ	O
/	NNP	O
red	VBD	O
visual	JJ	O
pigment	NN	O
rearrangements	NNS	O
3	CD	O
to	TO	O
the	DT	O
red	JJ	O
/	NN	O
green	JJ	O
color	NN	O
vision	NN	O
gene	NN	O
complex	NN	O
.	.	O

The	DT	O
previous	JJ	O
report	NN	O
of	IN	O
such	JJ	O
rearrangements	NNS	O
was	VBD	O
based	VBN	O
on	IN	O
small	JJ	O
numbers	NNS	O
and	CC	O
lack	NN	O
of	IN	O
knowledge	NN	O
that	IN	O
the	DT	O
frequency	NN	O
of	IN	O
"	NNP	O
abnormal	JJ	O
"	NNP	O
color	NN	O
vision	NN	O
arrays	NNS	O
on	IN	O
molecular	JJ	O
analysis	NN	O
was	VBD	O
twice	RB	O
as	RB	O
high	JJ	O
as	IN	O
expected	VBN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
frequency	NN	O
of	IN	O
phenotypic	NN	B_Disease
color	NN	I_Disease
vision	NN	I_Disease
defects	NNS	E_Disease
.	.	O

The	DT	O
red	JJ	O
/	NN	O
green	JJ	O
color	NN	O
pigment	NN	O
(	(	O
R	NNP	O
/	NNP	O
GCP	NNP	O
)	)	O
region	NN	O
was	VBD	O
studied	VBN	O
by	IN	O
pulsed	JJ	O
-	:	O
field	NN	O
gel	JJ	O
electrophoresis	NN	O
in	IN	O
14	CD	O
of	IN	O
these	DT	O
patients	NNS	O
,	,	O
and	CC	O
we	PRP	O
did	VBD	O
not	RB	O
find	VB	O
any	DT	O
fragment	JJ	O
size	NN	O
difference	NN	O
between	IN	O
the	DT	O
patients	NNS	O
and	CC	O
normal	JJ	O
individuals	NNS	O
who	WP	O
have	VBP	O
the	DT	O
same	JJ	O
number	NN	O
of	IN	O
pigment	JJ	O
genes	NNS	O
.	.	O

The	DT	O
R	NNP	O
/	NNP	O
GCP	NNP	O
region	NN	O
was	VBD	O
also	RB	O
analyzed	VBN	O
in	IN	O
29	CD	O
French	JJ	O
and	CC	O
seven	CD	O
North	JJ	O
American	JJ	O
ALD	NNP	S_Disease
patients	NNS	O
by	IN	O
using	VBG	O
six	CD	O
genomic	JJ	O
DNA	NNP	O
probes	NNS	O
,	,	O
isolated	VBN	O
from	IN	O
a	DT	O
cosmid	NN	O
walk	NN	O
,	,	O
that	WDT	O
flank	VBD	O
the	DT	O
color	NN	O
vision	NN	O
genes	NNS	O
.	.	O

No	DT	O
deletions	NNS	O
were	VBD	O
found	VBN	O
with	IN	O
probes	NNS	O
that	WDT	O
lie	VBP	O
3	CD	O
of	IN	O
the	DT	O
green	JJ	O
pigment	NN	O
genes	NNS	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
eight	CD	O
previously	RB	O
reported	VBN	O
ALD	NNP	S_Disease
individuals	NNS	O
has	VBZ	O
a	DT	O
long	JJ	O
deletion	NN	O
5	CD	O
of	IN	O
the	DT	O
red	JJ	O
pigment	NN	O
gene	NN	O
,	,	O
a	DT	O
deletion	NN	O
causing	VBG	O
blue	JJ	O
cone	NN	O
monochromacy	NN	O
.	.	O

This	DT	O
finding	NN	O
and	CC	O
the	DT	O
previous	JJ	O
findings	NNS	O
of	IN	O
a	DT	O
45	CD	O
%	NN	O
frequency	NN	O
of	IN	O
phenotypic	NN	O
color	NN	O
vision	NN	O
defects	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
AMN	NNP	S_Disease
may	MD	O
suggest	VB	O
that	IN	O
the	DT	O
ALD	NNP	S_Disease
/	NNP	O
AMN	NNP	S_Disease
gene	NN	O
lies	VBZ	O
5	CD	O
to	TO	O
the	DT	O
red	JJ	O
pigment	NN	O
gene	NN	O
and	CC	O
that	IN	O
the	DT	O
frequent	JJ	O
phenotypic	NN	O
color	NN	B_Disease
vision	NN	I_Disease
anomalies	NNS	E_Disease
owe	VBP	O
their	PRP$	O
origin	NN	O
to	TO	O
deleted	VB	O
DNA	NNP	O
that	WDT	O
includes	VBZ	O
regulatory	JJ	O
genes	NNS	O
for	IN	O
color	NN	O
vision	NN	O
.	.	O

It	PRP	O
is	VBZ	O
possible	JJ	O
,	,	O
however	RB	O
,	,	O
that	IN	O
phenotypic	NN	O
color	NN	B_Disease
vision	NN	I_Disease
anomalies	NNS	E_Disease
in	IN	O
AMN	NNP	S_Disease
may	MD	O
be	VB	O
phenocopies	NNS	O
secondary	JJ	O
to	TO	O
retinal	VB	O
or	CC	O
neural	JJ	O
involvement	NN	O
by	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
single	JJ	O
case	NN	O
of	IN	O
blue	JJ	O
cone	NN	O
monochromacy	NN	O
may	MD	O
therefore	RB	O
be	VB	O
a	DT	O
fortuitous	JJ	O
coincidence	NN	O
of	IN	O
two	CD	O
diseases	NNS	O
.	.	O
.	.	O

Paroxysmal	NNP	B_Disease
nocturnal	JJ	I_Disease
haemoglobinuria	NN	E_Disease
with	IN	O
coexisting	VBG	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
ninth	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
:	:	O
lack	NN	O
of	IN	O
massive	JJ	O
haemolytic	JJ	B_Disease
attack	NN	E_Disease
.	.	O

A	DT	O
47	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
woman	NN	O
with	IN	O
paroxysmal	JJ	B_Disease
nocturnal	JJ	I_Disease
haemoglobinuria	NN	E_Disease
(	(	O
PNH	NNP	S_Disease
)	)	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
an	DT	O
inherited	JJ	B_Disease
deficiency	NN	I_Disease
in	IN	I_Disease
the	DT	I_Disease
ninth	JJ	I_Disease
complement	NN	I_Disease
component	NN	E_Disease
(	(	O
C9	NNP	O
)	)	O
.	.	O

In	IN	O
complement	JJ	O
-	:	O
sensitivity	NN	O
lysis	NN	O
tests	NNS	O
,	,	O
80	CD	O
%	NN	O
of	IN	O
her	PRP$	O
erythrocytes	NNS	O
were	VBD	O
markedly	RB	O
complement	JJ	O
-	:	O
sensitive	JJ	O
(	(	O
PNH	NNP	O
-	:	O
III	NN	O
)	)	O
.	.	O

Laser	NNP	O
cytofluorimetry	NN	O
with	IN	O
a	DT	O
monoclonal	JJ	O
antibody	NN	O
against	IN	O
decay	JJ	O
-	:	O
accelerating	VBG	O
factor	NN	O
(	(	O
DAF	NNP	O
)	)	O
revealed	VBD	O
that	IN	O
95	CD	O
%	NN	O
of	IN	O
her	PRP$	O
erythrocytes	NNS	O
were	VBD	O
DAF	NNP	O
-	:	O
negative	JJ	O
.	.	O

Surprisingly	RB	O
,	,	O
she	PRP	O
has	VBZ	O
suffered	VBN	O
only	RB	O
mild	JJ	O
haemolysis	NN	S_Disease
and	CC	O
has	VBZ	O
never	RB	O
experienced	VBN	O
massive	JJ	O
spontaneous	JJ	O
haemolysis	NN	S_Disease
.	.	O

Gross	NNP	O
haemoglobinuria	NN	S_Disease
and	CC	O
jaundice	NN	S_Disease
occurred	VBD	O
only	RB	O
after	IN	O
receiving	VBG	O
postoperative	JJ	O
transfusion	NN	O
of	IN	O
whole	JJ	O
blood	NN	O
.	.	O

In	IN	O
her	PRP$	O
serum	NN	O
,	,	O
C9	NNP	O
was	VBD	O
not	RB	O
detectable	JJ	O
either	CC	O
by	IN	O
immunological	JJ	O
or	CC	O
by	IN	O
functional	JJ	O
assays	NNS	O
.	.	O

Both	DT	O
the	DT	O
Ham	NNP	O
test	NN	O
and	CC	O
the	DT	O
sugar	NN	O
water	NN	O
test	NN	O
using	VBG	O
normal	JJ	O
human	JJ	O
serum	NN	O
or	CC	O
plasma	NN	O
yielded	VBN	O
marked	JJ	O
haemolysis	NN	O
of	IN	O
the	DT	O
patients	NNS	O
erythrocytes	VBZ	O
.	.	O

When	WRB	O
the	DT	O
patients	NNS	O
serum	VBP	O
or	CC	O
plasma	NN	O
was	VBD	O
used	VBN	O
,	,	O
only	RB	O
a	DT	O
trace	NN	O
of	IN	O
lysis	NN	O
was	VBD	O
detected	VBN	O
.	.	O

Addition	NN	O
of	IN	O
purified	JJ	O
human	JJ	O
C9	NNP	O
to	TO	O
her	PRP$	O
plasma	NN	O
fully	RB	O
restored	VBN	O
haemolysis	NN	O
.	.	O

These	DT	O
observations	NNS	O
indicated	VBD	O
that	IN	O
C9	NNP	O
may	MD	O
play	VB	O
a	DT	O
critical	JJ	O
role	NN	O
in	IN	O
haemolytic	JJ	B_Disease
attacks	NNS	E_Disease
in	IN	O
patients	NNS	O
with	IN	O
PNH	NNP	S_Disease
and	CC	O
that	IN	O
characteristic	JJ	O
haemolysis	NN	S_Disease
in	IN	O
PNH	NNP	S_Disease
may	MD	O
be	VB	O
tempered	VBN	O
by	IN	O
coexisting	VBG	O
C9	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O
.	.	O

Duplicational	JJ	O
mutation	NN	O
at	IN	O
the	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
locus	NN	O
:	:	O
its	PRP$	O
frequency	NN	O
,	,	O
distribution	NN	O
,	,	O
origin	NN	O
,	,	O
and	CC	O
phenotypegenotype	JJ	O
correlation	NN	O
.	.	O

Partial	JJ	O
gene	NN	O
deletion	NN	O
is	VBZ	O
the	DT	O
major	JJ	O
cause	NN	O
of	IN	O
mutation	NN	O
leading	VBG	O
to	TO	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
and	CC	O
Becker	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
BMD	NNP	S_Disease
)	)	O
.	.	O

Partial	JJ	O
gene	NN	O
duplication	NN	O
has	VBZ	O
also	RB	O
been	VBN	O
recognized	VBN	O
in	IN	O
a	DT	O
few	JJ	O
cases	NNS	O
.	.	O

We	PRP	O
have	VBP	O
conducted	VBN	O
a	DT	O
survey	NN	O
for	IN	O
duplication	NN	O
in	IN	O
72	CD	O
unrelated	JJ	O
nondeletion	NN	O
patients	NNS	O
,	,	O
analyzed	VBN	O
by	IN	O
Southern	NNP	O
blot	NN	O
hybridization	NN	O
with	IN	O
clones	NNS	O
representing	VBG	O
the	DT	O
entire	JJ	O
DMD	NNP	S_Disease
cDNA	NN	O
.	.	O

With	IN	O
careful	JJ	O
quantitative	JJ	O
analysis	NN	O
of	IN	O
hybridization	NN	O
band	NN	O
intensity	NN	O
,	,	O
10	CD	O
cases	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
a	DT	O
duplication	NN	O
of	IN	O
part	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
a	DT	O
frequency	NN	O
of	IN	O
14	CD	O
%	NN	O
for	IN	O
nondeletion	NN	O
cases	NNS	O
(	(	O
10	CD	O
/	RB	O
72	CD	O
)	)	O
,	,	O
or	CC	O
6	CD	O
%	NN	O
for	IN	O
all	DT	O
cases	NNS	O
(	(	O
10	CD	O
/	RB	O
181	CD	O
)	)	O
.	.	O

The	DT	O
extent	NN	O
of	IN	O
these	DT	O
duplications	NNS	O
has	VBZ	O
been	VBN	O
characterized	VBN	O
according	VBG	O
to	TO	O
the	DT	O
published	VBN	O
exon	SYM	O
-	:	O
containing	VBG	O
HindIII	NNP	O
fragment	NN	O
map	NN	O
,	,	O
and	CC	O
in	IN	O
six	CD	O
of	IN	O
the	DT	O
10	CD	O
duplications	NNS	O
a	DT	O
novel	JJ	O
restriction	NN	O
fragment	NN	O
that	WDT	O
spanned	VBD	O
the	DT	O
duplication	NN	O
junction	NN	O
was	VBD	O
detected	VBN	O
.	.	O

The	DT	O
resulting	VBG	O
translational	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
mRNA	NN	O
has	VBZ	O
been	VBN	O
predicted	VBN	O
for	IN	O
nine	CD	O
duplications	NNS	O
.	.	O

A	DT	O
shift	NN	O
of	IN	O
the	DT	O
reading	NN	O
frame	NN	O
was	VBD	O
predicted	VBN	O
in	IN	O
four	CD	O
of	IN	O
the	DT	O
six	CD	O
DMD	NNP	S_Disease
cases	NNS	O
and	CC	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
intermediate	JJ	O
cases	NNS	O
,	,	O
while	IN	O
the	DT	O
reading	NN	O
frame	NN	O
remained	VBD	O
uninterrupted	JJ	O
in	IN	O
both	DT	O
BMD	NNP	S_Disease
cases	NNS	O
.	.	O

RFLP	NNP	O
and	CC	O
quantitative	JJ	O
Southern	NNP	O
blot	NN	O
analyses	NNS	O
revealed	VBD	O
a	DT	O
grandpaternal	JJ	O
origin	NN	O
of	IN	O
duplication	NN	O
in	IN	O
four	CD	O
families	NNS	O
and	CC	O
grandmaternal	JJ	O
origin	NN	O
in	IN	O
one	CD	O
family	NN	O
.	.	O

In	IN	O
all	DT	O
five	CD	O
families	NNS	O
,	,	O
the	DT	O
duplication	NN	O
was	VBD	O
found	VBN	O
to	TO	O
originate	VB	O
from	IN	O
a	DT	O
single	JJ	O
X	NNP	O
chromosome	NN	O
.	.	O

Unequal	JJ	O
sister	NN	O
-	:	O
chromatid	NN	O
exchange	NN	O
is	VBZ	O
proposed	VBN	O
to	TO	O
be	VB	O
the	DT	O
mechanism	NN	O
for	IN	O
the	DT	O
formation	NN	O
of	IN	O
these	DT	O
duplications	NNS	O
.	.	O
.	.	O

Glucose	NNP	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
variants	NNS	O
:	:	O
Gd	NNP	O
(	(	O
+	NNP	O
)	)	O
Alexandra	NNP	O
associated	VBN	O
with	IN	O
neonatal	JJ	B_Disease
jaundice	NN	E_Disease
and	CC	O
Gd	NNP	O
(	(	O
-	:	O
)	)	O
Camperdown	NNP	O
in	IN	O
a	DT	O
young	JJ	O
man	NN	O
with	IN	O
lamellar	JJ	B_Disease
cataracts	NNS	E_Disease
.	.	O

Two	CD	O
male	JJ	O
subjects	NNS	O
are	VBP	O
described	VBN	O
,	,	O
with	IN	O
unusual	JJ	O
clinical	JJ	O
presentations	NNS	O
and	CC	O
with	IN	O
hitherto	JJ	O
undescribed	JJ	O
G6PD	NNP	O
variants	NNS	O
.	.	O

The	DT	O
first	JJ	O
,	,	O
of	IN	O
Italian	JJ	O
extraction	NN	O
,	,	O
suffered	VBD	O
from	IN	O
severe	JJ	O
neonatal	JJ	B_Disease
jaundice	NN	E_Disease
following	VBG	O
maternal	JJ	O
ingestion	NN	O
of	IN	O
fresh	JJ	O
broad	JJ	O
beans	NNS	O
(	(	O
Vicia	NNP	O
fava	NN	O
)	)	O
both	DT	O
prenatally	RB	O
and	CC	O
postnatally	RB	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
enzymatic	JJ	O
defect	NN	O
was	VBD	O
much	RB	O
more	JJR	O
severe	JJ	O
in	IN	O
the	DT	O
neonatal	JJ	O
period	NN	O
than	IN	O
on	IN	O
retesting	VBG	O
in	IN	O
adolescence	NN	O
,	,	O
when	WRB	O
biochemical	JJ	O
characterization	NN	O
showed	VBD	O
unique	JJ	O
features	NNS	O
which	WDT	O
justify	VBP	O
designation	NN	O
as	IN	O
a	DT	O
new	JJ	O
variant	NN	O
Gd	NNP	O
(	(	O
+	NNP	O
)	)	O
Alexandra	NNP	O
.	.	O

The	DT	O
second	JJ	O
patient	NN	O
,	,	O
a	DT	O
boy	NN	O
of	IN	O
Maltese	JJ	O
extraction	NN	O
who	WP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
bilateral	JJ	B_Disease
lamellar	JJ	I_Disease
cataracts	NNS	E_Disease
at	IN	O
the	DT	O
age	NN	O
of	IN	O
4	CD	O
years	NNS	O
,	,	O
was	VBD	O
identified	VBN	O
as	IN	O
G6PD	NNP	B_Disease
deficient	NN	E_Disease
only	RB	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
a	DT	O
survey	NN	O
of	IN	O
children	NNS	O
of	IN	O
Mediterranean	NNP	O
origin	NN	O
with	IN	O
unexplained	JJ	O
cataract	JJ	S_Disease
formation	NN	O
;	:	O
he	PRP	O
has	VBZ	O
approximately	RB	O
15	CD	O
%	NN	O
of	IN	O
normal	JJ	O
enzyme	JJ	O
activity	NN	O
,	,	O
with	IN	O
another	DT	O
unique	JJ	O
combination	NN	O
of	IN	O
biochemical	JJ	O
characteristics	NNS	O
which	WDT	O
has	VBZ	O
led	VBN	O
to	TO	O
its	PRP$	O
designation	NN	O
as	IN	O
Gd	NNP	O
(	(	O
-	:	O
)	)	O
Camperdown	NNP	O
.	.	O

Although	IN	O
this	DT	O
association	NN	O
may	MD	O
be	VB	O
coincidental	JJ	O
,	,	O
it	PRP	O
prompts	VBZ	O
further	JJ	O
attention	NN	O
to	TO	O
the	DT	O
possibility	NN	O
that	WDT	O
under	IN	O
certain	JJ	O
circumstances	NNS	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
may	MD	O
favor	VB	O
cataract	JJ	S_Disease
formation	NN	O
.	.	O

The	DT	O
two	CD	O
cases	NNS	O
illustrate	VBP	O
the	DT	O
value	NN	O
of	IN	O
characterization	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
enzyme	NN	O
whenever	WRB	O
unexpected	JJ	O
clinical	JJ	O
or	CC	O
laboratory	JJ	O
results	NNS	O
are	VBP	O
obtained	VBN	O
.	.	O
.	.	O

Statistical	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
two	CD	O
stage	NN	O
mutation	NN	O
model	NN	O
in	IN	O
von	NN	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	I_Disease
disease	NN	E_Disease
,	,	O
and	CC	O
in	IN	O
sporadic	JJ	B_Disease
cerebellar	JJ	I_Disease
haemangioblastoma	NN	E_Disease
and	CC	O
renal	JJ	B_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
age	NN	O
incidence	NN	O
curves	NNS	O
for	IN	O
unilateral	JJ	B_Disease
and	CC	I_Disease
bilateral	JJ	I_Disease
retinoblastoma	NN	E_Disease
led	VBD	O
Knudson	NNP	O
to	TO	O
propose	VB	O
that	IN	O
hereditary	JJ	B_Disease
tumours	NNS	E_Disease
may	MD	O
arise	VB	O
by	IN	O
a	DT	O
single	JJ	O
event	NN	O
and	CC	O
sporadic	JJ	B_Disease
tumours	NNS	E_Disease
by	IN	O
a	DT	O
two	CD	O
stage	NN	O
mutation	NN	O
process	NN	O
.	.	O

It	PRP	O
has	VBZ	O
been	VBN	O
suggested	VBN	O
recently	RB	O
that	IN	O
sporadic	JJ	B_Disease
renal	JJ	I_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
may	MD	O
arise	VB	O
from	IN	O
a	DT	O
two	CD	O
stage	NN	O
mutation	NN	O
process	NN	O
.	.	O

We	PRP	O
analysed	VBD	O
the	DT	O
age	NN	O
incidence	NN	O
curves	NNS	O
for	IN	O
symptomatic	JJ	O
renal	NN	B_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
(	(	O
n	JJ	O
=	NNP	O
26	CD	O
)	)	O
and	CC	O
cerebellar	JJ	B_Disease
haemangioblastoma	NN	E_Disease
(	(	O
n	JJ	O
=	NNP	O
68	CD	O
)	)	O
in	IN	O
109	CD	O
patients	NNS	O
with	IN	O
von	JJ	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	I_Disease
(	(	I_Disease
VHL	NNP	I_Disease
)	)	I_Disease
disease	NN	E_Disease
,	,	O
and	CC	O
compared	VBN	O
them	PRP	O
to	TO	O
104	CD	O
patients	NNS	O
with	IN	O
sporadic	JJ	B_Disease
renal	JJ	I_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
and	CC	O
43	CD	O
patients	NNS	O
with	IN	O
sporadic	JJ	B_Disease
cerebellar	JJ	I_Disease
haemangioblastoma	NN	E_Disease
.	.	O

The	DT	O
age	NN	O
incidence	NN	O
curves	NNS	O
for	IN	O
renal	JJ	B_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
and	CC	O
cerebellar	JJ	B_Disease
haemangioblastoma	NN	E_Disease
in	IN	O
VHL	NNP	B_Disease
disease	NN	E_Disease
were	VBD	O
compatible	JJ	O
with	IN	O
a	DT	O
single	JJ	O
mutation	NN	O
model	NN	O
,	,	O
whereas	IN	O
the	DT	O
age	NN	O
incidence	NN	O
curves	NNS	O
for	IN	O
sporadic	JJ	B_Disease
renal	JJ	I_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
and	CC	O
cerebellar	JJ	B_Disease
haemangioblastoma	NN	E_Disease
suggested	VBD	O
a	DT	O
two	CD	O
stage	NN	O
mutation	NN	O
process	NN	O
.	.	O

These	DT	O
data	NNS	O
are	VBP	O
compatible	JJ	O
with	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
functioning	VBG	O
as	IN	O
a	DT	O
recessive	JJ	O
tumour	NN	S_Disease
suppressor	NN	O
gene	NN	O
.	.	O

Sporadic	JJ	B_Disease
cerebellar	JJ	I_Disease
haemangioblastoma	NN	E_Disease
and	CC	O
some	DT	O
renal	JJ	B_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
may	MD	O
arise	VB	O
from	IN	O
somatic	JJ	O
mutations	NNS	O
inactivating	VBG	O
both	DT	O
alleles	NNS	O
at	IN	O
the	DT	O
VHL	NNP	S_Disease
locus	NN	O
.	.	O
.	.	O

Screening	VBG	O
for	IN	O
carriers	NNS	O
of	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
among	IN	O
Ashkenazi	JJ	O
Jews	NNPS	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
DNA	NNP	O
-	:	O
based	VBN	O
and	CC	O
enzyme	SYM	O
-	:	O
based	VBN	O
tests	NNS	O
.	.	O

BACKGROUND	NNP	O
AND	NNP	O
METHODS	NNP	O
.	.	O

The	DT	O
prevention	NN	O
of	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
GM2	NNP	B_Disease
gangliosidosis	NN	I_Disease
,	,	I_Disease
type	RB	I_Disease
1	CD	E_Disease
)	)	O
depends	VBZ	O
on	IN	O
the	DT	O
identification	NN	O
of	IN	O
carriers	NNS	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
this	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
.	.	O

We	PRP	O
compared	VBN	O
the	DT	O
enzyme	NN	O
-	:	O
based	VBN	O
test	NN	O
widely	RB	O
used	VBN	O
in	IN	O
screening	VBG	O
for	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
with	IN	O
a	DT	O
test	NN	O
based	VBN	O
on	IN	O
analysis	NN	O
of	IN	O
DNA	NNP	O
.	.	O

We	PRP	O
developed	VBD	O
methods	NNS	O
to	TO	O
detect	VB	O
the	DT	O
three	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
that	WDT	O
occur	VBZ	O
with	IN	O
high	JJ	O
frequency	NN	O
among	IN	O
Ashkenazi	JJ	O
Jews	NNPS	O
two	CD	O
mutations	NNS	O
cause	VBP	O
infantile	JJ	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
,	,	O
and	CC	O
the	DT	O
third	JJ	O
causes	VBZ	O
the	DT	O
adult	NN	O
-	:	O
onset	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

DNA	NN	O
segments	NNS	O
containing	VBG	O
these	DT	O
mutation	NN	O
sites	NNS	O
were	VBD	O
amplified	VBN	O
with	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
and	CC	O
analyzed	VBN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
.	.	O

RESULTS	NNP	O
.	.	O

Among	IN	O
62	CD	O
Ashkenazi	NNP	O
obligate	JJ	O
carriers	NNS	O
of	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
,	,	O
the	DT	O
three	CD	O
specific	JJ	O
mutations	NNS	O
accounted	VBD	O
for	IN	O
all	DT	O
but	CC	O
one	CD	O
of	IN	O
the	DT	O
mutant	JJ	O
alleles	NNS	O
(	(	O
98	CD	O
percent	NN	O
)	)	O
.	.	O

In	IN	O
216	CD	O
Ashkenazi	NNP	O
carriers	NNS	O
identified	VBN	O
by	IN	O
the	DT	O
enzyme	JJ	O
test	NN	O
,	,	O
DNA	NNP	O
analysis	NN	O
showed	VBD	O
that	IN	O
177	CD	O
(	(	O
82	CD	O
percent	NN	O
)	)	O
had	VBD	O
one	CD	O
of	IN	O
the	DT	O
identified	JJ	O
mutations	NNS	O
.	.	O

Of	IN	O
the	DT	O
177	CD	O
,	,	O
79	CD	O
percent	NN	O
had	VBD	O
the	DT	O
exon	JJ	O
11	CD	O
insertion	NN	O
mutation	NN	O
,	,	O
18	CD	O
percent	NN	O
had	VBD	O
the	DT	O
intron	NN	O
12	CD	O
splice	NN	O
-	:	O
junction	NN	O
mutation	NN	O
,	,	O
and	CC	O
3	CD	O
percent	NN	O
had	VBD	O
the	DT	O
less	RBR	O
severe	JJ	O
exon	NN	O
7	CD	O
mutation	NN	O
associated	VBN	O
with	IN	O
adult	NN	O
-	:	O
onset	NN	O
disease	NN	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
the	DT	O
enzyme	NN	O
tests	NNS	O
in	IN	O
the	DT	O
39	CD	O
subjects	NNS	O
(	(	O
18	CD	O
percent	NN	O
)	)	O
who	WP	O
were	VBD	O
defined	VBN	O
as	IN	O
carriers	NNS	O
but	CC	O
in	IN	O
whom	WP	O
DNA	NNP	O
analysis	NN	O
did	VBD	O
not	RB	O
identify	VB	O
a	DT	O
mutant	JJ	O
allele	NN	O
were	VBD	O
probably	RB	O
false	JJ	O
positive	JJ	O
(	(	O
although	IN	O
there	EX	O
remains	VBZ	O
some	DT	O
possibility	NN	O
of	IN	O
unidentified	JJ	O
mutations	NNS	O
)	)	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
of	IN	O
152	CD	O
persons	NNS	O
defined	VBD	O
as	IN	O
noncarriers	NNS	O
by	IN	O
the	DT	O
enzyme	NN	O
-	:	O
based	VBN	O
test	NN	O
,	,	O
1	CD	O
was	VBD	O
identified	VBN	O
as	IN	O
a	DT	O
carrier	NN	O
by	IN	O
DNA	NN	O
analysis	NN	O
(	(	O
i	NN	O
.	.	O

e	NN	O
e	NN	O
.	.	O
,	,	O
a	DT	O
false	JJ	O
negative	JJ	O
enzyme	NN	O
-	:	O
test	NN	O
result	NN	O
)	)	O
.	.	O

CONCLUSIONS	NNP	O
.	.	O

The	DT	O
increased	VBN	O
specificity	NN	O
and	CC	O
predictive	JJ	O
value	NN	O
of	IN	O
the	DT	O
DNA	NNP	O
-	:	O
based	VBN	O
test	NN	O
make	VBP	O
it	PRP	O
a	DT	O
useful	JJ	O
adjunct	NN	O
to	TO	O
the	DT	O
diagnostic	JJ	O
tests	NNS	O
currently	RB	O
used	VBN	O
to	TO	O
screen	VB	O
for	IN	O
carriers	NNS	O
of	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
.	.	O

Total	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
plasma	NN	I_Disease
cholesteryl	NN	I_Disease
ester	NN	I_Disease
transfer	NN	I_Disease
protein	NN	E_Disease
in	IN	O
subjects	NNS	O
homozygous	JJ	O
and	CC	O
heterozygous	JJ	O
for	IN	O
the	DT	O
intron	NN	O
14	CD	O
splicing	NN	O
defect	NN	O
.	.	O

The	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
cholesteryl	NN	B_Disease
ester	NN	I_Disease
transfer	NN	I_Disease
protein	NN	I_Disease
(	(	I_Disease
CETP	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
was	VBD	O
investigated	VBN	O
in	IN	O
4	CD	O
unrelated	JJ	O
CETP	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
families	NNS	O
.	.	O

The	DT	O
high	JJ	O
density	NN	O
lipoprotein	SYM	O
-	:	O
cholesterol	NN	O
levels	NNS	O
of	IN	O
the	DT	O
probands	NNS	O
exceeded	VBD	O
150	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
.	.	O

The	DT	O
plasma	NN	O
of	IN	O
the	DT	O
probands	NNS	O
was	VBD	O
totally	RB	O
deficient	JJ	O
in	IN	O
CETP	NNP	O
activity	NN	O
and	CC	O
mass	NN	O
.	.	O

The	DT	O
genomic	JJ	O
DNA	NN	O
of	IN	O
the	DT	O
patients	NNS	O
was	VBD	O
amplified	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
,	,	O
using	VBG	O
two	CD	O
oligonucleotide	JJ	O
primers	NNS	O
located	VBN	O
in	IN	O
the	DT	O
intron	NN	O
12	CD	O
and	CC	O
14	CD	O
of	IN	O
the	DT	O
CETP	NNP	O
gene	NN	O
,	,	O
and	CC	O
the	DT	O
amplified	JJ	O
products	NNS	O
were	VBD	O
directly	RB	O
sequenced	VBN	O
.	.	O

Two	CD	O
patients	NNS	O
were	VBD	O
homozygous	JJ	O
for	IN	O
a	DT	O
G	NNP	O
-	:	O
to	TO	O
-	:	O
A	DT	O
change	NN	O
at	IN	O
the	DT	O
5	CD	O
-	:	O
splice	NN	O
donor	JJ	O
site	NN	O
of	IN	O
the	DT	O
intron	NN	O
14	CD	O
.	.	O

The	DT	O
G	NNP	O
-	:	O
to	TO	O
-	:	O
A	DT	O
change	NN	O
would	MD	O
cause	VB	O
impaired	JJ	O
splicing	NN	O
of	IN	O
pre	JJ	O
-	:	O
messenger	NN	O
RNA	NNP	O
.	.	O

The	DT	O
other	JJ	O
two	CD	O
probands	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
mutation	NN	O
,	,	O
but	CC	O
totally	RB	O
lacked	JJ	O
CETP	NNP	O
.	.	O

Their	PRP$	O
lipoprotein	NN	O
patterns	NNS	O
were	VBD	O
also	RB	O
similar	JJ	O
to	TO	O
those	DT	O
of	IN	O
the	DT	O
two	CD	O
homozygotes	NNS	O
.	.	O

Thus	RB	O
,	,	O
other	JJ	O
genetic	JJ	B_Disease
defects	NNS	E_Disease
or	CC	O
metabolic	JJ	O
factors	NNS	O
influencing	VBG	O
CETP	NNP	O
expression	NN	O
are	VBP	O
implicated	VBN	O
.	.	O

The	DT	O
data	NN	O
suggest	NN	O
that	IN	O
the	DT	O
G	NNP	O
-	:	O
to	TO	O
-	:	O
A	DT	O
mutation	NN	O
may	MD	O
be	VB	O
common	JJ	O
in	IN	O
human	JJ	O
plasma	NN	O
CETP	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Furthermore	RB	O
,	,	O
there	EX	O
could	MD	O
be	VB	O
compound	VBN	O
heterozygotes	NNS	O
who	WP	O
totally	RB	O
lack	VBP	O
plasma	JJ	O
CETP	NNP	O
and	CC	O
have	VBP	O
lipoprotein	VBN	O
profiles	NNS	O
similar	JJ	O
to	TO	O
those	DT	O
of	IN	O
homozygotes	NNS	O
.	.	O
.	.	O

Molecular	JJ	O
genetics	NNS	O
of	IN	O
the	DT	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
Mediterranean	NNP	O
variant	NN	O
and	CC	O
description	NN	O
of	IN	O
a	DT	O
new	JJ	O
G6PD	NNP	O
mutant	NN	O
,	,	O
G6PD	NNP	O
Andalus1361A	NNP	O
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
;	:	I_Disease
E	NNP	I_Disease
.	.	I_Disease
C	NNP	I_Disease
.	.	I_Disease
1	CD	I_Disease
.	.	I_Disease
1	CD	I_Disease
.	.	I_Disease
1	CD	I_Disease
.	.	I_Disease
49	CD	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
human	JJ	O
enzymopathy	NN	S_Disease
;	:	O
more	JJR	O
than	IN	O
300	CD	O
different	JJ	O
biochemical	JJ	O
variants	NNS	O
of	IN	O
the	DT	O
enzyme	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
.	.	O

In	IN	O
many	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
world	NN	O
the	DT	O
Mediterranean	NNP	O
type	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
prevalent	JJ	O
.	.	O

However	RB	O
,	,	O
G6PD	NNP	O
Mediterranean	NNP	O
has	VBZ	O
come	VBN	O
to	TO	O
be	VB	O
regarded	VBN	O
as	IN	O
a	DT	O
generic	JJ	O
term	NN	O
applied	VBN	O
to	TO	O
similar	JJ	O
G6PD	NNP	O
mutations	NNS	O
thought	VBD	O
,	,	O
however	RB	O
,	,	O
to	TO	O
represent	VB	O
a	DT	O
somewhat	RB	O
heterogeneous	JJ	O
group	NN	O
.	.	O

A	DT	O
C	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
T	NN	O
mutation	NN	O
at	IN	O
nucleotide	JJ	O
563	CD	O
of	IN	O
G6PD	NNP	O
Mediterranean	NNP	O
has	VBZ	O
been	VBN	O
identified	VBN	O
by	IN	O
Vulliamy	NNP	O
et	CC	O
al	NN	O
.	.	O
,	,	O
and	CC	O
the	DT	O
same	JJ	O
mutation	NN	O
has	VBZ	O
been	VBN	O
found	VBN	O
by	IN	O
De	NNP	O
Vita	NNP	O
et	CC	O
al	NN	O
.	.	O

in	IN	O
G6PD	NNP	O
Mediterranean	NNP	O
,	,	O
G6PD	NNP	O
Sassari	NNP	O
,	,	O
and	CC	O
G6PD	NNP	O
Cagliari	NNP	O
.	.	O

The	DT	O
latter	JJ	O
subjects	NNS	O
had	VBD	O
an	DT	O
additional	JJ	O
mutation	NN	O
,	,	O
at	IN	O
nucleotide	JJ	O
1311	CD	O
,	,	O
that	WDT	O
did	VBD	O
not	RB	O
produce	VB	O
a	DT	O
coding	NN	O
change	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
genomic	JJ	O
DNA	NN	O
of	IN	O
five	CD	O
patients	NNS	O
-	:	O
-	:	O
four	CD	O
of	IN	O
Spanish	JJ	O
origin	NN	O
and	CC	O
one	CD	O
of	IN	O
Jewish	JJ	O
origin	NN	O
-	:	O
-	:	O
having	VBG	O
enzymatically	RB	O
documented	VBN	O
G6PD	NNP	O
Mediterranean	NNP	O
.	.	O

All	DT	O
had	VBD	O
both	CC	O
the	DT	O
mutation	NN	O
at	IN	O
nucleotide	JJ	O
563	CD	O
and	CC	O
that	DT	O
at	IN	O
nucleotide	RB	O
1311	CD	O
.	.	O

A	DT	O
sixth	JJ	O
sample	NN	O
,	,	O
resembling	VBG	O
G6PD	NNP	O
Mediterranean	NNP	O
kinetically	RB	O
but	CC	O
with	IN	O
a	DT	O
slightly	RB	O
rapid	JJ	O
electrophoretic	JJ	O
mobility	NN	O
,	,	O
was	VBD	O
designated	VBN	O
G6PD	NNP	O
Andalus	NNP	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
different	JJ	O
mutation	NN	O
,	,	O
a	DT	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
A	DT	O
transition	NN	O
at	IN	O
nucleotide	JJ	O
1361	CD	O
,	,	O
producing	VBG	O
an	DT	O
arginine	JJ	O
-	:	O
to	TO	O
-	:	O
histidine	NN	O
substitution	NN	O
.	.	O

These	DT	O
studies	NNS	O
suggest	VBP	O
that	IN	O
G6PD	NNP	O
Mediterranean	NNP	O
is	VBZ	O
,	,	O
after	IN	O
all	DT	O
,	,	O
relatively	RB	O
homogeneous	JJ	O
.	.	O

A	DT	O
normal	JJ	O
male	NN	O
with	IN	O
an	DT	O
inherited	JJ	O
deletion	NN	O
of	IN	O
one	CD	O
exon	NN	O
within	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
.	.	O

We	PRP	O
describe	VBP	O
two	CD	O
brothers	NNS	O
with	IN	O
identical	JJ	O
inherited	JJ	O
deletions	NNS	O
of	IN	O
one	CD	O
single	JJ	O
exon	NN	O
within	IN	O
the	DT	O
middle	NN	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
;	:	O
one	CD	O
brother	NN	O
has	VBZ	O
Becker	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
diagnosed	VBD	O
at	IN	O
11	CD	O
years	NNS	O
of	IN	O
age	NN	O
,	,	O
whereas	IN	O
the	DT	O
older	JJR	O
brother	NN	O
is	VBZ	O
normal	JJ	O
at	IN	O
18	CD	O
.	.	O

These	DT	O
results	NNS	O
have	VBP	O
implications	NNS	O
for	IN	O
genetic	JJ	O
counselling	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
in	IN	O
families	NNS	O
with	IN	O
Becker	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O
.	.	O

Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
gene	NN	O
expression	NN	O
in	IN	O
normal	JJ	O
and	CC	O
diseased	JJ	O
human	JJ	O
muscle	NN	O
.	.	O

A	DT	O
probe	NN	O
for	IN	O
the	DT	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
gene	NN	O
was	VBD	O
used	VBN	O
to	TO	O
study	VB	O
expression	NN	O
of	IN	O
the	DT	O
gene	NN	O
in	IN	O
normal	JJ	O
human	JJ	O
muscle	NN	O
,	,	O
myogenic	JJ	O
cell	NN	O
cultures	NNS	O
,	,	O
and	CC	O
muscle	NN	O
from	IN	O
patients	NNS	O
with	IN	O
DMD	NNP	S_Disease
.	.	O

Expression	NN	O
was	VBD	O
found	VBN	O
in	IN	O
RNA	NNP	O
from	IN	O
normal	JJ	O
fetal	JJ	O
muscle	NN	O
,	,	O
adult	NN	O
cardiac	NN	O
and	CC	O
skeletal	JJ	O
muscle	NN	O
,	,	O
and	CC	O
cultured	VBD	O
muscle	NN	O
after	IN	O
myoblast	JJ	O
fusion	NN	O
.	.	O

In	IN	O
DMD	NNP	S_Disease
muscle	NN	O
,	,	O
expression	NN	O
of	IN	O
this	DT	O
portion	NN	O
of	IN	O
the	DT	O
gene	NN	O
was	VBD	O
also	RB	O
revealed	VBN	O
by	IN	O
in	IN	O
situ	NN	O
RNA	NNP	O
hybridization	NN	O
,	,	O
particularly	RB	O
in	IN	O
regenerating	VBG	O
muscle	NN	O
fibers	NNS	O
.	.	O
.	.	O

Molecular	JJ	O
and	CC	O
phenotypic	JJ	O
analysis	NN	O
of	IN	O
patients	NNS	O
with	IN	O
deletions	NNS	O
within	IN	O
the	DT	O
deletion	NN	O
-	:	O
rich	JJ	O
region	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
gene	NN	O
.	.	O

Eighty	NNP	O
unrelated	JJ	O
individuals	NNS	O
with	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
or	CC	O
Becker	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
BMD	NNP	S_Disease
)	)	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
deletions	NNS	O
in	IN	O
the	DT	O
major	JJ	O
deletion	NN	O
-	:	O
rich	JJ	O
region	NN	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
locus	NN	O
.	.	O

This	DT	O
region	NN	O
includes	VBZ	O
the	DT	O
last	JJ	O
five	CD	O
exons	NNS	O
detected	VBN	O
by	IN	O
cDNA5b	NN	O
-	:	O
7	CD	O
,	,	O
all	DT	O
exons	NNS	O
detected	VBN	O
by	IN	O
cDNA8	NN	O
,	,	O
and	CC	O
the	DT	O
first	JJ	O
two	CD	O
exons	NNS	O
detected	VBN	O
by	IN	O
cDNA9	NN	O
.	.	O

These	DT	O
80	CD	O
individuals	NNS	O
account	VBP	O
for	IN	O
approximately	RB	O
75	CD	O
%	NN	O
of	IN	O
109	CD	O
deletions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
detected	VBN	O
among	IN	O
181	CD	O
patients	NNS	O
analyzed	VBN	O
with	IN	O
the	DT	O
entire	JJ	O
dystrophin	NN	O
cDNA	NN	O
.	.	O

Endpoints	NNS	O
for	IN	O
many	JJ	O
of	IN	O
these	DT	O
deletions	NNS	O
were	VBD	O
further	RB	O
characterized	VBN	O
using	VBG	O
two	CD	O
genomic	JJ	O
probes	NNS	O
,	,	O
p20	NN	O
(	(	O
DXS269	NNP	O
;	:	O
Wapenaar	NNP	O
et	FW	O
al	NN	O
.	.	O
)	)	O
and	CC	O
GMGX11	NNP	O
(	(	O
DXS239	NNP	O
;	:	O
present	JJ	O
paper	NN	O
)	)	O
.	.	O

Clinical	JJ	O
findings	NNS	O
are	VBP	O
presented	VBN	O
for	IN	O
all	DT	O
80	CD	O
patients	NNS	O
allowing	VBG	O
a	DT	O
correlation	NN	O
of	IN	O
phenotypic	NN	O
severity	NN	O
with	IN	O
the	DT	O
genotype	NN	O
.	.	O

Thirty	NNP	O
-	:	O
eight	CD	O
independent	JJ	O
patients	NNS	O
were	VBD	O
old	JJ	O
enough	RB	O
to	TO	O
be	VB	O
classified	VBN	O
as	IN	O
DMD	NNP	S_Disease
,	,	O
BMD	NNP	S_Disease
,	,	O
or	CC	O
intermediate	JJ	O
phenotype	NN	O
and	CC	O
had	VBD	O
deletions	NNS	O
of	IN	O
exons	NNS	O
with	IN	O
sequenced	JJ	O
intron	NN	O
/	NNP	O
exon	NN	O
boundaries	NNS	O
.	.	O

Of	IN	O
these	DT	O
,	,	O
eight	CD	O
BMD	NNP	S_Disease
patients	NNS	O
and	CC	O
one	CD	O
intermediate	NN	O
patient	NN	O
had	VBD	O
gene	NN	O
deletions	NNS	O
predicted	VBD	O
to	TO	O
leave	VB	O
the	DT	O
reading	NN	O
frame	NN	O
intact	JJ	O
,	,	O
while	IN	O
21	CD	O
DMD	NNP	S_Disease
patients	NNS	O
,	,	O
7	CD	O
intermediate	JJ	O
patients	NNS	O
,	,	O
and	CC	O
1	CD	O
BMD	NNP	S_Disease
patient	NN	O
had	VBD	O
gene	NN	O
deletions	NNS	O
predicted	VBD	O
to	TO	O
disrupt	VB	O
the	DT	O
reading	NN	O
frame	NN	O
.	.	O

Thus	RB	O
,	,	O
with	IN	O
two	CD	O
exceptions	NNS	O
,	,	O
frameshift	JJ	O
deletions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
resulted	VBD	O
in	IN	O
more	RBR	O
severe	JJ	O
phenotype	NN	O
than	IN	O
did	VBD	O
in	IN	O
-	:	O
frame	NN	O
deletions	NNS	O
.	.	O

This	DT	O
is	VBZ	O
in	IN	O
agreement	NN	O
with	IN	O
recent	JJ	O
findings	NNS	O
by	IN	O
Baumbach	NNP	O
et	CC	O
al	NN	O
.	.	O

and	CC	O
Koenig	NNP	O
et	VBP	O
al	NN	O
.	.	O

but	CC	O
is	VBZ	O
in	IN	O
contrast	NN	O
to	TO	O
findings	NNS	O
,	,	O
by	IN	O
Malhotra	NNP	O
et	CC	O
al	NN	O
.	.	O

at	IN	O
the	DT	O
5	CD	O
'	POS	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

Cloning	NN	O
of	IN	O
breakpoints	NNS	O
of	IN	O
a	DT	O
chromosome	NN	O
translocation	NN	O
identifies	VBZ	O
the	DT	O
AN2	NNP	O
locus	NN	O
.	.	O

Chromosome	NNP	O
translocations	NNS	O
involving	VBG	O
11p13	CD	O
have	VBP	O
been	VBN	O
associated	VBN	O
with	IN	O
familial	JJ	B_Disease
aniridia	NN	E_Disease
in	IN	O
two	CD	O
kindreds	NNS	O
highlighting	VBG	O
the	DT	O
chromosomal	JJ	O
localization	NN	O
of	IN	O
the	DT	O
AN2	NNP	O
locus	NN	O
.	.	O

This	DT	O
locus	NN	O
is	VBZ	O
also	RB	O
part	NN	O
of	IN	O
the	DT	O
WAGR	NNP	S_Disease
complex	NN	O
(	(	O
Wilms	NNP	B_Disease
tumor	NN	E_Disease
,	,	O
aniridia	NN	S_Disease
,	,	O
genitourinary	JJ	B_Disease
abnormalities	NNS	E_Disease
,	,	O
and	CC	O
mental	JJ	B_Disease
retardation	NN	E_Disease
)	)	O
.	.	O

In	IN	O
one	CD	O
kindred	VBD	O
,	,	O
the	DT	O
translocation	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
deletion	NN	O
,	,	O
and	CC	O
probes	NNS	O
for	IN	O
this	DT	O
region	NN	O
were	VBD	O
used	VBN	O
to	TO	O
identify	VB	O
and	CC	O
clone	VB	O
the	DT	O
breakpoints	NNS	O
of	IN	O
the	DT	O
translocation	NN	O
in	IN	O
the	DT	O
second	JJ	O
kindred	VBN	O
.	.	O

Comparison	NNP	O
of	IN	O
phage	NN	O
restriction	NN	O
maps	NNS	O
exclude	VBP	O
the	DT	O
presence	NN	O
of	IN	O
any	DT	O
sizable	JJ	O
deletion	NN	O
in	IN	O
this	DT	O
case	NN	O
.	.	O

Sequences	NNS	O
at	IN	O
the	DT	O
chromosome	NN	O
11	CD	O
breakpoint	NN	O
are	VBP	O
conserved	VBN	O
in	IN	O
multiple	JJ	O
species	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
translocation	NN	O
falls	VBZ	O
within	IN	O
the	DT	O
AN2	NNP	O
gene	NN	O
.	.	O
.	.	O

Linkage	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
apolipoprotein	NN	O
C2	NNP	O
gene	NN	O
and	CC	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
on	IN	O
human	JJ	O
chromosome	NN	O
19	CD	O
reveals	NNS	O
linkage	JJ	O
disequilibrium	NN	O
in	IN	O
a	DT	O
French	JJ	O
-	:	O
Canadian	JJ	O
population	NN	O
.	.	O

The	DT	O
gene	NN	O
for	IN	O
human	JJ	O
apolipoprotein	NN	O
C2	NNP	O
(	(	O
APOC2	NNP	O
)	)	O
,	,	O
situated	VBN	O
on	IN	O
the	DT	O
proximal	NN	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
19	CD	O
,	,	O
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
adult	NN	O
muscular	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
.	.	O

Six	NNP	O
APOC2	NNP	O
RFLPs	NNP	O
(	(	O
TaqI	NNP	O
,	,	O
BglI	NNP	O
,	,	O
BanI	NNP	O
,	,	O
BamHI	NNP	O
,	,	O
NcoI	NNP	O
,	,	O
and	CC	O
AvaII	NNP	O
)	)	O
have	VBP	O
been	VBN	O
identified	VBN	O
to	TO	O
date	NN	O
.	.	O

We	PRP	O
have	VBP	O
conducted	VBN	O
a	DT	O
comprehensive	JJ	O
DM	NNP	S_Disease
linkage	NN	O
study	NN	O
utilizing	VBG	O
all	DT	O
six	CD	O
RFLPs	NNP	O
and	CC	O
involving	VBG	O
50	CD	O
families	NNS	O
and	CC	O
372	CD	O
individuals	NNS	O
.	.	O

The	DT	O
most	RBS	O
informative	JJ	O
RFLPs	NNP	O
are	VBP	O
,	,	O
in	IN	O
descending	VBG	O
order	NN	O
,	,	O
NcoI	NNP	O
(	(	O
lod	JJ	O
=	NN	O
6	CD	O
.	.	O

64	CD	O
,	,	O
theta	NN	O
=	VBD	O
0	CD	O
.	.	O

05	CD	O
)	)	O
,	,	O
BglI	NNP	O
(	(	O
lod	JJ	O
=	NN	O
6	CD	O
.	.	O

12	CD	O
,	,	O
theta	NN	O
=	VBD	O
0	CD	O
.	.	O

05	CD	O
)	)	O
,	,	O
AvaII	NNP	O
(	(	O
lod	JJ	O
=	NN	O
6	CD	O
.	.	O

02	CD	O
,	,	O
theta	NN	O
=	VBD	O
0	CD	O
.	.	O

03	CD	O
)	)	O
,	,	O
BanI	NNP	O
(	(	O
lod	JJ	O
=	NN	O
5	CD	O
.	.	O

76	CD	O
,	,	O
theta	NN	O
=	VBD	O
0	CD	O
.	.	O

04	CD	O
)	)	O
,	,	O
TaqI	NNP	O
(	(	O
lod	JJ	O
=	NN	O
4	CD	O
.	.	O

29	CD	O
,	,	O
theta	NN	O
=	VBD	O
0	CD	O
.	.	O

06	CD	O
)	)	O
,	,	O
and	CC	O
BamHI	NNP	O
(	(	O
lod	JJ	O
=	NN	O
1	CD	O
.	.	O

75	CD	O
,	,	O
theta	NN	O
=	VBD	O
0	CD	O
.	.	O

01	CD	O
)	)	O
.	.	O

A	DT	O
substantial	JJ	O
increase	NN	O
in	IN	O
the	DT	O
lod	NN	O
scores	VBZ	O
over	IN	O
those	DT	O
seen	VBN	O
with	IN	O
the	DT	O
individual	NN	O
RFLPs	NNP	O
was	VBD	O
obtained	VBN	O
when	WRB	O
the	DT	O
linkage	NN	O
of	IN	O
the	DT	O
entire	JJ	O
APOC2	NNP	O
haplotype	NN	O
(	(	O
composed	VBN	O
of	IN	O
the	DT	O
six	CD	O
RFLPs	NNP	O
)	)	O
was	VBD	O
studied	VBN	O
(	(	O
lod	JJ	O
=	NN	O
17	CD	O
.	.	O

87	CD	O
,	,	O
theta	NN	O
=	VBD	O
0	CD	O
.	.	O

04	CD	O
)	)	O
.	.	O

We	PRP	O
have	VBP	O
observed	VBN	O
significant	JJ	O
inter	NN	O
-	:	O
APOC2	NNP	O
RFLP	NNP	O
linkage	NN	O
disequilibrium	NN	O
.	.	O

Consequently	RB	O
,	,	O
the	DT	O
three	CD	O
most	RBS	O
informative	JJ	O
RFLPs	NNP	O
have	VBP	O
been	VBN	O
found	VBN	O
to	TO	O
be	VB	O
BanI	NNP	O
,	,	O
TaqI	NNP	O
,	,	O
and	CC	O
either	DT	O
BglI	NNP	O
,	,	O
AvaII	NNP	O
,	,	O
or	CC	O
NcoI	NNP	O
polymorphisms	NNS	O
.	.	O

We	PRP	O
also	RB	O
demonstrate	VBP	O
linkage	JJ	O
disequilibrium	NN	O
between	IN	O
DM	NNP	O
and	CC	O
APOC2	NNP	O
in	IN	O
our	PRP$	O
French	JJ	O
-	:	O
Canadian	JJ	O
population	NN	O
(	(	O
standardized	JJ	O
disequilibrium	NN	O
constant	JJ	O
phi	NN	O
=	NN	O
.	.	O

22	CD	O
,	,	O
chi	VBD	O
2	CD	O
=	JJ	O
5	CD	O
.	.	O

12	CD	O
,	,	O
df	NN	O
=	VBD	O
1	CD	O
,	,	O
P	NNP	O
less	JJR	O
than	IN	O
0	CD	O
.	.	O

04	CD	O
)	)	O
.	.	O

This	DT	O
represents	VBZ	O
the	DT	O
first	JJ	O
evidence	NN	O
of	IN	O
linkage	NN	O
disequilibrium	NN	O
between	IN	O
APOC2	NNP	O
and	CC	O
the	DT	O
DM	NNP	S_Disease
locus	NN	O
.	.	O

Phenylalanine	NNP	O
hydroxylase	NN	O
gene	NN	O
haplotypes	NNS	O
in	IN	O
Polynesians	NNS	O
:	:	O
evolutionary	JJ	O
origins	NNS	O
and	CC	O
absence	NN	O
of	IN	O
alleles	NNS	O
associated	VBN	O
with	IN	O
severe	JJ	O
phenylketonuria	NNS	S_Disease
.	.	O

A	DT	O
total	NN	O
of	IN	O
630	CD	O
haplotypes	NNS	O
for	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	(	O
PAH	NNP	O
)	)	O
gene	NN	O
locus	NN	O
were	VBD	O
established	VBN	O
in	IN	O
five	CD	O
groups	NNS	O
of	IN	O
Polynesians	NNPS	O
comprising	VBG	O
Samoans	NNPS	O
,	,	O
Tongans	NNPS	O
,	,	O
Cook	NNP	O
Islanders	NNP	O
,	,	O
Maori	NNP	O
,	,	O
and	CC	O
Niueans	NNP	O
.	.	O

Considerable	JJ	O
genetic	JJ	O
continuity	NN	O
was	VBD	O
demonstrated	VBN	O
between	IN	O
these	DT	O
widely	RB	O
dispersed	JJ	O
populations	NNS	O
,	,	O
since	IN	O
three	CD	O
common	JJ	O
haplotypes	NNS	O
(	(	O
4	CD	O
,	,	O
1	CD	O
,	,	O
and	CC	O
7	CD	O
)	)	O
constituted	VBD	O
over	IN	O
95	CD	O
%	NN	O
of	IN	O
alleles	NNS	O
.	.	O

A	DT	O
control	NN	O
group	NN	O
of	IN	O
individuals	NNS	O
from	IN	O
Southeast	NNP	O
Asia	NNP	O
shared	VBD	O
the	DT	O
same	JJ	O
major	JJ	O
haplotypes	NNS	O
,	,	O
4	CD	O
,	,	O
1	CD	O
,	,	O
and	CC	O
7	CD	O
,	,	O
with	IN	O
Polynesians	NNPS	O
.	.	O

These	DT	O
data	NNS	O
provide	VBP	O
further	JJ	O
support	NN	O
for	IN	O
the	DT	O
theories	NNS	O
of	IN	O
genetic	JJ	O
homogeneity	NN	O
and	CC	O
of	IN	O
Asian	JJ	O
affinities	NNS	O
of	IN	O
the	DT	O
Polynesian	NNP	O
precursor	NN	O
populations	NNS	O
.	.	O

The	DT	O
absence	NN	O
of	IN	O
severe	JJ	O
phenylketonuria	NN	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
in	IN	O
both	DT	O
Polynesians	NNP	O
and	CC	O
Southeast	NNP	O
Asians	NNPS	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
lack	NN	O
of	IN	O
PAH	NNP	O
haplotypes	VBZ	O
2	CD	O
and	CC	O
3	CD	O
,	,	O
on	IN	O
which	WDT	O
the	DT	O
severe	JJ	O
PKU	NNP	S_Disease
mutants	NNS	O
have	VBP	O
arisen	VBN	O
among	IN	O
Caucasians	NNPS	O
.	.	O
.	.	O

Preferential	JJ	O
germline	NN	O
mutation	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
allele	NN	O
in	IN	O
retinoblastoma	NN	S_Disease
.	.	O

The	DT	O
event	NN	O
triggering	VBG	O
malignant	JJ	O
proliferation	NN	O
in	IN	O
70	CD	O
%	NN	O
of	IN	O
retinoblastoma	NN	B_Disease
tumours	NNS	E_Disease
is	VBZ	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
for	IN	O
chromosome	NN	O
13q14	CD	O
,	,	O
whereby	WRB	O
the	DT	O
normal	JJ	O
retinoblastoma	NN	S_Disease
gene	NN	O
(	(	O
RB1	NNP	O
)	)	O
allele	NN	O
is	VBZ	O
lost	VBN	O
and	CC	O
an	DT	O
already	RB	O
mutated	VBN	O
RB1	NNP	O
allele	NN	O
remains	VBZ	O
in	IN	O
the	DT	O
tumour	NN	S_Disease
.	.	O

The	DT	O
first	JJ	O
allele	NN	O
suffers	NNS	O
a	DT	O
mutational	JJ	O
event	NN	O
-	:	O
-	:	O
deletion	NN	O
,	,	O
duplication	NN	O
or	CC	O
point	NN	O
mutation	NN	O
(	(	O
manuscript	NN	O
in	IN	O
preparation	NN	O
)	)	O
-	:	O
-	:	O
either	CC	O
in	IN	O
the	DT	O
germ	JJ	O
line	NN	O
(	(	O
all	DT	O
bilateral	JJ	O
patients	NNS	O
)	)	O
or	CC	O
in	IN	O
a	DT	O
somatic	JJ	O
retinal	NN	O
cell	NN	O
(	(	O
most	RBS	O
unilateral	JJ	O
patients	NNS	O
)	)	O
.	.	O

Most	JJS	O
bilateral	JJ	O
patients	NNS	O
have	VBP	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
retinoblastoma	NN	S_Disease
and	CC	O
are	VBP	O
presumed	VBN	O
to	TO	O
have	VB	O
new	JJ	O
germline	NN	O
mutations	NNS	O
which	WDT	O
arose	VBP	O
in	IN	O
the	DT	O
egg	NN	O
,	,	O
sperm	NN	O
or	CC	O
early	JJ	O
embryo	NN	O
.	.	O

We	PRP	O
have	VBP	O
determined	VBN	O
the	DT	O
parental	JJ	O
origin	NN	O
of	IN	O
the	DT	O
retained	JJ	O
allele	NN	O
in	IN	O
nine	CD	O
retinoblastoma	NN	B_Disease
tumours	NNS	E_Disease
from	IN	O
eight	CD	O
unrelated	JJ	O
non	SYM	O
-	:	O
familial	JJ	O
cases	NNS	O
by	IN	O
using	VBG	O
RB1	NNP	O
-	:	O
linked	VBN	O
genetic	JJ	O
markers	NNS	O
.	.	O

Six	CD	O
tumours	NNS	S_Disease
retained	VBD	O
the	DT	O
paternal	JJ	O
allele	NN	O
and	CC	O
three	CD	O
retained	VBD	O
the	DT	O
maternal	JJ	O
allele	NN	O
.	.	O

Of	IN	O
the	DT	O
three	CD	O
unilateral	JJ	B_Disease
tumours	NNS	E_Disease
,	,	O
only	RB	O
one	CD	O
retained	VBD	O
the	DT	O
paternal	JJ	O
RB1	NNP	O
allele	NN	O
.	.	O

Thus	RB	O
,	,	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
that	IN	O
the	DT	O
paternal	JJ	O
RB1	NNP	O
allele	NN	O
is	VBZ	O
preferentially	RB	O
retained	VBN	O
in	IN	O
retinoblastoma	NN	S_Disease
,	,	O
as	IN	O
has	VBZ	O
been	VBN	O
suggested	VBN	O
to	TO	O
be	VB	O
the	DT	O
case	NN	O
in	IN	O
osteosarcoma	NN	S_Disease
.	.	O

By	IN	O
contrast	NN	O
,	,	O
tumours	NNS	S_Disease
from	IN	O
four	CD	O
of	IN	O
the	DT	O
five	CD	O
bilateral	JJ	O
patients	NNS	O
retained	VBD	O
the	DT	O
paternal	JJ	O
RB1	NNP	O
allele	NN	O
.	.	O

This	DT	O
suggests	VBZ	O
either	CC	O
that	IN	O
new	JJ	O
germline	NN	O
RB1	NNP	O
mutations	NNS	O
arise	RB	O
more	RBR	O
frequently	RB	O
during	IN	O
spermatogenesis	NN	O
than	IN	O
during	IN	O
oogenesis	NN	O
,	,	O
or	CC	O
that	IN	O
imprinting	VBG	O
in	IN	O
the	DT	O
early	JJ	O
embryo	NN	O
affects	NNS	O
chromosomal	JJ	O
susceptibility	NN	O
to	TO	O
mutation	NN	O
.	.	O
.	.	O

Haplotype	NNP	O
analysis	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
in	IN	O
Turkish	JJ	O
phenylketonuria	NN	S_Disease
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
estimated	VBN	O
the	DT	O
haplotype	JJ	O
distribution	NN	O
of	IN	O
mutant	JJ	O
and	CC	O
normal	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
(	(	O
PAH	NNP	O
)	)	O
alleles	VBZ	O
for	IN	O
17	CD	O
Turkish	JJ	O
phenylketonuria	NN	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
families	NNS	O
20	CD	O
normal	JJ	O
and	CC	O
27	CD	O
mutated	VBD	O
PAH	NNP	O
alleles	NNS	O
could	MD	O
be	VB	O
identified	VBN	O
.	.	O

Of	IN	O
the	DT	O
latter	NN	O
,	,	O
the	DT	O
most	RBS	O
prevalent	JJ	O
were	VBD	O
associated	VBN	O
with	IN	O
haplotype	NN	O
6	CD	O
(	(	O
29	CD	O
.	.	O

6	CD	O
%	NN	O
)	)	O
,	,	O
1	CD	O
(	(	O
18	CD	O
.	.	O

5	CD	O
%	NN	O
)	)	O
and	CC	O
36	CD	O
(	(	O
11	CD	O
.	.	O

1	CD	O
%	NN	O
)	)	O
,	,	O
while	IN	O
the	DT	O
normal	JJ	O
alleles	NNS	O
were	VBD	O
preferentially	RB	O
associated	VBN	O
with	IN	O
haplotype	NN	O
1	CD	O
(	(	O
20	CD	O
%	NN	O
)	)	O
.	.	O

Of	IN	O
the	DT	O
19	CD	O
different	JJ	O
haplotypes	NNS	O
observed	VBD	O
,	,	O
5	CD	O
have	VBP	O
not	RB	O
been	VBN	O
described	VBN	O
previously	RB	O
.	.	O

The	DT	O
haplotype	NN	O
distribution	NN	O
differed	VBD	O
significantly	RB	O
from	IN	O
that	DT	O
of	IN	O
the	DT	O
Northern	NNP	O
European	NNP	O
population	NN	O
.	.	O

Two	CD	O
of	IN	O
the	DT	O
eight	CD	O
polymorphic	NNS	O
sites	NNS	O
were	VBD	O
in	IN	O
association	NN	O
with	IN	O
PKU	NNP	S_Disease
.	.	O

No	DT	O
deletions	NNS	O
of	IN	O
exon	JJ	O
sequences	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
families	NNS	O
analysed	VBD	O
.	.	O

Huntington	NNP	B_Disease
disease	NN	E_Disease
:	:	O
no	DT	O
evidence	NN	O
for	IN	O
locus	JJ	O
heterogeneity	NN	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
63	CD	O
families	NNS	O
with	IN	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
were	VBD	O
examined	VBN	O
for	IN	O
linkage	NN	O
between	IN	O
HD	NNP	S_Disease
and	CC	O
G8	NNP	O
(	(	O
D4S10	NNP	O
)	)	O
.	.	O

The	DT	O
families	NNS	O
included	VBD	O
57	CD	O
Caucasian	NNP	O
,	,	O
four	CD	O
Black	NNP	O
American	NNP	O
,	,	O
and	CC	O
two	CD	O
Japanese	JJ	O
.	.	O

The	DT	O
combined	JJ	O
maximum	JJ	O
lod	NN	O
score	NN	O
was	VBD	O
87	CD	O
.	.	O

69	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

04	CD	O
(	(	O
99	CD	O
%	NN	O
confidence	NN	O
interval	JJ	O
0	CD	O
.	.	O

018	CD	O
-	:	O
0	CD	O
.	.	O

071	CD	O
)	)	O
.	.	O

The	DT	O
maximum	JJ	O
frequency	NN	O
of	IN	O
recombination	NN	O
was	VBD	O
0	CD	O
.	.	O

03	CD	O
in	IN	O
males	NNS	O
and	CC	O
0	CD	O
.	.	O

05	CD	O
in	IN	O
females	NNS	O
.	.	O

Fifty	NNP	O
-	:	O
seven	CD	O
families	NNS	O
gave	VBD	O
positive	JJ	O
lod	NN	O
scores	NNS	O
;	:	O
five	CD	O
small	JJ	O
families	NNS	O
gave	VBD	O
mildly	RB	O
negative	JJ	O
lod	NN	O
scores	NNS	O
.	.	O

The	DT	O
maximum	JJ	O
likelihood	JJ	O
estimate	NN	O
of	IN	O
alpha	NN	O
,	,	O
the	DT	O
proportion	NN	O
of	IN	O
linked	VBN	O
loci	NN	O
,	,	O
was	VBD	O
1	CD	O
.	.	O

0	CD	O
with	IN	O
a	DT	O
lower	JJR	O
99	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
of	IN	O
0	CD	O
.	.	O

88	CD	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
there	EX	O
is	VBZ	O
only	RB	O
one	CD	O
HD	NNP	S_Disease
locus	NN	O
,	,	O
although	IN	O
a	DT	O
second	JJ	O
rare	JJ	O
locus	NN	O
cannot	NN	O
be	VB	O
ruled	VBN	O
out	RP	O
.	.	O

Haplotype	NNP	O
and	CC	O
multipoint	NN	O
linkage	NN	O
analysis	NN	O
in	IN	O
Finnish	JJ	O
choroideremia	NN	S_Disease
families	NNS	O
.	.	O

Multipoint	NNP	O
linkage	NN	O
analysis	NN	O
of	IN	O
choroideremia	NN	S_Disease
(	(	O
TCD	NNP	S_Disease
)	)	O
and	CC	O
seven	CD	O
X	NNP	O
chromosomal	JJ	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NN	O
(	(	O
RFLPs	NNP	O
)	)	O
was	VBD	O
carried	VBN	O
out	RP	O
in	IN	O
18	CD	O
Finnish	JJ	O
TCD	NNP	S_Disease
families	NNS	O
.	.	O

The	DT	O
data	NN	O
place	NN	O
TCD	NNP	S_Disease
distal	NN	O
to	TO	O
PGK	NNP	O
and	CC	O
DXS72	NNP	O
,	,	O
very	RB	O
close	RB	O
to	TO	O
DXYS1	NNP	O
and	CC	O
DXYS5	NNP	O
(	(	O
Zmax	NNP	O
=	VBZ	O
24	CD	O
at	IN	O
theta	NN	O
=	NNP	O
0	CD	O
)	)	O
and	CC	O
proximal	JJ	O
to	TO	O
DXYS4	NNP	O
and	CC	O
DXYS12	NNP	O
.	.	O

This	DT	O
agrees	VBZ	O
with	IN	O
the	DT	O
data	NNS	O
obtained	VBN	O
from	IN	O
other	JJ	O
linkage	NN	O
studies	NNS	O
and	CC	O
from	IN	O
physical	JJ	O
mapping	NN	O
.	.	O

All	PDT	O
the	DT	O
TCD	NNP	S_Disease
males	NNS	O
and	CC	O
carrier	NN	O
females	NNS	O
studied	VBN	O
have	VBP	O
the	DT	O
same	JJ	O
DXYS1	NNP	O
allele	NN	O
in	IN	O
coupling	VBG	O
with	IN	O
TCD	NNP	S_Disease
.	.	O

In	IN	O
Northeastern	NNP	O
Finland	NNP	O
,	,	O
66	CD	O
/	NN	O
69	CD	O
chromosomes	NNS	O
carrying	VBG	O
TCD	NNP	S_Disease
had	VBD	O
the	DT	O
same	JJ	O
haplotype	NN	O
at	IN	O
loci	JJ	O
DXS72	NNP	O
,	,	O
DXYS1	NNP	O
,	,	O
DXYS4	NNP	O
,	,	O
and	CC	O
DXYS12	NNP	O
.	.	O

The	DT	O
same	JJ	O
haplotype	NN	O
is	VBZ	O
seen	VBN	O
in	IN	O
only	RB	O
15	CD	O
/	JJ	O
99	CD	O
chromosomes	NNS	O
not	RB	O
carrying	VBG	O
TCD	NNP	S_Disease
.	.	O

Moreover	RB	O
,	,	O
in	IN	O
71	CD	O
/	JJ	O
104	CD	O
non	JJ	O
-	:	O
TCD	NN	O
chromosomes	NNS	O
,	,	O
the	DT	O
haplotype	NN	O
at	IN	O
six	CD	O
marker	NN	O
loci	NN	O
is	VBZ	O
different	JJ	O
from	IN	O
those	DT	O
seen	VBN	O
in	IN	O
any	DT	O
of	IN	O
the	DT	O
76	CD	O
TCD	NNP	S_Disease
chromosomes	NNS	O
.	.	O

This	DT	O
supports	VBZ	O
the	DT	O
previously	RB	O
described	VBN	O
hypothesis	NN	O
that	IN	O
the	DT	O
large	JJ	O
Northern	NNP	O
Finnish	NNP	O
choroideremia	NN	S_Disease
pedigrees	NNS	O
,	,	O
comprising	VBG	O
a	DT	O
total	NN	O
of	IN	O
over	IN	O
80	CD	O
living	JJ	O
patients	NNS	O
representing	VBG	O
more	JJR	O
than	IN	O
a	DT	O
fifth	NN	O
of	IN	O
all	DT	O
TCD	NNP	S_Disease
patients	NNS	O
described	VBD	O
worldwide	RB	O
,	,	O
carry	VBP	O
the	DT	O
same	JJ	O
mutation	NN	O
.	.	O

These	DT	O
linkage	NN	O
and	CC	O
haplotype	NN	O
data	NNS	O
provide	VBP	O
improved	JJ	O
opportunities	NNS	O
for	IN	O
prenatal	JJ	O
diagnosis	NN	O
based	VBN	O
on	IN	O
RFLP	NNP	O
studies	NNS	O
.	.	O
.	.	O

Autosomal	NNP	O
dominant	JJ	O
aniridia	NN	S_Disease
linked	VBN	O
to	TO	O
the	DT	O
chromosome	NN	O
11p13	CD	O
markers	NNS	O
catalase	NN	O
and	CC	O
D11S151	NNP	O
in	IN	O
a	DT	O
large	JJ	O
Dutch	NNP	O
family	NN	O
.	.	O

In	IN	O
a	DT	O
large	JJ	O
pedigree	NN	O
with	IN	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	S_Disease
,	,	O
we	PRP	O
found	VBD	O
close	JJ	O
linkage	NN	O
between	IN	O
the	DT	O
aniridia	NN	S_Disease
locus	NN	O
AN2	NNP	O
and	CC	O
the	DT	O
markers	NNS	O
catalase	VBP	O
(	(	O
CAT	NNP	O
)	)	O
(	(	O
zeta	JJ	O
=	NN	O
7	CD	O
.	.	O

27	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

00	CD	O
)	)	O
and	CC	O
D11S151	NNP	O
(	(	O
zeta	NNP	O
=	RB	O
3	CD	O
.	.	O

86	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

10	CD	O
)	)	O
flanking	VBG	O
the	DT	O
AN2	NNP	O
locus	NN	O
on	IN	O
11p13	CD	O
.	.	O

Positive	JJ	O
lod	NN	O
scores	NNS	O
were	VBD	O
also	RB	O
obtained	VBN	O
for	IN	O
the	DT	O
11p13	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
11p14	CD	O
markers	NNS	O
D11S16	NNP	O
and	CC	O
FSHB	NNP	O
with	IN	O
the	DT	O
linkage	NN	O
group	NN	O
CAT	NNP	O
/	NNP	O
AN2	NNP	O
/	NNP	O
D11S151	NNP	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	S_Disease
in	IN	O
this	DT	O
family	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
mutation	NN	O
at	IN	O
the	DT	O
AN2	NNP	O
locus	NN	O
on	IN	O
11p13	CD	O
.	.	O

We	PRP	O
have	VBP	O
excluded	VBN	O
linkage	NN	O
(	(	O
zeta	NN	O
less	JJR	O
than	IN	O
-	:	O
2	CD	O
at	IN	O
theta	NN	O
less	JJR	O
than	IN	O
0	CD	O
.	.	O

18	CD	O
)	)	O
between	IN	O
the	DT	O
aniridia	NN	S_Disease
and	CC	O
the	DT	O
chromosome	NN	O
2p25	CD	O
marker	NN	O
D2S1	NNP	O
(	(	O
linked	VBN	O
to	TO	O
ACP1	NNP	O
)	)	O
.	.	O

Recombination	NN	O
events	NNS	O
that	WDT	O
locate	VBP	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
distal	NN	O
to	TO	O
APOC2	NNP	O
on	IN	O
19q	CD	O
.	.	O

We	PRP	O
previously	RB	O
reported	VBD	O
a	DT	O
recombination	NN	O
in	IN	O
an	DT	O
individual	NN	O
with	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
which	WDT	O
placed	VBD	O
the	DT	O
markers	NNS	O
D19S19	NNP	O
and	CC	O
APOC2	NNP	O
on	IN	O
the	DT	O
same	JJ	O
side	NN	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
locus	NN	O
.	.	O

Haplotyping	VBG	O
of	IN	O
this	DT	O
family	NN	O
with	IN	O
more	RBR	O
recently	RB	O
characterized	VBN	O
probes	NNS	O
which	WDT	O
are	VBP	O
either	DT	O
tightly	RB	O
linked	VBN	O
to	TO	O
DM	NNP	S_Disease
or	CC	O
distal	NN	O
to	TO	O
the	DT	O
linkage	NN	O
group	NN	O
at	IN	O
q13	NN	O
.	.	O

2	CD	O
shows	NNS	O
that	IN	O
the	DT	O
DM	NNP	S_Disease
locus	NN	O
is	VBZ	O
distal	JJ	O
to	TO	O
APOC2	NNP	O
.	.	O

This	DT	O
is	VBZ	O
confirmed	VBN	O
by	IN	O
other	JJ	O
recombinants	NNS	O
where	WRB	O
DM	NNP	S_Disease
segregates	VBZ	O
with	IN	O
distal	JJ	O
probes	NNS	O
.	.	O

Additional	JJ	O
marker	NN	O
to	TO	O
marker	VB	O
recombinations	NNS	O
in	IN	O
unaffected	JJ	O
individuals	NNS	O
are	VBP	O
reported	VBN	O
and	CC	O
support	VB	O
the	DT	O
order	NN	O
and	CC	O
orientation	NN	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
linkage	NN	O
group	NN	O
as	IN	O
pter	NN	O
-	:	O
(	(	O
INSR	NNP	O
,	,	O
LDLR	NNP	O
,	,	O
S9	NNP	O
)	)	O
-	:	O
(	(	O
S19	NNP	O
,	,	O
BCL3	NNP	O
,	,	O
APOC2	NNP	O
)	)	O
-	:	O
(	(	O
CKMM	NNP	O
,	,	O
DM	NNP	O
)	)	O
-	:	O
(	(	O
S22	NNP	O
,	,	O
+	NNP	O
+	NNP	O
+	NNP	O
PRKCG	NNP	O
)	)	O
-	:	O
qter	NN	O
.	.	O

The	DT	O
data	NN	O
presented	VBD	O
here	RB	O
cannot	JJ	O
determine	VB	O
whether	IN	O
DM	NNP	S_Disease
is	VBZ	O
proximal	JJ	O
or	CC	O
distal	JJ	O
to	TO	O
CKMM	NNP	O
.	.	O

The	DT	O
consequences	NNS	O
of	IN	O
this	DT	O
probe	NN	O
order	NN	O
for	IN	O
antenatal	JJ	O
diagnosis	NN	O
and	CC	O
future	JJ	O
research	NN	O
aiming	VBG	O
to	TO	O
isolate	VB	O
the	DT	O
gene	NN	O
which	WDT	O
is	VBZ	O
affected	VBN	O
in	IN	O
DM	NNP	S_Disease
are	VBP	O
discussed	VBN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
RB1	NNP	O
gene	NN	O
and	CC	O
their	PRP$	O
effects	NNS	O
on	IN	O
transcription	NN	O
.	.	O

Inactivation	NN	O
of	IN	O
both	DT	O
alleles	NNS	O
of	IN	O
the	DT	O
RB1	NNP	O
gene	NN	O
during	IN	O
normal	JJ	O
retinal	JJ	O
development	NN	O
initiates	VBZ	O
the	DT	O
formation	NN	O
of	IN	O
a	DT	O
retinoblastoma	NN	B_Disease
(	(	I_Disease
RB	NNP	I_Disease
)	)	I_Disease
tumor	NN	E_Disease
.	.	O

To	TO	O
identify	VB	O
the	DT	O
mutations	NNS	O
which	WDT	O
inactivate	VBP	O
RB1	NNP	O
,	,	O
21	CD	O
RB	NNP	B_Disease
tumors	NNS	E_Disease
isolated	VBD	O
from	IN	O
19	CD	O
patients	NNS	O
were	VBD	O
analyzed	VBN	O
with	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
or	CC	O
an	DT	O
RNase	NNP	O
protection	NN	O
assay	NN	O
or	CC	O
both	DT	O
.	.	O

Mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
13	CD	O
of	IN	O
21	CD	O
RB	NNP	B_Disease
tumors	NNS	E_Disease
;	:	O
in	IN	O
8	CD	O
tumors	NNS	S_Disease
,	,	O
the	DT	O
precise	JJ	O
errors	NNS	O
in	IN	O
nucleotide	JJ	O
sequence	NN	O
were	VBD	O
characterized	VBN	O
.	.	O

Each	DT	O
of	IN	O
four	CD	O
germ	JJ	O
line	NN	O
mutations	NNS	O
involved	VBD	O
a	DT	O
small	JJ	O
deletion	NN	O
or	CC	O
duplication	NN	O
,	,	O
while	IN	O
three	CD	O
somatic	JJ	O
mutations	NNS	O
were	VBD	O
point	JJ	O
mutations	NNS	O
leading	VBG	O
to	TO	O
splice	VB	O
alterations	NNS	O
and	CC	O
loss	NN	O
of	IN	O
an	DT	O
exon	NN	O
from	IN	O
the	DT	O
mature	NN	O
RB1	NNP	O
mRNA	NN	O
.	.	O

We	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
detect	VB	O
expression	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
allele	NN	O
in	IN	O
lymphoblasts	NNS	O
of	IN	O
three	CD	O
bilaterally	RB	O
affected	JJ	O
patients	NNS	O
,	,	O
although	IN	O
the	DT	O
mutation	NN	O
was	VBD	O
present	JJ	O
in	IN	O
the	DT	O
genomic	JJ	O
DNA	NN	O
and	CC	O
transcripts	NNS	O
containing	VBG	O
the	DT	O
mutations	NNS	O
were	VBD	O
obvious	JJ	O
in	IN	O
the	DT	O
RB	NNP	B_Disease
tumors	NNS	E_Disease
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
normal	JJ	O
RB1	NNP	O
allele	NN	O
.	.	O

The	DT	O
variations	NNS	O
in	IN	O
the	DT	O
level	NN	O
of	IN	O
expression	NN	O
of	IN	O
mutant	JJ	O
transcripts	NNS	O
suggest	VBP	O
deregulation	NN	O
of	IN	O
RB1	NNP	O
transcription	NN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
functional	JJ	O
RB1	NNP	O
gene	NN	O
product	NN	O
.	.	O
.	.	O

Partial	JJ	O
deletion	NN	O
8q	CD	O
without	IN	O
Langer	NNP	B_Disease
-	:	I_Disease
Giedion	NN	I_Disease
syndrome	NN	E_Disease
:	:	O
a	DT	O
recognisable	JJ	O
syndrome	NN	O
.	.	O

We	PRP	O
report	VBP	O
two	CD	O
de	IN	O
novo	FW	O
cases	NNS	O
of	IN	O
del	NN	O
(	(	O
8	CD	O
)	)	O
(	(	O
pter	JJ	O
-	:	O
-	:	O
-	:	O
-	:	O
q24	NN	O
.	.	O

1	CD	O
)	)	O
with	IN	O
breakpoints	NNS	O
involving	VBG	O
the	DT	O
distal	JJ	O
part	NN	O
of	IN	O
band	NN	O
8q24	CD	O
.	.	O

1	CD	O
1	CD	O
.	.	O

The	DT	O
clinical	JJ	O
features	NNS	O
were	VBD	O
similar	JJ	O
and	CC	O
there	EX	O
were	VBD	O
no	DT	O
obvious	JJ	O
stigmata	NN	O
of	IN	O
Langer	NNP	B_Disease
-	:	I_Disease
Giedion	NN	I_Disease
syndrome	NN	E_Disease
(	(	O
LGS	NNP	S_Disease
)	)	O
.	.	O

There	EX	O
are	VBP	O
three	CD	O
other	JJ	O
cases	NNS	O
reported	VBN	O
with	IN	O
a	DT	O
deletion	NN	O
of	IN	O
chromosome	NN	O
8	CD	O
at	IN	O
approximately	RB	O
the	DT	O
same	JJ	O
breakpoint	NN	O
,	,	O
one	CD	O
without	IN	O
LGS	NNP	S_Disease
and	CC	O
some	DT	O
similarities	NNS	O
to	TO	O
our	PRP$	O
cases	NNS	O
,	,	O
the	DT	O
other	JJ	O
two	CD	O
with	IN	O
LGS	NNP	S_Disease
.	.	O

Our	PRP$	O
findings	NNS	O
would	MD	O
support	VB	O
the	DT	O
observation	NN	O
that	IN	O
the	DT	O
critical	JJ	O
segment	NN	O
for	IN	O
the	DT	O
assignment	NN	O
of	IN	O
LGS	NNP	S_Disease
is	VBZ	O
proximal	JJ	O
to	TO	O
or	CC	O
involves	VBZ	O
the	DT	O
proximal	JJ	O
part	NN	O
of	IN	O
8q24	CD	O
.	.	O

1	CD	O
,	,	O
but	CC	O
a	DT	O
review	NN	O
of	IN	O
published	VBN	O
reports	NNS	O
suggests	VBZ	O
that	IN	O
the	DT	O
aetiology	NN	O
of	IN	O
LGS	NNP	S_Disease
may	MD	O
be	VB	O
a	DT	O
more	RBR	O
complex	JJ	O
issue	NN	O

Myotonic	NNP	B_Disease
dystrophy	NN	E_Disease
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
gene	NN	O
for	IN	O
muscle	NN	O
-	:	O
type	NN	O
creatine	NN	O
kinase	NN	O
(	(	O
CKMM	NNP	O
)	)	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
genetic	JJ	O
linkage	NN	O
between	IN	O
the	DT	O
gene	NN	O
for	IN	O
creatine	JJ	O
kinase	NN	O
muscle	NN	O
type	NN	O
(	(	O
CKMM	NNP	O
)	)	O
and	CC	O
the	DT	O
gene	NN	O
for	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
.	.	O

In	IN	O
a	DT	O
panel	NN	O
of	IN	O
65	CD	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
families	NNS	O
from	IN	O
Canada	NNP	O
and	CC	O
the	DT	O
Netherlands	NNP	O
,	,	O
a	DT	O
maximum	JJ	O
lod	NN	O
score	NN	O
(	(	O
Zmax	NNP	O
)	)	O
of	IN	O
22	CD	O
.	.	O

8	CD	O
at	IN	O
a	DT	O
recombination	NN	O
frequency	NN	O
(	(	O
theta	NN	O
)	)	O
of	IN	O
0	CD	O
.	.	O

03	CD	O
was	VBD	O
obtained	VBN	O
.	.	O

Tight	NNP	O
linkage	NN	O
was	VBD	O
also	RB	O
demonstrated	VBN	O
for	IN	O
CKMM	NNP	O
and	CC	O
the	DT	O
gene	NN	O
for	IN	O
apolipoprotein	JJ	O
C2	NNP	O
(	(	O
ApoC2	NNP	O
)	)	O
.	.	O

This	DT	O
establishes	VBZ	O
CKMM	NNP	O
as	IN	O
a	DT	O
useful	JJ	O
marker	NN	O
for	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease

Color	NNP	B_Disease
vision	NN	I_Disease
defects	NNS	E_Disease
in	IN	O
adrenomyeloneuropathy	NN	S_Disease
.	.	O

The	DT	O
relationship	NN	O
between	IN	O
abnormal	JJ	B_Disease
color	NN	I_Disease
vision	NN	E_Disease
and	CC	O
adrenomyeloneuropathy	NN	S_Disease
(	(	O
AMN	NNP	S_Disease
)	)	O
was	VBD	O
investigated	VBN	O
in	IN	O
27	CD	O
AMN	NNP	S_Disease
patients	NNS	O
and	CC	O
31	CD	O
age	NN	O
-	:	O
matched	VBN	O
controls	NNS	O
by	IN	O
using	VBG	O
the	DT	O
Farnsworth	NNP	O
-	:	O
Munsell	NNP	O
100	CD	O
Hue	NNP	O
test	NN	O
.	.	O

Twelve	NNP	O
(	(	O
44	CD	O
%	NN	O
)	)	O
of	IN	O
27	CD	O
patients	NNS	O
showed	VBD	O
test	JJ	O
scores	NNS	O
significantly	RB	O
above	IN	O
normal	JJ	O
.	.	O

The	DT	O
axes	NNS	O
of	IN	O
bipolarity	NN	O
determined	VBN	O
by	IN	O
the	DT	O
testing	NN	O
differed	VBD	O
widely	RB	O
between	IN	O
the	DT	O
patients	NNS	O
with	IN	O
abnormal	JJ	O
scores	NNS	O
,	,	O
compatible	JJ	O
with	IN	O
the	DT	O
notion	NN	O
that	WDT	O
different	JJ	O
alterations	NNS	O
in	IN	O
visual	JJ	O
pigment	NN	O
genes	NNS	O
occur	VBP	O
in	IN	O
different	JJ	O
AMN	NNP	S_Disease
kindreds	NNS	O
.	.	O

These	DT	O
observations	NNS	O
confirm	VBP	O
our	PRP$	O
earlier	JJR	O
impression	NN	O
that	IN	O
the	DT	O
frequency	NN	O
of	IN	O
abnormal	JJ	B_Disease
color	NN	I_Disease
vision	NN	E_Disease
is	VBZ	O
increased	VBN	O
in	IN	O
these	DT	O
kindreds	NNS	O
,	,	O
and	CC	O
it	PRP	O
supports	VBZ	O
our	PRP$	O
contentions	NNS	O
that	IN	O
(	(	O
1	CD	O
)	)	O
AMN	NNP	S_Disease
(	(	O
and	CC	O
its	PRP$	O
companion	NN	O
,	,	O
adrenoleukodystrophy	NN	S_Disease
)	)	O
are	VBP	O
very	RB	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
visual	JJ	O
pigment	NN	O
loci	NN	O
at	IN	O
Xq28	NNP	O
and	CC	O
(	(	O
2	CD	O
)	)	O
this	DT	O
proximity	NN	O
might	MD	O
provide	VB	O
the	DT	O
opportunity	NN	O
to	TO	O
observe	VB	O
contiguous	JJ	B_Disease
gene	NN	I_Disease
defects	NNS	E_Disease
.	.	O
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
a	DT	O
female	JJ	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	E_Disease
patient	NN	O
.	.	O

We	PRP	O
report	VBP	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
female	JJ	O
patient	NN	O
with	IN	O
the	DT	O
X	NNP	O
-	:	O
linked	VBD	O
recessive	JJ	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
hypoxanthine	JJ	B_Disease
phosphoribosyltransferase	NN	I_Disease
[	NNP	I_Disease
HPRT	NNP	I_Disease
]	NNP	I_Disease
deficiency	NN	E_Disease
)	)	O
.	.	O

Cytogenetic	JJ	O
and	CC	O
carrier	NN	O
studies	NNS	O
revealed	VBD	O
structurally	RB	O
normal	JJ	O
chromosomes	NNS	O
for	IN	O
this	DT	O
patient	NN	O
and	CC	O
her	PRP$	O
parents	NNS	O
and	CC	O
demonstrated	VBD	O
that	IN	O
this	DT	O
mutation	NN	O
arose	VBD	O
through	IN	O
a	DT	O
de	FW	O
novo	FW	O
gametic	JJ	O
event	NN	O
.	.	O

Comparison	NNP	O
of	IN	O
this	DT	O
patients	NNS	O
DNA	VBZ	O
with	IN	O
the	DT	O
DNA	NN	O
of	IN	O
her	PRP$	O
parents	NNS	O
revealed	VBD	O
that	IN	O
a	DT	O
microdeletion	NN	O
,	,	O
which	WDT	O
occurred	VBD	O
within	IN	O
a	DT	O
maternal	JJ	O
gamete	NN	O
and	CC	O
involved	VBD	O
the	DT	O
entire	JJ	O
HPRT	NNP	O
gene	NN	O
,	,	O
was	VBD	O
partially	RB	O
responsible	JJ	O
for	IN	O
the	DT	O
disease	NN	O
in	IN	O
this	DT	O
patient	NN	O
.	.	O

Somatic	NNP	O
cell	NN	O
hybrids	NNS	O
,	,	O
generated	VBD	O
to	TO	O
separate	VB	O
maternal	JJ	O
and	CC	O
paternal	JJ	O
X	NNP	O
chromosomes	NNS	O
,	,	O
showed	VBD	O
that	IN	O
expression	NN	O
of	IN	O
two	CD	O
additional	JJ	O
X	NNP	O
-	:	O
linked	VBN	O
enzymes	NNS	O
,	,	O
phosphoglycerate	JJ	O
kinase	NN	O
and	CC	O
glucose	VB	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
,	,	O
were	VBD	O
expressed	VBN	O
only	RB	O
in	IN	O
cells	NNS	O
that	WDT	O
contained	VBD	O
the	DT	O
maternal	JJ	O
X	NNP	O
chromosome	NN	O
,	,	O
suggesting	VBG	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
functionally	RB	O
inactive	JJ	O
paternal	JJ	O
X	NNP	O
chromosome	NN	O
.	.	O

Furthermore	RB	O
,	,	O
comparison	NN	O
of	IN	O
methylation	NN	O
patterns	NNS	O
within	IN	O
a	DT	O
region	NN	O
of	IN	O
the	DT	O
HPRT	NNP	O
gene	NN	O
known	VBN	O
to	TO	O
be	VB	O
important	JJ	O
in	IN	O
gene	NN	O
regulation	NN	O
revealed	VBD	O
differences	NNS	O
between	IN	O
DNA	NN	O
from	IN	O
the	DT	O
father	NN	O
and	CC	O
the	DT	O
patient	NN	O
,	,	O
in	IN	O
keeping	VBG	O
with	IN	O
an	DT	O
active	JJ	O
HPRT	NNP	O
locus	NN	O
in	IN	O
the	DT	O
father	NN	O
and	CC	O
an	DT	O
inactive	JJ	O
HPRT	NNP	O
locus	NN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

Together	RB	O
these	DT	O
data	NNS	O
indicate	VBP	O
that	IN	O
nonrandom	JJ	O
inactivation	NN	O
of	IN	O
the	DT	O
cytogenetically	NN	O
normal	JJ	O
paternal	JJ	O
X	NNP	O
chromosome	NN	O
and	CC	O
a	DT	O
microdeletion	NN	O
of	IN	O
the	DT	O
HPRT	NNP	O
gene	NN	O
on	IN	O
an	DT	O
active	JJ	O
maternal	JJ	O
X	NN	O
chromosome	NN	O
were	VBD	O
responsible	JJ	O
for	IN	O
the	DT	O
absence	NN	O
of	IN	O
HPRT	NNP	O
in	IN	O
this	DT	O
patient	NN	O
.	.	O
.	.	O

Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
:	:	O
an	DT	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
neurologic	JJ	I_Disease
disorder	NN	I_Disease
of	IN	I_Disease
myelin	JJ	I_Disease
metabolism	NN	E_Disease
with	IN	O
a	DT	O
novel	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
proteolipid	JJ	O
protein	NN	O
.	.	O

The	DT	O
nosology	NN	O
of	IN	O
the	DT	O
inborn	JJ	B_Disease
errors	NNS	I_Disease
of	IN	I_Disease
myelin	NN	I_Disease
metabolism	NN	E_Disease
has	VBZ	O
been	VBN	O
stymied	VBN	O
by	IN	O
the	DT	O
lack	NN	O
of	IN	O
molecular	JJ	O
genetic	JJ	O
analysis	NN	O
.	.	O

Historically	RB	O
,	,	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
has	VBZ	O
encompassed	VBN	O
a	DT	O
host	NN	O
of	IN	O
neurologic	JJ	B_Disease
disorders	NNS	E_Disease
that	WDT	O
present	VBP	O
with	IN	O
a	DT	O
deficit	NN	B_Disease
of	IN	I_Disease
myelin	NN	E_Disease
,	,	O
the	DT	O
membrane	NN	O
elaborated	VBN	O
by	IN	O
glial	JJ	O
cells	NNS	O
that	IN	O
encircles	NNS	O
and	CC	O
successively	RB	O
enwraps	JJ	O
axons	NNS	O
.	.	O

We	PRP	O
describe	VBP	O
here	RB	O
a	DT	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	NNP	E_Disease
pedigree	NN	O
of	IN	O
the	DT	O
classical	JJ	O
type	NN	O
,	,	O
with	IN	O
X	NNP	O
-	:	O
linked	VBD	O
inheritance	NN	O
,	,	O
a	DT	O
typical	JJ	O
clinical	JJ	O
progression	NN	O
,	,	O
and	CC	O
a	DT	O
pathologic	JJ	O
loss	NN	O
of	IN	O
myelinating	VBG	O
cells	NNS	O
and	CC	O
myelin	NN	O
in	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
.	.	O

To	TO	O
discriminate	VB	O
variants	NNS	O
of	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	NNP	I_Disease
disease	NN	E_Disease
,	,	O
a	DT	O
set	NN	O
of	IN	O
oligonucleotide	JJ	O
primers	NNS	O
was	VBD	O
constructed	VBN	O
to	TO	O
polymerase	VB	O
-	:	O
chain	NN	O
-	:	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
amplify	NN	O
and	CC	O
sequence	VB	O
the	DT	O
gene	NN	O
encoding	VBG	O
proteolipid	JJ	O
protein	NN	O
(	(	O
PLP	NNP	O
)	)	O
,	,	O
a	DT	O
structural	JJ	O
protein	NN	O
that	WDT	O
comprises	VBZ	O
half	NN	O
of	IN	O
the	DT	O
protein	NN	O
of	IN	O
the	DT	O
myelin	NN	O
sheath	NN	O
.	.	O

The	DT	O
PLP	NNP	O
gene	NN	O
in	IN	O
one	CD	O
of	IN	O
two	CD	O
affected	JJ	O
males	NNS	O
and	CC	O
the	DT	O
carrier	NN	O
mother	NN	O
of	IN	O
this	DT	O
family	NN	O
exhibited	VBD	O
a	DT	O
single	JJ	O
base	NN	O
difference	NN	O
in	IN	O
the	DT	O
more	JJR	O
than	IN	O
2	CD	O
kb	NN	O
of	IN	O
the	DT	O
PLP	NNP	O
gene	NN	O
sequenced	VBD	O
,	,	O
a	DT	O
C	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
T	NN	O
transition	NN	O
that	WDT	O
would	MD	O
create	VB	O
a	DT	O
serine	JJ	O
substitution	NN	O
for	IN	O
proline	NN	O
at	IN	O
the	DT	O
carboxy	JJ	O
end	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
delineate	VB	O
the	DT	O
clinical	JJ	O
features	NNS	O
of	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	NNP	I_Disease
disease	NN	E_Disease
,	,	O
define	VB	O
the	DT	O
possible	JJ	O
molecular	JJ	O
pathology	NN	O
of	IN	O
this	DT	O
dysmyelinating	VBG	B_Disease
disorder	NN	E_Disease
,	,	O
and	CC	O
address	VB	O
the	DT	O
molecular	JJ	O
classification	NN	O
of	IN	O
inborn	JJ	B_Disease
errors	NNS	I_Disease
of	IN	I_Disease
myelin	NN	I_Disease
metabolism	NN	E_Disease
.	.	O

Patients	NNS	O
with	IN	O
the	DT	O
classical	JJ	O
form	NN	O
(	(	O
type	JJ	O
I	PRP	O
)	)	O
and	CC	O
the	DT	O
more	RBR	O
severely	RB	O
affected	JJ	O
,	,	O
connatal	JJ	O
variant	NN	O
of	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	I_Disease
(	(	I_Disease
type	JJ	I_Disease
II	NNP	I_Disease
)	)	E_Disease
would	MD	O
be	VB	O
predicted	VBN	O
to	TO	O
display	VB	O
mutation	NN	O
at	IN	O
the	DT	O
PLP	NNP	O
locus	NN	O
.	.	O

The	DT	O
other	JJ	O
variants	NNS	O
(	(	O
types	NNS	O
III	NNP	O
-	:	O
VI	NNP	O
)	)	O
,	,	O
which	WDT	O
have	VBP	O
sometimes	RB	O
been	VBN	O
categorized	VBN	O
as	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	NNP	I_Disease
disease	NN	E_Disease
,	,	O
may	MD	O
represent	VB	O
mutations	NNS	O
in	IN	O
genes	NNS	O
encoding	VBG	O
other	JJ	O
structural	JJ	O
myelin	NN	O
proteins	NNS	O
or	CC	O
proteins	VBZ	O
critical	JJ	O
to	TO	O
myelination	NN	O
.	.	O
.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
human	JJ	O
von	NN	B_Disease
Willebrand	NNP	I_Disease
disease	NN	E_Disease
:	:	O
analysis	NN	O
of	IN	O
platelet	NN	O
von	NNP	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
mRNA	NN	O
.	.	O

von	NN	B_Disease
Willebrand	NNP	I_Disease
disease	NN	E_Disease
(	(	O
vWD	NN	S_Disease
)	)	O
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
inherited	JJ	B_Disease
bleeding	VBG	I_Disease
disorder	NN	E_Disease
in	IN	O
humans	NNS	O
,	,	O
can	MD	O
result	VB	O
from	IN	O
either	CC	O
a	DT	O
quantitative	JJ	O
or	CC	O
a	DT	O
qualitative	JJ	O
defect	NN	O
in	IN	O
the	DT	O
adhesive	JJ	O
glycoprotein	NN	O
,	,	O
von	FW	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
(	(	O
vWF	NN	O
)	)	O
.	.	O

Molecular	JJ	O
studies	NNS	O
of	IN	O
vWD	NNS	S_Disease
have	VBP	O
been	VBN	O
limited	VBN	O
by	IN	O
the	DT	O
large	JJ	O
size	NN	O
of	IN	O
the	DT	O
vWF	JJ	O
gene	NN	O
and	CC	O
difficulty	NN	O
in	IN	O
obtaining	VBG	O
the	DT	O
vWF	NN	O
mRNA	NN	O
from	IN	O
patients	NNS	O
.	.	O

By	IN	O
use	NN	O
of	IN	O
an	DT	O
adaptation	NN	O
of	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
,	,	O
vWF	FW	O
mRNA	NN	O
was	VBD	O
amplified	VBN	O
and	CC	O
sequenced	VBN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
platelets	NNS	O
.	.	O

A	DT	O
silent	JJ	O
vWF	NN	O
allele	NN	O
was	VBD	O
identified	VBN	O
,	,	O
resulting	VBG	O
from	IN	O
a	DT	O
cis	NN	O
defect	NN	O
in	IN	O
vWF	NN	O
mRNA	NN	O
transcription	NN	O
or	CC	O
processing	NN	O
.	.	O

In	IN	O
two	CD	O
type	NN	B_Disease
IIA	NNP	I_Disease
vWD	NN	E_Disease
patients	NNS	O
,	,	O
two	CD	O
different	JJ	O
but	CC	O
adjacent	JJ	O
missense	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
the	DT	O
locations	NNS	O
of	IN	O
which	WDT	O
may	MD	O
identify	VB	O
an	DT	O
important	JJ	O
vWF	NN	O
functional	JJ	O
domain	NN	O
.	.	O

Expression	NN	O
in	IN	O
heterologous	JJ	O
cells	NNS	O
of	IN	O
recombinant	JJ	O
vWF	NN	O
containing	VBG	O
one	CD	O
of	IN	O
these	DT	O
latter	JJ	O
mutations	NNS	O
reproduced	VBD	O
the	DT	O
characteristic	JJ	O
structural	JJ	O
abnormality	NN	O
seen	VBN	O
in	IN	O
type	JJ	B_Disease
IIA	NNP	I_Disease
vWD	NN	E_Disease
plasma	NN	O
.	.	O
.	.	O

Familial	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
seventh	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
associated	VBN	O
with	IN	O
recurrent	JJ	O
meningococcal	JJ	B_Disease
infections	NNS	E_Disease
.	.	O

We	PRP	O
describe	VBP	O
an	DT	O
11	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
girl	NN	O
suffering	VBG	O
from	IN	O
recurrent	JJ	B_Disease
meningitis	NN	E_Disease
with	IN	O
a	DT	O
complete	JJ	O
absence	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
seventh	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
(	(	O
C7	NNP	O
)	)	O
.	.	O

Diagnosis	NN	O
was	VBD	O
established	VBN	O
by	IN	O
haemolytic	JJ	O
titration	NN	O
and	CC	O
western	JJ	O
blotting	NN	O
.	.	O

The	DT	O
patients	NNS	O
serum	VBP	O
lacked	VBD	O
the	DT	O
85	CD	O
kDa	NN	O
C7	NNP	O
chain	NN	O
.	.	O

Haemolytic	JJ	O
activity	NN	O
of	IN	O
serum	NN	O
was	VBD	O
reconstituted	VBN	O
with	IN	O
either	DT	O
pooled	VBN	O
normal	JJ	O
human	JJ	O
serum	NN	O
or	CC	O
with	IN	O
purified	JJ	O
C7	NNP	O
.	.	O

The	DT	O
relatives	NNS	O
(	(	O
parents	NNS	O
and	CC	O
one	CD	O
sister	NN	O
)	)	O
had	VBD	O
half	VBN	O
-	:	O
normal	JJ	O
levels	NNS	O
of	IN	O
both	DT	O
immunochemically	RB	O
and	CC	O
functionally	RB	O
determined	VBD	O
C7	NNP	O
,	,	O
indicating	VBG	O
a	DT	O
heterozygous	JJ	O
state	NN	O
for	IN	O
C7	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O
.	.	O

Translocation	NN	O
t	NN	O
(	(	O
5	CD	O
;	:	O
11	CD	O
)	)	O
(	(	O
q13	UH	O
.	.	O
1	CD	O
;	:	O
p13	NN	O
)	)	O
associated	VBN	O
with	IN	O
familial	JJ	O
isolated	JJ	B_Disease
aniridia	NN	E_Disease
.	.	O

A	DT	O
father	NN	O
and	CC	O
daughter	NN	O
with	IN	O
isolated	JJ	B_Disease
aniridia	NNS	E_Disease
were	VBD	O
observed	VBN	O
to	TO	O
have	VB	O
an	DT	O
apparently	RB	O
balanced	VBN	O
,	,	O
reciprocal	JJ	O
translocation	NN	O
involving	VBG	O
chromosomes	NNS	O
5	CD	O
and	CC	O
11	CD	O
[	NN	O
t	NN	O
(	(	O
5	CD	O
;	:	O
11	CD	O
)	)	O
(	(	O
q13	UH	O
.	.	O

1	CD	O
;	:	O
p13	NN	O
)	)	O
]	NN	O
.	.	O

No	DT	O
other	JJ	O
clinical	JJ	O
characteristics	NNS	O
often	RB	O
associated	VBN	O
with	IN	O
the	DT	O
deletion	NN	O
of	IN	O
11p13	CD	O
were	VBD	O
observed	VBN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

This	DT	O
finding	NN	O
,	,	O
in	IN	O
association	NN	O
with	IN	O
3	CD	O
other	JJ	O
instances	NNS	O
of	IN	O
single	JJ	O
breaks	NNS	O
at	IN	O
11p13	CD	O
and	CC	O
aniridia	RB	S_Disease
,	,	O
supports	VBZ	O
the	DT	O
assignment	NN	O
of	IN	O
AN2	NNP	O
to	TO	O
11p13	CD	O
.	.	O

Homozygous	JJ	B_Disease
hypobetalipoproteinemia	NN	E_Disease
:	:	O
a	DT	O
disease	NN	O
distinct	NN	O
from	IN	O
abetalipoproproteinemia	NN	S_Disease
at	IN	O
the	DT	O
molecular	JJ	O
level	NN	O
.	.	O

apoB	NN	O
DNA	NNP	O
,	,	O
RNA	NNP	O
,	,	O
and	CC	O
protein	RB	O
from	IN	O
two	CD	O
patients	NNS	O
with	IN	O
homozygous	JJ	B_Disease
hypobetalipoproteinemia	NN	E_Disease
(	(	O
HBL	NNP	S_Disease
)	)	O
were	VBD	O
evaluated	VBN	O
and	CC	O
compared	VBN	O
with	IN	O
normal	JJ	O
individuals	NNS	O
.	.	O

Southern	NNP	O
blot	NN	O
analysis	NN	O
with	IN	O
10	CD	O
different	JJ	O
cDNA	NN	O
probes	NNS	O
revealed	VBD	O
a	DT	O
normal	JJ	O
gene	NN	O
without	IN	O
major	JJ	O
insertions	NNS	O
,	,	O
deletions	NNS	O
,	,	O
or	CC	O
rearrangements	NNS	O
.	.	O

Northern	NNP	O
and	CC	O
slot	NN	O
blot	NN	O
analyses	NNS	O
of	IN	O
total	JJ	O
liver	NN	O
mRNA	NN	O
from	IN	O
HBL	NNP	S_Disease
patients	NNS	O
documented	VBD	O
a	DT	O
normal	JJ	O
size	NN	O
apoB	NN	O
mRNA	NN	O
that	WDT	O
was	VBD	O
present	JJ	O
in	IN	O
greatly	RB	O
reduced	JJ	O
quantities	NNS	O
.	.	O

ApoB	NNP	O
protein	NN	O
was	VBD	O
detected	VBN	O
within	IN	O
HBL	NNP	S_Disease
hepatocytes	VBZ	O
utilizing	JJ	O
immunohistochemical	JJ	O
techniques	NNS	O
;	:	O
however	RB	O
,	,	O
it	PRP	O
was	VBD	O
markedly	RB	O
reduced	VBN	O
in	IN	O
quantity	NN	O
when	WRB	O
compared	VBN	O
with	IN	O
control	NN	O
samples	NNS	O
.	.	O

No	DT	O
apoB	NN	O
was	VBD	O
detectable	JJ	O
in	IN	O
the	DT	O
plasma	NN	O
of	IN	O
HBL	NNP	S_Disease
individuals	NNS	O
with	IN	O
an	DT	O
ELISA	NNP	O
assay	NN	O
.	.	O

These	DT	O
data	NNS	O
are	VBP	O
most	RBS	O
consistent	JJ	O
with	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
coding	VBG	O
portion	NN	O
of	IN	O
the	DT	O
apoB	JJ	O
gene	NN	O
in	IN	O
HBL	NNP	S_Disease
patients	NNS	O
,	,	O
leading	VBG	O
to	TO	O
an	DT	O
abnormal	JJ	O
apoB	NN	O
protein	NN	O
and	CC	O
apoB	JJ	O
mRNA	NN	O
instability	NN	O
.	.	O

These	DT	O
results	NNS	O
are	VBP	O
distinct	JJ	O
from	IN	O
those	DT	O
previously	RB	O
noted	VBN	O
in	IN	O
abetalipoproteinemia	NN	S_Disease
,	,	O
which	WDT	O
was	VBD	O
characterized	VBN	O
by	IN	O
an	DT	O
elevated	JJ	O
level	NN	O
of	IN	O
hepatic	JJ	O
apoB	NN	O
mRNA	NN	O
and	CC	O
accumulation	NN	O
of	IN	O
intracellular	JJ	O
hepatic	JJ	O
apoB	NN	O
protein	NN	O
.	.	O
.	.	O

Spontaneous	JJ	O
reversion	NN	O
of	IN	O
novel	JJ	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	E_Disease
mutation	NN	O
by	IN	O
HPRT	NNP	O
gene	NN	O
rearrangement	NN	O
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
an	DT	O
unusual	JJ	O
patient	NN	O
with	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
has	VBZ	O
suggested	VBN	O
that	IN	O
the	DT	O
mutation	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
partial	JJ	O
HPRT	NNP	O
gene	NN	O
duplication	NN	O
.	.	O

We	PRP	O
now	RB	O
report	VBP	O
the	DT	O
cloning	NN	O
and	CC	O
sequencing	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
HPRT	NNP	O
cDNA	NN	O
which	WDT	O
shows	VBZ	O
the	DT	O
precise	JJ	O
duplication	NN	O
of	IN	O
exons	NNS	O
2	CD	O
and	CC	O
3	CD	O
.	.	O

This	DT	O
mutation	NN	O
is	VBZ	O
the	DT	O
result	NN	O
of	IN	O
an	DT	O
internal	JJ	O
duplication	NN	O
of	IN	O
16	CD	O
-	:	O
20	CD	O
kilobases	NNS	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

The	DT	O
structure	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
gene	NN	O
suggests	VBZ	O
that	IN	O
the	DT	O
duplication	NN	O
was	VBD	O
not	RB	O
generated	VBN	O
by	IN	O
a	DT	O
single	JJ	O
unequal	JJ	O
crossing	VBG	O
-	:	O
over	IN	O
event	NN	O
between	IN	O
two	CD	O
normal	JJ	O
HPRT	NNP	O
alleles	NNS	O
.	.	O

Growth	NNP	O
of	IN	O
Epstein	NNP	B_Disease
-	:	I_Disease
Barr	NNP	E_Disease
virus	SYM	O
-	:	O
transformed	JJ	O
lymphoblasts	NNS	O
from	IN	O
this	DT	O
patient	NN	O
in	IN	O
selective	JJ	O
medium	NN	O
has	VBZ	O
permitted	VBN	O
isolation	NN	O
of	IN	O
spontaneous	JJ	O
HPRT	NNP	O
+	NNP	O
revertants	NNS	O
of	IN	O
this	DT	O
mutation	NN	O
.	.	O

The	DT	O
reversion	NN	O
event	NN	O
involves	VBZ	O
a	DT	O
second	JJ	O
major	JJ	O
HPRT	NNP	O
gene	NN	O
rearrangement	NN	O
where	WRB	O
most	RBS	O
or	CC	O
all	DT	O
of	IN	O
the	DT	O
duplicated	JJ	O
portion	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
gene	NN	O
is	VBZ	O
deleted	VBN	O
.	.	O

The	DT	O
original	JJ	O
mutation	NN	O
therefore	NN	O
has	VBZ	O
the	DT	O
potential	NN	O
for	IN	O
spontaneous	JJ	O
somatic	JJ	O
reversion	NN	O
.	.	O

This	DT	O
may	MD	O
explain	VB	O
the	DT	O
relatively	RB	O
mild	JJ	O
symptoms	NNS	O
of	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
exhibited	VBN	O
by	IN	O
this	DT	O
patient	NN	O
.	.	O
.	.	O

Complex	NNP	B_Disease
glycerol	NN	I_Disease
kinase	NN	I_Disease
deficiency	NN	E_Disease
:	:	O
molecular	JJ	O
-	:	O
genetic	JJ	O
,	,	O
cytogenetic	JJ	O
,	,	O
and	CC	O
clinical	JJ	O
studies	NNS	O
of	IN	O
five	CD	O
Japanese	JJ	O
patients	NNS	O
.	.	O

Five	CD	O
male	JJ	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
complex	JJ	B_Disease
glycerol	NN	I_Disease
kinase	NN	I_Disease
deficiency	NN	E_Disease
(	(	O
CGKD	NNP	S_Disease
)	)	O
and	CC	O
their	PRP$	O
relatives	NNS	O
were	VBD	O
studied	VBN	O
clinically	RB	O
,	,	O
cytogenetically	RB	O
,	,	O
and	CC	O
molecular	JJ	O
-	:	O
genetically	RB	O
.	.	O

All	DT	O
patients	NNS	O
had	VBD	O
muscular	JJ	B_Disease
dystrophy	NN	E_Disease
or	CC	O
muscle	NN	B_Disease
weakness	NN	E_Disease
,	,	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
congenital	JJ	B_Disease
adrenal	JJ	I_Disease
hypoplasia	NN	E_Disease
,	,	O
and	CC	O
glycerol	NN	B_Disease
kinase	NN	I_Disease
deficiency	NN	E_Disease
.	.	O

High	JJ	O
-	:	O
resolution	NN	O
GTG	NNP	O
-	:	O
banded	VBD	O
chromosomes	NNS	O
showed	VBD	O
a	DT	O
microdeletion	NN	O
in	IN	O
the	DT	O
Xp21	NNP	O
region	NN	O
in	IN	O
all	DT	O
four	CD	O
patients	NNS	O
examined	VBN	O
and	CC	O
in	IN	O
all	DT	O
five	CD	O
mothers	NNS	O
.	.	O

Southern	JJ	O
hybridizations	NNS	O
,	,	O
after	IN	O
digestions	NNS	O
by	IN	O
restriction	NN	O
endonucleases	NNS	O
,	,	O
with	IN	O
various	JJ	O
cloned	VBN	O
DNAs	NNP	O
(	(	O
D2	NNP	O
,	,	O
99	CD	O
-	:	O
6	CD	O
,	,	O
B24	NNP	O
,	,	O
C7	NNP	O
,	,	O
L1	NNP	O
-	:	O
4	CD	O
,	,	O
cDMD13	SYM	O
-	:	O
14	CD	O
,	,	O
J66	NNP	O
-	:	O
HI	NNP	O
,	,	O
P20	NNP	O
,	,	O
J	NNP	O
-	:	O
Bir	NNP	O
,	,	O
ERT87	NNP	O
-	:	O
30	CD	O
,	,	O
ERT87	NNP	O
-	:	O
15	CD	O
,	,	O
ERT87	NNP	O
-	:	O
8	CD	O
,	,	O
ERT87	NNP	O
-	:	O
1	CD	O
,	,	O
XJ	NNP	O
-	:	O
1	CD	O
.	.	O

1	CD	O
,	,	O
754	CD	O
,	,	O
cx5	NN	O
.	.	O

7	CD	O
,	,	O
and	CC	O
OTC	NNP	O
-	:	O
1	CD	O
)	)	O
that	WDT	O
are	VBP	O
located	VBN	O
around	IN	O
Xp21	NNP	O
also	RB	O
showed	VBD	O
a	DT	O
deletion	NN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
all	DT	O
patients	NNS	O
and	CC	O
mothers	NNS	O
.	.	O

Although	IN	O
the	DT	O
deletion	NN	O
differed	VBD	O
in	IN	O
size	NN	O
among	IN	O
patients	NNS	O
,	,	O
a	DT	O
segment	NN	O
commonly	RB	O
absent	NN	O
was	VBD	O
located	VBN	O
between	IN	O
the	DT	O
genomic	JJ	O
sequences	NNS	O
corresponding	VBG	O
to	TO	O
L1	NNP	O
-	:	O
4	CD	O
and	CC	O
cDMD13	VB	O
-	:	O
14	CD	O
.	.	O

This	DT	O
finding	NN	O
indicated	VBD	O
that	IN	O
the	DT	O
gene	NN	O
coding	VBG	O
for	IN	O
glycerol	NN	O
kinase	NN	O
(	(	O
GK	NNP	O
)	)	O
is	VBZ	O
located	VBN	O
within	IN	O
this	DT	O
segment	NN	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
the	DT	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
the	DT	O
present	JJ	O
five	CD	O
patients	NNS	O
and	CC	O
reported	VBD	O
CGKD	NNP	S_Disease
or	CC	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
patients	NNS	O
with	IN	O
DNA	NNP	O
deletion	NN	O
suggests	VBZ	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
certain	JJ	O
gene	NN	O
responsible	JJ	O
for	IN	O
gonadotropin	JJ	B_Disease
deficiency	NN	E_Disease
(	(	O
GTD	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
result	NN	O
of	IN	O
the	DT	O
present	JJ	O
study	NN	O
and	CC	O
results	NNS	O
of	IN	O
previous	JJ	O
studies	NNS	O
suggest	VBP	O
that	IN	O
genes	NNS	O
for	IN	O
ornithine	JJ	O
transcarbamylase	NN	O
(	(	O
OTC	NNP	O
)	)	O
,	,	O
DMD	NNP	S_Disease
,	,	O
and	CC	O
GK	NNP	O
and	CC	O
putative	JJ	O
genes	NNS	O
responsible	JJ	O
for	IN	O
congenital	JJ	B_Disease
adrenal	JJ	I_Disease
hypoplasia	NN	E_Disease
(	(	O
AHC	NNP	S_Disease
)	)	O
and	CC	O
GTD	NNP	S_Disease
are	VBP	O
arranged	VBN	O
from	IN	O
telomere	RB	O
to	TO	O
centromere	VB	O
as	IN	O
pter	NN	O
-	:	O
-	:	O
GTD	NNP	O
-	:	O
-	:	O
AHC	SYM	O
-	:	O
-	:	O
GK	NNP	O
-	:	O
-	:	O
DMD	NNP	O
-	:	O
-	:	O
OTC	NNP	O
-	:	O
-	:	O
cen	NN	O

Genetically	RB	O
determined	VBN	O
low	JJ	O
C4	NNP	O
:	:	O
a	DT	O
predisposing	VBG	O
factor	NN	O
to	TO	O
autoimmune	VB	B_Disease
chronic	JJ	I_Disease
active	JJ	I_Disease
hepatitis	NN	E_Disease
.	.	O

Of	IN	O
26	CD	O
patients	NNS	O
with	IN	O
autoimmune	JJ	B_Disease
chronic	JJ	I_Disease
active	JJ	I_Disease
hepatitis	NN	E_Disease
(	(	O
CAH	NNP	S_Disease
)	)	O
starting	VBG	O
in	IN	O
childhood	NN	O
18	CD	O
(	(	O
69	CD	O
%	NN	O
)	)	O
had	VBD	O
low	JJ	O
C4	NNP	O
and	CC	O
5	CD	O
(	(	O
19	CD	O
%	NN	O
)	)	O
had	VBD	O
low	JJ	O
C3	NNP	O
serum	NN	O
levels	NNS	O
.	.	O

Impaired	NNP	O
hepatic	JJ	O
synthesis	NN	O
and	CC	O
immune	JJ	O
-	:	O
consumption	NN	O
were	VBD	O
unlikely	JJ	O
since	IN	O
transferrin	NN	O
levels	NNS	O
were	VBD	O
normal	JJ	O
in	IN	O
all	DT	O
patients	NNS	O
,	,	O
albumin	JJ	O
levels	NNS	O
were	VBD	O
persistently	RB	O
low	JJ	O
in	IN	O
only	RB	O
3	CD	O
,	,	O
and	CC	O
only	RB	O
3	CD	O
had	VBD	O
raised	VBN	O
levels	NNS	O
of	IN	O
activation	NN	O
fragment	NN	O
C3d	NNP	O
.	.	O

C4d	NNP	O
was	VBD	O
normal	JJ	O
in	IN	O
all	DT	O
patients	NNS	O
studied	VBN	O
.	.	O

In	IN	O
the	DT	O
families	NNS	O
of	IN	O
12	CD	O
probands	NNS	O
with	IN	O
low	JJ	O
C4	NNP	O
,	,	O
7	CD	O
parents	NNS	O
had	VBD	O
low	JJ	O
C4	NNP	O
and	CC	O
2	CD	O
had	VBD	O
levels	NNS	O
which	WDT	O
were	VBD	O
at	IN	O
the	DT	O
lower	JJR	O
limit	NN	O
of	IN	O
normal	JJ	O
.	.	O

5	CD	O
of	IN	O
10	CD	O
siblings	NNS	O
from	IN	O
5	CD	O
families	NNS	O
had	VBD	O
low	JJ	O
C4	NNP	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
low	JJ	O
C4	NNP	O
levels	NNS	O
in	IN	O
CAH	NNP	S_Disease
are	VBP	O
genetically	RB	O
determined	VBN	O
.	.	O

C4	NNP	O
phenotyping	NN	O
in	IN	O
20	CD	O
patients	NNS	O
and	CC	O
in	IN	O
26	CD	O
parents	NNS	O
showed	VBD	O
that	IN	O
90	CD	O
%	NN	O
and	CC	O
81	CD	O
%	NN	O
,	,	O
respectively	RB	O
,	,	O
had	VBD	O
null	JJ	O
allotypes	NNS	O
at	IN	O
either	CC	O
the	DT	O
C4A	NNP	O
or	CC	O
C4B	NNP	O
locus	NN	O
compared	VBN	O
with	IN	O
59	CD	O
%	NN	O
in	IN	O
controls	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
defective	JJ	O
expression	NN	O
of	IN	O
structural	JJ	O
genes	NNS	O
may	MD	O
contribute	VB	O
to	TO	O
the	DT	O
observed	VBN	O
C4	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O
.	.	O

An	DT	O
amino	NN	O
-	:	O
acid	JJ	O
substitution	NN	O
involved	VBN	O
in	IN	O
phenylketonuria	NN	S_Disease
is	VBZ	O
in	IN	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
DNA	NNP	O
haplotype	NN	O
2	CD	O
.	.	O

Phenylketonuria	NNP	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
human	JJ	I_Disease
genetic	JJ	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
hepatic	JJ	I_Disease
phenylalanine	NN	I_Disease
hydroxylase	NN	E_Disease
(	(	O
PAH	NNP	O
,	,	O
phenylalanine	NN	O
4	CD	O
-	:	O
monooxygenase	NN	O
,	,	O
EC	NNP	O
1	CD	O
.	.	O

14	CD	O
.	.	O

16	CD	O
.	.	O

1	CD	O
)	)	O
.	.	O

PKU	NNP	S_Disease
is	VBZ	O
a	DT	O
common	JJ	O
inborn	JJ	B_Disease
error	NN	I_Disease
of	IN	I_Disease
amino	NN	I_Disease
-	:	I_Disease
acid	NN	I_Disease
metabolism	NN	E_Disease
in	IN	O
caucasian	JJ	O
populations	NNS	O
and	CC	O
approximately	RB	O
1	CD	O
in	IN	O
50	CD	O
individuals	NNS	O
are	VBP	O
carriers	NNS	O
of	IN	O
a	DT	O
PKU	NNP	S_Disease
allele	NN	O
.	.	O

To	TO	O
define	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
PKU	NNP	S_Disease
,	,	O
we	PRP	O
characterized	VBD	O
twelve	JJ	O
restriction	NN	O
fragment	NN	O
-	:	O
length	NN	O
polymorphism	NN	O
(	(	O
RFLP	NNP	O
)	)	O
haplotypes	NNS	O
of	IN	O
the	DT	O
PAH	NNP	O
locus	NN	O
in	IN	O
the	DT	O
northern	JJ	O
European	JJ	O
population	NN	O
and	CC	O
observed	VBD	O
that	IN	O
90	CD	O
%	NN	O
of	IN	O
the	DT	O
PKU	NNP	S_Disease
alleles	NNS	O
in	IN	O
this	DT	O
population	NN	O
are	VBP	O
confined	VBN	O
to	TO	O
four	CD	O
common	JJ	O
RFLP	NNP	O
haplotypes	NNS	O
.	.	O

We	PRP	O
have	VBP	O
recently	RB	O
reported	VBN	O
a	DT	O
splicing	VBG	O
mutation	NN	O
in	IN	O
the	DT	O
PAH	NNP	O
gene	NN	O
that	WDT	O
is	VBZ	O
associated	VBN	O
with	IN	O
RFLP	NNP	O
haplotype	NN	O
3	CD	O
which	WDT	O
is	VBZ	O
present	JJ	O
at	IN	O
about	RB	O
40	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
.	.	O

We	PRP	O
now	RB	O
report	VBP	O
the	DT	O
molecular	JJ	B_Disease
lesion	NN	E_Disease
associated	VBN	O
with	IN	O
the	DT	O
RFLP	NNP	O
haplotype	NN	O
2	CD	O
mutant	JJ	O
allele	NN	O
.	.	O

This	DT	O
defect	NN	O
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
C	NNP	O
-	:	O
to	TO	O
-	:	O
T	NNP	O
transition	NN	O
in	IN	O
exon	$	O
12	CD	O
resulting	VBG	O
in	IN	O
an	DT	O
amino	NN	O
-	:	O
acid	NN	O
substitution	NN	O
(	(	O
Arg	NNP	O
to	TO	O
Trp	NNP	O
)	)	O
at	IN	O
residue	JJ	O
408	CD	O
of	IN	O
PAH	NNP	O
.	.	O

Direct	JJ	O
hybridization	NN	O
analysis	NN	O
of	IN	O
the	DT	O
point	NN	O
mutation	NN	O
using	VBG	O
a	DT	O
specific	JJ	O
oligonucleotide	NN	O
probe	NN	O
demonstrated	VBD	O
that	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
also	RB	O
in	IN	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
RFLP	NNP	O
haplotype	NN	O
2	CD	O
alleles	NNS	O
that	WDT	O
make	VBP	O
up	RP	O
about	RB	O
20	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
PAH	NNP	O
genes	NNS	O

Choroideremia	NN	S_Disease
:	:	O
close	JJ	O
linkage	NN	O
to	TO	O
DXYS1	NNP	O
and	CC	O
DXYS12	NNP	O
demonstrated	VBN	O
by	IN	O
segregation	NN	O
analysis	NN	O
and	CC	O
historical	JJ	O
-	:	O
genealogical	JJ	O
evidence	NN	O
.	.	O

Linkage	NN	O
studies	NNS	O
using	VBG	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
were	VBD	O
conducted	VBN	O
in	IN	O
the	DT	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
disorder	NN	E_Disease
,	,	O
choroideremia	NN	S_Disease
,	,	O
designated	VBN	O
TCD	NNP	S_Disease
for	IN	O
Progressive	NNP	B_Disease
Tapeto	NNP	I_Disease
-	:	I_Disease
Choroidal	NNP	I_Disease
Dystrophy	NNP	E_Disease
.	.	O

Previously	RB	O
demonstrated	VBN	O
close	JJ	O
linkage	NN	O
with	IN	O
locus	NN	O
DXYS1	NNP	O
was	VBD	O
confirmed	VBN	O
(	(	O
lod	JJ	O
11	CD	O
.	.	O

44	CD	O
at	IN	O
0	CD	O
recombination	NN	O
distance	NN	O
)	)	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
locus	NN	O
DXYS12	NNP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
closely	RB	O
linked	VBN	O
with	IN	O
TCD	NNP	S_Disease
(	(	O
lod	JJ	O
3	CD	O
.	.	O

31	CD	O
at	IN	O
0	CD	O
recombination	NN	O
distance	NN	O
)	)	O
.	.	O

The	DT	O
disease	NN	O
mainly	RB	O
occurs	VBZ	O
in	IN	O
three	CD	O
large	JJ	O
kindreds	NNS	O
in	IN	O
remote	JJ	O
Northern	NNP	O
Finland	NNP	O
.	.	O

While	IN	O
formal	JJ	O
genealogical	JJ	O
proof	NN	O
is	VBZ	O
lacking	VBG	O
,	,	O
all	DT	O
presently	RB	O
living	VBG	O
(	(	O
more	JJR	O
than	IN	O
80	CD	O
affected	JJ	O
males	NNS	O
and	CC	O
120	CD	O
carrier	NN	O
females	NNS	O
)	)	O
probably	RB	O
originate	VBP	O
from	IN	O
a	DT	O
common	JJ	O
founder	NN	O
couple	NN	O
born	VBN	O
in	IN	O
1644	CD	O
and	CC	O
1646	CD	O
,	,	O
twelve	VBP	O
generations	NNS	O
ago	RB	O
.	.	O

All	DT	O
36	CD	O
patients	NNS	O
and	CC	O
48	CD	O
carriers	NNS	O
tested	VBN	O
from	IN	O
the	DT	O
three	CD	O
kindreds	NNS	O
had	VBD	O
the	DT	O
same	JJ	O
haplotype	NN	O
(	(	O
TCD	NNP	S_Disease
/	NNP	O
DXYS1	NNP	O
,	,	O
11kb	CD	O
/	NN	O
DXYS12	NNP	O
,	,	O
1	CD	O
.	.	O

6kb	CD	O
)	)	O
.	.	O

Given	VBN	O
that	DT	O
at	IN	O
least	JJS	O
105	CD	O
female	JJ	O
meioses	NNS	O
transmitting	VBG	O
TCD	NNP	S_Disease
have	VBP	O
occurred	VBN	O
since	IN	O
1650	CD	O
in	IN	O
these	DT	O
kindreds	NNS	O
,	,	O
extremely	RB	O
close	JJ	O
linkage	NN	O
between	IN	O
TCD	NNP	S_Disease
,	,	O
DXYS1	NNP	O
and	CC	O
DXYS12	NNP	O
is	VBZ	O
suggested	VBN	O
.	.	O

The	DT	O
above	JJ	O
haplotype	NN	O
is	VBZ	O
a	DT	O
very	RB	O
useful	JJ	O
diagnostic	JJ	O
tool	NN	O
in	IN	O
these	DT	O
TCD	NNP	S_Disease
families	NNS	O
.	.	O

We	PRP	O
suggest	VBP	O
that	IN	O
our	PRP$	O
historical	JJ	O
-	:	O
genealogical	JJ	O
approach	NN	O
to	TO	O
linkage	VB	O
analysis	NN	O
may	MD	O
be	VB	O
possible	JJ	O
elsewhere	RB	O
in	IN	O
similar	JJ	O
isolated	JJ	O
populations	NNS	O

Von	NNP	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	I_Disease
disease	NN	E_Disease
maps	NNS	O
to	TO	O
the	DT	O
region	NN	O
of	IN	O
chromosome	NN	O
3	CD	O
associated	VBN	O
with	IN	O
renal	JJ	B_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
.	.	O

Von	NNP	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	I_Disease
disease	NN	E_Disease
(	(	O
VHL	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
disorder	NN	E_Disease
with	IN	O
inherited	JJ	O
susceptibility	NN	O
to	TO	O
various	JJ	O
forms	NNS	O
of	IN	O
cancer	NN	S_Disease
,	,	O
including	VBG	O
hemangioblastomas	NN	S_Disease
of	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
phaeochromocytomas	NN	S_Disease
,	,	O
pancreatic	JJ	B_Disease
malignancies	NNS	E_Disease
,	,	O
and	CC	O
renal	JJ	B_Disease
cell	NN	I_Disease
carcinomas	NN	E_Disease
.	.	O

Renal	NNP	B_Disease
cell	NN	I_Disease
carcinomas	NNS	E_Disease
constitute	VBP	O
a	DT	O
particularly	RB	O
frequent	JJ	O
cause	NN	O
of	IN	O
death	NN	O
in	IN	O
this	DT	O
disorder	NN	O
,	,	O
occurring	VBG	O
as	IN	O
bilateral	JJ	B_Disease
and	CC	I_Disease
multifocal	JJ	I_Disease
tumours	NNS	E_Disease
,	,	O
and	CC	O
presenting	VBG	O
at	IN	O
an	DT	O
earlier	JJR	O
age	NN	O
than	IN	O
in	IN	O
sporadic	JJ	O
,	,	O
non	JJ	O
-	:	O
familial	JJ	O
cases	NNS	O
of	IN	O
this	DT	O
tumour	NN	S_Disease
type	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
that	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
is	VBZ	O
linked	VBN	O
to	TO	O
the	DT	O
locus	NN	O
encoding	VBG	O
the	DT	O
human	JJ	O
homologoue	NN	O
of	IN	O
the	DT	O
RAF1	NNP	O
oncogene	NN	O
,	,	O
which	WDT	O
maps	VBZ	O
to	TO	O
chromosome	VB	O
3p25	CD	O
(	(	O
ref	NN	O
.	.	O

4	CD	O
)	)	O
.	.	O

Crossovers	NNS	O
with	IN	O
the	DT	O
VHL	NNP	S_Disease
locus	NN	O
suggest	VBP	O
that	IN	O
the	DT	O
defect	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
VHL	NNP	S_Disease
phenotype	NN	O
is	VBZ	O
not	RB	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
RAF1	NNP	O
gene	NN	O
itself	PRP	O
.	.	O

An	DT	O
alternative	NN	O
or	CC	O
prior	JJ	O
event	NN	O
to	TO	O
oncogene	VB	O
activation	NN	O
in	IN	O
tumour	JJ	S_Disease
formation	NN	O
may	MD	O
be	VB	O
the	DT	O
inactivation	NN	O
of	IN	O
a	DT	O
putative	JJ	O
tumour	NN	S_Disease
suppressor	NN	O
which	WDT	O
can	MD	O
be	VB	O
associated	VBN	O
with	IN	O
both	DT	O
the	DT	O
inherited	VBN	B_Disease
and	CC	I_Disease
sporadic	JJ	I_Disease
forms	NNS	I_Disease
of	IN	I_Disease
the	DT	I_Disease
cancer	NN	E_Disease
.	.	O

Sporadic	JJ	B_Disease
renal	NN	I_Disease
cell	NN	I_Disease
carcinomas	NNS	E_Disease
have	VBP	O
previously	RB	O
been	VBN	O
associated	VBN	O
with	IN	O
the	DT	O
loss	NN	O
of	IN	O
regions	NNS	O
on	IN	O
chromosome	NN	O
3p	CD	O
(	(	O
refs	VB	O
5	CD	O
,	,	O
6	CD	O
)	)	O
.	.	O

Consequently	RB	O
,	,	O
sporadic	JJ	O
and	CC	O
VHL	NNP	O
-	:	O
associated	VBD	O
forms	NNS	O
of	IN	O
renal	JJ	B_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
might	MD	O
both	DT	O
result	NN	O
from	IN	O
alterations	NNS	O
causing	VBG	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
the	DT	O
same	JJ	O
tumour	NN	S_Disease
suppressor	NN	O
gene	NN	O
on	IN	O
this	DT	O
chromosome	NN	O
.	.	O
.	.	O

Tightly	RB	O
linked	VBN	O
flanking	NN	O
markers	NNS	O
for	IN	O
the	DT	O
Lowe	NNP	B_Disease
oculocerebrorenal	JJ	I_Disease
syndrome	NN	E_Disease
,	,	O
with	IN	O
application	NN	O
to	TO	O
carrier	NN	O
assessment	NN	O
.	.	O

The	DT	O
Lowe	NNP	B_Disease
oculocerebrorenal	JJ	I_Disease
syndrome	NN	E_Disease
(	(	O
OCRL	NNP	S_Disease
)	)	O
is	VBZ	O
characterized	VBN	O
by	IN	O
congenital	JJ	O
cataract	NN	S_Disease
,	,	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
and	CC	O
defective	JJ	B_Disease
renal	JJ	I_Disease
tubular	JJ	I_Disease
function	NN	E_Disease
.	.	O

A	DT	O
map	JJ	O
assignment	NN	O
of	IN	O
OCRL	NNP	S_Disease
to	TO	O
Xq24	VB	O
-	:	O
q26	NN	O
has	VBZ	O
been	VBN	O
made	VBN	O
previously	RB	O
by	IN	O
linkage	NN	O
analysis	NN	O
with	IN	O
DXS42	NNP	O
at	IN	O
Xq24	NNP	O
-	:	O
q26	NN	O
(	(	O
theta	JJ	O
=	NN	O
0	CD	O
,	,	O
z	NN	O
=	VBD	O
5	CD	O
.	.	O

09	CD	O
)	)	O
and	CC	O
with	IN	O
DXS10	NNP	O
at	IN	O
Xq26	NNP	O
(	(	O
theta	JJ	O
=	NN	O
0	CD	O
,	,	O
z	NN	O
=	VBD	O
6	CD	O
.	.	O

45	CD	O
)	)	O
.	.	O

Two	CD	O
additional	JJ	O
families	NNS	O
were	VBD	O
studied	VBN	O
and	CC	O
three	CD	O
additional	JJ	O
polymorphisms	NNS	O
were	VBD	O
identified	VBN	O
at	IN	O
DXS42	NNP	O
by	IN	O
using	VBG	O
a	DT	O
35	CD	O
-	:	O
kb	NN	O
sequence	NN	O
isolated	VBN	O
with	IN	O
the	DT	O
probe	NN	O
detecting	VBG	O
the	DT	O
original	JJ	O
polymorphism	NN	O
at	IN	O
DXS42	NNP	O
.	.	O

With	IN	O
additional	JJ	O
OCRL	NNP	S_Disease
families	NNS	O
made	VBD	O
informative	JJ	O
for	IN	O
DXS42	NNP	O
,	,	O
theta	NN	O
remained	VBD	O
0	CD	O
with	IN	O
z	NN	O
=	$	O
6	CD	O
.	.	O

63	CD	O
;	:	O
and	CC	O
for	IN	O
DXS10	NNP	O
theta	NN	O
=	VBD	O
0	CD	O
.	.	O

03	CD	O
and	CC	O
z	NNP	O
=	NNP	O
7	CD	O
.	.	O

07	CD	O
.	.	O

Evidence	NN	O
for	IN	O
placing	VBG	O
OCRL	NNP	O
at	IN	O
Xq25	NNP	O
also	RB	O
comes	VBZ	O
from	IN	O
a	DT	O
female	NN	O
with	IN	O
Lowe	NNP	B_Disease
syndrome	NN	E_Disease
and	CC	O
an	DT	O
X	NN	O
;	:	O
3	CD	O
translocation	NN	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
the	DT	O
Xq25	NNP	O
breakpoint	NN	O
in	IN	O
this	DT	O
patient	NN	O
to	TO	O
determine	VB	O
the	DT	O
position	NN	O
of	IN	O
OCRL	NNP	O
relative	NN	O
to	TO	O
the	DT	O
two	CD	O
linked	VBD	O
markers	NNS	O
.	.	O

Each	DT	O
derivative	JJ	O
chromosome	NN	O
was	VBD	O
isolated	VBN	O
away	RB	O
from	IN	O
its	PRP$	O
normal	JJ	O
counterpart	NN	O
in	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
.	.	O

DXS42	NNP	O
was	VBD	O
mapped	VBN	O
to	TO	O
the	DT	O
derivative	JJ	O
chromosome	NN	O
X	NNP	O
containing	VBG	O
Xpterq25	NNP	O
,	,	O
and	CC	O
DXS10	NNP	O
was	VBD	O
mapped	VBN	O
to	TO	O
the	DT	O
derivative	JJ	O
chromosome	NN	O
3	CD	O
containing	VBG	O
Xq25	NNP	O
-	:	O
qter	NN	O
.	.	O

The	DT	O
markers	NNS	O
DXS10	NNP	O
and	CC	O
DXS42	NNP	O
therefore	RB	O
show	VBP	O
tight	JJ	O
linkage	NN	O
with	IN	O
OCRL	NNP	S_Disease
in	IN	O
six	CD	O
families	NNS	O
and	CC	O
flank	VB	O
the	DT	O
Xq25	NNP	O
breakpoint	NN	O
in	IN	O
a	DT	O
female	JJ	O
patient	NN	O
with	IN	O
an	DT	O
X	NN	O
;	:	O
3	CD	O
translocation	NN	O
.	.	O

Linkage	NN	O
analysis	NN	O
with	IN	O
flanking	VBG	O
markers	NNS	O
was	VBD	O
used	VBN	O
to	TO	O
assess	VB	O
OCRL	NNP	S_Disease
carrier	NN	O
status	NN	O
in	IN	O
women	NNS	O
at	IN	O
risk	NN	O
.	.	O

Results	NNS	O
,	,	O
when	WRB	O
compared	VBN	O
with	IN	O
carrier	NN	O
determination	NN	O
by	IN	O
ophthalmologic	JJ	O
examination	NN	O
,	,	O
indicated	VBD	O
that	IN	O
the	DT	O
slit	NN	O
-	:	O
lamp	NN	O
exam	NN	O
can	MD	O
be	VB	O
a	DT	O
sensitive	JJ	O
and	CC	O
specific	JJ	O
method	NN	O
of	IN	O
carrier	NN	O
determination	NN	O
in	IN	O
many	JJ	O
cases	NNS	O

Identification	NN	O
of	IN	O
a	DT	O
single	JJ	O
nucleotide	NN	O
change	NN	O
in	IN	O
the	DT	O
hypoxanthine	NN	O
-	:	O
guanine	NN	O
phosphoribosyltransferase	NN	O
gene	NN	O
(	(	O
HPRTYale	NNP	O
)	)	O
responsible	JJ	O
for	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Complete	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
hypoxanthine	NN	I_Disease
-	:	I_Disease
guanine	NN	I_Disease
phosphoribosyltransferase	NN	E_Disease
(	(	O
HPRT	NNP	O
)	)	O
causes	VBZ	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Previous	JJ	O
characterization	NN	O
of	IN	O
a	DT	O
mutant	JJ	O
form	NN	O
of	IN	O
HPRT	NNP	O
,	,	O
HPRTYale	NNP	O
,	,	O
from	IN	O
a	DT	O
subject	NN	O
with	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	VB	E_Disease
revealed	VBD	O
normal	JJ	O
mRNA	NN	O
and	CC	O
protein	NN	O
concentrations	NNS	O
,	,	O
no	DT	O
residual	JJ	O
catalytic	JJ	O
activity	NN	O
,	,	O
and	CC	O
cathodal	JJ	O
migration	NN	O
upon	IN	O
PAGE	NNP	O
.	.	O

We	PRP	O
have	VBP	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
HPRTYale	NNP	O
cDNA	NN	O
.	.	O

The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
full	JJ	O
-	:	O
length	NN	O
HPRTYale	NNP	O
cDNA	NN	O
revealed	VBD	O
a	DT	O
single	JJ	O
nucleotide	NN	O
substitution	NN	O
compared	VBN	O
with	IN	O
normal	JJ	O
HPRT	NNP	O
cDNA	NN	O
G	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
C	NN	O
at	IN	O
nucleotide	JJ	O
position	NN	O
211	CD	O
.	.	O

This	DT	O
transversion	NN	O
predicts	VBZ	O
substitution	NN	O
of	IN	O
arginine	NN	O
for	IN	O
glycine	NN	O
at	IN	O
amino	NN	O
acid	JJ	O
position	NN	O
71	CD	O
,	,	O
explaining	VBG	O
the	DT	O
cathodal	JJ	O
migration	NN	O
of	IN	O
HPRTYale	NNP	O
.	.	O

Chou	NNP	O
-	:	O
Fasman	NNP	O
secondary	JJ	O
structure	NN	O
analysis	NN	O
predicts	VBZ	O
a	DT	O
change	NN	O
in	IN	O
the	DT	O
probability	NN	O
of	IN	O
beta	NN	O
-	:	O
turn	NN	O
formation	NN	O
in	IN	O
the	DT	O
region	NN	O
containing	VBG	O
the	DT	O
mutation	NN	O
.	.	O

Inclusion	NN	O
of	IN	O
the	DT	O
bulky	JJ	O
arginine	JJ	O
side	NN	O
chain	NN	O
in	IN	O
place	NN	O
of	IN	O
glycine	NN	O
probably	RB	O
disrupts	VBZ	O
protein	JJ	O
folding	NN	O
as	RB	O
well	RB	O
.	.	O

Cloning	VBG	O
mutant	JJ	O
forms	NNS	O
of	IN	O
cDNA	NN	O
allows	VBZ	O
identification	NN	O
of	IN	O
specific	JJ	O
mutations	NNS	O
,	,	O
provides	VBZ	O
insight	JJ	O
into	IN	O
mutational	JJ	O
mechanisms	NNS	O
,	,	O
and	CC	O
facilitates	VBZ	O
structure	NN	O
-	:	O
function	NN	O
analysis	NN	O
of	IN	O
mutant	JJ	O
proteins	NNS	O
.	.	O
.	.	O

Two	CD	O
point	NN	O
mutations	NNS	O
are	VBP	O
responsible	JJ	O
for	IN	O
G6PD	NNP	O
polymorphism	NN	O
in	IN	O
Sardinia	NNP	O
.	.	O

The	DT	O
human	JJ	O
X	NNP	O
-	:	O
linked	VBN	O
gene	NN	O
encoding	VBG	O
glucose	JJ	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
is	VBZ	O
highly	RB	O
polymorphic	JJ	O
;	:	O
more	JJR	O
than	IN	O
300	CD	O
G6PD	NNP	O
variants	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
.	.	O

G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
different	JJ	O
geographical	JJ	O
areas	NNS	O
appears	VBZ	O
to	TO	O
have	VB	O
arisen	VBN	O
through	IN	O
independent	JJ	O
mutational	JJ	O
events	NNS	O
,	,	O
but	CC	O
within	IN	O
the	DT	O
same	JJ	O
population	NN	O
it	PRP	O
may	MD	O
also	RB	O
be	VB	O
heterogeneous	JJ	O
.	.	O

One	CD	O
example	NN	O
is	VBZ	O
the	DT	O
island	NN	O
of	IN	O
Sardinia	NNP	O
,	,	O
where	WRB	O
careful	JJ	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
studies	NNS	O
have	VBP	O
identified	VBN	O
four	CD	O
different	JJ	O
G6PD	NNP	O
variants	NNS	O
.	.	O

We	PRP	O
cloned	VBD	O
and	CC	O
sequenced	VBD	O
the	DT	O
four	CD	O
G6PD	NNP	O
variants	NNS	O
from	IN	O
Sardinia	NNP	O
and	CC	O
found	VBD	O
that	IN	O
only	RB	O
two	CD	O
mutations	NNS	O
are	VBP	O
responsible	JJ	O
for	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
this	DT	O
area	NN	O
one	CD	O
mutation	NN	O
is	VBZ	O
the	DT	O
cause	NN	O
of	IN	O
the	DT	O
G6PD	NNP	B_Disease
Seattle	NNP	I_Disease
-	:	I_Disease
like	IN	I_Disease
phenotype	NN	E_Disease
,	,	O
a	DT	O
milder	NN	O
form	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
;	:	O
the	DT	O
other	JJ	O
mutation	NN	O
is	VBZ	O
responsible	JJ	O
for	IN	O
all	DT	O
forms	NNS	O
of	IN	O
very	RB	O
severe	JJ	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
Sardinia	NNP	O
and	CC	O
,	,	O
possibly	RB	O
,	,	O
in	IN	O
the	DT	O
Mediterranean	NNP	O
.	.	O
.	.	O

Chronic	NNP	B_Disease
nonspherocytic	JJ	I_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
(	(	O
CNSHA	NNP	S_Disease
)	)	O
and	CC	O
glucose	$	B_Disease
6	CD	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
familial	JJ	B_Disease
amyloidotic	JJ	I_Disease
polyneuropathy	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
.	.	O

Molecular	JJ	O
study	NN	O
of	IN	O
a	DT	O
new	JJ	O
variant	NN	O
(	(	O
G6PD	NNP	O
Clinic	NNP	O
)	)	O
with	IN	O
markedly	RB	O
acidic	JJ	O
pH	NN	O
optimum	NN	O
.	.	O

A	DT	O
new	JJ	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
variant	NN	O
with	IN	O
severe	JJ	O
erythrocytic	JJ	B_Disease
G6PD	NNP	I_Disease
deficiency	NN	E_Disease
and	CC	O
a	DT	O
unique	JJ	O
pH	NN	O
optimum	NN	O
is	VBZ	O
described	VBN	O
in	IN	O
a	DT	O
young	JJ	O
patient	NN	O
with	IN	O
chronic	JJ	B_Disease
nonspherocytic	JJ	I_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
(	(	O
CNSHA	NNP	S_Disease
)	)	O
and	CC	O
familial	JJ	B_Disease
amyloidotic	JJ	I_Disease
polyneuropathy	NN	E_Disease
(	(	O
FAP	NNP	S_Disease
)	)	O
.	.	O

Chronic	JJ	B_Disease
hemolysis	NN	E_Disease
was	VBD	O
present	JJ	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
infections	NNS	O
,	,	O
oxidant	JJ	O
drugs	NNS	O
or	CC	O
ingestion	NN	O
of	IN	O
faba	JJ	O
beans	NNS	O
.	.	O

Residual	JJ	O
enzyme	NN	O
activity	NN	O
was	VBD	O
about	RB	O
2	CD	O
.	.	O

6	CD	O
%	NN	O
and	CC	O
63	CD	O
%	NN	O
of	IN	O
normal	JJ	O
activity	NN	O
in	IN	O
erythrocytes	NNS	O
and	CC	O
leucocytes	NNS	O
,	,	O
respectively	RB	O
.	.	O

A	DT	O
molecular	JJ	O
study	NN	O
using	VBG	O
standard	JJ	O
methods	NNS	O
showed	VBD	O
G6PD	NNP	O
in	IN	O
the	DT	O
patient	NN	O
to	TO	O
have	VB	O
normal	JJ	O
electrophoretic	JJ	O
mobility	NN	O
(	(	O
at	IN	O
pH	NN	O
7	CD	O
.	.	O

0	CD	O
,	,	O
8	CD	O
.	.	O

0	CD	O
and	CC	O
8	CD	O
.	.	O

8	CD	O
)	)	O
,	,	O
normal	JJ	O
apparent	JJ	O
affinity	NN	O
for	IN	O
substrates	NNS	O
(	(	O
Km	NNP	O
,	,	O
G6P	NNP	O
and	CC	O
NADP	NNP	O
)	)	O
and	CC	O
a	DT	O
slightly	RB	O
abnormal	JJ	O
utilization	NN	O
of	IN	O
substrate	NN	O
analogues	NNS	O
(	(	O
decreased	VBN	O
deamino	NN	O
-	:	O
NADP	NNP	O
and	CC	O
increased	VBD	O
2	CD	O
-	:	O
deoxyglucose	NN	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
utilization	NN	O
)	)	O
.	.	O

Heat	NNP	O
stability	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
markedly	RB	O
decreased	VBN	O
(	(	O
8	CD	O
%	NN	O
of	IN	O
residual	JJ	O
activity	NN	O
after	IN	O
20	CD	O
min	NN	O
of	IN	O
incubation	NN	O
at	IN	O
46	CD	O
degrees	NNS	O
C	NNP	O
)	)	O
and	CC	O
a	DT	O
particular	JJ	O
characteristic	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
was	VBD	O
a	DT	O
biphasic	JJ	O
pH	NN	O
curve	NN	O
with	IN	O
a	DT	O
greatly	RB	O
increased	JJ	O
activity	NN	O
at	IN	O
low	JJ	O
pH	NN	O
.	.	O

Although	IN	O
molecular	JJ	O
characteristics	NNS	O
of	IN	O
this	DT	O
variant	NN	O
closely	RB	O
resemble	JJ	O
those	DT	O
of	IN	O
G6PD	NNP	O
Bangkok	NNP	O
and	CC	O
G6PD	NNP	O
Duarte	NNP	O
,	,	O
it	PRP	O
can	MD	O
be	VB	O
distinguished	VBN	O
from	IN	O
these	DT	O
and	CC	O
all	DT	O
other	JJ	O
previously	RB	O
reported	VBN	O
variants	NNS	O
by	IN	O
virtue	NN	O
of	IN	O
its	PRP$	O
unusual	JJ	O
pH	NN	O
curve	NN	O
.	.	O

Therefore	RB	O
the	DT	O
present	JJ	O
variant	NN	O
has	VBZ	O
been	VBN	O
designated	VBN	O
G6PD	NNP	O
Clinic	NNP	O
to	TO	O
distinguish	VB	O
it	PRP	O
from	IN	O
other	JJ	O
G6PD	NNP	O
variants	NNS	O
previously	RB	O
described	VBD	O

Molecular	JJ	O
detection	NN	O
of	IN	O
chromosomal	JJ	O
translocations	NNS	O
that	WDT	O
disrupt	VBP	O
the	DT	O
putative	JJ	O
retinoblastoma	NN	S_Disease
susceptibility	NN	O
locus	NN	O
.	.	O

A	DT	O
candidate	NN	O
DNA	NN	O
sequence	NN	O
with	IN	O
many	JJ	O
of	IN	O
the	DT	O
properties	NNS	O
predicted	VBN	O
for	IN	O
the	DT	O
retinoblastoma	NN	S_Disease
susceptibility	NN	O
(	(	O
RB1	NNP	O
)	)	O
locus	NN	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
(	(	O
S	NNP	O
.	.	O

H	NNP	O
.	.	O

Friend	NN	O
,	,	O
R	NNP	O
.	.	O

Bernards	NNS	O
,	,	O
S	NNP	O
.	.	O

Rogelj	NNP	O
,	,	O
R	NNP	O
.	.	O

A	DT	O
.	.	O

Weinberg	NNP	O
,	,	O
J	NNP	O
.	.	O

M	NNP	O
.	.	O

Rapaport	NNP	O
,	,	O
D	NNP	O
.	.	O

M	NNP	O
.	.	O

Albert	NNP	O
,	,	O
and	CC	O
T	NNP	O
.	.	O

P	NNP	O
.	.	O

Dryja	NNP	O
,	,	O
Nature	NNP	O
[	NNP	O
London	NNP	O
]	VBD	O
323	CD	O
643	CD	O
-	:	O
645	CD	O
,	,	O
1986	CD	O
)	)	O
.	.	O

The	DT	O
large	JJ	O
size	NN	O
of	IN	O
this	DT	O
gene	NN	O
(	(	O
ca	MD	O
.	.	O

200	CD	O
kilobases	NNS	O
[	JJ	O
kb	NNP	O
]	NNP	O
)	)	O
and	CC	O
its	PRP$	O
multiple	NN	O
dispersed	VBN	O
exons	NNS	O
(	(	O
Wiggs	NNP	O
et	RB	O
al	RB	O
.	.	O
,	,	O
N	NNP	O
.	.	O

Engl	NNP	O
.	.	O

J	NNP	O
.	.	O

Med	NNP	O
.	.	O

318	CD	O
151	CD	O
-	:	O
157	CD	O
,	,	O
1988	CD	O
)	)	O
complicate	NN	O
molecular	JJ	O
screening	NN	O
strategies	NNS	O
important	JJ	O
in	IN	O
prenatal	JJ	O
and	CC	O
presymptomatic	JJ	O
diagnosis	NN	O
and	CC	O
in	IN	O
carrier	NN	O
detection	NN	O
.	.	O

Here	RB	O
we	PRP	O
used	VBD	O
field	NN	O
inversion	NN	O
gel	JJ	O
electrophoresis	NN	O
(	(	O
FIGE	NNP	O
)	)	O
to	TO	O
construct	VB	O
a	DT	O
restriction	NN	O
map	NN	O
of	IN	O
approximately	RB	O
1	CD	O
,	,	O
000	CD	O
kb	NN	O
of	IN	O
DNA	NNP	O
surrounding	VBG	O
the	DT	O
RB1	NNP	O
locus	NN	O
and	CC	O
to	TO	O
detect	VB	O
the	DT	O
translocation	NN	O
breakpoints	NNS	O
in	IN	O
three	CD	O
retinoblastoma	NN	S_Disease
patients	NNS	O
.	.	O

DNA	NN	O
probes	NNS	O
from	IN	O
either	CC	O
the	DT	O
5	CD	O
or	CC	O
3	CD	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
were	VBD	O
used	VBN	O
to	TO	O
detect	VB	O
a	DT	O
250	CD	O
-	:	O
kb	NN	O
EagI	NNP	O
restriction	NN	O
fragment	NN	O
in	IN	O
DNA	NN	O
from	IN	O
unaffected	JJ	O
individuals	NNS	O
.	.	O

Both	DT	O
probes	NNS	O
identified	VBD	O
an	DT	O
additional	JJ	O
hybridizing	NN	O
fragment	NN	O
in	IN	O
the	DT	O
DNA	NN	O
from	IN	O
each	DT	O
patient	NN	O
,	,	O
permitting	VBG	O
the	DT	O
breakpoints	NNS	O
in	IN	O
all	DT	O
three	CD	O
to	TO	O
be	VB	O
mapped	VBN	O
within	IN	O
the	DT	O
cloned	VBN	O
RB1	NNP	O
gene	NN	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
breakpoint	NN	O
in	IN	O
one	CD	O
translocation	NN	O
cell	NN	O
line	NN	O
allowed	VBD	O
the	DT	O
RB1	NNP	O
gene	NN	O
to	TO	O
be	VB	O
oriented	VBN	O
with	IN	O
its	PRP$	O
5	CD	O
end	NN	O
toward	IN	O
the	DT	O
centromere	NN	O
.	.	O

The	DT	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
also	RB	O
appeared	VBD	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
a	DT	O
clustering	NN	O
of	IN	O
sites	NNS	O
for	IN	O
several	JJ	O
infrequently	RB	O
cleaving	VBG	O
restriction	NN	O
enzymes	NNS	O
,	,	O
indicating	VBG	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
HpaII	NNP	O
tiny	JJ	O
fragment	NN	O
island	NN	O
.	.	O

The	DT	O
detection	NN	O
and	CC	O
mapping	NN	O
of	IN	O
the	DT	O
translocation	NN	O
breakpoints	NNS	O
of	IN	O
all	DT	O
three	CD	O
retinoblastoma	NN	S_Disease
patients	NNS	O
to	TO	O
within	IN	O
the	DT	O
putative	JJ	O
RB1	NNP	O
gene	NN	O
substantiated	VBD	O
the	DT	O
authenticity	NN	O
of	IN	O
this	DT	O
candidate	NN	O
sequence	NN	O
and	CC	O
demonstrated	VBD	O
the	DT	O
utility	NN	O
of	IN	O
FIGE	NNP	O
in	IN	O
detecting	VBG	O
chromosomal	JJ	O
rearrangements	NNS	O
affecting	VBG	O
this	DT	O
locus	NN	O
.	.	O

Inherited	VBN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
with	IN	O
recurrent	JJ	O
infections	NNS	O
and	CC	O
glomerulonephritis	NN	S_Disease
.	.	O

A	DT	O
10	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
Laotian	JJ	O
boy	NN	O
had	VBD	O
homozygous	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
third	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
and	CC	O
recurrent	JJ	O
bacterial	JJ	B_Disease
infections	NNS	E_Disease
beginning	VBG	O
at	IN	O
age	NN	O
5	CD	O
months	NNS	O
.	.	O

Cellular	JJ	O
and	CC	O
humoral	JJ	O
immunity	NN	O
were	VBD	O
normal	JJ	O
,	,	O
as	IN	O
were	VBD	O
polymorphonuclear	JJ	O
leukocyte	JJ	O
chemotaxis	NN	O
and	CC	O
bactericidal	JJ	O
activities	NNS	O
.	.	O

Serum	NNP	O
complement	NN	O
-	:	O
mediated	VBN	O
hemolytic	JJ	O
,	,	O
chemotactic	JJ	O
,	,	O
and	CC	O
opsonic	JJ	O
activities	NNS	O
were	VBD	O
deficient	NN	O
.	.	O

In	IN	O
vitro	JJ	O
addition	NN	O
of	IN	O
purified	JJ	O
C3	NNP	O
to	TO	O
patient	VB	O
serum	NN	O
restored	VBN	O
hemolytic	JJ	O
complement	NN	O
to	TO	O
normal	JJ	O
levels	NNS	O
,	,	O
and	CC	O
plasma	JJ	O
infusion	NN	O
during	IN	O
each	DT	O
of	IN	O
four	CD	O
episodes	NNS	O
of	IN	O
pneumonia	NN	S_Disease
significantly	RB	O
enhanced	VBD	O
serum	JJ	O
opsonic	JJ	O
activity	NN	O
for	IN	O
as	RB	O
long	RB	O
as	IN	O
36	CD	O
hours	NNS	O
.	.	O

A	DT	O
renal	JJ	O
biopsy	NN	O
specimen	NNS	O
revealed	VBD	O
mesangiopathic	JJ	B_Disease
glomerulonephritis	NN	E_Disease
,	,	O
although	IN	O
significant	JJ	O
levels	NNS	O
of	IN	O
circulating	VBG	O
IgG	NNP	O
immune	NN	O
complexes	NNS	O
were	VBD	O
not	RB	O
detected	VBN	O
.	.	O

These	DT	O
findings	NNS	O
further	RBR	O
support	VB	O
the	DT	O
association	NN	O
of	IN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
with	IN	O
immune	JJ	B_Disease
-	:	I_Disease
complex	JJ	I_Disease
disease	NN	E_Disease
and	CC	O
suggest	VBP	O
that	IN	O
plasma	JJ	O
infusion	NN	O
may	MD	O
be	VB	O
an	DT	O
adjunct	JJ	O
to	TO	O
antibiotic	JJ	O
therapy	NN	O
in	IN	O
the	DT	O
management	NN	O
of	IN	O
severe	JJ	O
pyogenic	JJ	B_Disease
infections	NNS	E_Disease
in	IN	O
patients	NNS	O
with	IN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O
.	.	O

DNA	NNP	O
restriction	NN	O
fragments	NNS	O
associated	VBN	O
with	IN	O
alpha	NN	O
1	CD	O
-	:	O
antitrypsin	NN	O
indicate	VBP	O
a	DT	O
single	JJ	O
origin	NN	O
for	IN	O
deficiency	NN	O
allele	NN	O
PI	NNP	O
Z	NNP	O
.	.	O

The	DT	O
alpha	NN	O
1	CD	O
-	:	O
protease	NN	O
inhibitor	NN	O
,	,	O
or	CC	O
alpha	SYM	O
-	:	O
antitrypsin	NN	O
(	(	O
AAT	NNP	O
)	)	O
,	,	O
a	DT	O
major	JJ	O
plasma	NN	O
inhibitor	NN	O
of	IN	O
leukocyte	JJ	O
elastase	NN	O
and	CC	O
bacterial	JJ	O
proteases	NNS	O
,	,	O
is	VBZ	O
encoded	VBN	O
at	IN	O
the	DT	O
PI	NNP	O
locus	NN	O
on	IN	O
chromosome	NN	O
14	CD	O
(	(	O
14q24	CD	O
.	.	O

3	LS	O
-	:	O
q32	NN	O
.	.	O

1	CD	O
)	)	O
.	.	O

A	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
AAT	NNP	E_Disease
in	IN	O
individuals	NNS	O
homozygous	JJ	O
for	IN	O
the	DT	O
PI	NNP	O
Z	NNP	O
allele	NN	O
occurs	VBZ	O
in	IN	O
about	RB	O
1	CD	O
in	IN	O
2	CD	O
,	,	O
000	CD	O
-	:	O
8	CD	O
,	,	O
000	CD	O
caucasians	NNS	O
and	CC	O
is	VBZ	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
early	JJ	O
adult	NN	O
onset	VBN	O
emphysema	NN	S_Disease
and	CC	O
liver	JJ	B_Disease
disease	NN	E_Disease
in	IN	O
childhood	NN	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
used	VBN	O
DNA	NNP	O
polymorphisms	NNS	O
associated	VBN	O
with	IN	O
the	DT	O
AAT	NNP	O
gene	NN	O
to	TO	O
investigate	VB	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
PI	NNP	O
Z	NNP	O
allele	NN	O
.	.	O

Using	VBG	O
two	CD	O
genomic	JJ	O
probes	NNS	O
extending	VBG	O
into	IN	O
the	DT	O
5	CD	O
and	CC	O
3	CD	O
flanking	NN	O
regions	NNS	O
,	,	O
respectively	RB	O
,	,	O
we	PRP	O
have	VBP	O
identified	VBN	O
eight	CD	O
polymorphic	JJ	O
restriction	NN	O
sites	NNS	O
.	.	O

Extensive	JJ	O
linkage	NN	O
disequilibrium	NN	O
occurs	VBZ	O
throughout	IN	O
the	DT	O
probed	JJ	O
region	NN	O
with	IN	O
the	DT	O
PI	NNP	O
Z	NNP	O
allele	NN	O
,	,	O
but	CC	O
not	RB	O
with	IN	O
normal	JJ	O
PI	NNP	O
M	NNP	O
alleles	NNS	O
.	.	O

The	DT	O
Z	NNP	O
allele	NN	O
occurs	VBZ	O
mainly	RB	O
with	IN	O
one	CD	O
haplotype	NN	O
,	,	O
indicating	VBG	O
a	DT	O
single	JJ	O
,	,	O
relatively	RB	O
recent	JJ	O
,	,	O
origin	NN	O
in	IN	O
caucasians	NNS	O

Segregation	NNP	O
analysis	NN	O
of	IN	O
a	DT	O
marker	NN	O
localised	VBN	O
Xp21	NNP	O
.	.	O
2	CD	O
-	:	O
Xp21	NN	O
.	.	O
3	CD	O
in	IN	O
Duchenne	NNP	B_Disease
and	CC	I_Disease
Becker	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
families	NNS	O
.	.	O

A	DT	O
DNA	NN	O
marker	NN	O
C7	NNP	O
,	,	O
localised	VBD	O
Xp21	NN	O
.	.	O

1	CD	O
-	:	O
Xp21	NN	O
.	.	O

3	CD	O
,	,	O
has	VBZ	O
been	VBN	O
studied	VBN	O
in	IN	O
kindreds	NNS	O
segregating	VBG	O
for	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
and	CC	O
Becker	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
BMD	NNP	S_Disease
)	)	O
.	.	O

In	IN	O
DMD	NNP	S_Disease
families	NNS	O
four	CD	O
crossovers	NNS	O
were	VBD	O
observed	VBN	O
in	IN	O
38	CD	O
informative	JJ	O
meioses	NNS	O
between	IN	O
C7	NNP	O
and	CC	O
the	DT	O
DMD	NNP	S_Disease
locus	NN	O
(	(	O
theta	JJ	O
=	NN	O
0	CD	O
.	.	O

12	CD	O
,	,	O
z	NN	O
max	NN	O
=	NNP	O
+	VBZ	O
2	CD	O
.	.	O

72	CD	O
)	)	O
.	.	O

In	IN	O
BMD	NNP	S_Disease
families	NNS	O
no	DT	O
recombinants	NNS	O
were	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
16	CD	O
informative	JJ	O
meioses	NNS	O
studied	VBN	O
.	.	O

These	DT	O
data	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
the	DT	O
localisation	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
in	IN	O
these	DT	O
disorders	NNS	O
being	VBG	O
in	IN	O
the	DT	O
same	JJ	O
region	NN	O
of	IN	O
Xp21	NNP	O
.	.	O

Studies	NNS	O
in	IN	O
families	NNS	O
also	RB	O
segregating	VBG	O
for	IN	O
the	DT	O
DNA	NNP	O
marker	NN	O
754	CD	O
support	NN	O
the	DT	O
previously	RB	O
reported	VBN	O
physical	JJ	O
order	NN	O
of	IN	O
these	DT	O
loci	NNS	O
as	IN	O
X	NN	O
centromere	SYM	O
-	:	O
754	CD	O
-	:	O
DMD	NNP	O
-	:	O
BMD	NNP	O
-	:	O
C7	NNP	O
-	:	O
X	NN	O
telomere	RB	O
.	.	O

A	DT	O
recombination	NN	O
fraction	NN	O
of	IN	O
0	CD	O
.	.	O

11	CD	O
(	(	O
z	NN	O
max	NN	O
=	NNP	O
+	VBZ	O
5	CD	O
.	.	O

58	CD	O
)	)	O
was	VBD	O
found	VBN	O
between	IN	O
DMD	NNP	O
-	:	O
754	CD	O
by	IN	O
combining	VBG	O
our	PRP$	O
previously	RB	O
published	VBN	O
data	NN	O
with	IN	O
the	DT	O
data	NNS	O
presented	VBN	O
here	RB	O
.	.	O

C7	NNP	O
and	CC	O
754	CD	O
thus	RB	O
provide	RB	O
good	JJ	O
bridging	NN	O
markers	NNS	O
for	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
DMD	NNP	S_Disease
and	CC	O
BMD	NNP	S_Disease

Isolation	NN	O
of	IN	O
molecular	JJ	O
probes	NNS	O
associated	VBN	O
with	IN	O
the	DT	O
chromosome	NN	O
15	CD	O
instability	NN	O
in	IN	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Flow	NNP	O
cytometry	NN	O
and	CC	O
recombinant	JJ	O
DNA	NNP	O
techniques	NNS	O
have	VBP	O
been	VBN	O
used	VBN	O
to	TO	O
obtain	VB	O
reagents	NNS	O
for	IN	O
a	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
.	.	O

HindIII	NNP	O
total	JJ	O
-	:	O
digest	JJS	O
libraries	NNS	O
were	VBD	O
prepared	VBN	O
in	IN	O
lambda	JJ	O
phage	NN	O
Charon	NNP	O
21A	CD	O
from	IN	O
flow	JJ	O
-	:	O
sorted	VBN	O
inverted	JJ	O
duplicated	VBD	O
no	DT	O
.	.	O

15	CD	O
human	JJ	O
chromosomes	NNS	O
and	CC	O
propagated	VBN	O
on	IN	O
recombination	NN	O
-	:	O
proficient	NN	O
(	(	O
LE392	NNP	O
)	)	O
and	CC	O
recBC	JJ	O
-	:	O
,	,	O
sbcB	SYM	O
-	:	O
(	(	O
DB1257	NNP	O
)	)	O
bacteria	NN	O
.	.	O

Twelve	NNP	O
distinct	VBZ	O
chromosome	NN	O
15	CD	O
-	:	O
specific	JJ	O
probes	NNS	O
have	VBP	O
been	VBN	O
isolated	VBN	O
.	.	O

Eight	CD	O
localized	VBN	O
to	TO	O
the	DT	O
region	NN	O
15q11	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
13	CD	O
.	.	O

Four	CD	O
of	IN	O
these	DT	O
eight	CD	O
sublocalized	NNS	O
to	TO	O
band	VB	O
15q11	CD	O
.	.	O

2	CD	O
and	CC	O
are	VBP	O
shown	VBN	O
to	TO	O
be	VB	O
deleted	VBN	O
in	IN	O
DNA	NN	O
of	IN	O
one	CD	O
of	IN	O
two	CD	O
patients	NNS	O
examined	VBN	O
with	IN	O
the	DT	O
PWS	NNP	S_Disease
.	.	O

Heteroduplex	NNP	O
analysis	NN	O
of	IN	O
two	CD	O
of	IN	O
these	DT	O
clones	NNS	O
,	,	O
which	WDT	O
grew	VBD	O
on	IN	O
DB1257	NNP	O
but	CC	O
not	RB	O
on	IN	O
LE392	NNP	O
,	,	O
revealed	VBD	O
stem	NN	O
-	:	O
loop	NN	O
structures	NNS	O
in	IN	O
the	DT	O
inserts	NNS	O
,	,	O
indicative	NN	O
of	IN	O
inverted	JJ	O
,	,	O
repeated	VBD	O
DNA	JJ	O
elements	NNS	O
.	.	O

Such	JJ	O
DNA	NNP	O
repeats	NNS	O
might	MD	O
account	VB	O
for	IN	O
some	DT	O
of	IN	O
the	DT	O
cloning	VBG	O
instability	NN	O
of	IN	O
DNA	NN	O
segments	NNS	O
from	IN	O
proximal	JJ	O
15q	CD	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
and	CC	O
physical	JJ	O
instability	NN	O
associated	VBN	O
with	IN	O
the	DT	O
repeated	JJ	O
sequences	NNS	O
we	PRP	O
have	VBP	O
isolated	VBN	O
from	IN	O
band	NN	O
15q11	CD	O
.	.	O

2	CD	O
may	MD	O
elucidate	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
for	IN	O
the	DT	O
instability	NN	O
of	IN	O
this	DT	O
chromosomal	JJ	O
region	NN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
PWS	NNP	S_Disease
or	CC	O
other	JJ	O
diseases	NNS	O
associated	VBN	O
with	IN	O
chromosomal	JJ	B_Disease
abnormalities	NNS	E_Disease
in	IN	O
the	DT	O
proximal	NN	O
long	JJ	O
arm	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
15	CD	O

Analysis	NN	O
of	IN	O
deletions	NNS	O
in	IN	O
DNA	NN	O
from	IN	O
patients	NNS	O
with	IN	O
Becker	NNP	B_Disease
and	CC	I_Disease
Duchenne	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
recessive	JJ	I_Disease
genetic	JJ	I_Disease
disorder	NN	E_Disease
for	IN	O
which	WDT	O
the	DT	O
biochemical	NN	O
defect	NN	O
is	VBZ	O
as	IN	O
yet	RB	O
unknown	JJ	O
.	.	O

Recently	RB	O
,	,	O
two	CD	O
cloned	VBD	O
segments	NNS	O
of	IN	O
human	JJ	O
X	NNP	O
-	:	O
chromosome	NN	O
DNA	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
which	WDT	O
detect	JJ	O
structural	JJ	O
alterations	NNS	O
within	IN	O
or	CC	O
near	IN	O
the	DT	O
genetic	JJ	O
locus	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
disorder	NN	O
.	.	O

Both	DT	O
of	IN	O
these	DT	O
cloned	VBN	O
segments	NNS	O
were	VBD	O
described	VBN	O
as	IN	O
tightly	RB	O
linked	VBN	O
to	TO	O
the	DT	O
locus	NN	O
and	CC	O
were	VBD	O
capable	JJ	O
of	IN	O
detecting	VBG	O
deletions	NNS	O
in	IN	O
the	DT	O
DNA	NN	O
of	IN	O
boys	NNS	O
affected	VBN	O
with	IN	O
DMD	NNP	S_Disease
.	.	O

In	IN	O
an	DT	O
attempt	NN	O
to	TO	O
determine	VB	O
more	RBR	O
precisely	RB	O
the	DT	O
occurrence	NN	O
of	IN	O
these	DT	O
deletions	NNS	O
within	IN	O
a	DT	O
large	JJ	O
population	NN	O
of	IN	O
DMD	NNP	S_Disease
patients	NNS	O
and	CC	O
the	DT	O
accuracy	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
segments	NNS	O
,	,	O
DXS164	NNP	O
(	(	O
pERT87	NN	O
)	)	O
,	,	O
in	IN	O
determining	VBG	O
the	DT	O
inheritance	NN	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
X	NNP	O
chromosome	NN	O
,	,	O
the	DT	O
subclones	NNS	O
1	CD	O
,	,	O
8	CD	O
and	CC	O
15	CD	O
were	VBD	O
made	VBN	O
available	JJ	O
to	TO	O
many	JJ	O
investigators	NNS	O
throughout	IN	O
the	DT	O
world	NN	O
.	.	O

Here	RB	O
we	PRP	O
describe	VBP	O
the	DT	O
combined	JJ	O
results	NNS	O
of	IN	O
more	JJR	O
than	IN	O
20	CD	O
research	NN	O
laboratories	NNS	O
with	IN	O
respect	NN	O
to	TO	O
the	DT	O
occurrence	NN	O
of	IN	O
deletions	NNS	O
at	IN	O
the	DT	O
DXS164	NNP	O
locus	NN	O
in	IN	O
DNA	NNP	O
samples	NNS	O
isolated	VBD	O
from	IN	O
patients	NNS	O
with	IN	O
DMD	NNP	S_Disease
and	CC	O
Becker	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
BMD	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
DXS164	NNP	O
locus	NN	O
apparently	RB	O
recombines	VBZ	O
with	IN	O
DMD	NNP	S_Disease
5	CD	O
%	NN	O
of	IN	O
the	DT	O
time	NN	O
,	,	O
but	CC	O
is	VBZ	O
probably	RB	O
located	VBN	O
between	IN	O
independent	JJ	O
sites	NNS	O
of	IN	O
mutation	NN	O
which	WDT	O
yield	NN	O
DMD	NNP	S_Disease
.	.	O

The	DT	O
breakpoints	NNS	O
of	IN	O
some	DT	O
deletions	NNS	O
are	VBP	O
delineated	VBN	O
within	IN	O
the	DT	O
DXS164	NNP	O
locus	NN	O
,	,	O
and	CC	O
it	PRP	O
is	VBZ	O
evident	JJ	O
that	IN	O
the	DT	O
deletions	NNS	O
at	IN	O
the	DT	O
DMD	NNP	S_Disease
locus	NN	O
are	VBP	O
frequent	JJ	O
and	CC	O
extremely	RB	O
large	JJ	O
.	.	O
.	.	O

A	DT	O
potential	JJ	O
animal	NN	O
model	NN	O
for	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	VBP	E_Disease
through	IN	O
introduction	NN	O
of	IN	O
HPRT	NNP	O
mutations	NNS	O
into	IN	O
mice	NN	O
.	.	O

The	DT	O
human	JJ	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
neurological	JJ	B_Disease
and	CC	I_Disease
behavioural	JJ	I_Disease
disorder	NN	E_Disease
,	,	O
affecting	VBG	O
only	RB	O
males	NNS	O
,	,	O
which	WDT	O
is	VBZ	O
caused	VBN	O
by	IN	O
an	DT	O
inherited	JJ	B_Disease
deficiency	NN	E_Disease
in	IN	O
the	DT	O
level	NN	O
of	IN	O
activity	NN	O
of	IN	O
the	DT	O
purine	NN	O
salvage	NN	O
enzyme	FW	O
hypoxanthine	NN	O
-	:	O
guanosine	NN	O
phosphoribosyl	NN	O
transferase	NN	O
(	(	O
HPRT	NNP	O
)	)	O
.	.	O

How	WRB	O
the	DT	O
resulting	JJ	O
alterations	NNS	O
in	IN	O
purine	JJ	O
metabolism	NN	O
lead	NN	O
to	TO	O
the	DT	O
severe	JJ	O
symptoms	NNS	O
characteristic	JJ	O
of	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NN	E_Disease
patients	NNS	O
is	VBZ	O
still	RB	O
not	RB	O
understood	JJ	O
.	.	O

No	DT	O
mutations	NNS	O
at	IN	O
the	DT	O
Hprt	NNP	O
locus	NN	O
leading	VBG	O
to	TO	O
loss	NN	O
of	IN	O
activity	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
in	IN	O
laboratory	NN	O
animals	NNS	O
.	.	O

To	TO	O
derive	VB	O
an	DT	O
animal	JJ	O
model	NN	O
for	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
we	PRP	O
have	VBP	O
used	VBN	O
cultured	VBN	O
mouse	NN	O
embryonic	JJ	O
stem	NN	O
cells	NNS	O
,	,	O
mutagenized	VBN	O
by	IN	O
retroviral	JJ	O
insertion	NN	O
and	CC	O
selected	VBN	O
for	IN	O
loss	NN	O
of	IN	O
HPRT	NNP	O
activity	NN	O
,	,	O
to	TO	O
construct	VB	O
chimaeric	JJ	O
mice	NN	O
.	.	O

Two	CD	O
clonal	JJ	O
lines	NNS	O
carrying	VBG	O
different	JJ	O
mutant	JJ	O
Hprt	NNP	O
alleles	NNS	O
have	VBP	O
given	VBN	O
rise	NN	O
to	TO	O
germ	VB	O
cells	NNS	O
in	IN	O
chimaeras	NNS	O
,	,	O
allowing	VBG	O
the	DT	O
derivation	NN	O
of	IN	O
strains	NNS	O
of	IN	O
mutant	JJ	O
mice	NN	O
having	VBG	O
the	DT	O
same	JJ	O
biochemical	JJ	O
defect	NN	O
as	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NN	E_Disease
patients	NNS	O
.	.	O

Male	JJ	O
mice	NN	O
carrying	VBG	O
the	DT	O
mutant	JJ	O
alleles	NNS	O
are	VBP	O
viable	JJ	O
and	CC	O
analysis	NN	O
of	IN	O
their	PRP$	O
cells	NNS	O
shows	VBZ	O
a	DT	O
total	JJ	O
lack	NN	O
of	IN	O
HPRT	NNP	O
activity	NN	O
.	.	O
.	.	O

Re	NNP	O
-	:	O
evaluation	NN	O
of	IN	O
the	DT	O
sublocalization	NN	O
of	IN	O
esterase	NN	O
D	NNP	O
and	CC	O
its	PRP$	O
relation	NN	O
to	TO	O
the	DT	O
retinoblastoma	NN	S_Disease
locus	NN	O
by	IN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
.	.	O

In	IN	O
situ	JJ	O
hybridization	NN	O
of	IN	O
a	DT	O
cDNA	NN	O
probe	NN	O
for	IN	O
the	DT	O
esterase	NN	O
D	NNP	O
gene	NN	O
(	(	O
ESD	NNP	O
)	)	O
was	VBD	O
carried	VBN	O
out	RP	O
on	IN	O
human	JJ	O
chromosomes	NNS	O
.	.	O

The	DT	O
probe	NN	O
hybridized	VBD	O
most	RBS	O
strongly	RB	O
to	TO	O
13q14	CD	O
.	.	O

2	CD	O
and	CC	O
13q14	CD	O
.	.	O

3	CD	O
.	.	O

This	DT	O
observation	NN	O
raises	VBZ	O
doubts	NNS	O
concerning	VBG	O
the	DT	O
most	RBS	O
recently	RB	O
published	VBN	O
assignment	NN	O
of	IN	O
ESD	NNP	O
to	TO	O
13q14	CD	O
.	.	O

1	CD	O
.	.	O

A	DT	O
deletion	NN	O
in	IN	O
an	DT	O
individual	NN	O
with	IN	O
retinoblastoma	NN	S_Disease
was	VBD	O
reported	VBN	O
to	TO	O
separate	VB	O
the	DT	O
closely	RB	O
linked	VBN	O
ESD	NNP	O
and	CC	O
retinoblastoma	NN	S_Disease
(	(	O
RB1	NNP	O
)	)	O
loci	NN	O
,	,	O
placing	VBG	O
ESD	NNP	O
proximal	NN	O
to	TO	O
RB1	NNP	O
.	.	O

Quantitative	JJ	O
in	IN	O
situ	JJ	O
hybridization	NN	O
studies	NNS	O
of	IN	O
this	DT	O
deletion	NN	O
do	VBP	O
not	RB	O
confirm	VB	O
this	DT	O
interpretation	NN	O
.	.	O

Rather	RB	O
,	,	O
they	PRP	O
suggest	VBP	O
that	IN	O
ESD	NNP	O
is	VBZ	O
missing	VBG	O
from	IN	O
the	DT	O
deleted	JJ	O
chromosome	NN	O
13	CD	O
and	CC	O
duplicated	VBN	O
on	IN	O
the	DT	O
normal	JJ	O
homolog	NN	O
.	.	O

From	IN	O
these	DT	O
findings	NNS	O
,	,	O
we	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
deletion	NN	O
in	IN	O
this	DT	O
individual	JJ	O
cannot	NN	O
be	VB	O
used	VBN	O
to	TO	O
determine	VB	O
the	DT	O
orientation	NN	O
nor	CC	O
the	DT	O
sublocalization	NN	O
of	IN	O
ESD	NNP	O
and	CC	O
RB1	NNP	O
within	IN	O
the	DT	O
13q14	CD	O
region	NN	O
.	.	O

Hereditary	NNP	B_Disease
C2	NNP	I_Disease
deficiency	NN	E_Disease
associated	VBN	O
with	IN	O
common	JJ	O
variable	JJ	O
immunodeficiency	NN	S_Disease
.	.	O

Homozygous	JJ	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
a	DT	O
19	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
boy	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
variable	JJ	O
immunodeficiency	NN	S_Disease
manifested	VBN	O
by	IN	O
marked	JJ	O
hypoimmunoglobulinemia	NN	S_Disease
and	CC	O
impaired	JJ	O
antibody	NN	O
responses	NNS	O
,	,	O
normal	JJ	O
circulating	VBG	O
B	NNP	O
lymphocytes	NNS	O
,	,	O
and	CC	O
subnormal	JJ	O
T	NNP	O
-	:	O
cell	NN	O
functions	NNS	O
.	.	O

Neither	CC	O
antilymphocytic	JJ	O
autoantibodies	NNS	O
nor	CC	O
chromosomal	JJ	B_Disease
abnormalities	NNS	E_Disease
were	VBD	O
found	VBN	O
.	.	O

Serum	NNP	O
immunoglobulin	NN	O
levels	NNS	O
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
in	IN	O
his	PRP$	O
parents	NNS	O
and	CC	O
brother	NN	O
who	WP	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

The	DT	O
patients	NNS	O
lymphocytes	NNS	O
were	VBD	O
homozygous	JJ	O
at	IN	O
the	DT	O
HLA	NNP	O
-	:	O
D	NNP	O
locus	NN	O
but	CC	O
expressed	VBD	O
an	DT	O
antigen	NN	O
different	JJ	O
from	IN	O
DW2	NNP	O
.	.	O
.	.	O

Mild	NNP	O
and	CC	O
severe	JJ	O
muscular	JJ	B_Disease
dystrophy	NN	E_Disease
associated	VBN	O
with	IN	O
deletions	NNS	O
in	IN	O
Xp21	NN	O
of	IN	O
the	DT	O
human	JJ	O
X	NNP	O
chromosome	NN	O
.	.	O

We	PRP	O
have	VBP	O
analysed	VBN	O
over	IN	O
300	CD	O
patients	NNS	O
suffering	VBG	O
from	IN	O
Duchenne	NNP	B_Disease
or	CC	I_Disease
Becker	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
or	CC	O
BMD	NNP	S_Disease
)	)	O
.	.	O

Deletions	NNS	O
have	VBP	O
been	VBN	O
characterised	VBN	O
which	WDT	O
encompass	NN	O
either	CC	O
the	DT	O
pERT87	NN	O
(	(	O
DXS164	NNP	O
)	)	O
locus	VBZ	O
only	RB	O
,	,	O
the	DT	O
XJ1	NNP	O
.	.	O

1	CD	O
(	(	O
DXS206	NNP	O
)	)	O
and	CC	O
HIP25	NNP	O
loci	VBZ	O
only	RB	O
,	,	O
or	CC	O
all	DT	O
three	CD	O
loci	NNS	O
.	.	O

These	DT	O
loci	NNS	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
lie	VB	O
within	IN	O
the	DT	O
DMD	NNP	S_Disease
region	NN	O
covering	VBG	O
several	JJ	O
hundred	CD	O
kilobases	NNS	O
(	(	O
kb	NN	O
)	)	O
of	IN	O
DNA	NN	O
.	.	O

One	CD	O
mildly	RB	O
affected	VBD	O
BMD	NNP	S_Disease
patient	NN	O
possesses	VBZ	O
a	DT	O
deletion	NN	O
of	IN	O
at	IN	O
least	JJS	O
110	CD	O
kb	NNS	O
including	VBG	O
exons	NNS	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
.	.	O

Other	JJ	O
patients	NNS	O
with	IN	O
similar	JJ	O
exon	NN	O
deletions	NNS	O
,	,	O
or	CC	O
smaller	JJR	O
deletions	NNS	O
,	,	O
show	VBP	O
the	DT	O
more	RBR	O
severe	JJ	O
phenotype	JJ	O
typical	NN	O
of	IN	O
DMD	NNP	S_Disease
.	.	O

We	PRP	O
conclude	VBP	O
from	IN	O
these	DT	O
studies	NNS	O
that	IN	O
the	DT	O
severity	NN	O
of	IN	O
the	DT	O
clinical	JJ	O
phenotype	NN	O
cannot	NN	O
be	VB	O
explained	VBN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
deletion	NN	O
.	.	O

We	PRP	O
discuss	VBP	O
this	DT	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
candidate	NN	O
gene	NN	O
sequences	NNS	O
.	.	O

Patterns	NNS	O
of	IN	O
exon	JJ	O
deletions	NNS	O
in	IN	O
Duchenne	NNP	B_Disease
and	CC	I_Disease
Becker	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

A	DT	O
panel	NN	O
of	IN	O
patients	NNS	O
with	IN	O
Duchenne	NNP	B_Disease
and	CC	I_Disease
Becker	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
and	CC	O
BMD	NNP	S_Disease
)	)	O
has	VBZ	O
been	VBN	O
screened	VBN	O
with	IN	O
the	DT	O
cDNA	NN	O
probes	NNS	O
Cf56a	NNP	O
and	CC	O
Cf23a	NNP	O
,	,	O
which	WDT	O
detect	VBP	O
exons	NNS	O
in	IN	O
the	DT	O
central	JJ	O
part	NN	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
.	.	O

One	CD	O
or	CC	O
more	JJR	O
exons	NNS	O
were	VBD	O
deleted	VBN	O
in	IN	O
60	CD	O
%	NN	O
of	IN	O
patients	NNS	O
.	.	O

The	DT	O
deletions	NNS	O
were	VBD	O
mapped	VBN	O
and	CC	O
prove	VB	O
to	TO	O
be	VB	O
heterogeneous	JJ	O
in	IN	O
size	NN	O
and	CC	O
extent	NN	O
,	,	O
particularly	RB	O
in	IN	O
DMD	NNP	S_Disease
.	.	O

Deletions	NNS	O
specific	VBP	O
to	TO	O
DMD	NNP	S_Disease
and	CC	O
to	TO	O
BMD	NNP	S_Disease
are	VBP	O
described	VBN	O
.	.	O

Half	NN	O
of	IN	O
all	DT	O
BMD	NNP	S_Disease
patients	NNS	O
have	VBP	O
a	DT	O
deletion	NN	O
of	IN	O
one	CD	O
particular	JJ	O
small	JJ	O
group	NN	O
of	IN	O
exons	NNS	O
;	:	O
smaller	JJR	O
deletions	NNS	O
within	IN	O
this	DT	O
same	JJ	O
group	NN	O
produce	VBD	O
the	DT	O
more	RBR	O
severe	JJ	O
DMD	NNP	S_Disease
.	.	O
.	.	O

Hereditary	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
third	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
in	IN	O
a	DT	O
child	NN	O
with	IN	O
fever	NN	S_Disease
,	,	O
skin	JJ	B_Disease
rash	NN	E_Disease
,	,	O
and	CC	O
arthralgias	NNS	S_Disease
:	:	O
response	NN	O
to	TO	O
transfusion	NN	O
of	IN	O
whole	JJ	O
blood	NN	O
.	.	O

A	DT	O
previously	RB	O
well	RB	O
34	CD	O
-	:	O
month	NN	O
-	:	O
old	JJ	O
male	JJ	O
presenting	NN	O
with	IN	O
fever	NN	S_Disease
,	,	O
skin	JJ	B_Disease
rash	NN	E_Disease
,	,	O
and	CC	O
arthralgias	NN	S_Disease
was	VBD	O
found	VBN	O
to	TO	O
lack	VB	O
C3	NNP	O
by	IN	O
immunochemical	JJ	O
(	(	O
undetectable	JJ	O
)	)	O
and	CC	O
hemolytic	JJ	O
(	(	O
1	CD	O
%	NN	O
normal	JJ	O
)	)	O
assays	NNS	O
.	.	O

No	DT	O
infectious	JJ	O
agent	NN	O
could	MD	O
be	VB	O
demonstrated	VBN	O
.	.	O

Protein	NNP	O
levels	NNS	O
of	IN	O
Clq	NNP	O
.	.	O

C4	NNP	O
,	,	O
C5	NNP	O
,	,	O
properdin	NN	O
,	,	O
and	CC	O
C3b	NNP	O
-	:	O
INA	NN	O
and	CC	O
hemolytic	JJ	O
activities	NNS	O
of	IN	O
complement	NN	O
components	NNS	O
C1	NNP	O
to	TO	O
C9	NNP	O
except	IN	O
C3	NNP	O
were	VBD	O
normal	JJ	O
or	CC	O
elevated	VBN	O
;	:	O
total	JJ	O
hemolytic	JJ	O
complement	NN	O
activity	NN	O
was	VBD	O
13	CD	O
%	NN	O
of	IN	O
normal	JJ	O
and	CC	O
was	VBD	O
reconstituted	VBN	O
by	IN	O
purified	JJ	O
C3	NNP	O
.	.	O

Properdin	NNP	O
factor	NN	O
B	NNP	O
was	VBD	O
702	CD	O
(	(	O
normal	JJ	O
175	CD	O
to	TO	O
275	CD	O
)	)	O
mug	NN	O
/	NNP	O
ml	NN	O
,	,	O
and	CC	O
was	VBD	O
not	RB	O
cleaver	JJ	O
upon	IN	O
addition	NN	O
of	IN	O
zymosan	NN	O
or	CC	O
cobra	NN	O
venom	JJ	O
factor	NN	O
.	.	O

The	DT	O
serum	NN	O
had	VBD	O
normal	JJ	O
immune	JJ	O
adherence	NN	O
activity	NN	O
,	,	O
but	CC	O
was	VBD	O
deficient	NN	O
in	IN	O
ability	NN	O
to	TO	O
opsonize	VB	O
Candida	NNP	O
albicans	NNS	O
for	IN	O
uptake	NN	O
and	CC	O
Escherichia	NNP	O
coli	VBP	O
for	IN	O
killing	VBG	O
by	IN	O
neurophils	NNS	O
,	,	O
generate	NN	O
neutrophil	JJ	O
chemotactic	JJ	O
factors	NNS	O
and	CC	O
inhibit	VB	O
the	DT	O
growth	NN	O
of	IN	O
E	NNP	O
.	.	O

coli	NNS	O
;	:	O
these	DT	O
activities	NNS	O
were	VBD	O
restored	VBN	O
by	IN	O
purified	JJ	O
C3	NNP	O
.	.	O

A	DT	O
transfusion	NN	O
of	IN	O
320	CD	O
ml	NNS	O
1	CD	O
-	:	O
hour	NN	O
-	:	O
old	JJ	O
normal	JJ	O
whole	JJ	O
blood	NN	O
on	IN	O
the	DT	O
fifty	JJ	O
-	:	O
second	JJ	O
day	NN	O
resulted	VBD	O
in	IN	O
transitory	JJ	O
elevation	NN	O
of	IN	O
the	DT	O
C3	NNP	O
level	NN	O
to	TO	O
25	CD	O
mg	NNS	O
/	JJ	O
dl	NN	O
with	IN	O
a	DT	O
fall	NN	O
-	:	O
off	NN	O
(	(	O
approximately	RB	O
2	CD	O
1	CD	O
/	JJ	O
2	CD	O
%	NN	O
per	IN	O
hour	NN	O
)	)	O
to	TO	O
undetectable	JJ	O
levels	NNS	O
by	IN	O
69	CD	O
hours	NNS	O
;	:	O
it	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
disappearance	NN	O
of	IN	O
the	DT	O
skin	NN	B_Disease
rash	NN	E_Disease
and	CC	O
arthralgias	NN	S_Disease
and	CC	O
return	NN	O
to	TO	O
normal	JJ	O
of	IN	O
the	DT	O
previously	RB	O
elevated	VBN	O
temperature	NN	O
and	CC	O
CRP	NNP	O
levels	NNS	O
.	.	O

C3	NNP	O
levels	NNS	O
in	IN	O
family	NN	O
members	NNS	O
(	(	O
seven	CD	O
of	IN	O
24	CD	O
half	JJ	O
-	:	O
normal	JJ	O
)	)	O
,	,	O
lack	NN	O
of	IN	O
anti	JJ	O
-	:	O
C3	NN	O
activity	NN	O
,	,	O
normal	JJ	O
C3b	NNP	O
-	:	O
INA	NN	O
levels	NNS	O
and	CC	O
a	DT	O
normal	JJ	O
rate	NN	O
of	IN	O
catabolism	NN	O
of	IN	O
transfused	JJ	O
C3	NNP	O
indicated	VBD	O
that	IN	O
the	DT	O
deficiency	NN	O
was	VBD	O
inherited	VBN	O
with	IN	O
autosomal	JJ	O
codominance	NN	O
and	CC	O
involved	VBN	O
decreased	JJ	B_Disease
synthesis	NN	I_Disease
of	IN	I_Disease
C3	NNP	E_Disease
.	.	O

Thus	RB	O
,	,	O
this	DT	O
child	NN	O
is	VBZ	O
a	DT	O
unique	JJ	O
individual	NN	O
with	IN	O
inherited	JJ	B_Disease
C3	NNP	I_Disease
deficiency	NN	E_Disease
presenting	VBG	O
with	IN	O
absence	NN	O
of	IN	O
repeated	JJ	O
infections	NNS	O
,	,	O
whose	WP$	O
symptoms	NNS	O
of	IN	O
fever	NN	S_Disease
,	,	O
skin	JJ	B_Disease
rash	NN	E_Disease
,	,	O
and	CC	O
arthralgia	NNS	S_Disease
were	VBD	O
abated	VBN	O
by	IN	O
whole	JJ	O
blood	NN	O
transfusion	NN	O
.	.	O
.	.	O

Glucose	NNP	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
variants	NNS	O
and	CC	O
their	PRP$	O
frequency	NN	O
in	IN	O
Guangdong	NNP	O
,	,	O
China	NNP	O
.	.	O

Erythrocyte	NNP	O
glucose	VBD	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
was	VBD	O
characterized	VBN	O
in	IN	O
blood	NN	O
samples	NNS	O
obtained	VBD	O
from	IN	O
97	CD	O
randomly	RB	O
selected	VBN	O
males	NNS	O
with	IN	O
enzyme	JJ	B_Disease
deficiency	NN	E_Disease
from	IN	O
various	JJ	O
regions	NNS	O
of	IN	O
Guangdong	NNP	O
Province	NNP	O
,	,	O
China	NNP	O
.	.	O

Nine	NNP	O
new	JJ	O
variants	NNS	O
(	(	O
Gd	NNP	O
Kaiping	NNP	O
,	,	O
Gd	NNP	O
Boluo	NNP	O
,	,	O
Gd	NNP	O
Huiyang	NNP	O
,	,	O
Gd	NNP	O
Gaomin	NNP	O
,	,	O
Gd	NNP	O
Qing	NNP	O
-	:	O
Baijiang	NNP	O
,	,	O
Gd	NNP	O
Gaozhou	NNP	O
,	,	O
Gd	NNP	O
Huazhou	NNP	O
,	,	O
Gd	NNP	O
Nanhai	NNP	O
,	,	O
and	CC	O
Gd	NNP	O
Guangzhou	NNP	O
)	)	O
were	VBD	O
identified	VBN	O
.	.	O

Of	IN	O
the	DT	O
31	CD	O
variants	NNS	O
found	VBN	O
in	IN	O
this	DT	O
province	NN	O
,	,	O
Gd	NNP	O
Kaiping	NNP	O
,	,	O
Gd	NNP	O
Taiwan	NNP	O
-	:	O
Hakka	NNP	O
,	,	O
Gd	NNP	O
Haad	NNP	O
Yai	NNP	O
,	,	O
Gd	NNP	O
Haad	NNP	O
Yai	NNP	O
-	:	O
like	IN	O
and	CC	O
Gd	NNP	O
Huiyang	NNP	O
occurred	VBD	O
most	JJS	O
frequently	RB	O
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
each	DT	O
variant	NN	O
was	VBD	O
calculated	VBN	O
.	.	O

The	DT	O
results	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
genetic	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
was	VBD	O
high	JJ	O
in	IN	O
this	DT	O
area	NN	O
.	.	O
.	.	O

Homozygous	JJ	O
and	CC	O
heterozygous	JJ	O
deletions	NNS	O
of	IN	O
the	DT	O
von	NN	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
gene	NN	O
in	IN	O
patients	NNS	O
and	CC	O
carriers	NNS	O
of	IN	O
severe	JJ	B_Disease
von	NN	I_Disease
Willebrand	NNP	I_Disease
disease	NN	E_Disease
.	.	O

Severe	NNP	B_Disease
von	NNP	I_Disease
Willebrand	NNP	I_Disease
disease	NN	E_Disease
is	VBZ	O
characterized	VBN	O
by	IN	O
undetectable	JJ	O
or	CC	O
trace	JJ	O
quantities	NNS	O
of	IN	O
von	NN	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
in	IN	O
plasma	NN	O
and	CC	O
tissue	NN	O
stores	NNS	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
the	DT	O
genomic	JJ	O
DNA	NN	O
of	IN	O
10	CD	O
affected	JJ	O
individuals	NNS	O
from	IN	O
six	CD	O
families	NNS	O
with	IN	O
this	DT	O
disorder	NN	O
using	VBG	O
probes	NNS	O
from	IN	O
the	DT	O
5	CD	O
and	CC	O
3	CD	O
ends	NNS	O
of	IN	O
the	DT	O
vWF	NN	O
cDNA	NN	O
and	CC	O
with	IN	O
a	DT	O
probe	NN	O
extending	VBG	O
from	IN	O
the	DT	O
5	CD	O
end	NN	O
into	IN	O
the	DT	O
central	JJ	O
region	NN	O
.	.	O

Southern	JJ	O
blots	NNS	O
of	IN	O
restriction	NN	O
endonuclease	NN	O
digests	NNS	O
and	CC	O
gene	NN	O
dosage	NN	O
analysis	NN	O
measurements	NNS	O
carried	VBD	O
out	RP	O
with	IN	O
quantitative	JJ	O
slot	NN	O
blots	NNS	O
of	IN	O
undigested	JJ	O
genomic	JJ	O
DNA	NN	O
separated	VBN	O
these	DT	O
patients	NNS	O
into	IN	O
three	CD	O
groups	NNS	O
.	.	O

The	DT	O
first	JJ	O
group	NN	O
consisted	VBD	O
of	IN	O
a	DT	O
family	NN	O
with	IN	O
complete	JJ	O
homozygous	JJ	O
deletions	NNS	O
of	IN	O
the	DT	O
vWF	JJ	O
gene	NN	O
in	IN	O
the	DT	O
four	CD	O
probands	NNS	O
.	.	O

Gene	NNP	O
dosage	NN	O
analysis	NN	O
was	VBD	O
consistent	JJ	O
with	IN	O
heterozygous	JJ	O
deletions	NNS	O
in	IN	O
both	DT	O
of	IN	O
the	DT	O
asymptomatic	JJ	O
parents	NNS	O
and	CC	O
four	CD	O
asymptomatic	JJ	O
siblings	NNS	O
of	IN	O
this	DT	O
kindred	VBN	O
(	(	O
P	NNP	O
less	JJR	O
than	IN	O
0	CD	O
.	.	O

01	CD	O
)	)	O
.	.	O

The	DT	O
second	JJ	O
group	NN	O
was	VBD	O
comprised	VBN	O
of	IN	O
a	DT	O
family	NN	O
in	IN	O
which	WDT	O
there	EX	O
was	VBD	O
a	DT	O
complete	JJ	O
heterozygous	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
vWF	JJ	O
gene	NN	O
in	IN	O
the	DT	O
proband	NN	O
and	CC	O
one	CD	O
asymptomatic	JJ	O
parent	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
a	DT	O
different	JJ	O
type	NN	O
of	IN	O
genetic	JJ	B_Disease
abnormality	NN	E_Disease
was	VBD	O
inherited	VBN	O
from	IN	O
the	DT	O
other	JJ	O
parent	NN	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
patient	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
doubly	RB	O
heterozygous	JJ	O
for	IN	O
interacting	VBG	O
genetic	JJ	B_Disease
abnormalities	NNS	E_Disease
affecting	VBG	O
vWF	JJ	O
expression	NN	O
.	.	O

In	IN	O
the	DT	O
third	JJ	O
group	NN	O
,	,	O
no	DT	O
gene	NN	O
deletions	NNS	O
could	MD	O
be	VB	O
detected	VBN	O
.	.	O

Alloantibodies	NNS	O
developed	VBD	O
only	RB	O
in	IN	O
the	DT	O
kindred	VBN	O
with	IN	O
homozygous	JJ	O
deletions	NNS	O
.	.	O

These	DT	O
techniques	NNS	O
should	MD	O
prove	VB	O
useful	JJ	O
in	IN	O
identifying	VBG	O
carriers	NNS	O
of	IN	O
severe	JJ	B_Disease
von	NN	I_Disease
Willebrand	NNP	I_Disease
disease	NN	E_Disease
and	CC	O
also	RB	O
in	IN	O
defining	VBG	O
patients	NNS	O
predictably	RB	O
at	IN	O
risk	NN	O
of	IN	O
developing	VBG	O
alloantibodies	NNS	O
to	TO	O
vWF	VB	O
.	.	O

Sjogren	NNP	B_Disease
-	:	I_Disease
Larsson	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Impaired	NNP	O
fatty	JJ	O
alcohol	NN	O
oxidation	NN	O
in	IN	O
cultured	JJ	O
fibroblasts	NNS	O
due	JJ	O
to	TO	O
deficient	VB	O
fatty	JJ	O
alcohol	NN	O
:	:	O
nicotinamide	JJ	O
adenine	NN	O
dinucleotide	JJ	O
oxidoreductase	NN	O
activity	NN	O
.	.	O

Lipid	JJ	O
metabolism	NN	O
was	VBD	O
studied	VBN	O
in	IN	O
cultured	JJ	O
skin	NN	O
fibroblasts	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
the	DT	O
inherited	JJ	B_Disease
disorder	NN	E_Disease
,	,	O
Sjogren	NNP	B_Disease
-	:	I_Disease
Larsson	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
SLS	NNP	S_Disease
)	)	O
.	.	O

Intact	JJ	O
SLS	NNP	S_Disease
fibroblasts	NNS	O
incubated	VBD	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
[	$	O
1	CD	O
-	:	O
14C	CD	O
]	JJ	O
palmitate	NN	O
accumulated	VBD	O
more	RBR	O
radioactive	JJ	O
hexadecanol	NN	O
than	IN	O
did	VBD	O
normal	JJ	O
cells	NNS	O
,	,	O
whereas	JJ	O
incorporation	NN	O
of	IN	O
radioactivity	NN	O
into	IN	O
other	JJ	O
cellular	JJ	O
lipids	NNS	O
was	VBD	O
unaltered	JJ	O
.	.	O

The	DT	O
hexadecanol	NN	O
content	NN	O
of	IN	O
SLS	NNP	S_Disease
fibroblasts	NNS	O
was	VBD	O
abnormally	RB	O
elevated	VBN	O
.	.	O

Hexadecanol	NNP	O
accumulation	NN	O
was	VBD	O
not	RB	O
due	JJ	O
to	TO	O
increased	VBN	O
fatty	RB	O
alcohol	JJ	O
synthesis	NN	O
nor	CC	O
its	PRP$	O
deficient	NN	O
utilization	NN	O
for	IN	O
glycerol	NN	O
ether	CC	O
synthesis	NN	O
.	.	O

The	DT	O
half	NN	O
-	:	O
life	NN	O
of	IN	O
intracellular	JJ	O
hexadecanol	NN	O
loaded	VBD	O
into	IN	O
SLS	NNP	S_Disease
fibroblasts	NNS	O
was	VBD	O
increased	VBN	O
(	(	O
70	CD	O
min	NN	O
)	)	O
compared	VBN	O
with	IN	O
normal	JJ	O
(	(	O
15	CD	O
min	NN	O
)	)	O
,	,	O
and	CC	O
intact	JJ	O
SLS	NNP	S_Disease
fibroblasts	NNS	O
showed	VBD	O
impaired	JJ	O
oxidation	NN	O
of	IN	O
[	$	O
14C	CD	O
]	NNP	O
-	:	O
hexadecanol	NN	O
to	TO	O
fatty	VB	O
acid	NN	O
.	.	O

Fatty	NNP	O
alcohol	NN	O
NAD	NNP	O
+	NNP	O
oxidoreductase	NN	O
,	,	O
the	DT	O
enzyme	NN	O
catalyzing	VBG	O
this	DT	O
reaction	NN	O
,	,	O
was	VBD	O
deficient	NN	O
in	IN	O
SLS	NNP	S_Disease
fibroblasts	NNS	O
.	.	O

Mean	JJ	O
total	JJ	O
activity	NN	O
in	IN	O
SLS	NNP	S_Disease
fibroblasts	NNS	O
(	(	O
n	JJ	O
=	NNP	O
5	CD	O
)	)	O
was	VBD	O
13	CD	O
%	NN	O
of	IN	O
that	DT	O
in	IN	O
normal	JJ	O
fibroblasts	NNS	O
,	,	O
and	CC	O
palmitoyl	NN	O
CoA	NNP	O
-	:	O
inhibitable	JJ	O
activity	NN	O
was	VBD	O
1	CD	O
%	NN	O
of	IN	O
normal	JJ	O
.	.	O

Fibroblasts	NNS	O
from	IN	O
two	CD	O
obligate	JJ	O
SLS	NNP	S_Disease
heterozygotes	NNS	O
had	VBD	O
enzyme	JJ	O
activities	NNS	O
intermediate	VBP	O
between	IN	O
that	DT	O
in	IN	O
normal	JJ	O
fibroblasts	NNS	O
and	CC	O
individuals	NNS	O
with	IN	O
SLS	NNP	S_Disease
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
primary	JJ	O
defect	NN	O
in	IN	O
SLS	NNP	S_Disease
is	VBZ	O
deficiency	NN	B_Disease
of	IN	I_Disease
fatty	JJ	I_Disease
alcohol	NN	I_Disease
NAD	NNP	I_Disease
+	NNP	I_Disease
oxidoreductase	NN	E_Disease
.	.	O

SLS	NNP	S_Disease
represents	VBZ	O
the	DT	O
first	JJ	O
inherited	JJ	B_Disease
disorder	NN	E_Disease
in	IN	O
man	NN	O
associated	VBN	O
with	IN	O
an	DT	O
isolated	JJ	O
abnormality	NN	B_Disease
in	IN	I_Disease
fatty	JJ	I_Disease
alcohol	NN	I_Disease
metabolism	NN	E_Disease
.	.	O
.	.	O

Germinal	JJ	O
mosaicism	NN	O
in	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
pedigree	VBP	O
where	WRB	O
the	DT	O
disease	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
molecular	JJ	O
deletion	NN	O
within	IN	O
the	DT	O
DMD	NNP	S_Disease
locus	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
the	DT	O
meiotic	JJ	O
segregation	NN	O
products	NNS	O
of	IN	O
the	DT	O
common	JJ	O
female	NN	O
ancestor	NN	O
using	VBG	O
marker	JJR	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NN	O
(	(	O
RFLPs	NNP	O
)	)	O
detected	VBN	O
by	IN	O
probes	NNS	O
that	WDT	O
lie	VBP	O
within	IN	O
this	DT	O
deletion	NN	O
.	.	O

These	DT	O
studies	NNS	O
show	VBP	O
that	IN	O
this	DT	O
female	NN	O
has	VBZ	O
transmitted	VBN	O
three	CD	O
distinct	JJ	O
types	NNS	O
of	IN	O
X	NNP	O
chromosome	NN	O
to	TO	O
her	PRP$	O
offspring	NN	O
.	.	O

This	DT	O
observation	NN	O
may	MD	O
be	VB	O
explained	VBN	O
by	IN	O
postulating	VBG	O
that	IN	O
the	DT	O
mutation	NN	O
arose	VBD	O
as	IN	O
a	DT	O
postzygotic	JJ	O
deletion	NN	O
within	IN	O
this	DT	O
common	JJ	O
ancestor	NN	O
,	,	O
who	WP	O
was	VBD	O
consequently	RB	O
germinally	RB	O
mosaic	JJ	O
.	.	O
.	.	O

Nebulin	NNP	O
seen	VBN	O
in	IN	O
DMD	NNP	S_Disease
males	NNS	O
including	VBG	O
one	CD	O
patient	NN	O
with	IN	O
a	DT	O
large	JJ	O
DNA	NNP	O
deletion	NN	O
encompassing	VBG	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
nebulin	NN	O
in	IN	O
a	DT	O
muscle	NN	O
specimen	NNS	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
due	JJ	O
to	TO	O
a	DT	O
large	JJ	O
deletion	NN	O
precludes	VBZ	O
the	DT	O
possibility	NN	O
that	IN	O
this	DT	O
protein	NN	O
is	VBZ	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
product	NN	O
.	.	O
.	.	O

Expression	NN	O
of	IN	O
the	DT	O
murine	NN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
gene	NN	O
in	IN	O
muscle	NN	O
and	CC	O
brain	NN	O
.	.	O

Complementary	JJ	O
DNA	NNP	O
clones	NNS	O
were	VBD	O
isolated	VBN	O
that	IN	O
represent	VBP	O
the	DT	O
5	CD	O
terminal	JJ	O
2	CD	O
.	.	O

5	CD	O
kilobases	NNS	O
of	IN	O
the	DT	O
murine	NN	O
Duchenne	NNP	B_Disease
muscular	NN	I_Disease
dystrophy	NN	E_Disease
(	(	O
Dmd	NNP	O
)	)	O
messenger	NN	O
RNA	NNP	O
(	(	O
mRNA	NN	O
)	)	O
.	.	O

Mouse	NNP	O
Dmd	NNP	O
mRNA	NN	O
was	VBD	O
detectable	JJ	O
in	IN	O
skeletal	JJ	O
and	CC	O
cardiac	JJ	O
muscle	NN	O
and	CC	O
at	IN	O
a	DT	O
level	NN	O
approximately	RB	O
90	CD	O
percent	NN	O
lower	JJR	O
in	IN	O
brain	NN	O
.	.	O

Dmd	NNP	O
mRNA	NN	O
is	VBZ	O
also	RB	O
present	JJ	O
,	,	O
but	CC	O
at	IN	O
much	RB	O
lower	JJR	O
than	IN	O
normal	JJ	O
levels	NNS	O
,	,	O
in	IN	O
both	DT	O
the	DT	O
muscle	NN	O
and	CC	O
brain	NN	O
of	IN	O
three	CD	O
different	JJ	O
strains	NNS	O
of	IN	O
dystrophic	JJ	S_Disease
mdx	NN	O
mice	NN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
Dmd	NNP	O
mRNA	NN	O
in	IN	O
brain	NN	O
raises	VBZ	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
relation	NN	O
between	IN	O
human	JJ	O
Duchenne	NNP	B_Disease
muscular	NN	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
gene	NN	O
expression	NN	O
and	CC	O
the	DT	O
mental	JJ	B_Disease
retardation	NN	E_Disease
found	VBN	O
in	IN	O
some	DT	O
DMD	NNP	S_Disease
males	NNS	O
.	.	O

These	DT	O
results	NNS	O
also	RB	O
provide	VBP	O
evidence	NN	O
that	IN	O
the	DT	O
mdx	NN	O
mutations	NNS	O
are	VBP	O
allelic	JJ	O
variants	NNS	O
of	IN	O
mouse	NN	O
Dmd	NNP	O
gene	NN	O
mutations	NNS	O
.	.	O

Glucose	NNP	B_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
deficiency	NN	E_Disease
and	CC	O
incidence	NN	O
of	IN	O
hematologic	JJ	B_Disease
malignancy	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
evaluated	VBN	O
the	DT	O
hypothesis	NN	O
of	IN	O
a	DT	O
negative	JJ	O
association	NN	O
between	IN	O
glucose	$	B_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
and	CC	O
cancer	NN	S_Disease
in	IN	O
a	DT	O
cohort	NN	O
of	IN	O
481	CD	O
Sardinian	JJ	O
males	NNS	O
with	IN	O
hematological	JJ	B_Disease
malignancies	NNS	E_Disease
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
the	DT	O
patients	NNS	O
was	VBD	O
not	RB	O
different	JJ	O
from	IN	O
the	DT	O
incidence	NN	O
in	IN	O
a	DT	O
group	NN	O
of	IN	O
16	CD	O
,	,	O
219	CD	O
controls	NNS	O
.	.	O

The	DT	O
same	JJ	O
conclusion	NN	O
resulted	VBD	O
from	IN	O
the	DT	O
comparison	NN	O
of	IN	O
the	DT	O
frequency	NN	O
of	IN	O
expression	NN	O
of	IN	O
the	DT	O
GdB	NNP	O
gene	NN	O
in	IN	O
23	CD	O
heterozygous	JJ	O
women	NNS	O
having	VBG	O
a	DT	O
clonal	JJ	O
hematologic	NN	B_Disease
disease	NN	E_Disease
and	CC	O
a	DT	O
control	NN	O
group	NN	O
of	IN	O
37	CD	O
healthy	JJ	O
heterozygotes	NNS	O
.	.	O

Therefore	RB	O
at	IN	O
present	JJ	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
that	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
has	VBZ	O
a	DT	O
protective	JJ	O
effect	NN	O
against	IN	O
development	NN	O
of	IN	O
hematologic	JJ	B_Disease
neoplasms	NNS	E_Disease
.	.	O
.	.	O

Hepatoblastoma	NNP	S_Disease
,	,	O
pigmented	VBD	B_Disease
ocular	JJ	I_Disease
fundus	NN	I_Disease
lesions	NNS	E_Disease
and	CC	O
jaw	NN	B_Disease
lesions	NNS	E_Disease
in	IN	O
Gardner	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O

Hepatoblastoma	NNP	S_Disease
is	VBZ	O
a	DT	O
rare	JJ	O
neoplasm	NN	S_Disease
of	IN	O
infants	NNS	O
and	CC	O
children	NNS	O
only	RB	O
recently	RB	O
documented	VBN	O
in	IN	O
association	NN	O
with	IN	O
hereditary	JJ	B_Disease
adenomatous	JJ	I_Disease
polyposis	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
colon	NN	E_Disease
[	NNP	O
Kingston	NNP	O
et	VBZ	O
al	NN	O
.	.	O
,	,	O
1983	CD	O
]	NN	O
.	.	O

We	PRP	O
report	VBP	O
four	CD	O
children	NNS	O
with	IN	O
hepatoblastoma	NN	S_Disease
from	IN	O
four	CD	O
unrelated	JJ	O
families	NNS	O
with	IN	O
Gardner	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
GS	NNP	S_Disease
)	)	O
.	.	O

One	CD	O
child	NN	O
,	,	O
now	RB	O
19	CD	O
years	NNS	O
old	JJ	O
,	,	O
survived	VBD	O
after	IN	O
a	DT	O
resection	NN	O
of	IN	O
a	DT	O
hepatoblastoma	NN	S_Disease
in	IN	O
infancy	NN	O
and	CC	O
recently	RB	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
GS	NNP	S_Disease
.	.	O

He	PRP	O
has	VBZ	O
an	DT	O
associated	VBN	O
odontoma	NN	S_Disease
and	CC	O
pigmented	VBD	B_Disease
ocular	JJ	I_Disease
fundus	NN	I_Disease
lesions	NNS	E_Disease
,	,	O
both	DT	O
of	IN	O
which	WDT	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
clinical	JJ	O
markers	NNS	O
of	IN	O
GS	NNP	S_Disease
.	.	O

Many	JJ	O
individuals	NNS	O
in	IN	O
these	DT	O
four	CD	O
GS	NNP	S_Disease
families	NNS	O
,	,	O
both	DT	O
affected	JJ	O
and	CC	O
at	IN	O
risk	NN	O
,	,	O
have	VBP	O
osteomatous	JJ	B_Disease
jaw	NN	I_Disease
lesions	NNS	E_Disease
and	CC	O
pigmented	VBD	B_Disease
ocular	JJ	I_Disease
fundus	NN	I_Disease
lesions	NNS	E_Disease
.	.	O

A	DT	O
search	NN	O
for	IN	O
colonic	JJ	B_Disease
polyps	NNS	E_Disease
should	MD	O
be	VB	O
made	VBN	O
in	IN	O
families	NNS	O
of	IN	O
infants	NNS	O
and	CC	O
children	NNS	O
with	IN	O
hepatoblastoma	NN	S_Disease
.	.	O

If	IN	O
the	DT	O
child	NN	O
survives	VBZ	O
,	,	O
he	PRP	O
or	CC	O
she	PRP	O
should	MD	O
be	VB	O
monitored	VBN	O
for	IN	O
the	DT	O
later	JJ	O
appearance	NN	O
of	IN	O
colonic	JJ	B_Disease
polyps	NNS	E_Disease
.	.	O

The	DT	O
finding	NN	O
of	IN	O
jaw	NN	B_Disease
lesions	NNS	E_Disease
and	CC	O
/	NN	O
or	CC	O
pigmented	VBN	B_Disease
ocular	JJ	I_Disease
fundus	NN	I_Disease
lesions	NNS	E_Disease
in	IN	O
relatives	NNS	O
at	IN	O
risk	NN	O
are	VBP	O
indications	NNS	O
of	IN	O
the	DT	O
possible	JJ	O
presence	NN	O
of	IN	O
the	DT	O
GS	NNP	S_Disease
gene	NN	O
.	.	O

Identification	NN	O
of	IN	O
an	DT	O
altered	JJ	O
splice	NN	O
site	NN	O
in	IN	O
Ashkenazi	NNP	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
.	.	O

Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
genetic	JJ	I_Disease
disorder	NN	E_Disease
resulting	VBG	O
from	IN	O
mutation	NN	O
of	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
encoding	VBG	O
the	DT	O
alpha	NN	O
-	:	O
subunit	NN	O
of	IN	O
the	DT	O
lysosomal	JJ	O
enzyme	NN	O
,	,	O
beta	SYM	O
-	:	O
N	NNP	O
-	:	O
acetylhexosaminidase	NN	O
A	NNP	O
(	(	O
ref	NN	O
.	.	O

1	CD	O
)	)	O
.	.	O

A	DT	O
relatively	RB	O
high	JJ	O
frequency	NN	O
of	IN	O
carriers	NNS	O
(	(	O
1	CD	O
/	RB	O
27	CD	O
)	)	O
of	IN	O
a	DT	O
lethal	NN	O
,	,	O
infantile	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
is	VBZ	O
found	VBN	O
in	IN	O
the	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
population	NN	O
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
not	RB	O
yet	RB	O
evident	JJ	O
whether	IN	O
this	DT	O
has	VBZ	O
resulted	VBN	O
from	IN	O
a	DT	O
founder	NN	O
effect	NN	O
and	CC	O
random	VB	O
genetic	JJ	O
drift	NN	O
or	CC	O
from	IN	O
a	DT	O
selective	JJ	O
advantage	NN	O
of	IN	O
heterozygotes	NNS	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
single	JJ	O
-	:	O
base	NN	O
mutation	NN	O
in	IN	O
a	DT	O
cloned	JJ	O
fragment	NN	O
of	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
from	IN	O
an	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
patient	NN	O
.	.	O

This	DT	O
change	NN	O
,	,	O
the	DT	O
substitution	NN	O
of	IN	O
a	DT	O
C	NNP	O
for	IN	O
G	NNP	O
in	IN	O
the	DT	O
first	JJ	O
nucleotide	NN	O
of	IN	O
intron	NN	O
12	CD	O
is	VBZ	O
expected	VBN	O
to	TO	O
result	VB	O
in	IN	O
defective	JJ	O
splicing	NN	O
of	IN	O
the	DT	O
messenger	NN	O
RNA	NNP	O
.	.	O

A	DT	O
test	NN	O
for	IN	O
the	DT	O
mutant	NN	O
allele	NN	O
based	VBN	O
on	IN	O
amplification	NN	O
of	IN	O
DNA	NN	O
by	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
rection	NN	O
and	CC	O
cleavage	NN	O
of	IN	O
a	DT	O
DdeI	NNP	O
restriction	NN	O
site	NN	O
generated	VBN	O
by	IN	O
the	DT	O
mutation	NN	O
revealed	VBD	O
that	IN	O
this	DT	O
case	NN	O
and	CC	O
two	CD	O
other	JJ	O
cases	NNS	O
of	IN	O
the	DT	O
Ashkenazi	NNP	O
,	,	O
infantile	JJ	O
form	NN	O
of	IN	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
are	VBP	O
heterozygous	JJ	O
for	IN	O
two	CD	O
different	JJ	O
mutations	NNS	O
.	.	O

The	DT	O
occurrence	NN	O
of	IN	O
multiple	JJ	O
mutant	JJ	O
alleles	NNS	O
warrants	NNS	O
further	JJ	O
examination	NN	O
of	IN	O
the	DT	O
selective	JJ	O
advantage	NN	O
hypothesis	NN	O
.	.	O
.	.	O

X	LS	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
glucose	JJ	I_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
deficiency	NN	E_Disease
in	IN	O
Mus	NNP	O
musculus	NN	O
.	.	O

A	DT	O
mouse	NN	O
with	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
glucose	JJ	I_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
has	VBZ	O
been	VBN	O
recovered	VBN	O
in	IN	O
offspring	VBG	O
of	IN	O
1	CD	O
-	:	O
ethyl	NN	O
-	:	O
1	CD	O
-	:	O
nitrosourea	JJ	O
-	:	O
treated	VBN	O
male	JJ	O
mice	NN	O
.	.	O

The	DT	O
activity	NN	O
alteration	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
blood	NN	O
but	CC	O
can	MD	O
also	RB	O
be	VB	O
observed	VBN	O
in	IN	O
other	JJ	O
tissue	NN	O
extracts	NNS	O
.	.	O

Hemizygous	NNP	O
,	,	O
heterozygous	JJ	O
,	,	O
and	CC	O
homozygous	JJ	O
mutants	NNS	O
have	VBP	O
,	,	O
respectively	RB	O
,	,	O
about	IN	O
15	CD	O
,	,	O
60	CD	O
,	,	O
and	CC	O
15	CD	O
%	NN	O
G6PD	NNP	O
remaining	VBG	O
activity	NN	O
in	IN	O
the	DT	O
blood	NN	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
wild	JJ	O
type	NN	O
.	.	O

Erythrocyte	NNP	O
indices	NNS	O
did	VBD	O
not	RB	O
show	VB	O
differences	NNS	O
between	IN	O
mutants	NNS	O
and	CC	O
wild	JJ	O
types	NNS	O
.	.	O

The	DT	O
mutation	NN	O
does	VBZ	O
not	RB	O
affect	VB	O
the	DT	O
electrophoretic	JJ	O
migration	NN	O
,	,	O
the	DT	O
isoelectric	JJ	O
point	NN	O
,	,	O
or	CC	O
the	DT	O
thermal	JJ	O
stability	NN	O
.	.	O

Kinetic	NNP	O
properties	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
Km	NNP	O
for	IN	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
or	CC	O
for	IN	O
NADP	NNP	O
and	CC	O
the	DT	O
relative	JJ	O
utilization	NN	O
of	IN	O
substrate	NN	O
analogues	NNS	O
,	,	O
showed	VBD	O
no	DT	O
differences	NNS	O
between	IN	O
wild	JJ	O
types	NNS	O
and	CC	O
mutants	NNS	O
with	IN	O
the	DT	O
exception	NN	O
of	IN	O
the	DT	O
relative	JJ	O
utilization	NN	O
of	IN	O
deamino	NN	O
-	:	O
NADP	NNP	O
which	WDT	O
was	VBD	O
significantly	RB	O
lower	JJR	O
in	IN	O
mutants	NNS	O
.	.	O

This	DT	O
is	VBZ	O
presently	RB	O
the	DT	O
only	JJ	O
animal	JJ	O
model	NN	O
for	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
G6PD	NNP	I_Disease
deficiency	NN	E_Disease
in	IN	O
humans	NNS	O
.	.	O
.	.	O

Diverse	NNP	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
gene	NN	O
cause	NN	O
enzyme	JJ	B_Disease
deficiency	NN	E_Disease
and	CC	O
mild	NN	O
or	CC	O
severe	JJ	O
hemolytic	JJ	B_Disease
anemia	NN	E_Disease
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
;	:	I_Disease
EC	NNP	I_Disease
1	CD	I_Disease
.	.	I_Disease
1	CD	I_Disease
.	.	I_Disease
1	CD	I_Disease
.	.	I_Disease
49	CD	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
is	VBZ	O
a	DT	O
common	JJ	O
genetic	JJ	B_Disease
abnormality	NN	E_Disease
affecting	VBG	O
an	DT	O
estimated	VBN	O
400	CD	O
million	CD	O
people	NNS	O
worldwide	VBP	O
.	.	O

Clinical	JJ	O
and	CC	O
biochemical	JJ	O
analyses	NNS	O
have	VBP	O
identified	VBN	O
many	JJ	O
variants	NNS	O
exhibiting	VBG	O
a	DT	O
range	NN	O
of	IN	O
phenotypes	NNS	O
,	,	O
which	WDT	O
have	VBP	O
been	VBN	O
well	RB	O
characterized	VBN	O
from	IN	O
the	DT	O
hematological	JJ	O
point	NN	O
of	IN	O
view	NN	O
.	.	O

However	RB	O
,	,	O
until	IN	O
now	RB	O
,	,	O
their	PRP$	O
precise	JJ	O
molecular	JJ	O
basis	NN	O
has	VBZ	O
remained	VBN	O
unknown	JJ	O
.	.	O

We	PRP	O
have	VBP	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
seven	CD	O
mutant	JJ	O
G6PD	NNP	O
alleles	NNS	O
.	.	O

In	IN	O
the	DT	O
nondeficient	JJ	O
polymorphic	JJ	O
African	NNP	O
variant	NN	O
G6PD	NNP	O
A	NNP	O
we	PRP	O
have	VBP	O
found	VBN	O
a	DT	O
single	JJ	O
point	NN	O
mutation	NN	O
.	.	O

The	DT	O
other	JJ	O
six	CD	O
mutants	NNS	O
investigated	VBN	O
were	VBD	O
all	DT	O
associated	VBN	O
with	IN	O
enzyme	JJ	B_Disease
deficiency	NN	E_Disease
.	.	O

In	IN	O
one	CD	O
of	IN	O
the	DT	O
commonest	JJS	O
,	,	O
G6PD	NNP	O
Mediterranean	NNP	O
,	,	O
which	WDT	O
is	VBZ	O
associated	VBN	O
with	IN	O
favism	NN	S_Disease
among	IN	O
other	JJ	O
clinical	JJ	O
manifestations	NNS	O
,	,	O
a	DT	O
single	JJ	O
amino	NN	O
acid	JJ	O
replacement	NN	O
was	VBD	O
found	VBN	O
(	(	O
serine	JJ	O
-	:	O
-	:	O
-	:	O
-	:	O
phenylalanine	NN	O
)	)	O
it	PRP	O
must	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
decreased	JJ	O
stability	NN	O
and	CC	O
the	DT	O
reduced	VBN	O
catalytic	JJ	O
efficiency	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
.	.	O

Single	NNP	O
point	NN	O
mutations	NNS	O
were	VBD	O
also	RB	O
found	VBN	O
in	IN	O
G6PD	NNP	O
Metaponto	NNP	O
(	(	O
Southern	NNP	O
Italy	NNP	O
)	)	O
and	CC	O
in	IN	O
G6PD	NNP	O
Ilesha	NNP	O
(	(	O
Nigeria	NNP	O
)	)	O
,	,	O
which	WDT	O
are	VBP	O
asymptomatic	JJ	O
,	,	O
and	CC	O
in	IN	O
G6PD	NNP	O
Chatham	NNP	O
,	,	O
which	WDT	O
was	VBD	O
observed	VBN	O
in	IN	O
an	DT	O
Indian	JJ	O
boy	NN	O
with	IN	O
neonatal	JJ	B_Disease
jaundice	NN	E_Disease
.	.	O

In	IN	O
G6PD	NNP	O
"	NNP	O
Matera	NNP	O
,	,	O
"	NNP	O
which	WDT	O
is	VBZ	O
now	RB	O
known	VBN	O
to	TO	O
be	VB	O
the	DT	O
same	JJ	O
as	IN	O
G6PD	NNP	O
A	NNP	O
-	:	O
,	,	O
two	CD	O
separate	JJ	O
point	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
,	,	O
one	CD	O
of	IN	O
which	WDT	O
is	VBZ	O
the	DT	O
same	JJ	O
as	IN	O
in	IN	O
G6PD	NNP	O
A	NNP	O
.	.	O

In	IN	O
G6PD	NNP	O
Santiago	NNP	O
,	,	O
a	DT	O
de	FW	O
novo	FW	O
mutation	NN	O
(	(	O
glycine	JJ	O
-	:	O
-	:	O
-	:	O
-	:	O
arginine	NN	O
)	)	O
is	VBZ	O
associated	VBN	O
with	IN	O
severe	JJ	O
chronic	JJ	O
hemolytic	JJ	B_Disease
anemia	NN	E_Disease
.	.	O

The	DT	O
mutations	NNS	O
observed	VBD	O
show	VBP	O
a	DT	O
striking	JJ	O
predominance	NN	O
of	IN	O
C	NNP	O
-	:	O
-	:	O
-	:	O
-	:	O
T	NN	O
transitions	NNS	O
,	,	O
with	IN	O
CG	NNP	O
doublets	NNS	O
involved	VBN	O
in	IN	O
four	CD	O
of	IN	O
seven	CD	O
cases	NNS	O
.	.	O

Thus	RB	O
,	,	O
diverse	JJ	O
point	NN	O
mutations	NNS	O
may	MD	O
account	VB	O
largely	RB	O
for	IN	O
the	DT	O
phenotypic	NN	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Tight	JJ	O
linkage	NN	O
between	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
and	CC	O
apolipoprotein	NN	O
E	NNP	O
genes	NNS	O
revealed	VBD	O
with	IN	O
allele	JJ	O
-	:	O
specific	JJ	O
oligonucleotides	NNS	O
.	.	O

In	IN	O
16	CD	O
families	NNS	O
with	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
a	DT	O
novel	JJ	O
approach	NN	O
based	VBN	O
on	IN	O
use	NN	O
of	IN	O
allele	JJ	O
-	:	O
specific	JJ	O
oligonucleotides	NNS	O
has	VBZ	O
been	VBN	O
employed	VBN	O
to	TO	O
study	VB	O
the	DT	O
linkage	NN	O
relationship	NN	O
between	IN	O
the	DT	O
apolipoprotein	NN	O
E	NNP	O
(	(	O
APOE	NNP	O
)	)	O
gene	NN	O
and	CC	O
DM	NNP	S_Disease
.	.	O

Synthetic	JJ	O
oligonucleotides	NNS	O
,	,	O
designed	VBN	O
to	TO	O
discriminate	VB	O
between	IN	O
APOE	NNP	O
alleles	VBZ	O
epsilon	RB	O
3	CD	O
and	CC	O
epsilon	$	O
4	CD	O
,	,	O
enabled	VBD	O
us	PRP	O
to	TO	O
distinguish	VB	O
heterozygous	JJ	O
carriers	NNS	O
in	IN	O
a	DT	O
hybridization	NN	O
assay	NN	O
.	.	O

In	IN	O
a	DT	O
subset	NN	O
of	IN	O
families	NNS	O
,	,	O
the	DT	O
relevant	JJ	O
segment	NN	O
of	IN	O
the	DT	O
APOE	NNP	O
gene	NN	O
was	VBD	O
enzymatically	RB	O
amplified	VBN	O
to	TO	O
increase	VB	O
the	DT	O
sensitivity	NN	O
of	IN	O
the	DT	O
method	NN	O
.	.	O

For	IN	O
DM	NNP	O
and	CC	O
APOE	NNP	O
,	,	O
a	DT	O
maximum	JJ	O
lod	NN	O
score	NN	O
(	(	O
zmax	NN	O
of	IN	O
7	CD	O
.	.	O

47	CD	O
was	VBD	O
obtained	VBN	O
at	IN	O
a	DT	O
recombination	NN	O
frequency	NN	O
(	(	O
theta	NN	O
)	)	O
of	IN	O
0	CD	O
.	.	O

047	CD	O
(	(	O
male	JJ	O
theta	NN	O
=	NNP	O
female	JJ	O
theta	NN	O
)	)	O
.	.	O

No	DT	O
recombination	NN	O
(	(	O
maximum	JJ	O
lod	NN	O
score	NN	O
of	IN	O
5	CD	O
.	.	O

61	CD	O
at	IN	O
theta	NN	O
=	$	O
0	CD	O
.	.	O

0	CD	O
)	)	O
was	VBD	O
found	VBN	O
between	IN	O
APOE	NNP	O
and	CC	O
the	DT	O
apolipoprotein	NN	O
CII	NNP	O
(	(	O
APOC2	NNP	O
)	)	O
gene	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
APOC2	NNP	O
,	,	O
APOE	NNP	O
is	VBZ	O
a	DT	O
useful	JJ	O
marker	NN	O
for	IN	O
presymptomatic	JJ	O
DM	NNP	S_Disease
diagnosis	NN	O
.	.	O

Regional	JJ	O
localization	NN	O
of	IN	O
polymorphic	JJ	O
DNA	NNP	O
loci	NN	O
on	IN	O
the	DT	O
proximal	NN	O
long	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
using	VBG	O
deletions	NNS	O
associated	VBN	O
with	IN	O
choroideremia	NN	S_Disease
.	.	O

In	IN	O
two	CD	O
unrelated	JJ	O
families	NNS	O
,	,	O
males	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
who	WP	O
suffer	VBP	O
from	IN	O
choroideremia	NN	S_Disease
and	CC	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
have	VBP	O
an	DT	O
interstitial	JJ	O
deletion	NN	O
on	IN	O
the	DT	O
proximal	NN	O
long	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
.	.	O

By	IN	O
high	JJ	O
-	:	O
resolution	NN	O
banding	NN	O
we	PRP	O
have	VBP	O
characterized	VBN	O
the	DT	O
deletion	NN	O
chromosomes	VBZ	O
as	IN	O
del	NN	O
(	(	O
X	NNP	O
)	)	O
(	(	O
q21	UH	O
.	.	O

1	CD	O
-	:	O
q21	NN	O
1	CD	O
-	:	O
q21	NN	O
.	.	O

33	CD	O
)	)	O
and	CC	O
del	FW	O
(	(	O
X	NN	O
)	)	O
(	(	O
q21	UH	O
.	.	O

2	CD	O
-	:	O
q21	NN	O
2	CD	O
-	:	O
q21	NN	O
.	.	O

31	CD	O
)	)	O
respectively	RB	O
.	.	O

By	IN	O
Southern	NNP	O
blot	NN	O
analysis	NN	O
we	PRP	O
have	VBP	O
mapped	VBN	O
ten	VB	O
different	JJ	O
polymorphic	JJ	O
DNA	NNP	O
loci	NN	O
relative	NN	O
to	TO	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
deletion	NN	O
and	CC	O
the	DT	O
choroideremia	NN	S_Disease
locus	NN	O
TCD	NNP	O
.	.	O

One	CD	O
probe	NN	O
,	,	O
p31	NN	O
,	,	O
was	VBD	O
shown	VBN	O
to	TO	O
cover	VB	O
one	CD	O
of	IN	O
the	DT	O
breakpoints	NNS	O
of	IN	O
the	DT	O
smallest	JJS	O
deletion	NN	O
.	.	O

The	DT	O
following	JJ	O
order	NN	O
of	IN	O
the	DT	O
loci	NN	O
was	VBD	O
suggested	VBN	O
by	IN	O
deletion	NN	O
mapping	NN	O
cen	SYM	O
-	:	O
DXS106	NNP	O
-	:	O
DXS72	NNP	O
-	:	O
TCD	NNP	O
-	:	O
(	(	O
DXYS1	NNP	O
/	NNP	O
DXYS23	NNP	O
/	NNP	O
DXYS5	NNP	O
)	)	O
-	:	O
DXYS2	NNP	O
-	:	O
(	(	O
DXYS12	NNP	O
/	NNP	O
DXS3	NNP	O
)	)	O
-	:	O
(	(	O
DXS17	NNP	O
/	NNP	O
DXS101	NNP	O
)	)	O
-	:	O
Xqter	NN	O
.	.	O

Retroviral	NNP	O
-	:	O
mediated	VBD	O
gene	NN	O
transfer	NN	O
of	IN	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
into	IN	O
NIH	NNP	O
3T3	CD	O
and	CC	O
hepatoma	JJ	S_Disease
cells	NNS	O
.	.	O

Phenylketonuria	NNP	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
hepatic	JJ	I_Disease
enzyme	NN	I_Disease
phenylalanine	NN	I_Disease
hydroxylase	NN	E_Disease
(	(	O
PAH	NNP	O
)	)	O
.	.	O

A	DT	O
full	JJ	O
-	:	O
length	NN	O
human	JJ	O
PAH	NNP	O
cDNA	NN	O
sequence	NN	O
has	VBZ	O
been	VBN	O
inserted	VBN	O
into	IN	O
pzip	NN	O
-	:	O
neoSV	NN	O
(	(	O
X	NNP	O
)	)	O
,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
retroviral	JJ	O
vector	NN	O
containing	VBG	O
the	DT	O
bacterial	JJ	O
neo	JJ	O
gene	NN	O
.	.	O

The	DT	O
recombinant	NN	O
has	VBZ	O
been	VBN	O
transfected	VBN	O
into	IN	O
psi	JJ	O
2	CD	O
cells	NNS	O
,	,	O
which	WDT	O
provide	VBP	O
synthesis	NN	O
of	IN	O
the	DT	O
retroviral	JJ	O
capsid	NN	O
.	.	O

Recombinant	JJ	O
virus	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
culture	NN	O
medium	NN	O
of	IN	O
the	DT	O
transfected	JJ	O
psi	NN	O
2	CD	O
cells	NNS	O
,	,	O
which	WDT	O
is	VBZ	O
capable	JJ	O
of	IN	O
transmitting	VBG	O
the	DT	O
human	JJ	O
PAH	NNP	O
gene	NN	O
into	IN	O
mouse	NN	O
NIH	NNP	O
3T3	CD	O
cells	NNS	O
by	IN	O
infection	NN	O
leading	VBG	O
to	TO	O
stable	JJ	O
incorporation	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
provirus	NN	O
.	.	O

Infected	VBN	O
cells	NNS	O
express	RBR	O
PAH	NNP	O
mRNA	NN	O
,	,	O
immunoreactive	JJ	O
PAH	NNP	O
protein	NN	O
,	,	O
and	CC	O
exhibit	NN	O
pterin	JJ	O
-	:	O
dependent	JJ	O
phenylalanine	JJ	O
hydroxylase	NN	O
activity	NN	O
.	.	O

The	DT	O
recombinant	JJ	O
virus	NN	O
is	VBZ	O
also	RB	O
capable	JJ	O
of	IN	O
infecting	VBG	O
a	DT	O
mouse	NN	O
hepatoma	NN	S_Disease
cell	NN	O
line	NN	O
that	WDT	O
does	VBZ	O
not	RB	O
normally	RB	O
synthesize	VB	O
PAH	NNP	O
.	.	O

PAH	NNP	O
activity	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
the	DT	O
cellular	JJ	O
extracts	NNS	O
and	CC	O
the	DT	O
entire	JJ	O
hydroxylation	NN	O
system	NN	O
is	VBZ	O
reconstituted	VBN	O
in	IN	O
the	DT	O
hepatoma	NN	S_Disease
cells	NNS	O
infected	VBN	O
with	IN	O
the	DT	O
recombinant	JJ	O
viruses	NNS	O
.	.	O

Thus	RB	O
,	,	O
recombinant	JJ	O
viruses	NNS	O
containing	VBG	O
human	JJ	O
PAH	NNP	O
cDNA	NN	O
provide	VBP	O
a	DT	O
means	NN	O
for	IN	O
introducing	VBG	O
functional	JJ	O
PAH	NNP	O
into	IN	O
mammalian	JJ	O
cells	NNS	O
of	IN	O
hepatic	JJ	O
origin	NN	O
and	CC	O
can	MD	O
potentially	RB	O
be	VB	O
introduced	VBN	O
into	IN	O
whole	JJ	O
animals	NNS	O
as	IN	O
a	DT	O
model	NN	O
for	IN	O
somatic	JJ	O
gene	NN	O
therapy	NN	O
for	IN	O
PKU	NNP	S_Disease
.	.	O
.	.	O

Estimation	NN	O
of	IN	O
the	DT	O
male	NN	O
to	TO	O
female	VB	O
ratio	NN	O
of	IN	O
mutation	NN	O
rates	NNS	O
from	IN	O
the	DT	O
segregation	NN	O
of	IN	O
X	NNP	O
-	:	O
chromosomal	JJ	O
DNA	NNP	O
haplotypes	NNS	O
in	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
families	NNS	O
.	.	O

A	DT	O
novel	JJ	O
procedure	NN	O
is	VBZ	O
presented	VBN	O
to	TO	O
estimate	VB	O
the	DT	O
ratio	NN	O
of	IN	O
male	NN	O
to	TO	O
female	JJ	O
mutation	NN	O
rates	NNS	O
for	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
.	.	O

X	LS	O
-	:	O
specific	JJ	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
are	VBP	O
used	VBN	O
to	TO	O
establish	VB	O
DNA	NNP	O
haplotypes	NNS	O
in	IN	O
three	CD	O
-	:	O
generation	NN	O
DMD	NNP	S_Disease
families	NNS	O
.	.	O

From	IN	O
the	DT	O
proportion	NN	O
of	IN	O
DMD	NNP	S_Disease
patients	NNS	O
who	WP	O
have	VBP	O
inherited	VBN	O
their	PRP$	O
maternal	JJ	O
grandfathers	NNS	O
X	VBP	O
chromosome	NN	O
,	,	O
the	DT	O
ratio	NN	O
of	IN	O
mutation	NN	O
rates	NNS	O
can	MD	O
be	VB	O
calculated	VBN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
classical	JJ	O
methods	NNS	O
,	,	O
the	DT	O
proposed	VBN	O
procedure	NN	O
is	VBZ	O
not	RB	O
restricted	VBN	O
to	TO	O
sporadic	VB	O
or	CC	O
familiar	JJ	O
cases	NNS	O
nor	CC	O
is	VBZ	O
any	DT	O
information	NN	O
on	IN	O
the	DT	O
carrier	NN	O
status	NN	O
of	IN	O
female	JJ	O
relatives	NNS	O
required	VBN	O
.	.	O
.	.	O

Deletions	NNS	O
of	IN	O
a	DT	O
DNA	NN	O
sequence	NN	O
in	IN	O
retinoblastomas	NN	S_Disease
and	CC	O
mesenchymal	JJ	B_Disease
tumors	NNS	E_Disease
:	:	O
organization	NN	O
of	IN	O
the	DT	O
sequence	NN	O
and	CC	O
its	PRP$	O
encoded	JJ	O
protein	NN	O
.	.	O

Retinoblastoma	NNP	S_Disease
is	VBZ	O
a	DT	O
childhood	NN	B_Disease
tumor	NN	E_Disease
that	WDT	O
can	MD	O
arise	VB	O
because	IN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
acquired	VBD	O
as	IN	O
somatic	JJ	O
or	CC	O
germinal	JJ	O
mutations	NNS	O
.	.	O

The	DT	O
mutant	JJ	O
allele	NN	O
can	MD	O
be	VB	O
carried	VBN	O
in	IN	O
the	DT	O
germ	JJ	O
line	NN	O
.	.	O

The	DT	O
mutations	NNS	O
creating	VBG	O
these	DT	O
alleles	NNS	O
act	NN	O
by	IN	O
inactivating	VBG	O
copies	NNS	O
of	IN	O
a	DT	O
recessive	JJ	O
oncogene	NN	O
located	VBN	O
within	IN	O
band	NN	O
q14	NN	O
of	IN	O
chromosome	NN	O
13	CD	O
and	CC	O
termed	VBD	O
the	DT	O
RB1	NNP	O
locus	NN	O
.	.	O

We	PRP	O
have	VBP	O
reported	VBN	O
isolation	NN	O
of	IN	O
a	DT	O
cDNA	NN	O
fragment	NN	O
that	WDT	O
recognizes	VBZ	O
chromosomal	JJ	O
sequences	NNS	O
possessing	VBG	O
many	JJ	O
of	IN	O
the	DT	O
attributes	NNS	O
of	IN	O
the	DT	O
retinoblastoma	NN	S_Disease
gene	NN	O
associated	VBN	O
with	IN	O
the	DT	O
RB1	NNP	O
locus	NN	O
.	.	O

We	PRP	O
now	RB	O
report	VBP	O
that	IN	O
this	DT	O
segment	NN	O
is	VBZ	O
additionally	RB	O
the	DT	O
target	NN	O
of	IN	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
mesenchymal	JJ	B_Disease
tumors	NNS	E_Disease
among	IN	O
patients	NNS	O
having	VBG	O
no	DT	O
apparent	JJ	O
predisposition	NN	O
to	TO	O
retinoblastoma	VB	S_Disease
and	CC	O
no	DT	O
previous	JJ	O
evidence	NN	O
of	IN	O
retinoblastoma	NN	S_Disease
.	.	O

These	DT	O
tumors	NNS	S_Disease
provide	VBP	O
additional	JJ	O
evidence	NN	O
that	IN	O
the	DT	O
cloned	JJ	O
sequences	NNS	O
are	VBP	O
representative	JJ	O
of	IN	O
a	DT	O
gene	NN	O
that	WDT	O
is	VBZ	O
a	DT	O
frequent	JJ	O
target	NN	O
of	IN	O
inactivation	NN	O
during	IN	O
tumorigenesis	NN	O
.	.	O

Sequence	NNP	O
analysis	NN	O
of	IN	O
this	DT	O
cDNA	NN	O
provides	VBZ	O
little	JJ	O
insight	JJ	O
into	IN	O
its	PRP$	O
normal	JJ	O
functional	JJ	O
role	NN	O
.	.	O
.	.	O

Treatment	NN	O
of	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
with	IN	O
growth	NN	O
hormone	NN	O
inhibitors	NNS	O
.	.	O

A	DT	O
controlled	VBN	O
,	,	O
double	JJ	O
-	:	O
blind	NN	O
therapeutic	JJ	O
trial	NN	O
with	IN	O
the	DT	O
drug	NN	O
mazindol	NN	O
,	,	O
a	DT	O
growth	NN	O
hormone	NN	O
inhibitor	NN	O
,	,	O
was	VBD	O
performed	VBN	O
in	IN	O
a	DT	O
pair	NN	O
of	IN	O
7	CD	O
1	CD	O
/	NN	O
2	CD	O
year	NN	O
-	:	O
old	JJ	O
monozygotic	JJ	O
twins	NNS	O
,	,	O
with	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
rationale	NN	O
for	IN	O
this	DT	O
trial	NN	O
was	VBD	O
based	VBN	O
on	IN	O
a	DT	O
patient	NN	O
(	(	O
reported	VBN	O
previously	RB	O
)	)	O
affected	VBD	O
simultaneously	RB	O
with	IN	O
DMD	NNP	S_Disease
and	CC	O
growth	NN	B_Disease
hormone	NN	I_Disease
(	(	I_Disease
GH	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
,	,	O
who	WP	O
is	VBZ	O
showing	VBG	O
a	DT	O
benign	JJ	O
course	NN	O
of	IN	O
the	DT	O
dystrophic	JJ	B_Disease
process	NN	E_Disease
and	CC	O
is	VBZ	O
still	RB	O
walking	VBG	O
at	IN	O
18	CD	O
years	NNS	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
twins	NNS	O
received	VBD	O
2	CD	O
mg	NN	O
of	IN	O
mazindol	JJ	O
daily	JJ	O
,	,	O
while	IN	O
the	DT	O
other	JJ	O
received	VBD	O
a	DT	O
placebo	NN	O
.	.	O

The	DT	O
assessment	NN	O
,	,	O
repeated	VBN	O
every	DT	O
2	CD	O
months	NNS	O
,	,	O
included	VBD	O
weight	NN	O
and	CC	O
height	NN	O
measurements	NNS	O
,	,	O
functional	JJ	O
and	CC	O
motor	NN	O
ability	NN	O
tests	NNS	O
,	,	O
ergometry	NN	O
and	CC	O
determinations	NNS	O
of	IN	O
serum	NN	O
enzymes	NNS	O
and	CC	O
GH	NNP	O
levels	NNS	O
.	.	O

After	IN	O
one	CD	O
year	NN	O
of	IN	O
trial	NN	O
the	DT	O
code	NN	O
was	VBD	O
broken	VBN	O
and	CC	O
it	PRP	O
was	VBD	O
seen	VBN	O
that	IN	O
the	DT	O
twin	NN	O
under	IN	O
placebo	NN	O
treatment	NN	O
was	VBD	O
strikingly	RB	O
worse	JJR	O
than	IN	O
his	PRP$	O
brother	NN	O
,	,	O
the	DT	O
progression	NN	O
of	IN	O
whose	WP$	O
condition	NN	O
was	VBD	O
practically	RB	O
arrested	VBN	O
.	.	O

These	DT	O
results	NNS	O
strongly	RB	O
suggest	VBP	O
that	IN	O
treatment	NN	O
with	IN	O
a	DT	O
GH	NNP	O
inhibitor	NN	O
is	VBZ	O
beneficial	JJ	O
for	IN	O
DMD	NNP	S_Disease
patients	NNS	O
.	.	O
.	.	O

Identification	NN	O
and	CC	O
localization	NN	O
of	IN	O
mutations	NNS	O
at	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	E_Disease
locus	NN	O
by	IN	O
ribonuclease	NN	O
A	NNP	O
cleavage	NN	O
.	.	O

Many	JJ	O
mutations	NNS	O
leading	VBG	O
to	TO	O
human	JJ	O
disease	NN	O
are	VBP	O
the	DT	O
result	NN	O
of	IN	O
single	JJ	O
DNA	NNP	O
base	NN	O
pair	NN	O
changes	NNS	O
that	IN	O
cannot	NN	O
be	VB	O
identified	VBN	O
by	IN	O
Southern	JJ	O
analysis	NN	O
.	.	O

This	DT	O
has	VBZ	O
prompted	VBN	O
the	DT	O
development	NN	O
of	IN	O
alternative	JJ	O
assays	NNS	O
for	IN	O
point	NN	O
mutation	NN	O
detection	NN	O
.	.	O

The	DT	O
recently	RB	O
described	VBN	O
ribonuclease	NN	O
A	DT	O
cleavage	NN	O
procedure	NN	O
,	,	O
with	IN	O
a	DT	O
polyuridylic	JJ	O
acid	NN	O
-	:	O
paper	NN	O
affinity	NN	O
chromatography	NN	O
step	NN	O
,	,	O
has	VBZ	O
been	VBN	O
used	VBN	O
to	TO	O
identify	VB	O
the	DT	O
mutational	JJ	O
lesions	NNS	O
in	IN	O
the	DT	O
hypoxanthine	NN	O
phosphoribosyltransferase	NN	O
(	(	O
HPRT	NNP	O
)	)	O
messenger	NN	O
RNAs	NNP	O
of	IN	O
patients	NNS	O
with	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Distinctive	JJ	O
ribonuclease	NN	O
A	NNP	O
cleavage	NN	O
patterns	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
messenger	NN	O
RNA	NNP	O
from	IN	O
5	CD	O
of	IN	O
14	CD	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NN	E_Disease
patients	NNS	O
who	WP	O
were	VBD	O
chosen	VBN	O
because	IN	O
no	DT	O
HPRT	NNP	O
Southern	NNP	O
or	CC	O
Northern	NNP	O
blotting	VBG	O
pattern	JJ	O
changes	NNS	O
had	VBD	O
been	VBN	O
found	VBN	O
.	.	O

This	DT	O
approach	NN	O
now	RB	O
allows	VBZ	O
HPRT	NNP	O
mutation	NN	O
detection	NN	O
in	IN	O
50	CD	O
percent	NN	O
of	IN	O
the	DT	O
cases	NNS	O
of	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

The	DT	O
polyuridylic	JJ	O
acid	SYM	O
-	:	O
paper	NN	O
affinity	NN	O
procedure	NN	O
provides	VBZ	O
a	DT	O
general	JJ	O
method	NN	O
for	IN	O
analysis	NN	O
of	IN	O
low	JJ	O
abundance	NN	O
messenger	NN	O
RNAs	NNP	O
.	.	O
.	.	O

Two	CD	O
new	JJ	O
variants	NNS	O
of	IN	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
associated	VBN	O
with	IN	O
hereditary	JJ	B_Disease
non	SYM	I_Disease
-	:	I_Disease
spherocytic	JJ	I_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
:	:	O
G6PD	NNP	O
Wayne	NNP	O
and	CC	O
G6PD	NNP	O
Huron	NNP	O
.	.	O

Two	CD	O
new	JJ	O
deficient	JJ	O
variants	NNS	O
of	IN	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
causing	VBG	O
hereditary	JJ	B_Disease
nonspherocytic	JJ	I_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
(	(	O
HNSHA	NNP	S_Disease
)	)	O
are	VBP	O
described	VBN	O
.	.	O

Both	DT	O
of	IN	O
these	DT	O
are	VBP	O
unique	JJ	O
and	CC	O
they	PRP	O
have	VBP	O
been	VBN	O
named	VBN	O
G6PD	NNP	O
Wayne	NNP	O
and	CC	O
G6PD	NNP	O
Huron	NNP	O
.	.	O

Patients	NNS	O
with	IN	O
G6PD	NNP	O
Wayne	NNP	O
underwent	JJ	O
splenectomy	NN	O
and	CC	O
no	DT	O
objective	JJ	O
improvement	NN	O
was	VBD	O
noted	VBN	O
.	.	O

The	DT	O
patients	NNS	O
with	IN	O
G6PD	NNP	O
Huron	NNP	O
were	VBD	O
under	IN	O
medical	JJ	O
observation	NN	O
for	IN	O
a	DT	O
considerable	JJ	O
period	NN	O
of	IN	O
time	NN	O
without	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
being	VBG	O
entertained	VBN	O
because	IN	O
the	DT	O
family	NN	O
was	VBD	O
of	IN	O
Northern	NNP	O
European	NNP	O
origin	NN	O
.	.	O

Since	IN	O
sporadic	JJ	O
variants	NNS	O
of	IN	O
G6PD	NNP	O
causing	VBG	O
HNSHA	NNP	S_Disease
show	NN	O
no	DT	O
special	JJ	O
racial	JJ	O
predilection	NN	O
,	,	O
the	DT	O
diagnosis	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
should	MD	O
always	RB	O
be	VB	O
considered	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
this	DT	O
syndrome	NN	O
.	.	O
.	.	O

Sialophorin	NNP	O
,	,	O
a	DT	O
surface	NN	O
sialoglycoprotein	NN	O
defective	JJ	O
in	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
is	VBZ	O
involved	VBN	O
in	IN	O
human	JJ	O
T	NNP	O
lymphocyte	NN	O
proliferation	NN	O
.	.	O

The	DT	O
mAb	NN	O
L10	NNP	O
was	VBD	O
used	VBN	O
to	TO	O
determine	VB	O
the	DT	O
distribution	NN	O
and	CC	O
the	DT	O
function	NN	O
of	IN	O
sialophorin	NN	O
,	,	O
the	DT	O
heavily	RB	O
glycosylated	VBN	O
surface	NN	O
molecule	NN	O
that	WDT	O
is	VBZ	O
deficient	JJ	O
/	RB	O
defective	JJ	O
in	IN	O
lymphocytes	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
the	DT	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
immunodeficiency	NN	I_Disease
Wiskott	NNP	I_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Dual	NNP	O
-	:	O
parameter	NN	O
FACS	NNP	O
analysis	NN	O
indicated	VBD	O
that	IN	O
sialophorin	NN	O
is	VBZ	O
expressed	VBN	O
on	IN	O
CD4	NNP	O
+	NNP	O
and	CC	O
CD8	NNP	O
+	NNP	O
lymphocytes	VBZ	O
,	,	O
on	IN	O
a	DT	O
subpopulation	NN	O
of	IN	O
peripheral	JJ	O
blood	NN	O
B	NNP	O
lymphocytes	VBZ	O
,	,	O
on	IN	O
all	DT	O
thymocytes	NNS	O
,	,	O
and	CC	O
on	IN	O
a	DT	O
subpopulation	NN	O
of	IN	O
bone	NN	O
marrow	NN	O
cells	NNS	O
.	.	O

Functional	JJ	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
L10	NNP	O
mAb	NN	O
stimulates	VBZ	O
the	DT	O
proliferation	NN	O
of	IN	O
peripheral	JJ	O
blood	NN	O
T	NNP	O
lymphocytes	VBZ	O
as	IN	O
measured	VBN	O
by	IN	O
stimulation	NN	O
of	IN	O
[	$	O
3H	CD	O
]	NNP	O
thymidine	NN	O
incorporation	NN	O
.	.	O

The	DT	O
time	NN	O
course	NN	O
and	CC	O
magnitude	NN	O
of	IN	O
increased	VBN	O
[	NN	O
3H	CD	O
]	JJ	O
thymidine	NN	O
incorporation	NN	O
by	IN	O
T	NNP	O
lymphocytes	NNS	O
in	IN	O
response	NN	O
to	TO	O
L10	NNP	O
mAb	NN	O
paralleled	VBD	O
that	IN	O
induced	VBN	O
by	IN	O
anti	JJ	O
-	:	O
CD3	NNP	O
mAb	NN	O
.	.	O

Effective	JJ	O
stimulation	NN	O
was	VBD	O
dependent	JJ	O
on	IN	O
the	DT	O
presence	NN	O
of	IN	O
monocytes	NNS	O
and	CC	O
the	DT	O
Fc	NNP	O
portion	NN	O
of	IN	O
L10	NNP	O
mAb	NN	O
.	.	O

Stimulation	NN	O
of	IN	O
lymphocytes	NNS	O
by	IN	O
L10	NNP	O
,	,	O
like	IN	O
stimulation	NN	O
by	IN	O
anti	JJ	O
-	:	O
CD3	NNP	O
mAb	NN	O
,	,	O
involves	VBZ	O
increased	JJ	O
expression	NN	O
of	IN	O
4F2	CD	O
,	,	O
HLA	NNP	O
-	:	O
DR	NNP	O
,	,	O
and	CC	O
IL	NNP	O
-	:	O
2	CD	O
-	:	O
R	NN	O
.	.	O

These	DT	O
observations	NNS	O
suggest	VBP	O
that	IN	O
sialophorin	JJ	O
functions	NNS	O
in	IN	O
T	NNP	O
cell	NN	O
activation	NN	O
.	.	O
.	.	O

Hypopigmentation	NN	S_Disease
in	IN	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Cutaneous	JJ	B_Disease
and	CC	I_Disease
ocular	JJ	I_Disease
pigmentation	NN	E_Disease
were	VBD	O
evaluated	VBN	O
in	IN	O
29	CD	O
individuals	NNS	O
with	IN	O
the	DT	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
.	.	O

Criteria	NNS	O
for	IN	O
hypopigmentation	NN	S_Disease
included	VBD	O
the	DT	O
presence	NN	O
of	IN	O
type	NN	O
I	PRP	O
or	CC	O
II	NNP	O
skin	NN	O
,	,	O
the	DT	O
lightest	JJS	O
skin	NN	O
type	NN	O
in	IN	O
the	DT	O
family	NN	O
by	IN	O
history	NN	O
,	,	O
and	CC	O
iris	JJ	O
translucency	NN	O
on	IN	O
globe	NN	O
transillumination	NN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
these	DT	O
criteria	NNS	O
,	,	O
48	CD	O
%	NN	O
of	IN	O
the	DT	O
PWS	NNP	S_Disease
individuals	NNS	O
were	VBD	O
hypopigmented	VBN	S_Disease
.	.	O

The	DT	O
presence	NN	O
of	IN	O
hypopigmentation	NN	S_Disease
correlated	VBN	O
with	IN	O
a	DT	O
small	JJ	O
interstitial	JJ	O
deletion	NN	O
on	IN	O
the	DT	O
proximal	NN	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
15	CD	O
;	:	O
however	RB	O
,	,	O
this	DT	O
deletion	NN	O
was	VBD	O
also	RB	O
found	VBN	O
in	IN	O
individuals	NNS	O
who	WP	O
did	VBD	O
not	RB	O
meet	VB	O
the	DT	O
full	JJ	O
criteria	NN	O
for	IN	O
hypopigmentation	NN	S_Disease
.	.	O

Hairbulb	NNP	O
tyrosinase	NN	O
activity	NN	O
and	CC	O
glutathione	NN	O
content	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
urine	JJ	O
cysteinyldopa	NN	O
excretion	NN	O
,	,	O
were	VBD	O
low	JJ	O
in	IN	O
PWS	NNP	S_Disease
individuals	NNS	O
with	IN	O
and	CC	O
without	IN	O
hypopigmentation	NN	S_Disease
and	CC	O
did	VBD	O
not	RB	O
separate	VB	O
these	DT	O
two	CD	O
groups	NNS	O
.	.	O

We	PRP	O
conclude	VBP	O
that	DT	O
hypopigmentation	NN	S_Disease
is	VBZ	O
found	VBN	O
in	IN	O
a	DT	O
significant	JJ	O
proportion	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
PWS	NNP	S_Disease
and	CC	O
that	IN	O
the	DT	O
hypopigmentation	NN	S_Disease
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
a	DT	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
15	CD	O
.	.	O

The	DT	O
mechanism	NN	O
for	IN	O
the	DT	O
hypopigmentation	NN	S_Disease
is	VBZ	O
unknown	JJ	O
.	.	O
.	.	O

Phenotype	NNP	O
heterogeneity	NN	O
among	IN	O
hemizygotes	NNS	O
in	IN	O
a	DT	O
family	NN	O
biochemically	RB	O
screened	VBN	O
for	IN	O
adrenoleukodystrophy	NN	S_Disease
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
two	CD	O
clinically	RB	O
,	,	O
neurologically	RB	O
normal	JJ	O
relatives	NNS	O
of	IN	O
a	DT	O
boy	NN	O
affected	VBN	O
by	IN	O
adrenoleukodystrophy	NN	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
;	:	O
they	PRP	O
were	VBD	O
found	VBN	O
repeatedly	RB	O
to	TO	O
have	VB	O
the	DT	O
biochemical	JJ	O
defect	NN	O
of	IN	O
an	DT	O
ALD	NNP	S_Disease
hemizygote	NN	O
.	.	O

The	DT	O
assay	NN	O
consisted	VBN	O
in	IN	O
the	DT	O
determination	NN	O
of	IN	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
in	IN	O
lyophilized	JJ	O
and	CC	O
reconstituted	JJ	O
plasma	NN	O
.	.	O

While	IN	O
no	DT	O
evidence	NN	O
of	IN	O
neurologic	JJ	B_Disease
disease	NN	E_Disease
(	(	O
leukodystrophy	NN	S_Disease
or	CC	O
myeloneuropathy	NN	S_Disease
)	)	O
was	VBD	O
present	JJ	O
in	IN	O
these	DT	O
hemizygotes	NNS	O
,	,	O
adrenocortical	JJ	B_Disease
insufficiency	NN	E_Disease
provoking	VBG	O
compensatory	JJ	O
high	JJ	O
ACTH	NNP	O
release	NN	O
was	VBD	O
found	VBN	O
in	IN	O
both	DT	O
.	.	O

These	DT	O
findings	NNS	O
should	MD	O
be	VB	O
taken	VBN	O
into	IN	O
consideration	NN	O
when	WRB	O
counseling	VBG	O
families	NNS	O
in	IN	O
which	WDT	O
cases	NNS	O
with	IN	O
clinically	RB	O
expressed	VBN	O
ALD	NNP	S_Disease
are	VBP	O
represented	VBN	O
in	IN	O
several	JJ	O
generations	NNS	O
.	.	O
.	.	O

The	DT	O
mapping	NN	O
of	IN	O
a	DT	O
cDNA	NN	O
from	IN	O
the	DT	O
human	JJ	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
Duchenne	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
gene	NN	O
to	TO	O
the	DT	O
mouse	NN	O
X	NNP	O
chromosome	NN	O
.	.	O

The	DT	O
recent	JJ	O
discovery	NN	O
of	IN	O
sequences	NNS	O
at	IN	O
the	DT	O
site	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
gene	NN	O
in	IN	O
humans	NNS	O
has	VBZ	O
opened	VBN	O
up	RP	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
detailed	JJ	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
genes	NNS	O
in	IN	O
humans	NNS	O
and	CC	O
in	IN	O
related	JJ	O
mammalian	JJ	O
species	NNS	O
.	.	O

Until	IN	O
relatively	RB	O
recently	RB	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
obvious	JJ	O
mouse	NN	O
model	NN	O
of	IN	O
this	DT	O
genetic	JJ	B_Disease
disease	NN	E_Disease
for	IN	O
the	DT	O
development	NN	O
of	IN	O
therapeutic	JJ	O
strategies	NNS	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
a	DT	O
mouse	NN	O
X	SYM	O
-	:	O
linked	VBN	O
mutant	JJ	O
showing	VBG	O
muscular	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
mdx	NN	O
,	,	O
has	VBZ	O
provided	VBN	O
a	DT	O
candidate	NN	O
mouse	NN	O
genetic	JJ	O
homologue	NN	O
to	TO	O
the	DT	O
DMD	NNP	S_Disease
locus	NN	O
;	:	O
the	DT	O
relatively	RB	O
mild	JJ	O
pathological	JJ	O
features	NNS	O
of	IN	O
mdx	NN	O
suggest	VBP	O
it	PRP	O
may	MD	O
have	VB	O
more	JJR	O
in	IN	O
common	JJ	O
with	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
Becker	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
type	NN	O
at	IN	O
the	DT	O
same	JJ	O
human	JJ	O
locus	NN	O
,	,	O
however	RB	O
.	.	O

But	CC	O
the	DT	O
close	JJ	O
genetic	JJ	O
linkage	NN	O
of	IN	O
mdx	NN	O
to	TO	O
G6PD	NNP	O
and	CC	O
Hprt	NNP	O
on	IN	O
the	DT	O
mouse	NN	O
X	NNP	O
chromosome	NN	O
,	,	O
coupled	VBN	O
with	IN	O
its	PRP$	O
comparatively	JJ	O
mild	JJ	O
pathology	NN	O
,	,	O
have	VBP	O
suggested	VBN	O
that	IN	O
the	DT	O
mdx	JJ	O
mutation	NN	O
may	MD	O
instead	RB	O
correspond	VB	O
to	TO	O
Emery	NNP	B_Disease
Dreifuss	NNP	I_Disease
muscular	NN	I_Disease
dystrophy	NN	E_Disease
which	WDT	O
itself	PRP	O
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
DNA	NNP	O
markers	NNS	O
at	IN	O
Xq28	NNP	O
-	:	O
qter	NN	O
in	IN	O
the	DT	O
region	NN	O
of	IN	O
G6PD	NNP	O
on	IN	O
the	DT	O
human	JJ	O
X	NNP	O
chromosome	NN	O
.	.	O

Using	VBG	O
an	DT	O
interspecific	NN	O
mouse	NN	O
domesticus	NN	O
/	NNP	O
spretus	NN	O
cross	NN	O
,	,	O
segregating	VBG	O
for	IN	O
a	DT	O
variety	NN	O
of	IN	O
markers	NNS	O
on	IN	O
the	DT	O
mouse	NN	O
X	NNP	O
chromosome	NN	O
,	,	O
we	PRP	O
have	VBP	O
positioned	VBN	O
on	IN	O
the	DT	O
mouse	NN	O
X	NNP	O
chromosome	NN	O
sequences	NNS	O
homologous	JJ	O
to	TO	O
a	DT	O
DMD	NNP	S_Disease
cDNA	NN	O
clone	NN	O
.	.	O

These	DT	O
sequences	NNS	O
map	VBP	O
provocatively	RB	O
close	JJ	O
to	TO	O
the	DT	O
mdx	NN	O
mutation	NN	O
and	CC	O
unexpectedly	RB	O
distant	JJ	O
from	IN	O
sparse	JJ	O
fur	NN	O
,	,	O
spf	NN	O
,	,	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
OTC	NNP	O
(	(	O
ornithine	JJ	O
transcarbamylase	NN	O
)	)	O
which	WDT	O
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
DMD	NNP	S_Disease
on	IN	O
the	DT	O
human	JJ	O
X	NNP	O
chromosome	NN	O
.	.	O
.	.	O

Localization	NN	O
of	IN	O
the	DT	O
region	NN	O
homologous	JJ	O
to	TO	O
the	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
locus	NN	O
on	IN	O
the	DT	O
mouse	NN	O
X	NNP	O
chromosome	NN	O
.	.	O

Recent	JJ	O
progress	NN	O
has	VBZ	O
resulted	VBN	O
in	IN	O
part	NN	O
of	IN	O
the	DT	O
gene	NN	O
mutated	VBN	O
in	IN	O
Duchenne	NNP	B_Disease
and	CC	I_Disease
the	DT	I_Disease
milder	NN	I_Disease
Becker	NNP	I_Disease
muscular	NN	I_Disease
dystrophies	NNS	E_Disease
being	VBG	O
cloned	VBN	O
and	CC	O
has	VBZ	O
suggested	VBN	O
that	IN	O
the	DT	O
gene	NN	O
itself	PRP	O
extends	VBZ	O
over	IN	O
1	CD	O
,	,	O
000	CD	O
to	TO	O
2	CD	O
,	,	O
000	CD	O
kilobases	NNS	O
(	(	O
kb	NN	O
)	)	O
.	.	O

To	TO	O
study	VB	O
how	WRB	O
mutations	NNS	O
in	IN	O
this	DT	O
gene	NN	O
affect	JJ	O
muscle	NN	O
development	NN	O
and	CC	O
integrity	NN	O
,	,	O
it	PRP	O
would	MD	O
be	VB	O
of	IN	O
interest	NN	O
to	TO	O
have	VB	O
available	JJ	O
a	DT	O
mouse	NN	O
model	NN	O
of	IN	O
the	DT	O
human	JJ	O
disease	NN	O
.	.	O

The	DT	O
mouse	NN	O
mdx	NN	O
mutation	NN	O
affects	VBZ	O
muscle	NN	O
and	CC	O
confers	NNS	O
a	DT	O
mild	JJ	O
dystrophic	JJ	B_Disease
syndrome	NN	E_Disease
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
not	RB	O
clear	JJ	O
whether	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
equivalent	JJ	O
to	TO	O
Duchenne	NNP	B_Disease
/	NNP	I_Disease
Becker	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
in	IN	O
man	NN	O
.	.	O

Here	RB	O
we	PRP	O
describe	VBP	O
the	DT	O
use	NN	O
of	IN	O
two	CD	O
sequences	NNS	O
from	IN	O
the	DT	O
human	JJ	O
Duchenne	NNP	B_Disease
muscular	NN	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
gene	NN	O
that	WDT	O
cross	VBZ	O
-	:	O
hybridize	NN	O
to	TO	O
mouse	VB	O
X	NNP	O
-	:	O
linked	VBD	O
sequences	NNS	O
to	TO	O
localize	VB	O
the	DT	O
gene	NN	O
homologous	JJ	O
to	TO	O
DMD	NNP	S_Disease
in	IN	O
the	DT	O
mouse	NN	O
.	.	O

Both	DT	O
sequences	NNS	O
map	VBP	O
to	TO	O
the	DT	O
region	NN	O
of	IN	O
10	CD	O
centimorgan	NNS	O
lying	VBG	O
between	IN	O
the	DT	O
Tabby	NNP	O
(	(	O
Ta	NNP	O
)	)	O
and	CC	O
St14	NNP	O
-	:	O
1	CD	O
(	(	O
DxPas8	NNP	O
)	)	O
loci	NN	O
,	,	O
close	RB	O
to	TO	O
the	DT	O
phosphorylase	NN	O
b	NN	O
kinase	NN	O
locus	NN	O
(	(	O
Phk	NNP	O
)	)	O
.	.	O

By	IN	O
analogy	NN	O
with	IN	O
the	DT	O
human	JJ	O
X	NNP	O
-	:	O
chromosome	NN	O
,	,	O
we	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
region	NN	O
in	IN	O
the	DT	O
mouse	NN	O
around	IN	O
the	DT	O
G6pd	NNP	O
and	CC	O
St14	NNP	O
-	:	O
1	CD	O
loci	NN	O
may	MD	O
contain	VB	O
two	CD	O
genes	NNS	O
corresponding	VBG	O
to	TO	O
distinct	VB	O
human	JJ	O
myopathies	NNS	S_Disease
Emery	NNP	B_Disease
Dreifuss	NNP	I_Disease
muscular	NN	I_Disease
dystrophy	NN	E_Disease
which	WDT	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
closely	RB	O
linked	VBN	O
to	TO	O
St14	NNP	O
-	:	O
1	CD	O
in	IN	O
man	NN	O
and	CC	O
the	DT	O
DMD	NNP	S_Disease
homologue	NN	O
described	VBD	O
here	RB	O
.	.	O
.	.	O

GT	NNP	O
to	TO	O
AT	NNP	O
transition	NN	O
at	IN	O
a	DT	O
splice	NN	O
donor	NN	O
site	NN	O
causes	VBZ	O
skipping	VBG	O
of	IN	O
the	DT	O
preceding	VBG	O
exon	NN	O
in	IN	O
phenylketonuria	NN	S_Disease
.	.	O

Classical	JJ	B_Disease
Phenylketonuria	NNP	E_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
human	JJ	I_Disease
genetic	JJ	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
hepatic	JJ	I_Disease
phenylalanine	NN	I_Disease
hydroxylase	NN	E_Disease
(	(	O
PAH	NNP	O
)	)	O
.	.	O

We	PRP	O
isolated	VBD	O
several	JJ	O
mutant	JJ	O
PAH	NNP	O
cDNA	NN	O
clones	NNS	O
from	IN	O
a	DT	O
PKU	NNP	S_Disease
carrier	NN	O
individual	NN	O
and	CC	O
showed	VBD	O
that	IN	O
they	PRP	O
contained	VBD	O
an	DT	O
internal	JJ	O
116	CD	O
base	NN	O
pair	NN	O
deletion	NN	O
,	,	O
corresponding	VBG	O
precisely	RB	O
to	TO	O
exon	VB	O
12	CD	O
of	IN	O
the	DT	O
human	JJ	O
chromosomal	NN	O
PAH	NNP	O
gene	NN	O
.	.	O

The	DT	O
deletion	NN	O
causes	VBZ	O
the	DT	O
synthesis	NN	O
of	IN	O
a	DT	O
truncated	JJ	O
protein	NN	O
lacking	VBG	O
the	DT	O
C	NNP	O
-	:	O
terminal	JJ	O
52	CD	O
amino	JJ	O
acids	NNS	O
.	.	O

Gene	NNP	O
transfer	NN	O
and	CC	O
expression	NN	O
studies	NNS	O
using	VBG	O
the	DT	O
mutant	JJ	O
PAH	NNP	O
cDNA	NN	O
indicated	VBD	O
that	IN	O
the	DT	O
deletion	NN	O
abolishes	VBZ	O
PAH	NNP	O
activity	NN	O
in	IN	O
the	DT	O
cell	NN	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
protein	NN	O
instability	NN	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
the	DT	O
deletion	NN	O
,	,	O
the	DT	O
mutant	JJ	O
chromosomal	JJ	O
PAH	NNP	O
gene	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
this	DT	O
individual	NN	O
and	CC	O
shown	VBN	O
to	TO	O
contain	VB	O
a	DT	O
GT	NNP	O
-	:	O
-	:	O
greater	JJR	O
than	IN	O
AT	NNP	O
substitution	NN	O
at	IN	O
the	DT	O
5	CD	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
intron	NN	O
12	CD	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
consequence	NN	O
of	IN	O
the	DT	O
splice	NN	O
donor	NN	O
site	NN	O
mutation	NN	O
in	IN	O
the	DT	O
human	JJ	O
liver	NN	O
is	VBZ	O
the	DT	O
skipping	NN	O
of	IN	O
the	DT	O
preceding	VBG	O
exon	NN	O
during	IN	O
RNA	NNP	O
splicing	VBG	O
.	.	O
.	.	O

Conservation	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
gene	NN	O
in	IN	O
mice	NNS	O
and	CC	O
humans	NNS	O
.	.	O

A	DT	O
portion	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
gene	NN	O
transcript	NN	O
from	IN	O
human	JJ	O
fetal	JJ	O
skeletal	JJ	O
muscle	NN	O
and	CC	O
mouse	NN	O
adult	NN	O
heart	NN	O
was	VBD	O
sequenced	VBN	O
,	,	O
representing	VBG	O
approximately	RB	O
25	CD	O
percent	NN	O
of	IN	O
the	DT	O
total	NN	O
,	,	O
14	CD	O
-	:	O
kb	NN	O
DMD	NNP	S_Disease
transcript	NN	O
.	.	O

The	DT	O
nucleic	JJ	O
acid	NN	O
and	CC	O
predicted	VBD	O
amino	NN	O
acid	NN	O
sequences	NNS	O
from	IN	O
the	DT	O
two	CD	O
species	NNS	O
are	VBP	O
nearly	RB	O
90	CD	O
percent	NN	O
homologous	JJ	O
.	.	O

The	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
that	WDT	O
is	VBZ	O
predicted	VBN	O
from	IN	O
this	DT	O
portion	NN	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
indicates	VBZ	O
that	IN	O
the	DT	O
protein	NN	O
product	NN	O
might	MD	O
serve	VB	O
a	DT	O
structural	JJ	O
role	NN	O
in	IN	O
muscle	NN	O
,	,	O
but	CC	O
the	DT	O
abundance	NN	O
and	CC	O
tissue	NN	O
distribution	NN	O
of	IN	O
the	DT	O
messenger	NN	O
RNA	NNP	O
suggests	VBZ	O
that	IN	O
the	DT	O
DMD	NNP	S_Disease
protein	NN	O
is	VBZ	O
not	RB	O
nebulin	JJ	O
.	.	O
.	.	O

Familial	JJ	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
with	IN	O
apparently	RB	O
normal	JJ	O
chromosomes	NNS	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
4	CD	O
sibs	NN	O
(	(	O
2F	CD	O
,	,	O
2M	CD	O
)	)	O
with	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
.	.	O

Diagnosis	NN	O
was	VBD	O
made	VBN	O
clinically	RB	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
history	NN	O
,	,	O
behavior	NN	O
,	,	O
and	CC	O
physical	JJ	O
findings	NNS	O
in	IN	O
3	CD	O
of	IN	O
the	DT	O
sibs	NN	O
.	.	O

The	DT	O
other	JJ	O
child	NN	O
had	VBD	O
died	VBN	O
at	IN	O
age	NN	O
10	CD	O
months	NNS	O
with	IN	O
a	DT	O
history	NN	O
and	CC	O
clinical	JJ	O
findings	NNS	O
typical	JJ	O
of	IN	O
first	JJ	O
phase	NN	O
of	IN	O
PWS	NNP	S_Disease
.	.	O

Results	NNS	O
of	IN	O
chromosome	NN	O
studies	NNS	O
on	IN	O
the	DT	O
parents	NNS	O
and	CC	O
surviving	VBG	O
sibs	NNS	O
were	VBD	O
normal	JJ	O
.	.	O

The	DT	O
implications	NNS	O
of	IN	O
this	DT	O
unusual	JJ	O
familial	JJ	O
occurrence	NN	O
for	IN	O
our	PRP$	O
understanding	NN	O
of	IN	O
PWS	NNP	S_Disease
are	VBP	O
discussed	VBN	O
.	.	O
.	.	O

Nebulin	NNP	O
and	CC	O
titin	JJ	O
expression	NN	O
in	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
appears	VBZ	O
normal	JJ	O
.	.	O

Monoclonal	NNP	O
antibodies	NNS	O
which	WDT	O
recognize	VBP	O
different	JJ	O
epitopes	NNS	O
on	IN	O
either	DT	O
titin	NN	O
or	CC	O
nebulin	JJ	O
show	NN	O
normal	JJ	O
staining	VBG	O
patterns	NNS	O
on	IN	O
frozen	JJ	O
sections	NNS	O
of	IN	O
three	CD	O
muscle	NN	O
biopsies	NNS	O
of	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
.	.	O

Gel	NNP	O
electrophoresis	NN	O
and	CC	O
immunoblotting	NN	O
performed	VBN	O
on	IN	O
two	CD	O
of	IN	O
these	DT	O
muscle	NN	O
biopsies	NNS	O
show	VBP	O
the	DT	O
normal	JJ	O
pattern	NN	O
of	IN	O
titin	NN	O
and	CC	O
nebulin	JJ	O
polypeptides	NNS	O
.	.	O

Since	IN	O
the	DT	O
donor	NN	O
of	IN	O
one	CD	O
of	IN	O
these	DT	O
biopsies	NNS	O
has	VBZ	O
a	DT	O
large	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
5	CD	O
-	:	O
region	NN	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
,	,	O
our	PRP$	O
results	NNS	O
argue	VBP	O
against	IN	O
the	DT	O
recent	JJ	O
proposal	NN	O
that	IN	O
nebulin	NN	O
is	VBZ	O
the	DT	O
gene	NN	O
mutated	VBN	O
in	IN	O
DMD	NNP	S_Disease
.	.	O
.	.	O

Heterozygous	JJ	B_Disease
C2	NNP	I_Disease
deficiency	NN	E_Disease
associated	VBN	O
with	IN	O
angioedema	NN	S_Disease
,	,	O
myasthenia	NN	B_Disease
gravis	NN	E_Disease
,	,	O
and	CC	O
systemic	JJ	B_Disease
lupus	NN	I_Disease
erythematosus	NN	E_Disease
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
patient	NN	O
with	IN	O
myasthenia	NN	B_Disease
gravis	NN	E_Disease
,	,	O
systemic	JJ	B_Disease
lupus	NN	I_Disease
erythematosus	NN	E_Disease
,	,	O
and	CC	O
angioedema	RB	S_Disease
associated	VBN	O
with	IN	O
heterozygous	JJ	O
complement	NN	B_Disease
factor	NN	I_Disease
2	CD	I_Disease
(	(	I_Disease
C2	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
.	.	O

The	DT	O
significance	NN	O
of	IN	O
this	DT	O
association	NN	O
is	VBZ	O
controversial	JJ	O
,	,	O
though	IN	O
the	DT	O
association	NN	O
of	IN	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
with	IN	O
certain	JJ	O
histocompatibility	NN	O
antigens	NNS	O
suggests	VBZ	O
possible	JJ	O
linkage	NN	O
to	TO	O
immune	VB	O
response	NN	O
genes	NNS	O
.	.	O

To	TO	O
our	PRP$	O
knowledge	NN	O
this	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
of	IN	O
heterozygous	JJ	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
association	NN	O
with	IN	O
this	DT	O
combination	NN	O
of	IN	O
autoimmune	NN	B_Disease
disorders	NNS	E_Disease
,	,	O
and	CC	O
we	PRP	O
discuss	VBP	O
the	DT	O
aetiological	JJ	O
implications	NNS	O
.	.	O
.	.	O

Genetic	JJ	O
analysis	NN	O
of	IN	O
an	DT	O
inherited	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
third	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
in	IN	O
Brittany	NNP	O
spaniel	JJ	O
dogs	NNS	O
.	.	O

Genetically	RB	O
determined	VBN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
Brittany	NNP	O
spaniel	JJ	O
dogs	NNS	O
shares	NNS	O
a	DT	O
number	NN	O
of	IN	O
biochemical	JJ	O
and	CC	O
clinical	JJ	O
characteristics	NNS	O
with	IN	O
the	DT	O
human	JJ	O
disorder	NN	O
.	.	O

In	IN	O
humans	NNS	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
a	DT	O
null	JJ	O
gene	NN	O
that	WDT	O
is	VBZ	O
allelic	JJ	O
to	TO	O
the	DT	O
structural	JJ	O
gene	NN	O
for	IN	O
C3	NNP	O
and	CC	O
is	VBZ	O
not	RB	O
linked	VBN	O
to	TO	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
locus	NN	O
.	.	O

The	DT	O
current	JJ	O
study	NN	O
used	VBD	O
allotype	JJ	O
analysis	NN	O
of	IN	O
canine	NN	O
C3	NNP	O
in	IN	O
order	NN	O
to	TO	O
demonstrate	VB	O
that	IN	O
the	DT	O
gene	NN	O
for	IN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
these	DT	O
dogs	NNS	O
is	VBZ	O
also	RB	O
a	DT	O
null	JJ	O
gene	NN	O
allelic	NN	O
to	TO	O
the	DT	O
structural	JJ	O
gene	NN	O
for	IN	O
C3	NNP	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
preliminary	JJ	O
pedigree	NN	O
analysis	NN	O
suggests	VBZ	O
that	IN	O
the	DT	O
gene	NN	O
for	IN	O
canine	NN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
apparently	RB	O
not	RB	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
complex	NN	O
of	IN	O
the	DT	O
dog	NN	O
.	.	O

Thus	RB	O
,	,	O
it	PRP	O
appears	VBZ	O
that	IN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
Brittany	NNP	O
spaniel	JJ	O
dogs	NNS	O
not	RB	O
only	RB	O
shares	NNS	O
biochemical	JJ	O
and	CC	O
clinical	JJ	O
features	NNS	O
with	IN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
humans	NNS	O
,	,	O
but	CC	O
also	RB	O
shares	NNS	O
some	DT	O
genetic	JJ	O
characteristics	NNS	O
with	IN	O
the	DT	O
human	JJ	O
disorder	NN	O
.	.	O
.	.	O

Gene	NNP	O
transfer	NN	O
and	CC	O
expression	NN	O
of	IN	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
.	.	O

Phenylketonuria	NNP	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
genetic	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
enzyme	JJ	I_Disease
phenylalanine	NN	I_Disease
hydroxylase	NN	E_Disease
(	(	O
PAH	NNP	O
)	)	O
.	.	O

A	DT	O
full	JJ	O
-	:	O
length	NN	O
complementary	JJ	O
DNA	NNP	O
clone	NN	O
of	IN	O
human	JJ	O
PAH	NNP	O
was	VBD	O
inserted	VBN	O
into	IN	O
a	DT	O
eukaryotic	JJ	O
expression	NN	O
vector	NN	O
and	CC	O
transferred	VBD	O
into	IN	O
mouse	NN	O
NIH3T3	NNP	O
cells	NNS	O
which	WDT	O
do	VBP	O
not	RB	O
normally	RB	O
express	JJ	O
PAH	NNP	O
.	.	O

The	DT	O
transformed	JJ	O
mouse	NN	O
cells	NNS	O
expressed	VBD	O
PAH	NNP	O
messenger	NN	O
RNA	NNP	O
,	,	O
immunoreactive	JJ	O
protein	NN	O
,	,	O
and	CC	O
enzymatic	JJ	O
activity	NN	O
that	WDT	O
are	VBP	O
characteristic	JJ	O
of	IN	O
the	DT	O
normal	JJ	O
human	JJ	O
liver	NN	O
products	NNS	O
,	,	O
demonstrating	VBG	O
that	IN	O
a	DT	O
single	JJ	O
gene	NN	O
contains	VBZ	O
all	DT	O
of	IN	O
the	DT	O
necessary	JJ	O
genetic	JJ	O
information	NN	O
to	TO	O
code	VB	O
for	IN	O
functional	JJ	O
PAH	NNP	O
.	.	O

These	DT	O
results	NNS	O
support	VBP	O
the	DT	O
use	NN	O
of	IN	O
the	DT	O
human	JJ	O
PAH	NNP	O
probe	NN	O
in	IN	O
prenatal	JJ	O
diagnosis	NN	O
and	CC	O
detection	NN	O
of	IN	O
carriers	NNS	O
,	,	O
to	TO	O
provide	VB	O
new	JJ	O
opportunities	NNS	O
for	IN	O
the	DT	O
biochemical	JJ	O
characterization	NN	O
of	IN	O
normal	JJ	O
and	CC	O
mutant	JJ	O
enzymes	NNS	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
investigation	NN	O
of	IN	O
alternative	JJ	O
genetic	JJ	O
therapies	NNS	O
for	IN	O
PKU	NNP	S_Disease
.	.	O
.	.	O

Regional	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
and	CC	O
the	DT	O
phenylketonuria	NN	S_Disease
locus	NN	O
in	IN	O
the	DT	O
human	JJ	O
genome	NN	O
.	.	O

Phenylketonuria	NNP	S_Disease
(	(	O
PKU	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
of	IN	O
amino	NN	O
acid	NN	O
metabolism	NN	O
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
hepatic	JJ	I_Disease
enzyme	NN	I_Disease
phenylalanine	NN	I_Disease
hydroxylase	NN	E_Disease
(	(	O
PAH	NNP	O
;	:	O
phenylalanine	NN	O
4	CD	O
-	:	O
monooxygenase	NN	O
,	,	O
EC	NNP	O
1	CD	O
.	.	O

14	CD	O
.	.	O

16	CD	O
.	.	O

1	CD	O
)	)	O
.	.	O

A	DT	O
cDNA	NN	O
clone	NN	O
for	IN	O
human	JJ	O
PAH	NNP	O
has	VBZ	O
previously	RB	O
been	VBN	O
used	VBN	O
to	TO	O
assign	VB	O
the	DT	O
corresponding	JJ	O
gene	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
12	CD	O
.	.	O

To	TO	O
define	VB	O
the	DT	O
regional	JJ	O
map	JJ	O
position	NN	O
of	IN	O
the	DT	O
disease	NN	O
locus	NN	O
and	CC	O
the	DT	O
PAH	NNP	O
gene	NN	O
on	IN	O
human	JJ	O
chromosome	NN	O
12	CD	O
,	,	O
DNA	NNP	O
was	VBD	O
isolated	VBN	O
from	IN	O
human	JJ	O
-	:	O
hamster	NN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
with	IN	O
various	JJ	O
deletions	NNS	O
of	IN	O
human	JJ	O
chromosome	NN	O
12	CD	O
and	CC	O
was	VBD	O
analyzed	VBN	O
by	IN	O
Southern	NNP	O
blot	NN	O
analysis	NN	O
using	VBG	O
the	DT	O
human	JJ	O
cDNA	NN	O
PAH	NNP	O
clone	NN	O
as	IN	O
a	DT	O
hybridization	NN	O
probe	NN	O
.	.	O

From	IN	O
these	DT	O
results	NNS	O
,	,	O
together	RB	O
with	IN	O
detailed	JJ	O
biochemical	JJ	O
and	CC	O
cytogenetic	JJ	O
characterization	NN	O
of	IN	O
the	DT	O
hybrid	JJ	O
cells	NNS	O
,	,	O
the	DT	O
region	NN	O
on	IN	O
chromosome	NN	O
12	CD	O
containing	VBG	O
the	DT	O
human	JJ	O
PAH	NNP	O
gene	NN	O
has	VBZ	O
been	VBN	O
defined	VBN	O
as	IN	O
12q14	CD	O
.	.	O

3	LS	O
-	:	O
-	:	O
-	:	O
-	:	O
qter	NN	O
3	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
qter	NN	O
.	.	O

The	DT	O
PAH	NNP	O
map	MD	O
position	NN	O
on	IN	O
chromosome	NN	O
12	CD	O
was	VBD	O
further	RB	O
localized	VBN	O
by	IN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
of	IN	O
125I	CD	O
-	:	O
labeled	VBN	O
human	JJ	O
PAH	NNP	O
cDNA	NN	O
to	TO	O
chromosomes	NNS	O
prepared	VBN	O
from	IN	O
a	DT	O
human	JJ	O
lymphoblastoid	NN	O
cell	NN	O
line	NN	O
.	.	O

Results	NNS	O
of	IN	O
these	DT	O
experiments	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
region	NN	O
on	IN	O
chromosome	NN	O
12	CD	O
containing	VBG	O
the	DT	O
PAH	NNP	O
gene	NN	O
and	CC	O
the	DT	O
PKU	NNP	S_Disease
locus	NN	O
in	IN	O
man	NN	O
is	VBZ	O
12q22	CD	O
-	:	O
-	:	O
-	:	O
-	:	O
12q24	CD	O
.	.	O

1	CD	O
.	.	O

These	DT	O
results	NNS	O
not	RB	O
only	RB	O
provide	VB	O
a	DT	O
regionalized	JJ	O
map	NN	O
position	NN	O
for	IN	O
a	DT	O
major	JJ	O
human	JJ	O
disease	NN	O
locus	NN	O
but	CC	O
also	RB	O
can	MD	O
serve	VB	O
as	IN	O
a	DT	O
reference	NN	O
point	NN	O
for	IN	O
linkage	NN	O
analysis	NN	O
with	IN	O
other	JJ	O
DNA	NNP	O
markers	NNS	O
on	IN	O
human	JJ	O
chromosome	NN	O
12	CD	O

Heterogeneity	NN	O
of	IN	O
type	NN	B_Disease
I	PRP	I_Disease
von	VBP	I_Disease
Willebrand	JJ	I_Disease
disease	NN	E_Disease
:	:	O
evidence	NN	O
for	IN	O
a	DT	O
subgroup	NN	O
with	IN	O
an	DT	O
abnormal	JJ	O
von	NN	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
.	.	O

Type	NN	B_Disease
I	PRP	I_Disease
von	VBP	I_Disease
Willebrand	NNP	I_Disease
disease	NN	E_Disease
(	(	O
vWD	NN	S_Disease
)	)	O
is	VBZ	O
characterized	VBN	O
by	IN	O
equally	RB	O
low	JJ	O
plasma	JJ	O
concentrations	NNS	O
of	IN	O
von	NN	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
antigen	NN	O
(	(	O
vWF	JJ	O
Ag	NNP	O
)	)	O
and	CC	O
ristocetin	JJ	O
cofactor	NN	O
(	(	O
RiCof	NNP	O
)	)	O
and	CC	O
by	IN	O
the	DT	O
presence	NN	O
of	IN	O
all	DT	O
vWF	NN	O
multimers	NNS	O
in	IN	O
sodium	NN	O
dodecyl	NN	O
sulfate	NN	O
(	(	O
SDS	NNP	O
)	)	O
-	:	O
agarose	JJ	O
gel	JJ	O
electrophoresis	NN	O
.	.	O

For	IN	O
17	CD	O
patients	NNS	O
(	(	O
13	CD	O
kindreds	NNS	O
)	)	O
diagnosed	VBD	O
with	IN	O
these	DT	O
criteria	NNS	O
,	,	O
we	PRP	O
have	VBP	O
studied	VBN	O
the	DT	O
platelet	NN	O
contents	NNS	O
of	IN	O
vWF	NN	O
Ag	NNP	O
and	CC	O
RiCof	NNP	O
and	CC	O
the	DT	O
changes	NNS	O
of	IN	O
these	DT	O
in	IN	O
plasma	NN	O
after	IN	O
DDAVP	NNP	O
infusion	NN	O
.	.	O

Platelet	NNP	O
vWF	NN	O
Ag	NNP	O
and	CC	O
RiCof	NNP	O
were	VBD	O
normal	JJ	O
in	IN	O
four	CD	O
kindreds	NNS	O
(	(	O
called	VBN	O
"	RB	O
platelet	NN	O
normal	JJ	O
"	NNP	O
subgroup	NN	O
)	)	O
;	:	O
following	VBG	O
1	CD	O
-	:	O
deamino	NN	O
-	:	O
8	CD	O
-	:	O
D	NNP	O
-	:	O
arginine	NN	O
vasopressin	NN	O
;	:	O
plasma	CC	O
vWF	FW	O
Ag	NNP	O
,	,	O
RiCof	NNP	O
and	CC	O
the	DT	O
bleeding	NN	O
time	NN	O
(	(	O
BT	NNP	O
)	)	O
became	VBD	O
normal	JJ	O
.	.	O

In	IN	O
six	CD	O
kindreds	NNS	O
,	,	O
platelet	NN	O
vWF	NN	O
Ag	NNP	O
and	CC	O
RiCof	NNP	O
were	VBD	O
equally	RB	O
low	JJ	O
(	(	O
platelet	VB	O
low	JJ	O
)	)	O
;	:	O
after	IN	O
DDAVP	NNP	O
,	,	O
plasma	NN	O
vWF	NN	O
Ag	NNP	O
and	CC	O
RiCof	NNP	O
remained	VBD	O
low	JJ	O
,	,	O
and	CC	O
the	DT	O
BT	NNP	O
was	VBD	O
prolonged	VBN	O
.	.	O

In	IN	O
three	CD	O
additional	JJ	O
kindreds	NNS	O
,	,	O
platelets	NNS	O
contained	VBD	O
normal	JJ	O
concentrations	NNS	O
of	IN	O
vWF	NN	O
Ag	NNP	O
,	,	O
but	CC	O
RiCof	NNP	O
was	VBD	O
very	RB	O
low	JJ	O
(	(	O
platelet	VB	O
discordant	NN	O
)	)	O
;	:	O
even	RB	O
though	IN	O
a	DT	O
complete	JJ	O
set	NN	O
of	IN	O
multimers	NNS	O
was	VBD	O
found	VBN	O
in	IN	O
plasma	NN	O
and	CC	O
platelets	NNS	O
,	,	O
there	EX	O
was	VBD	O
a	DT	O
relatively	RB	O
small	JJ	O
amount	NN	O
of	IN	O
large	JJ	O
multimers	NNS	O
.	.	O

After	IN	O
DDAVP	NNP	O
,	,	O
plasma	NN	O
vWF	NN	O
Ag	NNP	O
became	VBD	O
normal	JJ	O
,	,	O
but	CC	O
RiCof	NNP	O
remained	VBD	O
low	JJ	O
and	CC	O
the	DT	O
BT	NNP	O
was	VBD	O
very	RB	O
prolonged	JJ	O
.	.	O

These	DT	O
findings	NNS	O
demonstrated	VBD	O
that	IN	O
there	EX	O
can	MD	O
be	VB	O
an	DT	O
abnormal	JJ	O
vWF	NN	O
(	(	O
RiCof	NNP	O
less	JJR	O
than	IN	O
vWF	FW	O
Ag	NNP	O
)	)	O
even	RB	O
in	IN	O
type	NN	B_Disease
I	PRP	I_Disease
vWD	VBP	E_Disease
,	,	O
coexisting	VBG	O
with	IN	O
a	DT	O
complete	JJ	O
set	NN	O
of	IN	O
vWF	NN	O
multimers	NNS	O
(	(	O
platelet	VB	O
discordant	NN	O
)	)	O
;	:	O
that	IN	O
the	DT	O
abnormal	JJ	O
vWF	NN	O
can	MD	O
be	VB	O
shown	VBN	O
more	JJR	O
clearly	RB	O
in	IN	O
platelets	NNS	O
than	IN	O
in	IN	O
plasma	NN	O
or	CC	O
else	RB	O
in	IN	O
plasma	NN	O
after	IN	O
DDAVP	NNP	O
infusion	NN	O
;	:	O
and	CC	O
that	IN	O
DDAVP	NNP	O
normalizes	VBZ	O
the	DT	O
BT	NNP	O
only	RB	O
in	IN	O
those	DT	O
patients	NNS	O
with	IN	O
normal	JJ	O
platelet	NN	O
levels	NNS	O
of	IN	O
both	DT	O
vWF	NNP	O
Ag	NNP	O
and	CC	O
RiCof	NNP	O
(	(	O
platelet	VB	O
normal	JJ	O
)	)	O
.	.	O
.	.	O

Genetic	JJ	O
analysis	NN	O
in	IN	O
families	NNS	O
with	IN	O
van	JJ	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
brought	VBN	O
together	RB	O
information	NN	O
on	IN	O
864	CD	O
affected	JJ	O
individuals	NNS	O
in	IN	O
164	CD	O
families	NNS	O
(	(	O
including	VBG	O
three	CD	O
new	JJ	O
pedigrees	NNS	O
)	)	O
reported	VBD	O
in	IN	O
the	DT	O
137	CD	O
year	NN	O
period	NN	O
since	IN	O
1845	CD	O
when	WRB	O
Demarquay	NNP	O
first	RB	O
described	VBD	O
a	DT	O
family	NN	O
with	IN	O
what	WP	O
was	VBD	O
later	RB	O
called	VBN	O
van	NN	B_Disease
der	NN	I_Disease
Woude	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
VWS	NNP	S_Disease
)	)	O
.	.	O

Both	DT	O
types	NNS	O
of	IN	O
oral	JJ	B_Disease
cleft	NN	E_Disease
,	,	O
cleft	NN	B_Disease
palate	NN	E_Disease
(	(	O
CP	NNP	S_Disease
)	)	O
and	CC	O
cleft	$	B_Disease
lip	NN	E_Disease
with	IN	O
or	CC	O
without	IN	O
CP	NNP	S_Disease
(	(	O
CLP	NNP	S_Disease
)	)	O
,	,	O
segregate	VBP	O
in	IN	O
these	DT	O
families	NNS	O
together	RB	O
with	IN	O
lower	JJR	O
lip	NN	B_Disease
pits	NNS	E_Disease
or	CC	O
fistulae	NN	S_Disease
in	IN	O
an	DT	O
autosomal	JJ	O
dominant	JJ	O
mode	NN	O
with	IN	O
high	JJ	O
penetrance	NN	O
estimated	VBN	O
to	TO	O
be	VB	O
K	NNP	O
=	NNP	O
.	.	O

89	CD	O
and	CC	O
.	.	O

99	CD	O
by	IN	O
different	JJ	O
methods	NNS	O
.	.	O

Cleft	NNP	O
types	NNS	O
(	(	O
CLP	NNP	S_Disease
and	CC	O
CP	NNP	S_Disease
)	)	O
occur	VBP	O
in	IN	O
VWS	NNP	S_Disease
in	IN	O
the	DT	O
same	JJ	O
proportions	NNS	O
as	IN	O
in	IN	O
the	DT	O
general	JJ	O
non	NN	O
-	:	O
VWS	NNP	O
population	NN	O
,	,	O
ie	NN	O
,	,	O
about	RB	O
twice	RB	O
as	RB	O
many	JJ	O
cleft	SYM	O
-	:	O
bearing	NN	O
individuals	NNS	O
have	VBP	O
CLP	VBN	S_Disease
as	IN	O
have	JJ	O
CP	NNP	S_Disease
.	.	O

On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
we	PRP	O
do	VBP	O
not	RB	O
find	VB	O
the	DT	O
usually	RB	O
observed	JJ	O
excess	NN	O
of	IN	O
females	NNS	O
with	IN	O
CP	NNP	S_Disease
and	CC	O
excess	NN	O
of	IN	O
males	NNS	O
with	IN	O
CLP	NNP	S_Disease
;	:	O
in	IN	O
VWS	NNP	S_Disease
the	DT	O
sex	NN	O
ratios	NNS	O
are	VBP	O
more	JJR	O
nearly	RB	O
equal	JJ	O
.	.	O

Lip	NNP	B_Disease
pits	NNS	E_Disease
also	RB	O
are	VBP	O
equally	RB	O
distributed	VBN	O
between	IN	O
the	DT	O
sexes	NNS	O
.	.	O

Affected	JJ	O
males	NNS	O
and	CC	O
females	NNS	O
are	VBP	O
equally	RB	O
likely	JJ	O
to	TO	O
transmit	VB	O
VWS	NNP	S_Disease
.	.	O

However	RB	O
,	,	O
there	EX	O
is	VBZ	O
an	DT	O
excess	NN	O
of	IN	O
less	RBR	O
severely	RB	O
affected	JJ	O
individuals	NNS	O
among	IN	O
transmitters	NNS	O
and	CC	O
a	DT	O
deficiency	NN	O
of	IN	O
more	RBR	O
severely	RB	O
affected	JJ	O
,	,	O
brought	VBN	O
about	IN	O
by	IN	O
a	DT	O
proband	NN	O
bias	NN	O
and	CC	O
differential	JJ	O
fecundity	NN	O
.	.	O

The	DT	O
expression	NN	O
of	IN	O
VWS	NNP	S_Disease
is	VBZ	O
significantly	RB	O
modified	VBN	O
by	IN	O
the	DT	O
genetic	JJ	O
background	NN	O
More	RBR	O
extreme	JJ	O
phenotypes	NNS	O
in	IN	O
parents	NNS	O
tend	VBP	O
to	TO	O
produce	VB	O
more	JJR	O
extreme	JJ	O
expression	NN	O
in	IN	O
their	PRP$	O
children	NNS	O
.	.	O

For	IN	O
a	DT	O
VWS	NNP	S_Disease
gene	NN	O
carrier	NN	O
the	DT	O
relative	JJ	O
risk	NN	O
of	IN	O
transmitting	VBG	O
a	DT	O
cleft	NN	O
is	VBZ	O
26	CD	O
.	.	O

45	CD	O
%	NN	O
;	:	O
that	IN	O
of	IN	O
transmitting	VBG	O
lower	JJR	O
lip	NN	B_Disease
pits	NNS	E_Disease
is	VBZ	O
23	CD	O
.	.	O

55	CD	O
%	NN	O
.	.	O

Three	CD	O
pedigrees	NNS	O
of	IN	O
lip	NN	B_Disease
pits	NNS	E_Disease
in	IN	O
the	DT	O
literature	NN	O
show	NN	O
no	DT	O
clefts	NN	O
among	IN	O
a	DT	O
significant	JJ	O
number	NN	O
of	IN	O
affected	JJ	O
individuals	NNS	O
.	.	O

Control	NN	O
of	IN	O
gene	NN	O
expression	NN	O
in	IN	O
VWS	NNP	S_Disease
in	IN	O
the	DT	O
three	CD	O
target	NN	O
tissues	NNS	O
appears	VBZ	O
to	TO	O
be	VB	O
independent	JJ	O
and	CC	O
separately	RB	O
designated	VBN	O
.	.	O

Mutation	NNP	O
rate	NN	O
of	IN	O
the	DT	O
VWS	NNP	S_Disease
gene	NN	O
is	VBZ	O
calculated	VBN	O
to	TO	O
be	VB	O
1	CD	O
.	.	O

8	CD	O
X	$	O
10	CD	O
(	(	O
-	:	O
5	CD	O
)	)	O

Hereditary	NNP	B_Disease
C7	NNP	I_Disease
deficiency	NN	E_Disease
.	.	O

Diagnosis	NN	O
and	CC	O
HLA	NNP	O
studies	NNS	O
in	IN	O
a	DT	O
French	JJ	O
-	:	O
Canadian	JJ	O
family	NN	O
.	.	O

The	DT	O
serum	NN	O
of	IN	O
a	DT	O
44	CD	O
-	:	O
yr	NN	O
-	:	O
old	JJ	O
woman	NN	O
of	IN	O
French	NNP	O
-	:	O
Canadian	JJ	O
descent	NN	O
having	VBG	O
a	DT	O
B	NNP	O
-	:	O
27	CD	O
positive	JJ	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
was	VBD	O
deficient	NN	B_Disease
in	IN	I_Disease
the	DT	I_Disease
seventh	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
(	(	O
C7	NNP	O
)	)	O
as	IN	O
determined	VBN	O
by	IN	O
hemolytic	JJ	O
and	CC	O
immunochemical	JJ	O
methods	NNS	O
.	.	O

No	DT	O
inhibitor	NN	O
against	IN	O
C7	NNP	O
was	VBD	O
detected	VBN	O
,	,	O
and	CC	O
the	DT	O
levels	NNS	O
of	IN	O
all	DT	O
other	JJ	O
complement	JJ	O
components	NNS	O
were	VBD	O
normal	JJ	O
.	.	O

No	DT	O
deficiency	NN	O
in	IN	O
the	DT	O
opsonic	JJ	O
activity	NN	O
of	IN	O
the	DT	O
serum	NN	O
was	VBD	O
found	VBN	O
,	,	O
and	CC	O
the	DT	O
results	NNS	O
of	IN	O
basic	JJ	O
coagulation	NN	O
studies	NNS	O
of	IN	O
the	DT	O
plasma	NN	O
were	VBD	O
normal	JJ	O
.	.	O

On	IN	O
investigation	NN	O
of	IN	O
the	DT	O
patients	NNS	O
family	NN	O
,	,	O
two	CD	O
sisters	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
the	DT	O
same	JJ	O
deficiency	NN	O
but	CC	O
were	VBD	O
otherwise	RB	O
in	IN	O
good	JJ	O
health	NN	O
.	.	O

The	DT	O
seven	CD	O
other	JJ	O
siblings	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
C7	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
while	IN	O
the	DT	O
paternal	JJ	O
aunt	NN	O
had	VBD	O
a	DT	O
normal	JJ	O
C7	NNP	O
level	NN	O
.	.	O

In	IN	O
the	DT	O
third	JJ	O
generation	NN	O
,	,	O
six	CD	O
children	NNS	O
of	IN	O
the	DT	O
three	CD	O
homozygous	JJ	O
sisters	NNS	O
and	CC	O
five	CD	O
children	NNS	O
of	IN	O
heterozygotes	NNS	O
were	VBD	O
available	JJ	O
for	IN	O
testing	VBG	O
.	.	O

Studies	NNS	O
of	IN	O
the	DT	O
HLA	NNP	O
antigens	NNS	O
in	IN	O
all	PDT	O
the	DT	O
22	CD	O
subjects	NNS	O
and	CC	O
in	IN	O
three	CD	O
spouses	NNS	O
indicated	VBD	O
no	DT	O
close	JJ	O
linkage	NN	O
between	IN	O
the	DT	O
CM	NNP	B_Disease
deficienty	NN	E_Disease
and	CC	O
the	DT	O
HLA	NNP	O
system	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
simultaneous	JJ	O
occurrence	NN	O
of	IN	O
two	CD	O
hereditary	JJ	O
complement	NN	B_Disease
deficiencies	NNS	I_Disease
(	(	I_Disease
C2	NNP	I_Disease
and	CC	I_Disease
C7	NNP	I_Disease
)	)	E_Disease
was	VBD	O
discovered	VBN	O
in	IN	O
one	CD	O
family	NN	O
of	IN	O
this	DT	O
remarkable	JJ	O
kindred	VBN	O
.	.	O
.	.	O

Genetic	JJ	O
defect	NN	B_Disease
in	IN	I_Disease
secretion	NN	I_Disease
of	IN	I_Disease
complement	NN	I_Disease
C5	NNP	E_Disease
in	IN	O
mice	NN	O
.	.	O

A	DT	O
genetic	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
fifth	NN	I_Disease
(	(	I_Disease
C5	NNP	I_Disease
)	)	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement1	NN	I_Disease
-	:	I_Disease
3	CD	E_Disease
,	,	O
a	DT	O
serum	JJ	O
glycoprotein	NN	O
of	IN	O
molecular	JJ	O
weight	NN	O
(	(	O
MW	NNP	O
)	)	O
220	CD	O
,	,	O
000	CD	O
(	(	O
ref	NN	O
.	.	O

4	CD	O
)	)	O
,	,	O
has	VBZ	O
been	VBN	O
found	VBN	O
in	IN	O
39	CD	O
%	NN	O
of	IN	O
inbred	JJ	O
strains	NNS	O
of	IN	O
mice3	NN	O
.	.	O

Sera	NN	O
of	IN	O
deficient	JJ	O
mice	NNS	O
lack	VBP	O
detectable	JJ	O
C5	NNP	O
activity	NN	O
and	CC	O
protein2	NN	O
,	,	O
3	CD	O
.	.	O

In	IN	O
addition	NN	O
deficient	NN	O
mice	NN	O
produce	VBP	O
antibody	NN	O
to	TO	O
mouse	VB	O
C5	NNP	O
when	WRB	O
injected	VBN	O
with	IN	O
sera	NN	O
from	IN	O
C5	NNP	O
sufficient	NN	O
(	(	O
normal	JJ	O
)	)	O
strains	NNS	O
.	.	O

Levy	NNP	O
et	CC	O
al	NN	O
.	.	O

5	CD	O
showed	VBD	O
that	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
between	IN	O
C5	NNP	O
deficient	NN	O
(	(	O
B10	NNP	O
.	.	O

D2	NNP	O
/	NNP	O
old	JJ	O
line	NN	O
)	)	O
macrophages	NNS	O
and	CC	O
either	DT	O
C5	NNP	O
sufficient	NN	O
(	(	O
B10	NNP	O
.	.	O

D2	NNP	O
/	NNP	O
new	JJ	O
line	NN	O
)	)	O
mouse	NN	O
kidney	NN	O
or	CC	O
chicken	NN	O
erythroblasts	NNS	O
secreted	VBD	O
haemolytically	RB	O
active	JJ	O
mouse	NN	O
C5	NNP	O
in	IN	O
vitro	NN	O
.	.	O

Several	JJ	O
possible	JJ	O
molecular	JJ	O
mechanisms	NNS	O
to	TO	O
account	VB	O
for	IN	O
the	DT	O
findings	NNS	O
were	VBD	O
considered	VBN	O
,	,	O
but	CC	O
insufficient	JJ	O
direct	JJ	O
data	NNS	O
were	VBD	O
available	JJ	O
to	TO	O
choose	VB	O
among	IN	O
them	PRP	O
.	.	O

We	PRP	O
recently	RB	O
reported	VBD	O
that	IN	O
mouse	NN	O
(	(	O
CD	NN	O
.	.	O

1	CD	O
strain	NN	O
)	)	O
peritoneal	NN	O
cells	NNS	O
in	IN	O
culture	NN	O
synthesise	NN	O
and	CC	O
secrete	VB	O
a	DT	O
single	JJ	O
chain	NN	O
precursor	NN	O
,	,	O
pro	FW	O
-	:	O
C5	NN	O
(	(	O
MW	NNP	O
approximately	RB	O
210	CD	O
,	,	O
000	CD	O
)	)	O
,	,	O
of	IN	O
the	DT	O
two	CD	O
-	:	O
chain	NN	O
(	(	O
alpha	JJ	O
chain	NN	O
,	,	O
125	CD	O
,	,	O
000	CD	O
and	CC	O
beta	NN	O
chain	NN	O
83	CD	O
,	,	O
000	CD	O
MW	NNP	O
)	)	O
C5	NNP	O
protein6	NN	O
.	.	O

Radiolabelled	VBN	O
precursor	NN	O
C5	NNP	O
was	VBD	O
contained	VBN	O
within	IN	O
the	DT	O
cells	NNS	O
and	CC	O
was	VBD	O
secreted	VBN	O
into	IN	O
the	DT	O
tissue	NN	O
culture	NN	O
media	NNS	O
.	.	O

Using	VBG	O
similar	JJ	O
methods	NNS	O
,	,	O
we	PRP	O
now	RB	O
find	VBP	O
that	IN	O
C5	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
each	DT	O
of	IN	O
five	CD	O
different	JJ	O
mouse	NN	O
strains	NNS	O
(	(	O
AKR	NNP	O
,	,	O
SWR	NNP	O
,	,	O
DBA	NNP	O
/	VBZ	O
2J8	CD	O
A	NNP	O
/	NNP	O
HeJ	NNP	O
and	CC	O
B10	NNP	O
.	.	O

D2	NNP	O
/	NNP	O
old	JJ	O
line	NN	O
)	)	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
failure	NN	O
in	IN	O
secretion	NN	O
of	IN	O
C5	NNP	O
protein	NN	O
and	CC	O
not	RB	O
to	TO	O
a	DT	O
failure	NN	O
in	IN	O
biosynthesis	NN	O
of	IN	O
pro	JJ	O
-	:	O
C5	NN	O

Recurrent	NNP	O
meningococcal	JJ	B_Disease
meningitis	NN	E_Disease
with	IN	O
absence	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
sixth	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
:	:	O
an	DT	O
evaluation	NN	O
of	IN	O
underlying	VBG	O
immunologic	JJ	O
mechanisms	NNS	O
.	.	O

A	DT	O
51	CD	O
/	NN	O
2	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
black	JJ	O
girl	NN	O
with	IN	O
recurrent	JJ	O
meningococcal	JJ	B_Disease
meningitis	NN	E_Disease
and	CC	O
absence	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
sixth	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
(	(	O
C6	NNP	O
)	)	O
is	VBZ	O
reported	VBN	O
.	.	O

To	TO	O
explore	VB	O
the	DT	O
pathogenesis	NN	O
of	IN	O
recurrent	JJ	O
neisserial	JJ	B_Disease
infections	NNS	E_Disease
in	IN	O
C6	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
a	DT	O
detailed	JJ	O
analysis	NN	O
of	IN	O
her	PRP$	O
immune	JJ	O
competence	NN	O
was	VBD	O
conducted	VBN	O
.	.	O

Her	PRP$	O
serum	NN	O
had	VBD	O
normal	JJ	O
chemotactic	JJ	O
,	,	O
opsonic	JJ	O
,	,	O
alternative	JJ	O
complement	NN	O
pathway	NN	O
,	,	O
and	CC	O
specific	JJ	O
antibody	NN	O
activity	NN	O
,	,	O
but	CC	O
lacked	VBD	O
complement	JJ	O
-	:	O
mediated	VBN	O
bacteriolytic	JJ	O
activity	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
her	PRP$	O
C6	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
serum	NN	O
was	VBD	O
indistinguishable	JJ	O
from	IN	O
normal	JJ	O
serum	NN	O
in	IN	O
a	DT	O
complement	NN	O
-	:	O
dependent	JJ	O
assay	NN	O
of	IN	O
phagocyte	JJ	O
bactericidal	NN	O
activity	NN	O
.	.	O

Absent	JJ	O
bacteriolysis	NN	O
remains	VBZ	O
the	DT	O
only	JJ	O
consistent	JJ	O
defect	NN	O
associated	VBN	O
with	IN	O
recurrent	JJ	O
neisserial	JJ	B_Disease
infections	NNS	E_Disease
and	CC	O
absence	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
late	JJ	O
-	:	O
acting	VBG	O
complement	NN	O
components	NNS	O
.	.	O
.	.	O

Deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
fifth	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
in	IN	O
human	JJ	O
subjects	NNS	O
.	.	O

Clinical	NNP	O
,	,	O
genetic	JJ	O
and	CC	O
immunologic	JJ	O
studies	NNS	O
in	IN	O
a	DT	O
large	JJ	O
kindred	VBN	O
.	.	O

The	DT	O
discovery	NN	O
of	IN	O
a	DT	O
large	JJ	O
kindred	VBN	O
with	IN	O
a	DT	O
heritable	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
fifth	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
(	(	O
C5	NNP	O
)	)	O
has	VBZ	O
permitted	VBN	O
the	DT	O
accumulation	NN	O
of	IN	O
new	JJ	O
clinical	JJ	O
,	,	O
genetic	JJ	O
and	CC	O
immunologic	JJ	O
data	NNS	O
concerning	VBG	O
the	DT	O
role	NN	O
of	IN	O
C5	NNP	O
in	IN	O
human	JJ	O
subjects	NNS	O
.	.	O

The	DT	O
proband	NN	O
,	,	O
who	WP	O
has	VBZ	O
had	VBN	O
nine	CD	O
episodes	NNS	O
of	IN	O
disseminated	JJ	O
gonococcal	JJ	B_Disease
infection	NN	E_Disease
,	,	O
has	VBZ	O
a	DT	O
hemolytic	JJ	O
C5	NNP	O
level	NN	O
of	IN	O
approximately	RB	O
0	CD	O
.	.	O

5	CD	O
per	IN	O
cent	NN	O
of	IN	O
normal	JJ	O
.	.	O

No	DT	O
C5	NNP	O
protein	NN	O
was	VBD	O
detectable	JJ	O
,	,	O
but	CC	O
low	JJ	O
levels	NNS	O
of	IN	O
functional	JJ	O
C5	NNP	O
activity	NN	O
could	MD	O
be	VB	O
found	VBN	O
using	VBG	O
a	DT	O
sensitive	JJ	O
bactericidal	NN	O
assay	NN	O
.	.	O

The	DT	O
probands	NNS	O
twin	VBP	O
as	RB	O
well	RB	O
as	IN	O
another	DT	O
sister	NN	O
also	RB	O
had	VBD	O
extremely	RB	O
low	JJ	O
levels	NNS	O
of	IN	O
hemolytic	JJ	O
C5	NNP	O
(	(	O
approximately	RB	O
0	CD	O
.	.	O

5	CD	O
per	IN	O
cent	NN	O
normal	JJ	O
)	)	O
,	,	O
but	CC	O
both	DT	O
these	DT	O
subjects	NNS	O
have	VBP	O
been	VBN	O
healthy	JJ	O
.	.	O

Hemolytic	JJ	O
complement	NN	O
and	CC	O
bacteriolytic	JJ	O
activity	NN	O
could	MD	O
be	VB	O
restored	VBN	O
by	IN	O
the	DT	O
addition	NN	O
of	IN	O
purified	JJ	O
C5	NNP	O
.	.	O

No	DT	O
chemotactic	JJ	O
activity	NN	O
for	IN	O
polymorphonuclear	NN	O
leukocytes	NNS	O
could	MD	O
be	VB	O
generated	VBN	O
in	IN	O
the	DT	O
C5	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
serums	NNS	O
upon	IN	O
activation	NN	O
of	IN	O
either	CC	O
the	DT	O
classic	JJ	O
or	CC	O
alternative	JJ	O
pathways	NNS	O
,	,	O
again	RB	O
demonstrating	VBG	O
the	DT	O
importance	NN	O
of	IN	O
C5	NNP	O
in	IN	O
human	JJ	O
subjects	NNS	O
for	IN	O
the	DT	O
production	NN	O
of	IN	O
chemotactic	JJ	O
factors	NNS	O
.	.	O

The	DT	O
chemotactic	JJ	O
responsiveness	NN	O
of	IN	O
the	DT	O
patients	NNS	O
polymorphonuclear	VBP	O
leukocytes	NNS	O
and	CC	O
monocytes	NNS	O
to	TO	O
preformed	VB	O
chemotactic	JJ	O
factors	NNS	O
was	VBD	O
not	RB	O
depressed	VBN	O
.	.	O

Twenty	CD	O
-	:	O
two	CD	O
of	IN	O
32	CD	O
other	JJ	O
family	NN	O
members	NNS	O
from	IN	O
three	CD	O
generations	NNS	O
had	VBD	O
depressed	VBN	O
whole	JJ	O
hemolytic	JJ	O
complement	NN	O
levels	NNS	O
.	.	O

In	IN	O
19	CD	O
of	IN	O
30	CD	O
family	NN	O
members	NNS	O
,	,	O
levels	NNS	O
of	IN	O
hemolytic	JJ	O
C5	NNP	O
ranged	VBD	O
from	IN	O
13	CD	O
to	TO	O
64	CD	O
per	IN	O
cent	NN	O
of	IN	O
normal	JJ	O
.	.	O

No	DT	O
linkage	NN	O
for	IN	O
C5	NNP	B_Disease
deficiency	NN	E_Disease
and	CC	O
the	DT	O
A	NNP	O
or	CC	O
B	NNP	O
loci	NN	O
of	IN	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
complex	NN	O
could	MD	O
be	VB	O
found	VBN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
an	DT	O
autosomal	JJ	O
codominant	NN	O
mode	NN	O
of	IN	O
inheritance	NN	O
of	IN	O
C5	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Deficiency	NN	B_Disease
of	IN	I_Disease
C5	NNP	E_Disease
is	VBZ	O
compatible	JJ	O
with	IN	O
good	JJ	O
health	NN	O
,	,	O
but	CC	O
it	PRP	O
can	MD	O
be	VB	O
associated	VBN	O
with	IN	O
repeated	VBN	O
disseminated	JJ	O
gonococcal	JJ	B_Disease
infection	NN	E_Disease

Incidence	NN	O
and	CC	O
characteristics	NNS	O
of	IN	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
variants	NNS	O
in	IN	O
Japan	NNP	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
3000	CD	O
men	NNS	O
living	VBG	O
in	IN	O
Yamaguchi	NNP	O
were	VBD	O
screened	VBN	O
for	IN	O
glucose	JJ	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
using	VBG	O
Beutlers	NNP	O
spot	NN	O
test	NN	O
and	CC	O
three	CD	O
types	NNS	O
of	IN	O
starch	NN	O
gel	NN	O
electrophoresis	NN	O
.	.	O

These	DT	O
electrophoresis	NN	O
used	VBD	O
a	DT	O
phosphate	NN	O
buffer	NN	O
system	NN	O
at	IN	O
pH	JJ	O
7	CD	O
.	.	O

0	CD	O
,	,	O
a	DT	O
TRIS	NNP	O
-	:	O
EDTA	NNP	O
-	:	O
borate	NN	O
buffer	NN	O
system	NN	O
at	IN	O
pH	JJ	O
8	CD	O
.	.	O

6	CD	O
,	,	O
and	CC	O
a	DT	O
TRIS	NNP	O
-	:	O
hydrochloride	NN	O
buffer	NN	O
system	NN	O
at	IN	O
pH	JJ	O
8	CD	O
.	.	O
.	.	O

Fifteen	NNP	O
G6PD	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
variants	NNS	O
were	VBD	O
found	VBN	O
at	IN	O
the	DT	O
rate	NN	O
of	IN	O
0	CD	O
.	.	O

5	CD	O
%	NN	O
and	CC	O
classified	VBD	O
into	IN	O
four	CD	O
groups	NNS	O
.	.	O

As	IN	O
new	JJ	O
variants	NNS	O
,	,	O
G6PD	NNP	O
Konan	NNP	O
,	,	O
Kamiube	NNP	O
,	,	O
and	CC	O
Kiwa	NNP	O
were	VBD	O
identified	VBN	O
.	.	O

These	DT	O
three	CD	O
variants	NNS	O
had	VBD	O
a	DT	O
mild	JJ	O
to	TO	O
moderate	VB	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
and	CC	O
were	VBD	O
not	RB	O
associated	VBN	O
with	IN	O
any	DT	O
clinical	JJ	O
signs	NNS	O
.	.	O

G6PD	NNP	O
Konan	NNP	O
had	VBD	O
fast	VBN	O
electrophoretic	JJ	O
mobility	NN	O
as	IN	O
compared	VBN	O
with	IN	O
normal	JJ	O
levels	NNS	O
,	,	O
G6PD	NNP	O
Kiwa	NNP	O
had	VBD	O
slightly	RB	O
elevated	VBN	O
electrophoretic	JJ	O
mobility	NN	O
,	,	O
and	CC	O
G6PD	NNP	O
Kamiube	NNP	O
had	VBD	O
normal	JJ	O
electrophoretic	JJ	O
mobility	NN	O
.	.	O

These	DT	O
three	CD	O
variants	NNS	O
had	VBD	O
normal	JJ	O
levels	NNS	O
of	IN	O
Km	NNP	O
G6P	NNP	O
,	,	O
Km	NNP	O
NADP	NNP	O
,	,	O
and	CC	O
Ki	NNP	O
NADPH	NNP	O
,	,	O
normal	JJ	O
utilizations	NNS	O
of	IN	O
both	DT	O
2	CD	O
-	:	O
deoxy	NN	O
-	:	O
G6P	NNP	O
and	CC	O
deamino	NN	O
-	:	O
NAPD	NNP	O
,	,	O
normal	JJ	O
heat	NN	O
stability	NN	O
,	,	O
and	CC	O
a	DT	O
normal	JJ	O
pH	NN	O
curve	NN	O
.	.	O

The	DT	O
other	JJ	O
variant	NN	O
was	VBD	O
G6PD	NNP	O
Ube	NNP	O
,	,	O
which	WDT	O
we	PRP	O
had	VBD	O
previously	RB	O
found	VBN	O
in	IN	O
Yamaguchi	NNP	O
(	(	O
Nakashima	NNP	O
et	RB	O
al	RB	O
.	.	O
,	,	O
1977	CD	O
)	)	O
.	.	O

One	CD	O
boy	NN	O
with	IN	O
G6PD	NNP	O
Ube	NNP	O
was	VBD	O
Korean	JJ	O

Utilization	NN	O
of	IN	O
purines	NNS	O
by	IN	O
an	DT	O
HPRT	NNP	O
variant	NN	O
in	IN	O
an	DT	O
intelligent	NN	O
,	,	O
nonmutilative	JJ	O
patient	NN	O
with	IN	O
features	NNS	O
of	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

The	DT	O
patient	NN	O
,	,	O
H	NNP	O
.	.	O

Chr	NNP	O
.	.	O

B	NNP	O
.	.	O
,	,	O
was	VBD	O
among	IN	O
the	DT	O
first	JJ	O
reported	VBD	O
with	IN	O
hyperuricemia	NN	S_Disease
and	CC	O
central	JJ	B_Disease
nervous	JJ	I_Disease
system	NN	I_Disease
symptoms	NNS	E_Disease
.	.	O

He	PRP	O
has	VBZ	O
been	VBN	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
variant	NN	O
of	IN	O
hypoxanthine	JJ	O
guanine	NN	O
phosphoribosyl	NN	O
transferase	NN	O
(	(	O
HPRT	NNP	O
;	:	O
E	NNP	O
.	.	O

C	NNP	O
.	.	O

2	CD	O
.	.	O

4	CD	O
.	.	O

2	CD	O
.	.	O

8	CD	O
)	)	O
distinct	NN	O
from	IN	O
the	DT	O
enzyme	JJ	O
present	NN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
chroeoathetosis	NN	S_Disease
,	,	O
spasticity	NN	S_Disease
,	,	O
dysarthric	JJ	B_Disease
speech	NN	E_Disease
,	,	O
and	CC	O
hyperuricemia	NN	S_Disease
.	.	O

However	RB	O
,	,	O
his	PRP$	O
intelligence	NN	O
was	VBD	O
normal	JJ	O
and	CC	O
he	PRP	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
self	NN	O
-	:	O
mutilation	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
activity	NN	O
of	IN	O
HPRT	NNP	O
in	IN	O
the	DT	O
lysates	NNS	O
of	IN	O
erythrocytes	NNS	O
and	CC	O
cultured	JJ	O
fibroblasts	NNS	O
when	WRB	O
analyzed	VBN	O
in	IN	O
the	DT	O
usual	JJ	O
manner	NN	O
.	.	O

Using	VBG	O
a	DT	O
newly	RB	O
developed	VBN	O
method	NN	O
for	IN	O
the	DT	O
study	NN	O
of	IN	O
purine	JJ	O
metabolism	NN	O
in	IN	O
intact	JJ	O
cultured	JJ	O
cells	NNS	O
,	,	O
this	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
metabolize	VB	O
some	DT	O
9	CD	O
%	NN	O
of	IN	O
8	CD	O
-	:	O
14C	CD	O
-	:	O
hypoxanthine	NN	O
,	,	O
and	CC	O
90	CD	O
%	NN	O
of	IN	O
the	DT	O
isotope	NN	O
utilized	VBD	O
was	VBD	O
converted	VBN	O
to	TO	O
adenine	VB	O
and	CC	O
guanine	VB	O
nucleotides	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
cells	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
were	VBD	O
virtually	RB	O
completely	RB	O
unable	JJ	O
to	TO	O
convert	VB	O
hypoxanthine	NN	O
to	TO	O
nucleotides	NNS	O
.	.	O

The	DT	O
patients	NNS	O
fibroblasts	NNS	O
were	VBD	O
even	RB	O
more	RBR	O
efficient	JJ	O
in	IN	O
the	DT	O
metabolism	NN	O
of	IN	O
8	CD	O
-	:	O
14C	CD	O
-	:	O
guanine	NN	O
,	,	O
which	WDT	O
was	VBD	O
utilized	VBN	O
to	TO	O
the	DT	O
extent	NN	O
of	IN	O
27	CD	O
%	NN	O
,	,	O
over	IN	O
80	CD	O
%	NN	O
of	IN	O
which	WDT	O
was	VBD	O
converted	VBN	O
to	TO	O
guanine	VB	O
and	CC	O
adenine	VB	O
nucleotides	NNS	O
.	.	O

The	DT	O
growth	NN	O
of	IN	O
the	DT	O
cultured	JJ	O
fibroblasts	NNS	O
of	IN	O
this	DT	O
patient	NN	O
was	VBD	O
intermediate	JJ	O
in	IN	O
media	NNS	O
containing	VBG	O
hypoxanthine	NN	O
aminopterin	NN	O
thymidine	NN	O
(	(	O
HAT	NNP	O
)	)	O
,	,	O
whereas	IN	O
the	DT	O
growth	NN	O
of	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	E_Disease
cells	NNS	O
was	VBD	O
inhibited	VBN	O
and	CC	O
normal	JJ	O
cells	NNS	O
grew	VBD	O
normally	RB	O
.	.	O

Similarly	RB	O
in	IN	O
8	CD	O
-	:	O
azaguanine	NN	O
,	,	O
6	CD	O
-	:	O
thioguanine	NN	O
,	,	O
and	CC	O
8	CD	O
-	:	O
azahypoxanthine	NN	O
,	,	O
the	DT	O
growth	NN	O
of	IN	O
the	DT	O
patients	NNS	O
cells	NNS	O
was	VBD	O
intermediate	JJ	O
between	IN	O
normal	JJ	O
and	CC	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	E_Disease
cells	NNS	O
.	.	O

These	DT	O
observations	NNS	O
provide	VBP	O
further	JJ	O
evidence	NN	O
for	IN	O
genetic	JJ	O
heterogeneity	NN	O
among	IN	O
patients	NNS	O
with	IN	O
disorders	NNS	O
in	IN	O
purine	JJ	O
metabolism	NN	O
involving	VBG	O
the	DT	O
HPRT	NNP	O
gene	NN	O
.	.	O

They	PRP	O
document	VBP	O
that	IN	O
this	DT	O
famous	JJ	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
the	DT	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	VB	E_Disease

Localisation	NN	O
of	IN	O
the	DT	O
Becker	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
gene	NN	O
on	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
by	IN	O
linkage	NN	O
to	TO	O
cloned	VBN	O
DNA	NNP	O
sequences	NNS	O
.	.	O

A	DT	O
linkage	NN	O
study	NN	O
in	IN	O
30	CD	O
Becker	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
BMD	NNP	S_Disease
)	)	O
kindreds	VBZ	O
using	VBG	O
three	CD	O
cloned	VBN	O
DNA	NNP	O
sequences	NNS	O
from	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
which	WDT	O
demonstrate	VBP	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NN	O
(	(	O
RFLPs	NNP	O
)	)	O
,	,	O
suggests	VBZ	O
that	IN	O
the	DT	O
BMD	NNP	S_Disease
gene	NN	O
is	VBZ	O
located	VBN	O
on	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
,	,	O
in	IN	O
the	DT	O
p21	JJ	O
region	NN	O
.	.	O

The	DT	O
genes	NNS	O
for	IN	O
Becker	NNP	B_Disease
and	CC	I_Disease
Duchenne	NNP	I_Disease
dystrophies	NNS	E_Disease
must	MD	O
therefore	RB	O
be	VB	O
closely	RB	O
linked	VBN	O
,	,	O
if	IN	O
not	RB	O
allelic	JJ	O
,	,	O
and	CC	O
any	DT	O
future	JJ	O
DNA	NNP	O
probes	NNS	O
found	VBD	O
to	TO	O
be	VB	O
of	IN	O
practical	JJ	O
use	NN	O
in	IN	O
one	CD	O
disorder	NN	O
should	MD	O
be	VB	O
equally	RB	O
applicable	JJ	O
to	TO	O
the	DT	O
other	JJ	O
.	.	O

The	DT	O
linkage	NN	O
analysis	NN	O
also	RB	O
provides	VBZ	O
data	NNS	O
on	IN	O
the	DT	O
frequency	NN	O
of	IN	O
recombination	NN	O
along	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
,	,	O
and	CC	O
across	IN	O
the	DT	O
centromeric	JJ	O
region	NN	O
.	.	O
.	.	O

Molecular	JJ	O
evidence	NN	O
for	IN	O
new	JJ	O
mutation	NN	O
at	IN	O
the	DT	O
hprt	NN	O
locus	NN	O
in	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NN	E_Disease
patients	NNS	O
.	.	O

Hypoxanthine	NNP	O
-	:	O
guanine	NN	O
phosphoribosyltransferase	NN	O
(	(	O
HPRT	NNP	O
;	:	O
EC2	NNP	O
.	.	O

4	CD	O
.	.	O

2	CD	O
.	.	O

8	CD	O
)	)	O
,	,	O
which	WDT	O
functions	NNS	O
in	IN	O
the	DT	O
metabolic	JJ	O
salvage	NN	O
of	IN	O
purines	NNS	O
,	,	O
is	VBZ	O
encoded	VBN	O
by	IN	O
an	DT	O
X	NNP	O
-	:	O
linked	VBN	O
gene	NN	O
in	IN	O
man	NN	O
.	.	O

Partial	JJ	O
HPRT	NNP	B_Disease
deficiencies	NNS	E_Disease
are	VBP	O
associated	VBN	O
with	IN	O
gouty	NN	B_Disease
arthritis	NN	E_Disease
,	,	O
while	IN	O
absence	NN	O
of	IN	O
activity	NN	O
results	NNS	O
in	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
L	NNP	B_Disease
-	:	I_Disease
N	NNP	E_Disease
)	)	O
.	.	O

L	NNP	B_Disease
-	:	I_Disease
N	NN	E_Disease
patients	NNS	O
fail	VBP	O
to	TO	O
reproduce	VB	O
and	CC	O
the	DT	O
heterozygous	JJ	O
state	NN	O
appears	VBZ	O
to	TO	O
confer	VB	O
no	DT	O
selective	JJ	O
advantage	NN	O
.	.	O

Thus	RB	O
,	,	O
Haldanes	NNP	O
principle	NN	O
predicts	VBZ	O
that	IN	O
new	JJ	O
mutations	NNS	O
at	IN	O
the	DT	O
hprt	NN	O
locus	NN	O
must	MD	O
occur	VB	O
frequently	RB	O
in	IN	O
order	NN	O
for	IN	O
L	NNP	B_Disease
-	:	I_Disease
N	NNP	I_Disease
syndrome	NN	E_Disease
to	TO	O
be	VB	O
maintained	VBN	O
in	IN	O
the	DT	O
population	NN	O
.	.	O

This	DT	O
constant	JJ	O
introduction	NN	O
of	IN	O
new	JJ	O
mutations	NNS	O
would	MD	O
be	VB	O
expected	VBN	O
to	TO	O
result	VB	O
in	IN	O
a	DT	O
heterogeneous	JJ	O
collection	NN	O
of	IN	O
genetic	JJ	B_Disease
lesions	NNS	E_Disease
,	,	O
some	DT	O
of	IN	O
which	WDT	O
may	MD	O
be	VB	O
novel	JJ	O
.	.	O

As	IN	O
we	PRP	O
report	VBP	O
here	RB	O
,	,	O
the	DT	O
mutations	NNS	O
in	IN	O
the	DT	O
hprt	JJ	O
gene	NN	O
of	IN	O
seven	CD	O
L	NNP	B_Disease
-	:	I_Disease
N	NNP	E_Disease
patients	NNS	O
,	,	O
selected	VBN	O
from	IN	O
an	DT	O
initial	JJ	O
survey	NN	O
of	IN	O
28	CD	O
patients	NNS	O
,	,	O
have	VBP	O
been	VBN	O
characterized	VBN	O
and	CC	O
all	DT	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
distinctly	RB	O
different	JJ	O
,	,	O
as	IN	O
predicted	VBN	O
.	.	O

The	DT	O
origin	NN	O
of	IN	O
one	CD	O
unusual	JJ	O
mutation	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
by	IN	O
analysis	NN	O
of	IN	O
DNA	NNP	O
from	IN	O
four	CD	O
generations	NNS	O
of	IN	O
family	NN	O
members	NNS	O
.	.	O

Further	RB	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
origin	NN	O
of	IN	O
new	JJ	O
mutations	NNS	O
at	IN	O
the	DT	O
hprt	NN	O
locus	NN	O
should	MD	O
aid	VB	O
in	IN	O
resolving	VBG	O
the	DT	O
issue	NN	O
of	IN	O
an	DT	O
apparent	JJ	O
difference	NN	O
in	IN	O
the	DT	O
frequency	NN	O
of	IN	O
hprt	JJ	O
mutations	NNS	O
in	IN	O
males	NNS	O
and	CC	O
females	NNS	O

Allelic	JJ	O
exclusion	NN	O
of	IN	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
in	IN	O
platelets	NNS	O
and	CC	O
T	NNP	O
lymphocytes	VBZ	O
from	IN	O
a	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	VBD	E_Disease
carrier	NN	O
.	.	O

An	DT	O
obligate	NN	O
carrier	NN	O
of	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
who	WP	O
was	VBD	O
also	RB	O
heterozygous	JJ	O
for	IN	O
the	DT	O
A	NNP	O
and	CC	O
B	NNP	O
types	NNS	O
of	IN	O
X	NNP	O
-	:	O
linked	VBD	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
was	VBD	O
found	VBN	O
.	.	O

With	IN	O
her	PRP$	O
it	PRP	O
became	VBD	O
possible	JJ	O
to	TO	O
determine	VB	O
whether	IN	O
allelic	JJ	O
exclusion	NN	O
occurs	VBZ	O
in	IN	O
particular	JJ	O
cell	NN	O
-	:	O
types	NNS	O
of	IN	O
the	DT	O
WAS	NNP	S_Disease
carrier	NN	O
.	.	O

If	IN	O
so	RB	O
,	,	O
the	DT	O
remaining	VBG	O
cells	NNS	O
of	IN	O
a	DT	O
particular	JJ	O
cell	NN	O
-	:	O
type	NN	O
would	MD	O
express	VB	O
only	RB	O
the	DT	O
normal	JJ	O
X	NNP	O
chromosome	NN	O
and	CC	O
only	RB	O
one	CD	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
isoenzyme	NN	O
would	MD	O
be	VB	O
demonstrable	JJ	O
.	.	O

This	DT	O
carrier	NN	O
had	VBD	O
only	RB	O
the	DT	O
B	NNP	O
isoenzyme	NN	O
of	IN	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
in	IN	O
platelets	NNS	O
and	CC	O
thymus	SYM	O
-	:	O
derived	VBN	O
T	NNP	O
lymphocytes	NNS	O
,	,	O
although	IN	O
both	DT	O
isoenzymes	VBZ	O
A	NNP	O
and	CC	O
B	NNP	O
were	VBD	O
present	JJ	O
in	IN	O
erythrocytes	NNS	O
and	CC	O
neutrophils	NNS	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
selection	NN	O
against	IN	O
the	DT	O
WAS	NNP	S_Disease
gene	NN	O
occurs	VBZ	O
in	IN	O
platelets	NNS	O
and	CC	O
thymus	SYM	O
-	:	O
derived	VBN	O
T	NNP	O
lymphocytes	NNS	O
and	CC	O
that	IN	O
the	DT	O
defects	NNS	O
associated	VBN	O
with	IN	O
WAS	NNP	S_Disease
expressed	VBN	O
in	IN	O
these	DT	O
cell	NN	O
-	:	O
types	NNS	O
may	MD	O
be	VB	O
implicated	VBN	O
in	IN	O
the	DT	O
genesis	NN	O
of	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O
.	.	O

Complement	JJ	B_Disease
deficiency	NN	E_Disease
and	CC	O
nephritis	NN	S_Disease
.	.	O

A	DT	O
report	NN	O
of	IN	O
a	DT	O
family	NN	O
.	.	O

A	DT	O
family	NN	O
is	VBZ	O
described	VBN	O
in	IN	O
which	WDT	O
three	CD	O
children	NNS	O
had	VBD	O
homozygous	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
C3	NNP	E_Disease
and	CC	O
in	IN	O
which	WDT	O
both	DT	O
parents	NNS	O
and	CC	O
two	CD	O
other	JJ	O
children	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
C3	NNP	O
null	JJ	O
gene	NN	O
.	.	O

One	CD	O
child	NN	O
with	IN	O
heterozygous	JJ	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
membranoproliferative	JJ	O
glomerulonephritis	NN	S_Disease
;	:	O
proteinuria	NNS	S_Disease
and	CC	O
/	NN	O
or	CC	O
microscopical	JJ	O
haematuria	NN	S_Disease
was	VBD	O
present	JJ	O
in	IN	O
all	DT	O
three	CD	O
homozygous	JJ	O
C3	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
children	NNS	O
.	.	O

All	DT	O
children	NNS	O
with	IN	O
homozygous	JJ	O
or	CC	O
heterozygous	JJ	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
were	VBD	O
,	,	O
to	TO	O
a	DT	O
varying	NN	O
degree	NN	O
,	,	O
susceptible	JJ	O
to	TO	O
infection	NN	O
.	.	O

The	DT	O
only	JJ	O
child	NN	O
of	IN	O
the	DT	O
family	NN	O
with	IN	O
normal	JJ	O
complement	NN	O
had	VBD	O
no	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
infection	NN	O
and	CC	O
no	DT	O
renal	JJ	B_Disease
disease	NN	E_Disease
.	.	O

This	DT	O
family	NN	O
study	VB	O
provides	VBZ	O
further	JJ	O
support	NN	O
for	IN	O
the	DT	O
proposal	NN	O
that	IN	O
C3	NNP	B_Disease
deficiency	NN	E_Disease
predisposes	NNS	O
to	TO	O
nephritis	VB	S_Disease
.	.	O
.	.	O

Heterogeneity	NN	O
of	IN	O
glucose	JJ	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
deficiency	NN	E_Disease
in	IN	O
Algeria	NNP	O
.	.	O

Study	NN	O
in	IN	O
Northern	NNP	O
Algeria	NNP	O
with	IN	O
description	NN	O
of	IN	O
five	CD	O
new	JJ	O
variants	NNS	O
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
was	VBD	O
found	VBN	O
in	IN	O
3	CD	O
.	.	O

2	CD	O
%	NN	O
of	IN	O
the	DT	O
male	JJ	O
population	NN	O
living	NN	O
in	IN	O
the	DT	O
urban	JJ	O
area	NN	O
of	IN	O
Algiers	NNP	O
.	.	O

The	DT	O
deficient	JJ	O
subjects	NNS	O
originated	VBN	O
from	IN	O
multiple	JJ	O
geographic	JJ	O
regions	NNS	O
of	IN	O
Northern	NNP	O
Algeria	NNP	O
,	,	O
with	IN	O
prevalence	NN	O
of	IN	O
individuals	NNS	O
of	IN	O
Berber	NNP	O
-	:	O
Kabyle	NNP	O
origin	NN	O
.	.	O

Red	JJ	O
blood	NN	O
cell	NN	O
G6PD	NNP	O
was	VBD	O
partially	RB	O
purified	VBN	O
and	CC	O
characterized	VBN	O
in	IN	O
deficient	JJ	O
males	NNS	O
from	IN	O
17	CD	O
families	NNS	O
,	,	O
and	CC	O
six	CD	O
different	JJ	O
variants	NNS	O
were	VBD	O
found	VBN	O
.	.	O

Among	IN	O
them	PRP	O
,	,	O
only	RB	O
one	CD	O
,	,	O
the	DT	O
Gd	NNP	O
(	(	O
-	:	O
)	)	O
Kabyle	NNP	O
variant	NN	O
,	,	O
had	VBD	O
been	VBN	O
previously	RB	O
described	VBN	O
.	.	O

It	PRP	O
was	VBD	O
detected	VBN	O
in	IN	O
nine	CD	O
families	NNS	O
.	.	O

The	DT	O
other	JJ	O
five	CD	O
variants	NNS	O
were	VBD	O
new	JJ	O
Gd	NNP	O
(	(	O
-	:	O
)	)	O
Laghouat	NNP	O
(	(	O
four	CD	O
cases	NNS	O
)	)	O
,	,	O
Gd	NNP	O
(	(	O
-	:	O
)	)	O
Blida	NNP	O
(	(	O
one	CD	O
case	NN	O
)	)	O
,	,	O
Gd	NNP	O
(	(	O
-	:	O
)	)	O
Thenia	NNP	O
(	(	O
one	CD	O
case	NN	O
)	)	O
,	,	O
Gd	NNP	O
(	(	O
-	:	O
)	)	O
Titteri	NNP	O
(	(	O
one	CD	O
case	NN	O
)	)	O
,	,	O
and	CC	O
Gd	NNP	O
(	(	O
-	:	O
)	)	O
Alger	NNP	O
(	(	O
two	CD	O
brothers	NNS	O
)	)	O
.	.	O

Strikingly	RB	O
,	,	O
the	DT	O
common	JJ	O
Mediterranean	NNP	O
variant	NN	O
was	VBD	O
not	RB	O
found	VBN	O
.	.	O

G6PD	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
heterogeneous	JJ	O
in	IN	O
northern	JJ	O
Algeria	NNP	O
where	WRB	O
autochtonous	JJ	O
variants	NNS	O
seem	VBP	O
to	TO	O
prevail	VB	O
.	.	O

The	DT	O
Kabyle	NNP	O
variant	NN	O
may	MD	O
be	VB	O
common	JJ	O
in	IN	O
this	DT	O
country	NN	O
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
deficiency	NN	E_Disease
inhibits	NNS	O
in	IN	O
vitro	JJ	O
growth	NN	O
of	IN	O
Plasmodium	NNP	O
falciparum	NN	O
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
;	:	I_Disease
EC	NNP	I_Disease
1	CD	I_Disease
.	.	I_Disease
1	CD	I_Disease
.	.	I_Disease
1	CD	I_Disease
.	.	I_Disease
49	CD	I_Disease
)	)	I_Disease
-	:	I_Disease
deficient	NN	E_Disease
red	JJ	O
blood	NN	O
cells	NNS	O
from	IN	O
male	NN	O
hemizygotes	NNS	O
and	CC	O
female	JJ	O
heterozygotes	NNS	O
from	IN	O
the	DT	O
island	NN	O
of	IN	O
Sardinia	NNP	O
were	VBD	O
studied	VBN	O
for	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
support	VB	O
growth	NN	O
in	IN	O
vitro	NN	O
of	IN	O
the	DT	O
malaria	NNS	S_Disease
-	:	O
causing	VBG	O
organism	NN	O
Plasmodium	NNP	O
falciparum	NN	O
.	.	O

Parasite	NNP	O
growth	NN	O
was	VBD	O
approximately	RB	O
one	CD	O
-	:	O
third	NN	O
of	IN	O
normal	JJ	O
in	IN	O
both	DT	O
hemi	JJ	O
-	:	O
and	CC	O
heterozygotes	NNS	O
for	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

In	IN	O
Sardinians	NNPS	O
with	IN	O
the	DT	O
beta	NN	O
0	CD	O
-	:	O
thalassemia	NN	O
trait	NN	O
,	,	O
parasite	JJ	O
growth	NN	O
was	VBD	O
normal	JJ	O
except	IN	O
when	WRB	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
occurred	VBD	O
together	RB	O
with	IN	O
the	DT	O
thalassemia	NN	S_Disease
trait	NN	O
.	.	O

The	DT	O
data	NN	O
support	NN	O
the	DT	O
hypothesis	NN	O
that	WDT	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
may	MD	O
confer	VB	O
a	DT	O
selective	JJ	O
advantage	NN	O
in	IN	O
a	DT	O
malarious	JJ	S_Disease
area	NN	O
;	:	O
the	DT	O
female	JJ	O
heterozygote	NN	O
may	MD	O
be	VB	O
at	IN	O
a	DT	O
particular	JJ	O
advantage	NN	O
because	IN	O
resistance	NN	O
to	TO	O
malaria	VB	S_Disease
equals	NNS	O
that	IN	O
of	IN	O
male	NN	O
hemizygotes	NNS	O
,	,	O
but	CC	O
the	DT	O
risk	NN	O
of	IN	O
fatal	JJ	B_Disease
hemolysis	NN	E_Disease
may	MD	O
be	VB	O
less	JJR	O
.	.	O

However	RB	O
,	,	O
more	JJR	O
female	JJ	O
heterozygotes	NNS	O
must	MD	O
be	VB	O
studied	VBN	O
to	TO	O
confirm	VB	O
this	DT	O
hypothesis	NN	O
.	.	O

No	DT	O
protective	JJ	O
effect	NN	O
of	IN	O
beta	NN	O
0	CD	O
-	:	O
thalassemia	NN	O
trait	NN	O
could	MD	O
be	VB	O
demonstrated	VBN	O
in	IN	O
vitro	NN	O
.	.	O

Bone	NNP	O
marrow	NN	O
transplant	NN	O
in	IN	O
adrenoleukodystrophy	NN	S_Disease
.	.	O

An	DT	O
allogeneic	NN	O
bone	NN	O
marrow	NN	O
transplant	NN	O
(	(	O
BMT	NNP	O
)	)	O
from	IN	O
a	DT	O
normal	JJ	O
HLA	NNP	O
identical	JJ	O
sibling	VBG	O
donor	NN	O
was	VBD	O
performed	VBN	O
in	IN	O
a	DT	O
13	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
boy	NN	O
with	IN	O
rapidly	RB	O
progressive	JJ	O
adrenoleukodystrophy	NN	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
.	.	O

Engraftment	NN	O
and	CC	O
complete	JJ	O
hematologic	NN	O
recovery	NN	O
occurred	VBD	O
within	IN	O
4	CD	O
weeks	NNS	O
,	,	O
but	CC	O
neurologic	JJ	B_Disease
deterioration	NN	E_Disease
continued	VBD	O
.	.	O

The	DT	O
patient	NN	O
died	VBD	O
of	IN	O
an	DT	O
adenovirus	JJ	B_Disease
infection	NN	E_Disease
141	CD	O
days	NNS	O
after	IN	O
BMT	NNP	O
.	.	O

ALD	NNP	S_Disease
is	VBZ	O
characterized	VBN	O
by	IN	O
abnormally	RB	O
high	JJ	O
plasma	NN	O
levels	NNS	O
of	IN	O
very	RB	O
long	RB	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
(	(	O
VLCFA	NNP	O
)	)	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
impaired	JJ	O
capacity	NN	O
to	TO	O
degrade	VB	O
them	PRP	O
.	.	O

Ten	CD	O
days	NNS	O
after	IN	O
BMT	NNP	O
,	,	O
the	DT	O
white	JJ	O
blood	NN	O
cell	NN	O
VLCFA	NNP	O
levels	NNS	O
and	CC	O
enzyme	JJ	O
activity	NN	O
became	VBD	O
normal	JJ	O
;	:	O
after	IN	O
3	CD	O
months	NNS	O
,	,	O
there	EX	O
was	VBD	O
progressive	JJ	O
reduction	NN	O
of	IN	O
plasma	NN	O
VLCFA	NNP	O
to	TO	O
levels	NNS	O
only	RB	O
slightly	RB	O
above	IN	O
normal	JJ	O
.	.	O
.	.	O

[	NN	O
Gd	NNP	O
-	:	O
allele	JJ	O
distribution	NN	O
patterns	NNS	O
in	IN	O
Azerbaijan	NNP	O
.	.	O

III	NNP	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
mutant	JJ	O
forms	NNS	O
of	IN	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
]	NNP	O
In	IN	O
28	CD	O
families	NNS	O
with	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
living	NN	O
in	IN	O
3	CD	O
settlements	NNS	O
of	IN	O
Shekii	NNP	O
district	NN	O
of	IN	O
Azerbaijan	NNP	O
11	CD	O
G6PD	NNP	O
variants	NNS	O
of	IN	O
II	NNP	O
and	CC	O
III	NNP	O
classes	NNS	O
differing	VBG	O
by	IN	O
kinetic	JJ	O
properties	NNS	O
were	VBD	O
identified	VBN	O
according	VBG	O
WHO	JJ	O
program	NN	O
.	.	O

9	CD	O
of	IN	O
them	PRP	O
are	VBP	O
characterized	VBN	O
with	IN	O
the	DT	O
same	JJ	O
electrophoretic	JJ	O
mobility	NN	O
.	.	O

Comparison	NNP	O
of	IN	O
G6PD	NNP	O
spectra	NN	O
in	IN	O
two	CD	O
subpopulations	NNS	O
and	CC	O
in	IN	O
a	DT	O
mixed	JJ	O
group	NN	O
permits	VBZ	O
to	TO	O
make	VB	O
a	DT	O
conclusion	NN	O
about	IN	O
existence	NN	O
of	IN	O
common	JJ	O
and	CC	O
rare	JJ	O
G6PD	NNP	O
alleles	NNS	O
in	IN	O
examined	JJ	O
population	NN	O
.	.	O

They	PRP	O
distribute	VBP	O
by	IN	O
gene	NN	O
drift	NN	O
supported	VBN	O
by	IN	O
natural	JJ	O
selection	NN	O
.	.	O

Among	IN	O
7	CD	O
samples	NNS	O
of	IN	O
G6PD	NNP	O
with	IN	O
normal	JJ	O
and	CC	O
increased	JJ	O
activity	NN	O
two	CD	O
new	JJ	O
variants	NNS	O
of	IN	O
IV	NNP	O
class	NN	O
-	:	O
-	:	O
Nukha	NN	O
and	CC	O
Bash	NNP	O
-	:	O
Kungut	NNP	O
-	:	O
-	:	O
were	VBD	O
found	VBN	O
.	.	O
.	.	O

Adrenoleukodystrophy	NN	S_Disease
:	:	O
survey	NN	O
of	IN	O
303	CD	O
cases	NNS	O
:	:	O
biochemistry	NN	O
,	,	O
diagnosis	NN	O
,	,	O
and	CC	O
therapy	NN	O
.	.	O

Adrenoleukodystrophy	NNP	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
genetically	RB	O
determined	VBN	O
disorder	NN	O
associated	VBN	O
with	IN	O
progressive	JJ	B_Disease
central	JJ	I_Disease
demyelination	NN	E_Disease
and	CC	O
adrenal	JJ	B_Disease
cortical	JJ	I_Disease
insufficiency	NN	E_Disease
.	.	O

All	DT	O
affected	VBD	O
persons	NNS	O
show	VBP	O
increased	JJ	O
levels	NNS	O
of	IN	O
saturated	VBN	O
unbranched	JJ	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
,	,	O
particularly	RB	O
hexacosanoate	NN	O
(	(	O
C26	NNP	O
0	CD	O
)	)	O
,	,	O
because	IN	O
of	IN	O
impaired	JJ	O
capacity	NN	O
to	TO	O
degrade	VB	O
these	DT	O
acids	NNS	O
.	.	O

This	DT	O
degradation	NN	O
normally	RB	O
takes	VBZ	O
place	NN	O
in	IN	O
a	DT	O
subcellular	JJ	O
organelle	NN	O
called	VBD	O
the	DT	O
peroxisome	NN	O
,	,	O
and	CC	O
ALD	NNP	S_Disease
,	,	O
together	RB	O
with	IN	O
Zellwegers	NNP	B_Disease
cerebrohepatorenal	JJ	I_Disease
syndrome	NN	E_Disease
,	,	O
is	VBZ	O
now	RB	O
considered	VBN	O
to	TO	O
belong	VB	O
to	TO	O
the	DT	O
newly	RB	O
formed	VBN	O
category	NN	O
of	IN	O
peroxisomal	JJ	B_Disease
disorders	NNS	E_Disease
.	.	O

Biochemical	NNP	O
assays	VBZ	O
permit	VBP	O
prenatal	JJ	O
diagnosis	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
identification	NN	O
of	IN	O
most	JJS	O
heterozygotes	NNS	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
303	CD	O
patients	NNS	O
with	IN	O
ALD	NNP	S_Disease
in	IN	O
217	CD	O
kindreds	NNS	O
.	.	O

These	DT	O
patients	NNS	O
show	VBP	O
a	DT	O
wide	JJ	O
phenotypic	NN	O
variation	NN	O
.	.	O

Sixty	NNP	O
percent	NN	O
of	IN	O
patients	NNS	O
had	VBD	O
childhood	VBN	O
ALD	NNP	S_Disease
and	CC	O
17	CD	O
%	NN	O
adrenomyeloneuropathy	NN	S_Disease
,	,	O
both	DT	O
of	IN	O
which	WDT	O
are	VBP	O
X	NNP	O
-	:	O
linked	VBN	O
,	,	O
with	IN	O
the	DT	O
gene	NN	O
mapped	VBD	O
to	TO	O
Xq28	NNP	O
.	.	O

Neonatal	JJ	B_Disease
ALD	NNP	E_Disease
,	,	O
a	DT	O
distinct	JJ	O
entity	NN	O
with	IN	O
autosomal	JJ	O
recessive	JJ	O
inheritance	NN	O
and	CC	O
points	NNS	O
of	IN	O
resemblance	NN	O
to	TO	O
Zellwegers	NNP	B_Disease
syndrome	NN	E_Disease
,	,	O
accounted	VBD	O
for	IN	O
7	CD	O
%	NN	O
of	IN	O
the	DT	O
cases	NNS	O
.	.	O

Although	IN	O
excess	JJ	O
C26	NNP	O
0	CD	O
in	IN	O
the	DT	O
brain	NN	O
of	IN	O
patients	NNS	O
with	IN	O
ALD	NNP	S_Disease
is	VBZ	O
partially	RB	O
of	IN	O
dietary	JJ	O
origin	NN	O
,	,	O
dietary	JJ	O
C26	NNP	O
0	CD	O
restriction	NN	O
did	VBD	O
not	RB	O
produce	VB	O
clear	JJ	O
benefit	NN	O
.	.	O

Bone	NNP	O
marrow	NN	O
transplant	NN	O
lowered	VBD	O
the	DT	O
plasma	NN	O
C26	NNP	O
0	CD	O
level	NN	O
but	CC	O
failed	VBD	O
to	TO	O
arrest	VB	O
neurological	JJ	O
progression	NN	O
.	.	O
.	.	O

Genetic	JJ	O
polymorphism	NN	O
of	IN	O
G6PD	NNP	O
in	IN	O
a	DT	O
Bulgarian	JJ	O
population	NN	O
.	.	O

Considerable	JJ	O
genetic	JJ	O
heterogeneity	NN	O
in	IN	O
G6PD	NNP	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
Bulgarian	JJ	O
population	NN	O
-	:	O
14	CD	O
G6PD	NNP	O
variants	NNS	O
isolated	VBD	O
from	IN	O
117	CD	O
hemizygous	JJ	O
carriers	NNS	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Of	IN	O
these	DT	O
,	,	O
G6PD	NNP	O
Mediterranean	NNP	O
type	NN	O
was	VBD	O
a	DT	O
polymorphic	JJ	O
variant	NN	O
and	CC	O
G6PD	NNP	O
Corinth	NNP	O
occurred	VBD	O
with	IN	O
high	JJ	O
frequency	NN	O
.	.	O

Two	CD	O
new	JJ	O
variants	NNS	O
were	VBD	O
identified	VBN	O
-	:	O
G6PD	NNP	O
Rudosem	NNP	O
and	CC	O
G6PD	NNP	O
Nedelino	NNP	O
.	.	O

In	IN	O
a	DT	O
selected	VBN	O
group	NN	O
of	IN	O
78	CD	O
subjects	NNS	O
with	IN	O
clinical	JJ	O
manifestations	NNS	O
,	,	O
four	CD	O
variants	NNS	O
were	VBD	O
established	VBN	O
G6PD	NNP	O
Mediterranian	NNP	O
,	,	O
G6PD	NNP	O
Corinth	NNP	O
,	,	O
G6PD	NNP	O
Seattle	NNP	O
and	CC	O
G6PD	NNP	O
Ohut	NNP	O
II	NNP	O
.	.	O
.	.	O

Clinical	JJ	O
use	NN	O
of	IN	O
DNA	NN	O
markers	NNS	O
linked	VBD	O
to	TO	O
the	DT	O
gene	NN	O
for	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

Seventy	JJ	O
families	NNS	O
with	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
known	VBN	O
to	TO	O
the	DT	O
Institute	NNP	O
of	IN	O
Child	NNP	O
Health	NNP	O
fall	NN	O
into	IN	O
three	CD	O
categories	NNS	O
with	IN	O
respect	NN	O
to	TO	O
potential	JJ	O
linkage	NN	O
analysis	NN	O
with	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
DNA	NNP	O
markers	NNS	O
RC8	NNP	O
and	CC	O
L1	NNP	O
.	.	O

28	CD	O
that	WDT	O
bridge	VBP	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
.	.	O

Families	NNS	O
in	IN	O
which	WDT	O
there	EX	O
is	VBZ	O
at	IN	O
least	JJS	O
one	CD	O
obligatory	JJ	O
female	JJ	O
heterozygote	NN	O
(	(	O
n	JJ	O
=	NNP	O
13	CD	O
)	)	O
.	.	O

Here	RB	O
prediction	NN	O
and	CC	O
exclusion	NN	O
of	IN	O
DMD	NNP	S_Disease
gene	NN	O
transmission	NN	O
may	MD	O
be	VB	O
possible	JJ	O
,	,	O
the	DT	O
accuracy	NN	O
being	VBG	O
dependent	JJ	O
on	IN	O
the	DT	O
closeness	NN	O
of	IN	O
the	DT	O
linkage	NN	O
of	IN	O
the	DT	O
DNA	NN	O
marker	NN	O
(	(	O
s	PRP	O
)	)	O
to	TO	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
;	:	O
an	DT	O
illustrative	JJ	O
case	NN	O
is	VBZ	O
reported	VBN	O
.	.	O

Families	NNS	O
in	IN	O
which	WDT	O
there	EX	O
is	VBZ	O
a	DT	O
single	JJ	O
affected	JJ	O
boy	NN	O
,	,	O
who	WP	O
also	RB	O
has	VBZ	O
one	CD	O
or	CC	O
more	JJR	O
healthy	JJ	O
brothers	NNS	O
(	(	O
n	JJ	O
=	NNP	O
26	CD	O
)	)	O
.	.	O

Given	VBN	O
an	DT	O
informative	JJ	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
(	(	O
RFLP	NNP	O
)	)	O
,	,	O
the	DT	O
probability	NN	O
that	IN	O
the	DT	O
boy	NN	O
represents	VBZ	O
a	DT	O
new	JJ	O
mutation	NN	O
can	MD	O
be	VB	O
reassessed	VBN	O
;	:	O
it	PRP	O
is	VBZ	O
also	RB	O
possible	JJ	O
to	TO	O
exclude	VB	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
in	IN	O
a	DT	O
sister	NN	O
.	.	O

Families	NNS	O
with	IN	O
a	DT	O
single	JJ	O
affected	JJ	O
boy	NN	O
with	IN	O
no	DT	O
brother	NN	O
(	(	O
n	JJ	O
=	NNP	O
30	CD	O
)	)	O
.	.	O

Here	RB	O
exclusion	NN	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
in	IN	O
a	DT	O
sister	NN	O
may	MD	O
be	VB	O
possible	JJ	O
.	.	O

Only	RB	O
in	IN	O
one	CD	O
family	NN	O
was	VBD	O
there	RB	O
no	DT	O
possibility	NN	O
of	IN	O
useful	JJ	O
linkage	NN	O
analysis	NN	O
.	.	O

The	DT	O
linkage	NN	O
analysis	NN	O
required	VBN	O
is	VBZ	O
described	VBN	O
,	,	O
and	CC	O
the	DT	O
need	NN	O
to	TO	O
check	VB	O
DMD	NNP	S_Disease
families	NNS	O
for	IN	O
informative	JJ	O
RFLPs	NNP	O
is	VBZ	O
stressed	VBN	O
.	.	O

Family	RB	O
studies	NNS	O
in	IN	O
Bechterew	NNP	B_Disease
'	POS	I_Disease
s	JJ	I_Disease
syndrome	NN	E_Disease
(	(	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
)	)	O
III	NNP	O
.	.	O

Genetics	NNS	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
segregation	NN	O
analyses	NNS	O
in	IN	O
75	CD	O
families	NNS	O
where	WRB	O
the	DT	O
proband	NN	O
had	VBD	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
,	,	O
are	VBP	O
presented	VBN	O
.	.	O

Of	IN	O
the	DT	O
278	CD	O
adult	NN	O
,	,	O
living	VBG	O
first	JJ	O
degree	JJ	O
relatives	NNS	O
,	,	O
approximately	RB	O
85	CD	O
%	NN	O
cooperated	VBN	O
in	IN	O
the	DT	O
study	NN	O
.	.	O

Clinical	JJ	O
and	CC	O
radiographical	JJ	O
examinations	NNS	O
were	VBD	O
performed	VBN	O
and	CC	O
HLA	NNP	O
typing	NN	O
was	VBD	O
conducted	VBN	O
.	.	O

The	DT	O
results	NNS	O
were	VBD	O
in	IN	O
agreement	NN	O
with	IN	O
our	PRP$	O
hypothesis	NN	O
that	IN	O
ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
is	VBZ	O
part	NN	O
of	IN	O
a	DT	O
syndrome	NN	O
where	WRB	O
different	JJ	O
genetic	JJ	O
factors	NNS	O
interact	NN	O
.	.	O

Such	JJ	O
known	VBN	O
factors	NNS	O
are	VBP	O
HLA	NNP	O
B27	NNP	O
associated	VBD	O
disease	NN	O
susceptibility	NN	O
,	,	O
susceptibility	NN	O
to	TO	O
psoriatic	VB	B_Disease
arthropathy	NN	E_Disease
and	CC	O
susceptibility	NN	O
to	TO	O
entero	VB	B_Disease
-	:	I_Disease
arthropathy	NN	E_Disease
.	.	O

Radiographical	JJ	O
sacro	NN	B_Disease
-	:	I_Disease
iliitis	NN	E_Disease
was	VBD	O
restricted	VBN	O
to	TO	O
HLA	NNP	O
B27	NNP	O
positive	JJ	O
relatives	NNS	O
,	,	O
and	CC	O
was	VBD	O
more	RBR	O
frequently	RB	O
found	VBN	O
in	IN	O
relatives	NNS	O
to	TO	O
probands	NNS	O
with	IN	O
psoriasis	NN	S_Disease
than	IN	O
in	IN	O
relatives	NNS	O
to	TO	O
probands	NNS	O
without	IN	O
psoriasis	NN	S_Disease
.	.	O

Environmental	JJ	O
factors	NNS	O
(	(	O
intestinal	JJ	O
bacteria	NNS	O
)	)	O
are	VBP	O
known	VBN	O
to	TO	O
trigger	VB	O
the	DT	O
disease	NN	O
at	IN	O
least	JJS	O
in	IN	O
some	DT	O
persons	NNS	O
,	,	O
and	CC	O
we	PRP	O
have	VBP	O
postulated	VBN	O
that	IN	O
all	DT	O
or	CC	O
most	JJS	O
of	IN	O
them	PRP	O
have	VBP	O
the	DT	O
predisposition	NN	O
to	TO	O
develop	VB	O
disease	NN	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
syndrome	NN	O
has	VBZ	O
a	DT	O
multifactorial	JJ	O
etiology	NN	O
.	.	O

The	DT	O
phenotypic	JJ	O
expressions	NNS	O
of	IN	O
the	DT	O
different	JJ	O
genetic	JJ	O
predispositions	NNS	O
involved	VBN	O
,	,	O
include	VBP	O
sacro	JJ	B_Disease
-	:	I_Disease
iliitis	NN	E_Disease
,	,	O
psoriasis	NN	S_Disease
,	,	O
acute	JJ	B_Disease
anterior	JJ	I_Disease
uveitis	NN	E_Disease
,	,	O
peripheral	JJ	O
arthropathy	NN	S_Disease
and	CC	O
inflammatory	JJ	B_Disease
bowel	NN	I_Disease
disease	NN	E_Disease
.	.	O

We	PRP	O
suggest	VBP	O
the	DT	O
descriptive	JJ	O
name	NN	O
HEREDITARY	NNP	B_Disease
MULTIFOCAL	NNP	I_Disease
RELAPSING	NNP	I_Disease
INFLAMMATION	NNP	E_Disease
(	(	O
HEMRI	NNP	S_Disease
)	)	O
for	IN	O
this	DT	O
syndrome	NN	O
.	.	O

Ankylosing	VBG	B_Disease
spondylitis	NN	E_Disease
,	,	O
psoriatic	JJ	B_Disease
arthropathy	NN	E_Disease
and	CC	O
entero	NN	B_Disease
-	:	I_Disease
arthropathy	NN	E_Disease
may	MD	O
be	VB	O
regarded	VBN	O
as	IN	O
clinical	JJ	O
sub	NN	O
-	:	O
types	NNS	O
of	IN	O
the	DT	O
syndrome	NN	O
.	.	O
.	.	O

Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
and	CC	O
chromosome	NN	O
15	CD	O
.	.	O

A	DT	O
clinical	JJ	O
discussion	NN	O
of	IN	O
20	CD	O
cases	NNS	O
.	.	O

A	DT	O
chromosome	NN	B_Disease
15	CD	I_Disease
anomaly	NN	E_Disease
was	VBD	O
observed	VBN	O
in	IN	O
12	CD	O
of	IN	O
20	CD	O
patients	NNS	O
,	,	O
17	CD	O
of	IN	O
whom	WP	O
were	VBD	O
clinically	RB	O
suspected	VBN	O
of	IN	O
having	VBG	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
clinical	JJ	O
features	NNS	O
of	IN	O
eight	CD	O
cases	NNS	O
with	IN	O
15q11	CD	O
-	:	O
12	CD	O
deletion	NN	O
were	VBD	O
very	RB	O
similar	JJ	O
to	TO	O
those	DT	O
originally	RB	O
described	VBN	O
in	IN	O
PWS	NNP	S_Disease
.	.	O

On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
the	DT	O
group	NN	O
of	IN	O
normal	JJ	O
karyotype	NN	O
patients	NNS	O
is	VBZ	O
heterogeneous	JJ	O
,	,	O
and	CC	O
their	PRP$	O
features	NNS	O
do	VBP	O
not	RB	O
strictly	RB	O
correspond	NN	O
to	TO	O
the	DT	O
clinical	JJ	O
definition	NN	O
of	IN	O
PWS	NNP	S_Disease
.	.	O

However	RB	O
,	,	O
the	DT	O
hypothesis	NN	O
that	IN	O
PWS	NNP	S_Disease
is	VBZ	O
associated	VBN	O
with	IN	O
deletion	NN	O
of	IN	O
15q11	CD	O
-	:	O
12	CD	O
can	MD	O
neither	RB	O
explain	VB	O
the	DT	O
apparently	RB	O
balanced	JJ	O
translocations	NNS	O
of	IN	O
chromosome	NN	O
15	CD	O
nor	CC	O
account	NN	O
for	IN	O
the	DT	O
small	JJ	O
supernumerary	JJ	O
metacentric	NN	O
chromosomes	NNS	O
corresponding	VBG	O
to	TO	O
an	DT	O
isochromosome	JJ	O
15	CD	O
for	IN	O
band	NN	O
15q11	CD	O
observed	VBN	O
in	IN	O
some	DT	O
cases	NNS	O
.	.	O
.	.	O

The	DT	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
gene	NN	O
in	IN	O
North	JJ	O
American	JJ	O
Jewish	JJ	O
populations	NNS	O
:	:	O
geographic	JJ	O
variations	NNS	O
and	CC	O
origin	NN	O
.	.	O

From	IN	O
data	NNS	O
collected	VBN	O
in	IN	O
a	DT	O
North	JJ	O
American	JJ	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
TSD	NNP	S_Disease
)	)	O
heterozygote	VBP	O
screening	VBG	O
program	NN	O
,	,	O
the	DT	O
TSD	NNP	S_Disease
carrier	NN	O
frequency	NN	O
among	IN	O
46	CD	O
,	,	O
304	CD	O
Jewish	JJ	O
individuals	NNS	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
.	.	O

0324	CD	O
(	(	O
1	CD	O
in	IN	O
31	CD	O
individuals	NNS	O
)	)	O
.	.	O

This	DT	O
frequency	NN	O
is	VBZ	O
consistent	JJ	O
with	IN	O
earlier	JJR	O
estimates	NNS	O
based	VBN	O
on	IN	O
TSD	NNP	S_Disease
incidence	NN	O
data	NNS	O
.	.	O

TSD	NNP	S_Disease
carrier	NN	O
frequencies	NNS	O
were	VBD	O
then	RB	O
examined	VBN	O
by	IN	O
single	JJ	O
country	NN	O
and	CC	O
single	JJ	O
region	NN	O
of	IN	O
origin	NN	O
in	IN	O
28	CD	O
,	,	O
029	CD	O
Jews	NNPS	O
within	IN	O
this	DT	O
sample	NN	O
for	IN	O
whom	WP	O
such	JJ	O
data	NNS	O
were	VBD	O
available	JJ	O
for	IN	O
analysis	NN	O
.	.	O

Jews	NNS	O
with	IN	O
Polish	JJ	O
and	CC	O
/	JJ	O
or	CC	O
Russian	JJ	O
ancestry	NN	O
constituted	VBD	O
88	CD	O
%	NN	O
of	IN	O
this	DT	O
sample	NN	O
and	CC	O
had	VBD	O
a	DT	O
TSD	NNP	S_Disease
carrier	NN	O
frequency	NN	O
of	IN	O
.	.	O

0327	CD	O
.	.	O

No	DT	O
TSD	NNP	S_Disease
carriers	NNS	O
were	VBD	O
observed	VBN	O
among	IN	O
the	DT	O
166	CD	O
Jews	NNS	O
of	IN	O
Near	NNP	O
Eastern	NNP	O
origins	VBZ	O
.	.	O

Relative	JJ	O
to	TO	O
Jews	NNPS	O
of	IN	O
Polish	NNPS	O
and	CC	O
Russian	JJ	O
origins	NNS	O
,	,	O
there	EX	O
was	VBD	O
at	IN	O
least	JJS	O
a	DT	O
twofold	JJ	O
increase	NN	O
in	IN	O
the	DT	O
TSD	NNP	S_Disease
carrier	NN	O
frequency	NN	O
in	IN	O
Jews	NNP	O
of	IN	O
Austrian	NNP	O
,	,	O
Hungarian	NNP	O
,	,	O
and	CC	O
Czechoslovakian	JJ	O
origins	NNS	O
(	(	O
P	NNP	O
less	JJR	O
than	IN	O
.	.	O

005	CD	O
)	)	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
TSD	NNP	S_Disease
gene	NN	O
proliferated	VBD	O
among	IN	O
the	DT	O
antecedents	NNS	O
of	IN	O
modern	JJ	O
Ashkenazi	NNP	O
Jewry	NNP	O
after	IN	O
the	DT	O
Second	JJ	O
Diaspora	NNP	O
(	(	O
70	CD	O
A	NNP	O
.	.	O

D	NNP	O
.	.	O
)	)	O
and	CC	O
before	IN	O
their	PRP$	O
major	JJ	O
migrations	NNS	O
to	TO	O
regions	NNS	O
of	IN	O
Poland	NNP	O
and	CC	O
Russia	NNP	O
(	(	O
before	IN	O
1100	CD	O
A	NNP	O
.	.	O

D	NNP	O
.	.	O
)	)	O
.	.	O

Human	NNP	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
sixth	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
meningococcal	JJ	B_Disease
meningitis	NN	E_Disease
and	CC	O
no	DT	O
haemostasis	NN	B_Disease
abnormality	NN	E_Disease
.	.	O

A	DT	O
case	NN	O
of	IN	O
human	JJ	O
complete	JJ	O
C6	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
reported	VBN	O
.	.	O

The	DT	O
patient	NN	O
,	,	O
a	DT	O
31	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
,	,	O
was	VBD	O
seen	VBN	O
on	IN	O
the	DT	O
occasion	NN	O
of	IN	O
an	DT	O
isolated	JJ	O
episode	NN	O
of	IN	O
meningococcal	JJ	B_Disease
meningitis	NN	E_Disease
.	.	O

Serum	NNP	O
complement	NN	O
hemolytic	NN	O
and	CC	O
bactericidal	JJ	O
activities	NNS	O
were	VBD	O
lacking	VBG	O
and	CC	O
could	MD	O
be	VB	O
restored	VBN	O
to	TO	O
normal	JJ	O
by	IN	O
addition	NN	O
of	IN	O
appropriate	JJ	O
amounts	NNS	O
of	IN	O
purified	JJ	O
C6	NNP	O
.	.	O

No	DT	O
hemostatic	JJ	B_Disease
abnormalities	NNS	E_Disease
were	VBD	O
observed	VBN	O
.	.	O
.	.	O

Absence	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
seventh	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
chronic	JJ	B_Disease
meningococcemia	NN	E_Disease
presenting	NN	O
as	IN	O
vasculitis	NN	S_Disease
.	.	O

A	DT	O
previously	RB	O
healthy	JJ	O
40	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
man	NN	O
presenting	VBG	O
with	IN	O
fever	NN	S_Disease
,	,	O
arthritis	NN	S_Disease
,	,	O
and	CC	O
cutaneous	JJ	B_Disease
vasculitis	NN	E_Disease
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
chronic	JJ	B_Disease
meningococcemia	NN	E_Disease
.	.	O

Evaluation	NN	O
of	IN	O
his	PRP$	O
complement	NN	O
system	NN	O
showed	VBD	O
an	DT	O
absence	NN	O
of	IN	O
functional	JJ	O
and	CC	O
antigenic	JJ	O
C7	NNP	O
,	,	O
compatible	JJ	O
with	IN	O
a	DT	O
complete	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
seventh	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
.	.	O

Study	NN	O
of	IN	O
the	DT	O
patients	NNS	O
family	NN	O
spanning	VBG	O
four	CD	O
generations	NNS	O
showed	VBD	O
heterozygous	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
C7	NNP	E_Disease
in	IN	O
five	CD	O
members	NNS	O
.	.	O

Chronic	NNP	B_Disease
neisserial	JJ	I_Disease
infection	NN	E_Disease
can	MD	O
be	VB	O
associated	VBN	O
with	IN	O
C7	NNP	B_Disease
deficiency	NN	E_Disease
and	CC	O
must	MD	O
be	VB	O
distinguished	VBN	O
from	IN	O
other	JJ	O
causes	NNS	O
of	IN	O
cutaneous	JJ	B_Disease
vasculitis	NN	E_Disease
.	.	O
.	.	O

Familial	JJ	B_Disease
discoid	NN	I_Disease
lupus	NN	I_Disease
erythematosus	NN	E_Disease
associated	VBN	O
with	IN	O
heterozygote	NN	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Two	CD	O
siblings	NNS	O
with	IN	O
chronic	JJ	B_Disease
discoid	NN	I_Disease
lupus	NN	I_Disease
erythematosus	NN	E_Disease
and	CC	O
several	JJ	O
family	NN	O
members	NNS	O
were	VBD	O
found	VBN	O
with	IN	O
heterozygous	JJ	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

An	DT	O
association	NN	O
with	IN	O
histocompatibility	NN	O
markers	NNS	O
HLA	NNP	O
-	:	O
B18	NNP	O
and	CC	O
HLA	NNP	O
-	:	O
Dw2	NN	O
was	VBD	O
demonstrated	VBN	O
,	,	O
and	CC	O
the	DT	O
slow	JJ	O
allotype	NN	O
of	IN	O
factor	NN	O
B	NNP	O
was	VBD	O
present	JJ	O
.	.	O

Linkage	NN	O
studies	NNS	O
in	IN	O
this	DT	O
family	NN	O
suggested	VBD	O
a	DT	O
close	JJ	O
linkage	NN	O
between	IN	O
the	DT	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
gene	NN	O
and	CC	O
genes	NNS	O
coding	VBG	O
for	IN	O
B18	NNP	O
,	,	O
Dw2	NNP	O
,	,	O
and	CC	O
BfS	NNP	O
antigens	NNS	O
.	.	O

One	CD	O
HLA	NNP	O
-	:	O
ACB	NNP	O
/	NNP	O
DBf	NNP	O
recombinant	NN	O
was	VBD	O
observed	VBN	O
showing	VBG	O
closer	RBR	O
linkage	NN	O
between	IN	O
HLA	NNP	O
-	:	O
D	NN	O
and	CC	O
Bf	NNP	O
than	IN	O
between	IN	O
HLA	NNP	O
-	:	O
B	NN	O
and	CC	O
Bf	NNP	O
.	.	O
.	.	O

Severe	NNP	B_Disease
-	:	I_Disease
glucose	JJ	I_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
associated	VBN	O
with	IN	O
chronic	JJ	O
hemolytic	JJ	B_Disease
anemia	NN	E_Disease
,	,	O
granulocyte	JJ	B_Disease
dysfunction	NN	E_Disease
,	,	O
and	CC	O
increased	VBD	O
susceptibility	NN	O
to	TO	O
infections	NNS	O
:	:	O
description	NN	O
of	IN	O
a	DT	O
new	JJ	O
molecular	JJ	O
variant	NN	O
(	(	O
G6PD	NNP	O
Barcelona	NNP	O
)	)	O
.	.	O

Molecular	NNP	O
,	,	O
kinetic	JJ	O
,	,	O
and	CC	O
functional	JJ	O
studies	NNS	O
were	VBD	O
carried	VBN	O
out	RP	O
on	IN	O
erythrocytes	NNS	O
and	CC	O
leukocytes	NNS	O
in	IN	O
a	DT	O
Spanish	JJ	O
male	NN	O
with	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
congenital	JJ	B_Disease
nonspherocytic	JJ	I_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
(	(	O
CNSHA	NNP	S_Disease
)	)	O
,	,	O
and	CC	O
increased	VBD	O
susceptibility	NN	O
to	TO	O
infections	NNS	O
.	.	O

G6PD	NNP	O
activity	NN	O
was	VBD	O
absent	JJ	O
in	IN	O
patients	NNS	O
red	JJ	O
cells	NNS	O
and	CC	O
was	VBD	O
about	RB	O
2	CD	O
%	NN	O
of	IN	O
normal	JJ	O
in	IN	O
leukocytes	NNS	O
.	.	O

Molecular	JJ	O
studies	NNS	O
using	VBG	O
standard	JJ	O
methods	NNS	O
(	(	O
WHO	NNP	O
,	,	O
1967	CD	O
)	)	O
showed	VBD	O
G6PD	NNP	O
in	IN	O
the	DT	O
patient	NN	O
to	TO	O
have	VB	O
a	DT	O
slightly	RB	O
fast	JJ	O
electrophoretic	JJ	O
mobility	NN	O
at	IN	O
pH	JJ	O
8	CD	O
.	.	O

0	CD	O
with	IN	O
otherwise	RB	O
normal	JJ	O
properties	NNS	O
(	(	O
heat	NN	O
stability	NN	O
at	IN	O
46	CD	O
degrees	NNS	O
C	NNP	O
,	,	O
apparent	JJ	O
affinity	NN	O
for	IN	O
substrates	NNS	O
,	,	O
optimum	JJ	O
pH	NN	O
,	,	O
and	CC	O
utilization	NN	O
of	IN	O
substrate	NN	O
analogues	NNS	O
)	)	O
.	.	O

Other	JJ	O
tests	NNS	O
showed	VBD	O
the	DT	O
patients	NNS	O
granulocytes	VBZ	O
to	TO	O
engulf	VB	O
latex	JJ	O
particles	NNS	O
normally	RB	O
,	,	O
but	CC	O
to	TO	O
have	VB	O
impaired	JJ	O
reduction	NN	O
of	IN	O
nitroblue	JJ	O
tetrazolium	NN	O
and	CC	O
ferricytochrome	JJ	O
-	:	O
c	NN	O
as	RB	O
well	RB	O
as	IN	O
reduced	VBN	O
iodination	NN	O
.	.	O

Chemotaxis	NNP	O
and	CC	O
random	JJ	O
migration	NN	O
of	IN	O
the	DT	O
patients	NNS	O
granulocytes	NNS	O
were	VBD	O
normal	JJ	O
as	IN	O
were	VBD	O
myeloperoxidase	NN	O
,	,	O
leukocyte	JJ	O
alkaline	NN	O
phosphatase	NN	O
(	(	O
LAP	NNP	O
)	)	O
,	,	O
and	CC	O
ultrastructural	JJ	O
features	NNS	O
.	.	O

The	DT	O
molecular	JJ	O
characteristics	NNS	O
of	IN	O
G6PD	NNP	O
in	IN	O
the	DT	O
patient	NN	O
differed	VBD	O
from	IN	O
those	DT	O
of	IN	O
all	DT	O
previously	RB	O
reported	VBN	O
variants	NNS	O
associated	VBN	O
with	IN	O
CNSHA	NNP	S_Disease
,	,	O
so	IN	O
the	DT	O
present	JJ	O
variant	NN	O
was	VBD	O
provisionally	RB	O
called	VBN	O
G6PD	NNP	O
Barcelona	NNP	O
to	TO	O
distinguish	VB	O
it	PRP	O
from	IN	O
other	JJ	O
G6PD	NNP	O
variants	NNS	O
previously	RB	O
described	VBN	O
.	.	O

Possible	JJ	O
mechanisms	NN	O
for	IN	O
the	DT	O
severe	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
G6PD	NNP	E_Disease
in	IN	O
erythrocytes	NNS	O
and	CC	O
granulocytes	NNS	O
was	VBD	O
investigated	VBN	O
by	IN	O
studies	NNS	O
on	IN	O
the	DT	O
immunologic	JJ	O
specific	JJ	O
activity	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
enzyme	NN	O
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
deficiency	NN	E_Disease
in	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O

The	DT	O
description	NN	O
of	IN	O
13	CD	O
new	JJ	O
variants	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
362	CD	O
males	NNS	O
from	IN	O
various	JJ	O
regions	NNS	O
of	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
were	VBD	O
screened	VBN	O
for	IN	O
red	JJ	O
cell	NN	O
glucose	VB	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
activity	NN	O
.	.	O

Twenty	NNP	O
-	:	O
six	CD	O
G6PD	NNP	B_Disease
deficient	NN	E_Disease
individuals	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

Biochemical	JJ	O
characterization	NN	O
of	IN	O
G6PD	NNP	O
purified	VBD	O
from	IN	O
these	DT	O
subjects	NNS	O
has	VBZ	O
revealed	VBN	O
13	CD	O
new	JJ	O
variants	NNS	O
and	CC	O
several	JJ	O
copies	NNS	O
of	IN	O
previously	RB	O
described	VBN	O
forms	NNS	O
of	IN	O
G6PD	NNP	O
.	.	O

This	DT	O
study	NN	O
illustrates	VBZ	O
the	DT	O
extreme	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
among	IN	O
the	DT	O
people	NNS	O
of	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O
.	.	O

Heterogeneity	NN	O
of	IN	O
"	JJ	O
Mediterranean	NNP	O
type	NN	O
"	NN	O
glucose	VBD	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
in	IN	O
Spain	NNP	O
and	CC	O
description	NN	O
of	IN	O
two	CD	O
new	JJ	O
variants	NNS	O
associated	VBN	O
with	IN	O
favism	NN	S_Disease
.	.	O

Glucose	NNP	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
;	:	O
EC	NNP	O
1	CD	O
.	.	O

1	CD	O
.	.	O

1	CD	O
.	.	O

49	CD	O
from	IN	O
thirty	JJ	O
-	:	O
six	CD	O
unrelated	JJ	O
Spanish	JJ	O
males	NNS	O
was	VBD	O
partially	RB	O
purified	VBN	O
from	IN	O
blood	NN	O
,	,	O
and	CC	O
the	DT	O
variants	NNS	O
were	VBD	O
characterized	VBN	O
biochemically	RB	O
and	CC	O
electrophoretically	RB	O
according	VBG	O
to	TO	O
the	DT	O
methods	NNS	O
recommended	VBN	O
by	IN	O
the	DT	O
world	NN	O
Health	NNP	O
Organization	NNP	O
.	.	O

Subjects	NNS	O
were	VBD	O
from	IN	O
multiple	JJ	O
geographic	JJ	O
regions	NNS	O
within	IN	O
Spain	NNP	O
,	,	O
and	CC	O
all	DT	O
suffered	VBD	O
from	IN	O
hemolytic	JJ	B_Disease
anemia	NN	E_Disease
,	,	O
either	DT	O
acute	NN	O
(	(	O
34	CD	O
cases	NNS	O
)	)	O
or	CC	O
chronic	JJ	O
nonspherocytic	JJ	O
(	(	O
2	CD	O
cases	NNS	O
)	)	O
.	.	O

Almost	RB	O
all	PDT	O
the	DT	O
variants	NNS	O
studied	VBN	O
presented	VBN	O
residual	JJ	O
erythrocyte	NN	O
G6PD	NNP	O
activity	NN	O
ranging	VBG	O
from	IN	O
0	CD	O
to	TO	O
10	CD	O
%	NN	O
of	IN	O
normal	JJ	O
,	,	O
and	CC	O
five	CD	O
different	JJ	O
mutants	NNS	O
were	VBD	O
responsible	JJ	O
for	IN	O
the	DT	O
deficient	NN	O
phenotype	NN	O
.	.	O

Three	CD	O
variants	NNS	O
were	VBD	O
similar	JJ	O
to	TO	O
others	NNS	O
previously	RB	O
described	VBN	O
G6PD	NNP	O
Mediterranean	NNP	O
(	(	O
11	CD	O
cases	NNS	O
)	)	O
,	,	O
G6PD	NNP	O
Athens	NNP	O
-	:	O
like	IN	O
(	(	O
3	CD	O
cases	NNS	O
)	)	O
,	,	O
and	CC	O
G6PD	NNP	O
Union	NNP	O
(	(	O
2	CD	O
cases	NNS	O
)	)	O
.	.	O

The	DT	O
remaining	VBG	O
variants	NNS	O
were	VBD	O
different	JJ	O
from	IN	O
the	DT	O
numerous	JJ	O
variants	NNS	O
already	RB	O
reported	VBN	O
and	CC	O
have	VBP	O
been	VBN	O
considered	VBN	O
as	IN	O
new	JJ	O
mutants	NNS	O
.	.	O

Provisionally	RB	O
they	PRP	O
are	VBP	O
called	VBN	O
G6PD	NNP	O
Betica	NNP	O
(	(	O
19	CD	O
cases	NNS	O
)	)	O
and	CC	O
G6PD	NNP	O
Menorca	NNP	O
(	(	O
1	CD	O
case	NN	O
)	)	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
constitutes	VBZ	O
the	DT	O
first	JJ	O
attempt	NN	O
to	TO	O
characterize	VB	O
the	DT	O
deficient	NN	B_Disease
G6PD	NNP	E_Disease
variants	NNS	O
found	VBD	O
in	IN	O
Spain	NNP	O
and	CC	O
supplies	NNS	O
new	JJ	O
data	NNS	O
on	IN	O
the	DT	O
relationship	NN	O
between	IN	O
molecular	JJ	O
characteristics	NNS	O
of	IN	O
deficient	NN	O
variants	NNS	O
and	CC	O
their	PRP$	O
clinical	JJ	O
manifestations	NNS	O
.	.	O

The	DT	O
most	RBS	O
important	JJ	O
findings	NNS	O
can	MD	O
be	VB	O
summarized	VBN	O
as	IN	O
follows	VBZ	O
(	(	O
1	CD	O
)	)	O
The	DT	O
Spanish	JJ	O
population	NN	O
is	VBZ	O
characterized	VBN	O
by	IN	O
an	DT	O
important	JJ	O
heterogeneity	NN	O
in	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

(	(	O
2	CD	O
)	)	O
Although	IN	O
G6PD	NNP	O
Mediterranean	NNP	O
is	VBZ	O
very	RB	O
frequent	JJ	O
,	,	O
it	PRP	O
presents	VBZ	O
a	DT	O
relatively	RB	O
high	JJ	O
degree	NN	O
of	IN	O
polymorphism	NN	O
.	.	O

(	(	O
3	CD	O
)	)	O
Favism	NN	S_Disease
has	VBZ	O
been	VBN	O
observed	VBN	O
associated	VBN	O
with	IN	O
all	DT	O
kinds	NNS	O
of	IN	O
variants	NNS	O
described	VBN	O
here	RB	O
.	.	O

(	(	O
4	CD	O
)	)	O
G6PD	NNP	O
Betica	NNP	O
,	,	O
which	WDT	O
is	VBZ	O
the	DT	O
most	RBS	O
frequent	JJ	O
variant	NN	O
found	VBD	O
in	IN	O
subjects	NNS	O
of	IN	O
Southern	NNP	O
Spanish	NNP	O
origin	NN	O
,	,	O
has	VBZ	O
been	VBN	O
observed	VBN	O
associated	VBN	O
with	IN	O
favism	NN	S_Disease
in	IN	O
all	DT	O
cases	NNS	O
except	IN	O
one	CD	O
.	.	O

A	DT	O
new	JJ	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
variant	NN	O
(	(	O
G6PD	NNP	O
Nagano	NNP	O
)	)	O
associated	VBN	O
with	IN	O
congenital	JJ	B_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
.	.	O

A	DT	O
new	JJ	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
variant	NN	O
associated	VBN	O
with	IN	O
chronic	JJ	B_Disease
nonspherocytic	JJ	I_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
was	VBD	O
reported	VBN	O
.	.	O

The	DT	O
patient	NN	O
,	,	O
a	DT	O
6	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
Japanese	JJ	O
male	NN	O
,	,	O
was	VBD	O
noticed	VBN	O
to	TO	O
have	VB	O
hemolytic	JJ	B_Disease
anemia	NN	E_Disease
soon	RB	O
after	IN	O
birth	NN	O
,	,	O
and	CC	O
a	DT	O
diagnosis	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
was	VBD	O
made	VBN	O
at	IN	O
the	DT	O
age	NN	O
of	IN	O
2	CD	O
.	.	O

He	PRP	O
had	VBD	O
episodes	NNS	O
of	IN	O
hemolytic	JJ	B_Disease
crisis	NN	E_Disease
several	JJ	O
times	NNS	O
after	IN	O
upper	JJ	B_Disease
respiratory	NN	I_Disease
infection	NN	E_Disease
.	.	O

G6PD	NNP	O
activity	NN	O
of	IN	O
the	DT	O
patient	NN	O
was	VBD	O
5	CD	O
.	.	O

5	CD	O
%	NN	O
of	IN	O
normal	JJ	O
.	.	O

The	DT	O
enzymatic	JJ	O
characteristics	NNS	O
were	VBD	O
examined	VBN	O
when	WRB	O
he	PRP	O
was	VBD	O
5	CD	O
years	NNS	O
old	JJ	O
,	,	O
and	CC	O
his	PRP$	O
G6PD	NN	O
showed	VBD	O
faster	RBR	O
-	:	O
than	IN	O
-	:	O
normal	JJ	O
electrophoretic	JJ	O
mobility	NN	O
,	,	O
low	JJ	O
Km	NNP	O
G6P	NNP	O
,	,	O
high	JJ	O
Km	NNP	O
NADP	NNP	O
,	,	O
low	JJ	O
Ki	NNP	O
NADPH	NNP	O
,	,	O
normal	JJ	O
utilization	NN	O
of	IN	O
substrate	NN	O
analogues	NNS	O
,	,	O
heat	NN	O
instability	NN	O
,	,	O
and	CC	O
a	DT	O
normal	JJ	O
pH	NN	O
optimum	JJ	O
curve	NN	O
.	.	O

From	IN	O
these	DT	O
results	NNS	O
,	,	O
this	DT	O
was	VBD	O
considered	VBN	O
to	TO	O
be	VB	O
a	DT	O
new	JJ	O
variant	NN	O
and	CC	O
was	VBD	O
designated	VBN	O
G6PD	NNP	O
Nagano	NNP	O
.	.	O

Infection	NNP	O
-	:	O
induced	JJ	O
hemolysis	NN	S_Disease
and	CC	O
chronic	JJ	B_Disease
hemolytic	JJ	I_Disease
anemia	NN	E_Disease
seem	VBP	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
markedly	RB	O
impaired	JJ	O
enzyme	NN	O
activity	NN	O
and	CC	O
thermal	JJ	O
instability	NN	O
.	.	O

Heterozygous	JJ	O
C2	NNP	B_Disease
-	:	I_Disease
deficiency	NN	E_Disease
and	CC	O
myasthenia	NN	B_Disease
gravis	NN	E_Disease
.	.	O

Complement	NNP	B_Disease
deficiency	NN	E_Disease
states	NNS	O
in	IN	O
myasthenia	NN	B_Disease
gravis	NN	E_Disease
(	(	O
MG	NNP	S_Disease
)	)	O
have	VBP	O
not	RB	O
been	VBN	O
reported	VBN	O
previously	RB	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
19	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
woman	NN	O
with	IN	O
typical	JJ	O
MG	NNP	S_Disease
and	CC	O
heterozygous	JJ	O
C2	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
along	IN	O
with	IN	O
HLA	NNP	O
typing	NN	O
of	IN	O
the	DT	O
patient	NN	O
and	CC	O
her	PRP$	O
immediate	JJ	O
family	NN	O
.	.	O
.	.	O

Adrenoleukodystrophy	NN	S_Disease
:	:	O
increased	VBN	O
plasma	NN	O
content	NN	O
of	IN	O
saturated	JJ	O
very	RB	O
long	RB	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
.	.	O

With	IN	O
a	DT	O
new	JJ	O
method	NN	O
we	PRP	O
measured	VBD	O
the	DT	O
saturated	JJ	O
very	RB	O
long	RB	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
in	IN	O
the	DT	O
plasma	NN	O
of	IN	O
adrenoleukodystrophy	NN	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
hemizygotes	VBZ	O
,	,	O
ALD	NNP	S_Disease
heterozygotes	VBZ	O
,	,	O
and	CC	O
controls	NNS	O
.	.	O

ALD	NNP	S_Disease
hemizygotes	VBZ	O
showed	VBD	O
increased	JJ	O
levels	NNS	O
of	IN	O
hexacosanoate	NN	O
(	(	O
C26	NNP	O
fatty	RB	O
acid	NN	O
)	)	O
which	WDT	O
represented	VBD	O
0	CD	O
.	.	O

081	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

0066	CD	O
%	NN	O
(	(	O
SEM	NNP	O
)	)	O
of	IN	O
total	JJ	O
fatty	JJ	O
acids	NNS	O
,	,	O
compared	VBN	O
to	TO	O
0	CD	O
.	.	O

015	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

0032	CD	O
%	NN	O
in	IN	O
the	DT	O
controls	NNS	O
.	.	O

C25	NNP	O
,	,	O
C24	NNP	O
,	,	O
and	CC	O
C23	NNP	O
fatty	JJ	O
acids	NNS	O
were	VBD	O
also	RB	O
increased	VBN	O
,	,	O
but	CC	O
the	DT	O
C22	NNP	O
and	CC	O
C20	NNP	O
fatty	JJ	O
acids	NNS	O
were	VBD	O
normal	JJ	O
.	.	O

C26	NN	O
levels	NNS	O
were	VBD	O
also	RB	O
increased	VBN	O
in	IN	O
most	JJS	O
ALD	NNP	S_Disease
heterozygotes	VBZ	O
,	,	O
with	IN	O
a	DT	O
mean	JJ	O
level	NN	O
0	CD	O
.	.	O

057	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

0063	CD	O
%	NN	O
of	IN	O
total	JJ	O
fatty	JJ	O
acids	NNS	O
.	.	O

The	DT	O
technique	NN	O
can	MD	O
be	VB	O
used	VBN	O
for	IN	O
diagnosis	NN	O
and	CC	O
carrier	NN	O
identification	NN	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
evaluation	NN	O
of	IN	O
therapy	NN	O
.	.	O

Abnormal	JJ	O
high	JJ	O
density	NN	O
lipoproteins	NNS	O
in	IN	O
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
.	.	O

The	DT	O
plasma	NN	O
lipoprotein	NN	O
profiles	NNS	O
and	CC	O
high	JJ	O
density	NN	O
lipoproteins	NNS	O
(	(	O
HDL	NNP	O
)	)	O
were	VBD	O
characterized	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
genetic	JJ	B_Disease
disease	NN	E_Disease
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
(	(	O
CTX	NNP	S_Disease
)	)	O
.	.	O

Abnormalities	NNS	B_Disease
in	IN	I_Disease
the	DT	I_Disease
HDL	NNP	E_Disease
may	MD	O
contribute	VB	O
to	TO	O
their	PRP$	O
increased	VBN	O
atherogenesis	NN	O
and	CC	O
excessive	JJ	O
deposits	NNS	O
of	IN	O
tissue	NN	O
sterols	NNS	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
low	JJ	O
or	CC	O
low	JJ	O
-	:	O
normal	JJ	O
concentrations	NNS	O
of	IN	O
plasma	NN	O
cholesterol	NN	O
(	(	O
165	CD	O
+	NN	O
/	NNP	O
-	:	O
25	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
)	)	O
and	CC	O
low	JJ	O
density	NN	O
lipoproteins	NNS	O
(	(	O
LDL	NNP	O
)	)	O
.	.	O

The	DT	O
mean	NN	O
HDL	NNP	O
-	:	O
cholesterol	NN	O
concentration	NN	O
in	IN	O
the	DT	O
CTX	NNP	S_Disease
plasmas	NN	O
was	VBD	O
14	CD	O
.	.	O

5	CD	O
+	JJ	O
/	NNP	O
-	:	O
3	CD	O
.	.	O

2	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
,	,	O
about	IN	O
one	CD	O
-	:	O
third	VBZ	O
the	DT	O
normal	JJ	O
value	NN	O
.	.	O

The	DT	O
low	JJ	O
HDL	NNP	O
-	:	O
cholesterol	NN	O
reflects	VBZ	O
a	DT	O
low	JJ	O
concentration	NN	O
and	CC	O
an	DT	O
abnormal	JJ	O
lipid	JJ	O
composition	NN	O
of	IN	O
the	DT	O
plasma	NN	O
HDL	NNP	O
.	.	O

Relative	JJ	O
to	TO	O
normal	JJ	O
HDL	NNP	O
,	,	O
the	DT	O
cholesteryl	NN	O
esters	NNS	O
are	VBP	O
low	JJ	O
,	,	O
free	JJ	O
cholesterol	NN	O
and	CC	O
phospholipids	NNS	O
essentially	RB	O
normal	JJ	O
,	,	O
and	CC	O
triglycerides	NNS	O
increased	VBD	O
.	.	O

The	DT	O
ratio	NN	O
of	IN	O
apoprotein	NN	O
(	(	O
apo	NN	O
)	)	O
to	TO	O
total	JJ	O
cholesterol	NN	O
in	IN	O
the	DT	O
HDL	NNP	O
of	IN	O
CTX	NNP	S_Disease
was	VBD	O
two	CD	O
to	TO	O
three	CD	O
times	NNS	O
greater	JJR	O
than	IN	O
normal	JJ	O
.	.	O

In	IN	O
the	DT	O
CTX	NNP	S_Disease
HDL	NNP	O
,	,	O
the	DT	O
ratio	NN	O
of	IN	O
apoAI	NN	O
to	TO	O
apoAII	VB	O
was	VBD	O
high	JJ	O
,	,	O
the	DT	O
proportion	NN	O
of	IN	O
apoC	NN	O
low	JJ	O
,	,	O
and	CC	O
a	DT	O
normally	RB	O
minor	JJ	O
form	NN	O
of	IN	O
apoAI	NN	O
increased	VBD	O
relative	JJ	O
to	TO	O
other	JJ	O
forms	NNS	O
.	.	O

The	DT	O
HDL	NNP	O
in	IN	O
electron	NNP	O
micrographs	NN	O
appeared	VBD	O
normal	JJ	O
morphologically	RB	O
and	CC	O
in	IN	O
particle	NN	O
size	NN	O
.	.	O

The	DT	O
abnormalities	NNS	O
in	IN	O
lipoprotein	JJ	O
distribution	NN	O
profile	NN	O
and	CC	O
composition	NN	O
of	IN	O
the	DT	O
plasma	NN	O
HDL	NNP	O
result	NN	O
from	IN	O
metabolic	JJ	O
defects	NNS	O
that	WDT	O
are	VBP	O
not	RB	O
understood	JJ	O
but	CC	O
may	MD	O
be	VB	O
linked	VBN	O
to	TO	O
the	DT	O
genetic	JJ	B_Disease
defect	NN	E_Disease
in	IN	O
bile	JJ	O
acid	JJ	O
synthesis	NN	O
in	IN	O
CTX	NNP	S_Disease
.	.	O

As	IN	O
a	DT	O
consequence	NN	O
,	,	O
it	PRP	O
is	VBZ	O
probable	JJ	O
that	IN	O
the	DT	O
normal	JJ	O
functions	NNS	O
of	IN	O
the	DT	O
HDL	NNP	O
,	,	O
possibly	RB	O
including	VBG	O
modulation	NN	O
of	IN	O
LDL	NNP	O
-	:	O
cholesterol	NN	O
uptake	NN	O
and	CC	O
the	DT	O
removal	NN	O
of	IN	O
excess	JJ	O
cholesterol	NN	O
from	IN	O
peripheral	JJ	O
tissues	NNS	O
,	,	O
are	VBP	O
perturbed	VBN	O
significantly	RB	O
in	IN	O
this	DT	O
disease	NN	O
.	.	O

Genetics	NNS	O
of	IN	O
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
(	(	O
CTX	NNP	S_Disease
)	)	O
:	:	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
trait	NN	O
with	IN	O
high	JJ	O
gene	NN	O
frequency	NN	O
in	IN	O
Sephardim	NNP	O
of	IN	O
Moroccan	NNP	O
origin	NN	O
.	.	O

We	PRP	O
described	VBD	O
6	CD	O
patients	NNS	O
(	(	O
from	IN	O
3	CD	O
families	NNS	O
)	)	O
affected	VBD	O
with	IN	O
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
(	(	O
CTX	NNP	S_Disease
)	)	O
.	.	O

All	DT	O
are	VBP	O
Sephardic	JJ	O
Jews	NNP	O
of	IN	O
Moroccan	NNP	O
extraction	NN	O
.	.	O

In	IN	O
view	NN	O
of	IN	O
the	DT	O
small	JJ	O
number	NN	O
of	IN	O
CTX	NNP	S_Disease
patients	NNS	O
diagnosed	VBD	O
in	IN	O
the	DT	O
world	NN	O
(	(	O
a	DT	O
total	NN	O
of	IN	O
50	CD	O
including	VBG	O
our	PRP$	O
6	CD	O
patients	NNS	O
)	)	O
,	,	O
we	PRP	O
are	VBP	O
probably	RB	O
dealing	VBG	O
with	IN	O
an	DT	O
ethnic	JJ	O
subgroup	NN	O
with	IN	O
a	DT	O
high	JJ	O
CTX	NNP	O
gene	NN	O
frequency	NN	O
,	,	O
which	WDT	O
we	PRP	O
have	VBP	O
estimated	VBN	O
to	TO	O
be	VB	O
1	CD	O
/	JJ	O
108	CD	O
.	.	O

Since	IN	O
there	EX	O
are	VBP	O
differences	NNS	O
in	IN	O
expression	NN	O
in	IN	O
this	DT	O
disease	NN	O
,	,	O
we	PRP	O
recommend	VBP	O
cholestanol	JJ	O
study	NN	O
in	IN	O
cases	NNS	O
of	IN	O
undiagnosed	JJ	O
cataract	NN	S_Disease
or	CC	O
tendinous	JJ	B_Disease
xanthomas	NNS	E_Disease
in	IN	O
childhood	NN	O
or	CC	O
early	JJ	O
adolescence	NN	O
.	.	O

The	DT	O
diagnosis	NN	O
in	IN	O
CTX	NNP	S_Disease
is	VBZ	O
important	JJ	O
not	RB	O
only	RB	O
for	IN	O
genetic	JJ	O
counseling	NN	O
,	,	O
but	CC	O
also	RB	O
in	IN	O
veiw	NN	O
of	IN	O
possible	JJ	O
treatment	NN	O
.	.	O
.	.	O

New	NNP	O
genetic	JJ	O
variants	NNS	O
of	IN	O
glucose	JJ	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
in	IN	O
Italy	NNP	O
.	.	O

Six	CD	O
new	JJ	O
variants	NNS	O
of	IN	O
human	JJ	O
erythrocyte	NN	O
G6PD	NNP	O
have	VBP	O
been	VBN	O
characterized	VBN	O
.	.	O

All	DT	O
of	IN	O
them	PRP	O
were	VBD	O
found	VBN	O
in	IN	O
Italian	JJ	O
males	NNS	O
and	CC	O
all	DT	O
were	VBD	O
associated	VBN	O
with	IN	O
enzyme	JJ	B_Disease
deficiency	NN	E_Disease
,	,	O
but	CC	O
only	RB	O
two	CD	O
with	IN	O
signs	NNS	O
of	IN	O
haemolysis	NN	S_Disease
.	.	O

These	DT	O
and	CC	O
other	JJ	O
variants	NNS	O
reported	VBN	O
in	IN	O
the	DT	O
literature	NN	O
,	,	O
which	WDT	O
must	MD	O
thus	RB	O
far	RB	O
be	VB	O
regarded	VBN	O
as	IN	O
sporadic	NN	O
,	,	O
are	VBP	O
found	VBN	O
to	TO	O
map	VB	O
in	IN	O
parts	NNS	O
of	IN	O
Italy	NNP	O
where	WRB	O
common	JJ	O
types	NNS	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
are	VBP	O
also	RB	O
prevalent	JJ	O
.	.	O
.	.	O

Variants	NNS	O
of	IN	O
erythrocyte	NN	O
glucose	VBP	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
(	(	O
G6PD	NNP	O
)	)	O
in	IN	O
Bulgarian	JJ	O
populations	NNS	O
.	.	O

Ten	CD	O
variants	NNS	O
of	IN	O
erythrocyte	NN	O
glucose	VBP	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
were	VBD	O
identified	VBN	O
in	IN	O
22	CD	O
patients	NNS	O
with	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
from	IN	O
three	CD	O
districts	NNS	O
of	IN	O
Bulgaria	NNP	O
.	.	O

Corinth	NNP	O
-	:	O
like	IN	O
and	CC	O
Fayoum	NNP	O
-	:	O
like	IN	O
variants	NNS	O
were	VBD	O
the	DT	O
most	RBS	O
frequent	JJ	O
;	:	O
Mediterranean	NNP	O
,	,	O
Ohut	NNP	O
II	NNP	O
,	,	O
Kilgore	NNP	O
,	,	O
Boston	NNP	O
,	,	O
Poznan	NNP	O
,	,	O
and	CC	O
Panay	NNP	O
variants	NNS	O
and	CC	O
two	CD	O
new	JJ	O
variants	NNS	O
,	,	O
Petrich	NNP	O
and	CC	O
Gotze	NNP	O
Delchev	NNP	O
,	,	O
were	VBD	O
each	DT	O
found	VBN	O
in	IN	O
one	CD	O
or	CC	O
two	CD	O
carriers	NNS	O
.	.	O

No	DT	O
correlation	NN	O
was	VBD	O
revealed	VBN	O
between	IN	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
polymorphism	NN	O
.	.	O
.	.	O

Nephropathy	NNP	S_Disease
in	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Nephropathy	NNP	S_Disease
was	VBD	O
detected	VBN	O
in	IN	O
five	CD	O
of	IN	O
32	CD	O
patients	NNS	O
with	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
who	WP	O
were	VBD	O
participating	VBG	O
in	IN	O
a	DT	O
study	NN	O
of	IN	O
transfer	NN	O
factor	NN	O
(	(	O
TF	NNP	O
)	)	O
therapy	NN	O
.	.	O

In	IN	O
two	CD	O
patients	NNS	O
,	,	O
nephropathy	NN	S_Disease
was	VBD	O
present	JJ	O
before	IN	O
TF	NNP	O
and	CC	O
did	VBD	O
not	RB	O
appear	VB	O
changed	VBN	O
by	IN	O
TF	NNP	O
therapy	NN	O
.	.	O

One	CD	O
of	IN	O
these	DT	O
patients	NNS	O
subsequently	RB	O
developed	VBD	O
progressive	JJ	O
renal	JJ	B_Disease
failure	NN	E_Disease
requiring	VBG	O
dialysis	NN	O
beginning	VBG	O
5	CD	O
1	CD	O
/	JJ	O
2	CD	O
years	NNS	O
after	IN	O
TF	NNP	O
therapy	NN	O
.	.	O

In	IN	O
two	CD	O
patients	NNS	O
,	,	O
decreased	VBD	O
renal	JJ	O
function	NN	O
appeared	VBD	O
very	RB	O
soon	RB	O
after	IN	O
the	DT	O
administration	NN	O
of	IN	O
TF	NNP	O
.	.	O

One	CD	O
patient	NN	O
showed	VBD	O
gradually	RB	O
decreasing	VBG	O
renal	JJ	O
function	NN	O
beginning	VBG	O
after	IN	O
two	CD	O
years	NNS	O
of	IN	O
TF	NNP	O
therapy	NN	O
.	.	O

An	DT	O
additional	JJ	O
patient	NN	O
was	VBD	O
identified	VBN	O
who	WP	O
died	VBD	O
with	IN	O
renal	JJ	B_Disease
failure	NN	E_Disease
without	IN	O
having	VBG	O
received	VBN	O
TF	NNP	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
renal	JJ	B_Disease
failure	NN	E_Disease
occurs	VBZ	O
in	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	VBD	E_Disease
more	RBR	O
frequently	RB	O
than	IN	O
generally	RB	O
recognized	VBN	O
and	CC	O
that	DT	O
administration	NN	O
of	IN	O
TF	NNP	O
may	MD	O
precipitate	VB	O
or	CC	O
accelerate	VB	O
the	DT	O
renal	JJ	B_Disease
disease	NN	E_Disease
in	IN	O
patients	NNS	O
with	IN	O
this	DT	O
syndrome	NN	O
.	.	O
.	.	O

Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	JJ	I_Disease
syndrome	NN	E_Disease
:	:	O
cellular	JJ	O
impairments	NNS	O
and	CC	O
their	PRP$	O
implication	NN	O
for	IN	O
carrier	NN	O
detection	NN	O
.	.	O

A	DT	O
family	NN	O
in	IN	O
which	WDT	O
two	CD	O
male	NN	O
siblings	NNS	O
were	VBD	O
affected	VBN	O
with	IN	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
was	VBD	O
studied	VBN	O
using	VBG	O
G	NNP	O
-	:	O
6	CD	O
-	:	O
PD	NN	O
isoenzymes	NNS	O
as	IN	O
an	DT	O
X	NNP	O
-	:	O
linked	VBN	O
marker	NN	O
in	IN	O
order	NN	O
to	TO	O
investigate	VB	O
the	DT	O
nature	NN	O
of	IN	O
cellular	JJ	O
abnormalities	NNS	O
.	.	O

Isolated	JJ	O
peripheral	JJ	O
blood	NN	O
cell	NN	O
types	NNS	O
from	IN	O
the	DT	O
doubly	RB	O
heterozygous	JJ	O
mother	NN	O
of	IN	O
the	DT	O
affected	JJ	O
males	NNS	O
seemingly	RB	O
failed	VBD	O
to	TO	O
express	VB	O
the	DT	O
G	NNP	O
-	:	O
6	CD	O
-	:	O
PD	NN	O
allele	NN	O
in	IN	O
cis	JJ	O
position	NN	O
with	IN	O
the	DT	O
WAS	NNP	S_Disease
allele	NN	O
while	IN	O
her	PRP$	O
cultured	JJ	O
skin	NN	O
fibroblasts	NNS	O
expressed	VBD	O
both	DT	O
G	NNP	O
-	:	O
6	CD	O
-	:	O
PD	NN	O
alleles	NNS	O
.	.	O

Additionally	RB	O
,	,	O
a	DT	O
histogram	JJ	O
analysis	NN	O
of	IN	O
platelet	NN	O
size	NN	O
revealed	VBD	O
a	DT	O
single	JJ	O
population	NN	O
of	IN	O
abnormally	RB	O
small	JJ	O
platelets	NNS	O
in	IN	O
the	DT	O
affected	JJ	O
propositus	NN	O
,	,	O
whereas	IN	O
the	DT	O
heterozygous	JJ	O
mother	NN	O
had	VBD	O
no	DT	O
appreciable	JJ	O
small	JJ	O
platelet	NN	O
subpopulation	NN	O
.	.	O

In	IN	O
vitro	JJ	O
culture	NN	O
of	IN	O
hemopoietic	JJ	O
progenitor	NN	O
cells	NNS	O
of	IN	O
the	DT	O
heterozygous	JJ	O
mother	NN	O
showed	VBD	O
that	IN	O
the	DT	O
majority	NN	O
of	IN	O
progenitor	NN	O
cells	NNS	O
did	VBD	O
not	RB	O
express	VB	O
the	DT	O
WAS	NNP	S_Disease
allele	NN	O
.	.	O

However	RB	O
,	,	O
a	DT	O
small	JJ	O
number	NN	O
of	IN	O
cells	NNS	O
expressing	VBG	O
the	DT	O
G	NNP	O
-	:	O
6	CD	O
-	:	O
PD	NN	O
type	NN	O
linked	VBN	O
with	IN	O
the	DT	O
WAS	NNP	S_Disease
allele	NN	O
were	VBD	O
detected	VBN	O
.	.	O

The	DT	O
proportion	NN	O
of	IN	O
the	DT	O
latter	JJ	O
progenitors	NNS	O
was	VBD	O
significantly	RB	O
higher	JJR	O
among	IN	O
more	RBR	O
primitive	JJ	O
progenitors	NNS	O
(	(	O
those	DT	O
giving	VBG	O
rise	NN	O
to	TO	O
later	RB	O
appearing	VBG	O
colonies	NNS	O
)	)	O
.	.	O

This	DT	O
observation	NN	O
suggests	VBZ	O
that	IN	O
selection	NN	O
against	IN	O
cells	NNS	O
expressing	VBG	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
defect	VBP	E_Disease
takes	VBZ	O
place	NN	O
in	IN	O
the	DT	O
hemopoietic	JJ	O
system	NN	O
of	IN	O
the	DT	O
heterozygous	JJ	O
female	NN	O
and	CC	O
offers	VBZ	O
a	DT	O
possible	JJ	O
means	NN	O
of	IN	O
carrier	NN	O
detection	NN	O
in	IN	O
some	DT	O
women	NNS	O
.	.	O

Linkage	NN	O
studies	NNS	O
in	IN	O
this	DT	O
family	NN	O
revealed	VBD	O
one	CD	O
example	NN	O
of	IN	O
probable	JJ	O
recombination	NN	O
between	IN	O
the	DT	O
loci	NN	O
for	IN	O
WAS	NNP	S_Disease
and	CC	O
G	NNP	O
-	:	O
6	CD	O
-	:	O
PD	NN	O
among	IN	O
three	CD	O
informative	JJ	O
subjects	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
these	DT	O
two	CD	O
loci	NN	O
may	MD	O
not	RB	O
be	VB	O
closely	RB	O
linked	VBN	O
on	IN	O
the	DT	O
X	NNP	O
-	:	O
chromosome	NN	O
.	.	O
.	.	O

A	DT	O
new	JJ	O
CT	NNP	O
pattern	NN	O
in	IN	O
adrenoleukodystrophy	NN	S_Disease
.	.	O

A	DT	O
new	JJ	O
CT	NNP	O
pattern	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
2	CD	O
patients	NNS	O
with	IN	O
adrenoleukodystrophy	NN	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
.	.	O

This	DT	O
pattern	NN	O
,	,	O
which	WDT	O
the	DT	O
authors	NNS	O
call	VBP	O
Type	NNP	O
II	NNP	O
,	,	O
is	VBZ	O
characterized	VBN	O
by	IN	O
the	DT	O
absence	NN	O
of	IN	O
posterior	JJ	O
periventricular	JJ	O
areas	NNS	O
of	IN	O
decreased	JJ	O
attenuation	NN	O
around	IN	O
the	DT	O
trigone	NN	O
on	IN	O
non	JJ	O
-	:	O
contrast	NN	O
scans	NNS	O
after	IN	O
contrast	NN	O
infusion	NN	O
,	,	O
however	RB	O
,	,	O
there	EX	O
is	VBZ	O
striking	VBG	O
enhancement	NN	O
of	IN	O
various	JJ	O
white	JJ	O
-	:	O
matter	NN	O
structures	NNS	O
(	(	O
tracts	NNS	O
or	CC	O
fiber	VB	O
systems	NNS	O
)	)	O
such	JJ	O
as	IN	O
the	DT	O
internal	JJ	O
capsules	NNS	O
,	,	O
corpus	NN	O
callosum	NN	O
,	,	O
corona	NN	O
radiata	NN	O
,	,	O
forceps	JJ	O
major	JJ	O
,	,	O
and	CC	O
cerebral	JJ	O
peduncles	NNS	O
.	.	O

This	DT	O
is	VBZ	O
different	JJ	O
from	IN	O
numerous	JJ	O
previous	JJ	O
descriptions	NNS	O
of	IN	O
the	DT	O
CT	NNP	O
pattern	NN	O
in	IN	O
ALD	NNP	S_Disease
.	.	O

Type	NNP	B_Disease
II	NNP	I_Disease
ALD	NNP	E_Disease
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
have	VB	O
been	VBN	O
seen	VBN	O
in	IN	O
any	DT	O
other	JJ	O
leukoencephalopathy	NN	S_Disease
and	CC	O
is	VBZ	O
probably	RB	O
specific	JJ	O
for	IN	O
a	DT	O
phenotypic	NN	O
variant	NN	O
or	CC	O
an	DT	O
evolving	JJ	O
stage	NN	O
of	IN	O
ALD	NNP	S_Disease
.	.	O
.	.	O

Further	JJ	O
evidence	NN	O
for	IN	O
heterogeneity	NN	O
of	IN	O
glucose	JJ	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
deficiency	NN	E_Disease
in	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O

Four	CD	O
new	JJ	O
G6PD	NNP	O
variants	NNS	O
have	VBP	O
been	VBN	O
characterized	VBN	O
in	IN	O
individuals	NNS	O
from	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O

This	DT	O
study	NN	O
demonstrates	VBZ	O
that	IN	O
the	DT	O
previously	RB	O
reported	VBN	O
Markham	NNP	O
variant	NN	O
and	CC	O
the	DT	O
newly	RB	O
characterized	VBN	O
Salata	NNP	O
variant	NN	O
may	MD	O
be	VB	O
widely	RB	O
distributed	VBN	O
in	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O

Th	NNP	O
data	NNS	O
presented	VBD	O
here	RB	O
together	RB	O
with	IN	O
those	DT	O
of	IN	O
previously	RB	O
published	VBN	O
studies	NNS	O
demonstrate	VBP	O
a	DT	O
degree	NN	O
of	IN	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
that	WDT	O
is	VBZ	O
much	RB	O
higher	JJR	O
than	IN	O
that	DT	O
in	IN	O
other	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
world	NN	O
where	WRB	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
common	JJ	O
.	.	O
.	.	O

Increased	VBN	O
incidence	NN	O
of	IN	O
cataracts	NNS	S_Disease
in	IN	O
male	JJ	O
subjects	NNS	O
deficient	NN	B_Disease
in	IN	I_Disease
glucose	JJ	I_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	E_Disease
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
in	IN	O
RBCs	NNP	O
was	VBD	O
found	VBN	O
significantly	RB	O
more	RBR	O
frequently	RB	O
in	IN	O
210	CD	O
male	JJ	O
cataractous	JJ	S_Disease
patients	NNS	O
than	IN	O
in	IN	O
672	CD	O
control	NN	O
subjects	NNS	O
of	IN	O
Sardinian	JJ	O
origin	NN	O
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
the	DT	O
deficiency	NN	O
was	VBD	O
increasingly	RB	O
higher	JJR	O
in	IN	O
presenile	JJ	O
cataracts	NNS	S_Disease
.	.	O

In	IN	O
the	DT	O
G6PD	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
group	NN	O
,	,	O
the	DT	O
incidence	NN	O
of	IN	O
cortical	JJ	B_Disease
and	CC	I_Disease
total	JJ	I_Disease
cataracts	NNS	E_Disease
was	VBD	O
also	RB	O
increased	VBN	O
.	.	O

It	PRP	O
is	VBZ	O
suggested	VBN	O
that	IN	O
decrease	NN	O
of	IN	O
the	DT	O
G6PD	NNP	O
activity	NN	O
in	IN	O
the	DT	O
lens	NNS	O
,	,	O
which	WDT	O
accompanies	VBZ	O
its	PRP$	O
deficiency	NN	O
in	IN	O
the	DT	O
erythrocyte	NN	O
,	,	O
might	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
the	DT	O
cataracto	NN	O
-	:	O
genesis	NN	O
of	IN	O
these	DT	O
patients	NNS	O
.	.	O

Moreover	RB	O
,	,	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
should	MD	O
be	VB	O
added	VBN	O
to	TO	O
other	JJ	O
conditions	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
galactosemic	JJ	S_Disease
states	NNS	O
and	CC	O
riboflavin	JJ	B_Disease
deficiency	NN	E_Disease
,	,	O
where	WRB	O
cataracts	NNS	S_Disease
represent	VBP	O
a	DT	O
sensitive	JJ	O
indicator	NN	O
of	IN	O
metabolic	JJ	B_Disease
abnormalities	NNS	E_Disease
of	IN	O
the	DT	O
RBC	NNP	O
.	.	O
.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
human	JJ	O
mitochondrial	JJ	O
very	RB	B_Disease
-	:	I_Disease
long	JJ	I_Disease
-	:	I_Disease
chain	NN	I_Disease
acyl	IN	I_Disease
-	:	I_Disease
CoA	NNP	I_Disease
dehydrogenase	NN	I_Disease
deficiency	NN	E_Disease
causing	VBG	O
cardiomyopathy	NN	S_Disease
and	CC	O
sudden	JJ	B_Disease
death	NN	E_Disease
in	IN	O
childhood	NN	O
.	.	O

beta	SYM	O
-	:	O
Oxidation	NN	O
of	IN	O
long	JJ	O
-	:	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
provides	VBZ	O
the	DT	O
major	JJ	O
source	NN	O
of	IN	O
energy	NN	O
in	IN	O
the	DT	O
heart	NN	O
.	.	O

Defects	NNS	O
in	IN	O
enzymes	NNS	O
of	IN	O
the	DT	O
beta	NN	O
-	:	O
oxidation	NN	O
pathway	NN	O
cause	NN	O
sudden	JJ	B_Disease
,	,	I_Disease
unexplained	JJ	I_Disease
death	NN	E_Disease
in	IN	O
childhood	NN	O
,	,	O
acute	JJ	O
hepatic	JJ	B_Disease
encephalopathy	NN	E_Disease
or	CC	O
liver	JJ	B_Disease
failure	NN	E_Disease
,	,	O
skeletal	JJ	B_Disease
myopathy	NN	E_Disease
,	,	O
and	CC	O
cardiomyopathy	NN	S_Disease
.	.	O

Very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
acyl	IN	O
-	:	O
CoA	NNP	O
dehydrogenase	NN	O
[	NNP	O
VLCAD	NNP	O
;	:	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
-	:	O
acyl	NN	O
-	:	O
CoA	NNP	O
(	(	O
acceptor	NN	O
)	)	O
2	CD	O
,	,	O
3	CD	O
-	:	O
oxidoreductase	NN	O
,	,	O
EC	NNP	O
1	CD	O
.	.	O

3	CD	O
3	CD	O
.	.	O

99	CD	O
99	CD	O
.	.	O

13	CD	O
]	NN	O
catalyzes	VBZ	O
the	DT	O
first	JJ	O
step	NN	O
in	IN	O
beta	NN	O
-	:	O
oxidation	NN	O
.	.	O

We	PRP	O
have	VBP	O
isolated	VBN	O
the	DT	O
human	JJ	O
VLCAD	NNP	O
cDNA	NN	O
and	CC	O
gene	NN	O
and	CC	O
determined	VBD	O
the	DT	O
complete	JJ	O
nucleotide	NN	O
sequences	NNS	O
.	.	O

Polymerase	NNP	O
chain	NN	O
reaction	NN	O
amplification	NN	O
of	IN	O
VLCAD	NNP	O
mRNA	NN	O
and	CC	O
genomic	JJ	O
exons	NNS	O
defined	VBD	O
the	DT	O
molecular	JJ	O
defects	NNS	O
in	IN	O
two	CD	O
patients	NNS	O
with	IN	O
VLCAD	NNP	B_Disease
deficiency	NN	E_Disease
who	WP	O
presented	VBD	O
with	IN	O
unexplained	JJ	O
cardiac	JJ	B_Disease
arrest	NN	E_Disease
and	CC	O
cardiomyopathy	NN	S_Disease
.	.	O

In	IN	O
one	CD	O
,	,	O
a	DT	O
homozygous	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
consensus	NN	O
dinucleotide	NN	O
of	IN	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
(	(	O
g	JJ	O
+	NN	O
1	CD	O
-	:	O
-	:	O
>	VB	O
a	DT	O
)	)	O
was	VBD	O
associated	VBN	O
with	IN	O
universal	JJ	O
skipping	NN	O
of	IN	O
the	DT	O
prior	JJ	O
exon	NN	O
(	(	O
exon	JJ	O
11	CD	O
)	)	O
.	.	O

The	DT	O
second	JJ	O
patient	NN	O
was	VBD	O
a	DT	O
compound	NN	O
heterozygote	NN	O
,	,	O
with	IN	O
a	DT	O
missense	NN	O
mutation	NN	O
,	,	O
C1837	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
,	,	O
changing	VBG	O
the	DT	O
arginine	NN	O
at	IN	O
residue	JJ	O
613	CD	O
to	TO	O
tryptophan	VB	O
on	IN	O
one	CD	O
allele	NN	O
and	CC	O
a	DT	O
single	JJ	O
base	NN	O
deletion	NN	O
at	IN	O
the	DT	O
intron	NN	O
-	:	O
exon	NN	O
6	CD	O
boundary	NN	O
as	IN	O
the	DT	O
second	JJ	O
mutation	NN	O
.	.	O

This	DT	O
initial	JJ	O
delineation	NN	O
of	IN	O
human	JJ	O
mutations	NNS	O
in	IN	O
VLCAD	NNP	O
suggests	VBZ	O
that	IN	O
VLCAD	NNP	B_Disease
deficiency	NN	E_Disease
reduces	VBZ	O
myocardial	JJ	O
fatty	JJ	O
acid	NN	O
beta	SYM	O
-	:	O
oxidation	NN	O
and	CC	O
energy	NN	O
production	NN	O
and	CC	O
is	VBZ	O
associated	VBN	O
with	IN	O
cardiomyopathy	NN	S_Disease
and	CC	O
sudden	JJ	B_Disease
death	NN	E_Disease
in	IN	O
childhood	NN	O
.	.	O

Aberrant	NNP	O
subcellular	JJ	O
localization	NN	O
of	IN	O
BRCA1	NNP	O
in	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
.	.	O

The	DT	O
BRCA1	NNP	O
gene	NN	O
product	NN	O
was	VBD	O
identified	VBN	O
as	IN	O
a	DT	O
220	CD	O
-	:	O
kilodalton	NN	O
nuclear	JJ	O
phosphoprotein	NN	O
in	IN	O
normal	JJ	O
cells	NNS	O
,	,	O
including	VBG	O
breast	NN	O
ductal	JJ	O
epithelial	JJ	O
cells	NNS	O
,	,	O
and	CC	O
in	IN	O
18	CD	O
of	IN	O
20	CD	O
tumor	NN	S_Disease
cell	NN	O
lines	NNS	O
derived	VBN	O
from	IN	O
tissues	NNS	O
other	JJ	O
than	IN	O
breast	NN	O
and	CC	O
ovary	JJ	O
.	.	O

In	IN	O
16	CD	O
of	IN	O
17	CD	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
lines	NNS	O
and	CC	O
17	CD	O
of	IN	O
17	CD	O
samples	NNS	O
of	IN	O
cells	NNS	O
obtained	VBN	O
from	IN	O
malignant	JJ	O
effusions	NNS	O
,	,	O
however	RB	O
,	,	O
BRCA1	NNP	O
localized	VBD	O
mainly	RB	O
in	IN	O
cytoplasm	NN	O
.	.	O

Absence	NN	O
of	IN	O
BRCA1	NNP	O
or	CC	O
aberrant	JJ	O
subcellular	JJ	O
location	NN	O
was	VBD	O
also	RB	O
observed	VBN	O
to	TO	O
a	DT	O
variable	JJ	O
extent	NN	O
in	IN	O
histological	JJ	O
sections	NNS	O
of	IN	O
many	JJ	O
breast	NN	B_Disease
cancer	NN	E_Disease
biopsies	NNS	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
BRCA1	NNP	B_Disease
abnormalities	NNS	E_Disease
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
many	JJ	O
breast	NN	B_Disease
cancers	NNS	E_Disease
,	,	O
sporadic	JJ	O
as	RB	O
well	RB	O
as	IN	O
familial	JJ	O
.	.	O
.	.	O

Mapping	NN	O
of	IN	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
the	DT	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
to	TO	O
mouse	VB	O
chromosome	NN	O
8	CD	O
.	.	O

ATP7B	NNP	O
,	,	O
the	DT	O
gene	NN	O
altered	VBD	O
in	IN	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
(	(	O
WD	NNP	S_Disease
)	)	O
patients	NNS	O
,	,	O
lies	VBZ	O
in	IN	O
a	DT	O
block	NN	O
of	IN	O
homology	NN	O
shared	VBN	O
between	IN	O
human	JJ	O
chromosome	NN	O
13q14	CD	O
and	CC	O
the	DT	O
central	JJ	O
region	NN	O
of	IN	O
mouse	NN	O
chromosome	NN	O
14	CD	O
.	.	O

However	RB	O
,	,	O
we	PRP	O
have	VBP	O
mapped	VBN	O
the	DT	O
murine	NN	O
homologue	NN	O
of	IN	O
ATP7B	NNP	O
(	(	O
Atp7b	NNP	O
)	)	O
to	TO	O
mouse	VB	O
chromosome	NN	O
8	CD	O
by	IN	O
somatic	JJ	O
cell	NN	O
hybrid	JJ	O
analysis	NN	O
.	.	O

Analysis	NN	O
of	IN	O
80	CD	O
interspecific	JJ	O
backcross	NN	O
offspring	NN	O
was	VBD	O
used	VBN	O
to	TO	O
position	NN	O
Atp7b	NNP	O
close	NN	O
to	TO	O
D8Mit3	NNP	O
and	CC	O
another	DT	O
ATPase	NNP	O
locus	NN	O
,	,	O
Atp4b	NNP	O
,	,	O
on	IN	O
mouse	NN	O
chromosome	NN	O
8	CD	O
.	.	O

ATP4B	NNP	O
lies	VBZ	O
in	IN	O
13q34	CD	O
and	CC	O
is	VBZ	O
separated	VBN	O
from	IN	O
ATP7B	NNP	O
by	IN	O
several	JJ	O
loci	NNS	O
whose	WP$	O
mouse	NN	O
homologues	VBZ	O
map	NNS	O
to	TO	O
mouse	VB	O
chromosome	NN	O
14	CD	O
.	.	O

The	DT	O
assignment	NN	O
of	IN	O
Atp7b	NNP	O
to	TO	O
mouse	VB	O
chromosome	NN	O
8	CD	O
identifies	NNS	O
a	DT	O
previously	RB	O
unrecognized	JJ	O
region	NN	O
of	IN	O
homology	NN	O
between	IN	O
this	DT	O
chromosome	NN	O
and	CC	O
human	JJ	O
chromosome	NN	O
13	CD	O
.	.	O

This	DT	O
assignment	NN	O
suggests	VBZ	O
a	DT	O
possible	JJ	O
location	NN	O
for	IN	O
the	DT	O
toxic	JJ	O
milk	NN	O
mutation	NN	O
in	IN	O
the	DT	O
mouse	NN	O
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
proposed	VBN	O
as	IN	O
a	DT	O
homologue	NN	O
of	IN	O
WD	NNP	S_Disease
.	.	O
.	.	O

Germline	NNP	O
mutations	NNS	O
of	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
in	IN	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
provide	VBP	O
evidence	NN	O
for	IN	O
a	DT	O
genotype	JJ	O
-	:	O
phenotype	NN	O
correlation	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
,	,	O
discovered	VBN	O
in	IN	O
1994	CD	O
,	,	O
are	VBP	O
associated	VBN	O
with	IN	O
an	DT	O
80	CD	O
-	:	O
90	CD	O
%	NN	O
lifetime	NN	O
risk	NN	O
of	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
analysed	VBN	O
60	CD	O
families	NNS	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
breast	NN	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
for	IN	O
germline	JJ	O
mutations	NNS	O
in	IN	O
BRCA1	NNP	O
.	.	O

Twenty	CD	O
-	:	O
two	CD	O
different	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
32	CD	O
families	NNS	O
(	(	O
53	CD	O
%	NN	O
)	)	O
,	,	O
of	IN	O
which	WDT	O
14	CD	O
are	VBP	O
previously	RB	O
unreported	VBN	O
.	.	O

We	PRP	O
observed	VBD	O
a	DT	O
significant	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
the	DT	O
gene	NN	O
and	CC	O
the	DT	O
ratio	NN	O
of	IN	O
breast	NN	B_Disease
to	TO	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
incidence	NN	O
within	IN	O
each	DT	O
family	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
suggest	VBP	O
a	DT	O
transition	NN	O
in	IN	O
risk	NN	O
such	JJ	O
that	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
3	CD	O
third	NN	O
of	IN	O
the	DT	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
lower	JJR	O
proportion	NN	O
of	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Haplotype	NNP	O
analysis	NN	O
supports	VBZ	O
previous	JJ	O
data	NNS	O
which	WDT	O
suggest	VBP	O
some	DT	O
BRCA1	NNP	O
mutation	NN	O
carriers	NNS	O
have	VBP	O
common	JJ	O
ancestors	NNS	O
;	:	O
however	RB	O
,	,	O
we	PRP	O
have	VBP	O
found	VBN	O
at	IN	O
least	JJS	O
two	CD	O
examples	NNS	O
where	WRB	O
recurrent	JJ	O
mutations	NNS	O
appear	VBP	O
to	TO	O
have	VB	O
arisen	VBN	O
independently	RB	O
.	.	O
.	.	O

Hereditary	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
seventh	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
and	CC	O
recurrent	JJ	O
meningococcal	JJ	B_Disease
infection	NN	E_Disease
:	:	O
investigations	NNS	O
of	IN	O
an	DT	O
Irish	JJ	O
family	NN	O
using	VBG	O
a	DT	O
novel	JJ	O
haemolytic	JJ	O
screening	NN	O
assay	NN	O
for	IN	O
complement	NN	O
activity	NN	O
and	CC	O
C7	NNP	O
M	NNP	O
/	NNP	O
N	NNP	O
allotyping	NN	O
.	.	O

Terminal	NNP	B_Disease
complement	NN	I_Disease
component	NN	I_Disease
deficiency	NN	E_Disease
predisposes	VBZ	O
to	TO	O
meningococcal	JJ	B_Disease
infection	NN	E_Disease
and	CC	O
is	VBZ	O
inherited	VBN	O
in	IN	O
an	DT	O
autosomal	JJ	O
co	NN	O
-	:	O
dominant	JJ	O
manner	NN	O
.	.	O

An	DT	O
Irish	JJ	O
family	NN	O
is	VBZ	O
described	VBN	O
,	,	O
in	IN	O
which	WDT	O
2	CD	O
of	IN	O
3	CD	O
brothers	NNS	O
had	VBD	O
recurrent	JJ	O
meningococcal	JJ	B_Disease
infection	NN	E_Disease
.	.	O

A	DT	O
novel	JJ	O
screening	NN	O
assay	NN	O
was	VBD	O
used	VBN	O
to	TO	O
investigate	VB	O
for	IN	O
terminal	JJ	B_Disease
complement	NN	I_Disease
deficiency	NN	E_Disease
and	CC	O
the	DT	O
2	CD	O
affected	VBD	O
brothers	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
completely	RB	B_Disease
deficient	JJ	I_Disease
in	IN	I_Disease
the	DT	I_Disease
seventh	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
(	(	O
C7	NNP	O
)	)	O
.	.	O

Enzyme	NNP	O
-	:	O
linked	VBD	O
immunosorbent	JJ	O
assay	NN	O
for	IN	O
C7	NNP	O
revealed	VBD	O
lower	JJR	O
than	IN	O
normal	JJ	O
levels	NNS	O
in	IN	O
the	DT	O
remaining	VBG	O
brother	NN	O
and	CC	O
parents	NNS	O
.	.	O

C7	NNP	O
M	NNP	O
/	NNP	O
N	NNP	O
protein	VBD	O
polymorphism	NN	O
allotyping	NN	O
,	,	O
used	VBD	O
to	TO	O
investigate	VB	O
the	DT	O
segregation	NN	O
of	IN	O
the	DT	O
C7	NNP	B_Disease
deficiency	NN	E_Disease
genes	NNS	O
,	,	O
showed	VBD	O
that	IN	O
the	DT	O
apparently	RB	O
complement	JJ	O
sufficient	JJ	O
brother	NN	O
was	VBD	O
heterozygous	JJ	O
C7	NNP	B_Disease
deficient	NN	E_Disease
and	CC	O
a	DT	O
carrier	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
deficiency	NN	O
genes	NNS	O
.	.	O

Complement	JJ	O
screening	NN	O
should	MD	O
be	VB	O
carried	VBN	O
out	RP	O
in	IN	O
any	DT	O
individual	JJ	O
suffering	NN	O
recurrent	JJ	O
meningococcal	JJ	B_Disease
infection	NN	E_Disease
or	CC	O
infection	NN	O
with	IN	O
an	DT	O
uncommon	JJ	O
meningococcal	JJ	S_Disease
serogroup	NN	O
.	.	O

Identification	NN	O
of	IN	O
complement	JJ	B_Disease
deficient	NN	E_Disease
patients	NNS	O
allows	VBZ	O
the	DT	O
implementation	NN	O
of	IN	O
strategies	NNS	O
to	TO	O
prevent	VB	O
recurrent	JJ	O
infection	NN	O
.	.	O
.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
subtotal	JJ	B_Disease
complement	NN	I_Disease
C6	NNP	I_Disease
deficiency	NN	E_Disease
.	.	O

A	DT	O
carboxy	JJ	O
-	:	O
terminally	RB	O
truncated	VBN	O
but	CC	O
functionally	RB	O
active	JJ	O
C6	NNP	O
.	.	O

Individuals	NNS	O
with	IN	O
subtotal	JJ	B_Disease
complement	NN	I_Disease
C6	NNP	I_Disease
deficiency	NN	E_Disease
possess	NN	O
a	DT	O
C6	NNP	O
molecule	NN	O
that	WDT	O
is	VBZ	O
14	CD	O
%	NN	O
shorter	JJR	O
than	IN	O
normal	JJ	O
C6	NNP	O
and	CC	O
present	JJ	O
in	IN	O
low	JJ	O
but	CC	O
detectable	JJ	O
concentrations	NNS	O
(	(	O
1	CD	O
-	:	O
2	CD	O
%	NN	O
of	IN	O
the	DT	O
normal	JJ	O
mean	NN	O
)	)	O
.	.	O

We	PRP	O
now	RB	O
show	VBP	O
that	IN	O
this	DT	O
dysmorphic	JJ	O
C6	NNP	O
is	VBZ	O
bactericidally	RB	O
active	JJ	O
and	CC	O
lacks	VBZ	O
an	DT	O
epitope	NN	O
that	WDT	O
was	VBD	O
mapped	VBN	O
to	TO	O
the	DT	O
most	RBS	O
carboxy	JJ	O
-	:	O
terminal	JJ	O
part	NN	O
of	IN	O
C6	NNP	O
using	VBG	O
C6	NNP	O
cDNA	NN	O
fragments	NNS	O
expressed	VBD	O
as	IN	O
fusion	NN	O
proteins	NNS	O
in	IN	O
the	DT	O
pUEX	NN	O
expression	NN	O
system	NN	O
.	.	O

We	PRP	O
thus	RB	O
predicted	VBD	O
that	IN	O
the	DT	O
abnormal	JJ	O
C6	NNP	O
molecule	NN	O
might	MD	O
be	VB	O
carboxy	JJ	O
-	:	O
terminally	RB	O
truncated	VBN	O
and	CC	O
sought	VBD	O
a	DT	O
mutation	NN	O
in	IN	O
an	DT	O
area	NN	O
approximately	RB	O
14	CD	O
%	NN	O
from	IN	O
the	DT	O
carboxy	JJ	O
-	:	O
terminal	JJ	O
end	NN	O
of	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
.	.	O

By	IN	O
sequencing	VBG	O
PCR	NNP	O
-	:	O
amplified	JJ	O
products	NNS	O
from	IN	O
this	DT	O
region	NN	O
,	,	O
we	PRP	O
found	VBD	O
,	,	O
in	IN	O
three	CD	O
individuals	NNS	O
from	IN	O
two	CD	O
families	NNS	O
,	,	O
a	DT	O
mutation	NN	O
that	WDT	O
might	MD	O
plausibly	RB	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
defect	NN	O
.	.	O

All	DT	O
three	CD	O
have	VBP	O
an	DT	O
abnormal	JJ	O
5	CD	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
intron	NN	O
15	CD	O
,	,	O
which	WDT	O
would	MD	O
probably	RB	O
prevent	VB	O
splicing	NN	O
.	.	O

An	DT	O
in	IN	O
-	:	O
frame	NN	O
stop	JJ	O
codon	NN	O
is	VBZ	O
found	VBN	O
17	CD	O
codons	NNS	O
downstream	NN	O
from	IN	O
the	DT	O
intron	NN	O
boundary	NN	O
,	,	O
which	WDT	O
would	MD	O
lead	VB	O
to	TO	O
a	DT	O
truncated	VBN	O
polypeptide	NN	O
13	CD	O
.	.	O

5	CD	O
%	NN	O
smaller	JJR	O
than	IN	O
normal	JJ	O
C6	NNP	O
.	.	O

This	DT	O
result	NN	O
was	VBD	O
unexpected	JJ	O
,	,	O
as	IN	O
earlier	JJR	O
studies	NNS	O
mapped	VBD	O
the	DT	O
C5b	NNP	O
binding	NN	O
site	NN	O
,	,	O
or	CC	O
a	DT	O
putative	JJ	O
enzymatic	JJ	O
region	NN	O
,	,	O
to	TO	O
this	DT	O
part	NN	O
of	IN	O
C6	NNP	O
.	.	O

Interestingly	RB	O
,	,	O
all	DT	O
three	CD	O
subjects	NNS	O
were	VBD	O
probably	RB	O
heterozygous	JJ	O
for	IN	O
both	DT	O
subtotal	JJ	B_Disease
C6	NNP	I_Disease
and	CC	I_Disease
complete	JJ	I_Disease
C6	NNP	I_Disease
deficiency	NN	E_Disease
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
:	:	O
evidence	NN	O
for	IN	O
a	DT	O
possible	JJ	O
dominant	JJ	O
-	:	O
negative	JJ	O
RNA	NNP	O
mutation	NN	O
.	.	O

The	DT	O
trinucleotide	JJ	O
expansion	NN	O
mutation	NN	O
causing	VBG	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
is	VBZ	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
a	DT	O
protein	NN	O
kinase	NN	O
gene	NN	O
.	.	O

The	DT	O
molecular	JJ	O
mechanisms	NNS	O
by	IN	O
which	WDT	O
the	DT	O
expanded	VBN	O
repeat	NN	O
causes	VBZ	O
the	DT	O
clinically	RB	O
variable	JJ	O
and	CC	O
multisystemic	JJ	B_Disease
disease	NN	E_Disease
,	,	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
are	VBP	O
not	RB	O
understood	JJ	O
.	.	O

It	PRP	O
has	VBZ	O
been	VBN	O
particularly	RB	O
difficult	JJ	O
to	TO	O
rationalize	VB	O
the	DT	O
dominant	JJ	O
inheritance	NN	O
with	IN	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
expansion	NN	O
mutation	NN	O
lies	VBZ	O
outside	IN	O
of	IN	O
the	DT	O
protein	NN	O
-	:	O
encoding	VBG	O
gene	NN	O
elements	NNS	O
,	,	O
and	CC	O
should	MD	O
not	RB	O
be	VB	O
translated	VBN	O
into	IN	O
protein	NN	O
.	.	O

Here	RB	O
we	PRP	O
use	VBP	O
muscle	JJ	O
biopsies	NNS	O
from	IN	O
classical	JJ	O
adult	NN	O
-	:	O
onset	NN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
patients	NNS	O
to	TO	O
study	VB	O
the	DT	O
accumulation	NN	O
of	IN	O
transcripts	NNS	O
from	IN	O
both	DT	O
the	DT	O
normal	JJ	O
and	CC	O
expanded	VBD	O
DM	NNP	S_Disease
kinase	NNP	O
genes	NNS	O
in	IN	O
patient	JJ	O
muscle	NN	O
,	,	O
and	CC	O
compare	VB	O
the	DT	O
results	NNS	O
to	TO	O
normal	JJ	O
and	CC	O
myopathic	JJ	S_Disease
controls	NNS	O
.	.	O

We	PRP	O
found	VBD	O
relatively	RB	O
small	JJ	O
decreases	NNS	O
of	IN	O
DM	NNP	S_Disease
kinase	NNP	O
RNA	NNP	O
in	IN	O
the	DT	O
total	JJ	O
RNA	NNP	O
pool	NN	O
from	IN	O
muscle	NN	O
;	:	O
however	RB	O
,	,	O
these	DT	O
reductions	NNS	O
were	VBD	O
not	RB	O
disease	JJ	O
specific	NN	O
.	.	O

Analysis	NN	O
of	IN	O
poly	NN	O
(	(	O
A	DT	O
)	)	O
+	NN	O
RNA	NNP	O
showed	VBD	O
dramatic	JJ	O
decreases	NNS	O
of	IN	O
both	DT	O
the	DT	O
mutant	NN	O
and	CC	O
normal	JJ	O
DM	NNP	S_Disease
kinase	NN	O
RNAs	NNP	O
,	,	O
and	CC	O
these	DT	O
changes	NNS	O
were	VBD	O
disease	JJ	O
-	:	O
specific	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
a	DT	O
novel	JJ	O
molecular	JJ	O
pathogenetic	NN	O
mechanism	NN	O
for	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
both	DT	O
the	DT	O
normal	JJ	O
and	CC	O
expanded	VBD	O
DM	NNP	S_Disease
kinase	NN	O
genes	NNS	O
are	VBP	O
transcribed	VBN	O
in	IN	O
patient	JJ	O
muscle	NN	O
,	,	O
but	CC	O
the	DT	O
abnormal	JJ	O
expansion	NN	O
-	:	O
containing	NN	O
RNA	NNP	O
has	VBZ	O
a	DT	O
dominant	JJ	O
effect	NN	O
on	IN	O
RNA	NNP	O
metabolism	NN	O
by	IN	O
preventing	VBG	O
the	DT	O
accumulation	NN	O
of	IN	O
poly	NN	O
(	(	O
A	DT	O
)	)	O
+	NN	O
RNA	NNP	O
.	.	O

The	DT	O
ability	NN	O
of	IN	O
the	DT	O
expansion	NN	O
mutation	NN	O
to	TO	O
alter	VB	O
accumulation	NN	O
of	IN	O
poly	NN	O
(	(	O
A	DT	O
)	)	O
+	NN	O
RNA	NNP	O
in	IN	O
trans	NNS	O
suggests	NNS	O
that	WDT	O
myotonic	VBP	B_Disease
dystrophy	NN	E_Disease
may	MD	O
be	VB	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
a	DT	O
dominant	JJ	O
-	:	O
negative	JJ	O
mutation	NN	O
manifested	VBN	O
at	IN	O
the	DT	O
RNA	NNP	O
level	NN	O
.	.	O
.	.	O

A	DT	O
strong	JJ	O
candidate	NN	O
for	IN	O
the	DT	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
susceptibility	NN	O
gene	NN	O
BRCA1	NNP	O
.	.	O

A	DT	O
strong	JJ	O
candidate	NN	O
for	IN	O
the	DT	O
17q	CD	O
-	:	O
linked	VBN	O
BRCA1	NNP	O
gene	NN	O
,	,	O
which	WDT	O
influences	VBZ	O
susceptibility	NN	O
to	TO	O
breast	VB	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
,	,	O
has	VBZ	O
been	VBN	O
identified	VBN	O
by	IN	O
positional	JJ	O
cloning	NN	O
methods	NNS	O
.	.	O

Probable	JJ	O
predisposing	VBG	O
mutations	NNS	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
five	CD	O
of	IN	O
eight	CD	O
kindreds	NNS	O
presumed	VBN	O
to	TO	O
segregate	VB	O
BRCA1	NNP	O
susceptibility	NN	O
alleles	NNS	O
.	.	O

The	DT	O
mutations	NNS	O
include	VBP	O
an	DT	O
11	CD	O
-	:	O
base	NN	O
pair	NN	O
deletion	NN	O
,	,	O
a	DT	O
1	CD	O
-	:	O
base	NN	O
pair	NN	O
insertion	NN	O
,	,	O
a	DT	O
stop	NN	O
codon	NN	O
,	,	O
a	DT	O
missense	NN	O
substitution	NN	O
,	,	O
and	CC	O
an	DT	O
inferred	JJ	O
regulatory	JJ	O
mutation	NN	O
.	.	O

The	DT	O
BRCA1	NNP	O
gene	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
numerous	JJ	O
tissues	NNS	O
,	,	O
including	VBG	O
breast	NN	O
and	CC	O
ovary	JJ	O
,	,	O
and	CC	O
encodes	VBZ	O
a	DT	O
predicted	JJ	O
protein	NN	O
of	IN	O
1863	CD	O
amino	NN	O
acids	NNS	O
.	.	O

This	DT	O
protein	NN	O
contains	VBZ	O
a	DT	O
zinc	NN	O
finger	NN	O
domain	NN	O
in	IN	O
its	PRP$	O
amino	NN	O
-	:	O
terminal	JJ	O
region	NN	O
,	,	O
but	CC	O
is	VBZ	O
otherwise	RB	O
unrelated	JJ	O
to	TO	O
previously	RB	O
described	VBN	O
proteins	NNS	O
.	.	O

Identification	NN	O
of	IN	O
BRCA1	NNP	O
should	MD	O
facilitate	VB	O
early	JJ	O
diagnosis	NN	O
of	IN	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
susceptibility	NN	O
in	IN	O
some	DT	O
individuals	NNS	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
better	JJR	O
understanding	NN	O
of	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
biology	NN	O
.	.	O
.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
galactosemia	NN	S_Disease
(	(	O
type	JJ	O
1	CD	O
)	)	O
mutations	NNS	O
in	IN	O
Japanese	JJ	O
.	.	O

We	PRP	O
characterized	VBD	O
two	CD	O
novel	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
galactose	JJ	O
-	:	O
1	CD	O
-	:	O
phosphate	NN	O
uridyltransferase	NN	O
(	(	O
GALT	NNP	O
)	)	O
gene	NN	O
in	IN	O
two	CD	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
GALT	NNP	B_Disease
deficiency	NN	E_Disease
and	CC	O
identified	VBN	O
N314D	NNP	O
and	CC	O
R333W	NNP	O
mutations	NNS	O
,	,	O
previously	RB	O
found	VBN	O
in	IN	O
Caucasians	NNPS	O
.	.	O

One	CD	O
novel	NN	O
missense	NN	O
mutation	NN	O
was	VBD	O
an	DT	O
G	NNP	O
-	:	O
to	TO	O
-	:	O
A	DT	O
transition	NN	O
in	IN	O
exon	JJ	O
8	CD	O
,	,	O
resulting	VBG	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
arginine	NN	O
by	IN	O
histidine	NN	O
at	IN	O
the	DT	O
codon	NN	O
231	CD	O
(	(	O
R231H	NNP	O
)	)	O
.	.	O

GALT	NNP	O
activity	NN	O
of	IN	O
the	DT	O
R231H	NNP	O
mutant	JJ	O
construct	NN	O
was	VBD	O
reduced	VBN	O
to	TO	O
15	CD	O
%	NN	O
of	IN	O
normal	JJ	O
controls	NNS	O
in	IN	O
a	DT	O
COS	NNP	O
cell	NN	O
expression	NN	O
system	NN	O
.	.	O

The	DT	O
other	JJ	O
was	VBD	O
a	DT	O
splicing	JJ	O
mutation	NN	O
,	,	O
an	DT	O
A	NNP	O
-	:	O
to	TO	O
-	:	O
G	NNP	O
transition	NN	O
at	IN	O
the	DT	O
38th	CD	O
nucleotide	NN	O
in	IN	O
exon	JJ	O
3	CD	O
(	(	O
318A	CD	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
)	)	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
38	CD	O
-	:	O
bp	NN	O
deletion	NN	O
in	IN	O
the	DT	O
GALT	NNP	O
cDNA	NN	O
by	IN	O
activating	VBG	O
a	DT	O
cryptic	JJ	O
splice	NN	O
acceptor	NN	O
site	NN	O
.	.	O

In	IN	O
seven	CD	O
Japanese	JJ	O
families	NNS	O
(	(	O
14	CD	O
alleles	NNS	O
for	IN	O
classic	JJ	O
form	NN	O
and	CC	O
one	CD	O
allele	NN	O
for	IN	O
Duarte	NNP	O
variant	NN	O
)	)	O
with	IN	O
GALT	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
the	DT	O
R231H	NNP	O
and	CC	O
318A	CD	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
mutations	NNS	O
were	VBD	O
found	VBN	O
only	RB	O
on	IN	O
both	DT	O
alleles	NNS	O
of	IN	O
the	DT	O
proband	NN	O
.	.	O

The	DT	O
N314D	NNP	O
and	CC	O
R333W	NNP	O
mutations	NNS	O
were	VBD	O
found	VBN	O
on	IN	O
one	CD	O
allele	NN	O
each	DT	O
.	.	O

The	DT	O
Q188R	NNP	O
was	VBD	O
prevalent	VBN	O
in	IN	O
the	DT	O
United	NNP	O
States	NNPS	O
but	CC	O
not	RB	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
.	.	O

The	DT	O
N314D	NNP	O
mutation	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
the	DT	O
Duarte	NNP	O
variant	NN	O
in	IN	O
Japanese	JJ	O
persons	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
in	IN	O
the	DT	O
United	NNP	O
States	NNPS	O
.	.	O

We	PRP	O
speculate	VBP	O
that	IN	O
classic	JJ	B_Disease
galactosemia	NN	E_Disease
mutations	NNS	O
appear	VBP	O
to	TO	O
differ	VB	O
between	IN	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
patients	NNS	O
.	.	O

Our	PRP$	O
limited	JJ	O
data	NNS	O
set	VBN	O
on	IN	O
galactosemia	NN	S_Disease
mutations	NNS	O
in	IN	O
Japanese	JJ	O
suggests	NNS	O
that	IN	O
the	DT	O
N314D	NNP	O
GALT	NNP	O
mutation	NN	O
encoding	VBG	O
the	DT	O
Duarte	NNP	O
variant	NN	O
arose	VBD	O
before	IN	O
Asian	JJ	O
and	CC	O
Caucasian	JJ	O
people	NNS	O
diverged	VBD	O
and	CC	O
that	IN	O
classic	JJ	B_Disease
galactosemia	NN	E_Disease
mutations	NNS	O
arose	VBP	O
and	CC	O
/	VBP	O
or	CC	O
accumulated	VBN	O
after	IN	O
the	DT	O
divergence	NN	O
of	IN	O
Asian	JJ	O
and	CC	O
Caucasian	JJ	O
populations	NNS	O
.	.	O
.	.	O

Three	CD	O
novel	JJ	O
aniridia	JJ	S_Disease
mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
PAX6	NNP	O
gene	NN	O
.	.	O

Aniridia	NNP	S_Disease
(	(	O
iris	JJ	B_Disease
hypoplasia	NN	E_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
congenital	JJ	I_Disease
disorder	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
eye	NN	E_Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
aniridia	NN	S_Disease
(	(	O
PAX6	NNP	O
)	)	O
gene	NN	O
have	VBP	O
now	RB	O
been	VBN	O
identified	VBN	O
in	IN	O
many	JJ	O
patients	NNS	O
from	IN	O
various	JJ	O
ethnic	JJ	O
groups	NNS	O
.	.	O

In	IN	O
the	DT	O
study	NN	O
reported	VBD	O
here	RB	O
we	PRP	O
describe	VBP	O
PAX6	JJ	O
mutations	NNS	O
in	IN	O
one	CD	O
sporadic	NN	O
and	CC	O
five	CD	O
familial	JJ	O
cases	NNS	O
with	IN	O
aniridia	NN	S_Disease
.	.	O

Of	IN	O
the	DT	O
four	CD	O
different	JJ	O
mutations	NNS	O
identified	VBN	O
,	,	O
one	CD	O
was	VBD	O
identical	JJ	O
to	TO	O
a	DT	O
previously	RB	O
reported	VBN	O
mutation	NN	O
(	(	O
C	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
transition	NN	O
at	IN	O
codon	$	O
240	CD	O
)	)	O
,	,	O
and	CC	O
three	CD	O
were	VBD	O
novel	JJ	O
two	CD	O
in	IN	O
the	DT	O
glycine	NN	O
-	:	O
rich	JJ	O
region	NN	O
and	CC	O
one	CD	O
in	IN	O
the	DT	O
proline	NN	O
/	NNP	O
serine	NN	O
/	NNP	O
threonine	NN	O
-	:	O
rich	JJ	O
(	(	O
PST	NNP	O
)	)	O
region	NN	O
.	.	O

One	CD	O
PAX6	NNP	O
mutation	NN	O
found	VBD	O
in	IN	O
the	DT	O
PST	NNP	O
region	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
cataracts	NNS	S_Disease
in	IN	O
an	DT	O
aniridia	JJ	S_Disease
family	NN	O
.	.	O

Another	DT	O
splice	NN	O
mutation	NN	O
in	IN	O
the	DT	O
PST	NNP	O
domain	NN	O
occurred	VBD	O
in	IN	O
an	DT	O
aniridia	JJ	S_Disease
patient	NN	O
with	IN	O
anosmia	NN	S_Disease
(	(	O
inability	NN	O
to	TO	O
smell	VB	O
)	)	O
.	.	O

The	DT	O
six	CD	O
new	JJ	O
aniridia	NN	S_Disease
cases	NNS	O
reported	VBN	O
here	RB	O
have	VBP	O
mutations	NNS	O
predicted	VBN	O
to	TO	O
generate	VB	O
incomplete	JJ	O
PAX6	NNP	O
proteins	NNS	O
.	.	O

These	DT	O
results	NNS	O
support	VBD	O
the	DT	O
theory	NN	O
that	WDT	O
human	JJ	O
aniridia	NN	S_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
haploinsufficiency	NN	B_Disease
of	IN	I_Disease
PAX6	NNP	E_Disease
.	.	O
.	.	O

The	DT	O
carrier	NN	O
frequency	NN	O
of	IN	O
the	DT	O
BRCA1	NNP	O
185delAG	CD	O
mutation	NN	O
is	VBZ	O
approximately	RB	O
1	CD	O
percent	NN	O
in	IN	O
Ashkenazi	NNP	O
Jewish	JJ	O
individuals	NNS	O
.	.	O

Since	IN	O
BRCA1	NNP	O
,	,	O
the	DT	O
first	JJ	O
major	JJ	O
gene	NN	O
responsible	JJ	O
for	IN	O
inherited	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
,	,	O
was	VBD	O
cloned	VBN	O
,	,	O
more	JJR	O
than	IN	O
50	CD	O
unique	JJ	O
mutations	NNS	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
the	DT	O
germline	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

In	IN	O
high	JJ	O
-	:	O
risk	NN	O
pedigrees	NNS	O
,	,	O
female	JJ	O
carriers	NNS	O
of	IN	O
BRCA1	NNP	O
mutations	NNS	O
have	VBP	O
an	DT	O
80	CD	O
-	:	O
90	CD	O
%	NN	O
lifetime	NN	O
risk	NN	O
of	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
,	,	O
and	CC	O
a	DT	O
40	CD	O
-	:	O
50	CD	O
%	NN	O
risk	NN	O
of	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

However	RB	O
,	,	O
the	DT	O
mutation	NN	O
stats	NNS	O
of	IN	O
individuals	NNS	O
unselected	VBN	O
for	IN	O
breast	NN	B_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
has	VBZ	O
not	RB	O
been	VBN	O
determined	VBN	O
,	,	O
and	CC	O
it	PRP	O
is	VBZ	O
not	RB	O
known	VBN	O
whether	IN	O
mutations	NNS	O
in	IN	O
such	JJ	O
individuals	NNS	O
confer	VBP	O
the	DT	O
same	JJ	O
risk	NN	O
of	IN	O
cancer	NN	S_Disease
as	IN	O
in	IN	O
individuals	NNS	O
from	IN	O
the	DT	O
high	JJ	O
-	:	O
risk	NN	O
families	NNS	O
studied	VBN	O
so	RB	O
far	RB	O
.	.	O

Following	VBG	O
the	DT	O
finding	NN	O
of	IN	O
a	DT	O
185delAG	CD	O
frameshift	NN	O
mutation	NN	O
in	IN	O
several	JJ	O
Ashkenazi	NNP	O
Jewish	NNP	O
breast	NN	O
/	NNP	O
ovarian	JJ	O
families	NNS	O
,	,	O
we	PRP	O
have	VBP	O
determined	VBN	O
the	DT	O
frequency	NN	O
of	IN	O
this	DT	O
mutation	NN	O
in	IN	O
858	CD	O
Ashkenazim	NNP	O
seeking	VBG	O
genetic	JJ	O
testing	VBG	O
for	IN	O
conditions	NNS	O
unrelated	JJ	O
to	TO	O
cancer	NN	S_Disease
,	,	O
and	CC	O
in	IN	O
815	CD	O
reference	NN	O
individuals	NNS	O
not	RB	O
selected	VBN	O
for	IN	O
ethnic	JJ	O
origin	NN	O
.	.	O

We	PRP	O
observed	VBD	O
the	DT	O
185delAG	CD	O
mutation	NN	O
in	IN	O
0	CD	O
.	.	O

9	CD	O
%	NN	O
of	IN	O
Ashkenazim	NNP	O
(	(	O
95	CD	O
%	NN	O
confidence	NN	O
limit	NN	O
,	,	O
0	CD	O
.	.	O

4	CD	O
-	:	O
1	CD	O
.	.	O

8	CD	O
%	NN	O
)	)	O
and	CC	O
in	IN	O
none	NN	O
of	IN	O
the	DT	O
reference	NN	O
samples	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
one	CD	O
in	IN	O
a	DT	O
hundred	JJ	O
women	NNS	O
of	IN	O
Ashkenazi	NNP	O
descent	NN	O
may	MD	O
be	VB	O
at	IN	O
especially	RB	O
high	JJ	O
risk	NN	O
of	IN	O
developing	VBG	O
breast	NN	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

Identification	NN	O
and	CC	O
localization	NN	O
of	IN	O
huntingtin	NN	O
in	IN	O
brain	NN	O
and	CC	O
human	JJ	O
lymphoblastoid	NN	O
cell	NN	O
lines	NNS	O
with	IN	O
anti	JJ	O
-	:	O
fusion	NN	O
protein	NN	O
antibodies	NNS	O
.	.	O

The	DT	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
phenotype	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
expansion	NN	O
of	IN	O
a	DT	O
trinucleotide	JJ	O
repeat	NN	O
in	IN	O
the	DT	O
IT15	NNP	O
gene	NN	O
,	,	O
which	WDT	O
is	VBZ	O
predicted	VBN	O
to	TO	O
encode	VB	O
a	DT	O
348	CD	O
-	:	O
kDa	NN	O
protein	NN	O
named	VBN	O
huntington	NN	O
.	.	O

We	PRP	O
used	VBD	O
polyclonal	JJ	O
and	CC	O
monoclonal	JJ	O
anti	NN	O
-	:	O
fusion	NN	O
protein	NN	O
antibodies	NNS	O
to	TO	O
identify	VB	O
native	JJ	O
huntingtin	NN	O
in	IN	O
rat	NN	O
,	,	O
monkey	NN	O
,	,	O
and	CC	O
human	NN	O
.	.	O

Western	JJ	O
blots	NNS	O
revealed	VBD	O
a	DT	O
protein	NN	O
with	IN	O
the	DT	O
expected	JJ	O
molecular	NN	O
weight	NN	O
which	WDT	O
is	VBZ	O
present	JJ	O
in	IN	O
the	DT	O
soluble	JJ	O
fraction	NN	O
of	IN	O
rat	NN	O
and	CC	O
monkey	NN	O
brain	NN	O
tissues	NNS	O
and	CC	O
lymphoblastoid	JJ	O
cells	NNS	O
from	IN	O
control	NN	O
cases	NNS	O
.	.	O

In	IN	O
lymphoblastoid	NN	O
cell	NN	O
lines	NNS	O
from	IN	O
juvenile	NN	O
-	:	O
onset	NN	O
heterozygote	NN	O
HD	NNP	S_Disease
cases	NNS	O
,	,	O
both	DT	O
normal	JJ	O
and	CC	O
mutant	JJ	O
huntingtin	NN	O
are	VBP	O
expressed	VBN	O
,	,	O
and	CC	O
increasing	VBG	O
repeat	NN	O
expansion	NN	O
leads	VBZ	O
to	TO	O
lower	JJR	O
levels	NNS	O
of	IN	O
the	DT	O
mutant	JJ	O
protein	NN	O
.	.	O

Immunocytochemistry	NN	O
indicates	VBZ	O
that	IN	O
huntingtin	NN	O
is	VBZ	O
located	VBN	O
in	IN	O
neurons	NNS	O
throughout	IN	O
the	DT	O
brain	NN	O
,	,	O
with	IN	O
the	DT	O
highest	JJS	O
levels	NNS	O
evident	NN	O
in	IN	O
larger	JJR	O
neurons	NNS	O
.	.	O

In	IN	O
the	DT	O
human	JJ	O
striatum	NN	O
,	,	O
huntingtin	NN	O
is	VBZ	O
enriched	VBN	O
in	IN	O
a	DT	O
patch	NN	O
-	:	O
like	IN	O
distribution	NN	O
,	,	O
potentially	RB	O
corresponding	VBG	O
to	TO	O
the	DT	O
first	JJ	O
areas	NNS	O
affected	VBN	O
in	IN	O
HD	NNP	S_Disease
.	.	O

Subcellular	JJ	O
localization	NN	O
of	IN	O
huntingtin	NN	O
is	VBZ	O
consistent	JJ	O
with	IN	O
a	DT	O
cytosolic	JJ	O
protein	NN	O
primarily	RB	O
found	VBN	O
in	IN	O
somatodendritic	JJ	O
regions	NNS	O
.	.	O

Huntingtin	NNP	O
appears	VBZ	O
to	TO	O
particularly	RB	O
associate	VB	O
with	IN	O
microtubules	NNS	O
,	,	O
although	IN	O
some	DT	O
is	VBZ	O
also	RB	O
associated	VBN	O
with	IN	O
synaptic	JJ	O
vesicles	NNS	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
localization	NN	O
of	IN	O
huntingtin	NN	O
in	IN	O
association	NN	O
with	IN	O
microtubules	NNS	O
,	,	O
we	PRP	O
speculate	VBP	O
that	IN	O
the	DT	O
mutation	NN	O
impairs	VBZ	O
the	DT	O
cytoskeletal	JJ	O
anchoring	NN	O
or	CC	O
transport	NN	O
of	IN	O
mitochondria	NNS	O
,	,	O
vesicles	NNS	O
,	,	O
or	CC	O
other	JJ	O
organelles	NNS	O
or	CC	O
molecules	NNS	O
.	.	O
.	.	O

Marked	VBN	O
phenotypic	JJ	O
heterogeneity	NN	O
associated	VBN	O
with	IN	O
expansion	NN	O
of	IN	O
a	DT	O
CAG	NNP	O
repeat	NN	O
sequence	NN	O
at	IN	O
the	DT	O
spinocerebellar	JJ	B_Disease
ataxia	NN	I_Disease
3	CD	I_Disease
/	NN	I_Disease
Machado	NNP	I_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
locus	NN	O
.	.	O

The	DT	O
spinocerebellar	JJ	B_Disease
ataxia	NN	I_Disease
3	CD	E_Disease
locus	NN	O
(	(	O
SCA3	NNP	S_Disease
)	)	O
for	IN	O
type	NN	B_Disease
I	PRP	I_Disease
autosomal	VBP	I_Disease
dominant	JJ	I_Disease
cerebellar	JJ	I_Disease
ataxia	NN	E_Disease
(	(	O
ADCA	NNP	B_Disease
type	NN	I_Disease
I	PRP	E_Disease
)	)	O
,	,	O
a	DT	O
clinically	RB	O
and	CC	O
genetically	RB	O
heterogeneous	JJ	O
group	NN	O
of	IN	O
neurodegenerative	JJ	B_Disease
disorders	NNS	E_Disease
,	,	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
chromosome	VB	O
14q32	CD	O
.	.	O

1	CD	O
1	CD	O
.	.	O

ADCA	NNP	B_Disease
type	NN	I_Disease
I	PRP	E_Disease
patients	NNS	O
from	IN	O
families	NNS	O
segregating	VBG	O
SCA3	NNP	S_Disease
share	NN	O
clinical	JJ	O
features	NNS	O
in	IN	O
common	JJ	O
with	IN	O
those	DT	O
with	IN	O
Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
(	(	O
MJD	NNP	S_Disease
)	)	O
,	,	O
the	DT	O
gene	NN	O
of	IN	O
which	WDT	O
maps	NNS	O
to	TO	O
the	DT	O
same	JJ	O
region	NN	O
.	.	O

We	PRP	O
show	VBP	O
here	RB	O
that	IN	O
the	DT	O
disease	NN	O
gene	NN	O
segregating	VBG	O
in	IN	O
each	DT	O
of	IN	O
three	CD	O
French	JJ	O
ADCA	NNP	B_Disease
type	NN	I_Disease
I	PRP	E_Disease
kindreds	NNS	O
and	CC	O
in	IN	O
a	DT	O
French	JJ	O
family	NN	O
with	IN	O
neuropathological	JJ	O
findings	NNS	O
suggesting	VBG	O
the	DT	O
ataxochoreic	JJ	O
form	NN	O
of	IN	O
dentatorubropallidoluysian	JJ	B_Disease
atrophy	NN	E_Disease
carries	VBZ	O
an	DT	O
expanded	JJ	O
CAG	NNP	O
repeat	NN	O
sequence	NN	O
located	VBN	O
at	IN	O
the	DT	O
same	JJ	O
locus	NN	O
as	IN	O
that	DT	O
for	IN	O
MJD	NNP	S_Disease
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
these	DT	O
families	NNS	O
shows	VBZ	O
a	DT	O
strong	JJ	O
negative	JJ	O
correlation	NN	O
between	IN	O
size	NN	O
of	IN	O
the	DT	O
expanded	VBN	O
CAG	NNP	O
repeat	NN	O
and	CC	O
age	NN	O
at	IN	O
onset	NN	O
of	IN	O
clinical	JJ	O
disease	NN	O
.	.	O

Instability	NN	O
of	IN	O
the	DT	O
expanded	JJ	O
triplet	NN	O
repeat	NN	O
was	VBD	O
not	RB	O
found	VBN	O
to	TO	O
be	VB	O
affected	VBN	O
by	IN	O
sex	NN	O
of	IN	O
the	DT	O
parent	NN	O
transmitting	VBG	O
the	DT	O
mutation	NN	O
.	.	O

Evidence	NN	O
was	VBD	O
found	VBN	O
for	IN	O
somatic	JJ	O
and	CC	O
gonadal	JJ	O
mosaicism	NN	O
for	IN	O
alleles	NNS	O
carrying	VBG	O
expanded	VBD	O
trinucleotide	JJ	O
repeats	NNS	O
.	.	O

Overexpression	NN	O
of	IN	O
DM20	NNP	O
messenger	NN	O
RNA	NNP	O
in	IN	O
two	CD	O
brothers	NNS	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
.	.	O

Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
is	VBZ	O
a	DT	O
rare	JJ	B_Disease
,	,	I_Disease
sex	NN	I_Disease
-	:	I_Disease
linked	VBN	I_Disease
recessive	JJ	I_Disease
,	,	I_Disease
dysmyelinating	VBG	I_Disease
disease	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
central	JJ	I_Disease
nervous	JJ	I_Disease
system	NN	E_Disease
that	WDT	O
has	VBZ	O
been	VBN	O
associated	VBN	O
with	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
myelin	NN	O
proteolipid	JJ	O
protein	NN	O
(	(	O
PLP	NNP	O
)	)	O
gene	NN	O
.	.	O

Only	RB	O
25	CD	O
%	NN	O
of	IN	O
patients	NNS	O
studied	VBN	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
have	VBP	O
exonic	JJ	O
mutations	NNS	O
in	IN	O
this	DT	O
gene	NN	O
,	,	O
the	DT	O
underlying	VBG	O
cause	NN	O
of	IN	O
the	DT	O
disease	NN	O
in	IN	O
the	DT	O
remaining	VBG	O
patients	NNS	O
is	VBZ	O
unknown	JJ	O
.	.	O

The	DT	O
PLP	NNP	O
gene	NN	O
encodes	NNS	O
two	CD	O
major	JJ	O
alternatively	RB	O
spliced	VBN	O
transcripts	NNS	O
called	VBN	O
PLP	NNP	O
and	CC	O
DM20	NNP	O
.	.	O

PLP	NNP	O
messenger	NN	O
RNA	NNP	O
is	VBZ	O
specifically	RB	O
expressed	VBN	O
in	IN	O
central	JJ	O
nervous	JJ	O
system	NN	O
tissue	NN	O
,	,	O
whereas	WP	O
DM20	NNP	O
messenger	NN	O
RNA	NNP	O
is	VBZ	O
found	VBN	O
in	IN	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
cardiac	NN	O
,	,	O
and	CC	O
other	JJ	O
tissues	NNS	O
.	.	O

We	PRP	O
studied	VBD	O
cultured	JJ	O
skin	NN	O
fibroblasts	NNS	O
from	IN	O
2	CD	O
brothers	NNS	O
with	IN	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
who	WP	O
exhibited	VBD	O
no	DT	O
detectable	JJ	O
exonic	JJ	O
mutation	NN	O
of	IN	O
the	DT	O
PLP	NNP	O
gene	NN	O
.	.	O

Examination	NN	O
of	IN	O
RNA	NNP	O
from	IN	O
these	DT	O
cells	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
level	NN	O
of	IN	O
DM20	NNP	O
messenger	NN	O
RNA	NNP	O
is	VBZ	O
elevated	VBN	O
sixfold	RB	O
relative	JJ	O
to	TO	O
male	VB	O
control	NN	O
skin	JJ	O
fibroblasts	NNS	O
.	.	O

An	DT	O
unrelated	JJ	O
female	NN	O
carrier	NN	O
,	,	O
also	RB	O
with	IN	O
no	DT	O
detectable	JJ	O
exonic	JJ	O
mutation	NN	O
,	,	O
showed	VBD	O
a	DT	O
threefold	JJ	O
increase	NN	O
in	IN	O
DM20	NNP	O
messenger	NN	O
RNA	NNP	O
in	IN	O
cultured	JJ	O
skin	NN	O
fibroblasts	NNS	O
.	.	O

Our	PRP$	O
findings	NNS	O
suggest	VBP	O
that	IN	O
in	IN	O
some	DT	O
patients	NNS	O
,	,	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
overexpression	NN	O
of	IN	O
PLP	NNP	O
gene	NN	O
transcripts	NNS	O
,	,	O
and	CC	O
that	IN	O
in	IN	O
these	DT	O
families	NNS	O
a	DT	O
50	CD	O
%	NN	O
increase	NN	O
of	IN	O
DM20	NNP	O
messenger	NN	O
RNA	NNP	O
in	IN	O
females	NNS	O
,	,	O
relative	JJ	O
to	TO	O
the	DT	O
increase	NN	O
in	IN	O
affected	JJ	O
males	NNS	O
,	,	O
can	MD	O
identify	VB	O
a	DT	O
female	NN	O
carrier	NN	O
.	.	O
.	.	O

The	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
and	CC	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
congenital	JJ	I_Disease
thrombocytopenia	NN	E_Disease
are	VBP	O
caused	VBN	O
by	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
same	JJ	O
gene	NN	O
.	.	O

The	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
thrombocytopenia	NN	S_Disease
,	,	O
small	JJ	O
platelets	NNS	O
,	,	O
eczema	NN	S_Disease
,	,	O
recurrent	JJ	O
infections	NNS	O
,	,	O
and	CC	O
immunodeficiency	NN	S_Disease
.	.	O

Besides	IN	O
the	DT	O
classic	NN	O
WAS	NNP	S_Disease
phenotype	NN	O
,	,	O
there	EX	O
is	VBZ	O
a	DT	O
group	NN	O
of	IN	O
patients	NNS	O
with	IN	O
congenital	JJ	B_Disease
X	NNP	I_Disease
-	:	I_Disease
linked	VBN	I_Disease
thrombocytopenia	NN	E_Disease
(	(	O
XLT	NNP	S_Disease
)	)	O
who	WP	O
have	VBP	O
small	JJ	O
platelets	NNS	O
but	CC	O
only	RB	O
transient	JJ	O
eczema	NN	S_Disease
,	,	O
if	IN	O
any	DT	O
,	,	O
and	CC	O
minimal	JJ	O
immune	JJ	B_Disease
deficiency	NN	E_Disease
.	.	O

Because	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
WAS	NNP	S_Disease
has	VBZ	O
been	VBN	O
sequenced	VBN	O
,	,	O
it	PRP	O
was	VBD	O
possible	JJ	O
to	TO	O
correlate	VB	O
the	DT	O
WAS	NNP	S_Disease
phenotypes	NNS	O
with	IN	O
WAS	NNP	S_Disease
gene	NN	O
mutations	NNS	O
.	.	O

Using	VBG	O
a	DT	O
fingerprinting	VBG	O
screening	NN	O
technique	NN	O
,	,	O
we	PRP	O
determined	VBD	O
the	DT	O
approximate	JJ	O
location	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
13	CD	O
unrelated	JJ	O
WAS	NNP	S_Disease
patients	NNS	O
with	IN	O
mild	JJ	O
to	TO	O
severe	VB	O
clinical	JJ	O
symptoms	NNS	O
.	.	O

Direct	JJ	O
sequence	NN	O
analysis	NN	O
of	IN	O
cDNA	NN	O
and	CC	O
genomic	JJ	O
DNA	NN	O
obtained	VBN	O
from	IN	O
patient	JJ	O
-	:	O
derived	VBN	O
cell	NN	O
lines	NNS	O
showed	VBD	O
12	CD	O
unique	JJ	O
mutations	NNS	O
distributed	VBN	O
throughout	IN	O
the	DT	O
WAS	NNP	S_Disease
gene	NN	O
,	,	O
including	VBG	O
insertions	NNS	O
,	,	O
deletions	NNS	O
,	,	O
and	CC	O
point	NN	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
,	,	O
termination	NN	O
,	,	O
exon	FW	O
skipping	VBG	O
,	,	O
or	CC	O
splicing	VBG	O
defects	NNS	O
.	.	O

Of	IN	O
4	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
the	DT	O
XLT	NNP	S_Disease
phenotype	NN	O
,	,	O
3	CD	O
had	VBD	O
missense	NN	O
mutations	NNS	O
affecting	VBG	O
exon	JJ	O
2	CD	O
and	CC	O
1	CD	O
had	VBD	O
a	DT	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
affecting	VBG	O
exon	JJ	O
9	CD	O
.	.	O

Patients	NNS	O
with	IN	O
classic	JJ	O
WAS	NNP	S_Disease
had	VBD	O
more	RBR	O
complex	JJ	O
mutations	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
termination	NN	O
codons	NNS	O
,	,	O
frameshift	NN	O
,	,	O
and	CC	O
early	JJ	O
termination	NN	O
.	.	O

These	DT	O
findings	NNS	O
provide	VBP	O
direct	JJ	O
evidence	NN	O
that	IN	O
XLT	NNP	S_Disease
and	CC	O
WAS	NNP	S_Disease
are	VBP	O
caused	VBN	O
by	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
same	JJ	O
gene	NN	O
and	CC	O
suggest	VBP	O
that	IN	O
severe	JJ	O
clinical	JJ	O
phenotypes	NNS	O
are	VBP	O
associated	VBN	O
with	IN	O
complex	JJ	O
mutations	NNS	O
.	.	O
.	.	O

Myotonia	NNP	B_Disease
levior	NN	E_Disease
is	VBZ	O
a	DT	O
chloride	JJ	B_Disease
channel	NN	I_Disease
disorder	NN	E_Disease
.	.	O

The	DT	O
group	NN	O
of	IN	O
dominant	JJ	B_Disease
non	JJ	I_Disease
-	:	I_Disease
dystrophic	JJ	I_Disease
myotonias	NN	E_Disease
,	,	O
comprising	VBG	O
disorders	NNS	O
characterized	VBN	O
by	IN	O
clinically	RB	O
similar	JJ	O
forms	NNS	O
of	IN	O
myogenic	JJ	O
muscle	NN	O
stiffness	NN	O
,	,	O
is	VBZ	O
genetically	RB	O
inhomogeneous	JJ	O
.	.	O

Dominant	NNP	B_Disease
myotonia	NN	I_Disease
congenita	NN	E_Disease
(	(	O
Thomsens	NNP	B_Disease
disease	NN	E_Disease
)	)	O
is	VBZ	O
linked	VBN	O
to	TO	O
CLCN1	NNP	O
,	,	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
major	JJ	O
muscle	NN	O
chloride	NN	O
channel	NN	O
,	,	O
localized	VBN	O
on	IN	O
chromosome	NN	O
7q35	CD	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
dominant	JJ	B_Disease
myotonias	RBS	E_Disease
sensitive	JJ	O
to	TO	O
potassium	NN	O
are	VBP	O
caused	VBN	O
by	IN	O
point	NN	O
mutations	NNS	O
in	IN	O
SCN4A	NNP	O
on	IN	O
chromosome	NN	O
17q	CD	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
alpha	JJ	O
subunit	NN	O
of	IN	O
the	DT	O
adult	NN	O
skeletal	JJ	O
muscle	NN	O
sodium	NN	O
channel	NN	O
.	.	O

No	DT	O
linkage	NN	O
or	CC	O
molecular	JJ	O
genetic	JJ	O
data	NNS	O
are	VBP	O
as	IN	O
yet	RB	O
available	JJ	O
on	IN	O
myotonia	NN	B_Disease
levior	JJ	E_Disease
characterized	VBN	O
by	IN	O
milder	NN	O
symptoms	NNS	O
and	CC	O
later	RB	O
onset	NN	O
of	IN	O
myotonia	NN	S_Disease
than	IN	O
in	IN	O
Thomsens	NNP	B_Disease
disease	NN	E_Disease
,	,	O
and	CC	O
absence	NN	O
of	IN	O
muscle	NN	B_Disease
hypertrophy	NN	E_Disease
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
CLCN1	NNP	O
Gln	NNP	O
-	:	O
552	CD	O
-	:	O
Arg	NNP	O
substitution	NN	O
for	IN	O
a	DT	O
family	NN	O
with	IN	O
dominant	JJ	O
inheritance	NN	O
previously	RB	O
diagnosed	VBN	O
to	TO	O
have	VB	O
myotonia	VBN	B_Disease
levior	RB	E_Disease
.	.	O

Thus	RB	O
,	,	O
this	DT	O
disorder	NN	O
appears	VBZ	O
as	IN	O
a	DT	O
variant	NN	O
of	IN	O
Thomsens	NNP	B_Disease
disease	NN	E_Disease
due	JJ	O
to	TO	O
mutations	NNS	O
leading	VBG	O
to	TO	O
low	JJ	O
clinical	JJ	O
expressivity	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
report	VBP	O
a	DT	O
novel	JJ	O
Ile	NNP	O
-	:	O
290	CD	O
-	:	O
Met	NNP	O
CLCN1	NNP	O
mutation	NN	O
for	IN	O
a	DT	O
typical	JJ	O
Thomsen	NNP	O
pedigree	NN	O
.	.	O

In	IN	O
another	DT	O
family	NN	O
previously	RB	O
diagnosed	VBN	O
as	IN	O
having	VBG	O
Thomsens	NNP	B_Disease
disease	NN	E_Disease
,	,	O
we	PRP	O
unexpectedly	RB	O
found	VBD	O
a	DT	O
CLCN1	NNP	O
14	CD	O
bp	NN	O
deletion	NN	O
known	VBN	O
to	TO	O
cause	VB	O
recessive	JJ	B_Disease
myotonia	NN	E_Disease
,	,	O
and	CC	O
a	DT	O
rare	JJ	O
Trp	NNP	O
-	:	O
118	CD	O
-	:	O
Gly	NN	O
polymorphism	NN	O
.	.	O
.	.	O

Southern	JJ	O
analysis	NN	O
reveals	VBZ	O
a	DT	O
large	JJ	O
deletion	NN	O
at	IN	O
the	DT	O
hypoxanthine	NN	O
phosphoribosyltransferase	NN	O
locus	NN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Whole	JJ	O
genomic	JJ	O
hprt	NN	O
clones	NNS	O
were	VBD	O
used	VBN	O
in	IN	O
Southern	JJ	O
analysis	NN	O
to	TO	O
screen	VB	O
the	DT	O
integrity	NN	O
of	IN	O
the	DT	O
hprt	NN	O
gene	NN	O
in	IN	O
a	DT	O
family	NN	O
that	WDT	O
includes	VBZ	O
a	DT	O
patient	NN	O
with	IN	O
HPRT	NNP	B_Disease
enzyme	VBP	I_Disease
deficiency	NN	E_Disease
causal	NN	O
to	TO	O
Lesch	NNP	B_Disease
-	:	I_Disease
Nyhan	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

A	DT	O
5	CD	O
kb	NN	O
DNA	NNP	O
sequence	NN	O
deletion	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
its	PRP$	O
endpoints	NNS	O
in	IN	O
the	DT	O
first	JJ	O
and	CC	O
third	JJ	O
introns	NNS	O
.	.	O

The	DT	O
probes	NNS	O
identified	VBD	O
the	DT	O
carrier	NN	O
status	NN	O
of	IN	O
female	JJ	O
family	NN	O
members	NNS	O
,	,	O
aided	VBN	O
by	IN	O
an	DT	O
RFLP	NNP	O
carried	VBN	O
by	IN	O
the	DT	O
mothers	NNS	O
normal	JJ	O
X	NNP	O
-	:	O
chromosome	NN	O
.	.	O
.	.	O

Characterisation	NN	O
of	IN	O
molecular	JJ	O
defects	NNS	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
amelogenesis	NN	I_Disease
imperfecta	NN	E_Disease
(	(	O
AIH1	NNP	O
)	)	O
.	.	O

Amelogenins	NNS	O
are	VBP	O
an	DT	O
heterogenous	JJ	O
family	NN	O
of	IN	O
proteins	NNS	O
produced	VBN	O
by	IN	O
ameloblasts	NNS	O
of	IN	O
the	DT	O
enamel	JJ	O
organ	NN	O
during	IN	O
tooth	DT	O
development	NN	O
.	.	O

Disturbances	NNS	O
of	IN	O
enamel	JJ	O
formation	NN	O
occur	NN	O
in	IN	O
amelogenesis	NN	B_Disease
imperfecta	NN	E_Disease
,	,	O
a	DT	O
clinically	RB	O
heterogenous	JJ	O
group	NN	O
of	IN	O
inherited	JJ	B_Disease
disorders	NNS	E_Disease
characterised	VBN	O
by	IN	O
defective	JJ	O
enamel	JJ	O
biomineralisation	NN	O
.	.	O

An	DT	O
amelogenin	JJ	O
gene	NN	O
,	,	O
AMGX	NNP	O
,	,	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
the	DT	O
short	JJ	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
(	(	O
Xp22	NNP	O
.	.	O

1	CD	O
-	:	O
p22	NN	O
.	.	O

3	LS	O
)	)	O
and	CC	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
in	IN	O
the	DT	O
molecular	JJ	O
pathology	NN	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
amelogenesis	NN	I_Disease
imperfecta	NN	E_Disease
(	(	O
AIH1	NNP	S_Disease
)	)	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
three	CD	O
families	NNS	O
exhibiting	VBG	O
AIH1	NNP	S_Disease
and	CC	O
screened	VBD	O
the	DT	O
AMGX	NNP	O
gene	NN	O
for	IN	O
mutations	NNS	O
using	VBG	O
single	JJ	O
-	:	O
strand	NN	O
conformational	JJ	O
polymorphism	NN	O
analysis	NN	O
and	CC	O
DNA	NNP	O
sequencing	NN	O
.	.	O

Three	CD	O
novel	JJ	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
a	DT	O
C	NNP	O
-	:	O
T	NNP	O
substitution	NN	O
in	IN	O
exon	JJ	O
5	CD	O
,	,	O
and	CC	O
a	DT	O
G	NNP	O
-	:	O
T	NNP	O
substitution	NN	O
and	CC	O
single	JJ	O
cytosine	NN	O
deletion	NN	O
in	IN	O
exon	JJ	O
6	CD	O
,	,	O
confirming	VBG	O
the	DT	O
existence	NN	O
of	IN	O
extensive	JJ	O
allelic	JJ	O
heterogeneity	NN	O
in	IN	O
this	DT	O
condition	NN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
family	NN	O
-	:	O
specific	JJ	O
mutations	NNS	O
will	MD	O
enable	VB	O
early	JJ	O
identification	NN	O
of	IN	O
affected	JJ	O
individuals	NNS	O
and	CC	O
correlation	NN	O
of	IN	O
clinical	JJ	O
phenotype	NN	O
with	IN	O
genotype	NN	O
will	MD	O
facilitate	VB	O
an	DT	O
objective	JJ	O
system	NN	O
of	IN	O
disease	NN	O
classification	NN	O
.	.	O

Frequency	NN	O
of	IN	O
exon	$	O
15	CD	O
missense	NN	O
mutation	NN	O
(	(	O
442D	CD	O
:	:	O
G	NN	O
)	)	O
in	IN	O
cholesteryl	NN	O
ester	NN	O
transfer	NN	O
protein	NN	O
gene	NN	O
in	IN	O
hyperalphalipoproteinemic	JJ	S_Disease
Japanese	JJ	O
subjects	NNS	O
.	.	O

Cholesteryl	NNP	O
ester	NN	O
transfer	NN	O
protein	NN	O
(	(	O
CETP	NNP	O
)	)	O
transfers	NNS	O
cholesteryl	VBP	O
ester	NN	O
from	IN	O
high	JJ	O
density	NN	O
lipoprotein	NN	O
(	(	O
HDL	NNP	O
)	)	O
to	TO	O
apo	VB	O
B	NNP	O
-	:	O
containing	NN	O
lipoproteins	NNS	O
.	.	O

The	DT	O
hyperalphalipoproteinemia	NN	S_Disease
caused	VBN	O
by	IN	O
CETP	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
fairly	RB	O
common	JJ	O
in	IN	O
Japan	NNP	O
and	CC	O
one	CD	O
of	IN	O
the	DT	O
most	RBS	O
common	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
CETP	NNP	O
gene	NN	O
is	VBZ	O
the	DT	O
splicing	VBG	O
defect	NN	O
of	IN	O
the	DT	O
intron	NN	O
14	CD	O
,	,	O
the	DT	O
allelic	JJ	O
frequency	NN	O
of	IN	O
which	WDT	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
0	CD	O
.	.	O

0049	CD	O
in	IN	O
the	DT	O
Japanese	JJ	O
general	JJ	O
population	NN	O
.	.	O

Recently	RB	O
,	,	O
we	PRP	O
have	VBP	O
reported	VBN	O
a	DT	O
missense	NN	O
mutation	NN	O
in	IN	O
exon	JJ	O
15	CD	O
of	IN	O
the	DT	O
CETP	NNP	O
gene	NN	O
(	(	O
442D	CD	O
G	NNP	O
)	)	O
,	,	O
showing	VBG	O
a	DT	O
dominant	JJ	O
effect	NN	O
on	IN	O
the	DT	O
CETP	NNP	O
activity	NN	O
and	CC	O
HDL	NNP	O
-	:	O
cholesterol	NN	O
level	NN	O
.	.	O

In	IN	O
the	DT	O
current	JJ	O
study	NN	O
,	,	O
we	PRP	O
determined	VBD	O
the	DT	O
frequency	NN	O
of	IN	O
this	DT	O
new	JJ	O
mutation	NN	O
in	IN	O
Japanese	JJ	O
hyperalphalipoproteinemic	JJ	S_Disease
(	(	O
HDL	NNP	O
-	:	O
cholesterol	NN	O
>	NN	O
or	CC	O
=	$	O
100	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
)	)	O
subjects	NNS	O
.	.	O

A	DT	O
rapid	JJ	O
and	CC	O
easy	JJ	O
screening	NN	O
method	NN	O
for	IN	O
this	DT	O
new	JJ	O
mutation	NN	O
was	VBD	O
developed	VBN	O
using	VBG	O
a	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
-	:	O
mediated	VBN	O
site	NN	O
-	:	O
directed	JJ	O
mutagenesis	NN	O
.	.	O

Among	IN	O
117	CD	O
Japanese	JJ	O
hyperalphalipoproteinemic	JJ	S_Disease
subjects	NNS	O
(	(	O
HDL	NNP	O
-	:	O
cholesterol	NN	O
;	:	O
116	CD	O
.	.	O

7	CD	O
+	JJ	O
/	NNP	O
-	:	O
16	CD	O
.	.	O

5	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
,	,	O
mean	JJ	O
+	NNP	O
/	NNP	O
-	:	O
S	NN	O
.	.	O

D	NNP	O
.	.	O
)	)	O
without	IN	O
the	DT	O
intron	NN	O
14	CD	O
splice	NN	O
defect	NN	O
,	,	O
three	CD	O
homozygotes	NNS	O
(	(	O
2	CD	O
.	.	O

5	CD	O
%	NN	O
)	)	O
and	CC	O
34	CD	O
heterozygotes	NNS	O
(	(	O
29	CD	O
.	.	O

1	CD	O
%	NN	O
)	)	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
the	DT	O
442D	CD	O
G	NNP	O
mutation	NN	O
.	.	O

The	DT	O
relative	JJ	O
allelic	JJ	O
frequency	NN	O
of	IN	O
this	DT	O
mutation	NN	O
was	VBD	O
calculated	VBN	O
to	TO	O
be	VB	O
0	CD	O
.	.	O

17	CD	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
homozygotes	NNS	O
for	IN	O
the	DT	O
442D	CD	O
G	NNP	O
mutation	NN	O
was	VBD	O
the	DT	O
patient	NN	O
previously	RB	O
described	VBN	O
by	IN	O
us	PRP	O
as	IN	O
having	VBG	O
hyperalphalipoproteinemia	NN	S_Disease
with	IN	O
corneal	JJ	B_Disease
opacity	NN	E_Disease
and	CC	O
coronary	JJ	B_Disease
heart	NN	I_Disease
disease	NN	E_Disease
.	.	O

This	DT	O
was	VBD	O
the	DT	O
first	JJ	O
reported	VBD	O
subject	JJ	O
homozygous	JJ	O
for	IN	O
the	DT	O
CETP	NNP	B_Disease
deficiency	NN	E_Disease
who	WP	O
also	RB	O
demonstrated	VBD	O
atherosclerotic	JJ	B_Disease
symptoms	NNS	E_Disease
.	.	O

In	IN	O
homozygous	JJ	O
subjects	NNS	O
,	,	O
CETP	NNP	O
activity	NN	O
ranged	VBD	O
from	IN	O
37	CD	O
%	NN	O
to	TO	O
62	CD	O
%	NN	O
of	IN	O
the	DT	O
normal	JJ	O
value	NN	O
,	,	O
which	WDT	O
was	VBD	O
consistent	JJ	O
with	IN	O
the	DT	O
results	NNS	O
obtained	VBD	O
from	IN	O
the	DT	O
transient	JJ	O
expression	NN	O
experiment	NN	O
previously	RB	O
reported	VBD	O
;	:	O
however	RB	O
,	,	O
the	DT	O
specific	JJ	O
activity	NN	O
of	IN	O
CETP	NNP	O
was	VBD	O
not	RB	O
as	RB	O
low	JJ	O
as	IN	O
expected	VBN	O
.	.	O

(	(	O
ABSTRACT	NNP	O
TRUNCATED	NNP	O
AT	NNP	O
250	CD	O
WORDS	NNP	O
)	)	O

Mucopolysaccharidosis	NNP	B_Disease
type	NN	I_Disease
IVA	NN	E_Disease
:	:	O
common	JJ	O
double	JJ	O
deletion	NN	O
in	IN	O
the	DT	O
N	NNP	O
-	:	O
acetylgalactosamine	NN	O
-	:	O
6	CD	O
-	:	O
sulfatase	NN	O
gene	NN	O
(	(	O
GALNS	NNP	O
)	)	O
.	.	O

Mucopolysaccharidosis	NN	B_Disease
IVA	NNP	E_Disease
(	(	O
MPS	NNP	B_Disease
IVA	NNP	E_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B_Disease
in	IN	I_Disease
N	NNP	I_Disease
-	:	I_Disease
acetylgalactosamine	NN	I_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
sulfatase	NN	E_Disease
(	(	O
GALNS	NNP	O
)	)	O
.	.	O

We	PRP	O
found	VBD	O
two	CD	O
separate	JJ	O
deletions	NNS	O
of	IN	O
nearly	RB	O
8	CD	O
.	.	O

0	CD	O
and	CC	O
6	CD	O
.	.	O

0	CD	O
kb	NN	O
in	IN	O
the	DT	O
GALNS	NNP	O
gene	NN	O
,	,	O
including	VBG	O
some	DT	O
exons	NNS	O
.	.	O

There	EX	O
are	VBP	O
Alu	NNP	O
repetitive	JJ	O
elements	NNS	O
near	IN	O
the	DT	O
breakpoints	NNS	O
of	IN	O
the	DT	O
8	CD	O
.	.	O

0	CD	O
-	:	O
kb	NN	O
deletion	NN	O
,	,	O
and	CC	O
this	DT	O
deletion	NN	O
resulted	VBD	O
from	IN	O
an	DT	O
Alu	NNP	O
-	:	O
Alu	NNP	O
recombination	NN	O
.	.	O

The	DT	O
other	JJ	O
6	CD	O
.	.	O

0	CD	O
-	:	O
kb	NN	O
deletion	NN	O
involved	VBN	O
illegitimate	JJ	O
recombinational	JJ	O
events	NNS	O
between	IN	O
incomplete	JJ	O
short	JJ	O
direct	JJ	O
repeats	NNS	O
of	IN	O
8	CD	O
bp	NN	O
at	IN	O
deletion	NN	O
breakpoints	NNS	O
.	.	O

The	DT	O
same	JJ	O
rearrangement	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
in	IN	O
a	DT	O
heteroallelic	JJ	O
state	NN	O
in	IN	O
four	CD	O
unrelated	JJ	O
patients	NNS	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
documentation	NN	O
of	IN	O
a	DT	O
common	JJ	O
double	JJ	O
deletion	NN	O
a	DT	O
gene	NN	O
that	WDT	O
is	VBZ	O
not	RB	O
a	DT	O
member	NN	O
of	IN	O
a	DT	O
gene	NN	O
cluster	NN	O
.	.	O

Detection	NN	O
of	IN	O
eight	CD	O
BRCA1	NNP	O
mutations	NNS	O
in	IN	O
10	CD	O
breast	NN	B_Disease
/	JJ	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
,	,	O
including	VBG	O
1	CD	O
family	NN	O
with	IN	O
male	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
.	.	O

Genetic	JJ	O
epidemiological	JJ	O
evidence	NN	O
suggests	VBZ	O
that	IN	O
mutations	NNS	O
in	IN	O
BRCA1	NNP	O
may	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
approximately	RB	O
one	CD	O
half	NN	O
of	IN	O
early	JJ	O
onset	VBN	O
familial	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
and	CC	O
the	DT	O
majority	NN	O
of	IN	O
familial	JJ	B_Disease
breast	NN	I_Disease
/	JJ	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

The	DT	O
recent	JJ	O
cloning	NN	O
of	IN	O
BRCA1	NNP	O
allows	VBZ	O
for	IN	O
the	DT	O
direct	JJ	O
detection	NN	O
of	IN	O
mutations	NNS	O
,	,	O
but	CC	O
the	DT	O
feasibility	NN	O
of	IN	O
presymptomatic	JJ	O
screening	NN	O
for	IN	O
cancer	NN	S_Disease
susceptibility	NN	O
is	VBZ	O
unknown	JJ	O
.	.	O

We	PRP	O
analyzed	VBD	O
genomic	JJ	O
DNA	NN	O
from	IN	O
one	CD	O
affected	VBD	O
individual	JJ	O
from	IN	O
each	DT	O
of	IN	O
24	CD	O
families	NNS	O
with	IN	O
at	IN	O
least	JJS	O
three	CD	O
cases	NNS	O
of	IN	O
ovarian	JJ	B_Disease
or	CC	I_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
,	,	O
using	VBG	O
SSCP	NNP	O
assays	NNS	O
.	.	O

Variant	NNP	O
SSCP	NNP	O
bands	NNS	O
were	VBD	O
subcloned	VBN	O
and	CC	O
sequenced	VBN	O
.	.	O

Allele	NNP	O
-	:	O
specific	JJ	O
oligonucleotide	JJ	O
hybridization	NN	O
was	VBD	O
used	VBN	O
to	TO	O
verify	VB	O
sequence	NN	O
changes	NNS	O
and	CC	O
to	TO	O
screen	VB	O
DNA	NNP	O
from	IN	O
control	NN	O
individuals	NNS	O
.	.	O

Six	NNP	O
frameshift	NN	O
and	CC	O
two	CD	O
missense	NN	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
10	CD	O
different	JJ	O
families	NNS	O
.	.	O

A	DT	O
frameshift	NN	O
mutation	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
a	DT	O
male	JJ	O
proband	NN	O
affected	VBN	O
with	IN	O
both	DT	O
breast	NN	B_Disease
and	CC	I_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
.	.	O

A	DT	O
40	CD	O
-	:	O
bp	NN	O
deletion	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
a	DT	O
patient	NN	O
who	WP	O
developed	VBD	O
intra	JJ	B_Disease
-	:	I_Disease
abdominal	JJ	I_Disease
carcinomatosis	NN	E_Disease
1	CD	O
year	NN	O
after	IN	O
prophylactic	JJ	O
oophorectomy	NN	O
.	.	O

Mutations	NNS	O
were	VBD	O
detected	VBN	O
throughout	IN	O
the	DT	O
gene	NN	O
,	,	O
and	CC	O
only	RB	O
one	CD	O
was	VBD	O
detected	VBN	O
in	IN	O
more	JJR	O
than	IN	O
a	DT	O
single	JJ	O
family	NN	O
.	.	O

These	DT	O
results	NNS	O
provide	VBP	O
further	JJ	O
evidence	NN	O
that	WDT	O
inherited	VBD	B_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
can	MD	O
occur	VB	O
as	IN	O
a	DT	O
consequence	NN	O
of	IN	O
a	DT	O
wide	JJ	O
array	NN	O
of	IN	O
BRCA1	NNP	O
mutations	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggests	VBZ	O
that	IN	O
development	NN	O
of	IN	O
a	DT	O
screening	JJ	O
test	NN	O
for	IN	O
BRCA1	NNP	O
mutations	NNS	O
will	MD	O
be	VB	O
technically	RB	O
challenging	VBG	O
.	.	O

The	DT	O
finding	NN	O
of	IN	O
a	DT	O
mutation	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
male	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
,	,	O
not	RB	O
previously	RB	O
thought	VBN	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
BRCA1	NNP	O
,	,	O
also	RB	O
illustrates	VBZ	O
the	DT	O
potential	JJ	O
difficulties	NNS	O
of	IN	O
genetic	JJ	O
counseling	NN	O
for	IN	O
individuals	NNS	O
known	VBN	O
to	TO	O
carry	VB	O
mutations	NNS	O
.	.	O
.	.	O

Natural	JJ	O
selection	NN	O
of	IN	O
hemi	NN	O
-	:	O
and	CC	O
heterozygotes	NNS	O
for	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
Africa	NNP	O
by	IN	O
resistance	NN	O
to	TO	O
severe	VB	O
malaria	NNS	S_Disease
.	.	O

Glucose	NNP	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
enzymopathy	NN	S_Disease
of	IN	O
humans	NNS	O
,	,	O
affects	VBZ	O
over	IN	O
400	CD	O
million	CD	O
people	NNS	O
.	.	O

The	DT	O
geographical	JJ	O
correlation	NN	O
of	IN	O
its	PRP$	O
distribution	NN	O
with	IN	O
the	DT	O
historical	JJ	O
endemicity	NN	O
of	IN	O
malaria	NN	S_Disease
suggests	VBZ	O
that	IN	O
this	DT	O
disorder	NN	O
has	VBZ	O
risen	VBN	O
in	IN	O
frequency	NN	O
through	IN	O
natural	JJ	O
selection	NN	O
by	IN	O
malaria	NNS	S_Disease
.	.	O

However	RB	O
,	,	O
attempts	NNS	O
to	TO	O
confirm	VB	O
that	DT	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
protective	JJ	O
in	IN	O
case	NN	O
-	:	O
control	NN	O
studies	NNS	O
of	IN	O
malaria	NNS	S_Disease
have	VBP	O
yielded	VBN	O
conflicting	NN	O
results	NNS	O
.	.	O

Hence	NNP	O
,	,	O
for	IN	O
this	DT	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
disorder	NN	E_Disease
,	,	O
it	PRP	O
is	VBZ	O
unclear	JJ	O
whether	IN	O
both	DT	O
male	JJ	O
hemizygotes	NNS	O
and	CC	O
female	JJ	O
heterozygotes	NNS	O
are	VBP	O
protected	VBN	O
or	CC	O
,	,	O
as	IN	O
frequently	RB	O
suggested	VBN	O
,	,	O
only	RB	O
females	VBZ	O
.	.	O

Furthermore	RB	O
,	,	O
how	WRB	O
much	JJ	O
protection	NN	O
may	MD	O
be	VB	O
afforded	VBN	O
is	VBZ	O
unknown	JJ	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	DT	O
,	,	O
in	IN	O
two	CD	O
large	JJ	O
case	NN	O
-	:	O
control	NN	O
studies	NNS	O
of	IN	O
over	IN	O
2	CD	O
,	,	O
000	CD	O
African	JJ	O
children	NNS	O
,	,	O
the	DT	O
common	JJ	O
African	JJ	O
form	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
(	(	O
G6PD	NNP	B_Disease
A	NNP	I_Disease
-	:	E_Disease
)	)	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
46	CD	O
-	:	O
58	CD	O
%	NN	O
reduction	NN	O
in	IN	O
risk	NN	O
of	IN	O
severe	JJ	O
malaria	NN	S_Disease
for	IN	O
both	DT	O
female	JJ	O
heterozygotes	NNS	O
and	CC	O
male	NN	O
hemizygotes	NNS	O
.	.	O

A	DT	O
mathematical	JJ	O
model	NN	O
incorporating	VBG	O
the	DT	O
measured	VBN	O
selective	JJ	O
advantage	NN	O
against	IN	O
malaria	NN	S_Disease
suggests	VBZ	O
that	IN	O
a	DT	O
counterbalancing	VBG	O
selective	JJ	O
disadvantage	NN	O
,	,	O
associated	VBN	O
with	IN	O
this	DT	O
enzyme	JJ	B_Disease
deficiency	NN	E_Disease
,	,	O
has	VBZ	O
retarded	VBN	O
its	PRP$	O
rise	NN	O
in	IN	O
frequency	NN	O
in	IN	O
malaria	NN	S_Disease
-	:	O
endemic	JJ	O
regions	NNS	O
.	.	O

Although	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
now	RB	O
regarded	VBN	O
as	IN	O
a	DT	O
generally	RB	O
benign	JJ	O
disorder	NN	O
,	,	O
in	IN	O
earlier	JJR	O
environmental	JJ	O
conditions	NNS	O
it	PRP	O
could	MD	O
have	VB	O
been	VBN	O
significantly	RB	O
disadvantageous	JJ	O
.	.	O
.	.	O

The	DT	O
alveolar	JJ	B_Disease
rhabdomyosarcoma	NN	E_Disease
PAX3	NNP	O
/	NNP	O
FKHR	NNP	O
fusion	NN	O
protein	NN	O
is	VBZ	O
a	DT	O
transcriptional	JJ	O
activator	NN	O
.	.	O

Chimeric	JJ	O
transcription	NN	O
factors	NNS	O
,	,	O
created	VBN	O
by	IN	O
gene	NN	O
fusions	NNS	O
as	IN	O
the	DT	O
result	NN	O
of	IN	O
chromosomal	JJ	O
translocations	NNS	O
,	,	O
have	VBP	O
been	VBN	O
implicated	VBN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
several	JJ	O
pathologically	RB	O
disparate	VBP	O
solid	JJ	B_Disease
tumors	NNS	E_Disease
.	.	O

The	DT	O
PAX3	NNP	O
/	NNP	O
FKHR	NNP	O
fusion	NN	O
gene	NN	O
,	,	O
formed	VBN	O
by	IN	O
a	DT	O
t	NN	O
(	(	O
2	CD	O
;	:	O
13	CD	O
)	)	O
(	(	O
q35	NN	O
;	:	O
q14	NN	O
)	)	O
in	IN	O
alveolar	JJ	B_Disease
rhabdomyosarcoma	NN	E_Disease
,	,	O
encodes	VBZ	O
a	DT	O
hybrid	JJ	O
protein	NN	O
that	WDT	O
contains	VBZ	O
both	DT	O
PAX3	NNP	O
DNA	NNP	O
binding	NN	O
domains	NNS	O
,	,	O
the	DT	O
paired	VBN	O
box	NN	O
and	CC	O
homeodomain	NN	O
,	,	O
linked	VBN	O
to	TO	O
the	DT	O
bisected	VBN	O
DNA	NNP	O
binding	VBG	O
domain	NN	O
of	IN	O
FKHR	NNP	O
,	,	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
forkhead	JJ	O
family	NN	O
of	IN	O
transcription	NN	O
factors	NNS	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	DT	O
PAX3	NNP	O
and	CC	O
PAX3	NNP	O
/	NNP	O
FKHR	NNP	O
display	NN	O
similar	JJ	O
,	,	O
but	CC	O
not	RB	O
identical	JJ	O
transactivation	NN	O
activities	NNS	O
when	WRB	O
tested	VBN	O
with	IN	O
model	NN	O
Pax	NNP	O
recognition	NN	O
sequences	NNS	O
.	.	O

No	DT	O
functional	JJ	O
role	NN	O
could	MD	O
be	VB	O
ascribed	VBN	O
solely	RB	O
to	TO	O
the	DT	O
residual	JJ	O
FKHR	NNP	O
binding	NN	O
domain	NN	O
present	NN	O
in	IN	O
the	DT	O
fusion	NN	O
protein	NN	O
,	,	O
but	CC	O
FKHR	NNP	O
was	VBD	O
found	VBN	O
to	TO	O
contribute	VB	O
a	DT	O
strong	JJ	O
carboxyl	NN	O
terminal	JJ	O
activation	NN	O
domain	NN	O
replacing	VBG	O
the	DT	O
one	CD	O
located	VBN	O
in	IN	O
the	DT	O
unrearranged	JJ	O
PAX3	NNP	O
gene	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
the	DT	O
native	JJ	O
PAX3	NNP	O
/	NNP	O
FKHR	NNP	O
protein	NN	O
present	NN	O
in	IN	O
tumor	NN	S_Disease
cells	NNS	O
with	IN	O
this	DT	O
translocation	NN	O
has	VBZ	O
transcriptional	JJ	O
characteristics	NNS	O
similar	JJ	O
to	TO	O
the	DT	O
in	IN	O
vitro	NN	O
expressed	VBN	O
protein	NN	O
.	.	O

The	DT	O
ability	NN	O
of	IN	O
the	DT	O
PAX3	NNP	O
/	NNP	O
FKHR	NNP	O
hybrid	JJ	O
protein	NN	O
to	TO	O
bind	VB	O
DNA	NNP	O
in	IN	O
a	DT	O
sequence	NN	O
specific	JJ	O
manner	NN	O
and	CC	O
to	TO	O
transactivate	VB	O
the	DT	O
expression	NN	O
of	IN	O
artificial	JJ	O
reporter	NN	O
genes	NNS	O
suggests	VBZ	O
that	IN	O
its	PRP$	O
aberrant	JJ	O
expression	NN	O
could	MD	O
subvert	VB	O
the	DT	O
transcriptional	JJ	O
programs	NNS	O
that	WDT	O
normally	RB	O
control	VBP	O
the	DT	O
growth	NN	O
,	,	O
differentiation	NN	O
,	,	O
and	CC	O
survival	NN	O
of	IN	O
primitive	JJ	O
myogenic	JJ	O
precursors	NNS	O
in	IN	O
vivo	NN	O
.	.	O
.	.	O

A	DT	O
p16INK4a	JJ	O
-	:	O
insensitive	JJ	O
CDK4	NNP	O
mutant	NN	O
targeted	VBN	O
by	IN	O
cytolytic	JJ	O
T	NNP	O
lymphocytes	VBZ	O
in	IN	O
a	DT	O
human	JJ	O
melanoma	NN	S_Disease
.	.	O

A	DT	O
mutated	JJ	O
cyclin	NN	O
-	:	O
dependent	JJ	O
kinase	NN	O
4	CD	O
(	(	O
CDK4	NNP	O
)	)	O
was	VBD	O
identified	VBN	O
as	IN	O
a	DT	O
tumor	NN	S_Disease
-	:	O
specific	JJ	O
antigen	NN	O
recognized	VBN	O
by	IN	O
HLA	NNP	O
-	:	O
A2	NN	O
.	.	O

1	CD	O
-	:	O
restricted	VBN	O
autologous	JJ	O
cytolytic	JJ	O
T	NNP	O
lymphocytes	NNS	O
(	(	O
CTLs	NNP	O
)	)	O
in	IN	O
a	DT	O
human	JJ	O
melanoma	NN	S_Disease
.	.	O

The	DT	O
mutated	JJ	O
CDK4	NNP	O
allele	NN	O
was	VBD	O
present	JJ	O
in	IN	O
autologous	JJ	O
cultured	JJ	O
melanoma	NN	S_Disease
cells	NNS	O
and	CC	O
metastasis	NN	O
tissue	NN	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
the	DT	O
patients	NNS	O
lymphocytes	VBZ	O
.	.	O

The	DT	O
mutation	NN	O
,	,	O
an	DT	O
arginine	JJ	O
-	:	O
to	TO	O
-	:	O
cysteine	NN	O
exchange	NN	O
at	IN	O
residue	JJ	O
24	CD	O
,	,	O
was	VBD	O
part	NN	O
of	IN	O
the	DT	O
CDK4	NNP	O
peptide	NN	O
recognized	VBN	O
by	IN	O
CTLs	NNP	O
and	CC	O
prevented	VBD	O
binding	NN	O
of	IN	O
the	DT	O
CDK4	NNP	O
inhibitor	NN	O
p16INK4a	NN	O
,	,	O
but	CC	O
not	RB	O
of	IN	O
p21	NN	O
or	CC	O
of	IN	O
p27KIP1	NN	O
.	.	O

The	DT	O
same	JJ	O
mutation	NN	O
was	VBD	O
found	VBN	O
in	IN	O
one	CD	O
additional	JJ	O
melanoma	NN	S_Disease
among	IN	O
28	CD	O
melanomas	NNS	S_Disease
analyzed	VBN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
mutation	NN	O
of	IN	O
CDK4	NNP	O
can	MD	O
create	VB	O
a	DT	O
tumor	NN	S_Disease
-	:	O
specific	JJ	O
antigen	NN	O
and	CC	O
can	MD	O
disrupt	VB	O
the	DT	O
cell	NN	O
-	:	O
cycle	NN	O
regulation	NN	O
exerted	VBN	O
by	IN	O
the	DT	O
tumor	NN	S_Disease
suppressor	NN	O
p16INK4a	NN	O
.	.	O
.	.	O

Rapid	JJ	O
detection	NN	O
of	IN	O
BRCA1	NNP	O
mutations	NNS	O
by	IN	O
the	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
.	.	O

More	JJR	O
than	IN	O
75	CD	O
%	NN	O
of	IN	O
the	DT	O
reported	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
hereditary	JJ	B_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
gene	NN	O
,	,	O
BRCA1	NNP	O
,	,	O
result	NN	O
in	IN	O
truncated	JJ	O
proteins	NNS	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
the	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
(	(	O
PTT	NNP	O
)	)	O
to	TO	O
screen	VB	O
for	IN	O
mutations	NNS	O
in	IN	O
exon	JJ	O
11	CD	O
,	,	O
which	WDT	O
encodes	VBZ	O
61	CD	O
%	NN	O
of	IN	O
BRCA1	NNP	O
.	.	O

In	IN	O
45	CD	O
patients	NNS	O
from	IN	O
breast	NN	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
we	PRP	O
found	VBD	O
six	CD	O
novel	JJ	O
mutations	NNS	O
two	CD	O
single	JJ	O
nucleotide	JJ	O
insertions	NNS	O
,	,	O
three	CD	O
small	JJ	O
deletions	NNS	O
(	(	O
1	CD	O
-	:	O
5	CD	O
bp	NN	O
)	)	O
and	CC	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
identified	VBD	O
two	CD	O
unrelated	JJ	O
families	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
we	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
amplify	VB	O
the	DT	O
remaining	VBG	O
coding	VBG	O
region	NN	O
by	IN	O
RT	NNP	O
-	:	O
PCR	NN	O
using	VBG	O
lymphocyte	JJ	O
RNA	NNP	O
.	.	O

Combined	VBN	O
with	IN	O
PTT	NNP	O
,	,	O
we	PRP	O
detected	VBD	O
aberrantly	RB	O
spliced	VBN	O
products	NNS	O
affecting	VBG	O
exons	NNS	O
5	CD	O
and	CC	O
6	CD	O
in	IN	O
one	CD	O
of	IN	O
two	CD	O
BRCA1	NNP	O
-	:	O
linked	VBN	O
families	NNS	O
examined	VBD	O
.	.	O

The	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
promises	VBZ	O
to	TO	O
become	VB	O
a	DT	O
valuable	JJ	O
technique	NN	O
in	IN	O
detecting	VBG	O
BRCA1	NNP	O
mutations	NNS	O
.	.	O
.	.	O

Cloning	NN	O
of	IN	O
human	JJ	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
acyl	IN	O
-	:	O
coenzyme	NN	O
A	DT	O
dehydrogenase	NN	O
and	CC	O
molecular	JJ	O
characterization	NN	O
of	IN	O
its	PRP$	O
deficiency	NN	O
in	IN	O
two	CD	O
patients	NNS	O
.	.	O

Two	CD	O
overlapping	VBG	O
cDNA	NN	O
clones	NNS	O
(	(	O
1	CD	O
,	,	O
991	CD	O
bp	NN	O
and	CC	O
736	CD	O
bp	NN	O
,	,	O
respectively	RB	O
)	)	O
encoding	VBG	O
the	DT	O
precursor	NN	O
of	IN	O
human	JJ	O
mitochondrial	JJ	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
acyl	IN	O
-	:	O
coenzyme	NN	O
A	DT	O
dehydrogenase	NN	O
(	(	O
VLCAD	NNP	O
)	)	O
were	VBD	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
.	.	O

The	DT	O
cDNA	NN	O
inserts	NNS	O
of	IN	O
these	DT	O
clones	NNS	O
together	RB	O
encompass	VBP	O
a	DT	O
region	NN	O
of	IN	O
2	CD	O
,	,	O
177	CD	O
bases	NNS	O
,	,	O
encoding	VBG	O
the	DT	O
entire	JJ	O
protein	NN	O
of	IN	O
655	CD	O
amino	NN	O
acids	NNS	O
,	,	O
including	VBG	O
a	DT	O
40	CD	O
-	:	O
amino	NN	O
acid	JJ	O
leader	NN	O
peptide	NN	O
and	CC	O
a	DT	O
615	CD	O
-	:	O
amino	NN	O
acid	JJ	O
mature	NN	O
polypeptide	NN	O
.	.	O

PCR	NNP	O
-	:	O
amplified	VBD	O
VLCAD	NNP	O
cDNAs	NN	O
were	VBD	O
sequenced	VBN	O
in	IN	O
cultured	JJ	O
fibroblasts	NNS	O
from	IN	O
two	CD	O
VLCAD	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
patients	NNS	O
.	.	O

In	IN	O
both	DT	O
patients	NNS	O
,	,	O
a	DT	O
105	CD	O
-	:	O
bp	NN	O
deletion	NN	O
encompassing	VBG	O
bases	NNS	O
1078	CD	O
-	:	O
1182	CD	O
in	IN	O
VLCAD	NNP	O
cDNA	NN	O
was	VBD	O
identified	VBN	O
.	.	O

The	DT	O
deletion	NN	O
seems	VBZ	O
to	TO	O
occur	VB	O
due	JJ	O
to	TO	O
exon	VB	O
skipping	VBG	O
during	IN	O
processing	NN	O
of	IN	O
VLCAD	NNP	O
pre	FW	O
-	:	O
mRNA	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
demonstration	NN	O
of	IN	O
a	DT	O
mutation	NN	O
causing	VBG	O
VLCAD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

Quantitative	JJ	O
cDNA	NN	O
expression	NN	O
of	IN	O
normal	JJ	O
human	JJ	O
VLCAD	NNP	O
was	VBD	O
performed	VBN	O
in	IN	O
the	DT	O
patients	NNS	O
fibroblasts	NNS	O
,	,	O
using	VBG	O
vaccinia	JJ	O
viral	JJ	O
system	NN	O
,	,	O
which	WDT	O
demonstrated	VBD	O
that	IN	O
the	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
normal	JJ	I_Disease
VLCAD	NNP	I_Disease
protein	NN	E_Disease
causes	NNS	O
impaired	VBD	O
long	JJ	O
-	:	O
chain	NN	O
fatty	JJ	O
acid	NN	O
beta	SYM	O
-	:	O
oxidation	NN	O
activity	NN	O
in	IN	O
the	DT	O
patients	NNS	O
fibroblasts	NNS	O
.	.	O

In	IN	O
patient	JJ	O
fibroblasts	NNS	O
,	,	O
raising	VBG	O
VLCAD	NNP	O
activity	NN	O
to	TO	O
approximately	RB	O
20	CD	O
%	NN	O
of	IN	O
normal	JJ	O
control	NN	O
fibroblast	NN	O
activity	NN	O
raised	VBN	O
palmitic	JJ	O
acid	NN	O
beta	SYM	O
-	:	O
oxidation	NN	O
flux	NN	O
to	TO	O
the	DT	O
level	NN	O
found	VBD	O
in	IN	O
control	NN	O
fibroblasts	NNS	O
,	,	O
which	WDT	O
may	MD	O
offer	VB	O
important	JJ	O
information	NN	O
for	IN	O
the	DT	O
rational	JJ	O
design	NN	O
of	IN	O
future	JJ	O
somatic	JJ	O
gene	NN	O
therapy	NN	O
for	IN	O
VLCAD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O
.	.	O

Brain	NNP	B_Disease
disease	NN	E_Disease
and	CC	O
molecular	JJ	O
analysis	NN	O
in	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
.	.	O

Abnormal	JJ	O
amplification	NN	O
of	IN	O
a	DT	O
CTG	NNP	O
repeat	NN	O
on	IN	O
chromosome	NN	O
19	CD	O
is	VBZ	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
.	.	O

Expansion	NN	O
of	IN	O
the	DT	O
repeat	NN	O
has	VBZ	O
been	VBN	O
correlated	VBN	O
with	IN	O
severity	NN	O
of	IN	O
several	JJ	O
clinical	JJ	O
features	NNS	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

We	PRP	O
performed	VBD	O
extensive	JJ	O
cognitive	JJ	O
testing	NN	O
,	,	O
cerebral	JJ	O
magnetic	JJ	O
resonance	NN	O
imaging	NN	O
(	(	O
MRI	NNP	O
)	)	O
and	CC	O
a	DT	O
molecular	JJ	O
analysis	NN	O
in	IN	O
28	CD	O
cases	NNS	O
of	IN	O
DM	NNP	S_Disease
to	TO	O
determine	VB	O
the	DT	O
relationship	NN	O
between	IN	O
the	DT	O
molecular	JJ	O
defect	NN	O
and	CC	O
brain	NN	B_Disease
disease	NN	E_Disease
.	.	O

Performance	NN	O
in	IN	O
two	CD	O
or	CC	O
more	JJR	O
cognitive	JJ	O
tests	NNS	O
was	VBD	O
pathological	JJ	O
in	IN	O
10	CD	O
cases	NNS	O
.	.	O

Fourteen	JJ	O
patients	NNS	O
had	VBD	O
subcortical	JJ	O
white	JJ	B_Disease
matter	NN	I_Disease
lesions	NNS	E_Disease
on	IN	O
MRI	NNP	O
,	,	O
14	CD	O
had	VBD	O
cerebral	JJ	B_Disease
atrophy	NN	E_Disease
.	.	O

Amplification	NN	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
showed	VBD	O
a	DT	O
strong	JJ	O
correlation	NN	O
with	IN	O
cognitive	JJ	O
test	NN	O
deficits	NNS	O
when	WRB	O
exceeding	VBG	O
a	DT	O
length	NN	O
of	IN	O
over	IN	O
1000	CD	O
trinucleotides	NNS	O
.	.	O

MRI	NNP	O
lesions	NNS	O
were	VBD	O
associated	VBN	O
with	IN	O
impaired	JJ	O
psychometric	JJ	O
performance	NN	O
,	,	O
but	CC	O
MRI	NNP	O
and	CC	O
molecular	JJ	O
findings	NNS	O
were	VBD	O
only	RB	O
weakly	RB	O
related	VBN	O
.	.	O

Disease	NNP	O
duration	NN	O
influenced	VBD	O
the	DT	O
appearance	NN	O
and	CC	O
amount	NN	O
of	IN	O
white	JJ	B_Disease
matter	NN	I_Disease
lesions	NNS	E_Disease
on	IN	O
MRI	NNP	O
.	.	O

Quantification	NN	O
of	IN	O
CTG	NNP	O
repeat	NN	O
size	NN	O
may	MD	O
allow	VB	O
an	DT	O
early	JJ	O
estimate	NN	O
on	IN	O
the	DT	O
probability	NN	O
of	IN	O
brain	NN	O
involvement	NN	O
in	IN	O
DM	NNP	S_Disease
;	:	O
cognitive	JJ	B_Disease
dysfunction	NN	E_Disease
is	VBZ	O
associated	VBN	O
with	IN	O
white	JJ	B_Disease
matter	NN	I_Disease
lesions	NNS	E_Disease
and	CC	O
cerebral	JJ	B_Disease
atrophy	NN	E_Disease
later	RB	O
on	IN	O
in	IN	O
the	DT	O
course	NN	O
.	.	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
for	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
adrenoleukodystrophy	NN	E_Disease
in	IN	O
patients	NNS	O
with	IN	O
different	JJ	O
clinical	JJ	O
phenotypes	NNS	O
.	.	O

Recently	RB	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
most	RBS	O
common	JJ	O
peroxisomal	JJ	B_Disease
disorder	NN	E_Disease
,	,	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	NN	E_Disease
(	(	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
)	)	O
,	,	O
has	VBZ	O
been	VBN	O
described	VBN	O
encoding	VBG	O
a	DT	O
peroxisomal	JJ	O
membrane	NN	O
transporter	NN	O
protein	NN	O
.	.	O

We	PRP	O
analyzed	VBD	O
the	DT	O
entire	JJ	O
protein	NN	O
-	:	O
coding	VBG	O
sequence	NN	O
of	IN	O
this	DT	O
gene	NN	O
by	IN	O
reverse	JJ	O
-	:	O
transcription	NN	O
PCR	NNP	O
,	,	O
SSCP	NNP	O
,	,	O
and	CC	O
DNA	NNP	O
sequencing	VBG	O
in	IN	O
five	CD	O
patients	NNS	O
with	IN	O
different	JJ	O
clinical	JJ	O
expression	NN	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
and	CC	O
in	IN	O
their	PRP$	O
female	JJ	O
relatives	NNS	O
;	:	O
these	DT	O
clinical	JJ	O
expressions	NNS	O
were	VBD	O
cerebral	JJ	O
childhood	NN	O
ALD	NNP	S_Disease
,	,	O
adrenomyeloneuropathy	NN	S_Disease
(	(	O
AMN	NNP	S_Disease
)	)	O
,	,	O
and	CC	O
"	NNP	O
Addison	NNP	B_Disease
disease	NN	I_Disease
only	RB	E_Disease
"	NNP	O
(	(	O
ADO	NNP	S_Disease
)	)	O
phenotype	NN	O
.	.	O

In	IN	O
the	DT	O
three	CD	O
patients	NNS	O
exhibiting	VBG	O
the	DT	O
classical	JJ	O
picture	NN	O
of	IN	O
severe	JJ	O
childhood	NN	O
ALD	NNP	S_Disease
we	PRP	O
identified	VBD	O
in	IN	O
the	DT	O
5	CD	O
portion	NN	O
of	IN	O
the	DT	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
gene	NN	O
a	DT	O
38	CD	O
-	:	O
bp	NN	O
deletion	NN	O
that	WDT	O
causes	VBZ	O
a	DT	O
frameshift	JJ	O
mutation	NN	O
,	,	O
a	DT	O
3	CD	O
-	:	O
bp	NN	O
deletion	NN	O
leading	VBG	O
to	TO	O
a	DT	O
deletion	NN	O
of	IN	O
an	DT	O
amino	NN	O
acid	NN	O
in	IN	O
the	DT	O
ATP	NNP	O
-	:	O
binding	VBG	O
domain	NN	O
of	IN	O
the	DT	O
ALD	NNP	S_Disease
protein	NN	O
,	,	O
and	CC	O
a	DT	O
missense	JJ	O
mutation	NN	O
.	.	O

In	IN	O
the	DT	O
patient	NN	O
with	IN	O
the	DT	O
clinical	JJ	O
phenotype	NN	O
of	IN	O
AMN	NNP	S_Disease
,	,	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
in	IN	O
codon	NN	O
212	CD	O
,	,	O
along	IN	O
with	IN	O
a	DT	O
second	JJ	O
site	NN	O
mutation	NN	O
at	IN	O
codon	NN	O
178	CD	O
,	,	O
was	VBD	O
observed	VBN	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
patient	NN	O
with	IN	O
the	DT	O
ADO	NNP	S_Disease
phenotype	NN	O
revealed	VBD	O
a	DT	O
further	JJ	O
missense	NN	O
mutation	NN	O
at	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
position	NN	O
in	IN	O
the	DT	O
ALDP	NNP	O
/	NNP	O
PMP70	NNP	O
comparison	NN	O
.	.	O

The	DT	O
disruptive	JJ	O
nature	NN	O
of	IN	O
two	CD	O
mutations	NNS	O
(	(	O
i	NN	O
.	.	O

e	NN	O
.	.	O
,	,	O
the	DT	O
frameshift	NN	O
and	CC	O
the	DT	O
nonsense	JJ	O
mutation	NN	O
)	)	O
in	IN	O
patients	NNS	O
with	IN	O
biochemically	RB	O
proved	VBN	O
childhood	NN	O
ALD	NNP	S_Disease
and	CC	O
AMN	NNP	S_Disease
further	RB	O
strongly	RB	O
supports	VBZ	O
the	DT	O
hypothesis	NN	O
that	WDT	O
alterations	VBZ	O
in	IN	O
this	DT	O
gene	NN	O
play	VB	O
a	DT	O
crucial	JJ	O
role	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
.	.	O

Since	IN	O
the	DT	O
current	JJ	O
biochemical	JJ	O
techniques	NNS	O
for	IN	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
carrier	NN	O
detection	NN	O
in	IN	O
affected	JJ	O
families	NNS	O
lack	VBP	O
sufficient	JJ	O
reliability	NN	O
,	,	O
our	PRP$	O
procedure	NN	O
described	VBN	O
for	IN	O
systematic	JJ	O
mutation	NN	O
scanning	NN	O
is	VBZ	O
also	RB	O
capable	JJ	O
of	IN	O
improving	VBG	O
genetic	JJ	O
counseling	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O

Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
and	CC	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
in	IN	O
the	DT	O
same	JJ	O
patient	NN	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
the	DT	O
first	JJ	O
patient	NN	O
identified	VBN	O
with	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
and	CC	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
family	NN	O
of	IN	O
the	DT	O
propositus	NN	O
had	VBD	O
a	DT	O
strong	JJ	O
history	NN	O
of	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
and	CC	O
there	EX	O
was	VBD	O
an	DT	O
intrafamilial	JJ	O
pathological	JJ	O
expansion	NN	O
of	IN	O
the	DT	O
responsible	JJ	O
CTG	NNP	O
repeat	NN	O
between	IN	O
the	DT	O
mildly	RB	O
affected	JJ	O
mother	NN	O
(	(	O
160	CD	O
repeats	NNS	O
;	:	O
normal	JJ	O
27	CD	O
repeats	NNS	O
)	)	O
and	CC	O
her	PRP$	O
more	RBR	O
severely	RB	O
affected	JJ	O
son	NN	O
(	(	O
650	CD	O
repeats	NNS	O
)	)	O
,	,	O
and	CC	O
his	PRP$	O
sister	NN	O
(	(	O
650	CD	O
repeats	NNS	O
)	)	O
.	.	O

The	DT	O
propositus	NN	O
was	VBD	O
an	DT	O
isolated	JJ	O
case	NN	O
of	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
with	IN	O
marked	VBN	O
dystrophin	JJ	B_Disease
deficiency	NN	E_Disease
in	IN	O
muscle	NN	O
biopsy	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
still	RB	O
ambulatory	JJ	O
post	NN	O
age	NN	O
16	CD	O
.	.	O

Myotonic	NNP	B_Disease
dystrophy	NN	E_Disease
could	MD	O
interfere	VB	O
to	TO	O
some	DT	O
extent	NN	O
with	IN	O
the	DT	O
progression	NN	O
of	IN	O
Duchenne	NNP	B_Disease
dystrophy	NN	E_Disease
.	.	O

However	RB	O
,	,	O
other	JJ	O
interpretations	NNS	O
are	VBP	O
possible	JJ	O
.	.	O

Twelve	NNP	O
percent	NN	O
of	IN	O
dystrophin	JJ	O
revertant	JJ	O
fibers	NNS	O
as	IN	O
observed	VBN	O
by	IN	O
immunohistochemistry	NN	O
could	MD	O
be	VB	O
sufficient	JJ	O
to	TO	O
ameliorate	VB	O
typical	JJ	O
DMD	NNP	S_Disease
clinical	JJ	O
severity	NN	O
,	,	O
or	CC	O
the	DT	O
patient	NN	O
may	MD	O
present	VB	O
a	DT	O
somatic	JJ	O
mosaic	NN	O
.	.	O

The	DT	O
pathophysiological	JJ	O
interactions	NNS	O
of	IN	O
these	DT	O
two	CD	O
unlinked	VBD	O
disorders	NNS	O
are	VBP	O
discussed	VBN	O
at	IN	O
the	DT	O
clinical	JJ	O
and	CC	O
histopathological	JJ	O
levels	NNS	O
.	.	O
.	.	O

Age	NNP	O
at	IN	O
diagnosis	NN	O
as	IN	O
an	DT	O
indicator	NN	O
of	IN	O
eligibility	NN	O
for	IN	O
BRCA1	NNP	O
DNA	NNP	O
testing	VBG	O
in	IN	O
familial	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
.	.	O

We	PRP	O
searched	VBD	O
for	IN	O
criteria	NNS	O
that	WDT	O
could	MD	O
indicate	VB	O
breast	NN	B_Disease
cancer	NN	E_Disease
families	NNS	O
with	IN	O
a	DT	O
high	JJ	O
prior	JJ	O
probability	NN	O
of	IN	O
being	VBG	O
caused	VBN	O
by	IN	O
the	DT	O
breast	NN	B_Disease
/	JJ	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
susceptibility	NN	O
locus	VBP	O
BRCA1	NNP	O
on	IN	O
chromosome	NN	O
17	CD	O
.	.	O

To	TO	O
this	DT	O
end	NN	O
,	,	O
we	PRP	O
performed	VBD	O
a	DT	O
linkage	NN	O
study	NN	O
with	IN	O
59	CD	O
consecutively	RB	O
collected	VBN	O
Dutch	NNP	O
breast	NN	B_Disease
cancer	NN	E_Disease
families	NNS	O
,	,	O
including	VBG	O
16	CD	O
with	IN	O
at	IN	O
least	JJS	O
one	CD	O
case	NN	O
of	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

We	PRP	O
used	VBD	O
an	DT	O
intake	NN	O
cut	NN	O
-	:	O
off	IN	O
of	IN	O
at	IN	O
least	JJS	O
three	CD	O
first	JJ	O
-	:	O
degree	NN	O
relatives	NNS	O
with	IN	O
breast	NN	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
at	IN	O
any	DT	O
age	NN	O
.	.	O

Significant	JJ	O
evidence	NN	O
for	IN	O
linkage	NN	O
was	VBD	O
found	VBN	O
only	RB	O
among	IN	O
the	DT	O
13	CD	O
breast	NN	B_Disease
cancer	NN	E_Disease
families	NNS	O
with	IN	O
a	DT	O
mean	JJ	O
age	NN	O
at	IN	O
diagnosis	NN	O
of	IN	O
less	JJR	O
than	IN	O
45	CD	O
years	NNS	O
.	.	O

An	DT	O
unexpectedly	RB	O
low	JJ	O
proportion	NN	O
of	IN	O
the	DT	O
breast	NN	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
were	VBD	O
estimated	VBN	O
to	TO	O
be	VB	O
linked	VBN	O
to	TO	O
BRCA1	NNP	O
,	,	O
which	WDT	O
could	MD	O
be	VB	O
due	JJ	O
to	TO	O
a	DT	O
founder	NN	O
effect	NN	O
in	IN	O
the	DT	O
Dutch	JJ	O
population	NN	O
.	.	O

Given	VBN	O
the	DT	O
expected	JJ	O
logistical	JJ	O
problems	NNS	O
in	IN	O
clinical	JJ	O
management	NN	O
now	RB	O
that	IN	O
BRCA1	NNP	O
has	VBZ	O
been	VBN	O
identified	VBN	O
,	,	O
we	PRP	O
propose	VBP	O
an	DT	O
interim	JJ	O
period	NN	O
in	IN	O
which	WDT	O
only	JJ	O
families	NNS	O
with	IN	O
a	DT	O
strong	JJ	O
positive	JJ	O
family	NN	O
history	NN	O
for	IN	O
early	JJ	O
onset	NN	O
breast	NN	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
will	MD	O
be	VB	O
offered	VBN	O
BRCA1	NNP	O
mutation	NN	O
testing	VBG	O
.	.	O
.	.	O

Linkage	JJ	O
analysis	NN	O
of	IN	O
26	CD	O
Canadian	JJ	O
breast	NN	B_Disease
and	CC	I_Disease
breast	NN	I_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
26	CD	O
Canadian	JJ	O
families	NNS	O
with	IN	O
hereditary	JJ	B_Disease
breast	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
for	IN	O
linkage	NN	O
to	TO	O
markers	NNS	O
flanking	VBG	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
on	IN	O
chromosome	NN	O
17q12	CD	O
-	:	O
q21	NN	O
.	.	O

Of	IN	O
the	DT	O
15	CD	O
families	NNS	O
that	WDT	O
contain	VBP	O
cases	NNS	O
of	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
,	,	O
94	CD	O
%	NN	O
were	VBD	O
estimated	VBN	O
to	TO	O
be	VB	O
linked	VBN	O
to	TO	O
BRCA1	NNP	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
overall	JJ	O
evidence	NN	O
of	IN	O
linkage	NN	O
in	IN	O
the	DT	O
group	NN	O
of	IN	O
10	CD	O
families	NNS	O
with	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
without	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

A	DT	O
genetic	JJ	O
recombinant	NN	O
in	IN	O
a	DT	O
breast	NN	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
family	NN	O
indicates	VBZ	O
a	DT	O
placement	NN	O
of	IN	O
BRCA1	NNP	O
telomeric	NN	O
to	TO	O
D17S776	NNP	O
,	,	O
and	CC	O
helps	VBZ	O
to	TO	O
define	VB	O
the	DT	O
region	NN	O
of	IN	O
assignment	NN	O
of	IN	O
the	DT	O
cancer	NN	S_Disease
susceptibility	NN	O
gene	NN	O
.	.	O

Other	JJ	O
cancers	NNS	S_Disease
of	IN	O
interest	NN	O
that	WDT	O
appeared	VBD	O
in	IN	O
the	DT	O
BRCA1	NNP	O
-	:	O
linked	VBN	O
families	NNS	O
included	VBD	O
primary	JJ	B_Disease
peritoneal	NN	I_Disease
cancer	NN	E_Disease
,	,	O
cancer	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
fallopian	JJ	I_Disease
tube	NN	E_Disease
,	,	O
and	CC	O
malignant	JJ	B_Disease
melanoma	NN	E_Disease
.	.	O
.	.	O

Structural	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
5	CD	O
'	POS	O
region	NN	O
of	IN	O
mouse	NN	O
and	CC	O
human	JJ	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
genes	NNS	O
reveals	VBZ	O
conservation	NN	O
of	IN	O
putative	JJ	O
promoter	NN	O
region	NN	O
and	CC	O
di	VB	O
-	:	O
and	CC	O
trinucleotide	JJ	O
polymorphisms	NN	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
cloned	VBN	O
and	CC	O
characterized	VBN	O
the	DT	O
murine	NN	O
homologue	NN	O
of	IN	O
the	DT	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
gene	NN	O
and	CC	O
shown	VBN	O
that	IN	O
it	PRP	O
maps	VBZ	O
to	TO	O
mouse	VB	O
chromosome	NN	O
5	CD	O
within	IN	O
a	DT	O
region	NN	O
of	IN	O
conserved	VBN	O
synteny	NN	O
with	IN	O
human	JJ	O
chromosome	NN	O
4p16	CD	O
.	.	O

3	CD	O
3	CD	O
.	.	O

Here	RB	O
we	PRP	O
present	VBP	O
a	DT	O
detailed	JJ	O
comparison	NN	O
of	IN	O
the	DT	O
sequence	NN	O
of	IN	O
the	DT	O
putative	JJ	O
promoter	NN	O
and	CC	O
the	DT	O
organization	NN	O
of	IN	O
the	DT	O
5	CD	O
genomic	JJ	O
region	NN	O
of	IN	O
the	DT	O
murine	NN	O
(	(	O
Hdh	NNP	O
)	)	O
and	CC	O
human	JJ	O
HD	NNP	S_Disease
genes	NNS	O
encompassing	VBG	O
the	DT	O
first	JJ	O
five	CD	O
exons	NNS	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
in	IN	O
this	DT	O
region	NN	O
these	DT	O
two	CD	O
genes	NNS	O
share	NN	O
identical	JJ	O
exon	NN	O
boundaries	NNS	O
,	,	O
but	CC	O
have	VBP	O
different	JJ	O
-	:	O
size	NN	O
introns	NNS	O
.	.	O

Two	CD	O
dinucleotide	NN	O
(	(	O
CT	NNP	O
)	)	O
and	CC	O
one	CD	O
trinucleotide	NN	O
intronic	JJ	O
polymorphism	NN	O
in	IN	O
Hdh	NNP	O
and	CC	O
an	DT	O
intronic	JJ	O
CA	NNP	O
polymorphism	NN	O
in	IN	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
were	VBD	O
identified	VBN	O
.	.	O

Comparison	NNP	O
of	IN	O
940	CD	O
-	:	O
bp	NN	O
sequence	NN	O
5	CD	O
to	TO	O
the	DT	O
putative	JJ	O
translation	NN	O
start	NN	O
site	NN	O
reveals	VBZ	O
a	DT	O
highly	RB	O
conserved	VBN	O
region	NN	O
(	(	O
78	CD	O
.	.	O

8	CD	O
%	NN	O
nucleotide	JJ	O
identity	NN	O
)	)	O
between	IN	O
Hdh	NNP	O
and	CC	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
from	IN	O
nucleotide	JJ	O
-	:	O
56	CD	O
to	TO	O
-	:	O
206	CD	O
(	(	O
of	IN	O
Hdh	NNP	O
)	)	O
.	.	O

Neither	DT	O
Hdh	NNP	O
nor	CC	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
have	VBP	O
typical	JJ	O
TATA	NNP	O
or	CC	O
CCAAT	NNP	O
elements	NNS	O
,	,	O
but	CC	O
both	DT	O
show	VBP	O
one	CD	O
putative	JJ	O
AP2	NNP	O
binding	NN	O
site	NN	O
and	CC	O
numerous	JJ	O
potential	JJ	O
Sp1	NNP	O
binding	NN	O
sites	NNS	O
.	.	O

The	DT	O
high	JJ	O
sequence	NN	O
identity	NN	O
between	IN	O
Hdh	NNP	O
and	CC	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
for	IN	O
approximately	RB	O
200	CD	O
bp	NNS	O
5	CD	O
to	TO	O
the	DT	O
putative	JJ	O
translation	NN	O
start	NN	O
site	NN	O
indicates	VBZ	O
that	IN	O
these	DT	O
sequences	NNS	O
may	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
regulating	VBG	O
expression	NN	O
of	IN	O
the	DT	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O

The	DT	O
protein	NN	O
deficient	NN	O
in	IN	O
Lowe	NNP	B_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
phosphatidylinositol	JJ	O
-	:	O
4	CD	O
,	,	O
5	CD	O
-	:	O
bisphosphate	NN	O
5	CD	O
-	:	O
phosphatase	NN	O
.	.	O

Lowe	NNP	B_Disease
syndrome	NN	E_Disease
,	,	O
also	RB	O
known	VBN	O
as	IN	O
oculocerebrorenal	JJ	B_Disease
syndrome	NN	E_Disease
,	,	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
-	:	O
encoded	VBN	O
OCRL	NNP	O
gene	NN	O
.	.	O

The	DT	O
OCRL	NNP	O
protein	NN	O
is	VBZ	O
51	CD	O
%	NN	O
identical	JJ	O
to	TO	O
inositol	VB	O
polyphosphate	NN	O
5	CD	O
-	:	O
phosphatase	NN	O
II	NNP	O
(	(	O
5	CD	O
-	:	O
phosphatase	NN	O
II	NNP	O
)	)	O
from	IN	O
human	JJ	O
platelets	NNS	O
over	IN	O
a	DT	O
span	NN	O
of	IN	O
744	CD	O
aa	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
OCRL	NNP	O
may	MD	O
be	VB	O
a	DT	O
similar	JJ	O
enzyme	NN	O
.	.	O

We	PRP	O
engineered	VBD	O
a	DT	O
construct	NN	O
of	IN	O
the	DT	O
OCRL	NNP	O
cDNA	NN	O
that	WDT	O
encodes	VBZ	O
amino	JJ	O
acids	NNS	O
homologous	JJ	O
to	TO	O
the	DT	O
platelet	NN	O
5	CD	O
-	:	O
phosphatase	NN	O
for	IN	O
expression	NN	O
in	IN	O
baculovirus	NN	O
-	:	O
infected	JJ	O
Sf9	NNP	O
insect	NN	O
cells	NNS	O
.	.	O

This	DT	O
cDNA	NN	O
encodes	VBZ	O
aa	RB	O
264	CD	O
-	:	O
968	CD	O
of	IN	O
the	DT	O
OCRL	NNP	O
protein	NN	O
.	.	O

The	DT	O
recombinant	JJ	O
protein	NN	O
was	VBD	O
found	VBN	O
to	TO	O
catalyze	VB	O
the	DT	O
reactions	NNS	O
also	RB	O
carried	VBD	O
out	RP	O
by	IN	O
platelet	NN	O
5	CD	O
-	:	O
phosphatase	NN	O
II	NNP	O
.	.	O

Thus	RB	O
OCRL	NNP	O
converts	NNS	O
inositol	RB	O
1	CD	O
,	,	O
4	CD	O
,	,	O
5	CD	O
-	:	O
trisphosphate	NN	O
to	TO	O
inositol	VB	O
1	CD	O
,	,	O
4	CD	O
-	:	O
bisphosphate	NN	O
,	,	O
and	CC	O
it	PRP	O
converts	VBZ	O
inositol	JJ	O
1	CD	O
,	,	O
3	CD	O
,	,	O
4	CD	O
,	,	O
5	CD	O
-	:	O
tetrakisphosphate	NN	O
to	TO	O
inositol	VB	O
1	CD	O
,	,	O
3	CD	O
,	,	O
4	CD	O
-	:	O
trisphosphate	NN	O
.	.	O

Most	RBS	O
important	JJ	O
,	,	O
the	DT	O
enzyme	NN	O
converts	VBZ	O
phosphatidylinositol	RB	O
4	CD	O
,	,	O
5	CD	O
-	:	O
bisphosphate	NN	O
to	TO	O
phosphatidylinositol	VB	O
4	CD	O
-	:	O
phosphate	NN	O
.	.	O

The	DT	O
relative	JJ	O
ability	NN	O
of	IN	O
OCRL	NNP	O
to	TO	O
catalyze	VB	O
the	DT	O
three	CD	O
reactions	NNS	O
is	VBZ	O
different	JJ	O
from	IN	O
that	DT	O
of	IN	O
5	CD	O
-	:	O
phosphatase	NN	O
II	NNP	O
and	CC	O
from	IN	O
that	DT	O
of	IN	O
another	DT	O
5	CD	O
-	:	O
phosphatase	NN	O
isoenzyme	NN	O
from	IN	O
platelets	NNS	O
,	,	O
5	CD	O
-	:	O
phosphatase	NN	O
I	PRP	O
.	.	O

The	DT	O
recombinant	JJ	O
OCRL	NNP	O
protein	NN	O
hydrolyzes	VBZ	O
the	DT	O
phospholipid	JJ	O
substrate	NN	O
10	CD	O
-	:	O
to	TO	O
30	CD	O
-	:	O
fold	NN	O
better	JJR	O
than	IN	O
5	CD	O
-	:	O
phosphatase	NN	O
II	NNP	O
,	,	O
and	CC	O
5	CD	O
-	:	O
phosphatase	NN	O
I	PRP	O
does	VBZ	O
not	RB	O
cleave	VB	O
the	DT	O
lipid	NN	O
at	IN	O
all	DT	O
.	.	O

We	PRP	O
also	RB	O
show	VBP	O
that	IN	O
OCRL	NNP	O
functions	NNS	O
as	IN	O
a	DT	O
phosphatidylinositol	NN	O
4	CD	O
,	,	O
5	CD	O
-	:	O
bisphosphate	NN	O
5	CD	O
-	:	O
phosphatase	NN	O
in	IN	O
OCRL	NNP	O
-	:	O
expressing	VBG	O
Sf9	NNP	O
cells	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
OCRL	NNP	O
is	VBZ	O
mainly	RB	O
a	DT	O
lipid	JJ	O
phosphatase	NN	O
that	WDT	O
may	MD	O
control	VB	O
cellular	JJ	O
levels	NNS	O
of	IN	O
a	DT	O
critical	JJ	O
metabolite	NN	O
,	,	O
phosphatidylinositol	NN	O
4	CD	O
,	,	O
5	CD	O
-	:	O
bisphosphate	NN	O
.	.	O

Deficiency	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
apparently	RB	O
causes	VBZ	O
the	DT	O
protean	JJ	O
manifestations	NNS	O
of	IN	O
Lowe	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O
.	.	O

New	NNP	O
founder	NN	O
haplotypes	NNS	O
at	IN	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
locus	NN	O
in	IN	O
southern	JJ	O
Africa	NNP	O
.	.	O

The	DT	O
association	NN	O
between	IN	O
normal	JJ	O
alleles	NNS	O
at	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
and	CC	O
two	CD	O
nearby	JJ	O
polymorphisms	NNS	O
in	IN	O
the	DT	O
myotonin	NN	O
protein	NN	O
kinase	NN	O
gene	NN	O
,	,	O
the	DT	O
Alu	NNP	O
insertion	NN	O
/	NNP	O
deletion	NN	O
polymorphism	NN	O
and	CC	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
kinase	NN	O
(	(	O
DMK	NNP	O
)	)	O
(	(	O
G	NNP	O
/	NNP	O
T	NNP	O
)	)	O
intron	VBP	O
9	CD	O
/	JJ	O
HinfI	NNP	O
polymorphism	NN	O
,	,	O
has	VBZ	O
been	VBN	O
analyzed	VBN	O
in	IN	O
South	JJ	O
African	JJ	O
Negroids	NNP	O
,	,	O
a	DT	O
population	NN	O
in	IN	O
which	WDT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
has	VBZ	O
not	RB	O
been	VBN	O
described	VBN	O
.	.	O

South	JJ	O
African	JJ	O
Negroids	NNS	O
have	VBP	O
a	DT	O
CTG	NNP	O
allelic	JJ	O
distribution	NN	O
that	WDT	O
is	VBZ	O
significantly	RB	O
different	JJ	O
from	IN	O
that	DT	O
in	IN	O
Caucasoids	NNP	O
and	CC	O
Japanese	JJ	O
the	DT	O
CTG	NNP	O
repeat	NN	O
lengths	NNS	O
of	IN	O
>	NN	O
or	CC	O
=	VB	O
19	CD	O
are	VBP	O
very	RB	O
rare	JJ	O
.	.	O

The	DT	O
striking	JJ	O
linkage	NN	O
disequilibrium	NN	O
between	IN	O
specific	JJ	O
alleles	NNS	O
at	IN	O
the	DT	O
Alu	NNP	O
polymorphism	NN	O
(	(	O
Alu	NNP	O
(	(	O
ins	NNS	O
)	)	O
and	CC	O
Alu	NNP	O
(	(	O
del	FW	O
)	)	O
)	)	O
,	,	O
the	DT	O
HinfI	NNP	O
polymorphism	NN	O
(	(	O
HinfI	NNP	O
-	:	O
1	CD	O
and	CC	O
HinfI	NNP	O
-	:	O
2	CD	O
)	)	O
,	,	O
and	CC	O
the	DT	O
CTG	NNP	O
repeat	NN	O
polymorphism	NN	O
seen	VBN	O
in	IN	O
Caucasoid	NNP	O
(	(	O
Europeans	NNPS	O
and	CC	O
Canadians	NNPS	O
)	)	O
populations	NNS	O
was	VBD	O
also	RB	O
found	VBN	O
in	IN	O
the	DT	O
South	JJ	O
African	JJ	O
Negroid	NNP	O
population	NN	O
.	.	O

Numerous	JJ	O
haplotypes	NNS	O
,	,	O
not	RB	O
previously	RB	O
described	VBN	O
in	IN	O
Europeans	NNS	O
,	,	O
were	VBD	O
,	,	O
however	RB	O
,	,	O
found	VBN	O
.	.	O

It	PRP	O
thus	RB	O
seems	VBZ	O
likely	JJ	O
that	IN	O
only	RB	O
a	DT	O
small	JJ	O
number	NN	O
of	IN	O
these	DT	O
"	JJ	O
African	NNP	O
"	NNP	O
chromosomes	NNS	O
were	VBD	O
present	JJ	O
in	IN	O
the	DT	O
progenitors	NNS	O
of	IN	O
all	DT	O
non	FW	O
-	:	O
African	JJ	O
peoples	NNS	O
.	.	O

These	DT	O
data	NNS	O
provide	VBP	O
support	NN	O
for	IN	O
the	DT	O
"	NNP	O
out	IN	O
of	IN	O
Africa	NNP	O
"	NNP	O
model	NN	O
for	IN	O
the	DT	O
origin	NN	O
of	IN	O
modern	JJ	O
humans	NNS	O
and	CC	O
suggest	VBP	O
that	IN	O
the	DT	O
rare	JJ	O
ancestral	JJ	O
DM	NNP	S_Disease
mutation	NN	O
event	NN	O
may	MD	O
have	VB	O
occurred	VBN	O
after	IN	O
the	DT	O
migration	NN	O
from	IN	O
Africa	NNP	O
,	,	O
hence	RB	O
the	DT	O
absence	NN	O
of	IN	O
DM	NNP	S_Disease
in	IN	O
sub	JJ	O
-	:	O
Saharan	NN	O
Negroid	NNP	O
peoples	NNS	O
.	.	O
.	.	O

Discordant	NNP	O
clinical	JJ	O
outcome	NN	O
in	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
relatives	NNS	O
showing	VBG	O
(	(	O
CTG	NNP	O
)	)	O
n	VBP	O
>	$	O
700	CD	O
repeats	NNS	O
.	.	O

A	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
family	NN	O
is	VBZ	O
described	VBN	O
in	IN	O
which	WDT	O
discordant	JJ	O
DM	NNP	S_Disease
phenotypes	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
children	NNS	O
of	IN	O
two	CD	O
affected	JJ	O
sisters	NNS	O
with	IN	O
similar	JJ	O
CTG	NNP	O
expansion	NN	O
and	CC	O
clinical	JJ	O
manifestations	NNS	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
,	,	O
congenital	NN	O
as	RB	O
well	RB	O
as	IN	O
early	RB	O
severe	JJ	O
childhood	NN	O
and	CC	O
later	RB	O
childhood	NN	O
onset	NN	O
DM	NNP	S_Disease
coexist	NN	O
.	.	O

This	DT	O
observation	NN	O
strengthens	VBZ	O
the	DT	O
limited	JJ	O
ability	NN	O
of	IN	O
lymphocytes	NNS	O
CTG	NNP	O
repeat	NN	O
number	NN	O
analysis	NN	O
in	IN	O
predicting	VBG	O
genotype	JJ	O
-	:	O
phenotype	NN	O
correlations	NNS	O
in	IN	O
DM	NNP	S_Disease
patients	NNS	O
.	.	O
.	.	O

Purification	NN	O
of	IN	O
human	JJ	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
acyl	IN	O
-	:	O
coenzyme	NN	O
A	DT	O
dehydrogenase	NN	O
and	CC	O
characterization	NN	O
of	IN	O
its	PRP$	O
deficiency	NN	O
in	IN	O
seven	CD	O
patients	NNS	O
.	.	O

Mitochondrial	JJ	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
acyl	IN	O
-	:	O
coenzyme	NN	O
A	DT	O
dehydrogenase	NN	O
(	(	O
VLCAD	NNP	O
)	)	O
was	VBD	O
purified	VBN	O
from	IN	O
human	JJ	O
liver	NN	O
.	.	O

The	DT	O
molecular	JJ	O
masses	NNS	O
of	IN	O
the	DT	O
native	JJ	O
enzyme	NN	O
and	CC	O
the	DT	O
subunit	NN	O
were	VBD	O
estimated	VBN	O
to	TO	O
be	VB	O
154	CD	O
and	CC	O
70	CD	O
kD	NN	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
enzyme	NN	O
was	VBD	O
found	VBN	O
to	TO	O
catalyze	VB	O
the	DT	O
major	JJ	O
part	NN	O
of	IN	O
mitochondrial	JJ	O
palmitoylcoenzyme	NN	O
A	DT	O
dehydrogenation	NN	O
in	IN	O
liver	NN	O
,	,	O
heart	NN	O
,	,	O
skeletal	JJ	O
muscle	NN	O
,	,	O
and	CC	O
skin	JJ	O
fibroblasts	NNS	O
(	(	O
89	CD	O
-	:	O
97	CD	O
,	,	O
86	CD	O
-	:	O
99	CD	O
,	,	O
96	CD	O
-	:	O
99	CD	O
,	,	O
and	CC	O
78	CD	O
-	:	O
87	CD	O
%	NN	O
,	,	O
respectively	RB	O
)	)	O
.	.	O

Skin	NNP	O
fibroblasts	NNS	O
from	IN	O
26	CD	O
patients	NNS	O
suspected	VBN	O
of	IN	O
having	VBG	O
a	DT	O
disorder	NN	O
of	IN	O
mitochondrial	JJ	O
beta	NN	O
-	:	O
oxidation	NN	O
were	VBD	O
analyzed	VBN	O
for	IN	O
VLCAD	NNP	O
protein	NN	O
using	VBG	O
immunoblotting	NN	O
,	,	O
and	CC	O
7	CD	O
of	IN	O
them	PRP	O
contained	VBD	O
undetectable	JJ	O
or	CC	O
trace	NN	O
levels	NNS	O
of	IN	O
the	DT	O
enzyme	NN	O
.	.	O

The	DT	O
seven	CD	O
deficient	NN	O
fibroblast	NN	O
lines	NNS	O
were	VBD	O
characterized	VBN	O
by	IN	O
measuring	VBG	O
acyl	JJ	O
-	:	O
coenzyme	NN	O
A	DT	O
dehydrogenation	NN	O
activities	NNS	O
,	,	O
overall	JJ	O
palmitic	JJ	O
acid	NN	O
oxidation	NN	O
,	,	O
and	CC	O
VLCAD	NNP	O
protein	VBP	O
synthesis	NN	O
using	VBG	O
pulse	JJ	O
-	:	O
chase	NN	O
,	,	O
further	RB	O
confirming	VBG	O
the	DT	O
diagnosis	NN	O
of	IN	O
VLCAD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O

These	DT	O
results	NNS	O
suggested	VBD	O
the	DT	O
heterogenous	JJ	O
nature	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
causing	VBG	O
the	DT	O
deficiency	NN	O
in	IN	O
the	DT	O
seven	CD	O
patients	NNS	O
.	.	O

Clinically	RB	O
,	,	O
all	DT	O
patients	NNS	O
with	IN	O
VLCAD	NNP	B_Disease
deficiency	NN	E_Disease
exhibited	VBD	O
cardiac	JJ	B_Disease
disease	NN	E_Disease
.	.	O

At	IN	O
least	JJS	O
four	CD	O
of	IN	O
them	PRP	O
presented	VBN	O
with	IN	O
hypertrophic	JJ	B_Disease
cardiomyopathy	NN	E_Disease
.	.	O

This	DT	O
frequency	NN	O
(	(	O
>	JJ	O
57	CD	O
%	NN	O
)	)	O
was	VBD	O
much	RB	O
higher	JJR	O
than	IN	O
that	DT	O
observed	VBD	O
in	IN	O
patients	NNS	O
with	IN	O
other	JJ	O
disorders	NNS	O
of	IN	O
mitochondrial	JJ	O
long	JJ	O
-	:	O
chain	NN	O
fatty	JJ	O
acid	JJ	O
oxidation	NN	O
that	WDT	O
may	MD	O
be	VB	O
accompanied	VBN	O
by	IN	O
cardiac	JJ	B_Disease
disease	NN	E_Disease
in	IN	O
infants	NNS	O
.	.	O
.	.	O

Hereditary	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
fifth	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
in	IN	O
man	NN	O
.	.	O

II	NNP	O
.	.	O

Biological	JJ	O
properties	NNS	O
of	IN	O
C5	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
human	JJ	O
serum	NN	O
.	.	O

The	DT	O
first	JJ	O
known	VBN	O
human	JJ	O
kindred	VBN	O
with	IN	O
hereditary	JJ	B_Disease
deficiency	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
fifth	JJ	I_Disease
component	NN	I_Disease
of	IN	I_Disease
complement	NN	E_Disease
(	(	O
C5	NNP	O
)	)	O
was	VBD	O
documented	VBN	O
in	IN	O
the	DT	O
accompanying	VBG	O
report	NN	O
.	.	O

This	DT	O
study	NN	O
examines	VBZ	O
several	JJ	O
biological	JJ	O
properties	NNS	O
of	IN	O
C5	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
(	(	O
C5D	NNP	S_Disease
)	)	O
human	NN	O
serum	NN	O
,	,	O
particularly	RB	O
sera	NN	O
obtained	VBN	O
from	IN	O
two	CD	O
C5D	NNP	S_Disease
homozygotes	NNS	O
.	.	O

The	DT	O
proband	NN	O
,	,	O
who	WP	O
has	VBZ	O
inactive	JJ	O
systemic	JJ	B_Disease
lupus	NN	I_Disease
erythematosus	NN	E_Disease
is	VBZ	O
completely	RB	O
lacking	JJ	O
C5	NNP	O
,	,	O
while	IN	O
her	PRP$	O
healthy	JJ	O
half	NN	O
-	:	O
sister	NN	O
has	VBZ	O
1	CD	O
-	:	O
2	CD	O
%	NN	O
of	IN	O
normal	JJ	O
levels	NNS	O
.	.	O

Both	DT	O
sera	NN	O
were	VBD	O
severely	RB	O
impaired	VBN	O
in	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
generate	VB	O
chemotactic	JJ	O
activity	NN	O
for	IN	O
normal	JJ	O
human	JJ	O
neutrophils	NNS	O
upon	IN	O
incubation	NN	O
with	IN	O
aggregated	JJ	O
human	JJ	O
gamma	NN	O
-	:	O
globulin	NN	O
or	CC	O
Escherichia	NNP	O
coli	VBP	O
endotoxin	NN	O
.	.	O

This	DT	O
function	NN	O
was	VBD	O
fully	RB	O
restored	VBN	O
in	IN	O
the	DT	O
siblings	NNS	O
serum	NN	O
,	,	O
and	CC	O
substantially	RB	O
improved	VBN	O
in	IN	O
the	DT	O
probands	NNS	O
serum	NN	O
,	,	O
by	IN	O
addition	NN	O
of	IN	O
highly	RB	O
purified	VBN	O
human	JJ	O
C5	NNP	O
to	TO	O
normal	JJ	O
serum	JJ	O
concentrations	NNS	O
.	.	O

Sera	NN	O
from	IN	O
eight	CD	O
family	NN	O
members	NNS	O
who	WP	O
were	VBD	O
apparently	RB	O
heterozygous	JJ	O
for	IN	O
C5	NNP	B_Disease
deficiency	NN	E_Disease
gave	VBD	O
normal	JJ	O
chemotactic	JJ	O
scores	NNS	O
.	.	O

The	DT	O
ability	NN	O
of	IN	O
C5D	NNP	S_Disease
serum	NN	O
to	TO	O
opsonize	VB	O
Saccharomyces	NNS	O
cerevisiae	NN	O
(	(	O
bakers	NNS	O
yeast	RB	O
)	)	O
or	CC	O
Candida	NNP	O
albicans	NNS	O
for	IN	O
ingestion	NN	O
by	IN	O
normal	JJ	O
neutrophils	NNS	O
was	VBD	O
completely	RB	O
normal	JJ	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
C5D	NNP	S_Disease
serum	NN	O
was	VBD	O
capable	JJ	O
of	IN	O
promoting	VBG	O
normal	JJ	O
phagocytosis	NN	O
and	CC	O
intracellular	JJ	O
killing	NN	O
of	IN	O
Staphylococcus	NNP	O
aureus	NN	O
.	.	O

The	DT	O
probands	NNS	O
serum	NN	O
was	VBD	O
incapable	JJ	O
of	IN	O
mediating	VBG	O
lysis	NN	O
of	IN	O
erythrocytes	NNS	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
paroxysmal	JJ	B_Disease
nocturnal	JJ	I_Disease
hemoglobinuria	NN	E_Disease
in	IN	O
both	CC	O
the	DT	O
sucrose	JJ	O
hemolysia	NN	O
and	CC	O
acid	JJ	O
hemolysis	NN	O
tests	NNS	O
,	,	O
and	CC	O
also	RB	O
lacked	VBD	O
bactericidal	JJ	O
activity	NN	O
against	IN	O
sensitized	VBN	O
or	CC	O
unsensitized	VBN	O
Salmonella	NNP	O
typhi	NN	O
.	.	O

The	DT	O
siblings	NNS	O
serum	NN	O
,	,	O
containing	VBG	O
only	RB	O
1	CD	O
-	:	O
2	CD	O
%	NN	O
of	IN	O
normal	JJ	O
C5	NNP	O
,	,	O
effectively	RB	O
lysed	VBN	O
S	NNP	O
.	.	O

typhi	NN	O
,	,	O
but	CC	O
only	RB	O
at	IN	O
eightfold	JJ	O
lower	JJR	O
serum	NN	O
dilutions	NNS	O
as	IN	O
compared	VBN	O
to	TO	O
normals	NNS	O
.	.	O

These	DT	O
findings	NNS	O
underscore	VBP	O
the	DT	O
critical	JJ	O
role	NN	O
of	IN	O
C5	NNP	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
chemotactic	JJ	O
activity	NN	O
and	CC	O
in	IN	O
cytolytic	JJ	O
reactions	NNS	O
,	,	O
as	IN	O
opposed	VBN	O
to	TO	O
a	DT	O
nonobligatory	NN	O
or	CC	O
minimal	JJ	O
role	NN	O
in	IN	O
opsonization	NN	O
,	,	O
at	IN	O
least	JJS	O
for	IN	O
the	DT	O
organisms	NNS	O
under	IN	O
study	NN	O
.	.	O
.	.	O

Human	NNP	O
peroxisomal	JJ	O
targeting	VBG	O
signal	JJ	O
-	:	O
1	CD	O
receptor	NN	O
restores	NNS	O
peroxisomal	JJ	O
protein	NN	O
import	NN	O
in	IN	O
cells	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
fatal	JJ	O
peroxisomal	JJ	B_Disease
disorders	NNS	E_Disease
.	.	O

Two	CD	O
peroxisomal	JJ	O
targeting	VBG	O
signals	NNS	O
,	,	O
PTS1	NNP	O
and	CC	O
PTS2	NNP	O
,	,	O
are	VBP	O
involved	VBN	O
in	IN	O
the	DT	O
import	NN	O
of	IN	O
proteins	NNS	O
into	IN	O
the	DT	O
peroxisome	JJ	O
matrix	NN	O
.	.	O

Human	JJ	O
patients	NNS	O
with	IN	O
fatal	JJ	O
generalized	VBN	O
peroxisomal	JJ	B_Disease
deficiency	NN	I_Disease
disorders	NNS	E_Disease
fall	VBP	O
into	IN	O
at	IN	O
least	JJS	O
nine	CD	O
genetic	JJ	O
complementation	NN	O
groups	NNS	O
.	.	O

Cells	NNS	O
from	IN	O
many	JJ	O
of	IN	O
these	DT	O
patients	NNS	O
are	VBP	O
deficient	JJ	O
in	IN	O
the	DT	O
import	NN	O
of	IN	O
PTS1	NNP	O
-	:	O
containing	NN	O
proteins	NNS	O
,	,	O
but	CC	O
the	DT	O
causes	NNS	O
of	IN	O
the	DT	O
protein	NN	O
-	:	O
import	NN	O
defect	NN	O
in	IN	O
these	DT	O
patients	NNS	O
are	VBP	O
unknown	JJ	O
.	.	O

We	PRP	O
have	VBP	O
cloned	VBN	O
and	CC	O
sequenced	VBD	O
the	DT	O
human	JJ	O
cDNA	NN	O
homologue	NN	O
(	(	O
PTS1R	NNP	O
)	)	O
of	IN	O
the	DT	O
Pichia	NNP	O
pastoris	NN	O
PAS8	NNP	O
gene	NN	O
,	,	O
the	DT	O
PTS1	NNP	O
receptor	NN	O
(	(	O
McCollum	NNP	O
,	,	O
D	NNP	O
.	.	O
,	,	O
E	NNP	O
.	.	O

Monosov	NNP	O
,	,	O
and	CC	O
S	NNP	O
.	.	O

Subramani	NNP	O
.	.	O

1993	CD	O
.	.	O

J	NNP	O
.	.	O

Cell	NNP	O
Biol	NNP	O
.	.	O

121	CD	O
761	CD	O
-	:	O
774	CD	O
)	)	O
.	.	O

The	DT	O
PTS1R	NNP	O
mRNA	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
all	DT	O
human	JJ	O
tissues	NNS	O
examined	VBN	O
.	.	O

Antibodies	NNS	O
to	TO	O
the	DT	O
human	JJ	O
PTS1R	NNP	O
recognize	NN	O
this	DT	O
protein	NN	O
in	IN	O
human	JJ	O
,	,	O
monkey	NN	O
,	,	O
rat	NN	O
,	,	O
and	CC	O
hamster	NN	O
cells	NNS	O
.	.	O

The	DT	O
protein	NN	O
is	VBZ	O
localized	VBN	O
mainly	RB	O
in	IN	O
the	DT	O
cytosol	NN	O
but	CC	O
is	VBZ	O
also	RB	O
found	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
peroxisomes	NNS	O
.	.	O

Part	NN	O
of	IN	O
the	DT	O
peroxisomal	JJ	O
PTS1R	NNP	O
protein	NN	O
is	VBZ	O
tightly	RB	O
bound	VBN	O
to	TO	O
the	DT	O
peroxisomal	JJ	O
membrane	NN	O
.	.	O

Antibodies	NNS	O
to	TO	O
PTS1R	NNP	O
inhibit	NN	O
peroxisomal	JJ	O
protein	NN	O
-	:	O
import	NN	O
of	IN	O
PTS1	NNP	O
-	:	O
containing	VBG	O
proteins	NNS	O
in	IN	O
a	DT	O
permeabilized	JJ	O
CHO	NNP	O
cell	NN	O
system	NN	O
.	.	O

In	IN	O
vitro	JJ	O
-	:	O
translated	VBN	O
PTS1R	NNP	O
protein	NN	O
specifically	RB	O
binds	VBZ	O
a	DT	O
serine	JJ	O
-	:	O
lysine	NN	O
-	:	O
leucine	NN	O
-	:	O
peptide	NN	O
.	.	O

A	DT	O
PAS8	NNP	O
-	:	O
PTS1R	NNP	O
fusion	NN	O
protein	NN	O
complements	VBZ	O
the	DT	O
P	NNP	O
.	.	O

pastoris	NN	O
pas8	NN	O
mutant	NN	O
.	.	O

The	DT	O
PTS1R	NNP	O
cDNA	NN	O
also	RB	O
complements	VBZ	O
the	DT	O
PTS1	NNP	B_Disease
protein	SYM	I_Disease
-	:	I_Disease
import	NN	I_Disease
defect	NN	E_Disease
in	IN	O
skin	JJ	O
fibroblasts	NNS	O
from	IN	O
patients	NNS	O
-	:	O
-	:	O
belonging	NN	O
to	TO	O
complementation	VB	O
group	NN	O
two	CD	O
-	:	O
-	:	O
diagnosed	VBN	O
as	IN	O
having	VBG	O
neonatal	JJ	B_Disease
adrenoleukodystrophy	NN	E_Disease
or	CC	O
Zellweger	NNP	B_Disease
syndrome	VBP	E_Disease
.	.	O

The	DT	O
PTS1R	NNP	O
gene	NN	O
has	VBZ	O
been	VBN	O
localized	VBN	O
to	TO	O
a	DT	O
chromosomal	JJ	O
location	NN	O
where	WRB	O
no	DT	O
other	JJ	O
peroxisomal	JJ	B_Disease
disorder	NN	E_Disease
genes	NNS	O
are	VBP	O
known	VBN	O
to	TO	O
map	VB	O
.	.	O

Our	PRP$	O
findings	NNS	O
represent	VBP	O
the	DT	O
only	JJ	O
case	NN	O
in	IN	O
which	WDT	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
the	DT	O
protein	NN	B_Disease
-	:	I_Disease
import	NN	I_Disease
deficiency	NN	E_Disease
in	IN	O
human	JJ	O
peroxisomal	NN	B_Disease
disorders	NNS	E_Disease
is	VBZ	O
understood	JJ	O
.	.	O

Spectrum	NNP	O
of	IN	O
germline	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
RB1	NNP	O
gene	NN	O
:	:	O
a	DT	O
study	NN	O
of	IN	O
232	CD	O
patients	NNS	O
with	IN	O
hereditary	JJ	B_Disease
and	CC	I_Disease
non	JJ	I_Disease
hereditary	JJ	I_Disease
retinoblastoma	NN	E_Disease
.	.	O

Germline	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
RB1	NNP	O
gene	NN	O
confer	VBP	O
hereditary	JJ	O
predisposition	NN	O
to	TO	O
retinoblastoma	VB	S_Disease
.	.	O

We	PRP	O
have	VBP	O
performed	VBN	O
a	DT	O
mutation	NN	O
survey	NN	O
of	IN	O
the	DT	O
RB1	NNP	O
gene	NN	O
in	IN	O
232	CD	O
patients	NNS	O
with	IN	O
hereditary	JJ	B_Disease
or	CC	I_Disease
non	JJ	I_Disease
hereditary	JJ	I_Disease
retinoblastoma	NN	E_Disease
.	.	O

We	PRP	O
systematically	RB	O
explored	VBD	O
all	DT	O
27	CD	O
exons	NNS	O
and	CC	O
flanking	VBG	O
sequences	NNS	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
promotor	NN	O
.	.	O

All	DT	O
types	NNS	O
of	IN	O
point	NN	O
mutations	NNS	O
are	VBP	O
represented	VBN	O
and	CC	O
are	VBP	O
found	VBN	O
unequally	RB	O
distributed	VBN	O
along	IN	O
the	DT	O
RB1	NNP	O
gene	NN	O
sequence	NN	O
.	.	O

In	IN	O
the	DT	O
population	NN	O
we	PRP	O
studied	VBD	O
,	,	O
exons	NNS	O
3	CD	O
,	,	O
8	CD	O
,	,	O
18	CD	O
and	CC	O
19	CD	O
are	VBP	O
preferentially	RB	O
altered	VBN	O
.	.	O

The	DT	O
range	NN	O
of	IN	O
frequency	NN	O
of	IN	O
detection	NN	O
of	IN	O
germline	JJ	O
mutations	NNS	O
is	VBZ	O
about	IN	O
20	CD	O
%	NN	O
,	,	O
indicating	VBG	O
that	IN	O
other	JJ	O
mechanisms	NNS	O
of	IN	O
inactivation	NN	O
of	IN	O
RB1	NNP	O
should	MD	O
be	VB	O
involved	VBN	O
.	.	O

The	DT	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
presented	VBN	O
here	RB	O
should	MD	O
help	VB	O
to	TO	O
improve	VB	O
the	DT	O
clinical	JJ	O
management	NN	O
of	IN	O
retinoblastoma	NN	S_Disease
and	CC	O
to	TO	O
understand	VB	O
the	DT	O
molecular	JJ	O
mechanisms	NNS	O
leading	VBG	O
to	TO	O
tumorigenesis	NN	O
.	.	O
.	.	O

Aniridia	NNP	S_Disease
-	:	O
associated	VBN	O
cytogenetic	JJ	O
rearrangements	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
position	NN	O
effect	NN	O
may	MD	O
cause	VB	O
the	DT	O
mutant	JJ	O
phenotype	NN	O
.	.	O

Current	JJ	O
evidence	NN	O
suggests	VBZ	O
that	IN	O
aniridia	NN	S_Disease
(	(	O
absence	NN	B_Disease
of	IN	I_Disease
iris	NN	E_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
one	CD	O
copy	NN	O
of	IN	O
the	DT	O
PAX6	NNP	O
gene	NN	O
,	,	O
which	WDT	O
maps	VBZ	O
to	TO	O
11p13	CD	O
.	.	O

We	PRP	O
present	VBP	O
the	DT	O
further	JJ	O
characterisation	NN	O
of	IN	O
two	CD	O
aniridia	NN	S_Disease
pedigrees	NNS	O
in	IN	O
which	WDT	O
the	DT	O
disease	NN	O
segregates	VBZ	O
with	IN	O
chromosomal	JJ	O
rearrangements	NNS	O
which	WDT	O
involve	VBP	O
11p13	CD	O
but	CC	O
do	VBP	O
not	RB	O
disrupt	VB	O
the	DT	O
PAX6	NNP	O
gene	NN	O
.	.	O

We	PRP	O
have	VBP	O
isolated	VBN	O
three	CD	O
human	JJ	O
YAC	NNP	O
clones	NNS	O
which	WDT	O
encompass	VBP	O
the	DT	O
PAX6	NNP	O
locus	NN	O
and	CC	O
we	PRP	O
have	VBP	O
used	VBN	O
these	DT	O
to	TO	O
show	VB	O
that	IN	O
in	IN	O
both	DT	O
cases	NNS	O
the	DT	O
chromosomal	JJ	O
breakpoint	NN	O
is	VBZ	O
at	IN	O
least	JJS	O
85	CD	O
kb	JJ	O
distal	NN	O
of	IN	O
the	DT	O
3	CD	O
end	NN	O
of	IN	O
PAX6	NNP	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
PAX6	NNP	O
is	VBZ	O
apparently	RB	O
free	JJ	O
of	IN	O
mutations	NNS	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
the	DT	O
PAX6	NNP	O
gene	NN	O
on	IN	O
the	DT	O
rearranged	VBN	O
chromosome	NN	O
11	CD	O
is	VBZ	O
in	IN	O
an	DT	O
inappropriate	JJ	O
chromatin	NN	O
environment	NN	O
for	IN	O
normal	JJ	O
expression	NN	O
and	CC	O
therefore	NN	O
that	IN	O
a	DT	O
position	NN	O
effect	NN	O
is	VBZ	O
the	DT	O
underlying	VBG	O
mechanism	NN	O
of	IN	O
disease	NN	O
in	IN	O
these	DT	O
families	NNS	O
.	.	O
.	.	O

Somatic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
in	IN	O
sporadic	JJ	B_Disease
ovarian	JJ	I_Disease
tumours	NN	E_Disease
.	.	O

The	DT	O
BRCA1	NNP	O
gene	NN	O
on	IN	O
chromosome	NN	O
17q21	CD	O
is	VBZ	O
responsible	JJ	O
for	IN	O
an	DT	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
syndrome	NN	E_Disease
of	IN	O
increased	JJ	O
susceptibility	NN	O
to	TO	O
breast	VB	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
but	CC	O
no	DT	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
tumours	NNS	S_Disease
have	VBP	O
yet	RB	O
been	VBN	O
described	VBN	O
.	.	O

To	TO	O
study	VB	O
the	DT	O
potential	JJ	O
role	NN	O
of	IN	O
BRCA1	NNP	O
in	IN	O
sporadic	JJ	O
carcinogenesis	NN	O
,	,	O
we	PRP	O
analysed	VBD	O
the	DT	O
genomic	JJ	O
DNA	NN	O
of	IN	O
tumour	NN	S_Disease
and	CC	O
normal	JJ	O
fractions	NNS	O
of	IN	O
47	CD	O
ovarian	JJ	B_Disease
cancers	NNS	E_Disease
for	IN	O
mutations	NNS	O
in	IN	O
BRCA1	NNP	O
using	VBG	O
the	DT	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
technique	NN	O
.	.	O

We	PRP	O
now	RB	O
describe	VBZ	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
DNA	NN	O
of	IN	O
four	CD	O
tumours	NNS	S_Disease
which	WDT	O
also	RB	O
had	VBD	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
(	(	O
LOH	NNP	O
)	)	O
at	IN	O
a	DT	O
BRCA1	NNP	O
intragenic	JJ	O
marker	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
support	NN	O
a	DT	O
tumour	NN	S_Disease
suppressor	NN	O
mechanism	NN	O
for	IN	O
BRCA1	NNP	O
;	:	O
somatic	JJ	O
mutations	NNS	O
and	CC	O
LOH	NNP	O
may	MD	O
result	VB	O
in	IN	O
inactivation	NN	O
of	IN	O
BRCA1	NNP	O
in	IN	O
at	IN	O
least	JJS	O
a	DT	O
small	JJ	O
number	NN	O
of	IN	O
ovarian	JJ	B_Disease
cancers	NNS	E_Disease
.	.	O
.	.	O

Decreased	VBN	O
expression	NN	O
of	IN	O
BRCA1	NNP	O
accelerates	VBZ	O
growth	NN	O
and	CC	O
is	VBZ	O
often	RB	O
present	JJ	O
during	IN	O
sporadic	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
progression	NN	O
.	.	O

We	PRP	O
have	VBP	O
characterized	VBN	O
expression	NN	O
of	IN	O
the	DT	O
familial	JJ	B_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
gene	NN	O
,	,	O
BRCA1	NNP	O
,	,	O
in	IN	O
cases	NNS	O
of	IN	O
non	JJ	B_Disease
-	:	I_Disease
hereditary	NN	I_Disease
(	(	I_Disease
sporadic	JJ	I_Disease
)	)	I_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
and	CC	O
analyzed	VBD	O
the	DT	O
effect	NN	O
of	IN	O
antisense	JJ	O
inhibition	NN	O
of	IN	O
BRCA1	NNP	O
on	IN	O
the	DT	O
proliferative	JJ	O
rate	NN	O
of	IN	O
mammary	JJ	O
epithelial	JJ	O
cells	NNS	O
.	.	O

BRCA1	NNP	O
mRNA	NN	O
levels	NNS	O
are	VBP	O
markedly	RB	O
decreased	VBN	O
during	IN	O
the	DT	O
transition	NN	O
from	IN	O
carcinoma	NN	B_Disease
in	IN	I_Disease
situ	NN	E_Disease
to	TO	O
invasive	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Experimental	JJ	O
inhibition	NN	O
of	IN	O
BRCA1	NNP	O
expression	NN	O
with	IN	O
antisense	JJ	O
oligonucleotides	NNS	O
produced	VBD	O
accelerated	JJ	O
growth	NN	O
of	IN	O
normal	JJ	O
and	CC	O
malignant	JJ	O
mammary	JJ	O
cells	NNS	O
,	,	O
but	CC	O
had	VBD	O
no	DT	O
effect	NN	O
on	IN	O
non	JJ	O
-	:	O
mammary	JJ	O
epithelial	JJ	O
cells	NNS	O
.	.	O

These	DT	O
studies	NNS	O
suggest	VBP	O
that	IN	O
BRCA1	NNP	O
may	MD	O
normally	RB	O
serve	VB	O
as	IN	O
a	DT	O
negative	JJ	O
regulator	NN	O
of	IN	O
mammary	JJ	O
epithelial	JJ	O
cell	NN	O
growth	NN	O
whose	WP$	O
function	NN	O
is	VBZ	O
compromised	VBN	O
in	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
either	CC	O
by	IN	O
direct	JJ	O
mutation	NN	O
or	CC	O
alterations	NNS	O
in	IN	O
gene	NN	O
expression	NN	O
.	.	O
.	.	O

Additional	JJ	O
case	NN	O
of	IN	O
female	JJ	O
monozygotic	JJ	O
twins	NNS	O
discordant	VBP	O
for	IN	O
the	DT	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
due	JJ	O
to	TO	O
opposite	VB	O
X	NNP	O
-	:	O
chromosome	NN	O
inactivation	NN	O
.	.	O

A	DT	O
pair	NN	O
of	IN	O
female	JJ	O
monozygotic	JJ	O
(	(	O
MZ	NNP	O
)	)	O
twins	VBZ	O
,	,	O
heterozygous	JJ	O
carriers	NNS	O
for	IN	O
a	DT	O
deletion	NN	O
in	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
and	CC	O
discordant	NN	O
for	IN	O
the	DT	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
,	,	O
were	VBD	O
analyzed	VBN	O
by	IN	O
molecular	JJ	O
studies	NNS	O
,	,	O
in	IN	O
situ	JJ	O
hybridization	NN	O
,	,	O
and	CC	O
methylation	NN	O
pattern	NN	O
of	IN	O
X	NNP	O
chromosomes	NNS	O
to	TO	O
search	VB	O
for	IN	O
opposite	JJ	O
X	NNP	O
inactivation	NN	O
as	IN	O
an	DT	O
explanation	NN	O
of	IN	O
their	PRP$	O
clinical	JJ	O
discordance	NN	O
.	.	O

Results	NNS	O
in	IN	O
lymphocytes	NNS	O
and	CC	O
skin	VB	O
fibroblast	NN	O
cell	NN	O
lines	NNS	O
suggest	VBP	O
a	DT	O
partial	JJ	O
mirror	NN	O
inactivation	NN	O
with	IN	O
the	DT	O
normal	JJ	O
X	NNP	O
chromosome	NN	O
preferentially	RB	O
active	JJ	O
in	IN	O
the	DT	O
unaffected	JJ	O
twin	NN	O
,	,	O
and	CC	O
the	DT	O
maternal	JJ	O
deleted	JJ	O
X	NNP	O
chromosome	NN	O
preferentially	RB	O
active	JJ	O
in	IN	O
the	DT	O
affected	JJ	O
twin	NN	O
.	.	O

A	DT	O
review	NN	O
shows	VBZ	O
that	IN	O
MZ	NNP	O
female	NN	O
twins	NNS	O
discordant	VBP	O
for	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
diseases	NNS	E_Disease
are	VBP	O
not	RB	O
uncommon	JJ	O
.	.	O

Twinning	VBG	O
and	CC	O
X	NNP	O
inactivation	NN	O
may	MD	O
be	VB	O
interrelated	VBN	O
and	CC	O
could	MD	O
explain	VB	O
the	DT	O
female	NN	O
twins	VBZ	O
discordant	JJ	O
for	IN	O
X	NNP	O
-	:	O
linked	VBD	O
traits	NNS	O
.	.	O
.	.	O

X	LS	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	NN	E_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
:	:	O
a	DT	O
novel	JJ	O
mutation	NN	O
of	IN	O
the	DT	O
ALD	NNP	S_Disease
gene	NN	O
in	IN	O
6	CD	O
members	NNS	O
of	IN	O
a	DT	O
family	NN	O
presenting	VBG	O
with	IN	O
5	CD	O
different	JJ	O
phenotypes	NNS	O
.	.	O

Fragments	NNS	O
of	IN	O
the	DT	O
adrenoleukodystrophy	NN	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
cDNA	NN	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
adolescent	JJ	B_Disease
ALD	NNP	E_Disease
were	VBD	O
amplified	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
and	CC	O
subcloned	VBD	O
.	.	O

Bidirectional	NNP	O
sequencing	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
ALD	NNP	S_Disease
gene	NN	O
disclosed	VBD	O
a	DT	O
cytosine	NN	O
to	TO	O
guanine	VB	O
transversion	NN	O
at	IN	O
nucleotide	JJ	O
1451	CD	O
in	IN	O
exon	JJ	O
five	CD	O
,	,	O
resulting	VBG	O
in	IN	O
substitution	NN	O
of	IN	O
proline	NN	O
484	CD	O
by	IN	O
arginine	NN	O
.	.	O

Five	CD	O
of	IN	O
nine	CD	O
siblings	NNS	O
of	IN	O
the	DT	O
patient	NN	O
,	,	O
comprising	VBG	O
two	CD	O
cerebral	JJ	B_Disease
ALD	NNP	E_Disease
,	,	O
one	CD	O
adrenomyeloneuropathy	NN	S_Disease
,	,	O
one	CD	O
Addison	NNP	B_Disease
only	RB	E_Disease
as	RB	O
well	RB	O
as	IN	O
the	DT	O
symptomatic	JJ	O
mother	NN	O
(	(	O
all	DT	O
accumulating	VBG	O
very	RB	O
long	RB	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
)	)	O
carried	VBD	O
this	DT	O
mutation	NN	O
,	,	O
which	WDT	O
was	VBD	O
not	RB	O
found	VBN	O
in	IN	O
the	DT	O
unaffected	JJ	O
persons	NNS	O
,	,	O
in	IN	O
five	CD	O
unrelated	JJ	O
ALD	NNP	S_Disease
patients	NNS	O
,	,	O
and	CC	O
in	IN	O
twenty	NN	O
controls	NNS	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
this	DT	O
missense	JJ	O
mutation	NN	O
generated	VBD	O
the	DT	O
disease	NN	O
per	FW	O
se	NN	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
metabolic	JJ	O
defect	NN	O
;	:	O
the	DT	O
different	JJ	O
phenotypes	NNS	O
,	,	O
however	RB	O
,	,	O
must	MD	O
have	VB	O
originated	VBN	O
by	IN	O
means	NNS	O
of	IN	O
additional	JJ	O
pathogenetic	JJ	O
factors	NNS	O
.	.	O
.	.	O

Novel	JJ	O
mutation	NN	O
at	IN	O
the	DT	O
initiation	NN	O
codon	NN	O
in	IN	O
the	DT	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
in	IN	O
two	CD	O
Japanese	JJ	O
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
new	JJ	O
mutation	NN	O
of	IN	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
(	(	O
ND	NNP	S_Disease
)	)	O
gene	NN	O
in	IN	O
two	CD	O
Japanese	JJ	O
males	NNS	O
from	IN	O
unrelated	JJ	O
families	NNS	O
;	:	O
they	PRP	O
showed	VBD	O
typical	JJ	O
ocular	JJ	O
features	NNS	O
of	IN	O
ND	NNP	S_Disease
but	CC	O
no	DT	O
mental	JJ	B_Disease
retardation	NN	E_Disease
or	CC	O
hearing	NN	B_Disease
impairment	NN	E_Disease
.	.	O

A	DT	O
mutation	NN	O
was	VBD	O
found	VBN	O
in	IN	O
both	DT	O
patients	NNS	O
at	IN	O
the	DT	O
initiation	NN	O
codon	NN	O
of	IN	O
exon	JJ	O
2	CD	O
of	IN	O
the	DT	O
ND	NNP	S_Disease
gene	NN	O
(	(	O
ATG	NNP	O
to	TO	O
GTG	NNP	O
)	)	O
,	,	O
with	IN	O
otherwise	RB	O
normal	JJ	O
nucleotide	JJ	O
sequences	NNS	O
.	.	O

Their	PRP$	O
mothers	NNS	O
had	VBD	O
the	DT	O
normal	JJ	O
and	CC	O
mutant	JJ	O
types	NNS	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
which	WDT	O
was	VBD	O
expected	VBN	O
for	IN	O
heterozygotes	NNS	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
mutation	NN	O
of	IN	O
the	DT	O
initiation	NN	O
codon	NN	O
would	MD	O
cause	VB	O
the	DT	O
failure	NN	O
of	IN	O
ND	NNP	S_Disease
gene	NN	O
expression	NN	O
or	CC	O
a	DT	O
defect	NN	O
in	IN	O
translation	NN	O
thereby	RB	O
truncating	VBG	O
the	DT	O
amino	NN	O
terminus	NN	O
of	IN	O
ND	NNP	S_Disease
protein	NN	O
.	.	O

In	IN	O
view	NN	O
of	IN	O
the	DT	O
rarity	NN	O
and	CC	O
marked	JJ	O
heterogeneity	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ND	NNP	S_Disease
gene	NN	O
,	,	O
the	DT	O
present	JJ	O
apparently	RB	O
unrelated	JJ	O
Japanese	JJ	O
families	NNS	O
who	WP	O
have	VBP	O
lived	VBN	O
in	IN	O
the	DT	O
same	JJ	O
area	NN	O
for	IN	O
over	IN	O
two	CD	O
centuries	NNS	O
presumably	RB	O
share	NN	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
mutation	NN	O
.	.	O
.	.	O

Anticipation	NN	O
resulting	VBG	O
in	IN	O
elimination	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
gene	NN	O
:	:	O
a	DT	O
follow	VBP	O
up	RP	O
study	NN	O
of	IN	O
one	CD	O
extended	VBD	O
family	NN	O
.	.	O

We	PRP	O
have	VBP	O
re	VBN	O
-	:	O
examined	VBD	O
an	DT	O
extended	JJ	O
myotonic	NN	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
family	NN	O
,	,	O
previously	RB	O
described	VBN	O
in	IN	O
1955	CD	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
study	VB	O
the	DT	O
long	JJ	O
term	NN	O
effects	NNS	O
of	IN	O
anticipation	NN	O
in	IN	O
DM	NNP	S_Disease
and	CC	O
in	IN	O
particular	JJ	O
the	DT	O
implications	NNS	O
for	IN	O
families	NNS	O
affected	VBN	O
by	IN	O
this	DT	O
disease	NN	O
.	.	O

This	DT	O
follow	VBP	O
up	RP	O
study	NN	O
provides	VBZ	O
data	NNS	O
on	IN	O
35	CD	O
gene	NN	O
carriers	NNS	O
and	CC	O
46	CD	O
asymptomatic	JJ	O
at	IN	O
risk	NN	O
family	NN	O
members	NNS	O
in	IN	O
five	CD	O
generations	NNS	O
.	.	O

Clinical	JJ	O
anticipation	NN	O
,	,	O
defined	VBD	O
as	IN	O
the	DT	O
cascade	NN	O
of	IN	O
mild	NN	O
,	,	O
adult	NN	O
,	,	O
childhood	NN	O
,	,	O
or	CC	O
congenital	JJ	B_Disease
disease	NN	E_Disease
in	IN	O
subsequent	JJ	O
generations	NNS	O
,	,	O
appeared	VBD	O
to	TO	O
be	VB	O
a	DT	O
relentless	JJ	O
process	NN	O
,	,	O
occurring	VBG	O
in	IN	O
all	DT	O
affected	JJ	O
branches	NNS	O
of	IN	O
the	DT	O
family	NN	O
.	.	O

The	DT	O
cascade	NN	O
was	VBD	O
found	VBN	O
to	TO	O
proceed	VB	O
asynchronously	RB	O
in	IN	O
the	DT	O
different	JJ	O
branches	NNS	O
,	,	O
mainly	RB	O
because	IN	O
of	IN	O
an	DT	O
unequal	JJ	O
number	NN	O
of	IN	O
generations	NNS	O
with	IN	O
mild	JJ	O
disease	NN	O
.	.	O

The	DT	O
transition	NN	O
from	IN	O
the	DT	O
mild	NN	O
to	TO	O
the	DT	O
adult	NN	O
type	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
transmission	NN	O
through	IN	O
a	DT	O
male	JJ	O
parent	NN	O
.	.	O

Stable	JJ	O
transmission	NN	O
of	IN	O
the	DT	O
asymptomatic	JJ	O
/	NNP	O
mild	NN	O
phenotype	NN	O
showed	VBD	O
a	DT	O
female	JJ	O
transmission	NN	O
bias	NN	O
.	.	O

We	PRP	O
further	RB	O
examined	VBD	O
the	DT	O
extent	NN	O
and	CC	O
causes	NNS	O
of	IN	O
gene	NN	O
loss	NN	O
in	IN	O
this	DT	O
pedigree	NN	O
.	.	O

Gene	NNP	O
loss	NN	O
in	IN	O
the	DT	O
patient	NN	O
group	NN	O
was	VBD	O
complete	JJ	O
,	,	O
owing	VBG	O
to	TO	O
infertility	NN	S_Disease
of	IN	O
the	DT	O
male	NN	O
patients	NNS	O
with	IN	O
adult	JJ	O
onset	JJ	O
disease	NN	O
and	CC	O
the	DT	O
fact	NN	O
that	IN	O
mentally	RB	B_Disease
retarded	JJ	E_Disease
patients	NNS	O
did	VBD	O
not	RB	O
procreate	VB	O
.	.	O

Out	IN	O
of	IN	O
the	DT	O
46	CD	O
at	IN	O
risk	NN	O
subjects	NNS	O
in	IN	O
the	DT	O
two	CD	O
youngest	JJS	O
generations	NNS	O
,	,	O
only	RB	O
one	CD	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
full	JJ	O
mutation	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
only	JJ	O
subject	NN	O
who	WP	O
may	MD	O
transmit	VB	O
the	DT	O
gene	NN	O
to	TO	O
the	DT	O
sixth	JJ	O
generation	NN	O
.	.	O

No	DT	O
protomutation	NN	O
carriers	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
fourth	JJ	O
and	CC	O
fifth	JJ	O
generations	NNS	O
.	.	O

Therefore	IN	O
it	PRP	O
is	VBZ	O
highly	RB	O
probable	JJ	O
that	IN	O
the	DT	O
DM	NNP	S_Disease
gene	NN	O
will	MD	O
be	VB	O
eliminated	VBN	O
from	IN	O
this	DT	O
pedigree	NN	O
within	IN	O
one	CD	O
generation	NN	O
.	.	O

The	DT	O
high	JJ	O
population	NN	O
frequency	NN	O
of	IN	O
DM	NNP	S_Disease
can	MD	O
at	IN	O
present	JJ	O
not	RB	O
be	VB	O
explained	VBN	O
by	IN	O
the	DT	O
contribution	NN	O
of	IN	O
asymptomatic	JJ	O
cases	NNS	O
in	IN	O
the	DT	O
younger	JJR	O
generations	NNS	O
of	IN	O
known	JJ	O
families	NNS	O
,	,	O
but	CC	O
is	VBZ	O
probably	RB	O
caused	VBN	O
by	IN	O
the	DT	O
events	NNS	O
in	IN	O
the	DT	O
ancestral	JJ	O
generations	NNS	O
.	.	O
.	.	O

The	DT	O
gene	NN	O
for	IN	O
spinal	JJ	B_Disease
cerebellar	JJ	I_Disease
ataxia	NN	E_Disease
3	CD	O
(	(	O
SCA3	NNP	O
)	)	O
is	VBZ	O
located	VBN	O
in	IN	O
a	DT	O
region	NN	O
of	IN	O
approximately	RB	O
3	CD	O
cM	NNS	O
on	IN	O
chromosome	NN	O
14q24	CD	O
.	.	O
3	CD	O
-	:	O
q32	NN	O
.	.	O
2	CD	O
.	.	O

SCA3	NNP	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
spinal	JJ	B_Disease
cerebellar	JJ	I_Disease
ataxia	NN	E_Disease
3	CD	O
,	,	O
was	VBD	O
recently	RB	O
mapped	VBN	O
to	TO	O
a	DT	O
15	CD	O
-	:	O
cM	NN	O
interval	NN	O
between	IN	O
D14S67	NNP	O
and	CC	O
D14S81	NNP	O
on	IN	O
chromosome	NN	O
14q	CD	O
,	,	O
by	IN	O
linkage	NN	O
analysis	NN	O
in	IN	O
two	CD	O
families	NNS	O
of	IN	O
French	JJ	O
ancestry	NN	O
.	.	O

The	DT	O
SCA3	NNP	O
candidate	NN	O
region	NN	O
has	VBZ	O
now	RB	O
been	VBN	O
refined	VBN	O
by	IN	O
linkage	NN	O
analysis	NN	O
with	IN	O
four	CD	O
new	JJ	O
microsatellite	NN	O
markers	NNS	O
(	(	O
D14S256	NNP	O
,	,	O
D14S291	NNP	O
,	,	O
D14S280	NNP	O
,	,	O
and	CC	O
AFM343vf1	NNP	O
)	)	O
in	IN	O
the	DT	O
same	JJ	O
two	CD	O
families	NNS	O
,	,	O
in	IN	O
which	WDT	O
19	CD	O
additional	JJ	O
individuals	NNS	O
were	VBD	O
genotyped	VBN	O
,	,	O
and	CC	O
in	IN	O
a	DT	O
third	JJ	O
French	JJ	O
family	NN	O
.	.	O

Combined	VBN	O
two	CD	O
-	:	O
point	NN	O
linkage	NN	O
analyses	VBZ	O
show	VBP	O
that	IN	O
the	DT	O
new	JJ	O
markers	NNS	O
,	,	O
D14S280	NNP	O
and	CC	O
AFM343vf1	NNP	O
,	,	O
are	VBP	O
tightly	RB	O
linked	VBN	O
to	TO	O
the	DT	O
SCA3	NNP	O
locus	NN	O
,	,	O
with	IN	O
maximal	JJ	O
lod	NN	O
scores	NNS	O
,	,	O
at	IN	O
recombination	NN	O
fraction	NN	O
,	,	O
(	(	O
theta	NN	O
)	)	O
=	NN	O
.	.	O

00	CD	O
,	,	O
of	IN	O
7	CD	O
.	.	O

05	CD	O
and	CC	O
13	CD	O
.	.	O

70	CD	O
,	,	O
respectively	RB	O
.	.	O

Combined	VBN	O
multipoint	NN	O
and	CC	O
recombinant	JJ	O
haplotype	NN	O
analyses	NNS	O
localize	VBP	O
the	DT	O
SCA3	NNP	O
locus	NN	O
to	TO	O
a	DT	O
3	CD	O
-	:	O
cM	NN	O
interval	NN	O
flanked	VBN	O
by	IN	O
D14S291	NNP	O
and	CC	O
D14S81	NNP	O
.	.	O

The	DT	O
same	JJ	O
allele	NN	O
for	IN	O
D14S280	NNP	O
segregates	VBZ	O
with	IN	O
the	DT	O
disease	NN	O
locus	NN	O
in	IN	O
the	DT	O
three	CD	O
kindreds	NNS	O
.	.	O

This	DT	O
allele	NN	O
is	VBZ	O
frequent	JJ	O
in	IN	O
the	DT	O
French	JJ	O
population	NN	O
,	,	O
however	RB	O
,	,	O
and	CC	O
linkage	NN	O
disequilibrium	NN	O
is	VBZ	O
not	RB	O
clearly	RB	O
established	VBN	O
.	.	O

The	DT	O
SCA3	NNP	O
locus	NN	O
remains	VBZ	O
within	IN	O
the	DT	O
29	CD	O
-	:	O
cM	NN	O
region	NN	O
on	IN	O
14q24	CD	O
.	.	O

3	LS	O
-	:	O
q32	NN	O
.	.	O

2	CD	O
containing	VBG	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
,	,	O
which	WDT	O
is	VBZ	O
clinically	RB	O
related	VBN	O
to	TO	O
the	DT	O
phenotype	NN	O
determined	VBN	O
by	IN	O
SCA3	NNP	O
,	,	O
but	CC	O
it	PRP	O
cannot	VBZ	O
yet	RB	O
be	VB	O
concluded	VBN	O
that	IN	O
both	DT	O
diseases	NNS	O
result	VBP	O
from	IN	O
alterations	NNS	O
of	IN	O
the	DT	O
same	JJ	O
gene	NN	O

An	DT	O
evaluation	NN	O
of	IN	O
genetic	JJ	O
heterogeneity	NN	O
in	IN	O
145	CD	O
breast	NN	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
.	.	O

Breast	NNP	B_Disease
Cancer	NNP	E_Disease
Linkage	NNP	O
Consortium	NNP	O
.	.	O

The	DT	O
breast	NN	B_Disease
-	:	I_Disease
ovary	JJ	I_Disease
cancer	NN	I_Disease
-	:	I_Disease
family	NN	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
a	DT	O
dominant	JJ	O
predisposition	NN	O
to	TO	O
cancer	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovaries	NNS	E_Disease
which	WDT	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
chromosome	VB	O
region	NN	O
17q12	CD	O
-	:	O
q21	NN	O
.	.	O

The	DT	O
majority	NN	O
,	,	O
but	CC	O
not	RB	O
all	DT	O
,	,	O
of	IN	O
breast	SYM	B_Disease
-	:	I_Disease
ovary	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
show	VBP	O
linkage	NN	O
to	TO	O
this	DT	O
susceptibility	NN	O
locus	NN	O
,	,	O
designated	VBN	O
BRCA1	NNP	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
results	NNS	O
of	IN	O
a	DT	O
linkage	NN	O
analysis	NN	O
of	IN	O
145	CD	O
families	NNS	O
with	IN	O
both	DT	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

These	DT	O
families	NNS	O
contain	VBP	O
either	RB	O
a	DT	O
total	NN	O
of	IN	O
three	CD	O
or	CC	O
more	JJR	O
cases	NNS	O
of	IN	O
early	JJ	O
-	:	O
onset	NN	O
(	(	O
before	IN	O
age	NN	O
60	CD	O
years	NNS	O
)	)	O
breast	NN	B_Disease
cancer	NN	E_Disease
or	CC	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

All	DT	O
families	NNS	O
contained	VBN	O
at	IN	O
least	JJS	O
one	CD	O
case	NN	O
of	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Overall	JJ	O
,	,	O
an	DT	O
estimated	VBN	O
76	CD	O
%	NN	O
of	IN	O
the	DT	O
145	CD	O
families	NNS	O
are	VBP	O
linked	VBN	O
to	TO	O
the	DT	O
BRCA1	NNP	O
locus	NN	O
.	.	O

None	NN	O
of	IN	O
the	DT	O
13	CD	O
families	NNS	O
with	IN	O
cases	NNS	O
of	IN	O
male	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
appear	VBP	O
to	TO	O
be	VB	O
linked	VBN	O
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
estimated	VBN	O
that	IN	O
92	CD	O
%	NN	O
(	(	O
95	CD	O
%	NN	O
confidence	NN	O
interval	JJ	O
76	CD	O
%	NN	O
-	:	O
100	CD	O
%	NN	O
)	)	O
of	IN	O
families	NNS	O
with	IN	O
no	DT	O
male	NN	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
and	CC	O
with	IN	O
two	CD	O
or	CC	O
more	JJR	O
ovarian	JJ	B_Disease
cancers	NNS	E_Disease
are	VBP	O
linked	VBN	O
to	TO	O
BRCA1	NNP	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
breast	NN	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	I_Disease
-	:	I_Disease
family	NN	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
genetically	RB	O
heterogeneous	JJ	O
.	.	O

However	RB	O
,	,	O
the	DT	O
large	JJ	O
majority	NN	O
of	IN	O
families	NNS	O
with	IN	O
early	JJ	O
-	:	O
onset	NN	O
breast	NN	B_Disease
cancer	NN	E_Disease
and	CC	O
with	IN	O
two	CD	O
or	CC	O
more	JJR	O
cases	NNS	O
of	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
are	VBP	O
likely	JJ	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
BRCA1	NNP	O
mutations	NNS	O
.	.	O
.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
essential	JJ	B_Disease
fructosuria	NNS	E_Disease
:	:	O
molecular	JJ	O
cloning	NN	O
and	CC	O
mutational	JJ	O
analysis	NN	O
of	IN	O
human	JJ	O
ketohexokinase	NN	O
(	(	O
fructokinase	NN	O
)	)	O
.	.	O

Essential	JJ	B_Disease
fructosuria	NN	E_Disease
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
oldest	JJS	O
known	VBN	O
inborn	JJ	B_Disease
errors	NNS	I_Disease
of	IN	I_Disease
metabolism	NN	E_Disease
.	.	O

It	PRP	O
is	VBZ	O
a	DT	O
benign	JJ	O
condition	NN	O
which	WDT	O
is	VBZ	O
believed	VBN	O
to	TO	O
result	VB	O
from	IN	O
deficiency	NN	B_Disease
of	IN	I_Disease
hepatic	JJ	I_Disease
fructokinase	NN	E_Disease
(	(	O
ketohexokinase	NN	O
,	,	O
KHK	NNP	O
,	,	O
E	NNP	O
.	.	O

C	NNP	O
.	.	O

2	CD	O
.	.	O

7	CD	O
.	.	O

1	CD	O
.	.	O

3	LS	O
)	)	O
.	.	O

This	DT	O
enzyme	NN	O
catalyses	VBZ	O
the	DT	O
first	JJ	O
step	NN	O
of	IN	O
metabolism	NN	O
of	IN	O
dietary	JJ	O
fructose	NN	O
,	,	O
conversion	NN	O
of	IN	O
fructose	NN	O
to	TO	O
fructose	VB	O
-	:	O
1	CD	O
-	:	O
phosphate	NN	O
.	.	O

Despite	IN	O
the	DT	O
early	JJ	O
recognition	NN	O
of	IN	O
this	DT	O
disorder	NN	O
,	,	O
the	DT	O
primary	JJ	O
structure	NN	O
of	IN	O
human	JJ	O
KHK	NNP	O
and	CC	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
essential	JJ	B_Disease
fructosuria	NNS	E_Disease
have	VBP	O
not	RB	O
been	VBN	O
previously	RB	O
defined	VBN	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
the	DT	O
isolation	NN	O
and	CC	O
sequencing	NN	O
of	IN	O
full	JJ	O
-	:	O
length	NN	O
cDNA	NN	O
clones	NNS	O
encoding	VBG	O
human	JJ	O
ketohexokinase	NN	O
are	VBP	O
described	VBN	O
.	.	O

Alternative	JJ	O
mRNA	NN	O
species	NNS	O
and	CC	O
alternative	JJ	O
KHK	NNP	O
isozymes	NNS	O
are	VBP	O
produced	VBN	O
by	IN	O
alternative	JJ	O
polyadenylation	NN	O
and	CC	O
splicing	NN	O
of	IN	O
the	DT	O
KHK	NNP	O
gene	NN	O
.	.	O

The	DT	O
KHK	NNP	O
proteins	VBZ	O
show	VB	O
a	DT	O
high	JJ	O
level	NN	O
of	IN	O
sequence	NN	O
conservation	NN	O
relative	NN	O
to	TO	O
rat	VB	O
KHK	NNP	O
.	.	O

Direct	JJ	O
evidence	NN	O
that	IN	O
mutation	NN	O
of	IN	O
the	DT	O
KHK	NNP	O
structural	JJ	O
gene	NN	O
is	VBZ	O
the	DT	O
cause	NN	O
of	IN	O
essential	JJ	B_Disease
fructosuria	NN	E_Disease
was	VBD	O
also	RB	O
obtained	VBN	O
.	.	O

In	IN	O
a	DT	O
well	NN	O
-	:	O
characterized	VBN	O
family	NN	O
,	,	O
in	IN	O
which	WDT	O
three	CD	O
of	IN	O
eight	CD	O
siblings	NNS	O
have	VBP	O
fructosuria	VBN	S_Disease
,	,	O
all	DT	O
affected	JJ	O
individuals	NNS	O
are	VBP	O
compound	VBN	O
heterozygotes	NNS	O
for	IN	O
two	CD	O
mutations	NNS	O
Gly40Arg	NNP	O
and	CC	O
Ala43Thr	NNP	O
.	.	O

Both	DT	O
mutations	NNS	O
result	VBP	O
from	IN	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
transitions	NNS	O
,	,	O
and	CC	O
each	DT	O
alters	NNS	O
the	DT	O
same	JJ	O
conserved	JJ	O
region	NN	O
of	IN	O
the	DT	O
KHK	NNP	O
protein	NN	O
.	.	O

Neither	DT	O
mutation	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
a	DT	O
sample	NN	O
of	IN	O
52	CD	O
unrelated	JJ	O
control	NN	O
individuals	NNS	O
.	.	O

An	DT	O
additional	JJ	O
conservative	JJ	O
amino	NN	O
acid	NN	O
change	NN	O
(	(	O
Val49IIe	NNP	O
)	)	O
was	VBD	O
present	JJ	O
on	IN	O
the	DT	O
KHK	NNP	O
allele	NN	O
bearing	NN	O
Ala43Thr	NNP	O

Homozygous	JJ	O
presence	NN	O
of	IN	O
the	DT	O
crossover	NN	O
(	(	O
fusion	JJ	O
gene	NN	O
)	)	O
mutation	NN	O
identified	VBN	O
in	IN	O
a	DT	O
type	NN	B_Disease
II	NNP	I_Disease
Gaucher	NNP	I_Disease
disease	NN	E_Disease
fetus	NN	O
:	:	O
is	VBZ	O
this	DT	O
analogous	JJ	O
to	TO	O
the	DT	O
Gaucher	NNP	O
knock	NNP	O
-	:	O
out	RP	O
mouse	IN	O
model	NN	O
?	.	O
Gaucher	NNP	B_Disease
disease	NN	E_Disease
(	(	O
GD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
inherited	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
beta	NN	I_Disease
-	:	I_Disease
glucocerebrosidase	NN	E_Disease
(	(	O
EC	NNP	O
3	CD	O
.	.	O

1	CD	O
.	.	O

2	CD	O
.	.	O

45	CD	O
,	,	O
gene	NN	O
symbol	NN	O
GBA	NNP	O
)	)	O
.	.	O

In	IN	O
type	NN	B_Disease
I	PRP	I_Disease
GD	NNP	E_Disease
,	,	O
the	DT	O
CNS	NNP	O
is	VBZ	O
not	RB	O
involved	VBN	O
(	(	O
nonneuronopathic	JJ	O
)	)	O
,	,	O
whereas	RB	O
in	IN	O
type	NN	B_Disease
II	NNP	I_Disease
GD	NNP	E_Disease
(	(	O
acute	JJ	O
neuronopathic	NN	O
)	)	O
CNS	NNP	O
involvement	NN	O
is	VBZ	O
early	JJ	O
and	CC	O
rapidly	RB	O
progressive	JJ	O
,	,	O
while	IN	O
in	IN	O
type	NN	B_Disease
III	NNP	I_Disease
GD	NNP	E_Disease
(	(	O
subacute	JJ	O
neuronopathic	NN	O
)	)	O
CNS	NNP	O
involvement	NN	O
occurs	VBZ	O
later	RB	O
and	CC	O
is	VBZ	O
slowly	RB	O
progressive	JJ	O
.	.	O

The	DT	O
T6433C	NNP	O
(	(	O
L444P	NNP	O
)	)	O
substitution	NN	O
is	VBZ	O
prevalent	JJ	O
in	IN	O
type	NN	B_Disease
GD	NNP	I_Disease
II	NNP	E_Disease
.	.	O

It	PRP	O
may	MD	O
occur	VB	O
alone	RB	O
as	IN	O
a	DT	O
single	JJ	O
base	NN	O
-	:	O
pair	NN	O
mutation	NN	O
but	CC	O
often	RB	O
is	VBZ	O
found	VBN	O
as	IN	O
part	NN	O
of	IN	O
a	DT	O
complex	JJ	O
allele	NN	O
containing	VBG	O
additional	JJ	O
GBA	NNP	O
nucleotide	NN	O
substitutions	NNS	O
,	,	O
G6468C	NNP	O
(	(	O
A456P	NNP	O
)	)	O
and	CC	O
G6482C	NNP	O
(	(	O
V460V	NNP	O
)	)	O
,	,	O
without	IN	O
(	(	O
recNciI	NN	O
)	)	O
or	CC	O
with	IN	O
(	(	O
recTL	NN	O
)	)	O
G5957C	NNP	O
(	(	O
D409H	NNP	O
)	)	O
.	.	O

This	DT	O
complex	JJ	O
allele	NN	O
is	VBZ	O
presumed	VBN	O
to	TO	O
have	VB	O
formed	VBN	O
by	IN	O
recombination	NN	O
(	(	O
crossover	NN	O
,	,	O
fusion	NN	O
)	)	O
of	IN	O
the	DT	O
structural	JJ	O
gene	NN	O
with	IN	O
the	DT	O
pseudogene	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
the	DT	O
mutated	JJ	O
sequences	NNS	O
.	.	O

Two	CD	O
complex	JJ	O
alleles	NNS	O
have	VBP	O
never	RB	O
been	VBN	O
demonstrated	VBN	O
to	TO	O
coexist	VB	O
in	IN	O
any	DT	O
individual	NN	O
.	.	O

We	PRP	O
devised	VBD	O
a	DT	O
selective	JJ	O
PCR	NNP	O
method	NN	O
for	IN	O
the	DT	O
specific	JJ	O
amplification	NN	O
of	IN	O
the	DT	O
normal	JJ	O
and	CC	O
/	JJ	O
or	CC	O
fusion	JJ	O
gene	NN	O
.	.	O

Using	VBG	O
this	DT	O
procedure	NN	O
we	PRP	O
demonstrated	VBD	O
the	DT	O
fusion	NN	O
gene	NN	O
in	IN	O
homozygous	JJ	O
form	NN	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
,	,	O
in	IN	O
a	DT	O
Macedonian	JJ	O
/	NN	O
Ashkenazi	NNP	O
Jewish	NNP	O
GD	NNP	B_Disease
type	NN	I_Disease
II	NNP	E_Disease
fetus	NN	O
.	.	O

Both	DT	O
parents	NNS	O
were	VBD	O
carriers	NNS	O
of	IN	O
the	DT	O
recombination	NN	O
.	.	O

This	DT	O
was	VBD	O
confirmed	VBN	O
by	IN	O
direct	JJ	O
sequence	NN	O
analysis	NN	O
.	.	O

A	DT	O
previous	JJ	O
conceptus	NN	O
in	IN	O
this	DT	O
family	NN	O
was	VBD	O
stillborn	VBN	S_Disease
at	IN	O
36	CD	O
weeks	NNS	O
,	,	O
with	IN	O
features	NNS	O
of	IN	O
severe	JJ	O
type	NN	B_Disease
II	NNP	I_Disease
GD	NNP	E_Disease
.	.	O

Neonates	NNS	O
showing	VBG	O
a	DT	O
severe	JJ	O
clinical	JJ	O
phenotype	NN	O
,	,	O
analogous	JJ	O
to	TO	O
the	DT	O
early	JJ	O
neonatal	JJ	O
lethal	JJ	O
disease	NN	O
occurring	VBG	O
in	IN	O
mice	NNS	O
homozygous	JJ	O
for	IN	O
a	DT	O
null	JJ	O
allele	NN	O
produced	VBN	O
by	IN	O
targeted	JJ	O
disruption	NN	O
of	IN	O
GBA	NNP	O
,	,	O
have	VBP	O
been	VBN	O
described	VBN	O
elsewhere	RB	O
,	,	O
but	CC	O
the	DT	O
specific	JJ	O
mutations	NNS	O
in	IN	O
these	DT	O
cases	NNS	O
have	VBP	O
not	RB	O
yet	RB	O
been	VBN	O
characterized	VBN	O
.	.	O

(	(	O
ABSTRACT	NNP	O
TRUNCATED	NNP	O
AT	NNP	O
250	CD	O
WORDS	NNP	O
)	)	O

Late	RB	O
infantile	JJ	O
metachromatic	JJ	B_Disease
leukodystrophy	NN	E_Disease
in	IN	O
Israel	NNP	O
.	.	O

Metachromatic	JJ	B_Disease
Leukodystrophy	NNP	E_Disease
(	(	O
MLD	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
neurodegenerative	JJ	B_Disease
disease	NN	E_Disease
in	IN	O
which	WDT	O
the	DT	O
lysosomal	NN	O
enzyme	NN	O
,	,	O
Aryl	NNP	O
sulfatase	VBD	O
A	NNP	O
(	(	O
ARSA	NNP	O
)	)	O
is	VBZ	O
deficient	JJ	O
.	.	O

The	DT	O
disease	NN	O
is	VBZ	O
inherited	VBN	O
as	IN	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
trait	NN	O
and	CC	O
its	PRP$	O
frequency	NN	O
is	VBZ	O
estimated	VBN	O
to	TO	O
be	VB	O
1	CD	O
/	JJ	O
40	CD	O
,	,	O
000	CD	O
live	JJ	O
births	NNS	O
.	.	O

The	DT	O
gene	NN	O
of	IN	O
ARSA	NNP	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
and	CC	O
up	RB	O
to	TO	O
now	RB	O
eight	CD	O
mutations	NNS	O
causing	VBG	O
MLD	NNP	S_Disease
have	VBP	O
been	VBN	O
reported	VBN	O
.	.	O

Another	DT	O
mutation	NN	O
,	,	O
PD	NNP	O
,	,	O
leads	VBZ	O
to	TO	O
the	DT	O
deficiency	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
in	IN	O
vitro	NN	O
(	(	O
pseudodeficiency	NN	O
)	)	O
without	IN	O
any	DT	O
known	JJ	O
clinical	JJ	O
effect	NN	O
.	.	O

The	DT	O
PD	NNP	O
mutation	NN	O
is	VBZ	O
frequent	JJ	O
in	IN	O
all	DT	O
populations	NNS	O
.	.	O

In	IN	O
Israel	NNP	O
,	,	O
late	RB	O
infantile	JJ	O
MLD	NNP	S_Disease
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
very	RB	O
frequent	JJ	O
in	IN	O
a	DT	O
small	JJ	O
Jewish	JJ	O
isolate	NN	O
,	,	O
the	DT	O
Habbanite	NNP	O
Jews	NNP	O
(	(	O
1	CD	O
/	RB	O
75	CD	O
live	JJ	O
births	NNS	O
)	)	O
.	.	O

The	DT	O
molecular	JJ	O
analysis	NN	O
demonstrated	VBD	O
that	IN	O
in	IN	O
the	DT	O
Habbanite	NNP	O
population	NN	O
,	,	O
the	DT	O
mutation	NN	O
occurred	VBD	O
on	IN	O
an	DT	O
allele	NN	O
with	IN	O
the	DT	O
PD	NNP	O
mutation	NN	O
.	.	O

The	DT	O
loss	NN	O
of	IN	O
ARSA	NNP	O
activity	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
point	NN	O
mutation	NN	O
C	NNP	O
>	NNP	O
T	NNP	O
leading	VBG	O
to	TO	O
a	DT	O
change	NN	O
of	IN	O
proline	NN	O
to	TO	O
leucine	VB	O
.	.	O

MLD	NNP	S_Disease
is	VBZ	O
also	RB	O
frequent	JJ	O
among	IN	O
Moslem	NNP	O
Arabs	NNP	O
in	IN	O
Jerusalem	NNP	O
.	.	O

The	DT	O
mutation	NN	O
is	VBZ	O
a	DT	O
transition	NN	O
G	NNP	O
>	VBZ	O
A	NNP	O
destroying	VBG	O
the	DT	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
exon	JJ	O
2	CD	O
.	.	O

This	DT	O
mutation	NN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
late	JJ	O
infantile	NN	O
MLD	NNP	S_Disease
from	IN	O
different	JJ	O
ethnic	JJ	O
groups	NNS	O
.	.	O

The	DT	O
Christian	JJ	O
Arabs	NNPS	O
in	IN	O
Israel	NNP	O
also	RB	O
have	VBP	O
a	DT	O
high	JJ	O
incidence	NN	O
of	IN	O
the	DT	O
disease	NN	O
(	(	O
1	CD	O
/	RB	O
10	CD	O
,	,	O
000	CD	O
live	JJ	O
births	NNS	O
)	)	O
;	:	O
the	DT	O
mutation	NN	O
in	IN	O
this	DT	O
population	NN	O
is	VBZ	O
still	RB	O
unknown	JJ	O
.	.	O

Knowledge	NNP	O
of	IN	O
the	DT	O
different	JJ	O
mutations	NNS	O
causing	VBG	O
MLD	NNP	S_Disease
in	IN	O
these	DT	O
defined	VBN	O
populations	NNS	O
will	MD	O
allow	VB	O
a	DT	O
carrier	NN	O
screening	VBG	O
program	NN	O
to	TO	O
be	VB	O
carried	VBN	O
out	IN	O
and	CC	O
prevent	VB	O
the	DT	O
birth	NN	O
of	IN	O
additional	JJ	O
affected	JJ	O
children	NNS	O
.	.	O
.	.	O

A	DT	O
single	JJ	O
amino	NN	O
acid	JJ	O
substitution	NN	O
(	(	O
G103D	NNP	O
)	)	O
in	IN	O
the	DT	O
type	NN	O
II	NNP	O
collagen	NN	O
triple	NN	O
helix	NN	O
produces	VBZ	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
.	.	O

Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
is	VBZ	O
a	DT	O
moderately	RB	O
severe	JJ	O
chondrodysplasia	NN	S_Disease
phenotype	NN	O
that	WDT	O
results	NNS	O
from	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
for	IN	O
type	JJ	O
II	NNP	O
collagen	NN	O
,	,	O
COL2A1	NNP	O
.	.	O

Characteristics	NNS	O
of	IN	O
the	DT	O
disorder	NN	O
include	VBP	O
a	DT	O
short	JJ	B_Disease
trunk	NN	I_Disease
and	CC	I_Disease
extremities	NNS	E_Disease
,	,	O
mid	SYM	B_Disease
-	:	I_Disease
face	NN	I_Disease
hypoplasia	NN	E_Disease
,	,	O
cleft	NN	B_Disease
palate	NN	E_Disease
,	,	O
myopia	NN	S_Disease
,	,	O
retinal	JJ	B_Disease
detachment	NN	E_Disease
,	,	O
and	CC	O
hearing	JJ	B_Disease
loss	NN	E_Disease
.	.	O

Recently	RB	O
,	,	O
deletions	NNS	O
of	IN	O
all	DT	O
or	CC	O
part	NN	O
of	IN	O
exon	$	O
12	CD	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
individuals	NNS	O
with	IN	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
,	,	O
suggesting	VBG	O
that	IN	O
mutations	NNS	O
within	IN	O
this	DT	O
region	NN	O
of	IN	O
the	DT	O
protein	NN	O
may	MD	O
primarily	RB	O
result	VB	O
in	IN	O
the	DT	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
phenotype	NN	O
.	.	O

We	PRP	O
used	VBD	O
SSCP	NNP	O
to	TO	O
analyze	VB	O
an	DT	O
amplified	JJ	O
genomic	JJ	O
DNA	NNP	O
fragment	NN	O
containing	VBG	O
exon	$	O
12	CD	O
from	IN	O
seven	CD	O
individuals	NNS	O
with	IN	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
.	.	O

An	DT	O
abnormality	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
one	CD	O
patient	NN	O
.	.	O

DNA	NN	O
sequence	NN	O
analysis	NN	O
demonstrated	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
heterozygous	JJ	O
for	IN	O
a	DT	O
G	NNP	O
to	TO	O
A	DT	O
transition	NN	O
that	WDT	O
implied	VBD	O
substitution	NN	O
of	IN	O
glycine103	NN	O
of	IN	O
the	DT	O
triple	JJ	O
helical	JJ	O
domain	NN	O
by	IN	O
aspartate	NN	O
.	.	O

The	DT	O
mutation	NN	O
was	VBD	O
not	RB	O
observed	VBN	O
in	IN	O
DNA	NN	O
from	IN	O
either	DT	O
of	IN	O
the	DT	O
clinically	RB	O
unaffected	JJ	O
parents	NNS	O
of	IN	O
the	DT	O
proband	NN	O
.	.	O

Protein	NNP	O
microsequencing	VBG	O
demonstrated	JJ	O
expression	NN	O
of	IN	O
the	DT	O
abnormal	JJ	O
allele	NN	O
in	IN	O
cartilage	NN	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	NN	O
that	IN	O
point	NN	O
mutations	NNS	O
which	WDT	O
result	VBP	O
in	IN	O
single	JJ	O
amino	NN	O
acid	IN	O
substitutions	NNS	O
can	MD	O
produce	VB	O
Kniest	NNP	B_Disease
dysplasia	NN	E_Disease
and	CC	O
further	JJ	O
support	NN	O
the	DT	O
hypothesis	NN	O
that	IN	O
alteration	NN	O
of	IN	O
a	DT	O
domain	NN	O
,	,	O
which	WDT	O
includes	VBZ	O
the	DT	O
region	NN	O
encoded	VBN	O
by	IN	O
exon	NN	O
12	CD	O
,	,	O
in	IN	O
the	DT	O
type	NN	O
II	NNP	O
collagen	NN	O
protein	NN	O
leads	VBZ	O
to	TO	O
this	DT	O
disorder	NN	O
.	.	O
.	.	O

CAG	NNP	O
expansions	NNS	O
in	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
for	IN	O
Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
at	IN	O
chromosome	NN	O
14q32	CD	O
.	.	O
1	CD	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
novel	JJ	O
gene	NN	O
containing	VBG	O
CAG	NNP	O
repeats	NNS	O
and	CC	O
mapped	VBD	O
it	PRP	O
to	TO	O
chromosome	VB	O
14q32	CD	O
.	.	O

1	CD	O
,	,	O
the	DT	O
genetic	JJ	O
locus	NN	O
for	IN	O
Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
(	(	O
MJD	NNP	S_Disease
)	)	O
.	.	O

In	IN	O
normal	JJ	O
individuals	NNS	O
the	DT	O
gene	NN	O
contains	VBZ	O
between	IN	O
13	CD	O
and	CC	O
36	CD	O
CAG	NNP	O
repeats	NNS	O
,	,	O
whereas	IN	O
most	JJS	O
of	IN	O
the	DT	O
clinically	NN	O
diagnosed	VBD	O
patients	NNS	O
and	CC	O
all	DT	O
of	IN	O
the	DT	O
affected	JJ	O
members	NNS	O
of	IN	O
a	DT	O
family	NN	O
with	IN	O
the	DT	O
clinical	JJ	O
and	CC	O
pathological	JJ	O
diagnosis	NN	O
of	IN	O
MJD	NNP	S_Disease
show	VBP	O
expansion	NN	O
of	IN	O
the	DT	O
repeat	NN	O
-	:	O
number	NN	O
(	(	O
from	IN	O
68	CD	O
-	:	O
79	CD	O
)	)	O
.	.	O

Southern	NNP	O
blot	NN	O
analyses	NNS	O
and	CC	O
genomic	JJ	O
cloning	NN	O
demonstrates	VBZ	O
the	DT	O
existence	NN	O
of	IN	O
related	JJ	O
genes	NNS	O
.	.	O

These	DT	O
results	NNS	O
raise	VBP	O
the	DT	O
possibility	NN	O
that	IN	O
similar	JJ	O
abnormalities	NNS	O
in	IN	O
related	JJ	O
genes	NNS	O
may	MD	O
give	VB	O
rise	NN	O
to	TO	O
diseases	NNS	O
similar	JJ	O
to	TO	O
MJD	NNP	S_Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
in	IN	O
families	NNS	O
with	IN	O
early	JJ	O
-	:	O
onset	NN	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

We	PRP	O
analysed	VBD	O
50	CD	O
probands	NNS	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
breast	NN	B_Disease
and	CC	I_Disease
/	NN	I_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
for	IN	O
germline	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
coding	JJ	O
region	NN	O
of	IN	O
the	DT	O
BRCA1	NNP	O
candidate	NN	O
gene	NN	O
,	,	O
using	VBG	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
SSCP	NNP	O
)	)	O
analysis	NN	O
on	IN	O
PCR	NNP	O
-	:	O
amplified	JJ	O
genomic	JJ	O
DNA	NN	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
eight	CD	O
putative	JJ	O
disease	NN	O
-	:	O
causing	NN	O
alterations	NNS	O
were	VBD	O
identified	VBN	O
four	CD	O
of	IN	O
these	DT	O
are	VBP	O
frameshifts	NNS	O
and	CC	O
two	CD	O
are	VBP	O
nonsense	JJ	O
mutations	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
found	VBD	O
two	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
one	CD	O
of	IN	O
which	WDT	O
changes	VBZ	O
the	DT	O
final	JJ	O
cysteine	NN	O
of	IN	O
the	DT	O
BRCA1	NNP	O
zinc	NNP	O
finger	NN	O
motif	NN	O
to	TO	O
glycine	VB	O
.	.	O

These	DT	O
data	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
a	DT	O
tumour	NN	S_Disease
suppressor	NN	O
model	NN	O
,	,	O
and	CC	O
support	VB	O
the	DT	O
notion	NN	O
that	IN	O
this	DT	O
candidate	NN	O
gene	NN	O
is	VBZ	O
in	IN	O
fact	NN	O
BRCA1	NNP	O
.	.	O

The	DT	O
heterogeneity	NN	O
of	IN	O
mutations	NNS	O
,	,	O
coupled	VBN	O
with	IN	O
the	DT	O
large	JJ	O
size	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
indicates	VBZ	O
that	IN	O
clinical	JJ	O
application	NN	O
of	IN	O
BRCA1	NNP	O
mutation	NN	O
testing	NN	O
will	MD	O
be	VB	O
technically	RB	O
challenging	VBG	O
.	.	O
.	.	O

Confirmation	NN	O
of	IN	O
BRCA1	NNP	O
by	IN	O
analysis	NN	O
of	IN	O
germline	JJ	O
mutations	NNS	O
linked	VBN	O
to	TO	O
breast	VB	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
in	IN	O
ten	JJ	O
families	NNS	O
.	.	O

We	PRP	O
provide	VBP	O
genetic	JJ	O
evidence	NN	O
supporting	VBG	O
the	DT	O
identity	NN	O
of	IN	O
the	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
BRCA1	NNP	O
through	IN	O
the	DT	O
characterization	NN	O
of	IN	O
germline	JJ	O
mutations	NNS	O
in	IN	O
63	CD	O
breast	NN	B_Disease
cancer	NN	E_Disease
patients	NNS	O
and	CC	O
10	CD	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
patients	NNS	O
in	IN	O
ten	JJ	O
families	NNS	O
with	IN	O
cancer	NN	S_Disease
linked	VBN	O
to	TO	O
chromosome	VB	O
17q21	CD	O
.	.	O

Nine	NNP	O
different	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
by	IN	O
screening	VBG	O
BRCA1	NNP	O
DNA	NNP	O
and	CC	O
RNA	NNP	O
by	IN	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
analysis	NN	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

Seven	NNP	O
mutations	NNS	O
lead	VBP	O
to	TO	O
protein	VB	O
truncations	NNS	O
at	IN	O
sites	NNS	O
throughout	IN	O
the	DT	O
gene	NN	O
.	.	O

One	CD	O
missense	NN	O
mutation	NN	O
(	(	O
which	WDT	O
occurred	VBD	O
independently	RB	O
in	IN	O
two	CD	O
families	NNS	O
)	)	O
leads	VBZ	O
to	TO	O
loss	NN	O
of	IN	O
a	DT	O
cysteine	NN	O
in	IN	O
the	DT	O
zinc	NN	O
binding	NN	O
domain	NN	O
.	.	O

An	DT	O
intronic	JJ	O
single	JJ	O
basepair	NN	O
substitution	NN	O
destroys	VBZ	O
an	DT	O
acceptor	NN	O
site	NN	O
and	CC	O
activates	VBZ	O
a	DT	O
cryptic	JJ	O
splice	NN	O
site	NN	O
,	,	O
leading	VBG	O
to	TO	O
a	DT	O
59	CD	O
basepair	NN	O
insertion	NN	O
and	CC	O
chain	NN	O
termination	NN	O
.	.	O

The	DT	O
four	CD	O
families	NNS	O
with	IN	O
both	DT	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
had	VBD	O
chain	NN	O
termination	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
N	NNP	O
-	:	O
terminal	JJ	O
half	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O
.	.	O

High	JJ	O
resolution	NN	O
genetic	JJ	O
analysis	NN	O
suggests	VBZ	O
one	CD	O
ancestral	JJ	O
predisposing	VBG	O
haplotype	NN	O
for	IN	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
mutation	NN	O
.	.	O

The	DT	O
mutation	NN	O
causing	VBG	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
has	VBZ	O
been	VBN	O
identified	VBN	O
as	IN	O
an	DT	O
amplification	NN	O
of	IN	O
an	DT	O
unstable	JJ	O
trinucleotide	NN	O
(	(	O
CTG	NNP	O
)	)	O
n	VBP	O
repeat	NN	O
in	IN	O
over	IN	O
99	CD	O
%	NN	O
of	IN	O
the	DT	O
global	JJ	O
DM	NNP	S_Disease
population	NN	O
.	.	O

It	PRP	O
is	VBZ	O
in	IN	O
complete	JJ	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
an	DT	O
Alu	NNP	O
element	NN	O
polymorphism	NN	O
within	IN	O
the	DT	O
DM	NNP	S_Disease
kinase	NNP	O
gene	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
DM	NNP	S_Disease
is	VBZ	O
a	DT	O
consequence	NN	O
of	IN	O
one	CD	O
or	CC	O
few	JJ	O
ancestral	JJ	O
mutations	NNS	O
.	.	O

A	DT	O
recent	JJ	O
analysis	NN	O
utilizing	VBG	O
this	DT	O
polymorphism	NN	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
flanking	NN	O
dinucleotide	NN	O
marker	NN	O
,	,	O
suggested	VBD	O
that	IN	O
similar	JJ	O
to	TO	O
Fragile	NNP	B_Disease
X	NNP	I_Disease
syndrome	NN	E_Disease
,	,	O
DM	NNP	S_Disease
exhibited	VBD	O
a	DT	O
founder	NN	O
effect	NN	O
(	(	O
Imbert	NNP	O
et	RB	O
al	RB	O
.	.	O
,	,	O
1993	CD	O
Nature	NN	O
Genet	NNP	O
.	.	O

4	CD	O
,	,	O
72	CD	O
-	:	O
76	CD	O
)	)	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
the	DT	O
low	JJ	O
reproductive	JJ	O
fitness	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
congenital	JJ	O
DM	NNP	S_Disease
(	(	O
the	DT	O
endpoint	NN	O
of	IN	O
genetic	JJ	O
anticipation	NN	O
in	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
)	)	O
suggests	VBZ	O
a	DT	O
higher	JJR	O
rate	NN	O
of	IN	O
new	JJ	O
mutations	NNS	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
high	JJ	O
resolution	NN	O
genetic	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
locus	NN	O
using	VBG	O
PCR	NNP	O
based	VBN	O
assays	NNS	O
of	IN	O
nine	CD	O
polymorphisms	NNS	O
,	,	O
spanning	VBG	O
a	DT	O
physical	JJ	O
distance	NN	O
of	IN	O
30	CD	O
kb	NN	O
,	,	O
within	IN	O
and	CC	O
immediately	RB	O
flanking	VBG	O
the	DT	O
DM	NNP	S_Disease
kinase	NN	O
gene	NN	O
.	.	O

The	DT	O
persistent	JJ	O
complete	JJ	O
allelic	JJ	O
association	NN	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
mutation	NN	O
with	IN	O
all	PDT	O
these	DT	O
polymorphisms	NNS	O
provides	VBZ	O
further	JJ	O
support	NN	O
to	TO	O
previous	JJ	O
observations	NNS	O
and	CC	O
suggests	VBZ	O
more	RBR	O
strongly	RB	O
that	IN	O
the	DT	O
DM	NNP	S_Disease
mutation	NN	O
occurred	VBD	O
on	IN	O
the	DT	O
background	NN	O
of	IN	O
a	DT	O
particular	JJ	O
haplotype	NN	O
in	IN	O
which	WDT	O
the	DT	O
(	(	O
CTG	NNP	O
)	)	O
n	RB	O
repeat	NN	O
became	VBD	O
inherently	RB	O
unstable	JJ	O
and	CC	O
therefore	RB	O
predisposed	VBD	O
to	TO	O
amplification	NN	O
.	.	O

Genetic	JJ	O
instability	NN	O
in	IN	O
human	JJ	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
cell	NN	O
lines	NNS	O
.	.	O

We	PRP	O
have	VBP	O
analyzed	VBN	O
the	DT	O
stability	NN	O
of	IN	O
microsatellites	NNS	O
in	IN	O
cell	NN	O
lines	NNS	O
derived	VBN	O
from	IN	O
human	JJ	O
ovarian	JJ	B_Disease
cancers	NNS	E_Disease
and	CC	O
found	VBD	O
that	IN	O
5	CD	O
out	IN	O
of	IN	O
10	CD	O
of	IN	O
the	DT	O
ovarian	JJ	B_Disease
tumor	NN	E_Disease
cell	NN	O
lines	NNS	O
are	VBP	O
genetically	RB	O
unstable	JJ	O
at	IN	O
the	DT	O
majority	NN	O
of	IN	O
the	DT	O
loci	NN	O
analyzed	VBD	O
.	.	O

In	IN	O
clones	NNS	O
and	CC	O
subclones	NNS	O
derived	VBN	O
serially	RB	O
from	IN	O
one	CD	O
of	IN	O
these	DT	O
cell	NN	O
lines	NNS	O
(	(	O
2774	CD	O
;	:	O
serous	JJ	B_Disease
cystadenocarcinoma	NN	E_Disease
)	)	O
,	,	O
a	DT	O
very	RB	O
high	JJ	O
proportion	NN	O
of	IN	O
microsatellites	NNS	O
distributed	VBN	O
in	IN	O
many	JJ	O
different	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
genome	NN	O
change	VBP	O
their	PRP$	O
size	NN	O
in	IN	O
a	DT	O
mercurial	JJ	O
fashion	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
genomic	JJ	O
instability	NN	O
in	IN	O
ovarian	JJ	B_Disease
tumors	NNS	E_Disease
is	VBZ	O
a	DT	O
dynamic	JJ	O
and	CC	O
ongoing	JJ	O
process	NN	O
whose	WP$	O
high	JJ	O
frequency	NN	O
may	MD	O
have	VB	O
been	VBN	O
previously	RB	O
underestimated	VBN	O
by	IN	O
PCR	NNP	O
-	:	O
based	VBN	O
allelotyping	NN	O
of	IN	O
bulk	JJ	O
tumor	NN	S_Disease
tissue	NN	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
the	DT	O
source	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
instability	NN	O
in	IN	O
one	CD	O
ovarian	JJ	B_Disease
tumor	NN	E_Disease
as	IN	O
a	DT	O
point	NN	O
mutation	NN	O
(	(	O
R524P	NNP	O
)	)	O
in	IN	O
the	DT	O
human	JJ	O
mismatch	NN	O
-	:	O
repair	NN	O
gene	NN	O
MSH2	NNP	O
(	(	O
Salmonella	NNP	O
MutS	NNP	O
homologue	NN	O
)	)	O
,	,	O
which	WDT	O
has	VBZ	O
recently	RB	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
involved	VBN	O
in	IN	O
hereditary	JJ	B_Disease
nonpolyposis	NN	I_Disease
colorectal	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

Patient	JJ	O
2774	CD	O
was	VBD	O
a	DT	O
38	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
heterozygote	NN	O
,	,	O
and	CC	O
her	PRP$	O
normal	JJ	O
tissue	NN	O
carried	VBD	O
both	DT	O
mutant	JJ	O
and	CC	O
wild	JJ	O
-	:	O
type	NN	O
alleles	NNS	O
of	IN	O
the	DT	O
human	JJ	O
MSH2	NNP	O
gene	NN	O
.	.	O

However	RB	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
allele	NN	O
was	VBD	O
lost	VBN	O
at	IN	O
some	DT	O
point	NN	O
early	RB	O
during	IN	O
tumorigenesis	NN	O
so	RB	O
that	IN	O
DNA	NNP	O
isolated	VBD	O
either	CC	O
from	IN	O
the	DT	O
patients	NNS	O
ovarian	JJ	B_Disease
tumor	NN	E_Disease
or	CC	O
from	IN	O
the	DT	O
2774	CD	O
cell	NN	O
line	NN	O
carries	VBZ	O
only	RB	O
the	DT	O
mutant	JJ	O
allele	NN	O
of	IN	O
the	DT	O
human	JJ	O
MSH2	NNP	O
gene	NN	O
.	.	O

The	DT	O
genetic	JJ	O
instability	NN	O
observed	VBN	O
in	IN	O
the	DT	O
tumor	NN	S_Disease
and	CC	O
cell	NN	O
line	NN	O
DNA	NNP	O
,	,	O
together	RB	O
with	IN	O
the	DT	O
germ	JJ	O
-	:	O
line	NN	O
mutation	NN	O
in	IN	O
a	DT	O
mismatch	NN	O
-	:	O
repair	NN	O
gene	NN	O
,	,	O
suggest	VBP	O
that	IN	O
the	DT	O
MSH2	NNP	O
gene	NN	O
is	VBZ	O
involved	VBN	O
in	IN	O
the	DT	O
onset	NN	O
and	CC	O
/	NN	O
or	CC	O
progression	NN	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O
.	.	O

BRCA1	NNP	O
mutations	NNS	O
in	IN	O
primary	JJ	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
carcinomas	NN	E_Disease
.	.	O

Loss	NNP	O
of	IN	O
heterozygosity	NN	O
data	NNS	O
from	IN	O
familial	JJ	B_Disease
tumors	NNS	E_Disease
suggest	VBP	O
that	IN	O
BRCA1	NNP	O
,	,	O
a	DT	O
gene	NN	O
that	WDT	O
confers	VBZ	O
susceptibility	NN	O
to	TO	O
ovarian	JJ	B_Disease
and	CC	I_Disease
early	JJ	I_Disease
-	:	I_Disease
onset	NN	E_Disease
breast	NN	B_Disease
cancer	NN	E_Disease
,	,	O
encodes	VBZ	O
a	DT	O
tumor	NN	S_Disease
suppressor	NN	O
.	.	O

The	DT	O
BRCA1	NNP	O
region	NN	O
is	VBZ	O
also	RB	O
subject	JJ	O
to	TO	O
allelic	JJ	O
loss	NN	O
in	IN	O
sporadic	JJ	B_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
,	,	O
an	DT	O
indication	NN	O
that	IN	O
BRCA1	NNP	O
mutations	NNS	O
may	MD	O
occur	VB	O
somatically	RB	O
in	IN	O
these	DT	O
tumors	NNS	S_Disease
.	.	O

The	DT	O
BRCA1	NNP	O
coding	VBG	O
region	NN	O
was	VBD	O
examined	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
primary	JJ	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
tumors	NNS	E_Disease
that	WDT	O
show	VBP	O
allele	JJ	O
loss	NN	O
at	IN	O
the	DT	O
BRCA1	NNP	O
locus	NN	O
.	.	O

Mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
3	CD	O
of	IN	O
32	CD	O
breast	NN	O
and	CC	O
1	CD	O
of	IN	O
12	CD	O
ovarian	JJ	B_Disease
carcinomas	NN	E_Disease
;	:	O
all	DT	O
four	CD	O
mutations	NNS	O
were	VBD	O
germline	JJ	O
alterations	NNS	O
and	CC	O
occurred	VBD	O
in	IN	O
early	JJ	O
-	:	O
onset	NN	O
cancers	NNS	S_Disease
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
mutation	NN	O
of	IN	O
BRCA1	NNP	O
may	MD	O
not	RB	O
be	VB	O
critical	JJ	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
the	DT	O
majority	NN	O
of	IN	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancers	NNS	E_Disease
that	WDT	O
arise	VBP	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
mutant	JJ	O
germline	NN	O
allele	NN	O
.	.	O
.	.	O

PAX6	NNP	O
gene	NN	O
dosage	NN	O
effect	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
congenital	JJ	B_Disease
cataracts	NNS	E_Disease
,	,	O
aniridia	NN	S_Disease
,	,	O
anophthalmia	NN	S_Disease
and	CC	O
central	JJ	B_Disease
nervous	JJ	I_Disease
system	NN	I_Disease
defects	NNS	E_Disease
.	.	O

The	DT	O
human	JJ	O
eye	NN	O
malformation	NN	O
aniridia	JJ	S_Disease
results	NNS	O
from	IN	O
haploinsufficiency	NN	B_Disease
of	IN	I_Disease
PAX6	NNP	E_Disease
,	,	O
a	DT	O
paired	JJ	O
box	NN	O
DNA	NNP	O
-	:	O
binding	NN	O
protein	NN	O
.	.	O

To	TO	O
study	VB	O
this	DT	O
dosage	NN	O
effect	NN	O
,	,	O
we	PRP	O
characterized	VBD	O
two	CD	O
PAX6	NNP	O
mutations	NNS	O
in	IN	O
a	DT	O
family	NN	O
segregating	VBG	O
aniridia	NN	S_Disease
and	CC	O
a	DT	O
milder	NN	O
syndrome	NN	O
consisting	NN	O
of	IN	O
congenital	JJ	B_Disease
cataracts	NNS	E_Disease
and	CC	O
late	JJ	O
onset	NN	O
corneal	NN	B_Disease
dystrophy	NN	E_Disease
.	.	O

The	DT	O
nonsense	JJ	O
mutations	NNS	O
,	,	O
at	IN	O
codons	NNS	O
103	CD	O
and	CC	O
353	CD	O
,	,	O
truncate	NN	O
PAX6	NNP	O
within	IN	O
the	DT	O
N	NNP	O
-	:	O
terminal	NN	O
paired	VBN	O
and	CC	O
C	NNP	O
-	:	O
terminal	JJ	O
PST	NNP	O
domains	NNS	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
wild	JJ	O
-	:	O
type	NN	O
PST	NNP	O
domain	NN	O
activates	NNS	O
transcription	VBP	O
autonomously	RB	O
and	CC	O
the	DT	O
mutant	JJ	O
form	NN	O
has	VBZ	O
partial	JJ	O
activity	NN	O
.	.	O

A	DT	O
compound	NN	O
heterozygote	NN	O
had	VBD	O
severe	JJ	O
craniofacial	JJ	B_Disease
and	CC	I_Disease
central	JJ	I_Disease
nervous	JJ	I_Disease
system	NN	I_Disease
defects	NNS	E_Disease
and	CC	O
no	DT	B_Disease
eyes	NNS	E_Disease
.	.	O

The	DT	O
pattern	NN	O
of	IN	O
malformations	NNS	O
is	VBZ	O
similar	JJ	O
to	TO	O
that	DT	O
in	IN	O
homozygous	JJ	O
Sey	NNP	O
mice	NN	O
and	CC	O
suggests	VBZ	O
a	DT	O
critical	JJ	O
role	NN	O
for	IN	O
PAX6	NNP	O
in	IN	O
controlling	VBG	O
the	DT	O
migration	NN	O
and	CC	O
differentiation	NN	O
of	IN	O
specific	JJ	O
neuronal	JJ	O
progenitor	NN	O
cells	NNS	O
in	IN	O
the	DT	O
brain	NN	O
.	.	O
.	.	O

A	DT	O
physical	JJ	O
map	NN	O
and	CC	O
candidate	NN	O
genes	NNS	O
in	IN	O
the	DT	O
BRCA1	NNP	O
region	NN	O
on	IN	O
chromosome	NN	O
17q12	CD	O
-	:	O
21	CD	O
.	.	O

We	PRP	O
have	VBP	O
constructed	VBN	O
a	DT	O
physical	JJ	O
map	NN	O
of	IN	O
a	DT	O
4	CD	O
cM	JJ	O
region	NN	O
on	IN	O
chromosome	NN	O
17q12	CD	O
-	:	O
21	CD	O
that	WDT	O
contains	VBZ	O
the	DT	O
hereditary	JJ	B_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
gene	NN	O
BRCA1	NNP	O
.	.	O

The	DT	O
map	NN	O
comprises	VBZ	O
a	DT	O
contig	NN	O
of	IN	O
137	CD	O
overlapping	VBG	O
yeast	RB	O
artificial	JJ	O
chromosomes	NNS	O
and	CC	O
P1	NNP	O
clones	NNS	O
,	,	O
onto	IN	O
which	WDT	O
we	PRP	O
have	VBP	O
placed	VBN	O
112	CD	O
PCR	NNP	O
markers	NNS	O
.	.	O

We	PRP	O
have	VBP	O
localized	VBN	O
more	JJR	O
than	IN	O
20	CD	O
genes	NNS	O
on	IN	O
this	DT	O
map	NN	O
,	,	O
ten	NN	O
of	IN	O
which	WDT	O
had	VBD	O
not	RB	O
been	VBN	O
mapped	VBN	O
to	TO	O
the	DT	O
region	NN	O
previously	RB	O
,	,	O
and	CC	O
have	VBP	O
isolated	VBN	O
30	CD	O
cDNA	JJ	O
clones	NNS	O
representing	VBG	O
partial	JJ	O
sequences	NNS	O
of	IN	O
as	IN	O
yet	RB	O
unidentified	JJ	O
genes	NNS	O
.	.	O

Two	CD	O
genes	NNS	O
that	WDT	O
lie	VBP	O
within	IN	O
a	DT	O
narrow	JJ	O
region	NN	O
defined	VBN	O
by	IN	O
meiotic	JJ	O
breakpoints	NNS	O
in	IN	O
BRCA1	NNP	O
patients	NNS	O
have	VBP	O
been	VBN	O
sequenced	VBN	O
in	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
patients	NNS	O
without	IN	O
revealing	VBG	O
any	DT	O
deleterious	JJ	O
mutations	NNS	O
.	.	O

These	DT	O
new	JJ	O
reagents	NNS	O
should	MD	O
facilitate	VB	O
the	DT	O
identification	NN	O
of	IN	O
BRCA1	NNP	O
.	.	O
.	.	O

The	DT	O
LEC	NNP	O
rat	NN	O
has	VBZ	O
a	DT	O
deletion	NN	O
in	IN	O
the	DT	O
copper	NN	O
transporting	VBG	O
ATPase	NNP	O
gene	NN	O
homologous	JJ	O
to	TO	O
the	DT	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
.	.	O

The	DT	O
Long	NNP	O
-	:	O
Evans	NNS	O
Cinnamon	NNP	O
(	(	O
LEC	NNP	O
)	)	O
rat	NN	O
shows	VBZ	O
similarity	NN	O
to	TO	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
in	IN	O
many	JJ	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
features	NNS	O
.	.	O

We	PRP	O
have	VBP	O
cloned	VBN	O
cDNAs	NN	O
for	IN	O
the	DT	O
rat	NN	O
gene	NN	O
(	(	O
Atp7b	NNP	O
)	)	O
homologous	VBZ	O
to	TO	O
the	DT	O
human	JJ	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
(	(	O
ATP7B	NNP	O
)	)	O
and	CC	O
have	VBP	O
used	VBN	O
them	PRP	O
to	TO	O
identify	VB	O
a	DT	O
partial	JJ	O
deletion	NN	O
in	IN	O
the	DT	O
Atp7b	NNP	O
gene	NN	O
in	IN	O
the	DT	O
LEC	NNP	O
rat	NN	O
.	.	O

The	DT	O
deletion	NN	O
removes	VBZ	O
at	IN	O
least	JJS	O
900	CD	O
bp	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
at	IN	O
the	DT	O
3	CD	O
end	NN	O
,	,	O
includes	VBZ	O
the	DT	O
crucial	JJ	O
ATP	NNP	O
binding	NN	O
domain	NN	O
and	CC	O
extends	VBZ	O
downstream	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
provide	VBP	O
convincing	VBG	O
evidence	NN	O
for	IN	O
defining	VBG	O
the	DT	O
LEC	NNP	O
rat	NN	O
as	IN	O
an	DT	O
animal	JJ	O
model	NN	O
for	IN	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
.	.	O

This	DT	O
model	NN	O
will	MD	O
be	VB	O
important	JJ	O
for	IN	O
studying	VBG	O
liver	NN	O
pathophysiology	NN	O
,	,	O
for	IN	O
developing	VBG	O
therapy	NN	O
for	IN	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
and	CC	O
for	IN	O
studying	VBG	O
the	DT	O
pathway	NN	O
of	IN	O
copper	NN	O
transport	NN	O
and	CC	O
its	PRP$	O
possible	JJ	O
interaction	NN	O
with	IN	O
other	JJ	O
heavy	JJ	O
metals	NNS	O
.	.	O
.	.	O

Genomic	NNP	O
organization	NN	O
of	IN	O
the	DT	O
adrenoleukodystrophy	NN	S_Disease
gene	NN	O
.	.	O

Adrenoleukodystrophy	NNP	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
,	,	O
the	DT	O
most	RBS	O
frequent	JJ	O
peroxisomal	JJ	B_Disease
disorder	NN	E_Disease
,	,	O
is	VBZ	O
a	DT	O
severe	JJ	O
neurodegenerative	JJ	B_Disease
disease	NN	E_Disease
associated	VBN	O
with	IN	O
an	DT	O
impairment	NN	B_Disease
of	IN	I_Disease
very	RB	I_Disease
long	RB	I_Disease
chain	NN	I_Disease
fatty	JJ	I_Disease
acids	NNS	I_Disease
beta	SYM	I_Disease
-	:	I_Disease
oxidation	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
recently	RB	O
identified	VBN	O
by	IN	O
positional	JJ	O
cloning	VBG	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
ALD	NNP	S_Disease
,	,	O
located	VBN	O
in	IN	O
Xq28	NNP	O
.	.	O

It	PRP	O
encodes	VBZ	O
a	DT	O
new	JJ	O
member	NN	O
of	IN	O
the	DT	O
"	NNP	O
ABC	NNP	O
"	NNP	O
superfamily	RB	O
of	IN	O
membrane	NN	O
-	:	O
associated	VBN	O
transporters	NNS	O
that	WDT	O
shows	VBZ	O
,	,	O
in	IN	O
particular	JJ	O
,	,	O
significant	JJ	O
homology	NN	O
to	TO	O
the	DT	O
70	CD	O
-	:	O
kDa	NN	O
peroxisomal	JJ	O
membrane	NN	O
protein	NN	O
(	(	O
PMP70	NNP	O
)	)	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
a	DT	O
detailed	JJ	O
characterization	NN	O
of	IN	O
the	DT	O
ALD	NNP	S_Disease
gene	NN	O
structure	NN	O
.	.	O

It	PRP	O
extends	VBZ	O
over	IN	O
21	CD	O
kb	NNS	O
and	CC	O
consists	NNS	O
of	IN	O
10	CD	O
exons	NNS	O
.	.	O

To	TO	O
facilitate	VB	O
the	DT	O
detection	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
ALD	NNP	S_Disease
patients	NNS	O
,	,	O
we	PRP	O
have	VBP	O
determined	VBN	O
the	DT	O
intronic	JJ	O
sequences	NNS	O
flanking	VBG	O
the	DT	O
exons	NNS	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
sequence	NN	O
of	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
and	CC	O
of	IN	O
the	DT	O
immediate	JJ	O
5	CD	O
promoter	NN	O
region	NN	O
.	.	O

Sequences	NNS	O
present	JJ	O
in	IN	O
distal	JJ	O
exons	NNS	O
cross	VBP	O
-	:	O
hybridize	NN	O
strongly	RB	O
to	TO	O
additional	JJ	O
sequences	NNS	O
in	IN	O
the	DT	O
human	JJ	O
genome	NN	O
.	.	O

The	DT	O
ALD	NNP	S_Disease
gene	NN	O
has	VBZ	O
been	VBN	O
positioned	VBN	O
on	IN	O
a	DT	O
pulsed	JJ	O
-	:	O
field	NN	O
map	NN	O
between	IN	O
DXS15	NNP	O
and	CC	O
the	DT	O
L1CAM	NNP	O
gene	NN	O
,	,	O
about	RB	O
650	CD	O
kb	NNS	O
upstream	RB	O
from	IN	O
the	DT	O
color	NN	O
pigment	NN	O
genes	NNS	O
.	.	O

The	DT	O
frequent	JJ	O
occurrence	NN	O
of	IN	O
color	NN	O
vision	NN	O
anomalies	NNS	O
observed	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
adrenomyeloneuropathy	JJ	S_Disease
(	(	O
the	DT	O
adult	NN	O
onset	JJ	O
form	NN	O
of	IN	O
ALD	NNP	S_Disease
)	)	O
thus	RB	O
does	VBZ	O
not	RB	O
represent	VB	O
a	DT	O
contiguous	JJ	B_Disease
gene	NN	I_Disease
syndrome	NN	E_Disease
but	CC	O
a	DT	O
secondary	JJ	O
manifestation	NN	O
of	IN	O
ALD	NNP	S_Disease
.	.	O
.	.	O

The	DT	O
murine	NN	O
homologues	NNS	O
of	IN	O
the	DT	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
(	(	O
Hdh	NNP	O
)	)	O
and	CC	O
the	DT	O
alpha	JJ	O
-	:	O
adducin	NN	O
gene	NN	O
(	(	O
Add1	NNP	O
)	)	O
map	NN	O
to	TO	O
mouse	VB	O
chromosome	NN	O
5	CD	O
within	IN	O
a	DT	O
region	NN	O
of	IN	O
conserved	VBN	O
synteny	NN	O
with	IN	O
human	JJ	O
chromosome	NN	O
4p16	CD	O
.	.	O
3	CD	O
.	.	O

Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
severe	JJ	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
neurodegenerative	JJ	I_Disease
disorder	NN	E_Disease
associated	VBN	O
with	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
(	(	O
IT15	NNP	O
)	)	O
.	.	O

Recently	RB	O
,	,	O
we	PRP	O
reported	VBD	O
the	DT	O
cloning	NN	O
of	IN	O
Hdh	NNP	O
,	,	O
the	DT	O
murine	NN	O
homologue	NN	O
of	IN	O
IT15	NNP	O
.	.	O

Here	RB	O
,	,	O
using	VBG	O
an	DT	O
interspecific	JJ	O
backcross	NN	O
,	,	O
we	PRP	O
have	VBP	O
mapped	VBN	O
both	DT	O
Hdh	NNP	O
and	CC	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
human	JJ	O
alpha	SYM	O
-	:	O
adducin	NN	O
(	(	O
Add1	NNP	O
)	)	O
,	,	O
a	DT	O
membrane	NN	O
-	:	O
associated	VBN	O
cytoskeletal	JJ	O
protein	NN	O
gene	NN	O
.	.	O

Both	DT	O
of	IN	O
these	DT	O
genes	NNS	O
map	VBP	O
in	IN	O
the	DT	O
same	JJ	O
position	NN	O
on	IN	O
mouse	NN	O
chromosome	NN	O
5	CD	O
in	IN	O
a	DT	O
region	NN	O
associated	VBN	O
with	IN	O
ancestral	JJ	O
chromosomal	JJ	O
rearrangements	NNS	O
and	CC	O
show	VB	O
no	DT	O
recombination	NN	O
with	IN	O
D5H4S43	NNP	O
,	,	O
D5H4S115	NNP	O
,	,	O
and	CC	O
D5H4S62	NNP	O
,	,	O
the	DT	O
murine	NN	O
homologues	NNS	O
of	IN	O
D4S43	NNP	O
,	,	O
D4S115	NNP	O
,	,	O
and	CC	O
D4S62	NNP	O
,	,	O
respectively	RB	O
.	.	O

Further	RB	O
mapping	VBG	O
studies	NNS	O
of	IN	O
humans	NNS	O
,	,	O
mice	NN	O
,	,	O
and	CC	O
other	JJ	O
mammalian	JJ	O
species	NNS	O
should	MD	O
reveal	VB	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
rearrangements	NNS	O
affecting	VBG	O
this	DT	O
chromosomal	JJ	O
segment	NN	O
during	IN	O
mammalian	JJ	O
evolution	NN	O
.	.	O
.	.	O

Genetic	JJ	O
cholesteryl	NN	B_Disease
ester	NN	I_Disease
transfer	NN	I_Disease
protein	NN	I_Disease
deficiency	NN	E_Disease
caused	VBN	O
by	IN	O
two	CD	O
prevalent	JJ	O
mutations	NNS	O
as	IN	O
a	DT	O
major	JJ	O
determinant	NN	O
of	IN	O
increased	JJ	O
levels	NNS	O
of	IN	O
high	JJ	O
density	NN	O
lipoprotein	VBP	O
cholesterol	NN	O
.	.	O

Genetic	JJ	O
determinants	NNS	O
of	IN	O
HDL	NNP	O
cholesterol	NN	O
(	(	O
HDL	NNP	O
-	:	O
C	NNP	O
)	)	O
levels	NNS	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
are	VBP	O
poorly	RB	O
understood	JJ	O
.	.	O

We	PRP	O
previously	RB	O
described	VBD	O
plasma	JJ	O
cholesteryl	NN	B_Disease
ester	NN	I_Disease
transfer	NN	I_Disease
protein	NN	I_Disease
(	(	I_Disease
CETP	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
due	JJ	O
to	TO	O
an	DT	O
intron	NN	O
14	CD	O
G	NNP	O
(	(	O
+	NNP	O
1	CD	O
)	)	O
-	:	O
to	TO	O
-	:	O
A	DT	O
mutation	NN	O
(	(	O
Int14	NNP	O
A	NNP	O
)	)	O
in	IN	O
several	JJ	O
families	NNS	O
with	IN	O
very	RB	O
high	JJ	O
HDL	NNP	O
-	:	O
C	NN	O
levels	NNS	O
in	IN	O
Japan	NNP	O
.	.	O

Subjects	NNS	O
with	IN	O
HDL	NNP	O
-	:	O
C	NNP	O
>	NNP	O
or	CC	O
=	$	O
100	CD	O
mg	NN	O
/	NN	O
dl	NN	O
(	(	O
n	JJ	O
=	NNP	O
130	CD	O
)	)	O
were	VBD	O
screened	VBN	O
by	IN	O
PCR	NNP	O
single	JJ	O
strand	NN	O
conformational	JJ	O
polymorphism	NN	O
analysis	NN	O
of	IN	O
the	DT	O
CETP	NNP	O
gene	NN	O
.	.	O

Two	CD	O
other	JJ	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
by	IN	O
DNA	NNP	O
sequencing	VBG	O
or	CC	O
primer	JJ	O
-	:	O
mediated	VBN	O
restriction	NN	O
map	NN	O
modification	NN	O
of	IN	O
PCR	NNP	O
products	NNS	O
a	DT	O
novel	JJ	O
intron	NN	O
14	CD	O
splice	NN	O
donor	NN	O
site	NN	O
mutation	NN	O
caused	VBN	O
by	IN	O
a	DT	O
T	NNP	O
insertion	NN	O
at	IN	O
position	NN	O
+	FW	O
3	CD	O
from	IN	O
the	DT	O
exon14	NN	O
/	NNP	O
intron14	NN	O
boundary	NN	O
(	(	O
Int14	NNP	O
T	NNP	O
)	)	O
and	CC	O
a	DT	O
missense	JJ	O
mutation	NN	O
(	(	O
Asp442	NNP	O
to	TO	O
Gly	NNP	O
)	)	O
within	IN	O
exon	$	O
15	CD	O
(	(	O
D442G	NNP	O
)	)	O
.	.	O

The	DT	O
Int14	NNP	O
T	NNP	O
mutation	NN	O
was	VBD	O
only	RB	O
found	VBN	O
in	IN	O
one	CD	O
family	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
D442G	NNP	O
and	CC	O
Int14	NNP	O
A	NNP	O
mutations	NNS	O
were	VBD	O
highly	RB	O
prevalent	JJ	O
in	IN	O
subjects	NNS	O
with	IN	O
HDL	NNP	O
-	:	O
C	NNP	O
>	NNP	O
or	CC	O
=	$	O
60	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
,	,	O
with	IN	O
combined	VBN	O
allele	JJ	O
frequencies	NNS	O
of	IN	O
9	CD	O
%	NN	O
,	,	O
12	CD	O
%	NN	O
,	,	O
21	CD	O
%	NN	O
and	CC	O
43	CD	O
%	NN	O
for	IN	O
HDL	NNP	O
-	:	O
C	$	O
60	CD	O
-	:	O
79	CD	O
,	,	O
80	CD	O
-	:	O
99	CD	O
,	,	O
100	CD	O
-	:	O
119	CD	O
,	,	O
and	CC	O
>	NNP	O
or	CC	O
=	$	O
120	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
,	,	O
respectively	RB	O
.	.	O

Furthermore	RB	O
,	,	O
prevalences	NNS	O
of	IN	O
the	DT	O
D442G	NNP	O
and	CC	O
Int14	NNP	O
A	NNP	O
mutations	NNS	O
were	VBD	O
extremely	RB	O
high	JJ	O
in	IN	O
a	DT	O
general	JJ	O
sample	NN	O
of	IN	O
Japanese	JJ	O
men	NNS	O
(	(	O
n	JJ	O
=	NNP	O
236	CD	O
)	)	O
,	,	O
with	IN	O
heterozygote	JJ	O
frequencies	NNS	O
of	IN	O
7	CD	O
%	NN	O
and	CC	O
2	CD	O
%	NN	O
,	,	O
respectively	RB	O
.	.	O

These	DT	O
two	CD	O
mutations	NNS	O
accounted	VBD	O
for	IN	O
about	IN	O
10	CD	O
%	NN	O
of	IN	O
the	DT	O
total	JJ	O
variance	NN	O
of	IN	O
HDL	NNP	O
-	:	O
C	NN	O
in	IN	O
this	DT	O
population	NN	O
.	.	O

The	DT	O
phenotype	NN	O
in	IN	O
a	DT	O
genetic	JJ	O
compound	NN	O
heterozygote	NN	O
(	(	O
Int14	NNP	O
T	NNP	O
and	CC	O
Int14	NNP	O
A	NNP	O
)	)	O
was	VBD	O
similar	JJ	O
to	TO	O
that	DT	O
of	IN	O
Int14	NNP	O
A	NNP	O
homozygotes	NNS	O
(	(	O
no	DT	O
detectable	JJ	O
CETP	NNP	O
and	CC	O
markedly	RB	O
increased	VBD	O
HDL	NNP	O
-	:	O
C	NNP	O
)	)	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
Int14	NNP	O
T	NNP	O
produces	VBZ	O
a	DT	O
null	JJ	O
allele	NN	O
.	.	O

In	IN	O
four	CD	O
D442G	NNP	O
homozygotes	NNS	O
,	,	O
mean	VBP	O
HDL	NNP	O
-	:	O
C	NN	O
levels	NNS	O
(	(	O
86	CD	O
+	NN	O
/	NNP	O
-	:	O
26	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
)	)	O
were	VBD	O
lower	JJR	O
than	IN	O
in	IN	O
Int14	NNP	O
A	NNP	O
homozygotes	VBZ	O
(	(	O
158	CD	O
+	NN	O
/	NNP	O
-	:	O
35	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
)	)	O
,	,	O
reflecting	VBG	O
residual	JJ	O
CETP	NNP	O
activity	NN	O
in	IN	O
plasma	NN	O
.	.	O

In	IN	O
47	CD	O
D442G	NNP	O
heterozygotes	NNS	O
,	,	O
mean	VBP	O
HDL	NNP	O
-	:	O
C	NN	O
levels	NNS	O
were	VBD	O
91	CD	O
+	NNP	O
/	NNP	O
-	:	O
23	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
,	,	O
similar	JJ	O
to	TO	O
the	DT	O
level	NN	O
in	IN	O
D442G	NNP	O
homozygotes	NNS	O
,	,	O
and	CC	O
significantly	RB	O
greater	JJR	O
than	IN	O
mean	VB	O
HDL	NNP	O
-	:	O
C	NN	O
levels	NNS	O
in	IN	O
Int14	NNP	O
A	NNP	O
heterozygotes	VBZ	O
(	(	O
69	CD	O
+	NN	O
/	NNP	O
-	:	O
15	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
)	)	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
D442G	NNP	O
mutation	NN	O
acts	VBZ	O
differently	RB	O
to	TO	O
the	DT	O
null	JJ	O
mutations	NNS	O
with	IN	O
weaker	JJR	O
effects	NNS	O
on	IN	O
HDL	NNP	O
in	IN	O
the	DT	O
homozygous	JJ	O
state	NN	O
and	CC	O
stronger	JJR	O
effects	NNS	O
in	IN	O
the	DT	O
heterozygotes	NNS	O
,	,	O
suggesting	VBG	O
dominant	JJ	O
expression	NN	O
of	IN	O
a	DT	O
partially	RB	O
defective	JJ	O
allele	NNS	O
.	.	O

CETP	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
reflecting	VBG	O
two	CD	O
prevalent	JJ	O
mutations	NNS	O
(	(	O
D442G	NNP	O
and	CC	O
Int14	NNP	O
A	NNP	O
)	)	O
,	,	O
is	VBZ	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
a	DT	O
genetic	JJ	B_Disease
deficiency	NN	E_Disease
state	NN	O
which	WDT	O
is	VBZ	O
sufficiently	RB	O
common	JJ	O
to	TO	O
explain	VB	O
a	DT	O
significant	JJ	O
fraction	NN	O
of	IN	O
the	DT	O
variation	NN	O
in	IN	O
HDL	NNP	O
-	:	O
C	NN	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O
.	.	O

Treatment	NN	O
of	IN	O
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
:	:	O
effects	NNS	O
of	IN	O
chenodeoxycholic	JJ	O
acid	NN	O
,	,	O
pravastatin	NN	O
,	,	O
and	CC	O
combined	VBN	O
use	NN	O
.	.	O

Treatments	NNS	O
by	IN	O
oral	JJ	O
administration	NN	O
of	IN	O
chenodeoxycholic	JJ	O
acid	NN	O
(	(	O
CDCA	NNP	O
)	)	O
alone	RB	O
,	,	O
3	CD	O
-	:	O
hydroxy	NN	O
-	:	O
3	CD	O
-	:	O
methylglutaryl	NN	O
(	(	O
HMG	NNP	O
)	)	O
CoA	NNP	O
reductase	NN	O
inhibitor	NN	O
(	(	O
pravastatin	NN	O
)	)	O
alone	RB	O
,	,	O
and	CC	O
combination	NN	O
of	IN	O
the	DT	O
two	CD	O
drugs	NNS	O
were	VBD	O
attempted	VBN	O
for	IN	O
7	CD	O
patients	NNS	O
with	IN	O
cerebrotendinous	JJ	B_Disease
xanthomatosis	NN	E_Disease
(	(	O
CTX	NNP	S_Disease
)	)	O
.	.	O

CDCA	NNP	O
treatment	NN	O
at	IN	O
a	DT	O
dose	NN	O
of	IN	O
300	CD	O
mg	NNS	O
/	JJ	O
day	NN	O
reduced	VBD	O
serum	JJ	O
cholestanol	NN	O
(	(	O
67	CD	O
.	.	O

3	CD	O
%	NN	O
reduction	NN	O
)	)	O
,	,	O
lathosterol	NN	O
(	(	O
50	CD	O
.	.	O

8	CD	O
%	NN	O
)	)	O
,	,	O
campesterol	NN	O
(	(	O
61	CD	O
.	.	O

7	CD	O
%	NN	O
)	)	O
and	CC	O
sitosterol	NN	O
(	(	O
12	CD	O
.	.	O

7	CD	O
%	NN	O
)	)	O
.	.	O

However	RB	O
,	,	O
the	DT	O
sera	NN	O
of	IN	O
the	DT	O
patients	NNS	O
changed	VBD	O
to	TO	O
be	VB	O
"	JJ	O
atherogenic	JJ	O
"	NN	O
;	:	O
total	JJ	O
cholesterol	NN	O
,	,	O
triglyceride	RB	O
and	CC	O
low	JJ	O
-	:	O
density	NN	O
lipoprotein	NN	O
(	(	O
LDL	NNP	O
)	)	O
-	:	O
cholesterol	NN	O
were	VBD	O
increased	VBN	O
,	,	O
while	IN	O
high	JJ	O
-	:	O
density	NN	O
lipoprotein	NN	O
(	(	O
HDL	NNP	O
)	)	O
-	:	O
cholesterol	NN	O
was	VBD	O
decreased	VBN	O
.	.	O

Contrarily	RB	O
,	,	O
pravastatin	NN	O
at	IN	O
a	DT	O
dose	NN	O
of	IN	O
10	CD	O
mg	NNS	O
/	JJ	O
day	NN	O
improved	VBD	O
the	DT	O
sera	NN	O
of	IN	O
the	DT	O
patients	NNS	O
to	TO	O
be	VB	O
markedly	RB	O
"	JJ	O
anti	SYM	O
-	:	O
atherogenic	JJ	O
"	NN	O
,	,	O
but	CC	O
the	DT	O
reductions	NNS	O
of	IN	O
cholestanol	NN	O
(	(	O
30	CD	O
.	.	O

4	CD	O
%	NN	O
)	)	O
,	,	O
lathosterol	NN	O
(	(	O
44	CD	O
.	.	O

0	CD	O
%	NN	O
)	)	O
,	,	O
campesterol	NN	O
(	(	O
22	CD	O
.	.	O

9	CD	O
%	NN	O
)	)	O
and	CC	O
sitosterol	NN	O
(	(	O
9	CD	O
.	.	O

6	CD	O
%	NN	O
)	)	O
were	VBD	O
inadequate	JJ	O
.	.	O

Combined	VBN	O
treatment	NN	O
with	IN	O
CDCA	NNP	O
and	CC	O
pravastatin	NN	O
showed	VBD	O
good	JJ	O
overlapping	NN	O
of	IN	O
the	DT	O
effects	NNS	O
of	IN	O
each	DT	O
drug	NN	O
alone	RB	O
.	.	O

The	DT	O
sera	NN	O
of	IN	O
the	DT	O
patients	NNS	O
were	VBD	O
apparently	RB	O
more	RBR	O
"	JJ	O
anti	JJ	O
-	:	O
atherogenic	NN	O
"	NN	O
than	IN	O
those	DT	O
after	IN	O
CDCA	NNP	O
treatment	NN	O
.	.	O

Serum	NNP	O
cholestanol	NN	O
concentration	NN	O
was	VBD	O
still	RB	O
2	CD	O
.	.	O

7	CD	O
times	NNS	O
higher	JJR	O
than	IN	O
in	IN	O
controls	NNS	O
,	,	O
but	CC	O
the	DT	O
serum	NN	O
lathosterol	NN	O
level	NN	O
was	VBD	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
enhancement	NN	O
of	IN	O
overall	JJ	O
cholesterol	NN	O
synthesis	NN	O
in	IN	O
the	DT	O
patients	NNS	O
was	VBD	O
sufficiently	RB	O
suppressed	VBN	O
.	.	O

Plant	NNP	O
sterol	NN	O
levels	NNS	O
were	VBD	O
also	RB	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
.	.	O

The	DT	O
combination	NN	O
of	IN	O
CDCA	NNP	O
and	CC	O
pravastatin	NN	O
was	VBD	O
a	DT	O
good	JJ	O
treatment	NN	O
for	IN	O
CTX	NNP	S_Disease
,	,	O
based	VBN	O
on	IN	O
the	DT	O
improvement	NN	O
of	IN	O
serum	NN	O
lipoprotein	NN	O
metabolism	NN	O
,	,	O
the	DT	O
suppression	NN	O
of	IN	O
cholesterol	NN	O
synthesis	NN	O
,	,	O
and	CC	O
reductions	NNS	O
of	IN	O
cholestanol	NN	O
and	CC	O
plant	NN	O
sterol	NN	O
levels	NNS	O
.	.	O

In	IN	O
all	DT	O
of	IN	O
7	CD	O
patients	NNS	O
,	,	O
the	DT	O
progression	NN	O
of	IN	O
disease	NN	O
was	VBD	O
arrested	VBN	O
,	,	O
but	CC	O
dramatic	JJ	O
effects	NNS	O
on	IN	O
clinical	JJ	O
manifestations	NNS	O
,	,	O
xanthoma	NNP	S_Disease
,	,	O
and	CC	O
electrophysiological	JJ	O
findings	NNS	O
could	MD	O
not	RB	O
be	VB	O
found	VBN	O
after	IN	O
the	DT	O
treatment	NN	O
of	IN	O
these	DT	O
drugs	NNS	O

Mutation	NNP	O
spectrum	NN	O
in	IN	O
the	DT	O
CHM	NNP	S_Disease
gene	NN	O
of	IN	O
Danish	NNP	O
and	CC	O
Swedish	NNP	O
choroideremia	NN	S_Disease
patients	NNS	O
.	.	O

The	DT	O
recent	JJ	O
isolation	NN	O
of	IN	O
the	DT	O
complete	JJ	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
the	DT	O
choroideremia	NN	S_Disease
(	(	O
CHM	NNP	S_Disease
)	)	O
gene	NN	O
and	CC	O
the	DT	O
characterization	NN	O
of	IN	O
the	DT	O
exon	JJ	O
-	:	O
intron	NN	O
boundaries	NNS	O
has	VBZ	O
paved	VBN	O
the	DT	O
way	NN	O
to	TO	O
mutation	VB	O
detection	NN	O
in	IN	O
patients	NNS	O
with	IN	O
classical	JJ	O
choroideremia	NN	S_Disease
.	.	O

We	PRP	O
have	VBP	O
performed	VBN	O
mutation	NN	O
screening	VBG	O
in	IN	O
patients	NNS	O
from	IN	O
15	CD	O
Danish	JJ	O
and	CC	O
Swedish	JJ	O
families	NNS	O
by	IN	O
using	VBG	O
Southern	NNP	O
blot	NN	O
hybridization	NN	O
and	CC	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
PCR	NNP	O
-	:	O
SSCP	NN	O
)	)	O
technique	NN	O
.	.	O

Causative	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
CHM	NNP	S_Disease
gene	NN	O
were	VBD	O
detected	VBN	O
in	IN	O
at	IN	O
least	JJS	O
12	CD	O
families	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
a	DT	O
substantial	JJ	O
part	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
can	MD	O
be	VB	O
identified	VBN	O
by	IN	O
this	DT	O
approach	NN	O
.	.	O

In	IN	O
four	CD	O
of	IN	O
these	DT	O
families	NNS	O
deletions	NNS	O
of	IN	O
different	JJ	O
sizes	NNS	O
were	VBD	O
found	VBN	O
.	.	O

Thus	RB	O
,	,	O
in	IN	O
one	CD	O
patient	NN	O
,	,	O
the	DT	O
deletion	NN	O
resulted	VBD	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
only	RB	O
one	CD	O
exon	NN	O
,	,	O
while	IN	O
in	IN	O
another	DT	O
the	DT	O
deletion	NN	O
comprised	VBD	O
the	DT	O
entire	JJ	O
CHM	NNP	S_Disease
gene	NN	O
.	.	O

Mapping	NN	O
of	IN	O
the	DT	O
deletion	NN	O
endpoints	NNS	O
in	IN	O
these	DT	O
four	CD	O
patients	NNS	O
and	CC	O
in	IN	O
another	DT	O
11	CD	O
male	NN	O
patients	NNS	O
with	IN	O
sizeable	JJ	O
deletions	NNS	O
enabled	VBD	O
us	PRP	O
to	TO	O
construct	VB	O
a	DT	O
very	RB	O
detailed	JJ	O
map	NN	O
of	IN	O
intervals	NNS	O
2	CD	O
and	CC	O
3	CD	O
of	IN	O
Xq21	NN	O
.	.	O

In	IN	O
the	DT	O
remaining	VBG	O
11	CD	O
Danish	JJ	O
and	CC	O
Swedish	JJ	O
families	NNS	O
at	IN	O
least	JJS	O
8	CD	O
causative	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
by	IN	O
PCR	NNP	O
-	:	O
SSCP	NN	O
analysis	NN	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

Interestingly	RB	O
,	,	O
all	DT	O
CHM	NNP	S_Disease
gene	NN	O
mutations	NNS	O
detected	VBD	O
thus	RB	O
far	RB	O
in	IN	O
choroideremia	JJ	S_Disease
patients	NNS	O
give	VBP	O
rise	NN	O
to	TO	O
the	DT	O
introduction	NN	O
of	IN	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
.	.	O
.	.	O

Predominance	NN	O
of	IN	O
the	DT	O
adrenomyeloneuropathy	JJ	S_Disease
phenotype	NN	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
adrenoleukodystrophy	NN	E_Disease
in	IN	O
The	DT	O
Netherlands	NNPS	O
:	:	O
a	DT	O
survey	NN	O
of	IN	O
30	CD	O
kindreds	NNS	O
.	.	O

X	LS	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	NN	E_Disease
(	(	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
)	)	O
is	VBZ	O
an	DT	O
inherited	JJ	B_Disease
disorder	NN	E_Disease
of	IN	O
peroxisomal	JJ	O
beta	NN	O
-	:	O
oxidation	NN	O
associated	VBN	O
with	IN	O
accumulation	NN	O
of	IN	O
saturated	JJ	O
very	RB	O
long	RB	O
-	:	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
,	,	O
which	WDT	O
results	NNS	O
in	IN	O
central	JJ	O
and	CC	O
peripheral	JJ	O
demyelination	NN	S_Disease
and	CC	O
in	IN	O
impaired	JJ	B_Disease
function	NN	I_Disease
of	IN	I_Disease
adrenal	JJ	I_Disease
cortex	NN	I_Disease
and	CC	I_Disease
testes	NNS	E_Disease
.	.	O

The	DT	O
phenotypic	NN	O
expression	NN	O
is	VBZ	O
highly	RB	O
variable	JJ	O
,	,	O
childhood	JJ	B_Disease
cerebral	JJ	I_Disease
ALD	NNP	E_Disease
(	(	O
CCALD	NNP	S_Disease
)	)	O
and	CC	O
adrenomyeloneuropathy	JJ	S_Disease
(	(	O
AMN	NNP	S_Disease
)	)	O
being	VBG	O
the	DT	O
main	JJ	O
variants	NNS	O
.	.	O

We	PRP	O
explored	VBD	O
the	DT	O
30	CD	O
Dutch	NNP	O
kindreds	NNS	O
well	RB	O
known	VBN	O
to	TO	O
the	DT	O
Dutch	NNP	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
/	NNP	O
AMN	NNP	S_Disease
Study	NNP	O
Group	NNP	O
and	CC	O
phenotyped	VBD	O
77	CD	O
male	NN	O
patients	NNS	O
35	CD	O
(	(	O
46	CD	O
%	NN	O
)	)	O
had	VBD	O
AMN	NNP	S_Disease
and	CC	O
24	CD	O
(	(	O
31	CD	O
%	NN	O
)	)	O
CCALD	NNP	S_Disease
or	CC	O
adolescent	JJ	B_Disease
cerebral	JJ	I_Disease
ALD	NNP	E_Disease
(	(	O
AdolCALD	NNP	S_Disease
)	)	O
.	.	O

These	DT	O
percentages	NNS	O
differ	VBP	O
significantly	RB	O
from	IN	O
previous	JJ	O
reports	NNS	O
,	,	O
in	IN	O
which	WDT	O
25	CD	O
to	TO	O
28	CD	O
%	NN	O
of	IN	O
the	DT	O
patients	NNS	O
developed	VBD	O
AMN	NNP	S_Disease
and	CC	O
53	CD	O
to	TO	O
57	CD	O
%	NN	O
CCALD	NNP	S_Disease
or	CC	O
AdolCALD	NNP	S_Disease
.	.	O

Our	PRP$	O
findings	NNS	O
indicate	VBP	O
that	IN	O
-	:	O
-	:	O
at	IN	O
least	JJS	O
in	IN	O
the	DT	O
Netherlands	NNP	O
-	:	O
-	:	O
AMN	NN	S_Disease
may	MD	O
be	VB	O
the	DT	O
most	RBS	O
frequent	JJ	O
phenotype	NN	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
ALD	NNP	E_Disease
.	.	O
.	.	O

Adrenoleukodystrophy	NNP	S_Disease
gene	NN	O
encodes	VBZ	O
an	DT	O
80	CD	O
kDa	NN	O
membrane	NN	O
protein	NN	O
.	.	O

An	DT	O
antibody	NN	O
against	IN	O
the	DT	O
synthetic	JJ	O
C	NNP	O
-	:	O
terminal	JJ	O
peptides	NNS	O
deduced	VBN	O
from	IN	O
the	DT	O
cDNA	NN	O
of	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	NN	E_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
was	VBD	O
produced	VBN	O
to	TO	O
characterize	VB	O
the	DT	O
product	NN	O
of	IN	O
the	DT	O
ALD	NNP	S_Disease
gene	NN	O
.	.	O

The	DT	O
antibody	NN	O
reacted	VBD	O
with	IN	O
the	DT	O
80	CD	O
kDa	NNS	O
band	VBP	O
protein	RB	O
in	IN	O
control	NN	O
fibroblasts	NNS	O
,	,	O
while	IN	O
no	DT	O
bands	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
fibroblasts	NNS	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
ALD	NNP	S_Disease
(	(	O
#	#	O
163	CD	O
)	)	O
,	,	O
in	IN	O
which	WDT	O
mRNA	NN	O
of	IN	O
the	DT	O
ALD	NNP	S_Disease
gene	NN	O
was	VBD	O
undetectable	JJ	O
based	VBN	O
on	IN	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
.	.	O

The	DT	O
293T	CD	O
cells	NNS	O
transfected	VBN	O
with	IN	O
the	DT	O
full	JJ	O
-	:	O
coding	VBG	O
cDNA	NN	O
inserted	VBN	O
in	IN	O
the	DT	O
expression	NN	O
vector	NN	O
produced	VBD	O
a	DT	O
new	JJ	O
80	CD	O
kDa	NN	O
protein	NN	O
,	,	O
as	IN	O
detected	VBN	O
by	IN	O
Western	JJ	O
blot	NN	O
.	.	O

In	IN	O
an	DT	O
immunocytological	JJ	O
study	NN	O
,	,	O
the	DT	O
staining	NN	O
was	VBD	O
in	IN	O
a	DT	O
punctate	NN	O
pattern	NN	O
,	,	O
in	IN	O
the	DT	O
normal	JJ	O
fibroblasts	NNS	O
.	.	O

However	RB	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
punctate	NN	O
staining	NN	O
in	IN	O
the	DT	O
#	#	O
163	CD	O
cells	NNS	O
.	.	O

These	DT	O
data	NNS	O
thus	RB	O
indicate	VBP	O
that	IN	O
the	DT	O
ALD	NNP	S_Disease
gene	NN	O
encodes	VBZ	O
an	DT	O
80	CD	O
kDa	NN	O
membrane	NN	O
protein	NN	O
.	.	O
.	.	O

Isolation	NN	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
McLeod	NNP	B_Disease
syndrome	NN	E_Disease
that	WDT	O
encodes	VBZ	O
a	DT	O
novel	JJ	O
membrane	NN	O
transport	NN	O
protein	NN	O
.	.	O

McLeod	NNP	B_Disease
syndrome	NN	E_Disease
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
multisystem	NN	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
abnormalities	NNS	O
in	IN	O
the	DT	O
neuromuscular	JJ	O
and	CC	O
hematopoietic	JJ	O
systems	NNS	O
.	.	O

We	PRP	O
have	VBP	O
assembled	VBN	O
a	DT	O
cosmid	JJ	O
contig	NN	O
of	IN	O
360	CD	O
kb	NNS	O
that	WDT	O
encompasses	VBZ	O
the	DT	O
McLeod	NNP	S_Disease
gene	NN	O
locus	NN	O
.	.	O

A	DT	O
50	CD	O
kb	NN	O
deletion	NN	O
was	VBD	O
detected	VBN	O
by	IN	O
screening	VBG	O
DNA	NN	O
from	IN	O
patients	NNS	O
with	IN	O
radiolabeled	JJ	O
whole	JJ	O
cosmids	NNS	O
,	,	O
and	CC	O
two	CD	O
transcription	NN	O
units	NNS	O
were	VBD	O
identified	VBN	O
within	IN	O
this	DT	O
deletion	NN	O
.	.	O

The	DT	O
mRNA	JJ	O
expression	NN	O
pattern	NN	O
of	IN	O
one	CD	O
of	IN	O
them	PRP	O
,	,	O
designated	VBN	O
as	IN	O
XK	NNP	O
,	,	O
correlates	VBZ	O
closely	RB	O
to	TO	O
the	DT	O
McLeod	NNP	S_Disease
phenotype	NN	O
.	.	O

XK	NNP	O
encodes	VBZ	O
a	DT	O
novel	JJ	O
protein	NN	O
with	IN	O
structural	JJ	O
characteristics	NNS	O
of	IN	O
prokaryotic	JJ	O
and	CC	O
eukaryotic	JJ	O
membrane	NN	O
transport	NN	O
proteins	NNS	O
.	.	O

Nucleotide	NNP	O
sequence	NN	O
analysis	NN	O
of	IN	O
XK	NN	O
from	IN	O
two	CD	O
unrelated	JJ	O
McLeod	NNP	S_Disease
patients	NNS	O
has	VBZ	O
identified	VBN	O
point	NN	O
mutations	NNS	O
at	IN	O
conserved	JJ	O
splice	NN	O
donor	NN	O
and	CC	O
acceptor	NN	O
sites	NNS	O
.	.	O

These	DT	O
findings	NNS	O
provide	VBP	O
direct	JJ	O
evidence	NN	O
that	IN	O
XK	NNP	O
is	VBZ	O
responsible	JJ	O
for	IN	O
McLeod	NNP	B_Disease
syndrome	NN	E_Disease
.	.	O
.	.	O

X	LS	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
spastic	JJ	I_Disease
paraplegia	NN	E_Disease
and	CC	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
are	VBP	O
allelic	JJ	B_Disease
disorders	NNS	E_Disease
at	IN	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
locus	NN	O
.	.	O

Three	CD	O
forms	NNS	O
of	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
spastic	JJ	I_Disease
paraplegia	NN	E_Disease
(	(	O
SPG	NNP	S_Disease
)	)	O
have	VBP	O
been	VBN	O
defined	VBN	O
.	.	O

One	CD	O
locus	NN	O
(	(	O
SPG	NNP	O
1	CD	O
)	)	O
maps	NNS	O
to	TO	O
Xq28	VB	O
while	IN	O
two	CD	O
clinically	RB	O
distinct	JJ	O
forms	NNS	O
map	VBP	O
to	TO	O
Xq22	NNP	O
(	(	O
SPG2	NNP	O
)	)	O
.	.	O

A	DT	O
rare	JJ	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
dysmyelinating	VBG	I_Disease
disorder	NN	E_Disease
of	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
Pelizaeus	NNP	B_Disease
-	:	I_Disease
Merzbacher	PRP$	I_Disease
disease	NN	E_Disease
(	(	O
PMD	NNP	S_Disease
)	)	O
,	,	O
has	VBZ	O
also	RB	O
been	VBN	O
mapped	VBN	O
to	TO	O
Xq21	VB	O
-	:	O
q22	NN	O
,	,	O
and	CC	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
proteolipid	JJ	O
protein	NN	O
gene	NN	O
(	(	O
PLP	NNP	O
)	)	O
which	WDT	O
encodes	VBZ	O
two	CD	O
myelin	NN	O
proteins	NNS	O
,	,	O
PLP	NNP	O
and	CC	O
DM20	NNP	O
.	.	O

While	IN	O
narrowing	VBG	O
the	DT	O
genetic	JJ	O
interval	NN	O
containing	VBG	O
SPG2	NNP	O
in	IN	O
a	DT	O
large	JJ	O
pedigree	NN	O
,	,	O
we	PRP	O
found	VBD	O
that	IN	O
PLP	NNP	O
was	VBD	O
the	DT	O
closest	JJS	O
marker	NN	O
to	TO	O
the	DT	O
disease	NN	O
locus	NN	O
,	,	O
implicating	VBG	O
PLP	NNP	O
as	IN	O
a	DT	O
possible	JJ	O
candidate	NN	O
gene	NN	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
a	DT	O
point	NN	O
mutation	NN	O
(	(	O
His139Tyr	NNP	O
)	)	O
in	IN	O
exon	$	O
3B	CD	O
of	IN	O
an	DT	O
affected	JJ	O
male	NN	O
produces	VBZ	O
a	DT	O
mutant	JJ	O
PLP	NNP	O
but	CC	O
a	DT	O
normal	JJ	O
DM20	NNP	O
,	,	O
and	CC	O
segregates	VBZ	O
with	IN	O
the	DT	O
disease	NN	O
(	(	O
Zmax	NNP	O
=	VBZ	O
6	CD	O
.	.	O

63	CD	O
,	,	O
theta	NN	O
=	VBD	O
0	CD	O
.	.	O

00	CD	O
)	)	O
.	.	O

It	PRP	O
appears	VBZ	O
,	,	O
therefore	RB	O
,	,	O
that	IN	O
SPG2	NNP	O
and	CC	O
PMD	NNP	S_Disease
are	VBP	O
allelic	JJ	B_Disease
disorders	NNS	E_Disease

Canavan	NNP	B_Disease
disease	NN	E_Disease
:	:	O
mutations	NNS	O
among	IN	O
Jewish	JJ	O
and	CC	O
non	JJ	O
-	:	O
Jewish	JJ	O
patients	NNS	O
.	.	O

Canavan	NNP	B_Disease
disease	NN	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	NN	I_Disease
leukodystrophy	NN	E_Disease
caused	VBN	O
by	IN	O
the	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
aspartoacylase	NN	E_Disease
(	(	O
ASPA	NNP	O
)	)	O
.	.	O

Sixty	NNP	O
-	:	O
four	CD	O
probands	NNS	O
were	VBD	O
analyzed	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ASPA	NNP	O
gene	NN	O
.	.	O

Three	CD	O
point	NN	O
mutations	NNS	O
-	:	O
-	:	O
693C	CD	O
-	:	O
-	:	O
>	NN	O
A	NNP	O
,	,	O
854A	CD	O
-	:	O
-	:	O
>	NN	O
C	NNP	O
,	,	O
and	CC	O
914C	CD	O
-	:	O
-	:	O
>	NN	O
A	DT	O
-	:	O
-	:	O
were	VBD	O
identified	VBN	O
in	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
.	.	O

The	DT	O
693C	CD	O
-	:	O
-	:	O
>	VB	O
A	DT	O
and	CC	O
914C	CD	O
-	:	O
-	:	O
>	VB	O
A	DT	O
base	NN	O
changes	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
nonsense	NN	O
tyr231	NN	O
-	:	O
-	:	O
>	NN	O
ter	NN	O
and	CC	O
missense	NN	O
ala305	NN	O
-	:	O
-	:	O
>	NN	O
glu	NN	O
mutations	NNS	O
,	,	O
respectively	RB	O
,	,	O
lead	JJ	O
to	TO	O
complete	JJ	O
loss	NN	O
of	IN	O
ASPA	NNP	O
activity	NN	O
in	IN	O
in	IN	O
vitro	JJ	O
expression	NN	O
studies	NNS	O
.	.	O

The	DT	O
854A	CD	O
-	:	O
-	:	O
>	NN	O
C	NNP	O
transversion	NN	O
converted	VBD	O
glu	NN	O
to	TO	O
ala	VB	O
in	IN	O
codon	JJ	O
285	CD	O
.	.	O

The	DT	O
glu285	NN	O
-	:	O
-	:	O
>	NN	O
ala	NN	O
mutant	NN	O
ASPA	NNP	O
has	VBZ	O
2	CD	O
.	.	O

5	CD	O
%	NN	O
of	IN	O
the	DT	O
activity	NN	O
expressed	VBN	O
by	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
enzyme	NN	O
.	.	O

A	DT	O
fourth	JJ	O
mutation	NN	O
,	,	O
433	CD	O
-	:	O
-	:	O
2	CD	O
(	(	O
A	DT	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
)	)	O
transition	NN	O
,	,	O
was	VBD	O
identified	VBN	O
at	IN	O
the	DT	O
splice	NN	O
-	:	O
acceptor	NN	O
site	NN	O
in	IN	O
intron	NN	O
2	CD	O
.	.	O

The	DT	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
would	MD	O
lead	VB	O
to	TO	O
skipping	VBG	O
of	IN	O
exon	JJ	O
3	CD	O
,	,	O
accompanied	VBN	O
by	IN	O
a	DT	O
frameshift	NN	O
,	,	O
and	CC	O
thus	RB	O
would	MD	O
produce	VB	O
aberrant	JJ	O
ASPA	NNP	O
.	.	O

Of	IN	O
the	DT	O
128	CD	O
unrelated	JJ	O
Canavan	NNP	S_Disease
chromosomes	NNS	O
analyzed	VBD	O
,	,	O
88	CD	O
were	VBD	O
from	IN	O
probands	NNS	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
descent	NN	O
.	.	O

The	DT	O
glu285	NN	O
-	:	O
-	:	O
>	NN	O
ala	JJ	O
mutation	NN	O
was	VBD	O
predominant	JJ	O
(	(	O
82	CD	O
.	.	O

9	CD	O
%	NN	O
)	)	O
in	IN	O
this	DT	O
population	NN	O
,	,	O
followed	VBN	O
by	IN	O
the	DT	O
tyr231	NN	O
-	:	O
-	:	O
>	NN	O
ter	NN	O
(	(	O
14	CD	O
.	.	O

8	CD	O
%	NN	O
)	)	O
and	CC	O
433	CD	O
-	:	O
-	:	O
2	CD	O
(	(	O
A	DT	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
)	)	O
(	(	O
1	CD	O
.	.	O

1	CD	O
%	NN	O
)	)	O
mutations	NNS	O
.	.	O

The	DT	O
three	CD	O
mutations	NNS	O
account	VBP	O
for	IN	O
98	CD	O
.	.	O

8	CD	O
%	NN	O
of	IN	O
the	DT	O
Canavan	NNP	S_Disease
chromosomes	NNS	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
origin	NN	O
.	.	O

The	DT	O
ala305	NN	O
-	:	O
-	:	O
>	NN	O
glu	NN	O
mutation	NN	O
was	VBD	O
found	VBN	O
exclusively	RB	O
in	IN	O
non	JJ	O
-	:	O
Jewish	JJ	O
probands	NNS	O
of	IN	O
European	JJ	O
descent	NN	O
and	CC	O
constituted	VBD	O
60	CD	O
%	NN	O
of	IN	O
the	DT	O
40	CD	O
mutant	JJ	O
chromosomes	NNS	O
.	.	O

Predominant	JJ	O
occurrence	NN	O
of	IN	O
certain	JJ	O
mutations	NNS	O
among	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
and	CC	O
non	SYM	O
-	:	O
Jewish	JJ	O
patients	NNS	O
with	IN	O
Canavan	NNP	B_Disease
disease	NN	E_Disease
would	MD	O
suggest	VB	O
a	DT	O
founding	JJ	O
-	:	O
father	NN	O
effect	NN	O
in	IN	O
propagation	NN	O
of	IN	O
these	DT	O
mutant	JJ	O
chromosomes	NNS	O

Intelligence	NNP	O
quotient	NN	O
profile	NN	O
in	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
intergenerational	JJ	O
deficit	NN	O
,	,	O
and	CC	O
correlation	NN	O
with	IN	O
CTG	NNP	O
amplification	NN	O
.	.	O

An	DT	O
abbreviated	JJ	O
Wechsler	NNP	O
Adult	NNP	O
Intelligence	NNP	O
Scale	NNP	O
Revised	VBD	O
(	(	O
WAIS	NNP	O
-	:	O
R	NN	O
)	)	O
was	VBD	O
used	VBN	O
to	TO	O
assess	VB	O
verbal	JJ	O
and	CC	O
arithmetical	JJ	O
cognitive	JJ	O
performance	NN	O
in	IN	O
55	CD	O
subjects	NNS	O
with	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
,	,	O
covering	VBG	O
all	DT	O
grades	NNS	O
of	IN	O
disease	NN	O
severity	NN	O
,	,	O
and	CC	O
31	CD	O
controls	NNS	O
at	IN	O
50	CD	O
%	NN	O
risk	NN	O
of	IN	O
inheriting	VBG	O
DM	NNP	S_Disease
.	.	O

Scaled	JJ	O
scores	NNS	O
from	IN	O
the	DT	O
assessment	NN	O
were	VBD	O
converted	VBN	O
into	IN	O
an	DT	O
intelligence	NN	O
quotient	NN	O
(	(	O
IQ	NNP	O
)	)	O
estimation	NN	O
on	IN	O
each	DT	O
person	NN	O
.	.	O

Significant	JJ	O
IQ	NNP	O
differences	NNS	O
were	VBD	O
found	VBN	O
between	IN	O
(	(	O
1	CD	O
)	)	O
all	DT	O
55	CD	O
DM	NNP	S_Disease
subjects	NNS	O
(	(	O
mean	JJ	O
90	CD	O
.	.	O

2	CD	O
,	,	O
SD	NNP	O
16	CD	O
.	.	O

1	CD	O
)	)	O
and	CC	O
31	CD	O
controls	NNS	O
(	(	O
102	CD	O
.	.	O

6	CD	O
,	,	O
SD	NNP	O
9	CD	O
.	.	O

4	CD	O
)	)	O
,	,	O
with	IN	O
no	DT	O
sex	NN	O
differences	NNS	O
in	IN	O
either	DT	O
group	NN	O
;	:	O
(	(	O
2	CD	O
)	)	O
15	CD	O
affected	JJ	O
parents	NNS	O
(	(	O
99	CD	O
.	.	O

3	CD	O
,	,	O
SD	NNP	O
12	CD	O
.	.	O

2	CD	O
)	)	O
and	CC	O
their	PRP$	O
affected	JJ	O
children	NNS	O
(	(	O
88	CD	O
.	.	O

1	CD	O
,	,	O
SD	NNP	O
17	CD	O
.	.	O

2	CD	O
)	)	O
,	,	O
where	WRB	O
significance	NN	O
was	VBD	O
dependent	JJ	O
on	IN	O
parental	JJ	O
sex	NN	O
being	VBG	O
female	JJ	O
;	:	O
and	CC	O
(	(	O
3	CD	O
)	)	O
15	CD	O
pairs	NNS	O
of	IN	O
affected	JJ	O
sibs	NN	O
(	(	O
89	CD	O
.	.	O

6	CD	O
,	,	O
SD	NNP	O
13	CD	O
.	.	O

2	CD	O
)	)	O
and	CC	O
their	PRP$	O
normal	JJ	O
sibs	NN	O
(	(	O
100	CD	O
.	.	O

2	CD	O
,	,	O
SD	NNP	O
7	CD	O
.	.	O

6	CD	O
)	)	O
.	.	O

IQ	NNP	O
steadily	RB	O
declined	VBD	O
as	IN	O
(	(	O
1	CD	O
)	)	O
the	DT	O
age	NN	O
of	IN	O
onset	NN	O
of	IN	O
signs	NNS	O
and	CC	O
symptoms	NNS	O
decreased	VBN	O
,	,	O
and	CC	O
(	(	O
2	CD	O
)	)	O
the	DT	O
CTG	NNP	O
expansion	NN	O
size	NN	O
increased	VBD	O
.	.	O

The	DT	O
correlation	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
more	JJR	O
linear	JJ	O
with	IN	O
age	NN	O
of	IN	O
onset	NN	O
.	.	O

The	DT	O
correlation	NN	O
of	IN	O
IQ	NNP	O
difference	NN	O
and	CC	O
CTG	NNP	O
expansion	NN	O
difference	NN	O
in	IN	O
both	CC	O
the	DT	O
DM	NNP	S_Disease
parent	NN	O
-	:	O
child	NN	O
pairs	NNS	O
and	CC	O
normal	JJ	O
sib	NN	O
-	:	O
affected	JJ	O
sib	NN	O
pairs	NN	O
was	VBD	O
poor	JJ	O
,	,	O
indicating	VBG	O
that	IN	O
CTG	NNP	O
expansion	NN	O
is	VBZ	O
not	RB	O
a	DT	O
reliable	JJ	O
predictor	NN	O
of	IN	O
IQ	NNP	O
either	CC	O
in	IN	O
individual	JJ	O
persons	NNS	O
or	CC	O
families	NNS	O
.	.	O

Further	JJ	O
analysis	NN	O
of	IN	O
cognitive	JJ	O
function	NN	O
in	IN	O
DM	NNP	S_Disease
is	VBZ	O
required	VBN	O
to	TO	O
clarify	VB	O
specific	JJ	O
deficits	NNS	O
characteristic	JJ	O
of	IN	O
this	DT	O
patient	NN	O
group	NN	O

Adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
and	CC	O
a	DT	O
cytogenetic	JJ	O
deletion	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
resulting	VBG	O
from	IN	O
a	DT	O
maternal	JJ	O
intrachromosomal	JJ	O
insertion	NN	O
.	.	O

We	PRP	O
present	VBP	O
the	DT	O
clinical	JJ	O
and	CC	O
laboratory	JJ	O
findings	NNS	O
in	IN	O
an	DT	O
institutionalised	JJ	O
adult	NN	O
patient	NN	O
originally	RB	O
referred	VBN	O
for	IN	O
autism	NN	S_Disease
.	.	O

A	DT	O
high	JJ	O
risk	NN	O
of	IN	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
was	VBD	O
predicted	VBN	O
when	WRB	O
an	DT	O
interstitial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
,	,	O
del	NN	O
(	(	O
5	CD	O
)	)	O
(	(	O
q15q22	UH	O
.	.	O

3	CD	O
)	)	O
,	,	O
was	VBD	O
detected	VBN	O
in	IN	O
her	PRP$	O
lymphocytes	NNS	O
and	CC	O
deletion	NN	O
of	IN	O
the	DT	O
MCC	NNP	O
and	CC	O
APC	NNP	S_Disease
genes	NNS	O
confirmed	VBN	O
by	IN	O
molecular	JJ	O
analysis	NN	O
.	.	O

Adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
and	CC	O
carcinoma	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
rectum	NN	E_Disease
were	VBD	O
subsequently	RB	O
diagnosed	VBN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

She	PRP	O
was	VBD	O
profoundly	RB	O
mentally	RB	B_Disease
retarded	JJ	E_Disease
,	,	O
autistic	JJ	S_Disease
,	,	O
and	CC	O
had	VBD	O
minor	JJ	O
dysmorphic	JJ	B_Disease
features	NNS	E_Disease
consistent	JJ	O
with	IN	O
those	DT	O
of	IN	O
previous	JJ	O
patients	NNS	O
with	IN	O
similar	JJ	O
deletions	NNS	O
.	.	O

The	DT	O
deletion	NN	O
arose	VBD	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
recombination	NN	O
within	IN	O
the	DT	O
small	JJ	O
insertion	NN	O
loop	NN	O
formed	VBN	O
at	IN	O
meiosis	NN	O
by	IN	O
the	DT	O
direct	JJ	O
insertion	NN	O
(	(	O
dir	JJ	O
ins	NNS	O
(	(	O
5	CD	O
)	)	O
(	(	O
q22	UH	O
.	.	O

3q14	CD	O
.	.	O

2q15	CD	O
)	)	O
)	)	O
found	VBN	O
in	IN	O
the	DT	O
patients	NNS	O
mother	NN	O
.	.	O

This	DT	O
family	NN	O
further	RB	O
confirms	VBZ	O
the	DT	O
cytogenetic	JJ	O
mapping	NN	O
of	IN	O
both	DT	O
MCC	NNP	O
and	CC	O
APC	NNP	S_Disease
genes	NNS	O
to	TO	O
5q22	CD	O
and	CC	O
comparison	NN	O
with	IN	O
other	JJ	O
recent	JJ	O
cases	NNS	O
suggests	VBZ	O
that	IN	O
both	DT	O
genes	NNS	O
and	CC	O
their	PRP$	O
closely	RB	O
linked	VBN	O
markers	NNS	O
lie	RBR	O
within	IN	O
the	DT	O
5q22	CD	O
.	.	O

1	CD	O
subband	NN	O

Familial	NNP	B_Disease
male	NN	I_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
is	VBZ	O
not	RB	O
linked	VBN	O
to	TO	O
the	DT	O
BRCA1	NNP	O
locus	NN	O
on	IN	O
chromosome	NN	O
17q	CD	O
.	.	O

Breast	NNP	B_Disease
cancer	NN	E_Disease
in	IN	O
men	NNS	O
is	VBZ	O
about	IN	O
a	DT	O
hundredfold	NN	O
less	JJR	O
common	JJ	O
than	IN	O
in	IN	O
women	NNS	O
and	CC	O
this	DT	O
has	VBZ	O
hindered	VBN	O
research	NN	O
into	IN	O
its	PRP$	O
genetic	JJ	O
basis	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
22	CD	O
families	NNS	O
with	IN	O
at	IN	O
least	JJS	O
one	CD	O
case	NN	O
of	IN	O
male	NN	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
for	IN	O
linkage	NN	O
to	TO	O
the	DT	O
hereditary	JJ	B_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
locus	NN	O
,	,	O
BRCA1	NNP	O
,	,	O
on	IN	O
chromosome	NN	O
17q	CD	O
.	.	O

We	PRP	O
found	VBD	O
strong	JJ	O
evidence	NN	O
against	IN	O
linkage	NN	O
to	TO	O
BRCA1	NNP	O
(	(	O
lod	JJ	O
score	NN	O
-	:	O
16	CD	O
.	.	O

63	CD	O
)	)	O
and	CC	O
the	DT	O
best	JJS	O
estimate	NN	O
of	IN	O
the	DT	O
proportion	NN	O
of	IN	O
linked	JJ	O
families	NNS	O
was	VBD	O
0	CD	O
%	NN	O
(	(	O
95	CD	O
%	NN	O
CI	NNP	O
0	CD	O
-	:	O
18	CD	O
%	NN	O
)	)	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
there	EX	O
is	VBZ	O
a	DT	O
gene	NN	O
(	(	O
s	PRP	O
)	)	O
other	JJ	O
than	IN	O
BRCA1	NNP	O
which	WDT	O
predisposes	VBZ	O
to	TO	O
early	JJ	O
-	:	O
onset	NN	O
breast	NN	B_Disease
cancer	NN	E_Disease
in	IN	O
women	NNS	O
and	CC	O
which	WDT	O
confers	VBZ	O
a	DT	O
higher	JJR	O
risk	NN	O
of	IN	O
male	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
.	.	O

Identification	NN	O
of	IN	O
additional	JJ	O
pedigrees	NNS	O
that	IN	O
include	VBP	O
cases	NNS	O
of	IN	O
male	JJ	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
may	MD	O
therefore	VB	O
facilitate	VB	O
the	DT	O
mapping	NN	O
and	CC	O
isolation	NN	O
of	IN	O
this	DT	O
gene	NN	O
.	.	O

The	DT	O
EWS	NNP	O
gene	NN	O
,	,	O
involved	VBN	O
in	IN	O
Ewing	NNP	B_Disease
family	NN	I_Disease
of	IN	I_Disease
tumors	NNS	E_Disease
,	,	O
malignant	JJ	B_Disease
melanoma	NN	I_Disease
of	IN	I_Disease
soft	JJ	I_Disease
parts	NNS	E_Disease
and	CC	O
desmoplastic	JJ	B_Disease
small	JJ	I_Disease
round	NN	I_Disease
cell	NN	I_Disease
tumors	NNS	E_Disease
,	,	O
codes	NNS	O
for	IN	O
an	DT	O
RNA	NNP	O
binding	NN	O
protein	NN	O
with	IN	O
novel	JJ	O
regulatory	JJ	O
domains	NNS	O
.	.	O

The	DT	O
EWS	NNP	O
gene	NN	O
,	,	O
which	WDT	O
maps	VBZ	O
to	TO	O
band	VB	O
q12	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
22	CD	O
,	,	O
is	VBZ	O
involved	VBN	O
in	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
human	JJ	O
solid	JJ	B_Disease
tumors	NNS	E_Disease
including	VBG	O
Ewing	NNP	B_Disease
sarcoma	NN	E_Disease
,	,	O
related	JJ	O
primitive	JJ	O
neuroectodermal	JJ	B_Disease
tumors	NNS	E_Disease
,	,	O
malignant	JJ	B_Disease
melanoma	NN	I_Disease
of	IN	I_Disease
soft	JJ	I_Disease
parts	NNS	E_Disease
and	CC	O
desmoplastic	JJ	B_Disease
small	JJ	I_Disease
round	NN	I_Disease
cell	NN	I_Disease
tumors	NNS	E_Disease
.	.	O

In	IN	O
these	DT	O
tumors	NNS	S_Disease
,	,	O
the	DT	O
EWS	NNP	O
is	VBZ	O
fused	VBN	O
to	TO	O
genes	NNS	O
encoding	VBG	O
transcriptional	JJ	O
activators	NNS	O
/	VBP	O
repressors	NNS	O
,	,	O
like	IN	O
Fli	NNP	O
-	:	O
1	CD	O
or	CC	O
erg	VB	O
or	CC	O
ATF	VB	O
1	CD	O
or	CC	O
wt1	NN	O
.	.	O

To	TO	O
better	RBR	O
understand	VB	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
EWS	NNP	O
protein	NN	O
,	,	O
we	PRP	O
cloned	VBD	O
the	DT	O
EWS	NNP	O
cDNA	NN	O
.	.	O

Sequence	NNP	O
analysis	NN	O
of	IN	O
this	DT	O
cDNA	NN	O
revealed	VBD	O
differential	JJ	O
splicing	VBG	O
involving	VBG	O
two	CD	O
exons	NNS	O
encoding	VBG	O
72	CD	O
amino	JJ	O
acids	NNS	O
.	.	O

Both	DT	O
alternatively	RB	O
spliced	VBN	O
transcripts	NNS	O
,	,	O
EWS	NNP	O
and	CC	O
EWS	NNP	O
-	:	O
b	NN	O
,	,	O
are	VBP	O
expressed	VBN	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
cells	NNS	O
.	.	O

Because	IN	O
EWS	NNP	O
proteins	VBZ	O
contain	VBP	O
putative	JJ	O
conserved	VBN	O
RNA	NNP	O
binding	VBG	O
motifs	NNS	O
,	,	O
we	PRP	O
studied	VBD	O
the	DT	O
RNA	NNP	O
binding	NN	O
properties	NNS	O
of	IN	O
the	DT	O
EWS	NNP	O
protein	NN	O
.	.	O

The	DT	O
EWS	NNP	O
-	:	O
b	NN	O
protein	NN	O
binds	VBZ	O
to	TO	O
RNA	VB	O
in	IN	O
vitro	NN	O
and	CC	O
,	,	O
specifically	RB	O
,	,	O
to	TO	O
poly	VB	O
G	NNP	O
and	CC	O
poly	JJ	O
U	NNP	O
.	.	O

The	DT	O
RNA	NNP	O
binding	NN	O
activity	NN	O
was	VBD	O
localized	VBN	O
to	TO	O
the	DT	O
carboxy	JJ	O
terminal	NN	O
86	CD	O
amino	NN	O
acids	NNS	O
,	,	O
which	WDT	O
constitute	VBP	O
RGG	NNP	O
box	NN	O
.	.	O

Thus	RB	O
the	DT	O
amino	JJ	O
terminal	JJ	O
domain	NN	O
of	IN	O
EWS	NNP	O
(	(	O
NTD	NNP	O
-	:	O
EWS	NN	O
)	)	O
,	,	O
which	WDT	O
is	VBZ	O
involved	VBN	O
in	IN	O
chromosome	NN	O
translocation	NN	O
may	MD	O
regulate	VB	O
the	DT	O
specificity	NN	O
of	IN	O
RNA	NNP	O
binding	VBG	O
activity	NN	O
of	IN	O
EWS	NNP	O
.	.	O

An	DT	O
EWS	NNP	O
-	:	O
erg	NN	O
chimeric	JJ	O
protein	NN	O
,	,	O
which	WDT	O
is	VBZ	O
found	VBN	O
in	IN	O
Ewings	NNP	B_Disease
sarcoma	NN	E_Disease
cells	NNS	O
,	,	O
functions	NNS	O
as	IN	O
a	DT	O
transcriptional	JJ	O
activator	NN	O
.	.	O

Mutational	JJ	O
analysis	NN	O
of	IN	O
EWS	NNP	O
-	:	O
erg	NN	O
chimeric	JJ	O
protein	NN	O
revealed	VBD	O
that	IN	O
NTD	NNP	O
-	:	O
EWS	JJ	O
functions	NNS	O
as	IN	O
a	DT	O
regulatory	JJ	O
domain	NN	O
for	IN	O
the	DT	O
transcriptional	JJ	O
activation	NN	O
properties	NNS	O
of	IN	O
EWS	NNP	O
-	:	O
erg	NN	O
chimeric	JJ	O
protein	NN	O
.	.	O
.	.	O

Canavan	NNP	B_Disease
disease	NN	E_Disease
:	:	O
genomic	JJ	O
organization	NN	O
and	CC	O
localization	NN	O
of	IN	O
human	JJ	O
ASPA	NNP	O
to	TO	O
17p13	CD	O
-	:	O
ter	NN	O
and	CC	O
conservation	NN	O
of	IN	O
the	DT	O
ASPA	NNP	O
gene	NN	O
during	IN	O
evolution	NN	O
.	.	O

Canavan	NNP	B_Disease
disease	NN	E_Disease
,	,	O
or	CC	O
spongy	JJ	B_Disease
degeneration	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
brain	NN	E_Disease
,	,	O
is	VBZ	O
a	DT	O
severe	JJ	O
leukodystrophy	NN	S_Disease
caused	VBN	O
by	IN	O
the	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
aspartoacylase	NN	E_Disease
(	(	O
ASPA	NNP	O
)	)	O
.	.	O

Recently	RB	O
,	,	O
a	DT	O
missense	NN	O
mutation	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
human	JJ	O
ASPA	NNP	O
coding	VBG	O
sequence	NN	O
from	IN	O
patients	NNS	O
with	IN	O
Canavan	NNP	B_Disease
disease	NN	E_Disease
.	.	O

The	DT	O
human	JJ	O
ASPA	NNP	O
gene	NN	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
and	CC	O
found	VBN	O
to	TO	O
span	VB	O
29	CD	O
kb	NN	O
of	IN	O
the	DT	O
genome	NN	O
.	.	O

Human	JJ	O
aspartoacylase	NN	O
is	VBZ	O
coded	VBN	O
by	IN	O
six	CD	O
exons	NNS	O
intervened	VBN	O
by	IN	O
five	CD	O
introns	NNS	O
.	.	O

The	DT	O
exons	NNS	O
vary	VBP	O
from	IN	O
94	CD	O
(	(	O
exon	VB	O
III	NNP	O
)	)	O
to	TO	O
514	CD	O
(	(	O
exon	VB	O
VI	NNP	O
)	)	O
bases	NNS	O
.	.	O

The	DT	O
exon	NN	O
/	NNP	O
intron	NN	O
splice	NN	O
junction	NN	O
sites	VBZ	O
follow	VBP	O
the	DT	O
gt	NN	O
/	NNP	O
ag	VBZ	O
consensus	NN	O
sequence	NN	O
rule	NN	O
.	.	O

Southern	NNP	O
blot	NN	O
analysis	NN	O
of	IN	O
genomic	JJ	O
DNA	NN	O
from	IN	O
human	JJ	O
/	NN	O
mouse	NN	O
somatic	JJ	O
cell	NN	O
hybrid	NN	O
cell	NN	O
lines	NNS	O
localized	VBD	O
ASPA	NNP	O
to	TO	O
human	JJ	O
chromosome	NN	O
17	CD	O
.	.	O

The	DT	O
human	JJ	O
ASPA	NNP	O
locus	NN	O
was	VBD	O
further	RBR	O
mapped	VBN	O
in	IN	O
the	DT	O
17p13	CD	O
-	:	O
ter	NN	O
region	NN	O
by	IN	O
fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
.	.	O

The	DT	O
bovine	NN	O
aspa	NN	O
gene	NN	O
has	VBZ	O
also	RB	O
been	VBN	O
cloned	VBN	O
,	,	O
and	CC	O
its	PRP$	O
exon	NN	O
/	NNP	O
intron	NN	O
organization	NN	O
is	VBZ	O
identical	JJ	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
human	JJ	O
gene	NN	O
.	.	O

The	DT	O
500	CD	O
-	:	O
base	NN	O
sequence	NN	O
upstream	NN	O
of	IN	O
the	DT	O
initiator	NN	O
ATG	NNP	O
codon	NN	O
in	IN	O
the	DT	O
human	JJ	O
gene	NN	O
and	CC	O
that	IN	O
in	IN	O
the	DT	O
bovine	NN	O
gene	NN	O
are	VBP	O
77	CD	O
%	NN	O
identical	JJ	O
.	.	O

Human	NNP	O
ASPA	NNP	O
coding	VBG	O
sequences	NNS	O
cross	SYM	O
-	:	O
hybridize	NN	O
with	IN	O
genomic	JJ	O
DNA	NN	O
from	IN	O
yeast	NN	O
,	,	O
chicken	NN	O
,	,	O
rabbit	NN	O
,	,	O
cow	NN	O
,	,	O
dog	NN	O
,	,	O
mouse	NN	O
,	,	O
rat	NN	O
,	,	O
and	CC	O
monkey	NN	O
.	.	O

The	DT	O
specificity	NN	O
of	IN	O
cross	NN	O
-	:	O
species	NNS	O
hybridization	NN	O
of	IN	O
coding	VBG	O
sequences	NNS	O
suggests	VBZ	O
that	IN	O
aspartoacylase	NN	O
has	VBZ	O
been	VBN	O
conserved	VBN	O
during	IN	O
evolution	NN	O
.	.	O

It	PRP	O
should	MD	O
now	RB	O
be	VB	O
possible	JJ	O
to	TO	O
identify	VB	O
mutations	NNS	O
in	IN	O
the	DT	O
noncoding	JJ	O
genomic	JJ	O
sequences	NNS	O
that	WDT	O
lead	VBP	O
to	TO	O
Canavan	NNP	B_Disease
disease	NN	E_Disease
and	CC	O
to	TO	O
study	VB	O
the	DT	O
regulation	NN	O
of	IN	O
ASPA	NNP	O
.	.	O
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
:	:	O
size	NN	O
-	:	O
and	CC	O
sex	NN	O
-	:	O
dependent	JJ	O
dynamics	NNS	O
of	IN	O
CTG	NNP	O
meiotic	JJ	O
instability	NN	O
,	,	O
and	CC	O
somatic	JJ	O
mosaicism	NN	O
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
is	VBZ	O
a	DT	O
progressive	JJ	O
neuromuscular	NN	B_Disease
disorder	NN	E_Disease
which	WDT	O
results	NNS	O
from	IN	O
elongations	NNS	O
of	IN	O
an	DT	O
unstable	JJ	O
(	(	O
CTG	NNP	O
)	)	O
n	RB	O
repeat	NN	O
,	,	O
located	VBN	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
gene	NN	O
.	.	O

A	DT	O
correlation	NN	O
has	VBZ	O
been	VBN	O
demonstrated	VBN	O
between	IN	O
the	DT	O
increase	NN	O
in	IN	O
the	DT	O
repeat	NN	O
number	NN	O
of	IN	O
this	DT	O
sequence	NN	O
and	CC	O
the	DT	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
clinical	JJ	O
status	NN	O
of	IN	O
patients	NNS	O
cannot	JJ	O
be	VB	O
unambiguously	RB	O
ascertained	VBN	O
solely	RB	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
number	NN	O
of	IN	O
CTG	NNP	O
repeats	NNS	O
.	.	O

Moreover	RB	O
,	,	O
the	DT	O
exclusive	JJ	O
maternal	JJ	O
inheritance	NN	O
of	IN	O
the	DT	O
congenital	JJ	O
form	NN	O
remains	VBZ	O
unexplained	JJ	O
.	.	O

Our	PRP$	O
observation	NN	O
of	IN	O
differently	RB	O
sized	VBN	O
repeats	NNS	O
in	IN	O
various	JJ	O
DM	NNP	S_Disease
tissues	NNS	O
from	IN	O
the	DT	O
same	JJ	O
individual	NN	O
may	MD	O
explain	VB	O
why	WRB	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
mutation	NN	O
observed	VBD	O
in	IN	O
lymphocytes	NNS	O
does	VBZ	O
not	RB	O
necessarily	RB	O
correlate	VB	O
with	IN	O
the	DT	O
severity	NN	O
and	CC	O
nature	NN	O
of	IN	O
symptoms	NNS	O
.	.	O

Through	IN	O
a	DT	O
molecular	JJ	O
and	CC	O
genetic	JJ	O
study	NN	O
of	IN	O
142	CD	O
families	NNS	O
including	VBG	O
418	CD	O
DM	NNP	S_Disease
patients	NNS	O
,	,	O
we	PRP	O
have	VBP	O
investigated	VBN	O
the	DT	O
dynamics	NNS	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
meiotic	JJ	O
instability	NN	O
.	.	O

A	DT	O
positive	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
repeat	NN	O
and	CC	O
the	DT	O
intergenerational	JJ	O
enlargement	NN	O
was	VBD	O
observed	VBN	O
similarly	RB	O
through	IN	O
male	NN	O
and	CC	O
female	JJ	O
meioses	NNS	O
for	IN	O
<	NN	O
or	CC	O
=	$	O
0	CD	O
.	.	O

5	CD	O
-	:	O
kb	NN	O
CTG	NNP	O
sequences	NNS	O
.	.	O

Beyond	IN	O
0	CD	O
.	.	O

5	CD	O
kb	NN	O
,	,	O
the	DT	O
intergenerational	JJ	O
variation	NN	O
was	VBD	O
more	RBR	O
important	JJ	O
through	IN	O
female	JJ	O
meioses	NNS	O
,	,	O
whereas	IN	O
a	DT	O
tendency	NN	O
to	TO	O
compression	NN	O
was	VBD	O
observed	VBN	O
almost	RB	O
exclusively	RB	O
in	IN	O
male	NN	O
meioses	NNS	O
,	,	O
for	IN	O
>	NN	O
or	CC	O
=	$	O
1	CD	O
.	.	O

5	CD	O
-	:	O
kb	NN	O
fragments	NNS	O
.	.	O

This	DT	O
implies	VBZ	O
a	DT	O
size	NN	O
-	:	O
and	CC	O
sex	NN	O
-	:	O
dependent	JJ	O
meiotic	JJ	O
instability	NN	O
.	.	O

Moreover	RB	O
,	,	O
segregation	NN	O
analysis	NN	O
supports	VBZ	O
the	DT	O
hypothesis	NN	O
of	IN	O
a	DT	O
maternal	JJ	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
familial	JJ	O
predisposition	NN	O
for	IN	O
the	DT	O
occurrence	NN	O
of	IN	O
the	DT	O
congenital	JJ	O
form	NN	O
.	.	O

Finally	RB	O
,	,	O
this	DT	O
analysis	NN	O
reveals	VBZ	O
a	DT	O
significant	JJ	O
excess	NN	O
of	IN	O
transmitting	VBG	O
grandfathers	NNS	O
partially	RB	O
accounted	VBN	O
for	IN	O
by	IN	O
increased	JJ	O
fertility	NN	O
in	IN	O
affected	JJ	O
males	NNS	O

Illegitimate	NNP	O
transcription	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
in	IN	O
lymphocytes	NNS	O
for	IN	O
identification	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
phenylketonuria	NN	S_Disease
.	.	O

Taking	VBG	O
advantage	NN	O
of	IN	O
the	DT	O
illegitimate	JJ	O
transcription	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	(	O
PAH	NNP	O
)	)	O
gene	NN	O
,	,	O
we	PRP	O
have	VBP	O
been	VBN	O
able	JJ	O
to	TO	O
analyse	VB	O
the	DT	O
PAH	NNP	O
cDNA	NN	O
sequence	NN	O
of	IN	O
hyperphenylalaninemic	JJ	S_Disease
children	NNS	O
in	IN	O
circulating	VBG	O
lymphocytes	NNS	O
.	.	O

Using	VBG	O
this	DT	O
approach	NN	O
,	,	O
we	PRP	O
have	VBP	O
also	RB	O
identified	VBN	O
3	CD	O
novel	JJ	O
mutations	NNS	O
in	IN	O
cDNA	NN	O
from	IN	O
liver	NN	O
and	CC	O
lymphocytes	NNS	O
of	IN	O
two	CD	O
patients	NNS	O
.	.	O

One	CD	O
mutation	NN	O
,	,	O
detected	VBN	O
by	IN	O
the	DT	O
abnormal	JJ	O
pattern	NN	O
of	IN	O
migration	NN	O
of	IN	O
an	DT	O
amplified	JJ	O
fragment	NN	O
,	,	O
is	VBZ	O
a	DT	O
C	NNP	O
to	TO	O
T	NNP	O
transition	NN	O
in	IN	O
the	DT	O
splice	NN	O
acceptor	NN	O
site	NN	O
of	IN	O
intron	NN	O
10	CD	O
,	,	O
which	WDT	O
resulted	VBD	O
in	IN	O
the	DT	O
skipping	NN	O
of	IN	O
exon	$	O
11	CD	O
with	IN	O
the	DT	O
premature	JJ	O
termination	NN	O
of	IN	O
RNA	NNP	O
translation	NN	O
downstream	NN	O
from	IN	O
exon	JJ	O
12	CD	O
(	(	O
-	:	O
3	CD	O
IVS10	NNP	O
)	)	O
.	.	O

The	DT	O
other	JJ	O
two	CD	O
mutations	NNS	O
are	VBP	O
missense	JJ	O
mutations	NNS	O
in	IN	O
exons	NNS	O
10	CD	O
and	CC	O
11	CD	O
(	(	O
respectively	RB	O
,	,	O
L333F	NNP	O
and	CC	O
E390G	NNP	O
)	)	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
supports	VBZ	O
the	DT	O
view	NN	O
that	IN	O
circulating	VBG	O
lymphocytes	NNS	O
give	VBP	O
easy	JJ	O
access	NN	O
to	TO	O
PAH	NNP	O
gene	NN	O
transcripts	NNS	O
whose	WP$	O
nucleotide	JJ	O
sequence	NN	O
is	VBZ	O
identical	JJ	O
to	TO	O
that	DT	O
reported	VBN	O
in	IN	O
liver	NN	O
and	CC	O
therefore	RB	O
represent	VB	O
a	DT	O
useful	JJ	O
tool	NN	O
for	IN	O
molecular	JJ	O
genetic	JJ	O
studies	NNS	O
in	IN	O
phenylketonuria	NN	S_Disease
.	.	O
.	.	O

High	JJ	O
residual	JJ	O
arylsulfatase	NN	O
A	NNP	O
(	(	O
ARSA	NNP	O
)	)	O
activity	NN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
late	JJ	B_Disease
-	:	I_Disease
infantile	JJ	I_Disease
metachromatic	JJ	I_Disease
leukodystrophy	NN	E_Disease
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
patient	JJ	O
suffering	NN	O
from	IN	O
late	JJ	B_Disease
-	:	I_Disease
infantile	JJ	I_Disease
metachromatic	JJ	I_Disease
leukodystrophy	NN	E_Disease
(	(	O
MLD	NNP	S_Disease
)	)	O
who	WP	O
has	VBZ	O
a	DT	O
residual	JJ	O
arylsulfatase	NN	O
A	NNP	O
(	(	O
ARSA	NNP	O
)	)	O
activity	NN	O
of	IN	O
about	RB	O
10	CD	O
%	NN	O
.	.	O

Fibroblasts	NNS	O
of	IN	O
the	DT	O
patient	NN	O
show	NN	O
significant	JJ	O
sulfatide	JJ	O
degradation	NN	O
activity	NN	O
exceeding	VBG	O
that	IN	O
of	IN	O
adult	NN	B_Disease
MLD	NNP	E_Disease
patients	NNS	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
ARSA	NNP	O
gene	NN	O
in	IN	O
this	DT	O
patient	NN	O
revealed	VBD	O
heterozygosity	NN	O
for	IN	O
two	CD	O
new	JJ	O
mutant	JJ	O
alleles	NNS	O
in	IN	O
one	CD	O
allele	NN	O
,	,	O
deletion	NN	O
of	IN	O
C	NNP	O
447	CD	O
in	IN	O
exon	NN	O
2	CD	O
leads	VBZ	O
to	TO	O
a	DT	O
frameshift	NN	O
and	CC	O
to	TO	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
at	IN	O
amino	NN	O
acid	JJ	O
position	NN	O
105	CD	O
;	:	O
in	IN	O
the	DT	O
second	JJ	O
allele	NN	O
,	,	O
a	DT	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
transition	NN	O
in	IN	O
exon	$	O
5	CD	O
causes	VBZ	O
a	DT	O
Gly309	NNP	O
-	:	O
-	:	O
>	NN	O
Ser	NNP	O
substitution	NN	O
.	.	O

Transient	JJ	O
expression	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
Ser309	NNP	O
-	:	O
ARSA	NNP	O
resulted	VBD	O
in	IN	O
only	RB	O
13	CD	O
%	NN	O
enzyme	JJ	O
activity	NN	O
of	IN	O
that	DT	O
observed	VBD	O
in	IN	O
cells	NNS	O
expressing	VBG	O
normal	JJ	O
ARSA	NNP	O
.	.	O

The	DT	O
mutant	JJ	O
ARSA	NNP	O
is	VBZ	O
correctly	RB	O
targeted	VBN	O
to	TO	O
the	DT	O
lysosomes	NNS	O
but	CC	O
is	VBZ	O
unstable	JJ	O
.	.	O

These	DT	O
findings	NNS	O
are	VBP	O
in	IN	O
contrast	NN	O
to	TO	O
previous	JJ	O
results	NNS	O
showing	VBG	O
that	IN	O
the	DT	O
late	JJ	B_Disease
-	:	I_Disease
infantile	JJ	I_Disease
type	NN	I_Disease
of	IN	I_Disease
MLD	NNP	E_Disease
is	VBZ	O
always	RB	O
associated	VBN	O
with	IN	O
the	DT	O
complete	JJ	O
absence	NN	O
of	IN	O
ARSA	NNP	O
activity	NN	O
.	.	O

The	DT	O
expression	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
ARSA	NNP	O
protein	NN	O
may	MD	O
be	VB	O
influenced	VBN	O
by	IN	O
particular	JJ	O
features	NNS	O
of	IN	O
oligodendrocytes	NNS	O
,	,	O
such	JJ	O
that	IN	O
the	DT	O
level	NN	O
of	IN	O
mutant	JJ	O
enzyme	NN	O
is	VBZ	O
lower	JJR	O
in	IN	O
these	DT	O
cells	NNS	O
than	IN	O
in	IN	O
others	NNS	O
.	.	O
.	.	O

An	DT	O
arylsulfatase	NN	O
A	NNP	O
(	(	O
ARSA	NNP	O
)	)	O
missense	NN	O
mutation	NN	O
(	(	O
T274M	NNP	O
)	)	O
causing	VBG	O
late	JJ	B_Disease
-	:	I_Disease
infantile	JJ	I_Disease
metachromatic	JJ	I_Disease
leukodystrophy	NN	E_Disease
.	.	O

Metachromatic	JJ	B_Disease
leukodystrophy	NN	E_Disease
(	(	O
MLD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
recessive	NN	I_Disease
lysosomal	JJ	I_Disease
storage	NN	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B_Disease
of	IN	I_Disease
arylsulfatase	NN	I_Disease
A	NNP	E_Disease
(	(	O
ARSA	NNP	O
;	:	O
EC	NNP	O
3	CD	O
.	.	O

1	CD	O
.	.	O

6	CD	O
.	.	O

8	CD	O
)	)	O
.	.	O

The	DT	O
8	CD	O
ARSA	NNP	O
exons	NNS	O
and	CC	O
adjacent	JJ	O
intron	NN	O
boundaries	NNS	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
late	JJ	B_Disease
-	:	I_Disease
infantile	JJ	I_Disease
metachromatic	JJ	I_Disease
leukodystrophy	NN	E_Disease
were	VBD	O
polymerase	JJ	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
amplified	VBD	O
in	IN	O
seven	CD	O
discrete	JJ	O
reactions	NNS	O
.	.	O

Amplified	NNP	O
ARSA	NNP	O
exons	NNS	O
were	VBD	O
analysed	VBN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
sequence	NN	O
alterations	NNS	O
by	IN	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
analysis	NN	O
,	,	O
followed	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
of	IN	O
PCR	NNP	O
products	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
homozygous	JJ	O
for	IN	O
a	DT	O
C	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
transition	NN	O
in	IN	O
exon	JJ	O
IV	NNP	O
that	WDT	O
results	NNS	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
threonine	NN	O
residue	NN	O
at	IN	O
amino	NN	O
acid	VBP	O
274	CD	O
with	IN	O
a	DT	O
methionine	NN	O
(	(	O
T274M	NNP	O
)	)	O
.	.	O

Analysis	NN	O
of	IN	O
a	DT	O
further	JJ	O
29	CD	O
MLD	NNP	S_Disease
patients	NNS	O
revealed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
five	CD	O
additional	JJ	O
homozygotes	NNS	O
for	IN	O
T274M	NNP	O
.	.	O

All	DT	O
6	CD	O
T274M	NNP	O
homozygotes	NNS	O
(	(	O
representing	VBG	O
four	CD	O
families	NNS	O
)	)	O
were	VBD	O
of	IN	O
Lebanese	JJ	O
descent	NN	O
,	,	O
and	CC	O
all	DT	O
were	VBD	O
known	VBN	O
to	TO	O
be	VB	O
the	DT	O
result	NN	O
of	IN	O
consanguineous	JJ	O
marriages	NNS	O
.	.	O

The	DT	O
altered	JJ	O
amino	NN	O
acid	NN	O
is	VBZ	O
rigidly	RB	O
conserved	VBN	O
among	IN	O
10	CD	O
sulfatases	NNS	O
from	IN	O
Escherichia	NNP	O
coli	NNS	O
to	TO	O
humans	NNS	O
;	:	O
therefore	RB	O
,	,	O
it	PRP	O
is	VBZ	O
most	RBS	O
likely	JJ	O
that	IN	O
the	DT	O
resultant	NN	O
mutant	NN	O
protein	NN	O
will	MD	O
have	VB	O
little	JJ	O
or	CC	O
no	DT	O
enzyme	JJ	O
activity	NN	O
.	.	O

This	DT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
very	RB	O
low	JJ	O
ARSA	NNP	O
activity	NN	O
measured	VBN	O
in	IN	O
these	DT	O
patients	NNS	O
and	CC	O
their	PRP$	O
uniformly	NN	O
severe	RB	O
clinical	JJ	O
presentation	NN	O

Mutations	NNS	O
in	IN	O
the	DT	O
PAX6	NNP	O
gene	NN	O
in	IN	O
patients	NNS	O
with	IN	O
hereditary	JJ	O
aniridia	NN	S_Disease
.	.	O

The	DT	O
14	CD	O
exons	NNS	O
of	IN	O
the	DT	O
PAX6	NNP	O
gene	NN	O
have	VBP	O
been	VBN	O
analysed	VBN	O
exon	SYM	O
-	:	O
by	IN	O
-	:	O
exon	NN	O
using	VBG	O
SSCP	NNP	O
in	IN	O
6	CD	O
aniridia	JJ	S_Disease
families	NNS	O
.	.	O

In	IN	O
each	DT	O
family	NN	O
band	NN	O
shifts	NNS	O
were	VBD	O
observed	VBN	O
on	IN	O
the	DT	O
SSCP	NNP	O
gels	NNS	O
for	IN	O
only	RB	O
one	CD	O
exon	NN	O
and	CC	O
direct	JJ	O
PCR	NNP	O
-	:	O
sequencing	NN	O
revealed	VBD	O
mutations	NNS	O
in	IN	O
each	DT	O
case	NN	O
.	.	O

Two	CD	O
mutations	NNS	O
involved	VBN	O
C	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
transitions	NNS	O
in	IN	O
CGAarg	NNP	O
codons	NNS	O
in	IN	O
exons	NNS	O
9	CD	O
and	CC	O
11	CD	O
.	.	O

Another	DT	O
C	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
transition	NN	O
converted	VBD	O
a	DT	O
CAG	NNP	O
-	:	O
glutamine	NN	O
to	TO	O
a	DT	O
TAG	NNP	O
-	:	O
stop	NN	O
in	IN	O
exon	JJ	O
7	CD	O
.	.	O

Small	JJ	O
insertions	NNS	O
created	VBN	O
frameshifts	NNS	O
which	WDT	O
produced	VBD	O
downstream	NN	O
stop	NN	O
codons	NNS	O
in	IN	O
another	DT	O
two	CD	O
patients	NNS	O
and	CC	O
an	DT	O
A	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
mutation	NN	O
disrupted	VBD	O
the	DT	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
exon	JJ	O
5	CD	O
in	IN	O
the	DT	O
remaining	VBG	O
family	NN	O
.	.	O

Thus	RB	O
,	,	O
complete	JJ	O
inactivation	NN	O
of	IN	O
the	DT	O
PAX6	NNP	O
gene	NN	O
is	VBZ	O
predicted	VBN	O
in	IN	O
all	DT	O
cases	NNS	O
.	.	O

Analysis	NN	O
of	IN	O
other	JJ	O
affected	JJ	O
members	NNS	O
of	IN	O
the	DT	O
families	NNS	O
showed	VBD	O
that	IN	O
,	,	O
in	IN	O
each	DT	O
case	NN	O
,	,	O
all	DT	O
affected	JJ	O
individuals	NNS	O
carried	VBD	O
the	DT	O
same	JJ	O
family	NN	O
-	:	O
specific	JJ	O
mutation	NN	O
.	.	O

One	CD	O
polymorphism	NN	O
was	VBD	O
found	VBN	O
in	IN	O
exon	JJ	O
7	CD	O
.	.	O

This	DT	O
data	NN	O
strongly	RB	O
supports	VBZ	O
the	DT	O
candidature	NN	O
of	IN	O
PAX6	NNP	O
as	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
hereditary	JJ	O
aniridia	NN	S_Disease
.	.	O
.	.	O

Three	CD	O
novel	JJ	O
mutations	NNS	O
in	IN	O
five	CD	O
unrelated	JJ	O
subjects	NNS	O
with	IN	O
hereditary	JJ	O
protein	NN	B_Disease
S	NNP	I_Disease
deficiency	NN	I_Disease
type	NN	I_Disease
I	PRP	E_Disease
.	.	O

A	DT	O
panel	NN	O
of	IN	O
eight	CD	O
unrelated	JJ	O
subjects	NNS	O
with	IN	O
inherited	JJ	O
type	NN	B_Disease
I	PRP	I_Disease
protein	VBP	I_Disease
S	JJ	I_Disease
deficiency	NN	E_Disease
was	VBD	O
screened	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
PROS1	NNP	O
gene	NN	O
.	.	O

In	IN	O
five	CD	O
subjects	NNS	O
an	DT	O
abnormality	NN	O
was	VBD	O
found	VBN	O
but	CC	O
mutations	NNS	O
were	VBD	O
not	RB	O
detected	VBN	O
in	IN	O
the	DT	O
remaining	VBG	O
three	CD	O
subjects	NNS	O
.	.	O

Two	CD	O
subjects	NNS	O
shared	VBD	O
a	DT	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
transition	NN	O
at	IN	O
position	NN	O
+	FW	O
5	CD	O
of	IN	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
consensus	NN	O
sequence	NN	O
of	IN	O
intron	NN	O
10	CD	O
.	.	O

Also	RB	O
in	IN	O
two	CD	O
subjects	NNS	O
an	DT	O
A	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
transversion	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
stopcodon	NN	O
of	IN	O
the	DT	O
PROS1	NNP	O
gene	NN	O
;	:	O
this	DT	O
transversion	NN	O
predicts	VBZ	O
a	DT	O
protein	NN	O
S	NNP	O
molecule	NN	O
that	WDT	O
is	VBZ	O
extended	VBN	O
by	IN	O
14	CD	O
amino	JJ	O
acids	NNS	O
.	.	O

The	DT	O
fifth	NN	O
subject	NN	O
was	VBD	O
found	VBN	O
to	TO	O
possess	VB	O
two	CD	O
sequence	NN	O
abnormalities	NNS	O
.	.	O

One	CD	O
allele	NN	O
carried	VBD	O
a	DT	O
G	NNP	O
-	:	O
-	:	O
>	VB	O
A	DT	O
transition	NN	O
near	IN	O
the	DT	O
donor	NN	O
splice	NN	O
junction	NN	O
of	IN	O
intron	NN	O
2	CD	O
,	,	O
but	CC	O
this	DT	O
abnormality	NN	O
is	VBZ	O
probably	RB	O
neutral	JJ	O
,	,	O
since	IN	O
it	PRP	O
was	VBD	O
inherited	VBN	O
from	IN	O
the	DT	O
parent	NN	O
with	IN	O
normal	JJ	O
protein	NNS	O
S	NNP	O
antigen	NN	O
levels	NNS	O
.	.	O

In	IN	O
the	DT	O
other	JJ	O
allele	NN	O
a	DT	O
single	JJ	O
T	NNP	O
insertion	NN	O
in	IN	O
codon	JJ	O
-	:	O
25	CD	O
was	VBD	O
found	VBN	O
.	.	O

Analysis	NN	O
of	IN	O
platelet	NN	O
RNA	NNP	O
showed	VBD	O
that	IN	O
only	RB	O
the	DT	O
mRNA	NN	O
with	IN	O
the	DT	O
A	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
mutation	NN	O
in	IN	O
the	DT	O
stopcodon	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
amounts	NNS	O
comparable	JJ	O
to	TO	O
wildtype	VB	O
RNA	NNP	O
.	.	O

mRNA	NN	O
from	IN	O
the	DT	O
alleles	NNS	O
with	IN	O
the	DT	O
other	JJ	O
two	CD	O
mutations	NNS	O
was	VBD	O
either	CC	O
undetectable	JJ	O
or	CC	O
present	JJ	O
in	IN	O
greatly	RB	O
reduced	JJ	O
amounts	NNS	O
.	.	O

The	DT	O
latter	JJ	O
indicates	VBZ	O
that	IN	O
a	DT	O
mRNA	NN	O
based	VBN	O
approach	NN	O
is	VBZ	O
not	RB	O
feasible	JJ	O
for	IN	O
the	DT	O
genetic	JJ	O
analysis	NN	O
of	IN	O
protein	NN	B_Disease
S	NNP	I_Disease
deficiency	NN	I_Disease
type	NN	I_Disease
I	PRP	E_Disease
.	.	O
.	.	O

Characteristics	NNS	O
of	IN	O
intergenerational	JJ	O
contractions	NNS	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
.	.	O

In	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
,	,	O
the	DT	O
size	NN	O
of	IN	O
a	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
the	DT	O
DM	NNP	S_Disease
kinase	NN	O
gene	NN	O
generally	RB	O
increases	VBZ	O
in	IN	O
successive	JJ	O
generations	NNS	O
with	IN	O
clinical	JJ	O
evidence	NN	O
of	IN	O
anticipation	NN	O
.	.	O

However	RB	O
,	,	O
there	EX	O
have	VBP	O
also	RB	O
been	VBN	O
cases	NNS	O
with	IN	O
an	DT	O
intergenerational	JJ	O
contraction	NN	O
of	IN	O
the	DT	O
repeat	NN	O
.	.	O

We	PRP	O
examined	VBD	O
1	CD	O
,	,	O
489	CD	O
DM	NNP	S_Disease
parent	NN	O
-	:	O
offspring	VBG	O
pairs	NNS	O
,	,	O
of	IN	O
which	WDT	O
95	CD	O
(	(	O
6	CD	O
.	.	O

4	CD	O
%	NN	O
)	)	O
showed	VBD	O
such	JJ	O
contractions	NNS	O
in	IN	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
(	(	O
PBL	NNP	O
)	)	O
.	.	O

In	IN	O
56	CD	O
of	IN	O
the	DT	O
95	CD	O
pairs	NNS	O
,	,	O
clinical	JJ	O
data	NN	O
allowed	VBD	O
an	DT	O
analysis	NN	O
of	IN	O
their	PRP$	O
anticipation	NN	O
status	NN	O
.	.	O

It	PRP	O
is	VBZ	O
surprising	JJ	O
that	IN	O
anticipation	NN	O
occurred	VBD	O
in	IN	O
27	CD	O
(	(	O
48	CD	O
%	NN	O
)	)	O
of	IN	O
these	DT	O
56	CD	O
pairs	NNS	O
,	,	O
while	IN	O
none	NN	O
clearly	RB	O
showed	VBD	O
a	DT	O
later	JJ	O
onset	NN	O
of	IN	O
DM	NNP	S_Disease
in	IN	O
the	DT	O
symptomatic	JJ	O
offspring	NN	O
.	.	O

The	DT	O
contraction	NN	O
occurred	VBD	O
in	IN	O
76	CD	O
(	(	O
10	CD	O
%	NN	O
)	)	O
of	IN	O
753	CD	O
paternal	JJ	O
transmissions	NNS	O
and	CC	O
in	IN	O
19	CD	O
(	(	O
3	CD	O
%	NN	O
)	)	O
of	IN	O
736	CD	O
maternal	JJ	O
transmissions	NNS	O
.	.	O

Anticipation	NN	O
was	VBD	O
observed	VBN	O
more	RBR	O
frequently	RB	O
in	IN	O
maternal	JJ	O
(	(	O
85	CD	O
%	NN	O
)	)	O
than	IN	O
in	IN	O
paternal	JJ	O
(	(	O
37	CD	O
%	NN	O
)	)	O
transmissions	NNS	O
(	(	O
P	NNP	O
<	NNP	O
.	.	O

001	CD	O
)	)	O
.	.	O

The	DT	O
parental	JJ	O
repeat	NN	O
size	NN	O
correlated	VBN	O
with	IN	O
the	DT	O
size	NN	O
of	IN	O
intergenerational	JJ	O
contraction	NN	O
(	(	O
r2	JJ	O
=	NN	O
.	.	O

50	CD	O
,	,	O
P	NNP	O
<	NNP	O
<	NNP	O
.	.	O

001	CD	O
)	)	O
,	,	O
and	CC	O
the	DT	O
slope	NN	O
of	IN	O
linear	JJ	O
regression	NN	O
was	VBD	O
steeper	VBN	O
in	IN	O
paternal	NN	O
(	(	O
-	:	O
.	.	O

62	CD	O
)	)	O
than	IN	O
in	IN	O
maternal	JJ	O
(	(	O
-	:	O
.	.	O

30	CD	O
)	)	O
transmissions	NNS	O
(	(	O
P	NNP	O
<	NNP	O
<	NNP	O
.	.	O

001	CD	O
)	)	O
.	.	O

Sixteen	NNP	O
DM	NNP	S_Disease
parents	NNS	O
had	VBD	O
multiple	JJ	O
DM	NNP	S_Disease
offspring	VBG	O
with	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
contractions	NNS	O
.	.	O

This	DT	O
frequency	NN	O
was	VBD	O
higher	JJR	O
than	IN	O
the	DT	O
frequency	NN	O
expected	VBN	O
from	IN	O
the	DT	O
probability	NN	O
of	IN	O
the	DT	O
repeat	NN	O
contractions	NNS	O
(	(	O
6	CD	O
.	.	O

4	CD	O
%	NN	O
)	)	O
and	CC	O
the	DT	O
size	NN	O
of	IN	O
DM	NNP	S_Disease
sib	JJ	O
population	NN	O
(	(	O
1	CD	O
.	.	O

54	CD	O
DM	NNP	S_Disease
offspring	VBG	O
per	IN	O
DM	NNP	S_Disease
parent	NN	O
,	,	O
in	IN	O
968	CD	O
DM	NNP	S_Disease
parents	NNS	O
)	)	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
(	(	O
1	CD	O
)	)	O
intergenerational	JJ	O
contractions	NNS	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
leukocyte	NN	O
DNA	NNP	O
frequently	RB	O
accompanies	VBZ	O
apparent	JJ	O
anticipation	NN	O
,	,	O
especially	RB	O
when	WRB	O
DM	NNP	S_Disease
is	VBZ	O
maternally	RB	O
transmitted	VBN	O
,	,	O
and	CC	O
(	(	O
2	CD	O
)	)	O
the	DT	O
paternal	JJ	O
origin	NN	O
of	IN	O
the	DT	O
repeat	NN	O
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
repeat	NN	O
contraction	NN	O
in	IN	O
a	DT	O
sibling	JJ	O
increase	NN	O
the	DT	O
probability	NN	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
contraction	NN	O

Gonosomal	JJ	O
mosaicism	NN	O
in	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
patients	NNS	O
:	:	O
involvement	NN	O
of	IN	O
mitotic	JJ	O
events	NNS	O
in	IN	O
(	(	O
CTG	NNP	O
)	)	O
n	RB	O
repeat	JJ	O
variation	NN	O
and	CC	O
selection	NN	O
against	IN	O
extreme	JJ	O
expansion	NN	O
in	IN	O
sperm	NN	O
.	.	O

Myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
is	VBZ	O
caused	VBN	O
by	IN	O
abnormal	JJ	O
expansion	NN	O
of	IN	O
a	DT	O
polymorphic	JJ	O
(	(	O
CTG	NNP	O
)	)	O
n	RB	O
repeat	NN	O
,	,	O
located	VBN	O
in	IN	O
the	DT	O
DM	NNP	S_Disease
protein	NN	O
kinase	NN	O
gene	NN	O
.	.	O

We	PRP	O
determined	VBD	O
the	DT	O
(	(	O
CTG	NNP	O
)	)	O
n	RB	O
repeat	JJ	O
lengths	NNS	O
in	IN	O
a	DT	O
broad	JJ	O
range	NN	O
of	IN	O
tissue	NN	O
DNAs	NNP	O
from	IN	O
patients	NNS	O
with	IN	O
mild	JJ	O
,	,	O
classical	JJ	O
,	,	O
or	CC	O
congenital	JJ	O
manifestation	NN	O
of	IN	O
DM	NNP	S_Disease
.	.	O

Differences	NNS	O
in	IN	O
the	DT	O
repeat	NN	O
length	NN	O
were	VBD	O
seen	VBN	O
in	IN	O
somatic	JJ	O
tissues	NNS	O
from	IN	O
single	JJ	O
DM	NNP	S_Disease
individuals	NNS	O
and	CC	O
twins	NNS	O
.	.	O

Repeats	NNS	O
appeared	VBD	O
to	TO	O
expand	VB	O
to	TO	O
a	DT	O
similar	JJ	O
extent	NN	O
in	IN	O
tissues	NNS	O
originating	VBG	O
from	IN	O
the	DT	O
same	JJ	O
embryonal	JJ	O
origin	NN	O
.	.	O

In	IN	O
most	JJS	O
male	JJ	O
patients	NNS	O
carrying	VBG	O
intermediate	JJ	O
-	:	O
or	CC	O
small	JJ	O
-	:	O
sized	JJ	O
expansions	NNS	O
in	IN	O
blood	NN	O
,	,	O
the	DT	O
repeat	NN	O
lengths	NNS	O
covered	VBD	O
a	DT	O
markedly	RB	O
wider	NN	O
range	NN	O
in	IN	O
sperm	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
male	JJ	O
patients	NNS	O
with	IN	O
large	JJ	O
allele	JJ	O
expansions	NNS	O
in	IN	O
blood	NN	O
(	(	O
>	JJ	O
700	CD	O
CTGs	NNP	O
)	)	O
had	VBD	O
similar	JJ	O
or	CC	O
smaller	JJR	O
repeats	NNS	O
in	IN	O
sperm	NN	O
,	,	O
when	WRB	O
detectable	NN	O
.	.	O

Sperm	NNP	O
alleles	VBZ	O
with	IN	O
>	JJ	O
1	CD	O
,	,	O
000	CD	O
CTGs	NNP	O
were	VBD	O
not	RB	O
seen	VBN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
DM	NNP	S_Disease
patients	NNS	O
can	MD	O
be	VB	O
considered	VBN	O
gonosomal	JJ	O
mosaics	NNS	O
,	,	O
i	NN	O
.	.	O

e	NN	O
e	NN	O
.	.	O
,	,	O
combined	VBN	O
somatic	JJ	O
and	CC	O
germ	JJ	O
-	:	O
line	NN	O
tissue	NN	O
mosaics	NNS	O
.	.	O

Most	JJS	O
remarkably	RB	O
,	,	O
we	PRP	O
observed	VBD	O
multiple	JJ	O
cases	NNS	O
where	WRB	O
the	DT	O
length	NN	O
distributions	NNS	O
of	IN	O
intermediate	JJ	O
-	:	O
or	CC	O
small	JJ	O
-	:	O
sized	JJ	O
alleles	NNS	O
in	IN	O
fathers	NNS	O
sperm	VBP	O
were	VBD	O
significantly	RB	O
different	JJ	O
from	IN	O
that	DT	O
in	IN	O
their	PRP$	O
offsprings	NNS	O
blood	NN	O
.	.	O

Our	PRP$	O
combined	JJ	O
findings	NNS	O
indicate	VBP	O
that	IN	O
intergenerational	JJ	O
length	NN	O
changes	NNS	O
in	IN	O
the	DT	O
unstable	JJ	O
CTG	NNP	O
repeat	NN	O
are	VBP	O
most	RBS	O
likely	JJ	O
to	TO	O
occur	VB	O
during	IN	O
early	JJ	O
embryonic	JJ	O
mitotic	JJ	O
divisions	NNS	O
in	IN	O
both	DT	O
somatic	JJ	O
and	CC	O
germ	JJ	O
-	:	O
line	NN	O
tissue	NN	O
formation	NN	O
.	.	O

Both	DT	O
the	DT	O
initial	JJ	O
CTG	NNP	O
length	NN	O
,	,	O
the	DT	O
overall	JJ	O
number	NN	O
of	IN	O
cell	NN	O
divisions	NNS	O
involved	VBN	O
in	IN	O
tissue	NN	O
formation	NN	O
,	,	O
and	CC	O
perhaps	RB	O
a	DT	O
specific	JJ	O
selection	NN	O
process	NN	O
in	IN	O
spermatogenesis	NN	O
may	MD	O
influence	VB	O
the	DT	O
dynamics	NNS	O
of	IN	O
this	DT	O
process	NN	O
.	.	O

A	DT	O
model	NN	O
explaining	VBG	O
mitotic	JJ	O
instability	NN	O
and	CC	O
sex	NN	O
-	:	O
dependent	JJ	O
segregation	NN	O
phenomena	NN	O
in	IN	O
DM	NNP	S_Disease
manifestation	NN	O
is	VBZ	O
discussed	VBN	O

Regionally	RB	O
clustered	VBN	O
APC	NNP	S_Disease
mutations	NNS	O
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
severe	JJ	O
phenotype	NN	O
and	CC	O
occur	NN	O
at	IN	O
a	DT	O
high	JJ	O
frequency	NN	O
in	IN	O
new	JJ	O
mutation	NN	O
cases	NNS	O
of	IN	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
.	.	O

Germline	NNP	O
mutation	NN	O
in	IN	O
APC	NNP	O
at	IN	O
5q21	CD	O
-	:	O
22	CD	O
results	NNS	O
in	IN	O
the	DT	O
dominantly	RB	O
inherited	VBN	O
syndrome	RB	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
(	(	O
APC	NNP	S_Disease
)	)	O
.	.	O

Somatic	JJ	O
mutation	NN	O
in	IN	O
this	DT	O
gene	NN	O
is	VBZ	O
an	DT	O
early	JJ	O
event	NN	O
in	IN	O
colorectal	JJ	O
tumourigenesis	NN	O
.	.	O

Both	DT	O
types	NNS	O
of	IN	O
mutation	NN	O
are	VBP	O
concentrated	VBN	O
in	IN	O
the	DT	O
5	CD	O
half	NN	O
of	IN	O
exon	JJ	O
15	CD	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
single	JJ	O
strand	NN	O
conformational	JJ	O
polymorphism	NN	O
(	(	O
SSCP	NNP	O
)	)	O
and	CC	O
heteroduplex	JJ	O
analysis	NN	O
to	TO	O
screen	VB	O
for	IN	O
variants	NNS	O
in	IN	O
this	DT	O
region	NN	O
of	IN	O
the	DT	O
gene	NN	O
in	IN	O
a	DT	O
total	NN	O
of	IN	O
45	CD	O
affected	JJ	O
but	CC	O
unrelated	JJ	O
individuals	NNS	O
.	.	O

Eighteen	JJ	O
patients	NNS	O
had	VBD	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
the	DT	O
disease	NN	O
;	:	O
of	IN	O
these	DT	O
11	CD	O
were	VBD	O
classified	VBN	O
as	IN	O
having	VBG	O
a	DT	O
severe	JJ	O
phenotype	NN	O
,	,	O
based	VBN	O
on	IN	O
an	DT	O
early	JJ	O
age	NN	O
at	IN	O
presentation	NN	O
or	CC	O
cancer	NN	S_Disease
development	NN	O
.	.	O

This	DT	O
compared	VBN	O
with	IN	O
6	CD	O
of	IN	O
27	CD	O
familial	JJ	O
cases	NNS	O
.	.	O

A	DT	O
5	CD	O
bp	NN	O
deletion	NN	O
at	IN	O
codon	NN	O
1309	CD	O
reported	VBD	O
to	TO	O
occur	VB	O
in	IN	O
10	CD	O
-	:	O
15	CD	O
%	NN	O
of	IN	O
unselected	JJ	O
APC	NNP	S_Disease
patients	NNS	O
worldwide	RB	O
,	,	O
was	VBD	O
found	VBN	O
in	IN	O
5	CD	O
of	IN	O
the	DT	O
18	CD	O
new	JJ	O
mutation	NN	O
cases	NNS	O
and	CC	O
4	CD	O
of	IN	O
the	DT	O
27	CD	O
familial	JJ	O
cases	NNS	O
all	DT	O
nine	CD	O
were	VBD	O
classed	VBN	O
as	IN	O
severe	JJ	O
.	.	O

A	DT	O
further	JJ	O
3	CD	O
new	JJ	O
mutations	NNS	O
and	CC	O
1	CD	O
familial	JJ	O
mutation	NN	O
were	VBD	O
located	VBN	O
downstream	NN	O
from	IN	O
codon	NN	O
1309	CD	O
,	,	O
these	DT	O
individuals	NNS	O
similarly	RB	O
being	VBG	O
classed	VBN	O
as	IN	O
phenotypically	RB	O
severe	JJ	O
.	.	O

In	IN	O
contrast	NN	O
all	DT	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
mutations	NNS	O
detected	VBD	O
in	IN	O
affected	JJ	O
individuals	NNS	O
with	IN	O
an	DT	O
average	JJ	O
phenotype	NN	O
were	VBD	O
located	VBN	O
prior	RB	O
to	TO	O
codon	VB	O
1309	CD	O
.	.	O

The	DT	O
frequent	JJ	O
association	NN	O
of	IN	O
a	DT	O
severe	JJ	O
phenotype	NN	O
with	IN	O
fresh	JJ	O
mutation	NN	O
may	MD	O
explain	VB	O
the	DT	O
apparent	JJ	O
conflict	NN	O
of	IN	O
a	DT	O
high	JJ	O
mutation	NN	O
rate	NN	O
(	(	O
20	CD	O
-	:	O
30	CD	O
%	NN	O
)	)	O
in	IN	O
a	DT	O
condition	NN	O
,	,	O
which	WDT	O
on	IN	O
average	NN	O
,	,	O
is	VBZ	O
lethal	VBN	O
at	IN	O
a	DT	O
post	NN	O
-	:	O
reproductive	JJ	O
age	NN	O
.	.	O
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
PAX6	NNP	O
locus	NN	O
are	VBP	O
found	VBN	O
in	IN	O
heterogeneous	JJ	O
anterior	JJ	B_Disease
segment	NN	I_Disease
malformations	NNS	E_Disease
including	VBG	O
Peters	NNP	B_Disease
'	POS	I_Disease
anomaly	NN	E_Disease
.	.	O

Mutation	NN	O
or	CC	O
deletion	NN	O
of	IN	O
the	DT	O
PAX6	NNP	O
gene	NN	O
underlies	NNS	O
many	JJ	O
cases	NNS	O
of	IN	O
aniridia	NN	S_Disease
.	.	O

Three	CD	O
lines	NNS	O
of	IN	O
evidence	NN	O
now	RB	O
converge	VBZ	O
to	TO	O
implicate	VB	O
PAX6	NNP	O
more	RBR	O
widely	RB	O
in	IN	O
anterior	JJ	B_Disease
segment	NN	I_Disease
malformations	NNS	E_Disease
including	VBG	O
Peters	NNP	B_Disease
anomaly	NN	E_Disease
.	.	O

First	RB	O
,	,	O
a	DT	O
child	NN	O
with	IN	O
Peters	NNP	B_Disease
anomaly	VBP	E_Disease
is	VBZ	O
deleted	VBN	O
for	IN	O
one	CD	O
copy	NN	O
of	IN	O
PAX6	NNP	O
.	.	O

Second	JJ	O
,	,	O
affected	JJ	O
members	NNS	O
of	IN	O
a	DT	O
family	NN	O
with	IN	O
dominantly	RB	O
inherited	VBN	O
anterior	JJ	B_Disease
segment	NN	I_Disease
malformations	NNS	E_Disease
,	,	O
including	VBG	O
Peters	NNP	B_Disease
anomaly	NN	E_Disease
are	VBP	O
heterozygous	JJ	O
for	IN	O
an	DT	O
R26G	NNP	O
mutation	NN	O
in	IN	O
the	DT	O
PAX6	NNP	O
paired	VBD	O
box	NN	O
.	.	O

Third	NNP	O
,	,	O
a	DT	O
proportion	NN	O
of	IN	O
Sey	NNP	O
/	NNP	O
+	NNP	O
Smalleye	NNP	O
mice	NN	O
,	,	O
heterozygous	JJ	O
for	IN	O
a	DT	O
nonsense	JJ	O
mutation	NN	O
in	IN	O
murine	NN	O
Pax	NNP	O
-	:	O
6	CD	O
,	,	O
have	VBP	O
an	DT	O
ocular	JJ	O
phenotype	NN	O
resembling	VBG	O
Peters	NNP	B_Disease
anomaly	NN	E_Disease
.	.	O

We	PRP	O
therefore	VBP	O
propose	JJ	O
that	IN	O
a	DT	O
variety	NN	O
of	IN	O
anterior	JJ	B_Disease
segment	NN	I_Disease
anomalies	NNS	E_Disease
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
PAX6	NNP	O
mutations	NNS	O
.	.	O
.	.	O

Huntington	NNP	B_Disease
disease	NN	E_Disease
without	IN	O
CAG	NNP	O
expansion	NN	O
:	:	O
phenocopies	NNS	O
or	CC	O
errors	NNS	O
in	IN	O
assignment	NN	O
?	.	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
an	DT	O
expanded	VBN	O
CAG	NNP	O
repeat	NN	O
within	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
on	IN	O
4p16	CD	O
.	.	O

3	CD	O
(	(	O
IT15	NNP	O
)	)	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
30	CD	O
of	IN	O
1	CD	O
,	,	O
022	CD	O
affected	JJ	O
persons	NNS	O
(	(	O
2	CD	O
.	.	O

9	CD	O
%	NN	O
of	IN	O
our	PRP$	O
cohort	NN	O
)	)	O
did	VBD	O
not	RB	O
have	VB	O
an	DT	O
expanded	VBN	O
CAG	NN	O
in	IN	O
the	DT	O
disease	NN	O
range	NN	O
.	.	O

The	DT	O
reasons	NNS	O
for	IN	O
not	RB	O
observing	VBG	O
expansion	NN	O
in	IN	O
affected	JJ	O
individuals	NNS	O
are	VBP	O
important	JJ	O
for	IN	O
determining	VBG	O
the	DT	O
sensitivity	NN	O
of	IN	O
using	VBG	O
repeat	NN	O
length	NN	O
both	DT	O
for	IN	O
diagnosis	NN	O
of	IN	O
affected	JJ	O
patients	NNS	O
and	CC	O
for	IN	O
predictive	JJ	O
testing	NN	O
programs	NNS	O
and	CC	O
may	MD	O
have	VB	O
biological	JJ	O
relevance	NN	O
for	IN	O
the	DT	O
understanding	NN	O
of	IN	O
the	DT	O
molecular	JJ	O
mechanism	NN	O
underlying	VBG	O
HD	NNP	S_Disease
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
the	DT	O
majority	NN	O
(	(	O
18	CD	O
)	)	O
of	IN	O
the	DT	O
individuals	NNS	O
with	IN	O
normal	JJ	O
sized	JJ	O
alleles	NNS	O
represent	VBP	O
misdiagnosis	NN	O
,	,	O
sample	JJ	O
mix	SYM	O
-	:	O
up	RB	O
,	,	O
or	CC	O
clerical	JJ	O
error	NN	O
.	.	O

The	DT	O
remaining	VBG	O
12	CD	O
patients	NNS	O
represent	JJ	O
possible	JJ	O
phenocopies	NNS	O
for	IN	O
HD	NNP	S_Disease
.	.	O

In	IN	O
at	IN	O
least	JJS	O
four	CD	O
cases	NNS	O
,	,	O
family	NN	O
studies	NNS	O
of	IN	O
these	DT	O
phenocopies	NNS	O
excluded	VBD	O
4p16	CD	O
.	.	O

3	CD	O
as	IN	O
the	DT	O
region	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
phenotype	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
HD	NNP	S_Disease
gene	NN	O
that	WDT	O
are	VBP	O
other	JJ	O
than	IN	O
CAG	NNP	O
expansion	NN	O
have	VBP	O
not	RB	O
been	VBN	O
excluded	VBN	O
for	IN	O
the	DT	O
remaining	VBG	O
eight	CD	O
cases	NNS	O
;	:	O
however	RB	O
,	,	O
in	IN	O
as	RB	O
many	JJ	O
as	IN	O
seven	CD	O
of	IN	O
these	DT	O
persons	NNS	O
,	,	O
retrospective	JJ	O
review	NN	O
of	IN	O
these	DT	O
patients	NNS	O
clinical	JJ	O
features	NNS	O
identified	VBN	O
characteristics	NNS	O
not	RB	O
typical	JJ	O
for	IN	O
HD	NNP	S_Disease
.	.	O

This	DT	O
study	NN	O
shows	VBZ	O
that	IN	O
on	IN	O
rare	JJ	O
occasions	NNS	O
mutations	NNS	O
in	IN	O
other	JJ	O
,	,	O
as	IN	O
-	:	O
yet	RB	O
-	:	O
undefined	JJ	O
genes	NNS	O
can	MD	O
present	VB	O
with	IN	O
a	DT	O
clinical	JJ	O
phenotype	NN	O
very	RB	O
similar	JJ	O
to	TO	O
that	DT	O
of	IN	O
HD	NNP	S_Disease

Frequent	JJ	O
detection	NN	O
of	IN	O
codon	NN	O
877	CD	O
mutation	NN	O
in	IN	O
the	DT	O
androgen	NN	O
receptor	NN	O
gene	NN	O
in	IN	O
advanced	JJ	B_Disease
prostate	NN	I_Disease
cancers	NNS	E_Disease
.	.	O

Prostatic	JJ	O
tissue	NN	O
specimens	NNS	O
derived	VBN	O
from	IN	O
transurethral	JJ	O
resections	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
metastatic	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
were	VBD	O
analyzed	VBN	O
for	IN	O
genetic	JJ	O
alterations	NNS	O
in	IN	O
the	DT	O
hormone	NN	O
-	:	O
binding	NN	O
domain	NN	O
of	IN	O
the	DT	O
androgen	NN	O
receptor	NN	O
(	(	O
AR	NNP	O
)	)	O
gene	NN	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
-	:	O
derived	VBN	O
DNAs	NNP	O
of	IN	O
6	CD	O
of	IN	O
24	CD	O
specimens	NNS	O
revealed	VBD	O
a	DT	O
codon	NN	O
877	CD	O
mutation	NN	O
(	(	O
ACT	NNP	O
-	:	O
-	:	O
>	NN	O
GCT	NNP	O
,	,	O
Thr	NNP	O
-	:	O
-	:	O
>	NN	O
Ala	NNP	O
)	)	O
in	IN	O
the	DT	O
hormone	NN	O
-	:	O
binding	NN	O
domain	NN	O
of	IN	O
the	DT	O
AR	NNP	O
gene	NN	O
.	.	O

This	DT	O
same	JJ	O
AR	NNP	O
mutation	NN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
previously	RB	O
in	IN	O
a	DT	O
metastatic	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
cell	NN	O
line	NN	O
,	,	O
LNCaP	NNP	O
,	,	O
where	WRB	O
this	DT	O
mutation	NN	O
confers	VBZ	O
upon	IN	O
the	DT	O
AR	NNP	O
an	DT	O
altered	JJ	O
ligand	NN	O
-	:	O
binding	NN	O
specificity	NN	O
which	WDT	O
is	VBZ	O
stimulated	VBN	O
by	IN	O
estrogens	NNS	O
,	,	O
progestagens	NNS	O
,	,	O
and	CC	O
antiandrogens	NNS	O
.	.	O

It	PRP	O
is	VBZ	O
possible	JJ	O
that	IN	O
analogous	JJ	O
to	TO	O
an	DT	O
activated	VBN	O
/	NN	O
altered	VBD	O
growth	NN	O
factor	NN	O
receptor	NN	O
oncogene	NN	O
,	,	O
codon	VBP	O
877	CD	O
mutant	JJ	O
AR	NNP	O
with	IN	O
altered	JJ	O
ligand	NN	O
binding	NN	O
may	MD	O
provide	VB	O
a	DT	O
selective	JJ	O
growth	NN	O
advantage	NN	O
in	IN	O
the	DT	O
genesis	NN	O
of	IN	O
a	DT	O
subset	NN	O
of	IN	O
advanced	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
.	.	O

Although	IN	O
estrogens	NNS	O
are	VBP	O
used	VBN	O
infrequently	RB	O
,	,	O
antiandrogens	NNS	O
are	VBP	O
used	VBN	O
increasingly	RB	O
in	IN	O
hormonal	JJ	O
therapy	NN	O
for	IN	O
patients	NNS	O
with	IN	O
advanced	JJ	B_Disease
prostate	NN	I_Disease
cancer	NN	E_Disease
.	.	O

The	DT	O
stimulatory	JJ	O
effect	NN	O
of	IN	O
these	DT	O
therapeutic	JJ	O
agents	NNS	O
on	IN	O
the	DT	O
codon	NN	O
877	CD	O
mutant	NN	O
AR	NNP	O
further	RB	O
suggests	VBZ	O
that	IN	O
this	DT	O
frequently	RB	O
observed	VBN	O
AR	NNP	O
mutation	NN	O
may	MD	O
contribute	VB	O
to	TO	O
the	DT	O
treatment	NN	O
refractory	NN	O
disease	NN	O
.	.	O
.	.	O

The	DT	O
human	JJ	O
gene	NN	O
for	IN	O
alkaptonuria	NNS	S_Disease
(	(	O
AKU	NNP	S_Disease
)	)	O
maps	VBZ	O
to	TO	O
chromosome	VB	O
3q	CD	O
.	.	O

Alkaptonuria	NNP	S_Disease
(	(	O
AKU	NNP	S_Disease
;	:	O
McKusick	NNP	O
no	DT	O
.	.	O

203500	CD	O
)	)	O
is	VBZ	O
a	DT	O
rare	JJ	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
caused	VBN	O
by	IN	O
the	DT	O
lack	NN	O
of	IN	O
homogentisic	JJ	O
acid	JJ	O
oxidase	NN	O
activity	NN	O
.	.	O

Patients	NNS	O
excrete	VBP	O
large	JJ	O
amounts	NNS	O
of	IN	O
homogentisic	JJ	O
acid	NN	O
in	IN	O
their	PRP$	O
urine	NN	O
and	CC	O
a	DT	O
black	JJ	O
ochronotic	JJ	O
pigment	NN	O
is	VBZ	O
deposited	VBN	O
in	IN	O
their	PRP$	O
cartilage	NN	O
and	CC	O
collagenous	JJ	O
tissues	NNS	O
.	.	O

Ochronosis	NN	S_Disease
is	VBZ	O
the	DT	O
predominant	JJ	O
clinical	JJ	O
complication	NN	O
of	IN	O
the	DT	O
disease	NN	O
leading	VBG	O
to	TO	O
ochronotic	JJ	B_Disease
arthropathy	NN	E_Disease
,	,	O
dark	JJ	O
urine	NN	O
,	,	O
pigment	JJ	O
changes	NNS	O
of	IN	O
the	DT	O
skin	NN	O
,	,	O
and	CC	O
other	JJ	O
clinical	JJ	O
features	NNS	O
.	.	O

A	DT	O
mutation	NN	O
causing	VBG	O
alkaptonuria	NNS	S_Disease
in	IN	O
the	DT	O
mouse	NN	O
has	VBZ	O
mapped	VBN	O
to	TO	O
chromosome	VB	O
16	CD	O
.	.	O

Considering	VBG	O
conserved	VBN	O
synteny	NN	O
,	,	O
we	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
map	VB	O
the	DT	O
human	JJ	O
gene	NN	O
to	TO	O
chromosome	VB	O
3q	CD	O
in	IN	O
six	CD	O
alkaptonuria	NNS	S_Disease
pedigrees	NNS	O
of	IN	O
Slovak	NNP	O
origin	NN	O
.	.	O
.	.	O

Structure	NN	O
of	IN	O
the	DT	O
human	JJ	O
Na	NNP	O
+	NNP	O
/	NNP	O
glucose	VBP	O
cotransporter	NN	O
gene	NN	O
SGLT1	NNP	O
.	.	O

Intestinal	JJ	O
uptake	NN	O
of	IN	O
dietary	JJ	O
glucose	NN	O
and	CC	O
galactose	NN	O
is	VBZ	O
mediated	VBN	O
by	IN	O
the	DT	O
SGLT1	NNP	O
Na	NNP	O
+	NNP	O
/	NNP	O
glucose	VBP	O
cotransporter	NN	O
of	IN	O
the	DT	O
brush	NN	O
border	NN	O
.	.	O

An	DT	O
SGLT1	NNP	O
missense	NN	O
mutation	NN	O
underlies	NNS	O
hereditary	VBP	B_Disease
glucose	JJ	I_Disease
/	NNP	I_Disease
galactose	NN	I_Disease
malabsorption	NN	E_Disease
,	,	O
characterized	VBN	O
by	IN	O
potentially	RB	O
fatal	JJ	O
diarrhea	NN	S_Disease
;	:	O
conversely	RB	O
,	,	O
oral	JJ	O
rehydration	NN	O
therapy	NN	O
exploits	VBZ	O
normal	JJ	O
transport	NN	O
to	TO	O
alleviate	VB	O
life	NN	O
-	:	O
threatening	VBG	O
diarrhea	NN	S_Disease
of	IN	O
infectious	JJ	O
origin	NN	O
.	.	O

We	PRP	O
have	VBP	O
mapped	VBN	O
the	DT	O
entire	JJ	O
human	JJ	O
SGLT1	NNP	O
Na	NNP	O
+	NNP	O
/	NNP	O
glucose	VBP	O
cotransporter	JJ	O
gene	NN	O
from	IN	O
cosmid	NN	O
and	CC	O
lambda	JJ	O
phage	NN	O
clones	NNS	O
representing	VBG	O
a	DT	O
genomic	JJ	O
region	NN	O
of	IN	O
112	CD	O
kilobases	NNS	O
.	.	O

Transcription	NN	O
initiation	NN	O
occurred	VBD	O
from	IN	O
a	DT	O
site	NN	O
27	CD	O
base	NN	O
pairs	VBD	O
3	CD	O
of	IN	O
a	DT	O
TATAA	NNP	O
sequence	NN	O
.	.	O

All	DT	O
exon	SYM	O
-	:	O
flanking	NN	O
regions	NNS	O
were	VBD	O
sequenced	VBN	O
,	,	O
and	CC	O
the	DT	O
entire	JJ	O
112	CD	O
-	:	O
kilobase	NN	O
region	NN	O
mapped	VBD	O
with	IN	O
four	CD	O
restriction	NN	O
enzymes	NNS	O
.	.	O

SGLT1	NNP	O
is	VBZ	O
comprised	VBN	O
of	IN	O
15	CD	O
exons	NNS	O
(	(	O
spanning	VBG	O
72	CD	O
kilobases	NNS	O
)	)	O
;	:	O
a	DT	O
possible	JJ	O
evolutionary	JJ	O
origin	NN	O
from	IN	O
a	DT	O
six	CD	O
-	:	O
membrane	NN	O
-	:	O
span	JJ	O
ancestral	JJ	O
precursor	NN	O
via	IN	O
a	DT	O
gene	NN	O
duplication	NN	O
event	NN	O
is	VBZ	O
suggested	VBN	O
from	IN	O
comparison	NN	O
of	IN	O
exons	NNS	O
against	IN	O
protein	JJ	O
secondary	JJ	O
structure	NN	O
and	CC	O
from	IN	O
sequence	NN	O
considerations	NNS	O
.	.	O

A	DT	O
new	JJ	O
missense	NN	O
mutation	NN	O
in	IN	O
exon	$	O
1	CD	O
causing	VBG	O
glucose	JJ	B_Disease
/	NNS	I_Disease
galactose	JJ	I_Disease
malabsorption	NN	E_Disease
is	VBZ	O
also	RB	O
described	VBN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
Na	NNP	O
(	(	O
+	NNP	O
)	)	O
-	:	O
dependent	JJ	O
cotransporter	NN	O
gene	NN	O
structure	NN	O
reported	VBN	O
.	.	O

These	DT	O
data	NNS	O
facilitate	VBP	O
the	DT	O
search	NN	O
for	IN	O
new	JJ	O
glucose	JJ	B_Disease
/	NNS	I_Disease
galactose	JJ	I_Disease
malabsorption	NN	E_Disease
-	:	O
related	JJ	O
mutations	NNS	O
in	IN	O
this	DT	O
important	JJ	O
gene	NN	O
and	CC	O
provide	VB	O
a	DT	O
basis	NN	O
for	IN	O
future	JJ	O
evolutionary	JJ	O
comparisons	NNS	O
with	IN	O
other	JJ	O
Na	NNP	O
(	(	O
+	NNP	O
)	)	O
-	:	O
dependent	JJ	O
cotransporters	NNS	O
.	.	O
.	.	O

Four	CD	O
novel	JJ	O
PEPD	NNP	O
alleles	NNS	O
causing	VBG	O
prolidase	NN	B_Disease
deficiency	NN	E_Disease
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
PEPD	NNP	O
locus	NN	O
cause	NN	O
prolidase	NN	B_Disease
deficiency	NN	E_Disease
(	(	O
McKusick	NNP	O
170100	CD	O
)	)	O
,	,	O
a	DT	O
rare	JJ	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disorder	NN	E_Disease
characterized	VBN	O
by	IN	O
iminodipeptiduria	NN	S_Disease
,	,	O
skin	JJ	B_Disease
ulcers	NNS	E_Disease
,	,	O
mental	JJ	B_Disease
retardation	NN	E_Disease
,	,	O
and	CC	O
recurrent	JJ	O
infections	NNS	O
.	.	O

Four	CD	O
PEPD	NNP	O
mutations	NNS	O
from	IN	O
five	CD	O
severely	RB	O
affected	JJ	O
individuals	NNS	O
were	VBD	O
characterized	VBN	O
by	IN	O
analysis	NN	O
of	IN	O
reverse	NN	O
-	:	O
transcribed	NN	O
,	,	O
PCR	NNP	O
-	:	O
amplified	VBD	O
(	(	O
RT	NNP	O
-	:	O
PCR	NN	O
)	)	O
cDNA	NN	O
.	.	O

We	PRP	O
used	VBD	O
SSCP	NNP	O
analysis	NN	O
on	IN	O
four	CD	O
overlapping	VBG	O
cDNA	NN	O
fragments	NNS	O
covering	VBG	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
the	DT	O
PEPD	NNP	O
gene	NN	O
and	CC	O
detected	VBN	O
abnormal	JJ	O
SSCP	NNP	O
bands	NNS	O
for	IN	O
the	DT	O
fragment	NN	O
spanning	VBG	O
all	DT	O
or	CC	O
part	NN	O
of	IN	O
exons	NNS	O
13	CD	O
-	:	O
15	CD	O
in	IN	O
three	CD	O
of	IN	O
the	DT	O
probands	NNS	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
cDNAs	NN	O
showed	VBD	O
a	DT	O
G	NNP	O
-	:	O
-	:	O
>	NN	O
A	NNP	O
,	,	O
1342	CD	O
substitution	NN	O
(	(	O
G448R	NNP	O
)	)	O
in	IN	O
two	CD	O
patients	NNS	O
and	CC	O
a	DT	O
3	CD	O
-	:	O
bp	NN	O
deletion	NN	O
(	(	O
delta	JJ	O
E452	NNP	O
or	CC	O
delta	JJ	O
E453	NNP	O
)	)	O
in	IN	O
another	DT	O
.	.	O

In	IN	O
the	DT	O
other	JJ	O
two	CD	O
probands	VBZ	O
the	DT	O
amplified	JJ	O
products	NNS	O
were	VBD	O
of	IN	O
reduced	JJ	O
size	NN	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
these	DT	O
mutant	JJ	O
cDNAs	NN	O
revealed	VBD	O
a	DT	O
deletion	NN	O
of	IN	O
exon	$	O
5	CD	O
in	IN	O
one	CD	O
patient	NN	O
and	CC	O
of	IN	O
exon	JJ	O
7	CD	O
in	IN	O
the	DT	O
other	JJ	O
.	.	O

Intronic	JJ	O
sequences	NNS	O
flanking	VBG	O
exons	NNS	O
5	CD	O
and	CC	O
7	CD	O
were	VBD	O
identified	VBN	O
using	VBG	O
inverse	JJ	O
PCR	NNP	O
followed	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
.	.	O

Conventional	JJ	O
PCR	NNP	O
and	CC	O
direct	JJ	O
sequencing	NN	O
then	RB	O
established	VBD	O
the	DT	O
intron	NN	O
-	:	O
exon	JJ	O
borders	NNS	O
of	IN	O
the	DT	O
mutant	JJ	O
genomic	JJ	O
DNA	NN	O
revealing	VBG	O
two	CD	O
splice	JJ	O
acceptor	NN	O
mutations	NNS	O
a	DT	O
G	NNP	O
-	:	O
-	:	O
>	NN	O
C	NNP	O
substitution	NN	O
at	IN	O
position	NN	O
-	:	O
1	CD	O
of	IN	O
intron	NN	O
4	CD	O
and	CC	O
an	DT	O
A	NNP	O
-	:	O
-	:	O
>	NN	O
G	NNP	O
substitution	NN	O
at	IN	O
position	NN	O
-	:	O
2	CD	O
of	IN	O
intron	NN	O
6	CD	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
severe	JJ	O
form	NN	O
of	IN	O
prolidase	NN	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
multiple	JJ	O
PEPD	NNP	O
alleles	NNS	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
we	PRP	O
attempt	VBP	O
to	TO	O
begin	VB	O
the	DT	O
process	NN	O
of	IN	O
describing	VBG	O
these	DT	O
alleles	NNS	O
and	CC	O
cataloging	VBG	O
their	PRP$	O
phenotypic	NN	O
expression	NN	O
.	.	O
.	.	O

Recombinations	NNS	O
in	IN	O
individuals	NNS	O
homozygous	JJ	O
by	IN	O
descent	NN	O
localize	VB	O
the	DT	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
locus	NN	O
in	IN	O
a	DT	O
cloned	JJ	O
450	CD	O
-	:	O
kb	NN	O
interval	NN	O
.	.	O

The	DT	O
locus	NN	O
for	IN	O
Friedreich	NNP	B_Disease
ataxia	NN	E_Disease
(	(	O
FRDA	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
severe	JJ	O
neurodegenerative	JJ	B_Disease
disease	NN	E_Disease
,	,	O
is	VBZ	O
tightly	RB	O
linked	VBN	O
to	TO	O
markers	NNS	O
D9S5	NNP	O
and	CC	O
D9S15	NNP	O
,	,	O
and	CC	O
analysis	NN	O
of	IN	O
rare	JJ	O
recombination	NN	O
events	NNS	O
has	VBZ	O
suggested	VBN	O
the	DT	O
order	NN	O
cen	SYM	O
-	:	O
FRDA	NNP	O
-	:	O
D9S5	NNP	O
-	:	O
D9S15	NNP	O
-	:	O
qter	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
construction	NN	O
of	IN	O
a	DT	O
YAC	NNP	O
contig	NN	O
extending	VBG	O
800	CD	O
kb	JJ	O
centromeric	NN	O
to	TO	O
D9S5	NNP	O
and	CC	O
the	DT	O
isolation	NN	O
of	IN	O
five	CD	O
new	JJ	O
microsatellite	NN	O
markers	NNS	O
from	IN	O
this	DT	O
region	NN	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
map	VB	O
these	DT	O
markers	NNS	O
with	IN	O
respect	NN	O
to	TO	O
the	DT	O
FRDA	NNP	S_Disease
locus	NN	O
,	,	O
all	DT	O
within	IN	O
a	DT	O
1	CD	O
-	:	O
cM	NN	O
confidence	NN	O
interval	NN	O
,	,	O
we	PRP	O
sought	VBD	O
to	TO	O
increase	VB	O
the	DT	O
genetic	JJ	O
information	NN	O
of	IN	O
available	JJ	O
FRDA	NNP	S_Disease
families	NNS	O
by	IN	O
considering	VBG	O
homozygosity	NN	O
by	IN	O
descent	NN	O
and	CC	O
association	NN	O
with	IN	O
founder	NN	O
haplotypes	NNS	O
in	IN	O
isolated	JJ	O
populations	NNS	O
.	.	O

This	DT	O
approach	NN	O
allowed	VBD	O
us	PRP	O
to	TO	O
identify	VB	O
one	CD	O
phase	NN	O
-	:	O
known	VBN	O
recombination	NN	O
and	CC	O
one	CD	O
probable	JJ	O
historic	JJ	O
recombination	NN	O
on	IN	O
haplotypes	NNS	O
from	IN	O
Reunion	NNP	O
Island	NNP	O
patients	NNS	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
place	VBP	O
three	CD	O
of	IN	O
the	DT	O
five	CD	O
markers	NNS	O
proximal	VBP	O
to	TO	O
FRDA	NNP	S_Disease
.	.	O

This	DT	O
represents	VBZ	O
the	DT	O
first	JJ	O
identification	NN	O
of	IN	O
close	JJ	O
FRDA	NNP	S_Disease
flanking	NN	O
markers	NNS	O
on	IN	O
the	DT	O
centromeric	JJ	O
side	NN	O
.	.	O

The	DT	O
two	CD	O
other	JJ	O
markers	NNS	O
allowed	VBD	O
us	PRP	O
to	TO	O
narrow	VB	O
the	DT	O
breakpoint	NN	O
of	IN	O
a	DT	O
previously	RB	O
identified	VBN	O
distal	JJ	O
recombination	NN	O
that	WDT	O
is	VBZ	O
>	JJ	O
180	CD	O
kb	NN	O
from	IN	O
D9S5	NNP	O
(	(	O
26P	CD	O
)	)	O
.	.	O

Taken	VBN	O
together	RB	O
,	,	O
the	DT	O
results	NNS	O
place	VBP	O
the	DT	O
FRDA	NNP	S_Disease
locus	NN	O
in	IN	O
a	DT	O
450	CD	O
-	:	O
kb	NN	O
interval	NN	O
,	,	O
which	WDT	O
is	VBZ	O
small	JJ	O
enough	RB	O
for	IN	O
direct	JJ	O
search	NN	O
of	IN	O
candidate	NN	O
genes	NNS	O
.	.	O

A	DT	O
detailed	JJ	O
rare	JJ	O
cutter	NN	O
restriction	NN	O
map	NN	O
and	CC	O
a	DT	O
cosmid	NN	O
contig	NN	O
covering	VBG	O
this	DT	O
interval	NN	O
were	VBD	O
constructed	VBN	O
and	CC	O
should	MD	O
facilitate	VB	O
the	DT	O
search	NN	O
of	IN	O
genes	NNS	O
in	IN	O
this	DT	O
region	NN	O
.	.	O
.	.	O

Investigation	NN	O
of	IN	O
thermoregulatory	NN	O
characteristics	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

A	DT	O
survey	NN	O
instrument	NN	O
is	VBZ	O
used	VBN	O
to	TO	O
assess	VB	O
temperature	NN	O
regulation	NN	O
characteristics	NNS	O
in	IN	O
children	NNS	O
with	IN	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
compared	VBN	O
to	TO	O
3	CD	O
control	NN	O
groups	NNS	O
sibs	NN	O
of	IN	O
PWS	NNP	S_Disease
patients	NNS	O
(	(	O
SIB	NNP	O
)	)	O
,	,	O
neurodevelopmentally	RB	B_Disease
handicapped	VBD	E_Disease
children	NNS	O
(	(	O
ND	NNP	O
)	)	O
,	,	O
and	CC	O
age	NN	O
and	CC	O
gender	NN	O
matched	VBN	O
well	RB	O
children	NNS	O
(	(	O
WC	NNP	O
)	)	O
.	.	O

Significant	JJ	O
differences	NNS	O
were	VBD	O
found	VBN	O
between	IN	O
PWS	NNP	S_Disease
patients	NNS	O
,	,	O
SIB	NNP	O
controls	VBZ	O
,	,	O
and	CC	O
WC	NNP	O
controls	NNS	O
in	IN	O
the	DT	O
prevalence	NN	O
of	IN	O
febrile	JJ	O
convulsions	NNS	O
,	,	O
fever	SYM	O
-	:	O
associated	VBN	O
symptoms	NNS	O
,	,	O
and	CC	O
temperature	NN	O
less	JJR	O
than	IN	O
94	CD	O
degrees	NNS	O
F	NNP	O
.	.	O

No	DT	O
differences	NNS	O
were	VBD	O
noted	VBN	O
in	IN	O
any	DT	O
variable	JJ	O
between	IN	O
the	DT	O
PWS	NNP	S_Disease
patients	NNS	O
and	CC	O
the	DT	O
ND	NNP	O
controls	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
these	DT	O
abnormalities	NNS	O
are	VBP	O
not	RB	O
unique	JJ	O
to	TO	O
PWS	NNP	S_Disease
,	,	O
but	CC	O
can	MD	O
occur	VB	O
in	IN	O
any	DT	O
neurodevelopmentally	RB	B_Disease
handicapped	VBN	E_Disease
individual	NN	O
,	,	O
further	JJ	O
suggesting	VBG	O
these	DT	O
do	VBP	O
not	RB	O
necessarily	RB	O
reflect	VB	O
syndrome	JJ	O
-	:	O
specific	JJ	O
hypothalamic	JJ	B_Disease
abnormalities	NNS	E_Disease
.	.	O
.	.	O

Phenotypic	NNP	O
variation	NN	O
including	VBG	O
retinitis	NN	B_Disease
pigmentosa	NN	E_Disease
,	,	O
pattern	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
and	CC	O
fundus	NN	B_Disease
flavimaculatus	NN	E_Disease
in	IN	O
a	DT	O
single	JJ	O
family	NN	O
with	IN	O
a	DT	O
deletion	NN	O
of	IN	O
codon	NN	O
153	CD	O
or	CC	O
154	CD	O
of	IN	O
the	DT	O
peripherin	NN	O
/	NN	O
RDS	NNP	O
gene	NN	O
.	.	O

BACKGROUND	NNP	O
AND	NNP	O
OBJECTIVES	NNP	O
Mutations	NNP	O
of	IN	O
the	DT	O
peripherin	NN	O
/	NN	O
RDS	NNP	O
gene	NN	O
have	VBP	O
been	VBN	O
reported	VBN	O
in	IN	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
retinitis	NN	I_Disease
pigmentosa	NN	E_Disease
,	,	O
pattern	JJ	O
macular	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
and	CC	O
retinitis	NN	B_Disease
punctata	NN	I_Disease
albescens	NNS	E_Disease
.	.	O

We	PRP	O
report	VBP	O
herein	VBD	O
the	DT	O
occurrence	NN	O
of	IN	O
three	CD	O
separate	JJ	O
phenotypes	NNS	O
within	IN	O
a	DT	O
single	JJ	O
family	NN	O
with	IN	O
a	DT	O
novel	JJ	O
3	CD	O
-	:	O
base	NN	O
pair	NN	O
deletion	NN	O
of	IN	O
codon	NN	O
153	CD	O
or	CC	O
154	CD	O
of	IN	O
the	DT	O
peripherin	NN	O
/	NN	O
RDS	NNP	O
gene	NN	O
.	.	O

DESIGN	NNP	O
Case	NNP	O
reports	VBZ	O
with	IN	O
clinical	JJ	O
features	NNS	O
,	,	O
fluorescein	NN	O
angiography	NN	O
,	,	O
kinetic	JJ	O
perimetry	NN	O
,	,	O
electrophysiological	JJ	O
studies	NNS	O
,	,	O
and	CC	O
molecular	JJ	O
genetics	NNS	O
.	.	O

SETTING	NN	O
University	NNP	O
medical	JJ	O
centers	NNS	O
.	.	O

PATIENTS	VB	O
A	DT	O
75	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
woman	NN	O
,	,	O
her	PRP	O
two	CD	O
daughters	NNS	O
(	(	O
aged	VBN	O
44	CD	O
and	CC	O
50	CD	O
years	NNS	O
)	)	O
,	,	O
and	CC	O
her	PRP$	O
49	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
son	NN	O
were	VBD	O
screened	VBN	O
for	IN	O
peripherin	NN	O
/	NN	O
RDS	NNP	O
mutations	NNS	O
because	IN	O
of	IN	O
the	DT	O
presence	NN	O
of	IN	O
multiple	JJ	O
phenotypes	NNS	O
within	IN	O
the	DT	O
same	JJ	O
family	NN	O
.	.	O

RESULTS	VB	O
The	DT	O
mother	NN	O
presented	VBD	O
at	IN	O
age	NN	O
63	CD	O
years	NNS	O
with	IN	O
a	DT	O
profoundly	RB	O
abnormal	JJ	O
electroretinogram	NN	O
(	(	O
ERG	NNP	O
)	)	O
and	CC	O
adult	$	O
-	:	O
onset	NN	O
retinitis	NN	B_Disease
pigmentosa	NN	E_Disease
that	WDT	O
progressed	VBD	O
dramatically	RB	O
over	IN	O
12	CD	O
years	NNS	O
,	,	O
with	IN	O
marked	JJ	O
loss	NN	O
of	IN	O
peripheral	JJ	O
visual	JJ	O
field	NN	O
.	.	O

One	CD	O
daughter	NN	O
developed	VBD	O
pattern	JJ	B_Disease
macular	JJ	I_Disease
dystrophy	NN	E_Disease
at	IN	O
age	NN	O
31	CD	O
years	NNS	O
.	.	O

At	IN	O
age	NN	O
44	CD	O
years	NNS	O
,	,	O
her	PRP$	O
ERG	NNP	O
was	VBD	O
moderately	RB	O
abnormal	JJ	O
but	CC	O
her	PRP$	O
clinical	JJ	O
disease	NN	O
was	VBD	O
limited	VBN	O
to	TO	O
the	DT	O
macula	NN	O
.	.	O

Another	DT	O
daughter	NN	O
presented	VBN	O
at	IN	O
age	NN	O
42	CD	O
years	NNS	O
with	IN	O
macular	JJ	B_Disease
degeneration	NN	E_Disease
and	CC	O
over	IN	O
10	CD	O
years	NNS	O
developed	VBD	O
the	DT	O
clinical	JJ	O
picture	NN	O
of	IN	O
fundus	NN	B_Disease
flavimaculatus	NN	E_Disease
.	.	O

Her	PRP$	O
peripheral	JJ	O
visual	JJ	O
field	NN	O
was	VBD	O
preserved	VBN	O
but	CC	O
her	PRP$	O
ERG	NNP	O
was	VBD	O
moderately	RB	O
abnormal	JJ	O
.	.	O

The	DT	O
son	NN	O
had	VBD	O
onset	VBN	O
of	IN	O
macular	JJ	B_Disease
degeneration	NN	E_Disease
at	IN	O
age	NN	O
44	CD	O
years	NNS	O
.	.	O

Pericentral	JJ	B_Disease
scotomas	NNS	E_Disease
were	VBD	O
present	JJ	O
and	CC	O
the	DT	O
ERG	NNP	O
was	VBD	O
markedly	RB	O
abnormal	JJ	O
.	.	O

Fluorescein	NNP	O
angiography	NN	O
revealed	VBD	O
punctate	JJ	O
pigment	NN	O
epithelial	JJ	O
transmission	NN	O
defects	NNS	O
.	.	O

CONCLUSIONS	VB	O
A	DT	O
3	CD	O
-	:	O
base	NN	O
pair	NN	O
deletion	NN	O
of	IN	O
codon	NN	O
153	CD	O
or	CC	O
154	CD	O
of	IN	O
the	DT	O
peripherin	NN	O
/	NN	O
RDS	NNP	O
gene	NN	O
can	MD	O
produce	VB	O
clinically	RB	O
disparate	JJ	O
phenotypes	NNS	O
even	RB	O
within	IN	O
the	DT	O
same	JJ	O
family	NN	O
.	.	O
.	.	O

Assignment	NN	O
of	IN	O
the	DT	O
human	JJ	O
Na	NNP	O
+	NNP	O
/	NNP	O
glucose	VBP	O
cotransporter	NN	O
gene	NN	O
SGLT1	NNP	O
to	TO	O
chromosome	VB	O
22q13	CD	O
.	.	O
1	CD	O
.	.	O

The	DT	O
Na	NNP	O
+	NNP	O
/	NNP	O
glucose	VBP	O
cotransporter	NN	O
gene	NN	O
SGLT1	NNP	O
encodes	VBZ	O
the	DT	O
primary	JJ	O
carrier	NN	O
protein	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
uptake	NN	O
of	IN	O
the	DT	O
dietary	JJ	O
sugars	NNS	O
glucose	JJ	O
and	CC	O
galactose	JJ	O
from	IN	O
the	DT	O
intestinal	JJ	O
lumen	NNS	O
.	.	O

SGLT1	NNP	O
transport	NN	O
activity	NN	O
is	VBZ	O
currently	RB	O
exploited	VBN	O
in	IN	O
oral	JJ	O
rehydration	NN	O
therapy	NN	O
.	.	O

The	DT	O
75	CD	O
-	:	O
kDa	NN	O
glycoprotein	NN	O
is	VBZ	O
localized	VBN	O
in	IN	O
the	DT	O
brush	NN	O
border	NN	O
of	IN	O
the	DT	O
intestinal	JJ	O
epithelium	NN	O
and	CC	O
is	VBZ	O
predicted	VBN	O
to	TO	O
comprise	VB	O
12	CD	O
membrane	NN	O
spans	NNS	O
.	.	O

In	IN	O
two	CD	O
patients	NNS	O
with	IN	O
the	DT	O
autosomal	JJ	B_Disease
recessive	JJ	I_Disease
disease	NN	I_Disease
glucose	JJ	I_Disease
/	NNP	I_Disease
galactose	NN	I_Disease
malabsorption	NN	E_Disease
,	,	O
the	DT	O
underlying	VBG	O
cause	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
a	DT	O
missense	JJ	O
mutation	NN	O
in	IN	O
SGLT1	NNP	O
,	,	O
and	CC	O
the	DT	O
Asp28	NNP	O
-	:	O
-	:	O
>	NN	O
Asn	NNP	O
change	NN	O
was	VBD	O
demonstrated	VBN	O
in	IN	O
vitro	NN	O
to	TO	O
eliminate	VB	O
SGLT1	NNP	O
transport	NN	O
activity	NN	O
.	.	O

The	DT	O
SGLT1	NNP	O
gene	NN	O
was	VBD	O
previously	RB	O
shown	VBN	O
to	TO	O
reside	VB	O
on	IN	O
the	DT	O
distal	JJ	O
q	NN	O
arm	NN	O
of	IN	O
chromosome	NN	O
22	CD	O
(	(	O
11	CD	O
.	.	O

2	CD	O
-	:	O
-	:	O
>	NN	O
qter	NN	O
)	)	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
a	DT	O
cosmid	JJ	O
probe	NN	O
for	IN	O
fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
,	,	O
which	WDT	O
refines	VBZ	O
the	DT	O
localization	NN	O
to	TO	O
22q13	CD	O
.	.	O

1	CD	O
,	,	O
and	CC	O
provide	VB	O
an	DT	O
example	NN	O
of	IN	O
the	DT	O
utility	NN	O
of	IN	O
the	DT	O
SGLT1	NNP	O
probe	NN	O
as	IN	O
a	DT	O
diagnostic	JJ	O
for	IN	O
genetic	JJ	B_Disease
diseases	NNS	E_Disease
associated	VBN	O
with	IN	O
translocations	NNS	O
of	IN	O
chromosome	NN	O
22	CD	O
.	.	O

Restriction	NN	O
of	IN	O
ocular	JJ	O
fundus	NN	O
lesions	NNS	O
to	TO	O
a	DT	O
specific	JJ	O
subgroup	NN	O
of	IN	O
APC	NNP	S_Disease
mutations	NNS	O
in	IN	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
patients	NNS	O
.	.	O

In	IN	O
humans	NNS	O
,	,	O
alteration	NN	O
of	IN	O
the	DT	O
tumor	NN	S_Disease
suppressor	NN	O
gene	NN	O
,	,	O
APC	NNP	S_Disease
,	,	O
causes	VBZ	O
adenomatous	JJ	B_Disease
polyposis	NN	I_Disease
coli	NN	E_Disease
,	,	O
a	DT	O
condition	NN	O
causing	VBG	O
predisposition	NN	O
to	TO	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

The	DT	O
syndrome	NN	O
inconsistently	RB	O
associates	VBZ	O
characteristic	JJ	O
patches	NNS	O
of	IN	O
congenital	JJ	B_Disease
hypertrophy	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
retinal	JJ	I_Disease
pigment	NN	I_Disease
epithelium	NN	E_Disease
(	(	O
CHRPE	NNP	S_Disease
)	)	O
.	.	O

Ocular	JJ	O
examination	NN	O
revealed	VBD	O
that	IN	O
patients	NNS	O
expressing	VBG	O
CHRPE	NNP	S_Disease
tend	NN	O
to	TO	O
cluster	VB	O
within	IN	O
specific	JJ	O
families	NNS	O
.	.	O

The	DT	O
exact	JJ	O
APC	NNP	S_Disease
mutation	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
42	CD	O
unrelated	JJ	O
patients	NNS	O
.	.	O

In	IN	O
all	DT	O
cases	NNS	O
these	DT	O
mutations	NNS	O
were	VBD	O
predicted	VBN	O
to	TO	O
lead	VB	O
to	TO	O
the	DT	O
synthesis	NN	O
of	IN	O
a	DT	O
truncated	JJ	O
protein	NN	O
.	.	O

The	DT	O
extent	NN	O
of	IN	O
CHRPE	NNP	S_Disease
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
dependent	JJ	O
on	IN	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
mutation	NN	O
along	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
.	.	O

CHRPE	NNP	S_Disease
lesions	NNS	O
are	VBP	O
almost	RB	O
always	RB	O
absent	JJ	O
if	IN	O
the	DT	O
mutation	NN	O
occurs	VBZ	O
before	IN	O
exon	JJ	O
9	CD	O
,	,	O
but	CC	O
are	VBP	O
systematically	RB	O
present	JJ	O
if	IN	O
it	PRP	O
occurs	VBZ	O
after	IN	O
this	DT	O
exon	NN	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
range	NN	O
of	IN	O
phenotypic	NN	O
expression	NN	O
observed	VBD	O
among	IN	O
affected	JJ	O
patients	NNS	O
may	MD	O
result	VB	O
in	IN	O
part	NN	O
from	IN	O
different	JJ	O
allelic	JJ	O
manifestations	NNS	O
of	IN	O
APC	NNP	S_Disease
mutations	NNS	O
.	.	O
.	.	O

The	DT	O
effects	NNS	O
of	IN	O
dystrophin	JJ	O
gene	NN	O
mutations	NNS	O
on	IN	O
the	DT	O
ERG	NNP	O
in	IN	O
mice	NN	O
and	CC	O
humans	NNS	O
.	.	O

PURPOSE	NNP	O
.	.	O

The	DT	O
authors	NNS	O
earlier	RBR	O
findings	NNS	O
of	IN	O
a	DT	O
negative	JJ	O
electroretinogram	NN	O
(	(	O
ERG	NNP	O
)	)	O
in	IN	O
a	DT	O
boy	NN	O
with	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
led	VBD	O
them	PRP	O
to	TO	O
investigate	VB	O
dystrophin	JJ	O
gene	NN	O
deletions	NNS	O
and	CC	O
ERGs	NNP	O
in	IN	O
five	CD	O
boys	NNS	O
with	IN	O
DMD	NNP	S_Disease
.	.	O

The	DT	O
authors	NNS	O
wanted	VBD	O
to	TO	O
determined	VB	O
whether	IN	O
there	EX	O
were	VBD	O
similar	JJ	O
ERG	NNP	O
findings	NNS	O
in	IN	O
an	DT	O
animal	JJ	O
model	NN	O
for	IN	O
DMD	NNP	S_Disease
,	,	O
the	DT	O
mdx	NN	O
mouse	NN	O
.	.	O

METHODS	NNP	O
.	.	O

Ganzfeld	NNP	O
ERGs	NNP	O
were	VBD	O
recorded	VBN	O
in	IN	O
five	CD	O
boys	NNS	O
with	IN	O
DMD	NNP	S_Disease
after	IN	O
a	DT	O
complete	JJ	O
ophthalmic	JJ	O
examination	NN	O
.	.	O

The	DT	O
dystrophin	JJ	O
gene	NN	O
was	VBD	O
analyzed	VBN	O
by	IN	O
Southern	NNP	O
blot	NN	O
hybridization	NN	O
.	.	O

ERGs	NNS	O
were	VBD	O
recorded	VBN	O
in	IN	O
anesthetized	JJ	O
mdx	NN	O
and	CC	O
control	NN	O
mice	NN	O
with	IN	O
a	DT	O
modified	JJ	O
Grass	NNP	O
photostimulator	NN	O
(	(	O
Grass	NNP	O
Instrument	NNP	O
Company	NNP	O
,	,	O
Quincy	NNP	O
,	,	O
MA	NNP	O
)	)	O
.	.	O

RESULTS	NNP	O
.	.	O

Ophthalmic	JJ	O
examinations	NNS	O
in	IN	O
all	DT	O
five	CD	O
boys	NNS	O
had	VBD	O
normal	JJ	O
findings	NNS	O
,	,	O
yet	RB	O
an	DT	O
abnormal	JJ	O
negative	JJ	O
ERG	NNP	O
was	VBD	O
recorded	VBN	O
for	IN	O
each	DT	O
subject	NN	O
.	.	O

The	DT	O
subjects	NNS	O
gene	NN	O
deletions	NNS	O
were	VBD	O
variable	JJ	O
,	,	O
ranging	VBG	O
from	IN	O
large	JJ	O
deletions	NNS	O
to	TO	O
no	DT	O
detectable	JJ	O
deletions	NNS	O
.	.	O

The	DT	O
ERGs	NNP	O
of	IN	O
the	DT	O
mdx	NN	O
mice	NN	O
were	VBD	O
normal	JJ	O
and	CC	O
did	VBD	O
not	RB	O
differ	VB	O
significantly	RB	O
from	IN	O
those	DT	O
of	IN	O
the	DT	O
control	NN	O
mice	NN	O
.	.	O

CONCLUSIONS	NNP	O
.	.	O

The	DT	O
authors	NNS	O
believe	VBP	O
the	DT	O
unique	JJ	O
ERG	NNP	O
recorded	VBD	O
for	IN	O
the	DT	O
human	JJ	O
subjects	NNS	O
is	VBZ	O
a	DT	O
manifestation	NN	O
of	IN	O
DMD	NNP	S_Disease
associated	VBN	O
with	IN	O
defects	NNS	O
at	IN	O
the	DT	O
dystrophin	JJ	O
gene	NN	O
locus	NN	O
and	CC	O
represents	VBZ	O
a	DT	O
new	JJ	O
clinical	JJ	O
entity	NN	O
.	.	O

The	DT	O
ERG	NNP	O
of	IN	O
the	DT	O
mdx	NN	O
mouse	NN	O
may	MD	O
be	VB	O
spared	VBN	O
for	IN	O
several	JJ	O
reasons	NNS	O
,	,	O
including	VBG	O
milder	JJR	O
effects	NNS	O
of	IN	O
the	DT	O
mouse	NN	O
gene	NN	O
defect	NN	O
,	,	O
differences	NNS	O
in	IN	O
muscle	NN	O
and	CC	O
retinal	JJ	O
gene	NN	O
product	NN	O
,	,	O
or	CC	O
species	NNS	O
differences	NNS	O
in	IN	O
the	DT	O
biochemical	JJ	O
role	NN	O
of	IN	O
dystrophin	NN	O
.	.	O

The	DT	O
ERG	NNP	O
shows	VBZ	O
promise	NN	O
of	IN	O
becoming	VBG	O
a	DT	O
noninvasive	JJ	O
diagnostic	JJ	O
tool	NN	O
for	IN	O
DMD	NNP	S_Disease
and	CC	O
its	PRP$	O
milder	NN	O
allelic	NN	O
forms	NNS	O
.	.	O
.	.	O

Association	NNP	O
of	IN	O
the	DT	O
APC	NNP	B_Disease
tumor	NN	E_Disease
suppressor	NN	O
protein	NN	O
with	IN	O
catenins	NNS	O
.	.	O

Mutations	NNS	O
of	IN	O
APC	NNP	O
appear	VBP	O
to	TO	O
initiate	VB	O
sporadic	JJ	O
and	CC	O
inherited	JJ	O
forms	NNS	O
of	IN	O
human	JJ	O
colorectal	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Although	IN	O
these	DT	O
mutations	NNS	O
have	VBP	O
been	VBN	O
well	RB	O
characterized	VBN	O
,	,	O
little	JJ	O
is	VBZ	O
known	VBN	O
about	IN	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
APC	NNP	S_Disease
gene	NN	O
product	NN	O
.	.	O

Two	CD	O
cellular	JJ	O
proteins	NNS	O
that	WDT	O
associate	VBP	O
with	IN	O
APC	NNP	S_Disease
were	VBD	O
identified	VBN	O
by	IN	O
nucleotide	JJ	O
sequence	NN	O
analysis	NN	O
and	CC	O
peptide	RB	O
mapping	NN	O
as	IN	O
the	DT	O
E	NNP	O
-	:	O
cadherin	NN	O
-	:	O
associated	JJ	O
proteins	NNS	O
alpha	VBP	O
-	:	O
and	CC	O
beta	VB	O
-	:	O
catenin	NN	O
.	.	O

A	DT	O
27	CD	O
-	:	O
residue	JJ	O
fragment	NN	O
of	IN	O
APC	NNP	O
containing	VBG	O
a	DT	O
15	CD	O
-	:	O
amino	NN	O
acid	JJ	O
repeat	NN	O
was	VBD	O
sufficient	JJ	O
for	IN	O
the	DT	O
interaction	NN	O
with	IN	O
the	DT	O
catenins	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
an	DT	O
important	JJ	O
link	NN	O
between	IN	O
tumor	NN	S_Disease
initiation	NN	O
and	CC	O
cell	NN	O
adhesion	NN	O
.	.	O
.	.	O

Difference	NN	O
in	IN	O
methylation	NN	O
patterns	NNS	O
within	IN	O
the	DT	O
D15S9	NNP	O
region	NN	O
of	IN	O
chromosome	NN	O
15q11	CD	O
-	:	O
13	CD	O
in	IN	O
first	JJ	O
cousins	NNS	O
with	IN	O
Angelman	NNP	B_Disease
syndrome	NN	E_Disease
and	CC	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

Abnormalities	NNS	O
of	IN	O
chromosome	NN	O
region	NN	O
15q11	CD	O
-	:	O
13	CD	O
are	VBP	O
associated	VBN	O
with	IN	O
Angelman	NNP	B_Disease
syndrome	NN	E_Disease
(	(	O
AS	IN	S_Disease
)	)	O
and	CC	O
Prader	NNP	B_Disease
-	:	I_Disease
Willi	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
PWS	NNP	S_Disease
)	)	O
.	.	O

Differences	NNS	O
between	IN	O
the	DT	O
methylation	NN	O
patterns	NNS	O
of	IN	O
the	DT	O
region	NN	O
of	IN	O
chromosome	NN	O
15q11	CD	O
-	:	O
13	CD	O
which	WDT	O
hybridizes	VBZ	O
to	TO	O
the	DT	O
highly	RB	O
conserved	JJ	O
DNA	NNP	O
,	,	O
DN34	NNP	O
,	,	O
in	IN	O
normal	JJ	O
individuals	NNS	O
and	CC	O
in	IN	O
patients	NNS	O
with	IN	O
AS	NNP	S_Disease
and	CC	O
PWS	NNP	S_Disease
have	VBP	O
been	VBN	O
described	VBN	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
family	NN	O
in	IN	O
which	WDT	O
first	JJ	O
cousins	NNS	O
are	VBP	O
affected	VBN	O
by	IN	O
AS	NNP	S_Disease
and	CC	O
PWS	NNP	S_Disease
as	IN	O
a	DT	O
result	NN	O
of	IN	O
a	DT	O
familial	JJ	O
paracentric	JJ	O
inversion	NN	O
of	IN	O
15q11	CD	O
-	:	O
q13	NN	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
the	DT	O
studies	NNS	O
on	IN	O
this	DT	O
family	NN	O
demonstrate	VB	O
the	DT	O
differences	NNS	O
in	IN	O
the	DT	O
methylation	NN	O
patterns	NNS	O
in	IN	O
the	DT	O
2	CD	O
conditions	NNS	O
and	CC	O
the	DT	O
phenomenon	NN	O
of	IN	O
genomic	JJ	O
imprinting	NN	O
,	,	O
whereby	WRB	O
genetic	JJ	O
information	NN	O
is	VBZ	O
expressed	VBN	O
differently	RB	O
dependent	JJ	O
on	IN	O
the	DT	O
parent	NN	O
of	IN	O
origin	NN	O
.	.	O
.	.	O

Haplotype	NNP	O
studies	NNS	O
in	IN	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
.	.	O

In	IN	O
51	CD	O
families	NNS	O
with	IN	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
,	,	O
we	PRP	O
have	VBP	O
studied	VBN	O
DNA	NNP	O
haplotypes	NNS	O
of	IN	O
dinucleotide	JJ	O
repeat	NN	O
polymorphisms	NN	O
(	(	O
CA	NNP	O
repeats	NNS	O
)	)	O
in	IN	O
the	DT	O
13q14	CD	O
.	.	O

3	CD	O
region	NN	O
,	,	O
to	TO	O
examine	VB	O
these	DT	O
markers	NNS	O
for	IN	O
association	NN	O
with	IN	O
the	DT	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
(	(	O
WND	NNP	S_Disease
)	)	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
a	DT	O
marker	NN	O
(	(	O
D13S133	NNP	O
)	)	O
described	VBD	O
elsewhere	RB	O
,	,	O
we	PRP	O
have	VBP	O
developed	VBN	O
three	CD	O
new	JJ	O
highly	RB	O
polymorphic	JJ	O
markers	NNS	O
(	(	O
D13S314	NNP	O
,	,	O
D13S315	NNP	O
,	,	O
and	CC	O
D13S316	NNP	O
)	)	O
close	RB	O
to	TO	O
the	DT	O
WND	NNP	S_Disease
locus	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
the	DT	O
distribution	NN	O
of	IN	O
marker	NN	O
alleles	NNS	O
at	IN	O
the	DT	O
loci	NN	O
studied	VBN	O
and	CC	O
have	VBP	O
found	VBN	O
that	IN	O
D13S314	NNP	O
,	,	O
D13S133	NNP	O
,	,	O
and	CC	O
D13S316	NNP	O
each	DT	O
show	NN	O
nonrandom	JJ	O
distribution	NN	O
on	IN	O
chromosomes	NNS	O
carrying	VBG	O
the	DT	O
WND	NNP	S_Disease
mutation	NN	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
haplotypes	NNS	O
of	IN	O
these	DT	O
three	CD	O
markers	NNS	O
and	CC	O
have	VBP	O
found	VBN	O
that	IN	O
there	EX	O
are	VBP	O
highly	RB	O
significant	JJ	O
differences	NNS	O
between	IN	O
WND	NNP	S_Disease
and	CC	O
normal	JJ	O
haplotypes	NNS	O
in	IN	O
northern	JJ	O
European	JJ	O
families	NNS	O
.	.	O

These	DT	O
findings	NNS	O
have	VBP	O
important	JJ	O
implications	NNS	O
for	IN	O
mutation	NN	O
detection	NN	O
and	CC	O
molecular	JJ	O
diagnosis	NN	O
in	IN	O
families	NNS	O
with	IN	O
Wilson	NNP	B_Disease
disease	NN	E_Disease
.	.	O

Genetic	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
BRCA1	NNP	O
region	NN	O
in	IN	O
a	DT	O
large	JJ	O
breast	NN	O
/	NN	O
ovarian	JJ	O
family	NN	O
:	:	O
refinement	NN	O
of	IN	O
the	DT	O
minimal	JJ	O
region	NN	O
containing	VBG	O
BRCA1	NNP	O
.	.	O

We	PRP	O
have	VBP	O
analyzed	VBN	O
a	DT	O
single	JJ	O
multi	NN	O
-	:	O
affected	VBD	O
breast	JJ	B_Disease
/	JJ	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
pedigree	NN	O
(	(	O
BOV3	NNP	O
)	)	O
and	CC	O
have	VBP	O
shown	VBN	O
consistent	JJ	O
inheritance	NN	O
of	IN	O
markers	NNS	O
on	IN	O
chromosome	NN	O
17q	CD	O
with	IN	O
the	DT	O
disease	NN	O
confirming	VBG	O
that	IN	O
this	DT	O
family	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
.	.	O

Analysis	NN	O
of	IN	O
17q	CD	O
haplotypes	NNS	O
shows	VBZ	O
a	DT	O
recombination	NN	O
event	NN	O
in	IN	O
a	DT	O
bilateral	JJ	O
breast	NN	B_Disease
cancer	NN	E_Disease
case	NN	O
which	WDT	O
suggests	VBZ	O
that	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
lies	VBZ	O
distal	JJ	O
to	TO	O
D17S857	NNP	O
;	:	O
D17S857	NNP	O
is	VBZ	O
thus	RB	O
the	DT	O
new	JJ	O
proximal	JJ	O
boundary	NN	O
for	IN	O
the	DT	O
region	NN	O
containing	VBG	O
BRCA1	NNP	O
.	.	O

Combining	VBG	O
this	DT	O
information	NN	O
with	IN	O
previously	RB	O
published	VBN	O
mapping	NN	O
information	NN	O
suggests	VBZ	O
that	IN	O
BRCA1	NNP	O
is	VBZ	O
contained	VBN	O
in	IN	O
a	DT	O
region	NN	O
estimated	VBN	O
at	IN	O
1	CD	O
-	:	O
1	CD	O
.	.	O

5	CD	O
Mb	NNP	O
in	IN	O
length	NN	O
.	.	O

All	DT	O
seven	CD	O
breast	VBD	B_Disease
tumour	JJ	E_Disease
/	NNP	O
blood	NN	O
pairs	NNS	O
examined	VBD	O
from	IN	O
this	DT	O
family	NN	O
show	VB	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
in	IN	O
the	DT	O
tumours	NN	S_Disease
.	.	O

The	DT	O
allel	NN	O
retained	VBN	O
in	IN	O
each	DT	O
tumour	NN	S_Disease
was	VBD	O
from	IN	O
the	DT	O
disease	NN	O
-	:	O
bearing	NN	O
chromosome	NN	O
implicating	VBG	O
BRCA1	NNP	O
as	IN	O
a	DT	O
tumour	NN	S_Disease
suppressor	NN	O
gene	NN	O
.	.	O

We	PRP	O
have	VBP	O
sequenced	VBN	O
the	DT	O
17	CD	O
beta	NN	O
-	:	O
oestradiol	JJ	O
dehydrogenase	NN	O
genes	NNS	O
(	(	O
EDH17B1	NNP	O
and	CC	O
EDH17B2	NNP	O
)	)	O
which	WDT	O
have	VBP	O
been	VBN	O
suggested	VBN	O
as	IN	O
candidate	NN	O
genes	NNS	O
for	IN	O
BRCA1	NNP	O
in	IN	O
four	CD	O
members	NNS	O
of	IN	O
this	DT	O
family	NN	O
.	.	O

No	DT	O
germline	NN	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
.	.	O

Myotonic	NNP	B_Disease
dystrophy	NN	E_Disease
kinase	NN	O
is	VBZ	O
a	DT	O
component	NN	O
of	IN	O
neuromuscular	JJ	O
junctions	NNS	O
.	.	O

The	DT	O
clinical	JJ	O
manifestation	NN	O
of	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
is	VBZ	O
correlated	VBN	O
to	TO	O
the	DT	O
extent	NN	O
of	IN	O
expansion	NN	O
of	IN	O
an	DT	O
unstable	JJ	O
[	NN	O
CTG	NNP	O
]	NNP	O
n	MD	O
DNA	NNP	O
motif	NN	O
.	.	O

Recent	JJ	O
studies	NNS	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
this	DT	O
trinucleotide	NN	O
motif	NN	O
forms	NNS	O
part	NN	O
of	IN	O
the	DT	O
last	JJ	O
,	,	O
3	CD	O
untranslated	JJ	O
exon	NN	O
of	IN	O
a	DT	O
gene	NN	O
which	WDT	O
potentially	RB	O
encodes	VBZ	O
multiple	JJ	O
protein	NN	O
isoforms	NNS	O
of	IN	O
a	DT	O
serine	NN	O
/	NNP	O
threonine	NN	O
protein	NN	O
kinase	NN	O
(	(	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
protein	NN	O
kinase	NN	O
,	,	O
DM	NNP	O
-	:	O
PK	NN	O
)	)	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
on	IN	O
the	DT	O
development	NN	O
of	IN	O
antisera	NN	O
against	IN	O
synthetic	JJ	O
DM	NNP	O
-	:	O
PK	NNP	O
peptide	NN	O
antigens	NNS	O
and	CC	O
their	PRP$	O
use	NN	O
in	IN	O
biochemical	JJ	O
and	CC	O
histochemical	JJ	O
studies	NNS	O
.	.	O

Immunoreactive	JJ	O
DM	NNP	O
-	:	O
kinase	NN	O
protein	NN	O
of	IN	O
53	CD	O
kD	NN	O
is	VBZ	O
present	JJ	O
at	IN	O
low	JJ	O
levels	NNS	O
in	IN	O
skeletal	NN	O
and	CC	O
cardiac	JJ	O
muscle	NN	O
extracts	NNS	O
of	IN	O
DM	NNP	S_Disease
patients	NNS	O
and	CC	O
normal	JJ	O
controls	NNS	O
.	.	O

Immunohistochemical	JJ	O
staining	NN	O
revealed	VBD	O
that	IN	O
DM	NNP	O
-	:	O
PK	NN	O
is	VBZ	O
localised	VBN	O
prominently	RB	O
at	IN	O
sites	NNS	O
of	IN	O
neuromuscular	JJ	O
and	CC	O
myotendinous	JJ	O
junctions	NNS	O
(	(	O
NMJs	NNP	O
and	CC	O
MTJs	NNP	O
)	)	O
of	IN	O
human	NN	O
and	CC	O
rodent	NN	O
skeletal	JJ	O
muscles	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
very	RB	O
low	JJ	O
levels	NNS	O
of	IN	O
immunoreactive	JJ	O
DM	NNP	O
-	:	O
PK	NNP	O
protein	NN	O
are	VBP	O
present	JJ	O
in	IN	O
the	DT	O
sarcoplasm	NN	O
of	IN	O
predominantly	RB	O
type	JJ	O
I	PRP	O
fibres	VBP	O
in	IN	O
various	JJ	O
muscles	NNS	O
.	.	O

Strikingly	RB	O
,	,	O
presence	NN	O
of	IN	O
the	DT	O
protein	NN	O
can	MD	O
also	RB	O
be	VB	O
demonstrated	VBN	O
for	IN	O
NMJs	NNP	O
of	IN	O
muscular	JJ	O
tissues	NNS	O
of	IN	O
adult	NN	O
and	CC	O
congenital	JJ	O
cases	NNS	O
of	IN	O
DM	NNP	S_Disease
,	,	O
with	IN	O
no	DT	O
gross	JJ	O
changes	NNS	O
in	IN	O
structural	JJ	O
organisation	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
provide	VBP	O
a	DT	O
basis	NN	O
for	IN	O
further	JJ	O
characterisation	NN	O
of	IN	O
the	DT	O
role	NN	O
of	IN	O
the	DT	O
kinase	NN	O
in	IN	O
protein	NN	O
assembly	NN	O
processes	VBZ	O
or	CC	O
signal	JJ	O
mediation	NN	O
at	IN	O
synaptic	JJ	O
sites	NNS	O
and	CC	O
ultimately	RB	O
for	IN	O
the	DT	O
understanding	NN	O
of	IN	O
the	DT	O
complex	JJ	O
pathophysiology	NN	O
of	IN	O
DM	NNP	S_Disease
.	.	O
.	.	O

Markedly	RB	O
accelerated	VBD	O
catabolism	NN	O
of	IN	O
apolipoprotein	NN	O
A	NNP	O
-	:	O
II	NNP	O
(	(	O
ApoA	NNP	O
-	:	O
II	NNP	O
)	)	O
and	CC	O
high	JJ	O
density	NN	O
lipoproteins	VBZ	O
containing	VBG	O
ApoA	NNP	O
-	:	O
II	NN	O
in	IN	O
classic	JJ	O
lecithin	NN	O
:	:	O
cholesterol	NN	B_Disease
acyltransferase	NN	I_Disease
deficiency	NN	E_Disease
and	CC	O
fish	JJ	B_Disease
-	:	I_Disease
eye	NN	I_Disease
disease	NN	E_Disease
.	.	O

Classic	JJ	B_Disease
(	(	I_Disease
complete	JJ	I_Disease
)	)	I_Disease
lecithin	FW	I_Disease
cholesterol	NN	I_Disease
acyltransferase	NN	I_Disease
(	(	I_Disease
LCAT	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
and	CC	O
Fish	NNP	B_Disease
-	:	I_Disease
eye	NN	I_Disease
disease	NN	E_Disease
(	(	O
partial	JJ	B_Disease
LCAT	NNP	I_Disease
deficiency	NN	E_Disease
)	)	O
are	VBP	O
genetic	JJ	O
syndromes	NNS	O
associated	VBN	O
with	IN	O
markedly	RB	O
decreased	VBN	O
plasma	NN	O
levels	NNS	O
of	IN	O
high	JJ	O
density	NN	O
lipoprotein	NN	O
(	(	O
HDL	NNP	O
)	)	O
cholesterol	NN	O
but	CC	O
not	RB	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
atherosclerotic	JJ	B_Disease
cardiovascular	JJ	I_Disease
disease	NN	E_Disease
.	.	O

We	PRP	O
investigated	VBD	O
the	DT	O
metabolism	NN	O
of	IN	O
the	DT	O
HDL	NNP	O
apolipoproteins	NNS	O
(	(	O
apo	NN	O
)	)	O
apoA	IN	O
-	:	O
I	PRP	O
and	CC	O
apoA	VB	O
-	:	O
II	NNP	O
in	IN	O
a	DT	O
total	NN	O
of	IN	O
five	CD	O
patients	NNS	O
with	IN	O
LCAT	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
one	CD	O
with	IN	O
classic	JJ	B_Disease
LCAT	NNP	I_Disease
deficiency	NN	E_Disease
and	CC	O
four	CD	O
with	IN	O
Fish	NNP	B_Disease
-	:	I_Disease
eye	NN	I_Disease
disease	NN	E_Disease
.	.	O

Plasma	NNP	O
levels	NNS	O
of	IN	O
apoA	NN	O
-	:	O
II	NNP	O
were	VBD	O
decreased	VBN	O
to	TO	O
a	DT	O
proportionately	RB	O
greater	JJR	O
extent	NN	O
(	(	O
23	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	)	O
than	IN	O
apoA	SYM	O
-	:	O
I	PRP	O
(	(	O
30	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	)	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
plasma	JJ	O
concentrations	NNS	O
of	IN	O
HDL	NNP	O
particles	NNS	O
containing	VBG	O
both	DT	O
apoA	IN	O
-	:	O
I	PRP	O
and	CC	O
apoA	VB	O
-	:	O
II	NNP	O
(	(	O
LpA	NNP	O
-	:	O
I	PRP	O
A	VBP	O
-	:	O
II	NN	O
)	)	O
were	VBD	O
much	JJ	O
lower	JJR	O
(	(	O
18	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	)	O
than	IN	O
those	DT	O
of	IN	O
particles	NNS	O
containing	VBG	O
only	RB	O
apoA	JJ	O
-	:	O
I	PRP	O
(	(	O
LpA	NNP	O
-	:	O
I	PRP	O
)	)	O
(	(	O
51	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	)	O
.	.	O

The	DT	O
metabolic	JJ	O
basis	NN	O
for	IN	O
the	DT	O
low	JJ	O
levels	NNS	O
of	IN	O
apoA	NN	O
-	:	O
II	NNP	O
and	CC	O
LpA	NNP	O
-	:	O
I	PRP	O
A	VBP	O
-	:	O
II	NN	O
was	VBD	O
investigated	VBN	O
in	IN	O
all	DT	O
five	CD	O
patients	NNS	O
using	VBG	O
both	DT	O
exogenous	JJ	O
radiotracer	NN	O
and	CC	O
endogenous	JJ	O
stable	JJ	O
isotope	NN	O
labeling	VBG	O
techniques	NNS	O
.	.	O

The	DT	O
mean	JJ	O
plasma	NN	O
residence	NN	O
time	NN	O
of	IN	O
apoA	JJ	O
-	:	O
I	PRP	O
was	VBD	O
decreased	VBN	O
at	IN	O
2	CD	O
.	.	O

08	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

27	CD	O
d	NN	O
(	(	O
controls	VBZ	O
4	CD	O
.	.	O

74	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

65	CD	O
days	NNS	O
)	)	O
;	:	O
however	RB	O
,	,	O
the	DT	O
residence	NN	O
time	NN	O
of	IN	O
apoA	JJ	O
-	:	O
II	NN	O
was	VBD	O
even	RB	O
shorter	JJR	O
at	IN	O
1	CD	O
.	.	O

66	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

24	CD	O
d	NN	O
(	(	O
controls	VBZ	O
5	CD	O
.	.	O

25	CD	O
+	JJ	O
/	NNP	O
-	:	O
0	CD	O
.	.	O

61	CD	O
d	NN	O
)	)	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
catabolism	NN	O
of	IN	O
apoA	JJ	O
-	:	O
I	PRP	O
in	IN	O
LpA	NNP	O
-	:	O
I	PRP	O
A	VBP	O
-	:	O
II	NN	O
was	VBD	O
substantially	RB	O
faster	JJR	O
than	IN	O
that	DT	O
of	IN	O
apoA	JJ	O
-	:	O
I	PRP	O
in	IN	O
LpA	NNP	O
-	:	O
I	PRP	O
.	.	O

In	IN	O
summary	JJ	O
,	,	O
genetic	JJ	O
syndromes	NNS	O
of	IN	O
either	DT	O
complete	JJ	B_Disease
or	CC	I_Disease
partial	JJ	I_Disease
LCAT	NNP	I_Disease
deficiency	NN	E_Disease
result	NN	O
in	IN	O
low	JJ	O
levels	NNS	O
of	IN	O
HDL	NNP	O
through	IN	O
preferential	JJ	O
hypercatabolism	NN	O
of	IN	O
apoA	JJ	O
-	:	O
II	NN	O
and	CC	O
HDL	NNP	O
particles	NNS	O
containing	VBG	O
apoA	SYM	O
-	:	O
II	NN	O
.	.	O

Because	IN	O
LpA	NNP	O
-	:	O
I	PRP	O
has	VBZ	O
been	VBN	O
proposed	VBN	O
to	TO	O
be	VB	O
more	RBR	O
protective	JJ	O
than	IN	O
LpA	NNP	O
-	:	O
I	PRP	O
A	VBP	O
-	:	O
II	NNP	O
against	IN	O
atherosclerosis	NN	S_Disease
,	,	O
this	DT	O
selective	JJ	O
effect	NN	O
on	IN	O
the	DT	O
metabolism	NN	O
of	IN	O
LpA	NNP	O
-	:	O
I	PRP	O
A	VBP	O
-	:	O
II	NN	O
may	MD	O
provide	VB	O
a	DT	O
potential	JJ	O
explanation	NN	O
why	WRB	O
patients	NNS	O
with	IN	O
classic	JJ	B_Disease
LCAT	NNP	I_Disease
deficiency	NN	E_Disease
and	CC	O
Fish	NNP	B_Disease
-	:	I_Disease
eye	NN	I_Disease
disease	NN	E_Disease
are	VBP	O
not	RB	O
at	IN	O
increased	VBN	O
risk	NN	O
for	IN	O
premature	JJ	O
atherosclerosis	NN	S_Disease
despite	IN	O
markedly	RB	O
decreased	JJ	O
levels	NNS	O
of	IN	O
HDL	NNP	O
cholesterol	NN	O
and	CC	O
apoA	JJ	O
-	:	O
I	PRP	O

X	NN	B_Disease
linked	VBD	I_Disease
recessive	JJ	I_Disease
thrombocytopenia	NN	E_Disease
.	.	O

A	DT	O
Saudi	NNP	O
Arab	NNP	O
boy	NN	O
presented	VBN	O
in	IN	O
early	JJ	O
childhood	NN	O
with	IN	O
thrombocytopenia	NN	S_Disease
,	,	O
morphologically	RB	O
large	JJ	O
and	CC	O
normal	JJ	O
sized	JJ	O
platelets	NNS	O
,	,	O
increased	VBD	O
mean	JJ	O
platelet	NN	O
volume	NN	O
,	,	O
and	CC	O
a	DT	O
hypermegakaryocytic	JJ	O
bone	NN	O
marrow	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
clinical	JJ	O
and	CC	O
laboratory	JJ	O
evidence	NN	O
of	IN	O
any	DT	O
significant	JJ	O
immunological	JJ	B_Disease
abnormalities	NNS	E_Disease
.	.	O

Similar	JJ	O
findings	NNS	O
in	IN	O
two	CD	O
other	JJ	O
brothers	NNS	O
suggested	VBD	O
strongly	RB	O
that	IN	O
they	PRP	O
were	VBD	O
all	DT	O
suffering	VBG	O
from	IN	O
an	DT	O
X	NN	B_Disease
linked	VBD	I_Disease
recessive	JJ	I_Disease
thrombocytopenic	JJ	I_Disease
disorder	NN	E_Disease
.	.	O

Results	NNS	O
of	IN	O
DNA	NNP	O
analysis	NN	O
with	IN	O
the	DT	O
probe	NN	O
M27	NNP	O
beta	NN	O
are	VBP	O
consistent	JJ	O
with	IN	O
X	NNP	O
linkage	NN	O
and	CC	O
indicate	NN	O
also	RB	O
that	IN	O
the	DT	O
locus	NN	O
of	IN	O
the	DT	O
relevant	JJ	O
gene	NN	O
lies	VBZ	O
close	RB	O
to	TO	O
or	CC	O
is	VBZ	O
identical	JJ	O
to	TO	O
the	DT	O
locus	NN	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
.	.	O

Because	IN	O
of	IN	O
various	JJ	O
features	NNS	O
which	WDT	O
include	VBP	O
the	DT	O
presence	NN	O
of	IN	O
large	JJ	O
and	CC	O
normal	JJ	O
sized	VBN	O
platelets	NNS	O
(	(	O
rather	RB	O
than	IN	O
small	JJ	O
platelets	NNS	O
)	)	O
and	CC	O
freedom	NN	O
from	IN	O
significant	JJ	O
immune	JJ	B_Disease
deficiencies	NNS	E_Disease
,	,	O
it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
the	DT	O
X	NNP	B_Disease
linked	VBD	I_Disease
recessive	JJ	I_Disease
thrombocytopenia	NN	E_Disease
in	IN	O
this	DT	O
family	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
entity	NN	O
quite	RB	O
distinct	JJ	O
from	IN	O
the	DT	O
classical	JJ	O
WAS	NNP	S_Disease
phenotype	NN	O
.	.	O

However	RB	O
,	,	O
a	DT	O
modified	JJ	O
expression	NN	O
of	IN	O
the	DT	O
WAS	NNP	S_Disease
gene	NN	O
producing	VBG	O
a	DT	O
mild	JJ	O
phenotypic	NN	O
variant	NN	O
cannot	NN	O
be	VB	O
excluded	VBN	O
entirely	RB	O
.	.	O
.	.	O

Macular	JJ	B_Disease
dystrophy	NN	E_Disease
associated	VBN	O
with	IN	O
mutations	NNS	O
at	IN	O
codon	NN	O
172	CD	O
in	IN	O
the	DT	O
human	JJ	O
retinal	JJ	B_Disease
degeneration	NN	E_Disease
slow	JJ	O
gene	NN	O
.	.	O

BACKGROUND	NNP	O
Recently	NNP	O
,	,	O
mutations	NNS	O
in	IN	O
the	DT	O
retinal	JJ	B_Disease
degeneration	NN	E_Disease
slow	NN	O
(	(	O
rds	NNS	O
)	)	O
gene	NN	O
which	WDT	O
codes	VBZ	O
for	IN	O
peripherin	NN	O
-	:	O
rds	NNS	O
have	VBP	O
been	VBN	O
implicated	VBN	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
retinitis	NN	I_Disease
pigmentosa	NN	E_Disease
.	.	O

Because	IN	O
this	DT	O
gene	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
both	DT	O
rods	NNS	O
and	CC	O
cones	NNS	O
,	,	O
mutations	NNS	O
in	IN	O
the	DT	O
rds	NNS	O
gene	NN	O
might	MD	O
be	VB	O
expected	VBN	O
to	TO	O
cause	VB	O
degeneration	NN	O
affecting	VBG	O
either	CC	O
the	DT	O
scotopic	NN	O
or	CC	O
photopic	NN	O
systems	NNS	O
.	.	O

Mutations	NNS	O
at	IN	O
codon	JJ	O
172	CD	O
of	IN	O
the	DT	O
rds	NNS	O
gene	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
three	CD	O
families	NNS	O
with	IN	O
autosomal	JJ	O
dominantly	RB	O
inherited	VBN	O
,	,	O
progressive	JJ	O
macular	NN	B_Disease
dystrophy	NN	E_Disease
.	.	O

METHODS	NNP	O
Affected	NNP	O
individuals	NNS	O
underwent	JJ	O
ophthalmic	JJ	O
examination	NN	O
,	,	O
scotopic	JJ	O
perimetry	NN	O
,	,	O
dark	JJ	O
adaptometry	NN	O
,	,	O
measurement	NN	O
of	IN	O
color	NN	O
-	:	O
contrast	NN	O
sensitivity	NN	O
,	,	O
and	CC	O
electroretinography	NN	O
to	TO	O
characterize	VB	O
the	DT	O
photoreceptor	NN	O
dysfunction	NN	O
.	.	O

RESULTS	NNP	O
In	IN	O
all	DT	O
but	CC	O
one	CD	O
affected	JJ	O
member	NN	O
,	,	O
symptoms	NNS	O
of	IN	O
progressive	JJ	O
central	JJ	O
visual	JJ	B_Disease
loss	NN	E_Disease
developed	VBN	O
in	IN	O
the	DT	O
third	JJ	O
or	CC	O
fourth	JJ	O
decade	NN	O
of	IN	O
life	NN	O
accompanied	VBN	O
by	IN	O
central	JJ	B_Disease
scotoma	NN	E_Disease
and	CC	O
well	RB	O
-	:	O
demarcated	VBN	O
atrophy	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
retinal	JJ	I_Disease
pigment	NN	I_Disease
epithelium	NN	E_Disease
and	CC	O
choriocapillaris	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
macula	NN	E_Disease
.	.	O

In	IN	O
general	JJ	O
,	,	O
cone	NN	O
and	CC	O
rod	NN	O
thresholds	NNS	O
were	VBD	O
elevated	VBN	O
,	,	O
and	CC	O
color	NN	O
-	:	O
contrast	NN	O
sensitivity	NN	O
was	VBD	O
absent	JJ	O
in	IN	O
the	DT	O
central	JJ	O
visual	JJ	O
field	NN	O
.	.	O

Peripherally	RB	O
,	,	O
the	DT	O
scotopic	NN	O
sensitivities	NNS	O
were	VBD	O
normal	JJ	O
,	,	O
as	IN	O
was	VBD	O
the	DT	O
recovery	NN	O
from	IN	O
bleach	NN	O
.	.	O

Cone	NN	O
electroretinograms	NNS	O
were	VBD	O
diminished	VBN	O
in	IN	O
amplitude	NN	O
,	,	O
and	CC	O
delayed	VBN	O
in	IN	O
all	DT	O
affected	JJ	O
adults	NNS	O
except	IN	O
one	CD	O
.	.	O

Rod	NNP	O
electroretinograms	NNS	O
were	VBD	O
normal	JJ	O
or	CC	O
near	JJ	O
normal	JJ	O
in	IN	O
amplitude	NN	O
,	,	O
and	CC	O
had	VBD	O
normal	JJ	O
implicit	JJ	O
times	NNS	O
.	.	O

Affected	NNP	O
asymptomatic	JJ	O
children	NNS	O
had	VBD	O
macular	JJ	O
changes	NNS	O
,	,	O
abnormal	JJ	O
color	NN	O
-	:	O
contrast	NN	O
sensitivity	NN	O
,	,	O
and	CC	O
reduced	JJ	O
pattern	NN	O
and	CC	O
cone	NN	O
electroretinograms	NNS	O
.	.	O

CONCLUSION	NNP	O
These	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
rds	NNS	O
gene	NN	O
can	MD	O
be	VB	O
expressed	VBN	O
as	IN	O
a	DT	O
macular	JJ	B_Disease
dystrophy	NN	E_Disease
,	,	O
with	IN	O
evidence	NN	O
of	IN	O
primary	JJ	O
cone	NN	B_Disease
dysfunction	NN	E_Disease
and	CC	O
preservation	NN	O
of	IN	O
peripheral	JJ	O
rod	NN	O
function	NN	O
.	.	O
.	.	O

Anonymous	JJ	O
marker	NN	O
loci	NN	O
within	IN	O
400	CD	O
kb	NNS	O
of	IN	O
HLA	NNP	O
-	:	O
A	DT	O
generate	NN	O
haplotypes	NNS	O
in	IN	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
the	DT	O
hemochromatosis	NN	S_Disease
gene	NN	O
(	(	O
HFE	NNP	O
)	)	O
The	DT	O
hemochromatosis	NN	S_Disease
gene	NN	O
(	(	O
HFE	NNP	O
)	)	O
maps	VBZ	O
to	TO	O
6p21	CD	O
.	.	O

3	CD	O
and	CC	O
is	VBZ	O
less	JJR	O
than	IN	O
1	CD	O
cM	NN	O
from	IN	O
the	DT	O
HLA	NNP	O
class	NN	O
I	PRP	O
genes	NNS	O
;	:	O
however	RB	O
,	,	O
the	DT	O
precise	JJ	O
physical	JJ	O
location	NN	O
of	IN	O
the	DT	O
gene	NN	O
has	VBZ	O
remained	VBN	O
elusive	JJ	O
and	CC	O
controversial	JJ	O
.	.	O

The	DT	O
unambiguous	JJ	O
identification	NN	O
of	IN	O
a	DT	O
crossover	NN	O
event	NN	O
within	IN	O
hemochromatosis	NN	S_Disease
families	NNS	O
is	VBZ	O
very	RB	O
difficult	JJ	O
;	:	O
it	PRP	O
is	VBZ	O
particularly	RB	O
hampered	VBN	O
by	IN	O
the	DT	O
variability	NN	O
of	IN	O
the	DT	O
phenotypic	NN	O
expression	NN	O
as	RB	O
well	RB	O
as	IN	O
by	IN	O
the	DT	O
sex	NN	O
-	:	O
and	CC	O
age	NN	O
-	:	O
related	JJ	O
penetrance	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

For	IN	O
these	DT	O
practical	JJ	O
considerations	NNS	O
,	,	O
traditional	JJ	O
linkage	NN	O
analysis	NN	O
could	MD	O
prove	VB	O
of	IN	O
limited	JJ	O
value	NN	O
in	IN	O
further	JJ	O
refining	VBG	O
the	DT	O
extrapolated	JJ	O
physical	JJ	O
position	NN	O
of	IN	O
HFE	NNP	O
.	.	O

We	PRP	O
therefore	VBP	O
embarked	JJ	O
upon	IN	O
a	DT	O
linkage	NN	O
-	:	O
disequilibrium	NN	O
analysis	NN	O
of	IN	O
HFE	NNP	O
and	CC	O
normal	JJ	O
chromosomes	NNS	O
from	IN	O
the	DT	O
Brittany	NNP	O
population	NN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
report	NN	O
,	,	O
66	CD	O
hemochromatosis	NN	S_Disease
families	NNS	O
yielding	VBG	O
151	CD	O
hemochromatosis	NN	S_Disease
chromosomes	NNS	O
and	CC	O
182	CD	O
normal	JJ	O
chromosomes	NNS	O
were	VBD	O
RFLP	NNP	O
-	:	O
typed	VBD	O
with	IN	O
a	DT	O
battery	NN	O
of	IN	O
probes	NNS	O
,	,	O
including	VBG	O
two	CD	O
newly	RB	O
derived	VBN	O
polymorphic	JJ	O
markers	NNS	O
from	IN	O
the	DT	O
6	CD	O
.	.	O

7	CD	O
and	CC	O
HLA	NNP	O
-	:	O
F	NNP	O
loci	NN	O
located	VBD	O
150	CD	O
and	CC	O
250	CD	O
kb	NNS	O
telomeric	JJ	O
to	TO	O
HLA	NNP	O
-	:	O
A	NN	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
a	DT	O
strong	JJ	O
peak	NN	O
of	IN	O
existing	VBG	O
linkage	NN	O
disequilibrium	NN	O
focused	VBD	O
within	IN	O
the	DT	O
i82	JJ	O
-	:	O
to	TO	O
-	:	O
6	CD	O
.	.	O

7	CD	O
interval	NN	O
(	(	O
approximately	RB	O
250	CD	O
kb	NN	O
)	)	O
.	.	O

The	DT	O
zone	NN	O
of	IN	O
linkage	NN	O
disequilibrium	NN	O
is	VBZ	O
flanked	VBN	O
by	IN	O
the	DT	O
i97	NN	O
locus	NN	O
,	,	O
positioned	VBD	O
30	CD	O
kb	NNS	O
proximal	JJ	O
to	TO	O
i82	VB	O
,	,	O
and	CC	O
the	DT	O
HLA	NNP	O
-	:	O
F	NNP	O
gene	NN	O
,	,	O
found	VBD	O
250	CD	O
kb	NNS	O
distal	JJ	O
to	TO	O
HLA	NNP	O
-	:	O
A	NN	O
,	,	O
markers	NNS	O
of	IN	O
which	WDT	O
display	VBP	O
no	DT	O
significant	JJ	O
association	NN	O
with	IN	O
HFE	NNP	O
.	.	O

These	DT	O
data	NNS	O
support	NN	O
the	DT	O
possibility	NN	O
that	IN	O
HFE	NNP	O
resides	NNS	O
within	IN	O
the	DT	O
400	CD	O
-	:	O
kb	NN	O
expanse	NN	O
of	IN	O
DNA	NNP	O
between	IN	O
i97	NN	O
and	CC	O
HLA	NNP	O
-	:	O
F	NN	O
.	.	O

Alternatively	RB	O
,	,	O
the	DT	O
very	RB	O
tight	JJ	O
association	NN	O
of	IN	O
HLA	NNP	O
-	:	O
A3	NNP	O
and	CC	O
allele	VBD	O
1	CD	O
of	IN	O
the	DT	O
6	CD	O
.	.	O

7	CD	O
locus	NN	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
are	VBP	O
comprised	VBN	O
by	IN	O
the	DT	O
major	JJ	O
ancestral	JJ	O
or	CC	O
founder	NN	O
HFE	NNP	O
haplotype	NN	O
in	IN	O
Brittany	NNP	O
,	,	O
supports	VBZ	O
the	DT	O
possibility	NN	O
that	IN	O
the	DT	O
disease	NN	O
gene	NN	O
may	MD	O
reside	VB	O
immediately	RB	O
telomeric	JJ	O
to	TO	O
the	DT	O
6	CD	O
.	.	O

7	CD	O
locus	NN	O
within	IN	O
the	DT	O
linkage	NN	O
-	:	O
disequilibrium	NN	O
zone	NN	O
.	.	O

Additionally	RB	O
,	,	O
hemochromatosis	NN	S_Disease
haplotypes	NNS	O
possessing	VBG	O
HLA	NNP	O
-	:	O
A11	NN	O
and	CC	O
the	DT	O
low	JJ	O
-	:	O
frequency	NN	O
HLA	NNP	O
-	:	O
F	NN	O
polymorphism	NN	O
(	(	O
allele	JJ	O
2	CD	O
)	)	O
are	VBP	O
supportive	JJ	O
of	IN	O
a	DT	O
separate	JJ	O
founder	NN	O
chromosome	NN	O
containing	VBG	O
a	DT	O
second	JJ	O
,	,	O
independently	RB	O
arising	VBG	O
mutant	JJ	O
allele	NN	O
.	.	O

Overall	JJ	O
,	,	O
the	DT	O
establishment	NN	O
of	IN	O
a	DT	O
likely	JJ	O
"	JJ	O
hemochromatosis	NN	S_Disease
critical	JJ	O
region	NN	O
"	NNP	O
centromeric	NN	O
boundary	NN	O
and	CC	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
linkage	NN	O
-	:	O
disequilibrium	NN	O
zone	NN	O
both	DT	O
significantly	RB	O
contribute	VBP	O
to	TO	O
a	DT	O
reduction	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
DNA	NN	O
required	VBN	O
to	TO	O
be	VB	O
searched	VBN	O
for	IN	O
novel	JJ	O
coding	NN	O
sequences	NNS	O
constituting	VBG	O
the	DT	O
HFE	NNP	B_Disease
defect	NN	E_Disease

Genomic	NNP	O
structure	NN	O
of	IN	O
the	DT	O
EWS	NNP	O
gene	NN	O
and	CC	O
its	PRP$	O
relationship	NN	O
to	TO	O
EWSR1	NNP	O
,	,	O
a	DT	O
site	NN	O
of	IN	O
tumor	NN	S_Disease
-	:	O
associated	VBN	O
chromosome	NN	O
translocation	NN	O
.	.	O

The	DT	O
EWS	NNP	O
gene	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
based	VBN	O
on	IN	O
its	PRP$	O
location	NN	O
at	IN	O
the	DT	O
chromosome	NN	O
22	CD	O
breakpoint	NN	O
of	IN	O
the	DT	O
t	NN	O
(	(	O
11	CD	O
;	:	O
22	CD	O
)	)	O
(	(	O
q24	NN	O
;	:	O
q12	CC	O
)	)	O
translocation	NN	O
that	IN	O
characterizes	VBZ	O
Ewing	NNP	B_Disease
sarcoma	NN	E_Disease
and	CC	O
related	VBN	O
neuroectodermal	JJ	B_Disease
tumors	NNS	E_Disease
.	.	O

The	DT	O
EWS	NNP	O
gene	NN	O
spans	NNS	O
about	IN	O
40	CD	O
kb	NN	O
of	IN	O
DNA	NNP	O
and	CC	O
is	VBZ	O
encoded	VBN	O
by	IN	O
17	CD	O
exons	NNS	O
.	.	O

The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
exons	NNS	O
is	VBZ	O
identical	JJ	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
previously	RB	O
described	VBN	O
cDNA	NN	O
.	.	O

The	DT	O
first	JJ	O
7	CD	O
exons	NNS	O
encode	VBP	O
the	DT	O
N	NNP	O
-	:	O
terminal	JJ	O
domain	NN	O
of	IN	O
EWS	NNP	O
,	,	O
which	WDT	O
consists	VBZ	O
of	IN	O
a	DT	O
repeated	VBN	O
degenerated	JJ	O
polypeptide	NN	O
of	IN	O
7	CD	O
to	TO	O
12	CD	O
residues	NNS	O
rich	JJ	O
in	IN	O
tyrosine	NN	O
,	,	O
serine	NN	O
,	,	O
threonine	NN	O
,	,	O
glycine	NN	O
,	,	O
and	CC	O
glutamine	NN	O
.	.	O

Exons	NNS	O
11	CD	O
,	,	O
12	CD	O
,	,	O
and	CC	O
13	CD	O
encode	NN	O
the	DT	O
putative	JJ	O
RNA	NNP	O
binding	NN	O
domain	NN	O
.	.	O

The	DT	O
three	CD	O
glycine	NN	O
-	:	O
and	CC	O
arginine	VB	O
-	:	O
rich	JJ	O
motifs	NNS	O
of	IN	O
the	DT	O
gene	NN	O
are	VBP	O
mainly	RB	O
encoded	VBN	O
by	IN	O
exons	NNS	O
8	CD	O
-	:	O
9	CD	O
,	,	O
14	CD	O
,	,	O
and	CC	O
16	CD	O
.	.	O

The	DT	O
DNA	NN	O
sequence	NN	O
in	IN	O
the	DT	O
5	CD	O
region	NN	O
of	IN	O
the	DT	O
gene	NN	O
has	VBZ	O
features	NNS	O
of	IN	O
a	DT	O
CpG	NNP	O
-	:	O
rich	JJ	O
island	NN	O
and	CC	O
lacks	VBZ	O
canonical	JJ	O
promoter	NN	O
elements	NNS	O
,	,	O
such	JJ	O
as	IN	O
TATA	NNP	O
and	CC	O
CCAAT	NNP	O
consensus	NN	O
sequences	NNS	O
.	.	O

Positions	NNS	O
of	IN	O
the	DT	O
chromosome	NN	O
22	CD	O
breakpoints	NNS	O
were	VBD	O
determined	VBN	O
for	IN	O
19	CD	O
Ewing	NNP	B_Disease
tumors	NNS	E_Disease
.	.	O

They	PRP	O
were	VBD	O
localized	VBN	O
in	IN	O
introns	NNS	O
7	CD	O
or	CC	O
8	CD	O
in	IN	O
18	CD	O
cases	NNS	O
and	CC	O
in	IN	O
intron	NN	O
10	CD	O
in	IN	O
1	CD	O
case	NN	O
.	.	O
.	.	O

Norrie	NNP	B_Disease
disease	NN	E_Disease
gene	NN	O
:	:	O
characterization	NN	O
of	IN	O
deletions	NNS	O
and	CC	O
possible	JJ	O
function	NN	O
.	.	O

Positional	JJ	O
cloning	NN	O
experiments	NNS	O
have	VBP	O
resulted	VBN	O
recently	RB	O
in	IN	O
the	DT	O
isolation	NN	O
of	IN	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
(	(	O
pseudoglioma	NN	S_Disease
;	:	O
NDP	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
severe	JJ	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
neurodevelopmental	JJ	I_Disease
disorder	NN	E_Disease
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
the	DT	O
isolation	NN	O
and	CC	O
analysis	NN	O
of	IN	O
human	JJ	O
genomic	JJ	O
DNA	NNP	O
clones	NNS	O
encompassing	VBG	O
the	DT	O
NDP	NNP	S_Disease
gene	NN	O
.	.	O

The	DT	O
gene	NN	O
spans	VBZ	O
28	CD	O
kb	NN	O
and	CC	O
consists	VBZ	O
of	IN	O
3	CD	O
exons	NNS	O
,	,	O
the	DT	O
first	JJ	O
of	IN	O
which	WDT	O
is	VBZ	O
entirely	RB	O
contained	VBN	O
within	IN	O
the	DT	O
5	CD	O
untranslated	JJ	O
region	NN	O
.	.	O

Detailed	JJ	O
analysis	NN	O
of	IN	O
genomic	JJ	O
deletions	NNS	O
in	IN	O
Norrie	NNP	S_Disease
patients	NNS	O
shows	VBZ	O
that	IN	O
they	PRP	O
are	VBP	O
heterogeneous	JJ	O
,	,	O
both	DT	O
in	IN	O
size	NN	O
and	CC	O
in	IN	O
position	NN	O
.	.	O

By	IN	O
PCR	NNP	O
analysis	NN	O
,	,	O
we	PRP	O
found	VBD	O
that	IN	O
expression	NN	O
of	IN	O
the	DT	O
NDP	NNP	S_Disease
gene	NN	O
was	VBD	O
not	RB	O
confined	VBN	O
to	TO	O
the	DT	O
eye	NN	O
or	CC	O
to	TO	O
the	DT	O
brain	NN	O
.	.	O

An	DT	O
extensive	JJ	O
DNA	NN	O
and	CC	O
protein	JJ	O
sequence	NN	O
comparison	NN	O
between	IN	O
the	DT	O
human	JJ	O
NDP	NNP	S_Disease
gene	NN	O
and	CC	O
related	VBN	O
genes	NNS	O
from	IN	O
the	DT	O
database	NN	O
revealed	VBD	O
homology	NN	O
with	IN	O
cysteine	JJ	O
-	:	O
rich	JJ	O
protein	NN	O
-	:	O
binding	NN	O
domains	NNS	O
of	IN	O
immediate	JJ	O
-	:	O
-	:	O
early	JJ	O
genes	NNS	O
implicated	VBN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
cell	NN	O
proliferation	NN	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
NDP	NNP	O
is	VBZ	O
a	DT	O
molecule	NN	O
related	VBN	O
in	IN	O
function	NN	O
to	TO	O
these	DT	O
genes	NNS	O
and	CC	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
a	DT	O
pathway	NN	O
that	WDT	O
regulates	VBZ	O
neural	JJ	O
cell	NN	O
differentiation	NN	O
and	CC	O
proliferation	NN	O
.	.	O
.	.	O

The	DT	O
normal	JJ	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
allele	NN	O
,	,	O
or	CC	O
a	DT	O
closely	RB	O
linked	VBN	O
gene	NN	O
,	,	O
influences	NNS	O
age	NN	O
at	IN	O
onset	NN	O
of	IN	O
HD	NNP	S_Disease
.	.	O

We	PRP	O
evaluated	VBD	O
the	DT	O
hypothesis	NN	O
that	IN	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
(	(	O
HD	NNP	S_Disease
)	)	O
is	VBZ	O
influenced	VBN	O
by	IN	O
the	DT	O
normal	JJ	O
HD	NNP	S_Disease
allele	NN	O
by	IN	O
comparing	VBG	O
transmission	NN	O
patterns	NNS	O
of	IN	O
genetically	RB	O
linked	VBN	O
markers	NNS	O
at	IN	O
the	DT	O
D4S10	NNP	O
locus	NN	O
in	IN	O
the	DT	O
normal	JJ	O
parent	NN	O
against	IN	O
age	NN	O
at	IN	O
onset	NN	O
in	IN	O
the	DT	O
affected	JJ	O
offspring	NN	O
.	.	O

Analysis	NN	O
of	IN	O
information	NN	O
from	IN	O
21	CD	O
sibships	NNS	O
in	IN	O
14	CD	O
kindreds	NNS	O
showed	VBD	O
a	DT	O
significant	JJ	O
tendency	NN	O
for	IN	O
sibs	NN	O
who	WP	O
have	VBP	O
similar	JJ	O
onset	VBN	O
ages	NNS	O
to	TO	O
share	NN	O
the	DT	O
same	JJ	O
D4S10	NNP	O
allele	NN	O
from	IN	O
the	DT	O
normal	JJ	O
parent	NN	O
.	.	O

Affected	JJ	O
sibs	NN	O
who	WP	O
inherited	VBD	O
different	JJ	O
D4S10	NNP	O
alleles	NNS	O
from	IN	O
the	DT	O
normal	JJ	O
parent	NN	O
tended	VBD	O
to	TO	O
have	VB	O
more	RBR	O
variable	JJ	O
ages	NNS	O
at	IN	O
onset	NN	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
expression	NN	O
of	IN	O
HD	NNP	S_Disease
is	VBZ	O
modulated	VBN	O
by	IN	O
the	DT	O
normal	JJ	O
HD	NNP	S_Disease
allele	NN	O
or	CC	O
by	IN	O
a	DT	O
closely	RB	O
linked	VBN	O
locus	NN	O
.	.	O
.	.	O

Further	JJ	O
investigation	NN	O
of	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
intron	NN	O
9	CD	O
donor	NN	O
splice	NN	O
site	NN	O
mutation	NN	O
frequently	RB	O
found	VBN	O
in	IN	O
non	JJ	O
-	:	O
Jewish	JJ	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
patients	NNS	O
from	IN	O
the	DT	O
British	JJ	O
Isles	NNP	O
.	.	O

In	IN	O
a	DT	O
previous	JJ	O
study	NN	O
we	PRP	O
found	VBD	O
that	IN	O
a	DT	O
Tay	NNP	B_Disease
-	:	I_Disease
Sachs	NNP	I_Disease
disease	NN	E_Disease
(	(	O
TSD	NNP	S_Disease
)	)	O
causing	VBG	O
mutation	NN	O
in	IN	O
the	DT	O
intron	NN	O
9	CD	O
donor	NN	O
splice	NN	O
site	NN	O
of	IN	O
the	DT	O
HEXA	NNP	O
gene	NN	O
occurs	VBZ	O
at	IN	O
high	JJ	O
frequency	NN	O
in	IN	O
non	JJ	O
-	:	O
Jewish	JJ	O
patients	NNS	O
and	CC	O
carriers	NNS	O
from	IN	O
the	DT	O
British	JJ	O
Isles	NNP	O
.	.	O

It	PRP	O
was	VBD	O
found	VBN	O
more	RBR	O
frequently	RB	O
in	IN	O
subjects	NNS	O
of	IN	O
Irish	NNP	O
,	,	O
Scottish	NNP	O
,	,	O
and	CC	O
Welsh	NNP	O
origin	VBP	O
compared	VBN	O
with	IN	O
English	NNP	O
origin	NN	O
(	(	O
63	CD	O
%	NN	O
and	CC	O
31	CD	O
%	NN	O
respectively	RB	O
)	)	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
tested	VBN	O
,	,	O
in	IN	O
a	DT	O
blind	NN	O
study	NN	O
,	,	O
26	CD	O
American	JJ	O
TSD	NNP	S_Disease
carriers	NNS	O
and	CC	O
28	CD	O
non	JJ	O
-	:	O
carriers	NNS	O
who	WP	O
have	VBP	O
British	JJ	O
ancestry	NN	O
for	IN	O
the	DT	O
intron	NN	O
9	CD	O
splice	NN	O
site	NN	O
mutation	NN	O
.	.	O

Six	CD	O
of	IN	O
the	DT	O
carriers	NNS	O
and	CC	O
none	NN	O
of	IN	O
the	DT	O
controls	NNS	O
were	VBD	O
positive	JJ	O
for	IN	O
the	DT	O
mutation	NN	O
.	.	O

All	DT	O
six	CD	O
had	VBD	O
Irish	NNP	O
ancestry	NN	O
,	,	O
compared	VBN	O
with	IN	O
nine	CD	O
of	IN	O
the	DT	O
20	CD	O
other	JJ	O
(	(	O
intron	JJ	O
9	CD	O
mutation	NN	O
negative	JJ	O
)	)	O
TSD	FW	S_Disease
carriers	NNS	O
(	(	O
p	VB	O
<	RB	O
0	CD	O
.	.	O

05	CD	O
)	)	O
.	.	O

These	DT	O
results	NNS	O
confirm	VBP	O
the	DT	O
previously	RB	O
found	VBN	O
high	JJ	O
frequency	NN	O
of	IN	O
the	DT	O
intron	NN	O
9	CD	O
mutation	NN	O
in	IN	O
non	JJ	O
-	:	O
Jewish	JJ	O
TSD	NNP	S_Disease
families	NNS	O
of	IN	O
British	JJ	O
Isles	NNP	O
,	,	O
particularly	RB	O
Irish	JJ	O
,	,	O
origin	NN	O
,	,	O
and	CC	O
reinforce	VB	O
the	DT	O
need	NN	O
to	TO	O
screen	VB	O
such	JJ	O
families	NNS	O
for	IN	O
this	DT	O
mutation	NN	O
.	.	O

Molecular	JJ	O
mechanisms	NNS	O
of	IN	O
oncogenic	JJ	O
mutations	NNS	O
in	IN	O
tumors	NNS	S_Disease
from	IN	O
patients	NNS	O
with	IN	O
bilateral	JJ	B_Disease
and	CC	I_Disease
unilateral	JJ	I_Disease
retinoblastoma	NN	E_Disease
.	.	O

The	DT	O
RB1	NNP	O
gene	NN	O
from	IN	O
12	CD	O
human	JJ	O
retinoblastoma	NN	B_Disease
tumors	NNS	E_Disease
has	VBZ	O
been	VBN	O
analyzed	VBN	O
exon	SYM	O
-	:	O
by	IN	O
-	:	O
exon	NN	O
with	IN	O
the	DT	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
technique	NN	O
.	.	O

Mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
all	DT	O
tumors	NNS	S_Disease
,	,	O
and	CC	O
one	CD	O
-	:	O
third	NN	O
of	IN	O
the	DT	O
tumors	NNS	S_Disease
had	VBD	O
independent	JJ	O
mutations	NNS	O
in	IN	O
both	DT	O
alleles	NNS	O
neither	DT	O
of	IN	O
which	WDT	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
germ	JJ	O
line	NN	O
,	,	O
confirming	VBG	O
their	PRP$	O
true	JJ	O
sporadic	JJ	O
nature	NN	O
.	.	O

In	IN	O
the	DT	O
remaining	VBG	O
two	CD	O
-	:	O
thirds	NNS	O
of	IN	O
the	DT	O
tumors	NNS	S_Disease
only	RB	O
one	CD	O
mutation	NN	O
was	VBD	O
found	VBN	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
heterozygosity	NN	O
theory	NN	O
of	IN	O
tumorigenesis	NN	O
.	.	O

Point	NN	O
mutations	NNS	O
,	,	O
the	DT	O
majority	NN	O
of	IN	O
which	WDT	O
were	VBD	O
C	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
transitions	NNS	O
,	,	O
were	VBD	O
the	DT	O
most	RBS	O
common	JJ	O
abnormality	NN	O
and	CC	O
usually	RB	O
resulted	VBN	O
in	IN	O
the	DT	O
conversion	NN	O
of	IN	O
an	DT	O
arginine	JJ	O
codon	NN	O
to	TO	O
a	DT	O
stop	JJ	O
codon	NN	O
.	.	O

Small	JJ	O
deletions	NNS	O
were	VBD	O
the	DT	O
second	JJ	O
most	RBS	O
common	JJ	O
abnormality	NN	O
and	CC	O
most	RBS	O
often	RB	O
created	VBD	O
a	DT	O
downstream	NN	O
stop	NN	O
codon	NN	O
as	IN	O
the	DT	O
result	NN	O
of	IN	O
a	DT	O
reading	NN	O
frameshift	NN	O
.	.	O

Deletions	NNS	O
and	CC	O
point	NN	O
mutations	NNS	O
also	RB	O
affected	VBD	O
splice	JJ	O
junctions	NNS	O
.	.	O

Direct	JJ	O
repeats	NNS	O
were	VBD	O
present	JJ	O
at	IN	O
the	DT	O
breakpoint	NN	O
junctions	NNS	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
deletions	NNS	O
,	,	O
supporting	VBG	O
a	DT	O
slipped	JJ	O
-	:	O
mispairing	NN	O
mechanism	NN	O
.	.	O

Point	NN	O
mutations	NNS	O
generally	RB	O
produced	VBN	O
DNA	NNP	O
sequences	NNS	O
which	WDT	O
resulted	VBD	O
in	IN	O
perfect	JJ	O
homology	NN	O
with	IN	O
endogenous	JJ	O
sequences	NNS	O
which	WDT	O
lay	VBD	O
within	IN	O
14	CD	O
bp	NN	O
.	.	O
.	.	O

PAX6	NNP	O
mutations	NNS	O
in	IN	O
aniridia	NN	S_Disease
.	.	O

Aniridia	NNP	S_Disease
is	VBZ	O
a	DT	O
congenital	JJ	B_Disease
malformation	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
eye	NN	E_Disease
,	,	O
chiefly	NN	O
characterised	VBN	O
by	IN	O
iris	JJ	B_Disease
hypoplasia	NN	E_Disease
,	,	O
which	WDT	O
can	MD	O
cause	VB	O
blindness	NN	S_Disease
.	.	O

The	DT	O
PAX6	NNP	O
gene	NN	O
was	VBD	O
isolated	VBN	O
as	IN	O
a	DT	O
candidate	NN	O
aniridia	NN	S_Disease
gene	NN	O
by	IN	O
positional	JJ	O
cloning	NN	O
from	IN	O
the	DT	O
smallest	JJS	O
region	NN	O
of	IN	O
overlap	NN	O
of	IN	O
aniridia	JJ	S_Disease
-	:	O
associated	VBN	O
deletions	NNS	O
.	.	O

Subsequently	RB	O
PAX6	NNP	O
intragenic	JJ	O
mutations	NNS	O
were	VBD	O
demonstrated	VBN	O
in	IN	O
Smalleye	NNP	O
,	,	O
a	DT	O
mouse	NN	O
mutant	NN	O
which	WDT	O
is	VBZ	O
an	DT	O
animal	JJ	O
model	NN	O
for	IN	O
aniridia	NN	S_Disease
,	,	O
and	CC	O
six	CD	O
human	JJ	O
aniridia	NN	S_Disease
patients	NNS	O
.	.	O

In	IN	O
this	DT	O
paper	NN	O
we	PRP	O
describe	VBP	O
four	CD	O
additional	JJ	O
PAX6	NNP	O
point	NN	O
mutations	NNS	O
in	IN	O
aniridia	NN	S_Disease
patients	NNS	O
,	,	O
both	DT	O
sporadic	JJ	O
and	CC	O
familial	JJ	O
.	.	O

These	DT	O
mutations	NNS	O
highlight	VBD	O
regions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
which	WDT	O
are	VBP	O
essential	JJ	O
for	IN	O
normal	JJ	O
PAX6	NNP	O
function	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
frequency	NN	O
at	IN	O
which	WDT	O
we	PRP	O
have	VBP	O
found	VBN	O
PAX6	NNP	O
mutations	NNS	O
suggests	VBZ	O
that	IN	O
lesions	NNS	O
in	IN	O
PAX6	NNP	O
will	MD	O
account	VB	O
for	IN	O
most	JJS	O
cases	NNS	O
of	IN	O
aniridia	NN	S_Disease
.	.	O
.	.	O

Detection	NN	O
of	IN	O
a	DT	O
novel	JJ	O
arginine	NN	O
vasopressin	NN	O
defect	NN	O
by	IN	O
dideoxy	JJ	O
fingerprinting	NN	O
.	.	O

Autosomal	NNP	B_Disease
dominant	JJ	I_Disease
neurohypophyseal	NN	I_Disease
diabetes	NNS	I_Disease
insipidus	VBP	E_Disease
is	VBZ	O
a	DT	O
familial	JJ	O
form	NN	O
of	IN	O
diabetes	NNS	B_Disease
insipidus	VBP	E_Disease
.	.	O

This	DT	O
disorder	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
variable	JJ	O
levels	NNS	O
of	IN	O
arginine	NN	O
vasopressin	NN	O
(	(	O
AVP	NNP	O
)	)	O
and	CC	O
diabetes	VBZ	B_Disease
insipidus	NN	E_Disease
of	IN	O
varying	VBG	O
severity	NN	O
,	,	O
which	WDT	O
responds	VBZ	O
to	TO	O
exogenous	JJ	O
AVP	NNP	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
autosomal	JJ	B_Disease
dominant	JJ	I_Disease
neurohypophyseal	NN	I_Disease
diabetes	VBZ	I_Disease
insipidus	RB	E_Disease
,	,	O
the	DT	O
AVP	NNP	O
genes	NNS	O
of	IN	O
members	NNS	O
of	IN	O
a	DT	O
large	JJ	O
kindred	VBN	O
were	VBD	O
analyzed	VBN	O
.	.	O

A	DT	O
new	JJ	O
method	NN	O
,	,	O
called	VBN	O
dideoxy	NN	O
fingerprinting	NN	O
,	,	O
was	VBD	O
used	VBN	O
to	TO	O
detect	VB	O
an	DT	O
AVP	NNP	O
mutation	NN	O
that	WDT	O
was	VBD	O
characterized	VBN	O
by	IN	O
DNA	NNP	O
sequencing	NN	O
.	.	O

The	DT	O
novel	NN	O
defect	NN	O
found	VBD	O
changes	VBZ	O
the	DT	O
last	JJ	O
codon	NN	O
of	IN	O
the	DT	O
AVP	NNP	O
signal	JJ	O
peptide	NN	O
from	IN	O
alanine	NN	O
to	TO	O
threonine	VB	O
,	,	O
which	WDT	O
should	MD	O
perturb	VB	O
cleavage	NN	O
of	IN	O
mature	NN	O
AVP	NNP	O
from	IN	O
its	PRP$	O
precursor	NN	O
protein	NN	O
and	CC	O
inhibit	VB	O
its	PRP$	O
secretion	NN	O
or	CC	O
action	NN	O
.	.	O
.	.	O

Germinal	JJ	O
mosaicism	NN	O
in	IN	O
a	DT	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
family	NN	O
:	:	O
implications	NNS	O
for	IN	O
genetic	JJ	O
counselling	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
we	PRP	O
describe	VBP	O
a	DT	O
three	CD	O
-	:	O
generation	NN	O
family	NN	O
in	IN	O
which	WDT	O
two	CD	O
siblings	NNS	O
were	VBD	O
affected	VBN	O
by	IN	O
Duchenne	NNP	B_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
DMD	NNP	S_Disease
)	)	O
.	.	O

Immunohistochemical	JJ	O
analysis	NN	O
of	IN	O
muscle	NN	O
dystrophin	NN	O
and	CC	O
haplotype	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
DMD	NNP	S_Disease
locus	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
carrying	VBG	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
was	VBD	O
transmitted	VBN	O
from	IN	O
the	DT	O
healthy	JJ	O
maternal	NN	O
grandfather	NN	O
to	TO	O
his	PRP$	O
three	CD	O
daughters	NNS	O
,	,	O
including	VBG	O
the	DT	O
probands	NNS	O
mother	NN	O
.	.	O

These	DT	O
findings	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
grandfather	NN	O
was	VBD	O
a	DT	O
germinal	JJ	O
mosaic	NN	O
for	IN	O
the	DT	O
DMD	NNP	S_Disease
gene	NN	O
.	.	O

The	DT	O
definition	NN	O
of	IN	O
the	DT	O
carrier	NN	O
status	NN	O
in	IN	O
two	CD	O
possible	JJ	O
carriers	NNS	O
led	VBD	O
us	PRP	O
to	TO	O
give	VB	O
accurate	JJ	O
genetic	JJ	O
counselling	NN	O
and	CC	O
to	TO	O
prevent	VB	O
the	DT	O
birth	NN	O
of	IN	O
an	DT	O
affected	JJ	O
boy	NN	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
this	DT	O
study	NN	O
demonstrate	VB	O
the	DT	O
usefulness	NN	O
of	IN	O
haplotype	NN	O
analysis	NN	O
and	CC	O
immunohistochemical	JJ	O
muscle	NN	O
dystrophin	NN	O
studies	NNS	O
to	TO	O
detect	VB	O
hidden	JJ	O
germinal	JJ	O
mosaicism	NN	O
and	CC	O
to	TO	O
improve	VB	O
genetic	JJ	O
counselling	NN	O
.	.	O
.	.	O

Genetic	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
breast	NN	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	I_Disease
syndrome	NN	E_Disease
to	TO	O
a	DT	O
small	JJ	O
interval	NN	O
on	IN	O
chromosome	NN	O
17q12	CD	O
-	:	O
21	CD	O
:	:	O
exclusion	NN	O
of	IN	O
candidate	NN	O
genes	NNS	O
EDH17B2	NNP	O
and	CC	O
RARA	NNP	O
.	.	O

A	DT	O
susceptibility	NN	O
gene	NN	O
for	IN	O
hereditary	JJ	B_Disease
breast	NN	I_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
,	,	O
BRCA1	NNP	O
,	,	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
by	IN	O
linkage	NN	O
analysis	NN	O
to	TO	O
chromosome	VB	O
17q21	CD	O
.	.	O

Candidate	NNP	O
genes	NNS	O
in	IN	O
this	DT	O
region	NN	O
include	VBP	O
EDH17B2	NNP	O
,	,	O
which	WDT	O
encodes	VBZ	O
estradiol	VBP	O
17	CD	O
beta	SYM	O
-	:	O
hydroxysteroid	NN	O
dehydrogenase	NN	O
II	NNP	O
(	(	O
17	CD	O
beta	SYM	O
-	:	O
HSD	NNP	O
II	NNP	O
)	)	O
,	,	O
and	CC	O
RARA	NNP	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
retinoic	JJ	O
acid	JJ	O
receptor	NN	O
alpha	NN	O
.	.	O

We	PRP	O
have	VBP	O
typed	VBN	O
22	CD	O
breast	NN	B_Disease
and	CC	I_Disease
breast	NN	I_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
with	IN	O
eight	CD	O
polymorphisms	NNS	O
from	IN	O
the	DT	O
chromosome	NN	O
17q12	CD	O
-	:	O
21	CD	O
region	NN	O
,	,	O
including	VBG	O
two	CD	O
in	IN	O
the	DT	O
EDH17B2	NNP	O
gene	NN	O
.	.	O

Genetic	JJ	O
recombination	NN	O
with	IN	O
the	DT	O
breast	NN	B_Disease
cancer	NN	E_Disease
trait	NN	O
excludes	VBZ	O
RARA	NNP	O
from	IN	O
further	JJ	O
consideration	NN	O
as	IN	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
BRCA1	NNP	O
.	.	O

Both	DT	O
BRCA1	NNP	O
and	CC	O
EDH17B2	NNP	O
map	VBP	O
to	TO	O
a	DT	O
6	CD	O
cM	NN	O
interval	NN	O
(	(	O
between	IN	O
THRA1	NNP	O
and	CC	O
D17S579	NNP	O
)	)	O
and	CC	O
no	DT	O
recombination	NN	O
was	VBD	O
observed	VBN	O
between	IN	O
the	DT	O
two	CD	O
genes	NNS	O
.	.	O

However	RB	O
,	,	O
direct	JJ	O
sequencing	NN	O
of	IN	O
overlapping	VBG	O
PCR	NNP	O
products	NNS	O
containing	VBG	O
the	DT	O
entire	JJ	O
EDH17B2	NNP	O
gene	NN	O
in	IN	O
four	CD	O
unrelated	JJ	O
affected	VBD	O
women	NNS	O
did	VBD	O
not	RB	O
uncover	VB	O
any	DT	O
sequence	NN	O
variation	NN	O
,	,	O
other	JJ	O
than	IN	O
previously	RB	O
described	VBN	O
polymorphisms	NNS	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
EDH17B2	NNP	O
gene	NN	O
,	,	O
therefore	RB	O
do	VBP	O
not	RB	O
appear	VB	O
to	TO	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
hereditary	JJ	B_Disease
breast	NN	I_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	I_Disease
syndrome	NN	E_Disease
.	.	O

Single	NNP	O
meiotic	JJ	O
crossovers	NNS	O
in	IN	O
affected	JJ	O
women	NNS	O
suggest	VBP	O
that	IN	O
BRCA1	NNP	O
is	VBZ	O
flanked	VBN	O
by	IN	O
the	DT	O
loci	NN	O
RARA	NNP	O
and	CC	O
D17S78	NNP	O
.	.	O
.	.	O

A	DT	O
missense	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
cholesteryl	NN	O
ester	NN	O
transfer	NN	O
protein	VBZ	O
gene	NN	O
with	IN	O
possible	JJ	O
dominant	JJ	O
effects	NNS	O
on	IN	O
plasma	NN	O
high	JJ	O
density	NN	O
lipoproteins	NNS	O
.	.	O

Plasma	NNP	O
HDL	NNP	O
are	VBP	O
a	DT	O
negative	JJ	O
risk	NN	O
factor	NN	O
for	IN	O
atherosclerosis	NN	S_Disease
.	.	O

Cholesteryl	NNP	O
ester	NN	O
transfer	NN	O
protein	NN	O
(	(	O
CETP	NNP	O
;	:	O
476	CD	O
amino	NN	O
acids	NNS	O
)	)	O
transfers	NNS	O
cholesteryl	VBP	O
ester	NN	O
from	IN	O
HDL	NNP	O
to	TO	O
other	JJ	O
lipoproteins	NNS	O
.	.	O

Subjects	NNS	O
with	IN	O
homozygous	JJ	O
CETP	NNP	B_Disease
deficiency	NN	E_Disease
caused	VBN	O
by	IN	O
a	DT	O
gene	NN	O
splicing	VBG	O
defect	NNS	O
have	VBP	O
markedly	RB	O
elevated	VBN	O
HDL	NNP	O
;	:	O
however	RB	O
,	,	O
heterozygotes	NNS	O
have	VBP	O
only	RB	O
mild	JJ	O
increases	NNS	O
in	IN	O
HDL	NNP	O
.	.	O

We	PRP	O
describe	VBP	O
two	CD	O
probands	NNS	O
with	IN	O
a	DT	O
CETP	NNP	O
missense	NN	O
mutation	NN	O
(	(	O
442	CD	O
D	NNP	O
G	NNP	O
)	)	O
.	.	O

Although	IN	O
heterozygous	JJ	O
,	,	O
they	PRP	O
have	VBP	O
threefold	VBN	O
increases	NNS	O
in	IN	O
HDL	NNP	O
concentration	NN	O
and	CC	O
markedly	RB	O
decreased	VBD	O
plasma	JJ	O
CETP	NNP	O
mass	NN	O
and	CC	O
activity	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
mutation	NN	O
has	VBZ	O
dominant	JJ	O
effects	NNS	O
on	IN	O
CETP	NNP	O
and	CC	O
HDL	NNP	O
in	IN	O
vivo	NN	O
.	.	O

Cellular	JJ	O
expression	NN	O
of	IN	O
mutant	JJ	O
cDNA	NN	O
results	NNS	O
in	IN	O
secretion	NN	O
of	IN	O
only	RB	O
30	CD	O
%	NN	O
of	IN	O
wild	JJ	O
type	JJ	O
CETP	NNP	O
activity	NN	O
.	.	O

Moreover	RB	O
,	,	O
coexpression	NN	O
of	IN	O
wild	JJ	O
type	NN	O
and	CC	O
mutant	JJ	O
cDNAs	NN	O
leads	VBZ	O
to	TO	O
inhibition	NN	O
of	IN	O
wild	JJ	O
type	JJ	O
secretion	NN	O
and	CC	O
activity	NN	O
.	.	O

The	DT	O
dominant	JJ	O
effects	NNS	O
of	IN	O
the	DT	O
CETP	NNP	O
missense	NN	O
mutation	NN	O
during	IN	O
cellular	JJ	O
expression	NN	O
probably	RB	O
explains	VBZ	O
why	WRB	O
the	DT	O
probands	NNS	O
have	VBP	O
markedly	RB	O
increased	VBN	O
HDL	NNP	O
in	IN	O
the	DT	O
heterozygous	JJ	O
state	NN	O
,	,	O
and	CC	O
suggests	VBZ	O
that	IN	O
the	DT	O
active	JJ	O
molecular	JJ	O
species	NNS	O
of	IN	O
CETP	NNP	O
may	MD	O
be	VB	O
multimeric	JJ	O
.	.	O
.	.	O

Familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
in	IN	O
the	DT	O
colchicine	NN	O
era	NN	O
:	:	O
the	DT	O
fate	NN	O
of	IN	O
one	CD	O
family	NN	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
demonstrate	VB	O
the	DT	O
effect	NN	O
of	IN	O
prophylactic	JJ	O
colchicine	NN	O
treatment	NN	O
on	IN	O
the	DT	O
natural	JJ	O
history	NN	O
of	IN	O
familial	JJ	B_Disease
Mediterranean	NNP	I_Disease
fever	NN	E_Disease
(	(	O
FMF	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
family	NN	O
is	VBZ	O
presented	VBN	O
with	IN	O
6	CD	O
out	IN	O
of	IN	O
9	CD	O
siblings	NNS	O
affected	VBN	O
by	IN	O
FMF	NNP	S_Disease
.	.	O

Each	DT	O
patient	NN	O
represents	VBZ	O
a	DT	O
different	JJ	O
stage	NN	O
of	IN	O
the	DT	O
amyloidotic	JJ	B_Disease
kidney	NN	I_Disease
disease	NN	E_Disease
of	IN	O
FMF	NNP	S_Disease
and	CC	O
the	DT	O
effect	NN	O
of	IN	O
continuous	JJ	O
colchicine	NN	O
treatment	NN	O
on	IN	O
its	PRP$	O
course	NN	O
.	.	O

Considered	VBN	O
together	RB	O
,	,	O
the	DT	O
members	NNS	O
of	IN	O
this	DT	O
family	NN	O
present	VBD	O
an	DT	O
almost	RB	O
complete	JJ	O
clinical	JJ	O
,	,	O
genetic	JJ	O
,	,	O
and	CC	O
behavioral	JJ	O
picture	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O
.	.	O

Detection	NN	O
of	IN	O
a	DT	O
new	JJ	O
submicroscopic	NN	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
deletion	NN	O
interval	NN	O
with	IN	O
a	DT	O
novel	JJ	O
DNA	NNP	O
probe	NN	O
isolated	VBN	O
by	IN	O
differential	JJ	O
Alu	NNP	O
PCR	NNP	O
fingerprint	NN	O
cloning	NN	O
.	.	O

Differential	NNP	O
Alu	NNP	O
PCR	NNP	O
fingerprint	NN	O
cloning	NN	O
was	VBD	O
used	VBN	O
to	TO	O
isolate	VB	O
a	DT	O
DNA	NN	O
probe	NN	O
from	IN	O
the	DT	O
Xp11	NNP	O
.	.	O

4	CD	O
-	:	O
-	:	O
>	NN	O
p11	NN	O
.	.	O

21	CD	O
region	NN	O
of	IN	O
the	DT	O
human	JJ	O
X	NNP	O
chromosome	NN	O
.	.	O

This	DT	O
novel	JJ	O
sequence	NN	O
,	,	O
cpXr318	NN	O
(	(	O
DXS742	NNP	O
)	)	O
,	,	O
detects	VBZ	O
a	DT	O
new	JJ	O
submicroscopic	NN	O
deletion	NN	O
interval	NN	O
at	IN	O
the	DT	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
locus	NN	O
(	(	O
NDP	NNP	O
)	)	O
.	.	O

Combining	VBG	O
our	PRP$	O
data	NNS	O
with	IN	O
the	DT	O
consensus	NN	O
genetic	JJ	O
map	NN	O
of	IN	O
the	DT	O
proximal	JJ	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NNP	O
chromosome	NN	O
,	,	O
we	PRP	O
propose	VBP	O
the	DT	O
physical	JJ	O
order	NN	O
Xcen	NNP	O
-	:	O
DXS14	NNP	O
-	:	O
DXS255	NNP	O
-	:	O
(	(	O
DXS426	NNP	O
,	,	O
TIMP	NNP	O
)	)	O
-	:	O
(	(	O
DXS742	NNP	O
-	:	O
(	(	O
[	JJ	O
MAOB	NNP	O
-	:	O
MAOA	NNP	O
-	:	O
DXS7	NNP	O
]	NNP	O
,	,	O
NDP	NNP	O
)	)	O
-	:	O
DXS77	NNP	O
-	:	O
DXS228	NN	O
)	)	O
-	:	O
DXS209	NNP	O
-	:	O
DXS148	NNP	O
-	:	O
DXS196	NNP	O
-	:	O
+	NN	O
+	JJ	O
+	NNP	O
Xpter	NNP	O
.	.	O

The	DT	O
cpXr318	NN	O
probe	NN	O
and	CC	O
a	DT	O
subclone	NN	O
from	IN	O
a	DT	O
cosmid	NN	O
corresponding	VBG	O
to	TO	O
the	DT	O
DXS7	NNP	O
locus	NN	O
were	VBD	O
converted	VBN	O
into	IN	O
sequence	NN	O
-	:	O
tagged	VBN	O
sites	NNS	O
.	.	O

Finally	RB	O
,	,	O
DXS742	NNP	O
,	,	O
DSX7	NNP	O
,	,	O
DXS77	NNP	O
,	,	O
and	CC	O
MAOA	NNP	O
were	VBD	O
integrated	VBN	O
into	IN	O
a	DT	O
physical	JJ	O
map	NN	O
spanning	VBG	O
the	DT	O
Norrie	NNP	B_Disease
disease	NN	E_Disease
locus	NN	O

Putative	JJ	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
adrenoleukodystrophy	IN	E_Disease
gene	NN	O
shares	NNS	O
unexpected	VBD	O
homology	NN	O
with	IN	O
ABC	NNP	O
transporters	NNS	O
.	.	O

Adrenoleukodystrophy	NNP	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
is	VBZ	O
an	DT	O
X	JJ	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
disease	NN	E_Disease
affecting	VBG	O
1	CD	O
/	JJ	O
20	CD	O
,	,	O
000	CD	O
males	NNS	O
either	CC	O
as	IN	O
cerebral	JJ	B_Disease
ALD	NNP	E_Disease
in	IN	O
childhood	NN	O
or	CC	O
as	IN	O
adrenomyeloneuropathy	JJ	S_Disease
(	(	O
AMN	NNP	S_Disease
)	)	O
in	IN	O
adults	NNS	O
.	.	O

Childhood	NNP	O
ALD	NNP	S_Disease
is	VBZ	O
the	DT	O
more	RBR	O
severe	JJ	O
form	NN	O
,	,	O
with	IN	O
onset	NN	O
of	IN	O
neurological	JJ	O
symptoms	NNS	O
between	IN	O
5	CD	O
-	:	O
12	CD	O
years	NNS	O
of	IN	O
age	NN	O
.	.	O

Central	NNP	B_Disease
nervous	JJ	I_Disease
system	NN	I_Disease
demyelination	NN	E_Disease
progresses	VBZ	O
rapidly	RB	O
and	CC	O
death	NN	O
occurs	NNS	O
within	IN	O
a	DT	O
few	JJ	O
years	NNS	O
.	.	O

AMN	NNP	S_Disease
is	VBZ	O
a	DT	O
milder	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
with	IN	O
onset	NN	O
at	IN	O
15	CD	O
-	:	O
30	CD	O
years	NNS	O
of	IN	O
age	NN	O
and	CC	O
a	DT	O
more	RBR	O
progressive	JJ	O
course	NN	O
.	.	O

Adrenal	JJ	B_Disease
insufficiency	NN	E_Disease
(	(	O
Addisons	NNP	B_Disease
disease	NN	E_Disease
)	)	O
may	MD	O
remain	VB	O
the	DT	O
only	JJ	O
clinical	JJ	O
manifestation	NN	O
of	IN	O
ALD	NNP	S_Disease
.	.	O

The	DT	O
principal	JJ	O
biochemical	JJ	O
abnormality	NN	O
of	IN	O
ALD	NNP	S_Disease
is	VBZ	O
the	DT	O
accumulation	NN	O
of	IN	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
(	(	O
VLCFA	NNP	O
)	)	O
because	IN	O
of	IN	O
impaired	JJ	O
beta	NN	O
-	:	O
oxidation	NN	O
in	IN	O
peroxisomes	NNS	O
.	.	O

The	DT	O
normal	JJ	O
oxidation	NN	O
of	IN	O
VLCFA	NNP	O
-	:	O
CoA	NN	O
in	IN	O
patients	NNS	O
fibroblasts	NNS	O
suggested	VBD	O
that	IN	O
the	DT	O
gene	NN	O
coding	VBG	O
for	IN	O
the	DT	O
VLCFA	NNP	O
-	:	O
CoA	NNP	O
synthetase	NN	O
could	MD	O
be	VB	O
a	DT	O
candidate	JJ	O
gene	NN	O
for	IN	O
ALD	NNP	S_Disease
.	.	O

Here	RB	O
we	PRP	O
use	VBP	O
positional	JJ	O
cloning	NN	O
to	TO	O
identify	VB	O
a	DT	O
gene	NN	O
partially	RB	O
deleted	VBN	O
in	IN	O
6	CD	O
of	IN	O
85	CD	O
independent	JJ	O
patients	NNS	O
with	IN	O
ALD	NNP	S_Disease
.	.	O

In	IN	O
familial	JJ	O
cases	NNS	O
,	,	O
the	DT	O
deletions	NNS	O
segregated	VBN	O
with	IN	O
the	DT	O
disease	NN	O
.	.	O

An	DT	O
identical	JJ	O
deletion	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
two	CD	O
brothers	NNS	O
presenting	VBG	O
with	IN	O
different	JJ	O
clinical	JJ	O
ALD	NNP	S_Disease
phenotypes	NNS	O
.	.	O

Candidate	NNP	O
exons	NNS	O
were	VBD	O
identified	VBN	O
by	IN	O
computer	NN	O
analysis	NN	O
of	IN	O
genomic	JJ	O
sequences	NNS	O
and	CC	O
used	VBN	O
to	TO	O
isolate	VB	O
complementary	JJ	O
DNAs	NNP	O
by	IN	O
exon	JJ	O
connection	NN	O
and	CC	O
screening	NN	O
of	IN	O
cDNA	NN	O
libraries	NNS	O
.	.	O

The	DT	O
deduced	JJ	O
protein	NN	O
sequence	NN	O
shows	VBZ	O
significant	JJ	O
sequence	NN	O
identity	NN	O
to	TO	O
a	DT	O
peroxisomal	JJ	O
membrane	NN	O
protein	NN	O
of	IN	O
M	NNP	O
(	(	O
r	NN	O
)	)	O
70K	CD	O
that	WDT	O
is	VBZ	O
involved	VBN	O
in	IN	O
peroxisome	JJ	O
biogenesis	NN	O
and	CC	O
belongs	NNS	O
to	TO	O
the	DT	O
ATP	NNP	O
-	:	O
binding	NN	O
cassette	NN	O
superfamily	RB	O
of	IN	O
transporters	NNS	O
.	.	O
.	.	O

Targeted	VBN	O
modification	NN	O
of	IN	O
the	DT	O
apolipoprotein	NN	O
B	NNP	O
gene	NN	O
results	NNS	O
in	IN	O
hypobetalipoproteinemia	NN	S_Disease
and	CC	O
developmental	JJ	B_Disease
abnormalities	NNS	E_Disease
in	IN	O
mice	NN	O
.	.	O

Familial	JJ	B_Disease
hypobetalipoproteinemia	NN	E_Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B_Disease
codominant	NN	I_Disease
disorder	NN	E_Disease
resulting	VBG	O
in	IN	O
a	DT	O
dramatic	JJ	O
reduction	NN	O
in	IN	O
plasma	JJ	O
concentrations	NNS	O
of	IN	O
apolipoprotein	NN	O
(	(	O
apo	NN	O
)	)	O
B	NNP	O
,	,	O
cholesterol	NN	O
,	,	O
and	CC	O
beta	SYM	O
-	:	O
migrating	NN	O
lipoproteins	NNS	O
.	.	O

A	DT	O
benefit	NN	O
of	IN	O
hypobetalipoproteinemia	NN	S_Disease
is	VBZ	O
that	IN	O
mildly	RB	O
affected	JJ	O
individuals	NNS	O
may	MD	O
be	VB	O
protected	VBN	O
from	IN	O
coronary	JJ	B_Disease
vascular	JJ	I_Disease
disease	NN	E_Disease
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
gene	NN	O
targeting	VBG	O
to	TO	O
generate	VB	O
mice	NN	O
with	IN	O
a	DT	O
modified	JJ	O
Apob	NNP	O
allele	NN	O
.	.	O

Mice	NNP	O
containing	VBG	O
this	DT	O
allele	JJ	O
display	NN	O
all	DT	O
of	IN	O
the	DT	O
hallmarks	NNS	O
of	IN	O
human	JJ	O
hypobetalipoproteinemia	NN	S_Disease
they	PRP	O
produce	VBP	O
a	DT	O
truncated	JJ	O
apoB	NN	O
protein	NN	O
,	,	O
apoB70	NN	O
,	,	O
and	CC	O
have	VBP	O
markedly	RB	O
decreased	VBN	O
plasma	JJ	O
concentrations	NNS	O
of	IN	O
apoB	NN	O
,	,	O
beta	SYM	O
-	:	O
lipoproteins	NNS	O
,	,	O
and	CC	O
total	JJ	O
cholesterol	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
mice	NN	O
manifest	JJS	O
several	JJ	O
characteristics	NNS	O
that	WDT	O
are	VBP	O
occasionally	RB	O
observed	VBN	O
in	IN	O
human	JJ	O
hypobetalipoproteinemia	NN	S_Disease
,	,	O
including	VBG	O
reduced	VBN	O
plasma	JJ	O
triglyceride	NN	O
concentrations	NNS	O
,	,	O
fasting	VBG	O
chylomicronemia	NN	S_Disease
,	,	O
and	CC	O
reduced	JJ	O
high	JJ	O
density	NN	O
lipoprotein	VBP	O
cholesterol	NN	O
.	.	O

An	DT	O
unexpected	JJ	O
finding	NN	O
is	VBZ	O
that	IN	O
the	DT	O
modified	JJ	O
Apob	NNP	O
allele	NN	O
is	VBZ	O
strongly	RB	O
associated	VBN	O
with	IN	O
exencephalus	NN	S_Disease
and	CC	O
hydrocephalus	NN	S_Disease
.	.	O

These	DT	O
mice	NN	O
should	MD	O
help	VB	O
increase	VB	O
our	PRP$	O
understanding	NN	O
of	IN	O
hypobetalipoproteinemia	NN	S_Disease
,	,	O
atherogenesis	NN	S_Disease
,	,	O
and	CC	O
the	DT	O
etiology	NN	O
of	IN	O
exencephalus	NN	S_Disease
and	CC	O
hydrocephalus	NN	S_Disease
.	.	O
.	.	O

A	DT	O
novel	JJ	O
disease	NN	O
with	IN	O
deficiency	NN	B_Disease
of	IN	I_Disease
mitochondrial	JJ	I_Disease
very	RB	I_Disease
-	:	I_Disease
long	JJ	I_Disease
-	:	I_Disease
chain	NN	I_Disease
acyl	IN	I_Disease
-	:	I_Disease
CoA	NNP	I_Disease
dehydrogenase	NN	E_Disease
.	.	O

Palmitoyl	NNP	O
-	:	O
CoA	NNP	O
dehydrogenase	NN	O
activity	NN	O
in	IN	O
skin	JJ	O
fibroblasts	NNS	O
from	IN	O
seven	CD	O
patients	NNS	O
with	IN	O
unidentified	JJ	O
defects	NNS	O
of	IN	O
fatty	JJ	O
acid	JJ	O
oxidation	NN	O
was	VBD	O
measured	VBN	O
in	IN	O
the	DT	O
presence	NN	O
and	CC	O
absence	NN	O
of	IN	O
antibodies	NNS	O
against	IN	O
medium	NN	O
-	:	O
chain	NN	O
,	,	O
long	JJ	O
-	:	O
chain	NN	O
,	,	O
and	CC	O
very	RB	O
-	:	O
long	JJ	O
-	:	O
chain	NN	O
acyl	IN	O
-	:	O
CoA	NN	O
dehydrogenases	NNS	O
(	(	O
VLCAD	NNP	O
)	)	O
.	.	O

Two	CD	O
of	IN	O
the	DT	O
patients	NNS	O
,	,	O
4	CD	O
-	:	O
5	CD	O
month	NN	O
old	JJ	O
boys	NNS	O
,	,	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
novel	JJ	O
disease	NN	O
,	,	O
VLCAD	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
as	IN	O
judged	VBN	O
from	IN	O
the	DT	O
results	NNS	O
of	IN	O
very	RB	O
low	JJ	O
palmitoyl	NN	O
-	:	O
CoA	NNP	O
dehydrogenase	NN	O
activity	NN	O
and	CC	O
the	DT	O
lack	NN	O
of	IN	O
immunoreactivity	NN	O
toward	IN	O
antibody	NN	O
raised	VBN	O
to	TO	O
purified	VB	O
VLCAD	NNP	O
.	.	O
.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
glucose	JJ	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
deficiency	NN	E_Disease
in	IN	O
patients	NNS	O
of	IN	O
Chinese	JJ	O
descent	NN	O
and	CC	O
identification	NN	O
of	IN	O
new	JJ	O
base	NN	O
substitutions	NNS	O
in	IN	O
the	DT	O
human	JJ	O
G6PD	NNP	O
gene	NN	O
.	.	O

The	DT	O
underlying	VBG	O
DNA	NNP	O
changes	NNS	O
associated	VBN	O
with	IN	O
glucose	JJ	B_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	I_Disease
(	(	I_Disease
G6PD	NNP	I_Disease
)	)	I_Disease
-	:	I_Disease
deficient	NN	E_Disease
Asians	NNPS	O
have	VBP	O
not	RB	O
been	VBN	O
extensively	RB	O
investigated	VBN	O
.	.	O

To	TO	O
fill	VB	O
this	DT	O
gap	NN	O
,	,	O
we	PRP	O
sequenced	VBD	O
the	DT	O
G6PD	NNP	O
gene	NN	O
of	IN	O
43	CD	O
G6PD	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
Chinese	NNPS	O
whose	WP$	O
G6PD	NNP	O
was	VBD	O
well	RB	O
characterized	VBN	O
biochemically	RB	O
.	.	O

DNA	NN	O
samples	NNS	O
were	VBD	O
obtained	VBN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
of	IN	O
these	DT	O
individuals	NNS	O
for	IN	O
sequencing	VBG	O
using	VBG	O
a	DT	O
direct	JJ	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
sequencing	VBG	O
procedure	NN	O
.	.	O

From	IN	O
these	DT	O
43	CD	O
samples	NNS	O
,	,	O
we	PRP	O
have	VBP	O
identified	VBN	O
five	CD	O
different	JJ	O
types	NNS	O
of	IN	O
nucleotide	JJ	O
substitutions	NNS	O
in	IN	O
the	DT	O
G6PD	NNP	O
gene	NN	O
at	IN	O
cDNA	NN	O
1388	CD	O
from	IN	O
G	NNP	O
to	TO	O
A	NNP	O
(	(	O
Arg	NNP	O
to	TO	O
His	PRP$	O
)	)	O
;	:	O
at	IN	O
cDNA	NN	O
1376	CD	O
from	IN	O
G	NNP	O
to	TO	O
T	NNP	O
(	(	O
Arg	NNP	O
to	TO	O
Leu	NNP	O
)	)	O
;	:	O
at	IN	O
cDNA	NN	O
1024	CD	O
from	IN	O
C	NNP	O
to	TO	O
T	NNP	O
(	(	O
Leu	NNP	O
to	TO	O
Phe	NNP	O
)	)	O
;	:	O
at	IN	O
cDNA	NN	O
392	CD	O
from	IN	O
G	NNP	O
to	TO	O
T	NNP	O
(	(	O
Gly	NNP	O
to	TO	O
Val	NNP	O
)	)	O
;	:	O
at	IN	O
cDNA	NN	O
95	CD	O
from	IN	O
A	NN	O
to	TO	O
G	NNP	O
(	(	O
His	PRP$	O
to	TO	O
Arg	NNP	O
)	)	O
.	.	O

These	DT	O
five	CD	O
nucleotide	JJ	O
substitutions	NNS	O
account	VBP	O
for	IN	O
over	IN	O
83	CD	O
%	NN	O
of	IN	O
our	PRP$	O
43	CD	O
G6PD	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
samples	NNS	O
and	CC	O
these	DT	O
substitutions	NNS	O
have	VBP	O
not	RB	O
been	VBN	O
reported	VBN	O
in	IN	O
non	JJ	O
-	:	O
Asians	NNPS	O
.	.	O

The	DT	O
substitutions	NNS	O
found	VBD	O
at	IN	O
cDNA	NN	O
392	CD	O
and	CC	O
cDNA	NN	O
1024	CD	O
are	VBP	O
new	JJ	O
findings	NNS	O
.	.	O

The	DT	O
substitutions	NNS	O
at	IN	O
cDNA	NN	O
1376	CD	O
and	CC	O
1388	CD	O
account	NN	O
for	IN	O
over	IN	O
50	CD	O
%	NN	O
of	IN	O
the	DT	O
43	CD	O
samples	NNS	O
examined	VBD	O
indicating	VBG	O
a	DT	O
high	JJ	O
prevalence	NN	O
of	IN	O
these	DT	O
two	CD	O
alleles	NNS	O
among	IN	O
G6PD	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
Chinese	NNPS	O
.	.	O

Our	PRP$	O
findings	NNS	O
add	VBP	O
support	NN	O
to	TO	O
the	DT	O
notion	NN	O
that	WDT	O
diverse	VBZ	O
point	NN	O
mutations	NNS	O
may	MD	O
account	VB	O
largely	RB	O
for	IN	O
much	JJ	O
of	IN	O
the	DT	O
phenotypic	NN	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
.	.	O
.	.	O

Identification	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
Danish	NNP	O
choroideremia	NN	S_Disease
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
searched	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
choroideremia	NN	S_Disease
gene	NN	O
(	(	O
CHM	NNP	S_Disease
)	)	O
in	IN	O
patients	NNS	O
from	IN	O
12	CD	O
Danish	JJ	O
families	NNS	O
in	IN	O
which	WDT	O
CHM	NNP	S_Disease
is	VBZ	O
segregating	VBG	O
.	.	O

Employing	VBG	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
,	,	O
single	JJ	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	(	O
SSCP	NNP	O
)	)	O
analysis	NN	O
,	,	O
and	CC	O
direct	JJ	O
DNA	NNP	O
sequencing	NN	O
,	,	O
different	JJ	O
mutations	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
6	CD	O
patients	NNS	O
.	.	O

All	PDT	O
the	DT	O
mutations	NNS	O
will	MD	O
interfere	VB	O
with	IN	O
the	DT	O
correct	JJ	O
translation	NN	O
of	IN	O
the	DT	O
mRNA	NN	O
predicting	VBG	O
a	DT	O
truncated	JJ	O
protein	NN	O
or	CC	O
no	DT	O
gene	NN	O
product	NN	O
at	IN	O
all	DT	O
.	.	O
.	.	O

Structure	NN	O
and	CC	O
genomic	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
kinase	NN	O
)	)	O
gene	NN	O
.	.	O

The	DT	O
mutation	NN	O
causing	VBG	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
(	(	O
DM	NNP	S_Disease
)	)	O
has	VBZ	O
recently	RB	O
been	VBN	O
identified	VBN	O
as	IN	O
an	DT	O
unstable	JJ	O
CTG	NNP	O
trinucleotide	NN	O
repeat	NN	O
located	VBN	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
a	DT	O
gene	NN	O
encoding	VBG	O
for	IN	O
a	DT	O
protein	NN	O
with	IN	O
putative	JJ	O
serine	NN	O
-	:	O
threonine	NN	O
protein	JJ	O
kinase	NN	O
activity	NN	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
we	PRP	O
present	VBP	O
the	DT	O
genomic	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
human	JJ	O
and	CC	O
murine	JJ	O
DM	NNP	S_Disease
kinase	NN	O
gene	NN	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
these	DT	O
sequences	NNS	O
with	IN	O
each	DT	O
other	JJ	O
and	CC	O
with	IN	O
known	VBN	O
cDNA	NN	O
sequences	NNS	O
from	IN	O
both	DT	O
species	NNS	O
,	,	O
led	VBD	O
us	PRP	O
to	TO	O
predict	VB	O
a	DT	O
translation	NN	O
initiation	NN	O
codon	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
determine	VB	O
the	DT	O
organization	NN	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
kinase	NN	O
gene	NN	O
.	.	O

Several	JJ	O
polymorphisms	NNS	O
within	IN	O
the	DT	O
human	JJ	O
DM	NNP	S_Disease
kinase	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
,	,	O
and	CC	O
PCR	NNP	O
assays	NNS	O
to	TO	O
detect	VB	O
two	CD	O
of	IN	O
these	DT	O
are	VBP	O
described	VBN	O
.	.	O

The	DT	O
complete	JJ	O
sequence	NN	O
and	CC	O
characterization	NN	O
of	IN	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
DM	NNP	S_Disease
kinase	NNP	O
gene	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
identification	NN	O
of	IN	O
novel	JJ	O
polymorphisms	NNS	O
within	IN	O
the	DT	O
gene	NN	O
,	,	O
represent	VBP	O
an	DT	O
important	JJ	O
step	NN	O
in	IN	O
a	DT	O
further	JJ	O
understanding	NN	O
of	IN	O
the	DT	O
genetics	NNS	O
of	IN	O
myotonic	JJ	B_Disease
dystrophy	NN	E_Disease
and	CC	O
the	DT	O
molecular	JJ	O
biology	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O
.	.	O

Autosomal	NNP	O
recessive	JJ	O
transmission	NN	O
of	IN	O
hemophilia	NN	B_Disease
A	NNP	E_Disease
due	JJ	O
to	TO	O
a	DT	O
von	NN	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
mutation	NN	O
.	.	O

The	DT	O
differential	JJ	O
diagnosis	NN	O
of	IN	O
the	DT	O
genetic	JJ	B_Disease
bleeding	NN	I_Disease
disorders	NNS	E_Disease
,	,	O
hemophilia	VB	B_Disease
A	NNP	E_Disease
and	CC	O
von	NNP	B_Disease
Willebrand	NNP	I_Disease
disease	NN	E_Disease
,	,	O
is	VBZ	O
occasionally	RB	O
confounded	VBN	O
by	IN	O
the	DT	O
close	JJ	O
molecular	JJ	O
relationship	NN	O
of	IN	O
coagulation	NN	O
factor	NN	O
VIII	NNP	O
and	CC	O
von	NNP	B_Disease
Willebrand	NNP	E_Disease
factor	NN	O
(	(	O
vWF	NN	O
)	)	O
.	.	O

This	DT	O
report	NN	O
describes	VBZ	O
the	DT	O
autosomal	JJ	O
inheritance	NN	O
of	IN	O
a	DT	O
hemophilia	NN	B_Disease
A	NNP	E_Disease
phenotype	NN	O
due	JJ	O
to	TO	O
a	DT	O
mutation	NN	O
of	IN	O
vWF	NN	O
that	WDT	O
results	NNS	O
in	IN	O
defective	JJ	O
factor	NN	O
VIII	NNP	O
binding	NN	O
.	.	O

The	DT	O
proband	NN	O
was	VBD	O
a	DT	O
female	JJ	O
patient	NN	O
with	IN	O
low	JJ	O
levels	NNS	O
of	IN	O
factor	NN	O
VIII	NNP	O
activity	NN	O
.	.	O

Polymerase	NNP	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
amplification	NN	O
and	CC	O
DNA	NNP	O
sequencing	VBG	O
were	VBD	O
employed	VBN	O
to	TO	O
examine	VB	O
exons	NNS	O
encoding	VBG	O
the	DT	O
putative	JJ	O
factor	NN	O
VIII	NNP	O
binding	VBG	O
domain	NN	O
of	IN	O
vWF	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
homozygous	JJ	O
for	IN	O
a	DT	O
single	JJ	O
point	NN	O
mutation	NN	O
causing	VBG	O
a	DT	O
Thr	NNP	O
-	:	O
-	:	O
>	NN	O
Met	NNP	O
substitution	NN	O
at	IN	O
amino	NN	O
acid	JJ	O
position	NN	O
28	CD	O
in	IN	O
the	DT	O
mature	NN	O
vWF	NN	O
subunit	NN	O
.	.	O

The	DT	O
phenotypic	JJ	O
expression	NN	O
of	IN	O
the	DT	O
mutation	NN	O
was	VBD	O
determined	VBN	O
to	TO	O
be	VB	O
recessive	JJ	O
because	IN	O
heterozygous	JJ	O
family	NN	O
members	NNS	O
were	VBD	O
clinically	RB	O
unaffected	JJ	O
.	.	O

Recombinant	JJ	O
vWF	NN	O
containing	VBG	O
the	DT	O
observed	JJ	O
amino	NN	O
acid	JJ	O
substitution	NN	O
was	VBD	O
expressed	VBN	O
in	IN	O
COS	NNP	O
-	:	O
1	CD	O
cells	NNS	O
.	.	O

The	DT	O
mutant	JJ	O
vWF	NN	O
was	VBD	O
processed	VBN	O
and	CC	O
secreted	VBN	O
normally	RB	O
,	,	O
and	CC	O
was	VBD	O
functionally	RB	O
equivalent	JJ	O
to	TO	O
wild	VB	O
-	:	O
type	NN	O
vWF	NN	O
in	IN	O
its	PRP$	O
ability	NN	O
to	TO	O
bind	VB	O
to	TO	O
platelets	NNS	O
.	.	O

However	RB	O
,	,	O
the	DT	O
mutant	NN	O
failed	VBD	O
to	TO	O
bind	VB	O
factor	NN	O
VIII	NNP	O
,	,	O
demonstrating	VBG	O
that	IN	O
the	DT	O
mutation	NN	O
was	VBD	O
functionally	RB	O
related	VBN	O
to	TO	O
the	DT	O
observed	VBN	O
hemophilia	NN	S_Disease
phenotype	NN	O
.	.	O

The	DT	O
family	NN	O
we	PRP	O
describe	VBP	O
demonstrates	VBZ	O
the	DT	O
recessive	JJ	O
inheritance	NN	O
of	IN	O
a	DT	O
recently	RB	O
recognized	VBN	O
class	NN	O
of	IN	O
genetic	JJ	O
bleeding	NN	O
disorders	NNS	O
,	,	O
we	PRP	O
call	VBP	O
"	JJ	O
autosomal	JJ	O
hemophilia	NN	S_Disease
.	.	O

"	NN	O
We	PRP	O
conclude	VBP	O
that	IN	O
vWF	JJ	O
mutation	NN	O
may	MD	O
be	VB	O
an	DT	O
under	IN	O
recognized	VBN	O
cause	NN	O
of	IN	O
hemophilia	NN	S_Disease
,	,	O
especially	RB	O
in	IN	O
cases	NNS	O
where	WRB	O
the	DT	O
inheritance	NN	O
pattern	NN	O
is	VBZ	O
not	RB	O
consistent	JJ	O
with	IN	O
X	NNP	O
-	:	O
linked	VBN	O
transmission	NN	O
.	.	O

Somatic	JJ	O
von	NN	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	E_Disease
mutation	NN	O
in	IN	O
clear	JJ	O
cell	NN	O
papillary	JJ	B_Disease
cystadenoma	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
epididymis	NN	E_Disease
.	.	O

Papillary	JJ	B_Disease
cystadenoma	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
epididymis	NN	E_Disease
is	VBZ	O
an	DT	O
uncommon	JJ	O
benign	NN	O
lesion	NN	O
that	WDT	O
may	MD	O
occur	VB	O
sporadically	RB	O
or	CC	O
as	IN	O
a	DT	O
manifestation	NN	O
of	IN	O
von	NN	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	NNP	I_Disease
(	(	I_Disease
VHL	NNP	I_Disease
)	)	I_Disease
disease	NN	E_Disease
.	.	O

Neither	DT	O
immunohistochemical	JJ	O
studies	NNS	O
nor	CC	O
molecular	JJ	O
genetic	JJ	O
analyses	NNS	O
of	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
have	VBP	O
been	VBN	O
reported	VBN	O
previously	RB	O
for	IN	O
this	DT	O
lesion	NN	O
.	.	O

The	DT	O
authors	NNS	O
describe	VBP	O
two	CD	O
cases	NNS	O
of	IN	O
clear	JJ	O
cell	NN	O
papillary	JJ	B_Disease
cystadenoma	NN	I_Disease
of	IN	I_Disease
the	DT	I_Disease
epididymis	NN	E_Disease
,	,	O
both	DT	O
of	IN	O
which	WDT	O
were	VBD	O
initially	RB	O
confused	VBN	O
with	IN	O
metastatic	JJ	B_Disease
renal	NN	I_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
.	.	O

Both	DT	O
lesions	NNS	O
showed	VBD	O
positive	JJ	O
immunohistochemical	JJ	O
staining	VBG	O
for	IN	O
low	JJ	O
and	CC	O
intermediate	JJ	O
molecular	JJ	O
weight	NN	O
keratins	NNS	O
(	(	O
Cam	NNP	O
5	CD	O
.	.	O

2	CD	O
and	CC	O
AE1	NNP	O
/	NNP	O
AE3	NNP	O
)	)	O
,	,	O
EMA	NNP	O
,	,	O
vimentin	NN	O
,	,	O
alpha	RB	O
1	CD	O
-	:	O
antitrypsin	NN	O
,	,	O
and	CC	O
alpha	RB	O
1	CD	O
-	:	O
antichymotrypsin	NN	O
.	.	O

Each	DT	O
was	VBD	O
negative	JJ	O
for	IN	O
CEA	NNP	O
.	.	O

Because	IN	O
clear	JJ	O
cell	NN	O
papillary	JJ	B_Disease
cystadenoma	NN	E_Disease
is	VBZ	O
similar	JJ	O
to	TO	O
renal	VB	B_Disease
cell	NN	I_Disease
carcinoma	NN	E_Disease
histologically	RB	O
,	,	O
and	CC	O
because	IN	O
both	DT	O
occur	VBP	O
as	IN	O
components	NNS	O
of	IN	O
the	DT	O
von	NN	B_Disease
Hippel	NNP	I_Disease
-	:	I_Disease
Lindau	JJ	I_Disease
disease	NN	E_Disease
complex	NN	O
,	,	O
the	DT	O
authors	NNS	O
analyzed	VBD	O
both	DT	O
cases	NNS	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
.	.	O

A	DT	O
somatic	JJ	O
VHL	NNP	S_Disease
gene	NN	O
mutation	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
tumors	NNS	S_Disease
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
followed	VBN	O
by	IN	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
analysis	NN	O
.	.	O

Direct	JJ	O
sequencing	NN	O
revealed	VBD	O
a	DT	O
cytosine	NN	O
to	TO	O
thymine	VB	O
transition	NN	O
at	IN	O
nucleotide	JJ	O
694	CD	O
,	,	O
resulting	VBG	O
in	IN	O
the	DT	O
replacement	NN	O
of	IN	O
an	DT	O
arginine	NN	O
with	IN	O
a	DT	O
stop	NN	O
codon	NN	O
after	IN	O
the	DT	O
sixth	JJ	O
amino	NN	O
acid	NN	O
of	IN	O
exon	$	O
3	CD	O
.	.	O

As	IN	O
the	DT	O
VHL	NNP	S_Disease
gene	NN	O
is	VBZ	O
believed	VBN	O
to	TO	O
function	VB	O
as	IN	O
a	DT	O
tumor	NN	S_Disease
suppressor	NN	O
gene	NN	O
,	,	O
VHL	NNP	S_Disease
gene	NN	O
mutations	NNS	O
may	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
the	DT	O
initiation	NN	O
of	IN	O
tumorigenesis	NN	O
in	IN	O
sporadic	JJ	O
cystadenomas	NN	B_Disease
of	IN	I_Disease
the	DT	I_Disease
epididymis	NN	E_Disease
.	.	O

Identification	NN	O
of	IN	O
WASP	NNP	O
mutations	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
and	CC	O
isolated	JJ	B_Disease
thrombocytopenia	NN	E_Disease
reveals	NNS	O
allelic	JJ	O
heterogeneity	NN	O
at	IN	O
the	DT	O
WAS	NNP	S_Disease
locus	NN	O
.	.	O

Mutation	NN	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
recently	RB	O
isolated	VBN	O
WASP	NNP	O
protein	NN	O
has	VBZ	O
now	RB	O
been	VBN	O
identified	VBN	O
as	IN	O
the	DT	O
genetic	JJ	B_Disease
defect	NN	E_Disease
responsible	JJ	O
for	IN	O
the	DT	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBD	I_Disease
Wiskott	NNP	I_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
,	,	O
a	DT	O
primary	JJ	O
immunodeficiency	NN	B_Disease
disease	NN	E_Disease
associated	VBN	O
with	IN	O
extensive	JJ	O
phenotypic	NN	O
variability	NN	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
range	NN	O
of	IN	O
WASP	NNP	O
mutations	NNS	O
responsible	JJ	O
for	IN	O
WAS	NNP	S_Disease
,	,	O
we	PRP	O
used	VBD	O
PCR	NNP	O
-	:	O
SSCP	NN	O
analysis	NN	O
to	TO	O
screen	VB	O
for	IN	O
WASP	NNP	O
gene	NN	O
mutation	NN	O
in	IN	O
19	CD	O
unrelated	JJ	O
boys	NNS	O
with	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
classical	JJ	O
or	CC	O
attenuated	VBN	O
WAS	NNP	S_Disease
or	CC	O
isolated	VBN	B_Disease
thrombocytopenia	NN	E_Disease
.	.	O

All	DT	O
19	CD	O
patients	NNS	O
had	VBD	O
WASP	NNP	O
mutations	NNS	O
,	,	O
each	DT	O
of	IN	O
which	WDT	O
localized	VBD	O
to	TO	O
the	DT	O
initial	JJ	O
three	CD	O
or	CC	O
terminal	JJ	O
three	CD	O
exons	NNS	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
and	CC	O
the	DT	O
majority	NN	O
of	IN	O
which	WDT	O
were	VBD	O
unique	JJ	O
in	IN	O
each	DT	O
case	NN	O
.	.	O

However	RB	O
,	,	O
a	DT	O
missense	NN	O
mutation	NN	O
which	WDT	O
results	NNS	O
in	IN	O
substitution	NN	O
of	IN	O
the	DT	O
arginine	NN	O
at	IN	O
WAS	NNP	S_Disease
codon	VBG	O
86	CD	O
was	VBD	O
identified	VBN	O
in	IN	O
three	CD	O
boys	NNS	O
with	IN	O
severe	JJ	O
WAS	NNP	S_Disease
as	RB	O
well	RB	O
as	IN	O
in	IN	O
one	CD	O
boy	NN	O
presenting	VBG	O
with	IN	O
thrombocytopenia	NN	S_Disease
alone	RB	O
.	.	O

While	IN	O
the	DT	O
three	CD	O
mutations	NNS	O
found	VBN	O
in	IN	O
the	DT	O
isolated	JJ	B_Disease
thrombocytopenia	NN	E_Disease
patients	NNS	O
leave	VBP	O
the	DT	O
reading	NN	O
frame	NN	O
intact	JJ	O
,	,	O
about	IN	O
one	CD	O
-	:	O
half	NN	O
of	IN	O
the	DT	O
gene	NN	O
alterations	NNS	O
detected	VBN	O
in	IN	O
both	DT	O
severe	JJ	O
and	CC	O
attenuated	VBN	O
WAS	NNP	S_Disease
patients	NNS	O
result	VBP	O
in	IN	O
frameshifted	JJ	O
transcript	NN	O
and	CC	O
premature	NN	O
translation	NN	O
termination	NN	O
.	.	O

These	DT	O
findings	NNS	O
therefore	RB	O
confirm	VBP	O
the	DT	O
association	NN	O
of	IN	O
WAS	NNP	S_Disease
with	IN	O
WASP	NNP	O
mutation	NN	O
and	CC	O
identify	VB	O
WASP	NNP	O
mutation	NN	O
as	IN	O
a	DT	O
cause	NN	O
for	IN	O
isolated	JJ	O
congenital	JJ	B_Disease
thrombocytopenia	NN	E_Disease
in	IN	O
males	NNS	O
.	.	O

While	IN	O
the	DT	O
WASP	NNP	O
gene	NN	O
defects	NNS	O
responsible	JJ	O
for	IN	O
isolated	JJ	B_Disease
thrombocytopenia	NN	E_Disease
and	CC	O
other	JJ	O
mild	JJ	O
presentations	NNS	O
of	IN	O
WAS	NNP	S_Disease
do	VBP	O
not	RB	O
appear	VB	O
distinct	JJ	O
from	IN	O
those	DT	O
resulting	VBG	O
in	IN	O
severe	NN	O
WAS	NNP	S_Disease
,	,	O
these	DT	O
data	NNS	O
indicate	VBP	O
that	IN	O
analysis	NN	O
of	IN	O
WASP	NNP	O
gene	NN	O
mutation	NN	O
provides	VBZ	O
a	DT	O
valuable	JJ	O
tool	NN	O
for	IN	O
distinguishing	VBG	O
the	DT	O
spectrum	NN	O
of	IN	O
WAS	NNP	S_Disease
patients	NNS	O
and	CC	O
the	DT	O
subset	NN	O
of	IN	O
males	NNS	O
with	IN	O
isolated	JJ	B_Disease
thrombocytopenia	NN	E_Disease
who	WP	O
represent	VBP	O
mild	JJ	O
cases	NNS	O
of	IN	O
WAS	NNP	S_Disease
.	.	O
.	.	O

WASP	NNP	O
gene	NN	O
mutations	NNS	O
in	IN	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
and	CC	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
thrombocytopenia	NN	E_Disease
.	.	O

The	DT	O
WASP	NNP	O
gene	NN	O
has	VBZ	O
been	VBN	O
recently	RB	O
cloned	VBN	O
from	IN	O
Xp11	NNP	O
.	.	O

23	CD	O
and	CC	O
shown	VBN	O
to	TO	O
be	VB	O
mutated	VBN	O
in	IN	O
three	CD	O
patients	NNS	O
with	IN	O
the	DT	O
Wiskott	NNP	B_Disease
-	:	I_Disease
Aldrich	NNP	I_Disease
syndrome	NN	E_Disease
(	(	O
WAS	NNP	S_Disease
)	)	O
.	.	O

We	PRP	O
have	VBP	O
developed	VBN	O
a	DT	O
screening	NN	O
protocol	NN	O
for	IN	O
identifying	VBG	O
WASP	NNP	O
gene	NN	O
alterations	NNS	O
in	IN	O
genomic	JJ	O
DNA	NN	O
and	CC	O
have	VBP	O
identified	VBN	O
a	DT	O
spectrum	NN	O
of	IN	O
novel	JJ	O
mutations	NNS	O
in	IN	O
12	CD	O
additional	JJ	O
unrelated	JJ	O
families	NNS	O
.	.	O

These	DT	O
missense	NN	O
,	,	O
nonsense	NN	O
and	CC	O
frameshift	NN	O
mutations	NNS	O
involve	VBP	O
eight	CD	O
of	IN	O
the	DT	O
12	CD	O
exons	NNS	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

Two	CD	O
mutations	NNS	O
creating	VBG	O
premature	JJ	O
termination	NN	O
codons	NNS	O
were	VBD	O
associated	VBN	O
with	IN	O
lack	NN	O
of	IN	O
detectable	JJ	O
mRNA	NN	O
on	IN	O
Northern	NNP	O
blots	NNS	O
.	.	O

Four	CD	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
,	,	O
Leu27Phe	NNP	O
,	,	O
Thr48Ile	NNP	O
,	,	O
Val75Met	NNP	O
and	CC	O
Arg477Lys	NNP	O
,	,	O
were	VBD	O
found	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
congenital	JJ	B_Disease
thrombocytopenia	NN	E_Disease
and	CC	O
no	DT	O
clinically	RB	O
evident	JJ	O
immune	NN	O
defect	NN	O
indicating	VBG	O
that	IN	O
the	DT	O
WASP	NNP	O
gene	NN	O
is	VBZ	O
the	DT	O
site	NN	O
for	IN	O
mutations	NNS	O
in	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
thrombocytopenia	NN	E_Disease
as	RB	O
well	RB	O
as	IN	O
in	IN	O
WAS	NNP	S_Disease
.	.	O

A	DT	O
T	NNP	O
-	:	O
cell	NN	O
line	NN	O
from	IN	O
a	DT	O
WAS	NNP	S_Disease
patient	NN	O
contained	VBD	O
two	CD	O
independent	JJ	O
DNA	NNP	O
alterations	NNS	O
,	,	O
a	DT	O
constitutional	JJ	O
frameshift	NN	O
mutation	NN	O
,	,	O
also	RB	O
present	JJ	O
in	IN	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
from	IN	O
the	DT	O
patient	NN	O
,	,	O
and	CC	O
compensatory	JJ	O
splice	NN	O
site	NN	O
mutation	NN	O
unique	NN	O
to	TO	O
the	DT	O
cell	NN	O
line	NN	O
.	.	O

The	DT	O
distribution	NN	O
of	IN	O
eight	CD	O
missense	JJ	O
mutations	NNS	O
provides	VBZ	O
valuable	JJ	O
information	NN	O
on	IN	O
amino	NN	O
acids	NNS	O
which	WDT	O
are	VBP	O
essential	JJ	O
for	IN	O
normal	JJ	O
protein	NN	O
function	NN	O
,	,	O
and	CC	O
suggests	VBZ	O
that	DT	O
sites	VBZ	O
in	IN	O
the	DT	O
first	JJ	O
two	CD	O
exons	NNS	O
are	VBP	O
hot	JJ	O
-	:	O
spots	NNS	O
for	IN	O
mutation	NN	O
.	.	O

Evidence	NN	O
for	IN	O
inter	NN	O
-	:	O
generational	JJ	O
instability	NN	O
in	IN	O
the	DT	O
CAG	NNP	O
repeat	NN	O
in	IN	O
the	DT	O
MJD1	NNP	O
gene	NN	O
and	CC	O
for	IN	O
conserved	JJ	O
haplotypes	NNS	O
at	IN	O
flanking	VBG	O
markers	NNS	O
amongst	VBP	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
subjects	NNS	O
with	IN	O
Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
.	.	O

The	DT	O
size	NN	O
of	IN	O
the	DT	O
(	(	O
CAG	NNP	O
)	)	O
n	RB	O
repeat	JJ	O
array	NN	O
in	IN	O
the	DT	O
3	CD	O
'	POS	O
end	NN	O
of	IN	O
the	DT	O
MJD1	NNP	O
gene	NN	O
and	CC	O
the	DT	O
haplotype	NN	O
at	IN	O
a	DT	O
series	NN	O
of	IN	O
microsatellite	JJ	O
markers	NNS	O
surrounding	VBG	O
the	DT	O
MJD1	NNP	O
gene	NN	O
were	VBD	O
examined	VBN	O
in	IN	O
a	DT	O
large	JJ	O
cohort	NN	O
of	IN	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
subjects	NNS	O
affected	VBN	O
with	IN	O
Machado	NNP	B_Disease
-	:	I_Disease
Joseph	NNP	I_Disease
disease	NN	E_Disease
(	(	O
MJD	NNP	S_Disease
)	)	O
.	.	O

Our	PRP$	O
data	NNS	O
provide	VBP	O
five	CD	O
novel	JJ	O
observations	NNS	O
.	.	O

First	RB	O
,	,	O
MJD	NNP	S_Disease
is	VBZ	O
associated	VBN	O
with	IN	O
expansion	NN	O
fo	VBP	O
the	DT	O
array	NN	O
from	IN	O
the	DT	O
normal	JJ	O
range	NN	O
of	IN	O
14	CD	O
-	:	O
37	CD	O
repeats	NNS	O
to	TO	O
68	CD	O
-	:	O
84	CD	O
repeats	NNS	O
in	IN	O
most	JJS	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
subjects	NNS	O
,	,	O
but	CC	O
no	DT	O
subjects	NNS	O
were	VBD	O
observed	VBN	O
with	IN	O
expansions	NNS	O
intermediate	VBP	O
in	IN	O
size	NN	O
between	IN	O
those	DT	O
of	IN	O
the	DT	O
normal	JJ	O
and	CC	O
MJD	NNP	S_Disease
affected	VBD	O
groups	NNS	O
.	.	O

Second	JJ	O
,	,	O
the	DT	O
expanded	VBN	O
allele	NN	O
associated	VBN	O
with	IN	O
MJD	NNP	S_Disease
displays	NNS	O
inter	VBP	O
-	:	O
generational	JJ	O
instability	NN	O
,	,	O
particularly	RB	O
in	IN	O
male	NN	O
meioses	NNS	O
,	,	O
and	CC	O
this	DT	O
instability	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
the	DT	O
clinical	JJ	O
phenomenon	NN	O
of	IN	O
anticipation	NN	O
.	.	O

Third	NNP	O
,	,	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
expanded	VBN	O
allele	NN	O
is	VBZ	O
not	RB	O
only	RB	O
inversely	RB	O
correlated	VBN	O
with	IN	O
the	DT	O
age	NN	O
-	:	O
of	IN	O
-	:	O
onset	NN	O
of	IN	O
MJD	NNP	S_Disease
(	(	O
r	NN	O
=	NNP	O
-	:	O
0	CD	O
.	.	O
738	CD	O
,	,	O
p	NN	O
<	VBD	O
0	CD	O
.	.	O
001	CD	O
)	)	O
,	,	O
but	CC	O
is	VBZ	O
also	RB	O
correlated	VBN	O
with	IN	O
the	DT	O
frequency	NN	O
of	IN	O
other	JJ	O
clinical	JJ	O
features	NNS	O
[	VBP	O
e	NN	O
.	.	O
g	NN	O
.	.	O

pseudoexophthalmos	NN	O
and	CC	O
pyramidal	JJ	O
signs	NNS	O
were	VBD	O
more	RBR	O
frequent	JJ	O
in	IN	O
subjects	NNS	O
with	IN	O
large	JJ	O
repeats	NNS	O
(	(	O
p	JJ	O
<	NN	O
0	CD	O
.	.	O
001	CD	O
and	CC	O
p	VB	O
<	JJ	O
0	CD	O
.	.	O
05	CD	O
respectively	RB	O
)	)	O
]	NN	O
.	.	O

Fourth	NN	O
,	,	O
the	DT	O
disease	NN	O
phenotype	NN	O
is	VBZ	O
significantly	RB	O
more	RBR	O
severe	JJ	O
and	CC	O
had	VBD	O
an	DT	O
early	JJ	O
age	NN	O
of	IN	O
onset	NN	O
(	(	O
16	CD	O
years	NNS	O
)	)	O
in	IN	O
a	DT	O
subject	NN	O
homozygous	JJ	O
for	IN	O
the	DT	O
expanded	VBN	O
allele	NN	O
,	,	O
which	WDT	O
contrasts	VBZ	O
with	IN	O
Huntington	NNP	B_Disease
disease	NN	E_Disease
and	CC	O
suggests	VBZ	O
that	IN	O
the	DT	O
expanded	VBN	O
allele	NN	O
in	IN	O
the	DT	O
MJD1	NNP	O
gene	NN	O
could	MD	O
exert	VB	O
its	PRP$	O
effect	NN	O
either	DT	O
by	IN	O
a	DT	O
dominant	JJ	O
negative	JJ	O
effect	NN	O
(	(	O
putatively	RB	O
excluded	VBN	O
in	IN	O
HD	NNP	S_Disease
)	)	O
or	CC	O
by	IN	O
a	DT	O
gain	NN	O
of	IN	O
function	NN	O
effect	NN	O
as	IN	O
proposed	VBN	O
for	IN	O
HD	NNP	S_Disease
.	.	O

Finally	RB	O
,	,	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
subjects	NNS	O
affected	VBN	O
with	IN	O
MJD	NNP	S_Disease
share	NN	O
haplotypes	VBZ	O
at	IN	O
several	JJ	O
markers	NNS	O
surrounding	VBG	O
the	DT	O
MJD1	NNP	O
gene	NN	O
,	,	O
which	WDT	O
are	VBP	O
uncommon	JJ	O
in	IN	O
the	DT	O
normal	JJ	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
population	NN	O
,	,	O
and	CC	O
which	WDT	O
suggests	VBZ	O
the	DT	O
existence	NN	O
either	NN	O
of	IN	O
common	JJ	O
founders	NNS	O
in	IN	O
these	DT	O
populations	NNS	O
or	CC	O
of	IN	O
chromosomes	NNS	O
susceptible	JJ	O
to	TO	O
pathologic	JJ	O
expansion	NN	O
of	IN	O
the	DT	O
CAG	NNP	O
repeat	NN	O
in	IN	O
the	DT	O
MJD1	NNP	O
gene	NN	O
.	.	O

A	DT	O
4	CD	O
-	:	O
megabase	NN	O
YAC	NNP	O
contig	NN	O
that	WDT	O
spans	VBZ	O
the	DT	O
Langer	NNP	B_Disease
-	:	I_Disease
Giedion	NNP	I_Disease
syndrome	JJ	E_Disease
region	NN	O
on	IN	O
human	JJ	O
chromosome	NN	O
8q24	CD	O
.	.	O
1	CD	O
:	:	O
use	NN	O
in	IN	O
refining	VBG	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
trichorhinophalangeal	JJ	B_Disease
syndrome	NN	E_Disease
and	CC	O
multiple	JJ	O
exostoses	NNS	O
genes	NNS	O
(	(	O
TRPS1	NNP	O
and	CC	O
EXT1	NNP	O
)	)	O
.	.	O

We	PRP	O
have	VBP	O
constructed	VBN	O
a	DT	O
physical	JJ	O
map	NN	O
covering	VBG	O
over	IN	O
4	CD	O
Mb	NNP	O
of	IN	O
human	JJ	O
chromosome	NN	O
8q24	CD	O
.	.	O

1	CD	O
and	CC	O
used	VBD	O
this	DT	O
map	NN	O
to	TO	O
refine	VB	O
the	DT	O
locations	NNS	O
of	IN	O
the	DT	O
genes	NNS	O
responsible	JJ	O
for	IN	O
Langer	NNP	B_Disease
-	:	I_Disease
Giedion	NNP	I_Disease
syndrome	NN	E_Disease
.	.	O

The	DT	O
map	NN	O
is	VBZ	O
composed	VBN	O
of	IN	O
overlapping	VBG	O
YAC	NNP	O
clones	NNS	O
that	WDT	O
were	VBD	O
identified	VBN	O
and	CC	O
ordered	VBN	O
in	IN	O
relation	NN	O
to	TO	O
sequence	VB	O
tagged	VBN	O
sites	NNS	O
mapped	VBD	O
to	TO	O
the	DT	O
Langer	NNP	O
-	:	O
Giedion	NNP	O
chromosomal	JJ	O
region	NN	O
on	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
.	.	O

The	DT	O
minimal	JJ	O
region	NN	O
of	IN	O
overlap	NN	O
of	IN	O
Langer	NNP	B_Disease
-	:	I_Disease
Giedion	NNP	I_Disease
syndrome	JJ	E_Disease
deletions	NNS	O
,	,	O
previously	RB	O
identified	VBN	O
by	IN	O
analysis	NN	O
of	IN	O
15	CD	O
patients	NNS	O
,	,	O
was	VBD	O
placed	VBN	O
on	IN	O
the	DT	O
map	NN	O
by	IN	O
analysis	NN	O
of	IN	O
2	CD	O
patients	NNS	O
whose	WP$	O
deletions	NNS	O
define	VBP	O
the	DT	O
endpoints	NNS	O
.	.	O

The	DT	O
chromosome	NN	O
8	CD	O
breakpoint	NN	O
of	IN	O
a	DT	O
balanced	JJ	O
t	NN	O
(	(	O
8	CD	O
;	:	O
9	CD	O
)	)	O
(	(	O
q24	UH	O
.	.	O

11	CD	O
;	:	O
q33	NN	O
.	.	O

3	LS	O
)	)	O
translocation	NN	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
trichorhinophalangeal	JJ	B_Disease
syndrome	NN	E_Disease
(	(	O
TRPS	NNP	S_Disease
I	PRP	O
)	)	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
located	VBN	O
just	RB	O
within	IN	O
the	DT	O
proximal	JJ	O
end	NN	O
of	IN	O
the	DT	O
minimal	JJ	O
deletion	NN	O
region	NN	O
.	.	O

A	DT	O
deletion	NN	O
of	IN	O
8q24	CD	O
.	.	O

11	CD	O
-	:	O
q24	NN	O
.	.	O

3	CD	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
multiple	JJ	O
exostoses	NNS	O
was	VBD	O
found	VBN	O
to	TO	O
overlap	VB	O
the	DT	O
distal	JJ	O
end	NN	O
of	IN	O
the	DT	O
LGS	NNP	S_Disease
deletion	NN	O
region	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
EXT1	NNP	O
gene	NN	O
is	VBZ	O
distal	JJ	O
to	TO	O
the	DT	O
TRPS1	NNP	O
gene	NN	O
and	CC	O
supporting	VBG	O
the	DT	O
hypothesis	NN	O
that	WDT	O
Langer	NNP	B_Disease
-	:	I_Disease
Giedion	NNP	I_Disease
syndrome	NN	E_Disease
is	VBZ	O
due	JJ	O
to	TO	O
loss	NN	O
of	IN	O
functional	JJ	O
copies	NNS	O
of	IN	O
both	DT	O
the	DT	O
TRPS1	NNP	O
and	CC	O
the	DT	O
EXT1	NNP	O
genes	NNS	O

BRCA1	NNP	O
mutations	NNS	O
in	IN	O
a	DT	O
population	NN	O
-	:	O
based	VBN	O
sample	NN	O
of	IN	O
young	JJ	O
women	NNS	O
with	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
.	.	O

BACKGROUND	NNP	O
.	.	O

Inherited	VBN	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
high	JJ	O
risk	NN	O
of	IN	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
in	IN	O
some	DT	O
families	NNS	O
.	.	O

However	RB	O
,	,	O
little	JJ	O
is	VBZ	O
known	VBN	O
about	IN	O
the	DT	O
contribution	NN	O
of	IN	O
BRCA1	NNP	O
mutations	NNS	O
to	TO	O
breast	VB	B_Disease
cancer	NN	E_Disease
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

We	PRP	O
analyzed	VBD	O
DNA	NNP	O
samples	NNS	O
from	IN	O
women	NNS	O
enrolled	VBN	O
in	IN	O
a	DT	O
population	NN	O
-	:	O
based	VBN	O
study	NN	O
of	IN	O
early	JJ	O
-	:	O
onset	NN	O
breast	NN	B_Disease
cancer	NN	E_Disease
to	TO	O
assess	VB	O
the	DT	O
spectrum	NN	O
and	CC	O
frequency	NN	O
of	IN	O
germ	JJ	O
-	:	O
line	NN	O
BRCA1	NNP	O
mutations	NNS	O
in	IN	O
young	JJ	O
women	NNS	O
with	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
.	.	O

METHODS	NNP	O
.	.	O

We	PRP	O
studied	VBD	O
80	CD	O
women	NNS	O
in	IN	O
whom	WP	O
breast	NN	B_Disease
cancer	NN	E_Disease
was	VBD	O
diagnosed	VBN	O
before	IN	O
the	DT	O
age	NN	O
of	IN	O
35	CD	O
,	,	O
and	CC	O
who	WP	O
were	VBD	O
not	RB	O
selected	VBN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
family	NN	O
history	NN	O
.	.	O

Genomic	NNP	O
DNA	NNP	O
was	VBD	O
studied	VBN	O
for	IN	O
BRCA1	NNP	O
mutations	NNS	O
by	IN	O
analysis	NN	O
involving	VBG	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
polymorphisms	NNS	O
and	CC	O
with	IN	O
allele	JJ	O
-	:	O
specific	JJ	O
assays	NNS	O
.	.	O

Alterations	NNS	O
were	VBD	O
defined	VBN	O
by	IN	O
DNA	NNP	O
sequencing	NN	O
.	.	O

RESULTS	NNP	O
.	.	O

Germ	NNP	O
-	:	O
line	NN	O
BRCA1	NNP	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
6	CD	O
of	IN	O
the	DT	O
80	CD	O
women	NNS	O
.	.	O

Four	CD	O
additional	JJ	O
rare	NN	O
sequence	NN	O
variants	NNS	O
of	IN	O
unknown	JJ	O
functional	JJ	O
importance	NN	O
were	VBD	O
also	RB	O
identified	VBN	O
.	.	O

Two	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
and	CC	O
three	CD	O
of	IN	O
the	DT	O
rare	JJ	O
sequence	NN	O
variants	NNS	O
were	VBD	O
found	VBN	O
among	IN	O
the	DT	O
39	CD	O
women	NNS	O
who	WP	O
reported	VBD	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
breast	NN	B_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

None	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
and	CC	O
only	RB	O
one	CD	O
of	IN	O
the	DT	O
rare	JJ	O
variants	NNS	O
was	VBD	O
identified	VBN	O
in	IN	O
a	DT	O
reference	NN	O
population	NN	O
of	IN	O
73	CD	O
unrelated	JJ	O
subjects	NNS	O
.	.	O

CONCLUSIONS	NNP	O
.	.	O

Alterations	NNS	O
in	IN	O
BRCA1	NNP	O
were	VBD	O
identified	VBN	O
in	IN	O
approximately	RB	O
10	CD	O
percent	NN	O
of	IN	O
this	DT	O
cohort	NN	O
of	IN	O
young	JJ	O
women	NNS	O
with	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
.	.	O

The	DT	O
risk	NN	O
of	IN	O
harboring	VBG	O
a	DT	O
mutation	NN	O
was	VBD	O
not	RB	O
limited	VBN	O
to	TO	O
women	NNS	O
with	IN	O
family	NN	O
histories	NNS	O
of	IN	O
breast	NN	B_Disease
or	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

These	DT	O
results	NNS	O
represent	VBP	O
a	DT	O
minimal	JJ	O
estimate	NN	O
of	IN	O
the	DT	O
frequency	NN	O
of	IN	O
BRCA1	NNP	O
mutations	NNS	O
in	IN	O
this	DT	O
population	NN	O
.	.	O

Comprehensive	NNP	O
methods	NNS	O
of	IN	O
identifying	VBG	O
BRCA1	NNP	O
mutations	NNS	O
and	CC	O
understanding	VBG	O
their	PRP$	O
importance	NN	O
will	MD	O
be	VB	O
needed	VBN	O
before	IN	O
testing	VBG	O
of	IN	O
women	NNS	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
can	MD	O
be	VB	O
undertaken	VBN	O
.	.	O
.	.	O

Novel	NNP	O
inherited	VBD	O
mutations	NNS	O
and	CC	O
variable	JJ	O
expressivity	NN	O
of	IN	O
BRCA1	NNP	O
alleles	NNS	O
,	,	O
including	VBG	O
the	DT	O
founder	NN	O
mutation	NN	O
185delAG	CD	O
in	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
families	NNS	O
.	.	O

Thirty	NNP	O
-	:	O
seven	CD	O
families	NNS	O
with	IN	O
four	CD	O
or	CC	O
more	JJR	O
cases	NNS	O
of	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
or	CC	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
were	VBD	O
analyzed	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
BRCA1	NNP	O
.	.	O

Twelve	NNP	O
different	JJ	O
germ	SYM	O
-	:	O
line	NN	O
mutations	NNS	O
,	,	O
four	CD	O
novel	NN	O
and	CC	O
eight	CD	O
previously	RB	O
observed	VBN	O
,	,	O
were	VBD	O
detected	VBN	O
in	IN	O
16	CD	O
families	NNS	O
.	.	O

Five	CD	O
families	NNS	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
descent	NN	O
carried	VBD	O
the	DT	O
185delAG	CD	O
mutation	NN	O
and	CC	O
shared	VBD	O
the	DT	O
same	JJ	O
haplotype	NN	O
at	IN	O
eight	CD	O
polymorphic	JJ	O
markers	NNS	O
spanning	VBG	O
approximately	RB	O
850	CD	O
kb	NNS	O
at	IN	O
BRCA1	NNP	O
.	.	O

Expressivity	NN	O
of	IN	O
185delAG	CD	O
in	IN	O
these	DT	O
families	NNS	O
varied	VBD	O
,	,	O
from	IN	O
early	JJ	O
-	:	O
onset	NN	O
breast	NN	B_Disease
cancer	NN	E_Disease
without	IN	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

Mutation	NN	O
4184delTCAA	CD	O
occurred	VBD	O
independently	RB	O
in	IN	O
two	CD	O
families	NNS	O
.	.	O

In	IN	O
one	CD	O
family	NN	O
,	,	O
penetrance	NN	O
was	VBD	O
complete	JJ	O
,	,	O
with	IN	O
females	NNS	O
developing	VBG	O
early	JJ	O
-	:	O
onset	NN	O
breast	NN	B_Disease
cancer	NN	E_Disease
or	CC	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
and	CC	O
the	DT	O
male	NN	O
carrier	NN	O
developing	VBG	O
prostatic	JJ	B_Disease
cancer	NN	E_Disease
,	,	O
whereas	NNS	O
,	,	O
in	IN	O
the	DT	O
other	JJ	O
family	NN	O
,	,	O
penetrance	NN	O
was	VBD	O
incomplete	JJ	O
and	CC	O
only	JJ	O
breast	NN	B_Disease
cancer	NN	E_Disease
occurred	VBD	O
,	,	O
diagnosed	VBN	O
at	IN	O
ages	NNS	O
38	CD	O
-	:	O
81	CD	O
years	NNS	O
.	.	O

Two	CD	O
novel	JJ	O
nonsense	JJ	O
mutations	NNS	O
led	VBD	O
to	TO	O
the	DT	O
loss	NN	O
of	IN	O
mutant	JJ	O
BRCA1	NNP	O
transcript	NN	O
in	IN	O
families	NNS	O
with	IN	O
10	CD	O
and	CC	O
6	CD	O
cases	NNS	O
of	IN	O
early	JJ	O
-	:	O
onset	NN	O
breast	NN	B_Disease
cancer	NN	E_Disease
and	CC	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
.	.	O

A	DT	O
665	CD	O
-	:	O
nt	NN	O
segment	NN	O
of	IN	O
the	DT	O
BRCA1	NNP	O
3	CD	O
-	:	O
UTR	NN	O
and	CC	O
1	CD	O
.	.	O

3	CD	O
kb	NN	O
of	IN	O
genomic	JJ	O
sequence	NN	O
including	VBG	O
the	DT	O
putative	JJ	O
promoter	NN	O
region	NN	O
were	VBD	O
invariant	JJ	O
by	IN	O
single	JJ	O
-	:	O
strand	NN	O
conformation	NN	O
analysis	NN	O
in	IN	O
13	CD	O
families	NNS	O
without	IN	O
coding	VBG	O
-	:	O
sequence	NN	O
mutations	NNS	O
.	.	O

Overall	JJ	O
in	IN	O
our	PRP$	O
series	NN	O
,	,	O
BRCA1	NNP	O
mutations	NNS	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
26	CD	O
families	NNS	O
16	CD	O
with	IN	O
positive	JJ	O
BRCA1	NNP	O
lod	NN	O
scores	NNS	O
,	,	O
7	CD	O
with	IN	O
negative	JJ	O
lod	NN	O
scores	NNS	O
(	(	O
reflecting	VBG	O
multiple	NN	O
sporadic	JJ	O
breast	NN	B_Disease
cancers	NNS	E_Disease
)	)	O
,	,	O
and	CC	O
3	CD	O
not	RB	O
tested	VBN	O
for	IN	O
linkage	NN	O
.	.	O

Three	CD	O
other	JJ	O
families	NNS	O
have	VBP	O
positive	JJ	O
lod	NN	O
scores	NNS	O
for	IN	O
linkage	NN	O
to	TO	O
BRCA2	NNP	O
,	,	O
but	CC	O
13	CD	O
families	NNS	O
without	IN	O
detected	VBN	O
BRCA1	NNP	O
mutations	NNS	O
have	VBP	O
negative	JJ	O
lod	NN	O
scores	NNS	O
for	IN	O
both	DT	O
BRCA1	NNP	O
and	CC	O
BRCA2	NNP	O
.	.	O

A	DT	O
new	JJ	O
glucose	JJ	O
-	:	O
6	CD	O
-	:	O
phosphate	NN	O
dehydrogenase	NN	O
variant	NN	O
,	,	O
G6PD	NNP	O
Orissa	NNP	O
(	(	O
44	CD	O
Ala	NNP	O
-	:	O
-	:	O
>	NN	O
Gly	NNP	O
)	)	O
,	,	O
is	VBZ	O
the	DT	O
major	JJ	O
polymorphic	JJ	O
variant	NN	O
in	IN	O
tribal	JJ	O
populations	NNS	O
in	IN	O
India	NNP	O
.	.	O

Deficiency	NN	B_Disease
of	IN	I_Disease
glucose	JJ	I_Disease
-	:	I_Disease
6	CD	I_Disease
-	:	I_Disease
phosphate	NN	I_Disease
dehydrogenase	NN	E_Disease
(	(	O
G6PD	NNP	O
)	)	O
is	VBZ	O
usually	RB	O
found	VBN	O
at	IN	O
high	JJ	O
frequencies	NNS	O
in	IN	O
areas	NNS	O
of	IN	O
the	DT	O
world	NN	O
where	WRB	O
malaria	NN	S_Disease
has	VBZ	O
been	VBN	O
endemic	JJ	O
.	.	O

The	DT	O
frequency	NN	O
and	CC	O
genetic	JJ	O
basis	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
have	VBP	O
been	VBN	O
studied	VBN	O
in	IN	O
Africa	NNP	O
,	,	O
around	IN	O
the	DT	O
Mediterranean	NNP	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
Far	NNP	O
East	NNP	O
,	,	O
but	CC	O
little	JJ	O
such	JJ	O
information	NN	O
is	VBZ	O
available	JJ	O
about	IN	O
the	DT	O
situation	NN	O
in	IN	O
India	NNP	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
extent	NN	O
of	IN	O
heterogeneity	NN	O
of	IN	O
G6PD	NNP	O
,	,	O
we	PRP	O
have	VBP	O
studied	VBN	O
several	JJ	O
different	JJ	O
Indian	JJ	O
populations	NNS	O
by	IN	O
screening	VBG	O
for	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
,	,	O
followed	VBN	O
by	IN	O
molecular	JJ	O
analysis	NN	O
of	IN	O
deficient	NN	O
alleles	NNS	O
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
varies	NNS	O
between	IN	O
3	CD	O
%	NN	O
and	CC	O
15	CD	O
%	NN	O
in	IN	O
different	JJ	O
tribal	NNS	O
and	CC	O
urban	JJ	O
groups	NNS	O
.	.	O

Remarkably	RB	O
,	,	O
a	DT	O
previously	RB	O
unreported	JJ	O
deficient	NN	O
variant	NN	O
,	,	O
G6PD	NNP	O
Orissa	NNP	O
(	(	O
44	CD	O
Ala	NNP	O
-	:	O
-	:	O
>	NN	O
Gly	NNP	O
)	)	O
,	,	O
is	VBZ	O
responsible	JJ	O
for	IN	O
most	JJS	O
of	IN	O
the	DT	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
in	IN	O
tribal	JJ	O
Indian	JJ	O
populations	NNS	O
but	CC	O
is	VBZ	O
not	RB	O
found	VBN	O
in	IN	O
urban	JJ	O
populations	NNS	O
,	,	O
where	WRB	O
most	JJS	O
of	IN	O
the	DT	O
G6PD	NNP	B_Disease
deficiency	NN	E_Disease
is	VBZ	O
due	JJ	O
to	TO	O
the	DT	O
G6PD	NNP	O
Mediterranean	NNP	O
(	(	O
188	CD	O
Ser	NNP	O
-	:	O
-	:	O
>	NN	O
Phe	NNP	O
)	)	O
variant	NN	O
.	.	O

The	DT	O
KmNADP	NNP	O
of	IN	O
G6PD	NNP	O
Orissa	NNP	O
is	VBZ	O
fivefold	RB	O
higher	JJR	O
than	IN	O
that	DT	O
of	IN	O
the	DT	O
normal	JJ	O
enzyme	NN	O
.	.	O

This	DT	O
may	MD	O
be	VB	O
due	JJ	O
to	TO	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
alanine	NN	O
residue	NN	O
that	WDT	O
is	VBZ	O
replaced	VBN	O
by	IN	O
glycine	NN	O
is	VBZ	O
part	NN	O
of	IN	O
a	DT	O
putative	JJ	O
coenzyme	NN	O
-	:	O
binding	NN	O
site	NN	O
.	.	O
.	.	O

Evidence	NN	O
for	IN	O
linkage	NN	O
of	IN	O
bipolar	JJ	B_Disease
disorder	NN	E_Disease
to	TO	O
chromosome	VB	O
18	CD	O
with	IN	O
a	DT	O
parent	NN	O
-	:	O
of	IN	O
-	:	O
origin	NN	O
effect	NN	O
.	.	O

A	DT	O
susceptibility	NN	O
gene	NN	O
on	IN	O
chromosome	NN	O
18	CD	O
and	CC	O
a	DT	O
parent	NN	O
-	:	O
of	IN	O
-	:	O
origin	NN	O
effect	NN	O
have	VBP	O
been	VBN	O
suggested	VBN	O
for	IN	O
bipolar	JJ	B_Disease
affective	JJ	I_Disease
disorder	NN	E_Disease
(	(	O
BPAD	NNP	S_Disease
)	)	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
28	CD	O
nuclear	JJ	O
families	NNS	O
selected	VBN	O
for	IN	O
apparent	JJ	O
unilineal	JJ	O
transmission	NN	O
of	IN	O
the	DT	O
BPAD	NNP	S_Disease
phenotype	NN	O
,	,	O
by	IN	O
using	VBG	O
31	CD	O
polymorphic	JJ	O
markers	NNS	O
spanning	VBG	O
chromosome	NN	O
18	CD	O
.	.	O

Evidence	NN	O
for	IN	O
linkage	NN	O
was	VBD	O
tested	VBN	O
with	IN	O
affected	JJ	O
-	:	O
sib	NN	O
-	:	O
pair	NN	O
and	CC	O
LOD	NNP	O
score	VBP	O
methods	NNS	O
under	IN	O
two	CD	O
definitions	NNS	O
of	IN	O
the	DT	O
affected	JJ	O
phenotype	NN	O
.	.	O

The	DT	O
affected	JJ	O
-	:	O
sibpair	NN	O
analyses	NNS	O
indicated	VBD	O
excess	JJ	O
allele	JJ	O
sharing	VBG	O
for	IN	O
markers	NNS	O
on	IN	O
18p	CD	O
within	IN	O
the	DT	O
region	NN	O
reported	VBD	O
previously	RB	O
.	.	O

The	DT	O
greatest	JJS	O
sharing	NN	O
was	VBD	O
at	IN	O
D18S37	NNP	O
64	CD	O
%	NN	O
in	IN	O
bipolar	JJ	O
and	CC	O
recurrent	JJ	O
unipolar	JJ	O
(	(	O
RUP	NNP	O
)	)	O
sib	NN	O
pairs	NNS	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

0006	CD	O
)	)	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
excess	JJ	O
sharing	NN	O
of	IN	O
the	DT	O
paternally	NN	O
,	,	O
but	CC	O
not	RB	O
maternally	RB	O
,	,	O
transmitted	VBD	O
alleles	NNS	O
was	VBD	O
observed	VBN	O
at	IN	O
three	CD	O
markers	NNS	O
on	IN	O
18q	CD	O
at	IN	O
D18S41	NNP	O
,	,	O
51	CD	O
bipolar	NN	O
and	CC	O
RUP	NNP	O
sib	VBP	O
pairs	NNS	O
were	VBD	O
concordant	JJ	O
for	IN	O
paternally	RB	O
transmitted	VBN	O
alleles	NNS	O
,	,	O
and	CC	O
21	CD	O
pairs	NNS	O
were	VBD	O
discordant	JJ	O
(	(	O
P	NNP	O
=	NNP	O
0004	CD	O
)	)	O
.	.	O

The	DT	O
evidence	NN	O
for	IN	O
linkage	NN	O
to	TO	O
loci	VB	O
on	IN	O
both	DT	O
18p	CD	O
and	CC	O
18q	CD	O
was	VBD	O
strongest	VBN	O
in	IN	O
the	DT	O
11	CD	O
paternal	JJ	O
pedigrees	NNS	O
,	,	O
i	NN	O
.	.	O

e	NN	O
e	NN	O
.	.	O
,	,	O
those	DT	O
in	IN	O
which	WDT	O
the	DT	O
father	NN	O
or	CC	O
one	CD	O
of	IN	O
the	DT	O
fathers	NNS	O
sibs	VBP	O
is	VBZ	O
affected	VBN	O
.	.	O

In	IN	O
these	DT	O
pedigrees	NNS	O
,	,	O
the	DT	O
greatest	JJS	O
allele	NN	O
sharing	NN	O
(	(	O
81	CD	O
%	NN	O
;	:	O
P	NNP	O
=	NNP	O
.	.	O

00002	CD	O
)	)	O
and	CC	O
the	DT	O
highest	JJS	O
LOD	JJ	O
score	NN	O
(	(	O
3	CD	O
.	.	O

51	CD	O
;	:	O
phi	NN	O
=	VBZ	O
0	CD	O
.	.	O

0	CD	O
)	)	O
were	VBD	O
observed	VBN	O
at	IN	O
D18S41	NNP	O
.	.	O

Our	PRP$	O
results	NNS	O
provide	VB	O
further	JJ	O
support	NN	O
for	IN	O
linkage	NN	O
of	IN	O
BPAD	NNP	S_Disease
to	TO	O
chromosome	VB	O
18	CD	O
and	CC	O
the	DT	O
first	JJ	O
molecular	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
parent	NN	O
-	:	O
of	IN	O
-	:	O
origin	NN	O
effect	NN	O
operating	VBG	O
in	IN	O
this	DT	O
disorder	NN	O
.	.	O

The	DT	O
number	NN	O
of	IN	O
loci	NN	O
involved	VBN	O
,	,	O
and	CC	O
their	PRP$	O
precise	NN	O
location	NN	O
,	,	O
require	VB	O
further	JJR	O
study	NN	O

A	DT	O
prevalent	JJ	O
mutation	NN	O
for	IN	O
galactosemia	NN	S_Disease
among	IN	O
black	JJ	O
Americans	NNPS	O
.	.	O

OBJECTIVE	NN	O
To	TO	O
define	VB	O
the	DT	O
mutation	NN	O
causing	VBG	O
galactosemia	NN	S_Disease
in	IN	O
patients	NNS	O
of	IN	O
black	JJ	O
American	JJ	O
origin	NN	O
who	WP	O
have	VBP	O
no	DT	O
galactose	JJ	O
-	:	O
1	CD	O
-	:	O
phosphate	NN	O
uridyltransferase	NN	O
(	(	O
GALT	NNP	O
)	)	O
activity	NN	O
in	IN	O
erythrocytes	NNS	O
but	CC	O
good	JJ	O
clinical	JJ	O
outcome	NN	O
.	.	O

METHODS	NNP	O
We	PRP	O
discovered	VBD	O
a	DT	O
mutation	NN	O
caused	VBN	O
by	IN	O
a	DT	O
C	NNP	O
-	:	O
-	:	O
>	NN	O
T	NNP	O
transition	NN	O
at	IN	O
base	NN	O
-	:	O
pair	NN	O
1158	CD	O
of	IN	O
the	DT	O
GALT	NNP	O
gene	NN	O
that	WDT	O
results	NNS	O
in	IN	O
a	DT	O
serine	JJ	O
-	:	O
to	TO	O
-	:	O
leucine	NN	O
substitution	NN	O
at	IN	O
codon	NN	O
135	CD	O
(	(	O
S135L	NNP	O
)	)	O
.	.	O

We	PRP	O
developed	VBD	O
a	DT	O
method	NN	O
with	IN	O
which	WDT	O
to	TO	O
screen	VB	O
populations	NNS	O
for	IN	O
its	PRP$	O
prevalence	NN	O
.	.	O

We	PRP	O
compared	VBN	O
galactose	JJ	O
-	:	O
1	CD	O
-	:	O
phosphate	NN	O
uridyltransferase	NN	O
among	IN	O
erythrocytes	NNS	O
,	,	O
leukocytes	NNS	O
,	,	O
and	CC	O
transformed	VBD	O
lymphoblasts	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
total	JJ	O
body	NN	O
oxidation	NN	O
of	IN	O
D	NNP	O
-	:	O
(	(	O
13C	CD	O
)	)	O
-	:	O
galactose	NN	O
to	TO	O
13CO2	CD	O
among	IN	O
three	CD	O
genotypes	NNS	O
for	IN	O
GALT	NNP	O
(	(	O
S135L	NNP	O
/	NNP	O
S135L	NNP	O
,	,	O
Q188R	NNP	O
/	NNP	O
Q188R	NNP	O
,	,	O
and	CC	O
Normal	NNP	O
/	NNP	O
Normal	NNP	O
)	)	O
.	.	O

RESULTS	NN	O
We	PRP	O
found	VBD	O
a	DT	O
48	CD	O
%	NN	O
prevalence	NN	O
of	IN	O
the	DT	O
S135L	NNP	O
mutation	NN	O
among	IN	O
17	CD	O
black	JJ	O
American	JJ	O
patients	NNS	O
with	IN	O
classic	JJ	B_Disease
galactosemia	NN	E_Disease
and	CC	O
a	DT	O
1	CD	O
%	NN	O
prevalence	NN	O
in	IN	O
a	DT	O
population	NN	O
of	IN	O
50	CD	O
black	JJ	O
Americans	NNPS	O
without	IN	O
galactosemia	NN	S_Disease
.	.	O

The	DT	O
S135L	NNP	O
mutation	NN	O
was	VBD	O
not	RB	O
found	VBN	O
in	IN	O
84	CD	O
white	JJ	O
patients	NNS	O
with	IN	O
G	NNP	O
/	NNP	O
G	NNP	O
galactosemia	NN	S_Disease
nor	CC	O
in	IN	O
87	CD	O
white	JJ	O
control	NN	O
subjects	NNS	O
without	IN	O
galactosemia	NN	S_Disease
.	.	O

We	PRP	O
found	VBD	O
normal	JJ	O
whole	JJ	O
body	NN	O
oxidation	NN	O
of	IN	O
D	NNP	O
-	:	O
(	(	O
13C	CD	O
)	)	O
-	:	O
galactose	NN	O
by	IN	O
the	DT	O
patient	NN	O
homozygous	JJ	O
for	IN	O
S135L	NNP	O
and	CC	O
various	JJ	O
degrees	NNS	O
of	IN	O
enzyme	JJ	O
impairment	NN	O
among	IN	O
different	JJ	O
tissues	NNS	O
.	.	O

CONCLUSIONS	NNP	O
The	DT	O
S135L	NNP	O
mutation	NN	O
in	IN	O
the	DT	O
GALT	NNP	O
gene	NN	O
is	VBZ	O
a	DT	O
prevalent	JJ	O
cause	NN	O
of	IN	O
galactosemia	NN	S_Disease
among	IN	O
black	JJ	O
patients	NNS	O
.	.	O

Because	IN	O
GALT	NNP	O
activity	NN	O
varies	NNS	O
in	IN	O
different	JJ	O
tissues	NNS	O
of	IN	O
patients	NNS	O
homozygous	JJ	O
for	IN	O
S135L	NNP	O
,	,	O
they	PRP	O
may	MD	O
have	VB	O
a	DT	O
better	JJR	O
clinical	JJ	O
outcome	NN	O
than	IN	O
patients	NNS	O
who	WP	O
are	VBP	O
homozygous	JJ	O
for	IN	O
Q188R	NN	O
when	WRB	O
both	DT	O
are	VBP	O
treated	VBN	O
from	IN	O
infancy	NN	O
.	.	O
.	.	O

A	DT	O
high	JJ	O
incidence	NN	O
of	IN	O
BRCA1	NNP	O
mutations	NNS	O
in	IN	O
20	CD	O
breast	NN	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
analyzed	VBN	O
20	CD	O
breast	SYM	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
,	,	O
the	DT	O
majority	NN	O
of	IN	O
which	WDT	O
show	VBP	O
positive	JJ	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
chromosome	VB	O
17q12	CD	O
for	IN	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
.	.	O

BRCA1	NNP	O
mutations	NNS	O
cosegregating	VBG	O
with	IN	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
susceptibility	NN	O
were	VBD	O
identified	VBN	O
in	IN	O
16	CD	O
families	NNS	O
,	,	O
including	VBG	O
1	CD	O
family	NN	O
with	IN	O
a	DT	O
case	NN	O
of	IN	O
male	NN	B_Disease
breast	NN	I_Disease
cancer	NN	E_Disease
.	.	O

Nine	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
have	VBP	O
not	RB	O
been	VBN	O
reported	VBN	O
previously	RB	O
.	.	O

The	DT	O
majority	NN	O
of	IN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
generate	VB	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
leading	VBG	O
to	TO	O
the	DT	O
formation	NN	O
of	IN	O
a	DT	O
truncated	JJ	O
BRCA1	NNP	O
protein	NN	O
of	IN	O
2	CD	O
%	NN	O
-	:	O
88	CD	O
%	NN	O
of	IN	O
the	DT	O
expected	VBN	O
normal	JJ	O
length	NN	O
.	.	O

Two	CD	O
mutations	NNS	O
altered	VBD	O
the	DT	O
RING	NNP	O
finger	NN	O
domain	NN	O
.	.	O

Sequencing	VBG	O
of	IN	O
genomic	JJ	O
DNA	NNP	O
led	VBD	O
to	TO	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
coding	JJ	O
region	NN	O
of	IN	O
BRCA1	NNP	O
in	IN	O
12	CD	O
families	NNS	O
,	,	O
and	CC	O
cDNA	NN	O
analysis	NN	O
revealed	VBD	O
an	DT	O
abnormal	JJ	O
or	CC	O
missing	VBG	O
BRCA1	NNP	O
transcript	NN	O
in	IN	O
4	CD	O
of	IN	O
the	DT	O
8	CD	O
remaining	VBG	O
families	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
eight	CD	O
mutations	NNS	O
were	VBD	O
associated	VBN	O
with	IN	O
a	DT	O
reduced	JJ	O
quantity	NN	O
of	IN	O
BRCA1	NNP	O
transcript	NN	O
.	.	O

We	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
detect	VB	O
BRCA1	NNP	O
mutations	NNS	O
in	IN	O
4	CD	O
of	IN	O
the	DT	O
20	CD	O
families	NNS	O
,	,	O
but	CC	O
only	RB	O
1	CD	O
of	IN	O
these	DT	O
was	VBD	O
clearly	RB	O
linked	VBN	O
to	TO	O
BRCA1	NNP	O
.	.	O

It	PRP	O
is	VBZ	O
expected	VBN	O
that	IN	O
the	DT	O
majority	NN	O
of	IN	O
clear	JJ	O
examples	NNS	O
of	IN	O
the	DT	O
breast	NN	B_Disease
-	:	I_Disease
ovarian	JJ	I_Disease
syndrome	NN	E_Disease
will	MD	O
be	VB	O
associated	VBN	O
with	IN	O
germ	JJ	O
-	:	O
line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
coding	JJ	O
region	NN	O
of	IN	O
BRCA1	NNP	O
.	.	O
.	.	O

Brca1	NNP	B_Disease
deficiency	NN	E_Disease
results	NNS	O
in	IN	O
early	JJ	O
embryonic	JJ	B_Disease
lethality	NN	E_Disease
characterized	VBN	O
by	IN	O
neuroepithelial	JJ	B_Disease
abnormalities	NNS	E_Disease
.	.	O

The	DT	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
susceptibility	NN	O
gene	NN	O
,	,	O
BRCA1	NNP	O
,	,	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
and	CC	O
shown	VBN	O
to	TO	O
encode	VB	O
a	DT	O
zinc	NN	O
-	:	O
finger	NN	O
protein	NN	O
of	IN	O
unknown	JJ	O
function	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
BRCA1	NNP	O
account	NN	O
for	IN	O
at	IN	O
least	JJS	O
80	CD	O
%	NN	O
of	IN	O
families	NNS	O
with	IN	O
both	DT	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
,	,	O
as	RB	O
well	RB	O
as	IN	O
some	DT	O
non	JJ	O
-	:	O
familial	JJ	O
sporadic	JJ	O
ovarian	JJ	B_Disease
cancers	NNS	E_Disease
.	.	O

The	DT	O
loss	NN	O
of	IN	O
wild	JJ	O
-	:	O
type	NN	O
BRCA1	NNP	O
in	IN	O
tumours	NN	S_Disease
of	IN	O
individuals	NNS	O
carrying	VBG	O
one	CD	O
nonfunctional	JJ	O
BRCA1	NNP	O
allele	NN	O
suggests	VBZ	O
that	IN	O
BRCA1	NNP	O
encodes	VBZ	O
a	DT	O
tumour	NN	S_Disease
suppressor	NN	O
that	WDT	O
may	MD	O
inhibit	VB	O
the	DT	O
proliferation	NN	O
of	IN	O
mammary	JJ	O
epithelial	JJ	O
cells	NNS	O
.	.	O

To	TO	O
examine	VB	O
the	DT	O
role	NN	O
of	IN	O
BRCA1	NNP	O
in	IN	O
normal	JJ	O
tissue	NN	O
growth	NN	O
and	CC	O
differentiation	NN	O
,	,	O
and	CC	O
to	TO	O
generate	VB	O
a	DT	O
potential	JJ	O
model	NN	O
for	IN	O
the	DT	O
cancer	NN	S_Disease
susceptibility	NN	O
associated	VBN	O
with	IN	O
loss	NN	O
of	IN	O
BRCA1	NNP	O
function	NN	O
,	,	O
we	PRP	O
have	VBP	O
created	VBN	O
a	DT	O
mouse	NN	O
line	NN	O
carrying	VBG	O
a	DT	O
mutation	NN	O
in	IN	O
one	CD	O
Brca1	NNP	O
allele	NN	O
.	.	O

Analysis	NN	O
of	IN	O
mice	NNS	O
homozygous	JJ	O
for	IN	O
the	DT	O
mutant	JJ	O
allele	NN	O
indicate	VBP	O
that	IN	O
Brca1	NNP	O
is	VBZ	O
critical	JJ	O
for	IN	O
normal	JJ	O
development	NN	O
,	,	O
as	IN	O
these	DT	O
mice	NNS	O
died	VBD	O
in	IN	O
utero	NN	O
between	IN	O
10	CD	O
and	CC	O
13	CD	O
days	NNS	O
of	IN	O
gestation	NN	O
(	(	O
E10	NNP	O
-	:	O
E13	NN	O
)	)	O
.	.	O

Abnormalities	NNS	O
in	IN	O
Brca1	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
embryos	NN	O
were	VBD	O
most	RBS	O
evident	JJ	O
in	IN	O
the	DT	O
neural	JJ	O
tube	NN	O
,	,	O
with	IN	O
40	CD	O
%	NN	O
of	IN	O
the	DT	O
embryos	NN	O
presenting	VBG	O
with	IN	O
varying	VBG	O
degrees	NNS	O
of	IN	O
spina	NN	B_Disease
bifida	NN	E_Disease
and	CC	O
anencephaly	NN	S_Disease
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
neuroepithelium	NN	O
in	IN	O
Brca1	NNP	B_Disease
-	:	I_Disease
deficient	NN	E_Disease
embryos	NN	O
appeared	VBD	O
disorganized	VBN	O
,	,	O
with	IN	O
signs	NNS	O
of	IN	O
both	DT	O
rapid	JJ	O
proliferation	NN	O
and	CC	O
excessive	JJ	O
cell	NN	O
death	NN	O
.	.	O
.	.	O

Identification	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ALD	NNP	O
-	:	O
gene	NN	O
of	IN	O
20	CD	O
families	NNS	O
with	IN	O
adrenoleukodystrophy	NN	S_Disease
/	NNP	O
adrenomyeloneuropathy	NN	S_Disease
.	.	O

Adrenoleukodystrophy	NNP	S_Disease
(	(	O
ALD	NNP	S_Disease
)	)	O
,	,	O
an	DT	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
inherited	JJ	I_Disease
metabolic	JJ	I_Disease
disorder	NN	E_Disease
,	,	O
is	VBZ	O
the	DT	O
most	RBS	O
frequent	JJ	O
inborn	JJ	B_Disease
peroxisomal	JJ	I_Disease
disease	NN	E_Disease
.	.	O

It	PRP	O
leads	VBZ	O
to	TO	O
demyelination	NN	B_Disease
in	IN	I_Disease
the	DT	I_Disease
central	JJ	I_Disease
and	CC	I_Disease
peripheral	JJ	I_Disease
nervous	JJ	I_Disease
system	NN	E_Disease
.	.	O

Defective	JJ	O
beta	NN	O
-	:	O
oxidation	NN	O
of	IN	O
saturated	JJ	O
very	RB	O
long	RB	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
(	(	O
VLCFAs	NNP	O
;	:	O
C22	NNP	O
0	CD	O
-	:	O
C26	NNP	O
0	CD	O
)	)	O
in	IN	O
peroxisomes	NN	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
lead	VB	O
to	TO	O
an	DT	O
accumulation	NN	O
of	IN	O
VLCFAs	NNP	O
in	IN	O
leukoid	JJ	O
areas	NNS	O
of	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
peripheral	JJ	O
nerves	NNS	O
,	,	O
adrenal	JJ	O
gland	NN	O
,	,	O
and	CC	O
blood	NN	O
.	.	O

The	DT	O
ALD	NNP	S_Disease
gene	NN	O
has	VBZ	O
been	VBN	O
recently	RB	O
identified	VBN	O
and	CC	O
encodes	VBZ	O
a	DT	O
745	CD	O
-	:	O
amino	NN	O
-	:	O
acid	NN	O
protein	NN	O
.	.	O

We	PRP	O
screened	VBD	O
patients	NNS	O
with	IN	O
adrenoleukodystrophy	NN	S_Disease
/	NN	O
adrenomyeloneuropathy	NN	S_Disease
(	(	O
ALD	NNP	S_Disease
/	NNP	O
AMN	NNP	S_Disease
)	)	O
from	IN	O
20	CD	O
kindreds	NNS	O
for	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ALD	NNP	S_Disease
gene	NN	O
.	.	O

Eleven	NNP	O
missense	NN	O
and	CC	O
two	CD	O
nonsense	JJ	O
mutations	NNS	O
,	,	O
five	CD	O
deletions	NNS	O
,	,	O
and	CC	O
one	CD	O
insertion	NN	O
were	VBD	O
detected	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
of	IN	O
eight	CD	O
reverse	NNS	O
transcribed	VBD	O
fragments	NNS	O
of	IN	O
the	DT	O
ALD	NNP	S_Disease
-	:	O
gene	NN	O
mRNA	NN	O
.	.	O

Four	CD	O
mutations	NNS	O
could	MD	O
be	VB	O
shown	VBN	O
to	TO	O
be	VB	O
de	FW	O
novo	FW	O
.	.	O

All	DT	O
mutations	NNS	O
could	MD	O
be	VB	O
confirmed	VBN	O
in	IN	O
carriers	NNS	O
by	IN	O
sequencing	VBG	O
genomic	JJ	O
DNA	NN	O
.	.	O

No	DT	O
correlation	NN	O
between	IN	O
the	DT	O
type	NN	O
of	IN	O
mutation	NN	O
and	CC	O
the	DT	O
severity	NN	O
of	IN	O
the	DT	O
phenotype	NN	O
could	MD	O
be	VB	O
observed	VBN	O
.	.	O

The	DT	O
mutations	NNS	O
were	VBD	O
not	RB	O
detected	VBN	O
in	IN	O
the	DT	O
ALD	NNP	S_Disease
gene	NN	O
of	IN	O
30	CD	O
healthy	JJ	O
persons	NNS	O
.	.	O
.	.	O

The	DT	O
murine	NN	O
homolog	NN	O
of	IN	O
the	DT	O
human	JJ	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
susceptibility	NN	O
gene	NN	O
Brca1	NNP	O
maps	NNS	O
to	TO	O
mouse	VB	O
chromosome	NN	O
11D	CD	O
.	.	O

The	DT	O
recently	RB	O
cloned	VBN	O
human	JJ	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
susceptibility	NN	O
gene	NN	O
,	,	O
BRCA1	NNP	O
,	,	O
is	VBZ	O
located	VBN	O
on	IN	O
human	JJ	O
chromosome	NN	O
17q21	CD	O
.	.	O

We	PRP	O
have	VBP	O
isolated	VBN	O
murine	JJ	O
genomic	JJ	O
clones	NNS	O
containing	VBG	O
Brca1	NNP	O
as	IN	O
a	DT	O
first	JJ	O
step	NN	O
in	IN	O
generating	VBG	O
a	DT	O
mouse	NN	O
model	NN	O
for	IN	O
the	DT	O
loss	NN	O
of	IN	O
BRCA1	NNP	O
function	NN	O
.	.	O

A	DT	O
mouse	NN	O
genomic	JJ	O
library	NN	O
was	VBD	O
screened	VBN	O
using	VBG	O
probes	NNS	O
corresponding	VBG	O
to	TO	O
exon	VB	O
11	CD	O
of	IN	O
the	DT	O
human	JJ	O
BRCA1	NNP	O
gene	NN	O
.	.	O

Two	CD	O
overlapping	VBG	O
mouse	NN	O
clones	NNS	O
were	VBD	O
identified	VBN	O
that	IN	O
hybridized	VBD	O
to	TO	O
human	JJ	O
BRCA1	NNP	O
exons	NNS	O
9	CD	O
-	:	O
12	CD	O
.	.	O

Sequence	NNP	O
analysis	NN	O
of	IN	O
1	CD	O
.	.	O

4	CD	O
kb	NN	O
of	IN	O
the	DT	O
region	NN	O
of	IN	O
these	DT	O
clones	NNS	O
corresponding	VBG	O
to	TO	O
part	NN	O
of	IN	O
human	JJ	O
exon	FW	O
11	CD	O
revealed	VBD	O
72	CD	O
%	NN	O
nucleic	JJ	O
acid	JJ	O
identity	NN	O
but	CC	O
only	RB	O
50	CD	O
%	NN	O
amino	NN	O
acid	NN	O
identity	NN	O
with	IN	O
the	DT	O
human	JJ	O
gene	NN	O
.	.	O

The	DT	O
longest	JJS	O
of	IN	O
the	DT	O
mouse	NN	O
Brca1	NNP	O
genomic	JJ	O
clones	NNS	O
maps	NNS	O
to	TO	O
chromosome	VB	O
11D	CD	O
,	,	O
as	IN	O
determined	VBN	O
by	IN	O
two	CD	O
-	:	O
color	NN	O
fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
.	.	O

The	DT	O
synteny	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
17	CD	O
was	VBD	O
confirmed	VBN	O
by	IN	O
cohybridization	NN	O
with	IN	O
the	DT	O
mouse	NN	O
probe	NN	O
for	IN	O
the	DT	O
NF1	NNP	O
-	:	O
gene	NN	O
.	.	O

This	DT	O
comparative	JJ	O
study	NN	O
confirms	VBZ	O
that	IN	O
the	DT	O
relative	JJ	O
location	NN	O
of	IN	O
the	DT	O
BRCA1	NNP	O
gene	NN	O
has	VBZ	O
been	VBN	O
conserved	VBN	O
between	IN	O
mice	NNS	O
and	CC	O
humans	NNS	O
.	.	O

Atelosteogenesis	NNP	B_Disease
type	NN	I_Disease
II	NNP	E_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
diastrophic	JJ	B_Disease
dysplasia	NN	E_Disease
sulfate	NN	O
-	:	O
transporter	NN	O
gene	NN	O
(	(	O
DTDST	NNP	O
)	)	O
:	:	O
evidence	NN	O
for	IN	O
a	DT	O
phenotypic	NN	O
series	NN	O
involving	VBG	O
three	CD	O
chondrodysplasias	NNS	S_Disease
.	.	O

Atelosteogenesis	NNP	B_Disease
type	NN	I_Disease
II	NNP	E_Disease
(	(	O
AO	NNP	B_Disease
II	NNP	E_Disease
)	)	O
is	VBZ	O
a	DT	O
neonatally	RB	O
lethal	JJ	O
chondrodysplasia	NN	S_Disease
whose	WP$	O
clinical	JJ	O
and	CC	O
histological	JJ	O
characteristics	NNS	O
resemble	VBP	O
those	DT	O
of	IN	O
another	DT	O
chondrodysplasia	NN	S_Disease
,	,	O
the	DT	O
much	RB	O
less	RBR	O
severe	JJ	O
diastrophic	JJ	B_Disease
dysplasia	NN	E_Disease
(	(	O
DTD	NNP	S_Disease
)	)	O
.	.	O

The	DT	O
similarity	NN	O
suggests	VBZ	O
a	DT	O
shared	VBN	O
pathogenesis	NN	O
involving	VBG	O
lesions	NNS	O
in	IN	O
the	DT	O
same	JJ	O
biochemical	JJ	O
pathway	NN	O
and	CC	O
perhaps	RB	O
the	DT	O
same	JJ	O
gene	NN	O
.	.	O

DTD	NNP	S_Disease
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
recently	RB	O
identified	VBN	O
diastrophic	JJ	B_Disease
dysplasia	NN	E_Disease
sulfate	NN	O
-	:	O
transporter	NN	O
gene	NN	O
(	(	O
DTDST	NNP	O
)	)	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
that	DT	O
AOII	NNP	S_Disease
patients	NNS	O
also	RB	O
have	VBP	O
DTDST	NNP	O
mutations	NNS	O
,	,	O
which	WDT	O
lead	VBP	O
to	TO	O
defective	JJ	O
uptake	NN	O
of	IN	O
inorganic	JJ	O
sulfate	NN	O
and	CC	O
insufficient	JJ	O
sulfation	NN	O
of	IN	O
macromolecules	NNS	O
by	IN	O
patient	JJ	O
mesenchymal	JJ	O
cells	NNS	O
in	IN	O
vitro	NN	O
.	.	O

Together	RB	O
with	IN	O
our	PRP$	O
recent	JJ	O
observation	NN	O
that	IN	O
a	DT	O
third	JJ	O
even	RB	O
more	RBR	O
severe	JJ	O
chondrodysplasia	NN	S_Disease
,	,	O
achondrogenesis	NN	O
type	NN	O
IB	NNP	O
,	,	O
is	VBZ	O
also	RB	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
DTDST	NNP	O
,	,	O
these	DT	O
results	NNS	O
demonstrate	VBP	O
a	DT	O
phenotypic	NN	O
series	NN	O
of	IN	O
three	CD	O
chondrodysplasias	NNS	S_Disease
of	IN	O
increasing	VBG	O
severity	NN	O
caused	VBN	O
by	IN	O
lesions	NNS	O
in	IN	O
a	DT	O
single	JJ	O
sulfate	NN	O
-	:	O
transporter	NN	O
gene	NN	O
.	.	O

The	DT	O
severity	NN	O
of	IN	O
the	DT	O
phenotype	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
correlated	VBN	O
with	IN	O
the	DT	O
predicted	JJ	O
effect	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
on	IN	O
the	DT	O
residual	JJ	O
activity	NN	O
of	IN	O
the	DT	O
DTDST	NNP	O
protein	NN	O
.	.	O
.	.	O

Haplotype	NNP	O
and	CC	O
phenotype	JJ	O
analysis	NN	O
of	IN	O
six	CD	O
recurrent	JJ	O
BRCA1	NNP	O
mutations	NNS	O
in	IN	O
61	CD	O
families	NNS	O
:	:	O
results	NNS	O
of	IN	O
an	DT	O
international	JJ	O
study	NN	O
.	.	O

Several	JJ	O
BRCA1	NNP	O
mutations	NNS	O
have	VBP	O
now	RB	O
been	VBN	O
found	VBN	O
to	TO	O
occur	VB	O
in	IN	O
geographically	RB	O
diverse	JJ	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
.	.	O

To	TO	O
investigate	VB	O
mutation	NN	O
origin	NN	O
and	CC	O
mutation	NN	O
-	:	O
specific	JJ	O
phenotypes	NNS	O
due	JJ	O
to	TO	O
BRCA1	NNP	O
,	,	O
we	PRP	O
constructed	VBD	O
a	DT	O
haplotype	NN	O
of	IN	O
nine	CD	O
polymorphic	JJ	O
markers	NNS	O
within	IN	O
or	CC	O
immediately	RB	O
flanking	VBG	O
the	DT	O
BRCA1	NNP	O
locus	NN	O
in	IN	O
a	DT	O
set	NN	O
of	IN	O
61	CD	O
breast	NN	B_Disease
/	JJ	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
families	NNS	O
selected	VBN	O
for	IN	O
having	VBG	O
one	CD	O
of	IN	O
six	CD	O
recurrent	JJ	O
BRCA1	NNP	O
mutations	NNS	O
.	.	O

Tests	NNS	O
of	IN	O
both	DT	O
mutations	NNS	O
and	CC	O
family	NN	O
-	:	O
specific	JJ	O
differences	NNS	O
in	IN	O
age	NN	O
at	IN	O
diagnosis	NN	O
were	VBD	O
not	RB	O
significant	JJ	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
the	DT	O
six	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
relative	JJ	O
proportions	NNS	O
of	IN	O
cases	NNS	O
of	IN	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
was	VBD	O
suggestive	JJ	O
of	IN	O
an	DT	O
effect	NN	O
(	(	O
P	NNP	O
=	NNP	O
.	.	O

069	CD	O
)	)	O
,	,	O
with	IN	O
57	CD	O
%	NN	O
of	IN	O
women	NNS	O
presumed	VBN	O
affected	JJ	O
because	IN	O
of	IN	O
the	DT	O
1294	CD	O
del	NN	O
40	CD	O
BRCA1	NNP	O
mutation	NN	O
having	VBG	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
,	,	O
compared	VBN	O
with	IN	O
14	CD	O
%	NN	O
of	IN	O
affected	JJ	O
women	NNS	O
with	IN	O
the	DT	O
splice	NN	O
-	:	O
site	NN	O
mutation	NN	O
in	IN	O
intron	NN	O
5	CD	O
of	IN	O
BRCA1	NNP	O
.	.	O

For	IN	O
the	DT	O
BRCA1	NNP	O
mutations	NNS	O
studied	VBD	O
here	RB	O
,	,	O
the	DT	O
individual	JJ	O
mutations	NNS	O
are	VBP	O
estimated	VBN	O
to	TO	O
have	VB	O
arisen	VBN	O
9	CD	O
-	:	O
170	CD	O
generations	NNS	O
ago	RB	O
.	.	O

In	IN	O
general	JJ	O
,	,	O
a	DT	O
high	JJ	O
degree	NN	O
of	IN	O
haplotype	NN	O
conservation	NN	O
across	IN	O
the	DT	O
region	NN	O
was	VBD	O
observed	VBN	O
,	,	O
with	IN	O
haplotype	JJ	O
differences	NNS	O
most	RBS	O
often	RB	O
due	JJ	O
to	TO	O
mutations	NNS	O
in	IN	O
the	DT	O
short	JJ	O
-	:	O
tandem	NN	O
-	:	O
repeat	NN	O
markers	NNS	O
,	,	O
although	IN	O
some	DT	O
likely	JJ	O
instances	NNS	O
of	IN	O
recombination	NN	O
also	RB	O
were	VBD	O
observed	VBN	O
.	.	O

For	IN	O
several	JJ	O
of	IN	O
the	DT	O
instances	NNS	O
,	,	O
there	EX	O
was	VBD	O
evidence	NN	O
for	IN	O
multiple	JJ	O
,	,	O
independent	JJ	O
,	,	O
BRCA1	NNP	O
mutational	JJ	O
events	NNS	O
.	.	O

Isolation	NN	O
of	IN	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
BRCA1	NNP	O
and	CC	O
genetic	JJ	O
mapping	NN	O
to	TO	O
mouse	VB	O
chromosome	NN	O
11	CD	O
.	.	O

The	DT	O
BRCA1	NNP	O
gene	NN	O
is	VBZ	O
in	IN	O
large	JJ	O
part	NN	O
responsible	JJ	O
for	IN	O
hereditary	JJ	B_Disease
human	JJ	I_Disease
breast	NN	I_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
the	DT	O
isolation	NN	O
of	IN	O
the	DT	O
murine	NN	O
Brca1	NNP	O
homologue	NN	O
cDNA	NN	O
clones	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
identified	VBD	O
genomic	JJ	O
P1	NNP	O
clones	NNS	O
that	WDT	O
contain	VBP	O
most	RBS	O
,	,	O
if	IN	O
not	RB	O
all	DT	O
,	,	O
of	IN	O
the	DT	O
mouse	NN	O
Brca1	NNP	O
locus	NN	O
.	.	O

DNA	NN	O
sequence	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
mouse	NN	O
and	CC	O
human	JJ	O
coding	NN	O
regions	NNS	O
are	VBP	O
75	CD	O
%	NN	O
identical	JJ	O
at	IN	O
the	DT	O
nucleotide	JJ	O
level	NN	O
while	IN	O
the	DT	O
predicted	JJ	O
amino	NN	O
acid	NN	O
identity	NN	O
is	VBZ	O
only	RB	O
58	CD	O
%	NN	O
.	.	O

A	DT	O
DNA	NN	O
sequence	NN	O
variant	NN	O
in	IN	O
the	DT	O
Brca1	NNP	O
locus	NN	O
was	VBD	O
identified	VBN	O
and	CC	O
used	VBN	O
to	TO	O
map	VB	O
this	DT	O
gene	NN	O
on	IN	O
a	DT	O
(	(	O
Mus	NNP	O
m	NN	O
.	.	O

musculus	NN	O
Czech	NNP	O
II	NNP	O
x	NNP	O
C57BL	NNP	O
/	NNP	O
KsJ	NNP	O
)	)	O
F1	NNP	O
x	NNP	O
C57BL	NNP	O
/	NNP	O
KsJ	NNP	O
intersubspecific	JJ	O
backcross	NN	O
to	TO	O
distal	VB	O
mouse	NN	O
chromosome	NN	O
11	CD	O
.	.	O

The	DT	O
mapping	NN	O
of	IN	O
this	DT	O
gene	NN	O
to	TO	O
a	DT	O
region	NN	O
highly	RB	O
syntenic	JJ	O
with	IN	O
human	JJ	O
chromosome	NN	O
17	CD	O
,	,	O
coupled	VBN	O
with	IN	O
Southern	NNP	O
and	CC	O
Northern	NNP	O
analyses	NNS	O
,	,	O
confirms	NNS	O
that	IN	O
we	PRP	O
isolated	VBD	O
the	DT	O
murine	NN	O
Brca1	NNP	O
homologue	NN	O
rather	RB	O
than	IN	O
a	DT	O
related	JJ	O
RING	NN	O
finger	NN	O
gene	NN	O
.	.	O

The	DT	O
isolation	NN	O
of	IN	O
the	DT	O
mouse	NN	O
Brca1	NNP	O
homologue	NN	O
will	MD	O
facilitate	VB	O
the	DT	O
creation	NN	O
of	IN	O
mouse	NN	O
models	NNS	O
for	IN	O
germline	JJ	O
BRCA1	NNP	B_Disease
defects	NNS	E_Disease
.	.	O
.	.	O

Emerin	NNP	B_Disease
deficiency	NN	E_Disease
at	IN	O
the	DT	O
nuclear	JJ	O
membrane	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Emery	NNP	B_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
STA	NNP	O
gene	NN	O
at	IN	O
the	DT	O
Xq28	NNP	O
locus	NN	O
have	VBP	O
been	VBN	O
found	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
X	NNP	B_Disease
-	:	I_Disease
linked	VBN	I_Disease
Emery	NNP	I_Disease
-	:	I_Disease
Dreifuss	NNP	I_Disease
muscular	JJ	I_Disease
dystrophy	NN	E_Disease
(	(	O
EDMD	NNP	S_Disease
)	)	O
.	.	O

This	DT	O
gene	NN	O
encodes	VBZ	O
a	DT	O
hitherto	JJ	O
unknown	JJ	O
protein	NN	O
named	VBN	O
emerin	NN	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
subcellular	JJ	O
localization	NN	O
of	IN	O
emerin	NN	O
,	,	O
we	PRP	O
raised	VBD	O
two	CD	O
antisera	NN	O
against	IN	O
synthetic	JJ	O
peptide	NN	O
fragments	NNS	O
predicted	VBD	O
from	IN	O
emerin	JJ	O
cDNA	NN	O
.	.	O

Using	VBG	O
both	DT	O
antisera	NN	O
,	,	O
we	PRP	O
found	VBD	O
positive	JJ	O
nuclear	JJ	O
membrane	NN	O
staining	VBG	O
in	IN	O
skeletal	JJ	O
,	,	O
cardiac	JJ	O
and	CC	O
smooth	JJ	O
muscles	NNS	O
in	IN	O
the	DT	O
normal	JJ	O
controls	NNS	O
and	CC	O
in	IN	O
patients	NNS	O
with	IN	O
neuromuscular	JJ	B_Disease
diseases	NNS	E_Disease
other	JJ	O
than	IN	O
EDMD	NNP	S_Disease
.	.	O

In	IN	O
contrast	NN	O
,	,	O
a	DT	O
deficiency	NN	O
in	IN	O
immunofluorescent	JJ	O
staining	NN	O
of	IN	O
skeletal	JJ	O
and	CC	O
cardiac	JJ	O
muscle	NN	O
from	IN	O
EDMD	NNP	S_Disease
patients	NNS	O
was	VBD	O
observed	VBN	O
.	.	O

A	DT	O
34	CD	O
kD	NN	O
protein	NN	O
is	VBZ	O
immunoreactive	JJ	O
with	IN	O
the	DT	O
antisera	NN	O
-	:	O
-	:	O
the	DT	O
protein	NN	O
is	VBZ	O
equivalent	JJ	O
to	TO	O
that	DT	O
predicted	VBN	O
for	IN	O
emerin	NN	O
.	.	O

Together	RB	O
,	,	O
our	PRP$	O
findings	NNS	O
suggest	VBP	O
the	DT	O
specific	JJ	O
deficiency	NN	B_Disease
of	IN	I_Disease
emerin	NN	E_Disease
in	IN	O
the	DT	O
nuclear	JJ	O
membrane	NN	O
of	IN	O
muscle	NN	O
cells	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
EDMD	NNP	S_Disease
.	.	O
.	.	O

Growth	NNP	B_Disease
retardation	NN	E_Disease
and	CC	O
tumour	JJ	S_Disease
inhibition	NN	O
by	IN	O
BRCA1	NNP	O
.	.	O

Inherited	VBN	O
mutations	NNS	O
in	IN	O
BRCA1	NNP	O
predispose	NN	O
to	TO	O
breast	VB	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
,	,	O
but	CC	O
the	DT	O
role	NN	O
of	IN	O
BRCA1	NNP	O
in	IN	O
sporadic	JJ	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
has	VBZ	O
previously	RB	O
been	VBN	O
elusive	JJ	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
retroviral	JJ	O
transfer	NN	O
of	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
BRCA1	NNP	O
gene	NN	O
inhibits	NNS	O
growth	NN	O
in	IN	O
vitro	NN	O
of	IN	O
all	DT	O
breast	NN	B_Disease
and	CC	I_Disease
ovarian	JJ	I_Disease
cancer	NN	E_Disease
cell	NN	O
lines	NNS	O
tested	VBN	O
,	,	O
but	CC	O
not	RB	O
colon	NN	B_Disease
or	CC	I_Disease
lung	NN	I_Disease
cancer	NN	E_Disease
cells	NNS	O
or	CC	O
fibroblasts	NNS	O
.	.	O

Mutant	NNP	O
BRCA1	NNP	O
has	VBZ	O
no	DT	O
effect	NN	O
on	IN	O
growth	NN	O
of	IN	O
breast	NN	B_Disease
cancer	NN	E_Disease
cells	NNS	O
;	:	O
ovarian	JJ	B_Disease
cancer	NN	E_Disease
cell	NN	O
growth	NN	O
is	VBZ	O
not	RB	O
affected	VBN	O
by	IN	O
BRCA1	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
5	CD	O
portion	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
but	CC	O
is	VBZ	O
inhibited	VBN	O
by	IN	O
3	CD	O
BRCA1	NNP	O
mutations	NNS	O
.	.	O

Development	NNP	O
of	IN	O
MCF	NNP	B_Disease
-	:	I_Disease
7	CD	I_Disease
tumours	NNS	E_Disease
in	IN	O
nude	JJ	O
mice	NN	O
is	VBZ	O
inhibited	VBN	O
when	WRB	O
MCF	NNP	O
-	:	O
7	CD	O
cells	NNS	O
are	VBP	O
transfected	VBN	O
with	IN	O
wild	JJ	O
-	:	O
type	NN	O
,	,	O
but	CC	O
not	RB	O
mutant	JJ	O
,	,	O
BRCA1	NNP	O
.	.	O

Most	JJS	O
importantly	RB	O
,	,	O
among	IN	O
mice	NN	O
with	IN	O
established	VBN	O
MCF	NNP	B_Disease
-	:	I_Disease
7	CD	I_Disease
tumours	NNS	E_Disease
,	,	O
peritoneal	JJ	O
treatment	NN	O
with	IN	O
a	DT	O
retroviral	JJ	O
vector	NN	O
expressing	VBG	O
wild	JJ	O
-	:	O
type	NN	O
BRCA1	NNP	O
significantly	RB	O
inhibits	VBZ	O
tumour	JJ	S_Disease
growth	NN	O
and	CC	O
increased	VBD	O
survival	NN	O
.	.	O
.	.	O

